PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Powell, LW; Seckington, RC; Deugnier, Y				Powell, Lawrie W.; Seckington, Rebecca C.; Deugnier, Yves			Haemochromatosis	LANCET			English	Review							HEPATIC IRON OVERLOAD; LONG-TERM SURVIVAL; HEREDITARY HEMOCHROMATOSIS; GENETIC HEMOCHROMATOSIS; LIVER-TRANSPLANTATION; SERUM FERRITIN; HFE MUTATIONS; TRANSFERRIN SATURATION; NATURAL-HISTORY; MODIFIER GENE	Haemochromatosis is now known to be an iron-storage disease with genetic heterogeneity but with a final common metabolic pathway resulting in inappropriately low production of the hormone hepcidin. This leads to increase in intestinal absorption and deposition of excessive amounts of iron in parenchymal cells which in turn results in eventual tissue damage and organ failure. A clinical enigma has been the variable clinical expression with some patients presenting with hepatic cirrhosis at a young age and others almost asymptomatic for life. Research is unravelling this puzzle by identifying environmental factors-especially alcohol consumption-and associated modifying genes that modulate phenotypic expression. A high index of suspicion is required for early diagnosis but this can lead to presymptomatic therapy and a normal life expectancy. Venesection (phlebotomy) therapy remains the mainstay of therapy, but alternative therapies are the subject of current research.	[Powell, Lawrie W.] Royal Brisbane & Womens Hosp, Ctr Adv Clin Res, Brisbane, Qld, Australia; [Seckington, Rebecca C.] Univ Queensland, Fac Med & Biomed Sci, Brisbane, Qld, Australia; [Deugnier, Yves] Univ Hosp, Rennes, France; [Deugnier, Yves] Univ Rennes 1, Rennes, France	Royal Brisbane & Women's Hospital; University of Queensland; CHU Rennes; Universite de Rennes	Powell, LW (corresponding author), Royal Brisbane & Womens Hosp, Ctr Adv Clin Res, Brisbane, Qld, Australia.; Powell, LW (corresponding author), Univ Queensland, Brisbane, Qld 4029, Australia.	lawrie.powell@qimrberghofer.edu.au	Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899				Acton RT, 2006, DIABETES CARE, V29, P2084, DOI 10.2337/dc05-1592; Adams P, 2000, J HEPATOL, V33, P487, DOI 10.1016/S0168-8278(01)80874-6; Adams PC, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2007.02.027; Adams PC, 1996, HEPATOLOGY, V23, P724, DOI 10.1002/hep.510230411; Adams PC, 1998, CLIN GENET, V53, P176; Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; ADAMS PC, 1991, GASTROENTEROLOGY, V101, P368, DOI 10.1016/0016-5085(91)90013-B; Aguilar-Martinez P, 2010, HAEMATOL-HEMATOL J, V95, P551, DOI 10.3324/haematol.2009.014431; Ajioka RS, 2008, BLOOD, V112, P4723, DOI 10.1182/blood-2008-02-138222; Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Andersen RV, 2004, BLOOD, V103, P2914, DOI 10.1182/blood-2003-10-3564; Asberg A, 2001, SCAND J GASTROENTERO, V36, P1108; Asberg A, 2002, SCAND J GASTROENTERO, V37, P719, DOI 10.1080/00365520212510; BACON BR, 1990, HEPATOLOGY, V11, P127, DOI 10.1002/hep.1840110122; Bacon BR, 2011, HEPATOLOGY, V54, P328, DOI 10.1002/hep.24330; Bacon Bruce R., 1999, Gastroenterology, V116, P193, DOI 10.1016/S0016-5085(99)70244-1; Bardou-Jacquet E, 2015, HEPATOLOGY, V62, P1917, DOI 10.1002/hep.27854; Bardou-Jacquet E, 2015, J HEPATOL, V62, P682, DOI 10.1016/j.jhep.2014.10.025; Bardou-Jacquet E, 2014, HEPATOLOGY, V59, P839, DOI 10.1002/hep.26570; Barton JC, 2010, EUR J HAEMATOL, V85, P439, DOI 10.1111/j.1600-0609.2010.01511.x; Barton JC, 1998, ANN INTERN MED, V129, P932, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00003; Benyamin B, NAT COMMUN; Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Besson-Fournier C, 2016, HEPATOLOGY, V63, P2054, DOI 10.1002/hep.28259; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; BISMUTH M, 2005, PRISE CHARGE HEMOCHR; Bonkovsky HL, 1999, J HEPATOL, V31, P421, DOI 10.1016/S0168-8278(99)80032-4; Bridle KR, 2006, ALCOHOL CLIN EXP RES, V30, P106, DOI 10.1111/j.1530-0277.2006.00002.x; Brissot P, 2008, BLOOD REV, V22, P195, DOI 10.1016/j.blre.2008.03.001; Cade JE, 2005, AM J CLIN NUTR, V82, P813, DOI 10.1093/ajcn/82.4.813; COSTA-MATOS Luís, 2013, Arq. Gastroenterol., V50, P35, DOI 10.1590/S0004-28032013000100008; Cotler SJ, 1998, J HEPATOL, V29, P257, DOI 10.1016/S0168-8278(98)80011-1; Crawford DHG, 2009, HEPATOLOGY, V49, P418, DOI 10.1002/hep.22650; Crawford DHG, 2004, HEPATOLOGY, V39, P1655, DOI 10.1002/hep.20242; Dar FS, 2009, TRANSPL INT, V22, P717, DOI 10.1111/j.1432-2277.2009.00863.x; de Tayrac M, 2015, J HEPATOL, V62, P664, DOI 10.1016/j.jhep.2014.10.017; Delatycki BM, 2004, GENET TEST, V8, P98; Delatycki MB, 2015, J HEPATOL, V63, P282, DOI 10.1016/j.jhep.2015.03.028; Desmet VJ, 2005, DIGEST LIVER DIS, V37, P909, DOI 10.1016/j.dld.2005.08.007; Desmet VJ, 2004, J HEPATOL, V40, P860, DOI 10.1016/j.jhep.2004.03.007; Deugnier Y, 1997, AM J SURG PATHOL, V21, P669, DOI 10.1097/00000478-199706000-00007; Deugnier Y, 2002, BRIT J HAEMATOL, V118, P1170, DOI 10.1046/j.1365-2141.2002.03718.x; Deugnier Yves, 2008, Expert Rev Gastroenterol Hepatol, V2, P531, DOI 10.1586/17474124.2.4.531; Diwakaran HH, 2002, J HEPATOL, V36, P687, DOI 10.1016/S0168-8278(02)00018-1; Drakesmith H, 2005, BLOOD, V106, P1092, DOI 10.1182/blood-2005-02-0561; Duquenne M, 1996, OSTEOPOROSIS INT, V6, P338, DOI 10.1007/BF01623396; EYRES KS, 1992, BONE, V13, P431, DOI 10.1016/8756-3282(92)90086-C; Falize L, 2006, HEPATOLOGY, V44, P472, DOI 10.1002/hep.21260; Fletcher LM, 1999, J GASTROEN HEPATOL, V14, P202, DOI 10.1046/j.1440-1746.1999.01836.x; Fletcher LM, 2002, GASTROENTEROLOGY, V122, P281, DOI 10.1053/gast.2002.30992; Fracanzani AL, 2010, HEPATOLOGY, V51, P501, DOI 10.1002/hep.23333; Franchini M, 2008, HEPATOL INT, V2, P335, DOI 10.1007/s12072-008-9076-z; Gan EK, 2011, SEMIN LIVER DIS, V31, P293, DOI 10.1055/s-0031-1286060; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; George DK, 1998, GASTROENTEROLOGY, V114, P311, DOI 10.1016/S0016-5085(98)70482-2; Guggenbuhl P, 2005, OSTEOPOROSIS INT, V16, P1809, DOI 10.1007/s00198-005-1934-0; Guggenbuhl P, 2011, BEST PRACT RES CL RH, V25, P649, DOI 10.1016/j.berh.2011.10.014; Gurrin LC, 2009, HEPATOLOGY, V50, P94, DOI 10.1002/hep.22972; Gurrin LC, 2008, GASTROENTEROLOGY, V135, P1945, DOI 10.1053/j.gastro.2008.08.056; Guyader D, 1998, GASTROENTEROLOGY, V115, P929, DOI 10.1016/S0016-5085(98)70265-3; Guyader D, 1999, AM J GASTROENTEROL, V94, P1083; Harrison-Findik DD, 2007, HEPATOLOGY, V46, P1979, DOI 10.1002/hep.21895; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Jackson HA, 2001, BRIT J HAEMATOL, V114, P474, DOI 10.1046/j.1365-2141.2001.02949.x; Jacolot S, 2004, BLOOD, V103, P2835, DOI 10.1182/blood-2003-10-3366; Kaltwasser JP, 1998, GUT, V43, P699, DOI 10.1136/gut.43.5.699; KASPER D, 2015, HARRIONS PRINCIPLES; Kono S, 2012, CURR DRUG TARGETS, V13, P1190, DOI 10.2174/138945012802002320; Kowdley K V, 1995, Liver Transpl Surg, V1, P237, DOI 10.1002/lt.500010408; Kowdley KV, 2005, GASTROENTEROLOGY, V129, P494, DOI 10.1053/j.gastro.2005.05.004; Le Gac G, 2004, HUM MOL GENET, V13, P1913, DOI 10.1093/hmg/ddh206; Legros L, 2015, LIVER INT, V35, P1731, DOI 10.1111/liv.12762; LOREAL O, 1992, J HEPATOL, V16, P122, DOI 10.1016/S0168-8278(05)80104-7; Ludwig J, 1997, GASTROENTEROLOGY, V112, P882, DOI 10.1053/gast.1997.v112.pm9041250; McLaren CE, 1998, GASTROENTEROLOGY, V114, P543, DOI 10.1016/S0016-5085(98)70538-4; McLaren CE, 2015, HEPATOLOGY, V62, P429, DOI 10.1002/hep.27711; Merryweather-Clarke AT, 1998, BRIT J HAEMATOL, V101, P369, DOI 10.1046/j.1365-2141.1998.00736.x; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Milet J, 2007, AM J HUM GENET, V81, P799, DOI 10.1086/520001; Milet J, 2010, BLOOD CELL MOL DIS, V44, P34, DOI 10.1016/j.bcmd.2009.10.001; Milward EA, 2008, MAYO CLIN PROC, V83, P543, DOI 10.4065/83.5.543; Miyajima H, 2015, NEUROPATHOLOGY, V35, P83, DOI 10.1111/neup.12149; Moretti D, 2013, AM J CLIN NUTR, V98, P468, DOI 10.3945/ajcn.112.048264; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004; NIENHUIS AW, 1981, NEW ENGL J MED, V304, P170, DOI 10.1056/NEJM198101153040311; O'Neil J, 2005, SEMIN LIVER DIS, V25, P381, DOI 10.1055/s-2005-923310; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Olynyk JK, 2004, MAYO CLIN PROC, V79, P309, DOI 10.4065/79.3.309; Olynyk JK, 2008, HEPATOLOGY, V48, P991, DOI 10.1002/hep.22507; Ong SY, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008938; Osborne NJ, 2010, HEPATOLOGY, V51, P1311, DOI 10.1002/hep.23448; Pelucchi S, 2012, HAEMATOL-HEMATOL J, V97, P1818, DOI 10.3324/haematol.2012.062661; Phatak P, 2010, HEPATOLOGY, V52, P1671, DOI 10.1002/hep.23879; Pietrangelo A, 2010, J HEPATOL, V53, P3, DOI 10.1016/j.jhep.2010.03.001; Piperno A, 2000, GASTROENTEROLOGY, V119, P441, DOI 10.1053/gast.2000.9369; Powell EE, 2005, GASTROENTEROLOGY, V129, P1937, DOI 10.1053/j.gastro.2005.09.015; Powell LW, 2006, ARCH INTERN MED, V166, P294, DOI 10.1001/archinte.166.3.294; Powell LW, 2005, BEST PRACT RES CL HA, V18, P221, DOI 10.1016/j.beha.2004.10.001; Richette P, 2010, J RHEUMATOL, V37, P2145, DOI 10.3899/jrheum.100234; Rochette J, 2010, HUM GENET, V128, P233, DOI 10.1007/s00439-010-0852-1; Ryan E, 2016, HEPATOLOGY, V63, P2055, DOI 10.1002/hep.28258; Sahinbegovic E, 2010, ARTHRITIS RHEUM-US, V62, P3792, DOI 10.1002/art.27712; Schimanski LM, 2005, BLOOD, V105, P4096, DOI 10.1182/blood-2004-11-4502; Scotet V, 2003, AM J EPIDEMIOL, V158, P129, DOI 10.1093/aje/kwg123; Shimizu I, 2003, LIVER INT, V23, P63, DOI 10.1034/j.1600-0676.2003.00811.x; Sinigaglia L, 1997, J RHEUMATOL, V24, P1809; Stefashyna O, 2014, VOX SANG, V106, P111, DOI 10.1111/vox.12078; Stickel F, 2014, HUM MOL GENET, V23, P3883, DOI 10.1093/hmg/ddu076; Stuart KA, 1998, J HEPATOL, V28, P404, DOI 10.1016/S0168-8278(98)80313-9; Swinkels DW, 2007, NETH J MED, V65, P452; TSUKAMOTO H, 1995, J CLIN INVEST, V96, P620, DOI 10.1172/JCI118077; Valenti L, 2009, OSTEOPOROSIS INT, V20, P549, DOI 10.1007/s00198-008-0701-4; Van Vlierberghe H, 2001, J HEPATOL, V35, P707, DOI 10.1016/S0168-8278(01)00203-3; Waalen J, 2005, BEST PRACT RES CL HA, V18, P203, DOI 10.1016/j.beha.2004.08.023; Wallace DF, 1999, GASTROENTEROLOGY, V116, P1409, DOI 10.1016/S0016-5085(99)70505-6; Whitfield JB, 2001, ALCOHOL CLIN EXP RES, V25, P1037, DOI 10.1097/00000374-200107000-00014; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009; Wood MJ, 2008, BLOOD, V111, P4456, DOI 10.1182/blood-2007-11-122374; Yamashita C, 2003, CLIN GASTROENTEROL H, V1, P388, DOI 10.1053/S1542-3565(03)00187-3; Yu L, 2007, GASTROENTEROLOGY, V133, P489, DOI 10.1053/j.gastro.2007.05.054	122	161	171	1	83	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					706	716		10.1016/S0140-6736(15)01315-X	http://dx.doi.org/10.1016/S0140-6736(15)01315-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UX	26975792				2022-12-28	WOS:000381268700031
J	Hutchison, CA; Chuang, RY; Noskov, VN; Assad-Garcia, N; Deerinck, TJ; Ellisman, MH; Gill, J; Kannan, K; Karas, BJ; Ma, L; Pelletier, JF; Qi, ZQ; Richter, RA; Strychalski, EA; Sun, LJ; Suzuki, Y; Tsvetanova, B; Wise, KS; Smith, HO; Glass, JI; Merryman, C; Gibson, DG; Venter, JC				Hutchison, Clyde A., III; Chuang, Ray-Yuan; Noskov, Vladimir N.; Assad-Garcia, Nacyra; Deerinck, Thomas J.; Ellisman, Mark H.; Gill, John; Kannan, Krishna; Karas, Bogumil J.; Ma, Li; Pelletier, James F.; Qi, Zhi-Qing; Richter, R. Alexander; Strychalski, Elizabeth A.; Sun, Lijie; Suzuki, Yo; Tsvetanova, Billyana; Wise, Kim S.; Smith, Hamilton O.; Glass, John I.; Merryman, Chuck; Gibson, Daniel G.; Venter, J. Craig			Design and synthesis of a minimal bacterial genome	SCIENCE			English	Article							ESSENTIAL GENES; MYCOPLASMA; SEPF	We used whole-genome design and complete chemical synthesis to minimize the 1079-kilobase pair synthetic genome of Mycoplasma mycoides JCVI-syn1.0. An initial design, based on collective knowledge of molecular biology combined with limited transposon mutagenesis data, failed to produce a viable cell. Improved transposon mutagenesis methods revealed a class of quasi-essential genes that are needed for robust growth, explaining the failure of our initial design. Three cycles of design, synthesis, and testing, with retention of quasi-essential genes, produced JCVI-syn3.0 (531 kilobase pairs, 473 genes), which has a genome smaller than that of any autonomously replicating cell found in nature. JCVI-syn3.0 retains almost all genes involved in the synthesis and processing of macromolecules. Unexpectedly, it also contains 149 genes with unknown biological functions. JCVI-syn3.0 is a versatile platform for investigating the core functions of life and for exploring whole-genome design.	[Hutchison, Clyde A., III; Chuang, Ray-Yuan; Noskov, Vladimir N.; Assad-Garcia, Nacyra; Karas, Bogumil J.; Ma, Li; Richter, R. Alexander; Sun, Lijie; Suzuki, Yo; Wise, Kim S.; Smith, Hamilton O.; Glass, John I.; Merryman, Chuck; Gibson, Daniel G.; Venter, J. Craig] J Craig Venter Inst, La Jolla, CA 92037 USA; [Deerinck, Thomas J.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92037 USA; [Gill, John; Kannan, Krishna; Qi, Zhi-Qing; Tsvetanova, Billyana; Smith, Hamilton O.; Gibson, Daniel G.; Venter, J. Craig] Synthet Genom, La Jolla, CA 92037 USA; [Pelletier, James F.; Strychalski, Elizabeth A.] NIST, Gaithersburg, MD 20899 USA; [Chuang, Ray-Yuan] Amer Type Culture Collect, 10801 Univ Blvd, Manassas, VA 20110 USA; [Pelletier, James F.] MIT, Ctr Bits & Atoms, Room E15-401,20 Ames St, Cambridge, MA 02139 USA; [Sun, Lijie] CBRITE, 11575 Sorrento Valley Rd,Suite 204, San Diego, CA 92121 USA	J. Craig Venter Institute; University of California System; University of California San Diego; National Institute of Standards & Technology (NIST) - USA; Massachusetts Institute of Technology (MIT)	Hutchison, CA; Venter, JC (corresponding author), J Craig Venter Inst, La Jolla, CA 92037 USA.; Venter, JC (corresponding author), Synthet Genom, La Jolla, CA 92037 USA.	chutchis@jcvi.org; jcventer@jcvi.org	Pelletier, James F./AAB-8919-2021; Glass, John/A-6572-2015	Pelletier, James F./0000-0001-8064-0259; Glass, John/0000-0002-3784-5301; Kannan, Krishna/0000-0002-2301-7900	Synthetic Genomics (SGI); Defense Advanced Research Projects Agency's Living Foundries program [HR0011-12-C-0063]; NIH from National Institute of General Medical Sciences [P41GM103412]; Fannie and John Hertz Graduate Fellowship; Massachusetts Institute of Technology (MIT) Center for Bits and Atoms; MIT Department of Physics; National Institute of Standards and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412] Funding Source: NIH RePORTER	Synthetic Genomics (SGI); Defense Advanced Research Projects Agency's Living Foundries program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH from National Institute of General Medical Sciences; Fannie and John Hertz Graduate Fellowship; Massachusetts Institute of Technology (MIT) Center for Bits and Atoms; MIT Department of Physics; National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Synthetic Genomics (SGI) and the Defense Advanced Research Projects Agency's Living Foundries program (contract HR0011-12-C-0063) for funding this work. Microscopy work at the University of California-San Diego was supported by NIH grant P41GM103412 from the National Institute of General Medical Sciences to M.H.E. J.F.P. was supported by a Fannie and John Hertz Graduate Fellowship, the Massachusetts Institute of Technology (MIT) Center for Bits and Atoms, and the MIT Department of Physics. E.A.S. was supported by the National Institute of Standards and Technology (certain commercial equipment, instruments, or materials are identified in this paper to foster understanding; such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the materials or equipment identified are necessarily the best available for the stated purpose). We thank M. D. Adams, M. A. Algire, D. Brami, D. Brown, L. Brinkac, N. Caiazza, O. Fetzer, L. Fu, D. Haft, S. Kaushal, M. Lapointe, A. Lee, M. Lewis, D. Lomelin, C. Ludka, M. Montague, C. Orosco, T. Peterson, A. Ramon, T. Richardson, A. Schwartz, D. Smith, S. Vashee, and T. Yee for their contributions to this work and for helpful discussions. J. C. V. is chairman of the Board of Directors and co-chief scientific officer of SGI. H.O.S. is on the Board of Directors and co-chief scientific officer of SGI. C.A.H. is chairman of the SGI Scientific Advisory Board. D.G.G. is a vice president of SGI. J. C. V., H.O.S., C.A.H., D.G.G., J.G., K.K., and the J. Craig Venter Institute (JCVI) hold SGI stock and/or stock options. SGI and JCVI have filed patent applications on some of the methods and concepts described in this paper.	Bernander R, 2010, CURR OPIN MICROBIOL, V13, P747, DOI 10.1016/j.mib.2010.10.005; Blain JC, 2014, ANNU REV BIOCHEM, V83, P615, DOI 10.1146/annurev-biochem-080411-124036; DOBZHANSKY T, 1946, GENETICS, V31, P269; Duman R, 2013, P NATL ACAD SCI USA, V110, pE4601, DOI 10.1073/pnas.1313978110; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gola S, 2015, MOL MICROBIOL, V97, P560, DOI 10.1111/mmi.13050; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Jensen JS, 1996, J CLIN MICROBIOL, V34, P286, DOI 10.1128/JCM.34.2.286-291.1996; Juhas M, 2014, MICROBIOL-SGM, V160, P2341, DOI 10.1099/mic.0.079376-0; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Lluch-Senar M, 2015, MOL SYST BIOL, V11; Lluch-Senar M, 2010, MOL MICROBIOL, V78, P278, DOI 10.1111/j.1365-2958.2010.07306.x; Mercier R, 2013, CELL, V152, P997, DOI 10.1016/j.cell.2013.01.043; Mercier R, 2012, CELL REP, V1, P417, DOI 10.1016/j.celrep.2012.03.008; Merryman C, 2012, METAB ENG, V14, P196, DOI 10.1016/j.ymben.2012.02.005; MOROWITZ HJ, 1984, ISRAEL J MED SCI, V20, P750; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Noskov VN, 2015, BIOL PROCED ONLINE, V17, DOI 10.1186/s12575-015-0016-8; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Ramon A, 2011, BIOTECHNOL LETT, V33, P549, DOI 10.1007/s10529-010-0455-x; RAZIN S, 1967, ANN NY ACAD SCI, V143, P66, DOI 10.1111/j.1749-6632.1967.tb27645.x; Romero-Garcia J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081990; Schieck E, 2016, MOL MICROBIOL, V99, P55, DOI 10.1111/mmi.13213; Smanski MJ, 2014, NAT BIOTECHNOL, V32, P1241, DOI 10.1038/nbt.3063; Suzuki Y, 2015, GENOME RES, V25, P435, DOI 10.1101/gr.182477.114; Xavier JC, 2014, MICROBIOL MOL BIOL R, V78, P487, DOI 10.1128/MMBR.00050-13	35	662	691	24	647	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280							aad6253	10.1126/science.aad6253	http://dx.doi.org/10.1126/science.aad6253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013737				2022-12-28	WOS:000372756200036
J	Meyer, M; Arsuaga, JL; de Filippo, C; Nagel, S; Aximu-Petri, A; Nickel, B; Martinez, I; Gracia, A; de Castro, JMB; Carbonell, E; Viola, B; Kelso, J; Pruffer, K; Paabo, S				Meyer, Matthias; Arsuaga, Juan-Luis; de Filippo, Cesare; Nagel, Sarah; Aximu-Petri, Ayinuer; Nickel, Birgit; Martinez, Ignacio; Gracia, Ana; Maria Bermudez de Castro, Jose; Carbonell, Eudald; Viola, Bence; Kelso, Janet; Prueffer, Kay; Paeaebo, Svante			Nuclear DNA sequences from the Middle Pleistocene Sima de los Huesos hominins	NATURE			English	Article							MITOCHONDRIAL GENOME SEQUENCE; ANCIENT; NEANDERTHAL; CAVE; CONTAMINATION; DISPERSALS; ALIGNMENT	A unique assemblage of 28 hominin individuals, found in Sima de los Huesos in the Sierra de Atapuerca in Spain, has recently been dated to approximately 430,000 years ago(1). An interesting question is how these Middle Pleistocene hominins were related to those who lived in the Late Pleistocene epoch, in particular to Neanderthals in western Eurasia and to Denisovans, a sister group of Neanderthals so far known only from southern Siberia. While the Sima de los Huesos hominins share some derived morphological features with Neanderthals, the mitochondrial genome retrieved from one individual from Sima de los Huesos is more closely related to the mitochondrial DNA of Denisovans than to that of Neanderthals(2). However, since the mitochondrial DNA does not reveal the full picture of relationships among populations, we have investigated DNA preservation in several individuals found at Sima de los Huesos. Here we recover nuclear DNA sequences from two specimens, which show that the Sima de los Huesos hominins were related to Neanderthals rather than to Denisovans, indicating that the population divergence between Neanderthals and Denisovans predates 430,000 years ago. A mitochondrial DNA recovered from one of the specimens shares the previously described relationship to Denisovan mitochondrial DNAs, suggesting, among other possibilities, that the mitochondrial DNA gene pool of Neanderthals turned over later in their history.	[Meyer, Matthias; de Filippo, Cesare; Nagel, Sarah; Aximu-Petri, Ayinuer; Nickel, Birgit; Kelso, Janet; Prueffer, Kay; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Deutsch Pl 6, D-04103 Leipzig, Germany; [Arsuaga, Juan-Luis; Martinez, Ignacio; Gracia, Ana] Univ Complutense Madrid, Inst Salud Carlos 3, Ctr Invest Evoluc & Comportamiento Humanos, Madrid 28029, Spain; [Arsuaga, Juan-Luis] Univ Complutense Madrid, Fac Ciencias Geol, Dept Palaeontol, E-28040 Madrid, Spain; [Martinez, Ignacio; Gracia, Ana] Univ Alcala, Dept Geog & Geol, Area Paleontol, Madrid 28871, Spain; [Maria Bermudez de Castro, Jose] Ctr Nacl Invest Evoluc Humana, Paseo Sierra de Atapuerca, Burgos 09002, Spain; [Maria Bermudez de Castro, Jose] UCL, Dept Anthropol, 14 Taviton St, London WC1H 0BW, England; [Carbonell, Eudald] Inst Catala Paleoecol Humana & Evolucio Social, C Marcelli Domingo S-N,Edifici W3, Tarragona 43007, Spain; [Carbonell, Eudald] Univ Rovira & Virgili, Fac Lletres, Dept Hist & Hist Art, Area Prehist, Avinguda Catalunya 35, Tarragona 43002, Spain; [Viola, Bence] Univ Toronto, Dept Anthropol, 19 Russell St, Toronto, ON M5S 2S2, Canada	Max Planck Society; Complutense University of Madrid; Complutense University of Madrid; Universidad de Alcala; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of London; University College London; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; University of Toronto	Meyer, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Deutsch Pl 6, D-04103 Leipzig, Germany.	mmeyer@eva.mpg.de	Kelso, Janet/N-1812-2019	Kelso, Janet/0000-0002-3618-322X; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; Arsuaga, Juan Luis/0000-0001-5361-2295; Viola, Bence/0000-0001-8052-707X; martinez, ignacio/0000-0002-1835-9199	Max Planck Society; Junta de Castilla y Leon; Fundacion Atapuerca; Spanish Ministerio de Ciencia e Innovacion [CGL2009-12703-C03]; Spanish Ministerio de Economia y Competitividad [CGL2012-38434-C03]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion Atapuerca; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government)	We thank B. Hober and A. Weihmann for help with sequencing the libraries, G. Renaud for processing the raw sequence data, S. Castellano and U. Stenzel for discussions and comments on the manuscript. Genetics work was funded by the Max Planck Society and its Presidential Innovation Fund. Field work at the Sierra de Atapuerca sites was funded by the Junta de Castilla y Leon, the Fundacion Atapuerca, the Spanish Ministerio de Ciencia e Innovacion (project CGL2009-12703-C03) and the Spanish Ministerio de Economia y Competitividad (project CGL2012-38434-C03).	Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Dabney J, 2012, BIOTECHNIQUES, V52, P87, DOI 10.2144/000113809; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gansauge MT, 2014, GENOME RES, V24, P1543, DOI 10.1101/gr.174201.114; Gansauge MT, 2013, NAT PROTOC, V8, P737, DOI 10.1038/nprot.2013.038; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Arsuaga JL, 2015, P NATL ACAD SCI USA, V112, P11524, DOI 10.1073/pnas.1514828112; Lycett SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007404; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Qin PF, 2015, MOL BIOL EVOL, V32, P2665, DOI 10.1093/molbev/msv141; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Renaud G, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku699; Renaud G, 2013, BIOINFORMATICS, V29, P1208, DOI 10.1093/bioinformatics/btt117; Rink WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054608; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Slon V., 2015, QUAT INT; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311	36	290	301	4	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					504	+		10.1038/nature17405	http://dx.doi.org/10.1038/nature17405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26976447				2022-12-28	WOS:000372701300041
J	Ohman, EM				Ohman, E. Magnus			Chronic Stable Angina	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; LONG-TERM SURVIVAL; INCOMPLETE REVASCULARIZATION; CARDIOVASCULAR EVENTS; PREDICTING PROGNOSIS; MYOCARDIAL-ISCHEMIA; BETA-BLOCKERS; RIVER-PCI; RANOLAZINE; RISK	A 73-year-old farmer with a 15-month history of stable angina presents for consultation. He has curtailed his farming activity to avoid chest discomfort, for which he uses nitroglycerin (0.4 mg sublingually) approximately 3 times per month. His heart rate is 59 beats per minute, and his blood pressure is 132/72 mm Hg. He had unstable angina 12 years earlier, and a drug-eluting stent was implanted in his left anterior descending artery; no other obstructive coronary artery disease was noted at that time. His medications include aspirin, lisinopril (20 mg daily) for hypertension, and atorvastatin (40 mg daily). How should this case be evaluated and managed?	[Ohman, E. Magnus] Duke Univ, Div Cardiol, Program Adv Coronary Dis, Durham, NC 27710 USA; [Ohman, E. Magnus] Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University	Ohman, EM (corresponding author), Duke Univ, Med Ctr, Box 3126 DUMC, Durham, NC 27710 USA.	ohman001@mc.duke.edu			Abiomed; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Eli Lilly; Janssen; Stealth Peptides; Medicines Company; Angel Medical Systems; Biotie Therapies; Faculty Connection; Merck; Medscape; Gilead Sciences	Abiomed; AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Stealth Peptides; Medicines Company; Angel Medical Systems; Biotie Therapies; Faculty Connection; Merck(Merck & Company); Medscape; Gilead Sciences(Gilead Sciences)	Dr. Ohman reports receiving consulting fees from Abiomed, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Janssen, Stealth Peptides, the Medicines Company, Angel Medical Systems, Biotie Therapies, Faculty Connection, Merck, and Medscape, and grant support through his institution from Daiichi Sankyo, Eli Lilly, Gilead Sciences, and Janssen. No other potential conflict of interest relevant to this article was reported.	Alexander KP, 2016, CIRCULATION, V133, P39, DOI 10.1161/CIRCULATIONAHA.115.019768; Bangalore S, 2014, CIRC-CARDIOVASC QUAL, V7, P872, DOI 10.1161/CIRCOUTCOMES.114.001073; Bangalore S, 2012, JAMA-J AM MED ASSOC, V308, P1340, DOI 10.1001/jama.2012.12559; Bashore TM, 2012, J AM COLL CARDIOL, V59, P2221, DOI 10.1016/j.jacc.2012.02.010; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Bittner V, 2015, J AM COLL CARDIOL, V66, P765, DOI 10.1016/j.jacc.2015.06.019; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bourque JM, 2015, JACC-CARDIOVASC IMAG, V8, P1309, DOI 10.1016/j.jcmg.2015.09.006; Cavender MA, 2009, AM HEART J, V158, P933, DOI 10.1016/j.ahj.2009.10.013; Chaitman BR, 2006, CIRCULATION, V113, P2462, DOI 10.1161/CIRCULATIONAHA.105.597500; Chaitman BR, 2004, J AM COLL CARDIOL, V43, P1375, DOI 10.1016/j.jacc.2003.11.045; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; Cheng Victor Y, 2011, Circulation, V124, P2423, DOI 10.1161/CIRCULATIONAHA.111.039255; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Daly CA, 2006, BMJ-BRIT MED J, V332, P262, DOI 10.1136/bmj.38695.605440.AE; Deanfield JE, 2010, EUR HEART J, V31, P2650, DOI 10.1093/eurheartj/ehq133; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Fox K, 2014, NEW ENGL J MED, V371, P1091, DOI 10.1056/NEJMoa1406430; Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927; Henry TD, 2013, EUR HEART J, V34, P2683, DOI 10.1093/eurheartj/eht165; Husted SE, 2015, LANCET, V386, P691, DOI 10.1016/S0140-6736(15)61283-1; Johnson NP, 2014, J AM COLL CARDIOL, V64, P1641, DOI 10.1016/j.jacc.2014.07.973; Jolicoeur EM, 2008, AM HEART J, V155, P435, DOI 10.1016/j.ahj.2007.12.005; Jones M, 2006, FAM PRACT, V23, P520, DOI 10.1093/fampra/cml038; Kosiborod M, 2013, J AM COLL CARDIOL, V61, P2038, DOI 10.1016/j.jacc.2013.02.011; Leape LL, 2000, AM HEART J, V139, P106, DOI 10.1016/S0002-8703(00)90316-8; MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Morrow DA, 2007, JAMA-J AM MED ASSOC, V297, P1775, DOI 10.1001/jama.297.16.1775; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Pehrsson SK, 2000, CLIN CARDIOL, V23, P763; Pepine CJ, 2015, CIRCULATION, V131, P1044, DOI 10.1161/CIRCULATIONAHA.115.015553; Piccolo R, 2015, LANCET, V386, P702, DOI 10.1016/S0140-6736(15)61220-X; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Povsic TJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001287; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; Reynolds HR, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.113.000362; Rozanski A, 2013, J AM COLL CARDIOL, V61, P1054, DOI 10.1016/j.jacc.2012.11.056; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Stone PH, 2006, J AM COLL CARDIOL, V48, P566, DOI 10.1016/j.jacc.2006.05.044; Stone PH, 2005, CIRCULATION, V111, P1747, DOI 10.1161/01.CIR.0000160866.90148.76; UPTON MT, 1980, CIRCULATION, V62, P341, DOI 10.1161/01.CIR.62.2.341; Weisz G, 2016, LANCET, V387, P136, DOI 10.1016/S0140-6736(15)00459-6; Windecker S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3859; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2259, DOI 10.1001/jama.260.15.2259	50	45	47	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2016	374	12					1167	1176		10.1056/NEJMcp1502240	http://dx.doi.org/10.1056/NEJMcp1502240			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AA	27007960				2022-12-28	WOS:000372585100009
J	Roy, DS; Arons, A; Mitchell, TI; Pignatelli, M; Ryan, TJ; Tonegawa, S				Roy, Dheeraj S.; Arons, Autumn; Mitchell, Teryn I.; Pignatelli, Michele; Ryan, Tomas J.; Tonegawa, Susumu			Memory retrieval by activating engram cells in mouse models of early Alzheimer's disease	NATURE			English	Article							ADULT NEUROGENESIS; HIPPOCAMPAL; IMPAIRMENT; BETA; DYSFUNCTION; CORRELATE; NEURONS	Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory decline and subsequent loss of broader cognitive functions(1). Memory decline in the early stages of AD is mostly limited to episodic memory, for which the hippocampus has a crucial role(2). However, it has been uncertain whether the observed amnesia in the early stages of AD is due to disrupted encoding and consolidation of episodic information, or an impairment in the retrieval of stored memory information. Here we show that in transgenic mouse models of early AD, direct optogenetic activation of hippocampal memory engram cells results in memory retrieval despite the fact that these mice are amnesic in long-term memory tests when natural recall cues are used, revealing a retrieval, rather than a storage impairment. Before amyloid plaque deposition, the amnesia in these mice is age-dependent(3-5), which correlates with a progressive reduction in spine density of hippocampal dentate gyrus engram cells. We show that optogenetic induction of long-term potentiation at perforant path synapses of dentate gyrus engram cells restores both spine density and long-term memory. We also demonstrate that an ablation of dentate gyrus engram cells containing restored spine density prevents the rescue of long-term memory. Thus, selective rescue of spine density in engram cells may lead to an effective strategy for treating memory loss in the early stages of AD.	[Roy, Dheeraj S.; Arons, Autumn; Mitchell, Teryn I.; Pignatelli, Michele; Ryan, Tomas J.; Tonegawa, Susumu] MIT, Dept Biol, Picower Inst Learning & Memory, RIKEN Ctr Neural Circuit Genet, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Roy, Dheeraj S.; Arons, Autumn; Mitchell, Teryn I.; Pignatelli, Michele; Ryan, Tomas J.; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Arons, Autumn; Ryan, Tomas J.; Tonegawa, Susumu] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Tonegawa, S (corresponding author), MIT, Dept Biol, Picower Inst Learning & Memory, RIKEN Ctr Neural Circuit Genet, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Tonegawa, S (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Tonegawa, S (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	tonegawa@mit.edu		Pignatelli, Michele/0000-0002-4918-2066; Ryan, Tomas/0000-0003-0121-8514	RIKEN Brain Science Institute; Howard Hughes Medical Institute; JPB Foundation	RIKEN Brain Science Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); JPB Foundation	We thank X. Liu for the c-Fos-tTA construct; S. Huang, T. Okuyama and T. Kitamura for help with experiments; W. Yu, S. LeBlanc and X. Zhou for technical assistance; L. Brenner for proofreading; and all members of the Tonegawa laboratory for their support. We thank M. Luo for sharing the DTR coding sequence. This work was supported by the RIKEN Brain Science Institute, the Howard Hughes Medical Institute, and the JPB Foundation (to S.T.).	Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; GRANHOLM E, 1988, BRAIN COGNITION, V7, P335, DOI 10.1016/0278-2626(88)90007-3; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P1089, DOI 10.1136/jnnp.53.12.1089; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Ryan TJ, 2015, SCIENCE, V348, P1007, DOI 10.1126/science.aaa5542; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; TAMAMAKI N, 1993, HIPPOCAMPUS, V3, P471, DOI 10.1002/hipo.450030408; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013	29	277	298	7	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					508	+		10.1038/nature17172	http://dx.doi.org/10.1038/nature17172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26982728	Green Submitted, Green Accepted			2022-12-28	WOS:000372701300042
J	Hawkes, N				Hawkes, Nigel			THE BMJ AWARDS 2016 Clinical leadership team	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2016	352								i1587	10.1136/bmj.i1587	http://dx.doi.org/10.1136/bmj.i1587			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LL	27009594				2022-12-28	WOS:000373044600001
J	Burki, T				Burki, Talha			HEALTHCARE FACILITIES A beacon for free healthcare in Pakistan	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												talhakburki@gmail.com							0	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2016	352								i1681	10.1136/bmj.i1681	http://dx.doi.org/10.1136/bmj.i1681			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LK	27004744				2022-12-28	WOS:000373044500015
J	Coupland, C; Hill, T; Morriss, R; Moore, M; Arthur, A; Hippisley-Cox, J				Coupland, Carol; Hill, Trevor; Morriss, Richard; Moore, Michael; Arthur, Antony; Hippisley-Cox, Julia			Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEROTONIN REUPTAKE INHIBITORS; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; SELF-HARM; DEPRESSION; STROKE; METAANALYSIS; EVENTS; DRUGS; ASSOCIATION	OBJECTIVE To assess associations between different antidepressant treatments and rates of three cardiovascular outcomes (myocardial infarction, stroke or transient ischaemic attack, and arrhythmia) in people with depression. DESIGN Cohort study. SETTING UK general practices contributing to the QResearch primary care database. PARTICIPANTS 238 963 patients aged 20 to 64 years with a first diagnosis of depression between 1 January 2000 and 31 July 2011. EXPOSURES Antidepressant class (tricyclic and related antidepressants, selective serotonin reuptake inhibitors, other antidepressants), dose, duration of use, and commonly prescribed individual antidepressant drugs. MAIN OUTCOME MEASURES First diagnoses of myocardial infarction, stroke or transient ischaemic attack, and arrhythmia during five years' follow-up. Cox proportional hazards models were used to estimate hazard ratios, adjusting for potential confounding variables. RESULTS During five years of follow-up, 772 patients had a myocardial infarction, 1106 had a stroke or transient ischaemic attack, and 1452 were diagnosed as having arrhythmia. No significant associations were found between antidepressant class and myocardial infarction over five years' follow-up. In the first year of follow-up, patients treated with selective serotonin reuptake inhibitors had a significantly reduced risk of myocardial infarction (adjusted hazard ratio 0.58, 95% confidence interval 0.42 to 0.79) compared with no use of antidepressants; among individual drugs, fluoxetine was associated with a significantly reduced risk (0.44, 0.27 to 0.72) and lofepramine with a significantly increased risk (3.07, 1.50 to 6.26). No significant associations were found between antidepressant class or individual drugs and risk of stroke or transient ischaemic attack. Antidepressant class was not significantly associated with arrhythmia over five years' follow-up, although the risk was significantly increased during the first 28 days of treatment with tricyclic and related antidepressants (adjusted hazard ratio 1.99, 1.27 to 3.13). Fluoxetine was associated with a significantly reduced risk of arrhythmia (0.74, 0.59 to 0.92) over five years, but citalopram was not significantly associated with risk of arrhythmia even at high doses (1.11, 0.72 to 1.71 for doses >= 40 mg/day). CONCLUSIONS This study found no evidence that selective serotonin reuptake inhibitors are associated with an increased risk of arrhythmia or stroke/transient ischaemic attack in people diagnosed as having depression between the ages of 20 to 64 or that citalopram is associated with a significantly increased risk of arrhythmia. It found some indication of a reduced risk of myocardial infarction with selective serotonin reuptake inhibitors, particularly fluoxetine, and of an increased risk with lofepramine.	[Coupland, Carol; Hill, Trevor; Hippisley-Cox, Julia] Univ Nottingham, Div Primary Care, Sch Med, Nottingham NG7 2RD, England; [Morriss, Richard] Inst Mental Hlth, Nottingham NG8 1BB, England; [Moore, Michael] Univ Southampton, Sch Med, Primary Care & Populat Sci, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England; [Arthur, Antony] Univ E Anglia, Sch Hlth Sci, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England	University of Nottingham; University of Southampton; University of East Anglia	Coupland, C (corresponding author), Univ Nottingham, Div Primary Care, Sch Med, Nottingham NG7 2RD, England.	carol.coupland@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020; Moore, Michael/C-3447-2011	Hippisley-Cox, Julia/0000-0002-2479-7283; Moore, Michael/0000-0002-5127-4509; Coupland, Carol/0000-0002-2327-3306; Morriss, Richard/0000-0003-2910-4121; Arthur, Antony/0000-0001-8617-5714; Hill, Trevor/0000-0002-0277-4988	National Institute for Health Research (NIHR) School for Primary Care Research [81]; NIHR; NIHR Collaboration for Leadership in Applied Health Research and Care East Midlands (CLAHRC EM)	National Institute for Health Research (NIHR) School for Primary Care Research(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); NIHR Collaboration for Leadership in Applied Health Research and Care East Midlands (CLAHRC EM)	The project was funded by the National Institute for Health Research (NIHR) School for Primary Care Research (project number 81). The funding body did not play a role in the study design, the writing of the manuscript, or the decision to submit the manuscript for publication. This paper presents independent research funded by the NIHR. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. RM's contribution to the study has been funded through the NIHR Collaboration for Leadership in Applied Health Research and Care East Midlands (CLAHRC EM).	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Blanchette CM, 2005, ANN EPIDEMIOL, V15, P643, DOI [10.1016/j.annepidem.2005.06.039, DOI 10.1016/J.ANNEPIDEM.2005.06.039]; Castro VM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f288; Castro VM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000544; Chen Y, 2008, ANN PHARMACOTHER, V42, P177, DOI 10.1345/aph.1K369; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; Coupland CAC, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15280; Coupland C, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h517, 10.1136/bmj.h517]; Coupland C, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-135; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Department of Health, 2004, PRESCR COST AN ENGL; El-Sherif N, 2003, CURR OPIN CARDIOL, V18, P6, DOI 10.1097/00001573-200301000-00002; FDA Drug Safety Communication, 2012, FDA DRUG SAF COMM RE; Girardin FR, 2013, AM J PSYCHIAT, V170, P1468, DOI 10.1176/appi.ajp.2013.12060860; Hatcher S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8300; Health and Social Care Information Centre, 2014, PRESCR COST AN; Hennessy S, 2008, PHARMACOEPIDEM DR S, V17, P1131, DOI 10.1002/pds.1632; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hill T, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0701-9; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Hippisley-Cox J, 2001, BRIT MED J, V323, P666, DOI 10.1136/bmj.323.7314.666; Hippisley-Cox J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2573; Hung CC, 2013, AM J GERIAT PSYCHIAT, V21, P811, DOI 10.1016/j.jagp.2013.01.018; Jolly K, 2009, HEART, V95, P1893, DOI 10.1136/hrt.2009.179127; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Kimmel SE, 2011, BRIT J CLIN PHARMACO, V72, P514, DOI 10.1111/j.1365-2125.2011.04008.x; Leonard CE, 2011, PHARMACOEPIDEM DR S, V20, P903; Lockhart P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593848; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Meier CR, 2001, BRIT J CLIN PHARMACO, V52, P179, DOI 10.1046/j.0306-5251.2001.01426.x; Monster TBM, 2004, AM J MED, V117, P732, DOI 10.1016/j.amjmed.2004.06.027; National Institute for Health and Care Excellence, 2009, DEPR TREATM MAN DEPR; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Oh SW, 2014, BRIT J CLIN PHARMACO, V78, P727, DOI 10.1111/bcp.12383; Olfson M, 2009, ARCH GEN PSYCHIAT, V66, P848, DOI 10.1001/archgenpsychiatry.2009.81; Pan A, 2011, STROKE, V42, P2770, DOI 10.1161/STROKEAHA.111.617043; Pan A, 2011, JAMA-J AM MED ASSOC, V306, P1241, DOI 10.1001/jama.2011.1282; ROOSE SP, 1987, ARCH GEN PSYCHIAT, V44, P273; Sauer WH, 2001, CIRCULATION, V104, P1894, DOI 10.1161/hc4101.097519; Schlienger RG, 2004, DRUG SAFETY, V27, P1157, DOI 10.2165/00002018-200427140-00006; Shin D, 2014, J NEUROL, V261, P686, DOI 10.1007/s00415-014-7251-9; Smoller JW, 2009, ARCH INTERN MED, V169, P2128, DOI 10.1001/archinternmed.2009.436; Stephenson CP, 2013, AUST NZ J PSYCHIAT, V47, P74, DOI 10.1177/0004867412466595; Tata LJ, 2005, HEART, V91, P465, DOI 10.1136/hrt.2004.037457; Taylor D, 2008, ACTA PSYCHIAT SCAND, V118, P434, DOI 10.1111/j.1600-0447.2008.01260.x; Thanacoody H K Ruben, 2005, Toxicol Rev, V24, P205, DOI 10.2165/00139709-200524030-00013; Trifiro G, 2010, J CLIN PSYCHOPHARM, V30, P252, DOI 10.1097/JCP.0b013e3181dca10a; US Food and Drug Administration, 2011, FDA DRUG SAF COMM AB; Zivin K, 2013, AM J PSYCHIAT, V170, P642, DOI 10.1176/appi.ajp.2013.12030408	50	47	50	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2016	352								i1350	10.1136/bmj.i1350	http://dx.doi.org/10.1136/bmj.i1350			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LK	27005565	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000373044500003
J	Roman, J; Kraska, J				Roman, Joe; Kraska, James			Reboot Gitmo for US-Cuba research diplomacy	SCIENCE			English	Editorial Material							PROTECTION; FISH		[Roman, Joe] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA; [Kraska, James] US Naval War Coll, Stockton Ctr Study Int Law, Newport, RI 02841 USA	University of Vermont	Roman, J (corresponding author), Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA.	jroman@uvm.edu						All S. H., 2007, PEACE PARKS CONSERVA; Binder D., 1977, NY TIMES; Crowley Michael, 2013, TIME; Francis, 2015, LAUDATO SI; Holpuch Amanda, 2015, GUARDIAN; Jackson J, 2014, STATUS TRENDS CARIBB, DOI DOI 10.1111/1365-2664.12388; Moore Molly, 1990, WASHINGTON POST; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pina-Amargos F, 2014, PEERJ, V2, DOI 10.7717/peerj.274; Riecken, 2006, GREEN BELT EUROPE VI; Schweig J. E., 2009, CUBA WHAT EVERYONE N; Sedaghatkish G., 1999, US NAVAL STATION GUA; Whittle D., 2006, CUBAN STUDIES, V37, P73, DOI DOI 10.1353/CUB.2007.0018; Whittle D, 2015, MEDICC REV, V17, P49, DOI 10.37757/MR2015.V17.N2.11	15	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1258	1260		10.1126/science.aad4247	http://dx.doi.org/10.1126/science.aad4247			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989232				2022-12-28	WOS:000372397700015
J	Sicoli, G; Mouesca, JM; Zeppieri, L; Amara, P; Martin, L; Barra, AL; Fontecilla-Camps, JC; Gambarelli, S; Nicolet, Y				Sicoli, Giuseppe; Mouesca, Jean-Marie; Zeppieri, Laura; Amara, Patricia; Martin, Lydie; Barra, Anne-Laure; Fontecilla-Camps, Juan C.; Gambarelli, Serge; Nicolet, Yvain			Fine-tuning of a radical-based reaction by radical S-adenosyl-L-methionine tryptophan lyase	SCIENCE			English	Article							THIAZOLYL PEPTIDE ANTIBIOTICS; BIOSYNTHESIS; NOSIHEPTIDE; TYROSINE; SUBSTRATE; ENZYME; INTERMEDIATE; NOCATHIACINS; ANALOGS	The radical S-adenosyl-L-methionine tryptophan lyase NosL converts L-tryptophan into 3-methylindolic acid, which is a precursor in the synthesis of the thiopeptide antibiotic nosiheptide. Using electron paramagnetic resonance spectroscopy and multiple L-tryptophan isotopologues, we trapped and characterized radical intermediates that indicate a carboxyl fragment migration mechanism for NosL. This is in contrast to a proposed fragmentation-recombination mechanism that implied Ca-Cp bond cleavage of L-tryptophan. Although NosL resembles related tyrosine lyases, subtle substrate motions in its active site are responsible for a fine-tuned radical chemistry, which selects the Cot-C bond for disruption. This mechanism highlights evolutionary adaptation to structural constraints in proteins as a route to alternative enzyme function.	[Sicoli, Giuseppe; Mouesca, Jean-Marie; Gambarelli, Serge] Univ Grenoble Alpes, Inst Nanosci & Cryogenie INAC, SCIB, LRM, F-38000 Grenoble, France; [Sicoli, Giuseppe; Mouesca, Jean-Marie; Gambarelli, Serge] Commissariat Energie Atom & Energies Alternat CEA, INAC, SCIB, LRM, F-38000 Grenoble, France; [Zeppieri, Laura; Amara, Patricia; Martin, Lydie; Fontecilla-Camps, Juan C.; Nicolet, Yvain] Univ Grenoble Alpes, Metalloprot Unit, Inst Biol Struct, CEA,CNRS, 71 Ave Martyrs, F-38044 Grenoble 9, France; [Barra, Anne-Laure] CNRS, UPR 3228, Lab Natl Champs Magnet Intenses, F-38048 Grenoble, France	CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Gambarelli, S (corresponding author), Univ Grenoble Alpes, Inst Nanosci & Cryogenie INAC, SCIB, LRM, F-38000 Grenoble, France.; Gambarelli, S (corresponding author), Commissariat Energie Atom & Energies Alternat CEA, INAC, SCIB, LRM, F-38000 Grenoble, France.; Nicolet, Y (corresponding author), Univ Grenoble Alpes, Metalloprot Unit, Inst Biol Struct, CEA,CNRS, 71 Ave Martyrs, F-38044 Grenoble 9, France.	serge.gambarelli@cea.fr; yvain.nicolet@ibs.fr	Sicoli, Giuseppe/Y-9727-2019; Yvain, Nicolet/AAP-9763-2020; Sicoli, Giuseppe/I-6554-2013	Yvain, Nicolet/0000-0002-4189-7067; Sicoli, Giuseppe/0000-0003-4872-5660; Amara, Patricia/0000-0001-9634-7305	Enhanced Eurotalents fellowship [600382]; French Agence Nationale pour la Recherche [ANR-12-BSV8-0013]; Grenoble Instruct center (Integrated Structural Biology Grenoble) [HMS 3518]; French Infrastructure for Integrated Structural Biology within the Grenoble Partnership for Structural Biology (PSB) [ANR-10-INSB-05-02]	Enhanced Eurotalents fellowship; French Agence Nationale pour la Recherche(French National Research Agency (ANR)); Grenoble Instruct center (Integrated Structural Biology Grenoble); French Infrastructure for Integrated Structural Biology within the Grenoble Partnership for Structural Biology (PSB)	The authors thank the Commissariat a l'Energie Atomique et aux Energies Alternatives (CEA), the Centre National de la Recherche Scientifique (CNRS), and the Universite Grenoble-Alper for institutional support. G.S. was the recipient of an Enhanced Eurotalents fellowship (FP7 framework program, N. 600382). We appreciate the help from the staff of the computing facility provided by CEA (CEA/Direction des Sciences du Vivant/Groupe Intormaque pour les Scierititiques d'Ile-de-France), Saclay and Centre de Calcul Recherche et Technologie, Bruyeres-le-Chatel. This work was supported by contract ANR-12-BSV8-0013 from the French Agence Nationale pour la Recherche and used the platforms of the Grenoble Instruct center (Integrated Structural Biology Grenoble; HMS 3518 CNRS-CEA University Joseph Fourier European Molecular Biology Laboratory) with support from the French Infrastructure for Integrated Structural Biology (ANR-10-INSB-05-02) within the Grenoble Partnership for Structural Biology (PSB). Data are available in the supplementary materials.	Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; BENAZET F, 1980, EXPERIENTIA, V36, P414, DOI 10.1007/BF01975121; Bhandari DM, 2015, BIOCHEMISTRY-US, V54, P4767, DOI 10.1021/acs.biochem.5b00764; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Decamps L, 2012, J AM CHEM SOC, V134, P18173, DOI 10.1021/ja307762b; Duffus BR, 2014, J AM CHEM SOC, V136, P13086, DOI 10.1021/ja504618y; Ji XJ, 2015, ANGEW CHEM INT EDIT, V54, P9021, DOI 10.1002/anie.201503976; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kuchenreuther JM, 2013, SCIENCE, V342, P472, DOI 10.1126/science.1241859; Li WY, 2003, J ANTIBIOT, V56, P226, DOI 10.7164/antibiotics.56.226; Naidu BN, 2004, BIOORG MED CHEM LETT, V14, P5573, DOI 10.1016/j.bmcl.2004.08.058; Nicolet Y, 2014, ANGEW CHEM INT EDIT, V53, P11840, DOI 10.1002/anie.201407320; Nicolet Y, 2012, J BIOL CHEM, V287, P13532, DOI 10.1074/jbc.R111.310797; PASCARD C, 1977, J AM CHEM SOC, V99, P6418, DOI 10.1021/ja00461a039; Philmus B, 2015, J AM CHEM SOC, V137, P5406, DOI 10.1021/ja513287k; PRANGE T, 1977, NATURE, V265, P189, DOI 10.1038/265189a0; Pucci MJ, 2004, ANTIMICROB AGENTS CH, V48, P3697, DOI 10.1128/AAC.48.10.3697-3701.2004; Warncke K, 2001, BBA-PROTEIN STRUCT M, V1545, P1, DOI 10.1016/S0167-4838(00)00289-2; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]	20	42	42	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1320	1323		10.1126/science.aad8995	http://dx.doi.org/10.1126/science.aad8995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989252				2022-12-28	WOS:000372397700043
J	Paskins, Z; Warburton, L				Paskins, Zoe; Warburton, Louise			10 MINUTE CONSULTATION Bisphosphonates beyond five years	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FRACTURE; WOMEN		[Paskins, Zoe; Warburton, Louise] Keele Univ, Stoke On Trent ST6 7AG, Staffs, England; [Paskins, Zoe] Haywood Hosp, Haywood Rheumatol Ctr, Stoke On Trent, Staffs, England	Keele University	Warburton, L (corresponding author), Keele Univ, Stoke On Trent ST6 7AG, Staffs, England.	louise.warburton@nhs.net						Compston J, 2013, MATURITAS, V75, P392, DOI 10.1016/j.maturitas.2013.05.013; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Diez-Perez A, 2012, OSTEOPOROSIS INT, V23, P2769, DOI 10.1007/s00198-012-2093-8; Schilcher J, 2014, NEW ENGL J MED, V371, P974, DOI 10.1056/NEJMc1403799; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11; Scottish Intercollegiate Guidelines Network (SIGN), 2015, SIGN PUBL, V142	6	4	4	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2016	352								i264	10.1136/bmj.i264	http://dx.doi.org/10.1136/bmj.i264			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1ZX	26984812				2022-12-28	WOS:000372584800011
J	Zemek, R; Barrowman, N; Freedman, SB; Gravel, J; Gagnon, I; McGahern, C; Aglipay, M; Sangha, G; Boutis, K; Beer, D; Craig, W; Burns, E; Farion, KJ; Mikrogianakis, A; Barlow, K; Dubrovsky, AS; Meeuwisse, W; Gioia, G; Meehan, WP; Beauchamp, MH; Kamil, Y; Grool, AM; Hoshizaki, B; Anderson, P; Brooks, BL; Yeates, KO; Vassilyadi, M; Klassen, T; Keightley, M; Richer, L; DeMatteo, C; Osmond, MH				Zemek, Roger; Barrowman, Nick; Freedman, Stephen B.; Gravel, Jocelyn; Gagnon, Isabelle; McGahern, Candice; Aglipay, Mary; Sangha, Gurinder; Boutis, Kathy; Beer, Darcy; Craig, William; Burns, Emma; Farion, Ken J.; Mikrogianakis, Angelo; Barlow, Karen; Dubrovsky, Alexander S.; Meeuwisse, Willem; Gioia, Gerard; Meehan, William P., III; Beauchamp, Miriam H.; Kamil, Yael; Grool, Anne M.; Hoshizaki, Blaine; Anderson, Peter; Brooks, Brian L.; Yeates, Keith Owen; Vassilyadi, Michael; Klassen, Terry; Keightley, Michelle; Richer, Lawrence; DeMatteo, Carol; Osmond, Martin H.		Pediat Emergency Res Canada PERC	Clinical Risk Score for Persistent Postconcussion Symptoms Among Children With Acute Concussion in the ED	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; RECOVERY; SCHOOL; EPIDEMIOLOGY; PREDICTORS	IMPORTANCE Approximately one-third of children experiencing acute concussion experience ongoing somatic, cognitive, and psychological or behavioral symptoms, referred to as persistent postconcussion symptoms (PPCS). However, validated and pragmatic tools enabling clinicians to identify patients at risk for PPCS do not exist. OBJECTIVE To derive and validate a clinical risk score for PPCS among children presenting to the emergency department. DESIGN, SETTING, AND PARTICIPANTS Prospective, multicenter cohort study (Predicting and Preventing Postconcussive Problems in Pediatrics [5P]) enrolled young patients (aged 5-<18 years) who presented within 48 hours of an acute head injury at 1 of 9 pediatric emergency departments within the Pediatric Emergency Research Canada (PERC) network from August 2013 through September 2014 (derivation cohort) and from October 2014 through June 2015 (validation cohort). Participants completed follow-up 28 days after the injury. EXPOSURES All eligible patients had concussions consistent with the Zurich consensus diagnostic criteria. MAIN OUTCOMES AND MEASURES The primary outcomewas PPCS risk score at 28 days, which was defined as 3 or more new or worsening symptoms using the patient-reported Postconcussion Symptom Inventory compared with recalled state of being prior to the injury. RESULTS In total, 3063 patients (median age, 12.0 years [interquartile range, 9.2-14.6 years]; 1205 [39.3%] girls) were enrolled (n = 2006 in the derivation cohort; n = 1057 in the validation cohort) and 2584 of whom (n = 1701 [85%] in the derivation cohort; n = 883 [84%] in the validation cohort) completed follow-up at 28 days after the injury. Persistent postconcussion symptoms were present in 801 patients (31.0%) (n = 510 [30.0%] in the derivation cohort and n = 291 [33.0%] in the validation cohort). The 12-point PPCS risk score model for the derivation cohort included the variables of female sex, age of 13 years or older, physician-diagnosed migraine history, prior concussion with symptoms lasting longer than 1 week, headache, sensitivity to noise, fatigue, answering questions slowly, and 4 or more errors on the Balance Error Scoring System tandem stance. The area under the curve was 0.71 (95% CI, 0.69-0.74) for the derivation cohort and 0.68 (95% CI, 0.65-0.72) for the validation cohort. CONCLUSIONS AND RELEVANCE A clinical risk score developed among children presenting to the emergency department with concussion and head injury within the previous 48 hours had modest discrimination to stratify PPCS risk at 28 days. Before this score is adopted in clinical practice, further research is needed for external validation, assessment of accuracy in an office setting, and determination of clinical utility.	[Barrowman, Nick; McGahern, Candice; Aglipay, Mary; Kamil, Yael; Grool, Anne M.] Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd,Room R-139, Ottawa, ON K1H 8L1, Canada; [Zemek, Roger; Farion, Ken J.; Osmond, Martin H.] Univ Ottawa, Dept Pediat, Childrens Hosp Eastern Ontario, Ottawa, ON K1N 6N5, Canada; [Freedman, Stephen B.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Res Inst, Calgary, AB T2N 1N4, Canada; [Gravel, Jocelyn] Univ Montreal, Dept Pediat, Hosp Ste Justine, Montreal, PQ H3C 3J7, Canada; [Gagnon, Isabelle; Dubrovsky, Alexander S.] McGill Univ, Dept Pediat, Montreal Childrens Hosp, Ctr Hlth, Montreal, PQ H3A 2T5, Canada; [Sangha, Gurinder] Univ Western Ontario, Dept Pediat, Childrens Hosp ofWestern Ontario, London, ON N6A 3K7, Canada; [Boutis, Kathy] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Beer, Darcy; Klassen, Terry] Manitoba Childrens Hosp, Dept Pediat, Winnipeg, MB, Canada; [Craig, William] Stollery Childrens Hosp, Dept Pediat, Edmonton, AB, Canada; [Burns, Emma] IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada; [Mikrogianakis, Angelo] Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB, Canada; [Barlow, Karen] Univ Calgary, Dept Pediat & Clin Neurosci, Albertas Childrens Hosp, Calgary, AB, Canada; [Meeuwisse, Willem] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Gioia, Gerard] George Washington Univ, Sch Med, Childrens Natl Hlth Syst, Dept Neuropsychol, Rockville, MD USA; [Meehan, William P., III] Boston Childrens Hosp, Sports Concuss Clin, Boston, MA USA; [Beauchamp, Miriam H.] Univ Montreal, Ste Justine Res Ctr, Montreal, PQ, Canada; [Hoshizaki, Blaine] Univ Ottawa, Dept Kinesiol, Ottawa, ON, Canada; [Anderson, Peter] Childrens Hosp Eastern Ontario, Dept Psychol, Ottawa, ON K1H 8L1, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Vassilyadi, Michael] Childrens Hosp Eastern Ontario, Dept Neurosurg, Ottawa, ON K1H 8L1, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Richer, Lawrence] Stollery Childrens Hosp, Dept Neurol, Edmonton, AB, Canada; [DeMatteo, Carol] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; Alberta Childrens Hospital; University of Calgary; Universite de Montreal; McGill University; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Stollery Children's Hospital; Dalhousie University; Alberta Childrens Hospital; University of Calgary; University of Calgary; University of Calgary; George Washington University; Harvard University; Boston Children's Hospital; Universite de Montreal; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; Stollery Children's Hospital; McMaster University	Zemek, R (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, 401 Smyth Rd,Room R-139, Ottawa, ON K1H 8L1, Canada.	rzemek@cheo.on.ca	Yeates, Keith/AAJ-4223-2020; Mikrogianakis, Angelo/AAW-5929-2021; Barrowman, Nick/AAL-3166-2020; Richer, Lawrence/D-3622-2009; Meijer, Anna/K-5118-2016; Zemek, Roger/H-1039-2018; Barlow, Karen/C-1323-2014; Barlow, Karen/I-6492-2019; Freedman, Stephen/H-9102-2012	Mikrogianakis, Angelo/0000-0002-8854-0620; Barrowman, Nick/0000-0002-4704-9595; Richer, Lawrence/0000-0002-6897-8668; Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Burns, Emma/0000-0001-8042-7124; Craig, William/0000-0002-4804-194X; Freedman, Stephen/0000-0003-2319-6192; Yeates, Keith Owen/0000-0001-7680-2892; Klassen, Terry/0000-0002-5309-7091; Osmond, Martin/0000-0001-8275-8381; Gagnon, Isabelle/0000-0003-2043-1644; Gravel, Jocelyn/0000-0001-5901-4990	Canadian Institutes of Health Research [126197, 119829]; Canadian Institutes of Health Research-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team [127047]; Alberta Children's Hospital Foundation Professorship in Child Health and Wellness	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team(Canadian Institutes of Health Research (CIHR)); Alberta Children's Hospital Foundation Professorship in Child Health and Wellness	This study was supported by operating grant 126197 from the Canadian Institutes of Health Research; grant TM1:#127047 from the Canadian Institutes of Health Research-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team; and planning grant MRP: #119829 from the Canadian Institutes of Health Research. Dr Freedman is supported by the Alberta Children's Hospital Foundation Professorship in Child Health and Wellness.	[Anonymous], 2013, Br J Sports Med, V47, P263; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Belisario JSM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000042.pub2; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Graham R, 2013, SPORTS RELATED CONCU; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Steindel SJ, 2010, J AM MED INFORM ASSN, V17, P274, DOI 10.1136/jamia.2009.001230; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550corr1; Zemek R., 2014, GUIDELINES DIAGNOSIN; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	43	440	440	0	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					1014	1025		10.1001/jama.2016.1203	http://dx.doi.org/10.1001/jama.2016.1203			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26954410	Green Published, Bronze			2022-12-28	WOS:000371540200014
J	Levin, M; Kaforou, M				Levin, Michael; Kaforou, Myrsini			Predicting active tuberculosis progression by RNA analysis	LANCET			English	Editorial Material							LATENT TUBERCULOSIS; EXPRESSION; INFECTION		[Levin, Michael; Kaforou, Myrsini] Univ London Imperial Coll Sci Technol & Med, Sect Paediat Infect Dis, Div Infect Dis, Dept Med, London W2 1PG, England	Imperial College London	Levin, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Paediat Infect Dis, Div Infect Dis, Dept Med, London W2 1PG, England.	m.levin@imperial.ac.uk	Kaforou, Myrsini/L-2470-2019	Kaforou, Myrsini/0000-0001-9878-4007; Levin, Michael/0000-0003-2767-6919				Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Esmail H, 2012, DRUG DISCOV TODAY, V17, P514, DOI 10.1016/j.drudis.2011.12.013; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Satproedprai N, 2015, GENES IMMUN, V16, P253, DOI 10.1038/gene.2015.4; Stagg HR, 2014, ANN INTERN MED, V161, P419, DOI 10.7326/M14-1019; World Health Organisation, 2015, GUID MAN LAT TUB INF; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2014, GLOB STRAT TARG TUB; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1	12	7	7	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2268	2270		10.1016/S0140-6736(16)00165-3	http://dx.doi.org/10.1016/S0140-6736(16)00165-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27017311				2022-12-28	WOS:000376969100006
J	Warner, BB; Deych, E; Zhou, Y; Hall-Moore, C; Weinstock, GM; Sodergren, E; Shaikh, N; Hoffmann, JA; Linneman, LA; Hamvas, A; Khanna, G; Rouggly-Nickless, LC; Ndao, IM; Shands, BA; Escobedo, M; Sullivan, JE; Radmacher, PG; Shannon, WD; Tarr, PI				Warner, Barbara B.; Deych, Elena; Zhou, Yanjiao; Hall-Moore, Carla; Weinstock, George M.; Sodergren, Erica; Shaikh, Nurmohammad; Hoffmann, Julie A.; Linneman, Laura A.; Hamvas, Aaron; Khanna, Geetika; Rouggly-Nickless, Lucina C.; Ndao, I. Malick; Shands, Berkley A.; Escobedo, Marilyn; Sullivan, Janice E.; Radmacher, Paula G.; Shannon, William D.; Tarr, Phillip I.			Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study	LANCET			English	Article							EMPIRICAL ANTIBIOTIC-TREATMENT; ONSET; RISK	Background Gut bacteria might predispose to or protect from necrotising enterocolitis, a severe illness linked to prematurity. In this observational prospective study we aimed to assess whether one or more bacterial taxa in the gut differ between infants who subsequently develop necrotising enterocolitis (cases) and those who do not (controls). Methods We enrolled very low birthweight (1500 g and lower) infants in the primary cohort (St Louis Children's Hospital) between July 7, 2009, and Sept 16, 2013, and in the secondary cohorts (Kosair Children's Hospital and Children's Hospital at Oklahoma University) between Sept 12, 2011 and May 25, 2013. We prospectively collected and then froze stool samples for all infants. Cases were defined as infants whose clinical courses were consistent with necrotising enterocolitis and whose radiographs fulfilled criteria for Bell's stage 2 or 3 necrotising enterocolitis. Control infants (one to four per case; not fixed ratios) with similar gestational ages, birthweight, and birth dates were selected from the population after cases were identified. Using primers specific for bacterial 16S rRNA genes, we amplified and then pyrosequenced faecal DNA from stool samples. With use of Dirichlet multinomial analysis and mixed models to account for repeated measures, we identified host factors, including development of necrotising enterocolitis, associated with gut bacterial populations. Findings We studied 2492 stool samples from 122 infants in the primary cohort, of whom 28 developed necrotising enterocolitis; 94 infants were used as controls. The microbial community structure in case stools differed significantly from those in control stools. These differences emerged only after the first month of age. In mixed models, the time-by-necrotising-enterocolitis interaction was positively associated with Gammaproteobacteria (p=0.0010) and negatively associated with strictly anaerobic bacteria, especially Negativicutes (p=0.0019). We studied 1094 stool samples from 44 infants in the secondary cohorts. 18 infants developed necrotising enterocolitis (cases) and 26 were controls. After combining data from all cohorts (166 infants, 3586 stools, 46 cases of necrotising enterocolitis), there were increased proportions of Gammaproteobacteria (p=0.0011) and lower proportions of both Negativicutes (p=0.0013) and the combined Clostridia-Negativicutes class (p=0.0051) in infants who went on to develop necrotising enterocolitis compared with controls. These associations were strongest in both the primary cohort and the overall cohort for infants born at less than 27 weeks' gestation. Interpretation A relative abundance of Gammaproteobacteria (ie, Gram-negative facultative bacilli) and relative paucity of strict anaerobic bacteria (especially Negativicutes) precede necrotising enterocolitis in very low birthweight infants. These data off er candidate targets for interventions to prevent necrotising enterocolitis, at least among infants born at less than 27 weeks' gestation.	[Warner, Barbara B.; Zhou, Yanjiao; Hall-Moore, Carla; Shaikh, Nurmohammad; Hoffmann, Julie A.; Linneman, Laura A.; Hamvas, Aaron; Rouggly-Nickless, Lucina C.; Ndao, I. Malick; Tarr, Phillip I.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Deych, Elena; Shands, Berkley A.; Shannon, William D.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Weinstock, George M.; Sodergren, Erica] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO USA; [Khanna, Geetika] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Tarr, Phillip I.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Escobedo, Marilyn] Univ Oklahoma, Sch Med, Dept Pediat, Oklahoma City, OK USA; [Sullivan, Janice E.; Radmacher, Paula G.] Univ Louisville, Sch Med, Dept Pediat, Louisville, KY 40292 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Louisville	Tarr, PI (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.; Shannon, WD (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	wshannon@dom.wustl.edu; tarr@wustl.edu	Riazi, Gholamhossein/X-9768-2019; Hamvas, Aaron/R-5721-2019; Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Hamvas, Aaron/0000-0002-5749-7797	National Institutes of Health (NIH); Foundation for the NIH; Children's Discovery Institute; NIH [UH3AI083265, U54HG004968, U01HL101465, P30DK052574, UL1TR000448, P30CA091842]; Melvin E Carnahan Professorship (PIT); Children's Discovery Institute of Washington University; St Louis Children's Hospital; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL101465] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UH3AI083265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melvin E Carnahan Professorship (PIT); Children's Discovery Institute of Washington University; St Louis Children's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (NIH), Foundation for the NIH, the Children's Discovery Institute.; The project described was supported by NIH Grant Numbers UH3AI083265, U54HG004968, U01HL101465, P30DK052574 (for the Biobank Core) and UL1TR000448 and P30CA091842 (for REDCap), along with funding from the Melvin E Carnahan Professorship (PIT), and the Children's Discovery Institute of Washington University and the St Louis Children's Hospital. The paper's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. We thank families and clinical staff in the Neonatal Intensive Care Units at the three study sites for their cooperation with our study; Harry Stevens, Kathie Mihindukulasuriya, Brandi Herter, Catherine Hoffmann, Brittany Kurowski, Alisa Moyer, Robert Cristel, Ryan McDonough, and The McDonnell Genome Institute production team for technical assistance; Harry Stevens and William Bennett for laboratory database development; Joanne Nelson and Ally McClure for data deposition; Ann Thomson for artwork; James Johnson and Alexander Mellmann for comments on the manuscript; and Maida Redzic for manuscript preparation.	Afrazi A, 2014, J BIOL CHEM, V289, P9584, DOI 10.1074/jbc.M113.526517; Alexander VN, 2011, J PEDIATR-US, V159, P392, DOI 10.1016/j.jpeds.2011.02.035; AlFaleh K, 2014, COCHRANE DB SYST REV, V4; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; BOYLE R, 1978, J PEDIATR-US, V93, P857, DOI 10.1016/S0022-3476(78)81101-9; Bury RG, 2001, COCHRANE DB SYST REV, V2001, pCD000405, DOI DOI 10.1002/14651858.CD000405; Carl MA, 2014, CLIN INFECT DIS, V58, P1211, DOI 10.1093/cid/ciu084; Carlisle EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018084; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; Costeloe K, 2015, LANCET; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; Gordon PV, 2007, J PERINATOL, V27, P661, DOI 10.1038/sj.jp.7211782; Jensen ML, 2014, AM J PHYSIOL-GASTR L, V306, pG59, DOI 10.1152/ajpgi.00213.2013; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Meinzen-Derr J, 2009, J PERINATOL, V29, P57, DOI 10.1038/jp.2008.117; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Neu Josef, 2005, Semin Pediatr Surg, V14, P137, DOI 10.1053/j.sempedsurg.2005.05.001; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Normann E, 2013, ACTA PAEDIATR, V102, P129, DOI 10.1111/apa.12059; Raveh-Sadka T, 2015, ELIFE, P4; Sim K, 2015, CLIN INFECT DIS, V60, P389, DOI 10.1093/cid/ciu822; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Torrazza RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083304; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Zhou YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118632	31	224	239	3	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1928	1936		10.1016/S0140-6736(16)00081-7	http://dx.doi.org/10.1016/S0140-6736(16)00081-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL1EE	26969089	Green Accepted			2022-12-28	WOS:000375374200037
J	Lauer, MS				Lauer, Michael S.			PCSK9 Inhibitors: Lots of Work Done, Lots More to Do	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARDIOVASCULAR EVENTS; REDUCING LIPIDS; HYPERCHOLESTEROLEMIA; EFFICACY; DISEASE; SAFETY; LDL		[Lauer, Michael S.] NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Lauer, MS (corresponding author), NIH, Off Extramural Res, Bldg 1,1 Ctr Dr, Bethesda, MD 20892 USA.	michael.lauer@nih.gov						Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2013, SCIENCE, V340, P689, DOI 10.1126/science.1239101; Everett BM, 2015, NEW ENGL J MED, V373, P1588, DOI 10.1056/NEJMp1508120; Navarese EP, 2016, ANN INTERN MED, V164, P600, DOI 10.7326/M15-2994; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Williams RS, 2015, CELL, V163, P21, DOI 10.1016/j.cell.2015.09.007	10	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					624	625		10.7326/M16-0422	http://dx.doi.org/10.7326/M16-0422			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	26999561				2022-12-28	WOS:000375744000026
J	Nelles, DA; Fang, MY; O'Connell, MR; Xu, JL; Markmiller, SJ; Doudna, JA; Yeo, GW				Nelles, David A.; Fang, Mark Y.; O'Connell, Mitchell R.; Xu, Jia L.; Markmiller, Sebastian J.; Doudna, Jennifer A.; Yeo, Gene W.			Programmable RNA Tracking in Live Cells with CRISPR/Cas9	CELL			English	Article							STRESS GRANULES; LIVING CELLS; CAS SYSTEM; RECOGNITION; PLATFORM; DNA; LOCALIZATION; NUCLEASES; PROTEINS; DYNAMICS	RNA-programmed genome editing using CRISPR/Cas9 from Streptococcus pyogenes has enabled rapid and accessible alteration of specific genomic loci in many organisms. A flexible means to target RNA would allow alteration and imaging of endogenous RNA transcripts analogous to CRISPR/Cas-based genomic tools, but most RNA targeting methods rely on incorporation of exogenous tags. Here, we demonstrate that nuclease-inactive S. pyogenes CRISPR/Cas9 can bind RNA in a nucleic-acid-programmed manner and allow endogenous RNA tracking in living cells. We show that nuclear-localized RNA-targeting Cas9 (RCas9) is exported to the cytoplasm only in the presence of sgRNAs targeting mRNA and observe accumulation of ACTB, CCNA2, and TFRC mRNAs in RNA granules that correlate with fluorescence in situ hybridization. We also demonstrate time-resolved measurements of ACTB mRNA trafficking to stress granules. Our results establish RCas9 as a means to track RNA in living cells in a programmable manner without genetically encoded tags.	[Nelles, David A.; Fang, Mark Y.; Xu, Jia L.; Markmiller, Sebastian J.; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92037 USA; [Nelles, David A.; Fang, Mark Y.; Xu, Jia L.; Markmiller, Sebastian J.; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92037 USA; [Nelles, David A.; Yeo, Gene W.] Univ Calif San Diego, Mat Sci & Engn Grad Program, La Jolla, CA 92093 USA; [Yeo, Gene W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 1190777, Singapore; [O'Connell, Mitchell R.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [O'Connell, Mitchell R.; Doudna, Jennifer A.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National University of Singapore; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Yeo, GW (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92037 USA.; Yeo, GW (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92037 USA.; Yeo, GW (corresponding author), Univ Calif San Diego, Mat Sci & Engn Grad Program, La Jolla, CA 92093 USA.; Yeo, GW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 1190777, Singapore.	geneyeo@ucsd.edu	Yeo, Gene/AAE-7676-2019	Yeo, Gene/0000-0002-0799-6037; O'Connell, Mitchell/0000-0002-8642-3973	NIH [HG004659, NS075449]; California Institute of Regenerative Medicine [RB3-05009, RB4-06045]; National Science Foundation Graduate Research Fellowship [DGE-1144086]; Powell-Focht graduate fellowship; CJ Martin fellowship from the National Health and Medical Research Council (Australia); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Powell-Focht graduate fellowship; CJ Martin fellowship from the National Health and Medical Research Council (Australia); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge members of the G.W.Y. lab, particularly Ashleigh Schaffer, Stefan Aigner, and Ron Batra for critical comments. This work was supported by grants from the NIH (HG004659 and NS075449) and from the California Institute of Regenerative Medicine (RB3-05009 and RB4-06045) to G.W.Y. D.A.N. is supported by the National Science Foundation Graduate Research Fellowship (DGE-1144086) and Powell-Focht graduate fellowship. M.R.O. is supported by a CJ Martin fellowship from the National Health and Medical Research Council (Australia). J.A.D. is a Howard Hughes Medical Institute Investigator. G.W.Y. is an Alfred P. Sloan Research Fellow. J.A.D. is a co-founder of Editas Medicine, Intellia Therapeutics, and Caribou Biosciences and a scientific advisor to Caribou, Intellia, eFFECTOR Therapeutics, and Driver.	Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chou HH, 2004, BIOINFORMATICS, V20, P2893, DOI 10.1093/bioinformatics/bth347; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Filipovska A, 2011, NAT CHEM BIOL, V7, P425, DOI [10.1038/NCHEMBIO.577, 10.1038/nchembio.577]; Fouts DE, 1997, NUCLEIC ACIDS RES, V25, P4464, DOI 10.1093/nar/25.22.4464; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MANDERS EMM, 1992, J CELL SCI, V103, P857; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Price AA, 2015, P NATL ACAD SCI USA, V112, P6164, DOI 10.1073/pnas.1422340112; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Sachdeva G, 2014, NUCLEIC ACIDS RES, V42, P9493, DOI 10.1093/nar/gku617; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sokol DL, 1998, P NATL ACAD SCI USA, V95, P11538, DOI 10.1073/pnas.95.20.11538; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Unsworth H, 2010, FASEB J, V24, P3370, DOI 10.1096/fj.09-151142; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Wernersson R, 2005, NUCLEIC ACIDS RES, V33, pW611, DOI 10.1093/nar/gki399; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Yang DS, 2014, J MOL CELL BIOL, V6, P97, DOI 10.1093/jmcb/mjt047; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	36	341	366	8	221	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					488	496		10.1016/j.cell.2016.02.054	http://dx.doi.org/10.1016/j.cell.2016.02.054			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	26997482	Bronze, Green Accepted			2022-12-28	WOS:000374123000025
J	Sagi, I; Chia, G; Golan-Lev, T; Peretz, M; Weissbein, U; Sui, L; Sauer, MV; Yanuka, O; Egli, D; Benvenisty, N				Sagi, Ido; Chia, Gloryn; Golan-Lev, Tamar; Peretz, Mordecai; Weissbein, Uri; Sui, Lina; Sauer, Mark V.; Yanuka, Ofra; Egli, Dieter; Benvenisty, Nissim			Derivation and differentiation of haploid human embryonic stem cells	NATURE			English	Article							IN-VITRO; NUCLEAR TRANSFER; SOMATIC-CELLS; MOUSE EMBRYOS; GENERATION; LINES; INACTIVATION; PIGGYBAC; GENOME; GENE	Diploidy is a fundamental genetic feature in mammals, in which haploid cells normally arise only as post-meiotic germ cells that serve to ensure a diploid genome upon fertilization. Gamete manipulation has yielded haploid embryonic stem (ES) cells from several mammalian species(1-6), but haploid human ES cells have yet to be reported. Here we generated and analysed a collection of human parthenogenetic ES cell lines originating from haploid oocytes, leading to the successful isolation and maintenance of human ES cell lines with a normal haploid karyotype. Haploid human ES cells exhibited typical pluripotent stem cell characteristics, such as self-renewal capacity and a pluripotency-specific molecular signature. Moreover, we demonstrated the utility of these cells as a platform for loss-of-function genetic screening. Although haploid human ES cells resembled their diploid counterparts, they also displayed distinct properties including differential regulation of X chromosome inactivation and of genes involved in oxidative phosphorylation, alongside reduction in absolute gene expression levels and cell size. Surprisingly, we found that a haploid human genome is compatible not only with the undifferentiated pluripotent state, but also with differentiated somatic fates representing all three embryonic germ layers both in vitro and in vivo, despite a persistent dosage imbalance between the autosomes and X chromosome. We expect that haploid human ES cells will provide novel means for studying human functional genomics and development.	[Sagi, Ido; Golan-Lev, Tamar; Peretz, Mordecai; Weissbein, Uri; Yanuka, Ofra; Benvenisty, Nissim] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Azrieli Ctr Stem Cells & Genet Res, Dept Genet, IL-91904 Jerusalem, Israel; [Chia, Gloryn; Sui, Lina; Egli, Dieter] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Ctr Womens Reprod Care, New York, NY 10019 USA; [Egli, Dieter] New York Stem Cell Fdn Res Inst, New York, NY 10032 USA	Hebrew University of Jerusalem; Columbia University; Columbia University	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Silberman Inst Life Sci, Azrieli Ctr Stem Cells & Genet Res, Dept Genet, IL-91904 Jerusalem, Israel.; Egli, D (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10032 USA.; Egli, D (corresponding author), New York Stem Cell Fdn Res Inst, New York, NY 10032 USA.	de2220@cumc.columbia.edu; nissimb@cc.huji.ac.il	Sui, Lina/I-4830-2019	Sui, Lina/0000-0002-5876-2409	Adams Fellowships Program; A*STAR International Fellowship; Rosetrees Trust; Azrieli Foundation; Russell Berrie Foundation Program in Cellular Therapies of Diabetes; New York State Stem Cell Science (NYSTEM) IIRP Award [C026184]; New York Stem Cell Foundation; Rosetrees Trust [M108-F1] Funding Source: researchfish	Adams Fellowships Program; A*STAR International Fellowship(Agency for Science Technology & Research (A*STAR)); Rosetrees Trust(Rosetrees Trust); Azrieli Foundation; Russell Berrie Foundation Program in Cellular Therapies of Diabetes; New York State Stem Cell Science (NYSTEM) IIRP Award; New York Stem Cell Foundation; Rosetrees Trust(Rosetrees Trust)	We thank all members of the Benvenisty and Egli laboratories for input and support. We thank Y. Avior and W. Breuer for their assistance with experimental procedures. I.S. is supported by the Adams Fellowships Program for Doctoral Students, G.C. is supported by the A*STAR International Fellowship, U.W. is a Clore Fellow, D.E. is a NYSCF-Robertson Investigator, and N.B. is the Herbert Cohn Chair in Cancer Research. This work was partially supported by The Rosetrees Trust and by The Azrieli Foundation (to N.B.), by the Russell Berrie Foundation Program in Cellular Therapies of Diabetes, by the New York State Stem Cell Science (NYSTEM) IIRP Award number C026184, and by the New York Stem Cell Foundation (to D.E.).	Ben-David U, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2992; Biancotti JC, 2012, STEM CELL RES, V9, P218, DOI 10.1016/j.scr.2012.07.002; Bruck T, 2013, CELL REP, V4, P262, DOI 10.1016/j.celrep.2013.06.026; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chen L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-93; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Egli D, 2011, CELL STEM CELL, V9, P293, DOI 10.1016/j.stem.2011.08.002; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Hua H, 2013, J CLIN INVEST, V123, P3146, DOI 10.1172/JCI67638; Johannesson B, 2014, CELL STEM CELL, V15, P634, DOI 10.1016/j.stem.2014.10.002; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kim K, 2007, CELL STEM CELL, V1, P346, DOI 10.1016/j.stem.2007.07.001; Leeb M, 2012, DEVELOPMENT, V139, P3301, DOI 10.1242/dev.083675; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li W, 2014, CELL STEM CELL, V14, P404, DOI 10.1016/j.stem.2013.11.016; Li W, 2012, NATURE, V490, P407, DOI 10.1038/nature11435; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Otto SP, 2001, SCIENCE, V292, P2441, DOI 10.1126/science.1062890; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Rao Pulivarthi H., 2007, V383, P165, DOI 10.1007/978-1-59745-335-6_11; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Stelzer Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3724; Takahashi S, 2014, DEVELOPMENT, V141, P3842, DOI 10.1242/dev.110726; TARKOWSKI AK, 1970, NATURE, V226, P163, DOI 10.1038/226162a0; Wanet A, 2014, INT J BIOCHEM CELL B, V54, P174, DOI 10.1016/j.biocel.2014.07.015; Wang L, 2015, J CLIN INVEST, V125, P796, DOI 10.1172/JCI79220; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wutz A, 2014, ANNU REV CELL DEV BI, V30, P705, DOI 10.1146/annurev-cellbio-100913-012920; Yamada M, 2014, NATURE, V510, P533, DOI 10.1038/nature13287; Yang H, 2013, CELL RES, V23, P1187, DOI 10.1038/cr.2013.93; Yang H, 2012, CELL, V149, P605, DOI 10.1016/j.cell.2012.04.002	41	96	108	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					107	+		10.1038/nature17408	http://dx.doi.org/10.1038/nature17408			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	26982723				2022-12-28	WOS:000373555500043
J	Nuber, S; Zabel, U; Lorenz, K; Nuber, A; Milligan, G; Tobin, AB; Lohse, MJ; Hoffmann, C				Nuber, Susanne; Zabel, Ulrike; Lorenz, Kristina; Nuber, Andreas; Milligan, Graeme; Tobin, Andrew B.; Lohse, Martin J.; Hoffmann, Carsten			beta-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle	NATURE			English	Article							G-PROTEIN; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; 48-KDA PROTEIN; ACTIVATION; BINDING; RHODOPSIN; ENERGY; SPECIFICITY; COMPLEX	(beta-) Arrestins are important regulators of G-protein-coupled receptors (GPCRs)(1-3). They bind to active, phosphorylated GPCRs and thereby shut off 'classical' signalling to G proteins(3,)4, trigger internalization of GPCRs via interaction with the clathrin machinery(5-7) and mediate signalling via 'non-classical' pathways(1,2). In addition to two visual arrestins that bind to rod and cone photoreceptors (termed arrestin1 and arrestin4), there are only two (non-visual) beta-arrestin proteins (beta-arrestin1 and beta-arrestin2, also termed arrestin2 and arrestin3), which regulate hundreds of different (non-visual) GPCRs. Binding of these proteins to GPCRs usually requires the active form of the receptors plus their phosphorylation by G-protein-coupled receptor kinases (GRKs)(1,3,4). The binding of receptors or their carboxy terminus as well as certain truncations induce active conformations of (beta-) arrestins that have recently been solved by X-ray crystallography(8-10). Here we investigate both the interaction of beta-arrestin with GPCRs, and the beta-arrestin conformational changes in real time and in living human cells, using a series of fluorescence resonance energy transfer (FRET)-based beta-arrestin2 biosensors. We observe receptor-specific patterns of conformational changes in beta-arrestin2 that occur rapidly after the receptor-beta-arrestin2 interaction. After agonist removal, these changes persist for longer than the direct receptor interaction. Our data indicate a rapid, receptor-type-specific, two-step binding and activation process between GPCRs and beta-arrestins. They further indicate that beta-arrestins remain active after dissociation from receptors, allowing them to remain at the cell surface and presumably signal independently. Thus, GPCRs trigger a rapid, receptor-specific activation/deactivation cycle of beta-arrestins, which permits their active signalling.	[Nuber, Susanne; Zabel, Ulrike; Lorenz, Kristina; Nuber, Andreas; Lohse, Martin J.; Hoffmann, Carsten] Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany; [Nuber, Susanne; Zabel, Ulrike; Lohse, Martin J.; Hoffmann, Carsten] Univ Wurzburg, Rudolf Virchow Ctr, Versbacher Str 9, D-97078 Wurzburg, Germany; [Lorenz, Kristina; Lohse, Martin J.] Univ Wurzburg, Comprehens Heart Failure Ctr, Versbacher Str 9, D-97078 Wurzburg, Germany; [Milligan, Graeme] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Tobin, Andrew B.] Univ Leicester, MRC Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England; [Lorenz, Kristina] Leibniz Inst Analyt Sci ISAS, Bunsen Kirchhoff Str 11, D-44139 Dortmund, Germany; [Lohse, Martin J.] Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Glasgow; University of Leicester; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Lohse, MJ; Hoffmann, C (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.; Lohse, MJ; Hoffmann, C (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, Versbacher Str 9, D-97078 Wurzburg, Germany.; Lohse, MJ (corresponding author), Univ Wurzburg, Comprehens Heart Failure Ctr, Versbacher Str 9, D-97078 Wurzburg, Germany.; Lohse, MJ (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	lohse@toxi.uni-wuerzburg.de; c.hoffmann@toxi.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012; Lorenz, Kristina/F-3522-2016	Lohse, Martin J/0000-0002-0599-3510; Lorenz, Kristina/0000-0002-5747-2207	Deutsche Forschungsgemeinschaft [SFB-487 TPA1, SFB-TR166]; Bundesministerium fur Bildung und Forschung grant OptiMAR; ERC; NIH [1 R01 DA038882]; Biotechnology and Biological Sciences Research Council [BB/K019864/1]; BBSRC [BB/K019864/1] Funding Source: UKRI; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA038882] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung grant OptiMAR(Federal Ministry of Education & Research (BMBF)); ERC(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank N. Ziegler, N. Yurdagul-Hemmrich and M. Fischer for technical assistance and C. Krasel for discussions. This work was supported by the Deutsche Forschungsgemeinschaft grants SFB-487 TPA1 and SFB-TR166 (M.J.L. and C.H.), the Bundesministerium fur Bildung und Forschung grant OptiMAR (M.J.L.), the ERC grants Topas and Fresca and the NIH grant 1 R01 DA038882 (M.J.L.), the Biotechnology and Biological Sciences Research Council (grant BB/K019864/1 to G.M.)	Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2009, N-S ARCH PHARMACOL, V379, P435, DOI 10.1007/s00210-008-0383-7; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kang DS, 2013, METHOD ENZYMOL, V521, P91, DOI 10.1016/B978-0-12-391862-8.00005-3; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Klenk C, 2010, J BIOL CHEM, V285, P30355, DOI 10.1074/jbc.M110.114900; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; Lee M.-H., NATURE; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Lohse Martin J, 2014, Handb Exp Pharmacol, V219, P15, DOI 10.1007/978-3-642-41199-1_2; Lohse MJ, 2013, NATURE, V495, P457, DOI 10.1038/nature12086; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; SOHLEMANN P, 1995, EUR J BIOCHEM, V232, P464, DOI 10.1111/j.1432-1033.1995.tb20832.x; Sykes DA, 2014, MOL PHARMACOL, V85, P608, DOI 10.1124/mol.113.090209; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Zurn A, 2010, BIOCONJUGATE CHEM, V21, P853, DOI 10.1021/bc900394j	38	135	137	0	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					661	+		10.1038/nature17198	http://dx.doi.org/10.1038/nature17198			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27007855	Green Accepted			2022-12-28	WOS:000373027400043
J	Goolam, M; Scialdone, A; Graham, SJL; Macaulay, IC; Jedrusik, A; Hupalowska, A; Voet, T; Marioni, JC; Zernicka-Goetz, M				Goolam, Mubeen; Scialdone, Antonio; Graham, Sarah J. L.; Macaulay, Iain C.; Jedrusik, Agnieszka; Hupalowska, Anna; Voet, Thierry; Marioni, John C.; Zernicka-Goetz, Magdalena			Heterogeneity in Oct4 and Sox2 Targets Biases Cell Fate in 4-Cell Mouse Embryos	CELL			English	Article							RNA-SEQ; REGULATES PLURIPOTENCY; SPATIAL ARRANGEMENT; GENE-EXPRESSION; TROPHECTODERM; BLASTOMERES; CLEAVAGE; MASS; DIFFERENTIATION; SPECIFICATION	The major and essential objective of pre-implantation development is to establish embryonic and extra-embryonic cell fates. To address when and how this fundamental process is initiated in mammals, we characterize transcriptomes of all individual cells throughout mouse pre-implantation development. This identifies targets of master pluripotency regulators Oct4 and Sox2 as being highly heterogeneously expressed between blastomeres of the 4-cell embryo, with Sox21 showing one of the most heterogeneous expression profiles. Live-cell tracking demonstrates that cells with decreased Sox21 yield more extra-embryonic than pluripotent progeny. Consistently, decreasing Sox21 results in premature upregulation of the differentiation regulator Cdx2, suggesting that Sox21 helps safeguard pluripotency. Furthermore, Sox21 is elevated followig increased expression of the histone H3R26-methylase CARM1 and is lowered following CARM1 inhibition, indicating the importance of epigenetic regulation. Therefore, our results indicate that heterogeneous gene expressionn, as early as the 4-cell stage, initiates cell-fate decisions by modulating the balance of pluripotency and differentiation.	[Goolam, Mubeen; Graham, Sarah J. L.; Jedrusik, Agnieszka; Hupalowska, Anna; Zernicka-Goetz, Magdalena] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England; [Scialdone, Antonio; Marioni, John C.] European Bioinformat Inst, EMBL, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Scialdone, Antonio; Macaulay, Iain C.; Voet, Thierry; Marioni, John C.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Voet, Thierry] Katholieke Univ Leuven, Dept Human Genet, Lab Reprod Genom, Herestr 49, B-3000 Leuven, Belgium; [Marioni, John C.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	University of Cambridge; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; KU Leuven; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Zernicka-Goetz, M (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.; Marioni, JC (corresponding author), European Bioinformat Inst, EMBL, Wellcome Genome Campus, Cambridge CB10 1SD, England.; Marioni, JC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.; Marioni, JC (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England.	marioni@ebi.ac.uk; mz205@cam.ac.uk	Voet, Thierry/E-8877-2017; Goolam, Mubeen/AAL-1787-2020	Voet, Thierry/0000-0003-1204-9963; Goolam, Mubeen/0000-0003-3506-607X; Macaulay, Iain/0000-0002-6761-757X; Graham, Sarah/0000-0002-3021-5542; Scialdone, Antonio/0000-0002-4956-2843; Zernicka-Goetz, Magdalena/0000-0002-7004-2471; Marioni, John/0000-0001-9092-0852	Wellcome Trust; EMBL; CRUK; KU Leuven SymBioSys [PFV/10/016]; Cancer Research UK [22231] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EMBL; CRUK(Cancer Research UK); KU Leuven SymBioSys(KU Leuven); Cancer Research UK(Cancer Research UK)	We are grateful to the Wellcome Trust, EMBL, and CRUK for supporting our work and our colleagues: M. Shahbazi, D. Glover, and F. Antonica for feedback and G. Recher for imaging assistance. T.V. also acknowledges KU Leuven SymBioSys (PFV/10/016).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bischoff M, 2008, DEVELOPMENT, V135, P953, DOI 10.1242/dev.014316; Blase FH, 2014, GENOME RES, V24, P1787, DOI 10.1101/gr.177725.114; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Burton A, 2013, CELL REP, V5, P687, DOI 10.1016/j.celrep.2013.09.044; Chakravarthy H, 2011, FASEB J, V25, P206, DOI 10.1096/fj.10-166926; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; Gardner RL, 2002, HUM REPROD, V17, P3178, DOI 10.1093/humrep/17.12.3178; Goke J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002304; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; HILLMAN N, 1972, J EMBRYOL EXP MORPH, V28, P263; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kiso M, 2009, P NATL ACAD SCI USA, V106, P9292, DOI 10.1073/pnas.0808324106; Kuzmichev AN, 2012, CURR BIOL, V22, P1705, DOI 10.1016/j.cub.2012.07.013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; McDole K, 2011, DEV BIOL, V355, P239, DOI 10.1016/j.ydbio.2011.04.024; Morris SA, 2012, CELL REP, V2, P756, DOI 10.1016/j.celrep.2012.08.029; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Parfitt DE, 2010, MOL BIOL CELL, V21, P2649, DOI 10.1091/mbc.E10-01-0053; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Piotrowska-Nitsche K, 2005, MECH DEVELOP, V122, P487, DOI 10.1016/j.mod.2004.11.014; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; Samarage CR, 2015, DEV CELL, V34, P435, DOI 10.1016/j.devcel.2015.07.004; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Shi JC, 2015, DEVELOPMENT, V142, P3468, DOI 10.1242/dev.123950; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tabansky I, 2013, CURR BIOL, V23, P21, DOI 10.1016/j.cub.2012.10.054; Takaoka K, 2012, DEVELOPMENT, V139, P3, DOI 10.1242/dev.060095; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; TARKOWSKI AK, 1959, NATURE, V184, P1286, DOI 10.1038/1841286a0; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Watanabe T, 2014, DEVELOPMENT, V141, P2279, DOI 10.1242/dev.103267; Wu Q, 2009, STEM CELLS, V27, P2637, DOI 10.1002/stem.131; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564	46	240	249	2	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					61	74		10.1016/j.cell.2016.01.047	http://dx.doi.org/10.1016/j.cell.2016.01.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015307	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000372785600010
J	Li, B; Wang, F; Zhou, D; Peng, Y; Ni, R; Han, YL				Li, Bo; Wang, Feng; Zhou, Di; Peng, Yi; Ni, Ran; Han, Yilong			Modes of surface premelting in colloidal crystals composed of attractive particles	NATURE			English	Article							2 DIMENSIONS; TRANSITIONS; ICE; SIMULATION; INTERFACE; DYNAMICS; DISORDER; PHASE	Crystal surfaces typically melt into a thin liquid layer at temperatures slightly below the melting point of the crystal. Such surface premelting is prevalent in all classes of solids and is important in a variety of metallurgical, geological and meteorological phenomena(1). Premelting has been studied using X-ray diffraction(2) and differential scanning calorimetry(3), but the lack of single-particle resolution makes it hard to elucidate the underlying mechanisms. Colloids are good model systems for studying phase transitions(4) because the thermal motions of individual micrometre-sized particles can be tracked directly using optical microscopy(5). Here we use colloidal spheres with tunable attractions to form equilibrium crystal-vapour interfaces, and study their surface premelting behaviour at the single-particle level. We find that monolayer colloidal crystals exhibit incomplete premelting at their perimeter, with a constant liquid-layer thickness. In contrast, two-and three-layer crystals exhibit conventional complete melting, with the thickness of the surface liquid diverging as the melting point is approached. The microstructures of the surface liquids differ in certain aspects from what would be predicted by conventional premelting theories. Incomplete premelting in the monolayer crystals is triggered by a bulk isostructural solid-solid transition and truncated by a mechanical instability that separately induces homogeneous melting within the bulk. This finding is in contrast to the conventional assumption that two-dimensional crystals melt heterogeneously from their free surfaces(3,6) (that is, at the solid-vapour interface). The unexpected bulk melting that we observe for the monolayer crystals is accompanied by the formation of grain boundaries, which supports a previously proposed grain-boundary-mediated two-dimensional melting theory(7). The observed interplay between surface premelting, bulk melting and solid-solid transitions challenges existing theories of surface premelting and two-dimensional melting.	[Li, Bo; Wang, Feng; Zhou, Di; Peng, Yi; Han, Yilong] Hong Kong Univ Sci & Technol, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Ni, Ran] Nanyang Technol Univ, Sch Chem & Biomed Engn, 62 Nanyang Dr, Singapore 637459, Singapore; [Ni, Ran] Univ Amsterdam, Vant Hoff Inst Mol Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands	Hong Kong University of Science & Technology; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Amsterdam	Han, YL (corresponding author), Hong Kong Univ Sci & Technol, Dept Phys, Hong Kong, Hong Kong, Peoples R China.	yilong@ust.hk	Ni, Ran/B-3274-2008	Ni, Ran/0000-0001-9478-0674; Peng, Yi/0000-0003-1132-7140; Li, Bo/0000-0003-3596-5542	RGC [GRF601911, GRF16301514, C6004-14G]; NWO VENI grant [680-47-441]; Nanyang Technological University	RGC(Hong Kong Research Grants Council); NWO VENI grant; Nanyang Technological University(Nanyang Technological University)	We thank X. Cao and M. Liao for the discussions and Chromatech Inc. for the dye sample. This study was supported by RGC grants GRF601911, GRF16301514 and C6004-14G (Y.H.) and an NWO VENI grant 680-47-441 and the Start-Up Grant from Nanyang Technological University (R.N.).	Alsayed AM, 2005, SCIENCE, V309, P1207, DOI 10.1126/science.1112399; BOLHUIS P, 1994, PHYS REV LETT, V72, P2211, DOI 10.1103/PhysRevLett.72.2211; BROUGHTON JQ, 1987, J PHYS CHEM-US, V91, P6347, DOI 10.1021/j100309a009; CARNEVALI P, 1987, PHYS REV B, V36, P6701, DOI 10.1103/PhysRevB.36.6701; CHUI ST, 1982, PHYS REV LETT, V48, P933, DOI 10.1103/PhysRevLett.48.933; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Dash JG, 2006, REV MOD PHYS, V78, P695, DOI 10.1103/RevModPhys.78.695; Dash JG, 1999, REV MOD PHYS, V71, P1737, DOI 10.1103/RevModPhys.71.1737; DiTolla FD, 1997, SURF SCI, V377, P499, DOI 10.1016/S0039-6028(96)01435-5; ELBAUM M, 1993, J CRYST GROWTH, V129, P491, DOI 10.1016/0022-0248(93)90483-D; FRENKEN JWM, 1985, PHYS REV LETT, V54, P134, DOI 10.1103/PhysRevLett.54.134; HALPERIN BI, 1978, PHYS REV LETT, V41, P121, DOI 10.1103/PhysRevLett.41.121; Han Y, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041406; Hertlein C, 2008, NATURE, V451, P172, DOI 10.1038/nature06443; Kapfer SC, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.035702; KARIM OA, 1988, J CHEM PHYS, V89, P6889, DOI 10.1063/1.455363; Lee S, 2008, NATURE, V451, P805, DOI 10.1038/nature06507; Li B, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2015.11; LIPOWSKY R, 1983, Z PHYS B CON MAT, V51, P165, DOI 10.1007/BF01308770; Nosenko V, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.015001; PLUIS B, 1990, SURF SCI, V239, P282, DOI 10.1016/0039-6028(90)90231-V; Qi WK, 2015, SOFT MATTER, V11, P2852, DOI 10.1039/c4sm02876g; Rogers WB, 2015, SCIENCE, V347, P639, DOI 10.1126/science.1259762; Savage JR, 2006, SCIENCE, V314, P795, DOI 10.1126/science.1128649; Still T, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012301; STRANDBURG KJ, 1988, REV MOD PHYS, V60, P161, DOI 10.1103/RevModPhys.60.161; VANDERGON AWD, 1991, SURF SCI, V241, P335, DOI 10.1016/0039-6028(91)90093-8; von Grunberg HH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.255703; Yang Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.096102; Zahn K, 1999, PHYS REV LETT, V82, P2721, DOI 10.1103/PhysRevLett.82.2721; ZHU DM, 1988, PHYS REV B, V37, P5586, DOI 10.1103/PhysRevB.37.5586	31	53	55	8	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					485	488		10.1038/nature16987	http://dx.doi.org/10.1038/nature16987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26976448	Green Published			2022-12-28	WOS:000372701300036
J	Eisenstein, M				Eisenstein, Michael			LIVING FACTORIES OF THE FUTURE	NATURE			English	Editorial Material							SYNTHETIC BIOLOGY											Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Galdzicki M, 2014, NAT BIOTECHNOL, V32, P545, DOI 10.1038/nbt.2891; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Sainz de Murieta I., 2016, ACS SYNTH BIOL; Schukur L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4964; Sullivan CJ, 2016, BIOTECHNOL J, V11, P238, DOI 10.1002/biot.201500214	6	25	26	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					401	403		10.1038/531401a	http://dx.doi.org/10.1038/531401a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26983542	Bronze			2022-12-28	WOS:000372064300062
J	Salomon, DR				Salomon, Daniel R.			A CRISPR Way to Block PERVs - Engineering Organs for Transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							XENOTRANSPLANTATION; NUCLEASES		[Salomon, Daniel R.] Scripps Res Inst, Dept Mol & Expt Med, San Diego, CA USA	Scripps Research Institute	Salomon, DR (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, San Diego, CA USA.							CHAPMAN LE, 1995, NEW ENGL J MED, V333, P1498, DOI 10.1056/NEJM199511303332211; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; van der Laan LJW, 2000, NATURE, V407, P90, DOI 10.1038/35024089; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191	5	16	20	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1089	1091		10.1056/NEJMcibr1515623	http://dx.doi.org/10.1056/NEJMcibr1515623			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4TR	26981939				2022-12-28	WOS:000372066100016
J	Saukkonen, K; Sharma, A; Mark, EJ				Saukkonen, Kai; Sharma, Amita; Mark, Eugene J.			Case 8-2016: A 71-Year-Old Man with Recurrent Fevers, Hypoxemia, and Lung Infiltrates	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UPDATE; CLASSIFICATION; DIAGNOSIS		[Saukkonen, Kai] Massachusetts Gen Hosp, Dept Pulm & Crit Care, Boston, MA 02114 USA; [Sharma, Amita] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Saukkonen, Kai] Harvard Univ, Sch Med, Dept Pulm & Crit Care, Boston, MA 02115 USA; [Sharma, Amita] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Saukkonen, K (corresponding author), Massachusetts Gen Hosp, Dept Pulm & Crit Care, Boston, MA 02114 USA.; Saukkonen, K (corresponding author), Harvard Univ, Sch Med, Dept Pulm & Crit Care, Boston, MA 02115 USA.							Hanak V, 2007, MAYO CLIN PROC, V82, P812, DOI 10.4065/82.7.812; Lee YC, 2005, J THORAC CARDIOV SUR, V129, P984, DOI 10.1016/j.jtcvs.2004.07.033; Ryerson CJ, 2013, CURR OPIN PULM MED, V19, P453, DOI 10.1097/MCP.0b013e328363f48d; Schlesinger C, 2005, CURR OPIN PULM MED, V11, P422, DOI 10.1097/01.mcp.0000175521.41729.07; Selman M, 2012, AM J RESP CRIT CARE, V186, P314, DOI 10.1164/rccm.201203-0513CI; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Wechsler ME, 2007, IMMUNOL ALLERGY CLIN, V27, P477, DOI 10.1016/j.iac.2007.07.005; Wells AU, 2008, THORAX, V63, DOI 10.1136/thx.2008.101691	8	1	1	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1077	1085		10.1056/NEJMcpc1505680	http://dx.doi.org/10.1056/NEJMcpc1505680			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4TR	26981938				2022-12-28	WOS:000372066100014
J	Kuzma, J				Kuzma, Jennifer			Reboot the debate on genetic engineerin	NATURE			English	Editorial Material									[Kuzma, Jennifer] N Carolina State Univ, Social Sci, Raleigh, NC 27695 USA; [Kuzma, Jennifer] N Carolina State Univ, Genet Engn & Soc Ctr, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Kuzma, J (corresponding author), N Carolina State Univ, Social Sci, Raleigh, NC 27695 USA.; Kuzma, J (corresponding author), N Carolina State Univ, Genet Engn & Soc Ctr, Raleigh, NC 27695 USA.	jkuzma@ncsu.edu		Kuzma, Jennifer/0000-0003-4456-9613				Animal and Plant Health Inspection Service, 2016, FED REGISTER, V81, P6225; [Anonymous], 1986, FED REGISTER, V51; Huang SW, 2016, NAT GENET, V48, P109, DOI 10.1038/ng.3484; Kokotovich A., 2014, Bulletin of Science, Technology and Society, V34, P108; Potrykus I, 2010, NEW BIOTECHNOL, V27, P466, DOI 10.1016/j.nbt.2010.07.012; Ramachandran G, 2011, J NANOPART RES, V13, P1345, DOI 10.1007/s11051-011-0233-2; Waltz E, 2015, NAT BIOTECHNOL, V33, P1221, DOI 10.1038/nbt1215-1221; Wolt JD, 2016, PLANT BIOTECHNOL J, V14, P510, DOI 10.1111/pbi.12444; 2015, NATURE, V528, P319	9	48	49	0	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					165	167		10.1038/531165a	http://dx.doi.org/10.1038/531165a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF9EZ	26961641	Bronze			2022-12-28	WOS:000371665100015
J	Munoz-Sanjuan, I				Munoz-Sanjuan, Ignacio			Support communities involved in disease studies	NATURE			English	Editorial Material									[Munoz-Sanjuan, Ignacio] CHDI Fdn, Biol, Los Angeles, CA USA; [Munoz-Sanjuan, Ignacio] Factor H, Los Angeles, CA USA		Munoz-Sanjuan, I (corresponding author), CHDI Fdn, Biol, Los Angeles, CA USA.; Munoz-Sanjuan, I (corresponding author), Factor H, Los Angeles, CA USA.	ignacio.munoz@chdifoundation.org							0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					141	141		10.1038/531141a	http://dx.doi.org/10.1038/531141a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF9EZ	26961621	Bronze			2022-12-28	WOS:000371665100006
J	Schwartz, AB				Schwartz, Andrew B.			Movement: How the Brain Communicates with the World	CELL			English	Review							MOTOR CORTICAL ACTIVITY; OPTIMAL FEEDBACK-CONTROL; ARM MOVEMENTS; REACHING MOVEMENTS; COMPUTER INTERFACE; POPULATION REPRESENTATION; DRAWING MOVEMENTS; STRETCH-RECEPTOR; AIMED MOVEMENTS; NEUROPROSTHETIC CONTROL	Voluntary movement is a result of signals transmitted through a communication channel that links the internal world in our minds to the physical world around us. Intention can be considered the desire to effect change on our environment, and this is contained in the signals from the brain, passed through the nervous system to converge on muscles that generate displacements and forces on our surroundings. The resulting changes in the world act to generate sensations that feed back to the nervous system, closing the control loop. This Perspective discusses the experimental and theoretical underpinnings of current models of movement generation and the way they are modulated by external information. Movement systems embody intentionality and prediction, two factors that are propelling a revolution in engineering. Development of movement models that include the complexities of the external world may allow a better understanding of the neuronal populations regulating these processes, as well as the development of solutions for autonomous vehicles and robots, and neural prostheses for those who are motor impaired.	[Schwartz, Andrew B.] Univ Pittsburgh, Sch Med, Dept Neurobiol, E1440 BSTWR,200 Lothrop St, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schwartz, AB (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, E1440 BSTWR,200 Lothrop St, Pittsburgh, PA 15213 USA.	abs21@pitt.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047356, R01NS050256, P30NS076405, RC1NS070311] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS050256, R01 NS047356, P30 NS076405, RC1 NS070311] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Accot J., 1997, P ACM SIGCHI C HUMAN, P295, DOI [10.1145/258549.258760, DOI 10.1145/258549.258760]; Adams RA, 2013, BRAIN STRUCT FUNCT, V218, P611, DOI 10.1007/s00429-012-0475-5; Alexander RM, 1997, BIOL CYBERN, V76, P97, DOI 10.1007/s004220050324; Bard C, 1999, EXP BRAIN RES, V125, P410, DOI 10.1007/s002210050697; BARD C, 1985, CAN J PSYCHOL, V39, P151, DOI 10.1037/h0080120; Beer R., 2008, HDB COGNITIVE SCI EM, P99, DOI DOI 10.1016/B978-0-08-046616-3.00006-2; BEGGS WDA, 1972, Q J EXP PSYCHOL, V24, P448, DOI 10.1080/14640747208400304; BIGUER B, 1982, EXP BRAIN RES, V46, P301; BIZZI E, 1984, J NEUROSCI, V4, P2738; BLOUIN J, 1993, CAN J EXP PSYCHOL, V47, P678, DOI 10.1037/h0078869; BORSELLINO A, 1965, COLD SPRING HARB SYM, V30, P581, DOI 10.1101/SQB.1965.030.01.056; Brooks R, 2002, FLESH AND MACHINES; BROOKS RA, 1991, SCIENCE, V253, P1227, DOI 10.1126/science.253.5025.1227; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chase SM, 2012, J NEUROPHYSIOL, V108, P624, DOI 10.1152/jn.00371.2011; Chase SM, 2011, PROG BRAIN RES, V192, P103, DOI 10.1016/B978-0-444-53355-5.00007-5; Chase SM, 2010, J NEUROSCI, V30, P13873, DOI 10.1523/JNEUROSCI.2325-10.2010; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; CONRAD B, 1975, BRAIN RES, V94, P219, DOI 10.1016/0006-8993(75)90058-X; COOKE JD, 1984, J MOTOR BEHAV, V16, P348; CORDO PJ, 1989, TRENDS NEUROSCI, V12, P110, DOI 10.1016/0166-2236(89)90167-7; Crevecoeur F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003177; Desmurget M, 2003, BRADFORD BOOKS, P289; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Ebner T, 2008, CEREBELLUM, V7, P583, DOI 10.1007/s12311-008-0059-3; EVARTS EV, 1973, SCIENCE, V179, P501, DOI 10.1126/science.179.4072.501; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; EVARTS EV, 1974, BRAIN RES, V71, P479, DOI 10.1016/0006-8993(74)90992-5; EVARTS EV, 1966, METHOD MED RES, P241; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; FITTS PM, 1964, J EXP PSYCHOL, V67, P103, DOI 10.1037/h0045689; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; FLANAGAN JR, 1993, J MOTOR BEHAV, V25, P140, DOI 10.1080/00222895.1993.9942045; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; FLANDERS M, 1992, BEHAV BRAIN SCI, V15, P309, DOI 10.1017/S0140525X00068813; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FLASH T, 1987, BIOL CYBERN, V57, P257, DOI 10.1007/BF00338819; FLASH T, 1995, HDB BRAIN THEORY NEU, P682; Francois-Franck C.E., 1887, LECONS FONCTIONS MOT; Ganguly K, 2011, NAT NEUROSCI, V14, P662, DOI 10.1038/nn.2797; Georgopoulos A. P., 1984, DYNAMIC ASPECTS NEOC, P501; GEORGOPOULOS AP, 1988, EXP BRAIN RES, V69, P315; GEORGOPOULOS AP, 1992, SCIENCE, V256, P1692, DOI 10.1126/science.256.5064.1692; GEORGOPOULOS AP, 1981, J NEUROPHYSIOL, V46, P725, DOI 10.1152/jn.1981.46.4.725; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GEORGOPOULOS AP, 1983, EXP BRAIN RES, V49, P327; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; Gibson J.J., 1986, ECOLOGICAL APPROACH; Golub M., 2013, P INT C MACH LEARN, P606; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HASAN Z, 1986, BIOL CYBERN, V53, P373, DOI 10.1007/BF00318203; HIGGINS JR, 1970, J EXP PSYCHOL, V84, P412, DOI 10.1037/h0029275; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HOFF B, 1993, J MOTOR BEHAV, V25, P175, DOI 10.1080/00222895.1993.9942048; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; HOLLERBACH JM, 1982, TRENDS NEUROSCI, V5, P189, DOI 10.1016/0166-2236(82)90111-4; Isaacs RE, 2000, IEEE T REHABIL ENG, V8, P196, DOI 10.1109/86.847814; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Jasper H., 1960, ELECTROENCEPHALO S13, V13, P137; Jeannerod M, 2003, BRADFORD BOOKS, P139; Johansson RS, 2008, SENSES COMPREHENSIVE, P67, DOI DOI 10.1016/B978-012370880-9.00346-7; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kaufman MT, 2014, NAT NEUROSCI, V17, P440, DOI 10.1038/nn.3643; KEELE SW, 1968, J EXP PSYCHOL, V77, P155, DOI 10.1037/h0025754; Keller EL, 1996, VISUAL NEUROSCI, V13, P1059, DOI 10.1017/S0952523800007719; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kistemaker DA, 2014, J NEUROPHYSIOL, V112, P1815, DOI 10.1152/jn.00291.2014; Koyama S, 2010, J COMPUT NEUROSCI, V29, P73, DOI 10.1007/s10827-009-0196-9; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Lai SC, 2005, ACTA PSYCHOL, V119, P283, DOI 10.1016/j.actpsy.2005.02.005; Legenstein R, 2010, J NEUROSCI, V30, P8400, DOI 10.1523/JNEUROSCI.4284-09.2010; Levinson J, 2011, IEEE INT VEH SYM, P163, DOI 10.1109/IVS.2011.5940562; Liddell EGT, 1924, P R SOC LOND B-CONTA, V96, P212, DOI 10.1098/rspb.1924.0023; LOEWENSTEIN WR, 1963, SCIENCE, V142, P1180, DOI 10.1126/science.142.3596.1180; LOU JS, 1988, NEUROSCI LETT, V84, P185, DOI 10.1016/0304-3940(88)90405-3; MacKay D. M., 1965, BRAIN CONSCIOUS EXPE, P422; Massey J.T., 1986, EXP BRAIN RES, P242; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; MEYER DE, 1982, PSYCHOL REV, V89, P449, DOI 10.1037/0033-295X.89.5.449; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Moran DW, 1999, J NEUROPHYSIOL, V82, P2693, DOI 10.1152/jn.1999.82.5.2693; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Mountcastle V.B., 1998, THE CEREBRAL CORTEX; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Muelling K, 2015, ARXIV150305451; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Nelissen K, 2011, J NEUROSCI, V31, P3743, DOI 10.1523/JNEUROSCI.4803-10.2011; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; NEWELL KM, 1983, J EXP PSYCHOL HUMAN, V9, P58; Orsborn AL, 2014, NEURON, V82, P1380, DOI 10.1016/j.neuron.2014.04.048; Paillard J, 1996, CAN J PHYSIOL PHARM, V74, P401, DOI 10.1139/cjpp-74-4-401; Pasalar S, 2006, NAT NEUROSCI, V9, P1404, DOI 10.1038/nn1783; PELISSON D, 1986, EXP BRAIN RES, V62, P303; Pew R.W., 1974, TUTORIALS PERFORMANC, P1; Pew R.W., 1978, INFORM PROCESSING MO, P71; Pfeifer R., 2008, HDB COGNITIVE SCI, P121, DOI [DOI 10.1016/B978-0-08-046616-3.00007-4, 10.1016/B978-0-08-046616-3.00007-4]; POLIT A, 1979, J NEUROPHYSIOL, V42, P183, DOI 10.1152/jn.1979.42.1.183; POPPELE RE, 1968, SCIENCE, V159, P743, DOI 10.1126/science.159.3816.743; PORTER R, 1976, BRAIN RES, V103, P201, DOI 10.1016/0006-8993(76)90794-0; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; ROBERTS WJ, 1971, J NEUROPHYSIOL, V34, P620, DOI 10.1152/jn.1971.34.4.620; ROBINSON DA, 1981, ANNU REV NEUROSCI, V4, P463, DOI 10.1146/annurev.ne.04.030181.002335; Sadtler PT, 2014, NATURE, V512, P423, DOI 10.1038/nature13665; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; Sanz R., 2008, HDB COGNITIVE SCI EM, P395; Savaki H. E, 2010, COGNITIVE CRITIQUE, V2, P99; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; Schmidt RA., 1978, INFORM PROCESSING MO, P183, DOI DOI 10.1016/B978-0-12-665960-3.50014-1; Schwartz AB, 2000, EUR J NEUROSCI, V12, P1851, DOI 10.1046/j.1460-9568.2000.00097.x; Schwartz AB, 1999, J NEUROPHYSIOL, V82, P2705, DOI 10.1152/jn.1999.82.5.2705; SCHWARTZ AB, 1993, J NEUROPHYSIOL, V70, P28, DOI 10.1152/jn.1993.70.1.28; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Schwartz AB, 2007, J PHYSIOL-LONDON, V579, P581, DOI 10.1113/jphysiol.2006.126698; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Scott SH, 2015, CURR OPIN NEUROBIOL, V33, P85, DOI 10.1016/j.conb.2015.03.006; Sergio LE, 2005, J NEUROPHYSIOL, V94, P2353, DOI 10.1152/jn.00989.2004; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Sherrington C, 1906, INTEGRATIVE ACTION N; So K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026004; Stentz A, 2015, J FIELD ROBOT, V32, P209, DOI 10.1002/rob.21569; STRICK PL, 1983, J NEUROSCI, V3, P2007; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; TERZUOLO CA, 1962, J NEUROPHYSIOL, V25, P56, DOI 10.1152/jn.1962.25.1.56; Todorov E, 2002, NEURAL COMPUT, V14, P1233, DOI 10.1162/089976602753712918; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Turvey M., 1977, PERCEIVING ACTING KN, P211; Umilta MA, 2008, P NATL ACAD SCI USA, V105, P2209, DOI 10.1073/pnas.0705985105; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; van Hemmen JL, 2008, BIOL CYBERN, V98, P509, DOI 10.1007/s00422-008-0215-3; VANSONDEREN JF, 1989, EXP BRAIN RES, V78, P139, DOI 10.1007/BF00230693; Vaziri S, 2006, J NEUROSCI, V26, P4188, DOI 10.1523/JNEUROSCI.4747-05.2006; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Velliste M, 2014, J NEUROSCI, V34, P6011, DOI 10.1523/JNEUROSCI.3520-13.2014; Vindras P, 1998, J EXP PSYCHOL HUMAN, V24, P569, DOI 10.1037/0096-1523.24.2.569; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WASHIZU Y, 1966, ARCH ITAL BIOL, V104, P181; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wodlinger B, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016011; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; YARDLEY L, 1990, PERCEPT PSYCHOPHYS, V48, P131, DOI 10.3758/BF03207079; Young D.S., 1988, COMPLEX MOVEMENT BEH, P419; Zahedi K, 2010, ADAPT BEHAV, V18, P338, DOI 10.1177/1059712310375314; Zhang Y, 2012, IEEE ENG MED BIO, P2740, DOI 10.1109/EMBC.2012.6346531; Zhong H, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00112	154	53	53	2	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1122	1135		10.1016/j.cell.2016.02.038	http://dx.doi.org/10.1016/j.cell.2016.02.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967280	Green Accepted, Bronze			2022-12-28	WOS:000372784900011
J	Detsky, AS; Garber, AM				Detsky, Allan S.; Garber, Alan M.			Uber's Message for Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Garber, Alan M.] Harvard Univ, Off Provost, Cambridge, MA 02138 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University	Detsky, AS (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Detsky, AS (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada.; Detsky, AS (corresponding author), Univ Hlth Network, Dept Med, Toronto, ON, Canada.							Cheney P., 2015, GLOBE MAIL; Hauser Christine, 2015, NY TIMES; Japsen B, 2015, FORBES; Newcomer E., UBER RAISES FUNDING; Nguyen M., 2015, GLOBE MAIL	5	12	12	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					806	809		10.1056/NEJMp1512206	http://dx.doi.org/10.1056/NEJMp1512206			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF2FT	26962900				2022-12-28	WOS:000371158400003
J	Duensing, S; Hohenfellner, M				Duensing, Stefan; Hohenfellner, Markus			Adjuvant therapy for renal-cell carcinoma: settled for now	LANCET			English	Editorial Material							IMATINIB MESYLATE; INTERFERON; SUNITINIB; ALPHA		[Duensing, Stefan] Heidelberg Univ, Med Fac Heidelberg, Sect Mol Urooncol, D-69120 Heidelberg, Germany; [Duensing, Stefan; Hohenfellner, Markus] Heidelberg Univ, Med Fac Heidelberg, Dept Urol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Duensing, S (corresponding author), Heidelberg Univ, Med Fac Heidelberg, Sect Mol Urooncol, D-69120 Heidelberg, Germany.; Duensing, S (corresponding author), Heidelberg Univ, Med Fac Heidelberg, Dept Urol, D-69120 Heidelberg, Germany.	stefan.duensing@med.uni-heidelberg.de						Capitanio U, 2009, BJU INT, V103, P33, DOI 10.1111/j.1464-410X.2008.08014.x; Chin Arnold I, 2006, Rev Urol, V8, P1; DeCaprio JA, 2014, CURR OPIN ONCOL, V26, P415, DOI 10.1097/CCO.0000000000000090; DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Griffioen AW, 2012, CLIN CANCER RES, V18, P3961, DOI 10.1158/1078-0432.CCR-12-0002; Haas NB, 2016, LANCET, V387, P2008, DOI 10.1016/S0140-6736(16)00559-6; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Johnsen JA, 1997, J UROLOGY, V157, P450, DOI 10.1016/S0022-5347(01)65167-X; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; ROSENBERG SA, 1989, J CLIN ONCOL, V7, P1863, DOI 10.1200/JCO.1989.7.12.1863; Znaor A, 2015, EUR UROL, V67, P519, DOI 10.1016/j.eururo.2014.10.002	12	14	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					1973	1974		10.1016/S0140-6736(16)00653-X	http://dx.doi.org/10.1016/S0140-6736(16)00653-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	26969091				2022-12-28	WOS:000375881500005
J	Leening, MJG; Berry, JD; Allen, NB				Leening, Maarten J. G.; Berry, Jarett D.; Allen, Norrina B.			Lifetime Perspectives on Primary Prevention of Atherosclerotic Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EARLY ADULTHOOD; RISK		[Leening, Maarten J. G.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Cardiol, Rotterdam, Netherlands; [Leening, Maarten J. G.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Berry, Jarett D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Berry, Jarett D.] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Allen, Norrina B.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Northwestern University; Feinberg School of Medicine	Leening, MJG (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.leening@erasmusmc.nl		Allen, Norrina/0000-0002-6993-4384				Allen NB, 2014, JAMA-J AM MED ASSOC, V311, P490, DOI 10.1001/jama.2013.285122; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Leening MJG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5992; Navar-Boggan AM, 2015, CIRCULATION, V131, P451, DOI 10.1161/CIRCULATIONAHA.114.012477; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	7	24	24	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1449	1450		10.1001/jama.2016.1654	http://dx.doi.org/10.1001/jama.2016.1654			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	26999711				2022-12-28	WOS:000373873800007
J	Jaber, S; Lescot, T; Futier, E; Paugam-Burtz, C; Seguin, P; Ferrandiere, M; Lasocki, S; Mimoz, O; Hengy, B; Sannini, A; Pottecher, J; Abback, PS; Riu, B; Belafia, F; Constantin, JM; Masseret, E; Beaussier, M; Verzilli, D; De Jong, A; Chanques, G; Brochard, L; Molinari, N				Jaber, Samir; Lescot, Thomas; Futier, Emmanuel; Paugam-Burtz, Catherine; Seguin, Philippe; Ferrandiere, Martine; Lasocki, Sigismond; Mimoz, Olivier; Hengy, Baptiste; Sannini, Antoine; Pottecher, Julien; Abback, Paer-Selim; Riu, Beatrice; Belafia, Fouad; Constantin, Jean-Michel; Masseret, Elodie; Beaussier, Marc; Verzilli, Daniel; De Jong, Audrey; Chanques, Gerald; Brochard, Laurent; Molinari, Nicolas		NIVAS Study Grp	Effect of Noninvasive Ventilation on Tracheal Reintubation Among Patients With Hypoxemic Respiratory Failure Following Abdominal Surgery A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE-PRESSURE VENTILATION; INTENSIVE-CARE-UNIT; HIGH-FLOW OXYGEN; THORACIC-SURGERY; ENDOTRACHEAL INTUBATION; POSTOPERATIVE HYPOXEMIA; PULMONARY COMPLICATIONS; EXTUBATION FAILURE; MORTALITY; SURVIVAL	IMPORTANCE It has not been established whether noninvasive ventilation (NIV) reduces the need for invasive mechanical ventilation in patients who develop hypoxemic acute respiratory failure after abdominal surgery. OBJECTIVE To evaluate whether noninvasive ventilation improves outcomes among patients developing hypoxemic acute respiratory failure after abdominal surgery. DESIGN, SETTING, AND PARTICIPANTS Multicenter, randomized, parallel-group clinical trial conducted between May 2013 and September 2014 in 20 French intensive care units among 293 patients who had undergone abdominal surgery and developed hypoxemic respiratory failure (partial oxygen pressure <60 mm Hg or oxygen saturation [SpO(2)] <= 90% when breathing room air or <80 mm Hg when breathing 15 L/min of oxygen, plus either [1] a respiratory rate above 30/min or [2] clinical signs suggestive of intense respiratory muscle work and/or labored breathing) if it occurred within 7 days after surgical procedure. INTERVENTIONS Patients were randomly assigned to receive standard oxygen therapy (up to 15 L/min to maintain SpO(2) of 94% or higher) (n = 145) or NIV delivered via facial mask (inspiratory pressure support level, 5-15 cm H2O; positive end-expiratory pressure, 5-10 cm H2O; fraction of inspired oxygen titrated to maintain SpO(2) >94%) (n = 148). MAIN OUTCOMES AND MEASURES The primary outcome was tracheal reintubation for any cause within 7 days of randomization. Secondary outcomes were gas exchange, invasive ventilation-free days at day 30, health care-associated infections, and 90-day mortality. RESULTS Among the 293 patients (mean age, 63.4 [SD, 13.8] years; n=224 men) included in the intention-to-treat analysis, reintubation occurred in 49 of 148 (33.1%) in the NIV group and in 66 of 145 (45.5%) in the standard oxygen therapy group within+7 days after randomization (absolute difference, -12.4%; 95% CI, -23.5% to -1.3%; P=.03). Noninvasive ventilation was associated with significantly more invasive ventilation-free days compared with standard oxygen therapy (25.4 vs 23.2 days; absolute difference, -2.2 days; 95% CI, -0.1 to 4.6 days; P=.04), while fewer patients developed health care-associated infections (43/137 [31.4%] vs 63/128 [49.2%]; absolute difference, -17.8%; 95% CI, -30.2% to -5.4%; P=.003). At 90 days, 22 of 148 patients (14.9%) in the NIV group and 31 of 144 (21.5%) in the standard oxygen therapy group had died (absolute difference, -6.5%; 95% CI, -16.0% to 3.0%; P=.15). There were no significant differences in gas exchange. CONCLUSIONS AND RELEVANCE Among patients with hypoxemic respiratory failure following abdominal surgery, use of NIV compared with standard oxygen therapy reduced the risk of tracheal reintubation within 7 days. These findings support use of NIV in this setting.	[Jaber, Samir; Belafia, Fouad; Verzilli, Daniel; De Jong, Audrey; Chanques, Gerald] St Eloi Univ Hosp, Montpellier, France; [Jaber, Samir; Belafia, Fouad; Verzilli, Daniel; De Jong, Audrey; Chanques, Gerald] Montpellier Sch Med, INSERM, Res Unit, U1046, Montpellier, France; [Lescot, Thomas; Beaussier, Marc] St Antoine Hosp, AP HP, Paris, France; [Futier, Emmanuel; Constantin, Jean-Michel] Estaing Hosp, Clermont Ferrand, France; [Paugam-Burtz, Catherine; Abback, Paer-Selim] Beaujon Hosp, AP HP, Paris, France; [Seguin, Philippe; Masseret, Elodie] Rennes Univ Hosp, Rennes, France; [Ferrandiere, Martine] Tours Univ Hosp, Tours, France; [Lasocki, Sigismond] Angers Univ Hosp, Angers, France; [Mimoz, Olivier] Univ Poitiers Hosp, Poitiers, France; [Hengy, Baptiste] Hop Edouard Herriot, Lyon, France; [Sannini, Antoine] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Pottecher, Julien] CHU Strasbourg, F-67000 Strasbourg, France; [Riu, Beatrice] Purpan Hosp, Toulouse, France; [Brochard, Laurent] St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Molinari, Nicolas] Lapeyronie Univ Hosp, Montpellier, France; [Molinari, Nicolas] Montpellier Sch Pharm, IMAG, Res Unit, U5149, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Universite de Rennes; CHU Tours; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Poitiers; Universite de Poitiers; CHU Lyon; UNICANCER; Institut Paoli-Calmette (IPC); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Jaber, S (corresponding author), DAR B, 80 Ave Augustin Fliche, F-34295 Montpellier, France.	s-jaber@chu-montpellier.fr	molinari, nicolas/Y-9681-2019; lasocki, sigismond/G-9443-2016; De Jong, Audrey/N-6406-2018; De Jong, Audrey/AAA-8553-2020; Pottecher, Julien/AAH-1572-2020	De Jong, Audrey/0000-0002-3413-2752; Pottecher, Julien/0000-0001-6073-4354; mimoz, olivier/0000-0003-1737-7915; Paugam-Burtz, Catherine/0000-0002-8168-7152; capdevila, xavier/0000-0002-9791-8779; Seguin, Philippe/0000-0002-7774-4257; wallet, florent/0000-0003-3174-6246	Montpellier University Hospital; APARD Foundation	Montpellier University Hospital; APARD Foundation	This investigator-initiated trial was funded by Montpellier University Hospital and the APARD Foundation.	Ahmed AA, 2012, NEW ENGL J MED, V366, P2036, DOI 10.1056/NEJMc1204076; BROCHARD L, 1990, NEW ENGL J MED, V323, P1523, DOI 10.1056/NEJM199011293232204; Brueckmann B, 2013, ANESTHESIOLOGY, V118, P1276, DOI 10.1097/ALN.0b013e318293065c; Canet J, 2010, MINERVA ANESTESIOL, V76, P138; Canet J, 2011, EUR J ANAESTH, V28, P459, DOI 10.1097/EJA.0b013e328344be2d; Chiumello D, 2011, INTENS CARE MED, V37, P918, DOI 10.1007/s00134-011-2210-8; Conti G, 2007, RESP CARE, V52, P1463; Epstein SK, 2004, CRIT CARE, V8, P310, DOI 10.1186/cc2927; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Faria DAS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009134.pub2; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Futier E, 2014, ANESTHESIOLOGY, V121, P400, DOI 10.1097/ALN.0000000000000335; Futier E, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-341; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Girou E, 2000, JAMA-J AM MED ASSOC, V284, P2361, DOI 10.1001/jama.284.18.2361; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Hemmes SNT, 2014, LANCET, V384, P495, DOI 10.1016/S0140-6736(14)60416-5; Ireland CJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008930.pub2; Jaber S, 2005, CHEST, V128, P2688, DOI 10.1378/chest.128.4.2688; Jaber S, 2006, CRIT CARE MED, V34, P2355, DOI 10.1097/01.CCM.0000233879.58720.87; Jaber S, 2014, INTENS CARE MED, V40, P280, DOI 10.1007/s00134-014-3213-z; Jaber S, 2010, ANESTHESIOLOGY, V112, P453, DOI 10.1097/ALN.0b013e3181c5e5f2; Jaber S, 2010, INTENS CARE MED, V36, P248, DOI 10.1007/s00134-009-1717-8; Kelly CR, 2015, NEW ENGL J MED, V372, DOI 10.1056/NEJMvcm1313336; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Lellouche F, 2014, INTENS CARE MED, V40, P211, DOI 10.1007/s00134-013-3145-z; Lemiale V, 2015, JAMA-J AM MED ASSOC, V314, P1711, DOI 10.1001/jama.2015.12402; Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124; Neto AS, 2015, CRIT CARE MED, V43, P2155, DOI 10.1097/CCM.0000000000001189; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Popping DM, 2008, ARCH SURG-CHICAGO, V143, P990, DOI 10.1001/archsurg.143.10.990; Neto AS, 2014, LANCET RESP MED, V2, P1007, DOI 10.1016/S2213-2600(14)70228-0; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Squadrone V, 2005, JAMA-J AM MED ASSOC, V293, P589, DOI 10.1001/jama.293.5.589; STEPHAN F, 2015, JAMA-J AM MED ASSOC, V313, P2331, DOI [DOI 10.1001/JAMA.2015.5213, 10.1001/jama.2015.5213]; Thille AW, 2013, AM J RESP CRIT CARE, V187, P1294, DOI 10.1164/rccm.201208-1523CI; Thille AW, 2011, CRIT CARE MED, V39, P2612, DOI 10.1097/CCM.0b013e3182282a5a; van Kaam AH, 2004, AM J RESP CRIT CARE, V169, P1046, DOI 10.1164/rccm.200312-1779OC; Wallet F, 2010, EUR J ANAESTH, V27, P270, DOI 10.1097/EJA.0b013e32832dbd49	40	124	130	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1345	1353		10.1001/jama.2016.2706	http://dx.doi.org/10.1001/jama.2016.2706			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	26975890	Green Published, Bronze			2022-12-28	WOS:000373381500018
J	Barrera, LA; Vedenko, A; Kurland, JV; Rogers, JM; Gisselbrecht, SS; Rossin, EJ; Woodard, J; Mariani, L; Kock, KH; Inukai, S; Siggers, T; Shokri, L; Gordan, R; Sahni, N; Cotsapas, C; Hao, T; Yi, S; Kellis, M; Daly, MJ; Vidal, M; Hill, DE; Bulyk, ML				Barrera, Luis A.; Vedenko, Anastasia; Kurland, Jesse V.; Rogers, Julia M.; Gisselbrecht, Stephen S.; Rossin, Elizabeth J.; Woodard, Jaie; Mariani, Luca; Kock, Kian Hong; Inukai, Sachi; Siggers, Trevor; Shokri, Leila; Gordan, Raluca; Sahni, Nidhi; Cotsapas, Chris; Hao, Tong; Yi, Song; Kellis, Manolis; Daly, Mark J.; Vidal, Marc; Hill, David E.; Bulyk, Martha L.			Survey of variation in human transcription factors reveals prevalent DNA binding changes	SCIENCE			English	Article							CONE-ROD DYSTROPHY; HOMEOBOX GENE; IDENTIFICATION; EXPRESSION; MUTATIONS; MODEL; LIMB; CRX	Sequencing of exomes and genomes has revealed abundant genetic variation affecting the coding sequences of human transcription factors (TFs), but the consequences of such variation remain largely unexplored. We developed a computational, structure-based approach to evaluate TF variants for their impact on DNA binding activity and used universal protein-binding microarrays to assay sequence-specific DNA binding activity across 41 reference and 117 variant alleles found in individuals of diverse ancestries and families with Mendelian diseases. We found 77 variants in 28 genes that affect DNA binding affinity or specificity and identified thousands of rare alleles likely to alter the DNA binding activity of human sequence-specific TFs. Our results suggest that most individuals have unique repertoires of TF DNA binding activities, which may contribute to phenotypic variation.	[Barrera, Luis A.; Vedenko, Anastasia; Kurland, Jesse V.; Rogers, Julia M.; Gisselbrecht, Stephen S.; Woodard, Jaie; Mariani, Luca; Kock, Kian Hong; Inukai, Sachi; Siggers, Trevor; Shokri, Leila; Gordan, Raluca; Bulyk, Martha L.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Barrera, Luis A.; Vedenko, Anastasia; Kurland, Jesse V.; Rogers, Julia M.; Gisselbrecht, Stephen S.; Woodard, Jaie; Mariani, Luca; Kock, Kian Hong; Inukai, Sachi; Siggers, Trevor; Shokri, Leila; Gordan, Raluca; Bulyk, Martha L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Barrera, Luis A.; Rogers, Julia M.; Woodard, Jaie; Bulyk, Martha L.] Harvard Univ, Comm Higher Degrees Biophys, Cambridge, MA 02138 USA; [Barrera, Luis A.; Rossin, Elizabeth J.; Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; [Barrera, Luis A.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Rossin, Elizabeth J.; Cotsapas, Chris; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Rossin, Elizabeth J.; Cotsapas, Chris; Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Rossin, Elizabeth J.; Cotsapas, Chris; Kellis, Manolis; Bulyk, Martha L.] Broad Inst Harvard & MIT, Cambridge, MA 02139 USA; [Kock, Kian Hong; Bulyk, Martha L.] Harvard Univ, Program Biol & Biomed Sci, Cambridge, MA 02138 USA; [Sahni, Nidhi; Hao, Tong; Yi, Song; Vidal, Marc; Hill, David E.; Bulyk, Martha L.] Dana Farber Canc Inst, CCSB, Boston, MA 02215 USA; [Sahni, Nidhi; Hao, Tong; Yi, Song; Vidal, Marc; Hill, David E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Sahni, Nidhi; Hao, Tong; Yi, Song; Vidal, Marc; Hill, David E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Bulyk, ML (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Bulyk, ML (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.; Bulyk, ML (corresponding author), Harvard Univ, Comm Higher Degrees Biophys, Cambridge, MA 02138 USA.; Bulyk, ML (corresponding author), Harvard Univ, Sch Med, Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA.; Bulyk, ML (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02139 USA.; Bulyk, ML (corresponding author), Harvard Univ, Program Biol & Biomed Sci, Cambridge, MA 02138 USA.; Bulyk, ML (corresponding author), Dana Farber Canc Inst, CCSB, Boston, MA 02215 USA.; Bulyk, ML (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	mlbulyk@receptor.med.harvard.edu	Daly, Mark J/B-2453-2017; Yi, Song/ABG-6526-2020; Kellis, Manolis/ABE-7385-2020	Daly, Mark J/0000-0002-0949-8752; Yi, Song/0000-0003-0047-8103; Kellis, Manolis/0000-0001-7113-9630; Rossin, Elizabeth/0000-0002-0052-9575; Sahni, Nidhi/0000-0002-9155-5882; Rogers, Julia M/0000-0001-6518-5470	National Institutes of Health [NHGRI R01 HG003985, P50 HG004233]; A*STAR National Science Scholarship; National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003985, P50HG004233, R01HG008155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*STAR National Science Scholarship(Agency for Science Technology & Research (A*STAR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Hume, Y.-H. Hsu, Y. Shen, and D. Balcha for technical assistance and A. Gimelbrant for helpful discussions. We are grateful to the Exome Aggregation Consortium for making its data publicly available prior to publication. This work was supported by the National Institutes of Health (grants NHGRI R01 HG003985 to M.L.B. and T.H. and P50 HG004233 to M.V. and D.E.H.), an A*STAR National Science Scholarship to K.H.K., and National Science Foundation Graduate Research Fellowships to L.A.B. and J.M.R. TF PBM data have been deposited into UniPROBE (publication data set accession BAR15A). GST negative control PBM 8-mer data are provided in table S7. M.L.B. is a coinventor on U.S. patents no. 6,548,021 and no. 8,530,638 on PBM technology and corresponding universal sequence designs, respectively. Universal PBM array designs used in this study are available via a materials transfer agreement with The Brigham and Women's Hospital. A.V., J.V.K., J.M.R., N.S., T.H., and S.Y. performed experiments; L.A.B., J.V.K., J.M.R., S.S.G., E.J.R., J.W., L.M., K.H.K., S.I., T.S., L.S., R.G., and C.C. performed data analysis; M.K., M.J.D., M.V., D.E.H., and M.L.B. supervised research; L.A.B., L.M., K.H.K., D.E.H., and M.L.B. designed the study and wrote the manuscript; and L.A.B., J.V.K., J.M.R., S.S.G., L.M., K.H.K., S.I., and M.L.B. prepared figures and tables.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bass JIF, 2015, CELL, V161, P661, DOI 10.1016/j.cell.2015.03.003; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Brison N, 2014, DEV DYNAM, V243, P37, DOI 10.1002/dvdy.24037; Exome Aggregation Consortium, 2015, BIORXIV; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Ibrahim DM, 2013, GENOME RES, V23, P2091, DOI 10.1101/gr.157610.113; Jiang B, 2013, BIOINFORMATICS, V29, P1390, DOI 10.1093/bioinformatics/btt152; Lappalainen T, 2011, AM J HUM GENET, V89, P459, DOI 10.1016/j.ajhg.2011.08.004; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ouedraogo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050653; Salsi V, 2008, DEV BIOL, V317, P497, DOI 10.1016/j.ydbio.2008.02.048; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Veraksa A, 2000, MOL GENET METAB, V69, P85, DOI 10.1006/mgme.2000.2963; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756	22	76	78	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1450	1454		10.1126/science.aad2257	http://dx.doi.org/10.1126/science.aad2257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013732	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000372756200049
J	Lu, C				Lu, Cindy			Finding Hidden Motives	CELL			English	Editorial Material																		Haroush K, 2015, CELL, V160, P1233, DOI 10.1016/j.cell.2015.01.045; Matthews GA, 2016, CELL, V164, P617, DOI 10.1016/j.cell.2015.12.040; Morishima Y, 2012, NEURON, V75, P73, DOI 10.1016/j.neuron.2012.05.021; Ruff CC, 2013, SCIENCE, V342, P482, DOI 10.1126/science.1241399; Tervo DGR, 2014, CELL, V159, P21, DOI 10.1016/j.cell.2014.08.037	5	1	1	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					5	7						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015299	Bronze			2022-12-28	WOS:000372785600001
J	Sprenger, M; Fukuda, K				Sprenger, Marc; Fukuda, Keiji			New mechanisms, new worries	SCIENCE			English	Editorial Material							BETA-LACTAMASES; CARBAPENEMASES; RESISTANT		[Sprenger, Marc; Fukuda, Keiji] WHO, Antimicrobial Resistance Secretariat, CH-1211 Geneva 27, Switzerland	World Health Organization	Sprenger, M; Fukuda, K (corresponding author), WHO, Antimicrobial Resistance Secretariat, CH-1211 Geneva 27, Switzerland.	sprengerm@who.int; fukudak@who.int		Fukuda, Keiji/0000-0002-9598-9565	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Albiger B, 2015, EUROSURVEILLANCE, V20, P17, DOI 10.2807/1560-7917.ES.2015.20.45.30062; Antunes NT, 2014, ANTIMICROB AGENTS CH, V58, P2119, DOI 10.1128/AAC.02522-13; Bakthavatchalam YD, 2016, J GLOB INFECT DIS, V8, P41, DOI 10.4103/0974-777X.176149; Borer A, 2009, INFECT CONT HOSP EP, V30, P972, DOI 10.1086/605922; Edelstein MV, 2013, LANCET INFECT DIS, V13, P867, DOI 10.1016/S1473-3099(13)70168-3; Giani T, 2015, J CLIN MICROBIOL, V53, P3341, DOI 10.1128/JCM.01017-15; Hasman H, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.49.30085; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Miriagou V, 2010, CLIN MICROBIOL INFEC, V16, P112, DOI 10.1111/j.1469-0691.2009.03116.x; O'Neill J, 2014, ANTIMICROBIAL RESIST; Perrin-Guyomard A, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.6.30135; Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217/17460913.2.5.501; Pumart P., 2012, J HLTH SYST RES, V6, P352, DOI DOI 10.1093/CLINIDS/9.6.1065; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07	14	34	35	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1264	1265		10.1126/science.aad9450	http://dx.doi.org/10.1126/science.aad9450			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989235				2022-12-28	WOS:000372397700018
J	Ditters, J				Ditters, J.			PERSONAL VIEW True patient participation is difficult and takes dialogue	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ditters, J.] Vondellaan 60, NL-6824 NG Arnhem, Netherlands		Ditters, J (corresponding author), Vondellaan 60, NL-6824 NG Arnhem, Netherlands.	jessica.ditters@gmail.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2016	352								i1506	10.1136/bmj.i1506	http://dx.doi.org/10.1136/bmj.i1506			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AD	26987881				2022-12-28	WOS:000372585400003
J	Morral, AFI				Fontcuberta i Morral, Anna			MATERIALS SCIENCE How crystals get an edge	NATURE			English	Editorial Material							SILICON-CARBIDE		[Fontcuberta i Morral, Anna] Ecole Polytech Fed Lausanne, Inst Mat, Lab Semicond Mat, CH-1015 Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne	Morral, AFI (corresponding author), Ecole Polytech Fed Lausanne, Inst Mat, Lab Semicond Mat, CH-1015 Lausanne, Switzerland.	anna.fontcuberta-morral@epfl.ch	Morral, Anna Fontcuberta i/B-9884-2008					Bechstedt F, 1997, PHYS STATUS SOLIDI B, V202, P35, DOI 10.1002/1521-3951(199707)202:1<35::AID-PSSB35>3.0.CO;2-8; Dubrovskii VG, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.235301; Falk AL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2854; Glas F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.146101; Kroemer H, 2001, REV MOD PHYS, V73, P783, DOI 10.1103/RevModPhys.73.783; Krogstrup P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.125505	7	5	5	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					308	309		10.1038/531308a	http://dx.doi.org/10.1038/531308a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26983533				2022-12-28	WOS:000372064300036
J	Hodson, R				Hodson, Richard			URBAN HEALTH AND WELL-BEING	NATURE			English	Editorial Material																			0	5	5	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S49	S49		10.1038/531S49a	http://dx.doi.org/10.1038/531S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26981725	Bronze			2022-12-28	WOS:000372064300064
J	Kuehn, HS; Boisson, B; Cunningham-Rundles, C; Reichenbach, J; Stray-Pedersen, A; Gelfand, EW; Maffucci, P; Pierce, KR; Abbott, JK; Voelkerding, KV; South, ST; Augustine, NH; Bush, JS; Dolen, WK; Wray, BB; Itan, Y; Cobat, A; Sorte, HS; Ganesan, S; Prader, S; Martins, TB; Lawrence, MG; Orange, JS; Calvo, KR; Niemela, JE; Casanova, JL; Fleisher, TA; Hill, HR; Kumanovics, A; Conley, ME; Rosenzweig, SD				Kuehn, H. S.; Boisson, B.; Cunningham-Rundles, C.; Reichenbach, J.; Stray-Pedersen, A.; Gelfand, E. W.; Maffucci, P.; Pierce, K. R.; Abbott, J. K.; Voelkerding, K. V.; South, S. T.; Augustine, N. H.; Bush, J. S.; Dolen, W. K.; Wray, B. B.; Itan, Y.; Cobat, A.; Sorte, H. S.; Ganesan, S.; Prader, S.; Martins, T. B.; Lawrence, M. G.; Orange, J. S.; Calvo, K. R.; Niemela, J. E.; Casanova, J. -L.; Fleisher, T. A.; Hill, H. R.; Kumanovics, A.; Conley, M. E.; Rosenzweig, S. D.			Loss of B Cells in Patients with Heterozygous Mutations in IKAROS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSCRIPTION FACTOR; GERMLINE MUTATIONS; GENE; AGAMMAGLOBULINEMIA; DIFFERENTIATION; HAPLOINSUFFICIENCY; HEMATOPOIESIS; EXPRESSION; LEUKEMIA; DELETION	BACKGROUND Common variable immunodeficiency (CVID) is characterized by late-onset hypo-gammaglobulinemia in the absence of predisposing factors. The genetic cause is unknown in the majority of cases, and less than 10% of patients have a family history of the disease. Most patients have normal numbers of B cells but lack plasma cells. METHODS We used whole-exome sequencing and array-based comparative genomic hybridization to evaluate a subset of patients with CVID and low B-cell numbers. Mutant proteins were analyzed for DNA binding with the use of an electrophoretic mobility-shift assay (EMSA) and confocal microscopy. Flow cytometry was used to analyze peripheral-blood lymphocytes and bone marrow aspirates. RESULTS Six different heterozygous mutations in IKZF1, the gene encoding the transcription factor IKAROS, were identified in 29 persons from six families. In two families, the mutation was a de novo event in the proband. All the mutations, four amino acid substitutions, an intragenic deletion, and a 4.7-Mb multigene deletion involved the DNA-binding domain of IKAROS. The proteins bearing missense mutations failed to bind target DNA sequences on EMSA and confocal microscopy; however, they did not inhibit the binding of wild-type IKAROS. Studies in family members showed progressive loss of B cells and serum immunoglobulins. Bone marrow aspirates in two patients had markedly decreased early B-cell precursors, but plasma cells were present. Acute lymphoblastic leukemia developed in 2 of the 29 patients. CONCLUSIONS Heterozygous mutations in the transcription factor IKAROS caused an autosomal dominant form of CVID that is associated with a striking decrease in B-cell numbers.	[Boisson, B.; Itan, Y.; Cobat, A.; Casanova, J. -L.; Conley, M. E.] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, 1230 York Ave,Box 163, New York, NY 10065 USA; [Kuehn, H. S.; Calvo, K. R.; Niemela, J. E.; Fleisher, T. A.; Rosenzweig, S. D.] NIAID, Dept Lab Med, NIH, Ctr Clin, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Rosenzweig, S. D.] NIAID, Primary Immunodeficiency Clin, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Ganesan, S.] NIAID, Biol Imaging Sect, Res Technol Branch, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Casanova, J. -L.] Howard Hughes Med Inst, New York, NY USA; [Cunningham-Rundles, C.; Maffucci, P.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Cunningham-Rundles, C.; Maffucci, P.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Cobat, A.; Casanova, J. -L.] INSERM, U1163, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [Cobat, A.; Casanova, J. -L.] Paris Descartes Univ, Imagine Inst, Paris, France; [Reichenbach, J.; Prader, S.] Univ Childrens Hosp Zurich, Div Immunol, Zurich, Switzerland; [Reichenbach, J.; Prader, S.] Childrens Res Ctr, Zurich, Switzerland; [Reichenbach, J.] Univ Zurich, Zurich, Switzerland; [Stray-Pedersen, A.; Orange, J. S.] Texas Childrens Hosp, Ctr Human Immunobiol, Houston, TX 77030 USA; [Stray-Pedersen, A.; Orange, J. S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Stray-Pedersen, A.] Baylor Coll Med, Baylor Hopkins Ctr Mendelian Genom, Dept Mol & Human Genet, Houston, TX 77030 USA; [Stray-Pedersen, A.] Oslo Univ Hosp, Norwegian Unit Natl Newborn Screening, Oslo, Norway; [Sorte, H. S.] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Pierce, K. R.] Univ Tennessee, Coll Med, Memphis, TN USA; [Gelfand, E. W.; Abbott, J. K.] Natl Jewish Hlth, Dept Pediat, Div Allergy & Immunol, Denver, CO USA; [Voelkerding, K. V.; South, S. T.; Augustine, N. H.; Martins, T. B.; Hill, H. R.; Kumanovics, A.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA; [Hill, H. R.] Univ Utah, Sch Med, Dept Pediat & Med, Salt Lake City, UT USA; [Martins, T. B.] ARUP Labs, ARUP Associated Reg & Univ Pathologists Inst Clin, Salt Lake City, UT USA; [Bush, J. S.; Dolen, W. K.; Wray, B. B.] Augusta Univ, Med Coll Georgia, Dept Pediat, Div Allergy Immunol & Pediat Rheumatol, Augusta, GA USA; [Lawrence, M. G.] Univ Virginia, Dept Med, Div Asthma Allergy & Immunol, Charlottesville, VA USA	Rockefeller University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University Children's Hospital Zurich; University of Zurich; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Oslo; University of Oslo; University of Tennessee System; University of Tennessee Health Science Center; National Jewish Health; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; University System of Georgia; Augusta University; University of Virginia	Conley, ME (corresponding author), Rockefeller Univ, St Giles Lab Human Genet Infect Dis, 1230 York Ave,Box 163, New York, NY 10065 USA.	mconley@rockefeller.edu	Casanova, Jean-Laurent/I-3418-2017; Abbott, Jordan K/P-2509-2016; Boisson, Bertrand/I-2485-2017; Boisson, Bertrand/AAC-6058-2019; Cobat, Aurélie/H-4722-2017; Reichenbach, Janine/U-2171-2018	Abbott, Jordan K/0000-0001-6334-5266; Boisson, Bertrand/0000-0001-5240-3555; Boisson, Bertrand/0000-0001-5240-3555; Cobat, Aurélie/0000-0001-7209-6257; Reichenbach, Janine/0000-0002-9008-1312; Stray-Pedersen, Asbjorg/0000-0002-9168-0878; Casanova, Jean-Laurent/0000-0002-7782-4169; orange, jordan/0000-0001-7117-7725	National Institutes of Health and others; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094004, R21AI101093, R01AI104857, U24AI086037, P01AI061093, R18AI048693] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007280] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010304, ZIACL090025] Funding Source: NIH RePORTER	National Institutes of Health and others(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CLINICAL CENTER	Funded by the National Institutes of Health and others.	Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Boisson B, 2013, J CLIN INVEST, V123, P4781, DOI 10.1172/JCI71927; Bolze A, 2013, SCIENCE, V340, P976, DOI 10.1126/science.1234864; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chapel H, 2009, BRIT J HAEMATOL, V145, P709, DOI 10.1111/j.1365-2141.2009.07669.x; Chen K, 2013, AM J HUM GENET, V93, P812, DOI 10.1016/j.ajhg.2013.09.009; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Conley ME, 2014, CURR OPIN IMMUNOL, V30, P17, DOI 10.1016/j.coi.2014.05.004; Conley ME, 2012, J EXP MED, V209, P463, DOI 10.1084/jem.20112533; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Fliegauf M, 2015, AM J HUM GENET, V97, P389, DOI 10.1016/j.ajhg.2015.07.008; Gathmann B, 2014, J ALLERGY CLIN IMMUN, V134, P116, DOI 10.1016/j.jaci.2013.12.1077; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Goldman FD, 2012, PEDIATR BLOOD CANCER, V58, P591, DOI 10.1002/pbc.23160; Iacobucci I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040934; John LB, 2011, MOL IMMUNOL, V48, P1272, DOI 10.1016/j.molimm.2011.03.006; Kastner P, 2013, AM J BLOOD RES, V3, P1; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; LO K, 1991, MOL CELL BIOL, V11, P5229, DOI 10.1128/MCB.11.10.5229; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Mendoza-Londono R, 2005, GENE CHROMOSOME CANC, V42, P82, DOI 10.1002/gcc.20100; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nunez C, 1996, J IMMUNOL, V156, P866; O'Brien S, 2014, J IMMUNOL, V192, P5118, DOI 10.4049/jimmunol.1301992; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Rieux-Laucat F, 2014, SCIENCE, V345, P1560, DOI 10.1126/science.1260791; Ronni T, 2007, J BIOL CHEM, V282, P2538, DOI 10.1074/jbc.M605627200; Samarakoon PS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-661; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528; Sun L, 1996, EMBO J, V15, P5358, DOI 10.1002/j.1460-2075.1996.tb00920.x; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Tian CX, 2007, MOL IMMUNOL, V44, P2173, DOI 10.1016/j.molimm.2006.11.020; Tonnelle Cecile, 2003, Hematol J, V4, P104, DOI 10.1038/sj.thj.6200235; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Winkelstein JA, 2006, MEDICINE, V85, P193, DOI 10.1097/01.md.0000229482.27398.ad; Yoshida T, 2014, INT J HEMATOL, V100, P220, DOI 10.1007/s12185-014-1644-5	41	148	154	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1032	1043		10.1056/NEJMoa1512234	http://dx.doi.org/10.1056/NEJMoa1512234			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4TR	26981933	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-28	WOS:000372066100007
J	Pollock, K				Pollock, Kevin			POLICY Urban physics	NATURE			English	Editorial Material																			0	16	18	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S64	S66		10.1038/531S64a	http://dx.doi.org/10.1038/531S64a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG4TA	26981733	Bronze			2022-12-28	WOS:000372064300007
J	Elmore, JG				Elmore, Joann G.			Review: Mammography screening reduces breast cancer mortality in women at average risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BENEFITS		[Elmore, Joann G.] Univ Washington, Sch Med, Seattle, WA USA	University of Washington; University of Washington Seattle	Elmore, JG (corresponding author), Univ Washington, Sch Med, Seattle, WA USA.							Alston C., 2012, COMMUNICATING PATIEN; Mandelblatt JS, 2016, ANN INTERN MED, V164, P215, DOI 10.7326/M15-1536; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Post TW, UPTODATE	4	4	4	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					JC26	JC26		10.7326/ACPJC-2016-164-6-026	http://dx.doi.org/10.7326/ACPJC-2016-164-6-026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26974726				2022-12-28	WOS:000372207200001
J	Morgan, MSC; Pearle, MS				Morgan, Monica S. C.; Pearle, Margaret S.			Medical management of renal stones	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; URINARY OXALATE EXCRETION; LOW-ANIMAL-PROTEIN; KIDNEY-STONES; POTASSIUM CITRATE; JUICE CONSUMPTION; DIETARY-PROTEIN; ORANGE-JUICE; IDIOPATHIC HYPERCALCIURIA; CALCIUM NEPHROLITHIASIS	The prevalence of kidney stones is increasing in industrialized nations, resulting in a corresponding rise in economic burden. Nephrolithiasis is now recognized as both a chronic and systemic condition, which further underscores the impact of the disease. Diet and environment play an important role in stone disease, presumably by modulating urine composition. Dietary modification as a preventive treatment to decrease lithogenic risk factors and prevent stone recurrence has gained interest because of its potential to be safer and more economical than drug treatment. However, not all abnormalities are likely to be amenable to dietary therapy, and in some cases drugs are necessary to reduce the risk of stone formation. Unfortunately, no new drugs have been developed for stone prevention since the 1980s when potassium citrate was introduced, perhaps because the long observation period needed to demonstrate efficacy discourages investigators from embarking on clinical trials. Nonetheless, effective established treatment regimens are currently available for stone prevention.	[Morgan, Monica S. C.; Pearle, Margaret S.] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Pearle, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA.	margaret.pearle@utsouthwestern.edu						Ahlstrand C, 1995, RENAL STONES ASPECTS, P195; ALAOPAS M, 1987, SCAND J UROL NEPHROL, V21, P311, DOI 10.3109/00365598709180789; American Urological Association (AUA), 2014, MED MAN KIDN STON AU; Aras B, 2008, UROL RES, V36, P313, DOI 10.1007/s00240-008-0152-6; BARCELO P, 1993, J UROLOGY, V150, P1761, DOI 10.1016/S0022-5347(17)35888-3; Baxmann AC, 2003, KIDNEY INT, V63, P1066, DOI 10.1046/j.1523-1755.2003.00815.x; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; Borghi L, 2002, NEW ENGL J MED, V346, P77, DOI 10.1056/NEJMoa010369; Borghi L, 1999, NEPHRON, V81, P31, DOI 10.1159/000046296; BORGHI L, 1993, J CARDIOVASC PHARM, V22, pS78; Borghi L, 1999, KIDNEY INT, V55, P2397, DOI 10.1046/j.1523-1755.1999.00483.x; BRESLAU NA, 1988, J CLIN ENDOCR METAB, V66, P140, DOI 10.1210/jcem-66-1-140; BROCKS P, 1981, LANCET, V2, P124, DOI 10.1016/S0140-6736(81)90302-0; Bushinsky DA, 2001, AM J PHYSIOL-RENAL, V281, pF1058, DOI 10.1152/ajprenal.0355.2000; COE FL, 1977, ANN INTERN MED, V87, P404, DOI 10.7326/0003-4819-87-4-404; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; Curhan GC, 2004, ARCH INTERN MED, V164, P885, DOI 10.1001/archinte.164.8.885; Curhan GC, 1999, J AM SOC NEPHROL, V10, P840; Curhan GC, 1997, ANN INTERN MED, V126, P497, DOI 10.7326/0003-4819-126-7-199704010-00001; Curhan GC, 2001, KIDNEY INT, V59, P2290, DOI 10.1046/j.1523-1755.2001.0590062290.x; CURHAN GC, 1993, NEW ENGL J MED, V328, P833, DOI 10.1056/NEJM199303253281203; DeBerardinis RJ, 2008, J UROLOGY, V180, P2620, DOI 10.1016/j.juro.2008.08.057; Domrongkitchaiporn S, 2004, KIDNEY INT, V65, P1835, DOI 10.1111/j.1523-1755.2004.00587.x; Dussol B, 2008, NEPHRON CLIN PRACT, V110, pC185, DOI 10.1159/000167271; ETTINGER B, 1988, J UROLOGY, V139, P679, DOI 10.1016/S0022-5347(17)42599-7; ETTINGER B, 1986, NEW ENGL J MED, V315, P1386, DOI 10.1056/NEJM198611273152204; Ettinger B, 1997, J UROLOGY, V158, P2069, DOI 10.1016/S0022-5347(01)68155-2; Fernandez-Rodriguez A, 2006, Actas Urol Esp, V30, P305; Ferraro PM, 2013, CLIN J AM SOC NEPHRO, V8, P1389, DOI 10.2215/CJN.11661112; Fink HA, 2013, ANN INTERN MED, V158, P535, DOI 10.7326/0003-4819-158-7-201304020-00005; Gettman MT, 2005, J UROLOGY, V174, P590, DOI 10.1097/01.ju.0000165168.68054.f8; Goldfarb DS, 2013, CLIN J AM SOC NEPHRO, V8, P1960, DOI 10.2215/CJN.01760213; Goldfarb DS, 2001, J UROLOGY, V166, P263, DOI 10.1016/S0022-5347(05)66142-3; Hatch M, 2006, KIDNEY INT, V69, P691, DOI 10.1038/sj.ki.5000162; Healy KA, 2013, J ENDOUROL, V27, P374, DOI 10.1089/end.2012.0216; Heller HJ, 1999, J AM COLL NUTR, V18, p373S, DOI 10.1080/07315724.1999.10718901; Hess B, 1998, NEPHROL DIAL TRANSPL, V13, P2241, DOI 10.1093/ndt/13.9.2241; Hiatt RA, 1996, AM J EPIDEMIOL, V144, P25, DOI 10.1093/oxfordjournals.aje.a008851; Holmes RP, 2004, UROL RES, V32, P311, DOI 10.1007/s00240-004-0437-3; Holmes RP, 2001, KIDNEY INT, V59, P270, DOI 10.1046/j.1523-1755.2001.00488.x; Honow R, 2003, BRIT J NUTR, V90, P295, DOI 10.1079/BJN2003897; Hoppe B, 2012, NAT REV NEPHROL, V8, P467, DOI 10.1038/nrneph.2012.113; HOSKING DH, 1983, J UROLOGY, V130, P1115, DOI 10.1016/S0022-5347(17)51711-5; Hoyer-Kuhn H, 2014, CLIN J AM SOC NEPHRO, V9, P468, DOI 10.2215/CJN.06820613; Huen SC, 2007, J UROLOGY, V177, P1238, DOI 10.1016/j.juro.2006.11.040; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; JAEGER P, 1986, NEW ENGL J MED, V315, P1120, DOI 10.1056/NEJM198610303151803; Kang DE, 2007, J UROLOGY, V177, P1358, DOI 10.1016/j.juro.2006.11.058; Kang DE, 2007, J UROLOGY, V177, P591; Kang DE, 2007, J UROLOGY, V177, P62; Kaufman DW, 2008, J AM SOC NEPHROL, V19, P1197, DOI 10.1681/ASN.2007101058; Knight J, 2007, UROL RES, V35, P111, DOI 10.1007/s00240-007-0090-8; Koff SG, 2007, UROLOGY, V69, P1013, DOI 10.1016/j.urology.2007.02.008; KOK DJ, 1990, J CLIN ENDOCR METAB, V71, P861, DOI 10.1210/jcem-71-4-861; Krishnamurthy MS, 2003, J UROLOGY, V169, P2030, DOI 10.1097/01.ju.0000062527.37579.49; LAERUM E, 1984, ACTA MED SCAND, V215, P383; Lemann J, 1999, NEPHRON, V81, P18; LINDELL A, 1995, NEPHRON, V71, P407, DOI 10.1159/000188760; Maalouf NM, 2011, J CLIN ENDOCR METAB, V96, P3733, DOI 10.1210/jc.2011-1531; Madore F, 1998, AM J HYPERTENS, V11, P46, DOI 10.1016/S0895-7061(97)00371-3; Matsumoto ED, 2006, J UROLOGY, V176, P132, DOI 10.1016/S0022-5347(06)00565-9; Mattoo A, 2008, SEMIN NEPHROL, V28, P181, DOI 10.1016/j.semnephrol.2008.01.011; Mendonca CDG, 2003, J RENAL NUTR, V13, P39, DOI 10.1053/jren.2003.50002; MICHELAKAKIS H, 1993, J INHERIT METAB DIS, V16, P1042, DOI 10.1007/BF00711523; Milose JC, 2014, J UROLOGY, V191, P376, DOI 10.1016/j.juro.2013.08.080; Mission Pharmacal, THIOL TIOPR TABL PAC; Moe OW, 2006, J NEPHROL, V19, pS53; MORTENSEN J T, 1986, International Urology and Nephrology, V18, P265, DOI 10.1007/BF02082712; Nayan M, 2012, CUAJ-CAN UROL ASSOC, V6, P30, DOI 10.5489/cuaj.11131; Ng C S, 2001, Curr Opin Urol, V11, P353, DOI 10.1097/00042307-200107000-00003; Ng CS, 1999, J ENDOUROL, V13, P647, DOI 10.1089/end.1999.13.647; NICAR MJ, 1984, J UROLOGY, V131, P430, DOI 10.1016/S0022-5347(17)50438-3; Noori N, 2014, AM J KIDNEY DIS, V63, P456, DOI 10.1053/j.ajkd.2013.11.022; NORMAN RW, 1990, J UROLOGY, V143, P1193, DOI 10.1016/S0022-5347(17)40222-9; Nouvenne A, 2010, AM J CLIN NUTR, V91, P565, DOI 10.3945/ajcn.2009.28614; Odvina CV, 2006, CLIN J AM SOC NEPHRO, V1, P1269, DOI 10.2215/CJN.00800306; OHKAWA M, 1992, BRIT J UROL, V69, P571, DOI 10.1111/j.1464-410X.1992.tb15624.x; Ortiz-Alvarado O, 2011, UROLOGY, V77, P1054, DOI 10.1016/j.urology.2010.08.002; Pak CYC, 2011, J UROLOGY, V185, P915, DOI 10.1016/j.juro.2010.10.067; PAK CYC, 1980, AM J MED, V69, P19, DOI 10.1016/0002-9343(80)90495-7; PAK CYC, 1986, J UROLOGY, V136, P1003, DOI 10.1016/S0022-5347(17)45188-3; Pak CYC, 2001, J UROLOGY, V165, P378, DOI 10.1097/00005392-200102000-00006; PAK CYC, 1986, KIDNEY INT, V30, P422, DOI 10.1038/ki.1986.201; Parks JH, 2002, J UROLOGY, V167, P1607, DOI 10.1016/S0022-5347(05)65163-4; Passman CM, 2009, J ENDOUROL, V23, P347, DOI 10.1089/end.2008.0225; Pearle MS, 2014, J UROLOGY, V192, P316, DOI 10.1016/j.juro.2014.05.006; Pearle MS, 2005, J UROLOGY, V173, P848, DOI 10.1097/01.ju.0000152082.14384.d7; PECES R, 1991, NEPHRON, V57, P421, DOI 10.1159/000186306; Penniston KL, 2007, UROLOGY, V70, P856, DOI 10.1016/j.urology.2007.06.1115; Rimer JD, 2010, SCIENCE, V330, P337, DOI 10.1126/science.1191968; RODMAN JS, 1984, CLIN NEPHROL, V22, P273; RODRIGUEZ LM, 1995, NEPHRON, V71, P416, DOI 10.1159/000188761; Romero Victoriano, 2010, Rev Urol, V12, pe86; Rule AD, 2009, CLIN J AM SOC NEPHRO, V4, P804, DOI 10.2215/CJN.05811108; Sahota A, 2012, J INHERIT METAB DIS, V35, pS27; Saigal CS, 2005, KIDNEY INT, V68, P1808, DOI 10.1111/j.1523-1755.2005.00599.x; Sakhaee K, 2012, J CLIN ENDOCR METAB, V97, P1847, DOI 10.1210/jc.2011-3492; Scales CD, 2007, J UROLOGY, V177, P979, DOI 10.1016/j.juro.2006.10.069; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Seltzer MA, 1996, J UROLOGY, V156, P907, DOI 10.1016/S0022-5347(01)65659-3; SHUSTER J, 1992, J CLIN EPIDEMIOL, V45, P911, DOI 10.1016/0895-4356(92)90074-W; SMITH MJV, 1977, J UROLOGY, V117, P690, DOI 10.1016/S0022-5347(17)58588-2; SOUCIE JM, 1994, KIDNEY INT, V46, P893, DOI 10.1038/ki.1994.347; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Sumorok NT, 2012, UROL RES, V40, P237, DOI 10.1007/s00240-011-0418-2; SUTTON RAL, 1979, KIDNEY INT, V15, P520, DOI 10.1038/ki.1979.67; Tang MH, 2008, AM J CLIN NUTR, V87, P1262, DOI 10.1093/ajcn/87.5.1262; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Taylor EN, 2005, KIDNEY INT, V68, P1230, DOI 10.1111/j.1523-1755.2005.00516.x; Taylor EN, 2013, J UROLOGY, V190, P1255, DOI 10.1016/j.juro.2013.03.074; Taylor EN, 2010, CLIN J AM SOC NEPHRO, V5, P2315, DOI 10.2215/CJN.04420510; Taylor EN, 2009, J AM SOC NEPHROL, V20, P2253, DOI 10.1681/ASN.2009030276; Terris MK, 2001, UROLOGY, V57, P26, DOI 10.1016/S0090-4295(00)00884-0; Tracy CR, 2014, J UROLOGY, V192, P137, DOI 10.1016/j.juro.2014.01.093; Traxer O, 2003, J UROLOGY, V170, P397, DOI 10.1097/01.ju.0000076001.21606.53; Turk C, 2016, EUR UROL, V69, P468, DOI 10.1016/j.eururo.2015.07.040; Turk C, 2011, 29 EAU ANN C STOCKH; URIBARRI J, 1989, ANN INTERN MED, V111, P1006, DOI 10.7326/0003-4819-111-12-1006; Von Unruh GE, 2004, J AM SOC NEPHROL, V15, P1567, DOI 10.1097/01.ASN.0000127864.26968.7F; WABNER CL, 1993, J UROLOGY, V149, P1405, DOI 10.1016/S0022-5347(17)36401-7; Wallace RB, 2011, AM J CLIN NUTR, V94, P270, DOI 10.3945/ajcn.110.003350; Yasui T, 2008, UROLOGY, V71, P209, DOI 10.1016/j.urology.2007.09.034; Yeh BI, 2003, J BIOL CHEM, V278, P51044, DOI 10.1074/jbc.M306326200; ZERWEKH JE, 1983, KIDNEY INT, V23, P838, DOI 10.1038/ki.1983.103; Zuckerman Jack M, 2009, Rev Urol, V11, P134	125	71	77	1	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2016	352								i52	10.1136/bmj.i52	http://dx.doi.org/10.1136/bmj.i52			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1XO	26977089				2022-12-28	WOS:000372578500015
J	Banerjee, A; Dick, GR; Yoshino, T; Kanan, MW				Banerjee, Aanindeeta; Dick, Graham R.; Yoshino, Tatsuhiko; Kanan, Matthew W.			Carbon dioxide utilization via carbonate-promoted C-H carboxylation	NATURE			English	Article							ACID; CHEMICALS; BIOMASS; TRANSFORMATION; PLATFORM	Using carbon dioxide (CO2) as a feedstock for commodity synthesis is an attractive means of reducing greenhouse gas emissions and a possible stepping-stone towards renewable synthetic fuels(1,2). A major impediment to synthesizing compounds from CO2 is the difficulty of forming carbon-carbon (C-C) bonds efficiently: although CO2 reacts readily with carbon-centred nucleophiles, generating these intermediates requires high-energy reagents (such as highly reducing metals or strong organic bases), carbon-heteroatom bonds or relatively acidic carbon-hydrogen (C-H) bonds(3-5). These requirements negate the environmental benefit of using CO2 as a substrate and limit the chemistry to low-volume targets. Here we show that intermediate-temperature (200 to 350 degrees Celsius) molten salts containing caesium or potassium cations enable carbonate ions (CO32-) to deprotonate very weakly acidic C-H bonds (pK(a) > 40), generating carbon-centred nucleophiles that react with CO2 to form carboxylates. To illustrate a potential application, we use C-H carboxylation followed by protonation to convert 2-furoic acid into furan-2,5-dicarboxylic acid (FDCA)-a highly desirable bio-based feedstock(6) with numerous applications, including the synthesis of polyethylene furandicarboxylate (PEF), which is a potential large-scale substitute for petroleum-derived polyethylene terephthalate (PET)(7,8). Since 2-furoic acid can readily be made from lignocellulose9, CO32--promoted C-H carboxylation thus reveals a way to transform inedible biomass and CO2 into a valuable feedstock chemical. Our results provide a new strategy for using CO2 in the synthesis of multi-carbon compounds.	[Banerjee, Aanindeeta; Dick, Graham R.; Yoshino, Tatsuhiko; Kanan, Matthew W.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Yoshino, Tatsuhiko] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Stanford University; Hokkaido University	Kanan, MW (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	mkanan@stanford.edu	Yoshino, Tatsuhiko/J-6809-2016	Yoshino, Tatsuhiko/0000-0001-9441-9272; Dick, Graham/0000-0001-5544-6868; Kanan, Matthew/0000-0002-5932-6289	Stanford University; Henry and Camille Dreyfus Foundation; Stanford Center for Molecular Analysis and Design; Japan Society for the Promotion of Science	Stanford University(Stanford University); Henry and Camille Dreyfus Foundation; Stanford Center for Molecular Analysis and Design; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Stanford University and the Henry and Camille Dreyfus Foundation for support of this work through a Teacher-Scholar Award to M. W. K. G. R. D. gratefully acknowledges a fellowship through the Stanford Center for Molecular Analysis and Design, and T. Y. acknowledges a Postdoctoral Fellowship for Research Abroad through the Japan Society for the Promotion of Science. We thank T. Veltman for installation of the Parr reactor, S. Lynch for assistance with <SUP>2</SUP>H NMR, and J. Du Bois for discussions. High-resolution mass spectrometry was performed at the Vincent Coates Foundation Mass Spectrometry Laboratory, Stanford University Mass Spectrometry.	Aresta M, 2014, CHEM REV, V114, P1709, DOI 10.1021/cr4002758; Barve PP, 2012, IND ENG CHEM RES, V51, P1498, DOI 10.1021/ie200632v; Binder JB, 2009, J AM CHEM SOC, V131, P1979, DOI 10.1021/ja808537j; Cai XH, 2013, SYNTHESIS-STUTTGART, V45, P3305, DOI 10.1055/s-0033-1340061; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Lopes AMD, 2015, CHEMSUSCHEM, V8, P947, DOI 10.1002/cssc.201402950; Darensbourg D. J., 2008, ENCY REAGENTS ORGANI; Davis JR, 2015, ACS SUSTAIN CHEM ENG, V3, P2337, DOI 10.1021/acssuschemeng.5b00654; de Jong E, 2012, ACS SYM SER, V1105, P1; Diban N, 2013, IND ENG CHEM RES, V52, P10342, DOI 10.1021/ie3029625; Eerhart AJJE, 2012, ENERG ENVIRON SCI, V5, P6407, DOI 10.1039/c2ee02480b; Fischer R, 2013, ARKIVOC, P405, DOI 10.3998/ark.5550190.p008.285; FRASER RR, 1985, CAN J CHEM, V63, P3505, DOI 10.1139/v85-574; Hoydonckx H., 2007, ULLMANNS ENCY IND CH, V16, P285, DOI DOI 0.1002/14356007.A12_119.PUB2; Kudo K., 1995, J JPN PETROL INST, V38, P48; Kudo K., 1995, J JPN PETROL INST, V38, P40; Lange JP, 2012, CHEMSUSCHEM, V5, P150, DOI 10.1002/cssc.201100648; Liu AH, 2015, GREENH GASES, V5, P17, DOI 10.1002/ghg.1461; Luterbacher JS, 2014, SCIENCE, V343, P277, DOI 10.1126/science.1246748; MANI KN, 1991, J MEMBRANE SCI, V58, P117, DOI 10.1016/S0376-7388(00)82450-3; Mikkelsen M, 2010, ENERG ENVIRON SCI, V3, P43, DOI 10.1039/b912904a; RENAUD P, 1988, J AM CHEM SOC, V110, P5705, DOI 10.1021/ja00225a021; Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337; Sheldon RA, 2014, GREEN CHEM, V16, P950, DOI [10.1039/c3gc41935e, 10.1039/C3GC41935E]; Taarning E, 2008, CHEMSUSCHEM, V1, P75, DOI 10.1002/cssc.200700033; Thiyagarajan S, 2013, RSC ADV, V3, P15678, DOI 10.1039/c3ra42457j; van Putten RJ, 2013, CHEM REV, V113, P1499, DOI 10.1021/cr300182k; Vechorkin O, 2010, ORG LETT, V12, P3567, DOI 10.1021/ol101450u; Werpy T., 2004, TOP VALUE ADDED CHEM, V1, DOI [DOI 10.2172/15008859, 10.2172/15008859]; Yu DY, 2011, GREEN CHEM, V13, P1275, DOI 10.1039/c0gc00819b	30	237	245	32	700	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					215	+		10.1038/nature17185	http://dx.doi.org/10.1038/nature17185			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26961655				2022-12-28	WOS:000371665100037
J	Konopka, G; Roberts, TF				Konopka, Genevieve; Roberts, Todd F.			Insights into the Neural and Genetic Basis of Vocal Communication	CELL			English	Review							AUTISM SPECTRUM DISORDERS; BASAL GANGLIA CIRCUITS; TRANSGENIC SONGBIRDS; ZEBRA FINCH; ULTRASONIC VOCALIZATIONS; SENSORIMOTOR INTEGRATION; DOPAMINERGIC MODULATION; BRAIN ABNORMALITIES; SIGNALING PATHWAYS; FOREBRAIN CIRCUIT	The use of vocalizations to communicate information and elaborate social bonds is an adaptation seen in many vertebrate species. Human speech is an extreme version of this pervasive form of communication. Unlike the vocalizations exhibited by the majority of land vertebrates, speech is a learned behavior requiring early sensory exposure and auditory feedback for its development and maintenance. Studies in humans and a small number of other species have provided insights into the neural and genetic basis for learned vocal communication and are helping to delineate the roles of brain circuits across the cortex, basal ganglia, and cerebellum in generating vocal behaviors. This Review provides an outline of the current knowledge about these circuits and the genes implicated in vocal communication, as well as a perspective on future research directions in this field.	[Konopka, Genevieve; Roberts, Todd F.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Konopka, G; Roberts, TF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	genevieve.konopka@utsouthwestern.edu; todd.roberts@utsouthwestern.edu		Konopka, Genevieve/0000-0002-3363-7302	UT Southwestern Jon Heighten Scholar in Autism Research; Thomas O. Hicks Scholar in Medical Research; National Institutes of Health [R01DC014702, R01MH102603, R01MH103517, R21MH107672, R01DC014364]; National Science Foundation [IOS-1451034, IOS-1457206]; UT BRAIN Initiative Seed Grants [366582, 362808, 365231]; Friends of the Alzheimer's Disease Center at UT Southwestern; Klingenstein-Simons Award in Neuroscience; NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102603, R21MH107672, R01MH103517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014702, R01DC014364] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1457206] Funding Source: National Science Foundation	UT Southwestern Jon Heighten Scholar in Autism Research; Thomas O. Hicks Scholar in Medical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); UT BRAIN Initiative Seed Grants; Friends of the Alzheimer's Disease Center at UT Southwestern; Klingenstein-Simons Award in Neuroscience; NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We apologize for being unable to cover and cite all of the relevant literature due to space constraints. We thank Brad Lega for comments on the manuscript. Work from the authors' laboratories is supported by the UT Southwestern Jon Heighten Scholar in Autism Research (G.K.) and Thomas O. Hicks Scholar in Medical Research (T.F.R.), grants from the National Institutes of Health (R01DC014702, R01MH102603, R01MH103517, R21MH107672 to G.K. and R01DC014364 to T.F.R.), National Science Foundation (IOS-1451034 to G.K. and T.F.R. and IOS-1457206 to T.F.R.), UT BRAIN Initiative Seed Grants (366582 to G.K. and 362808 and 365231 to T.F.R.), Friends of the Alzheimer's Disease Center at UT Southwestern (G.K.), and Klingenstein-Simons Award in Neuroscience (T.F.R.). T.F.R is an Essel Investigator supported by a NARSAD Young Investigator Grant from the Brain and Behavior Research Foundation.	Abe K, 2015, P NATL ACAD SCI USA, V112, P7599, DOI 10.1073/pnas.1413484112; Adret P, 2012, J NEUROPHYSIOL, V108, P1977, DOI 10.1152/jn.00905.2011; Agate RJ, 2009, P NATL ACAD SCI USA, V106, P17963, DOI 10.1073/pnas.0909139106; Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Amador A, 2013, NATURE, V495, P59, DOI 10.1038/nature11967; Araujo DJ, 2015, GENE DEV, V29, P2081, DOI 10.1101/gad.267989.115; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Bacon C, 2015, MOL PSYCHIATR, V20, P632, DOI 10.1038/mp.2014.116; Barbas H, 2013, BRAIN LANG, V126, P49, DOI 10.1016/j.bandl.2012.10.001; Becker EBE, 2013, INT REV NEUROBIOL, V113, P1, DOI 10.1016/B978-0-12-418700-9.00001-0; Belton E, 2003, HUM BRAIN MAPP, V18, P194, DOI 10.1002/hbm.10093; Betley JN, 2011, HUM GENE THER, V22, P669, DOI 10.1089/hum.2010.204; Blank I, 2016, NEUROIMAGE, V127, P307, DOI 10.1016/j.neuroimage.2015.11.069; Bloomfield TC, 2011, NAT NEUROSCI, V14, P947, DOI 10.1038/nn.2884; Bolhuis JJ, 2015, NEUROSCI BIOBEHAV R, V50, P41, DOI 10.1016/j.neubiorev.2014.11.019; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bouchard KE, 2013, NATURE, V495, P327, DOI 10.1038/nature11911; Brainard MS, 2013, ANNU REV NEUROSCI, V36, P489, DOI 10.1146/annurev-neuro-060909-152826; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Brawn TP, 2015, CURR TOP BEHAV NEURO, V25, P207, DOI 10.1007/7854_2014_349; Cattaneo Luigi, 2013, Handb Clin Neurol, V116, P681, DOI 10.1016/B978-0-444-53497-2.00054-1; Chang EF, 2015, J NEUROSURG, V122, P250, DOI 10.3171/2014.10.JNS132647; Charlesworth JD, 2012, NATURE, V486, P251, DOI 10.1038/nature11078; Cogan GB, 2014, NATURE, V507, P94, DOI 10.1038/nature12935; Craig-McQuaide A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00884; Devlin JT, 2007, BRAIN, V130, P610, DOI 10.1093/brain/awl331; Dichter Gabriel S, 2012, Dialogues Clin Neurosci, V14, P319; Ding N, 2016, NAT NEUROSCI, V19, P158, DOI 10.1038/nn.4186; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dronkers NF, 2007, BRAIN, V130, P1432, DOI 10.1093/brain/awm042; Enard W, 2011, CURR OPIN NEUROBIOL, V21, P415, DOI 10.1016/j.conb.2011.04.008; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; French CA, 2014, CURR OPIN NEUROBIOL, V28, P72, DOI 10.1016/j.conb.2014.07.003; Graham SA, 2015, ANNU REV GENET, V49, P131, DOI 10.1146/annurev-genet-120213-092236; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Gronholm EO, 2016, EUR J NEUROL, V23, P148, DOI 10.1111/ene.12822; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Gunaydin LA, 2016, ANNU REV PHYSIOL, V78, P327, DOI 10.1146/annurev-physiol-021115-105355; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hammerschmidt K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08808; Hampson DR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2075.00420, 10.3389/fnins.2015.00420]; Hawrylycz M, 2015, NAT NEUROSCI, V18, P1832, DOI 10.1038/nn.4171; Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heinks-Maldonado TH, 2007, ARCH GEN PSYCHIAT, V64, P286, DOI 10.1001/archpsyc.64.3.286; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Holmes G, 1917, BRAIN, V40, P461, DOI 10.1093/brain/40.4.461; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Horga G, 2014, J NEUROSCI, V34, P8072, DOI 10.1523/JNEUROSCI.0200-14.2014; Hugdahl K, 2015, WORLD J PSYCHIATR, V5, P193, DOI 10.5498/wjp.v5.i2.193; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Kleinhans NM, 2008, BRAIN RES, V1221, P115, DOI 10.1016/j.brainres.2008.04.080; Konopka G, 2016, BIOL PSYCHIAT, V79, P53, DOI 10.1016/j.biopsych.2015.07.001; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Kosche G, 2015, J NEUROSCI, V35, P1217, DOI 10.1523/JNEUROSCI.4346-14.2015; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Kuebrich BD, 2015, NEUROSCIENCE, V296, P48, DOI 10.1016/j.neuroscience.2014.09.068; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Leblois A, 2012, EUR J NEUROSCI, V35, P1771, DOI 10.1111/j.1460-9568.2012.08095.x; Leblois A, 2010, J NEUROSCI, V30, P5730, DOI 10.1523/JNEUROSCI.5974-09.2010; Lepp S, 2013, INT REV NEUROBIOL, V113, P97, DOI 10.1016/B978-0-12-418700-9.00004-6; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Liegeois F, 2011, EUR J PAEDIATR NEURO, V15, P283, DOI 10.1016/j.ejpn.2011.04.006; Liu WC, 2015, NAT NEUROSCI, V18, P1617, DOI 10.1038/nn.4133; Lombardo MV, 2015, NEURON, V86, P567, DOI 10.1016/j.neuron.2015.03.023; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Marien P, 2014, CEREBELLUM, V13, P386, DOI 10.1007/s12311-013-0540-5; Markowitz JE, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002158; MATHEWS PJ, 1994, BRAIN LANG, V46, P439, DOI 10.1006/brln.1994.1024; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Mooney R, 2008, LEARNING MEMORY COMP; Mooney R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0179; Mosconi MW, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00296; Murdoch BE, 2010, CORTEX, V46, P858, DOI 10.1016/j.cortex.2009.07.018; Murugan M, 2013, NEURON, V80, P1464, DOI 10.1016/j.neuron.2013.09.021; Nelson AB, 2014, ANNU REV NEUROSCI, V37, P117, DOI 10.1146/annurev-neuro-071013-013916; Newbury DF, 2010, NEURON, V68, P309, DOI 10.1016/j.neuron.2010.10.001; Norman-Haignere S, 2015, NEURON, V88, P1281, DOI 10.1016/j.neuron.2015.11.035; Okano H, 2015, PHILOS T R SOC B, V370, P33, DOI 10.1098/rstb.2014.0310; Okubo TS, 2015, NATURE, V528, P352, DOI 10.1038/nature15741; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Peh WYX, 2015, J NEUROSCI, V35, P5589, DOI 10.1523/JNEUROSCI.2308-14.2015; PENFIELD W, 1949, ARCH NEURO PSYCHIATR, V61, P21, DOI 10.1001/archneurpsyc.1949.02310070027002; Poeppel D, 2012, COGN NEUROPSYCHOL, V29, P34, DOI 10.1080/02643294.2012.710600; Portfors CV, 2014, CURR OPIN NEUROBIOL, V28, P115, DOI 10.1016/j.conb.2014.07.002; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; Prather JF, 2010, J NEUROSCI, V30, P10586, DOI 10.1523/JNEUROSCI.6042-09.2010; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Richiardi J, 2015, SCIENCE, V348, P1241, DOI 10.1126/science.1255905; Roberts TF, 2013, HEARING RES, V303, P48, DOI 10.1016/j.heares.2013.01.009; Roberts TF, 2012, NAT NEUROSCI, V15, P1454, DOI 10.1038/nn.3206; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Roll P, 2010, HUM MOL GENET, V19, P4848, DOI 10.1093/hmg/ddq415; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Scharff C, 2011, PHILOS T R SOC B, V366, P2124, DOI 10.1098/rstb.2011.0001; Schneider DM, 2015, CURR OPIN NEUROBIOL, V33, P78, DOI 10.1016/j.conb.2015.03.004; Schreiweis C, 2014, P NATL ACAD SCI USA, V111, P14253, DOI 10.1073/pnas.1414542111; Schulz SB, 2010, GENES BRAIN BEHAV, V9, P732, DOI 10.1111/j.1601-183X.2010.00607.x; Scott BB, 2010, ILAR J, V51, P353, DOI 10.1093/ilar.51.4.353; Shank SS, 2009, NATURE, V458, P73, DOI 10.1038/nature07615; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Sia GM, 2013, SCIENCE, V342, P987, DOI 10.1126/science.1245079; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Takahashi DY, 2015, SCIENCE, V349, P734, DOI 10.1126/science.aab1058; Takahashi K, 2003, J NEUROSCI RES, V73, P61, DOI 10.1002/jnr.10638; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Tschida K, 2012, CURR OPIN NEUROBIOL, V22, P320, DOI 10.1016/j.conb.2011.11.006; Usui N, 2014, BRAIN BEHAV EVOLUT, V84, P103, DOI 10.1159/000365182; Vallentin D, 2016, SCIENCE, V351, P267, DOI 10.1126/science.aad3023; Wang CZH, 2008, PLOS BIOL, V6, P2154, DOI 10.1371/journal.pbio.0060250; Wang GZ, 2015, NEURON, V88, P659, DOI 10.1016/j.neuron.2015.10.022; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Watkins K, 2011, PROG BRAIN RES, V189, P225, DOI 10.1016/B978-0-444-53884-0.00027-0; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057; Zhang GJ, 2014, SCIENCE, V346, P1308, DOI 10.1126/science.346.6215.1308	129	49	49	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1269	1276		10.1016/j.cell.2016.02.039	http://dx.doi.org/10.1016/j.cell.2016.02.039			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967292	Bronze, Green Accepted			2022-12-28	WOS:000372784900023
J	Orandi, BJ; Luo, X; Massie, AB; Garonzik-Wang, JM; Lonze, BE; Ahmed, R; Van Arendonk, KJ; Stegall, MD; Jordan, SC; Oberholzer, J; Dunn, TB; Ratner, LE; Kapur, S; Pelletier, RP; Roberts, JP; Melcher, ML; Singh, P; Sudan, DL; Posner, MP; El-Amm, JM; Shapiro, R; Cooper, M; Lipkowitz, GS; Rees, MA; Marsh, CL; Sankari, BR; Gerber, DA; Nelson, PW; Wellen, J; Bozorgzadeh, A; Gaber, AO; Montgomery, RA; Segev, DL				Orandi, B. J.; Luo, X.; Massie, A. B. .; Garonzik-Wang, J. M.; Lonze, B. E.; Ahmed, R.; Van Arendonk, K. J.; Stegall, M. D.; Jordan, S. C.; Oberholzer, J.; Dunn, T. B.; Ratner, L. E.; Kapur, S.; Pelletier, R. P.; Roberts, J. P.; Melcher, M. L.; Singh, P.; Sudan, D. L.; Posner, M. P.; El-Amm, J. M.; Shapiro, R.; Cooper, M.; Lipkowitz, G. S.; Rees, M. A.; Marsh, C. L.; Sankari, B. R.; Gerber, D. A.; Nelson, P. W.; Wellen, J.; Bozorgzadeh, A.; Gaber, A. O.; Montgomery, R. A.; Segev, D. L.			Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITIVE CROSS-MATCH; STAGE RENAL-DISEASE; PAIRED DONATION; DESENSITIZATION; OUTCOMES; TERM; ANTIBODIES; THERAPY; RISK	BACKGROUND A report from a high-volume single center indicated a survival benefit of receiving a kidney transplant from an HLA-incompatible live donor as compared with remaining on the waiting list, whether or not a kidney from a deceased donor was received. The generalizability of that finding is unclear. METHODS In a 22-center study, we estimated the survival benefit for 1025 recipients of kidney transplants from HLA-incompatible live donors who were matched with controls who remained on the waiting list or received a transplant from a deceased donor (waitinglist-or-transplant control group) and controls who remained on the waiting list but did not receive a transplant (waiting-list-only control group). We analyzed the data with and without patients from the highest-volume center in the study. RESULTS Recipients of kidney transplants from incompatible live donors had a higher survival rate than either control group at 1 year (95.0%, vs. 94.0% for the waiting-list-ortransplant control group and 89.6% for the waiting-list-only control group), 3 years (91.7% vs. 83.6% and 72.7%, respectively), 5 years (86.0% vs. 74.4% and 59.2%), and 8 years (76.5% vs. 62.9% and 43.9%) (P<0.001 for all comparisons with the two control groups). The survival benefit was significant at 8 years across all levels of donorspecific antibody: 89.2% for recipients of kidney transplants from incompatible live donors who had a positive Luminex assay for anti-HLA antibody but a negative flow-cytometric cross-match versus 65.0% for the waiting-list-or-transplant control group and 47.1% for the waiting-list-only control group; 76.3% for recipients with a positive flow-cytometric cross-match but a negative cytotoxic cross-match versus 63.3% and 43.0% in the two control groups, respectively; and 71.0% for recipients with a positive cytotoxic cross-match versus 61.5% and 43.7%, respectively. The findings did not change when patients from the highest-volume center were excluded. CONCLUSIONS This multicenter study validated single-center evidence that patients who received kidney transplants from HLA-incompatible live donors had a substantial survival benefit as compared with patients who did not undergo transplantation and those who waited for transplants from deceased donors. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases.)	[Orandi, B. J.; Luo, X.; Massie, A. B. .; Lonze, B. E.; Ahmed, R.; Van Arendonk, K. J.; Montgomery, R. A.; Segev, D. L.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Garonzik-Wang, J. M.; Wellen, J.] Barnes Jewish Hosp, Dept Surg, St Louis, MO USA; [Stegall, M. D.] Mayo Clin, Dept Surg, Rochester, MN USA; [Dunn, T. B.] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Jordan, S. C.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Roberts, J. P.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Melcher, M. L.] Stanford Univ, Dept Surg, Palo Alto, CA 94304 USA; [Marsh, C. L.] Scripps Clin & Green Hosp, Dept Surg, La Jolla, CA USA; [Oberholzer, J.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Ratner, L. E.] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10027 USA; [Kapur, S.] New York Presbyterian Weill Cornell Med Ctr, Dept Surg, New York, NY USA; [Pelletier, R. P.] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Rees, M. A.] Univ Toledo, Med Ctr, Dept Urol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Sankari, B. R.] Cleveland Clin, Dept Urol, Cleveland, OH 44106 USA; [Singh, P.] Thomas Jefferson Univ Hosp, Dept Med, Philadelphia, PA 19107 USA; [Shapiro, R.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburg, KS USA; [Sudan, D. L.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Gerber, D. A.] Univ N Carolina, Sch Med, Dept Surg, Chapel Hill, NC USA; [Posner, M. P.] Virginia Commonwealth Univ, Dept Surg, Richmond, VA USA; [El-Amm, J. M.] Integris Baptist Med Ctr, Transplant Div, Oklahoma City, OK USA; [Cooper, M.] Med Star Georgetown Transplant Inst, Washington, DC USA; [Lipkowitz, G. S.] Baystate Med Ctr, Dept Surg, Springfield, MA 01107 USA; [Bozorgzadeh, A.] Univ Massachusetts, Mem Med Ctr, Dept Surg, Worcester, MA 01605 USA; [Nelson, P. W.] St Vincent Hosp, Dept Surg, Indianapolis, IN USA; [Gaber, A. O.] Houston Methodist Hosp, Dept Surg, Houston, TX USA	Johns Hopkins University; Barnes-Jewish Hospital; Washington University (WUSTL); Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Cedars Sinai Medical Center; University of California System; University of California San Francisco; Stanford University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Columbia University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University System of Ohio; Ohio State University; University System of Ohio; University of Toledo; Cleveland Clinic Foundation; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Virginia Commonwealth University; Baystate Medical Center; University of Massachusetts System; University of Massachusetts Worcester; The Methodist Hospital System; The Methodist Hospital - Houston	Segev, DL (corresponding author), Johns Hopkins Univ, Dept Surg, 720 Rutland Ave,Turner 034, Baltimore, MD 21287 USA.	dorry@jhmi.edu	Rees, Michael/AAW-1385-2021; Orandi, Babak/I-6760-2019; Dunn, Ty B./H-7593-2019; Luo, Xun/R-3307-2017; Jordan, Stan/AAI-1250-2021; Stegall, Mark/AAX-6496-2020; Melcher, Marc L./AAC-6130-2020	Dunn, Ty B./0000-0002-5941-0659; Luo, Xun/0000-0003-0244-9832; Jordan, Stan/0000-0002-0456-8635; Stegall, Mark/0000-0002-1392-0792; Melcher, Marc L./0000-0002-7185-4383; Lonze, Bonnie/0000-0002-0973-1657; Marsh, Christopher/0000-0002-6517-076X; Garonzik Wang, Jacqueline/0000-0002-2789-7503; Sudan, Debra/0000-0003-4315-4459; Van Arendonk, Kyle/0000-0002-0367-0881	National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK093218, RC1DK086731, K24DK101828, R01DK098431] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institute of Diabetes and Digestive and Kidney Diseases.	Bentall A, 2013, AM J TRANSPLANT, V13, P76, DOI 10.1111/j.1600-6143.2012.04291.x; Berger JC, 2011, CLIN J AM SOC NEPHRO, V6, P2887, DOI 10.2215/CJN.04160511; Blumberg JM, 2013, KIDNEY INT, V84, P1009, DOI 10.1038/ki.2013.206; Ejaz NS, 2013, AM J TRANSPLANT, V13, P3142, DOI 10.1111/ajt.12493; Fuggle SV, 2008, TRANSPLANTATION, V86, P384, DOI 10.1097/TP.0b013e31817c90f5; Gentry SE, 2007, AM J TRANSPLANT, V7, P2361, DOI 10.1111/j.1600-6143.2007.01935.x; Gloor JM, 2010, AM J TRANSPLANT, V10, P582, DOI 10.1111/j.1600-6143.2009.02985.x; Gloor JM, 2003, AM J TRANSPLANT, V3, P1017, DOI 10.1034/j.1600-6143.2003.00180.x; Glotz D, 2002, AM J TRANSPLANT, V2, P758, DOI 10.1034/j.1600-6143.2002.20809.x; Haririan A, 2009, AM J TRANSPLANT, V9, P536, DOI 10.1111/j.1600-6143.2008.02524.x; Higgins R, 2011, TRANSPLANTATION, V92, P900, DOI 10.1097/TP.0b013e31822dc38d; Jordan SC, 2004, J AM SOC NEPHROL, V15, P3256, DOI 10.1097/01.ASN.0000145878.92906.9F; Magee CC, 2008, TRANSPLANTATION, V86, P96, DOI 10.1097/TP.0b013e318176ae2c; Massie AB, 2013, AM J TRANSPLANT, V13, P1317, DOI 10.1111/ajt.12189; Montgomery JR, 2012, TRANSPLANTATION, V93, P603, DOI 10.1097/TP.0b013e318245b2af; Montgomery RA, 2010, AM J TRANSPLANT, V10, P449, DOI 10.1111/j.1600-6143.2009.03001.x; Montgomery RA, 2005, JAMA-J AM MED ASSOC, V294, P1655, DOI 10.1001/jama.294.13.1655; Montgomery RA, 2004, PEDIATR TRANSPLANT, V8, P535, DOI 10.1111/j.1399-3046.2004.00214.x; Montgomery RA, 2000, TRANSPLANTATION, V70, P887, DOI 10.1097/00007890-200009270-00006; Montgomery RA, 2006, TRANSPLANTATION, V82, P164, DOI 10.1097/01.tp.0000226105.42713.37; Montgomery RA, 2011, NEW ENGL J MED, V365, P318, DOI 10.1056/NEJMoa1012376; Montgomery RA, 2011, CURR OPIN ORGAN TRAN, V16, P439, DOI 10.1097/MOT.0b013e32834897c1; Montgomery RA, 2009, TRANSPLANTATION, V87, P1246, DOI 10.1097/TP.0b013e31819f2024; Muzaale AD, 2014, JAMA-J AM MED ASSOC, V311, P579, DOI 10.1001/jama.2013.285141; Newson R, 2002, STATA J, V2, P45, DOI 10.1177/1536867X0200200103; Orandi BJ, 2015, AM J TRANSPLANT, V15, P489, DOI 10.1111/ajt.12982; Orandi BJ, 2014, AM J TRANSPLANT, V14, P1573, DOI 10.1111/ajt.12786; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Reed EF, 2013, AM J TRANSPLANT, V13, P1859, DOI 10.1111/ajt.12287; Schweitzer EJ, 2000, TRANSPLANTATION, V70, P1531, DOI 10.1097/00007890-200011270-00023; Segev DL, 2005, JAMA-J AM MED ASSOC, V293, P1883, DOI 10.1001/jama.293.15.1883; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Tait BD, 2013, TRANSPLANTATION, V95, P19, DOI 10.1097/TP.0b013e31827a19cc; Therneau TM, 2000, MODELING SURVIVAL DA; Van Arendonk KJ, 2013, J PEDIATR SURG, V48, P1277, DOI 10.1016/j.jpedsurg.2013.03.023; Wilcox RR, 1998, BIOMETRICAL J, V40, P261, DOI 10.1002/(SICI)1521-4036(199807)40:3<261::AID-BIMJ261>3.0.CO;2-V; ZACHARY AA, 1995, TRANSPLANTATION, V60, P498, DOI 10.1097/00007890-199509000-00016; Zachary AA, 2009, HUM IMMUNOL, V70, P496, DOI 10.1016/j.humimm.2009.04.001	38	215	222	2	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					940	950		10.1056/NEJMoa1508380	http://dx.doi.org/10.1056/NEJMoa1508380			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF9DH	26962729	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000371660000007
J	Stelten, BML; Post, B				Stelten, Bianca M. L.; Post, Bart			Midline Destructive Lesions in a Cocaine User	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Stelten, Bianca M. L.] Canisius Wilhelmina Hosp, Nijmegen, Netherlands; [Post, Bart] Radboud Univ Nijmegen, Med Ctr Nijmegen, NL-6525 ED Nijmegen, Netherlands	Canisius-Wilhelmina Hospital; Radboud University Nijmegen	Stelten, BML (corresponding author), Canisius Wilhelmina Hosp, Nijmegen, Netherlands.	b.stelten@cwz.nl							0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					969	969		10.1056/NEJMicm1503043	http://dx.doi.org/10.1056/NEJMicm1503043			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF9DH	26962731				2022-12-28	WOS:000371660000010
J	Mukkanna, KS				Mukkanna, Krishna Sumanth			SPOT DIAGNOSIS Annular, scaly, erythematous rash on the buttocks and thighs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mukkanna, Krishna Sumanth] Royal Gwent Hosp, Dept Dermatol, Newport, Gwent, Wales	Royal Gwent Hospital	Mukkanna, KS (corresponding author), Royal Gwent Hosp, Dept Dermatol, Newport, Gwent, Wales.	ksumanth@doctors.org.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2016	352								i1147	10.1136/bmj.i1147	http://dx.doi.org/10.1136/bmj.i1147			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NI	26956869				2022-12-28	WOS:000372048500004
J	Richards, C				Richards, Cecile			Protecting and Expanding Access to Birth Control	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Richards, Cecile] Planned Parenthood Federat Amer & Planned Parenth, New York, NY USA		Richards, C (corresponding author), Planned Parenthood Federat Amer & Planned Parenth, New York, NY USA.							Becker NV, 2015, HEALTH AFFAIR, V34, P1204, DOI 10.1377/hlthaff.2015.0127; Department of Health and Human Services, 2015, ASPE DAT POINT AFF C; Kost K, 2014, US TEENAGE PREGNANCI; Thompson KM, 2016, AM J PUBLIC HLTH	4	5	5	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					801	803		10.1056/NEJMp1601150	http://dx.doi.org/10.1056/NEJMp1601150			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF2FT	26962898				2022-12-28	WOS:000371158400001
J	Snow, SJ				Snow, Stephanie J.			Stroke and t-PA - Triggering New Paradigms of Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE ISCHEMIC-STROKE		[Snow, Stephanie J.] Univ Manchester, Ctr Hist Sci Med & Technol, Manchester, Lancs, England	University of Manchester	Snow, SJ (corresponding author), Univ Manchester, Ctr Hist Sci Med & Technol, Manchester, Lancs, England.			Snow, Stephanie/0000-0001-9957-7835	Wellcome Trust [092782] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Audebert HJ, 2014, NAT REV NEUROL, V10, P675, DOI 10.1038/nrneurol.2014.194; Hoffman JR, 2000, WESTERN J MED, V173, P149, DOI 10.1136/ewjm.173.3.149; Laureno Robert, 2009, R ADAMS LIFE MIND MU; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; WRIGHT IS, 1954, ANN INTERN MED, V41, P682, DOI 10.7326/0003-4819-41-4-682	5	26	26	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					809	811		10.1056/NEJMp1514696	http://dx.doi.org/10.1056/NEJMp1514696			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF2FT	26962901	Green Accepted			2022-12-28	WOS:000371158400004
J	Talan, DA; Mower, WR; Krishnadasan, A; Abrahamian, FM; Lovecchio, F; Karras, DJ; Steele, MT; Rothman, RE; Hoagland, R; Moran, GJ				Talan, David A.; Mower, William R.; Krishnadasan, Anusha; Abrahamian, Fredrick M.; Lovecchio, Frank; Karras, David J.; Steele, Mark T.; Rothman, Richard E.; Hoagland, Rebecca; Moran, Gregory J.			Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SOFT-TISSUE INFECTIONS; PRACTICE GUIDELINES; DISEASES SOCIETY; DOUBLE-BLIND; MANAGEMENT; POPULATION; EMERGENCE	BACKGROUND U.S. emergency department visits for cutaneous abscess have increased with the emergence of methicillin-resistant Staphylococcus aureus (MRSA). The role of antibiotics for patients with a drained abscess is unclear. METHODS We conducted a randomized trial at five U.S. emergency departments to determine whether trimethoprim-sulfamethoxazole (at doses of 320 mg and 1600 mg, respectively, twice daily, for 7 days) would be superior to placebo in outpatients older than 12 years of age who had an uncomplicated abscess that was being treated with drainage. The primary outcome was clinical cure of the abscess, assessed 7 to 14 days after the end of the treatment period. RESULTS The median age of the participants was 35 years (range, 14 to 73); 45.3% of the participants had wound cultures that were positive for MRSA. In the modified intention-to-treat population, clinical cure of the abscess occurred in 507 of 630 participants (80.5%) in the trimethoprim-sulfamethoxazole group versus 454 of 617 participants (73.6%) in the placebo group (difference, 6.9 percentage points; 95% confidence interval [CI], 2.1 to 11.7; P = 0.005). In the per-protocol population, clinical cure occurred in 487 of 524 participants (92.9%) in the trimethoprim-sulfamethoxazole group versus 457 of 533 participants (85.7%) in the placebo group (difference, 7.2 percentage points; 95% CI, 3.2 to 11.2; P<0.001). Trimethoprim-sulfamethoxazole was superior to placebo with respect to most secondary outcomes in the per-protocol population, resulting in lower rates of subsequent surgical drainage procedures (3.4% vs. 8.6%; difference, -5.2 percentage points; 95% CI, -8.2 to -2.2), skin infections at new sites (3.1% vs. 10.3%; difference, -7.2 percentage points; 95% CI, -10.4 to -4.1), and infections in household members (1.7% vs. 4.1%; difference, -2.4 percentage points; 95% CI, -4.6 to -0.2) 7 to 14 days after the treatment period. Trimethoprim-sulfamethoxazole was associated with slightly more gastrointestinal side effects (mostly mild) than placebo. At 7 to 14 days after the treatment period, invasive infections had developed in 2 of 524 participants (0.4%) in the trimethoprim-sulfamethoxazole group and in 2 of 533 participants (0.4%) in the placebo group; at 42 to 56 days after the treatment period, an invasive infection had developed in 1 participant (0.2%) in the trimethoprim-sulfamethoxazole group. CONCLUSIONS In settings in which MRSA was prevalent, trimethoprim-sulfamethoxazole treatment resulted in a higher cure rate among patients with a drained cutaneous abscess than placebo.	[Talan, David A.; Krishnadasan, Anusha; Abrahamian, Fredrick M.; Moran, Gregory J.] Olive View UCLA Med Ctr, Dept Emergency Med, Los Angeles, CA USA; [Talan, David A.; Moran, Gregory J.] Olive View UCLA Med Ctr, Dept Med, Div Infect Dis, Los Angeles, CA USA; [Mower, William R.] Univ Calif Los Angeles, David Geffen Sch Med, Ronald Reagan Med Ctr, Dept Emergency Med, Los Angeles, CA 90095 USA; [Lovecchio, Frank] Univ Arizona, Maricopa Med Ctr, Dept Emergency Med, Phoenix, AZ USA; [Lovecchio, Frank] Mayo Clin & Mayo Grad Sch Med, Phoenix, AZ USA; [Karras, David J.] Temple Univ, Sch Med, Med Ctr, Dept Emergency Med, Philadelphia, PA 19122 USA; [Steele, Mark T.] Univ Missouri, Sch Med, Truman Med Ctr, Dept Emergency Med, Kansas City, KS USA; [Rothman, Richard E.] Johns Hopkins Sch Med, Johns Hopkins Med Ctr, Dept Emergency Med, Baltimore, MD USA; [Hoagland, Rebecca] Cota Enterprises, Mclouth, KS USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ronald Reagan UCLA Medical Center; University of Arizona; Mayo Clinic; Mayo Clinic Phoenix; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Missouri System; University of Missouri Kansas City; Johns Hopkins University; Johns Hopkins Medicine	Talan, DA (corresponding author), Olive View UCLA Med Ctr, 14445 Olive View Dr,North Annex, Sylmar, CA 91342 USA.	idnet@ucla.edu		Rothman, Richard/0000-0002-1017-9505	National Institute of Allergy and Infectious Diseases	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institute of Allergy and Infectious Diseases; - ClinicalTrials.gov number, NCT00729937.	BRUUN JN, 1981, ANTIMICROB AGENTS CH, V19, P82, DOI 10.1128/AAC.19.1.82; CHAN HL, 1990, ARCH DERMATOL, V126, P43, DOI 10.1001/archderm.126.1.43; Duong M, 2010, ANN EMERG MED, V55, P401, DOI 10.1016/j.annemergmed.2009.03.014; FDA, 2013, GUID IND AC BACT SKI; Fitch MT, 2007, NEW ENGL J MED, V357, pe20; Gilbert DN, 2008, SANFORD GUIDE ANTIMI; Gorwitz RJ., 2006, STRATEGIES CLIN MANA; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Llera J L, 1984, J Emerg Med, V1, P489, DOI 10.1016/0736-4679(84)90002-7; LLERA JL, 1985, ANN EMERG MED, V14, P15, DOI 10.1016/S0196-0644(85)80727-7; MACFIE J, 1977, BRIT J SURG, V64, P264, DOI 10.1002/bjs.1800640410; MEISLIN HW, 1977, ANN INTERN MED, V87, P145, DOI 10.7326/0003-4819-87-2-145; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Pallin DJ, 2008, ANN EMERG MED, V51, P291, DOI 10.1016/j.annemergmed.2007.12.004; Qualls ML, 2012, CLIN INFECT DIS, V55, P103, DOI 10.1093/cid/cis342; Rajendran PM, 2007, ANTIMICROB AGENTS CH, V51, P4044, DOI 10.1128/AAC.00377-07; Ruhe JJ, 2007, CLIN INFECT DIS, V44, P777, DOI 10.1086/511872; Schmitz GR, 2010, ANN EMERG MED, V56, P283, DOI 10.1016/j.annemergmed.2010.03.002; Singer AJ, 2014, NEW ENGL J MED, V370, P1039, DOI 10.1056/NEJMra1212788; Spellberg B, 2011, ANN EMERG MED, V57, P183, DOI 10.1016/j.annemergmed.2010.04.027; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]; Szumowski JD, 2007, ANTIMICROB AGENTS CH, V51, P423, DOI 10.1128/AAC.01244-06; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Talan DA, 2010, ANN EMERG MED, V55, P412, DOI 10.1016/j.annemergmed.2010.02.024	25	45	49	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					823	832		10.1056/NEJMoa1507476	http://dx.doi.org/10.1056/NEJMoa1507476			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF2FT	26962903	Green Accepted			2022-12-28	WOS:000371158400006
J	Elmore, JG; Nelson, HD; Pepe, MS; Longton, GM; Tosteson, ANA; Geller, B; Onega, T; Carney, PA; Jackson, SL; Allison, KH; Weaver, DL				Elmore, Joann G.; Nelson, Heidi D.; Pepe, Margaret S.; Longton, Gary M.; Tosteson, Anna N. A.; Geller, Berta; Onega, Tracy; Carney, Patricia A.; Jackson, Sara L.; Allison, Kimberly H.; Weaver, Donald L.			Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective	ANNALS OF INTERNAL MEDICINE			English	Article							LESIONS; CANCER	Background: The effect of physician diagnostic variability on accuracy at a population level depends on the prevalence of diagnoses. Objective: To estimate how diagnostic variability affects accuracy from the perspective of a U.S. woman aged 50 to 59 years having a breast biopsy. Design: Applied probability using Bayes theorem. Setting: B-Path (Breast Pathology) Study comparing pathologists' interpretations of a single biopsy slide versus a reference consensus interpretation from 3 experts. Participants: 115 practicing pathologists (6900 total interpretations from 240 distinct cases). Measurements: A single representative slide from each of the 240 cases was used to estimate the proportion of biopsies with a diagnosis that would be verified if the same slide were interpreted by a reference group of 3 expert pathologists. Probabilities of confirmation (predictive values) were estimated using B-Path Study results and prevalence of biopsy diagnoses for women aged 50 to 59 years in the Breast Cancer Surveillance Consortium. Results: Overall, if 1 representative slide were used per case, 92.3% (95% CI, 91.4% to 93.1%) of breast biopsy diagnoses would be verified by reference consensus diagnoses, with 4.6% (CI, 3.9% to 5.3%) overinterpreted and 3.2% (CI, 2.7% to 3.6%) underinterpreted. Verification of invasive breast cancer and benign without atypia diagnoses is highly probable; estimated predictive values were 97.7% (CI, 96.5% to 98.7%) and 97.1% (CI, 96.7% to 97.4%), respectively. Verification is less probable for atypia (53.6% overinterpreted and 8.6% underinterpreted) and ductal carcinoma in situ (DCIS) (18.5% overinterpreted and 11.8% underinterpreted). Limitations: Estimates are based on a testing situation with 1 slide used per case and without access to second opinions. Population-adjusted estimates may differ for women from other age groups, unscreened women, or women in different practice settings. Conclusion: This analysis, based on interpretation of a single breast biopsy slide per case, predicts a low likelihood that a diagnosis of atypia or DCIS would be verified by a reference consensus diagnosis. This diagnostic gray zone should be considered in clinical management decisions in patients with these diagnoses.	Univ Washington, Sch Med, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; Providence Hlth & Serv Oregon, Providence Canc Ctr, Portland, OR USA; [Nelson, Heidi D.; Carney, Patricia A.] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Tosteson, Anna N. A.] Geisel Sch Med Dartmouth, One Med Ctr Dr HB7505, Lebanon, NH 03756 USA; Univ Vermont, Burlington, VT USA; Stanford Univ, Sch Med, Stanford, CA 93195 USA; [Elmore, Joann G.; Jackson, Sara L.] Univ Washington, Mailbox 359780,325 Ninth Ave, Seattle, WA 98104 USA; [Pepe, Margaret S.; Longton, Gary M.] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, M2-B500,1100 Fairview Ave North,Box 19024, Seattle, WA 98109 USA; [Geller, Berta] Univ Vermont, Family Med, 1 South Prospect St, Burlington, VT 05401 USA; [Onega, Tracy] Geisel Sch Med Dartmouth, Sect Biostat & Epidemiol, One Med Ctr Dr HB7937, Lebanon, NH 03756 USA; [Allison, Kimberly H.] Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 93195 USA; [Weaver, Donald L.] Univ Vermont, Dept Pathol, 89 Beaumont Ave, Burlington, VT 05405 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Oregon Health & Science University; Dartmouth College; University of Vermont; Stanford University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Vermont; Dartmouth College; Stanford University; University of Vermont	Elmore, JG (corresponding author), Univ Washington, Mailbox 359780,325 Ninth Ave, Seattle, WA 98104 USA.	jelmore@u.washington.edu			National Cancer Institute of the National Institutes of Health [R01 CA140560, U01CA86082, U01 CA70013, R01 CA172343]; National Cancer Institute [HHSN261201100031C]; NATIONAL CANCER INSTITUTE [P30CA023108, U01CA070013, U01CA086082, R01CA140560, R01CA172343] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute of the National Institutes of Health (award numbers R01 CA140560, U01CA86082, U01 CA70013, and R01 CA172343) and by the National Cancer Institute-funded BCSC (award number HHSN261201100031C). The collection of cancer and vital status data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. A full description of sources is available at www.breastscreening.cancer.gov/work/acknowledgement.html.	Abraham J., 2015, US NEWS WORLD REPORT; Allison KH, 2014, HISTOPATHOLOGY, V65, P240, DOI 10.1111/his.12387; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Elmore JG, 2015, JAMA-J AM MED ASSOC, V314, P83, DOI 10.1001/jama.2015.6239; Elmore JG, 2015, JAMA-J AM MED ASSOC, V313, P1122, DOI 10.1001/jama.2015.1405; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Fisher LD., 1997, BIOMETRICS, V53, P1182; Hall FM, 2010, RADIOLOGY, V254, P655, DOI 10.1148/radiol.09092100; Hartmann LC, 2015, NEW ENGL J MED, V372, P78, DOI 10.1056/NEJMsr1407164; Holt L, 2015, STUDY FINDS BREAST C; National Comprehensive Cancer Network, 2015, CLIN PRACT GUID BREA; Oster NV, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-3; ROSAI J, 1991, AM J SURG PATHOL, V15, P209, DOI 10.1097/00000478-199103000-00001; RUBIN E, 1988, CANCER, V61, P2077, DOI 10.1002/1097-0142(19880515)61:10<2077::AID-CNCR2820611024>3.0.CO;2-M; SCHNITT SJ, 1992, AM J SURG PATHOL, V16, P1133, DOI 10.1097/00000478-199212000-00001; Weaver DL, 2006, CANCER, V106, P732, DOI 10.1002/cncr.21652	17	40	41	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					649	+		10.7326/M15-0964	http://dx.doi.org/10.7326/M15-0964			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	26999810	Green Accepted			2022-12-28	WOS:000375878500012
J	Morain, SR; Winickoff, JP; Mello, MM				Morain, Stephanie R.; Winickoff, Jonathan P.; Mello, Michelle M.			Have Tobacco 21 Laws Come of Age?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Morain, Stephanie R.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Winickoff, Jonathan P.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Winickoff, Jonathan P.] Amer Acad Pediat, Julius B Richmond Ctr Excellence, Elk Grove Village, IL USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Stanford Law Sch, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA	Baylor College of Medicine; Harvard University; Harvard Medical School; American Academy of Pediatrics; Stanford University; Stanford University	Morain, SR (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.			Morain, Stephanie/0000-0001-7278-7517; Mello, Michelle/0000-0003-2877-4270				Institute of Medicine, 2015, PUBL HLTH IMPL RAIS; King BA, 2015, AM J PREV MED, V49, P583, DOI 10.1016/j.amepre.2015.05.012; Schneider S. K., 2015, TOB CONTROL; Winickoff J. G., 2015, TOB CONTROL; Winickoff JP, 2014, AM J PUBLIC HEALTH, V104, pE18, DOI 10.2105/AJPH.2014.302174	5	32	32	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2016	374	17					1601	1604		10.1056/NEJMp1603294	http://dx.doi.org/10.1056/NEJMp1603294			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK3UR	27007697	Bronze			2022-12-28	WOS:000374843400002
J	Shao, H; Guo, WN; Sandvik, AW				Shao, Hui; Guo, Wenan; Sandvik, Anders W.			Quantum criticality with two length scales	SCIENCE			English	Article							ANTIFERROMAGNETS	The theory of deconfined quantum critical (DQC) points describes phase transitions at absolute temperature T = 0 outside the standard paradigm, predicting continuous transformations between certain ordered states where conventional theory would require discontinuities. Numerous computer simulations have offered no proof of such transitions, instead finding deviations from expected scaling relations that neither were predicted by the DQC theory nor conform to standard scenarios. Here we show that this enigma can be resolved by introducing a critical scaling form with two divergent length scales. Simulations of a quantum magnet with antiferromagnetic and dimerized ground states confirm the form, proving a continuous transition with deconfined excitations and also explaining anomalous scaling at T > 0. Our findings revise prevailing paradigms for quantum criticality, with potential implications for many strongly correlated materials.	[Shao, Hui; Guo, Wenan] Beijing Normal Univ, Dept Phys, Beijing 100875, Peoples R China; [Shao, Hui] Beijing Computat Sci Res Ctr, Beijing 100084, Peoples R China; [Shao, Hui; Sandvik, Anders W.] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA; [Guo, Wenan] Chinese Acad Sci, Inst Theoret Phys, State Key Lab Theoret Phys, Beijing 100190, Peoples R China	Beijing Normal University; Chinese Academy of Engineering Physics; Beijing Computational Science Research Center (CSRC); Boston University; Chinese Academy of Sciences; Institute of Theoretical Physics, CAS	Guo, WN (corresponding author), Beijing Normal Univ, Dept Phys, Beijing 100875, Peoples R China.; Sandvik, AW (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.; Guo, WN (corresponding author), Chinese Acad Sci, Inst Theoret Phys, State Key Lab Theoret Phys, Beijing 100190, Peoples R China.	waguo@bnu.edu.cn; sandvik@bu.edu	Guo, WenAn/G-3827-2013	Guo, WenAn/0000-0003-4632-4636	National Natural Science Foundation of China [11175018]; Fundamental Research Funds for the Central Universities; U.S. NSF [DMR-1410126]; Simons Foundation; Condensed Matter Theory Visitors Program at Boston University; Institute of Physics of the Chinese Academy of Sciences; Beijing Normal University; Division Of Materials Research [1410126] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); U.S. NSF(National Science Foundation (NSF)); Simons Foundation; Condensed Matter Theory Visitors Program at Boston University; Institute of Physics of the Chinese Academy of Sciences; Beijing Normal University; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The research was supported by the National Natural Science Foundation of China, grant no. 11175018 (W.G.); the Fundamental Research Funds for the Central Universities (W.G.); U.S. NSF grant no. DMR-1410126 (A.W.S.); and the Simons Foundation (A.W.S.). H.S. and W.G. gratefully acknowledge support from the Condensed Matter Theory Visitors Program at Boston University, and A.W.S. is grateful to the Institute of Physics of the Chinese Academy of Sciences and to Beijing Normal University for their support. Some computations were carried out using Boston University's Shared Computing Cluster. We thank K. Damle for suggesting a definition of spinons that uses valence-bond strings. Computer code is available from the authors upon request.	Banerjee A, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/08/P08017; Bartosch L, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.195140; Block MS, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.137202; Chen K, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.185701; CHUBUKOV AV, 1994, PHYS REV B, V49, P11919, DOI 10.1103/PhysRevB.49.11919; Dyer E, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP06(2015)037; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Gong SS, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.027201; Harada K, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.220408; Huh Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.166401; Jiang FJ, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/02/P02009; Kaul RK, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155105; Kaul RK, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054407; Kuklov AB, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.050405; Leonard F, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.200601; Li T, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.075111; LUCK JM, 1985, PHYS REV B, V31, P3069, DOI 10.1103/PhysRevB.31.3069; Melko RG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.017203; Metlitski MA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.214418; Motrunich OI, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.075104; MURTHY G, 1990, NUCL PHYS B, V344, P557, DOI 10.1016/0550-3213(90)90670-9; Nahum A, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041048; Pujari S, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.104411; READ N, 1990, PHYS REV B, V42, P4568, DOI 10.1103/PhysRevB.42.4568; READ N, 1991, PHYS REV LETT, V66, P1773, DOI 10.1103/PhysRevLett.66.1773; Sandvik AW, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.227202; Sandvik AW, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.207203; Sandvik AW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.177201; Senthil T, 2004, SCIENCE, V303, P1490, DOI 10.1126/science.1091806; Sreejith GJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.014404; Tang Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.217213; Tang Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.157201	33	127	129	4	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					213	216		10.1126/science.aad5007	http://dx.doi.org/10.1126/science.aad5007			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	26989196	Green Submitted			2022-12-28	WOS:000373681600043
J	Harnden, K; Pease, C; Jackson, A				Harnden, Kate; Pease, Colin; Jackson, Andrew			EASILY MISSED? Rheumatoid arthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DELAY		[Harnden, Kate] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Pease, Colin] Chapel Allerton Hosp, Rheumatol, Leeds LS7 4SA, W Yorkshire, England; [Jackson, Andrew] Canalside Hlth Care Ctr, Bingley Med Practice, Bingley BD16 4RP, England	Saint James's University Hospital; Chapel Allerton Hospital	Harnden, K (corresponding author), St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.	kateharnden@doctors.org.uk						Bykerk V, 2010, ARTHRITIS RHEUM-US, V62, P3519, DOI 10.1002/art.27691; Mottonen T, 2002, ARTHRITIS RHEUM, V46, P894, DOI 10.1002/art.10135; Myasoedova E, 2010, ARTHRITIS RHEUM-US, V62, P1576, DOI 10.1002/art.27425; Nam JL, 2016, ANN RHEUM DIS, V75, P2060, DOI 10.1136/annrheumdis-2015-208235; National Audit Office, 2009, SERV PEOPL RHEUM ART; National Collaborating Centre for Chronic Conditions (UK), RHEUM ARTHR NAT CLIN; National Institute for Health and Care Excellence, 2009, RHEUM ARTHR AD MAN C, V79; National Rheumatoid Arthritis Society, 2007, I WANT WORK NAT RHEU; Nishimura K, 2007, ANN INTERN MED, V146, P797, DOI 10.7326/0003-4819-146-11-200706050-00008; Symmons DPM, 1998, J RHEUMATOL, V25, P1072; Turesson C, 2003, ANN RHEUM DIS, V62, P722, DOI 10.1136/ard.62.8.722; Turkcapar N, 2006, ARCH GERONTOL GERIAT, V42, P225, DOI 10.1016/j.archger.2005.07.003; van Nies JAB, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0616-3; Visser H, 2005, BEST PRACT RES CL RH, V19, P55, DOI 10.1016/j.berh.2004.08.005; Wiles N, 1999, ARTHRITIS RHEUM, V42, P1339, DOI 10.1002/1529-0131(199907)42:7<1339::AID-ANR6>3.0.CO;2-Y	15	9	10	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2016	352								i387	10.1136/bmj.i387	http://dx.doi.org/10.1136/bmj.i387			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LL	27009280				2022-12-28	WOS:000373044600010
J	Crowley, RA; Kirschner, N; Moyer, DV				Crowley, Ryan A.; Kirschner, Neil; Moyer, Darilyn V.			The Integration of Care for Mental Health, Substance Abuse, and Other Behavioral Health Conditions Into Primary Care IN RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Crowley, Ryan A.; Kirschner, Neil; Moyer, Darilyn V.] Amer Coll Physicians, Washington, DC USA	American College of Physicians	Crowley, RA (corresponding author), Amer Coll Physicians, Washington, DC USA.							American Psychiatric Association Division of Research, 2013, FOCUS, V11, P525, DOI [10.1176/appi.focus.11.4.525, DOI 10.1176/APPI.FOCUS.11.4.525]; Peek C.J., 2013, LEXICON BEHAV HLTH P	2	2	2	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					447	448		10.7326/L15-0524	http://dx.doi.org/10.7326/L15-0524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26974720				2022-12-28	WOS:000372207200022
J	Frank, MC				Frank, Michael C.			Comment on "Math at home adds up to achievement in school"	SCIENCE			English	Editorial Material								Berkowitz et al. (Reports, 9 October 2015, p. 196) described a randomized field experiment testing whether a math app designed to increase parent-child interaction could also bring academic benefits. A reanalysis of the data suggests that this well-designed trial failed to find strong evidence for the efficacy of the intervention. In particular, there was no significant effect of the intervention on math performance.	[Frank, Michael C.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Frank, MC (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	mcfrank@stanford.edu		Frank, Michael/0000-0002-7551-4378				Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Berkowitz T, 2015, SCIENCE, V350, P196, DOI 10.1126/science.aac7427; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; Gelman A, 2014, AM SCI, V102, P460, DOI 10.1511/2014.111.460; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078	7	3	3	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278								10.1126/science.aad8008	http://dx.doi.org/10.1126/science.aad8008			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ8YI	26965619				2022-12-28	WOS:000386158400035
J	Palucka, AK; Coussens, LM				Palucka, A. Karolina; Coussens, Lisa M.			The Basis of Oncoimmunology	CELL			English	Review							TUMOR-ASSOCIATED MACROPHAGES; CD4(+) T-CELLS; DENDRITIC CELLS; CHECKPOINT BLOCKADE; CTLA-4 BLOCKADE; STEADY-STATE; HUMAN CANCER; MAST-CELLS; ANTIBODY THERAPY; IFN-GAMMA	Cancer heterogeneity, a hallmark enabling clonal survival and therapy resistance, is shaped by active immune responses. Antigen-specific T cells can control cancer, as revealed clinically by immunotherapeutics such as adoptive T-cell transfer and checkpoint blockade. The host immune system is thus a powerful tool that, if better harnessed, could significantly enhance the efficacy of cytotoxic therapy and improve outcomes for cancer sufferers. To realize this vision, however, a number of research frontiers must be tackled. These include developing strategies for neutralizing tumor-promoting inflammation, broadening T-cell repertoires (via vaccination), and elucidating the mechanisms by which immune cells organize tumor microenvironments to regulate T-cell activity. Such efforts will pave the way for identifying new targets for combination therapies that overcome resistance to current treatments and promote long-term cancer control.	[Palucka, A. Karolina] Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA; [Palucka, A. Karolina] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Coussens, Lisa M.] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell Dev & Canc Biol, 3181 SW Sam Jackson Pk Rd,Mail Code L215, Portland, OR 97239 USA	Jackson Laboratory; Baylor Scott & White Health; Oregon Health & Science University	Palucka, AK (corresponding author), Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA.; Palucka, AK (corresponding author), Baylor Inst Immunol Res, Dallas, TX 75204 USA.; Coussens, LM (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell Dev & Canc Biol, 3181 SW Sam Jackson Pk Rd,Mail Code L215, Portland, OR 97239 USA.	karolina.palucka@jax.org; coussenl@ohsu.edu	Coussens, Lisa/ABH-9834-2020		NIH/NCI; Susan B. Komen Foundation; Baylor Research Foundation; DOD BCRP Era of Hope Scholar Expansion Award; Breast Cancer Research Foundation; Stand Up To Cancer-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant [SU2C-AACR-DT14-14]; Brenden-Colson Center for Pancreatic Care; NATIONAL CANCER INSTITUTE [R01CA155331, R01CA195712, R01CA130980, P30CA034196, U54CA163123] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan B. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Baylor Research Foundation; DOD BCRP Era of Hope Scholar Expansion Award; Breast Cancer Research Foundation; Stand Up To Cancer-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant; Brenden-Colson Center for Pancreatic Care; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank members of the Palucka and Coussens laboratories for critical insight and discussions; Amanda Lund and Jeffrey Nolz for critical feedback; Anna Lisa Lucido for help with editing the manuscript; and all authors contributing to studies discussed herein but not mentioned due to space consideration. A.K.P. thanks Jacques Banchereau, a long-time collaborator. The authors acknowledge support from the NIH/NCI and Susan B. Komen Foundation (A.K.P. and L.M.C.), Baylor Research Foundation (A.K.P.), DOD BCRP Era of Hope Scholar Expansion Award, Breast Cancer Research Foundation, a Stand Up To Cancer-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant (SU2C-AACR-DT14-14), and Brenden-Colson Center for Pancreatic Care (to L.M.C.).	Affara NI, 2014, CANCER CELL, V25, P809, DOI 10.1016/j.ccr.2014.04.026; Aharinejad S, 2013, ENDOCR-RELAT CANCER, V20, P777, DOI 10.1530/ERC-13-0198; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Ascierto PA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-54; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Best MG, 2015, CANCER CELL, V28, P666, DOI 10.1016/j.ccell.2015.09.018; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Butowski N, 2015, NEUROONCOL; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Carretero R, 2015, NAT IMMUNOL, V16, P609, DOI 10.1038/ni.3159; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chittezhath M, 2014, IMMUNITY, V41, P815, DOI 10.1016/j.immuni.2014.09.014; Coffelt S.B., 2015, 17 PRODUCING GAMMADE; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Davis BP, 2014, CANCER IMMUNOL RES, V2, P1, DOI 10.1158/2326-6066.CIR-13-0196; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Eyob H, 2013, CANCER DISCOV, V3, P751, DOI 10.1158/2159-8290.CD-12-0480; Fehervari Z, 2004, J CLIN INVEST, V114, P1209, DOI 10.1172/JCI200434495; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghatnekar O, 2013, INT J CANCER, V133, P2392, DOI 10.1002/ijc.28256; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Gunderson A.J., 2016, CANC DISCOV; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hendriks RW, 2014, NAT REV CANCER, V14, P219, DOI 10.1038/nrc3702; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Inoue S, 2006, CANCER RES, V66, P7741, DOI 10.1158/0008-5472.CAN-05-3766; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Karsten CM, 2012, IMMUNOBIOLOGY, V217, P1067, DOI 10.1016/j.imbio.2012.07.015; Kerbel Robert, 2011, Int J Dev Biol, V55, P395, DOI 10.1387/ijdb.103217fb; Klebanoff CA, 2011, IMMUNOL REV, V239, P27, DOI 10.1111/j.1600-065X.2010.00979.x; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Komohara Y, 2014, CANCER SCI, V105, P1, DOI 10.1111/cas.12314; Krysko DV, 2012, NAT REV CANCER, V12, P860, DOI 10.1038/nrc3380; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Le DT, 2015, J CLIN ONCOL, V33, P1325, DOI 10.1200/JCO.2014.57.4244; Le DT, 2012, SEMIN ONCOL, V39, P311, DOI 10.1053/j.seminoncol.2012.02.008; Le DT, 2010, CANCER J, V16, P304, DOI 10.1097/PPO.0b013e3181eb33d7; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Marichal T, 2013, CANCER IMMUNOL RES, V1, P269, DOI 10.1158/2326-6066.CIR-13-0119; Masso-Valles D, 2015, CANCER RES, V75, P1675, DOI 10.1158/0008-5472.CAN-14-2852; Melero I, 2015, NEW ENGL J MED, V372, P783, DOI 10.1056/NEJMc1415938; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Metz M, 2007, IMMUNOL REV, V217, P304, DOI 10.1111/j.1600-065X.2007.00520.x; Mitchem JB, 2013, CANCER RES, V73, P1128, DOI 10.1158/0008-5472.CAN-12-2731; Muller P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4925; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205; Pfannenstiel LW, 2010, CELL IMMUNOL, V263, P79, DOI 10.1016/j.cellimm.2010.03.001; Plaks V, 2015, DEV CELL, V34, P493, DOI 10.1016/j.devcel.2015.07.015; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sagiv-Barfi I, 2015, P NATL ACAD SCI USA, V112, pE966, DOI 10.1073/pnas.1500712112; Sandoval F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004888; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; SHEPARD HM, 1991, J CLIN IMMUNOL, V11, P117, DOI 10.1007/BF00918679; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Shiao SL, 2015, CANCER IMMUNOL RES, V3, P518, DOI 10.1158/2326-6066.CIR-14-0232; Sippel TR, 2011, CLIN CANCER RES, V17, P6992, DOI 10.1158/1078-0432.CCR-11-1107; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; Soares H, 2007, J EXP MED, V204, P1095, DOI 10.1084/jem.20070176; Soucek L, 2011, NEOPLASIA, V13, P1093, DOI 10.1593/neo.11980; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Srivastava PK, 2000, NAT IMMUNOL, V1, P363, DOI 10.1038/80795; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Steinman R, 2011, ONCOLOGIST, V16, P1479, DOI 10.1634/theoncologist.2011-0241; STOUT RD, 1989, J IMMUNOL, V142, P760; Tap WD, 2015, NEW ENGL J MED, V373, P428, DOI 10.1056/NEJMoa1411366; Thun Michael J, 2004, Novartis Found Symp, V256, P6; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Wang JL, 2014, INT J CANCER, V135, P956, DOI 10.1002/ijc.28738; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Whitehurst AW, 2014, ANNU REV PHARMACOL, V54, P251, DOI 10.1146/annurev-pharmtox-011112-140326; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yu CI, 2013, IMMUNITY, V38, P818, DOI 10.1016/j.immuni.2013.03.004; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Zitvogel L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010473	110	494	514	10	198	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1233	1247		10.1016/j.cell.2016.01.049	http://dx.doi.org/10.1016/j.cell.2016.01.049			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967289	Green Accepted, Bronze			2022-12-28	WOS:000372784900020
J	Burrell, JR; Halliday, GM; Kril, JJ; Ittner, LM; Gotz, J; Kiernan, MC; Hodges, JR				Burrell, James R.; Halliday, Glenda M.; Kril, Jillian J.; Ittner, Lars M.; Gotz, Jurgen; Kiernan, Matthew C.; Hodges, John R.			The frontotemporal dementia-motor neuron disease continuum	LANCET			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT EXPANSION; BRAIN NETWORK CONNECTIVITY; LOBAR DEGENERATION; C9ORF72 EXPANSION; RNA FOCI; ANTISENSE TRANSCRIPTS; COGNITIVE IMPAIRMENT; PTDP-43 PATHOLOGY; EXPANDED C9ORF72	Early reports of cognitive and behavioural deficits in motor neuron disease might have been overlooked initially, but the concept of a frontotemporal dementia-motor neuron disease continuum has emerged during the past decade. Frontotemporal dementia-motor neuron disease is now recognised as an important dementia syndrome, which presents substantial challenges for diagnosis and management. Frontotemporal dementia, motor neuron disease, and frontotemporal dementia-motor neuron disease are characterised by overlapping patterns of TAR DNA binding protein (TDP-43) pathology, while the chromosome 9 open reading frame 72 (C9orf72) repeat expansion is common across the disease spectrum. Indeed, the C9orf72 repeat expansion provides important clues to disease pathogenesis and suggests potential therapeutic targets. Variable diagnostic criteria identify motor, cognitive, and behavioural deficits, but further refinement is needed to defi ne the clinical syndromes encountered in frontotemporal dementia-motor neuron disease.	[Burrell, James R.; Halliday, Glenda M.; Ittner, Lars M.; Kiernan, Matthew C.; Hodges, John R.] Neurosci Res Australia, Sydney, NSW 2031, Australia; [Burrell, James R.; Halliday, Glenda M.; Ittner, Lars M.; Hodges, John R.] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Kril, Jillian J.] Univ Sydney, Sydney Med Sch, Disciplines Med & Pathol, Sydney, NSW, Australia; [Kiernan, Matthew C.] Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Sydney, NSW, Australia; [Gotz, Jurgen] Univ Queensland, Queensland Brain Inst, Clem Jones Ctr Ageing Dementia Res, Brisbane, Qld, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Queensland	Hodges, JR (corresponding author), Neurosci Res Australia, Sydney, NSW 2031, Australia.	j.hodges@neura.edu.au	Kiernan, Matthew C/E-4460-2011; Halliday, Glenda M/E-8555-2011; Götz, Jürgen/C-2448-2014	Halliday, Glenda M/0000-0003-0422-8398; Götz, Jürgen/0000-0001-8501-7896; Ittner, Lars/0000-0001-6738-3825; Kiernan, Matthew/0000-0001-9054-026X; Kril, Jillian/0000-0001-9407-8674; Burrell, James/0000-0001-9638-2768	National Health and Medical Research Council (NHMRC) [1037746]; Australian Research Council Centre of Excellence in Cognition and its Disorders Memory Node [CE110001021]; NHMRC [1037746, 1072451, 630434, 1003083]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence in Cognition and its Disorders Memory Node(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding to ForeFront, a collaborative research group dedicated to the study of frontotemporal dementia and motor neuron disease, from the National Health and Medical Research Council (NHMRC) programme grant (1037746) and the Australian Research Council Centre of Excellence in Cognition and its Disorders Memory Node (CE110001021). JRB is supported by an NHMRC Early Career Fellowship (1072451). GMH is supported by grants from NHMRC research fellowship (number 630434) and programme grant (number 1037746). LMI is supported by a grant from NHMRC senior research fellowship (number 1003083). We are grateful to the research participants involved with the ForeFront research studies. There was no direct role of any funding body in the contents, preparation, or submission of the manuscript.	Abrahams S, 1997, J NEUROL NEUROSUR PS, V62, P464, DOI 10.1136/jnnp.62.5.464; Abrahams S, 2005, NEUROLOGY, V64, P1222, DOI 10.1212/01.WNL.0000156519.41681.27; Abrahams S, 2014, AMYOTROPH LAT SCL FR, V15, P9, DOI 10.3109/21678421.2013.805784; Abrahams S, 2011, NEURODEGENER DIS MAN, V1, P397, DOI 10.2217/NMT.11.54; Agosta F, 2013, NEUROLOGY, V81, P134, DOI 10.1212/WNL.0b013e31829a33f8; Agosta F, 2013, NEUROBIOL AGING, V34, P419, DOI 10.1016/j.neurobiolaging.2012.04.015; Ahmed RM, 2014, J NEUROL, V261, P1774, DOI 10.1007/s00415-014-7416-6; Akimoto C, 2014, J MED GENET, V51, P419, DOI 10.1136/jmedgenet-2014-102360; Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; [Anonymous], [No title captured]; Arai T, 2014, NEUROPATHOLOGY, V34, P578, DOI 10.1111/neup.12138; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Bak TH, 2001, BRAIN, V124, P103, DOI 10.1093/brain/124.1.103; Bede P, 2014, NEUROIMAGE-CLIN, V4, P436, DOI 10.1016/j.nicl.2014.02.011; Bede P, 2013, NEUROLOGY, V81, P361, DOI 10.1212/WNL.0b013e31829c5eee; Belzil VV, 2013, ACTA NEUROPATHOL, V126, P895, DOI 10.1007/s00401-013-1199-1; Benajiba L, 2009, ANN NEUROL, V65, P470, DOI 10.1002/ana.21612; Benatar M, 2013, NEUROLOGY, V80, P1874, DOI 10.1212/WNL.0b013e3182929fc3; Bieniek KF, 2014, JAMA NEUROL, V71, P775, DOI 10.1001/jamaneurol.2013.6368; Blair IP, 2010, J NEUROL NEUROSUR PS, V81, P639, DOI 10.1136/jnnp.2009.194399; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Braak H, 2010, ACTA NEUROPATHOL, V120, P67, DOI 10.1007/s00401-010-0683-0; Brettschneider J, 2014, ACTA NEUROPATHOL, V127, P423, DOI 10.1007/s00401-013-1238-y; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195; Canosa A, 2014, J NEUROL NEUROSUR PS, V85, P1437, DOI 10.1136/jnnp-2013-307552; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; Cavallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025948; Cerami C, 2014, AMYOTROPH LAT SCL FR, V15, P21, DOI 10.3109/21678421.2013.785568; Chare L, 2014, J NEUROL NEUROSUR PS, V85, P866, DOI 10.1136/jnnp-2013-306948; Cistaro A, 2014, EUR J NUCL MED MOL I, V41, P844, DOI 10.1007/s00259-013-2667-5; Ciura S, 2013, ANN NEUROL, V74, P180, DOI 10.1002/ana.23946; Cooper-Knock J, 2014, ACTA NEUROPATHOL, V127, P333, DOI 10.1007/s00401-014-1251-9; Cooper-Knock J, 2012, BRAIN, V135, P751, DOI 10.1093/brain/awr365; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Devenney E, 2014, NEUROCASE, P1; Devenney E, 2014, JAMA NEUROL, V71, P331, DOI 10.1001/jamaneurol.2013.6002; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Elamin M, 2013, NEUROLOGY, V80, P1590, DOI 10.1212/WNL.0b013e31828f18ac; Fekete T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085190; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Girardi A, DEFICITS EMOTIONAL S; Goldstein LH, 2013, LANCET NEUROL, V12, P368, DOI 10.1016/S1474-4422(13)70026-7; Hardy J, 2014, EXP NEUROL, V262, P75, DOI 10.1016/j.expneurol.2013.11.006; Irwin DJ, 2013, J NEUROL NEUROSUR PS, V84, P163, DOI 10.1136/jnnp-2012-303507; Josephs KA, 2006, ARCH NEUROL-CHICAGO, V63, P506, DOI 10.1001/archneur.63.4.506; Kersaitis C, 2006, NEUROPATH APPL NEURO, V32, P83, DOI 10.1111/j.1365-2990.2005.00704.x; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lee SE, 2014, BRAIN, V137, P3047, DOI 10.1093/brain/awu248; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Lillo P, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-156; Lillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043993; Lillo P, 2010, ARCH NEUROL-CHICAGO, V67, P826, DOI 10.1001/archneurol.2010.146; Limousin N, 2010, J NEUROL SCI, V297, P36, DOI 10.1016/j.jns.2010.06.028; Lindquist SG, 2013, CLIN GENET, V83, P279, DOI 10.1111/j.1399-0004.2012.01903.x; Liu EY, 2014, ACTA NEUROPATHOL, V128, P525, DOI 10.1007/s00401-014-1286-y; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Lule D, 2005, J NEUROL, V252, P1517, DOI 10.1007/s00415-005-0907-8; Mackenzie IRA, 2014, ACTA NEUROPATHOL, V127, P347, DOI 10.1007/s00401-013-1232-4; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; McCluskey L, 2014, J NEUROL SCI, V345, P118, DOI 10.1016/j.jns.2014.07.022; Meier SL, 2010, BRAIN, V133, P3444, DOI 10.1093/brain/awq254; Miller RG, 2009, NEUROLOGY, V73, P1227, DOI 10.1212/WNL.0b013e3181bc01a4; Mioshi E, 2014, AMYOTROPH LAT SCL FR, V15, P298, DOI 10.3109/21678421.2014.896927; Mioshi E, 2014, NEUROLOGY, V82, P149, DOI 10.1212/WNL.0000000000000023; Montuschi A, 2015, J NEUROL NEUROSUR PS, V86, P168, DOI 10.1136/jnnp-2013-307223; NEARY D, 1990, J NEUROL NEUROSUR PS, V53, P23, DOI 10.1136/jnnp.53.1.23; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Po K, 2014, J NEUROL, V261, P2170, DOI 10.1007/s00415-014-7474-9; Pupillo E, 2014, ANN NEUROL, V75, P287, DOI 10.1002/ana.24096; Raaphorst J, 2012, NEUROLOGY, V79, P1377, DOI 10.1212/WNL.0b013e31826c1aa1; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Russ J, 2015, ACTA NEUROPATHOL, V129, P39, DOI 10.1007/s00401-014-1365-0; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Snowden JS, 2012, BRAIN, V135, P693, DOI 10.1093/brain/awr355; Stevens M, 1998, NEUROLOGY, V50, P1541, DOI 10.1212/WNL.50.6.1541; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Stukovnik V, 2010, J CLIN EXP NEUROPSYC, V32, P1095, DOI 10.1080/13803391003749236; Tan RH, 2014, BRAIN, V137, P2065, DOI 10.1093/brain/awu118; Tan RH, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-33; Taylor LJ, 2013, J NEUROL NEUROSUR PS, V84, P494, DOI 10.1136/jnnp-2012-303526; Therrien M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083450; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; van Blitterswijk M, 2013, LANCET NEUROL, V12, P978, DOI 10.1016/S1474-4422(13)70210-2; van Blitterswijk M, 2012, HUM MOL GENET, V21, P3776, DOI 10.1093/hmg/dds199; van der Zee J, 2013, HUM MUTAT, V34, P363, DOI 10.1002/humu.22244; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030; Waite AJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.016; Wood EM, 2013, JAMA NEUROL, V70, P1411, DOI 10.1001/jamaneurol.2013.3956; Woolley SC, 2010, AMYOTROPH LATERAL SC, V11, P303, DOI 10.3109/17482961003727954; Xi ZR, 2014, NEUROLOGY, V83, P1476, DOI 10.1212/WNL.0000000000000886; Xi ZR, 2013, AM J HUM GENET, V92, P981, DOI 10.1016/j.ajhg.2013.04.017; Zhang Dapeng, 2012, Frontiers in Genetics, V3, P283, DOI 10.3389/fgene.2012.00283; Zimmerman EK, 2007, COGN BEHAV NEUROL, V20, P79, DOI 10.1097/WNN.0b013e31804c700b; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	100	194	194	5	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 27	2016	388	10047					919	931		10.1016/S0140-6736(16)00737-6	http://dx.doi.org/10.1016/S0140-6736(16)00737-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU0RI	26987909				2022-12-28	WOS:000381911800031
J	Fasano, A				Fasano, Alessio			Gut microbiome and necrotising enterocolitis: time for intervention?	LANCET			English	Editorial Material							PRETERM INFANTS; MORTALITY		[Fasano, Alessio] Harvard Univ, Sch Med, Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA; [Fasano, Alessio] EBRIS, Via Renzi 50, I-84125 Salerno, Italy	Harvard University	Fasano, A (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Charlestown, MA 02129 USA.; Fasano, A (corresponding author), EBRIS, Via Renzi 50, I-84125 Salerno, Italy.	afasano@mgh.harvard.edu	Fasano, Alessio/K-5486-2016	Fasano, Alessio/0000-0002-2134-0261				Christensen RD, 2010, J PERINATOL, V30, P54, DOI 10.1038/jp.2009.93; Claud EC, 2008, J CLIN GASTROENTEROL, V42, pS46, DOI 10.1097/MCG.0b013e31815a57a8; Costeloe K, 2016, LANCET, V387, P649, DOI 10.1016/S0140-6736(15)01027-2; Fitzgibbons SC, 2009, J PEDIATR SURG, V44, P1072, DOI 10.1016/j.jpedsurg.2009.02.013; Halpern MD, 2002, PEDIATR RES, V51, P733, DOI 10.1023/01.PDR.0000017480.64723.56; Harris MC, 2005, J PEDIATR-US, V147, P462, DOI 10.1016/j.jpeds.2005.04.037; Lau CSM, 2015, J PEDIATR SURG, V50, P1405, DOI 10.1016/j.jpedsurg.2015.05.008; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Neu J, 2014, NEONATOLOGY, V106, P289, DOI 10.1159/000365130; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Seitz G, 2005, J PEDIATR SURG, V40, P1440, DOI 10.1016/j.jpedsurg.2005.05.043; UAUY RD, 1991, J PEDIATR-US, V119, P630, DOI 10.1016/S0022-3476(05)82418-7; Viscardi RM, 1997, PEDIATR PATHOL LAB M, V17, P547, DOI 10.1080/107710497174516; Warner BB, 2016, LANCET, V387, P1928, DOI 10.1016/S0140-6736(16)00081-7	15	2	3	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 7	2016	387	10031					1884	1885		10.1016/S0140-6736(15)00952-6	http://dx.doi.org/10.1016/S0140-6736(15)00952-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL1EE	26969092				2022-12-28	WOS:000375374200006
J	Katzmarzyk, PT				Katzmarzyk, Peter T.			Physical Fitness and Risk for Type 2 Diabetes Mellitus: Reducing Risk at Any Weight	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METABOLIC SYNDROME; CONTROLLED-TRIAL; ALL-CAUSE; MORTALITY; MEN; REDUCTION; DISEASE		[Katzmarzyk, Peter T.] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Katzmarzyk, PT (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	peter.katzmarzyk@pbrc.edu	Katzmarzyk, Peter T/N-1974-2017	Katzmarzyk, Peter T/0000-0002-9280-6022				Barry VW, 2014, PROG CARDIOVASC DIS, V56, P382, DOI 10.1016/j.pcad.2013.09.002; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Crump C, 2016, ANN INTERN MED, V164, P577, DOI 10.7326/M15-2002; Jurca R, 2005, MED SCI SPORT EXER, V37, P1849, DOI 10.1249/01.mss.0000175865.17614.74; Katzmarzyk PT, 2004, ARCH INTERN MED, V164, P1092, DOI 10.1001/archinte.164.10.1092; Katzmarzyk PT, 2002, MED SCI SPORT EXER, V34, P740, DOI 10.1097/00005768-200205000-00002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008	10	3	3	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					620	621		10.7326/M16-0269	http://dx.doi.org/10.7326/M16-0269			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	26954619				2022-12-28	WOS:000375744000024
J	Kalesan, B; Mobily, ME; Keiser, O; Fagan, JRA; Galea, S				Kalesan, Bindu; Mobily, Matthew E.; Keiser, Olivia; Fagan, Jeff Rey A.; Galea, Sandro			Firearm legislation and firearm mortality in the USA: a cross-sectional, state-level study	LANCET			English	Article							BACKGROUND CHECK; GUN OWNERSHIP; UNITED-STATES; ASSOCIATION; SUICIDE; CHILDREN; INJURY; DEATH; RISK; LAWS	Background In an effort to reduce firearm mortality rates in the USA, US states have enacted a range of firearm laws to either strengthen or deregulate the existing main federal gun control law, the Brady Law. We set out to determine the independent association of different firearm laws with overall firearm mortality, homicide firearm mortality, and suicide firearm mortality across all US states. We also projected the potential reduction of firearm mortality if the three most strongly associated firearm laws were enacted at the federal level. Methods We constructed a cross-sectional, state-level dataset from Nov 1, 2014, to May 15, 2015, using counts of firearm-related deaths in each US state for the years 2008-10 (stratified by intent [homicide and suicide]) from the US Centers for Disease Control and Prevention's Web-based Injury Statistics Query and Reporting System, data about 25 firearm state laws implemented in 2009, and state-specific characteristics such as firearm ownership for 2013, firearm export rates, and non-firearm homicide rates for 2009, and unemployment rates for 2010. Our primary outcome measure was overall firearm-related mortality per 100 000 people in the USA in 2010. We used Poisson regression with robust variances to derive incidence rate ratios (IRRs) and 95% CIs. Findings 31 672 firearm-related deaths occurred in 2010 in the USA (10.1 per 100 000 people; mean state-specific count 631.5 [SD 629.1]). Of 25 firearm laws, nine were associated with reduced firearm mortality, nine were associated with increased firearm mortality, and seven had an inconclusive association. After adjustment for relevant covariates, the three state laws most strongly associated with reduced overall firearm mortality were universal background checks for firearm purchase (multivariable IRR 0.39 [95% CI 0.23-0.67]; p=0.001), ammunition background checks (0.18 [0.09-0.36]; p<0.0001), and identification requirement for firearms (0.16 [0.09-0.29]; p<0.0001). Projected federal-level implementation of universal background checks for firearm purchase could reduce national firearm mortality from 10.35 to 4.46 deaths per 100 000 people, background checks for ammunition purchase could reduce it to 1.99 per 100 000, and firearm identification to 1.81 per 100 000. Interpretation Very few of the existing state-specific firearm laws are associated with reduced firearm mortality, and this evidence underscores the importance of focusing on relevant and effective firearms legislation. Implementation of universal background checks for the purchase of firearms or ammunition, and firearm identification nationally could substantially reduce firearm mortality in the USA.	[Kalesan, Bindu] Boston Univ, Dept Med, Boston, MA 02118 USA; [Galea, Sandro] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Mobily, Matthew E.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Fagan, Jeff Rey A.] Columbia Univ, Columbia Law Sch, New York, NY USA; [Fagan, Jeff Rey A.] Columbia Univ, Dept Epidemiol, New York, NY USA; [Keiser, Olivia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	Boston University; Boston University; Columbia University; Columbia University; Columbia University; University of Bern	Kalesan, B (corresponding author), Boston Univ, Dept Med, Boston, MA 02118 USA.	kalesan@bu.edu	Galea, Sandro/GLR-6066-2022	Galea, Sandro/0000-0002-7534-0945				Agresti A, 2013, CATEGORICAL DATA ANA; [Anonymous], 2010, EMPLOYMENT STATUS CI; [Anonymous], 2009, FIREARMS TRACE DATA; [Anonymous], 2013 STAT SCOR WHY G; Bangalore S, 2013, AM J MED, V126, P873, DOI 10.1016/j.amjmed.2013.04.012; Fleegler EW, 2013, JAMA INTERN MED, V173, DOI [10.1001/jamainternmed.2013.9957, 10.1001/jamainternmed.2013.1286]; Gjertsen F, 2014, INT J ENV RES PUB HE, V11, P487, DOI 10.3390/ijerph110100487; Hemenway D, 2013, NEW ENGL J MED, V368, P2033, DOI 10.1056/NEJMsb1302631; Irvin N, 2014, AM J PUBLIC HEALTH, V104, P1384, DOI 10.2105/AJPH.2014.301999; Kalesan B, 2016, INJURY PREV, V22, P216, DOI 10.1136/injuryprev-2015-041586; Kalesan B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005628; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Kwon IWG, 2005, AM J ECON SOCIOL, V64, P533, DOI 10.1111/j.1536-7150.2005.00378.x; Lee J, 2013, J TRAUMA ACUTE CARE, V75, P50, DOI 10.1097/TA.0b013e3182999b7a; Long J.S., 2014, REGRESSION MODELS CA; Miller M, 2012, ANNU REV PUBL HEALTH, V33, P393, DOI 10.1146/annurev-publhealth-031811-124636; National Centers for Injury Prevention and Control Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Norstrom T, 2015, J EPIDEMIOL COMMUN H, V69, P110, DOI 10.1136/jech-2014-204602; Prickett KC, 2014, AM J PUBLIC HEALTH, V104, P1080, DOI 10.2105/AJPH.2014.301928; Safavi A, 2014, J TRAUMA ACUTE CARE, V76, P146, DOI 10.1097/TA.0b013e3182ab10fb; Statistics U. S. B. o. L, 2015, LOCAL AREA UNEMPLOYM; Sumner SA, 2008, AM J PREV MED, V35, P1, DOI 10.1016/j.amepre.2008.03.023; United States Department of Labor, 2002, CURR POP SURV CPS; Webster DW, 2015, ANNU REV PUBL HEALTH, V36, P21, DOI 10.1146/annurev-publhealth-031914-122516; Weinberger SE, 2015, ANN INTERN MED, V162, P513, DOI 10.7326/M15-0337; Wintemute GJ, 2014, J URBAN HEALTH, V91, P303, DOI 10.1007/s11524-013-9842-7; Wintemute GJ, 2011, INJURY PREV, V17, P422, DOI 10.1136/ip.2010.031443	27	75	75	0	43	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1847	1855		10.1016/S0140-6736(15)01026-0	http://dx.doi.org/10.1016/S0140-6736(15)01026-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK6SS	26972843	Green Submitted			2022-12-28	WOS:000375056100033
J	Reade, MC; Eastwood, GM; Bellomo, R; Bailey, M; Bersten, A; Cheung, B; Davies, A; Delaney, A; Ghosh, A; van Haren, F; Harley, N; Knight, D; McGuiness, S; Mulder, J; O'Donoghue, S; Simpson, N; Young, P				Reade, Michael C.; Eastwood, Glenn M.; Bellomo, Rinaldo; Bailey, Michael; Bersten, Andrew; Cheung, Benjamin; Davies, Andrew; Delaney, Anthony; Ghosh, Angaj; van Haren, Frank; Harley, Nerina; Knight, David; McGuiness, Shay; Mulder, John; O'Donoghue, Steve; Simpson, Nicholas; Young, Paul		DahLIA Investigators Australian	Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL PATIENTS; SEDATION SCALE; UNIT PATIENTS; CAM-ICU; RELIABILITY; MIDAZOLAM; VALIDITY	IMPORTANCE Effective therapy has not been established for patients with agitated delirium receiving mechanical ventilation. OBJECTIVE To determine the effectiveness of dexmedetomidine when added to standard care in patients with agitated delirium receiving mechanical ventilation. DESIGN, SETTING, AND PARTICIPANTS The Dexmedetomidine to Lessen ICU Agitation (DahLIA) study was a double-blind, placebo-controlled, parallel-group randomized clinical trial involving 74 adult patients in whom extubation was considered inappropriate because of the severity of agitation and delirium. The study was conducted at 15 intensive care units in Australia and New Zealand from May 2011 until December 2013. Patients with advanced dementia or traumatic brain injury were excluded. INTERVENTIONS Bedside nursing staff administered dexmedetomidine (or placebo) initially at a rate of 0.5 mu g/kg/h and then titrated to rates between 0 and 1.5 mu g/kg/h to achieve physician-prescribed sedation goals. The study drug or placebo was continued until no longer required or up to 7 days. All other care was at the discretion of the treating physician. MAIN OUTCOMES AND MEASURES Ventilator-free hours in the 7 days following randomization. There were 21 reported secondary outcomes that were defined a priori. RESULTS Of the 74 randomized patients (median age, 57 years; 18 [24%] women), 2 withdrew consent later and 1 was found to have been randomized incorrectly, leaving 39 patients in the dexmedetomidine group and 32 patients in the placebo group for analysis. Dexmedetomidine increased ventilator-free hours at 7 days compared with placebo (median, 144.8 hours vs 127.5 hours, respectively; median difference between groups, 17.0 hours [95% CI, 4.0 to 33.2 hours]; P = .01). Among the 21 a priori secondary outcomes, none were significantly worse with dexmedetomidine, and several showed statistically significant benefit, including reduced time to extubation (median, 21.9 hours vs 44.3 hours with placebo; median difference between groups, 19.5 hours [95% CI, 5.3 to 31.1 hours]; P < .001) and accelerated resolution of delirium (median, 23.3 hours vs 40.0 hours; median difference between groups, 16.0 hours [95% CI, 3.0 to 28.0 hours]; P = .01). Using hierarchical Cox modeling to adjust for imbalanced baseline characteristics, allocation to dexmedetomidine was significantly associated with earlier extubation (hazard ratio, 0.47 [95% CI, 0.27-0.82]; P = .007). CONCLUSIONS AND RELEVANCE Among patients with agitated delirium receiving mechanical ventilation in the intensive care unit, the addition of dexmedetomidine to standard care compared with standard care alone (placebo) resulted in more ventilator-free hours at 7 days. The findings support the use of dexmedetomidine in patients such as these.	[Reade, Michael C.] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia; [Reade, Michael C.] Australian Def Force, Joint Hlth Command, Brisbane, Qld, Australia; [Eastwood, Glenn M.; Bellomo, Rinaldo] Austin Hosp, Melbourne, Vic 3084, Australia; [Bellomo, Rinaldo] Univ Melbourne, Sch Med, Melbourne, Vic, Australia; [Bailey, Michael] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Bersten, Andrew] Flinders Med Ctr, Adelaide, SA, Australia; [Cheung, Benjamin] Toowoomba Hosp, Toowoomba, Qld, Australia; [Davies, Andrew] Peninsula Hlth, Melbourne, Vic, Australia; [Delaney, Anthony] Royal North Shore Hosp Sydney, Sydney, NSW, Australia; [Ghosh, Angaj] Northern Hosp, Melbourne, Vic, Australia; [van Haren, Frank] Canberra Hosp, Canberra, ACT, Australia; [Harley, Nerina] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Knight, David] Christchurch Hosp, Christchurch, New Zealand; [McGuiness, Shay] Auckland City Hosp, Auckland, New Zealand; [Mulder, John] Western Hosp, Melbourne, Vic, Australia; [O'Donoghue, Steve] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Simpson, Nicholas] Geelong Hosp, Geelong, Vic, Australia; [Young, Paul] Wellington Hosp, Wellington, New Zealand; [Young, Paul] Med Res Inst New Zealand, Wellington, New Zealand	University of Queensland; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University; Flinders Medical Centre; Royal North Shore Hospital; Australian National University; Canberra Hospital; Royal Melbourne Hospital; Christchurch Hospital New Zealand; Auckland City Hospital; Western Hospital; Royal Brisbane & Women's Hospital; Geelong Hospital; Medical Research Institute Of New Zealand	Reade, MC (corresponding author), Univ Queensland, Hlth Sci Bldg, Herston, Qld 4029, Australia.	m.reade@uq.edu.au	Bailey, Michael J/A-4499-2012; Delaney, Anthony/AAE-3365-2019; Van Haren, Frank/G-1335-2015; /X-2859-2019; Reade, Michael/G-7035-2012; cheung, benjamin k/F-6452-2014; Roberts, Jason A/F-6272-2010	Bailey, Michael J/0000-0002-5551-1401; Van Haren, Frank/0000-0001-8037-4229; /0000-0002-2067-7276; Reade, Michael/0000-0003-1570-0707; cheung, benjamin k/0000-0002-6139-7756; Roberts, Jason A/0000-0001-6218-435X; Bersten, Andrew/0000-0001-9908-394X; Bellomo, Rinaldo/0000-0002-1650-8939; McGuinness, Shay/0000-0003-0620-4787; Delaney, Anthony/0000-0002-1015-7146; Young, Paul/0000-0002-3428-3083	Hospira Australia; Wellington Hospital Research Office; Austin Hospital Intensive Care Specialists Trust Fund	Hospira Australia; Wellington Hospital Research Office; Austin Hospital Intensive Care Specialists Trust Fund	This study was partly funded by Hospira Australia through an unrestricted grant of A$25000 plus free study drug supply. Individual site funding was supplemented by grants from the Wellington Hospital Research Office and the Austin Hospital Intensive Care Specialists Trust Fund.	Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Devlin JW, 2010, CRIT CARE MED, V38, P419, DOI 10.1097/CCM.0b013e3181b9e302; Devlin JW, 1999, CRIT CARE MED, V27, P1271, DOI 10.1097/00003246-199907000-00008; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Ely EW, 2007, CRIT CARE MED, V35, P112, DOI 10.1097/01.CCM.0000251925.18961.CA; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Haenggi M, 2013, INTENS CARE MED, V39, P2171, DOI 10.1007/s00134-013-3034-5; Hart Graeme K, 2008, Crit Care Resusc, V10, P83; Hoy SM, 2011, DRUGS, V71, P1481, DOI 10.2165/11207190-000000000-00000; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Lehmann E. L., 2006, NONPARAMETRICS STAT; Mo Y, 2013, ANN PHARMACOTHER, V47, P869, DOI 10.1345/aph.1AR708; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Patel SB, 2014, AM J RESP CRIT CARE, V189, P658, DOI 10.1164/rccm.201310-1815OC; Reade MC, 2012, CRIT CARE RESUSC, V14, P236; Reade MC, 2009, CRIT CARE, V13, DOI 10.1186/cc7890; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Therapeutic Goods Administration, 2014, DEXM HYDR PREC PROD; van den Boogaard M, 2012, CRIT CARE MED, V40, P112, DOI 10.1097/CCM.0b013e31822e9fc9; Yapici N, 2011, HEART SURG FORUM, V14, pE93, DOI 10.1532/HSF98.201011102	25	211	226	0	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1460	1468		10.1001/jama.2016.2707	http://dx.doi.org/10.1001/jama.2016.2707			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	26975647	Bronze			2022-12-28	WOS:000373873800012
J	Okin, D; Medzhitov, R				Okin, Daniel; Medzhitov, Ruslan			The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia	CELL			English	Article							INDUCED INSULIN-RESISTANCE; NF-KAPPA-B; GLUCOSE-HOMEOSTASIS; RHEUMATOID-ARTHRITIS; DIABETES-MELLITUS; GLYCEMIC CONTROL; BILE-ACIDS; IKK-BETA; IN-VIVO; METABOLISM	Control of plasma glucose level is essential to organismal survival. Sustained inflammation has been implicated in control of glucose homeostasis in cases of infection, obesity, and type 2 diabetes; however, the precise role of inflammation in these complex disease states remains poorly understood. Here, we find that sustained inflammation results in elevated plasma glucose due to increased hepatic glucose production. We find that sustained inflammation suppresses CYP7A1, leading to accumulation of intermediate metabolites at the branch point of the mevalonate pathway. This results in prenylation of RHOC, which is concomitantly induced by inflammatory cytokines. Subsequent activation of RHO-associated protein kinase results in elevated plasma glucose. These findings uncover an unexpected mechanism by which sustained inflammation alters glucose homeostasis.	[Okin, Daniel; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu		Okin, Daniel/0000-0002-3802-4695	NIH [DK059635, AI046688, AI089771, CA157461]; NIH training grant [2T32GM7205-36]; NIDDK fellowship [1F30DK094480]; HHMI; Blavatnik Family Foundation; Else Kroner Fresenius Foundation; NATIONAL CANCER INSTITUTE [R01CA157461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046688, R01AI089771, R01AI055502, R01AI046688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094480, P30DK034989, U24DK059635, U2CDK059635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK fellowship; HHMI(Howard Hughes Medical Institute); Blavatnik Family Foundation; Else Kroner Fresenius Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank members of the R.M. lab for discussion and advice, Maya Kotas for experimental advice and technical expertise, Scott Pope for assistance and advice on RNA sequencing experiments and analysis, Sophie Cronin and Chuck Annicelli for technical assistance, Gerald Shulman for experimental advice and discussions, and Morris White for kindly providing IRS-1 S307A mice. Hyperinsulinemic-euglycemic clamp experiments were performed by the Yale Mouse Metabolic Phenotyping Center (supported by NIH DK059635). LC-MS/MS analysis was performed by the Yale Keck facility. D.O. is supported by NIH training grant (2T32GM7205-36) and a NIDDK fellowship (1F30DK094480). R.M. is supported by the HHMI, The Blavatnik Family Foundation, Else Kroner Fresenius Foundation, and grants from the NIH (AI046688, AI089771, and CA157461).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Butte NF, 2000, AM J CLIN NUTR, V71, p1256S, DOI 10.1093/ajcn/71.5.1256s; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chun KH, 2012, ENDOCRINOLOGY, V153, P1649, DOI 10.1210/en.2011-1036; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Falciglia M, 2009, CRIT CARE MED, V37, P3001, DOI 10.1097/CCM.0b013e3181b083f7; Feingold KR, 2012, INNATE IMMUN-LONDON, V18, P231, DOI 10.1177/1753425911398678; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldberg RB, 2008, ARCH INTERN MED, V168, P1531, DOI 10.1001/archinte.168.14.1531; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang H, 2013, TRENDS ENDOCRIN MET, V24, P506, DOI 10.1016/j.tem.2013.06.003; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Lalli CA, 2008, METABOLISM, V57, P57, DOI 10.1016/j.metabol.2007.07.021; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee DH, 2009, J BIOL CHEM, V284, P11776, DOI 10.1074/jbc.C900014200; Lee SH, 2014, AM J PHYSIOL-ENDOC M, V306, pE332, DOI 10.1152/ajpendo.00619.2013; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Magee T, 2005, CURR OPIN CELL BIOL, V17, P190, DOI 10.1016/j.ceb.2005.02.003; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; McGuinness OP, 2005, ANNU REV NUTR, V25, P9, DOI 10.1146/annurev.nutr.24.012003.132159; Miyake JH, 2001, J BIOL CHEM, V276, P23304, DOI 10.1074/jbc.M101853200; Mizock BA, 2001, BEST PRACT RES CL EN, V15, P533, DOI 10.1053/beem.2001.0168; Nakata M, 2006, DIABETOLOGIA, V49, P1881, DOI 10.1007/s00125-006-0269-5; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Okin D, 2012, CURR BIOL, V22, pR733, DOI 10.1016/j.cub.2012.07.029; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Redman LM, 2009, MOL CELL ENDOCRINOL, V299, P129, DOI 10.1016/j.mce.2008.10.014; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Solomon DH, 2010, ANN RHEUM DIS, V69, P2114, DOI 10.1136/ard.2009.125476; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	57	72	72	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					343	356		10.1016/j.cell.2016.02.023	http://dx.doi.org/10.1016/j.cell.2016.02.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	26997483	Green Accepted, Bronze			2022-12-28	WOS:000374123000013
J	Hernandez, G; Vaquero, C; Gonzalez, P; Subira, C; Frutos-Vivar, F; Rialp, G; Laborda, C; Colinas, L; Cuena, R; Fernandez, R				Hernandez, Gonzalo; Vaquero, Concepcion; Gonzalez, Paloma; Subira, Carles; Frutos-Vivar, Fernando; Rialp, Gemma; Laborda, Cesar; Colinas, Laura; Cuena, Rafael; Fernandez, Rafael			Effect of Postextubation High-Flow Nasal Cannula vs Conventional Oxygen Therapy on Reintubation in Low-Risk Patients A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE-UNIT PATIENTS; MECHANICAL VENTILATION; RESPIRATORY-FAILURE; NONINVASIVE VENTILATION; EXTUBATION FAILURE; CRITICALLY-ILL; OUTCOMES; METAANALYSIS; PREDICTION; MORTALITY	IMPORTANCE Studies of mechanically ventilated critically ill patients that combine populations that are at high and low risk for reintubation suggest that conditioned high-flow nasal cannula oxygen therapy after extubation improves oxygenation compared with conventional oxygen therapy. However, conclusive data about reintubation are lacking. OBJECTIVE To determine whether high-flow nasal cannula oxygen therapy is superior to conventional oxygen therapy for preventing reintubation in mechanically ventilated patients at low risk for reintubation. DESIGN, SETTING, AND PARTICIPANTS Multicenter randomized clinical trial conducted between September 2012 and October 2014 in 7 intensive care units (ICUs) in Spain. Participants were 527 adult critical patients at low risk for reintubation who fulfilled criteria for planned extubation. Low risk for reintubation was defined as younger than 65 years; Acute Physiology and Chronic Health Evaluation II score less than 12 on day of extubation; body mass index less than 30; adequate secretions management; simple weaning; 0 or 1 comorbidity; and absence of heart failure, moderate-to-severe chronic obstructive pulmonary disease, airway patency problems, and prolonged mechanical ventilation. INTERVENTIONS Patients were randomized to undergo either high-flow or conventional oxygen therapy for 24 hours after extubation. MAIN OUTCOMES AND MEASURES The primary outcome was reintubation within 72 hours, compared with the Cochran-Mantel-Haenszel chi(2) test. Secondary outcomes included postextubation respiratory failure, respiratory infection, sepsis and multiorgan failure, ICU and hospital length of stay and mortality, adverse events, and time to reintubation. RESULTS Of 527 patients (mean age, 51 years [range, 18-64]; 62% men), 264 received high-flow therapy and 263 conventional oxygen therapy. Reintubation within 72 hours was less common in the high-flow group (13 patients [4.9%] vs 32 [12.2%] in the conventional group; absolute difference, 7.2%[95% CI, 2.5% to 12.2%]; P=.004). Postextubation respiratory failure was less common in the high-flow group (22/264 patients [8.3%] vs 38/263 [14.4%] in the conventional group; absolute difference, 6.1%[95% CI, 0.7% to 11.6%]; P=.03). Time to reintubation was not significantly different between groups (19 hours [interquartile range, 12-28] in the high-flow group vs 15 hours [interquartile range, 9-31] in the conventional group; absolute difference, -4 [95% CI, -54 to 46]; P=.66]. No adverse effects were reported. CONCLUSIONS AND RELEVANCE Among extubated patients at low risk for reintubation, the use of high-flow nasal cannula oxygen compared with conventional oxygen therapy reduced the risk of reintubation within 72 hours.	[Hernandez, Gonzalo; Colinas, Laura] Hosp Virgen de la Salud, Toledo, Spain; [Vaquero, Concepcion] Hosp Univ Ramon y Cajal, Madrid, Spain; [Gonzalez, Paloma] Hosp Univ Infanta Sofia, Madrid, Spain; [Subira, Carles; Fernandez, Rafael] Fundacio Althaia, Hosp St Joan de Deu, Manresa, Spain; [Frutos-Vivar, Fernando] Hosp Univ Getafe, Madrid, Spain; [Frutos-Vivar, Fernando; Fernandez, Rafael] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Rialp, Gemma] Hosp Son Llatzer, Palma De Mallorca, Spain; [Laborda, Cesar] Hosp Univ Vall dHebron, Barcelona, Spain; [Cuena, Rafael] Med Council, Res Unit, Toledo, Spain; [Fernandez, Rafael] Univ Int Catalunya, Madrid, Spain	Complejo Hospitalario de Toledo; Hospital Universitario Ramon y Cajal; Hospital Universitario Infanta Sofia; Hospital Universitario de Getafe; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Hospital Universitari Son Llatzer; Hospital Universitari Vall d'Hebron; Universitat Internacional de Catalunya (UIC)	Hernandez, G (corresponding author), Hosp Virgen de la Salud, Dept Crit Care Med, Mezquite 12,6 A, Madrid 28045, Spain.	ghernandezm@telefonica.net	Fernandez, Rafael/A-9586-2010; Rialp, Gemma/I-3353-2016	Fernandez, Rafael/0000-0001-5711-5317; Rialp, Gemma/0000-0003-3614-3639; Frutos-Vivar, Fernando/0000-0002-4648-9636; Cuena, Rafael/0000-0002-3091-6955; Subira, Carles/0000-0003-2285-2311; Laborda, Cesar/0000-0002-5642-5847				Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Brown CVR, 2011, J TRAUMA, V71, P37, DOI 10.1097/TA.0b013e31821e0c6e; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Doorduin J, 2013, AM J RESP CRIT CARE, V187, P20, DOI 10.1164/rccm.201206-1117CP; El Solh AA, 2006, EUR RESPIR J, V28, P588, DOI 10.1183/09031936.06.00150705; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC; Ferrer M, 2006, AM J RESP CRIT CARE, V173, P164, DOI 10.1164/rccm.200505-718OC; Ferrer M, 2009, LANCET, V374, P1082, DOI 10.1016/S0140-6736(09)61038-2; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Funk GC, 2010, EUR RESPIR J, V35, P88, DOI 10.1183/09031936.00056909; Glossop AJ, 2012, BRIT J ANAESTH, V109, P305, DOI 10.1093/bja/aes270; Hernandez G, 2012, EUR SOC INT CAR MED; HOLM S, 1979, SCAND J STAT, V6, P65; Jaber S, 2009, CRIT CARE, V13, DOI 10.1186/cc7772; Kang BJ, 2015, INTENS CARE MED, V41, P623, DOI 10.1007/s00134-015-3693-5; Kilgour E, 2004, INTENS CARE MED, V30, P1491, DOI 10.1007/s00134-004-2235-3; Lee JH, 2013, INTENS CARE MED, V39, P247, DOI 10.1007/s00134-012-2743-5; Maggiore SM, 2014, AM J RESP CRIT CARE, V190, P282, DOI 10.1164/rccm.201402-0364OC; Manley BJ, 2013, NEW ENGL J MED, V369, P1425, DOI 10.1056/NEJMoa1300071; Nava S, 2005, CRIT CARE MED, V33, P2465, DOI 10.1097/01.CCM.0000186416.44752.72; Parke RL, 2013, RESP CARE, V58, P1621, DOI 10.4187/respcare.02358; Penuelas O, 2011, AM J RESP CRIT CARE, V184, P430, DOI 10.1164/rccm.201011-1887OC; Riera J, 2013, RESP CARE, V58, P589, DOI 10.4187/respcare.02086; Roca O, 2010, RESP CARE, V55, P408; Salam A, 2004, INTENS CARE MED, V30, P1334, DOI 10.1007/s00134-004-2231-7; Saugel B, 2012, J CRIT CARE, V27, P571, DOI 10.1016/j.jcrc.2012.01.010; Stephan F, 2015, JAMA-J AM MED ASSOC, V313, P2331, DOI 10.1001/jama.2015.5213; Thille AW, 2015, CRIT CARE MED, V43, P613, DOI 10.1097/CCM.0000000000000748; Thille AW, 2011, CRIT CARE MED, V39, P2612, DOI 10.1097/CCM.0b013e3182282a5a; Vallverdu I, 1998, AM J RESP CRIT CARE, V158, P1855, DOI 10.1164/ajrccm.158.6.9712135	31	297	331	0	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2016	315	13					1354	1361		10.1001/jama.2016.2711	http://dx.doi.org/10.1001/jama.2016.2711			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI3EP	26975498	Bronze			2022-12-28	WOS:000373381500019
J	Dustin, ML				Dustin, Michael L.			Killers on sterols	NATURE			English	Editorial Material							ACYL-COENZYME; CELL		[Dustin, Michael L.] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England	University of Oxford	Dustin, ML (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England.	michael.dustin@kennedy.ox.ac.uk	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389				Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Dustin ML, 2014, CANCER IMMUNOL RES, V2, P1023, DOI 10.1158/2326-6066.CIR-14-0161; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yang W, 2016, NATURE, V531, P651, DOI 10.1038/nature17412; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741	13	10	10	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					583	584		10.1038/nature17310	http://dx.doi.org/10.1038/nature17310			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	26982727				2022-12-28	WOS:000373027400024
J	Lee, MH; Appleton, KM; Strungs, EG; Kwon, JY; Morinelli, TA; Peterson, YK; Laporte, SA; Luttrell, LM				Lee, Mi-Hye; Appleton, Kathryn M.; Strungs, Erik G.; Kwon, Joshua Y.; Morinelli, Thomas A.; Peterson, Yuri K.; Laporte, Stephane A.; Luttrell, Louis M.			The conformational signature of beta-arrestin2 predicts its trafficking and signalling functions	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; CRYSTAL-STRUCTURE; CLATHRIN ADAPTER; BIASED AGONISM; ENDOCYTOSIS; ACTIVATION; MECHANISM; PHOSPHORYLATION; DESENSITIZATION	Arrestins are cytosolic proteins that regulate G-protein-coupled receptor (GPCR) desensitization, internalization, trafficking and signalling(1,2). Arrestin recruitment uncouples GPCRs from heterotrimeric G proteins, and targets the proteins for internalization via clathrin-coated pits(3,4). Arrestins also function as ligand-regulated scaffolds that recruit multiple non-G-protein effectors into GPCR-based 'signalsomes'(5,6). Although the dominant function(s) of arrestins vary between receptors, the mechanism whereby different GPCRs specify these divergent functions is unclear. Using a panel of intramolecular fluorescein arsenical hairpin (FlAsH) bioluminescence resonance energy transfer (BRET) reporters(7) to monitor conformational changes in beta-arrestin2, here we show that GPCRs impose distinctive arrestin 'conformational signatures' that reflect the stability of the receptor-arrestin complex and role of a-arrestin2 in activating or dampening downstream signalling events. The predictive value of these signatures extends to structurally distinct ligands activating the same GPCR, such that the innate properties of the ligand are reflected as changes in beta-arrestin2 conformation. Our findings demonstrate that information about ligand-receptor conformation is encoded within the population average a-arrestin2 conformation, and provide insight into how different GPCRs can use a common effector for different purposes. This approach may have application in the characterization and development of functionally selective GPCR ligands(8,9) and in identifying factors that dictate arrestin conformation and function.	[Lee, Mi-Hye; Appleton, Kathryn M.; Strungs, Erik G.; Kwon, Joshua Y.; Morinelli, Thomas A.; Luttrell, Louis M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Peterson, Yuri K.] Med Univ S Carolina, Coll Pharm, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Laporte, Stephane A.] McGill Univ, Res Inst, Ctr Hlth, Dept Med, Quebec City, PQ H4A 3J1, Canada; [Laporte, Stephane A.] McGill Univ, Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Laporte, Stephane A.] McGill Univ, Anat & Cell Biol, Quebec City, PQ H3A 0C7, Canada; [Luttrell, Louis M.] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; McGill University; McGill University; McGill University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Luttrell, LM (corresponding author), Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA.; Luttrell, LM (corresponding author), Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA.	luttrell@musc.edu	Laporte, Stephane/ABC-4228-2021; Laporte, Stephane A/F-3282-2012	Laporte, Stephane/0000-0002-0633-543X; Luttrell, Louis/0000-0003-2805-6949	National Institutes of Health [DK055524, GM095497, RR027777]; Dialysis Clinics, Inc.; Research Service of the Charleston, SC Veterans Affairs Medical Center; Canadian Institutes of Health [MOP-74603]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK055524, R01DK055524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716, R01GM095497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dialysis Clinics, Inc.; Research Service of the Charleston, SC Veterans Affairs Medical Center; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants DK055524 (L.M.L.) and GM095497 (L.M.L.), funds provided by Dialysis Clinics, Inc. (T.A.M), and the Research Service of the Charleston, SC Veterans Affairs Medical Center (L.M.L.). Supported by Canadian Institutes of Health Research operating grant MOP-74603 (S.A.L.). National Institutes of Health grant RR027777 (L.M.L.) supported the FLIPR<SUP>TETRA</SUP> facility. The contents of this article do not represent the views of the Department of Veterans Affairs or the United States Government.	Appleton KM, 2013, METHOD ENZYMOL, V522, P229, DOI 10.1016/B978-0-12-407865-9.00013-3; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Binkowski BF, 2011, METHODS MOL BIOL, V756, P263, DOI 10.1007/978-1-61779-160-4_14; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich VV, 2013, PROG MOL BIOL TRANSL, V118, P57, DOI 10.1016/B978-0-12-394440-5.00003-6; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Kommaddi RP, 2013, PROG MOL BIOL TRANSL, V118, P175, DOI 10.1016/B978-0-12-394440-5.00007-3; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Leonard AP, 2013, MICROSC MICROANAL, V19, P150, DOI 10.1017/S1431927612014067; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 2014, MOL ENDOCRINOL, V28, P281, DOI 10.1210/me.2013-1314; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm14, DOI 10.1126/stke.3112005cm14; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wilson PC, 2013, J BIOL CHEM, V288, P18872, DOI 10.1074/jbc.M113.472381; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	34	138	140	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					665	+		10.1038/nature17154	http://dx.doi.org/10.1038/nature17154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27007854	Green Submitted, Green Accepted			2022-12-28	WOS:000373027400044
J	Berg, RD; Levitte, S; O'Sullivan, MP; O'Leary, SM; Cambier, CJ; Cameron, J; Takaki, KK; Moens, CB; Tobin, DM; Keane, J; Ramakrishnan, L				Berg, Russell D.; Levitte, Steven; O'Sullivan, Mary P.; O'Leary, Seonadh M.; Cambier, C. J.; Cameron, James; Takaki, Kevin K.; Moens, Cecilia B.; Tobin, David M.; Keane, Joseph; Ramakrishnan, Lalita			Lysosomal Disorders Drive Susceptibility to Tuberculosis by Compromising Macrophage Migration	CELL			English	Article							HUMAN ALVEOLAR MACROPHAGES; MYCOBACTERIUM-TUBERCULOSIS; GAUCHER-DISEASE; STORAGE DISORDERS; CIGARETTE-SMOKING; CELL-DEATH; INFECTION; PULMONARY; CLEARANCE; FUSION	A zebrafish genetic screen for determinants of susceptibility to Mycobacterium marinum identified a hypersusceptible mutant deficient in lysosomal cysteine cathepsins that manifests hallmarks of human lysosomal storage diseases. Under homeostatic conditions, mutant macrophages accumulate undigested lysosomal material, which disrupts endocytic recycling and impairs their migration to, and thus engulfment of, dying cells. This causes a buildup of unengulfed cell debris. During mycobacterial infection, macrophages with lysosomal storage cannot migrate toward infected macrophages undergoing apoptosis in the tuberculous granuloma. The unengulfed apoptotic macrophages undergo secondary necrosis, causing granuloma breakdown and increased mycobacterial growth. Macrophage lysosomal storage similarly impairs migration to newly infecting mycobacteria. This phenotype is recapitulated in human smokers, who are at increased risk for tuberculosis. A majority of their alveolar macrophages exhibit lysosomal accumulations of tobacco smoke particulates and do not migrate to Mycobacterium tuberculosis. The incapacitation of highly microbicidal first-responding macrophages may contribute to smokers' susceptibility to tuberculosis.	[Berg, Russell D.; Levitte, Steven] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98195 USA; [Berg, Russell D.; Levitte, Steven] Univ Washington, Med Scientist Training Program, Seattle, WA 98195 USA; [Levitte, Steven; Takaki, Kevin K.; Ramakrishnan, Lalita] Univ Cambridge, Dept Med, MRC Lab Mol Biol, Cambridge CB2 0QH, England; [O'Sullivan, Mary P.; O'Leary, Seonadh M.; Keane, Joseph] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin 8, Ireland; [Cambier, C. J.] Univ Washington, Grad Program Immunol, Seattle, WA 98195 USA; [Cameron, James; Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Moens, Cecilia B.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Tobin, David M.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Tobin, David M.] Duke Univ, Dept Immunol, Durham, NC 27710 USA; [Cambier, C. J.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Cameron, James] NOAA, Environm & Fisheries Sci Div, Seattle, WA 98115 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; MRC Laboratory Molecular Biology; University of Cambridge; Trinity College Dublin; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Duke University; Duke University; Stanford University; National Oceanic Atmospheric Admin (NOAA) - USA	Ramakrishnan, L (corresponding author), Univ Cambridge, Dept Med, MRC Lab Mol Biol, Cambridge CB2 0QH, England.; Keane, J (corresponding author), Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin 8, Ireland.; Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	josephmk@tcd.ie; lr404@hermes.cam.ac.uk	Moens, Cecilia/AAN-1536-2020; Keane, Joseph/AAX-6658-2021; O'Sullivan, Mary P/C-9413-2012	Keane, Joseph/0000-0001-5313-385X; O'Sullivan, Mary P/0000-0002-6104-8943; Takaki, Kevin/0000-0002-4790-4598; Ramakrishnan, Lalita/0000-0003-0692-5533; O'Leary, Seonadh/0000-0002-7903-2325; Tobin, David/0000-0003-3465-5518; Levitte, Steven/0000-0002-3324-5464	Wellcome Trust; NIH [R37AI054503, R01NS082567, 5F30HL110455, 1DP2-OD008614]; National Institute of Health Research Cambridge Biomedical Research Centre; Health Research Board of Ireland [HRA_POR/2013/387, CSA/2012/16]; Royal City of Dublin Hospital Trust [146]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL110455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082567] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008614] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Health Research Board of Ireland; Royal City of Dublin Hospital Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Luzio, G. Griffiths, and R. Kay for insights and advice on lysosome biology and cell migration; G. Godaly for advice on human macrophage cell migration assays; P. Edelstein, A. Pagan, and S. Falkow for manuscript review; N. Goodwin and R. Keeble for zebrafish husbandry; and F. O'Connell, the research nurses of the Wellcome Trust-HRB Clinical Research Facility, and the staff and patients of the St. James's Hospital Bronchoscopy clinic, Dublin. This work was supported by the Wellcome Trust (L.R.), the NIH (R37AI054503, L.R., R01NS082567, C.B.M., 5F30HL110455, R.D.B., 1DP2-OD008614, D.M.T.), the National Institute of Health Research Cambridge Biomedical Research Centre (L. R.), the Health Research Board of Ireland (HRA_POR/2013/387, M.P.O'S. and CSA/2012/16, J.K.), and The Royal City of Dublin Hospital Trust (grant 146, J.K.).	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Aflaki E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008659; AKER M, 1993, BRIT J HAEMATOL, V83, P187, DOI 10.1111/j.1365-2141.1993.tb08270.x; Allen TC, 2008, ARCH PATHOL LAB MED, V132, P1171, DOI 10.1043/1543-2165(2008)132[1171:PLCHAO]2.0.CO;2; Anderson RH, 1997, AM J PREV MED, V13, P175, DOI 10.1016/S0749-3797(18)30190-9; Aston C, 1998, AM J RESP CRIT CARE, V157, P1943, DOI 10.1164/ajrccm.157.6.9705028; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Baillat D, 2012, MOL CELL BIOL, V32, P4642, DOI 10.1128/MCB.00906-12; Barlow PG, 2008, CELL BIOL TOXICOL, V24, P243, DOI 10.1007/s10565-007-9033-y; BATES JH, 1965, NEW ENGL J MED, V272, P714, DOI 10.1056/NEJM196504082721403; BETZ P, 1993, FORENSIC SCI INT, V62, P217, DOI 10.1016/0379-0738(93)90210-2; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; Bretscher MS, 1998, CURR BIOL, V8, P721, DOI 10.1016/S0960-9822(98)70281-7; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Bright NA, 2015, METHOD CELL BIOL, V126, P101, DOI 10.1016/bs.mcb.2014.10.029; Cambier CJ, 2014, CELL, V159, P1497, DOI 10.1016/j.cell.2014.11.024; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clements WK, 2013, NAT REV IMMUNOL, V13, P336, DOI 10.1038/nri3443; Cosma Christine L, 2006, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/0471729256.mc10b02s3; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; FERIN J, 1982, ANAT RECORD, V203, P265, DOI 10.1002/ar.1092030208; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Fraldi A, 2010, EMBO J, V29, P3607, DOI 10.1038/emboj.2010.237; GREEN GM, 1964, J EXP MED, V119, P167, DOI 10.1084/jem.119.1.167; Gyawali N, 2012, Nepal Med Coll J, V14, P303; HARRIS JO, 1970, J CLIN INVEST, V49, P2086, DOI 10.1172/JCI106426; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Henry RW, 1998, GENE DEV, V12, P2664, DOI 10.1101/gad.12.17.2664; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; HOCKING WG, 1979, NEW ENGL J MED, V301, P639, DOI 10.1056/NEJM197909203011205; Hsu CL, 2012, SCIENCE, V335, P89, DOI 10.1126/science.1213682; Huang JQ, 1997, HUM MOL GENET, V6, P1879, DOI 10.1093/hmg/6.11.1879; Jain Vishakha V, 2011, Indian J Endocrinol Metab, V15, P224, DOI 10.4103/2230-8210.83415; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Kieseier BC, 1997, ACTA NEUROPATHOL, V94, P359, DOI 10.1007/s004010050719; LEHNERT BE, 1992, ENVIRON HEALTH PERSP, V97, P17, DOI 10.2307/3431327; LIEL Y, 1994, BLOOD, V83, P2646, DOI 10.1182/blood.V83.9.2646.bloodjournal8392646; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Machaczka M, 2014, UPSALA J MED SCI, V119, P44, DOI 10.3109/03009734.2013.857373; Malatack JJ, 2003, PEDIATR NEUROL, V29, P391, DOI 10.1016/j.pediatrneurol.2003.09.003; Marques LJ, 1997, AM J RESP CRIT CARE, V156, P1700, DOI 10.1164/ajrccm.156.5.9611052; MARTIN RR, 1973, AM REV RESPIR DIS, V107, P596, DOI 10.1164/arrd.1973.107.4.596; Murray EJB, 1997, METABOLISM, V46, P1090, DOI 10.1016/S0026-0495(97)90284-5; Nepal RM, 2008, J LEUKOCYTE BIOL, V84, P1011, DOI 10.1189/jlb.1207852; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; O'Leary SM, 2014, AM J RESP CRIT CARE, V190, P1430, DOI 10.1164/rccm.201407-1385OC; Pagan AJ, 2015, CELL HOST MICROBE, V18, P15, DOI 10.1016/j.chom.2015.06.008; PEAO MND, 1993, ACTA ANAT, V147, P227; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; RATCLIFFE HL, 1948, J EXP MED, V87, P575, DOI 10.1084/jem.87.6.575; Srivastava S, 2014, IMMUNOL REV, V262, P179, DOI 10.1111/imr.12217; Sumpter C, 2013, TROP MED INT HEALTH, V18, P101, DOI 10.1111/tmi.12013; Sweeney S, 2015, INT J NANOMED, V10, P3115, DOI 10.2147/IJN.S77867; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Traynor D, 2007, J CELL SCI, V120, P2318, DOI 10.1242/jcs.007732; Urdahl KB, 2014, SEMIN IMMUNOL, V26, P578, DOI 10.1016/j.smim.2014.10.003; Varshney GK, 2013, GENOME RES, V23, P727, DOI 10.1101/gr.151464.112; Veale KJ, 2010, TRAFFIC, V11, P1370, DOI 10.1111/j.1600-0854.2010.01094.x; Verrall AJ, 2014, IMMUNOLOGY, V141, P506, DOI 10.1111/imm.12223; Zimran A, 2011, BLOOD, V118, P1463, DOI 10.1182/blood-2011-04-308890	66	73	79	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					139	152		10.1016/j.cell.2016.02.034	http://dx.doi.org/10.1016/j.cell.2016.02.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015311	Green Published, hybrid			2022-12-28	WOS:000372785600016
J	Iezzoni, LI; Dorner, SC; Ajayi, T				Iezzoni, Lisa I.; Dorner, Stephen C.; Ajayi, Toyin			Community Paramedicine - Addressing Questions as Programs Expand	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Iezzoni, Lisa I.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Iezzoni, Lisa I.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Dorner, Stephen C.] Harvard Univ, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Ajayi, Toyin] Commonwealth Care Alliance, Boston, MA USA; [Dorner, Stephen C.] Vanderbilt Univ, Sch Med, 221 Kirkland Hall, Nashville, TN 37235 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Vanderbilt University	Iezzoni, LI (corresponding author), Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA.; Iezzoni, LI (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.							American College of Emergency Physicians (ACEP), 2015, ANN EMERG MED, V66, P692, DOI [10.1016/j.annemergmed.2015.08.020, DOI 10.1016/J.ANNEMERGMED.2015.08.020]; Choi BY, 2016, ANN EMERG MED, V67, P361, DOI 10.1016/j.annemergmed.2015.06.005; Morganti KG, 2014, ANN EMERG MED, V63, P615, DOI 10.1016/j.annemergmed.2013.09.025; National Highway Traffic Safety Administration Office of the Assistant Secretary for Preparedness and Response Health Resources and Services Administration, 2013, INN OPP EM MED SERV; Snooks HA, 2013, SCI WORLD J, DOI 10.1155/2013/182102	5	30	31	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2016	374	12					1107	1109		10.1056/NEJMp1516100	http://dx.doi.org/10.1056/NEJMp1516100			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AA	27007957				2022-12-28	WOS:000372585100003
J	White, MD; Angiolini, JF; Alvarez, YD; Kaur, G; Zhao, ZPW; Mocskos, E; Bruno, L; Bissiere, S; Levi, V; Plachta, N				White, Melanie D.; Angiolini, Juan F.; Alvarez, Yanina D.; Kaur, Gurpreet; Zhao, Ziqing W.; Mocskos, Esteban; Bruno, Luciana; Bissiere, Stephanie; Levi, Valeria; Plachta, Nicolas			Long-Lived Binding of Sox2 to DNA Predicts Cell Fate in the Four-Cell Mouse Embryo	CELL			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; TRANSCRIPTION FACTOR-BINDING; ONE-DIMENSIONAL DIFFUSION; MAMMALIAN EMBRYO; STEM-CELLS; REGULATES PLURIPOTENCY; BIOLOGICAL-SYSTEMS; GENE-EXPRESSION; TARGET SEARCH; LIVING CELLS	Transcription factor (TF) binding to DNA is fundamental for gene regulation. However, it remains unknown how the dynamics of TF-DNA interactions change during cell-fate determination in vivo. Here, we use photo-activatable FCS to quantify TF-DNA binding in single cells of developing mouse embryos. In blastocysts, the TFs Oct4 and Sox2, which control pluripotency, bind DNA more stably in pluripotent than in extraembryonic cells. By contrast, in the four-cell embryo, Sox2 engages in more long-lived interactions than does Oct4. Sox2 long-lived binding varies between blastomeres and is regulated by H3R26 methylation. Live-cell tracking demonstrates that those blastomeres with more long-lived binding contribute more pluripotent progeny, and reducing H3R26 methylation decreases long-lived binding, Sox2 target expression, and pluripotent cell numbers. Therefore, Sox2-DNA binding predicts mammalian cell fate as early as the four-cell stage. More generally, we reveal the dynamic repartitioning of TFs between DNA sites driven by physiological epigenetic changes.	[White, Melanie D.; Kaur, Gurpreet; Zhao, Ziqing W.; Bissiere, Stephanie; Plachta, Nicolas] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore; [Angiolini, Juan F.; Alvarez, Yanina D.; Mocskos, Esteban; Bruno, Luciana; Levi, Valeria] Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat, C1428EHA, Buenos Aires, DF, Argentina	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Plachta, N (corresponding author), ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.; Levi, V (corresponding author), Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat, C1428EHA, Buenos Aires, DF, Argentina.	vlevi12@gmail.com; plachtan@imcb.a-star.edu.sg	White, Melanie/J-5565-2019; Zhao, Ziqing Winston/M-8960-2019	White, Melanie/0000-0002-7399-8348; Mocskos, Esteban/0000-0002-6473-7672; Levi, Valeria/0000-0002-1666-4675	A*STAR Investigatorship; EMBO Young Investigator grants; ANPCyT [PICT 2012-0899]; UBACyT [20020110100074]; A*STAR National Science Scholarship	A*STAR Investigatorship(Agency for Science Technology & Research (A*STAR)); EMBO Young Investigator grants; ANPCyT(ANPCyT); UBACyT; A*STAR National Science Scholarship(Agency for Science Technology & Research (A*STAR))	We thank Juan Silva for embryo microinjections. This work was supported by A*STAR Investigatorship and EMBO Young Investigator grants (to N.P.) and ANPCyT (PICT 2012-0899) and UBACyT (20020110100074) grants (to V.L.); E.M., L.B., and V.L. are CONICET members. Z.W.Z. is supported by an A*STAR National Science Scholarship.	Amano T, 2009, BIOL REPROD, V80, P473, DOI 10.1095/biolreprod.108.069542; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BEECHEM JM, 1992, METHOD ENZYMOL, V210, P37; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Blase FH, 2014, GENOME RES, V24, P1787, DOI 10.1101/gr.177725.114; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Burton A, 2014, NAT REV MOL CELL BIO, V15, P722, DOI 10.1038/nrm3885; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; De-Leon SBT, 2007, ANNU REV BIOPH BIOM, V36, P191, DOI 10.1146/annurev.biophys.35.040405.102002; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Digman MA, 2011, ANNU REV PHYS CHEM, V62, P645, DOI 10.1146/annurev-physchem-032210-103424; Doucleff M, 2008, P NATL ACAD SCI USA, V105, P13871, DOI 10.1073/pnas.0805050105; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elson EL, 2013, METHOD ENZYMOL, V518, P11, DOI 10.1016/B978-0-12-388422-0.00002-9; Gardner RL, 2001, DEVELOPMENT, V128, P839; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/nmeth.2411, 10.1038/NMETH.2411]; Gorman J, 2008, NAT STRUCT MOL BIOL, V15, P768, DOI 10.1038/nsmb.1441; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; Kaur G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2657; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Liu Z, 2014, ELIFE, V3, DOI 10.7554/eLife.04236; Louvet-Vallee S, 2005, CURR BIOL, V15, P464, DOI 10.1016/j.cub.2004.12.078; Maekawa M, 2007, DEVELOPMENT, V134, P2751, DOI 10.1242/dev.003756; Michelman-Ribeiro A, 2009, BIOPHYS J, V97, P337, DOI 10.1016/j.bpj.2009.04.027; Morisaki T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5456; Morris SA, 2010, P NATL ACAD SCI USA, V107, P6364, DOI 10.1073/pnas.0915063107; Mueller F, 2013, CRIT REV BIOCHEM MOL, V48, P492, DOI 10.3109/10409238.2013.833891; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Normanno D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8357; Normanno D, 2012, BBA-GENE REGUL MECH, V1819, P482, DOI 10.1016/j.bbagrm.2012.02.001; Paramanathan T, 2012, NUCLEIC ACIDS RES, V40, P4925, DOI 10.1093/nar/gks069; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; ROSSANT J, 1976, J EMBRYOL EXP MORPH, V36, P283; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Ruan QQ, 2004, BIOPHYS J, V87, P1260, DOI 10.1529/biophysj.103.036483; Samarage CR, 2015, DEV CELL, V34, P435, DOI 10.1016/j.devcel.2015.07.004; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Shi JC, 2015, DEVELOPMENT, V142, P3468, DOI 10.1242/dev.123950; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tabansky I, 2013, CURR BIOL, V23, P21, DOI 10.1016/j.cub.2012.10.054; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Vigano MA, 1996, NUCLEIC ACIDS RES, V24, P2112, DOI 10.1093/nar/24.11.2112; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Wicklow E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004618; Yeap LS, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-12; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zhang FP, 2008, MOL CELL BIOL, V28, P5381, DOI 10.1128/MCB.00651-08; Zhao HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027026	70	128	132	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					75	87		10.1016/j.cell.2016.02.032	http://dx.doi.org/10.1016/j.cell.2016.02.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015308	Bronze			2022-12-28	WOS:000372785600011
J	Sinnott, JD; Howlett, DC				Sinnott, Joseph Dalby; Howlett, David C.			SPOT DIAGNOSIS A woman with abdominal distension and pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sinnott, Joseph Dalby] ESHT, Eastbourne, England; East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, England		Sinnott, JD (corresponding author), ESHT, Eastbourne, England.	j.d.sinnott@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2016	352								i1382	10.1136/bmj.i1382	http://dx.doi.org/10.1136/bmj.i1382			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LK	27005764				2022-12-28	WOS:000373044500005
J	Maxmen, A				Maxmen, Amy			STRESS The privilege of health	NATURE			English	Editorial Material							MEN											Chen E, 2006, J ALLERGY CLIN IMMUN, V117, P1014, DOI 10.1016/j.jaci.2006.01.036; Cole SW, 1996, PSYCHOSOM MED, V58, P219, DOI 10.1097/00006842-199605000-00005; Martikainen PT, 1996, LANCET, V348, P909, DOI 10.1016/S0140-6736(96)03291-6	3	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S58	S59		10.1038/531S58a	http://dx.doi.org/10.1038/531S58a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG4TA	26981730	Bronze			2022-12-28	WOS:000372064300004
J	Thal, DM; Sun, BF; Feng, D; Nawaratne, V; Leach, K; Felder, CC; Bures, MG; Evans, DA; Weis, WI; Bachhawat, P; Kobilka, TS; Sexton, PM; Kobilka, BK; Hristopoulos, AC				Thal, David M.; Sun, Bingfa; Feng, Dan; Nawaratne, Vindhya; Leach, Katie; Felder, Christian C.; Bures, Mark G.; Evans, David A.; Weis, William I.; Bachhawat, Priti; Kobilka, Tong Sun; Sexton, Patrick M.; Kobilka, Brian K.; Hristopoulos, Arthur C.			Crystal structures of the M1 and M4 muscarinic acetylcholine receptors	NATURE			English	Article							2ND EXTRACELLULAR LOOP; IN-VIVO VALIDATION; ALLOSTERIC MODULATION; EVOLUTIONARY CONSERVATION; SWISS-MODEL; BINDING; ACTIVATION; PROTEINS; CONSURF; INSIGHTS	Muscarinic M1-M5 acetylcholine receptors are G-protein-coupled receptors that regulate many vital functions of the central and peripheral nervous systems. In particular, the M1 and M4 receptor subtypes have emerged as attractive drug targets for treatments of neurological disorders, such as Alzheimer's disease and schizophrenia, but the high conservation of the acetylcholine-binding pocket has spurred current research into targeting allosteric sites on these receptors. Here we report the crystal structures of the M1 and M4 muscarinic receptors bound to the inverse agonist, tiotropium. Comparison of these structures with each other, as well as with the previously reported M2 and M3 receptor structures, reveals differences in the orthosteric and allosteric binding sites that contribute to a role in drug selectivity at this important receptor family. We also report identification of a cluster of residues that form a network linking the orthosteric and allosteric sites of the M4 receptor, which provides new insight into how allosteric modulation may be transmitted between the two spatially distinct domains.	[Thal, David M.; Nawaratne, Vindhya; Leach, Katie; Sexton, Patrick M.; Hristopoulos, Arthur C.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Thal, David M.; Nawaratne, Vindhya; Leach, Katie; Sexton, Patrick M.; Hristopoulos, Arthur C.] Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic 3052, Australia; [Sun, Bingfa; Feng, Dan; Bachhawat, Priti; Kobilka, Tong Sun; Kobilka, Brian K.] ConfometRx, 3070 Kenneth St, Santa Clara, CA 95054 USA; [Felder, Christian C.] Eli Lilly & Co, Neurosci, Indianapolis, IN 46285 USA; [Bures, Mark G.] Eli Lilly & Co, Computat Chem & Chemoinformat, Indianapolis, IN 46285 USA; [Evans, David A.] Eli Lilly & Co, Computat Chem & Chemoinformat, Sunninghill Rd, Windlesham GU20 6PH, Surrey, England; [Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA	Monash University; Monash University; Eli Lilly; Eli Lilly; Eli Lilly; Stanford University; Stanford University	Sexton, PM; Hristopoulos, AC (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia.; Sexton, PM; Hristopoulos, AC (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Dept Pharmacol, Parkville, Vic 3052, Australia.; Kobilka, BK (corresponding author), ConfometRx, 3070 Kenneth St, Santa Clara, CA 95054 USA.; Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	patrick.sexton@monash.edu; kobilka@stanford.edu; arthur.christopoulos@monash.edu	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008; Weis, William I/G-1437-2011	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Weis, William I/0000-0002-5583-6150; Leach, Katherine/0000-0002-9280-1803; Sun, Bingfa/0000-0001-5001-5065; Felder, Christian/0000-0003-1134-8881; Thal, David/0000-0002-0325-2524; Kobilka, Brian/0000-0001-5958-3990	National Health and Medical Research Council (NHMRC) of Australia [APP1055134]; Lilly Research Award Program; Mathers Foundation; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM106990] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Lilly Research Award Program; Mathers Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Lopez for generating initial M4 homology models. This work was funded by Program Grant APP1055134 of the National Health and Medical Research Council (NHMRC) of Australia (A.C., P.M.S.). Portions of this work were supported by a Lilly Research Award Program grant. W.I.W. and B.K.K. were supported by the Mathers Foundation. A.C. is a Senior Principal, and P.M.S. a Principal, Research Fellow of the NHMRC. GM/CA @ APS has been funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Use of the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-ENG-38.	Abdul-Ridha A, 2014, J BIOL CHEM, V289, P33701, DOI 10.1074/jbc.M114.604967; Abdul-Ridha A, 2014, J BIOL CHEM, V289, P6067, DOI 10.1074/jbc.M113.539080; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2015, MOL OP ENV MOE; [Anonymous], 2014, SCHROD REL 2014 2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chan WY, 2008, P NATL ACAD SCI USA, V105, P10978, DOI 10.1073/pnas.0800567105; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Croy CH, 2014, MOL PHARMACOL, V86, P106, DOI 10.1124/mol.114.091751; Digby GJ, 2010, MOL BIOSYST, V6, P1345, DOI 10.1039/c002938f; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foster DJ, 2012, DISCOV MED, V14, P413; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gnagey AL, 1999, MOL PHARMACOL, V56, P1245, DOI 10.1124/mol.56.6.1245; Goodwin JA, 2007, MOL PHARMACOL, V72, P1484, DOI 10.1124/mol.107.038265; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hasselmo ME, 2006, J MOL NEUROSCI, V30, P133, DOI 10.1385/JMN:30:1:133; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Heinrich JN, 2009, EUR J PHARMACOL, V605, P53, DOI 10.1016/j.ejphar.2008.12.044; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Khoury E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00068; Kruse AC, 2014, CURR OPIN PHARMACOL, V16, P24, DOI 10.1016/j.coph.2014.02.006; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leach K, 2011, MOL PHARMACOL, V79, P855, DOI 10.1124/mol.111.070938; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Nawaratne V, 2010, J BIOL CHEM, V285, P19012, DOI 10.1074/jbc.M110.125096; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Schober DA, 2014, MOL PHARMACOL, V86, P116, DOI 10.1124/mol.114.091785; Schrodinger L, 2010, PYMOL MOL GRAPH SYST; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; STOCKTON JM, 1983, MOL PHARMACOL, V23, P551; Suratman S, 2011, BRIT J PHARMACOL, V162, P1659, DOI 10.1111/j.1476-5381.2010.01184.x; Tautermann CS, 2013, J MED CHEM, V56, P8746, DOI 10.1021/jm401219y; Thorsen TS, 2014, STRUCTURE, V22, P1657, DOI 10.1016/j.str.2014.08.022; vanRhee AM, 1996, DRUG DEVELOP RES, V37, P1, DOI 10.1002/(SICI)1098-2299(199601)37:1<1::AID-DDR1>3.0.CO;2-S; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379	66	208	212	5	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					335	+		10.1038/nature17188	http://dx.doi.org/10.1038/nature17188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26958838	Green Accepted, Green Submitted			2022-12-28	WOS:000372064300045
J	[Anonymous]				[Anonymous]			A GUIDE TO THE NATURE INDEX	NATURE			English	Editorial Material																			0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S136	S136		10.1038/531S136a	http://dx.doi.org/10.1038/531S136a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26982024	Bronze			2022-12-28	WOS:000372064300013
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Liraglutide (Saxenda) for Weight Loss	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material													Pflomm, Jean-Marie/HDO-0765-2022					[Anonymous], 2015, MED LETT DRUGS THER, V57, P21; [Anonymous], 2014, MED LETT DRUGS THER, V56, P112; [Anonymous], 2010, MED LETT DRUGS THER, V52, P25; [Anonymous], 2012, MED LETT DRUGS THER, V54, P76; [Anonymous], 2012, MED LETT DRUGS THER, V54, P69; 2015, MED LETT DRUGS THER, V57, P66	6	0	0	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1161	1162		10.1001/jama.2016.2083	http://dx.doi.org/10.1001/jama.2016.2083			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978212				2022-12-28	WOS:000372159800022
J	Hollander, AC; Dal, H; Lewis, G; Magnusson, C; Kirkbride, JB; Dalman, C				Hollander, Anna-Clara; Dal, Henrik; Lewis, Glyn; Magnusson, Cecilia; Kirkbride, James B.; Dalman, Christina			Refugee migration and risk of schizophrenia and other non-affective psychoses: cohort study of 1.3 million people in Sweden	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MENTAL-HEALTH; IMMIGRANTS; DISORDERS; COUNTRIES; 1ST-GENERATION; ASSOCIATION; PREVALENCE; REGISTER; STRESS	OBJECTIVE To determine whether refugees are at elevated risk of schizophrenia and other non-affective psychotic disorders, relative to non-refugee migrants from similar regions of origin and the Swedish-born population. DESIGN Cohort study of people living in Sweden, born after 1 January 1984 and followed from their 14th birthday or arrival in Sweden, if later, until diagnosis of a non-affective psychotic disorder, emigration, death, or 31 December 2011. SETTING Linked Swedish national register data. PARTICIPANTS 1 347 790 people, including people born in Sweden to two Swedish-born parents (1 191 004; 88.4%), refugees (24 123; 1.8%), and non-refugee migrants (132 663; 9.8%) from four major refugee generating regions: the Middle East and north Africa, sub-Saharan Africa, Asia, and Eastern Europe and Russia. MAIN OUTCOME MEASURES Cox regression analysis was used to estimate adjusted hazard ratios for non-affective psychotic disorders by refugee status and region of origin, controlling for age at risk, sex, disposable income, and population density. RESULTS 3704 cases of non-affective psychotic disorder were identified during 8.9 million person years of follow-up. The crude incidence rate was 38.5 (95% confidence interval 37.2 to 39.9) per 100 000 person years in the Swedish-born population, 80.4 (72.7 to 88.9) per 100 000 person years in non-refugee migrants, and 126.4 (103.1 to 154.8) per 100 000 person years in refugees. Refugees were at increased risk of psychosis compared with both the Swedish-born population (adjusted hazard ratio 2.9, 95% confidence interval 2.3 to 3.6) and non-refugee migrants (1.7, 1.3 to 2.1) after adjustment for confounders. The increased rate in refugees compared with non-refugee migrants was more pronounced in men (likelihood ratio test for interaction chi(2) (df=2) z=13.5; P=0.001) and was present for refugees from all regions except sub-Saharan Africa. Both refugees and non-refugee migrants from sub-Saharan Africa had similarly high rates relative to the Swedish-born population. CONCLUSIONS Refugees face an increased risk of schizophrenia and other non-affective psychotic disorders compared with non-refugee migrants from similar regions of origin and the native-born Swedish population. Clinicians and health service planners in refugee receiving countries should be aware of a raised risk of psychosis in addition to other mental and physical health inequalities experienced by refugees.	[Hollander, Anna-Clara; Magnusson, Cecilia; Dalman, Christina] Karolinska Inst, Dept Publ Hlth Sci, S-17177 Stockholm, Sweden; [Dal, Henrik; Magnusson, Cecilia; Dalman, Christina] Stockholm Cty Council, Ctr Epidemiol & Community Med, SE-17177 Stockholm, Sweden; [Lewis, Glyn; Kirkbride, James B.] UCL, Div Psychiat, London W1T 7NF, England	Karolinska Institutet; Stockholm County Council; University of London; University College London	Hollander, AC (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, S-17177 Stockholm, Sweden.	anna-clara.hollander@ki.se	Lewis, Glyn/E-9944-2012; Hollander, Anna-Clara/O-7106-2019; Kirkbride, James B./A-9345-2008	Lewis, Glyn/0000-0001-5205-8245; Hollander, Anna-Clara/0000-0002-1246-5804; Kirkbride, James B./0000-0003-3401-0824; Magnusson, Cecilia/0000-0002-8567-6725; Dalman, Christina/0000-0002-3579-2357	FORTE [2014-1430, 2014-2678]; Sir Henry Dale fellowship - Wellcome Trust [101272/Z/13/Z]; Sir Henry Dale fellowship - Royal Society [101272/Z/13/Z]; Swedish Research Council [523-2010-1052]	FORTE; Sir Henry Dale fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale fellowship - Royal Society; Swedish Research Council(Swedish Research CouncilEuropean Commission)	A-CH is supported by FORTE (grant number 2014-1430; 2014-2678). JBK is supported by a Sir Henry Dale fellowship jointly funded by the Wellcome Trust and the Royal Society (grant number 101272/Z/13/Z). CD is supported by the Swedish Research Council (grant number 523-2010-1052). The funders had no involvement in any aspect of the design of this study, preparation of results, or decision to submit for publication.	Abel KM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7679; Anderson KK, 2015, CAN MED ASSOC J, V187, pE279, DOI 10.1503/cmaj.141420; Bourque F, 2011, PSYCHOL MED, V41, P897, DOI 10.1017/S0033291710001406; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Cantor-Graae E, 2003, BRIT J PSYCHIAT, V182, P117, DOI 10.1192/bjp.182.2.117; Dalman C, 2002, SOC PSYCH PSYCH EPID, V37, P527, DOI 10.1007/s00127-002-0582-3; Domoney J, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0679-3; European Commission, 2015, EUR AS MAN MIGR; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Fearon P, 2006, PSYCHOL MED, V36, P1541, DOI 10.1017/S0033291706008774; Hjern A, 2004, PSYCHOL MED, V34, P1025, DOI 10.1017/S003329170300148X; Hollander AC, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21059; Hollander AC, 2013, J NERV MENT DIS, V201, P645, DOI 10.1097/NMD.0b013e31829dbd64; JABLENSKY A, 1992, PSYCHOL MED, P1; Jorgensen L, 2014, NORD J PSYCHIAT, V68, P60, DOI 10.3109/08039488.2013.772234; Kirkbride J, 2011, MIGRATION MENTAL HLT; Kirkbride JB, 2008, BRIT J PSYCHIAT, V193, P18, DOI 10.1192/bjp.bp.107.041566; Kirkbride JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031660; Kirkbride JB, 2006, ARCH GEN PSYCHIAT, V63, P250, DOI 10.1001/archpsyc.63.3.250; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; Leao TS, 2006, J NERV MENT DIS, V194, P27, DOI 10.1097/01.nmd.0000195312.81334.81; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mahy GE, 1999, BRIT J PSYCHIAT, V175, P28, DOI 10.1192/bjp.175.1.28; Myers NL, 2011, CURR PSYCHIAT REP, V13, P305, DOI 10.1007/s11920-011-0208-0; Norredam M, 2009, SOC PSYCH PSYCH EPID, V44, P1023, DOI 10.1007/s00127-009-0024-6; OConghaile A, 2015, CURR OPIN PSYCHIATR, V28, P249, DOI 10.1097/YCO.0000000000000158; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Rai D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2059; Selten JP, 2008, SOC PSYCH PSYCH EPID, V43, P937, DOI 10.1007/s00127-008-0390-5; Shaw RJ, 2012, BRIT J PSYCHIAT, V201, P11, DOI 10.1192/bjp.bp.110.083675; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; UNHCR, 2013, PROOF CRED ASS EU AS; United Nations High Commissioner for Refugees, 2011, 1951 CONV REL STAT R; United Nations High Commissioner for Refugees (UNHCR), 2015, GLB APP 2005 UPD; van der Ven E, 2015, PSYCHOL MED, V45, P727, DOI 10.1017/S0033291714001780; Veling W, 2007, INT J EPIDEMIOL, V36, P761, DOI 10.1093/ije/dym085; Wangdahl J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1030; World Bank, 2015, WORLD DATABANK	39	132	134	1	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2016	352								i1030	10.1136/bmj.i1030	http://dx.doi.org/10.1136/bmj.i1030			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DH1ZT	26979256	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000372584400001
J	Tyrrell, J; Richmond, RC; Palmer, TM; Feenstra, B; Rangarajan, J; Metrustry, S; Cavadino, A; Paternoster, L; Armstrong, LL; De Silva, NMG; Wood, AR; Horikoshi, M; Geller, F; Myhre, R; Bradfield, JP; Kreiner-Moller, E; Huikari, V; Painter, JN; Hottenga, JJ; Allard, C; Berry, DJ; Bouchard, L; Das, S; Evans, DM; Hakonarson, H; Hayes, MG; Heikkinen, J; Hofman, A; Knight, B; Lind, PA; McCarthy, MI; McMahon, G; Medland, SE; Melbye, M; Morris, AP; Nodzenski, M; Reichetzeder, C; Ring, SM; Sebert, S; Sengpiel, V; Sorensen, TIA; Willemsen, G; de Geus, EJC; Martin, NG; Spector, TD; Power, C; Jarvelin, MR; Bisgaard, H; Grant, SFA; Nohr, EA; Jaddoe, VW; Jacobsson, B; Murray, JC; Hocher, B; Hattersley, AT; Scholtens, DM; Smith, GD; Hivert, MF; Felix, JF; Hypponen, E; Lowe, WL; Frayling, TM; Lawlor, DA; Freathy, RM				Tyrrell, Jessica; Richmond, Rebecca C.; Palmer, Tom M.; Feenstra, Bjarke; Rangarajan, Janani; Metrustry, Sarah; Cavadino, Alana; Paternoster, Lavinia; Armstrong, Loren L.; De Silva, N. Maneka G.; Wood, Andrew R.; Horikoshi, Momoko; Geller, Frank; Myhre, Ronny; Bradfield, Jonathan P.; Kreiner-Moller, Eskil; Huikari, Ville; Painter, Jodie N.; Hottenga, Jouke-Jan; Allard, Catherine; Berry, Diane J.; Bouchard, Luigi; Das, Shikta; Evans, David M.; Hakonarson, Hakon; Hayes, M. Geoffrey; Heikkinen, Jani; Hofman, Albert; Knight, Bridget; Lind, Penelope A.; McCarthy, Mark I.; McMahon, George; Medland, Sarah E.; Melbye, Mads; Morris, Andrew P.; Nodzenski, Michael; Reichetzeder, Christoph; Ring, Susan M.; Sebert, Sylvain; Sengpiel, Verena; Sorensen, Thorkild I. A.; Willemsen, Gonneke; de Geus, Eco J. C.; Martin, Nicholas G.; Spector, Tim D.; Power, Christine; Jarvelin, Marjo-Riitta; Bisgaard, Hans; Grant, Struan F. A.; Nohr, Ellen A.; Jaddoe, Vincent W.; Jacobsson, Bo; Murray, Jeffrey C.; Hocher, Berthold; Hattersley, Andrew T.; Scholtens, Denise M.; Smith, George Davey; Hivert, Marie-France; Felix, Janine F.; Hypponen, Elina; Lowe, William L., Jr.; Frayling, Timothy M.; Lawlor, Debbie A.; Freathy, Rachel M.		EGG Consortium	Genetic Evidence for Causal Relationships Between Maternal Obesity-Related Traits and Birth Weight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; GESTATIONAL DIABETES-MELLITUS; VITAMIN-D STATUS; MENDELIAN RANDOMIZATION; INSULIN-RESISTANCE; COHORT PROFILE; BLOOD-PRESSURE; FETAL-GROWTH; ADIPONECTIN LEVELS; PREGNANCY	IMPORTANCE Neonates born to overweight or obese women are larger and at higher risk of birth complications. Many maternal obesity-related traits are observationally associated with birth weight, but the causal nature of these associations is uncertain. OBJECTIVE To test for genetic evidence of causal associations of maternal body mass index (BMI) and related traits with birth weight. DESIGN, SETTING, AND PARTICIPANTS Mendelian randomization to test whether maternal BMI and obesity-related traits are potentially causally related to offspring birth weight. Data from 30 487 women in 18 studies were analyzed. Participants were of European ancestry from population-or community-based studies in Europe, North America, or Australia and were part of the Early Growth Genetics Consortium. Live, term, singleton offspring born between 1929 and 2013 were included. EXPOSURES Genetic scores for BMI, fasting glucose level, type 2 diabetes, systolic blood pressure (SBP), triglyceride level, high-density lipoprotein cholesterol (HDL-C) level, vitamin D status, and adiponectin level. MAIN OUTCOME AND MEASURE Offspring birth weight from 18 studies. RESULTS Among the 30 487 newborns the mean birth weight in the various cohorts ranged from 3325 g to 3679 g. The maternal genetic score for BMI was associated with a 2-g (95% CI, 0 to 3 g) higher offspring birth weight per maternal BMI-raising allele (P =.008). The maternal genetic scores for fasting glucose and SBP were also associated with birth weight with effect sizes of 8 g (95% CI, 6 to 10 g) per glucose-raising allele (P = 7 x 10(-14)) and -4 g (95% CI, -6 to -2g) per SBP-raising allele (P = 1x10(-5)), respectively. A 1-SD (approximate to 4 points) genetically higher maternal BMI was associated with a 55-g higher offspring birth weight (95% CI, 17 to 93 g). A 1-SD (approximate to 7.2mg/dL) genetically higher maternal fasting glucose concentration was associated with 114-g higher offspring birth weight (95% CI, 80 to 147 g). However, a 1-SD (approximate to 10mmHg) genetically higher maternal SBP was associated with a 208-g lower offspring birth weight (95% CI, -394 to -21 g). For BMI and fasting glucose, genetic associations were consistent with the observational associations, but for systolic blood pressure, the genetic and observational associations were in opposite directions. CONCLUSIONS AND RELEVANCE In this mendelian randomization study, genetically elevated maternal BMI and blood glucose levels were potentially causally associated with higher offspring birth weight, whereas genetically elevated maternal SBP was potentially causally related to lower birth weight. If replicated, these findings may have implications for counseling and managing pregnancies to avoid adverse weight-related birth outcomes.	[Freathy, Rachel M.] Royal Devon & Exeter Hosp, Inst Biomed & Clin Sci, Univ Exeter, Barrack Rd, Exeter EX2 5DW, Devon, England; [Lawlor, Debbie A.] Univ Bristol, MRC Integrat Epidemiol Unit, Oakfield Rd, Bristol BS8 2BN, Avon, England; [Tyrrell, Jessica; Wood, Andrew R.; Knight, Bridget; Hattersley, Andrew T.; Frayling, Timothy M.; Freathy, Rachel M.] Univ Exeter, Royal Devon & Exeter Hosp, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [Tyrrell, Jessica] Univ Exeter, Knowledge Spa, European Ctr Environm & Human Hlth, Truro, England; [Richmond, Rebecca C.; Evans, David M.; McMahon, George; Ring, Susan M.; Smith, George Davey; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Richmond, Rebecca C.; Jaddoe, Vincent W.; Smith, George Davey; Felix, Janine F.] Univ Med Ctr Rotterdam, Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands; [Richmond, Rebecca C.; Paternoster, Lavinia; De Silva, N. Maneka G.; Evans, David M.; Ring, Susan M.; Sorensen, Thorkild I. A.; Lawlor, Debbie A.; Freathy, Rachel M.] Univ Bristol, Integrat Epidemiol Unit, Med Res Council, Bristol BS8 1TH, Avon, England; [Palmer, Tom M.] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Palmer, Tom M.] Univ Lancaster, Dept Math & Stat, Lancaster, England; [Feenstra, Bjarke; Geller, Frank; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Rangarajan, Janani; Nodzenski, Michael; Scholtens, Denise M.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Metrustry, Sarah; Spector, Tim D.] St Thomas Hosp, Kings Coll London, Dept Twin Res, London, England; [Cavadino, Alana; Berry, Diane J.] Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, Barts, England; [Cavadino, Alana; Berry, Diane J.] Queen Mary Univ London, London Sch Med & Dent, London, England; [Cavadino, Alana; Power, Christine; Hypponen, Elina] UCL, UCL Inst Child Hlth, Populat Policy & Practice, London WC1E 6BT, England; [Armstrong, Loren L.; Hayes, M. Geoffrey; Lowe, William L., Jr.] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Horikoshi, Momoko; McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX1 2JD, England; [Horikoshi, Momoko; McCarthy, Mark I.; Morris, Andrew P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Myhre, Ronny; Jacobsson, Bo] Norwegian Inst Publ Hlth, Dept Genes & Environm, Div Epidemiol, Oslo, Norway; [Bradfield, Jonathan P.; Hakonarson, Hakon; Grant, Struan F. A.] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Kreiner-Moller, Eskil; Bisgaard, Hans] Univ Copenhagen, Fac Hlth Sci, COPSAC, Copenhagen, Denmark; [Kreiner-Moller, Eskil; Bisgaard, Hans] Copenhagen Univ Hosp, Danish Pediat Asthma Ctr, Gentofte, Denmark; [Huikari, Ville; Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Painter, Jodie N.; Lind, Penelope A.; Medland, Sarah E.; Martin, Nicholas G.] Royal Brisbane Hosp, QIMR Berghofer Med Res Inst, Herston, Qld, Australia; [Hottenga, Jouke-Jan; Willemsen, Gonneke; de Geus, Eco J. C.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Hottenga, Jouke-Jan; Willemsen, Gonneke; de Geus, Eco J. C.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Allard, Catherine] Univ Sherbrooke, Dept Math, Quebec City, PQ, Canada; [Allard, Catherine; Bouchard, Luigi] CHU Sherbrooke, Ctr Rech, Quebec City, PQ, Canada; [Bouchard, Luigi] Chicoutimi Hosp, ECOGENE & Lipid Clin 21, Quebec City, PQ, Canada; [Bouchard, Luigi] Univ Sherbrooke, Dept Biochem, Quebec City, PQ, Canada; [Das, Shikta] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Evans, David M.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Hakonarson, Hakon; Grant, Struan F. A.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Hakonarson, Hakon; Grant, Struan F. A.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Heikkinen, Jani] Univ Helsinki, FIMM Inst Mol Med Finland, Helsinki, Finland; [Hofman, Albert; Jaddoe, Vincent W.; Felix, Janine F.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [McCarthy, Mark I.] Churchill Hosp, Biomed Res Ctr, Oxford Natl Inst Hlth Res NIHR, Oxford OX3 7LJ, England; [Melbye, Mads] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Morris, Andrew P.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Reichetzeder, Christoph; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Reichetzeder, Christoph] Charite, Ctr Cardiovasc Res, Berlin, Germany; [Sebert, Sylvain; Jarvelin, Marjo-Riitta] Imperial Coll London, Fac Med, Hlth Protect Agcy Ctr Environm & Hlth, Med Res Council,Sch Publ Hlth,Dept Epidemiol & Bi, London, England; [Sengpiel, Verena; Jacobsson, Bo] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, S-41345 Gothenburg, Sweden; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metabol Res, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark; [Jarvelin, Marjo-Riitta] Natl Inst Hlth andWelfare, Dept Children & Young People & Families, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Nohr, Ellen A.] Univ So Denmark, Inst Clin Res, Res Unit Obstet & Gynecol, Odense, Denmark; [Jaddoe, Vincent W.; Felix, Janine F.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Hocher, Berthold] Jinan Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Hivert, Marie-France] Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, Boston, MA USA; [Hivert, Marie-France] Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA; [Hivert, Marie-France] Univ Sherbrooke, Dept Med, Quebec City, PQ, Canada; [Hypponen, Elina] Univ S Australia, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA 5001, Australia; [Hypponen, Elina] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Hypponen, Elina] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Hofman, Albert] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Exeter; University of Bristol; University of Exeter; University of Exeter; University of Bristol; Erasmus University Rotterdam; Erasmus MC; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bristol; University of Warwick; Lancaster University; Statens Serum Institut; Northwestern University; Feinberg School of Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; Queen Mary University London; University of London; University College London; Northwestern University; Feinberg School of Medicine; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Norwegian Institute of Public Health (NIPH); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Copenhagen; University of Copenhagen; University of Oulu; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; Imperial College London; University of Queensland; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Helsinki; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Stanford University; University of Liverpool; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Sahlgrenska University Hospital; University of Copenhagen; Bispebjerg Hospital; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Oulu; University of Oulu; University of Southern Denmark; Erasmus University Rotterdam; Erasmus MC; University of Iowa; Jinan University; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Sherbrooke; University of South Australia; University of South Australia; South Australian Health & Medical Research Institute (SAHMRI); Harvard University; Harvard T.H. Chan School of Public Health	Freathy, RM (corresponding author), Royal Devon & Exeter Hosp, Inst Biomed & Clin Sci, Univ Exeter, Barrack Rd, Exeter EX2 5DW, Devon, England.; Lawlor, DA (corresponding author), Univ Bristol, MRC Integrat Epidemiol Unit, Oakfield Rd, Bristol BS8 2BN, Avon, England.	d.a.lawlor@bristol.ac.uk; r.freathy@ex.ac.uk	Lind, Penelope A/ABC-5341-2021; Davey Smith, George/A-7407-2013; Bisgaard, Hans/N-4761-2016; Horikoshi, Momoko/AAF-9034-2019; Evans, David M/H-6325-2013; de Geus, Eco J.C./M-9318-2015; Cavadino, Alana/CAG-8915-2022; Painter, Jodie N/AAC-6332-2019; Jacobsson, Bo/O-8007-2014; Hocher, Berthold/AAC-3510-2020; Medland, Sarah/AAT-7595-2020; Lind, Penelope A/B-2553-2009; Wood, Andrew R/AAB-3807-2019; Hypponen, Elina/B-2596-2014; Palmer, Tom Michael/X-6807-2019; Medland, Sarah E/C-7630-2013; Hivert, Marie-France/GWN-0455-2022; McCarthy, Mark/M-3763-2015; Paternoster, Lavinia/C-1292-2015	Lind, Penelope A/0000-0002-3887-2598; Davey Smith, George/0000-0002-1407-8314; Bisgaard, Hans/0000-0003-4131-7592; Evans, David M/0000-0003-0663-4621; de Geus, Eco J.C./0000-0001-6022-2666; Cavadino, Alana/0000-0002-5709-367X; Painter, Jodie N/0000-0002-4992-2458; Jacobsson, Bo/0000-0001-5079-2374; Medland, Sarah/0000-0003-1382-380X; Lind, Penelope A/0000-0002-3887-2598; Wood, Andrew R/0000-0003-1726-948X; Hypponen, Elina/0000-0003-3670-9399; Palmer, Tom Michael/0000-0003-4655-4511; Medland, Sarah E/0000-0003-1382-380X; Lawlor, Debbie A/0000-0002-6793-2262; Doyon, Myriam/0000-0001-9787-7367; melbye, mads/0000-0001-8264-6785; McCarthy, Mark/0000-0002-4393-0510; Geller, Frank/0000-0002-9238-3269; Hocher, Berthold/0000-0001-8143-0579; s, hema/0000-0002-3440-9475; Hattersley, Andrew/0000-0001-5620-473X; Grant, Struan/0000-0003-2025-5302; Allard, Catherine/0000-0002-8829-4984; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Sebert, Sylvain/0000-0001-6681-6983; Heikkinen, Jani/0000-0001-8804-1007; Willemsen, Gonneke/0000-0003-3755-0236; Hayes, M Geoffrey/0000-0002-4617-3981; Richmond, Rebecca/0000-0003-0574-5071; Paternoster, Lavinia/0000-0003-2514-0889; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Freathy, Rachel/0000-0003-4152-2238; Frayling, Timothy/0000-0001-8362-2603	CIHR Funding Source: Medline; European Research Council [323195] Funding Source: Medline; Medical Research Council [MC_PC_15018, G0701603, MC_UU_1201/1, MC_UU_1201/4, MC_UU_12013/1, MR/J012165/1, G1001799, G0500070, MC_UU_1201/1/5, MR/N01104X/1, MC_QA137853, MC_UU_12013/3, MC_UU_12013/5, G0601261, G9815508, MC_UU_12013/4] Funding Source: Medline; NICHD NIH HHS [R01 HD056465] Funding Source: Medline; NIDDK NIH HHS [R01 DK10324, R01 DK103246] Funding Source: Medline; NIEHS NIH HHS [P30 ES013508] Funding Source: Medline; Wellcome Trust [098395, WT083431MF, 102215, WT088806, WT098017, WT094529MA, 104150, 104150/Z/14/Z] Funding Source: Medline; MRC [MC_UU_12013/4, G1001799, MC_UU_12013/3, MC_UU_12013/5, G0500070, G0601261, MR/N01104X/1, MR/J012165/1, G0701603, MC_UU_12013/1] Funding Source: UKRI; Medical Research Council [MC_qA137853] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10099, NF-SI-0611-10196, NF-SI-0611-10219, NF-SI-0514-10027] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Berry DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037465; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Burgess S, 2011, INT J EPIDEMIOL, V40, P755, DOI 10.1093/ije/dyr036; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ehret GB, 2010, CURR HYPERTENS REP, V12, P17, DOI 10.1007/s11906-009-0086-6; Fall T, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001474; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Freathy RM, 2010, DIABETES, V59, P2682, DOI 10.2337/db10-0177; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Gaillard R, 2013, OBESITY, V21, P1046, DOI 10.1002/oby.20088; Harmon KA, 2011, DIABETES CARE, V34, P2198, DOI 10.2337/dc11-0723; Hayes MG, 2013, DIABETES, V62, P3282, DOI 10.2337/db12-1692; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; Kulkarni SR, 2013, DIABETES CARE, V36, P2706, DOI 10.2337/dc12-2445; Kwak SH, 2012, DIABETES, V61, P531, DOI 10.2337/db11-1034; Lacroix M, 2013, DIABETES CARE, V36, P1577, DOI 10.2337/dc12-1731; Landon MB, 2011, OBSTET GYNECOL, V117, P218, DOI 10.1097/AOG.0b013e318203ebe0; Lawlor DA, 2010, DIABETOLOGIA, V53, P89, DOI 10.1007/s00125-009-1560-z; Lawlor DA, 2002, BMJ-BRIT MED J, V325, P359, DOI 10.1136/bmj.325.7360.359; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lawlor DA, 2012, NAT REV ENDOCRINOL, V8, P679, DOI 10.1038/nrendo.2012.176; Leffelaar ER, 2010, BRIT J NUTR, V104, P108, DOI 10.1017/S000711451000022X; Lowe LP, 2010, J CLIN ENDOCR METAB, V95, P5427, DOI 10.1210/jc.2010-1662; Macdonald-Wallis C, 2014, HYPERTENSION, V64, P36, DOI 10.1161/HYPERTENSIONAHA.113.02766; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Misra VK, 2011, OBESITY, V19, P1476, DOI 10.1038/oby.2011.43; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nohr EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008444; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; PEDERSEN J, 1977, PREGNANT DIABETIC HE; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006; Schlemm L, 2010, J HYPERTENS, V28, P732, DOI 10.1097/HJH.0b013e328336a090; Shin D, 2015, J MATERN-FETAL NEO M, V28, P1679, DOI 10.3109/14767058.2014.964675; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Silverwood RJ, 2014, INT J EPIDEMIOL, V43, P1781, DOI 10.1093/ije/dyu187; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vimaleswaran KS, 2014, LANCET DIABETES ENDO, V2, P719, DOI 10.1016/S2213-8587(14)70113-5; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Wurtz P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001765; Yaghootkar H, 2013, DIABETES, V62, P3589, DOI 10.2337/db13-0128; Zhao JH, 2009, DIABETES, V58, P2414, DOI 10.2337/db09-0506	55	154	158	2	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1129	1140		10.1001/jama.2016.1975	http://dx.doi.org/10.1001/jama.2016.1975			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978208	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000372159800018
J	Chen, SH; Forrester, W; Lahav, G				Chen, Sheng-Hong; Forrester, William; Lahav, Galit			Schedule-dependent interaction between anticancer treatments	SCIENCE			English	Article							P53-MDM2 FEEDBACK LOOP; P53 PATHWAY; DNA-DAMAGE; CELL-CYCLE; MDMX; DYNAMICS; PULSES; TARGET	The oncogene MDMX is overexpressed in many cancers, leading to suppression of the tumor suppressor p53. Inhibitors of the oncogene product MDMX therefore might help reactivate p53 and enhance the efficacy of DNA-damaging drugs. However, we currently lack a quantitative understanding of how MDMX inhibition affects the p53 signaling pathway and cell sensitivity to DNA damage. Live cell imaging showed that MDMX depletion triggered two distinct phases of p53 accumulation in single cells: an initial postmitotic pulse, followed by low-amplitude oscillations. The response to DNA damage was sharply different in these two phases; in the first phase, MDMX depletion was synergistic with DNA damage in causing cell death, whereas in the second phase, depletion of MDMX inhibited cell death. Thus a quantitative understanding of signal dynamics and cellular states is important for designing an optimal schedule of dual-drug administration.	[Chen, Sheng-Hong; Lahav, Galit] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Forrester, William] Novartis Inst Biomed Res, Dev & Mol Pathways, Cambridge, MA USA	Harvard University; Harvard Medical School; Novartis	Chen, SH (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.		Chen, Sheng-hong/AAU-4018-2021	Chen, Sheng-hong/0000-0002-7722-2221	National Institutes of Health [GM083303, F32GM105205]; Novartis Institutes for Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM105205, R01GM083303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Institutes for Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. G. Jochemsen, J. C. Marine, X. Wang, and J. Chen for sharing their experience and thoughts on MDMX regulation; R. Ward, S. Gruver, G. Gaglia, J. Porter, L. Bruett, and members of the Lahav laboratory for comments, support, and discussion; and the Nikon Imaging Center at Harvard Medical School for support with live cell imaging. This research was supported by National Institutes of Health grant GM083303 to G.L., grant F32GM105205 to S.C., and funding from the Novartis Institutes for Biomedical Research.	Barboza JA, 2008, MOL CANCER RES, V6, P947, DOI 10.1158/1541-7786.MCR-07-2079; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Behar M, 2013, CELL, V155, P448, DOI 10.1016/j.cell.2013.09.018; Bieler J, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145218; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Feillet C, 2014, P NATL ACAD SCI USA, V111, P9828, DOI 10.1073/pnas.1320474111; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Graves B, 2012, P NATL ACAD SCI USA, V109, P11788, DOI 10.1073/pnas.1203789109; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mancini F, 2010, INT J BIOCHEM CELL B, V42, P1080, DOI 10.1016/j.biocel.2010.04.010; Morton SW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005261; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Reed D, 2010, J BIOL CHEM, V285, P10786, DOI 10.1074/jbc.M109.056747; Sancar A, 2010, FEBS LETT, V584, P2618, DOI 10.1016/j.febslet.2010.03.017; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang XJ, 2011, J BIOL CHEM, V286, P23725, DOI 10.1074/jbc.M110.213868	22	48	48	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1204	1208		10.1126/science.aac5610	http://dx.doi.org/10.1126/science.aac5610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965628	Green Accepted			2022-12-28	WOS:000386158400047
J	Knockenhauer, KE; Schwartz, TU				Knockenhauer, Kevin E.; Schwartz, Thomas U.			The Nuclear Pore Complex as a Flexible and DynamicGate	CELL			English	Review							MEMBRANE-COATING MODULE; CRYSTAL-STRUCTURE; MOLECULAR ARCHITECTURE; STRUCTURAL-ANALYSIS; NUP107-160 COMPLEX; CELL-DIFFERENTIATION; PROTEOMIC ANALYSIS; TRANSPORT CHANNEL; MAMMALIAN-CELLS; FG HYDROGELS	Nuclear pore complexes (NPCs) perforate the nuclear envelope and serve as the primary transport gates for molecular exchange between nucleus and cytoplasm. Stripping the megadalton complex down to its most essential organizational elements, one can divide the NPC into scaffold components and the disordered elements attached to them that generate a selective barrier between compartments. These structural elements exhibit flexibility, which may hold a clue in understanding NPC assembly and function. Here we review the current status of NPC research with a focus on the functional implications of its structural and compositional heterogeneity.	[Knockenhauer, Kevin E.; Schwartz, Thomas U.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Schwartz, TU (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tus@mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512	NIH [R01 GM077537, R01 AR065484]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sarah Nordeen for help with figures. Work in the Schwartz laboratory is supported by grants from the NIH (R01 GM077537, R01 AR065484). We apologize to our colleagues whose important contributions were not cited due to space limitations.	Ader C, 2010, P NATL ACAD SCI USA, V107, P6281, DOI 10.1073/pnas.0910163107; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Allen TD, 2000, J CELL SCI, V113, P1651; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Andersen KR, 2013, ELIFE, V2, DOI 10.7554/eLife.00745; Asakawa H, 2014, NUCLEUS-PHILA, V5, P149, DOI 10.4161/nucl.28487; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Bestembayeva A, 2015, NAT NANOTECHNOL, V10, P60, DOI [10.1038/nnano.2014.262, 10.1038/NNANO.2014.262]; Bilokapic S, 2012, P NATL ACAD SCI USA, V109, P15241, DOI 10.1073/pnas.1205151109; Bilokapic S, 2012, CURR OPIN CELL BIOL, V24, P86, DOI 10.1016/j.ceb.2011.12.011; Boni A, 2015, J CELL BIOL, V209, P705, DOI 10.1083/jcb.201409133; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Chug H, 2015, SCIENCE, V350, P106, DOI 10.1126/science.aac7420; Cook AG, 2010, CURR OPIN STRUC BIOL, V20, P247, DOI 10.1016/j.sbi.2010.01.012; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Angelo MA, 2012, DEV CELL, V22, P446, DOI 10.1016/j.devcel.2011.11.021; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; DeGrasse JA, 2010, METHODS MOL BIOL, V673, P231, DOI 10.1007/978-1-60761-842-3_15; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Doucet CM, 2010, CHROMOSOMA, V119, P469, DOI 10.1007/s00412-010-0289-2; Dultz E, 2010, J CELL BIOL, V191, P15, DOI 10.1083/jcb.201007076; Eibauer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8532; Eisenhardt N, 2014, J CELL SCI, V127, P908, DOI 10.1242/jcs.141739; Fay N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00467; Field MC, 2014, TRAFFIC, V15, P141, DOI 10.1111/tra.12141; Fischer J, 2015, NAT STRUCT MOL BIOL, V22, P774, DOI 10.1038/nsmb.3084; Fiserova J, 2009, PLANT J, V59, P243, DOI 10.1111/j.1365-313X.2009.03865.x; Flemming D, 2012, J STRUCT BIOL, V177, P99, DOI 10.1016/j.jsb.2011.11.008; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237; Gomez-Cavazos JS, 2015, J CELL BIOL, V208, P671, DOI 10.1083/jcb.201410047; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; Handa N, 2006, J MOL BIOL, V363, P114, DOI 10.1016/j.jmb.2006.07.089; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; Hough LE, 2015, ELIFE, V4, DOI 10.7554/eLife.10027; Hulsmann BB, 2012, CELL, V150, P738, DOI 10.1016/j.cell.2012.07.019; Hurt E, 2015, CURR OPIN CELL BIOL, V34, P31, DOI 10.1016/j.ceb.2015.04.009; Jeudy S, 2007, J BIOL CHEM, V282, P34904, DOI 10.1074/jbc.M705479200; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Kelley K, 2015, NAT STRUCT MOL BIOL, V22, P425, DOI 10.1038/nsmb.2998; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Kim SJ, 2014, MOL CELL PROTEOMICS, V13, P2911, DOI 10.1074/mcp.M114.040915; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kirchhausen T, 2014, COLD SPRING HARB PER, V6; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Koh J, 2015, CELL, V161, P1361, DOI 10.1016/j.cell.2015.05.013; Koumandou VL, 2013, CRIT REV BIOCHEM MOL, V48, P373, DOI 10.3109/10409238.2013.821444; Kubitscheck U, 1996, BIOPHYS J, V70, P2067, DOI 10.1016/S0006-3495(96)79811-9; Labokha AA, 2013, EMBO J, V32, P204, DOI 10.1038/emboj.2012.302; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Liu XP, 2012, P NATL ACAD SCI USA, V109, P16498, DOI 10.1073/pnas.1214557109; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Lowe AR, 2015, ELIFE, V4, DOI 10.7554/eLife.04052; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; Maimon T, 2012, STRUCTURE, V20, P998, DOI 10.1016/j.str.2012.03.025; Mans BJ, 2004, CELL CYCLE, V3, P1612; Matreyek KA, 2013, VIRUSES-BASEL, V5, P2483, DOI 10.3390/v5102483; Meinema AC, 2011, SCIENCE, V333, P90, DOI 10.1126/science.1205741; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Miller EA, 2013, CURR OPIN CELL BIOL, V25, P420, DOI 10.1016/j.ceb.2013.04.005; Milles S, 2015, CELL, V163, P734, DOI 10.1016/j.cell.2015.09.047; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Morchoisne-Bolhy S, 2015, MOL BIOL CELL, V26, P2343, DOI 10.1091/mbc.E15-02-0060; Neumann N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013241; Onischenko E, 2009, J CELL BIOL, V185, P475, DOI 10.1083/jcb.200810030; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Peleg O, 2010, BIOL CHEM, V391, P719, DOI 10.1515/BC.2010.092; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rothballer A, 2013, TRENDS BIOCHEM SCI, V38, P292, DOI 10.1016/j.tibs.2013.04.001; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Sampathkumar P, 2013, STRUCTURE, V21, P560, DOI 10.1016/j.str.2013.02.005; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Schmidt HB, 2015, ELIFE, V4, DOI 10.7554/eLife.04251; Schooley A, 2012, CHROMOSOMA, V121, P539, DOI 10.1007/s00412-012-0388-3; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Seo HS, 2013, P NATL ACAD SCI USA, V110, P16450, DOI 10.1073/pnas.1316607110; Siniossoglou S, 2000, J CELL BIOL, V149, P41, DOI 10.1083/jcb.149.1.41; Solmaz SR, 2011, CELL, V147, P590, DOI 10.1016/j.cell.2011.09.034; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Stuwe T, 2015, SCIENCE, V350, P56, DOI 10.1126/science.aac9176; Stuwe T, 2015, SCIENCE, V347, P1148, DOI 10.1126/science.aaa4136; Stuwe T, 2014, P NATL ACAD SCI USA, V111, P2530, DOI 10.1073/pnas.1311081111; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Theerthagiri G, 2010, J CELL BIOL, V189, P1129, DOI 10.1083/jcb.200912045; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Ulrich A, 2014, MOL BIOL CELL, V25, P1484, DOI 10.1091/mbc.E13-12-0745; Ungricht R, 2015, CURR OPIN CELL BIOL, V34, P135, DOI 10.1016/j.ceb.2015.04.005; Ungricht R, 2015, J CELL BIOL, V209, P687, DOI 10.1083/jcb.201409127; Vollmer B, 2014, BIOL CHEM, V395, P515, DOI 10.1515/hsz-2013-0285; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Whittle JRR, 2009, J BIOL CHEM, V284, P28442, DOI 10.1074/jbc.M109.023580; Wild P, 2009, J VIROL, V83, P408, DOI 10.1128/JVI.01568-08; Xu C, 2015, FEBS LETT, V589, P3247, DOI 10.1016/j.febslet.2015.09.008; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390	116	239	239	2	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1162	1171		10.1016/j.cell.2016.01.034	http://dx.doi.org/10.1016/j.cell.2016.01.034			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967283	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000372784900014
J	Theriot, J; Huang, KC; Goulian, M				Theriot, Julie; Huang, K. C.; Goulian, Mark			When Biology Doesn't Add Up	CELL			English	Editorial Material								Physical models are increasingly used to inform our understanding of biology. Where such models still run into limits was the question that Cell's Robert Kruger posed to Julie Theriot, K.C. Huang, and Mark Goulian. Annotated excerpts from this conversation are presented below, and the full conversation is available with the article online.	[Theriot, Julie; Huang, K. C.] Stanford Univ, Stanford, CA 94305 USA; [Goulian, Mark] Univ Penn, Philadelphia, PA 19104 USA	Stanford University; University of Pennsylvania	Theriot, J (corresponding author), Stanford Univ, Stanford, CA 94305 USA.		Theriot, Julie/HHN-2034-2022		NIAID NIH HHS [R37 AI036929] Funding Source: Medline; NIGMS NIH HHS [R01 GM080279] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080279] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bray Dennis, CELL MOVEMENTS; Hazen Robert M., COMPLEXITY; Ideker Trey, WETWARE COMPUTER EVE	3	0	0	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1089	1091		10.1016/j.cell.2016.02.003	http://dx.doi.org/10.1016/j.cell.2016.02.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967273	Bronze			2022-12-28	WOS:000372784900004
J	Tolles, J; Lewis, RJ				Tolles, Juliana; Lewis, Roger J.			Time-to-Event Analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tolles, Juliana; Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Bldg D9,1000 W Carson St, Torrance, CA 90509 USA; [Tolles, Juliana; Lewis, Roger J.] Los Angeles Biomed Res Inst, Torrance, CA USA; [Tolles, Juliana; Lewis, Roger J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lewis, Roger J.] Berry Consultants LLC, Austin, TX USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lewis, RJ (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, Bldg D9,1000 W Carson St, Torrance, CA 90509 USA.	roger@emedharbor.edu						HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; Lee E, 2013, STAT METHODS SURVIVA; Nissen SE, 2016, JAMA-J AM MED ASSOC, V315, P990, DOI 10.1001/jama.2016.1558; Young KD, 1999, ACAD EMERG MED, V6, P244, DOI 10.1111/j.1553-2712.1999.tb00165.x	4	21	21	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					1046	1047		10.1001/jama.2016.1825	http://dx.doi.org/10.1001/jama.2016.1825			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26954413				2022-12-28	WOS:000371540200017
J	Johnson, P; Hol, A				Johnson, Paul; Hol, Alberta			Case Report Comment The art of managing medical uncertainty	LANCET			English	Editorial Material									[Johnson, Paul] Austin Hlth, Dept Infect Dis, Heidelberg, Vic, Australia; [Johnson, Paul] Univ Melbourne, Austin Hlth, Heidelberg, Vic 3084, Australia; [Hol, Alberta] Austin Hlth, Dept Rheumatol, Heidelberg, Vic, Australia; [Hol, Alberta] Monash Univ, Sch Clin Sci, Dept Med, Clayton, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University	Johnson, P (corresponding author), Univ Melbourne, Austin Hlth, Dept Infect Dis, 145 Studley Rd, Heidelberg, Vic 3084, Australia.	paul.johnson@austin.org.au		Hoi, Alberta/0000-0002-9416-7383				Durack D T, 1991, Curr Clin Top Infect Dis, V11, P35; Elstein AS, 2002, BRIT MED J, V324, P729, DOI 10.1136/bmj.324.7339.729; Lai FYX, 2016, LANCET, V387, P1025, DOI 10.1016/S0140-6736(16)00501-8; Lega JC, 2014, SEMIN ARTHRITIS RHEU, V43, P681, DOI 10.1016/j.semarthrit.2013.09.001; Mahr A, 2015, CURR OPIN RHEUMATOL, V27, P1, DOI 10.1097/BOR.0000000000000134	5	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					1026	1026		10.1016/S0140-6736(16)00207-5	http://dx.doi.org/10.1016/S0140-6736(16)00207-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF8XP	26972246				2022-12-28	WOS:000371644200036
J	Tefera, L; Lehrman, WG; Conway, P				Tefera, Lemeneh; Lehrman, William G.; Conway, Patrick			Measurement of the Patient Experience Clarifying Facts, Myths, and Approaches	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NONRESPONSE; CARE		[Tefera, Lemeneh] Ctr Medicare & Medicaid Serv, Qual Measurement & Value Based Incent Grp, 7500 Secur Blvd,S3-02-04, Baltimore, MD 21244 USA; [Lehrman, William G.] Ctr Medicare & Medicaid Serv, Div Consumer Assessment & Plan Performance, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Tefera, L (corresponding author), Ctr Medicare & Medicaid Serv, Qual Measurement & Value Based Incent Grp, 7500 Secur Blvd,S3-02-04, Baltimore, MD 21244 USA.	lemeneh.tefera@cms.hhs.gov						Carrus B, MEASURING PATIENT EX; Chatterjee P, 2015, AM J MANAG CARE, V21, P735; Elliott MN, 2009, MED CARE, V47, P842, DOI 10.1097/MLR.0b013e318197b22a; Elliott MN, 2009, HEALTH SERV RES, V44, P501, DOI 10.1111/j.1475-6773.2008.00914.x; Gunderman R., ATLANTIC; Halbesleben JRB, 2013, HEALTH SERV RES, V48, P913, DOI 10.1111/1475-6773.12002; Johnson TP, 2012, JAMA-J AM MED ASSOC, V307, P1805, DOI 10.1001/jama.2012.3532; Zgierska A, 2014, PATIENT PREFER ADHER, V8, P437, DOI 10.2147/PPA.S59077	8	46	47	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2016	315	20					2167	2168		10.1001/jama.2016.1652	http://dx.doi.org/10.1001/jama.2016.1652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM4US	26967744				2022-12-28	WOS:000376343000009
J	Crump, C; Sundquist, J; Winkleby, MA; Sieh, W; Sundquist, K				Crump, Casey; Sundquist, Jan; Winkleby, Marilyn A.; Sieh, Weiva; Sundquist, Kristina			Physical Fitness Among Swedish Military Conscripts and Long-Term Risk for Type 2 Diabetes Mellitus A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIORESPIRATORY FITNESS; NEIGHBORHOOD DEPRIVATION; METABOLIC SYNDROME; MUSCULAR STRENGTH; EXERCISE; ASSOCIATION; PREVALENCE; GLUCOSE; RESISTANCE; OBESITY	Background: Early-life physical fitness has rarely been examined in relation to type 2 diabetes mellitus (DM) in adulthood because of the lengthy follow-up required. Elucidation of modifiable risk factors at young ages may help facilitate earlier and more effective interventions. Objective: To examine aerobic capacity and muscle strength at age 18 years in relation to risk for type 2 DM in adulthood. Design: National cohort study. Setting: Sweden. Participants: 1 534 425 military conscripts from 1969 to 1997 (97% to 98% of all men aged 18 years nationwide) without prior type 2 DM. Measurements: Aerobic capacity and muscle strength (measured in watts and newtons per kilogram of body weight, respectively) were examined in relation to type 2 DM identified from outpatient and inpatient diagnoses from 1987 to 2012 (maximum age, 62 years). Results: 34 008 men were diagnosed with type 2 DM in 39.4 million person-years of follow-up. Low aerobic capacity and muscle strength were independently associated with increased risk for type 2 DM. The absolute difference in cumulative incidence of type 2 DM between the lowest and highest tertiles of both aerobic capacity and strength was 0.22% at 20 years of follow-up (95% CI, 0.20% to 0.25%), 0.76% at 30 years (CI, 0.71% to 0.81%), and 3.97% at 40 years (CI, 3.87% to 4.06%). Overall, the combination of low aerobic capacity and muscle strength was associated with a 3-fold risk for type 2 DM(adjusted hazard ratio, 3.07 [CI, 2.88 to 3.27]; P < 0.001), with a positive additive interaction (P < 0.001). These associations were seen even among men with normal body mass index. Limitation: This cohort did not include women and did not measure physical fitness at older ages. Conclusion: In this large cohort of Swedish male military conscripts, low aerobic capacity and muscle strength at age 18 years were associated with increased long-term risk for type 2 DM, even among those with normal body mass index.	[Crump, Casey] Icahn Sch Med Mt Sinai, Dept Family Med & Community Hlth, One Gustave L Levy Pl,Box 1077, New York, NY 10029 USA; [Sundquist, Jan; Sundquist, Kristina] Lund Univ, Ctr Primary Hlth Care Res, Clin Res Ctr, Skane Univ Hosp, Bldg 28,Floor 11,Jan Waldenstroms Gata 35, Malmo, Sweden; [Winkleby, Marilyn A.] Stanford Univ, Stanford Prevent Res Ctr, 251 Campus Dr,Med Sch Off Bldg,Room X318, Stanford, CA 94305 USA; [Sieh, Weiva] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, One Gustave L Levy Pl,Box 1077, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Lund University; Skane University Hospital; Stanford University; Icahn School of Medicine at Mount Sinai	Crump, C (corresponding author), Icahn Sch Med Mt Sinai, Dept Family Med & Community Hlth, One Gustave L Levy Pl,Box 1077, New York, NY 10029 USA.	casey.crump@mssm.edu	Crump, Casey/AAO-8802-2021	Crump, Casey/0000-0002-2990-1166	National Heart, Lung, and Blood Institute, National Institutes of Health [R01 HL116381]; Swedish Research Council; Region Skane/Lund University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116381] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Skane/Lund University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the National Heart, Lung, and Blood Institute, National Institutes of Health (grant R01 HL116381); the Swedish Research Council; and Region Skane/Lund University (Avtal om Lakarutbildning och Forskning, or Agreement on Medical Training and Research, project grant).	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Andersen L. B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P318; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Carnethon MR, 2003, JAMA-J AM MED ASSOC, V290, P3092, DOI 10.1001/jama.290.23.3092; Church T, 2011, PROG CARDIOVASC DIS, V53, P412, DOI 10.1016/j.pcad.2011.03.013; Crump C, 2011, ANN EPIDEMIOL, V21, P231, DOI 10.1016/j.annepidem.2011.01.005; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Eriksson KF, 1996, DIABETOLOGIA, V39, P573, DOI 10.1007/BF00403304; Furberg H, 2006, ADDICTION, V101, P1509, DOI 10.1111/j.1360-0443.2006.01550.x; Fyfe JJ, 2014, SPORTS MED, V44, P743, DOI 10.1007/s40279-014-0162-1; Ganz ML, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-50; Grontved A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001587; Grontved A, 2012, ARCH INTERN MED, V172, P1306, DOI 10.1001/archinternmed.2012.3138; Hawley JA, 2009, APPL PHYSIOL NUTR ME, V34, P355, DOI 10.1139/H09-023; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; HOOK O, 1969, Scandinavian Journal of Rehabilitation Medicine, V1, P139; Juraschek SP, 2015, DIABETES CARE, V38, P1075, DOI 10.2337/dc14-2714; Jurca R, 2005, MED SCI SPORT EXER, V37, P1849, DOI 10.1249/01.mss.0000175865.17614.74; Katzmarzyk PT, 2007, DIABETOLOGIA, V50, P538, DOI 10.1007/s00125-006-0554-3; LeBrasseur NK, 2011, AM J PHYSIOL-ENDOC M, V300, pE3, DOI 10.1152/ajpendo.00512.2010; Lee DC, 2009, DIABETES CARE, V32, P257, DOI 10.2337/dc08-1377; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lynch J, 1996, ARCH INTERN MED, V156, P1307, DOI 10.1001/archinte.156.12.1307; Mezuk B, 2013, HEALTH PLACE, V23, P63, DOI 10.1016/j.healthplace.2013.05.004; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nordesjo LO, 1974, SWEDISH J DEFENCE ME, V10, P11; Ogden Cynthia L, 2010, Natl Health Stat Report, P1; Orsini N, 2008, STATA J, V8, P29, DOI 10.1177/1536867X0800800103; PATTON JF, 1982, EUR J APPL PHYSIOL, V49, P131, DOI 10.1007/BF00428971; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sawada SS, 2003, DIABETES CARE, V26, P2918, DOI 10.2337/diacare.26.10.2918; SIMON R, 1984, STAT MED, V3, P35, DOI 10.1002/sim.4780030106; Stoddard PJ, 2013, DIABETES CARE, V36, P1200, DOI 10.2337/dc11-1866; Sui X, 2008, DIABETES CARE, V31, P550, DOI 10.2337/dc07-1870; Sundquist K, 2015, HEALTH PLACE, V31, P24, DOI 10.1016/j.healthplace.2014.10.011; Swift DL, 2013, CIRC J, V77, P281, DOI 10.1253/circj.CJ-13-0007; Umpierre D, 2011, JAMA-J AM MED ASSOC, V305, P1790, DOI 10.1001/jama.2011.576; VanderWeele TJ, 2014, EPIDEMIOL METHODS, V3, P33, DOI [DOI 10.1515/EM-2013-0005, 10.1515/em-2013-0005]; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; Wijndaele K, 2007, MED SCI SPORT EXER, V39, P233, DOI 10.1249/01.mss.0000247003.32589.a6; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654	42	55	55	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					577	+		10.7326/M15-2002	http://dx.doi.org/10.7326/M15-2002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	26954518	Green Accepted			2022-12-28	WOS:000375744000015
J	Lindson-Hawley, N; Banting, M; West, R; Michie, S; Shinkins, B; Aveyard, P				Lindson-Hawley, Nicola; Banting, Miriam; West, Robert; Michie, Susan; Shinkins, Bethany; Aveyard, Paul			Gradual Versus Abrupt Smoking Cessation A Randomized, Controlled Noninferiority Trial	ANNALS OF INTERNAL MEDICINE			English	Article							THERAPY	Background: Most smoking cessation guidelines advise quitting abruptly. However, many quit attempts involve gradual cessation. If gradual cessation is as successful, smokers can be advised to quit either way. Objective: To examine the success of quitting smoking by gradual compared with abrupt quitting. Design: Randomized, controlled noninferiority trial. (International Standardized Randomized Controlled Trial Number Register: ISRCTN22526020) Setting: Primary care clinics in England. Participants: 697 adult smokers with tobacco addiction. Intervention: Participants quit smoking abruptly or reduced smoking gradually by 75% in the 2 weeks before quitting. Both groups received behavioral support from nurses and used nicotine replacement before and after quit day. Measurements: The primary outcome measure was prolonged validated abstinence from smoking 4 weeks after quit day. The secondary outcome was prolonged, validated, 6-month abstinence. Results: At 4 weeks, 39.2% (95% CI, 34.0% to 44.4%) of the participants in the gradual-cessation group were abstinent compared with 49.0% (CI, 43.8% to 54.2%) in the abrupt-cessation group (relative risk, 0.80 [CI, 0.66 to 0.93]). At 6 months, 15.5% (CI, 12.0% to 19.7%) of the participants in the gradual-cessation group were abstinent compared with 22.0% (CI, 18.0% to 26.6%) in the abrupt-cessation group (relative risk, 0.71 [CI, 0.46 to 0.91]). Participants who preferred gradual cessation were significantly less likely to be abstinent at 4 weeks than those who preferred abrupt cessation (38.3% vs 52.2%; P = 0.007). Limitations: Blinding was impossible. Most participants were white. Conclusion: Quitting smoking abruptly is more likely to lead to lasting abstinence than cutting down first, even for smokers who initially prefer to quit by gradual reduction.	[Lindson-Hawley, Nicola; Shinkins, Bethany; Aveyard, Paul] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, New Radcliffe House,Woodstock Rd, Oxford OX2 6GG, England; [Banting, Miriam] Univ Birmingham, Learning Ctr, Primary Care Clin Sci, Birmingham B15 2TT, W Midlands, England; [West, Robert] UCL, Dept Epidemiol & Publ Hlth, Hlth Behav Res Ctr, 1-19 Torrington Pl, London WC1E 6BT, England; [Michie, Susan] UCL, Res Dept Clin Educ & Hlth Psychol, 1-19 Torrington Pl, London WC1E 7HB, England	University of Oxford; University of Birmingham; University of London; University College London; University of London; University College London	Lindson-Hawley, N (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, New Radcliffe House,Woodstock Rd, Oxford OX2 6GG, England.	nicola.lindson-hawley@phc.ox.ac.uk	Shinkins, Bethany/AAX-4045-2020; West, Robert/B-5414-2009	Shinkins, Bethany/0000-0001-5350-1018; Lindson, Nicola/0000-0003-2539-9268; West, Robert/0000-0001-6398-0921; Aveyard, Paul/0000-0002-1802-4217	British Heart Foundation; Cancer Research UK [14135] Funding Source: researchfish; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	From the British Heart Foundation.	AVEYARD P, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G2787; Blalock JA, 2001, SRNT ANN C SEATTL WA; Cheong Y, 2007, NICOTINE TOB RES, V9, P801, DOI 10.1080/14622200701484961; CINCIRIPINI PM, 1995, J CONSULT CLIN PSYCH, V63, P388, DOI 10.1037/0022-006X.63.3.388; HAJEK P, 1989, BRIT J ADDICT, V84, P591; Haustein KO, 2003, NICOTINE TOB RES, V5, P195, DOI 10.1080/146222003100073676; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hughes JR, 2007, ADDICTION, V102, P1326, DOI 10.1111/j.1360-0443.2007.01948.x; Hughes JR, 2010, DRUG ALCOHOL DEPEN, V111, P105, DOI 10.1016/j.drugalcdep.2010.04.007; Lindson-Hawley N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008033.pub3; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; McEwen A, 2012, STANDARD TREATMENT P; Moore David, 2009, BMJ, V338, pb1024, DOI 10.1136/bmj.b1024; National Institute for Health and Care Excellence, 2013, SMOK HARM RED; New Zealand Ministry of Health, 2007, NZ SMOK CESS GUID; Peters EN, 2007, ADDICTION, V102, P1158, DOI 10.1111/j.1360-0443.2007.01870.x; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Shiffman S, 2008, ADDICTION, V103, P557, DOI 10.1111/j.1360-0443.2008.02138.x; Society for Research on Nicotine and Tobacco, 2012, NAT TREATM GUID; The National Health and Social Care Information Centre, 2010, STAT NHS STOP SMOK S; The National Health and Social Care Information Centre, 2005, HLTH SURV ENGL 2004; Tobacco Use and Dependence Guideline Panel, 2008, TREATING TOBACCO USE; Wee LH, 2011, J SMOK CESS, V6, P37, DOI 10.1375/jsc.6.1.37; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; West R, 2004, PSYCHOPHARMACOLOGY, V177, P195, DOI 10.1007/s00213-004-1923-6; West R., 2012, SMOKING SMOKING CESS; West R, 2008, BEHAV CHANGE THEORY	27	61	63	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					585	+		10.7326/M14-2805	http://dx.doi.org/10.7326/M14-2805			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	26975007				2022-12-28	WOS:000375744000016
J	Ruffieux, P; Wang, SY; Yang, B; Sanchez-Sanchez, C; Liu, J; Dienel, T; Talirz, L; Shinde, P; Pignedoli, CA; Passerone, D; Dumslaff, T; Feng, XL; Mullen, K; Fasel, R				Ruffieux, Pascal; Wang, Shiyong; Yang, Bo; Sanchez-Sanchez, Carlos; Liu, Jia; Dienel, Thomas; Talirz, Leopold; Shinde, Prashant; Pignedoli, Carlo A.; Passerone, Daniele; Dumslaff, Tim; Feng, Xinliang; Muellen, Klaus; Fasel, Roman			On-surface synthesis of graphene nanoribbons with zigzag edge topology	NATURE			English	Article							ATOMIC-FORCE MICROSCOPY; BAND-GAP; RIBBONS; HETEROJUNCTIONS; STATE	Graphene-based nanostructures exhibit electronic properties that are not present in extended graphene. For example, quantum confinement in carbon nanotubes and armchair graphene nanoribbons leads to the opening of substantial electronic bandgaps that are directly linked to their structural boundary conditions(1,2). Nanostructures with zigzag edges are expected to host spin-polarized electronic edge states and can thus serve as key elements for graphene-based spintronics(3). The edge states of zigzag graphene nanoribbons (ZGNRs) are predicted to couple ferromagnetically along the edge and antiferromagnetically between the edges(4), but direct observation of spin-polarized edge states for zigzag edge topologies-including ZGNRs-has not yet been achieved owing to the limited precision of current top-down approaches(5-10). Here we describe the bottom-up synthesis of ZGNRs through surface-assisted polymerization and cyclodehydrogenation of specifically designed precursor monomers to yield atomically precise zigzag edges. Using scanning tunnelling spectroscopy we show the existence of edge-localized states with large energy splittings. We expect that the availability of ZGNRs will enable the characterization of their predicted spin-related properties, such as spin confinement(11) and filtering(12,13), and will ultimately add the spin degree of freedom to graphene-based circuitry.	[Ruffieux, Pascal; Wang, Shiyong; Sanchez-Sanchez, Carlos; Liu, Jia; Dienel, Thomas; Talirz, Leopold; Shinde, Prashant; Pignedoli, Carlo A.; Passerone, Daniele; Fasel, Roman] Empa, Swiss Fed Labs Mat Sci & Technol, CH-8600 Dubendorf, Switzerland; [Yang, Bo; Dumslaff, Tim; Muellen, Klaus] Max Planck Inst Polymer Res, D-55128 Mainz, Germany; [Pignedoli, Carlo A.] Empa, Swiss Fed Labs Mat Sci & Technol, NCCR MARVEL, CH-8600 Dubendorf, Switzerland; [Feng, Xinliang] Tech Univ Dresden, Ctr Adv Elect Dresden, D-01062 Dresden, Germany; [Feng, Xinliang] Tech Univ Dresden, Dept Chem & Food Chem, D-01062 Dresden, Germany; [Fasel, Roman] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Max Planck Society; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Technische Universitat Dresden; Technische Universitat Dresden; University of Bern	Fasel, R (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, CH-8600 Dubendorf, Switzerland.; Mullen, K (corresponding author), Max Planck Inst Polymer Res, D-55128 Mainz, Germany.; Fasel, R (corresponding author), Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland.	muellen@mpip-mainz.mpg.de; roman.fasel@empa.ch	sanchez, carlos/HDO-1962-2022; Passerone, Daniele/C-2494-2011; Ruffieux, Pascal/E-8227-2010; Shinde, Prashant/M-5310-2016; Fasel, Roman/B-5396-2011; pignedoli, carlo antonio/J-9732-2014; Dienel, Thomas/F-2356-2010; Fasel, Roman/M-9992-2019; SANCHEZ, CARLOS SANCHEZ/M-2767-2014	Ruffieux, Pascal/0000-0001-5729-5354; Shinde, Prashant/0000-0002-7307-8197; Fasel, Roman/0000-0002-1553-6487; Dienel, Thomas/0000-0001-8146-8841; Fasel, Roman/0000-0002-1553-6487; SANCHEZ, CARLOS SANCHEZ/0000-0001-8644-3766; Passerone, Daniele/0000-0001-5690-9000; Talirz, Leopold/0000-0002-1524-5903; Feng, Xinliang/0000-0003-3885-2703; Pignedoli, Carlo Antonio/0000-0002-8273-6390; wang, shiyong/0000-0001-6603-9926	Swiss National Science Foundation; Office of Naval Research BRC Program; European Research Council; DFG Priority Program SPP 1459; Graphene Flagship [CNECT-ICT-604391]; European Union; Swiss Supercomputing Center (CSCS) [s507]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Office of Naval Research BRC Program(Office of Naval Research); European Research Council(European Research Council (ERC)European Commission); DFG Priority Program SPP 1459; Graphene Flagship; European Union(European Commission); Swiss Supercomputing Center (CSCS)	This work was supported by the Swiss National Science Foundation, the Office of Naval Research BRC Program, the European Research Council (grant NANOGRAPH), the DFG Priority Program SPP 1459, the Graphene Flagship (No. CNECT-ICT-604391), and the European Union Projects UPGRADE, GENIUS and MoQuaS. We acknowledge the Swiss Supercomputing Center (CSCS) for computational resources (project s507). We thank A. Ferretti for his contribution to this project and O. Groning for discussions.	Bartels L, 1998, PHYS REV LETT, V80, P2004, DOI 10.1103/PhysRevLett.80.2004; Bronner C, 2013, ANGEW CHEM INT EDIT, V52, P4422, DOI 10.1002/anie.201209735; Cai JM, 2014, NAT NANOTECHNOL, V9, P896, DOI [10.1038/NNANO.2014.184, 10.1038/nnano.2014.184]; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Chen YC, 2015, NAT NANOTECHNOL, V10, P156, DOI [10.1038/NNANO.2014.307, 10.1038/nnano.2014.307]; Chen YC, 2013, ACS NANO, V7, P6123, DOI 10.1021/nn401948e; Dutta S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00519; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; GODBY RW, 1989, PHYS REV LETT, V62, P1169, DOI 10.1103/PhysRevLett.62.1169; Goedecker S, 1996, PHYS REV B, V54, P1703, DOI 10.1103/PhysRevB.54.1703; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Han W, 2014, NAT NANOTECHNOL, V9, P794, DOI [10.1038/nnano.2014.214, 10.1038/NNANO.2014.214]; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Li YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5311; Li YF, 2013, SCI REP-UK, V3, DOI 10.1038/srep02030; Li Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216804; Ma L, 2013, CHEMPHYSCHEM, V14, P47, DOI 10.1002/cphc.201200253; Magda GZ, 2014, NATURE, V514, P608, DOI 10.1038/nature13831; Marini A, 2009, COMPUT PHYS COMMUN, V180, P1392, DOI 10.1016/j.cpc.2009.02.003; Nakada K, 1996, PHYS REV B, V54, P17954, DOI 10.1103/PhysRevB.54.17954; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Repp J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026803; Ritter KA, 2009, NAT MATER, V8, P235, DOI [10.1038/NMAT2378, 10.1038/nmat2378]; Rozzi CA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205119; SAITO R, 1992, PHYS REV B, V46, P1804, DOI 10.1103/PhysRevB.46.1804; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Tao CG, 2011, NAT PHYS, V7, P616, DOI [10.1038/NPHYS1991, 10.1038/nphys1991]; Topsakal M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2919525; van der Lit J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3023; VandeVondele J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770708; Wakabayashi K, 1999, PHYS REV B, V59, P8271, DOI 10.1103/PhysRevB.59.8271; Wang XR, 2010, NAT CHEM, V2, P661, DOI [10.1038/nchem.719, 10.1038/NCHEM.719]; Wimmer M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.177207; Yang L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.186801; Yang L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.186401; Yazyev OV, 2013, ACCOUNTS CHEM RES, V46, P2319, DOI 10.1021/ar3001487; Zhang HM, 2015, J AM CHEM SOC, V137, P4022, DOI 10.1021/ja511995r	40	481	489	35	1020	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					489	+		10.1038/nature17151	http://dx.doi.org/10.1038/nature17151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	27008967	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000372701300037
J	Cherkin, DC; Sherman, KJ; Balderson, BH; Cook, AJ; Anderson, ML; Hawkes, RJ; Hansen, KE; Turner, JA				Cherkin, Daniel C.; Sherman, Karen J.; Balderson, Benjamin H.; Cook, Andrea J.; Anderson, Melissa L.; Hawkes, Rene J.; Hansen, Kelly E.; Turner, Judith A.			Effect of Mindfulness-Based Stress Reduction vs Cognitive Behavioral Therapy or Usual Care on Back Pain and Functional Limitations in Adults With Chronic Low Back Pain A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERVENTIONS; YOGA	IMPORTANCE Mindfulness-based stress reduction (MBSR) has not been rigorously evaluated for young and middle-aged adults with chronic low back pain. OBJECTIVE To evaluate the effectiveness for chronic low back pain of MBSR vs cognitive behavioral therapy (CBT) or usual care. DESIGN, SETTING, AND PARTICIPANTS Randomized, interviewer-blind, clinical trial in an integrated health care system in Washington State of 342 adults aged 20 to 70 years with chronic low back pain enrolled between September 2012 and April 2014 and randomly assigned to receive MBSR (n = 116), CBT (n = 113), or usual care (n = 113). INTERVENTIONS CBT (training to change pain-related thoughts and behaviors) and MBSR (training in mindfulness meditation and yoga) were delivered in 8 weekly 2-hour groups. Usual care included whatever care participants received. MAIN OUTCOMES AND MEASURES Coprimary outcomes were the percentages of participants with clinically meaningful (>= 30%) improvement from baseline in functional limitations (modified Roland Disability Questionnaire [RDQ]; range, 0-23) and in self-reported back pain bothersomeness (scale, 0-10) at 26weeks. Outcomes were also assessed at 4, 8, and 52 weeks. RESULTS There were 342 randomized participants, the mean (SD) [range] age was 49.3 (12.3) [20-70] years, 224 (65.7%) were women, mean duration of back pain was 7.3 years (range, 3 months-50 years), 123 (53.7%) attended 6 or more of the 8 sessions, 294 (86.0%) completed the study at 26 weeks, and 290 (84.8%) completed the study at 52 weeks. In intent-to-treat analyses at 26 weeks, the percentage of participants with clinically meaningful improvement on the RDQ was higher for those who received MBSR (60.5%) and CBT (57.7%) than for usual care (44.1%) (overall P =.04; relative risk [RR] for MBSR vs usual care, 1.37 [95% CI, 1.06-1.77]; RR for MBSR vs CBT, 0.95 [95% CI, 0.77-1.18]; and RR for CBT vs usual care, 1.31 [95% CI, 1.01-1.69]). The percentage of participants with clinically meaningful improvement in pain bothersomeness at 26 weeks was 43.6% in the MBSR group and 44.9% in the CBT group, vs 26.6% in the usual care group (overall P =.01; RR for MBSR vs usual care, 1.64 [95% CI, 1.15-2.34]; RR for MBSR vs CBT, 1.03 [95% CI, 0.78-1.36]; and RR for CBT vs usual care, 1.69 [95% CI, 1.18-2.41]). Findings for MBSR persisted with little change at 52 weeks for both primary outcomes. CONCLUSIONS AND RELEVANCE Among adults with chronic low back pain, treatment with MBSR or CBT, compared with usual care, resulted in greater improvement in back pain and functional limitations at 26 weeks, with no significant differences in outcomes between MBSR and CBT. These findings suggest that MBSR may be an effective treatment option for patients with chronic low back pain.	[Cherkin, Daniel C.; Sherman, Karen J.; Balderson, Benjamin H.; Cook, Andrea J.; Anderson, Melissa L.; Hawkes, Rene J.; Hansen, Kelly E.] Grp Hlth Res Inst, 1730 Minor Ave,Ste 1600, Seattle, WA 98101 USA; [Cherkin, Daniel C.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Cherkin, Daniel C.] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Sherman, Karen J.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Cook, Andrea J.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Turner, Judith A.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Turner, Judith A.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cherkin, DC (corresponding author), Grp Hlth Res Inst, 1730 Minor Ave,Ste 1600, Seattle, WA 98101 USA.	cherkin.d@ghc.org			National Center for Complementary and Integrative Health (NICCIH) of the National Institutes of Health (NIH) [R01AT006226]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT006226] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health (NICCIH) of the National Institutes of Health (NIH); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Research reported in this article was supported by the National Center for Complementary and Integrative Health (NICCIH) of the National Institutes of Health (NIH) under award number R01AT006226.	Blacker M., 2009, STRESS REDUCTION CLI; Cherkin DC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-211; Cherkin DC, 2011, ANN INTERN MED, V155, P1, DOI 10.7326/0003-4819-155-1-201107050-00002; Cherkin DC, 2009, ARCH INTERN MED, V169, P858, DOI 10.1001/archinternmed.2009.65; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Cramer H, 2013, CLIN J PAIN, V29, P450, DOI 10.1097/AJP.0b013e31825e1492; Cramer H, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-162; Ehde DM, 2014, AM PSYCHOL, V69, P153, DOI 10.1037/a0035747; Fjorback LO, 2011, ACTA PSYCHIAT SCAND, V124, P102, DOI 10.1111/j.1600-0447.2011.01704.x; Guy W., 1976, EARLY CLIN DRUG EVAL; Henschke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub3; Kabat-Zinn J., 2013, FULL CATASTROPHE LIV; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lamb SE, 2012, PAIN, V153, P494, DOI 10.1016/j.pain.2011.11.016; Lamb SE, 2010, LANCET, V375, P916, DOI 10.1016/S0140-6736(09)62164-4; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mafi JN, 2013, JAMA INTERN MED, V173, P1573, DOI 10.1001/jamainternmed.2013.8992; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Moreno S, 2013, PSYCHOSOM MED, V75, P600, DOI 10.1097/PSY.0b013e31829a8904; Morone NE, 2016, JAMA INTERN MED, V176, P329, DOI 10.1001/jamainternmed.2015.8033; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Otis J. D., 2007, MANAGING CHRONIC PAI; PATRICK DL, 1995, SPINE, V20, P1899, DOI 10.1097/00007632-199509000-00011; R Core Team, R LANG ENV STAT COMP; Reiner K, 2013, PAIN MED, V14, P230, DOI 10.1111/pme.12006; Richmond H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134192; Roland M, 2000, SPINE, V25, P3115, DOI 10.1097/00007632-200012150-00006; Sherman KJ, 2011, ARCH INTERN MED, V171, P2019, DOI 10.1001/archinternmed.2011.524; Skapinakis Petros, 2007, Evid Based Med, V12, P149, DOI 10.1136/ebm.12.5.149; Turk DC, 2005, PAIN SURVIVAL GUIDE; Turner JA., 2001, BONICAS MANAGEMENT P, P1751; Veehof MM, 2011, PAIN, V152, P533, DOI 10.1016/j.pain.2010.11.002; Von Korff M, 2005, PAIN, V113, P323, DOI 10.1016/j.pain.2004.11.007; von Korff M., 2011, HDB PAIN ASSESSMENT, V3rd ed., P455; Wang ML, 2006, BIOMETRICAL J, V48, P302, DOI 10.1002/bimj.200510188; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Williams ACD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub3; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	328	338	12	161	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1240	1249		10.1001/jama.2016.2323	http://dx.doi.org/10.1001/jama.2016.2323			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DH0YQ	27002445	Green Accepted, Bronze			2022-12-28	WOS:000372511100010
J	Dreischulte, T; Donnan, P; Grant, A; Hapca, A; McCowan, C; Guthrie, B				Dreischulte, Tobias; Donnan, Peter; Grant, Aileen; Hapca, Adrian; McCowan, Colin; Guthrie, Bruce			Safer Prescribing - A Trial of Education, Informatics, and Financial Incentives	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADVERSE DRUG EVENTS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PRIMARY-CARE; HOSPITAL ADMISSIONS; RISK; PERFORMANCE; MULTICENTER; INHIBITORS; DESIGN; PAY	BACKGROUND High-risk prescribing and preventable drug-related complications are common in primary care. We evaluated whether the rates of high-risk prescribing by primary care clinicians and the related clinical outcomes would be reduced by a complex intervention. METHODS In this cluster-randomized, stepped-wedge trial conducted in Tayside, Scotland, we randomly assigned participating primary care practices to various start dates for a 48-week intervention comprising professional education, informatics to facilitate review, and financial incentives for practices to review patients' charts to assess appropriateness. The primary outcome was patient-level exposure to any of nine measures of high-risk prescribing of nonsteroidal antiinflammatory drugs (NSAIDs) or selected antiplatelet agents (e.g., NSAID prescription in a patient with chronic kidney disease or coprescription of an NSAID and an oral anticoagulant without gastroprotection). Prespecified secondary outcomes included the incidence of related hospital admissions. Analyses were performed according to the intention-to-treat principle, with the use of mixed-effect models to account for clustering in the data. RESULTS A total of 34 practices underwent randomization, 33 of which completed the study. Data were analyzed for 33,334 patients at risk at one or more points in the preintervention period and for 33,060 at risk at one or more points in the intervention period. Targeted high-risk prescribing was significantly reduced, from a rate of 3.7% (1102 of 29,537 patients at risk) immediately before the intervention to 2.2% (674 of 30,187) at the end of the intervention (adjusted odds ratio, 0.63; 95% confidence interval [CI], 0.57 to 0.68; P<0.001). The rate of hospital admissions for gastrointestinal ulcer or bleeding was significantly reduced from the preintervention period to the intervention period (from 55.7 to 37.0 admissions per 10,000 person-years; rate ratio, 0.66; 95% CI, 0.51 to 0.86; P=0.002), as was the rate of admissions for heart failure (from 707.7 to 513.5 admissions per 10,000 person-years; rate ratio, 0.73; 95% CI, 0.56 to 0.95; P=0.02), but admissions for acute kidney injury were not (101.9 and 86.0 admissions per 10,000 person-years, respectively; rate ratio, 0.84; 95% CI, 0.68 to 1.09; P=0.19). CONCLUSIONS A complex intervention combining professional education, informatics, and financial incentives reduced the rate of high-risk prescribing of antiplatelet medications and NSAIDs and may have improved clinical outcomes.	[Dreischulte, Tobias] Univ Dundee, NHS Tayside, Med Governance Unit, Dundee, Scotland; [Donnan, Peter; Hapca, Adrian; Guthrie, Bruce] Univ Dundee, Populat Hlth Sci Div, Dundee, Scotland; [Grant, Aileen] Univ Stirling, Sch Hlth Sci, Stirling FK9 4LA, Scotland; [McCowan, Colin] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland	University of Dundee; University of Dundee; University of Stirling; University of Glasgow	Guthrie, B (corresponding author), Univ Dundee, Mackenzie Bldg,Kirsty Semple Way, Dundee DD2 4BF, Scotland.	b.guthrie@dundee.ac.uk	Guthrie, Bruce/HHM-9696-2022; Grant, Aileen M/J-4839-2018; Dreischulte, Tobias/E-6686-2012	McCowan, Colin/0000-0002-9466-833X; Guthrie, Bruce/0000-0003-4191-4880; Grant, Aileen/0000-0001-6146-101X; Donnan, Peter/0000-0001-7828-0610	Scottish Government Chief Scientist Office; Chief Scientist Office [ARPG/07/02] Funding Source: researchfish	Scottish Government Chief Scientist Office; Chief Scientist Office	Funded by the Scottish Government Chief Scientist Office; ClinicalTrials.gov number, NCT01425502.	Aspden P, 2007, QUALITY CHASM SERIES; Australian Childrens Education and Care Quality Authority, 2022, NQF SNAPSH STAT SECT; Avery AJ, 2012, LANCET, V379, P1310, DOI 10.1016/S0140-6736(11)61817-5; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Crabtree BF, 2011, MED CARE, V49, pS28, DOI 10.1097/MLR.0b013e3181cad65c; Cribb A, 1997, HEALTH CARE ANAL, V5, P292, DOI 10.1002/(SICI)1099-1042(199712)5:4<292::AID-HCA238>3.0.CO;2-J; Davidoff AJ, 2015, J AM GERIATR SOC, V63, P486, DOI 10.1111/jgs.13320; Dreischulte T, 2015, KIDNEY INT, V88, P396, DOI 10.1038/ki.2015.101; Dreischulte T, 2012, THER ADV DRUG SAF, V3, P175, DOI 10.1177/2042098612444867; Dreischulte T, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-24; Dreischulte Tobias, 2012, BMC Clin Pharmacol, V12, P5, DOI 10.1186/1472-6904-12-5; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gislason GH, 2009, ARCH INTERN MED, V169, P141, DOI 10.1001/archinternmed.2008.525; Gooch K, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.02.015; Grant AM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004153; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Guthrie B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3514; Hakkarainen KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033236; Hallas J, 2006, BMJ-BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Harrison MJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6423; Hawkey CJ, 2003, GUT, V52, P600, DOI 10.1136/gut.52.4.600; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Huerta C, 2005, AM J KIDNEY DIS, V45, P531, DOI 10.1053/j.ajkd.2004.12.005; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; IMS Institute for Health Care Informatics, 2013, AV COSTS US HEALTHC; Leendertse AJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-4; Martin DO, 1996, EPIDEMIOLOGY, V7, P29, DOI 10.1097/00001648-199601000-00006; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Purdy S, 2009, PUBLIC HEALTH, V123, P169, DOI 10.1016/j.puhe.2008.11.001; Roland M, 2014, NEW ENGL J MED, V370, P1944, DOI 10.1056/NEJMhpr1316051; Thomsen LA, 2007, ANN PHARMACOTHER, V41, P1411, DOI 10.1345/aph.1H658; Zhang YT, 2010, NEW ENGL J MED, V363, P1985, DOI 10.1056/NEJMp1010220	35	92	93	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1053	1064		10.1056/NEJMsa1508955	http://dx.doi.org/10.1056/NEJMsa1508955			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG4TR	26981935	Green Published, Green Accepted			2022-12-28	WOS:000372066100009
J	Mayor, S				Mayor, Susan			Cervical pessary does not prevent preterm births, study shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Nicolaides KH, 2016, NEW ENGL J MED, V374, P1044, DOI 10.1056/NEJMoa1511014	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2016	352								i1597	10.1136/bmj.i1597	http://dx.doi.org/10.1136/bmj.i1597			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AD	26989209				2022-12-28	WOS:000372585400009
J	Nicolaides, KH; Syngelaki, A; Poon, LC; Picciarelli, G; Tul, N; Zamprakou, A; Skyfta, E; Parra-Cordero, M; Palma-Dias, R; Calvo, JR				Nicolaides, Kypros H.; Syngelaki, Argyro; Poon, Liona C.; Picciarelli, Gemma; Tul, Natasa; Zamprakou, Aikaterini; Skyfta, Evdoxia; Parra-Cordero, Mauro; Palma-Dias, Ricardo; Calvo, Jesus Rodriguez			A Randomized Trial of a Cervical Pessary to Prevent Preterm Singleton Birth	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VAGINAL PROGESTERONE; DOUBLE-BLIND; WOMEN; LENGTH; RISK; MORTALITY; CERCLAGE	BACKGROUND Preterm birth is the leading cause of neonatal and infant death and of disability among survivors. It is unclear whether a pessary inserted around the cervix reduces the risk of preterm singleton birth. METHODS We conducted a multicenter, randomized, controlled trial comparing pessary placement with expectant management (control) in girls and women who were pregnant with singletons (singleton pregnancies) and who had a cervical length of 25 mm or less at 20 weeks 0 days to 24 weeks 6 days of gestation. Participants in either group who had a cervical length of 15 mm or less, at randomization or at subsequent visits, received treatment with vaginal progesterone. The primary outcome was spontaneous delivery before 34 weeks of gestation. RESULTS In an intention-to-treat analysis, there was no significant difference between the pessary group (465 participants) and the control group (467 participants) in the rate of spontaneous delivery before 34 weeks (12.0% and 10.8%, respectively; odds ratio in the pessary group, 1.12; 95% confidence interval, 0.75 to 1.69; P = 0.57). There were no significant differences in the rates of perinatal death (3.2% in the pessary group and 2.4% in the control group, P = 0.42), adverse neonatal outcome (6.7% and 5.7%, respectively; P = 0.55), or neonatal special care (11.6% and 12.9%, respectively; P = 0.59). The incidence of new or increased vaginal discharge was significantly higher in the pessary group than in the control group. CONCLUSIONS Among girls and women with singleton pregnancies who had a short cervix, a cervical pessary did not result in a lower rate of spontaneous early preterm delivery than the rate with expectant management.	[Nicolaides, Kypros H.; Syngelaki, Argyro; Poon, Liona C.; Zamprakou, Aikaterini; Skyfta, Evdoxia; Calvo, Jesus Rodriguez] Kings Coll London, Harris Birthright Res Ctr Fetal Med, Denmark Hill, London SE5 9RS, England; [Picciarelli, Gemma] Medway Maritime Hosp, Dept Fetal Med, Gillingham, Medway, England; [Tul, Natasa] Univ Med Ctr Ljubljana, Dept Perinatol, Ljubljana, Slovenia; [Parra-Cordero, Mauro] Univ Chile, Hosp Clin, Fetal Med Unit, Santiago, Chile; [Palma-Dias, Ricardo] Royal Womens Hosp, Pregnancy Res Ctr, Melbourne, Vic, Australia	University of London; King's College London; Medway Maritime Hospital; University Medical Centre Ljubljana; Universidad de Chile	Nicolaides, KH (corresponding author), Kings Coll London, Harris Birthright Res Ctr Fetal Med, Denmark Hill, London SE5 9RS, England.	kypros@fetalmedicine.com	Poon, Liona C./P-9311-2017; Parra-Cordero, Mauro/H-8367-2014	Poon, Liona C./0000-0002-3944-4130; Syngelaki, Argyro/0000-0001-5856-6072; Nicolaides, Kypros/0000-0003-1266-0711	Fetal Medicine Foundation	Fetal Medicine Foundation	Funded by the Fetal Medicine Foundation; Current Controlled Trials number, ISRCTN01096902.	Altman D.G., 1991, PRACTICAL STAT MED R; Arabin B, 2003, J PERINAT MED, V31, P122, DOI 10.1515/JPM.2003.017; Berghella V, 2005, OBSTET GYNECOL, V106, P181, DOI 10.1097/01.AOG.0000168435.17200.53; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Celik E, 2008, ULTRASOUND OBST GYN, V31, P549, DOI 10.1002/uog.5333; D'Onofrio BM, 2013, JAMA PSYCHIAT, V70, P1231, DOI 10.1001/jamapsychiatry.2013.2107; DeFranco EA, 2007, ULTRASOUND OBST GYN, V30, P697, DOI 10.1002/uog.5159; Dharan VB, 2009, SEMIN PERINATOL, V33, P338, DOI 10.1053/j.semperi.2009.06.008; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P312, DOI 10.1046/j.1469-0705.1998.12050312.x; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hui SYA, 2013, AM J PERINAT, V30, P283, DOI 10.1055/s-0032-1322550; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Kodjebacheva GD, 2015, J PUBLIC HLTH; Nicolaides KH, 2016, AM J OBSTET GYNECOL, V214, P302, DOI 10.1016/j.ajog.2015.09.107; Office for National Statistics, 2012, GEST SPEC INF MORT; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Sonek J, 1998, ULTRASOUND OBST GYN, V11, P71, DOI 10.1046/j.1469-0705.1998.11010071.x	23	104	111	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1044	1052		10.1056/NEJMoa1511014	http://dx.doi.org/10.1056/NEJMoa1511014			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4TR	26981934	Bronze			2022-12-28	WOS:000372066100008
J	Chatterjee, S				Chatterjee, Soumya			Neck Pain, Stiffness, and Periorbital Edema in a Man With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SCLEREDEMA		[Chatterjee, Soumya] Cleveland Clin, Dept Rheumat & Immunol Dis, 9500 Euclid Ave,Desk A50, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Chatterjee, S (corresponding author), Cleveland Clin, Dept Rheumat & Immunol Dis, 9500 Euclid Ave,Desk A50, Cleveland, OH 44195 USA.	chattes@ccf.org						Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Boin F, 2008, RHEUM DIS CLIN N AM, V34, P199, DOI 10.1016/j.rdc.2007.11.001; CARRINGTON PR, 1984, INT J DERMATOL, V23, P514, DOI 10.1111/j.1365-4362.1984.tb04202.x; Patterson JW, 2016, WEEDONS SKIN PATHOLO, P405; Tate B J, 1996, Australas J Dermatol, V37, P139, DOI 10.1111/j.1440-0960.1996.tb01032.x; VENENCIE PY, 1984, J AM ACAD DERMATOL, V11, P128, DOI 10.1016/S0190-9622(84)70146-0	6	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1159	1160		10.1001/jama.2016.1770	http://dx.doi.org/10.1001/jama.2016.1770			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978211				2022-12-28	WOS:000372159800021
J	Robb, MA; McInnes, PM; Califf, RM				Robb, Melissa A.; McInnes, Pamela M.; Califf, Robert M.			Biomarkers and Surrogate Endpoints Developing Common Terminology and Definitions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Robb, Melissa A.] US FDA, Off Med Policy, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave,White Oak,Bldg 51,Rm 6360, Silver Spring, MD 20993 USA; [McInnes, Pamela M.] NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA; [Califf, Robert M.] US FDA, Silver Spring, MD USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); US Food & Drug Administration (FDA)	Robb, MA (corresponding author), US FDA, Off Med Policy, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave,White Oak,Bldg 51,Rm 6360, Silver Spring, MD 20993 USA.	melissa.robb@fda.hhs.gov	Cerviño, Alejandro/L-5853-2014	Cerviño, Alejandro/0000-0001-8014-3279	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200319] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], FED REG; FDA-NIH Biomarker Working Group, BEST BIOM ENDPOINTS; Fiore LD, 2011, JAMA-J AM MED ASSOC, V306, P1914, DOI 10.1001/jama.2011.1605; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; US FDA, 2013, MED DEV DEV TOOLS DR; US Food and Drug Administration. Center for Drug Evaluation and Research, 2014, GUID IND FDA STAFF Q	6	75	75	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1107	1108		10.1001/jama.2016.2240	http://dx.doi.org/10.1001/jama.2016.2240			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978201				2022-12-28	WOS:000372159800011
J	Weed, HG				Weed, Harrison G.			Review: Peripheral thermometers do not have clinically acceptable accuracy for measuring core body temperature	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Weed, Harrison G.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Weed, HG (corresponding author), Ohio State Univ, Coll Med, Columbus, OH 43210 USA.							Mackowiak PA, 1998, ARCH INTERN MED, V158, P1870, DOI 10.1001/archinte.158.17.1870	1	0	0	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					JC32	JC32		10.7326/ACPJC-2016-164-6-032	http://dx.doi.org/10.7326/ACPJC-2016-164-6-032			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26974732				2022-12-28	WOS:000372207200007
J	De las Cuevas, G; Cubitt, TS				De las Cuevas, Gemma; Cubitt, Toby S.			Simple universal models capture all classical spin physics	SCIENCE			English	Article							COMPUTATIONAL-COMPLEXITY; STATISTICAL-MECHANICS	Spin models are used in many studies of complex systems because they exhibit rich macroscopic behavior despite their microscopic simplicity. Here, we prove that all the physics of every classical spin model is reproduced in the low-energy sector of certain "universal models," with at most polynomial overhead. This holds for classical models with discrete or continuous degrees of freedom. We prove necessary and sufficient conditions for a spin model to be universal and show that one of the simplest and most widely studied spin models, the two-dimensional Ising model with fields, is universal. Our results may facilitate physical simulations of Hamiltonians with complex interactions.	[De las Cuevas, Gemma] Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany; [Cubitt, Toby S.] UCL, Dept Comp Sci, Gower St, London WC1E 6EA, England	Max Planck Society; University of London; University College London	De las Cuevas, G (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	gemma.delascuevas@mpq.mpg.de	De las Cuevas, Gemma/AAB-4853-2019	De las Cuevas, Gemma/0000-0002-0977-7727; Cubitt, Toby/0000-0002-5087-9346	Alexander von Humboldt foundation; Simulators and Interfaces with Quantum Systems (SIQS); Royal Society; John Templeton Foundation [48322]	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); Simulators and Interfaces with Quantum Systems (SIQS); Royal Society(Royal Society of London); John Templeton Foundation	We thank D. Perez-Garcia, W. Dur, and M. Van den Nest for discussions. G.D.L.C. acknowledges support from the Alexander von Humboldt foundation and Simulators and Interfaces with Quantum Systems (SIQS). T.S.C. is supported by the Royal Society. This work was made possible through the support of grant 48322 from the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. The authors declare no competing financial interests.	Ambjorn JA, 2009, NUCL PHYS B, V807, P251, DOI 10.1016/j.nuclphysb.2008.08.030; BARAHONA F, 1982, J PHYS A-MATH GEN, V15, P3241, DOI 10.1088/0305-4470/15/10/028; Baxter RJ, 1982, EXACTLY SOLVABLE MOD; Binder K., 2005, GLASSY MAT DISORDERE; Bollobas B., 1998, MODERN GRAPH THEORY; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Childs AM, 2014, LECT NOTES COMPUT SC, V8572, P308; Creignou N, 1995, J COMPUT SYST SCI, V51, P511, DOI 10.1006/jcss.1995.1087; De las Cuevas G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.230502; De las Cuevas G, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/24/243001; De las Cuevas G, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07001; Diep HT, 2005, FRUSTRATED SPIN SYSTEMS, P1, DOI 10.1142/9789812567819; Durlauf SN, 1999, P NATL ACAD SCI USA, V96, P10582, DOI 10.1073/pnas.96.19.10582; Garey M.R., 1979, COMPUTERS INTRACTABI; Gottesman D, 2009, ANN IEEE SYMP FOUND, P95, DOI 10.1109/FOCS.2009.22; Gu M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011116; Karimipour V, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.052303; Karimipour V, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.032316; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Nishimori H., 2001, STAT PHYS SPIN GLASS; Nishimori H., 2011, ELEMENTS PHASE TRANS, DOI [10.1093/acprof:oso/9780199577224.001.0001, DOI 10.1093/ACPROF:OSO/9780199577224.001.0001]; Rojas R., 1996, NEURAL NETWORKS SYST, DOI [10.1007/978-3-642-61068-4{\_}7, DOI 10.1007/978-3-642-61068-4]; Schaefer T., 1978, STOC, P216, DOI DOI 10.1145/800133.804350; Schuch N, 2009, NAT PHYS, V5, P732, DOI 10.1038/NPHYS1370; Trabesinger A, 2012, NAT PHYS, V8, P263, DOI 10.1038/nphys2258; Van den Nest M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.110501; Xu Y, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/02/P02013	27	58	58	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1180	1183		10.1126/science.aab3326	http://dx.doi.org/10.1126/science.aab3326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965624	Green Submitted			2022-12-28	WOS:000386158400041
J	Wehner, S				Wehner, Stephanie			To see the world in a grain of spins	SCIENCE			English	Editorial Material									[Wehner, Stephanie] Delft Univ Technol, QuTech, NL-2628 CJ Delft, Netherlands	Delft University of Technology	Wehner, S (corresponding author), Delft Univ Technol, QuTech, NL-2628 CJ Delft, Netherlands.	s.d.c.wehner@tudelft.nl						Arora S, 2009, COMPUTATIONAL COMPLEXITY: A MODERN APPROACH, P1, DOI 10.1017/CBO9780511804090; De las Cuevas G, 2016, SCIENCE, V351, P1180, DOI 10.1126/science.aab3326; Kadanof L. P., 1993, WORLD SCI SERIES NON; McCoy B.M., 2014, 2 DIMENSIONAL ISING, V2nd	4	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1156	1156		10.1126/science.aaf0748	http://dx.doi.org/10.1126/science.aaf0748			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965615				2022-12-28	WOS:000386158400029
J	Shamir, M; Bar-On, Y; Phillips, R; Milo, R				Shamir, Maya; Bar-On, Yinon; Phillips, Rob; Milo, Ron			SnapShot: Timescales in Cell Biology	CELL			English	Editorial Material									[Shamir, Maya; Bar-On, Yinon; Milo, Ron] Weizmann Inst Sci, IL-7610001 Rehovot, Israel; [Phillips, Rob] CALTECH, Pasadena, CA 91125 USA	Weizmann Institute of Science; California Institute of Technology	Shamir, M (corresponding author), Weizmann Inst Sci, IL-7610001 Rehovot, Israel.			Milo, Ron/0000-0003-1641-2299; Voichek, Maya/0000-0002-0508-0682; Bar-On, Yinon/0000-0001-8477-609X				Alon U., 2006, INTRO SYSTEMS BIOL D; Milo R., 2016, CELL BIOL NUMBERS GA; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Phillips R., 2013, GARLAND SCI	4	103	104	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1302	U235		10.1016/j.cell.2016.02.058	http://dx.doi.org/10.1016/j.cell.2016.02.058			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967295	Bronze			2022-12-28	WOS:000372784900026
J	Jain, A; Cifu, AS				Jain, Atul; Cifu, Adam S.			Prevention, Diagnosis, and Treatment of Postthrombotic Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPRESSION		[Jain, Atul] Mayo Clin, Div Consultat Med, Scottsdale, AZ USA; [Jain, Atul] Mayo Clin, Div Prevent Occupat & Aerosp Med, Scottsdale, AZ USA; [Cifu, Adam S.] Univ Chicago, Gen Internal Med Sect, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; University of Chicago	Cifu, AS (corresponding author), Univ Chicago, Gen Internal Med Sect, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Barwell JR, 2004, LANCET, V363, P1854, DOI 10.1016/S0140-6736(04)16353-8; Cohen JM, 2012, CHEST, V141, P308, DOI 10.1378/chest.11-1175; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Enden T, 2012, LANCET, V379, P31, DOI 10.1016/S0140-6736(11)61753-4; Fox MA, 2008, J VASC INTERV RADIOL, V19, P981, DOI 10.1016/j.jvir.2008.03.022; Jull AB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001733.pub3; Kahn SR, 2014, CIRCULATION, V130, P1636, DOI 10.1161/CIR.0000000000000130; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; O'Meara S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000265.pub3	9	5	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					1048	1049		10.1001/jama.2016.0225	http://dx.doi.org/10.1001/jama.2016.0225			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26954414				2022-12-28	WOS:000371540200018
J	Liao, JM; Navathe, AS				Liao, Joshua M.; Navathe, Amol S.			The art of medicine Paying for performance: money, motivation, and uncertainty	LANCET			English	Editorial Material									[Liao, Joshua M.; Navathe, Amol S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19146 USA	University of Pennsylvania	Liao, JM (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19146 USA.	joshliao@upenn.edu		Navathe, Amol/0000-0001-7182-4988	NIA NIH HHS [P30 AG034546] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Roland M, 2014, NEW ENGL J MED, V370, P1944, DOI 10.1056/NEJMhpr1316051; Saint-Lary O, 2012, J MED ETHICS, V38, P485, DOI 10.1136/medethics-2011-100159; Welch H, 2011, OVERDIAGNOSED MAKING; [No title captured]	4	1	1	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					936	937		10.1016/S0140-6736(16)00574-2	http://dx.doi.org/10.1016/S0140-6736(16)00574-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF8XP	26977482				2022-12-28	WOS:000371644200015
J	Lazear, HM; Stringer, EM; de Silva, AM				Lazear, Helen M.; Stringer, Elizabeth M.; de Silva, Aravinda M.			The Emerging Zika Virus Epidemic in the Americas Research Priorities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lazear, Helen M.; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Stringer, Elizabeth M.] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Chapel Hill, NC USA; [Stringer, Elizabeth M.; de Silva, Aravinda M.] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA; [Lazear, Helen M.] Univ N Carolina, Sch Med, 160 Dent Circle,9021 Burnett Womack Bldg, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lazear, HM (corresponding author), Univ N Carolina, Sch Med, 160 Dent Circle,9021 Burnett Womack Bldg, Chapel Hill, NC 27599 USA.	helen.lazear@med.unc.edu	desilva, Aravinda/ABE-6260-2020	desilva, Aravinda/0000-0003-3317-5950				Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267; Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15; Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670; Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459	8	31	31	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2016	315	18					1945	1946		10.1001/jama.2016.2899	http://dx.doi.org/10.1001/jama.2016.2899			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL2JP	26963564	Bronze			2022-12-28	WOS:000375461100008
J	Mello, MM; Livingston, EH				Mello, Michelle M.; Livingston, Edward H.			Managing the Risks of Concurrent Surgeries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mello, Michelle M.] Stanford Univ, Stanford Law Sch, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Livingston, Edward H.] JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA; [Livingston, Edward H.] UT Southwestern Sch Med, Dept Surg, Dallas, TX USA; [Livingston, Edward H.] Northwestern Univ, Chicago, IL 60611 USA	Stanford University; Stanford University; Northwestern University	Livingston, EH (corresponding author), JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA.	edward.livingston@jamanetwork.org		Mello, Michelle/0000-0003-2877-4270				Abelson J., 2015, CLASH NAME CARE; Beasley GM, 2015, ANN SURG, V261, P1044, DOI 10.1097/SLA.0000000000001208; Centers for Medicare & Medicaid Services, CTR MED MED SERV PUB; Saltzman J., 2016, BOSTON GLOBE; Yount KW, 2015, 96 ANN AM ASS THOR S	5	46	46	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15					1563	1564		10.1001/jama.2016.2305	http://dx.doi.org/10.1001/jama.2016.2305			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5ZK	26985632				2022-12-28	WOS:000374289300010
J	Liu, Y; Chen, C; Xu, ZM; Scuoppo, C; Rillahan, CD; Gao, JJ; Spitzer, B; Bosbach, B; Kastenhuber, ER; Baslan, T; Ackermann, S; Cheng, LH; Wang, QG; Niu, T; Schultz, N; Levine, RL; Mills, AA; Lowe, SW				Liu, Yu; Chen, Chong; Xu, Zhengmin; Scuoppo, Claudio; Rillahan, Cory D.; Gao, Jianjiong; Spitzer, Barbara; Bosbach, Benedikt; Kastenhuber, Edward R.; Baslan, Timour; Ackermann, Sarah; Cheng, Lihua; Wang, Qingguo; Niu, Ting; Schultz, Nikolaus; Levine, Ross L.; Mills, Alea A.; Lowe, Scott W.			Deletions linked to TP53 loss drive cancer through p53-independent mechanisms	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR GENE; MOUSE MODELS; P53; EXPRESSION; MUTATIONS; SURVIVAL; MICE; INDUCTION; REVEALS	Mutations disabling the TP53 tumour suppressor gene represent the most frequent events in human cancer and typically occur through a two-hit mechanism involving a missense mutation in one allele and a 'loss of heterozygosity' deletion encompassing the other. While TP53 missense mutations can also contribute gain-of-function activities that impact tumour progression, it remains unclear whether the deletion event, which frequently includes many genes, impacts tumorigenesis beyond TP53 loss alone. Here we show that somatic heterozygous deletion of mouse chromosome 11B3, a 4-megabase region syntenic to human 17p13.1, produces a greater effect on lymphoma and leukaemia development than Trp53 deletion. Mechanistically, the effect of 11B3 loss on tumorigenesis involves co-deleted genes such as Eif5a and Alox15b (also known as Alox8), the suppression of which cooperates with Trp53 loss to produce more aggressive disease. Our results imply that the selective advantage produced by human chromosome 17p deletion reflects the combined impact of TP53 loss and the reduced dosage of linked tumour suppressor genes.	[Liu, Yu; Chen, Chong; Xu, Zhengmin] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu 610041, Peoples R China; [Liu, Yu; Chen, Chong; Xu, Zhengmin] Sichuan Univ, West China Hosp, Dept Liver Surg, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Liu, Yu; Chen, Chong; Xu, Zhengmin] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Peoples R China; [Liu, Yu; Chen, Chong; Xu, Zhengmin] Natl Collaborat Innovat Ctr, Chengdu 610041, Peoples R China; [Liu, Yu; Chen, Chong; Rillahan, Cory D.; Bosbach, Benedikt; Kastenhuber, Edward R.; Baslan, Timour; Ackermann, Sarah; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Scuoppo, Claudio] Columbia Univ, Inst Canc Genet, Med Ctr, New York, NY 10032 USA; [Gao, Jianjiong; Wang, Qingguo; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Kravis Ctr Mol Oncol, New York, NY 10065 USA; [Spitzer, Barbara] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Spitzer, Barbara] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Spitzer, Barbara; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10065 USA; [Cheng, Lihua; Niu, Ting] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu 610041, Peoples R China; [Cheng, Lihua; Niu, Ting] Sichuan Univ, West China Hosp, Res Lab Hematol, Chengdu 610041, Peoples R China; [Mills, Alea A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Sichuan University; Sichuan University; Sichuan University; Memorial Sloan Kettering Cancer Center; Columbia University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Sichuan University; Sichuan University; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA.; Lowe, SW (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	lowes@mskcc.org	Liu, Yu/X-5864-2019; Schultz, Nikolaus/ABE-6347-2020; Chen, Chong/AAR-4186-2021; levine, ross/AAE-7658-2019; Paulson, James/AAG-3565-2019; Gao, JianJiong/B-5673-2016	Chen, Chong/0000-0002-6787-0495; Gao, JianJiong/0000-0002-5739-1781; Spitzer, Barbara/0000-0003-1603-1381; Wang, Qingguo/0000-0002-5125-3724; Kastenhuber, Edward/0000-0002-1872-212X	National Cancer Institute; Center grant for Cancer Target Discovery and Development; Memorial Sloan Kettering Cancer Center Support Grant; American Association for Cancer Research Millennium Fellowship in Lymphoma Research; Thousand Young Talents Plan; National Natural Science Foundation of China [81522003, 81570150]; NATIONAL CANCER INSTITUTE [F31CA192835, R01CA190261, R01CA190997, P30CA045508, P01CA087497, P30CA008748, P30CA016042] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center grant for Cancer Target Discovery and Development; Memorial Sloan Kettering Cancer Center Support Grant; American Association for Cancer Research Millennium Fellowship in Lymphoma Research; Thousand Young Talents Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. P. Morris, L. Dow, D. Tschaharganeh, E. Manchado, T. Kitzing, E. Loizou and other Lowe laboratory members for their critical discussions and technical help, C. J. Sherr for invaluable advice, L. Dai and M. Tang for liquid chromatography-mass spectrometry support, and Y. Park and S. Kim for their help in constructing the 11B3 mouse model. This work was supported by a programme project and an R01 grant from the National Cancer Institute (S.W.L.), a Center grant for Cancer Target Discovery and Development (S.W.L.), and a Memorial Sloan Kettering Cancer Center Support Grant. Y.L. was supported by an American Association for Cancer Research Millennium Fellowship in Lymphoma Research. C. C. is supported by the Thousand Young Talents Plan and the National Natural Science Foundation of China (81522003, 81570150). S.W.L. is the Geoffrey Beene Chair for Cancer Biology and a Howard Hughes Medical Institute Investigator.	Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Ahn YH, 2011, MOL CELL BIOL, V31, P4270, DOI 10.1128/MCB.05562-11; Balatti V, 2015, P NATL ACAD SCI USA, V112, P2169, DOI 10.1073/pnas.1500010112; Baslan T, 2014, CURR OPIN GENET DEV, V26, P59, DOI 10.1016/j.gde.2014.06.004; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Brown T., 2001, CURR PROTOC PROT SCI, V13; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Chen WY, 2006, BLOOD, V107, P2477, DOI 10.1182/blood-2005-07-2950; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Chigrinova E, 2013, BLOOD, V122, P2673, DOI 10.1182/blood-2013-03-489518; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; El-Ghammaz AMS, 2015, CLIN EXP MED, V15, P493, DOI 10.1007/s10238-014-0317-2; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kelly GL, 2014, GENE DEV, V28, P58, DOI 10.1101/gad.232009.113; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Marino S, 2000, GENE DEV, V14, P994; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monti S, 2012, CANCER CELL, V22, P359, DOI 10.1016/j.ccr.2012.07.014; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Rubio-Moscardo F, 2005, BLOOD, V105, P4445, DOI 10.1182/blood-2004-10-3907; Ruckner FG, 2012, BLOOD, V119, P2114, DOI 10.1182/blood-2011-08-375758; Salaverria I, 2007, J CLIN ONCOL, V25, P1216, DOI 10.1200/JCO.2006.08.4251; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Tang DG, 1997, INT J CANCER, V72, P1078, DOI 10.1002/(SICI)1097-0215(19970917)72:6<1078::AID-IJC24>3.0.CO;2-#; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; Ye X, 2011, J PHARMACEUT BIOMED, V56, P366, DOI 10.1016/j.jpba.2011.05.031; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	55	147	149	13	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					471	+		10.1038/nature17157	http://dx.doi.org/10.1038/nature17157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26982726	Green Accepted			2022-12-28	WOS:000372701300033
J	Morreale, FE; Walden, H				Morreale, Francesca Ester; Walden, Helen			SnapShot: Types of Ubiquitin Ligases	CELL			English	Editorial Material							INSIGHTS		[Morreale, Francesca Ester; Walden, Helen] Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland	University of Dundee	Morreale, FE (corresponding author), Univ Dundee, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland.				Medical Research Council [MC_UU_12016/12] Funding Source: Medline; MRC [MC_UU_12016/12] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Vittal V, 2015, J BIOL CHEM, V290, P21244, DOI 10.1074/jbc.R115.675165; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	8	195	213	10	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					248	+		10.1016/j.cell.2016.03.003	http://dx.doi.org/10.1016/j.cell.2016.03.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015313	Bronze			2022-12-28	WOS:000372785600024
J	Aranson, IS				Aranson, Igor S.			MICROROBOTICS Swimmers by design	NATURE			English	Editorial Material									[Aranson, Igor S.] Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Aranson, IS (corresponding author), Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.	aronson@anl.gov						Camacho-Lopez M, 2004, NAT MATER, V3, P307, DOI 10.1038/nmat1118; Chang ST, 2007, NAT MATER, V6, P235, DOI 10.1038/nmat1843; Cheang UK, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-014-2737-z; Dreyfus R, 2005, NATURE, V437, P862, DOI 10.1038/nature04090; Gao W, 2011, J AM CHEM SOC, V133, P11862, DOI 10.1021/ja203773g; Ghosh A, 2009, NANO LETT, V9, P2243, DOI 10.1021/nl900186w; Katsu-Kimura Y, 2009, J EXP BIOL, V212, P1819, DOI 10.1242/jeb.028894; Medina-Sanchez M, 2016, NANO LETT, V16, P555, DOI 10.1021/acs.nanolett.5b04221; Palagi S., 2016, NATURE MAT; Paxton WF, 2004, J AM CHEM SOC, V126, P13424, DOI 10.1021/ja047697z; Sanchez S, 2011, J AM CHEM SOC, V133, P14860, DOI [10.1021/ja205012J, 10.1021/ja205012j]; Snezhko A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118103	13	9	9	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					312	313		10.1038/531312a	http://dx.doi.org/10.1038/531312a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26983536				2022-12-28	WOS:000372064300039
J	Chavalarias, D; Wallach, JD; Li, AHT; Ioannidis, JPA				Chavalarias, David; Wallach, Joshua David; Li, Alvin Ho Ting; Ioannidis, John P. A.			Evolution of Reporting P Values in the Biomedical Literature, 1990-2015	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE SIGNIFICANCE; PUBLICATION BIAS; MEDICAL STATISTICS; EFFECT SIZE; ABSTRACTS; TRIALS; FALSE	IMPORTANCE The use and misuse of P values has generated extensive debates. OBJECTIVE To evaluate in large scale the P values reported in the abstracts and full text of biomedical research articles over the past 25 years and determine how frequently statistical information is presented in ways other than P values. DESIGN Automated text-mining analysis was performed to extract data on P values reported in 12 821 790 MEDLINE abstracts and in 843 884 abstracts and full-text articles in PubMed Central (PMC) from 1990 to 2015. Reporting of P values in 151 English-language core clinical journals and specific article types as classified by PubMed also was evaluated. A random sample of 1000 MEDLINE abstracts was manually assessed for reporting of P values and other types of statistical information; of those abstracts reporting empirical data, 100 articles were also assessed in full text. MAIN OUTCOMES AND MEASURES P values reported. RESULTS Text mining identified 4 572 043 P values in 1 608 736 MEDLINE abstracts and 3 438 299 P values in 385 393 PMC full-text articles. Reporting of P values in abstracts increased from 7.3% in 1990 to 15.6% in 2014. In 2014, P values were reported in 33.0% of abstracts from the 151 core clinical journals (n = 29 725 abstracts), 35.7% of meta-analyses (n = 5620), 38.9% of clinical trials (n = 4624), 54.8% of randomized controlled trials (n = 13 544), and 2.4% of reviews (n = 71 529). The distribution of reported P values in abstracts and in full text showed strong clustering at P values of .05 and of .001 or smaller. Over time, the "best" (most statistically significant) reported P values were modestly smaller and the "worst" (least statistically significant) reported P values became modestly less significant. Among the MEDLINE abstracts and PMC full-text articles with P values, 96% reported at least 1 P value of .05 or lower, with the proportion remaining steady over time in PMC full-text articles. In 1000 abstracts that were manually reviewed, 796 were from articles reporting empirical data; P values were reported in 15.7%(125/796 [95% CI, 13.2%-18.4%]) of abstracts, confidence intervals in 2.3%(18/796 [95% CI, 1.3%-3.6%]), Bayes factors in 0% (0/796 [95% CI, 0%-0.5%]), effect sizes in 13.9%(111/796 [95% CI, 11.6%-16.5%]), other information that could lead to estimation of P values in 12.4%(99/796 [95% CI, 10.2%-14.9%]), and qualitative statements about significance in 18.1%(181/1000 [95% CI, 15.8%-20.6%]); only 1.8%(14/796 [95% CI, 1.0%-2.9%]) of abstracts reported at least 1 effect size and at least 1 confidence interval. Among 99 manually extracted full-text articles with data, 55 reported P values, 4 presented confidence intervals for all reported effect sizes, none used Bayesian methods, 1 used false-discovery rates, 3 used sample size/power calculations, and 5 specified the primary outcome. CONCLUSIONS AND RELEVANCE In this analysis of P values reported in MEDLINE abstracts and in PMC articles from 1990-2015, more MEDLINE abstracts and articles reported P values over time, almost all abstracts and articles with P values reported statistically significant results, and, in a subgroup analysis, few articles included confidence intervals, Bayes factors, or effect sizes. Rather than reporting isolated P values, articles should include effect sizes and uncertainty metrics.	[Chavalarias, David] EHESS CNRS UMR8557, CAMS, Paris, France; [Chavalarias, David] Complex Syst Inst Paris Ile de France ISC PIF, UPS3611, Paris, France; [Wallach, Joshua David] Stanford Univ, Dept Hlth Res, Stanford, CA 94305 USA; [Wallach, Joshua David] Stanford Univ, Dept Policy, Stanford, CA 94305 USA; [Wallach, Joshua David; Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METR, 1265 Welch Rd,MSOB X306, Stanford, CA 94305 USA; [Li, Alvin Ho Ting] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Ioannidis, John P. A.] Stanford Univ, Dept Med, 1265 Welch Rd,MSOB X306, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, 1265 Welch Rd,MSOB X306, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, 1265 Welch Rd,MSOB X306, Stanford, CA 94305 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Stanford University; Stanford University; Stanford University; Western University (University of Western Ontario); Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Meta Res Innovat Ctr Stanford METR, 1265 Welch Rd,MSOB X306, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Stanford Univ, Dept Med, 1265 Welch Rd,MSOB X306, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Stanford Univ, Dept Hlth Res & Policy, 1265 Welch Rd,MSOB X306, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Stanford Univ, Dept Stat, 1265 Welch Rd,MSOB X306, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011	Chavalarias, David/0000-0001-9485-1399; Wallach, Joshua/0000-0002-2816-6905	Laura and John Arnold Foundation; Complex Systems Institutes of Paris Ile-de-France (ISC-PIF); Region Ile-de-France; CNRS Mastodons program; Canadian Institute for Health Research; Michael Smith Foreign Study Supplement	Laura and John Arnold Foundation; Complex Systems Institutes of Paris Ile-de-France (ISC-PIF); Region Ile-de-France(Region Ile-de-France); CNRS Mastodons program; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foreign Study Supplement(Canadian Institutes of Health Research (CIHR)Social Sciences and Humanities Research Council of Canada (SSHRC)Natural Sciences and Engineering Research Council of Canada (NSERC))	The Meta-Research Innovation Center at Stanford (METRICS) is supported by a grant by the Laura and John Arnold Foundation. The work of Dr Chavalarias is supported by the Complex Systems Institutes of Paris Ile-de-France (ISC-PIF), the Region Ile-de-France and a grant from the CNRS Mastodons program. Mr Li was supported by a Canadian Institute for Health Research Doctoral Scholarship with a Michael Smith Foreign Study Supplement. The work of Dr Ioannidis is supported by an unrestricted gift by Sue and Bob O'Donnell to Stanford Prevention Research Center.	BERLIN JA, 1989, J AM STAT ASSOC, V84, P381; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; de Winter JCF, 2015, PEERJ, V3, DOI 10.7717/peerj.733; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; GARDNER MJ, 1989, STAT CONFIDENCE CONF; Gelman A, 2013, EPIDEMIOLOGY, V24, P69, DOI 10.1097/EDE.0b013e31827886f7; Gigerenzer G., 2004, SAGE HDB QUANTITATIV, P391, DOI DOI 10.4135/9781412986311.N21; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Gotzsche PC, 2006, BMJ-BRIT MED J, V333, P231, DOI 10.1136/bmj.38895.410451.79; Hartley J, 2004, J MED LIBR ASSOC, V92, P368; Head ML, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002106; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2014, BIOSTATISTICS, V15, P28, DOI 10.1093/biostatistics/kxt036; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jager LR, 2014, BIOSTATISTICS, V15, P1, DOI 10.1093/biostatistics/kxt007; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Lehmann HP, 2000, J AM MED INFORM ASSN, V7, P254, DOI 10.1136/jamia.2000.0070254; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Simonsohn U, 2014, PERSPECT PSYCHOL SCI, V9, P666, DOI 10.1177/1745691614553988; Simonsohn U, 2014, J EXP PSYCHOL GEN, V143, P534, DOI 10.1037/a0033242; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; van Assen MALM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084896; VEVEA JL, 1995, PSYCHOMETRIKA, V60, P419, DOI 10.1007/BF02294384; Xu CJ, 2014, GENET EPIDEMIOL, V38, P281, DOI 10.1002/gepi.21797; Young SS, 2011, SIGNIFICANCE, V8, P116, DOI DOI 10.1111/J.1740-9713.2011.00506.X	33	206	207	5	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1141	1148		10.1001/jama.2016.1952	http://dx.doi.org/10.1001/jama.2016.1952			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978209	Bronze			2022-12-28	WOS:000372159800019
J	Saitz, R; Wakeman, SE; Kelly, JF				Saitz, Richard; Wakeman, Sarah E.; Kelly, John F.			The Integration of Care for Mental Health, Substance Abuse, and Other Behavioral Health Conditions Into Primary Care	ANNALS OF INTERNAL MEDICINE			English	Letter							INTERVENTION; ALCOHOL		[Saitz, Richard] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Saitz, Richard] Boston Univ, Sch Med, Boston, MA 02118 USA; [Wakeman, Sarah E.; Kelly, John F.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Boston University; Boston University; Harvard University; Massachusetts General Hospital	Saitz, R (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA USA.; Saitz, R (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.		Kelly, John/Q-6780-2019	Kelly, John/0000-0001-6915-0750; /0000-0002-2535-1427				Crowley RA, 2015, ANN INTERN MED, V163, P298, DOI 10.7326/M15-0510; Glass JE, 2015, ADDICTION, V110, P1404, DOI 10.1111/add.12950; Hingson R, 2014, JAMA-J AM MED ASSOC, V312, P488, DOI 10.1001/jama.2014.7863; Saitz R, 2015, J ADDICT MED; Saitz R, 2013, JAMA-J AM MED ASSOC, V310, P1156, DOI 10.1001/jama.2013.277609	5	3	3	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					447	447		10.7326/L15-0525	http://dx.doi.org/10.7326/L15-0525			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26974721				2022-12-28	WOS:000372207200021
J	Clair, DG; Beach, JM				Clair, Daniel G.; Beach, Jocelyn M.			Mesenteric Ischemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VENOUS THROMBOSIS; INTESTINAL ISCHEMIA; ENDOVASCULAR REVASCULARIZATION; VEIN-THROMBOSIS; DISEASE; ARTERY; MANAGEMENT; DIAGNOSIS; OCCLUSION; SURVIVAL		[Clair, Daniel G.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Clair, Daniel G.; Beach, Jocelyn M.] Cleveland Clin, Dept Vasc Surg, Inst Heart & Vasc, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Clair, DG (corresponding author), Cleveland Clin, Dept Vasc Surg, 9500 Euclid Ave,Desk F30, Cleveland, OH 44195 USA.	claird@ccf.org		/0000-0003-3048-0343	Abbott; Boston Scientific; Medtronic; Endologix	Abbott(Abbott Laboratories); Boston Scientific(Boston Scientific); Medtronic(Medtronic); Endologix	Dr. Clair reports receiving fees for serving on advisory boards from Abbott, Boston Scientific, and Medtronic and consulting fees from Endologix, and serving on a data and safety monitoring board for Bard. No other potential conflict of interest relevant to this article was reported.	AbuRahma AF, 2012, J VASC SURG, V55, P428, DOI 10.1016/j.jvs.2011.08.052; Acosta S, 2008, BRIT J SURG, V95, P1245, DOI 10.1002/bjs.6319; Acosta S, 2010, EUR J VASC ENDOVASC, V39, P726, DOI 10.1016/j.ejvs.2010.01.017; Acosta S, 2015, CURR OPIN CRIT CARE, V21, P171, DOI 10.1097/MCC.0000000000000189; Acosta S, 2012, J THROMB THROMBOLYS, V33, P355, DOI 10.1007/s11239-011-0660-z; Acosta S, 2010, SEMIN VASC SURG, V23, P4, DOI 10.1053/j.semvascsurg.2009.12.001; Acosta-Merida MA, 2006, WORLD J SURG, V30, P1579, DOI 10.1007/s00268-005-0560-5; Arthurs ZM, 2011, J VASC SURG, V53, P698, DOI 10.1016/j.jvs.2010.09.049; Atkins MD, 2007, J VASC SURG, V45, P1162, DOI 10.1016/j.jvs.2007.01.067; Beaulieu RJ, 2014, J VASC SURG, V59, P159, DOI 10.1016/j.jvs.2013.06.084; Biolato M, 2009, AM J MED SCI, V338, P389, DOI 10.1097/MAJ.0b013e3181a85c3b; Bjornsson S, 2011, J VASC SURG, V54, P1734, DOI 10.1016/j.jvs.2011.07.054; Bjornsson S, 2013, J GASTROINTEST SURG, V17, P973, DOI 10.1007/s11605-013-2139-z; Blauw JTM, 2014, J VASC SURG, V60, P726, DOI 10.1016/j.jvs.2014.04.001; Boley SJ, 1997, SURG CLIN N AM, V77, P275, DOI 10.1016/S0039-6109(05)70548-X; BOLEY SJ, 1977, SURGERY, V82, P848; BOWERSOX JC, 1991, J VASC SURG, V14, P780, DOI 10.1067/mva.1991.33215; Cai WW, 2015, ANN VASC SURG, V29, P934, DOI 10.1016/j.avsg.2015.01.010; Cho JS, 2002, J VASC SURG, V35, P453, DOI 10.1067/mva.2002.118593; Corcos O, 2013, BEST PRACT RES CL GA, V27, P709, DOI 10.1016/j.bpg.2013.08.006; Corcos O, 2013, CLIN GASTROENTEROL H, V11, P158, DOI 10.1016/j.cgh.2012.10.027; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; Di Minno MND, 2010, THROMB RES, V126, P295, DOI 10.1016/j.thromres.2009.12.015; Evennett NJ, 2009, WORLD J SURG, V33, P1374, DOI 10.1007/s00268-009-0074-7; Gatt M, 2007, ALIMENT PHARM THER, V25, P741, DOI 10.1111/j.1365-2036.2006.03174.x; Hagspiel KD, 2015, TECH VASC INTERV RAD, V18, P2, DOI 10.1053/j.tvir.2014.12.002; Hmoud B, 2014, J CLIN EXP HEPATOL, V4, P257, DOI 10.1016/j.jceh.2014.03.052; JAMIESON WG, 1988, SURG GYNECOL OBSTET, V167, P103; Jimenez JG, 2002, J VASC SURG, V35, P1078, DOI 10.1067/mva.2002.124377; Karkkainen JM, 2015, J GASTROINTEST SURG, V19, P1407, DOI 10.1007/s11605-015-2830-3; Kassahun WT, 2008, LANGENBECK ARCH SURG, V393, P163, DOI 10.1007/s00423-007-0263-5; Kirkpatrick IDC, 2003, RADIOLOGY, V229, P91, DOI 10.1148/radiol.2291020991; Kles KA, 2001, JPEN-PARENTER ENTER, V25, P246, DOI 10.1177/0148607101025005246; Kougias P, 2007, J VASC SURG, V46, P467, DOI 10.1016/j.jvs.2007.04.045; Kozar RA, 2002, JPEN-PARENTER ENTER, V26, P226, DOI 10.1177/0148607102026004226; Kruger AJ, 2007, J VASC SURG, V46, P941, DOI 10.1016/j.jvs.2007.06.036; Kumar S, 2001, NEW ENGL J MED, V345, P1683, DOI 10.1056/NEJMra010076; Meilahn JE, 2001, ANN SURG, V234, P107, DOI 10.1097/00000658-200107000-00016; Milner Ross, 2004, Vasc Endovascular Surg, V38, P89, DOI 10.1177/153857440403800112; Moneta G L, 2001, Semin Vasc Surg, V14, P186, DOI 10.1053/svas.2001.25498; MONETA GL, 1991, J VASC SURG, V14, P511, DOI 10.1016/0741-5214(91)90245-P; Oderich GS, 2009, ANN VASC SURG, V23, P700, DOI 10.1016/j.avsg.2009.03.002; Oderich GS, 2009, J VASC SURG, V49, P1472, DOI 10.1016/j.jvs.2009.02.006; Oldenburg WA, 2004, ARCH INTERN MED, V164, P1054, DOI 10.1001/archinte.164.10.1054; Oliva IB, 2013, ABDOM IMAGING, V38, P714, DOI 10.1007/s00261-012-9975-2; Ozdogan M, 2006, SURG TODAY, V36, P846, DOI 10.1007/s00595-006-3243-4; Park WM, 2002, J VASC SURG, V35, P445, DOI 10.1067/mva.2002.120373; Plumereau F, 2015, J VISC SURG, V152, P17, DOI 10.1016/j.jviscsurg.2014.11.001; Quiroga B, 2013, J SURG RES, V180, P51, DOI 10.1016/j.jss.2012.10.008; RHEE RY, 1994, J VASC SURG, V20, P688, DOI 10.1016/S0741-5214(94)70155-5; Ryer EJ, 2012, J VASC SURG, V55, P1682, DOI 10.1016/j.jvs.2011.12.017; Schermerhorn ML, 2009, J VASC SURG, V50, P341, DOI 10.1016/j.jvs.2009.03.004; Schoots IG, 2005, J VASC INTERV RADIOL, V16, P317, DOI 10.1097/01.RVI.0000141719.24321.0B; Schoots IG, 2004, BRIT J SURG, V91, P17, DOI 10.1002/bjs.4459; Silva JA, 2013, PRIMARY CARE, V40, P153, DOI 10.1016/j.pop.2012.11.007; Silvestri L, 2010, CRIT CARE MED, V38, P1370, DOI 10.1097/CCM.0b013e3181d9db8c; Takahashi N, 2005, J ENDOVASC THER, V12, P508, DOI 10.1583/04-1335MR.1; Tallarita T, 2011, J VASC SURG, V54, P1422, DOI 10.1016/j.jvs.2011.06.002; van Petersen AS, 2010, J VASC SURG, V51, P1309, DOI 10.1016/j.jvs.2009.12.064; White CJ, 2011, PROG CARDIOVASC DIS, V54, P36, DOI 10.1016/j.pcad.2011.04.005; Wyers MC, 2007, J VASC SURG, V45, P269, DOI 10.1016/j.jvs.2006.10.047; Wyers MC, 2010, SEMIN VASC SURG, V23, P9, DOI 10.1053/j.semvascsurg.2009.12.002; Zwolak R M, 1999, Semin Vasc Surg, V12, P252	63	227	259	2	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					959	968		10.1056/NEJMra1503884	http://dx.doi.org/10.1056/NEJMra1503884			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF9DH	26962730				2022-12-28	WOS:000371660000009
J	Tyrrell, J; Jones, SE; Beaumont, R; Astley, CM; Lovell, R; Yaghootkar, H; Tuke, M; Ruth, KS; Freathy, RM; Hirschhorn, JN; Wood, AR; Murray, A; Weedon, MN; Frayling, TM				Tyrrell, Jessica; Jones, Samuel E.; Beaumont, Robin; Astley, Christina M.; Lovell, Rebecca; Yaghootkar, Hanieh; Tuke, Marcus; Ruth, Katherine S.; Freathy, Rachel M.; Hirschhorn, Joel N.; Wood, Andrew R.; Murray, Anna; Weedon, Michael N.; Frayling, Timothy M.			Height, body mass index, and socioeconomic status: mendelian randomisation study in UK Biobank	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WEIGHT DISCRIMINATION; INSTRUMENTS; OBESITY; HEALTH; INCOME; INTELLIGENCE; ASSOCIATION; PERCEPTIONS; REGRESSION; MEN	OBJECTIVE To determine whether height and body mass index (BMI) have a causal role in five measures of socioeconomic status. DESIGN Mendelian randomisation study to test for causal effects of differences in stature and BMI on five measures of socioeconomic status. Mendelian randomisation exploits the fact that genotypes are randomly assigned at conception and thus not confounded by non-genetic factors. SETTING UK Biobank. PARTICIPANTS 119 669 men and women of British ancestry, aged between 37 and 73 years. MAIN OUTCOME MEASURES Age completed full time education, degree level education, job class, annual household income, and Townsend deprivation index. RESULTS In the UK Biobank study, shorter stature and higher BMI were observationally associated with several measures of lower socioeconomic status. The associations between shorter stature and lower socioeconomic status tended to be stronger in men, and the associations between higher BMI and lower socioeconomic status tended to be stronger in women. For example, a 1 standard deviation (SD) higher BMI was associated with a 210 pound ((sic)276; $300; 95% confidence interval 84 pound to 420; pound P= 6x10(-3)) lower annual household income in men and a 1890 pound (1680 pound to 2100; pound P=6x10(-15)) lower annual household income in women. Genetic analysis provided evidence that these associations were partly causal. A genetically determined 1 SD (6.3 cm) taller stature caused a 0.06 (0.02 to 0.09) year older age of completing full time education (P=0.01), a 1.12 (1.07 to 1.18) times higher odds of working in a skilled profession (P=6x10(-7)), and a 1130 pound (680 pound to 1580) pound higher annual household income (P=4x10(-8)). Associations were stronger in men. A genetically determined 1 SD higher BMI (4.6 kg/m(2)) caused a 2940 pound (1680 pound to 4200; pound P=1x10(-5)) lower annual household income and a 0.10 (0.04 to 0.16) SD (P=0.001) higher level of deprivation in women only. CONCLUSIONS These data support evidence that height and BMI play an important partial role in determining several aspects of a person's socioeconomic status, especially women's BMI for income and deprivation and men's height for education, income, and job class. These findings have important social and health implications, supporting evidence that overweight people, especially women, are at a disadvantage and that taller people, especially men, are at an advantage.	[Tyrrell, Jessica; Jones, Samuel E.; Beaumont, Robin; Yaghootkar, Hanieh; Tuke, Marcus; Ruth, Katherine S.; Freathy, Rachel M.; Wood, Andrew R.; Murray, Anna; Weedon, Michael N.; Frayling, Timothy M.] Univ Exeter, Sch Med, Royal Devon & Exeter Hosp, Genet Complex Traits,Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Tyrrell, Jessica; Lovell, Rebecca; Hirschhorn, Joel N.] Univ Exeter, Sch Med, European Ctr Environm & Human Hlth, Knowledge Spa, Truro TR1 3HD, England; [Astley, Christina M.; Hirschhorn, Joel N.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Astley, Christina M.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA 02115 USA; [Astley, Christina M.] Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Exeter; University of Exeter; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Frayling, TM (corresponding author), Univ Exeter, Sch Med, Royal Devon & Exeter Hosp, Genet Complex Traits,Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England.	T.M.Frayling@exeter.ac.uk	Jones, Samuel/AAF-3100-2019; Ruth, Katherine/K-2745-2019; Wood, Andrew R/AAB-3807-2019	Jones, Samuel/0000-0003-0153-922X; Ruth, Katherine/0000-0003-4966-9170; Wood, Andrew R/0000-0003-1726-948X; /0000-0002-5063-8470; Lovell, Rebecca/0000-0002-6962-0350; Frayling, Timothy/0000-0001-8362-2603; Freathy, Rachel/0000-0003-4152-2238; Beaumont, Robin/0000-0003-0750-8248; Murray, Anna/0000-0002-2351-2522; Weedon, Michael/0000-0002-6174-6135; , Hanieh/0000-0001-9672-9477	Diabetes Research and Wellness Foundation; Medical Research Council [MR/M005070/1]; Wellcome Trust [WT097835MF]; European Research Council [SZ-245 50371-GLUCOSEGENES-FP7-IDEAS-ERC, 323195]; Wellcome Trust; Royal Society [104150/Z/14/Z]; National Institutes of Health [R01 DK075787]; Endocrine Society's Endocrine Scholars Award - Lilly USA, LLC; MRC [G0500070, G0601261] Funding Source: UKRI; Medical Research Council [G0601261, G0500070, MC_qA137853] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007699, R01DK075787] Funding Source: NIH RePORTER	Diabetes Research and Wellness Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Society's Endocrine Scholars Award - Lilly USA, LLC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	JT is funded by a Diabetes Research and Wellness Foundation fellowship. SEJ is funded by the Medical Research Council (grant: MR/M005070/1). MAT, MNW, and AM are supported by a Wellcome Trust institutional strategic support award (WT097835MF). ARW and TMF are supported by a European Research Council grant (SZ-245 50371-GLUCOSEGENES-FP7-IDEAS-ERC). RMF is a Sir Henry Dale fellow (Wellcome Trust and Royal Society grant 104150/Z/14/Z). RB is funded by a Wellcome Trust and Royal Society grant (104150/Z/14/Z). HY is funded by a European Research Council award (323195). JNH is supported by the National Institutes of Health (R01 DK075787). CMA is funded by the Endocrine Society's Endocrine Scholars Award (supported by Lilly USA, LLC). The funders had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; Andreyeva T, 2008, OBESITY, V16, P1129, DOI 10.1038/oby.2008.35; Asao K, 2006, DIABETES CARE, V29, P1632, DOI 10.2337/dc05-1997; Baum C, 2007, IVENDOG STATA MODULE; Blaker NM, 2013, GROUP PROCESS INTERG, V16, P17, DOI 10.1177/1368430212437211; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Case A, 2008, J POLIT ECON, V116, P499, DOI 10.1086/589524; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Ding W, 2009, J HEALTH ECON, V28, P578, DOI 10.1016/j.jhealeco.2008.11.006; Fall T, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001474; Fletcher JM, 2011, J HEALTH ECON, V30, P647, DOI 10.1016/j.jhealeco.2011.04.005; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Grabner M, 2012, OBESITY FACTS, V5, P112, DOI 10.1159/000337018; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Judge TA, 2011, J APPL PSYCHOL, V96, P95, DOI 10.1037/a0020860; Kennedy BP, 1998, BRIT MED J, V317, P917; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lundborg P, 2014, DEMOGRAPHY, V51, P1573, DOI 10.1007/s13524-014-0325-6; Magnusson PKE, 2006, INT J EPIDEMIOL, V35, P658, DOI 10.1093/ije/dyl011; Marioni RE, 2014, BEHAV GENET, V44, P91, DOI 10.1007/s10519-014-9644-z; Marmot M, 2015, LANCET, V386, P2442, DOI 10.1016/S0140-6736(15)00150-6; Morris S, 2006, J HEALTH ECON, V25, P347, DOI 10.1016/j.jhealeco.2005.09.005; Orth U, 2012, J PERS SOC PSYCHOL, V102, P1271, DOI 10.1037/a0025558; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Puhl RM, 2008, INT J OBESITY, V32, P992, DOI 10.1038/ijo.2008.22; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; READING R, 1993, BRIT MED J, V307, P1458, DOI 10.1136/bmj.307.6917.1458; Rosenburg IB., 2009, UTAH LAW REV, V3, P907; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Sundet JM, 2005, TWIN RES HUM GENET, V8, P307, DOI 10.1375/twin.8.4.307; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Whitley E, 2012, J EPIDEMIOL COMMUN H, V66, P18, DOI 10.1136/jech.2009.104216; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097	37	165	168	1	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2016	352								i582	10.1136/bmj.i582	http://dx.doi.org/10.1136/bmj.i582			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG4NI	26956984	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000372048500001
J	Huang, YH; Zhu, C; Kondo, Y; Anderson, AC; Gandhi, A; Russell, A; Dougan, SK; Petersen, BS; Melum, E; Pertel, T; Clayton, KL; Raab, M; Chen, Q; Beauchemin, N; Yazaki, PJ; Pyzik, M; Ostrowski, MA; Glickman, JN; Rudd, CE; Ploegh, HL; Franke, A; Petsko, GA; Kuchroo, VK; Blumberg, RS				Huang, Yu-Hwa; Zhu, Chen; Kondo, Yasuyuki; Anderson, Ana C.; Gandhi, Amit; Russell, Andrew; Dougan, Stephanie K.; Petersen, Britt-Sabina; Melum, Espen; Pertel, Thomas; Clayton, Kiera L.; Raab, Monika; Chen, Qiang; Beauchemin, Nicole; Yazaki, Paul J.; Pyzik, Michal; Ostrowski, Mario A.; Glickman, Jonathan N.; Rudd, Christopher E.; Ploegh, Hidde L.; Franke, Andre; Petsko, Gregory A.; Kuchroo, Vijay K.; Blumberg, Richard S.			CEACAM1 regulates TIM-3-mediated tolerance and exhaustion (vol 517, pg 386, 2015)	NATURE			English	Correction													chen, qiang/HGU-5418-2022; chen, qiang/GWZ-7308-2022; Petsko, Gregory/AAO-7962-2020; Rudd, Christopher E/ABF-7259-2021; Anderson, Ana C/ABD-6829-2021; Pyzik, Michal/AAC-7220-2019; Rudd, Christopher E/GOH-2021-2022; Löscher, Britt-Sabina/I-1671-2012; Franke, Andre/B-2151-2010	Anderson, Ana C/0000-0002-0877-2932; Rudd, Christopher E/0000-0001-5295-9019; Löscher, Britt-Sabina/0000-0001-9022-9017; Franke, Andre/0000-0003-1530-5811; Pertel, Thomas/0000-0002-2286-6011	NIAID NIH HHS [P01 AI073748] Funding Source: Medline; NIDDK NIH HHS [R01 DK051362] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051362] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bonsor DA, 2015, P NATL ACAD SCI USA, V112, P13561, DOI 10.1073/pnas.1509511112; Huang YH, 2015, NATURE, V517, P386, DOI 10.1038/nature13848	2	23	24	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					359	359		10.1038/nature17421	http://dx.doi.org/10.1038/nature17421			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	26982724	Bronze, Green Accepted			2022-12-28	WOS:000381804900041
J	Dursteler, KM; Vogel, M				Dursteler, Kenneth M.; Vogel, Marc			Effective drug therapy for cocaine dependence: a milestone	LANCET			English	Editorial Material							CONTINGENCY MANAGEMENT; TRIAL; METAANALYSIS; METHADONE		[Dursteler, Kenneth M.; Vogel, Marc] Psychiat Univ Clin Basel, Wilhelm Klein Str 27, CH-4012 Basel, Switzerland	University of Basel	Dursteler, KM (corresponding author), Psychiat Univ Clin Basel, Wilhelm Klein Str 27, CH-4012 Basel, Switzerland.	kenneth.duersteler@upkbs.ch	Vogel, Marc/CAG-0220-2022; Dürsteler, Kenneth Michael/AAJ-2374-2021	Vogel, Marc/0000-0002-3088-0331; Dürsteler, Kenneth Michael/0000-0003-1552-5822				Aubin HJ, 2014, BRIT J CLIN PHARMACO, V77, P324, DOI 10.1111/bcp.12116; Benishek LA, 2014, ADDICTION, V109, P1426, DOI 10.1111/add.12589; Brokowski L, 2014, AM J HEALTH-SYST PH, V71, P634, DOI 10.2146/ajhp130543; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; Dursteler KM, 2015, SUBST ABUSE REHABIL, V6, P61, DOI 10.2147/SAR.S50807; Dursteler-MacFarland KM, 2013, J CLIN PSYCHOPHARM, V33, P104, DOI 10.1097/JCP.0b013e31827bfff4; Grabowski J, 2004, NEUROPSYCHOPHARMACOL, V29, P969, DOI 10.1038/sj.npp.1300392; Nuijten M, 2016, LANCET; Petitjean SA, 2014, DRUG ALCOHOL DEPEN, V145, P94, DOI 10.1016/j.drugalcdep.2014.09.785; Prendergast M, 2006, ADDICTION, V101, P1546, DOI 10.1111/j.1360-0443.2006.01581.x; Shearer J, 2003, ADDICTION, V98, P1137, DOI 10.1046/j.1360-0443.2003.00447.x; Strain EC, 1999, JAMA-J AM MED ASSOC, V281, P1000, DOI 10.1001/jama.281.11.1000; Vogel M, J PSYCHOACT IN PRESS	13	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2171	2173		10.1016/S0140-6736(16)00563-8	http://dx.doi.org/10.1016/S0140-6736(16)00563-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN1IZ	27015910				2022-12-28	WOS:000376820800009
J	Zhang, B; Zheng, XL; Voznyy, O; Comin, R; Bajdich, M; Garcia-Melchor, M; Han, LL; Xu, JX; Liu, M; Zheng, LR; de Arquer, FPG; Dinh, CT; Fan, FJ; Yuan, MJ; Yassitepe, E; Chen, N; Regier, T; Liu, PF; Li, YH; De Luna, P; Janmohamed, A; Xin, HLL; Yang, HG; Vojvodic, A; Sargent, EH				Zhang, Bo; Zheng, Xueli; Voznyy, Oleksandr; Comin, Riccardo; Bajdich, Michal; Garcia-Melchor, Max; Han, Lili; Xu, Jixian; Liu, Min; Zheng, Lirong; de Arquer, F. Pelayo Garcia; Dinh, Cao Thang; Fan, Fengjia; Yuan, Mingjian; Yassitepe, Emre; Chen, Ning; Regier, Tom; Liu, Pengfei; Li, Yuhang; De Luna, Phil; Janmohamed, Alyf; Xin, Huolin L.; Yang, Huagui; Vojvodic, Aleksandra; Sargent, Edward H.			Homogeneously dispersed multimetal oxygen-evolving catalysts	SCIENCE			English	Article							WATER OXIDATION; EVOLUTION REACTION; PEROVSKITE PHOTOVOLTAICS; NI; ELECTROCATALYSTS; CRYSTALLINE; CO; OXIDES	Earth-abundant first-row (3d) transition metal-based catalysts have been developed for the oxygen-evolution reaction (OER); however, they operate at overpotentials substantially above thermodynamic requirements. Density functional theory suggested that non-3d high-valency metals such as tungsten can modulate 3d metal oxides, providing nearoptimal adsorption energies for OER intermediates. We developed a room-temperature synthesis to produce gelled oxyhydroxides materials with an atomically homogeneous metal distribution. These gelled FeCoW oxyhydroxides exhibit the lowest overpotential (191 millivolts) reported at 10 milliamperes per square centimeter in alkaline electrolyte. The catalyst shows no evidence of degradation after more than 500 hours of operation. X-ray absorption and computational studies reveal a synergistic interplay between tungsten, iron, and cobalt in producing a favorable local coordination environment and electronic structure that enhance the energetics for OER.	[Zhang, Bo; Zheng, Xueli; Voznyy, Oleksandr; Comin, Riccardo; Xu, Jixian; Liu, Min; de Arquer, F. Pelayo Garcia; Dinh, Cao Thang; Fan, Fengjia; Yuan, Mingjian; Yassitepe, Emre; De Luna, Phil; Janmohamed, Alyf; Sargent, Edward H.] Univ Toronto, Dept Elect & Comp Engn, 35 St George St, Toronto, ON M5S 1A4, Canada; [Zhang, Bo] E China Univ Sci & Technol, Dept Phys, 130 Meilong Rd, Shanghai 200237, Peoples R China; [Zheng, Xueli] Tianjin Univ, Sch Mat Sci & Engn, Tianjin Key Lab Composite & Funct Mat, Tianjin 300072, Peoples R China; [Bajdich, Michal; Garcia-Melchor, Max; Vojvodic, Aleksandra] Stanford Univ, Dept Chem Engn, SUNCAT Ctr Interface Sci & Catalysis, Stanford, CA 94305 USA; [Bajdich, Michal; Garcia-Melchor, Max; Vojvodic, Aleksandra] SLAC Natl Accelerator Lab, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA; [Han, Lili; Xin, Huolin L.] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11973 USA; [Zheng, Lirong] Chinese Acad Sci, Beijing Synchrotron Radiat Facil, Inst High Energy Phys, Beijing 100049, Peoples R China; [Chen, Ning; Regier, Tom] Canadian Light Source CLS, 44 Innovation Blvd, Saskatoon, SK S7N 2V3, Canada; [Liu, Pengfei; Li, Yuhang; Yang, Huagui] E China Univ Sci & Technol, Sch Mat Sci & Engn, Key Lab Ultrafine Mat, Minist Educ, 130 Meilong Rd, Shanghai 200237, Peoples R China	University of Toronto; East China University of Science & Technology; Tianjin University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; University of Saskatchewan; East China University of Science & Technology	Sargent, EH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, 35 St George St, Toronto, ON M5S 1A4, Canada.; Vojvodic, A (corresponding author), Stanford Univ, Dept Chem Engn, SUNCAT Ctr Interface Sci & Catalysis, Stanford, CA 94305 USA.; Vojvodic, A (corresponding author), SLAC Natl Accelerator Lab, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	alevoj@stanford.edu; ted.sargent@utoronto.ca	De+Luna, Phil/ABD-8341-2021; Li, Yu Hang/H-3048-2018; Comin, Riccardo/H-7731-2016; Liu, Min/ABI-4990-2020; Garcia de Arquer, F. Pelayo/AAF-1803-2019; Vojvodic, Aleksandra/C-3383-2014; Yang, Hug Gui/N-7612-2018; Xin, Huolin L./E-2747-2010; Fan, Fengjia/A-7173-2018; Zhang, Bo/AAX-9762-2020; Garcia-Melchor, Max/D-3046-2017; Liu, Min/AFZ-6452-2022; Sargent, Edward H./O-9520-2014; Liu, Min/CAA-4092-2022; Yassitepe, Emre/C-9035-2011; Dinh, Cao Thang/AAE-7837-2019; Liu, Min/H-3699-2011; Liu, Peng Fei/P-1535-2018	De+Luna, Phil/0000-0002-7729-8816; Li, Yu Hang/0000-0003-4086-0323; Comin, Riccardo/0000-0002-1069-9973; Garcia de Arquer, F. Pelayo/0000-0003-2422-6234; Vojvodic, Aleksandra/0000-0002-5584-6711; Yang, Hug Gui/0000-0003-0436-8622; Xin, Huolin L./0000-0002-6521-868X; Fan, Fengjia/0000-0002-5447-6296; Zhang, Bo/0000-0002-7853-979X; Garcia-Melchor, Max/0000-0003-1348-4692; Liu, Min/0000-0002-9007-4817; Sargent, Edward H./0000-0003-0396-6495; Liu, Min/0000-0002-9007-4817; Yassitepe, Emre/0000-0002-4487-2631; Dinh, Cao Thang/0000-0001-9641-9815; Liu, Min/0000-0002-9007-4817; Liu, Peng Fei/0000-0003-0411-0488; chen, ning/0000-0002-1269-6119; Janmohamed, Alyf/0000-0003-0813-6503; Han, Lili/0000-0003-0817-7372; Bajdich, Michal/0000-0003-1168-8616; xu, jixian/0000-0001-8119-3411	Ontario Research Fund-Research Excellence Program; Natural Sciences and Engineering Research Council of Canada; Canadian Insititute for Advanced Research Bio-Inspired Solar Energy program; China Scholarship Council/University of Toronto [201406745001]; Shanghai Municipal Natural Science Foundation [14ZR1410200]; National Natural Science Foundation of China [21503079]; China Scholarship Council (CSC) [20140625004]; U.S. Department of Energy (DOE), Office of Basic Energy Science; Laboratory-Directed Research and Development program through the SLAC National Accelerator Laboratory; Agency for Administration of University and Research Grants of Catalonia (AGAUR) [2013 BP-A 00464]; Center for Functional Nanomaterials, DOE Office of Science Facility, at Brookhaven National Laboratory [DE-SC0012704]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-Bolsa Estagio de Pesquisa no Exterior fellowship [2014/18327-9]; Connaught Global Challenge program of the University of Toronto	Ontario Research Fund-Research Excellence Program; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Insititute for Advanced Research Bio-Inspired Solar Energy program; China Scholarship Council/University of Toronto; Shanghai Municipal Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council (CSC)(China Scholarship Council); U.S. Department of Energy (DOE), Office of Basic Energy Science(United States Department of Energy (DOE)); Laboratory-Directed Research and Development program through the SLAC National Accelerator Laboratory; Agency for Administration of University and Research Grants of Catalonia (AGAUR); Center for Functional Nanomaterials, DOE Office of Science Facility, at Brookhaven National Laboratory; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-Bolsa Estagio de Pesquisa no Exterior fellowship; Connaught Global Challenge program of the University of Toronto	This work was supported by the Ontario Research Fund-Research Excellence Program, Natural Sciences and Engineering Research Council of Canada, and the Canadian Insititute for Advanced Research Bio-Inspired Solar Energy program. B. Z. acknowledges funding from China Scholarship Council/University of Toronto Joint Funding Program (201406745001), Shanghai Municipal Natural Science Foundation (14ZR1410200), and the National Natural Science Foundation of China (21503079). X.Z. acknowledges a scholarship from the China Scholarship Council (CSC) (20140625004). This work was also supported by the U.S. Department of Energy (DOE), Office of Basic Energy Science grant to the SUNCAT Center for Interface Science and Catalysis and the Laboratory-Directed Research and Development program funded through the SLAC National Accelerator Laboratory. M.G.-M. acknowledges funding from the Agency for Administration of University and Research Grants of Catalonia (AGAUR, 2013 BP-A 00464). This work has also benefited from the Hard X-ray Micro-Analysis and Spherical Grating Monochromator beamlines at CLS and the BL14W1 beamline at the Shanghai Synchrotron Radiation Facility (SSRF). B. Z. and R. C. acknowledge the CLS Post-Doctoral Student Travel Support Program. The TEM study in this work is supported by the Center for Functional Nanomaterials, which is a DOE Office of Science Facility, at Brookhaven National Laboratory under contract DE-SC0012704. E. Y. acknowledges a Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-Bolsa Estagio de Pesquisa no Exterior (2014/18327-9) fellowship. E. H. S. and F.P.G.A acknowledge funding from the Connaught Global Challenge program of the University of Toronto. The authors thank D. Belanger and G. Chamoulaud at Universite du Quebec a Montreal for assistance in EQCM measurements and T.-O. Do and C.-C. Nguyen at Laval University for surface area analysis. The authors thank Y. J. Pang, X. Lan, L. N. Quan, and S. Hoogland for fruitful discussions; M. X. Liu and X. W. Gong for fabrication assistance; and R. Wolowiec and D. Kopilovic for assistance. B. Z., X. Z., J.X., M.L., C.T.D, and E.H.S. of the University of Toronto have filed provisional patent application no. 62288648 regarding the preparation of multimetal catalysts for oxygen evolution.	Augustyn V, 2013, NAT MATER, V12, P518, DOI [10.1038/nmat3601, 10.1038/NMAT3601]; Bajdich M, 2013, J AM CHEM SOC, V135, P13521, DOI 10.1021/ja405997s; BALERNA A, 1991, NUCL INSTRUM METH A, V308, P240, DOI 10.1016/0168-9002(91)90637-6; Batchellor AS, 2015, ACS CATAL, V5, P6680, DOI 10.1021/acscatal.5b01551; Burke MS, 2015, J AM CHEM SOC, V137, P3638, DOI 10.1021/jacs.5b00281; Cox CR, 2014, P NATL ACAD SCI USA, V111, P14057, DOI 10.1073/pnas.1414290111; Danilovic N., 2014, ANGEW CHEM, V126, P14240, DOI DOI 10.1002/ANIE.201406455; Dinca M, 2010, P NATL ACAD SCI USA, V107, P10337, DOI 10.1073/pnas.1001859107; Friebel D, 2015, J AM CHEM SOC, V137, P1305, DOI 10.1021/ja511559d; Friebel D, 2013, PHYS CHEM CHEM PHYS, V15, P17460, DOI 10.1039/c3cp52981a; Haber JA, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201402307; Haber JA, 2014, ENERG ENVIRON SCI, V7, P682, DOI 10.1039/c3ee43683g; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Liao PL, 2012, J AM CHEM SOC, V134, P13296, DOI 10.1021/ja301567f; Ling C, 2014, RSC ADV, V4, P24692, DOI 10.1039/c4ra03893b; Louie MW, 2013, J AM CHEM SOC, V135, P12329, DOI 10.1021/ja405351s; Luo JS, 2014, SCIENCE, V345, P1593, DOI 10.1126/science.1258307; Ma W, 2015, ACS NANO, V9, P1977, DOI 10.1021/nn5069836; McCrory CCL, 2015, J AM CHEM SOC, V137, P4347, DOI 10.1021/ja510442p; Rosalbino F, 2013, INT J HYDROGEN ENERG, V38, P10170, DOI 10.1016/j.ijhydene.2013.06.035; Schreier M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8326; Smith RDL, 2013, SCIENCE, V340, P60, DOI 10.1126/science.1233638; Song F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5477; Subbaraman R, 2012, NAT MATER, V11, P550, DOI [10.1038/NMAT3313, 10.1038/nmat3313]; Suntivich J, 2011, SCIENCE, V334, P1383, DOI 10.1126/science.1212858; Swierk JR, 2015, J PHYS CHEM C, V119, P19022, DOI 10.1021/acs.jpcc.5b05861; Toma FM, 2010, NAT CHEM, V2, P826, DOI [10.1038/nchem.761, 10.1038/NCHEM.761]; Vojvodic A, 2011, SCIENCE, V334, P1355, DOI 10.1126/science.1215081; Yin QS, 2010, SCIENCE, V328, P342, DOI 10.1126/science.1185372	29	1508	1527	111	1770	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					333	337		10.1126/science.aaf1525	http://dx.doi.org/10.1126/science.aaf1525			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27013427	Green Submitted			2022-12-28	WOS:000373990100038
J	Reich, PB; Sendall, KM; Stefanski, A; Wei, XR; Rich, RL; Montgomery, RA				Reich, Peter B.; Sendall, Kerrie M.; Stefanski, Artur; Wei, Xiaorong; Rich, Roy L.; Montgomery, Rebecca A.			Boreal and temperate trees show strong acclimation of respiration to warming	NATURE			English	Article							LEAF RESPIRATION; THERMAL-ACCLIMATION; PLANT RESPIRATION; CLIMATE; PHOTOSYNTHESIS; NITROGEN; VEGETATION; FEEDBACKS; CANOPY; SUGARS	Plant respiration results in an annual flux of carbon dioxide (CO2) to the atmosphere that is six times as large as that due to the emissions from fossil fuel burning, so changes in either will impact future climate. As plant respiration responds positively to temperature, a warming world may result in additional respiratory CO2 release, and hence further atmospheric warming(1,2). Plant respiration can acclimate to altered temperatures, however, weakening the positive feedback of plant respiration to rising global air temperature(3-7), but a lack of evidence on long-term (weeks to years) acclimation to climate warming in field settings currently hinders realistic predictions of respiratory release of CO2 under future climatic conditions. Here we demonstrate strong acclimation of leaf respiration to both experimental warming and seasonal temperature variation for juveniles of ten North American tree species growing for several years in forest conditions. Plants grown and measured at 3.4 degrees C above ambient temperature increased leaf respiration by an average of 5% compared to plants grown and measured at ambient temperature; without acclimation, these increases would have been 23%. Thus, acclimation eliminated 80% of the expected increase in leaf respiration of non-acclimated plants. Acclimation of leaf respiration per degree temperature change was similar for experimental warming and seasonal temperature variation. Moreover, the observed increase in leaf respiration per degree increase in temperature was less than half as large as the average reported for previous studies(4,7), which were conducted largely over shorter time scales in laboratory settings. If such dampening effects of leaf thermal acclimation occur generally, the increase in respiration rates of terrestrial plants in response to climate warming may be less than predicted, and thus may not raise atmospheric CO2 concentrations as much as anticipated.	[Reich, Peter B.; Sendall, Kerrie M.; Stefanski, Artur; Wei, Xiaorong; Rich, Roy L.; Montgomery, Rebecca A.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2753, Australia; [Wei, Xiaorong] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Peoples R China; [Rich, Roy L.] Smithsonian Environm Res Ctr, Edgewater, MD 20137 USA	University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; Northwest A&F University - China; Smithsonian Institution; Smithsonian Environmental Research Center	Reich, PB (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.; Reich, PB (corresponding author), Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2753, Australia.	preich@umn.edu	Rich, Roy/N-3794-2018	Rich, Roy/0000-0002-0461-7388; Reich, Peter/0000-0003-4424-662X; Stefanski, Artur/0000-0002-5412-1014	US Department of Energy, Office of Science, Office of Biological and Environmental Research award [DE-FG02-07ER64456]; Minnesota Agricultural Experiment Station [MIN-42-030, MIN-42-060]; Minnesota Department of Natural Resources; College of Food, Agricultural, and Natural Resources Sciences; Wilderness Research Foundation; University of Minnesota	US Department of Energy, Office of Science, Office of Biological and Environmental Research award(United States Department of Energy (DOE)); Minnesota Agricultural Experiment Station; Minnesota Department of Natural Resources; College of Food, Agricultural, and Natural Resources Sciences; Wilderness Research Foundation; University of Minnesota(University of Minnesota System)	This research was supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research award DE-FG02-07ER64456; Minnesota Agricultural Experiment Station MIN-42-030 and MIN-42-060; the Minnesota Department of Natural Resources; and the College of Food, Agricultural, and Natural Resources Sciences and Wilderness Research Foundation, University of Minnesota. Assistance with experimental operation and data collection was provided by K. Rice, C. Buschena, C. Zhao, H. Jihua and numerous summer interns.	Arneth A, 2010, NAT GEOSCI, V3, P525, DOI [10.1038/NGEO905, 10.1038/ngeo905]; Atkin OK, 2000, PLANT CELL ENVIRON, V23, P15, DOI 10.1046/j.1365-3040.2000.00511.x; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Atkin OK, 2015, NEW PHYTOL, V206, P614, DOI 10.1111/nph.13253; Atkin OK, 2014, NEW PHYTOL, V202, P743, DOI 10.1111/nph.12686; Bolstad PV, 2003, TREE PHYSIOL, V23, P969, DOI 10.1093/treephys/23.14.969; Campbell C, 2007, NEW PHYTOL, V176, P375, DOI 10.1111/j.1469-8137.2007.02183.x; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Gunderson CA, 2000, TREE PHYSIOL, V20, P87; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Heskel M. A., P NATL ACAD IN PRESS; Huve K, 2012, PHYSIOL PLANTARUM, V144, P320, DOI 10.1111/j.1399-3054.2011.01562.x; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kruse J, 2011, NEW PHYTOL, V189, P659, DOI 10.1111/j.1469-8137.2010.03576.x; Lee TD, 2005, FUNCT ECOL, V19, P640, DOI 10.1111/j.1365-2435.2005.01023.x; Lombardozzi DL, 2015, GEOPHYS RES LETT, V42, P8624, DOI 10.1002/2015GL065934; Loveys BR, 2003, GLOBAL CHANGE BIOL, V9, P895, DOI 10.1046/j.1365-2486.2003.00611.x; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Mitchell KA, 1999, TREE PHYSIOL, V19, P861; O'Sullivan OS, 2013, PLANT CELL ENVIRON, V36, P1268, DOI 10.1111/pce.12057; Ow LF, 2008, NEW PHYTOL, V178, P123, DOI 10.1111/j.1469-8137.2007.02357.x; Reich PB, 2008, ECOL LETT, V11, P793, DOI 10.1111/j.1461-0248.2008.01185.x; Reich PB, 2015, NAT CLIM CHANGE, V5, P148, DOI [10.1038/NCLIMATE2497, 10.1038/nclimate2497]; Rich RL, 2015, GLOBAL CHANGE BIOL, V21, P2334, DOI 10.1111/gcb.12855; Sendall KM, 2015, GLOBAL CHANGE BIOL, V21, P1342, DOI 10.1111/gcb.12781; Slot M, 2015, OECOLOGIA, V177, P885, DOI 10.1007/s00442-014-3159-4; Slot M, 2014, GLOBAL CHANGE BIOL, V20, P2915, DOI 10.1111/gcb.12563; Smith N. G., 2016, NATURE CLIM CHANGE; Smith NG, 2013, GLOBAL CHANGE BIOL, V19, P45, DOI 10.1111/j.1365-2486.2012.02797.x; Tjoelker MG, 2008, GLOBAL CHANGE BIOL, V14, P782, DOI 10.1111/j.1365-2486.2008.01548.x; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x	31	165	172	13	281	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					633	+		10.1038/nature17142	http://dx.doi.org/10.1038/nature17142			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	26982730	Green Published			2022-12-28	WOS:000373027400037
J	Hotta, H; Rempel, M; Yokoyama, T				Hotta, H.; Rempel, M.; Yokoyama, T.			Large-scale magnetic fields at high Reynolds numbers in magnetohydrodynamic simulations	SCIENCE			English	Article							DIFFERENTIAL ROTATION; CONVECTIVE DYNAMO; SOLAR CONVECTION; REDUCED SPEED; SUN; CYCLES; ENVELOPE; WREATHS	The 11-year solarmagnetic cycle shows a high degree of coherence in spite of the turbulent nature of the solar convection zone. It has been found in recent high-resolution magnetohydrodynamics simulations that the maintenance of a large-scale coherent magnetic field is difficult with small viscosity and magnetic diffusivity (<= 10(12) square centimenters per second). We reproduced previous findings that indicate a reduction of the energy in the large-scalemagnetic field for lower diffusivities and demonstrate the recovery of the global-scalemagnetic field using unprecedentedly high resolution. We found an efficient small-scale dynamo that suppresses small-scale flows, which mimics the properties of large diffusivity. As a result, the global-scale magnetic field is maintained even in the regime of small diffusivities-that is, large Reynolds numbers.	[Hotta, H.] Chiba Univ, Grad Sch Sci, Dept Phys, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan; [Hotta, H.; Rempel, M.] Natl Ctr Atmospher Res, High Altitude Observ, Pob 3000, Boulder, CO 80307 USA; [Yokoyama, T.] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan	Chiba University; National Center Atmospheric Research (NCAR) - USA; University of Tokyo	Hotta, H (corresponding author), Chiba Univ, Grad Sch Sci, Dept Phys, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.; Hotta, H (corresponding author), Natl Ctr Atmospher Res, High Altitude Observ, Pob 3000, Boulder, CO 80307 USA.	hotta@chiba-u.jp		Hotta, Hideyuki/0000-0002-6312-7944; Yokoyama, Takaaki/0000-0001-5457-4999	Japan Society for the Promotion of Science; National Science Foundation; Yellowstone Supercomputer at NCAR [NHA00005]; Ministry of Education, Culture, Sports, Science and Technology; Joint Institute for Computational Fundamental Science; Project for Solar-Terrestrial Environment Prediction	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation(National Science Foundation (NSF)); Yellowstone Supercomputer at NCAR; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Joint Institute for Computational Fundamental Science; Project for Solar-Terrestrial Environment Prediction	We are grateful to M. Miesch, R. Cameron, and M. Schussler for helpful comments. H.H. is supported by a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad. The National Center for Atmospheric Research is sponsored by the National Science Foundation. The results were obtained by using the K computer at the RIKEN Advanced Institute for Computational Science (Proposal no. hp140212 and hp150226) and the Yellowstone Supercomputer at NCAR (project code NHA00005). This work was supported by the Ministry of Education, Culture, Sports, Science and Technology Strategic Programs for Innovative Research, Joint Institute for Computational Fundamental Science, and Project for Solar-Terrestrial Environment Prediction. Statistical data from the calculations and executable software are available in the supplementary materials.	Brown BP, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/69; Brown BP, 2010, ASTROPHYS J, V711, P424, DOI 10.1088/0004-637X/711/1/424; Brun AS, 2004, ASTROPHYS J, V614, P1073, DOI 10.1086/423835; Cattaneo F, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/70; CHAPMAN S, 1954, ASTROPHYS J, V120, P151, DOI 10.1086/145890; ChristensenDalsgaard J, 1996, SCIENCE, V272, P1286, DOI 10.1126/science.272.5266.1286; Cowling T. G., 1953, THE SUN, P532; Fan YH, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/35; Featherstone NA, 2015, ASTROPHYS J, V804, DOI 10.1088/0004-637X/804/1/67; Gastine T, 2014, MON NOT R ASTRON SOC, V438, pL76, DOI 10.1093/mnrasl/slt162; Ghizaru M, 2010, ASTROPHYS J LETT, V715, pL133, DOI 10.1088/2041-8205/715/2/L133; Hale GE, 1925, ASTROPHYS J, V62, P270, DOI 10.1086/142933; Hotta H, 2015, ASTROPHYS J, V803, DOI 10.1088/0004-637X/803/1/42; Hotta H, 2015, ASTROPHYS J, V798, DOI 10.1088/0004-637X/798/1/51; Hotta H, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/24; Hotta H, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201118268; Kageyama A, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000734; Nelson NJ, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/73; PARKER EN, 1955, ASTROPHYS J, V122, P293, DOI 10.1086/146087; Rempel M, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/132; Thompson MJ, 2003, ANNU REV ASTRON ASTR, V41, P599, DOI 10.1146/annurev.astro.41.011802.094848; Tobias SM, 2013, NATURE, V497, P463, DOI 10.1038/nature12177; Usoskin IG, 2003, SOL PHYS, V218, P295, DOI 10.1023/B:SOLA.0000013029.99907.97	23	72	73	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1427	1430		10.1126/science.aad1893	http://dx.doi.org/10.1126/science.aad1893			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013727				2022-12-28	WOS:000372756200042
J	Garrick-Bethell, I				Garrick-Bethell, Ian			PLANETARY SCIENCE Signs of a wandering Moon	NATURE			English	Editorial Material							ICE	The presence of ice at two positions on opposite sides of the Moon suggests that the satellite's orientation was once shifted away from its present spin axis - a finding that has implications for the Moon's volcanic history. See Letter p.480	[Garrick-Bethell, Ian] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Garrick-Bethell, I (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	igarrick@ucsc.edu		Garrick-Bethell, Ian/0000-0002-6327-5867				Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Garrick-Bethell I, 2014, NATURE, V512, P181, DOI 10.1038/nature13639; RUNCORN SK, 1983, NATURE, V304, P589, DOI 10.1038/304589a0; Siegler MA, 2016, NATURE, V531, P480, DOI 10.1038/nature17166; Takahashi F, 2014, NAT GEOSCI, V7, P409, DOI [10.1038/NGEO2150, 10.1038/ngeo2150]; WATSON K, 1961, J GEOPHYS RES, V66, P1598, DOI 10.1029/JZ066i005p01598	6	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					455	456		10.1038/531455a	http://dx.doi.org/10.1038/531455a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	27008964				2022-12-28	WOS:000372701300029
J	Hallett, JEH; Manning, BD				Hallett, James E. Hughes; Manning, Brendan D.			CASTORing New Light on Amino Acid Sensing	CELL			English	Editorial Material							MTORC1; SUFFICIENCY	The activation state of mTORC1, a master regulator of cell growth, is particularly sensitive to changes in the intracellular levels of the amino acid arginine, but the sensing mechanisms are poorly understood. In this issue of Cell, Chantranupong et al. identify CASTOR1 as a direct arginine sensor that acts through the GATOR2 complex to regulate mTORC1.	[Hallett, James E. Hughes; Manning, Brendan D.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Manning, BD (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	bmanning@hsph.harvard.edu	Manning, Brendan/ABD-6528-2021	Manning, Brendan/0000-0003-3895-5956				Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Carroll B, 2016, ELIFE, V5, DOI 10.7554/eLife.11058; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674	10	12	13	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					15	17		10.1016/j.cell.2016.03.002	http://dx.doi.org/10.1016/j.cell.2016.03.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015302	Bronze			2022-12-28	WOS:000372785600004
J	Koh, MJ; Nguyen, TT; Zhang, HM; Schrock, RR; Hoveyda, AH				Koh, Ming Joo; Nguyen, Thach T.; Zhang, Hanmo; Schrock, Richard R.; Hoveyda, Amir H.			Direct synthesis of Z-alkenyl halides through catalytic cross-metathesis	NATURE			English	Article							(E)-BETA-ARYL VINYL HALIDES; NATURAL-PRODUCT SYNTHESIS; ONE-POT SYNTHESIS; STEREOSELECTIVE-SYNTHESIS; OLEFIN METATHESIS; BORONIC ACIDS; ENANTIOSELECTIVE SYNTHESIS; TERMINAL ALKYNES; CONVERSION; OXIDATION	Olefin metathesis has had a large impact on modern organic chemistry, but important shortcomings remain: for example, the lack of efficient processes that can be used to generate acyclic alkenyl halides. Halo-substituted ruthenium carbene complexes decompose rapidly or deliver low activity and/or minimal stereoselectivity, and our understanding of the corresponding high-oxidation-state systems is limited. Here we show that previously unknown halo-substituted molybdenum alkylidene species are exceptionally reactive and are able to participate in high-yielding olefin metathesis reactions that afford acyclic 1,2-disubstituted Z-alkenyl halides. Transformations are promoted by small amounts of a catalyst that is generated in situ and used with unpurified, commercially available and easy-to-handle liquid 1,2-dihaloethene reagents, and proceed to high conversion at ambient temperature within four hours. We obtain many alkenyl chlorides, bromides and fluorides in up to 91 per cent yield and complete Z selectivity. This method can be used to synthesize biologically active compounds readily and to perform site-and stereoselective fluorination of complex organic molecules.	[Koh, Ming Joo; Nguyen, Thach T.; Zhang, Hanmo; Hoveyda, Amir H.] Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA; [Schrock, Richard R.] MIT, Dept Chem, Cambridge, MA 02139 USA	Boston College; Massachusetts Institute of Technology (MIT)	Hoveyda, AH (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Koh, Ming Joo/GOV-7124-2022; Koh, Ming Joo/M-6641-2018; Koh, Ming Joo/O-8549-2019	Koh, Ming Joo/0000-0002-2534-4921; Koh, Ming Joo/0000-0002-2534-4921; Koh, Ming Joo/0000-0002-2534-4921	United States National Institutes of Health, Institute of General Medical Sciences [GM-59426, GM-57212]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059426, R01GM057212] Funding Source: NIH RePORTER	United States National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the United States National Institutes of Health, Institute of General Medical Sciences (GM-59426 and in part GM-57212).	Addington DE, 2011, J CLIN PSYCHIAT, V72, P75, DOI 10.4088/JCP.09m05258gre; Akiyama T, 2013, TETRAHEDRON, V69, P6560, DOI 10.1016/j.tet.2013.06.007; Berger R, 2011, CHEM SOC REV, V40, P3496, DOI 10.1039/c0cs00221f; Bronner SM, 2014, CHEM SCI, V5, P4091, DOI 10.1039/c4sc01541j; BROWN HC, 1989, J ORG CHEM, V54, P6079, DOI 10.1021/jo00287a020; Bull JA, 2008, ORG LETT, V10, P5485, DOI 10.1021/ol802315k; Campbell MG, 2014, ORG PROCESS RES DEV, V18, P474, DOI 10.1021/op400349g; Crane EA, 2011, ANGEW CHEM INT EDIT, V50, P9112, DOI 10.1002/anie.201102790; ENGLISH AR, 1990, J MED CHEM, V33, P344, DOI 10.1021/jm00163a055; Fujiwara T, 2014, J FLUORINE CHEM, V167, P16, DOI 10.1016/j.jfluchem.2014.06.014; Furuya T, 2009, ORG LETT, V11, P2860, DOI 10.1021/ol901113t; Fustero S, 2015, CHEM REV, V115, P871, DOI 10.1021/cr500182a; Gao F, 2010, J AM CHEM SOC, V132, P10961, DOI 10.1021/ja104896b; GENSCH KH, 1968, J AM CHEM SOC, V90, P2096, DOI 10.1021/ja01010a031; Gillingham DG, 2007, ANGEW CHEM INT EDIT, V46, P3860, DOI 10.1002/anie.200700501; Gillis EP, 2015, J MED CHEM, V58, P8315, DOI 10.1021/acs.jmedchem.5b00258; HAGINAKA J, 1984, CHEM PHARM BULL, V32, P2752; Hamri S, 2012, TETRAHEDRON, V68, P6269, DOI 10.1016/j.tet.2012.05.053; Hoveyda AH, 2014, J ORG CHEM, V79, P4763, DOI 10.1021/jo500467z; Hoye RC, 2010, J ORG CHEM, V75, P7400, DOI 10.1021/jo100971j; Imaizumi Y, 2002, MOL PHARMACOL, V62, P836, DOI 10.1124/mol.62.4.836; Jang H, 2011, J AM CHEM SOC, V133, P7859, DOI 10.1021/ja2007643; Kiesewetter ET, 2013, J AM CHEM SOC, V135, P6026, DOI 10.1021/ja403188t; Koh MJ, 2015, NATURE, V517, P181, DOI 10.1038/nature14061; KOLB M, 1987, J MED CHEM, V30, P267, DOI 10.1021/jm00385a007; Landelle G, 2011, ORG LETT, V13, P1568, DOI 10.1021/ol200302h; Lopez S, 2005, J ORG CHEM, V70, P6346, DOI 10.1021/jo050807f; Macnaughtan ML, 2007, J AM CHEM SOC, V129, P7708, DOI 10.1021/ja0715952; Macnaughtan ML, 2009, ORGANOMETALLICS, V28, P2880, DOI 10.1021/om800463n; Meek SJ, 2011, NATURE, V471, P461, DOI 10.1038/nature09957; Molander GA, 2008, J ORG CHEM, V73, P6841, DOI 10.1021/jo801191v; Morrill C, 2003, J ORG CHEM, V68, P6031, DOI 10.1021/jo0345345; Nakagawa M, 2005, TETRAHEDRON LETT, V46, P5257, DOI 10.1016/j.tetlet.2005.06.035; Nunnery JK, 2012, J ORG CHEM, V77, P4198, DOI 10.1021/jo300160e; Ohmura T, 2000, J AM CHEM SOC, V122, P4990, DOI 10.1021/ja0002823; Pawluc P, 2009, ORG LETT, V11, P3390, DOI 10.1021/ol901233j; Petasis NA, 1996, TETRAHEDRON LETT, V37, P567, DOI 10.1016/0040-4039(95)02262-7; Rosebrugh LE, 2013, J AM CHEM SOC, V135, P1276, DOI 10.1021/ja311916m; Rosen TC, 2004, CHEMBIOCHEM, V5, P1033, DOI 10.1002/cbic.200400053; Sashuk V, 2008, CHEM COMMUN, P2468, DOI 10.1039/b801687a; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Silverio DL, 2013, NATURE, V494, P216, DOI 10.1038/nature11844; Silverman RB, 1996, J AM CHEM SOC, V118, P1253, DOI 10.1021/ja952789x; Speed AWH, 2014, J AM CHEM SOC, V136, P16136, DOI 10.1021/ja509973r; STORK G, 1989, TETRAHEDRON LETT, V30, P2173, DOI 10.1016/S0040-4039(00)99640-0; Townsend EM, 2013, ORGANOMETALLICS, V32, P4612, DOI 10.1021/om400584f; Tran THH, 2011, ASIAN PAC J TROP MED, V4, P760, DOI 10.1016/S1995-7645(11)60189-2; Vasiliu M, 2011, J PHYS CHEM C, V115, P12106, DOI 10.1021/jp202668p; Zhang HM, 2014, J AM CHEM SOC, V136, P16493, DOI 10.1021/ja510768c; ZHANG XP, 1993, TETRAHEDRON LETT, V34, P1925, DOI 10.1016/S0040-4039(00)91964-6	50	115	117	4	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					459	465		10.1038/nature17396	http://dx.doi.org/10.1038/nature17396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	27008965	Green Submitted, Green Accepted			2022-12-28	WOS:000372701300031
J	Natoli, G				Natoli, Gioacchino			From the Beauty of Genomic Landscapes to the Strength of Transcriptional Mechanisms	CELL			English	Editorial Material							BINDING; SEQ	Genomic analyses are commonly used to infer trends and broad rules underlying transcriptional control. The innovative approach by Tong et al. to interrogate genomic datasets allows extracting mechanistic information on the specific regulation of individual genes.	[Natoli, Gioacchino] European Inst Oncol IEO, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Natoli, G (corresponding author), European Inst Oncol IEO, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	gioacchino.natoli@ieo.eu	Natoli, gioacchino/J-2100-2018; Natoli, gioacchino/ABB-8679-2020	Natoli, Gioacchino/0000-0003-0711-2411				Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Tong AJ, 2016, CELL, V165, P165, DOI 10.1016/j.cell.2016.01.020; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	10	1	2	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					18	19		10.1016/j.cell.2016.03.011	http://dx.doi.org/10.1016/j.cell.2016.03.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015303	Bronze			2022-12-28	WOS:000372785600005
J	Horwitz, RI				Horwitz, Ralph I.			Equity in Cancer Care and Outcomes of Treatment A Different Type of Cancer Moonshot	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Horwitz, Ralph I.] Temple Inst Transformat Med, Philadelphia, PA USA; [Horwitz, Ralph I.] Natl Acad Med, Washington, DC USA	National Academies of Sciences, Engineering & Medicine	Horwitz, RI (corresponding author), Temple Univ, Med, 3400 N Broad St,MERB 1111E, Philadelphia, PA 19140 USA.	ralph.horwitz@temple.edu						American Cancer Society, 2013, CANC FACTS FIG 2013; Hunt BR, 2014, CANCER EPIDEMIOL, V38, P118, DOI 10.1016/j.canep.2013.09.009; LaVeist TA, 2011, INT J HEALTH SERV, V41, P231, DOI 10.2190/HS.41.2.c; Obama B., STATE OF THE UNION; Sui AL, 2015, EVIDENCE BASED CLIN, V314, P2021; Virnig BA, 2009, HEALTH AFFAIR, V28, P160, DOI 10.1377/hlthaff.28.1.160	6	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1231	1232		10.1001/jama.2016.2242	http://dx.doi.org/10.1001/jama.2016.2242			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	27002441				2022-12-28	WOS:000372511100005
J	Tenery, RM				Tenery, Robert M.			Medical Ethics (Reprinted from JAMA, vol 195, pg 1137, 1966)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Tenery R M, 1966, JAMA, V195, P1137, DOI 10.1001/jama.195.13.1137	1	2	2	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1291	1291		10.1001/jama.2015.17079	http://dx.doi.org/10.1001/jama.2015.17079			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	27002461				2022-12-28	WOS:000372511100025
J	Peter, JG; Zijenah, LS; Chanda, D; Clowes, P; Lesosky, M; Gina, P; Mehta, N; Calligaro, G; Lombard, CJ; Kadzirange, G; Bandason, T; Chansa, A; Liusha, N; Mangu, C; Mtafya, B; Msila, H; Rachow, A; Hoelscher, M; Mwaba, P; Theron, G; Dheda, K				Peter, Jonny G.; Zijenah, Lynn S.; Chanda, Duncan; Clowes, Petra; Lesosky, Maia; Gina, Phindile; Mehta, Nirja; Calligaro, Greg; Lombard, Carl J.; Kadzirange, Gerard; Bandason, Tsitsi; Chansa, Abidan; Liusha, Namakando; Mangu, Chacha; Mtafya, Bariki; Msila, Henry; Rachow, Andrea; Hoelscher, Michael; Mwaba, Peter; Theron, Grant; Dheda, Keertan			Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial	LANCET			English	Article							XPERT MTB/RIF; DIAGNOSTIC-ACCURACY; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; ASSAY; PREVALENCE; INFECTION; SETTINGS; ANTIGEN	Background HIV-associated tuberculosis is difficult to diagnose and results in high mortality. Frequent extra-pulmonary presentation, inability to obtain sputum, and paucibacillary samples limits the usefulness of nucleic-acid amplification tests and smear microscopy. We therefore assessed a urine-based, lateral flow, point-of-care, lipoarabinomannan assay (LAM) and the effect of a LAM-guided anti-tuberculosis treatment initiation strategy on mortality. Methods We did a pragmatic, randomised, parallel-group, multicentre trial in ten hospitals in Africa-four in South Africa, two in Tanzania, two in Zambia, and two in Zimbabwe. Eligible patients were HIV-positive adults aged at least 18 years with at least one of the following symptoms of tuberculosis (fever, cough, night sweats, or self-reported weightloss) and illness severity necessitating admission to hospital. Exclusion criteria included receipt of any anti-tuberculosis medicine in the 60 days before enrolment. We randomly assigned patients (1: 1) to either LAM plus routine diagnostic tests for tuberculosis (smear microscopy, Xpert-MTB/RIF, and culture; LAM group) or routine diagnostic tests alone (no LAM group) using computer-generated allocation lists in blocks of ten. All patients were asked to provide a urine sample of at least 30 mL at enrolment, and trained research nurses did the LAM test in patients allocated to this group using the Alere Determine tuberculosis LAM Ag lateral flow strip test (Alere, USA) at the bedside on enrolment. On the basis of a positive test result, the nurses made a recommendation for initiating anti-tuberculosis treatment. The attending physician made an independent decision about whether to start treatment or not. Neither patients nor health-care workers were masked to group allocation and test results. The primary endpoint was 8-week all-cause mortality assessed in the modified intention-to-treat population (those who received their allocated intervention). This trial is registered with ClinicalTrials.gov, number NCT01770730. Findings Between Jan 1, 2013, and Oct 2, 2014, we screened 8728 patients and randomly assigned 2659 to treatment (1336 to LAM, 1323 to no LAM). 108 patients did not receive their allocated treatment, mainly because they did not meet the inclusion criteria, and 23 were excluded from analysis, leaving 2528 in the final modified intention-to-treat analysis (1257 in the LAM group, 1271 in the no LAM group). Overall all-cause 8-week mortality occurred in 578 (23%) patients, 261 (21%) in LAM and 317 (25%) in no LAM, an absolute reduction of 4% (95% CI 1-7). The risk ratio adjusted for country was 0.83 (95% CI 0.73-0.96), p= 0.012, with a relative risk reduction of 17% (95% CI 4-28). With the time-to-event analysis, there were 159 deaths per 100 person-years in LAM and 196 per 100 person-years in no LAM (hazard ratio adjusted for country 0.82 [95% CI 0.70-0.96], p= 0.015). No adverse events were associated with LAM testing. Interpretation Bedside LAM-guided initiation of anti-tuberculosis treatment in HIV-positive hospital inpatients with suspected tuberculosis was associated with reduced 8-week mortality. The implementation of LAM testing is likely to off er the greatest benefit in hospitals where diagnostic resources are most scarce and where patients present with severe illness, advanced immunosuppression, and an inability to self-expectorate sputum.	[Peter, Jonny G.; Chanda, Duncan; Lesosky, Maia; Gina, Phindile; Mehta, Nirja; Calligaro, Greg; Theron, Grant; Dheda, Keertan] South African Med Res Council, Sch Publ Hlth & Family Med, Dept Med, Div Pulmonol, Cape Town, South Africa; [Lombard, Carl J.] South African Med Res Council, Sch Publ Hlth & Family Med, Biostat Unit, Cape Town, South Africa; [Peter, Jonny G.; Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Peter, Jonny G.; Dheda, Keertan] Univ Cape Town, Dept Med, Div Clin Immunol & Allergol, ZA-7925 Cape Town, South Africa; [Zijenah, Lynn S.] Univ Zimbabwe, Coll Hlth Sci, Dept Immunol, Harare, Zimbabwe; [Kadzirange, Gerard] Univ Zimbabwe, Coll Hlth Sci, Dept Med, Harare, Zimbabwe; [Bandason, Tsitsi; Mtafya, Bariki] Biomed Res & Training Inst, Harare, Zimbabwe; [Chanda, Duncan; Chansa, Abidan; Liusha, Namakando; Mwaba, Peter] Univ Teaching Hosp, Lusaka, Zambia; [Clowes, Petra; Mangu, Chacha; Mtafya, Bariki; Msila, Henry; Rachow, Andrea; Hoelscher, Michael] Natl Inst Med Res, Mbeya Med Res Ctr, Mbeya, Tanzania; [Clowes, Petra; Rachow, Andrea; Hoelscher, Michael] Univ Munich, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Rachow, Andrea; Hoelscher, Michael] German Ctr Infect Res, Munich, Germany; [Peter, Jonny G.; Dheda, Keertan] Univ Cape Town, Lung Inst, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Chanda, Duncan; Chansa, Abidan; Liusha, Namakando] Univ Teaching Hosp, Inst Med Res & Training, Lusaka, Zambia; [Theron, Grant] Natl Res Fdn Ctr Excellence Biomed TB Res, Dept Sci & Technol, Tygerberg, South Africa; [Theron, Grant] Univ Stellenbosch, Fac Med & Hlth Sci, Div Mol Biol & Human Genet, Med Res Council,Ctr Mol & Cellular Biol, ZA-7505 Tygerberg, South Africa	South African Medical Research Council; South African Medical Research Council; University of Cape Town; University of Cape Town; University of Zimbabwe; University of Zimbabwe; Biomedical Research Training Institute; University of Zambia; National Institute of Medical Research; University of Munich; German Center for Infection Research; University of Cape Town; University of Zambia; National Research Foundation - South Africa; South African Medical Research Council; Stellenbosch University	Dheda, K (corresponding author), Groote Schuur Hosp, H47 Old Main Bldg, ZA-7925 Observatory, South Africa.	keertan.dheda@uct.ac.za	Hoelscher, Michael/D-3436-2012; Chanda, Duncan/N-1045-2019; Calligaro, Greg/U-7472-2019; Theron, Grant/ABB-1167-2020; Mwaba, Peter/V-6017-2019; Lesosky, Maia/AAM-4174-2020	Theron, Grant/0000-0002-9216-2415; Lesosky, Maia/0000-0002-2026-958X; Peter, Jonathan/0000-0002-2658-0723; Lombard, Carl/0000-0002-2136-6533; Calligaro, Gregory/0000-0001-7324-0775	European Developing Clinical Trials Partnership for the TB Neat project	European Developing Clinical Trials Partnership for the TB Neat project	Funding was provided by the European Developing Clinical Trials Partnership for the TB Neat project.	Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Cox JA, 2010, AIDS REV, V12, P183; Cummings MJ, 2015, INT J TUBERC LUNG D, V19, P1128, DOI 10.5588/ijtld.14.0967; Dheda K, 2016, LANCET, V387, P1211, DOI 10.1016/S0140-6736(15)00151-8; Dheda K, 2013, RESPIROLOGY, V18, P217, DOI 10.1111/resp.12022; Drain PK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006833; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Holtz TH, 2011, LANCET INFECT DIS, V11, P533, DOI 10.1016/S1473-3099(11)70057-3; Kaplan R, 2014, JAIDS-J ACQ IMM DEF, V66, P487, DOI 10.1097/QAI.0000000000000201; Kerkhoff AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103285; Lawn SD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0432-2; Lawn SD, 2015, JAIDS-J ACQ IMM DEF, V69, pE144, DOI 10.1097/QAI.0000000000000672; Lawn SD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-407; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Meldau R, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-58; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Nakiyingi L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0812-4; Pandie S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-101; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Peter JG, 2014, EUR RESPIR J, V43, P185, DOI 10.1183/09031936.00198012; Peter JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054875; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Rudolf F, 2013, SCAND J INFECT DIS, V45, P256, DOI 10.3109/00365548.2012.731077; Shah M, 2014, INT J TUBERC LUNG D, V18, pS1; Shah M, 2010, J CLIN MICROBIOL, V48, P2972, DOI 10.1128/JCM.00363-10; Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Wejse C, 2008, SCAND J INFECT DIS, V40, P111, DOI 10.1080/00365540701558698; World Health Organization (WHO), 2014, WHO REP 2014 GLOB TU	31	158	159	2	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1187	1197		10.1016/S0140-6736(15)01092-2	http://dx.doi.org/10.1016/S0140-6736(15)01092-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG9OB	26970721				2022-12-28	WOS:000372412000030
J	Kobayashi, G; Hinuma, Y; Matsuoka, S; Watanabe, A; Iqbal, M; Hirayama, M; Yonemura, M; Kamiyama, T; Tanaka, I; Kanno, R				Kobayashi, Genki; Hinuma, Yoyo; Matsuoka, Shinji; Watanabe, Akihiro; Iqbal, Muhammad; Hirayama, Masaaki; Yonemura, Masao; Kamiyama, Takashi; Tanaka, Isao; Kanno, Ryoji			Pure H- conduction in oxyhydrides	SCIENCE			English	Article							CRYSTAL-STRUCTURES; HYDRIDE ION; OXIDE; ELECTROLYTE; DIFFUSION; HYDROGEN; DONOR	A variety of proton (H+)-conducting oxides are known, including those used in electrochemical devices such as fuel cells. In contrast, pure H- conduction, not mixed with electron conduction, has not been demonstrated for oxide-based materials. Considering that hydride ions have an ionic size appropriate for fast transport and also a strong reducing ability suitable for high-energy storage and conversion devices, we prepared a series of K2NiF4-type oxyhydrides, La2-x-ySrx+yLiH1-x+yO3-y, in the hope of observing such H- conductors. The performance of an all-solid-state TiH2/o-La2LiHO3 (x = y = 0, o: orthorhombic)/Ti cell provided conclusive evidence of pure H- conduction.	[Kobayashi, Genki; Watanabe, Akihiro] Inst Mol Sci, Res Ctr Integrat Mol Syst CIMoS, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan; [Kobayashi, Genki] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan; [Hinuma, Yoyo; Tanaka, Isao] Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan; [Matsuoka, Shinji; Watanabe, Akihiro; Iqbal, Muhammad; Hirayama, Masaaki; Kanno, Ryoji] Tokyo Inst Technol, Dept Elect Chem, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan; [Yonemura, Masao; Kamiyama, Takashi] High Energy Accelerator Res Org KEK, Neutron Sci Lab KENS, Inst Mat Struct Sci, 203-1 Shirakata, Tokai, Ibaraki 3191106, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Japan Science & Technology Agency (JST); Kyoto University; Tokyo Institute of Technology; High Energy Accelerator Research Organization (KEK)	Kobayashi, G (corresponding author), Inst Mol Sci, Res Ctr Integrat Mol Syst CIMoS, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.; Kobayashi, G (corresponding author), Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.; Kanno, R (corresponding author), Tokyo Inst Technol, Dept Elect Chem, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	gkobayashi@ims.ac.jp; kanno@echem.titech.ac.jp	Iqbal, Muhammad/U-8072-2019; Tanaka, Isao/B-5941-2009; Kobayashi, Genki/GPK-5266-2022; Hirayama, Masaaki/B-5781-2011; Hinuma, Yoyo/AAC-5761-2019; Kobayashi, Genki/D-4928-2016	Tanaka, Isao/0000-0002-4616-118X; Kobayashi, Genki/0000-0001-6528-0355; Hirayama, Masaaki/0000-0003-4804-4208; Kobayashi, Genki/0000-0001-6528-0355; Hinuma, Yoyo/0000-0003-2272-1178; Yonemura, Masao/0000-0002-4444-1997	JST PRESTO [15H05497, 24750209]; Japan Society for the Promotion of Science [25106005, 25106009]; Japan Synchrotron Radiation Research Institute (JASRI) [2013A1/04]; Japan Proton Accelerator Research Complex (J-PARC) [2010A0058]; Spallation Neutron Source (SNS) in the Oakridge National Laboratory [IPTS5808]; Neutron Scattering Program Advisory Committee of IMSS, KEK [2014S10];  [15K13803];  [23655191];  [25620180]; Grants-in-Aid for Scientific Research [15H05497] Funding Source: KAKEN	JST PRESTO(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Synchrotron Radiation Research Institute (JASRI); Japan Proton Accelerator Research Complex (J-PARC); Spallation Neutron Source (SNS) in the Oakridge National Laboratory; Neutron Scattering Program Advisory Committee of IMSS, KEK; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JST PRESTO, and Grant-in-Aid for Young Scientists (A) no. 15H05497 and (B) no. 24750209; Grant-in-Aid for Challenging Exploratory Research nos. 15K13803, 23655191, and 25620180; and Grant-in-Aid for Scientific Research on Innovative Areas nos. 25106005 and 25106009 from the Japan Society for the Promotion of Science. Synchrotron and neutron radiation experiments were carried out as four projects approved by the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal no. 2013A1/04), the Japan Proton Accelerator Research Complex (J-PARC) (Proposal no. 2010A0058), the Spallation Neutron Source (SNS) in the Oakridge National Laboratory (Proposal no. IPTS5808) and the Neutron Scattering Program Advisory Committee of IMSS, KEK (Proposal no. 2014S10). A part of neutron experiments (Proposal no. 2014510) was performed at BL09 Special environment motion powder diffractometer (SHCA) developed by the Research and Development Initiative for Scientific Innovation of New Generation Batteries (RISING) project of the New Energy and Industrial Technology Development Organization (NEDO). Supercomputing time on the Academic Center for Computing and Media Studies (ACCMS) at Kyoto University is gratefully acknowledged. Further information regarding the materials and methods is included in the supplementary materials. G.K., A.W., M.H., and R.K. have filed for a patent application with the Japan Patent Office under no. JP2015-22868 on the H<SUP>-</SUP> conductive oxyhydride system and its manufacture.	ALTORFER F, 1994, SOLID STATE IONICS, V70, P272, DOI 10.1016/0167-2738(94)90322-0; ANDRESEN AF, 1977, J SOLID STATE CHEM, V20, P93, DOI 10.1016/0022-4596(77)90055-X; ATTFIELD JP, 1989, J SOLID STATE CHEM, V80, P112, DOI 10.1016/0022-4596(89)90037-6; Bang J, 2014, J AM CHEM SOC, V136, P7221, DOI 10.1021/ja502277r; Denes G, 1996, SOLID STATE IONICS, V86-8, P77, DOI 10.1016/0167-2738(96)00094-X; Hayashi K, 2005, J PHYS CHEM B, V109, P23836, DOI 10.1021/jp053990p; Hayashi K, 2002, NATURE, V419, P462, DOI 10.1038/nature01053; Hayward MA, 2002, SCIENCE, V295, P1882, DOI 10.1126/science.1068321; Helps RM, 2010, INORG CHEM, V49, P11062, DOI 10.1021/ic101613b; Hull S, 2004, REP PROG PHYS, V67, P1233, DOI 10.1088/0034-4885/67/7/R05; IWAHARA H, 1988, J ELECTROCHEM SOC, V135, P529, DOI 10.1149/1.2095649; Kamaya N, 2011, NAT MATER, V10, P682, DOI [10.1038/NMAT3066, 10.1038/nmat3066]; KANNO R, 1986, SOLID STATE IONICS, V18-9, P1068, DOI 10.1016/0167-2738(86)90310-3; Kobayashi Y, 2012, NAT MATER, V11, P507, DOI [10.1038/nmat3302, 10.1038/NMAT3302]; Lang PF, 2010, DALTON T, V39, P7786, DOI 10.1039/c0dt00401d; Malavasi L, 2010, CHEM SOC REV, V39, P4370, DOI 10.1039/b915141a; Matsuishi S, 2005, J AM CHEM SOC, V127, P12454, DOI 10.1021/ja053568m; Neudecker BJ, 1996, J ELECTROCHEM SOC, V143, P2198, DOI 10.1149/1.1836980; Sakaguchi T, 2012, INORG CHEM, V51, P11371, DOI 10.1021/ic300859n; San-Martin A., 1987, B ALLOY PHASE DIAGR, V8, P30, DOI [10.1007/BF02868888, DOI 10.1007/BF02868888]; Schwarz H., 1991, THESIS U KARLSRUHE; Van de Walle CG, 2000, PHYS REV LETT, V85, P1012, DOI 10.1103/PhysRevLett.85.1012; Van de Walle CG, 2003, NATURE, V423, P626, DOI 10.1038/nature01665; Verbraeken MC, 2015, NAT MATER, V14, P95, DOI [10.1038/nmat4136, 10.1038/NMAT4136]; Verbraeken MC, 2009, J MATER CHEM, V19, P2766, DOI 10.1039/b820173k; WEGNER B, 1992, EUR J SOL STATE INOR, V29, P1217; Zhang JJ, 2014, J PHYS CHEM C, V118, P17254, DOI 10.1021/jp5030334; Zhu B, 2000, ELECTROCHEM COMMUN, V2, P10, DOI 10.1016/S1388-2481(99)00139-3	28	110	109	14	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1314	1317		10.1126/science.aac9185	http://dx.doi.org/10.1126/science.aac9185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989251				2022-12-28	WOS:000372397700041
J	Zastrow, M				Zastrow, Mark			SWIMMING AGAINST THE TIDE	NATURE			English	Editorial Material																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S118	S121		10.1038/531S118a	http://dx.doi.org/10.1038/531S118a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26982022	Bronze			2022-12-28	WOS:000372064300011
J	Albrecht, SM; Higginbotham, AP; Madsen, M; Kuemmeth, F; Jespersen, TS; Nygard, J; Krogstrup, P; Marcus, CM				Albrecht, S. M.; Higginbotham, A. P.; Madsen, M.; Kuemmeth, F.; Jespersen, T. S.; Nygard, J.; Krogstrup, P.; Marcus, C. M.			Exponential protection of zero modes in Majorana islands	NATURE			English	Article							SEMICONDUCTOR NANOWIRE; QUANTUM COMPUTATION; ANDREEV REFLECTION; COULOMB-BLOCKADE; SUPERCONDUCTOR; FERMIONS; PARITY; SIGNATURE; ANYONS; STATES	Majorana zero modes are quasiparticle excitations in condensed matter systems that have been proposed as building blocks of fault-tolerant quantum computers(1). They are expected to exhibit non-Abelian particle statistics, in contrast to the usual statistics of fermions and bosons, enabling quantum operations to be performed by braiding isolated modes around one another(1,2). Quantum braiding operations are topologically protected insofar as these modes are pinned near zero energy, with the departure from zero expected to be exponentially small as the modes become spatially separated(3,4). Following theoretical proposals(5,6), several experiments have identified signatures of Majorana modes in nanowires with proximity-induced superconductivity(7-11) and atomic chains(12), with small amounts of mode splitting potentially explained by hybridization of Majorana modes(13-15). Here, we use Coulombblockade spectroscopy in an InAs nanowire segment with epitaxial aluminium, which forms a proximity-induced superconducting Coulomb island (a ;Majorana island') that is isolated from normalmetal leads by tunnel barriers, to measure the splitting of near-zeroenergy Majorana modes. We observe exponential suppression of energy splitting with increasing wire length. For short devices of a few hundred nanometres, sub-gap state energies oscillate as the magnetic field is varied, as is expected for hybridized Majorana modes. Splitting decreases by a factor of about ten for each half a micrometre of increased wire length. For devices longer than about one micrometre, transport in strong magnetic fields occurs through a zero-energy state that is energetically isolated from a continuum, yielding uniformly spaced Coulomb-blockade conductance peaks, consistent with teleportation via Majorana modes(16,17). Our results help to explain the trivial-to-topological transition in finite systems and to quantify the scaling of topological protection with end-mode separation.	[Albrecht, S. M.; Higginbotham, A. P.; Madsen, M.; Kuemmeth, F.; Jespersen, T. S.; Nygard, J.; Krogstrup, P.; Marcus, C. M.] Univ Copenhagen, Ctr Quantum Devices, Copenhagen, Denmark; [Albrecht, S. M.; Higginbotham, A. P.; Madsen, M.; Kuemmeth, F.; Jespersen, T. S.; Nygard, J.; Krogstrup, P.; Marcus, C. M.] Univ Copenhagen, Niels Bohr Inst, Stn Copenhagen Q, Blegdamsvej 17, DK-2100 Copenhagen, Denmark; [Higginbotham, A. P.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	University of Copenhagen; University of Copenhagen; Niels Bohr Institute; Harvard University	Marcus, CM (corresponding author), Univ Copenhagen, Ctr Quantum Devices, Copenhagen, Denmark.; Marcus, CM (corresponding author), Univ Copenhagen, Niels Bohr Inst, Stn Copenhagen Q, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	marcus@nbi.dk	Kuemmeth, Ferdinand/M-7232-2014; Nygård, Jesper/F-5113-2014; Jespersen, Thomas/L-1490-2015; Krogstrup, Peter/G-4323-2011	Kuemmeth, Ferdinand/0000-0003-3675-7331; Nygård, Jesper/0000-0002-4639-5314; Jespersen, Thomas/0000-0002-7879-976X; Krogstrup, Peter/0000-0002-1930-8553	Microsoft Project Q; Danish National Research Foundation; Lundbeck Foundation; Carlsberg Foundation; European Commission; Villum Foundation	Microsoft Project Q(Microsoft); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Villum Foundation(Villum Fonden)	We thank K. Flensberg, M. Leijnse, M. Deng, W. Chang and R. Lutchyn for discussions, and G. Ungaretti, S. Upadhyay, C. Sorensen, M. von Soosten and D. Sherman for contributions to growth and fabrication. This research was supported by Microsoft Project Q, the Danish National Research Foundation, the Lundbeck Foundation, the Carlsberg Foundation and the European Commission. C. M. M. acknowledges support from the Villum Foundation.	Churchill HOH, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.241401; Csonka S, 2008, NANO LETT, V8, P3932, DOI 10.1021/nl802418w; Das A, 2012, NAT PHYS, V8, P887, DOI [10.1038/NPHYS2479, 10.1038/nphys2479]; Das Sarma S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.220506; Deng MT, 2012, NANO LETT, V12, P6414, DOI 10.1021/nl303758w; Fasth C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.266801; Fu L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.056402; HEKKING FWJ, 1993, PHYS REV LETT, V70, P4138, DOI 10.1103/PhysRevLett.70.4138; HERGENROTHER JM, 1994, PHYS REV LETT, V72, P1742, DOI 10.1103/PhysRevLett.72.1742; Higginbotham AP, 2015, NAT PHYS, V11, P1017, DOI [10.1038/nphys3461, 10.1038/NPHYS3461]; Hutzen R, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.166403; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Kitaev AY., 2001, PHYS-USP+, V44, P131, DOI [10.1070/1063-7869/44/10S/S29, DOI 10.1070/1063-7869/44/10S/S29]; Krogstrup P, 2015, NAT MATER, V14, P400, DOI [10.1038/nmat4176, 10.1038/NMAT4176]; Lutchyn RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077001; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Nadj-Perge S, 2014, SCIENCE, V346, P602, DOI 10.1126/science.1259327; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Oreg Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177002; Rainis D, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.024515; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; Rokhinson LP, 2012, NAT PHYS, V8, P795, DOI [10.1038/NPHYS2429, 10.1038/nphys2429]; Sau JD, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.020511; Schroer MD, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.176811; Stanescu TD, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.094518; TUOMINEN MT, 1992, PHYS REV LETT, V69, P1997, DOI 10.1103/PhysRevLett.69.1997	30	760	767	17	286	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					206	+		10.1038/nature17162	http://dx.doi.org/10.1038/nature17162			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26961654	Green Submitted			2022-12-28	WOS:000371665100035
J	Kullo, IJ; Rooke, TW				Kullo, Iftikhar J.; Rooke, Thom W.			Peripheral Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANKLE-BRACHIAL INDEX; CARDIOVASCULAR EVENTS; LOWER-EXTREMITY; TASK-FORCE; SUPERVISED EXERCISE; PRACTICE GUIDELINES; RISK-FACTORS; MANAGEMENT; REVASCULARIZATION; PREVALENCE	A 61-year-old woman presents with a 3-year history of discomfort in the right thigh on exertion. Her symptoms have recently progressed to involve the right calf. She is able to walk no more than 50 m before having to stop because of leg pain. Her medical history is notable for coronary-artery bypass surgery after a myocardial infarction at 55 years of age and for hyperlipidemia, for which she takes atorvastatin at a dose of 40 mg daily. She has a smoking history of 50 pack-years and currently smokes eight cigarettes per day. On examination, the blood pressure is 126/82 mm Hg, there is a bruit over the right femoral artery, and pulses are diminished in the right leg. How would you evaluate and manage this case?	[Kullo, Iftikhar J.] Mayo Clin, Div Cardiovasc Dis, 200 First St SW, Rochester, MN 55905 USA; Mayo Clin, Gonda Vasc Ctr, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Kullo, IJ (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 First St SW, Rochester, MN 55905 USA.	kullo.iftikhar@mayo.edu						Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; Anand S, 2007, NEW ENGL J MED, V357, P217; Arain FA, 2012, J AM COLL CARDIOL, V59, P400, DOI 10.1016/j.jacc.2011.09.055; Berger JS, 2009, JAMA-J AM MED ASSOC, V301, P1909, DOI 10.1001/jama.2009.623; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bonaca MP, 2013, CIRCULATION, V127, P1522, DOI 10.1161/CIRCULATIONAHA.112.000679; Cacoub PP, 2009, EUR HEART J, V30, P192, DOI 10.1093/eurheartj/ehn534; Chen Q, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000304; Chiu KWH, 2010, EUR J VASC ENDOVASC, V39, P460, DOI 10.1016/j.ejvs.2009.12.014; Conte MS, 2015, J VASC SURG, V61, p1S, DOI 10.1016/j.jvs.2014.12.006; Cooke JP, 2015, CIRC RES, V116, P1561, DOI 10.1161/CIRCRESAHA.115.303565; Coutinho T, 2011, VASC MED, V16, P203, DOI 10.1177/1358863X11400935; Dougherty M, 2007, J VASC SURG, V45, P653; Fakhry F, 2015, JAMA-J AM MED ASSOC, V314, P1936, DOI 10.1001/jama.2015.14851; Fleisher LA, 2014, J AM COLL CARDIOL, V64, P2373, DOI 10.1016/j.jacc.2014.07.945; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Khaleghi M, 2014, AM J CARDIOL, V114, P928, DOI 10.1016/j.amjcard.2014.06.029; Khawaja FJ, 2009, VASC MED, V14, P381, DOI 10.1177/1358863X09106869; Kullo IJ, 2015, CIRC RES, V116, P1551, DOI 10.1161/CIRCRESAHA.116.303518; Kullo IJ, 2003, VASC MED, V8, P237, DOI 10.1191/1358863x03vm511oa; Kumbhani DJ, 2014, EUR HEART J, V35, P2864, DOI 10.1093/eurheartj/ehu080; Lin JS, 2013, ANN INTERN MED, V159, P333, DOI 10.7326/0003-4819-159-5-201309030-00007; Mahoney EM, 2008, CIRC-CARDIOVASC QUAL, V1, P38, DOI 10.1161/CIRCOUTCOMES.108.775247; McDermott MM, 2013, JAMA-J AM MED ASSOC, V310, P57, DOI 10.1001/jama.2013.7231; McFalls EO, 2004, NEW ENGL J MED, V351, P2795, DOI 10.1056/NEJMoa041905; Mohler ER, 2003, CIRCULATION, V108, P1481, DOI 10.1161/01.CIR.0000090686.57897.F5; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Murphy TP, 2012, CIRCULATION, V125, P130, DOI 10.1161/CIRCULATIONAHA.111.075770; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Singh S, 2013, INT J CARDIOL, V162, P228, DOI 10.1016/j.ijcard.2011.05.068; Sobieszczyk P, 2013, CIRCULATION, V128, P749, DOI 10.1161/CIRCULATIONAHA.113.001560; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Stevens JW, 2012, BRIT J SURG, V99, P1630, DOI 10.1002/bjs.8895; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tangelder MJD, 2000, LANCET, V355, P346; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wahlgren CM, 2011, ARTERIOSCL THROM VAS, V31, P678, DOI 10.1161/ATVBAHA.110.210385; Wennberg PW, 2013, CIRCULATION, V128, P2241, DOI 10.1161/CIRCULATIONAHA.113.000502; Willigendael EM, 2005, J VASC SURG, V42, P67, DOI 10.1016/j.jvs.2005.03.024; Yusuf S, 2000, NEW ENGL J MED, V342, P145	50	134	147	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					861	871		10.1056/NEJMcp1507631	http://dx.doi.org/10.1056/NEJMcp1507631			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF2FT	26962905				2022-12-28	WOS:000371158400010
J	O'Loghlen, S; Hall, GJ; Zeiadin, N; Milne, L; Mussari, B				O'Loghlen, Sean; Hall, Grayson J.; Zeiadin, Nadil; Milne, Laura; Mussari, Benedetto			Adventitial Cystic Disease of the Common Femoral Vein-A Rare Mimic of Deep Venous Thrombosis: A Case Report	ANNALS OF INTERNAL MEDICINE			English	Letter									[O'Loghlen, Sean; Hall, Grayson J.; Zeiadin, Nadil; Milne, Laura; Mussari, Benedetto] Queens Univ, Kingston, ON, Canada	Queens University - Canada	O'Loghlen, S (corresponding author), Queens Univ, Kingston, ON, Canada.							Jayaraj A, 2011, ANN VASC SURG, V25, DOI 10.1016/j.avsg.2010.10.016; Jones DW, 2012, J VASC SURG, V55, P522, DOI 10.1016/j.jvs.2011.06.117; Maldonado-Fernandez N, 2004, EJVES EXTRA, V8, P10, DOI DOI 10.1016/J.EJVSEXTRA.2004.05.009; Paravastu SCV, 2012, VASC ENDOVASC SURG, V46, P5, DOI 10.1177/1538574411419377; Seo JY, 2009, KOREAN J RADIOL, V10, P89, DOI 10.3348/kjr.2009.10.1.89	5	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					75	76		10.7326/L15-0532	http://dx.doi.org/10.7326/L15-0532			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	26955006				2022-12-28	WOS:000379215800028
J	Tartof, SY; Qian, L; Rieg, GK; Yu, KC; Sy, LS; Tseng, HF; Hechter, RC; Jacobsen, SJ				Tartof, Sara Y.; Qian, Lei; Rieg, Gunter K.; Yu, Kalvin C.; Sy, Lina S.; Tseng, Hung Fu; Hechter, Rulin C.; Jacobsen, Steven J.			Safety of Seasonal Influenza Vaccination in Hospitalized Surgical Patients A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INCREASE INFLUENZA; RATES; SCORE; IMMUNIZATION; VACCINES; ADULTS; RISKS	Background: Despite recommendations to vaccinate surgical inpatients against influenza, vaccination rates remain low in this population, due in part to concerns about potential negative effects on postsurgical care. Objective: To evaluate whether influenza vaccination in the perioperative period increases health care utilization and evaluations for postsurgical infection after discharge. Design: Retrospective cohort study. Setting: Members of Kaiser Permanente Southern California. Participants: Patients aged 6 months or older who had inpatient surgery with admission and discharge between 1 September and 31 March from 2010 to 2013. Measurements: All influenza vaccinations administered between 1 August and 30 April in the 2010-2011, 2011-2012, and 2012-2013 influenza seasons. Outcomes included rates of outpatient visits, readmission, emergency department (ED) visits, fever (temperature >= 38.0 degrees C), and clinical laboratory evaluations for infection (urine culture, complete blood count, blood culture, and wound culture) in the 7 days after discharge. Results: Of the 42 777 surgeries included in adjusted analyses, vaccine was administered during hospitalization in 6420. No differences were detected between the vaccinated and unvaccinated groups in risk for inpatient visits (rate ratio [RR], 1.12 [95% CI, 0.96 to 1.32]), ED visits (RR, 1.07 [CI, 0.96 to 1.20]), postdischarge fever (RR, 1.00 [CI, 0.76 to 1.31]), or clinical evaluations for infection (RR, 1.06 [CI, 0.99 to 1.13]). A marginal increase in risk for outpatient visits (RR, 1.05 [CI, 1.00 to 1.10]; P = 0.032) was found. Limitation: The study did not distinguish between planned and unplanned readmissions or outpatient visits. Conclusion: No strong evidence of increased risk for adverse outcomes was found in comparisons of patients who received influenza vaccine during a surgical hospitalization and those who did not. The data support the recommendation to vaccinate surgical inpatients against influenza.	[Tartof, Sara Y.; Qian, Lei; Rieg, Gunter K.; Yu, Kalvin C.; Sy, Lina S.; Tseng, Hung Fu; Hechter, Rulin C.; Jacobsen, Steven J.] Kaiser Permanente So Calif, 100 South Los Robles Ave,2nd Floor, Pasadena, CA 91101 USA	Kaiser Permanente	Tartof, SY (corresponding author), Kaiser Permanente So Calif, 100 South Los Robles Ave,2nd Floor, Pasadena, CA 91101 USA.	sara.y.tartof@kp.org; lei.x.qian@kp.org	Hechter, Rulin/AAQ-7132-2021; Sy, Lina/AFM-9458-2022	Sy, Lina/0000-0003-2762-9266; Tartof, Sara/0000-0003-2336-8476	Centers for Disease Control and Prevention [200-2012-53580]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded through the Vaccine Safety Datalink under contract 200-2012-53580 from the Centers for Disease Control and Prevention.	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Berry BB, 2001, VACCINE, V19, P3493, DOI 10.1016/S0264-410X(01)00068-8; Bloom HG, 1999, J AM GERIATR SOC, V47, P106, DOI 10.1111/j.1532-5415.1999.tb01910.x; Chen WS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-82; FEDSON DS, 1992, ANN INTERN MED, V116, P550, DOI 10.7326/0003-4819-116-7-550; Freedman JL, 2015, PEDIATRICS, V135, pE540, DOI 10.1542/peds.2014-0943; GLEZEN WP, 1982, EPIDEMIOL REV, V4, P25, DOI 10.1093/oxfordjournals.epirev.a036250; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Grohskopf LA, 2015, AM J TRANSPLANT, V15, P2767, DOI [10.15585/mmwr.mm6430a3, 10.1111/ajt.13505]; Grohskopf LA, 2013, MMWR RECOMM REP, V62, P1; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Koebnick Corinna, 2012, Perm J, V16, P37; Lawson F, 2000, J GERONTOL A-BIOL, V55, pM522, DOI 10.1093/gerona/55.9.M522; Localio AR, 2007, J CLIN EPIDEMIOL, V60, P874, DOI 10.1016/j.jclinepi.2006.12.001; Merkow RP, 2015, JAMA-J AM MED ASSOC, V313, P483, DOI 10.1001/jama.2014.18614; Nichol KL, 1998, AM J MED, V105, P385, DOI 10.1016/S0002-9343(98)00293-9; Rhee D, 2013, PEDIATRICS, V131, pE829, DOI 10.1542/peds.2012-2244; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Short JA, 2006, PEDIATR ANESTH, V16, P514, DOI 10.1111/j.1460-9592.2006.01897.x; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Vellozzi C, 2009, VACCINE, V27, P2114, DOI 10.1016/j.vaccine.2009.01.125; Yang D, 2012, SAS GLOB FOR ORL FLO; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	25	10	10	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					593	+		10.7326/M15-1667	http://dx.doi.org/10.7326/M15-1667			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	26974053				2022-12-28	WOS:000375744000017
J	Miller, MR; Mannowetz, N; Iavarone, AT; Safavi, R; Gracheva, EO; Smith, JF; Hill, RZ; Bautista, DM; Kirichok, Y; Lishko, PV				Miller, Melissa R.; Mannowetz, Nadja; Iavarone, Anthony T.; Safavi, Rojin; Gracheva, Elena O.; Smith, James F.; Hill, Rose Z.; Bautista, Diana M.; Kirichok, Yuriy; Lishko, Polina V.			Unconventional endocannabinoid signaling governs sperm activation via the sex hormone progesterone	SCIENCE			English	Article							MALE-FERTILITY; CA2+ CHANNEL; NONGENOMIC ACTIONS; STEROID-HORMONES; PATCH-CLAMP; SPERMATOZOA; MOTILITY; 2-ARACHIDONOYLGLYCEROL; PRINCIPAL; RECEPTOR	Steroids regulate cell proliferation, tissue development, and cell signaling via two pathways: a nuclear receptor mechanism and genome-independent signaling. Sperm activation, egg maturation, and steroid-induced anesthesia are executed via the latter pathway, the key components of which remain unknown. Here, we present characterization of the human sperm progesterone receptor that is conveyed by the orphan enzyme alpha/beta hydrolase domain-containing protein 2 (ABHD2). We show that ABHD2 is highly expressed in spermatozoa, binds progesterone, and acts as a progesterone-dependent lipid hydrolase by depleting the endocannabinoid 2-arachidonoylglycerol (2AG) from plasma membrane. The 2AG inhibits the sperm calcium channel (CatSper), and its removal leads to calcium influx via CatSper and ensures sperm activation. This study reveals that progesterone-activated endocannabinoid depletion by ABHD2 is a general mechanism by which progesterone exerts its genome-independent action and primes sperm for fertilization.	[Miller, Melissa R.; Mannowetz, Nadja; Safavi, Rojin; Hill, Rose Z.; Bautista, Diana M.; Lishko, Polina V.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Iavarone, Anthony T.] Univ Calif Berkeley, Chem Mass Spectrometry Facil QB3, 229 Stanley Hall, Berkeley, CA 94720 USA; [Gracheva, Elena O.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06536 USA; [Gracheva, Elena O.] Yale Univ, Sch Med, Dept Neurosci, Program Cellular Neurosci Neurodegenerat & Repair, 333 Cedar St, New Haven, CT 06536 USA; [Smith, James F.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Kirichok, Yuriy] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Yale University; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lishko, PV (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	lishko@berkeley.edu	Lishko, Polina/GQH-9569-2022; Lishko, Polina/L-1191-2017	Hill, Rose/0000-0001-9558-6400; Gracheva, Elena O/0000-0002-0846-3427; Safavi, Rojin/0000-0002-5584-269X	NIH [R01GM111802, R21HD081403, R01HD068914, NIH R01AR059385, S10RR025622, 1S100D020062-01]; Pew Scholars, and Alfred P. Sloan Awards; UC Berkeley; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD081403, R01HD068914] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111802] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020062] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars, and Alfred P. Sloan Awards; UC Berkeley; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank L Kohlstaedt for protein mass spectrometry and peptide identification. This work was supported by NIH R01GM111802 to P.V.L. and J.F.S, R21HD081403, Pew Scholars, and Alfred P. Sloan Awards to P.V.L.; NIH R01HD068914 to Y.K., and NIH R01AR059385 to D.M.B. The Vincent J. Proteomics and Mass Spectrometry Laboratory at University of California (QC) Berkeley, is supported. by NIH S10 Instrumentation grant S10RR025622. The combined (QB3/Chemistry Mass Spectrometry Facility at UC Berkeley is supported. by NIH S10 grant 1S100D020062-01. The authors thank R. Heald (UC Berkeley) for critical reading of the manuscript, D. Julius (UC San Francisco) for help with next-generation sequencing, and M. Okabe (Osaka University, Japan) and J.-J. Chung (Yale University) for transgenic nice used in this study. P.V.L., RPM., and Y.K. are inventors on a patent application filed by UC Berkeley related to usage and application of ABHD2. B6D2-Tg(CAG/Su9-DsRed2,Acr3-EGFP) RB3S0020sb transgenic mice were transferred to TIC Berkeley under material transfer agreement 13-176 with Osaka University. M.R.M. and P.V.L conceived the project, designed the experiments, and wrote the manuscript. M.R.M. performed most of the experiments. P.V.L led, the study, helped with plot experiments, generated transcriptomes, and provided financial support for the project. A.T.I. performed lipid mass spectrometry, and lipid analysis and identification. N.M. helped with pilot experiments. R.S. helped with recombinant protein binding experiments. Y.K. provided support for the transcriptome construction and P4* synthesis. E.O.G. generated libraries for the transcriptomes. J.F.S. helped. with computer-aided sperm analysis experiments. R.Z.H. and D.M.B. helped with calcium imaging All authors discussed the results and commenter on the manuscript.	BALDI E, 1991, J ANDROL, V12, P323; BLACKMORE PF, 1990, J BIOL CHEM, V265, P1376; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Catanzaro G, 2011, MOL CELL ENDOCRINOL, V343, P88, DOI 10.1016/j.mce.2011.01.022; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; Cobellis G, 2010, BIOL REPROD, V82, P451, DOI 10.1095/biolreprod.109.079210; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Grimaldi P, 2012, CELL MOL LIFE SCI, V69, P4177, DOI 10.1007/s00018-012-1074-6; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Lenzi A, 2000, MOL HUM REPROD, V6, P226, DOI 10.1093/molehr/6.3.226; Lishko P, 2013, METHOD ENZYMOL, V525, P59, DOI 10.1016/B978-0-12-397944-5.00004-3; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Maccarrone M, 2003, J BIOL CHEM, V278, P32726, DOI 10.1074/jbc.M302123200; Miyata K, 2005, BIOCHEM BIOPH RES CO, V329, P296, DOI 10.1016/j.bbrc.2005.01.127; OSMAN RA, 1989, BIOCHEM BIOPH RES CO, V160, P828, DOI 10.1016/0006-291X(89)92508-4; Poisbeau P, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00174; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Rejraji H, 2006, BIOL REPROD, V74, P1104, DOI 10.1095/biolreprod.105.049304; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Revelli A, 1998, ENDOCR REV, V19, P3, DOI 10.1210/er.19.1.3; Smith JF, 2013, P NATL ACAD SCI USA, V110, P6823, DOI 10.1073/pnas.1216588110; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775	29	145	155	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285					555	559		10.1126/science.aad6887	http://dx.doi.org/10.1126/science.aad6887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	26989199	Green Accepted			2022-12-28	WOS:000374998600038
J	McCoy, VE; Saupe, EE; Lamsdell, JC; Tarhan, LG; McMahon, S; Lidgard, S; Mayer, P; Whalen, CD; Soriano, C; Finney, L; Vogt, S; Clark, EG; Anderson, RP; Petermann, H; Locatelli, ER; Briggs, DEG				McCoy, Victoria E.; Saupe, Erin E.; Lamsdell, James C.; Tarhan, Lidya G.; McMahon, Sean; Lidgard, Scott; Mayer, Paul; Whalen, Christopher D.; Soriano, Carmen; Finney, Lydia; Vogt, Stefan; Clark, Elizabeth G.; Anderson, Ross P.; Petermann, Holger; Locatelli, Emma R.; Briggs, Derek E. G.			The 'Tully monster' is a vertebrate	NATURE			English	Article							FOSSIL; ILLINOIS	Problematic fossils, extinct taxa of enigmatic morphology that cannot be assigned to a known major group, were once a major issue in palaeontology. A long-favoured solution to the 'problem of the problematica'(1), particularly the 'weird wonders'(2) of the Cambrian Burgess Shale, was to consider them representatives of extinct phyla. A combination of new evidence and modern approaches to phylogenetic analysis has now resolved the affinities of most of these forms. Perhaps the most notable exception is Tullimonstrum gregarium(3), popularly known as the Tully monster, a large soft-bodied organism from the late Carboniferous Mazon Creek biota (approximately 309-307 million years ago) of Illinois, USA, which was designated the official state fossil of Illinois in 1989. Its phylogenetic position has remained uncertain and it has been compared with nemerteans(4,5), polychaetes(4), gastropods(4), conodonts(6), and the stem arthropod Opabinia(4). Here we review the morphology of Tullimonstrum based on an analysis of more than 1,200 specimens. We find that the anterior proboscis ends in a buccal apparatus containing teeth, the eyes project laterally on a long rigid bar, and the elongate segmented body bears a caudal fin with dorsal and ventral lobes(3-6). We describe new evidence for a notochord, cartilaginous arcualia, gill pouches, articulations within the proboscis, and multiple tooth rows adjacent to the mouth. This combination of characters, supported by phylogenetic analysis, identifies Tullimonstrum as a vertebrate, and places it on the stem lineage to lampreys (Petromyzontida). In addition to increasing the known morphological disparity of extinct lampreys(7-9), a chordate affinity for T. gregarium resolves the nature of a soft-bodied fossil which has been debated for more than 50 years.	[McCoy, Victoria E.; Saupe, Erin E.; Lamsdell, James C.; Tarhan, Lidya G.; McMahon, Sean; Whalen, Christopher D.; Clark, Elizabeth G.; Anderson, Ross P.; Petermann, Holger; Locatelli, Emma R.; Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, 210 Whitney Ave, New Haven, CT 06511 USA; [Lamsdell, James C.] Amer Museum Nat Hist, Cent Pk West & 79th St, New York, NY 10024 USA; [Lidgard, Scott; Mayer, Paul] Field Museum Nat Hist, 1400 S Lake Shore Dr, Chicago, IL 60605 USA; [Soriano, Carmen; Finney, Lydia; Vogt, Stefan] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Briggs, Derek E. G.] Yale Peabody Museum Nat Hist, 170 Whitney Ave, New Haven, CT 06511 USA	Yale University; American Museum of Natural History (AMNH); Field Museum of Natural History (Chicago); United States Department of Energy (DOE); Argonne National Laboratory; Yale University	McCoy, VE (corresponding author), Yale Univ, Dept Geol & Geophys, 210 Whitney Ave, New Haven, CT 06511 USA.	victoria.mccoy@yale.edu	Vogt, Stefan/B-9547-2009; Vogt, Stefan/J-7937-2013	Vogt, Stefan/0000-0002-8034-5513; Vogt, Stefan/0000-0002-8034-5513; soriano, carmen/0000-0003-3963-3393; McMahon, Sean/0000-0001-8589-2041; Saupe, Erin/0000-0002-0370-9897; Whalen, Christopher/0000-0002-9929-8526; Anderson, Ross/0000-0002-0558-7563; Tarhan, Lidya/0000-0002-5878-929X; Lamsdell, James/0000-0002-1045-9574	US Department of Energy Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; Field Museum visiting scholarship; NASA Astrobiology Institute Foundations of Complex Life, Evolution, Preservation and Detection on Earth and Beyond [NNA13AA90A]	US Department of Energy Office of Science by Argonne National Laboratory; Field Museum visiting scholarship; NASA Astrobiology Institute Foundations of Complex Life, Evolution, Preservation and Detection on Earth and Beyond	We thank affiliates of the Field Museum of Natural History: J. Voight and J. Wittry for discussion; P. Heck for help with scanning electron microscopy and energy-dispersive spectroscopy; and N. Karpus for specimen photography. This research used resources of the Advanced Photon Source, a US Department of Energy Office of Science User Facility operated for the US Department of Energy Office of Science by Argonne National Laboratory under contract number DE-AC02-06CH11357. The Field Museum of Natural History, the Sedgwick Museum in Cambridge, UK, and C. Eaton at the University of Wisconsin-Madison Geology Museum provided access to specimens. Access to the software TNT for phylogenetic analysis was provided by the Willi Hennig Society. Funding was provided by a Field Museum visiting scholarship to V.E.M. and by the NASA Astrobiology Institute (NNA13AA90A) Foundations of Complex Life, Evolution, Preservation and Detection on Earth and Beyond.	Alibardi L, 2011, ZOOL STUD, V50, P416; BAIRD G C, 1986, Palaios, V1, P271, DOI 10.2307/3514690; BARDACK D, 1977, Fieldiana Geology, V33, P489; BARDACK D, 1991, SCIENCE, V254, P701, DOI 10.1126/science.254.5032.701; Bardack D., 1971, BIOL LAMPREYS, V1, P67; Beall B.S., 1991, P271; BENGTSON S., 1986, PROBLEMATIC FOSSIL T, P3; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foster M.W., 1979, P269; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gould S. J., 1990, WONDERFUL LIFE BURGE; Jacobs DK, 2000, EVOL DEV, V2, P340, DOI 10.1046/j.1525-142x.2000.00077.x; JANVIER P, 1981, Journal of Vertebrate Paleontology, V1, P121; Janvier P, 2015, HAGFISH BIOL, P73; Janvier P, 1996, OXFORD MONOGRAPHS GE, V33; Janvier P, 2015, NATURE, V520, P483, DOI 10.1038/nature14437; JOHNSON R G, 1969, Fieldiana Geology, V12, P119; Maddison WP., 2021, MESQUITE MODULAR SYS; McDowall RM, 2008, J BIOGEOGR, V35, P501, DOI 10.1111/j.1365-2699.2007.01823.x; Meeuwig MH, 2006, J MORPHOL, V267, P623, DOI 10.1002/jmor.10427; Morris SC, 2014, NATURE, V512, P419, DOI 10.1038/nature13414; RICHARDSON ES, 1966, SCIENCE, V151, P75, DOI 10.1126/science.151.3706.75-a; Sansom RS, 2013, PALAEONTOLOGY, V56, P457, DOI 10.1111/pala.12037; Scheltema AH, 2003, J MORPHOL, V257, P219, DOI 10.1002/jmor.10121; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; YALDEN DW, 1985, ZOOL J LINN SOC-LOND, V84, P291, DOI 10.1111/j.1096-3642.1985.tb01802.x	28	23	24	3	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 28	2016	532	7600					496	+		10.1038/nature16992	http://dx.doi.org/10.1038/nature16992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK3KQ	26982721	Green Submitted			2022-12-28	WOS:000374815900046
J	Frieden, TR; Houry, D				Frieden, Thomas R.; Houry, Debra			Reducing the Risks of Relief - The CDC Opioid-Prescribing Guideline	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PAIN		[Frieden, Thomas R.; Houry, Debra] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA USA.			Frieden, Thomas/0000-0002-4759-2256	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Braden JB, 2012, J PAIN, V13, P64, DOI 10.1016/j.jpain.2011.10.007; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Hina N, 2015, EUR J ANAESTH, V32, P255, DOI 10.1097/EJA.0000000000000197; Kaplovitch E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134550; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714	5	159	160	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16					1501	1504		10.1056/NEJMp1515917	http://dx.doi.org/10.1056/NEJMp1515917			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ7IA	26977701	Green Accepted, Bronze			2022-12-28	WOS:000374383900001
J	Gostin, LO; Mundaca-Shah, CC; Kelley, PW				Gostin, Lawrence O.; Mundaca-Shah, Carmen C.; Kelley, Patrick W.			Neglected Dimensions of Global Security The Global Health Risk Framework Commission	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA; [Mundaca-Shah, Carmen C.; Kelley, Patrick W.] Natl Acad Sci Engn & Med, Washington, DC USA	Georgetown University; National Academies of Sciences, Engineering & Medicine	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2008, INT HLTH REG; Commission on a Global Health Risk Framework for the Future; National Academy of Medicine Secretariat, 2016, NEGL DIM GLOB SEC; Implementation of the International Health Regulations, 2015, REPORT IMPLEMENTATIO; Lee JW, 2008, LEARNING SARS PREPAR, P92; Medecins Sans Frontieres, PUSH LIM; UN Development Group Western and Central Africa,, 2015, SOC IMP EB VIR DIS W	6	14	14	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1451	1452		10.1001/jama.2016.1964	http://dx.doi.org/10.1001/jama.2016.1964			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	27010490				2022-12-28	WOS:000373873800008
J	Zhang, Y; Zhang, XF; Fleming, MR; Amiri, A; El-Hassar, L; Surguchev, AA; Hyland, C; Jenkins, DP; Desai, R; Brown, MR; Gazula, VR; Waters, MF; Large, CH; Horvath, TL; Navaratnam, D; Vaccarino, FM; Forscher, P; Kaczmarek, LK				Zhang, Yalan; Zhang, Xiao-Feng; Fleming, Matthew R.; Amiri, Anahita; El-Hassar, Lynda; Surguchev, Alexei A.; Hyland, Callen; Jenkins, David P.; Desai, Rooma; Brown, Maile R.; Gazula, Valeswara-Rao; Waters, Michael F.; Large, Charles H.; Horvath, Tamas L.; Navaratnam, Dhasakumar; Vaccarino, Flora M.; Forscher, Paul; Kaczmarek, Leonard K.			Kv3.3 Channels Bind Hax-1 and Arp2/3 to Assemble a Stable Local Actin Network that Regulates Channel Gating	CELL			English	Article							POTASSIUM CHANNELS; PROTEIN; COMPLEX; INACTIVATION; MODULATION; CORTACTIN; SUBUNITS	Mutations in the Kv3.3 potassium channel (KCNC3) cause cerebellar neurodegeneration and impair auditory processing. The cytoplasmic C terminus of Kv3.3 contains a proline-rich domain conserved in proteins that activate actin nucleation through Arp2/3. We found that Kv3.3 recruits Arp2/3 to the plasma membrane, resulting in formation of a relatively stable cortical actin filament network resistant to cytochalasin D that inhibits fast barbed end actin assembly. These Kv3.3-associated actin structures are required to prevent very rapid N-type channel inactivation during short depolarizations of the plasma membrane. The effects of Kv3.3 on the actin cytoskeleton are mediated by the binding of the cytoplasmic C terminus of Kv3.3 to Hax-1, an antiapoptotic protein that regulates actin nucleation through Arp2/3. A human Kv3.3 mutation within a conserved proline-rich domain produces channels that bind Hax-1 but are impaired in recruiting Arp2/3 to the plasma membrane, resulting in growth cones with deficient actin veils in stem cell-derived neurons.	[Zhang, Yalan; Fleming, Matthew R.; El-Hassar, Lynda; Surguchev, Alexei A.; Jenkins, David P.; Desai, Rooma; Brown, Maile R.; Gazula, Valeswara-Rao; Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA; [Kaczmarek, Leonard K.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA; [Amiri, Anahita; Vaccarino, Flora M.] Yale Univ, Sch Med, Child Study Ctr, 333 Cedar St, New Haven, CT 06520 USA; [Amiri, Anahita; Vaccarino, Flora M.] Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06520 USA; [Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06520 USA; [Horvath, Tamas L.] Yale Univ, Sch Med, Dept Comparat Med, 333 Cedar St, New Haven, CT 06520 USA; [Zhang, Xiao-Feng; Hyland, Callen; Forscher, Paul] Yale Univ, Dept Mol Cellular & Dev Biol, 219 Prospect St, New Haven, CT 06520 USA; [Waters, Michael F.] Univ Florida, Coll Med, Dept Neurol, HSC Box 100236, Gainesville, FL 32610 USA; [Large, Charles H.] Imperial Coll Incubator, Autifony Therapeut Ltd, Level 1 Bessemer Bldg, London SW7 2AZ, England	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; State University System of Florida; University of Florida; Imperial College London	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.; Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.; Forscher, P (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, 219 Prospect St, New Haven, CT 06520 USA.	paul.forscher@yale.edu; leonard.kaczmarek@yale.edu	; Zhang, Xiao-Feng/P-7407-2015	Forscher, Paul/0000-0003-1988-5155; Zhang, Xiao-Feng/0000-0001-7240-1397; Vaccarino, Flora/0000-0003-2167-981X	NIH [DC01919, NS028695]; Harris Professorship fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001919, R01DC007894] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harris Professorship fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grants DC01919 (to L.K.K.) and NS028695 (to P.F.) and the Harris Professorship fund (to F.M.V.). We also very gratefully acknowledge the support of Lisa and Mark Shufro.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chang SY, 2007, J COMP NEUROL, V502, P953, DOI 10.1002/cne.21353; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Chen BY, 2014, CELL, V156, P195, DOI 10.1016/j.cell.2013.11.048; Chia PH, 2014, CELL, V156, P208, DOI 10.1016/j.cell.2013.12.009; Cunningham BT, 2004, J BIOMOL SCREEN, V9, P481, DOI 10.1177/1087057104267604; Desai R, 2008, J BIOL CHEM, V283, P22283, DOI 10.1074/jbc.M801663200; Edelstein Arthur D, 2014, J Biol Methods, V1; Fadeel B, 2009, BBA-GEN SUBJECTS, V1790, P1139, DOI 10.1016/j.bbagen.2009.06.004; Fleming MR, 2009, J RECEPT SIG TRANSD, V29, P173, DOI 10.1080/10799890903056883; Gallego-Iradi C, 2014, NEUROBIOL DIS, V71, P270, DOI 10.1016/j.nbd.2014.08.020; Gomathinayagam Rohini, 2014, Genes Cancer, V5, P84; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Hoshi T, 2013, J GEN PHYSIOL, V141, P151, DOI 10.1085/jgp.201210888; Huang CY, 2012, J COMP NEUROL, V520, P3650, DOI 10.1002/cne.23119; Irie T, 2014, J PHYSIOL-LONDON, V592, P229, DOI 10.1113/jphysiol.2013.264309; KANEMASA T, 1995, J NEUROPHYSIOL, V74, P207, DOI 10.1152/jn.1995.74.1.207; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Lee A, 2014, J NEUROSCI, V34, P15159, DOI 10.1523/JNEUROSCI.3275-14.2014; Li W, 2001, J COMP NEUROL, V437, P196, DOI 10.1002/cne.1279; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Macica CM, 2003, J NEUROSCI, V23, P1133, DOI 10.1523/JNEUROSCI.23-04-01133.2003; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Middlebrooks JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076749; Minassian NA, 2012, J PHYSIOL-LONDON, V590, P1599, DOI 10.1113/jphysiol.2012.228205; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollock NS, 2005, EUR J NEUROSCI, V22, P569, DOI 10.1111/j.1460-9568.2005.04242.x; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Sacco T, 2006, MOL CELL NEUROSCI, V33, P170, DOI 10.1016/j.mcn.2006.07.006; Schnizler MK, 2009, J BIOL CHEM, V284, P2697, DOI 10.1074/jbc.M805110200; Simmen T, 2011, EXPERT OPIN THER TAR, V15, P741, DOI 10.1517/14728222.2011.561787; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Yang Q, 2012, J CELL BIOL, V197, P939, DOI 10.1083/jcb.201111052; Yang YM, 2006, J NEUROSCI, V26, P5698, DOI 10.1523/JNEUROSCI.4889-05.2006; Zhang Y., 2015, J PHYSL; Zhao JP, 2013, MOL CELL BIOL, V33, P38, DOI 10.1128/MCB.00734-12	42	44	48	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					434	448		10.1016/j.cell.2016.02.009	http://dx.doi.org/10.1016/j.cell.2016.02.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	26997484	Bronze, Green Accepted			2022-12-28	WOS:000374123000021
J	Koltonow, AR; Huang, JX				Koltonow, Andrew R.; Huang, Jiaxing			IONIC TRANSPORT Two-dimensional nanofluidics	SCIENCE			English	Editorial Material							CHANNELS		[Koltonow, Andrew R.; Huang, Jiaxing] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University	Huang, JX (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.	jiaxing-huang@northwestern.edu	Huang, Jiaxing/B-7521-2009	Huang, Jiaxing/0000-0001-9176-8901				Cheng C, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501272; Gao W, 2011, NAT NANOTECHNOL, V6, P496, DOI [10.1038/NNANO.2011.110, 10.1038/nnano.2011.110]; Guo W, 2013, ADV MATER, V25, P6064, DOI 10.1002/adma.201302441; Nicolosi V, 2013, SCIENCE, V340, P1420, DOI 10.1126/science.1226419; Raidongia K, 2012, J AM CHEM SOC, V134, P16528, DOI 10.1021/ja308167f; Shao JJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8602; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901	7	190	193	20	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1395	1396		10.1126/science.aaf5289	http://dx.doi.org/10.1126/science.aaf5289			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013715				2022-12-28	WOS:000372756200021
J	Knowles, B; Silveira, CB; Bailey, BA; Barott, K; Cantu, VA; Cobian-Guemes, AG; Coutinho, FH; Dinsdale, EA; Felts, B; Furby, KA; George, EE; Green, KT; Gregoracci, GB; Haas, AF; Haggerty, JM; Hester, ER; Hisakawa, N; Kelly, LW; Lim, YW; Little, M; Luque, A; McDole-Somera, T; McNair, K; de Oliveira, LS; Quistad, SD; Robinett, NL; Sala, E; Salamon, P; Sanchez, SE; Sandin, S; Silva, GGZ; Smith, J; Sullivan, C; Thompson, C; Vermeij, MJA; Youle, M; Young, C; Zgliczynski, B; Brainard, R; Edwards, RA; Nulton, J; Thompson, F; Rohwer, F				Knowles, B.; Silveira, C. B.; Bailey, B. A.; Barott, K.; Cantu, V. A.; Cobian-Gueemes, A. G.; Coutinho, F. H.; Dinsdale, E. A.; Felts, B.; Furby, K. A.; George, E. E.; Green, K. T.; Gregoracci, G. B.; Haas, A. F.; Haggerty, J. M.; Hester, E. R.; Hisakawa, N.; Kelly, L. W.; Lim, Y. W.; Little, M.; Luque, A.; McDole-Somera, T.; McNair, K.; de Oliveira, L. S.; Quistad, S. D.; Robinett, N. L.; Sala, E.; Salamon, P.; Sanchez, S. E.; Sandin, S.; Silva, G. G. Z.; Smith, J.; Sullivan, C.; Thompson, C.; Vermeij, M. J. A.; Youle, M.; Young, C.; Zgliczynski, B.; Brainard, R.; Edwards, R. A.; Nulton, J.; Thompson, F.; Rohwer, F.			Lytic to temperate switching of viral communities	NATURE			English	Article							VIRUS-LIKE PARTICLES; LIFE STRATEGIES; CYSTIC-FIBROSIS; METAGENOMIC ANALYSIS; RESPIRATORY-TRACT; BACTERIAL-VIRUSES; MARINE-BACTERIA; GROWTH-RATE; CORAL; DIVERSITY	Microbial viruses can control host abundances via density-dependent lytic predator-prey dynamics. Less clear is how temperate viruses, which coexist and replicate with their host, influence microbial communities. Here we show that virus-like particles are relatively less abundant at high host densities. This suggests suppressed lysis where established models predict lytic dynamics are favoured. Meta-analysis of published viral and microbial densities showed that this trend was widespread in diverse ecosystems ranging from soil to freshwater to human lungs. Experimental manipulations showed viral densities more consistent with temperate than lytic life cycles at increasing microbial abundance. An analysis of 24 coral reef viromes showed a relative increase in the abundance of hallmark genes encoded by temperate viruses with increased microbial abundance. Based on these four lines of evidence, we propose the Piggyback-the-Winner model wherein temperate dynamics become increasingly important in ecosystems with high microbial densities; thus 'more microbes, fewer viruses'.	[Knowles, B.; Silveira, C. B.; Cobian-Gueemes, A. G.; Dinsdale, E. A.; George, E. E.; Green, K. T.; Haas, A. F.; Haggerty, J. M.; Hester, E. R.; Hisakawa, N.; Kelly, L. W.; Lim, Y. W.; Little, M.; Quistad, S. D.; Robinett, N. L.; Sanchez, S. E.; Rohwer, F.] San Diego State Univ, Dept Biol, 5500 Campanile Dr, San Diego, CA 92182 USA; [Silveira, C. B.; Coutinho, F. H.; de Oliveira, L. S.; Thompson, C.; Thompson, F.] Univ Fed Rio de Janeiro, Inst Biol, Ave Carlos Chagas Filho 373, BR-21941599 Rio De Janeiro, Brazil; [Bailey, B. A.; Felts, B.; Luque, A.; Salamon, P.; Nulton, J.] San Diego State Univ, Dept Math & Stat, 5500 Campanile Dr, San Diego, CA 92182 USA; [Barott, K.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, 46-007 Lilipuna Rd, Kaneohe, HI 96744 USA; [Cantu, V. A.; Luque, A.; McNair, K.; Silva, G. G. Z.; Edwards, R. A.] San Diego State Univ, Computat Sci Res Ctr, 5500 Campanile Dr, San Diego, CA 92182 USA; [Coutinho, F. H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 HP Nijmegen, Netherlands; [Dinsdale, E. A.; Luque, A.; Salamon, P.; Edwards, R. A.; Rohwer, F.] San Diego State Univ, Viral Informat Inst, 5500 Campanile Dr, San Diego, CA 92182 USA; [Furby, K. A.; McDole-Somera, T.; Sandin, S.; Smith, J.; Zgliczynski, B.] Scripps Inst Oceanog, 8622 Kennel Way, La Jolla, CA 92037 USA; [Gregoracci, G. B.] Sao Paulo Fed Univ Baixada Santista, Marine Sci Dept, Ave Alm Saldanha da Gama 89, BR-11030400 Sao Paulo, Brazil; [Sala, E.] Natl Geog Soc, 1145 17th St NW, Washington, DC 20036 USA; [Sullivan, C.] Univ Calif San Diego, Dept Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Vermeij, M. J. A.] CARMABI Fdn, Piscaderabaai Z-N, Willemstad, Curacao, Netherlands; [Vermeij, M. J. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Aquat Microbiol, NL-1098 XH Amsterdam, Netherlands; [Youle, M.] Rainbow Rock, Ocean View, HI 96737 USA; [Young, C.; Brainard, R.] NOAA, Coral Reef Ecosyst Div, PIFSC, 1845 Wasp Blvd, Honolulu, HI 96818 USA; [Edwards, R. A.] San Diego State Univ, Dept Comp Sci, 5500 Campanile Dr, San Diego, CA 92182 USA	California State University System; San Diego State University; Universidade Federal do Rio de Janeiro; California State University System; San Diego State University; University of Hawaii System; University of Hawaii Manoa; California State University System; San Diego State University; Radboud University Nijmegen; California State University System; San Diego State University; University of California System; University of California San Diego; Scripps Institution of Oceanography; National Geographic Society; University of California System; University of California San Diego; University of Amsterdam; National Oceanic Atmospheric Admin (NOAA) - USA; California State University System; San Diego State University	Knowles, B; Rohwer, F (corresponding author), San Diego State Univ, Dept Biol, 5500 Campanile Dr, San Diego, CA 92182 USA.; Rohwer, F (corresponding author), San Diego State Univ, Viral Informat Inst, 5500 Campanile Dr, San Diego, CA 92182 USA.	benjaminwilliamknowles@gmail.com; frohwer@gmail.com	Vermeij, Mark/B-2752-2013; Vermeij, Mark/AAR-6757-2020; Santolaria, Toni Luque/ABD-8741-2020; Gregoracci, Gustavo B/E-1848-2013; Thompson, Cristiane C/I-5783-2016; Rohwer, Forest/AAC-5315-2019; Coutinho, Felipe Hernandes/R-3714-2019; Edwards, Robert/Q-1691-2019	Vermeij, Mark/0000-0001-9612-9527; Vermeij, Mark/0000-0001-9612-9527; Santolaria, Toni Luque/0000-0002-5817-4914; Coutinho, Felipe Hernandes/0000-0001-6430-7069; Edwards, Robert/0000-0001-8383-8949; Quistad, Steven/0000-0003-4384-8100; Silveira, Cynthia/0000-0002-9533-5588; Barott, Katie/0000-0001-7371-4870; , Adrian/0000-0002-3168-5140; Gregoracci, Gustavo/0000-0001-6896-1068; Hester, Eric/0000-0002-5232-5574; Little, Mark/0000-0002-6783-8452; Thompson, Fabiano/0000-0002-7562-1683; Rohwer, Forest/0000-0003-1548-5429; dinsdale, elizabeth/0000-0002-2177-203X	Canadian Institute for Advanced Research Integrated Microbial Biodiversity Program Fellowship Award [141679]; National Science Foundation [OISE-1243541, DEB-1046413, CNS-1305112, MCB-1330800, DUE-1323809]; Gordon and Betty Moore Foundation Investigator Award [GBMF-3781]; Brazilian National Research Council (CNPq); Brazilian National Research Council Science Without Borders Program (CNPq/CAPES); Direct For Biological Sciences [1330800] Funding Source: National Science Foundation; Division Of Mathematical Sciences [1107046] Funding Source: National Science Foundation	Canadian Institute for Advanced Research Integrated Microbial Biodiversity Program Fellowship Award; National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation Investigator Award; Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian National Research Council Science Without Borders Program (CNPq/CAPES); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This paper is dedicated to the memory of Mike Furlan, mentor, friend, and colleague. We are grateful to the National Oceanographic and Atmospheric Administration Coral Reef Ecosystem Division for supporting this research, and to the captains and crews of the NOAA ship Hi'ialakai and the Hanse Explorer. Thanks to J. Payet for providing viral and microbial abundance data. Sampling was carried out under research permits from the US Fish and Wildlife Service, Palmyra Atoll National Wildlife Refuge, the Environment and Conservation Division of the Republic of Kiribati (n. 021/13) and ICMBio, Brazil (n. 27147-2). This work was funded by the Canadian Institute for Advanced Research Integrated Microbial Biodiversity Program Fellowship Award 141679 (to F.R.) and National Science Foundation grants OISE-1243541 and DEB-1046413 (to F.R.), CNS-1305112 and MCB-1330800 (to R.A.E.), DUE-1323809 (to E.A.D.), Gordon and Betty Moore Foundation Investigator Award GBMF-3781 (to F.R.), and the Brazilian National Research Council (CNPq; to F.T.) and Brazilian National Research Council Science Without Borders Program (CNPq/CAPES; to C.B.S.).	Alongi DM, 2015, J MARINE SYST, V142, P25, DOI 10.1016/j.jmarsys.2014.09.010; Amosse J, 2013, SOIL BIOL BIOCHEM, V66, P197, DOI 10.1016/j.soilbio.2013.07.007; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Avrani S, 2015, P NATL ACAD SCI USA, V112, pE2191, DOI 10.1073/pnas.1420347112; Barott KL, 2012, TRENDS MICROBIOL, V20, P621, DOI 10.1016/j.tim.2012.08.004; Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110; Bettarel Y, 2006, APPL ENVIRON MICROB, V72, P5274, DOI 10.1128/AEM.00863-06; Bongiorni L, 2005, APPL ENVIRON MICROB, V71, P6644, DOI 10.1128/AEM.71.11.6644-6650.2005; Bouvier T, 2011, MICROB ECOL, V62, P669, DOI 10.1007/s00248-011-9862-3; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Brum JR, 2016, ISME J, V10, P437, DOI 10.1038/ismej.2015.125; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Duhaime MB, 2012, ENVIRON MICROBIOL, V14, P2526, DOI 10.1111/j.1462-2920.2012.02791.x; Dutilh BE, 2012, BIOINFORMATICS, V28, P3225, DOI 10.1093/bioinformatics/bts613; Evans C, 2012, LIMNOL OCEANOGR, V57, P1826, DOI 10.4319/lo.2012.57.6.1826; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Furlan M., 2009, VIRAL MICROBIAL DYNA; Giovannoni S, 2013, NATURE, V499, pE4, DOI 10.1038/nature12388; Glud RN, 2004, LIMNOL OCEANOGR, V49, P2073, DOI 10.4319/lo.2004.49.6.2073; Haas AF, 2014, JOVE-J VIS EXP, DOI 10.3791/52131; HENNES KP, 1995, APPL ENVIRON MICROB, V61, P3623, DOI 10.1128/AEM.61.10.3623-3627.1995; Hewson I, 2001, LIMNOL OCEANOGR, V46, P1734, DOI 10.4319/lo.2001.46.7.1734; James CE, 2015, ISME J, V9, P1391, DOI 10.1038/ismej.2014.223; Jiang SC, 1998, MICROBIAL ECOL, V35, P235, DOI 10.1007/s002489900079; Kelly LW, 2014, P NATL ACAD SCI USA, V111, P10227, DOI 10.1073/pnas.1403319111; Kelly LW, 2012, ISME J, V6, P638, DOI 10.1038/ismej.2011.114; Kim MS, 2011, APPL ENVIRON MICROB, V77, P8062, DOI 10.1128/AEM.06331-11; Laybourn-Parry J, 2007, POLAR BIOL, V30, P351, DOI 10.1007/s00300-006-0191-9; Lisle JT, 2004, MICROB ECOL, V47, P427, DOI 10.1007/s00248-003-1007-x; Madan NJ, 2005, FRESHWATER BIOL, V50, P1291, DOI 10.1111/j.1365-2427.2005.01399.x; Maurice CF, 2013, ENVIRON MICROBIOL, V15, P2463, DOI 10.1111/1462-2920.12120; Maurice CF, 2010, ENVIRON MICROBIOL, V12, P628, DOI 10.1111/j.1462-2920.2009.02103.x; Maurice CF, 2011, ISME J, V5, P831, DOI 10.1038/ismej.2010.181; McDaniel LD, 2014, ENVIRON MICROBIOL, V16, P570, DOI 10.1111/1462-2920.12184; McDole T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043233; Mei ML, 2004, LIMNOL OCEANOGR, V49, P459, DOI 10.4319/lo.2004.49.2.0459; Muck S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00264; Murray, 2002, MATH BIOL I INTRO IN; Needham DM, 2013, ISME J, V7, P1274, DOI 10.1038/ismej.2013.19; Parsons RJ, 2015, ENVIRON MICROBIOL, V17, P3481, DOI 10.1111/1462-2920.12445; Parsons RJ, 2012, ISME J, V6, P273, DOI 10.1038/ismej.2011.101; Patten NL, 2008, CORAL REEFS, V27, P569, DOI 10.1007/s00338-008-0356-9; Paul JH, 2010, MANUAL AQUATIC VIRAL, P30, DOI DOI 10.4319/MAVE.2010.978-0-9845591-0-7.30; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Payet J. P., 2010, MAN AQUAT VIRAL ECOL, P102, DOI [10.4319/mave.2010.978-0-9845591-0-7.102, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.102]; Payet JP, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00493; Payet JP, 2013, LIMNOL OCEANOGR, V58, P465, DOI 10.4319/lo.2013.58.2.0465; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rinta-Kanto JM, 2004, WATER RES, V38, P2614, DOI 10.1016/j.watres.2004.03.008; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Sanchez SE, 2015, JOVE-J VIS EXP, DOI 10.3791/52854; Schapira M, 2009, AQUAT MICROB ECOL, V54, P171, DOI 10.3354/ame01262; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Silva GGZ, 2014, PEERJ, V2, DOI 10.7717/peerj.425; Silveira CB, 2015, ENVIRON MICROBIOL, V17, P3832, DOI 10.1111/1462-2920.12851; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thingstad TF, 2014, P NATL ACAD SCI USA, V111, P7813, DOI 10.1073/pnas.1400909111; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Vage S, 2013, ENVIRON MICROBIOL, V15, P1842, DOI 10.1111/1462-2920.12077; Weinbauer MG, 1998, APPL ENVIRON MICROB, V64, P431; Weitz JS, 2015, ISME J, V9, P1352, DOI 10.1038/ismej.2014.220; Weitz JS, 2008, THEOR ECOL, V1, P13, DOI 10.1007/s12080-007-0001-1; Whiteson KL, 2014, AM J RESP CRIT CARE, V189, P1309, DOI 10.1164/rccm.201312-2129PP; WILCOX RM, 1994, MAR ECOL PROG SER, V114, P35, DOI 10.3354/meps114035; Williamson SJ, 2002, APPL ENVIRON MICROB, V68, P4307, DOI 10.1128/AEM.68.9.4307-4314.2002; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	79	266	273	17	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					466	+		10.1038/nature17193	http://dx.doi.org/10.1038/nature17193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26982729	Green Published			2022-12-28	WOS:000372701300032
J	Leucci, E; Vendramin, R; Spinazzi, M; Laurette, P; Fiers, M; Wouters, J; Radaelli, E; Eyckerman, S; Leonelli, C; Vanderheyden, K; Rogiers, A; Hermans, E; Baatsen, P; Aerts, S; Amant, F; Van Aelst, S; van den Oord, J; de Strooper, B; Davidson, I; Lafontaine, DLJ; Gevaert, K; Vandesompele, J; Mestdagh, P; Marine, JC				Leucci, Eleonora; Vendramin, Roberto; Spinazzi, Marco; Laurette, Patrick; Fiers, Mark; Wouters, Jasper; Radaelli, Enrico; Eyckerman, Sven; Leonelli, Carina; Vanderheyden, Katrien; Rogiers, Aljosja; Hermans, Els; Baatsen, Pieter; Aerts, Stein; Amant, Frederic; Van Aelst, Stefan; van den Oord, Joost; de Strooper, Bart; Davidson, Irwin; Lafontaine, Denis L. J.; Gevaert, Kris; Vandesompele, Jo; Mestdagh, Pieter; Marine, Jean-Christophe			Melanoma addiction to the long non-coding RNA SAMMSON	NATURE			English	Article							P-32 PROTEIN; MITOCHONDRIAL TRANSLATION; OXIDATIVE-PHOSPHORYLATION; METABOLISM; PROLIFERATION; PGC1-ALPHA; MORPHOLOGY; P32/GC1QR; SURVIVAL; TARGET	Focal amplifications of chromosome 3p13-3p14 occur in about 10% of melanomas and are associated with a poor prognosis. The melanoma-specific oncogene MITF resides at the epicentre of this amplicon(1). However, whether other loci present in this amplicon also contribute to melanomagenesis is unknown. Here we show that the recently annotated long non-coding RNA (lncRNA) gene SAMMSON is consistently co-gained with MITF. In addition, SAMMSON is a target of the lineage-specific transcription factor SOX10 and its expression is detectable in more than 90% of human melanomas. Whereas exogenous SAMMSON increases the clonogenic potential in trans, SAMMSON knockdown drastically decreases the viability of melanoma cells irrespective of their transcriptional cell state and BRAF, NRAS or TP53 mutational status. Moreover, SAMMSON targeting sensitizes melanoma to MAPK-targeting therapeutics both in vitro and in patient-derived xenograft models. Mechanistically, SAMMSON interacts with p32, a master regulator of mitochondrial homeostasis and metabolism, to increase its mitochondrial targeting and pro-oncogenic function. Our results indicate that silencing of the lineage addiction oncogene SAMMSON disrupts vital mitochondrial functions in a cancer-cell-specific manner; this silencing is therefore expected to deliver highly effective and tissue-restricted anti-melanoma therapeutic responses.	[Leucci, Eleonora; Vendramin, Roberto; Rogiers, Aljosja; Marine, Jean-Christophe] KULeuven, Lab Mol Canc Biol, Ctr Human Genet, Herestr 49, B-3000 Leuven, Belgium; [Leucci, Eleonora; Vendramin, Roberto; Spinazzi, Marco; Fiers, Mark; Rogiers, Aljosja; Baatsen, Pieter; de Strooper, Bart; Marine, Jean-Christophe] VIB, Ctr Biol Dis, Herestr 49, B-3000 Leuven, Belgium; [Laurette, Patrick; Davidson, Irwin] IGBMC, Rue Laurent Fries 1, F-67404 Illkirch Graffenstaden, France; [Wouters, Jasper; van den Oord, Joost] KULeuven, Dept Pathol, Lab Translat Cell & Tissue Res, Herestr 49, B-3000 Leuven, Belgium; [Wouters, Jasper; van den Oord, Joost] UZ Leuven, Herestr 49, B-3000 Leuven, Belgium; [Radaelli, Enrico] VIB KULeuven, Ctr Biol Dis, Mouse Histopathol Core Facil, Herestr 49, B-3000 Leuven, Belgium; [Eyckerman, Sven; Gevaert, Kris] VIB, Ctr Med Biotechnol, Albert Baertsoenkaai 3, B-9000 Ghent, Belgium; [Eyckerman, Sven; Gevaert, Kris] Univ Ghent, Dept Biochem, Albert Baertsoenkaai 3, B-9000 Ghent, Belgium; [Leonelli, Carina; Vanderheyden, Katrien; Vandesompele, Jo; Mestdagh, Pieter] Univ Ghent, Ctr Med Genet, De Pintelaan 185, B-9000 Ghent, Belgium; [Leonelli, Carina; Vanderheyden, Katrien; Vandesompele, Jo; Mestdagh, Pieter] Univ Ghent, Canc Res Inst Gent, De Pintelaan 185, B-9000 Ghent, Belgium; [Hermans, Els; Amant, Frederic] Katholieke Univ Leuven, Gynaecol Oncol, Herestr 49, B-3000 Leuven, Belgium; [Aerts, Stein] KULeuven, Ctr Human Genet, Lab Computat Biol, Herestr 49, B-3000 Leuven, Belgium; [Van Aelst, Stefan] Univ Ghent, Dept Appl Math Comp Sci & Stat, De Pintelaan 185, B-9000 Ghent, Belgium; [Van Aelst, Stefan] Katholieke Univ Leuven, Dept Math, Celestijnenlann 200B, B-3001 Leuven, Belgium; [Lafontaine, Denis L. J.] Univ Libre Bruxelles, Ctr Microscopy & Mol Imaging, RNA Mol Biol, Rue Prof Jeener & Brachet 12, B-6041 Charleroi, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); Institut National de la Sante et de la Recherche Medicale (Inserm); KU Leuven; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; KU Leuven; KU Leuven; Ghent University; Ghent University Hospital; KU Leuven; Universite Libre de Bruxelles	Marine, JC (corresponding author), KULeuven, Lab Mol Canc Biol, Ctr Human Genet, Herestr 49, B-3000 Leuven, Belgium.; Marine, JC (corresponding author), VIB, Ctr Biol Dis, Herestr 49, B-3000 Leuven, Belgium.	JeanChristophe.Marine@cme.vib-kuleuven.be	Gevaert, Kris/AAE-4212-2019; Wouters, Jasper/AAK-8597-2020; Van Aelst, Stefan/B-5201-2012; de+Strooper, Bart/Z-1638-2019; Rogiers, Aljosja/AHA-0759-2022; Leucci, Eleonora/G-4938-2011; Fiers, Mark WEJ/E-6755-2010; Vandesompele, Jo/W-3411-2018; Gevaert, Kris/D-6489-2017; Amant, Frédéric/W-7436-2019; Lafontaine, Denis/I-7673-2013; Marine, Jean-Christophe/K-3292-2016; Aerts, Stein/A-1100-2009	Gevaert, Kris/0000-0002-4237-0283; Wouters, Jasper/0000-0002-7129-2990; Van Aelst, Stefan/0000-0002-9931-5330; Leucci, Eleonora/0000-0002-2898-748X; Fiers, Mark WEJ/0000-0001-5694-2409; Vandesompele, Jo/0000-0001-6274-0184; Gevaert, Kris/0000-0002-4237-0283; Amant, Frédéric/0000-0002-5452-4905; Lafontaine, Denis/0000-0001-7295-6288; Marine, Jean-Christophe/0000-0003-2433-9837; Aerts, Stein/0000-0002-8006-0315; Vanderheyden, Katrien/0000-0001-5934-0366; Mestdagh, Pieter/0000-0001-7821-9684; SPINAZZI, Marco/0000-0003-0048-9558; Davidson, Irwin/0000-0001-5533-1171; Vendramin, Roberto/0000-0001-7191-4887	Fonds Wetenschappelijk Onderzoek (FWO) [G.0646.14N, 3G056613]; Foundation Against Cancer (STK) [2014-126]; UGent-IOF [F2013/IOF-Advanced/676]; STK grant [F/2014/376]; KULeuven [GOA/14/012]; Belgian Ministries of Health [KPC_29_005]; Marie-Curie/VIB OMICS program; EMBO fellowship [ALTF 648-2013]; FWO; Fonds National de la Recherche (FRS/FNRS); Institut National du Cancer PAIR melanoma [MELA13-002]; "France Genomique" consortium [ANR10-INBS-09-08];  [ANR-10-LABX-0030-INRT]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Foundation Against Cancer (STK); UGent-IOF; STK grant; KULeuven(KU Leuven); Belgian Ministries of Health; Marie-Curie/VIB OMICS program; EMBO fellowship(European Molecular Biology Organization (EMBO)); FWO(FWO); Fonds National de la Recherche (FRS/FNRS)(Fonds de la Recherche Scientifique - FNRS); Institut National du Cancer PAIR melanoma; "France Genomique" consortium; 	GapmeRs were designed by J. Lai. This work was supported by the Fonds Wetenschappelijk Onderzoek (FWO; #G.0646.14N and #3G056613), Foundation Against Cancer (STK#2014-126), UGent-IOF (F2013/IOF-Advanced/676) and STK grant F/2014/376. The PDX studies were funded by GOA/14/012 (KULeuven) and KPC_29_005 (Belgian Ministries of Health). The authors wish to thank N. Samyn for help with MS, M. Van Gele for providing NHME cultures and P. Wolter for scientific discussions and his central role in the establishment of the melanoma PDX platform. E.L. is a recipient of a postdoctoral fellowship from the Marie-Curie/VIB OMICS program. M.S. is the recipient of EMBO fellowship (ALTF 648-2013). F.A. is a senior researcher from the Research Fund Flanders (FWO). P. M. and R.V. are recipients of FWO postdoctoral and PhD fellowships, respectively. D.L. is supported by the Fonds National de la Recherche (FRS/FNRS). I.D. is supported by the Institut National du Cancer PAIR melanoma (MELA13-002), the "France Genomique" consortium (ANR10-INBS-09-08), and ANR-10-LABX-0030-INRT. The I.D. laboratory is an "equipe labellisee Ligue Nationale contre le Cancer".	Amamoto R, 2011, CANCER SCI, V102, P639, DOI 10.1111/j.1349-7006.2010.01828.x; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Fantin VR, 2006, ONCOGENE, V25, P4787, DOI 10.1038/sj.onc.1209599; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; Fogal V, 2015, ONCOTARGET, V6, P1157, DOI 10.18632/oncotarget.2708; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Harris ML, 2010, PIGM CELL MELANOMA R, V23, P496, DOI 10.1111/j.1755-148X.2010.00711.x; Hu MJ, 2013, BIOCHEM J, V453, P381, DOI 10.1042/BJ20121829; Jiao H, 2015, CELL DEATH DIFFER, V22, P1812, DOI [10.1038/cdd.2015.34, 10.1038/xyza.2015.34]; Laurette P, 2015, ELIFE, V4, DOI 10.7554/eLife.06857; Li Y, 2011, NEUROSCIENCE, V199, P346, DOI 10.1016/j.neuroscience.2011.10.003; Matos P, 2014, MOL HUM REPROD, V20, P745, DOI 10.1093/molehr/gau039; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Muta T, 1997, J BIOL CHEM, V272, P24363, DOI 10.1074/jbc.272.39.24363; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Richter U, 2013, CURR BIOL, V23, P535, DOI 10.1016/j.cub.2013.02.019; Richter-Dennerlein R, 2015, NAT REV MOL CELL BIO, V16, P586, DOI 10.1038/nrm4051; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wrobel L, 2015, NATURE, V524, P485, DOI 10.1038/nature14951; Yagi M, 2012, NUCLEIC ACIDS RES, V40, P9717, DOI 10.1093/nar/gks774	30	351	364	9	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					518	+		10.1038/nature17161	http://dx.doi.org/10.1038/nature17161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	27008969				2022-12-28	WOS:000372701300044
J	Tran, MT; Zsengeller, ZK; Berg, AH; Khankin, EV; Bhasin, MK; Kim, W; Clish, CB; Stillman, IE; Karumanchi, SA; Rhee, EP; Parikh, SM				Tran, Mei T.; Zsengeller, Zsuzsanna K.; Berg, Anders H.; Khankin, Eliyahu V.; Bhasin, Manoj K.; Kim, Wondong; Clish, Clary B.; Stillman, Isaac E.; Karumanchi, S. Ananth; Rhee, Eugene P.; Parikh, Samir M.			PGC1 alpha drives NAD biosynthesis linking oxidative metabolism to renal protection	NATURE			English	Article							ACUTE KIDNEY INJURY; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; MITOCHONDRIAL INJURY; COACTIVATOR; PROMOTES; INFLAMMATION; INHIBITION; FAILURE; PATHWAY; ENZYME	The energetic burden of continuously concentrating solutes against gradients along the tubule may render the kidney especially vulnerable to ischaemia. Acute kidney injury (AKI) affects 3% of all hospitalized patients(1,2). Here we show that the mitochondrial biogenesis regulator, PGC1 alpha(3,4), is a pivotal determinant of renal recovery from injury by regulating nicotinamide adenine dinucleotide (NAD) biosynthesis. Following renal ischaemia, PGC1 alpha(-/-) (also known as Ppargc1a(-/-)) mice develop local deficiency of the NAD precursor niacinamide (NAM, also known as nicotinamide), marked fat accumulation, and failure to reestablish normal function. Notably, exogenous NAM improves local NAD levels, fat accumulation, and renal function in post-ischaemic PGC1 alpha(-/-) mice. Inducible tubular transgenic mice (iNephPGC1 alpha) recapitulate the effects of NAM supplementation, including more local NAD and less fat accumulation with better renal function after ischaemia. PGC1 alpha coordinately upregulates the enzymes that synthesize NAD de novo from amino acids whereas PGC1 alpha deficiency or AKI attenuates the de novo pathway. NAM enhances NAD via the enzyme NAMPT and augments production of the fat breakdown product beta-hydroxybutyrate, leading to increased production of prostaglandin PGE(2) (ref. 5), a secreted autacoid that maintains renal function. NAM treatment reverses established ischaemic AKI and also prevented AKI in an unrelated toxic model. Inhibition of beta-hydroxybutyrate signalling or prostaglandin production similarly abolishes PGC1 alpha-dependent renoprotection. Given the importance of mitochondrial health in ageing and the function of metabolically active organs, the results implicate NAM and NAD as key effectors for achieving PGC1 alpha-dependent stress resistance.	[Tran, Mei T.; Zsengeller, Zsuzsanna K.; Khankin, Eliyahu V.; Karumanchi, S. Ananth; Parikh, Samir M.] Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; [Tran, Mei T.; Zsengeller, Zsuzsanna K.; Khankin, Eliyahu V.; Karumanchi, S. Ananth; Parikh, Samir M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Tran, Mei T.; Zsengeller, Zsuzsanna K.; Berg, Anders H.; Khankin, Eliyahu V.; Bhasin, Manoj K.; Stillman, Isaac E.; Karumanchi, S. Ananth; Parikh, Samir M.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Tran, Mei T.; Zsengeller, Zsuzsanna K.; Khankin, Eliyahu V.; Bhasin, Manoj K.; Karumanchi, S. Ananth; Parikh, Samir M.] Beth Israel Deaconess Med Ctr, Ctr Vasc Biol Res, Boston, MA 02215 USA; [Zsengeller, Zsuzsanna K.; Berg, Anders H.] Beth Israel Deaconess Med Ctr, Div Clin Chem, Boston, MA 02215 USA; [Berg, Anders H.; Stillman, Isaac E.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Bhasin, Manoj K.] Beth Israel Deaconess Med Ctr, Bioinformat & Syst Biol Core, Boston, MA 02215 USA; [Kim, Wondong; Rhee, Eugene P.] Massachusetts Gen Hosp, Nephrol Div, Boston, MA 02114 USA; [Kim, Wondong; Rhee, Eugene P.] Massachusetts Gen Hosp, Div Endocrine, Boston, MA 02114 USA; [Kim, Wondong; Rhee, Eugene P.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Clish, Clary B.; Rhee, Eugene P.] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Karumanchi, S. Ananth] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute	Parikh, SM (corresponding author), Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA.; Parikh, SM (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.; Parikh, SM (corresponding author), Harvard Univ, Sch Med, Boston, MA 02215 USA.; Parikh, SM (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Vasc Biol Res, Boston, MA 02215 USA.	sparikh1@bidmc.harvard.edu	Khankin, Eli/M-7648-2013; Clish, Clary/AAB-7124-2019; Stillman, Isaac E/ABC-7278-2020; Clish, Clary B/ABB-9374-2021; Karumanchi, Subbian Ananth/AAI-1694-2021	Clish, Clary B/0000-0001-8259-9245; Tran, Mei/0000-0003-1114-0984; Khankin, Eliyahu/0000-0002-1695-7267; Bhasin, Manoj/0000-0001-5172-420X; Zsengeller, Zsuzsanna/0000-0002-4540-5728; Kim, Wondong/0000-0001-9030-9164	Satellite Healthcare;  [R01-DK095072];  [K08-DK090142];  [K08-DK101560]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL121801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337, K08DK090142, P30DK057521, R01DK095072, K08DK101560] Funding Source: NIH RePORTER	Satellite Healthcare; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank B. Spiegelman (Harvard Medical School, Dana Farber Cancer Institute) for support from this project's inception; M. Zeidel (Harvard Medical School, BIDMC) for advice; Z. Arany (University of Pennsylvania) for the VE-cadherin-tTA x TRE-PGC1 alpha mice; A. Agarwal (University of Alabama, NIH P30-DK079337) for LC-MS measurements of serum creatinine; A. Kurmann and A. Hollenberg (Harvard Medical School, BIDMC) for thyroxine measurements; and P. Pacher (NIH) for cisplatin-treated kidneys for microscopy. This work was supported by R01-DK095072 and philanthropic funds to S.M.P.; K08-DK090142 and a grant from Satellite Healthcare to E.P.R.; and K08-DK101560 to E.V.K.	Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Breyer MD, 1996, J AM SOC NEPHROL, V7, P8; COLLINS PB, 1972, J BIOL CHEM, V247, P778; Ebrahimkhani MR, 2014, P NATL ACAD SCI USA, V111, pE4878, DOI 10.1073/pnas.1413582111; Feingold KR, 2014, J LIPID RES, V55, P2501, DOI 10.1194/jlr.M050955; Feldkamp T, 2004, AM J PHYSIOL-RENAL, V286, pF749, DOI 10.1152/ajprenal.00276.2003; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Hanson J, 2010, J CLIN INVEST, V120, P2910, DOI 10.1172/JCI42273; Hasmann M, 2003, CANCER RES, V63, P7436; Jesinkey SR, 2014, J AM SOC NEPHROL, V25, P1157, DOI 10.1681/ASN.2013090952; Kang C, 2013, J APPL PHYSIOL, V115, P1618, DOI 10.1152/japplphysiol.01354.2012; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Lewington AJP, 2013, KIDNEY INT, V84, P457, DOI 10.1038/ki.2013.153; Liu LJ, 2014, J CLIN INVEST, V124, P768, DOI 10.1172/JCI69413; MAUK RH, 1977, KIDNEY INT, V12, P122, DOI 10.1038/ki.1977.89; Morigi M, 2015, J CLIN INVEST, V125, P715, DOI 10.1172/JCI77632; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PAPANICOLAOU N, 1975, CLIN SCI MOL MED, V49, P507, DOI 10.1042/cs0490507; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Rajakumar SV, 2010, TRANSPLANTATION, V90, P1260, DOI 10.1097/TP.0b013e3182003d9b; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rhee EP, 2013, CELL METAB, V18, P130, DOI 10.1016/j.cmet.2013.06.013; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Singh V, 2012, CELL HOST MICROBE, V12, P669, DOI 10.1016/j.chom.2012.09.012; Sketch M H Jr, 2001, Am J Ther, V8, P155, DOI 10.1097/00045391-200105000-00004; Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; WEIDEMANN MJ, 1969, BIOCHEM J, V112, P149, DOI 10.1042/bj1120149; Zsengeller ZK, 2012, J HISTOCHEM CYTOCHEM, V60, P521, DOI 10.1369/0022155412446227	41	284	297	5	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					528	+		10.1038/nature17184	http://dx.doi.org/10.1038/nature17184			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26982719	Green Accepted, Green Submitted			2022-12-28	WOS:000372701300046
J	Zhu, WF; Gregory, JC; Org, E; Buffa, JA; Gupta, N; Wang, ZN; Li, L; Fu, XM; Wu, YP; Mehrabian, M; Sartor, RB; McIntyre, TM; Silverstein, RL; Tang, WHW; DiDonato, JA; Brown, JM; Lusis, AJ; Hazen, SL				Zhu, Weifei; Gregory, Jill C.; Org, Elin; Buffa, Jennifer A.; Gupta, Nilaksh; Wang, Zeneng; Li, Lin; Fu, Xiaoming; Wu, Yuping; Mehrabian, Margarete; Sartor, R. Balfour; McIntyre, Thomas M.; Silverstein, Roy L.; Tang, W. H. Wilson; DiDonato, Joseph A.; Brown, J. Mark; Lusis, Aldons J.; Hazen, Stanley L.			Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk	CELL			English	Article							TRIMETHYLAMINE-N-OXIDE; CONTAINING MONOOXYGENASE 3; INTESTINAL MICROBIOTA; PROGNOSTIC VALUE; L-CARNITINE; PHOSPHATIDYLCHOLINE; ATHEROSCLEROSIS; ACTIVATION; MECHANISMS; MORTALITY	Normal platelet function is critical to blood hemostasis and maintenance of a closed circulatory system. Heightened platelet reactivity, however, is associated with cardiometabolic diseases and enhanced potential for thrombotic events. We now show gut microbes, through generation of trimethylamine N-oxide (TMAO), directly contribute to platelet hyperreactivity and enhanced thrombosis potential. Plasma TMAO levels in subjects (n > 4,000) independently predicted incident (3 years) thrombosis (heart attack, stroke) risk. Direct exposure of platelets to TMAO enhanced sub-maximal stimulus-dependent platelet activation from multiple agonists through augmented Ca2+ release from intracellular stores. Animal model studies employing dietary choline or TMAO, germ-free mice, and microbial transplantation collectively confirm a role for gut microbiota and TMAO in modulating platelet hyperresponsiveness and thrombosis potential and identify microbial taxa associated with plasma TMAO and thrombosis potential. Collectively, the present results reveal a previously unrecognized mechanistic link between specific dietary nutrients, gut microbes, platelet function, and thrombosis risk.	[Zhu, Weifei; Gregory, Jill C.; Buffa, Jennifer A.; Gupta, Nilaksh; Wang, Zeneng; Li, Lin; Fu, Xiaoming; McIntyre, Thomas M.; Tang, W. H. Wilson; DiDonato, Joseph A.; Brown, J. Mark; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Org, Elin; Mehrabian, Margarete; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Org, Elin; Mehrabian, Margarete; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Sartor, R. Balfour] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Sartor, R. Balfour] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Silverstein, Roy L.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Silverstein, Roy L.] Blood Res Inst, Milwaukee, WI 53226 USA; [Wu, Yuping] Cleveland State Univ, Dept Math, Cleveland, OH 44115 USA; [Tang, W. H. Wilson; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation	Hazen, SL (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA.; Hazen, SL (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA.	hazens@ccf.org	Tang, Wai Hong Wilson/I-1238-2013; Hazen, Stanley L/ABD-5845-2021; Gupta, Nilaksh/AAC-5005-2020; Org, Elin/AAJ-9631-2021; Wang, Zeneng/AAK-6119-2021	Gupta, Nilaksh/0000-0002-9449-2610; Org, Elin/0000-0003-1451-9375; Org, Elin/0000-0001-8688-9717; Tang, W. H. Wilson/0000-0002-8335-735X	NIH [P01HL076491, P01HL098055, R01HL103931, UL1TR 000439]; Office of Dietary Supplements [R01HL103866, P20HL113452, HL28481, HL30568, R01DK106000, R01 HL122283, P40 OD010995, P30 DK034987]; AHA Scientist Development Grants; FP7 grant [330381]; Leonard Krieger endowment; Siemens; Esperion; Frantz Biomarkers, LLC; PG; Astra Zeneca; Pfizer Inc.; Roche Diagnostics; Takeda; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122283, P01HL028481, P01HL076491, P20HL113452, P01HL030568, R01HL111614, R01HL103866, P01HL098055, R01HL103931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, R01DK106000] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA Scientist Development Grants; FP7 grant; Leonard Krieger endowment; Siemens(Siemens AG); Esperion; Frantz Biomarkers, LLC; PG; Astra Zeneca(AstraZeneca); Pfizer Inc.(Pfizer); Roche Diagnostics; Takeda(Takeda Pharmaceutical Company Ltd); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Daniel I. Simon and Yunmei Wang (Case Western Reserve University) for technical assistance on the photochemical thrombosis model. We thank Sorel Fitz-Gibbon (UCLA) for assistance with metagenomic sequencing data. This research was supported by grants from the NIH and the Office of Dietary Supplements (R01HL103866, P20HL113452, HL28481, HL30568, R01DK106000, R01 HL122283, P40 OD010995, and P30 DK034987). Gene-Bank was supported by NIH grants (P01HL076491, P01HL098055, R01HL103931 and UL1TR 000439). W.Z. and Z.W. were supported in part by AHA Scientist Development Grants. E.O. was supported by an FP7 grant (no. 330381). S.L.H. was partially supported by the Leonard Krieger endowment. Mass spectrometry instruments used were supported in part by AB SCIEX. Z.W. and S.L.H. are named as co-inventors on pending patents held by the Cleveland Clinic relating to cardiovascular diagnostics or therapeutics. Z.W. and S.L.H. report having the right to receive royalty payment for inventions or discoveries related to cardiovascular diagnostics from Cleveland Heart Lab, Inc. S.L.H. also reports having the right to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Siemens, Esperion, and Frantz Biomarkers, LLC. S.L.H. reports having been paid as a consultant for Esperion and P&G and receiving research funds from Astra Zeneca, P&G, Pfizer Inc., Roche Diagnostics, and Takeda.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bennett BJ, 2013, CELL METAB, V17, P49, DOI 10.1016/j.cmet.2012.12.011; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Chen K, 2008, CIRC RES, V102, P1512, DOI 10.1161/CIRCRESAHA.108.172064; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Falony G, 2015, ANNU REV MICROBIOL, V69, P305, DOI 10.1146/annurev-micro-091014-104422; Frossard M, 2004, CIRCULATION, V110, P1392, DOI 10.1161/01.CIR.0000141575.92958.9C; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gregory JC, 2015, J BIOL CHEM, V290, P5647, DOI 10.1074/jbc.M114.618249; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Jennings LK, 2009, THROMB HAEMOSTASIS, V102, P248, DOI 10.1160/TH09-03-0192; Koch R., 1880, INVESTIGATIONS ETIOL; Koeth RA, 2014, CELL METAB, V20, P799, DOI 10.1016/j.cmet.2014.10.006; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Lever M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114969; Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Organ CL, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002314; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; RINK TJ, 1990, ANNU REV PHYSIOL, V52, P431, DOI 10.1146/annurev.ph.52.030190.002243; Rohrmann S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-63; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; Seldin MM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002767; Shih DM, 2015, J LIPID RES, V56, P22, DOI 10.1194/jlr.M051680; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Tang WHW, 2014, J AM COLL CARDIOL, V64, P1908, DOI 10.1016/j.jacc.2014.02.617; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Troseid M, 2015, J INTERN MED, V277, P717, DOI 10.1111/joim.12328; Wallrabenstein I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054950; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wang ZN, 2014, ANAL BIOCHEM, V455, P35, DOI 10.1016/j.ab.2014.03.016; Wang ZN, 2014, EUR HEART J, V35, P904, DOI 10.1093/eurheartj/ehu002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Warrier M, 2015, CELL REP, pS2211; Zhu WF, 2012, BLOOD, V119, P6136, DOI 10.1182/blood-2011-10-387506	37	915	1012	18	266	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					111	124		10.1016/j.cell.2016.02.011	http://dx.doi.org/10.1016/j.cell.2016.02.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	26972052	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000372785600014
J	Hawkes, N				Hawkes, Nigel			THE BMJ AWARDS 2016 Gastroenterology team	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2016	352								i1592	10.1136/bmj.i1592	http://dx.doi.org/10.1136/bmj.i1592			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LL	27009528				2022-12-28	WOS:000373044600002
J	Smith, JM				Smith, Jeanette M.			Evening Kenneth M. Adams	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1212	1213		10.1001/jama.2015.14177	http://dx.doi.org/10.1001/jama.2015.14177			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	27002432				2022-12-28	WOS:000372511100001
J	Edwards, A				Edwards, Aled			Team up with industry	NATURE			English	Editorial Material									[Edwards, Aled] Struct Genom Consortium, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium	Edwards, A (corresponding author), Struct Genom Consortium, Toronto, ON, Canada.	aled.edwards@utoronto.ca		Edwards, Aled/0000-0002-4782-6016					0	17	17	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					299	301		10.1038/531299a	http://dx.doi.org/10.1038/531299a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG4TA	26983524	hybrid			2022-12-28	WOS:000372064300028
J	Meharg, AA				Meharg, Andrew A.			City farming needs monitoring	NATURE			English	Editorial Material									[Meharg, Andrew A.] Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Meharg, AA (corresponding author), Queens Univ Belfast, Belfast BT7 1NN, Antrim, North Ireland.	aa.meharg@qub.ac.uk	Meharg, Andrew Alexander/F-8182-2014	Meharg, Andrew Alexander/0000-0003-2019-0449				Afrane YA, 2004, ACTA TROP, V89, P125, DOI 10.1016/j.actatropica.2003.06.001; Leake JR, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S6; Norton G, 2013, ENVIRON SCI TECHNOL, V47, P6164, DOI 10.1021/es400720r; Thomaier S, 2015, RENEW AGR FOOD SYST, V30, P43, DOI 10.1017/S1742170514000143	4	21	24	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S60	S60		10.1038/531S60a	http://dx.doi.org/10.1038/531S60a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26981731	Bronze			2022-12-28	WOS:000372064300005
J	Morgan, JLW; McNamara, JT; Fischer, M; Rich, J; Chen, HM; Withers, SG; Zimmer, J				Morgan, Jacob L. W.; McNamara, Joshua T.; Fischer, Michael; Rich, Jamie; Chen, Hong-Ming; Withers, Stephen G.; Zimmer, Jochen			Observing cellulose biosynthesis and membrane translocation in crystallo	NATURE			English	Article							NEISSERIA-MENINGITIDIS; SYNTHASE; DYNAMICS; GLYCOSYLTRANSFERASES; POLYMERIZATION; STABILIZATION; MECHANISM; PROTEIN; SYSTEM	Many biopolymers, including polysaccharides, must be translocated across at least one membrane to reach their site of biological function. Cellulose is a linear glucose polymer synthesized and secreted by a membrane-integrated cellulose synthase. Here, in crystallo enzymology with the catalytically active bacterial cellulose synthase BcsA-BcsB complex reveals structural snapshots of a complete cellulose biosynthesis cycle, from substrate binding to polymer translocation. Substrate-and product-bound structures of BcsA provide the basis for substrate recognition and demonstrate the stepwise elongation of cellulose. Furthermore, the structural snapshots show that BcsA translocates cellulose via a ratcheting mechanism involving a 'finger helix' that contacts the polymer's terminal glucose. Cooperating with BcsA's gating loop, the finger helix moves 'up' and 'down' in response to substrate binding and polymer elongation, respectively, thereby pushing the elongated polymer into BcsA's transmembrane channel. This mechanism is validated experimentally by tethering BcsA's finger helix, which inhibits polymer translocation but not elongation.	[Morgan, Jacob L. W.; McNamara, Joshua T.; Zimmer, Jochen] Univ Virginia, Sch Med, Ctr Membrane Biol Mol Physiol & Biol Phys, 480 Ray C Hunt Dr, Charlottesville, VA 22908 USA; [Fischer, Michael; Rich, Jamie; Chen, Hong-Ming; Withers, Stephen G.] Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada; [Fischer, Michael] Sandoz GmbH, Biochem Str 10, A-6250 Kundl, Austria; [Rich, Jamie] Kairos Therapeut, 2405 Wesbrook Mall,Fourth Floor, Vancouver, BC V6T 1Z3, Canada	University of Virginia; University of British Columbia; Novartis; Sandoz	Zimmer, J (corresponding author), Univ Virginia, Sch Med, Ctr Membrane Biol Mol Physiol & Biol Phys, 480 Ray C Hunt Dr, Charlottesville, VA 22908 USA.	jochen_zimmer@virginia.edu		Zimmer, Jochen/0000-0002-8423-2882	Federal funds from the National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; NIH-ORIP HEI grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; National Science Foundation Graduate Research Fellowship [DGE-1315231]; Austrian Science Fund (FWF) [J3293-B21]; National Institutes of Health [1R01GM101001]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101001] Funding Source: NIH RePORTER	Federal funds from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; DOE Office of Science(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Rapoport for critical comments on the manuscript and J. Acheson for advice on reducing BcsA-BcsB complexes in crystallo. Diffraction data were collected at the Argonne National Laboratory's Advanced Photon Source (APS) beam lines 23-ID-D (GM/CA-), 22-ID (SER-) and 24-ID-C (NE-CAT). GM/CA@APS has been funded in whole or in part with Federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). The NE-CAT beam lines are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). Data for this research was also in part collected at the APS SER-CAT beam line, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by ANL under Contract No. DE-AC02-06CH11357. J.L.W.M. is supported by a National Science Foundation Graduate Research Fellowship, Grant No. DGE-1315231. M.F. thanks the Austrian Science Fund (FWF) (J3293-B21) for an Erwin Schrodinger postdoctoral fellowship. This research was primarily supported by the National Institutes of Health, Grant 1R01GM101001, awarded to J.Z.; S.G.W. thanks the Natural Sciences and Engineering Research Council of Canada for financial support.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bokranz W, 2005, J MED MICROBIOL, V54, P1171, DOI 10.1099/jmm.0.46064-0; Brown C, 2012, NAT PROTOC, V7, P1634, DOI 10.1038/nprot.2012.089; Cao Z, 2012, P NATL ACAD SCI USA, V109, P8121, DOI 10.1073/pnas.1201298109; Carpita NC, 2011, PLANT PHYSIOL, V155, P171, DOI 10.1104/pp.110.163360; Chan PHW, 2013, BIOCHEMISTRY-US, V52, P320, DOI 10.1021/bi301317d; Dirr HW, 2005, J BIOL CHEM, V280, P19480, DOI 10.1074/jbc.M413608200; FOROOD B, 1993, P NATL ACAD SCI USA, V90, P838, DOI 10.1073/pnas.90.3.838; GARDNER KH, 1974, BIOCHIM BIOPHYS ACTA, V343, P232, DOI 10.1016/0304-4165(74)90256-6; Hubbard C, 2012, J MOL BIOL, V418, P21, DOI 10.1016/j.jmb.2012.01.053; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Keiski CL, 2010, STRUCTURE, V18, P265, DOI 10.1016/j.str.2009.11.015; Kimura S, 2001, PROTOPLASMA, V216, P71, DOI 10.1007/BF02680133; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; MARTIN JL, 1990, BIOCHEMISTRY-US, V29, P10745, DOI 10.1021/bi00500a005; McNamara JT, 2015, ANNU REV BIOCHEM, V84, P895, DOI 10.1146/annurev-biochem-060614-033930; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Morgan JLW, 2014, NAT STRUCT MOL BIOL, V21, P489, DOI 10.1038/nsmb.2803; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Omadjela O, 2013, P NATL ACAD SCI USA, V110, P17856, DOI 10.1073/pnas.1314063110; Persson K, 2001, NAT STRUCT BIOL, V8, P166, DOI 10.1038/84168; PyMol, DELANO SCI; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Rehm BHA, 2009, MICROBIOL MONOGR, V13, P55, DOI 10.1007/978-3-540-92679-5_2; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Saxena IM, 2001, PHYTOCHEMISTRY, V57, P1135, DOI 10.1016/S0031-9422(01)00048-6; Scharnagl C, 2014, BIOPHYS J, V106, P1318, DOI 10.1016/j.bpj.2014.02.013; Serra DO, 2013, J BACTERIOL, V195, P5540, DOI 10.1128/JB.00946-13; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108; Yang H, 2015, J PHYS CHEM B, V119, P6525, DOI 10.1021/acs.jpcb.5b01433	36	88	88	9	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					329	+		10.1038/nature16966	http://dx.doi.org/10.1038/nature16966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26958837	Green Accepted, Green Submitted			2022-12-28	WOS:000372064300044
J	Yoshida, S; Hiraga, K; Takehana, T; Taniguchi, I; Yamaji, H; Maeda, Y; Toyohara, K; Miyamoto, K; Kimura, Y; Oda, K				Yoshida, Shosuke; Hiraga, Kazumi; Takehana, Toshihiko; Taniguchi, Ikuo; Yamaji, Hironao; Maeda, Yasuhito; Toyohara, Kiyotsuna; Miyamoto, Kenji; Kimura, Yoshiharu; Oda, Kohei			A bacterium that degrades and assimilates poly(ethylene terephthalate)	SCIENCE			English	Article							HYDROLYSIS; CUTINASE; POLYESTERS; HYDROLASE; FIBERS	Poly(ethylene terephthalate) (PET) is used extensively worldwide in plastic products, and its accumulation in the environment has become a global concern. Because the ability to enzymatically degrade PET has been thought to be limited to a few fungal species, biodegradation is not yet a viable remediation or recycling strategy. By screening natural microbial communities exposed to PET in the environment, we isolated a novel bacterium, Ideonella sakaiensis 201-F6, that is able to use PET as its major energy and carbon source. When grown on PET, this strain produces two enzymes capable of hydrolyzing PET and the reaction intermediate, mono(2-hydroxyethyl) terephthalic acid. Both enzymes are required to enzymatically convert PET efficiently into its two environmentally benign monomers, terephthalic acid and ethylene glycol.	[Yoshida, Shosuke; Hiraga, Kazumi; Yamaji, Hironao; Oda, Kohei] Kyoto Inst Technol, Fac Text Sci, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Yoshida, Shosuke; Miyamoto, Kenji] Keio Univ, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan; [Takehana, Toshihiko] ADEKA, Life Sci Mat Lab, Arakawa Ku, 7-2-34 Higashiogu, Tokyo 1168553, Japan; [Taniguchi, Ikuo; Kimura, Yoshiharu] Kyoto Inst Technol, Fac Text Sci, Dept Polymer Sci, Sakyo Ku, Kyoto 6068585, Japan; [Maeda, Yasuhito; Toyohara, Kiyotsuna] Innovat Res Inst, Ecol Related Mat Grp, Hinode Cho 2-1, Yamaguchi 7408511, Japan; [Yoshida, Shosuke] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Nishikyo Ku, Kyoto 6158530, Japan	Kyoto Institute of Technology; Keio University; Kyoto Institute of Technology; Kyoto University	Oda, K (corresponding author), Kyoto Inst Technol, Fac Text Sci, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan.; Miyamoto, K (corresponding author), Keio Univ, Dept Biosci & Informat, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	kmiyamoto@bio.keio.ac.jp; bika@kit.ac.jp		Kimura, Yoshiharu/0000-0003-4431-0193	Noda Institute for Scientific Research;  [24780078];  [26850053]; Grants-in-Aid for Scientific Research [26850053] Funding Source: KAKEN	Noda Institute for Scientific Research(Noda Institute for Scientific Research); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Y. Horiuchi, M. Uemura, T. Kawai, K. Sasage, and S. Hase for research assistance. We thank D. Dodd, H. Atomi, T. Nakayama, and A. Wlodawer for comments on this manuscript. This study was supported by grants-in-aid for scientific research (24780078 and 26850053 to S.Y.) and the Noda Institute for Scientific Research (S.Y.). The reported nucleotide sequence data, including assembly and annotation, have been deposited in the DNA Data Bank of Japan, European Molecular Biology Laboratory, and GenBank databases under the accession numbers BBYR01000001 to BBYR01000227. All other data are reported in the supplementary materials. The reported strain Ideonella sakaiensis 201-F6<SUP>T</SUP> was deposited at the National Institute of Technology and Evaluation Biological Resource Center as strain NBRC 110686<SUP>T</SUP> and at Thailand Institute of Scientific and Technological Research as strain TISTR 2288<SUP>T</SUP>.	Hosaka M, 2013, APPL ENVIRON MICROB, V79, P6148, DOI 10.1128/AEM.01600-13; Kersey P, 2005, NUCLEIC ACIDS RES, V33, pD297, DOI 10.1093/nar/gri039; Kint D, 1999, POLYM INT, V48, P346, DOI 10.1002/(SICI)1097-0126(199905)48:5<346::AID-PI156>3.0.CO;2-N; Marten E, 2005, POLYM DEGRAD STABIL, V88, P371, DOI 10.1016/j.polymdegradstab.2004.12.001; Muller RJ, 2005, MACROMOL RAPID COMM, V26, P1400, DOI 10.1002/marc.200500410; Muller RJ, 2001, J BIOTECHNOL, V86, P87, DOI 10.1016/S0168-1656(00)00407-7; Neufeld L., 2016, WORLD EC FORUM, P7; Nimchua T, 2008, J IND MICROBIOL BIOT, V35, P843, DOI 10.1007/s10295-008-0356-3; Nimchua Thidarat, 2007, Biotechnology Journal, V2, P361, DOI 10.1002/biot.200600095; Ribitsch D, 2012, BIOCATAL BIOTRANSFOR, V30, P2, DOI 10.3109/10242422.2012.644435; Silva CM, 2005, J POLYM SCI POL CHEM, V43, P2448, DOI 10.1002/pola.20684; Sinha V, 2010, J POLYM ENVIRON, V18, P8, DOI 10.1007/s10924-008-0106-7; Sulaiman S, 2012, APPL ENVIRON MICROB, V78, P1556, DOI 10.1128/AEM.06725-11; Suzuki K, 2014, PROTEINS, V82, P2857, DOI 10.1002/prot.24649; Vertommen MAME, 2005, J BIOTECHNOL, V120, P376, DOI 10.1016/j.jbiotec.2005.06.015; Zimmermann W, 2011, ADV BIOCHEM ENG BIOT, V125, P97, DOI 10.1007/10_2010_87	16	941	1024	545	2480	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1196	1199		10.1126/science.aad6359	http://dx.doi.org/10.1126/science.aad6359			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965627				2022-12-28	WOS:000386158400045
J	Blenner, SR; Kollmer, M; Rouse, AJ; Daneshvar, N; Williams, C; Andrews, LB				Blenner, Sarah R.; Koellmer, Melanie; Rouse, Adam J.; Daneshvar, Nadia; Williams, Curry; Andrews, Lori B.			Privacy Policies of Android Diabetes Apps and Sharing of Health Information	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Blenner, Sarah R.; Koellmer, Melanie; Rouse, Adam J.; Daneshvar, Nadia; Williams, Curry; Andrews, Lori B.] IIT, Chicago Kent Coll Law, 565 W Adams St,Ste 530, Chicago, IL 60661 USA; [Koellmer, Melanie] Almirall Hermal GmbH, Reinbek, Germany	Illinois Institute of Technology; Almirall	Blenner, SR (corresponding author), IIT, Chicago Kent Coll Law, 565 W Adams St,Ste 530, Chicago, IL 60661 USA.	sblenner@gmail.com						Andrews Lori, 2013, I KNOW WHO YOU ARE I; Bauer AM, 2014, J AM BOARD FAM MED, V27, P780, DOI 10.3122/jabfm.2014.06.140108; International Data Corporation, SMARTPH OS MARK SHAR; Pew Internet and American Life Project, 2012, MOB HLTH 2012; US Food and Drug Administration (FDA), RESP FDA FEEDB 510 K; Wang JT, 2014, TELEMED E-HEALTH, V20, P570, DOI 10.1089/tmj.2013.0243	6	59	61	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					1051	1052		10.1001/jama.2015.19426	http://dx.doi.org/10.1001/jama.2015.19426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26954415	Bronze			2022-12-28	WOS:000371540200019
J	Raab, M; Gentili, M; de Belly, H; Thiam, HR; Vargas, P; Jimenez, AJ; Lautenschlaeger, F; Voituriez, R; Lennon-Dumenil, AM; Manel, N; Piel, M				Raab, M.; Gentili, M.; de Belly, H.; Thiam, H. R.; Vargas, P.; Jimenez, A. J.; Lautenschlaeger, F.; Voituriez, Raphael; Lennon-Dumenil, A. M.; Manel, N.; Piel, M.			ESCRT III repairs nuclear envelope ruptures during cell migration to limit DNA damage and cell death	SCIENCE			English	Article							GENOME INSTABILITY; DEFORMATION; CONFINEMENT; PROTEOLYSIS; SPACE; GEN1	In eukaryotic cells, the nuclear envelope separates the genomic DNA from the cytoplasmic space and regulates protein trafficking between the two compartments. This barrier is only transiently dissolved during mitosis. Here, we found that it also opened at high frequency in migrating mammalian cells during interphase, which allowed nuclear proteins to leak out and cytoplasmic proteins to leak in. This transient opening was caused by nuclear deformation and was rapidly repaired in an ESCRT (endosomal sorting complexes required for transport)-dependent manner. DNA double-strand breaks coincided with nuclear envelope opening events. As a consequence, survival of cells migrating through confining environments depended on efficient nuclear envelope and DNA repair machineries. Nuclear envelope opening in migrating leukocytes could have potentially important consequences for normal and pathological immune responses.	[Raab, M.; de Belly, H.; Thiam, H. R.; Vargas, P.; Jimenez, A. J.; Lautenschlaeger, F.; Piel, M.] PSL Res Univ, Inst Curie, CNRS, UMR 144, F-75005 Paris, France; [Raab, M.; Vargas, P.; Piel, M.] PSL Res Univ, Inst Pierre Gilles de Gennes, F-75005 Paris, France; [Gentili, M.; Lennon-Dumenil, A. M.; Manel, N.] PSL Res Univ, Inst Curie, INSERM, U932, F-75005 Paris, France; [Voituriez, Raphael] Univ Paris 06, CNRS, Lab Phys Theor Mat Condensee, UMR 7600, Paris, France; [Voituriez, Raphael] Univ Paris 06, CNRS, Lab Jean Perrin, UMR 8237, Paris, France; [Lautenschlaeger, F.] Univ Saarland, Dept Phys, D-66123 Saarbrucken, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Saarland University	Piel, M (corresponding author), PSL Res Univ, Inst Curie, CNRS, UMR 144, F-75005 Paris, France.; Piel, M (corresponding author), PSL Res Univ, Inst Pierre Gilles de Gennes, F-75005 Paris, France.	matthieu.piel@curie.fr	Manel, Nicolas/E-2128-2011; voituriez, raphael/V-3418-2017; Thiam, Hawa Racine/AAY-4658-2021; VARGAS, Pablo/HHM-4543-2022; Lennon-Dumenil, Ana-Maria/I-6716-2016; Thiam, Hawa Racine/AAQ-2006-2020; Lautenschläger, Franziska/L-3484-2016; Vargas, Pablo/L-9858-2017	Manel, Nicolas/0000-0002-1481-4430; Thiam, Hawa Racine/0000-0002-2381-1442; VARGAS, Pablo/0000-0002-6475-494X; Lautenschläger, Franziska/0000-0001-8263-3386; Vargas, Pablo/0000-0002-6475-494X; Jimenez Salazar, Ana Joaquina/0000-0003-4108-6632; Gentili, Matteo/0000-0002-6970-8133; voituriez, raphael/0000-0001-8746-5713	European Research Council (ERC) [311205]; Human Frontier Science Program Fellowship; Agence Nationale de Research grant for cell migration in confined environments (MICEMICO); ERC grant for spatio-temporal regulation of antigen presentation and cell migration (STRAPACEMI); ERC grant [309848]; Ville de Paris Emergence program; Dendritic Cell Biology (DCBIOL) Laboratories of Excellence (LabEx DCBIOL); Fondation Acting on European Research in Immunology and Allergology (ACTERIA Foundation); Fondation Schlumberger (FSER)	European Research Council (ERC)(European Research Council (ERC)); Human Frontier Science Program Fellowship(Human Frontier Science Program); Agence Nationale de Research grant for cell migration in confined environments (MICEMICO); ERC grant for spatio-temporal regulation of antigen presentation and cell migration (STRAPACEMI); ERC grant; Ville de Paris Emergence program; Dendritic Cell Biology (DCBIOL) Laboratories of Excellence (LabEx DCBIOL); Fondation Acting on European Research in Immunology and Allergology (ACTERIA Foundation); Fondation Schlumberger (FSER)	The authors thank I. Poser, M. Hetzer, R. Medema, B. Baum, and M. Petronczki for kindly providing cell lines and plasmids and E. Zlotek-Zlotkieviz for help with the figures. We are grateful to J. Lammerding and coauthors for sharing their unpublished results and manuscripts. We also thank P. Maiuri, F. Perez, and M. Le Berre for helpful discussions and help with the methods and analysis; V. Fraisier; L. Sengmanivong; the Nikon imaging center and the BioImaging Cell and Tissue Core Facility of the Institut Curie (PICT IBiSA) platform at Institut Curie for technical support in microscopy; the Institut Curie animal facility; S. Kitchen-Goosen for animal husbandry and technical support; and M. Maurin for help in image analysis. This work was supported by European Research Council (ERC) grant 311205 for proliferation and migration under external constraints (PROMICO) to M.P., Human Frontier Science Program Fellowship to M.R., Agence Nationale de Research grant for cell migration in confined environments (MICEMICO) to M.P. and A.M.L.-D., ERC grant for spatio-temporal regulation of antigen presentation and cell migration (STRAPACEMI) to A.M.L.-D., ERC grant 309848 for innate sensing of HIV and immune responses (HIVINNATE) to N.M.; Ville de Paris Emergence program; Dendritic Cell Biology (DCBIOL) Laboratories of Excellence (LabEx DCBIOL); Fondation Acting on European Research in Immunology and Allergology (ACTERIA Foundation); and Fondation Schlumberger (FSER). Additional experimental details and data are available in the supplementary materials.	Chan YW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5844; Davidson PM, 2014, CELL MOL BIOENG, V7, P293, DOI 10.1007/s12195-014-0342-y; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Fidzianska A, 2008, J NEUROL SCI, V271, P91, DOI 10.1016/j.jns.2008.03.017; Gonzalo S, 2015, CURR OPIN CELL BIOL, V34, P75, DOI 10.1016/j.ceb.2015.05.007; Gritenaite D, 2014, GENE DEV, V28, P1604, DOI 10.1101/gad.240515.114; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Hatch E, 2014, J CELL BIOL, V205, P133, DOI 10.1083/jcb.201402003; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Heuze ML, 2011, METHODS MOL BIOL, V769, P415, DOI 10.1007/978-1-61779-207-6_28; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Krause M, 2015, CELL ADHES MIGR, V9, P357, DOI 10.1080/19336918.2015.1061173; Le Berre M, 2012, INTEGR BIOL-UK, V4, P1406, DOI 10.1039/c2ib20056b; Lee CP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002904; Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054; Olmos Y, 2015, NATURE, V522, P236, DOI 10.1038/nature14503; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rowat AC, 2013, J BIOL CHEM, V288, P8610, DOI 10.1074/jbc.M112.441535; Sarbajna S, 2014, GENE DEV, V28, P1124, DOI 10.1101/gad.238303.114; Scheffer LL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6646; Shimi T, 2014, ADV EXP MED BIOL, V773, P415, DOI 10.1007/978-1-4899-8032-8_19; Sixt M, 2011, IMMUNOL LETT, V138, P32, DOI 10.1016/j.imlet.2011.02.013; Soria-Valles C, 2015, NAT CELL BIOL, V17, P1004, DOI 10.1038/ncb3207; Vargas JD, 2012, NUCLEUS-PHILA, V3, P88, DOI 10.4161/nucl.18954; Vietri M, 2015, NATURE, V522, P231, DOI 10.1038/nature14408; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152	30	509	513	5	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					359	362		10.1126/science.aad7611	http://dx.doi.org/10.1126/science.aad7611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27013426				2022-12-28	WOS:000373990100044
J	Hollon, NG; Phillips, PEM				Hollon, Nick G.; Phillips, Paul E. M.			Making risk-takers settle	NATURE			English	Editorial Material							DOPAMINE		[Hollon, Nick G.] Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Phillips, Paul E. M.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Phillips, Paul E. M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Salk Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hollon, NG (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Phillips, PEM (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.; Phillips, PEM (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nhollon@salk.edu; pemp@uw.edu	Phillips, Paul E. M./A-4463-2008	Phillips, Paul E. M./0000-0002-8749-7026; Hollon, Nick/0000-0003-4827-1582				Dodd ML, 2005, ARCH NEUROL-CHICAGO, V62, P1377, DOI 10.1001/archneur.62.9.noc50009; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Jin X, 2014, NAT NEUROSCI, V17, P423, DOI 10.1038/nn.3632; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Kupchik YM, 2015, NAT NEUROSCI, V18, P1230, DOI 10.1038/nn.4068; Orsini CA, 2015, NEUROSCI BIOBEHAV R, V58, P147, DOI 10.1016/j.neubiorev.2015.04.009; Zalocusky KA, 2016, NATURE, V531, P642, DOI 10.1038/nature17400	10	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					588	589		10.1038/nature17314	http://dx.doi.org/10.1038/nature17314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27007851				2022-12-28	WOS:000373027400028
J	Stanley, SA; Kelly, L; Latcha, KN; Schmidt, SF; Yu, XF; Nectow, AR; Sauer, J; Dyke, JP; Dordick, JS; Friedman, JM				Stanley, Sarah A.; Kelly, Leah; Latcha, Kaamashri N.; Schmidt, Sarah F.; Yu, Xiaofei; Nectow, Alexander R.; Sauer, Jeremy; Dyke, Jonathan P.; Dordick, Jonathan S.; Friedman, Jeffrey M.			Bidirectional electromagnetic control of the hypothalamus regulates feeding and metabolism	NATURE			English	Article							GLUCOSE-HOMEOSTASIS; BRAIN; RECEPTOR; GLUCAGON; KEY	Targeted, temporally regulated neural modulation is invaluable in determining the physiological roles of specific neural populations or circuits. Here we describe a system for non-invasive, temporal activation or inhibition of neuronal activity in vivo and its use to study central nervous system control of glucose homeostasis and feeding in mice. We are able to induce neuronal activation remotely using radio waves or magnetic fields via Cre-dependent expression of a GFP-tagged ferritin fusion protein tethered to the cation-conducting transient receptor potential vanilloid 1 (TRPV1) by a camelid anti-GFP antibody (anti-GFP-TRPV1)(1). Neuronal inhibition via the same stimuli is achieved by mutating the TRPV1 pore, rendering the channel chloride-permeable. These constructs were targeted to glucose-sensing neurons in the ventromedial hypothalamus in glucokinase-Cre mice, which express Cre in glucose-sensing neurons(2). Acute activation of glucose-sensing neurons in this region increases plasma glucose and glucagon, lowers insulin levels and stimulates feeding, while inhibition reduces blood glucose, raises insulin levels and suppresses feeding. These results suggest that pancreatic hormones function as an effector mechanism of central nervous system circuits controlling blood glucose and behaviour. The method we employ obviates the need for permanent implants and could potentially be applied to study other neural processes or used to regulate other, even dispersed, cell types.	[Stanley, Sarah A.; Kelly, Leah; Latcha, Kaamashri N.; Schmidt, Sarah F.; Yu, Xiaofei; Nectow, Alexander R.; Friedman, Jeffrey M.] Rockefeller Univ, Lab Mol Genet, New York, NY 10065 USA; [Sauer, Jeremy; Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Dyke, Jonathan P.] Weill Cornell Med Coll, Dept Radiol, New York, NY 10065 USA; [Friedman, Jeffrey M.] Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Rensselaer Polytechnic Institute; Cornell University; Howard Hughes Medical Institute	Friedman, JM (corresponding author), Rockefeller Univ, Lab Mol Genet, New York, NY 10065 USA.; Friedman, JM (corresponding author), Howard Hughes Med Inst, New York, NY 10065 USA.	friedj@mail.rockefeller.edu	Yu, Xiaofei/J-9245-2017; Dyke, Jonathan/AAX-4362-2020	Yu, Xiaofei/0000-0002-1712-331X; Dyke, Jonathan/0000-0001-7170-488X	Howard Hughes Medical Institute; JPB Foundation; National Institutes of Health [GM095654, MH105941]; Rensselaer Fellowship under an NIH predoctoral training grant [GM067545]; Robertson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095654, T32GM067545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105941] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); JPB Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rensselaer Fellowship under an NIH predoctoral training grant; Robertson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank A. North, P. Ariel and K. Thomas for help with confocal imaging, D. Acehan and K. Uryu for performing EM studies and S. Korres for assistance with the manuscript. This work was funded by Howard Hughes Medical Institute, the JPB Foundation, the National Institutes of Health (GM095654 and MH105941) and a Rensselaer Fellowship (to J.S.) under an NIH predoctoral training grant (GM067545). Support for this project was provided by a grant from the Robertson Foundation.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Anthony TE, 2014, CELL, V156, P522, DOI 10.1016/j.cell.2013.12.040; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen R, 2015, SCIENCE, V347, P1477, DOI 10.1126/science.1261821; DAVIES R, 1974, J COMP PHYSIOL PSYCH, V86, P414, DOI 10.1037/h0036563; Evans ML, 2004, DIABETES, V53, P2542, DOI 10.2337/diabetes.53.10.2542; Falowski SM, 2015, NEUROMODULATION, V18, P670, DOI 10.1111/ner.12335; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; GOTO Y, 1980, METABOLISM, V29, P986, DOI 10.1016/0026-0495(80)90044-X; Horvath TL, 1999, J NEUROSCI, V19, P10417; Kang L, 2004, DIABETES, V53, P549, DOI 10.2337/diabetes.53.3.549; Kim T, 2012, J BIOTECHNOL, V162, P237, DOI 10.1016/j.jbiotec.2012.09.019; Kuhn FJP, 2007, J BIOL CHEM, V282, P27598, DOI 10.1074/jbc.M702247200; LANDAU BR, 1958, P SOC EXP BIOL MED, V99, P124; Lozano Andres M, 2004, Suppl Clin Neurophysiol, V57, P733; Murphy BA, 2009, AM J PHYSIOL-CELL PH, V297, pC750, DOI 10.1152/ajpcell.00127.2009; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; ROWLAND NE, 1985, BRAIN RES BULL, V14, P617, DOI 10.1016/0361-9230(85)90111-X; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; SHIMAZU T, 1966, NATURE, V210, P1178, DOI 10.1038/2101178a0; Stanley S, 2013, CELL METAB, V18, P596, DOI 10.1016/j.cmet.2013.09.002; Stanley SA, 2015, NAT MED, V21, P92, DOI 10.1038/nm.3730; Stanley SA, 2012, SCIENCE, V336, P604, DOI 10.1126/science.1216753; WU SY, 2002, CURR PROTOC MOL BIOL, pCH16	29	156	159	5	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					647	+		10.1038/nature17183	http://dx.doi.org/10.1038/nature17183			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27007848	Green Accepted			2022-12-28	WOS:000373027400040
J	Bridwell-Rabb, J; Drennan, CL				Bridwell-Rabb, Jennifer; Drennan, Catherine L.			A radically unexpected mechanism	SCIENCE			English	Editorial Material							BIOSYNTHESIS; SUBSTRATE; TYROSINE; INTERMEDIATE; TRYPTOPHAN; REQUIRES		[Bridwell-Rabb, Jennifer; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Bridwell-Rabb, Jennifer; Drennan, Catherine L.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bridwell-Rabb, Jennifer; Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bridwell-Rabb, J; Drennan, CL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Bridwell-Rabb, J; Drennan, CL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Bridwell-Rabb, J; Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	jb_rabb@mit.edu; cdrennan@mit.edu		Bridwell-Rabb, Jennifer/0000-0002-7437-6217	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [F32 GM108189] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM108189] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhandari DM, 2015, BIOCHEMISTRY-US, V54, P4767, DOI 10.1021/acs.biochem.5b00764; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Decamps L, 2012, J AM CHEM SOC, V134, P18173, DOI 10.1021/ja307762b; Douglas P, 2006, ANGEW CHEM INT EDIT, V45, P5197, DOI 10.1002/anie.200601910; Just-Baringo X, 2014, MAR DRUGS, V12, P317, DOI 10.3390/md12010317; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kuchenreuther JM, 2013, SCIENCE, V342, P472, DOI 10.1126/science.1241859; Magnusson O.T., 2001, BIOCHEMISTRY-US, V40, P7773; Martinez-Gomez NC, 2008, BIOCHEMISTRY-US, V47, P9054, DOI 10.1021/bi8010253; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P3847, DOI 10.1021/bi900400e; Nicolet Y, 2014, ANGEW CHEM INT EDIT, V53, P11840, DOI 10.1002/anie.201407320; Sicoli G, 2016, SCIENCE, V351, P1320, DOI 10.1126/science.aad8995; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]	13	1	1	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1267	1268		10.1126/science.aaf4942	http://dx.doi.org/10.1126/science.aaf4942			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989237				2022-12-28	WOS:000372397700020
J	Lagerlof, O; Slocomb, JE; Hong, I; Aponte, Y; Blackshaw, S; Hart, GW; Huganir, RL				Lagerloef, Olof; Slocomb, Julia E.; Hong, Ingie; Aponte, Yeka; Blackshaw, Seth; Hart, Gerald W.; Huganir, Richard L.			The nutrient sensor OGT in PVN neurons regulates feeding	SCIENCE			English	Article							O-GLCNACYLATION; N-ACETYLGLUCOSAMINE; X-CHROMOSOME; GLUCOSE; PHOSPHORYLATION; EXPRESSION; CIRCUITS; ROLES; RATS	Maintaining energy homeostasis is crucial for the survival and health of organisms. The brain regulates feeding by responding to dietary factors and metabolic signals from peripheral organs. It is unclear how the brain interprets these signals. O-GlcNAc transferase (OGT) catalyzes the posttranslational modification of proteins by O-GlcNAc and is regulated by nutrient access. Here, we show that acute deletion of OGT from alpha CaMKII-positive neurons in adult mice caused obesity from overeating. The hyperphagia derived from the paraventricular nucleus (PVN) of the hypothalamus, where loss of OGT was associated with impaired satiety. These results identify O-GlcNAcylation in alpha CaMKII neurons of the PVN as an important molecular mechanism that regulates feeding behavior.	[Lagerloef, Olof; Hong, Ingie; Aponte, Yeka; Blackshaw, Seth; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Lagerloef, Olof; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Slocomb, Julia E.] Natl Inst Drug Abuse Natl Inst Hlth Johns Hopkins, Baltimore, MD 21224 USA; [Aponte, Yeka] NIDA, Intramural Res Program, Neuronal Circuits & Behav Unit, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu	Aponte, Yeka/AAL-4643-2020	Aponte, Yeka/0000-0002-5967-2579; Hong, Ingie/0000-0002-7246-9233; Lagerlof, Olof/0000-0002-6440-0957; Hart, Gerald/0000-0001-7812-4351	NIH [R01NS036715, R01DK6167, N01-HV-00240, P01HL107153]; National Institute on Drug Abuse Intramural Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715, P30NS050274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000595] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	O.L., G.W.H., and R.L.H. designed all experiments; the optogenetics experiments were also designed by Y.A. and J.E.S., and the elecotrophysiological experiments were also designed by I.H. O.L. performed all experiments and analyzed all data but the electrophysiology (I.H.) and the optogenetics (J.E.S.). The optogenetics data were analyzed by J.E.S., Y.A., and O.L. O.L., G.W.H., and R.L.H. wrote the manuscript. We thank G. Schutz for providing the alpha CaMKII-CreER<SUP>T2</SUP> mice, J. L. Bedont for help with in situ hybridization experiments, and R. H. White for assistance with mating and genotyping. All data necessary to understand and assess the conclusions of the manuscript are in the body of the paper and in the supplementary materials. All primary data are archived on a secure server located in the Department of Neuroscience at Johns Hopkins University (JHU). All data will be made available upon request. G.W.H. receives a share of royalty received by the university on sales of the CTD 110.6 antibody, which are managed by JHU. The research was supported by NIH (grant R01NS036715 to R.L.H. and grants R01DK6167, N01-HV-00240, and P01HL107153 to G.W.H.) and the National Institute on Drug Abuse Intramural Research Program (Y.A.).	American Diabetes Association, 2001, Diabetes Care, V24, P775; Gutierrez-Aguilar R, 2012, OBESITY, V20, P306, DOI 10.1038/oby.2011.236; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hettes SR, 2003, BRAIN RES, V992, P167, DOI 10.1016/j.brainres.2003.08.032; Karnani M, 2011, AM J PHYSIOL-REG I, V300, pR47, DOI 10.1152/ajpregu.00527.2010; Lewis CE, 2009, CIRCULATION, V119, P3263, DOI 10.1161/CIRCULATIONAHA.109.192574; Li X, 2006, EUR J NEUROSCI, V23, P2078, DOI 10.1111/j.1460-9568.2006.04735.x; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Sohn JW, 2013, TRENDS NEUROSCI, V36, P504, DOI 10.1016/j.tins.2013.05.003; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STEFFENS AB, 1988, AM J PHYSIOL, V255, pR200, DOI 10.1152/ajpregu.1988.255.2.R200; Sutton AK, 2014, J NEUROSCI, V34, P15306, DOI 10.1523/JNEUROSCI.0226-14.2014; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; VIJAYAN E, 1977, ENDOCRINOLOGY, V100, P1727, DOI 10.1210/endo-100-6-1727; Wallen-Mackenzie A, 2009, J NEUROSCI, V29, P2238, DOI 10.1523/JNEUROSCI.5851-08.2009; Wolosker H, 1998, FASEB J, V12, P91, DOI 10.1096/fasebj.12.1.91; Xu YZ, 2013, CELL METAB, V18, P860, DOI 10.1016/j.cmet.2013.11.003	23	86	87	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1293	1296		10.1126/science.aad5494	http://dx.doi.org/10.1126/science.aad5494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989246	Green Accepted			2022-12-28	WOS:000372397700036
J	Lerner, TN; Ye, L; Deisseroth, K				Lerner, Talia N.; Ye, Li; Deisseroth, Karl			Communication in Neural Circuits: Tools, Opportunities, and Challenges	CELL			English	Article							MIDBRAIN DOPAMINE NEURONS; FLUORESCENT LATEX MICROSPHERES; MEDIAL PREFRONTAL CORTEX; TOP-DOWN CONTROL; BASAL GANGLIA; CELLULAR-RESOLUTION; NUCLEUS-ACCUMBENS; MOUSE-BRAIN; IN-VIVO; OPTOGENETIC STIMULATION	Communication, the effective delivery of information, is fundamental to life across all scales and species. Nervous systems (by necessity) may be most specifically adapted among biological tissues for high rate and complexity of information transmitted, and thus, the properties of neural tissue and principles of its organization into circuits may illuminate capabilities and limitations of biological communication. Here, we consider recent developments in tools for studying neural circuits with particular attention to defining neuronal cell types by input and output information streams- i.e., by how they communicate. Complementing approaches that define cell types by virtue of genetic promoter/enhancer properties, this communication-based approach to defining cell types operationally by input/output (I/O) relationships links structure and function, resolves difficulties associated with single-genetic-feature definitions, leverages technology for observing and testing significance of precisely these I/O relationships in intact brains, and maps onto processes through which behavior may be adapted during development, experience, and evolution.	[Lerner, Talia N.; Ye, Li; Deisseroth, Karl] Stanford Univ, Dept Bioengn, 318 Campus Dr, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat, 318 Campus Dr, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, 318 Campus Dr, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, 318 Campus Dr, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Dept Psychiat, 318 Campus Dr, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, 318 Campus Dr, Stanford, CA 94305 USA.	deissero@stanford.edu	Lerner, Talia/AAB-5439-2020; Lerner, Talia/AGW-7812-2022	Lerner, Talia/0000-0002-3875-0654	NRSA [1F32MH105053-01]; National Institute of Mental Health; National Institute on Drug Abuse; Wiegers Family Fund; Nancy and James Grosfeld Foundation; H.L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund; U.S. Army Research Laboratory and Defense Advanced Research Projects Agency [W911NF-14-20013]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH105053] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Wiegers Family Fund; Nancy and James Grosfeld Foundation; H.L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund; U.S. Army Research Laboratory and Defense Advanced Research Projects Agency; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	T.N.L. is supported by an NRSA Postdoctoral Fellowship (1F32MH105053-01). K.D. is supported by the National Institute of Mental Health, National Institute on Drug Abuse, the Wiegers Family Fund, the Nancy and James Grosfeld Foundation, the H.L. Snyder Medical Foundation, the Samuel and Betsy Reeves Fund, and the U.S. Army Research Laboratory and Defense Advanced Research Projects Agency (Cooperative Agreement Number W911NF-14-20013); nothing in this material represents official views or policies of our funders. We acknowledge R. Tomer and A. Adhikari for their work on the data cited and shown in Figures 2 and 3, respectively, and we thank R. Poldrack, B. Knutson, and the entire Deisseroth lab for advice and support. All tools and methods are distributed and supported freely (www.optogenetics.org, clarityresourcecenter.org).	Adhikari A, 2015, NATURE, V527, P179, DOI 10.1038/nature15698; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Atasoy D, 2014, NAT NEUROSCI, V17, P1830, DOI 10.1038/nn.3854; Ballesteros-Yanez I, 2006, NEUROSCIENCE, V138, P403, DOI 10.1016/j.neuroscience.2005.11.038; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Britt JP, 2012, NEURON, V76, P790, DOI 10.1016/j.neuron.2012.09.040; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; Cazorla M, 2014, NEURON, V81, P153, DOI 10.1016/j.neuron.2013.10.041; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Chuhma N, 2014, NEURON, V81, P901, DOI 10.1016/j.neuron.2013.12.027; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Conte WL, 2009, NAT PROTOC, V4, P1157, DOI 10.1038/nprot.2009.93; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Dorocic IP, 2014, NEURON, V83, P663, DOI 10.1016/j.neuron.2014.07.002; Ekstrand MI, 2014, CELL, V157, P1230, DOI 10.1016/j.cell.2014.03.059; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Ferenczi EA, 2016, SCIENCE, V351, DOI 10.1126/science.aac9698; Garcia-Moreno F, 2014, DEVELOPMENT, V141, P1589, DOI 10.1242/dev.105254; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; Gong YY, 2015, SCIENCE, V350, P1361, DOI 10.1126/science.aab0810; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Grun D, 2015, CELL, V163, P799, DOI 10.1016/j.cell.2015.10.039; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guenthner CJ, 2013, NEURON, V78, P773, DOI 10.1016/j.neuron.2013.03.025; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Guo QC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123381; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566; HONIG MG, 1989, TRENDS NEUROSCI, V12, P333, DOI 10.1016/0166-2236(89)90040-4; HONIG MG, 1989, TRENDS NEUROSCI, V12, P340; Jonas E, 2015, ELIFE, V4, DOI 10.7554/eLife.04250; Jorgenson L. A., 2015, PHILOS T R SOC LON B, V370; KATZ LC, 1990, NEUROSCIENCE, V34, P511, DOI 10.1016/0306-4522(90)90159-2; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; Khaliq ZM, 2010, J NEUROSCI, V30, P7401, DOI 10.1523/JNEUROSCI.0143-10.2010; Kim C.K., 2016, NAT METHODS; Kim HF, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00120; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Kim JS, 2014, NATURE, V509, P331, DOI 10.1038/nature13240; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Kim Y, 2015, CELL REP, V10, P292, DOI 10.1016/j.celrep.2014.12.014; Kissa K, 2002, MOL CELL NEUROSCI, V20, P627, DOI 10.1006/mcne.2002.1141; Kupchik YM, 2015, NAT NEUROSCI, V18, P1230, DOI 10.1038/nn.4068; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; LAVAIL JH, 1972, SCIENCE, V176, P1416, DOI 10.1126/science.176.4042.1416; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Little JP, 2013, J NEUROSCI, V33, P15333, DOI 10.1523/JNEUROSCI.2385-13.2013; Little JP, 2012, J NEUROSCI, V32, P12808, DOI 10.1523/JNEUROSCI.1616-12.2012; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Llinas RR, 2004, SYNAPTIC ORG BRAIN; Loulier K, 2014, NEURON, V81, P505, DOI 10.1016/j.neuron.2013.12.016; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; MacAskill AF, 2012, NAT NEUROSCI, V15, P1624, DOI 10.1038/nn.3254; Maglione M, 2013, NAT NEUROSCI, V16, P790, DOI 10.1038/nn.3403; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Menegas W, 2015, ELIFE, V4, DOI 10.7554/eLife.10032; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mingote S, 2015, J NEUROSCI, V35, P16259, DOI 10.1523/JNEUROSCI.1674-15.2015; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Naumann T, 2000, J NEUROSCI METH, V103, P11, DOI 10.1016/S0165-0270(00)00292-2; Nelson AB, 2014, NEURON, V82, P63, DOI 10.1016/j.neuron.2014.01.023; Ogawa SK, 2014, CELL REP, V8, P1105, DOI 10.1016/j.celrep.2014.06.042; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Packer AM, 2015, NAT METHODS, V12, P140, DOI 10.1038/nmeth.3217; Packer AM, 2012, NAT METHODS, V9, P1202, DOI [10.1038/NMETH.2249, 10.1038/nmeth.2249]; Pan Y. A., 2011, COLD SPRING HARB PRO, V2011, pt5546; Pascoli V, 2014, NATURE, V509, P459, DOI 10.1038/nature13257; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Phillips R, 2015, TRENDS CELL BIOL, V25, P723, DOI 10.1016/j.tcb.2015.10.007; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Ragan T, 2012, NAT METHODS, V9, P255, DOI [10.1038/nmeth.1854, 10.1038/NMETH.1854]; Rajasethupathy P, 2015, NATURE, V526, P653, DOI 10.1038/nature15389; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Reutsky-Gefen I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2500; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Rickgauer JP, 2014, NAT NEUROSCI, V17, P1816, DOI 10.1038/nn.3866; Saunders A, 2015, NATURE, V521, P85, DOI 10.1038/nature14179; Schulz K, 2012, NAT METHODS, V9, P597, DOI [10.1038/NMETH.2013, 10.1038/nmeth.2013]; SCHWAB ME, 1978, BRAIN RES, V152, P145, DOI 10.1016/0006-8993(78)90140-3; Schwarz LA, 2015, NATURE, V524, P88, DOI 10.1038/nature14600; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Steinberg EE, 2015, CURR OPIN NEUROBIOL, V30, P9, DOI 10.1016/j.conb.2014.08.004; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sun Q.-Q., 2014, PLOS ONE, V9; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Szabo V, 2014, NEURON, V84, P1157, DOI 10.1016/j.neuron.2014.11.005; Tomer R, 2015, CELL, V163, P1796, DOI 10.1016/j.cell.2015.11.061; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tsetsenis T, 2014, J NEUROSCI, V34, P15083, DOI 10.1523/JNEUROSCI.0348-14.2014; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Weissbourd B, 2014, NEURON, V83, P645, DOI 10.1016/j.neuron.2014.06.024; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zalocusky K.A., 2016, NATURE, V23, P2016	118	99	101	1	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1136	1150		10.1016/j.cell.2016.02.027	http://dx.doi.org/10.1016/j.cell.2016.02.027			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967281	Green Accepted, Bronze			2022-12-28	WOS:000372784900012
J	Rosenbaum, L				Rosenbaum, Lisa			N-of-1 Policymaking - Tragedy, Trade-offs, and the Demise of Morcellation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		American Cancer Society, 2015, SURV RAT UT SARC STA; Angell M, 1996, NEW ENGL J MED, V334, P1513, DOI 10.1056/NEJM199606063342306; Food & Administration D., 2014, QUANT ASS PREV UNS U; Food and Drug Administration, 2014, UPD LAP UT POW MORC; Friedman RA, 2014, NEW ENGL J MED, V371, P1666, DOI 10.1056/NEJMp1408480; Gigerenzer G, 2006, RISK ANAL, V26, P347, DOI 10.1111/j.1539-6924.2006.00753.x; Hall T, 2015, ONCOLOGIST, V20, P1274, DOI 10.1634/theoncologist.2015-0061; Kuran T, 1999, STANFORD LAW REV, V51, P683, DOI 10.2307/1229439; Levitz J, 2015, DEADLY MED COMMON SU; Lu CY, 2014, BMJ-BRIT MED J, pg3596; Miller HI., 2006, NATL REV        0502; Motluk A., 2015, MAISONNEUVE     1110; Noorchashm H, 2015, PHILADELPHIA IN 0413; Parker WH, 2016, OBSTET GYNECOL, V127, P18, DOI 10.1097/AOG.0000000000001157; Pritts EA, 2015, GYNECOL SURG, V12, P165, DOI 10.1007/s10397-015-0894-4; Siedhoff MT, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.03.006; Stewart EA, 2015, NEW ENGL J MED, V372, P1646, DOI [10.1056/NEJMcp1411029, 10.1038/nrdp.2016.43]; Vanderford M, 2009, SILICONE BREAST IMPL	18	31	33	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					986	990		10.1056/NEJMms1516161	http://dx.doi.org/10.1056/NEJMms1516161			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF9DH	26962735				2022-12-28	WOS:000371660000016
J	Zimmer, C				Zimmer, Carl			Staying Afloat in the Rising Tide of Science	CELL			English	Editorial Material								New York Times columnist and science writer Carl Zimmer discusses the challenges of effectively communicating with the public about science.				carl@carlzimmer.com						Ball P., 2015, NATURE NEWS; Pinker Steven, 2014, SENSE STYLE THINKING; Roberts D., 2015, TOP SCI COMMITTEE DE; Van Noorden R, 2014, NATURE NEWSBLOG; Wai J., 2015, PSYCHOL TODAY	5	3	3	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1094	1096		10.1016/j.cell.2016.02.042	http://dx.doi.org/10.1016/j.cell.2016.02.042			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967275	Bronze			2022-12-28	WOS:000372784900006
J	Norris, DP				Norris, Dominic P.			Calcium contradictions in cilia	NATURE			English	Editorial Material									[Norris, Dominic P.] MRC Harwell, Mammalian Genet Unit, Harwell Campus, Didcot OX11 0RD, Oxon, England	MRC Harwell	Norris, DP (corresponding author), MRC Harwell, Mammalian Genet Unit, Harwell Campus, Didcot OX11 0RD, Oxon, England.	d.norris@har.mrc.ac.uk			MRC [MC_U142670370] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114276, R01GM121565] Funding Source: NIH RePORTER; Medical Research Council [MC_U142670370] Funding Source: Medline; NIGMS NIH HHS [R01 GM121565, R01 GM114276] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	18	18	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					582	582		10.1038/nature17313	http://dx.doi.org/10.1038/nature17313			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27007852				2022-12-28	WOS:000373027400022
J	Grosmark, AD; Buzsaki, G				Grosmark, Andres D.; Buzsaki, Gyoergy			Diversity in neural firing dynamics supports both rigid and learned hippocampal sequences	SCIENCE			English	Article							PLACE-CELL SEQUENCES; SPATIAL MEMORY; EXPERIENCE; REACTIVATION; NETWORKS; RIPPLES; NEURONS; REPLAY; SLEEP; STATE	Cell assembly sequences during learning are "replayed" during hippocampal ripples and contribute to the consolidation of episodic memories. However, neuronal sequences may also reflect preexisting dynamics. We report that sequences of place-cell firing in a novel environment are formed from a combination of the contributions of a rigid, predominantly fast-firing subset of pyramidal neurons with low spatial specificity and limited change across sleep-experience-sleep and a slow-firing plastic subset. Slow-firing cells, rather than fast-firing cells, gained high place specificity during exploration, elevated their association with ripples, and showed increased bursting and temporal coactivation during postexperience sleep. Thus, slow-and fast-firing neurons, although forming a continuous distribution, have different coding and plastic properties.	[Grosmark, Andres D.] Columbia Univ, Dept Neurosci, Med Ctr, New York, NY 10019 USA; [Grosmark, Andres D.; Buzsaki, Gyoergy] NYU, Sch Med, Neurosci Inst, New York, NY 10016 USA; [Buzsaki, Gyoergy] NYU, Ctr Neural Sci, New York, NY 10016 USA	Columbia University; New York University; New York University	Buzsaki, G (corresponding author), NYU, Sch Med, Neurosci Inst, New York, NY 10016 USA.; Buzsaki, G (corresponding author), NYU, Ctr Neural Sci, New York, NY 10016 USA.	gyorgy.buzsaki@nyumc.org		Buzsaki, Gyorgy/0000-0002-3100-4800	NIH [NS075015, MH54671, MH102840]; Simons Foundation; G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102840, R01MH107396, R01MH054671] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; G. Harold and Leila Y. Mathers Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grants NS075015, MH54671, and MH102840; the Simons Foundation; and the G. Harold and Leila Y. Mathers Foundation. We thank J. Long for invaluable experimental support and B. Watson, S. McKenzie, L. Roux, and S. Tuncdemir for discussion and advice. Spike and LFP data are available at CRCNS.org.	Bittner KC, 2015, NAT NEUROSCI, V18, P1133, DOI 10.1038/nn.4062; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Buzsaki G, 2015, HIPPOCAMPUS, V25, P1073, DOI 10.1002/hipo.22488; Buzsaki G, 2015, SCIENCE, V347, P612, DOI 10.1126/science.aaa6505; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Ciocchi S, 2015, SCIENCE, V348, P560, DOI 10.1126/science.aaa3245; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Dragoi G, 2013, P NATL ACAD SCI USA, V110, P9100, DOI 10.1073/pnas.1306031110; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gerstner W, 2014, NEURONAL DYNAMICS: FROM SINGLE NEURONS TO NETWORKS AND MODELS OF COGNITION, P1, DOI 10.1017/CBO9781107447615; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Mizuseki K, 2013, CELL REP, V4, P1010, DOI 10.1016/j.celrep.2013.07.039; OKeefe John., 1978, HIPPOCAMPUS COGNITIV; Olafsdottir HF, 2015, ELIFE, V4, DOI 10.7554/eLife.06063; Panas D, 2015, J NEUROSCI, V35, P8480, DOI 10.1523/JNEUROSCI.4421-14.2015; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Rich PD, 2014, SCIENCE, V345, P814, DOI 10.1126/science.1255635; Silva D, 2015, NAT NEUROSCI, V18, P1772, DOI 10.1038/nn.4151; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	26	151	151	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1440	1443		10.1126/science.aad1935	http://dx.doi.org/10.1126/science.aad1935			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013730	Green Accepted			2022-12-28	WOS:000372756200046
J	Wala, J; Beroukhim, R				Wala, Jeremiah; Beroukhim, Rameen			CANCER The oncogene makes its escape	SCIENCE			English	Editorial Material							TERT PROMOTER MUTATIONS		[Beroukhim, Rameen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Broad Inst, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Beroukhim, R (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	rameen_beroukhim@dfci.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG002295] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Phillips-Cremins JE, 2013, MOL CELL, V50, P461, DOI 10.1016/j.molcel.2013.04.018	13	1	1	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1398	1399		10.1126/science.aaf5542	http://dx.doi.org/10.1126/science.aaf5542			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013717				2022-12-28	WOS:000372756200023
J	Fivez, T; Kerklaan, D; Mesotten, D; Verbruggen, S; Wouters, PJ; Vanhorebeek, I; Debaveye, Y; Vlasselaers, D; Desmet, L; Casaer, MP; Guerra, GG; Hanot, J; Joffe, A; Tibboel, D; Joosten, K; Van den Berghe, G				Fivez, Tom; Kerklaan, Dorian; Mesotten, Dieter; Verbruggen, Sascha; Wouters, Pieter J.; Vanhorebeek, Ilse; Debaveye, Yves; Vlasselaers, Dirk; Desmet, Lars; Casaer, Michael P.; Guerra, Gonzalo Garcia; Hanot, Jan; Joffe, Ari; Tibboel, Dick; Joosten, Koen; Van den Berghe, Greet			Early versus Late Parenteral Nutrition in Critically Ill Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVENOUS LIPID EMULSION; OPEN-HEART-SURGERY; CRITICAL ILLNESS; ENTERAL NUTRITION; ACID; PRETREATMENT; AUTOPHAGY; OUTCOMES; INFANTS	BACKGROUND Recent trials have questioned the benefit of early parenteral nutrition in adults. The effect of early parenteral nutrition on clinical outcomes in critically ill children is unclear. METHODS We conducted a multicenter, randomized, controlled trial involving 1440 critically ill children to investigate whether withholding parenteral nutrition for 1 week (i.e., providing late parenteral nutrition) in the pediatric intensive care unit (ICU) is clinically superior to providing early parenteral nutrition. Fluid loading was similar in the two groups. The two primary end points were new infection acquired during the ICU stay and the adjusted duration of ICU dependency, as assessed by the number of days in the ICU and as time to discharge alive from ICU. For the 723 patients receiving early parenteral nutrition, parenteral nutrition was initiated within 24 hours after ICU admission, whereas for the 717 patients receiving late parenteral nutrition, parenteral nutrition was not provided until the morning of the 8th day in the ICU. In both groups, enteral nutrition was attempted early and intravenous micronutrients were provided. RESULTS Although mortality was similar in the two groups, the percentage of patients with a new infection was 10.7% in the group receiving late parenteral nutrition, as compared with 18.5% in the group receiving early parenteral nutrition (adjusted odds ratio, 0.48; 95% confidence interval [CI], 0.35 to 0.66). The mean (+/- SE) duration of ICU stay was 6.5 +/- 0.4 days in the group receiving late parenteral nutrition, as compared with 9.2 +/- 0.8 days in the group receiving early parenteral nutrition; there was also a higher likelihood of an earlier live discharge from the ICU at any time in the late-parenteral-nutrition group (adjusted hazard ratio, 1.23; 95% CI, 1.11 to 1.37). Late parenteral nutrition was associated with a shorter duration of mechanical ventilatory support than was early parenteral nutrition (P = 0.001), as well as a smaller proportion of patients receiving renal-replacement therapy (P = 0.04) and a shorter duration of hospital stay (P = 0.001). Late parenteral nutrition was also associated with lower plasma levels of.-glutamyltransferase and alkaline phosphatase than was early parenteral nutrition (P = 0.001 and P = 0.04, respectively), as well as higher levels of bilirubin (P = 0.004) and C-reactive protein (P = 0.006). CONCLUSIONS In critically ill children, withholding parenteral nutrition for 1 week in the ICU was clinically superior to providing early parenteral nutrition.	[Fivez, Tom; Mesotten, Dieter; Wouters, Pieter J.; Vanhorebeek, Ilse; Debaveye, Yves; Vlasselaers, Dirk; Desmet, Lars; Casaer, Michael P.; Hanot, Jan; Van den Berghe, Greet] KU Leuven Univ Hosp, Clin Div, Dept Cellular & Mol Med, Leuven, Belgium; [Fivez, Tom; Mesotten, Dieter; Wouters, Pieter J.; Vanhorebeek, Ilse; Debaveye, Yves; Vlasselaers, Dirk; Desmet, Lars; Casaer, Michael P.; Hanot, Jan; Van den Berghe, Greet] KU Leuven Univ Hosp, Lab Intens Care Med, Leuven, Belgium; [Kerklaan, Dorian; Verbruggen, Sascha; Tibboel, Dick; Joosten, Koen] Erasmus MC Sophia Childrens Hosp, Dept Pediat & Pediat Surg, Intens Care, Rotterdam, Netherlands; [Guerra, Gonzalo Garcia; Hanot, Jan; Joffe, Ari] Univ Alberta, Stollery Childrens Hosp, Dept Pediat, Intens Care Unit, Edmonton, AB, Canada	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Erasmus University Rotterdam; Erasmus MC; Stollery Children's Hospital; University of Alberta	Van den Berghe, G (corresponding author), KU Leuven Univ & Hosp, Intens Care Med, Herestr 49, B-3000 Louvain, Belgium.	greet.vandenberghe@kuleuven.be	Verbruggen, Sascha/ABB-7745-2020; Casaer, Michael/Y-7131-2019; Mesotten, Dieter/ABE-4176-2020	Verbruggen, Sascha/0000-0003-4866-9865; Casaer, Michael/0000-0002-7087-0795; Mesotten, Dieter/0000-0002-3258-4720; Van den Berghe, Greet/0000-0002-5320-1362; Vanhorebeek, Ilse/0000-0002-5261-5192	Flemish Agency for Innovation through Science and Technology [IWT-TBM110685]; Fund for Scientific Research Flanders; UZ Leuven Clinical Research Fund; Methusalem Program - Flemish Government through KU Leuven [METH/08/07, METH/14/06]; European Research Council under the European Union [321670]; Fonds NutsOhra; Erasmus MC Cost-Effectiveness Research Grant; Erasmus Trustfonds through Erasmus University Rotterdam; Nutricia	Flemish Agency for Innovation through Science and Technology; Fund for Scientific Research Flanders(FWO); UZ Leuven Clinical Research Fund; Methusalem Program - Flemish Government through KU Leuven; European Research Council under the European Union(European Research Council (ERC)); Fonds NutsOhra; Erasmus MC Cost-Effectiveness Research Grant; Erasmus Trustfonds through Erasmus University Rotterdam; Nutricia(Danone Nutricia)	Supported by a grant from the Flemish Agency for Innovation through Science and Technology (IWT-TBM110685, to Dr. Van den Berghe), a private donation by an anonymous Dutch family through the Leuven University Hospitals to Drs. Van den Berghe and Casaer, a senior clinical research fellowship from the Fund for Scientific Research Flanders to Dr. Mesotten, a postdoctoral fellowship from the UZ Leuven Clinical Research Fund to Dr. Casaer, a grant from the Methusalem Program funded by the Flemish Government (METH/08/07 and METH/14/06 through KU Leuven, to Dr. Van den Berghe), the European Research Council under the European Union's Seventh Framework Program ([FP7/2013-2018]/ERC Advanced Grant Agreement no 321670, to Dr. Van den Berghe), a grant from Fonds NutsOhra to Dr. Verbruggen, an Erasmus MC Cost-Effectiveness Research Grant to Dr. Verbruggen; and a grant from the Erasmus Trustfonds through Erasmus University Rotterdam to Dr. Verbruggen.; Dr. Verbruggen reports receiving lecture fees from Nutricia. No other potential conflict of interest relevant to this article was reported.	Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Chaloupecky V, 1997, J THORAC CARDIOV SUR, V114, P1053, DOI 10.1016/S0022-5223(97)70019-9; Chaloupecky V., 1994, Cor et Vasa, V36, P26; de Betue CTI, 2015, CLIN NUTR, V34, P115, DOI 10.1016/j.clnu.2014.01.019; Doig GS, 2013, JAMA-J AM MED ASSOC, V309, P2130, DOI 10.1001/jama.2013.5124; Fivez T, 2015, CLIN NUTR; Fivez T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0728-8; Heidegger CP, 2013, LANCET, V381, P385, DOI 10.1016/S0140-6736(12)61351-8; Hermans G, 2013, LANCET RESP MED, V1, P621, DOI 10.1016/S2213-2600(13)70183-8; Hulst JM, 2010, CLIN NUTR, V29, P106, DOI 10.1016/j.clnu.2009.07.006; Jenniskens M, 2016, INTENS CARE MED, V42, P16, DOI 10.1007/s00134-015-4054-0; Joffe A, 2009, COCHRANE DB SYST REV, V2; Kerklaan D, 2016, PEDIATR CRIT CARE ME, V17, P10, DOI 10.1097/PCC.0000000000000542; Koletzko Berthold, 2005, J Pediatr Gastroenterol Nutr, V41 Suppl 2, pS1, DOI 10.1097/01.mpg.0000181841.07090.f4; Larsen BMK, 2015, JPEN-PARENTER ENTER, V39, P171, DOI 10.1177/0148607113505326; Larsen BMK, 2012, CLIN NUTR, V31, P322, DOI 10.1016/j.clnu.2011.11.006; Lekmanov A. U., 2013, Anesteziologiya i Reanimatologiya, P49; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; McKinlay CJD, 2015, NEW ENGL J MED, V373, P1507, DOI 10.1056/NEJMoa1504909; Mehta N. M., 2008, Nutrition in pediatrics: basic science and clinical applications, P663; Mehta NM, 2012, CRIT CARE MED, V40, P2204, DOI 10.1097/CCM.0b013e31824e18a8; Mehta NM, 2010, JPEN-PARENTER ENTER, V34, P38, DOI 10.1177/0148607109348065; Mehta NM, 2009, JPEN-PARENTER ENTER, V33, P260, DOI 10.1177/0148607109333114; Mesotten D, 2012, JAMA-J AM MED ASSOC, V308, P1641, DOI 10.1001/jama.2012.12424; POLLACK MM, 1985, JPEN-PARENTER ENTER, V9, P309, DOI 10.1177/0148607185009003309; Skillman HE., 2015, PEDIAT CRITICAL CARE; Tin W, 2012, PEDIATRICS, V130, pE1497, DOI 10.1542/peds.2012-0776; Vanwijngaerden YM, 2014, HEPATOLOGY, V60, P202, DOI 10.1002/hep.26928; Vanwijngaerden YM, 2011, HEPATOLOGY, V54, P1741, DOI 10.1002/hep.24582; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Ziegler TR, 2009, NEW ENGL J MED, V361, P1088, DOI 10.1056/NEJMct0806956	32	278	301	1	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2016	374	12					1111	1122		10.1056/NEJMoa1514762	http://dx.doi.org/10.1056/NEJMoa1514762			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AA	26975590	Bronze			2022-12-28	WOS:000372585100004
J	Fuller, RA				Fuller, Richard A.			ANIMAL MIGRATION Dispersion explains declines	NATURE			English	Editorial Material								Migratory birds are declining globally. A broad study of European migratory birds finds that species that disperse widely during the non-breeding season are less likely to be in decline than are species with more restricted dispersion.	[Fuller, Richard A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	University of Queensland	Fuller, RA (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	r.fuller@uq.edu.au	Fuller, Richard/B-7971-2008	Fuller, Richard/0000-0001-9468-9678				Clare H., 2015, ORISON FOR A CURLEW; DeLuca WV, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.1045; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Gilroy JJ, 2016, ECOL LETT, V19, P308, DOI 10.1111/ele.12569; Kirby JS, 2008, BIRD CONSERV INT, V18, pS49, DOI 10.1017/S0959270908000439; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Rushing CS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2846; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188	9	5	5	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					451	452		10.1038/531451a	http://dx.doi.org/10.1038/531451a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	27008961				2022-12-28	WOS:000372701300026
J	Sarlah, D				Sarlah, David			No double bond left behind	NATURE			English	Editorial Material							METATHESIS REACTIONS; ALKENYL BROMIDES; VINYL HALIDES; ACID	Alkenyl halides are some of the most useful building blocks for synthesizing small organic molecules. A catalyst has now allowed their direct preparation from widely available alkenes using the cross-metathesis reaction. See Article P.459	[Sarlah, David] Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Sarlah, D (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.	sarlah@illinois.edu		Sarlah, David/0000-0002-8736-8953				BROWN HC, 1973, J AM CHEM SOC, V95, P6456, DOI 10.1021/ja00800a054; Hodgson DM, 2008, J AM CHEM SOC, V130, P16500, DOI 10.1021/ja8076999; Jana R, 2011, CHEM REV, V111, P1417, DOI 10.1021/cr100327p; Koh MJ, 2016, NATURE, V531, P459, DOI 10.1038/nature17396; Lopez S, 2005, J ORG CHEM, V70, P6346, DOI 10.1021/jo050807f; Macnaughtan ML, 2007, J AM CHEM SOC, V129, P7708, DOI 10.1021/ja0715952; Meek SJ, 2011, NATURE, V471, P461, DOI 10.1038/nature09957; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4490, DOI 10.1002/anie.200500369; NICOLAOU KC, 1985, J AM CHEM SOC, V107, P7515, DOI 10.1021/ja00311a048; Pawluc P, 2009, ORG LETT, V11, P3390, DOI 10.1021/ol901233j; Renner MK, 1998, J ORG CHEM, V63, P8346, DOI 10.1021/jo981226b; Silverman RB, 1996, J AM CHEM SOC, V118, P1253, DOI 10.1021/ja952789x	12	1	1	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					453	454		10.1038/531453a	http://dx.doi.org/10.1038/531453a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	27008963				2022-12-28	WOS:000372701300027
J	Stahel, WR				Stahel, Walter R.			Circular economy	NATURE			English	Editorial Material									[Stahel, Walter R.] Prod Life Inst, Geneva, Switzerland; [Stahel, Walter R.] Univ Surrey, Fac Engn & Phys Sci, Guildford GU2 5XH, Surrey, England	University of Surrey	Stahel, WR (corresponding author), Prod Life Inst, Geneva, Switzerland.; Stahel, WR (corresponding author), Univ Surrey, Fac Engn & Phys Sci, Guildford GU2 5XH, Surrey, England.	wrstahel2014@gmail.com						Ellen MacArthur Foundation, 2016, NEW PLAST EC RETH FU, P61; Stahel, 1989, LIMITS CERTAINTY FAC; Stahel, 2006, PERFORMANCE EC; STAHEL W., 2008, HDB PERFORMABILITY E, P127; Stahel W.R., 2016, TAKING STOCK IND ECO, P137, DOI [10.1007/978-3-319-20571-7_7, DOI 10.1007/978-3-319-20571-7_7]; Stahel W. R., 1986, SCI PUBL POLICY, V13, P91; Stahel W. R., 2015, CIRCULAR EC WEALTH F, P86; Stahel W. R., 2001, OUR FRAGILE WORLD CH, VII, P1553; Stahel W. R., 1981, JOBS TOMORROW POTENT; Stahel WR, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0567	10	787	796	38	339	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					435	438		10.1038/531435a	http://dx.doi.org/10.1038/531435a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QK	27008952	Bronze			2022-12-28	WOS:000372701300013
J	Laskowski, RJ				Laskowski, Robert J.			The Power of "My"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Laskowski, Robert J.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA	Jefferson University	Laskowski, RJ (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA.	laskowskiadvisors@gmail.com							0	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1235	1235		10.1001/jama.2015.17153	http://dx.doi.org/10.1001/jama.2015.17153			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	27002442				2022-12-28	WOS:000372511100007
J	Thomas, AE; Baird, SF; Anderson, J				Thomas, Angela E.; Baird, Susan F.; Anderson, Julia			PRACTICE POINTER Purpuric and petechial rashes in adults and children: initial assessment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FEVER		[Thomas, Angela E.; Baird, Susan F.] Royal Hosp Sick Children, Dept Haematol, Edinburgh EH9 1LF, Midlothian, Scotland; [Anderson, Julia] Royal Edinburgh Infirm, Dept Haematol, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh	Thomas, AE (corresponding author), Royal Hosp Sick Children, Dept Haematol, Edinburgh EH9 1LF, Midlothian, Scotland.	angela.thomas2@nhs.net						Anderson JAM, 2009, HAZZARDS GERIATRIC M; Anderson Julia A M, 2010, BMJ, V341, pc4565, DOI 10.1136/bmj.c4565; BAKER RC, 1989, PEDIATRICS, V84, P1051; Brogan PA, 2000, ARCH DIS CHILD, V83, P506, DOI 10.1136/adc.83.6.506; Cancer Research UK, LEUK ALL SUB TYP COM; Centers for Disease Control and Prevention, 2015, VACC IMM MEN DIS; Chell J, 2001, ANN ROY COLL SURG, V83, P186; Kemp AM, 2015, ARCH DIS CHILD, V100, P426, DOI 10.1136/archdischild-2014-307120; National Institute for Health and Care Excellence, SUSP CANC REC REF; National Institute for Health and Care Excellence, 2010, BACT MEN MEN SEPT MA; Public Health England, 2015, INV MEN DIS LAB CONF; Scottish Intercollegiate Guidelines Network, 2008, MAN INV MEN DIS CHIL; Terrell DR, 2010, AM J HEMATOL, V85, P174, DOI 10.1002/ajh.21616; Warkentin TE, 1997, TRANSFUS MED REV, V11, P296, DOI 10.1016/S0887-7963(97)80095-8	14	6	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2016	352								i1285	10.1136/bmj.i1285	http://dx.doi.org/10.1136/bmj.i1285			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LK	27004477				2022-12-28	WOS:000373044500002
J	Troyan, I; Gavriliuk, A; Ruffer, R; Chumakov, A; Mironovich, A; Lyubutin, I; Perekalin, D; Drozdov, AP; Eremets, MI				Troyan, Ivan; Gavriliuk, Alexander; Rueffer, Rudolf; Chumakov, Alexander; Mironovich, Anna; Lyubutin, Igor; Perekalin, Dmitry; Drozdov, Alexander P.; Eremets, Mikhail I.			Observation of superconductivity in hydrogen sulfide from nuclear resonant scattering	SCIENCE			English	Article							MAGNETIC-FIELD; HYDRIDE	High-temperature superconductivity remains a focus of experimental and theoretical research. Hydrogen sulfide (H2S) has been reported to be superconducting at high pressures and with a high transition temperature. We report on the direct observation of the expulsion of the magnetic field in H2S compressed to 153 gigapascals. A thin Sn-119 film placed inside the H2S sample was used as a sensor of the magnetic field. The magnetic field on the Sn-119 sensor was monitored by nuclear resonance scattering of synchrotron radiation. Our results demonstrate that an external static magnetic field of about 0.7 tesla is expelled from the volume of Sn-119 foil as a result of the shielding by the H2S sample at temperatures between 4.7 K and approximately 140 K, revealing a superconducting state of H2S.	[Troyan, Ivan; Drozdov, Alexander P.; Eremets, Mikhail I.] Max Planck Inst Chem, D-55020 Mainz, Germany; [Troyan, Ivan; Gavriliuk, Alexander; Lyubutin, Igor] Russian Acad Sci, Shubnikov Inst Crystallog, Moscow 119333, Russia; [Gavriliuk, Alexander; Mironovich, Anna] Russian Acad Sci, Inst Nucl Res, Moscow 142190, Russia; [Rueffer, Rudolf; Chumakov, Alexander] European Synchrotron Radiat Facil, CS40220, F-38043 Grenoble 9, France; [Chumakov, Alexander] Natl Res Ctr Kurchatov Inst, Moscow 123182, Russia; [Perekalin, Dmitry] Russian Acad Sci, AN Nesmeyanov Inst Organoelement Cpds, Moscow 119991, Russia	Max Planck Society; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; Russian Academy of Sciences; Institute for Nuclear Research of the Russian Academy of Sciences; European Synchrotron Radiation Facility (ESRF); National Research Centre - Kurchatov Institute; Russian Academy of Sciences; Nesmeyanov Institute of Organoelement Compounds	Troyan, I (corresponding author), Max Planck Inst Chem, D-55020 Mainz, Germany.; Troyan, I (corresponding author), Russian Acad Sci, Shubnikov Inst Crystallog, Moscow 119333, Russia.	itrojan64@gmail.com	Gavriliuk, Alexander G/G-1317-2011; Mironovich, Anna A/K-2303-2015; Perekalin, Dmitry/B-5924-2013; Drozdov, Alexander/Q-8609-2018; Troyan, Ivan/AAQ-9617-2021	Gavriliuk, Alexander G/0000-0003-0604-586X; Mironovich, Anna A/0000-0002-0808-4355; Perekalin, Dmitry/0000-0002-0864-8907; Drozdov, Alexander/0000-0001-6444-9016; Troyan, Ivan/0000-0001-8065-1687	European Research Council (ERC) [267777]; Max Planck Institute for Chemistry, Mainz; Russian Science Foundation [14-12-00848]; Russian Foundation for Basic Research [14-02-00483-a]; Russian Academy of Sciences program "Physics of elementary particles, fundamental nuclear physics and nuclear technologies"	European Research Council (ERC)(European Research Council (ERC)); Max Planck Institute for Chemistry, Mainz(Max Planck Society); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences program "Physics of elementary particles, fundamental nuclear physics and nuclear technologies"	The high-pressure samples of hydrogen sulfide and hydrogen investigated in this study have been prepared using the techniques and equipment designed and built by M.I.E. and A.P.D. Funding was provided by the European Research Council (ERC Advanced Grant 267777 of M.I.E.) and the Max Planck Institute for Chemistry, Mainz. This work was also supported by Russian Science Foundation grant 14-12-00848 (I.T., A.G., and I.L.), Russian Foundation for Basic Research grant 14-02-00483-a (A.G.), and the Russian Academy of Sciences program "Physics of elementary particles, fundamental nuclear physics and nuclear technologies."	Akahama Y, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012195; Ashcroft NW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187002; Brandt EH, 1996, PHYS REV B, V54, P4246, DOI 10.1103/PhysRevB.54.4246; Brandt EH, 1998, PHYS REV B, V58, P6506, DOI 10.1103/PhysRevB.58.6506; Drozdov AP, 2015, NATURE, V525, P73, DOI 10.1038/nature14964; Duan DF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06968; Dubrovinskaia N, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3529454; Feng J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.017006; Gao GY, 2010, P NATL ACAD SCI USA, V107, P1317, DOI 10.1073/pnas.0908342107; Gao GY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107002; Gerdau E, 1999, HYPERFINE INTERACT, V123, P1; HASTINGS JB, 1991, PHYS REV LETT, V66, P770, DOI 10.1103/PhysRevLett.66.770; Kim DY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.117002; Kim DY, 2010, P NATL ACAD SCI USA, V107, P2793, DOI 10.1073/pnas.0914462107; Li YW, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4874158; LYUBUTIN IS, 1975, JETP LETT+, V21, P59; Mikitik GP, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.014520; Shvyd'ko Y. V., 1999, PHYS REV B, V59, P9132; Wang H, 2012, P NATL ACAD SCI USA, V109, P6463, DOI 10.1073/pnas.1118168109	19	101	106	3	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1303	1306		10.1126/science.aac8176	http://dx.doi.org/10.1126/science.aac8176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989248				2022-12-28	WOS:000372397700038
J	Decorsiere, A; Mueller, H; Van Breugel, PC; Abdul, F; Gerossier, L; Beran, RK; Livingston, CM; Niu, CR; Fletcher, SP; Hantz, O; Strubin, M				Decorsiere, Adrien; Mueller, Henrik; Van Breugel, Pieter C.; Abdul, Fabien; Gerossier, Laetitia; Beran, Rudolf K.; Livingston, Christine M.; Niu, Congrong; Fletcher, Simon P.; Hantz, Olivier; Strubin, Michel			Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor	NATURE			English	Article							IN-VIVO; HUMAN HEPATOCYTES; HBV REPLICATION; CELL-DEATH; DNA; INFECTION; BINDING; CHROMOSOME; EXPRESSION; COHESIN	Chronic hepatitis B virus infection is a leading cause of cirrhosis and liver cancer(1,2). Hepatitis B virus encodes the regulatory HBx protein whose primary role is to promote transcription of the viral genome, which persists as an extrachromosomal DNA circle in infected cells(3-5). HBx accomplishes this task by an unusual mechanism, enhancing transcription only from extrachromosomal DNA templates(6). Here we show that HBx achieves this by hijacking the cellular DDB1-containing E3 ubiquitin ligase to target the 'structural maintenance of chromosomes' (Smc) complex Smc5/6 for degradation. Blocking this event inhibits the stimulatory effect of HBx both on extrachromosomal reporter genes and on hepatitis B virus transcription. Conversely, silencing the Smc5/6 complex enhances extrachromosomal reporter gene transcription in the absence of HBx, restores replication of an HBx-deficient hepatitis B virus, and rescues wild-type hepatitis B virus in a DDB1-knockdown background. The Smc5/6 complex associates with extrachromosomal reporters and the hepatitis B virus genome, suggesting a direct mechanism of transcriptional inhibition. These results uncover a novel role for the Smc5/6 complex as a restriction factor selectively blocking extrachromosomal DNA transcription. By destroying this complex, HBx relieves the inhibition to allow productive hepatitis B virus gene expression.	[Decorsiere, Adrien; Mueller, Henrik; Van Breugel, Pieter C.; Abdul, Fabien; Strubin, Michel] Univ Med Ctr CMU, Dept Microbiol & Mol Med, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland; [Gerossier, Laetitia; Hantz, Olivier] Univ Lyon, CRCL, INSERM U1052, CNRS 5286, 151 Cours A Thomas, F-69424 Lyon, France; [Beran, Rudolf K.; Livingston, Christine M.; Niu, Congrong; Fletcher, Simon P.] Gilead Sci Inc, 333 Lakeside Dr, Foster City, CA 94404 USA; [Mueller, Henrik] F Hoffmann La Roche Ltd, Infect Dis Discovery & Translat Area, Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Grenzacherstr 124, CH-4070 Basel, Switzerland; [Van Breugel, Pieter C.] Netherlands Canc Inst, Div Biol Stress Response, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); Gilead Sciences; Roche Holding; Netherlands Cancer Institute	Strubin, M (corresponding author), Univ Med Ctr CMU, Dept Microbiol & Mol Med, Rue Michel Servet 1, CH-1211 Geneva 4, Switzerland.; Hantz, O (corresponding author), Univ Lyon, CRCL, INSERM U1052, CNRS 5286, 151 Cours A Thomas, F-69424 Lyon, France.; Fletcher, SP (corresponding author), Gilead Sci Inc, 333 Lakeside Dr, Foster City, CA 94404 USA.	Simon.Fletcher@gilead.com; olivier.hantz@inserm.fr; michel.strubin@unige.ch		decorsiere, adrien/0000-0002-5716-6154; Gerossier, Laetitia/0000-0002-3110-115X	CLARA (Lyon); French National Agency for Research against AIDS and viral hepatitis (ANRS); Swiss National Science Foundation [31003A-127384, 310030-149626]; Canton of Geneva	CLARA (Lyon); French National Agency for Research against AIDS and viral hepatitis (ANRS)(ANRS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Geneva	We are most grateful to M. Rivoire for providing liver samples, L. Lefrancois and M. Michelet for help in preparing hepatocytes, U. Protzer for the HBV(Delta X)-producing cell line, C. J. Gloeckner for the StrepII/Flag TAP-tag construct, C. E. P. Goldring for the tetracyclin-inducible HepG2 cell line, S. Elledge for the lentiviral pINDUCER vectors, A. R. Lehmann for anti-Smc5 and anti-Smc6 antibodies, M. A. Petit for anti-HBsAg and anti-HBcAg antibodies, D. Garcin for the Cardif shRNA construct, Q. Seguin-Estevez, Y. Grimaldi and P. Ferrari for help with the ChIP assay, P. Arboit and the Geneva Proteomics Core Facility for mass spectrometry analysis, the Centre d'imagerie Quantitative Lyon-Est for help in confocal microscopy, A. Joshi for statistical analysis support, and J. Curran for reading the manuscript. This study was supported by grants from CLARA (Lyon) and the French National Agency for Research against AIDS and viral hepatitis (ANRS) (to O.H.) and from the Swiss National Science Foundation (31003A-127384 and 310030-149626) (to M.S.) and by the Canton of Geneva (to M.S).	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Aragon L, 2013, CURR OPIN GENET DEV, V23, P204, DOI 10.1016/j.gde.2012.11.004; Benhenda S, 2013, J VIROL, V87, P4360, DOI 10.1128/JVI.02574-12; Benhenda S, 2009, ADV CANCER RES, V103, P75, DOI 10.1016/S0065-230X(09)03004-8; Bontron S, 2002, J BIOL CHEM, V277, P38847, DOI 10.1074/jbc.M205722200; CHEMIN I, 1991, J MED VIROL, V33, P51, DOI 10.1002/jmv.1890330111; De Iaco A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-98; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Feitelson MA, 2014, EXPERT OPIN THER TAR, V18, P293, DOI 10.1517/14728222.2014.867947; Fujiwara S, 2012, WORLD J GASTROENTERO, V18, P3875, DOI 10.3748/wjg.v18.i29.3875; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Goldring CEP, 2006, AM J PHYSIOL-CELL PH, V290, pC104, DOI 10.1152/ajpcell.00133.2005; GRIPON P, 1993, VIROLOGY, V192, P534, DOI 10.1006/viro.1993.1069; Hantz O, 2009, J GEN VIROL, V90, P127, DOI 10.1099/vir.0.004861-0; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hodgson AJ, 2012, VIROLOGY, V426, P73, DOI 10.1016/j.virol.2012.01.021; Ishida Y, 2015, AM J PATHOL, V185, P1275, DOI 10.1016/j.ajpath.2015.01.028; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Kanno T, 2015, CELL REP, V12, P1471, DOI 10.1016/j.celrep.2015.07.048; Kegel A, 2010, COLD SH Q B, V75, P179, DOI 10.1101/sqb.2010.75.047; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Leupin O, 2005, J VIROL, V79, P4238, DOI 10.1128/JVI.79.7.4238-4245.2005; Leupin O, 2003, J VIROL, V77, P6274, DOI 10.1128/JVI.77.11.6274-6283.2003; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Lin-Marq N, 2001, VIROLOGY, V287, P266, DOI 10.1006/viro.2001.1036; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Martin-Lluesma S, 2008, HEPATOLOGY, V48, P1467, DOI 10.1002/hep.22542; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; Rothe M, 2012, GENE THER, V19, P425, DOI 10.1038/gt.2011.117; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Sitterlin D, 2000, ONCOGENE, V19, P4417, DOI 10.1038/sj.onc.1203771; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tapia-Alveal C, 2014, CHROMOSOMA, V123, P437, DOI 10.1007/s00412-014-0474-9; Taylor EM, 2008, MOL CELL BIOL, V28, P1197, DOI 10.1128/MCB.00767-07; Taylor EM, 2001, MOL BIOL CELL, V12, P1583, DOI 10.1091/mbc.12.6.1583; Ulane CM, 2002, VIROLOGY, V304, P160, DOI 10.1006/viro.2002.1773; van Breugel PC, 2012, HEPATOLOGY, V56, P2116, DOI 10.1002/hep.25928; Zhang ZS, 2010, J VIROL, V84, P9326, DOI 10.1128/JVI.00579-10	44	305	323	6	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					386	+		10.1038/nature17170	http://dx.doi.org/10.1038/nature17170			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26983541				2022-12-28	WOS:000372064300056
J	Liang, TJ				Liang, T. Jake			VIROLOGY The X-Files of hepatitis B	NATURE			English	Editorial Material							IN-VIVO; INFECTION; PROTEIN; CCCDNA; DNA		[Liang, T. Jake] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Liang, TJ (corresponding author), NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA.	jliang@nih.gov			Intramural NIH HHS [Z01 DK054500-12, Z01 DK054500-11, ZIA DK054500-19, ZIA DK054500-18] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054500] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Decorsiere A, 2016, NATURE, V531, P386, DOI 10.1038/nature17170; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Kegel A, 2010, COLD SH Q B, V75, P179, DOI 10.1101/sqb.2010.75.047; LEE TH, 1995, J VIROL, V69, P1107, DOI 10.1128/JVI.69.2.1107-1114.1995; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Randow F, 2009, NAT CELL BIOL, V11, P527, DOI 10.1038/ncb0509-527; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Tavalai N, 2011, VIRUS RES, V157, P128, DOI 10.1016/j.virusres.2010.10.002; Wiebe M. S., 2016, J VIROL; Zhang ZS, 2001, J CLIN INVEST, V108, P1523, DOI 10.1172/JCI13787; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994	13	5	5	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					313	314		10.1038/531313a	http://dx.doi.org/10.1038/531313a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26983537	Green Accepted			2022-12-28	WOS:000372064300040
J	Shiddiq, M; Komijani, D; Duan, Y; Gaita-Arino, A; Coronado, E; Hill, S				Shiddiq, Muhandis; Komijani, Dorsa; Duan, Yan; Gaita-Arino, Alejandro; Coronado, Eugenio; Hill, Stephen			Enhancing coherence in molecular spin qubits via atomic clock transitions	NATURE			English	Article							QUANTUM INFORMATION; DECOHERENCE; TM; TB; HO; DY; ER	Quantum computing is an emerging area within the information sciences revolving around the concept of quantum bits (qubits). A major obstacle is the extreme fragility of these qubits due to interactions with their environment that destroy their quantumness. This phenomenon, known as decoherence, is of fundamental interest(1,2). There are many competing candidates for qubits, including superconducting circuits(3), quantum optical cavities(4), ultracold atoms(5) and spin qubits(6-8), and each has its strengths and weaknesses. When dealing with spin qubits, the strongest source of decoherence is the magnetic dipolar interaction(9). To minimize it, spins are typically diluted in a diamagnetic matrix. For example, this dilution can be taken to the extreme of a single phosphorus atom in silicon(6), whereas in molecular matrices a typical ratio is one magnetic molecule per 10,000 matrix molecules(10). However, there is a fundamental contradiction between reducing decoherence by dilution and allowing quantum operations via the interaction between spin qubits. To resolve this contradiction, the design and engineering of quantum hardware can benefit from a 'bottom-up' approach whereby the electronic structure of magnetic molecules is chemically tailored to give the desired physical behaviour. Here we present a way of enhancing coherence in solid-state molecular spin qubits without resorting to extreme dilution. It is based on the design of molecular structures with crystal field ground states possessing large tunnelling gaps that give rise to optimal operating points, or atomic clock transitions, at which the quantum spin dynamics become protected against dipolar decoherence. This approach is illustrated with a holmium molecular nanomagnet in which long coherence times (up to 8.4 microseconds at 5 kelvin) are obtained at unusually high concentrations. This finding opens new avenues for quantum computing based on molecular spin qubits.	[Shiddiq, Muhandis; Komijani, Dorsa; Hill, Stephen] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Shiddiq, Muhandis; Komijani, Dorsa; Hill, Stephen] Florida State Univ, Dept Phys, Tallahassee, FL 32310 USA; [Duan, Yan; Gaita-Arino, Alejandro; Coronado, Eugenio] Univ Valencia, Inst Ciencia Mol, C Catedrat Jose Beltran 2, Paterna 46980, Spain	State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Valencia	Hill, S (corresponding author), Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA.; Hill, S (corresponding author), Florida State Univ, Dept Phys, Tallahassee, FL 32310 USA.; Coronado, E (corresponding author), Univ Valencia, Inst Ciencia Mol, C Catedrat Jose Beltran 2, Paterna 46980, Spain.	eugenio.coronado@uv.es; shill@magnet.fsu.edu	Gaita-Ariño, Alejandro/D-2110-2014; Hill, Stephen/J-5383-2014; DUAN, Yan/G-7948-2016; DUAN, Yan/N-3962-2019; Coronado, Eugenio/E-8960-2014; Shiddiq, Muhandis/O-9213-2015	Hill, Stephen/0000-0001-6742-3620; DUAN, Yan/0000-0002-2849-5602; DUAN, Yan/0000-0002-2849-5602; Cador, Olivier/0000-0003-2064-6223; Shiddiq, Muhandis/0000-0002-8032-0949; Coronado Miralles, Eugenio/0000-0002-1848-8791; Gaita Arino, Alejandro/0000-0002-1600-8627	NSF [DMR-1309463, DMR-1157490]; US AFOSR (AOARD) [134031 FA2386-13-1-4029]; State of Florida; European Research Council; Spanish MINECO [MAT-2014-56143-R, CTQ2014-52758-P]; Spanish MINECO (Excellence Unit Maria de Maeztu) [MDM-2015-0538]; Generalidad Valenciana (Prometeo); Generalidad Valenciana (ISIC-Nano Programs of Excellence); Spanish MINECO; Direct For Mathematical & Physical Scien [1309463] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); US AFOSR (AOARD)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); State of Florida; European Research Council(European Research Council (ERC)European Commission); Spanish MINECO(Spanish Government); Spanish MINECO (Excellence Unit Maria de Maeztu)(Spanish Government); Generalidad Valenciana (Prometeo); Generalidad Valenciana (ISIC-Nano Programs of Excellence); Spanish MINECO(Spanish Government); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank L. Song and J. van Tol for technical assistance with the X-band EPR spectrometer. This work was supported by the NSF (grant DMR-1309463) and the US AFOSR (AOARD contract 134031 FA2386-13-1-4029). Work performed at the NHMFL was supported by the NSF (DMR-1157490) and by the State of Florida. Work performed at the Instituto de Ciencia Molecular was supported by the European Research Council (grants SPINMOL and DECRESIM), by the Spanish MINECO (projects MAT-2014-56143-R, CTQ2014-52758-P and Excellence Unit Maria de Maeztu MDM-2015-0538) and by the Generalidad Valenciana (Prometeo and ISIC-Nano Programs of Excellence). A. G.-A. thanks the Spanish MINECO for a Ramon y Cajal Fellowship.	AlDamen MA, 2008, J AM CHEM SOC, V130, P8874, DOI 10.1021/ja801659m; AlDamen MA, 2009, INORG CHEM, V48, P3467, DOI 10.1021/ic801630z; Ardavan A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057201; Bader K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6304; Balian SJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.045403; BOLLINGER JJ, 1985, PHYS REV LETT, V54, P1000, DOI 10.1103/PhysRevLett.54.1000; Cardona-Serra S, 2012, J AM CHEM SOC, V134, P14982, DOI 10.1021/ja305163t; Clemente-Juan JM, 1999, COORDIN CHEM REV, V193-5, P361, DOI 10.1016/S0010-8545(99)00170-8; Clemente-Juan JM, 2012, CHEM SOC REV, V41, P7464, DOI 10.1039/c2cs35205b; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Duan LM, 2014, NATURE, V508, P195, DOI 10.1038/508195a; Ghosh S, 2012, DALTON T, V41, P13697, DOI 10.1039/c2dt31674a; Graham MJ, 2014, J AM CHEM SOC, V136, P7623, DOI 10.1021/ja5037397; Kaminski D, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.184419; Lehmann J, 2007, NAT NANOTECHNOL, V2, P312, DOI 10.1038/nnano.2007.110; Leuenberger MN, 2001, NATURE, V410, P789, DOI 10.1038/35071024; Martinez-Perez MJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.247213; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; Rudowicz C, 2004, J PHYS-CONDENS MAT, V16, P5825, DOI 10.1088/0953-8984/16/32/018; Schlosshauer M, 2007, FRONT COLLECT, P1; Schweiger A., 2001, PRINCIPLES PULSE ELE; Stamp PCE, 2008, NATURE, V453, P167, DOI 10.1038/453167a; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Takahashi S, 2011, NATURE, V476, P76, DOI 10.1038/nature10314; Taminiau TH, 2014, NAT NANOTECHNOL, V9, P171, DOI [10.1038/NNANO.2014.2, 10.1038/nnano.2014.2]; Thiele S, 2014, SCIENCE, V344, P1135, DOI 10.1126/science.1249802; van Hoogdalem K, 2014, NANOSCI TECHNOL, P275, DOI 10.1007/978-3-642-40609-6_11; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Warner M, 2013, NATURE, V503, P504, DOI 10.1038/nature12597; Wedge CJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.107204; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Wolfowicz G, 2013, NAT NANOTECHNOL, V8, P561, DOI [10.1038/NNANO.2013.117, 10.1038/nnano.2013.117]	32	365	365	9	255	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					348	+		10.1038/nature16984	http://dx.doi.org/10.1038/nature16984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26983539				2022-12-28	WOS:000372064300048
J	Torjesen, I				Torjesen, Ingrid			Obesity may increase risk of rare type of stroke in women taking oral contraceptives	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Zuurbier SM, 2016, JAMA NEUROL, DOI [10.1001/jamaneurol.2015.5107, DOI 10.1001/JAMANEUROL.2015.5107]	1	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2016	352								i1554	10.1136/bmj.i1554	http://dx.doi.org/10.1136/bmj.i1554			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1ZX	26984274				2022-12-28	WOS:000372584800005
J	Fan, X; Rudensky, AY				Fan, Xiying; Rudensky, Alexander Y.			Hallmarks of Tissue-Resident Lymphocytes	CELL			English	Review							INNATE LYMPHOID-CELLS; DELTA-T-CELLS; INVARIANT NKT CELLS; DENDRITIC EPIDERMAL-CELLS; VISCERAL ADIPOSE-TISSUE; RECEPTOR-GAMMA-DELTA; INTRAEPITHELIAL LYMPHOCYTES; CUTTING EDGE; TYPE-2 IMMUNITY; RETINOIC-ACID	Although they are classically viewed as continuously recirculating through the lymphoid organs and blood, lymphocytes also establish residency in non-lymphoid tissues, most prominently at barrier sites, including the mucosal surfaces and skin. These specialized tissue-resident lymphocyte subsets span the innate-adaptive continuum and include innate lymphoid cells (ILCs), unconventional T cells (e.g., NKT, MAIT, gamma delta T cells, and CD8 alpha alpha(+) IELs), and tissue-resident memory T (T-RM) cells. Although these diverse cell types differ in the particulars of their biology, they nonetheless exhibit important shared features, including a role in the preservation of tissue integrity and function during homeostasis, infection, and non-infectious perturbations. In this Review, we discuss the hallmarks of tissue-resident innate, innate-like, and adaptive lymphocytes, as well as their potential functions in non-lymphoid organs.	[Fan, Xiying; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 417 East 68th St, New York, NY 10065 USA; [Fan, Xiying; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, 417 East 68th St, New York, NY 10065 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, 417 East 68th St, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Fan, X; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 417 East 68th St, New York, NY 10065 USA.; Fan, X; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 417 East 68th St, New York, NY 10065 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, 417 East 68th St, New York, NY 10065 USA.	xif2003@med.cornell.edu; rudenska@mskcc.org		Fan, Xiying/0000-0003-3090-381X	National Institutes of Health [R37 AI034206, F30 AI122721]; National Institutes of Health (MSTP grant) [T32 GM07739]; Ludwig Cancer Center at Memorial Sloan-Kettering Cancer Center; Hilton Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI122721, R37AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (MSTP grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Cancer Center at Memorial Sloan-Kettering Cancer Center; Hilton Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to the many scientists whose work could not be cited in this Review due to space constraints. We thank Ruslan Medzhitov for inspiring ideas and Ashutosh Chaudhry for helpful discussions. This work was supported by the National Institutes of Health (R37 AI034206 to A.Y.R.; F30 AI122721 to X.F.; MSTP grant T32 GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program), the Ludwig Cancer Center at Memorial Sloan-Kettering Cancer Center (A.Y.R.), Hilton Foundation (A.Y.R.), and the Howard Hughes Medical Institute (AY.R.).	Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Allen JE, 2014, SEMIN IMMUNOL, V26, P329, DOI 10.1016/j.smim.2014.06.003; Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; BANDEIRA A, 1990, J EXP MED, V172, P239, DOI 10.1084/jem.172.1.239; Bando Jennifer K, 2015, Nat Immunol, V16, P153, DOI 10.1038/ni.3057; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; BEAGLEY KW, 1995, J IMMUNOL, V154, P5611; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Brennan PJ, 2014, P NATL ACAD SCI USA, V111, P13433, DOI 10.1073/pnas.1415357111; Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Carnaud C, 1999, J IMMUNOL, V163, P4647; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Chiba A, 2008, J IMMUNOL, V181, P2292, DOI 10.4049/jimmunol.181.4.2292; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Chua WJ, 2012, INFECT IMMUN, V80, P3256, DOI 10.1128/IAI.00279-12; Cipolletta D, 2015, P NATL ACAD SCI USA, V112, P482, DOI 10.1073/pnas.1423486112; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010641; Cohen NR, 2011, CELL HOST MICROBE, V10, P437, DOI 10.1016/j.chom.2011.09.011; Constantinides MG, 2015, P NATL ACAD SCI USA, V112, P5123, DOI 10.1073/pnas.1423244112; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Coquet JM, 2008, P NATL ACAD SCI USA, V105, P11287, DOI 10.1073/pnas.0801631105; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Cui Y, 2015, J CLIN INVEST, V125, P4171, DOI 10.1172/JCI82424; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Georgel P, 2011, MOL IMMUNOL, V48, P769, DOI 10.1016/j.molimm.2010.12.002; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; HAVRAN WL, 1989, P NATL ACAD SCI USA, V86, P4185, DOI 10.1073/pnas.86.11.4185; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; Hein WR, 1997, IMMUNOLOGY, V91, P58, DOI 10.1046/j.1365-2567.1997.00224.x; HEIN WR, 1991, IMMUNOL TODAY, V12, P30, DOI 10.1016/0167-5699(91)90109-7; Helgeland L, 1996, IMMUNOLOGY, V89, P494, DOI 10.1046/j.1365-2567.1996.d01-783.x; Hintz M, 2001, FEBS LETT, V509, P317, DOI 10.1016/S0014-5793(01)03191-X; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Hung LY, 2013, P NATL ACAD SCI USA, V110, P282, DOI 10.1073/pnas.1206587110; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; ITO K, 1989, P NATL ACAD SCI USA, V86, P631, DOI 10.1073/pnas.86.2.631; ITOHARA S, 1989, P NATL ACAD SCI USA, V86, P5094, DOI 10.1073/pnas.86.13.5094; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kain L, 2015, MOL IMMUNOL, V68, P94, DOI 10.1016/j.molimm.2015.06.009; KELLY KA, 1992, EUR J IMMUNOL, V22, P329, DOI 10.1002/eji.1830220207; Kenna T, 2003, J IMMUNOL, V171, P1775, DOI 10.4049/jimmunol.171.4.1775; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Komori HK, 2012, J IMMUNOL, V188, P2972, DOI 10.4049/jimmunol.1100887; Kong Y, 2009, BLOOD, V114, P310, DOI 10.1182/blood-2008-12-196287; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kovalovsky D, 2010, J IMMUNOL, V184, P6746, DOI 10.4049/jimmunol.1000776; Kumar H, 2000, J IMMUNOL, V165, P4797, DOI 10.4049/jimmunol.165.9.4797; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Lee YJ, 2015, IMMUNITY, V43, P566, DOI 10.1016/j.immuni.2015.06.025; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Leishman AJ, 2001, SCIENCE, V294, P1936, DOI 10.1126/science.1063564; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Lu Y, 2015, J IMMUNOL, V195, P4273, DOI 10.4049/jimmunol.1500939; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Mackay C R, 1989, Int Immunol, V1, P540, DOI 10.1093/intimm/1.5.540; Mackley EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6862; Maryanski JL, 1996, IMMUNITY, V4, P47, DOI 10.1016/S1074-7613(00)80297-6; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mayans S, 2014, IMMUNITY, V41, P207, DOI 10.1016/j.immuni.2014.07.010; McDonald BD, 2015, IMMUNITY, V43, P859, DOI 10.1016/j.immuni.2015.09.009; McDonald BD, 2014, IMMUNITY, V41, P219, DOI 10.1016/j.immuni.2014.07.008; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Meierovics A, 2013, P NATL ACAD SCI USA, V110, pE3119, DOI 10.1073/pnas.1302799110; Menezes JD, 2003, INT IMMUNOL, V15, P447, DOI 10.1093/intimm/dxg043; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Monticelli LA, 2015, P NATL ACAD SCI USA, V112, P10762, DOI 10.1073/pnas.1509070112; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Mucida D, 2009, IMMUNITY, V30, P471, DOI 10.1016/j.immuni.2009.03.008; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Pearson C, 2016, ELIFE, V5, DOI 10.7554/eLife.10066; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Perdiguero EG, 2016, NAT IMMUNOL, V17, P2, DOI 10.1038/ni.3341; POUSSIER P, 1992, J EXP MED, V176, P187, DOI 10.1084/jem.176.1.187; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; ROCHA B, 1992, P NATL ACAD SCI USA, V89, P5336, DOI 10.1073/pnas.89.12.5336; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Salio M, 2014, ANNU REV IMMUNOL, V32, P323, DOI 10.1146/annurev-immunol-032713-120243; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Savage AK, 2011, J IMMUNOL, V186, P5801, DOI 10.4049/jimmunol.1100119; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Selin LK, 2001, J IMMUNOL, V166, P6784, DOI 10.4049/jimmunol.166.11.6784; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Suzuki S, 1998, EUR J IMMUNOL, V28, P3719, DOI 10.1002/(SICI)1521-4141(199811)28:11<3719::AID-IMMU3719>3.3.CO;2-F; Thomas SY, 2011, J EXP MED, V208, P1179, DOI 10.1084/jem.20102630; Tomura M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06030; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Tupin E, 2008, P NATL ACAD SCI USA, V105, P19863, DOI 10.1073/pnas.0810519105; Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452; UMESAKI Y, 1993, IMMUNOLOGY, V79, P32; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Van Rhijn I, 2007, MOL IMMUNOL, V44, P3155, DOI 10.1016/j.molimm.2007.02.003; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Watarai H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001255; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	204	218	228	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1198	1211		10.1016/j.cell.2016.02.048	http://dx.doi.org/10.1016/j.cell.2016.02.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967286	Green Accepted, Bronze			2022-12-28	WOS:000372784900017
J	Watts, G				Watts, Geoff			Alfred Goodman Gilman Obituary	LANCET			English	Biographical-Item																		GILMAN A, PUBLICATION LIST	1	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					938	938		10.1016/S0140-6736(16)00575-4	http://dx.doi.org/10.1016/S0140-6736(16)00575-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF8XP	26977483	Bronze			2022-12-28	WOS:000371644200016
J	Velibey, Y; Guvenc, TS; Ugur, M; Guzelburc, O; Eren, M; Ersek, S				Velibey, Yalcin; Guvenc, Tolga S.; Ugur, Murat; Guzelburc, Ozge; Eren, Mehmet; Ersek, Siyami			Diaphragmatic Cardiac Compression Mimicking Defecation Syncope: A Case Report	ANNALS OF INTERNAL MEDICINE			English	Letter							RISK		[Velibey, Yalcin; Guvenc, Tolga S.; Ugur, Murat; Guzelburc, Ozge; Eren, Mehmet; Ersek, Siyami] Dr Siyami Ersek Thorac & Cardiovasc Surg Training, Istanbul, Turkey	Dr. Siyami Ersek Cardiac & Vascular Surgery Training & Research Hospital	Velibey, Y (corresponding author), Dr Siyami Ersek Thorac & Cardiovasc Surg Training, Istanbul, Turkey.		Güvenç, Tolga Sinan/AAK-6020-2020; Eren, Mehmet/ACD-8031-2022	Güvenç, Tolga Sinan/0000-0002-6738-266X; Eren, Mehmet/0000-0002-5570-705X				Alboni P, 2001, J AM COLL CARDIOL, V37, P1921, DOI 10.1016/S0735-1097(01)01241-4; Allan L, 2004, EUROPACE, V6, P192, DOI 10.1016/j.eupc.2004.01.003; Martin TP, 1997, ANN EMERG MED, V29, P459, DOI 10.1016/S0196-0644(97)70217-8; MIDDLEKAUFF HR, 1993, J AM COLL CARDIOL, V21, P110, DOI 10.1016/0735-1097(93)90724-F; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2016	165	6					454	456		10.7326/L15-0594	http://dx.doi.org/10.7326/L15-0594			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW9FR	27018536				2022-12-28	WOS:000383962000035
J	Yi, F; Danko, T; Botelho, SC; Patzke, C; Pak, C; Wernig, M; Sudhof, TC				Yi, Fei; Danko, Tamas; Botelho, Salome Calado; Patzke, Christopher; Pak, ChangHui; Wernig, Marius; Sudhof, Thomas C.			Autism-associated SHANK3 haploinsufficiency causes I-h channelopathy in human neurons	SCIENCE			English	Article							POSTSYNAPTIC DENSITY PROTEINS; CA1 PYRAMIDAL NEURONS; SYNAPTIC-TRANSMISSION; SHANK3-DEFICIENT MICE; SPECTRUM DISORDERS; CATION CHANNELS; HCN1 CHANNEL; MUTANT MICE; DEFICITS; FAMILY	Heterozygous SHANK3 mutations are associated with idiopathic autism and Phelan-McDermid syndrome. SHANK3 is a ubiquitously expressed scaffolding protein that is enriched in postsynaptic excitatory synapses. Here, we used engineered conditional mutations in human neurons and found that heterozygous and homozygous SHANK3 mutations severely and specifically impaired hyperpolarization-activated cation (I-h) channels. SHANK3 mutations caused alterations in neuronal morphology and synaptic connectivity; chronic pharmacological blockage of I-h channels reproduced these phenotypes, suggesting that they may be secondary to I-h-channel impairment. Moreover, mouse Shank3-deficient neurons also exhibited severe decreases in I-h currents. SHANK3 protein interacted with hyperpolarization-activated cyclic nucleotide-gated channel proteins (HCN proteins) that form I-h channels, indicating that SHANK3 functions to organize HCN channels. Our data suggest that SHANK3 mutations predispose to autism, at least partially, by inducing an I-h channelopathy that may be amenable to pharmacological intervention.	[Yi, Fei; Danko, Tamas; Botelho, Salome Calado; Patzke, Christopher; Pak, ChangHui; Sudhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, 265 Campus Dr, Stanford, CA 94305 USA; [Danko, Tamas; Wernig, Marius] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, 265 Campus Dr, Stanford, CA 94305 USA; [Danko, Tamas; Wernig, Marius] Stanford Univ, Sch Med, Dept Pathol, 265 Campus Dr, Stanford, CA 94305 USA; [Sudhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Sch Med, 265 Campus Dr, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, 265 Campus Dr, Stanford, CA 94305 USA.; Sudhof, TC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, 265 Campus Dr, Stanford, CA 94305 USA.	tcs1@stanford.edu	Patzke, Christopher/J-5679-2019	Patzke, Christopher/0000-0001-7293-8936	NIH [MH092931, NS077906, U19MH104172]; Vetenskapsradet, Sweden; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH104172, R01MH092931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077906] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vetenskapsradet, Sweden(Swedish Research Council); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Zhang, S. Maxeiner, and S. J. Lee for advice, G. Feng (MIT) for reagents, and V. Sebastiano (Stanford) for sharing instruments. This work was supported by grants from NIH (MH092931 to M.W.; NS077906 to T.C.S.; and U19MH104172 to M.W. and T.C.S.) and a postdoctoral fellowship from Vetenskapsradet, Sweden (to S.C.B.). The data are included in the main manuscript and in the supplementary materials. Author contributions: F.Y. performed the ES cell, molecular biology, expression, and cell-biology experiments, T.D. the electrophysiological experiments, S.C.B. the protein chemistry experiments, C.P. the immunoblotting experiments, and C.H.P. the gene-expression experiments. All authors planned the experiments, analyzed data, and edited the paper written by T.C.S.	Anderson GR, 2015, CELL, V162, P593, DOI 10.1016/j.cell.2015.06.056; Benarroch EE, 2013, NEUROLOGY, V80, P304, DOI 10.1212/WNL.0b013e31827dec42; Betancur C, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-17; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Carbonetto S, 2014, DEV NEUROBIOL, V74, P85, DOI 10.1002/dneu.22150; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; DiFrancesco JC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00071; Drapeau E, 2014, DIS MODEL MECH, V7, P667, DOI 10.1242/dmm.013821; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Grabrucker AM, 2011, TRENDS CELL BIOL, V21, P594, DOI 10.1016/j.tcb.2011.07.003; Guilmatre A, 2014, DEV NEUROBIOL, V74, P113, DOI 10.1002/dneu.22128; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Kouser M, 2013, J NEUROSCI, V33, P18448, DOI 10.1523/JNEUROSCI.3017-13.2013; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Lee J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00094; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Pak C, 2015, CELL STEM CELL, V17, P316, DOI 10.1016/j.stem.2015.07.017; Patzke C, 2015, J CLIN INVEST, V125, P3560, DOI 10.1172/JCI78612; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Phillips AM, 2014, NEUROBIOL DIS, V64, P30, DOI 10.1016/j.nbd.2013.12.007; Postea O, 2011, NAT REV DRUG DISCOV, V10, P903, DOI 10.1038/nrd3576; Proepper C, 2014, NEUROSCIENCE, V261, P133, DOI 10.1016/j.neuroscience.2013.10.045; Rosti RO, 2014, DEV MED CHILD NEUROL, V56, P12, DOI 10.1111/dmcn.12278; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Sheng M, 2000, J CELL SCI, V113, P1851; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; SOLOMON JS, 1993, J PHYSIOL-LONDON, V462, P393, DOI 10.1113/jphysiol.1993.sp019561; Speed HE, 2015, J NEUROSCI, V35, P9648, DOI 10.1523/JNEUROSCI.3125-14.2015; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Uppal N, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0036-x; Vaidya SP, 2013, NAT NEUROSCI, V16, P1812, DOI 10.1038/nn.3562; Wang M, 2011, NATURE, V476, P210, DOI 10.1038/nature10243; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	43	180	183	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2016	352	6286							aaf2669	10.1126/science.aaf2669	http://dx.doi.org/10.1126/science.aaf2669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DL1UC	26966193	Green Accepted			2022-12-28	WOS:000375417100028
J	Faria, NR; Azevedo, RDD; Kraemer, MUG; Souza, R; Cunha, MS; Hill, SC; Theze, J; Bonsall, MB; Bowden, TA; Rissanen, I; Rocco, IM; Nogueira, JS; Maeda, AY; Vasami, FGD; Macedo, FLD; Suzuki, A; Rodrigues, SG; Cruz, ACR; Nunes, BT; Medeiros, DBD; Rodrigues, DSG; Queiroz, ALN; da Silva, EVP; Henriques, DF; da Rosa, EST; de Oliveira, CS; Martins, LC; Vasconcelos, HB; Casseb, LMN; Simith, DD; Messina, JP; Abade, L; Loureno, J; Alcantara, LCJ; de Lima, MM; Giovanetti, M; Hay, SI; de Oliveira, RS; Lemos, PD; de Oliveira, LF; de Lima, CPS; da Silva, SP; de Vasconcelos, JM; Franco, L; Cardoso, JF; Vianez, JLDG; Mir, D; Bello, G; Delatorre, E; Khan, K; Creatore, M; Coelho, GE; de Oliveira, WK; Tesh, R; Pybus, OG; Nunes, MRT; Vasconcelos, PFC				Faria, Nuno Rodrigues; da Silva Azevedo, Raimunda do Socorro; Kraemer, Moritz U. G.; Souza, Renato; Cunha, Mariana Sequetin; Hill, Sarah C.; Theze, Julien; Bonsall, Michael B.; Bowden, Thomas A.; Rissanen, Ilona; Rocco, Iray Maria; Nogueira, Juliana Silva; Maeda, Adriana Yurika; da Silva Vasami, Fernanda Giseli; de Lima Macedo, Fernando Luiz; Suzuki, Akemi; Rodrigues, Sueli Guerreiro; Ribeiro Cruz, Ana Cecilia; Nunes, Bruno Tardeli; de Almeida Medeiros, Daniele Barbosa; Guerreiro Rodrigues, Daniela Sueli; Nunes Queiroz, Alice Louize; Pinto da Silva, Eliana Vieira; Henriques, Daniele Freitas; Travassos da Rosa, Elisabeth Salbe; de Oliveira, Consuelo Silva; Martins, Livia Caricio; Vasconcelos, Helena Baldez; Neves Casseb, Livia Medeiros; Simith, Darlene de Brito; Messina, Jane P.; Abade, Leandro; Loureno, Jose; Junior Alcantara, Luiz Carlos; de Lima, Maricelia Maia; Giovanetti, Marta; Hay, Simon I.; de Oliveira, Rodrigo Santos; Lemos, Poliana da Silva; de Oliveira, Layanna Freitas; Silva de Lima, Clayton Pereira; da Silva, Sandro Patroca; de Vasconcelos, Janaina Mota; Franco, Luciano; Cardoso, Jedson Ferreira; da Silva Gonalves Vianez-Junior, Joao Lidio; Mir, Daiana; Bello, Gonzalo; Delatorre, Edson; Khan, Kamran; Creatore, Marisa; Coelho, Giovanini Evelim; de Oliveira, Wanderson Kleber; Tesh, Robert; Pybus, Oliver G.; Nunes, Marcio R. T.; Vasconcelos, Pedro F. C.			Zika virus in the Americas: Early epidemiological and genetic findings	SCIENCE			English	Article							FRENCH-POLYNESIA; TRANSMISSION; INFECTION; BRAZIL; OUTBREAK; EVOLUTION; ISLAND; TRAVEL; CHILD	Brazil has experienced an unprecedented epidemic of Zika virus (ZIKV), with similar to 30,000 cases reported to date. ZIKV was first detected in Brazil in May 2015, and cases of microcephaly potentially associated with ZIKV infection were identified in November 2015. We performed next-generation sequencing to generate seven Brazilian ZIKV genomes sampled from four self-limited cases, one blood donor, one fatal adult case, and one newborn with microcephaly and congenital malformations. Results of phylogenetic and molecular clock analyses show a single introduction of ZIKV into the Americas, which we estimated to have occurred between May and December 2013, more than 12 months before the detection of ZIKV in Brazil. The estimated date of origin coincides with an increase in air passengers to Brazil from ZIKV-endemic areas, as well as with reported outbreaks in the Pacific Islands. ZIKV genomes from Brazil are phylogenetically interspersed with those from other South American and Caribbean countries. Mapping mutations onto existing structural models revealed the context of viral amino acid changes present in the outbreak lineage; however, no shared amino acid changes were found among the three currently available virus genomes from microcephaly cases. Municipality-level incidence data indicate that reports of suspected microcephaly in Brazil best correlate with ZIKV incidence around week 17 of pregnancy, although this correlation does not demonstrate causation. Our genetic description and analysis of ZIKV isolates in Brazil provide a baseline for future studies of the evolution and molecular epidemiology of this emerging virus in the Americas.	[Faria, Nuno Rodrigues; de Oliveira, Rodrigo Santos; Lemos, Poliana da Silva; de Oliveira, Layanna Freitas; Silva de Lima, Clayton Pereira; da Silva, Sandro Patroca; de Vasconcelos, Janaina Mota; Franco, Luciano; Cardoso, Jedson Ferreira; da Silva Gonalves Vianez-Junior, Joao Lidio; Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil; [Faria, Nuno Rodrigues; Kraemer, Moritz U. G.; Hill, Sarah C.; Theze, Julien; Bonsall, Michael B.; Messina, Jane P.; Abade, Leandro; Loureno, Jose; Pybus, Oliver G.] Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England; [da Silva Azevedo, Raimunda do Socorro; Rodrigues, Sueli Guerreiro; Ribeiro Cruz, Ana Cecilia; Nunes, Bruno Tardeli; de Almeida Medeiros, Daniele Barbosa; Guerreiro Rodrigues, Daniela Sueli; Nunes Queiroz, Alice Louize; Pinto da Silva, Eliana Vieira; Henriques, Daniele Freitas; Travassos da Rosa, Elisabeth Salbe; de Oliveira, Consuelo Silva; Martins, Livia Caricio; Vasconcelos, Helena Baldez; Neves Casseb, Livia Medeiros; Simith, Darlene de Brito; Vasconcelos, Pedro F. C.] Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Para, Brazil; [Souza, Renato; Cunha, Mariana Sequetin; Rocco, Iray Maria; Nogueira, Juliana Silva; Maeda, Adriana Yurika; da Silva Vasami, Fernanda Giseli; de Lima Macedo, Fernando Luiz; Suzuki, Akemi] Univ Sao Paulo, Inst Adolfo Lutz, Sao Paulo, Brazil; [Bowden, Thomas A.; Rissanen, Ilona; Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Messina, Jane P.; Pybus, Oliver G.] Metabiota, San Francisco, CA 94104 USA; [Junior Alcantara, Luiz Carlos; Giovanetti, Marta] Oswaldo Cruz Fdn FIOCRUZ, Salvador, BA, Brazil; [de Lima, Maricelia Maia] Univ Estadual Feira de Santana, Ctr Post Grad Collect Hlth, Dept Hlth, Feira De Santana, BA, Brazil; [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Mir, Daiana; Bello, Gonzalo; Delatorre, Edson] Fiocruz MS, Lab AIDS & Imunol Mol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada; [Creatore, Marisa] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Coelho, Giovanini Evelim; de Oliveira, Wanderson Kleber] Brazilian Minist Hlth, Brasilia, DF, Brazil; [Tesh, Robert; Nunes, Marcio R. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	Instituto Evandro Chagas; University of Oxford; Instituto Evandro Chagas; Instituto Adolfo Lutz; Universidade de Sao Paulo; University of Oxford; Wellcome Centre for Human Genetics; Fundacao Oswaldo Cruz; Universidade Estadual de Feira de Santana; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Fundacao Oswaldo Cruz; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Texas System; University of Texas Medical Branch Galveston	Nunes, MRT (corresponding author), Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, BR-67030000 Ananindeua, PA, Brazil.; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.; Vasconcelos, PFC (corresponding author), Minist Hlth, Dept Arbovirol & Hemorrhag Fevers, Evandro Chagas Inst, Ananindeua, Para, Brazil.; Pybus, OG (corresponding author), Metabiota, San Francisco, CA 94104 USA.; Nunes, MRT (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	oliver.pybus@zoo.ox.ac.uk; marcionunesbrasil@yahoo.com.br; pedrovasconcelos@iec.pa.gov.br	Hay, Simon Iain/F-8967-2015; Delatorre, Edson/J-8330-2015; Cunha, Mariana/AAA-5340-2021; Bentancor, Gonzalo Jose Bello/N-7377-2019; Giovanetti, Marta/AAK-7408-2020; Ribeiro Cruz, Ana Cecilia/V-9276-2019; Alcantara, Luiz Carlos Júnior/AAK-9468-2021; Bello, Gonzalo/E-6842-2013; Faria, Nuno R/I-2975-2012; Vasconcelos, Pedro/AAH-3142-2019; Azevedo, Raimunda/T-4656-2019; , daiana/J-5515-2019; Pybus, Oliver G/B-2640-2012; Oliveira, Wanderson/AAF-5182-2019; Vianez Junior, Joao Lidio/I-9547-2016	Hay, Simon Iain/0000-0002-0611-7272; Delatorre, Edson/0000-0002-5746-0820; Cunha, Mariana/0000-0001-8903-604X; Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Ribeiro Cruz, Ana Cecilia/0000-0002-4607-9346; Faria, Nuno R/0000-0001-8839-2798; Azevedo, Raimunda/0000-0003-1932-9976; , daiana/0000-0002-3172-4867; Pybus, Oliver G/0000-0002-8797-2667; Oliveira, Wanderson/0000-0002-9662-1930; Hill, Sarah/0000-0002-2995-2596; Lourenco, Jose/0000-0002-9318-2581; Vianez Junior, Joao Lidio/0000-0001-6226-9441; Rissanen, Ilona/0000-0003-4937-1825; Bowden, Thomas/0000-0002-8066-8785; Pereira de Souza, Renato/0000-0003-1315-7085; Alcantara, Luiz/0000-0002-6769-9931; Giovanetti, Marta/0000-0002-5849-7326; Theze, Julien/0000-0001-8188-9494; Patroca da Silva, Sandro/0000-0001-7185-4538; de Lima Macedo, Fernando Luiz/0000-0003-2097-0429	European Research Council (ERC) under the European Union [614725-PATHPHYLODYN]; ERC under the European Union [268904-DIVERSITY]; Metabiota; American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats Program-PREDICT; Wellcome Trust [095066, 102427, 090532/Z/09/Z]; Bill and Melinda Gates Foundation [OPP1119467, OPP1093011, OPP1106023, OPP1132415]; Evandro Chagas Institute; Brazilian Ministry of Health; CNPq (Brazilian National Council for Scientific and Technological Development) [302032/2011-8, 200024/2015-9]; National Institute of Science and Technology for Viral Hemorrhagic Fevers; U.S. NIH [R24 AT 120942]; UK Medical Research Council [MR/L009528/1]; CNPq-National Agency for Scientific and Technologic Development [573739/2008-0, 301641/2010-2, 457664/2013-4]; MRC [MR/L009528/1] Funding Source: UKRI; Medical Research Council [MR/L009528/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI120942] Funding Source: NIH RePORTER	European Research Council (ERC) under the European Union(European Research Council (ERC)); ERC under the European Union; Metabiota; American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats Program-PREDICT(United States Agency for International Development (USAID)); Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Evandro Chagas Institute; Brazilian Ministry of Health; CNPq (Brazilian National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Science and Technology for Viral Hemorrhagic Fevers; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CNPq-National Agency for Scientific and Technologic Development(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank X. de Lamballerie and J. Lednicky for permission to include their unpublished ZIKV genomes in our analysis. We thank the Death Verification Service (SVO); Central Laboratories of Public Health (LACEN); and health departments of the Ceara State and Maranhao State, Brazil, for collaboration. O.G.P. is supported by the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant 614725-PATHPHYLODYN. J.L. is supported by the ERC under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant 268904-DIVERSITY. O.G.P. received consulting fees from Metabiota between 2015 and 2016. This study is made possible in part by the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats Program-PREDICT. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the U.S. government. S.I.H. is funded by a Senior Research Fellowship from the Wellcome Trust (095066) and grants from the Bill and Melinda Gates Foundation (OPP1119467, OPP1093011, OPP1106023, and OPP1132415). M.R.T.N. is funded as an associated researcher in public health by the Evandro Chagas Institute, Brazilian Ministry of Health, and as a researcher in scientific productivity by CNPq (Brazilian National Council for Scientific and Technological Development) grants 302032/2011-8 and 200024/2015-9 and is also supported in part by the National Institute of Science and Technology for Viral Hemorrhagic Fevers. R.T. is funded by grant R24 AT 120942 from the U.S. NIH. S.C.H. is supported by a Wellcome Trust grant (102427). T.A.B. and I.R. are supported by grants from the UK Medical Research Council (MR/L009528/1) and the Wellcome Trust (090532/Z/09/Z). P.F.C.V. is supported by CNPq-National Agency for Scientific and Technologic Development (grants 573739/2008-0, 301641/2010-2, and 457664/2013-4). All samples were obtained from persons visiting local clinics or hospitalized by the Brazilian Ministry of Health personnel as part of dengue, chikungunya, and Zika fever surveillance activities. In these cases, patient consent was oral and not recorded. The study was authorized by the Coordination of the National Program for Dengue, Chikungunya, and Zika Control coordinated by Brazil's Ministry of Health. The data are available at DRYAD (DOI: 10.5061/dryad.6kn23). The ZIKV genomes reported in this study are deposited in GenBank under accession numbers KU321639, KU365777 to KU365780, KU729217, and KU729218.	Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553; European Centre for Disease Prevention and Control (ECDC), 2015, RAP RISK ASS MICR BR; FAGBAMI A, 1988, AM J TROP MED HYG, V38, P205, DOI 10.4269/ajtmh.1988.38.205; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1; Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008; Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Meyer AG, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev006; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769; PAHO, 2015, EP AL NEUR SYNDR CON; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878; Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109; Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e; Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Secretaria de Vigilancia em Saude, 2016, B EP MON CAS DENG FE, V47; Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495; Sorichetta A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.45; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x; Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217; Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5; Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002; Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4; Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7; Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302; World Health Organization, 2016, ASS INF MICR CONT ZI; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	45	676	696	5	269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					345	349		10.1126/science.aaf5036	http://dx.doi.org/10.1126/science.aaf5036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27013429	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000373990100041
J	Casso, G; Schoettker, P				Casso, Gabriele; Schoettker, Patrick			Tracheobronchomegaly	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Casso, Gabriele] Cardioctr Ticino, Lugano, Switzerland; [Schoettker, Patrick] Univ Lausanne Hosp, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Casso, G (corresponding author), Cardioctr Ticino, Lugano, Switzerland.	gabriele.casso@cardiocentro.org	Schoettker, Patrick/AAE-4462-2020	Schoettker, Patrick/0000-0001-5370-048X					0	4	4	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2016	374	12					E14	E14		10.1056/NEJMicm1508462	http://dx.doi.org/10.1056/NEJMicm1508462			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AA	27007971	Green Accepted, Green Published			2022-12-28	WOS:000372585100011
J	Evan, AT; Flamant, C; Gaetani, M; Guichard, F				Evan, Amato T.; Flamant, Cyrille; Gaetani, Marco; Guichard, Franoise			The past, present and future of African dust	NATURE			English	Article							NORTH-ATLANTIC OSCILLATION; REANALYSIS PROJECT; TROPICAL ATLANTIC; SOIL-MOISTURE; MINERAL DUST; EMISSION; VARIABILITY; CLIMATE; IMPACT; ATMOSPHERE	African dust emission and transport exhibits variability on diurnal(1) to decadal(2) timescales and is known to influence processes such as Amazon productivity(3), Atlantic climate modes(4), regional atmospheric composition and radiative balance(5) and precipitation in the Sahel(6). To elucidate the role of African dust in the climate system, it is necessary to understand the factors governing its emission and transport. However, African dust is correlated with seemingly disparate atmospheric phenomena, including the El Nino/Southern Oscillation(7,8), the North Atlantic Oscillation(9), the meridional position of the intertropical convergence zone(10,11), Sahelian rainfall(8) and surface temperatures over the Sahara Desert(12), all of which obfuscate the connection between dust and climate. Here we show that the surface wind field responsible for most of the variability in North African dust emission reflects the topography of the Sahara, owing to orographic acceleration of the surface flow. As such, the correlations between dust and various climate phenomena probably arise from the projection of the winds associated with these phenomena onto an orographically controlled pattern of wind variability. A 161-year time series of dust from 1851 to 2011, created by projecting this wind field pattern onto surface winds from a historical reanalysis(13), suggests that the highest concentrations of dust occurred from the 1910s to the 1940s and the 1970s to the 1980s, and that there have been three periods of persistent anomalously low dust concentrations-in the 1860s, 1950s and 2000s. Projections of the wind pattern onto climate models give a statistically significant downward trend in African dust emission and transport as greenhouse gas concentrations increase over the twenty-first century, potentially associated with a slow-down of the tropical circulation. Such a dust feedback, which is not represented in climate models, may be of benefit to human and ecosystem health in West Africa via improved air quality(14) and increased rainfall(6). This feedback may also enhance warming of the tropical North Atlantic(15), which would make the basin more suitable for hurricane formation and growth(16).	[Evan, Amato T.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Evan, Amato T.; Flamant, Cyrille; Gaetani, Marco] Sorbonne Univ, Univ Paris 06, Observat Spatiales LATMOS IPSL, Lab Atmospheres,Milieux,UVSQ,CNRS, Paris, France; [Guichard, Franoise] CNRS, UMR 3589, CNRM GAME, Toulouse, France; [Guichard, Franoise] Meteo France, Toulouse, France	University of California System; University of California San Diego; Scripps Institution of Oceanography; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU)	Evan, AT (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.; Evan, AT (corresponding author), Sorbonne Univ, Univ Paris 06, Observat Spatiales LATMOS IPSL, Lab Atmospheres,Milieux,UVSQ,CNRS, Paris, France.	aevan@ucsd.edu	Evan, Amato/GZL-2684-2022; Gaetani, Marco/AAQ-7802-2020	Evan, Amato/0000-0003-2812-3750; Gaetani, Marco/0000-0003-2923-6773	Agence Nationale de la Recherche (ANR) of the national Programme Investissements d'Avenir by the Laboratoire d'excellence Institut Pierre Simon Laplace (L-IPSL) [ANR-10-LABX-18-01]	Agence Nationale de la Recherche (ANR) of the national Programme Investissements d'Avenir by the Laboratoire d'excellence Institut Pierre Simon Laplace (L-IPSL)(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche (ANR) grant ANR-10-LABX-18-01 of the national Programme Investissements d'Avenir provided by the Laboratoire d'excellence Institut Pierre Simon Laplace (L-IPSL). We appreciate comments from our colleagues.	Bristow CS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043486; Chaboureau JP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027771; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; Cowie SM, 2013, GEOPHYS RES LETT, V40, P1868, DOI 10.1002/grl.50273; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Dee DP, 2014, B AM METEOROL SOC, V95, P1235, DOI 10.1175/BAMS-D-13-00043.1; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; DeFlorio MJ, 2016, CLIM DYNAM, V46, P585, DOI 10.1007/s00382-015-2600-7; Doherty OM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017767; Doherty OM, 2014, GEOPHYS RES LETT, V41, P6935, DOI 10.1002/2014GL060897; Doherty OM, 2014, TELLUS B, V66, DOI 10.3402/tellusb.v66.23191; Dunion JP, 2004, B AM METEOROL SOC, V85, P353, DOI 10.1175/BAMS-85-3-353; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Evan AT, 2015, AEOLIAN RES, V16, P153, DOI 10.1016/j.aeolia.2015.01.001; Evan AT, 2014, GEOPHYS RES LETT, V41, P5996, DOI 10.1002/2014GL060545; Evan AT, 2011, NAT GEOSCI, V4, P762, DOI [10.1038/ngeo1276, 10.1038/NGEO1276]; Evan AT, 2010, J APPL METEOROL CLIM, V49, P2213, DOI 10.1175/2010JAMC2485.1; Evan AT, 2009, SCIENCE, V324, P778, DOI 10.1126/science.1167404; Fecan F, 1999, ANN GEOPHYS-ATM HYDR, V17, P149, DOI 10.1007/s005850050744; Griffin D.W., 2004, ECOHEALTH, V1, P284, DOI [10.1007/s10393-004-0120-8, DOI 10.1007/S10393-004-0120-8]; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Jones PD, 1997, INT J CLIMATOL, V17, P1433, DOI 10.1002/(SICI)1097-0088(19971115)17:13<1433::AID-JOC203>3.0.CO;2-P; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/BAMS-83-11-1631(2002)083<1631:NAR>2.3.CO;2, 10.1175/Bams-83-11-1631]; Kossin JP, 2007, B AM METEOROL SOC, V88, P1767, DOI 10.1175/BAMS-88-11-1767; Largeron Y, 2015, GEOPHYS RES LETT, V42, P2490, DOI 10.1002/2014GL062938; Lavaysse C, 2009, CLIM DYNAM, V33, P313, DOI 10.1007/s00382-009-0553-4; Liousse C, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/035003; Mahowald NM, 2010, ATMOS CHEM PHYS, V10, P10875, DOI 10.5194/acp-10-10875-2010; Marsham JH, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048368; MARTICORENA B, 1995, J GEOPHYS RES-ATMOS, V100, P16415, DOI 10.1029/95JD00690; Moulin C, 1997, NATURE, V387, P691, DOI 10.1038/42679; Prospero JM, 2003, SCIENCE, V302, P1024, DOI 10.1126/science.1089915; Prospero JM, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000095; Ridley DA, 2014, ATMOS CHEM PHYS, V14, P5735, DOI 10.5194/acp-14-5735-2014; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; TEGEN I, 1994, J GEOPHYS RES-ATMOS, V99, P22897, DOI 10.1029/94JD01928; Vecchi GA, 2007, NATURE, V450, P1066, DOI 10.1038/nature06423; Wang WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500646; Washington R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025827; Washington R, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006502; WESTPHAL DL, 1987, J GEOPHYS RES-ATMOS, V92, P3027, DOI 10.1029/JD092iD03p03027; Yoshioka M, 2007, J CLIMATE, V20, P1445, DOI 10.1175/JCLI4056.1	44	133	133	3	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					493	+		10.1038/nature17149	http://dx.doi.org/10.1038/nature17149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	27008968				2022-12-28	WOS:000372701300038
J	Woolston, C				Woolston, Chris			MANAGEMENT When jobs go wrong	NATURE			English	Editorial Material																			0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					539	541		10.1038/nj7595-539a	http://dx.doi.org/10.1038/nj7595-539a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QK	27014783	Bronze			2022-12-28	WOS:000372701300050
J	Cote, GA; Slivka, A; Tarnasky, P; Mullady, DK; Elmunzer, BJ; Elta, G; Fogel, E; Lehman, G; McHenry, L; Romagnuolo, J; Menon, S; Siddiqui, UD; Watkins, J; Lynch, S; Denski, C; Xu, HP; Sherman, S				Cote, Gregory A.; Slivka, Adam; Tarnasky, Paul; Mullady, Daniel K.; Elmunzer, B. Joseph; Elta, Grace; Fogel, Evan; Lehman, Glen; McHenry, Lee; Romagnuolo, Joseph; Menon, Shyam; Siddiqui, Uzma D.; Watkins, James; Lynch, Sheryl; Denski, Cheryl; Xu, Huiping; Sherman, Stuart			Effect of Covered Metallic Stents Compared With Plastic Stents on Benign Biliary Stricture Resolution A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIVER-TRANSPLANTATION; CHRONIC-PANCREATITIS; MANAGEMENT; MULTICENTER; EFFICACY; THERAPY; SAFETY	IMPORTANCE Endoscopic placement of multiple plastic stents in parallel is the first-line treatment for most benign biliary strictures; it is possible that fully covered, self-expandable metallic stents (cSEMS) may require fewer endoscopic retrograde cholangiopancreatography procedures (ERCPs) to achieve resolution. OBJECTIVE To assess whether use of cSEMS is noninferior to plastic stents with respect to stricture resolution. DESIGN, SETTING, AND PARTICIPANTS Multicenter (8 endoscopic referral centers), open-label, parallel, randomized clinical trial involving patients with treatment-naive, benign biliary strictures (N = 112) due to orthotopic liver transplant (n = 73), chronic pancreatitis (n = 35), or postoperative injury (n = 4), who were enrolled between April 2011 and September 2014 (with follow-up ending October 2015). Patients with a bile duct diameter less than 6 mm and those with an intact gallbladder in whom the cystic duct would be overlapped by a cSEMS were excluded. INTERVENTIONS Patients (N = 112) were randomized to receive multiple plastic stents or a single cSEMS, stratified by stricture etiology and with endoscopic reassessment for resolution every 3 months (plastic stents) or every 6 months (cSEMS). Patients were followed up for 12 months after stricture resolution to assess for recurrence. MAIN OUTCOMES AND MEASURES Primary outcome was stricture resolution after no more than 12 months of endoscopic therapy. The sample size was estimated based on the noninferiority of cSEMS to plastic stents, with a noninferiority margin of -15%. RESULTS There were 55 patients in the plastic stent group (mean [SD] age, 57 [11] years; 17 women [31%]) and 57 patients in the cSEMS group (mean [SD] age, 55 [10] years; 19 women [33%]). Compared with plastic stents (41/48, 85.4%), the cSEMS resolution rate was 50 of 54 patients (92.6%), with a rate difference of 7.2%(1-sided 95% CI, -3.0% to infinity; P <.001). Given the prespecified noninferiority margin of -15%, the null hypothesis that cSEMS is less effective than plastic stents was rejected. The mean number of ERCPs to achieve resolution was lower for cSEMS (2.14) vs plastic (3.24; mean difference, 1.10; 95% CI, 0.74 to 1.46; P <.001). CONCLUSIONS AND RELEVANCE Among patients with benign biliary strictures and a bile duct diameter 6 mm or more in whom the covered metallic stent would not overlap the cystic duct, cSEMS were not inferior to multiple plastic stents after 12 months in achieving stricture resolution. Metallic stents should be considered an appropriate option in patients such as these.	[Cote, Gregory A.; Fogel, Evan; Lehman, Glen; McHenry, Lee; Watkins, James; Lynch, Sheryl; Sherman, Stuart] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Cote, Gregory A.; Elmunzer, B. Joseph; Romagnuolo, Joseph] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Slivka, Adam] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Tarnasky, Paul] Methodist Dallas Med Ctr, Dallas, TX USA; [Mullady, Daniel K.] Washington Univ, Dept Med, St Louis, MO USA; [Elmunzer, B. Joseph; Elta, Grace] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Menon, Shyam] Royal Wolverhampton Trust, Wolverhampton, England; [Siddiqui, Uzma D.] Univ Chicago, Sch Med, Ctr Endoscop Res & Therapeut, Chicago, IL 60637 USA; [Denski, Cheryl; Xu, Huiping] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); University of Michigan System; University of Michigan; University of Chicago; Indiana University System; Indiana University Bloomington	Cote, GA (corresponding author), Med Univ S Carolina, 114 Doughty St,MSC 702,Ste 249, Charleston, SC 29425 USA.	cotea@musc.edu	Menon, Shyam/K-8366-2019	Menon, Shyam/0000-0002-7529-167X; Romagnuolo, Joseph/0000-0002-5630-3022	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R21DK090708]; American Society for Gastrointestinal Endoscopy Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK090708] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Society for Gastrointestinal Endoscopy Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (R21DK090708). This research was also supported by an American Society for Gastrointestinal Endoscopy Career Development Award (Dr Cote).	Abraha I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2697; Alazmi WM, 2006, ENDOSCOPY, V38, P571, DOI 10.1055/s-2006-925027; Costamagna G, 2001, GASTROINTEST ENDOSC, V54, P162, DOI 10.1067/mge.2001.116876; DEVIERE J, 1994, GUT, V35, P122, DOI 10.1136/gut.35.1.122; Deviere J, 2014, GASTROENTEROLOGY, V147, P385, DOI 10.1053/j.gastro.2014.04.043; Draganov P, 2002, GASTROINTEST ENDOSC, V55, P680, DOI 10.1067/mge.2002.122955; Dumonceau JM, 2012, ENDOSCOPY, V44, P277, DOI 10.1055/s-0031-1291633; Haapamaki C, 2015, ENDOSCOPY, V47, P606, DOI 10.1055/s-0034-1391331; Kaffes A, 2014, THER ADV GASTROENTER, V7, P64, DOI 10.1177/1756283X13503614; Kahaleh M, 2013, J CLIN GASTROENTEROL, V47, P695, DOI [10.1097/MCG.0b013e3182951a32, 10.1097/MCG.0b013e31827fd311]; Kao DN, 2013, GASTROINTEST ENDOSC, V77, P679, DOI 10.1016/j.gie.2013.01.015; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; ROSSI P, 1990, RADIOLOGY, V175, P661, DOI 10.1148/radiology.175.3.2343110; Saxena P, 2015, DIGEST DIS SCI, V60, P3442, DOI 10.1007/s10620-015-3653-5; Siiki A, 2014, J CLIN GASTROENTEROL, V48, P635, DOI 10.1097/MCG.0000000000000020; Tabibian JH, 2010, GASTROINTEST ENDOSC, V71, P505, DOI 10.1016/j.gie.2009.10.023; Traina M, 2009, LIVER TRANSPLANT, V15, P1493, DOI 10.1002/lt.21886; van Berkel AM, 2004, ENDOSCOPY, V36, P381, DOI 10.1055/s-2004-814319; Walter D, 2015, GASTROINTEST ENDOSC, V81, P1197, DOI 10.1016/j.gie.2014.10.026; WARSHAW AL, 1976, GASTROENTEROLOGY, V70, P562	20	131	150	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1250	1257		10.1001/jama.2016.2619	http://dx.doi.org/10.1001/jama.2016.2619			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	27002446	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000372511100011
J	Woolston, C				Woolston, Chris			A lab of their own	NATURE			English	Editorial Material																			0	12	13	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					263	265		10.1038/521263f	http://dx.doi.org/10.1038/521263f			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26966744	Bronze			2022-12-28	WOS:000371665100048
J	Nuijten, M; Blanken, P; van de Wetering, B; Nuijen, B; van den Brink, W; Hendriks, VM				Nuijten, Mascha; Blanken, Peter; van de Wetering, Ben; Nuijen, Bastiaan; van den Brink, Wim; Hendriks, Vincent M.			Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							USE DISORDERS; AGONIST-LIKE; PHARMACOTHERAPY; PRESCRIPTION; MEDICATION; ADHERENCE; EFFICACY; ADDICTS; ALCOHOL	Background Heroin-assisted treatment is effective for methadone treatment-refractory heroin-dependent patients, but continued comorbid cocaine dependence remains problematic. Sustained-release dexamfetamine is a promising agonist pharmacotherapy for cocaine dependence and we aimed to assess its acceptance, efficacy, and safety. Methods In this multicentre, randomised, double-blind, placebo-controlled trial, patients who were treatment-refractory, as indicated by at least two earlier failed treatments aimed at reducing or abstaining from cocaine use, and who regularly (>= 8 days/month) used crack-cocaine were enrolled from four heroin-assisted treatment centres in the Netherlands. Eligible patients were randomly assigned (1: 1) to receive either 12 weeks of daily, supervised prescription of 60 mg/day oral sustained-release dexamfetamine or placebo in addition to co-prescribed methadone and diacetylmorphine. Randomisation was done by the collaborating pharmacist, using a computer-generated random number sequence with stratification by treatment centre in blocks of four per stratum. Randomisation was masked to patients, staff, and researchers throughout the study. The primary outcome was the number of self-reported days of cocaine use during study treatment, assessed every 4 weeks. Primary and safety analyses were done in the intention-to-treat population. The study was registered with the European Union Drug Regulating Authorities Clinical Trials (EUdraCT 2013-004024-11) and with The Netherlands Trial Register (NTR2576). Findings Between Aug 8, 2014, and Feb 27, 2015, 111 patients were assessed for eligibility, of whom 73 were enrolled and randomised; 38 patients were assigned to the sustained-release dexamfetamine group and 35 to the placebo group. Sustained-release dexamfetamine treatment resulted in significantly fewer days of cocaine use than placebo treatment (mean 44.9 days [SD 29.4] vs 60.6 days [24.3], respectively [95% CI of difference 3.1-28.4]; p=0.031; Cohen's standardised effect size d=0.58). One or more adverse events were reported by 28 (74%) patients in the dexamfetamine group and by 16 (46%) patients in the placebo group. Most adverse events were transient and well-tolerated. Interpretation Sustained-release dexamfetamine is a well accepted, effective, and safe agonist pharmacotherapy for comorbid treatment-refractory cocaine dependence in heroin-dependent patients in heroin-assisted treatment. Future research should aim to replicate these findings in chronic cocaine-dependent and other stimulant-dependent patients in more routine treatment settings, including strategies to optimise treatment adherence like medication management interventions and contingency management.	[Nuijten, Mascha; Blanken, Peter; Hendriks, Vincent M.] Parnassia Addict Res Ctr PARC, Brijder Addict Treatment, Monsterseweg 83, NL-2553 RJ The Hague, Netherlands; [van de Wetering, Ben] Antes Grp, Rotterdam, Netherlands; [Nuijen, Bastiaan] Antoni van Leeuwenhoek Netherlands Canc Inst, Med Ctr Slotervaart, Amsterdam, Netherlands; [van den Brink, Wim] Univ Amsterdam, Acad Med Ctr, Ctr Psychiat, Amsterdam Inst Addict Res, Tafelbergweg 25, NL-1105 BC Amsterdam, Netherlands; [Hendriks, Vincent M.] Leiden Univ, Dept Child & Adolescent Psychiat, Med Ctr, Curium, Leiden, Netherlands	Parnassia Psychiatric Institute; Netherlands Cancer Institute; Slotervaart Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Nuijten, M (corresponding author), Parnassia Addict Res Ctr PARC, Brijder Addict Treatment, Monsterseweg 83, NL-2553 RJ The Hague, Netherlands.	mascha.nuijten@brijder.nl	Blanken, Peter/J-4209-2012	Blanken, Peter/0000-0003-4847-4259	Netherlands Organisation for Health Research and Development	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	Netherlands Organisation for Health Research and Development.	APA, 1994, DIAGN STAT MAN MENT; Blanken P, 2010, EUR NEUROPSYCHOPHARM, V20, pS105, DOI 10.1016/S0924-977X(10)70001-8; Castells X, 2010, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD007380.PUB3; Cottler L. B., 2000, COMPOSITE INT DIAGNO; De Wilde EF, 2005, EUR ADDICT RES, V11, P157, DOI 10.1159/000086396; de Wildt WAJM, 2005, ALCOHOL CLIN EXP RES, V29, P509, DOI 10.1097/01.ALC.0000158844.35608.48; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Dursteler-MacFarland KM, 2013, J CLIN PSYCHOPHARM, V33, P104, DOI 10.1097/JCP.0b013e31827bfff4; Ferri M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003410.pub4; Galloway GP, 2011, CLIN PHARMACOL THER, V89, P276, DOI 10.1038/clpt.2010.307; Grabowski J, 2004, NEUROPSYCHOPHARMACOL, V29, P969, DOI 10.1038/sj.npp.1300392; Grabowski J, 2001, J CLIN PSYCHOPHARM, V21, P522, DOI 10.1097/00004714-200110000-00010; HENDRIKS VM, 1989, J SUBST ABUSE TREAT, V6, P133, DOI 10.1016/0740-5472(89)90041-X; Herin DV, 2010, ANN NY ACAD SCI, V1187, P76, DOI 10.1111/j.1749-6632.2009.05145.x; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; Maisel NC, 2013, ADDICTION, V108, P275, DOI 10.1111/j.1360-0443.2012.04054.x; Marsden J, 1998, ADDICTION, V93, P1857, DOI 10.1046/j.1360-0443.1998.9312185711.x; Marsden J, 2009, LANCET, V374, P1262, DOI 10.1016/S0140-6736(09)61420-3; Mooney ME, 2015, DRUG ALCOHOL DEPEN, V153, P94, DOI 10.1016/j.drugalcdep.2015.05.042; Nuijten M, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-135; Petry NM, 2012, AM J MED, V125, P888, DOI 10.1016/j.amjmed.2012.01.003; Prendergast M, 2006, ADDICTION, V101, P1546, DOI 10.1111/j.1360-0443.2006.01581.x; Rehm J, 2001, LANCET, V358, P1417, DOI 10.1016/S0140-6736(01)06529-1; Schierenberg Alwin, 2012, Curr Drug Abuse Rev, V5, P320; Schmitz Joy M, 2012, Front Psychiatry, V3, P77, DOI 10.3389/fpsyt.2012.00077; Shearer J, 2003, ADDICTION, V98, P1137, DOI 10.1046/j.1360-0443.2003.00447.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sobell L. C., 1992, MEASURING ALCOHOL CO, P41, DOI [10.1007/978-1-4612-0357-5_3, 10.1007/978-1-4612-0357-5, DOI 10.1007/978-1-4612-0357-5_3]; van den Brink W, 2003, BRIT MED J, V327, P310, DOI 10.1136/bmj.327.7410.310; Weiss RD, 2004, ADDICTION, V99, P1382, DOI 10.1111/j.1360-0443.2004.00884.x	30	48	48	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 28	2016	387	10034					2226	2234		10.1016/S0140-6736(16)00205-1	http://dx.doi.org/10.1016/S0140-6736(16)00205-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN1IZ	27015909				2022-12-28	WOS:000376820800032
J	Bozyigit, D; Yazdani, N; Yarema, M; Yarema, O; Lin, WMM; Volk, S; Vuttivorakulchai, K; Luisier, M; Juranyi, F; Wood, V				Bozyigit, Deniz; Yazdani, Nuri; Yarema, Maksym; Yarema, Olesya; Lin, Weyde Matteo Mario; Volk, Sebastian; Vuttivorakulchai, Kantawong; Luisier, Mathieu; Juranyi, Fanni; Wood, Vanessa			Soft surfaces of nanomaterials enable strong phonon interactions	NATURE			English	Article							QUANTUM DOTS; RAMAN-SCATTERING; PBSE; THERMODYNAMICS; NANOCRYSTALS; RELAXATION; DYNAMICS	Phonons and their interactions with other phonons, electrons or photons drive energy gain, loss and transport in materials. Although the phonon density of states has been measured and calculated in bulk crystalline semiconductors(1), phonons remain poorly understood in nanomaterials(2-5), despite the increasing prevalence of bottom-up fabrication of semiconductors from nanomaterials and the integration of nanometre-sized components into devices(6-8). Here we quantify the phononic properties of bottom-up fabricated semiconductors as a function of crystallite size using inelastic neutron scattering measurements and ab initio molecular dynamics simulations. We show that, unlike in microcrystalline semiconductors, the phonon modes of semiconductors with nanocrystalline domains exhibit both reduced symmetry and low energy owing to mechanical softness at the surface of those domains. These properties become important when phonons couple to electrons in semiconductor devices. Although it was initially believed that the coupling between electrons and phonons is suppressed in nanocrystalline materials owing to the scarcity of electronic states and their large energy separation(9), it has since been shown that the electron-phonon coupling is large and allows high energy-dissipation rates exceeding one electronvolt per picosecond (refs 10-13). Despite detailed investigations into the role of phonons in exciton dynamics, leading to a variety of suggestions as to the origins of these fast transition rates(14,15) and including attempts to numerically calculate them(12,13,16), fundamental questions surrounding electron-phonon interactions in nanomaterials remain unresolved. By combining the microscopic and thermodynamic theories of phonons(1,17-19) and our findings on the phononic properties of nanomaterials, we are able to explain and then experimentally confirm the strong electron-phonon coupling and fast multi-phonon transition rates of charge carriers to trap states. This improved understanding of phonon processes permits the rational selection of nanomaterials, their surface treatments, and the design of devices incorporating them.	[Bozyigit, Deniz; Yazdani, Nuri; Yarema, Maksym; Yarema, Olesya; Lin, Weyde Matteo Mario; Volk, Sebastian; Wood, Vanessa] ETH, Dept Informat Technol & Elect Engn, Lab Nanoelect, CH-8092 Zurich, Switzerland; [Vuttivorakulchai, Kantawong; Luisier, Mathieu] ETH, Dept Informat Technol & Elect Engn, Nano TCAD Grp, CH-8092 Zurich, Switzerland; [Juranyi, Fanni] Paul Scherrer Inst, Lab Neutron Scattering & Imaging, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Bozyigit, D; Wood, V (corresponding author), ETH, Dept Informat Technol & Elect Engn, Lab Nanoelect, CH-8092 Zurich, Switzerland.	denizb@iis.ee.ethz.ch; vwood@ethz.ch	Juranyi, Fanni/Q-3831-2017; Yazdani, Nuri/D-5291-2018; Yarema, Maksym/A-2851-2015; Bozyigit, Deniz/J-5950-2014	Juranyi, Fanni/0000-0002-3223-072X; Yazdani, Nuri/0000-0001-6593-7601; Yarema, Maksym/0000-0002-2006-2466; Lin, Weyde/0000-0002-7572-499X; Bozyigit, Deniz/0000-0002-3798-7561; /0000-0001-8751-6971	Swiss National Science Foundation through the NCCR Quantum Science and Technology; ETH Research Grant; SNF TORNAD [149454]; Swiss National Supercomputing Centre (CSCS) [s579]	Swiss National Science Foundation through the NCCR Quantum Science and Technology; ETH Research Grant; SNF TORNAD; Swiss National Supercomputing Centre (CSCS)	D.B., N.Y., M.Y., W.M.M.L., O.Y., S.V. and V.W. acknowledge funding from the Swiss National Science Foundation through the NCCR Quantum Science and Technology and an ETH Research Grant. K.V. and M.L. acknowledge funding from SNF TORNAD under project 149454. Neutron scattering experiments were performed at the Swiss spallation neutron source SINQ, Paul Scherrer Institute. Molecular dynamics simulations were supported by a grant from the Swiss National Supercomputing Centre (CSCS; project ID s579). We thank D. Norris for access to SEM and EDX, C. Hierold for access to the confocal Raman spectrometer, and M. Worle for access to XRD at the Small Molecule Crystallography Center at ETH Zurich.	Bae WK, 2012, J AM CHEM SOC, V134, P20160, DOI 10.1021/ja309783v; BOCKELMANN U, 1990, PHYS REV B, V42, P8947, DOI 10.1103/PhysRevB.42.8947; Bozin ES, 2010, SCIENCE, V330, P1660, DOI 10.1126/science.1192759; Bozyigit D, 2013, NANO LETT, V13, P5284, DOI 10.1021/nl402803h; Combe N, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.205425; Cooney RR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.177403; Han P, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.085305; Han P, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.041306; Harbold JM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.195312; Herberholz R, 1996, APPL PHYS LETT, V69, P2888, DOI 10.1063/1.117352; Ip AH, 2012, NAT NANOTECHNOL, V7, P577, DOI [10.1038/nnano.2012.127, 10.1038/NNANO.2012.127]; Kambhampati P, 2015, CHEM PHYS, V446, P92, DOI 10.1016/j.chemphys.2014.11.008; Keuleyan S, 2014, J PHYS CHEM C, V118, P2749, DOI 10.1021/jp409061g; Kilina S, 2015, CHEM REV, V115, P5929, DOI 10.1021/acs.chemrev.5b00012; Kilina SV, 2011, J PHYS CHEM C, V115, P21641, DOI 10.1021/jp206594e; Kilina SV, 2009, ACS NANO, V3, P93, DOI 10.1021/nn800674n; Konstantatos G, 2006, NATURE, V442, P180, DOI 10.1038/nature04855; Kramer IJ, 2014, CHEM REV, V114, P863, DOI 10.1021/cr400299t; Krauss TD, 1997, PHYS REV B, V55, P9860, DOI 10.1103/PhysRevB.55.9860; LANG DV, 1980, PHYS REV B, V22, P3917, DOI 10.1103/PhysRevB.22.3917; Liu J, 2014, J PHYS CHEM C, V118, P20702, DOI 10.1021/jp5067296; Marcus RA, 1997, J ELECTROANAL CHEM, V438, P251, DOI 10.1016/S0022-0728(97)00091-0; MITTLEMAN DM, 1994, PHYS REV B, V49, P14435, DOI 10.1103/PhysRevB.49.14435; Mooney J, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4807054; Pandey A, 2008, SCIENCE, V322, P929, DOI 10.1126/science.1159832; Ridley B. K., 1999, QUANTUM PROCESSES SE, P235; Schaller RD, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.196401; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI 10.1038/nphoton.2012.328; Sun LF, 2012, NAT NANOTECHNOL, V7, P369, DOI [10.1038/nnano.2012.63, 10.1038/NNANO.2012.63]; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; TANAKA A, 1993, PHYS REV B, V47, P1237, DOI 10.1103/PhysRevB.47.1237; Yelon A, 2006, REP PROG PHYS, V69, P1145, DOI 10.1088/0034-4885/69/4/R04; Zhao LD, 2011, J AM CHEM SOC, V133, P20476, DOI 10.1021/ja208658w	33	113	113	6	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					618	622		10.1038/nature16977	http://dx.doi.org/10.1038/nature16977			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	26958836				2022-12-28	WOS:000373027400034
J	Herbst, DA; Jakob, RP; Zahringer, F; Maier, T				Herbst, Dominik A.; Jakob, Roman P.; Zaehringer, Franziska; Maier, Timm			Mycocerosic acid synthase exemplifies the architecture of reducing polyketide synthases	NATURE			English	Article							CRYSTAL-STRUCTURE; PROTEIN INTERACTIONS; SWISS-MODEL; BIOSYNTHESIS; MODULE; SOFTWARE; DOMAIN; ORGANIZATION; FLEXIBILITY; ITERATION	Polyketide synthases (PKSs) are biosynthetic factories that produce natural products with important biological and pharmacological activities(1-3). Their exceptional product diversity is encoded in a modular architecture. Modular PKSs (modPKSs) catalyse reactions colinear to the order of modules in an assembly line(3), whereas iterative PKSs (iPKSs) use a single module iteratively as exemplified by fungal iPKSs (fiPKSs)(3). However, in some cases non-colinear iterative action is also observed for modPKSs modules and is controlled by the assembly line environment(4,5). PKSs feature a structural and functional separation into a condensing and a modifying region as observed for fatty acid synthases(6). Despite the outstanding relevance of PKSs, the detailed organization of PKSs with complete fully reducing modifying regions remains elusive. Here we report a hybrid crystal structure of Mycobacterium smegmatis mycocerosic acid synthase based on structures of its condensing and modifying regions. Mycocerosic acid synthase is a fully reducing iPKS, closely related to modPKSs, and the prototype of mycobacterial mycocerosic acid synthase-like(7,8) PKSs. It is involved in the biosynthesis of C20-C28 branched-chain fatty acids, which are important virulence factors of mycobacteria(9). Our structural data reveal a dimeric linker-based organization of the modifying region and visualize dynamics and conformational coupling in PKSs. On the basis of comparative small-angle X-ray scattering, the observed modifying region architecture may be common also in modPKSs. The linker-based organization provides a rationale for the characteristic variability of PKS modules as a main contributor to product diversity. The comprehensive architectural model enables functional dissection and re-engineering of PKSs.	[Herbst, Dominik A.; Jakob, Roman P.; Zaehringer, Franziska; Maier, Timm] Univ Basel, Dept Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland; [Zaehringer, Franziska] F Hoffmann La Roche & Cie AG, Grenzacherstr 124, CH-4070 Basel, Switzerland	University of Basel; Roche Holding	Maier, T (corresponding author), Univ Basel, Dept Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	timm.maier@unibas.ch	Maier, Timm/A-8835-2016	Maier, Timm/0000-0002-7459-1363; Jakob, Roman/0000-0002-6451-8656; Herbst, Dominik A./0000-0003-4671-5493	Swiss National Science Foundation [125357, 138262, 159696, 145023]; Werner-Siemens Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Werner-Siemens Foundation	We acknowledge F. Widdel and J. Zedelius for providing gammaproteobacterium HdN1, P. Leadlay and L. Betancor for providing plasmid pETcoco-2A-L1SL2, and EMBL Heidelberg for providing the pETG-10A vector; J. Missimer and A. Menzel for support in SAXS data acquisition and raw data processing; T. Sharpe for analytical ultracentrifugation, A. Mazur for SAXS refinement, and M. Bertoni for support of the homology-based assignment of the oligomeric state of MAS KS-AT. Data were collected at beamlines PXI, PXIII, and cSAXS of PSI; we acknowledge support from the beamline teams. This work was supported by the Swiss National Science Foundation project grants 125357, 138262, 159696 and R'equip grant 145023. D.A.H. acknowledges a fellowship by the Werner-Siemens Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akey DL, 2010, STRUCTURE, V18, P94, DOI 10.1016/j.str.2009.10.018; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beck BJ, 2003, J AM CHEM SOC, V125, P4682, DOI 10.1021/ja029974c; Betancor L, 2008, CHEMBIOCHEM, V9, P2962, DOI 10.1002/cbic.200800475; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bonnett SA, 2013, CHEM BIOL, V20, P772, DOI 10.1016/j.chembiol.2013.04.014; Bretschneider T, 2013, NATURE, V502, P124, DOI 10.1038/nature12588; Bricogne G., 2011, BUSTER VERSION 2 10; Brignole EJ, 2009, NAT STRUCT MOL BIOL, V16, P190, DOI 10.1038/nsmb.1532; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Busch B, 2013, ANGEW CHEM INT EDIT, V52, P5285, DOI 10.1002/anie.201301322; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Chopra T, 2009, METHOD ENZYMOL, V459, P259, DOI 10.1016/S0076-6879(09)04612-6; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dutta S, 2014, NATURE, V510, P512, DOI 10.1038/nature13423; Edwards AL, 2014, J MOL BIOL, V426, P2229, DOI 10.1016/j.jmb.2014.03.015; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabiola F, 2006, ACTA CRYSTALLOGR D, V62, P227, DOI 10.1107/S0907444905040680; Gay D, 2013, BIOCHEMISTRY-US, V52, P8916, DOI 10.1021/bi400988t; Hardwicke MA, 2014, NAT CHEM BIOL, V10, P774, DOI [10.1038/NCHEMBIO.1603, 10.1038/nchembio.1603]; He J, 2003, CHEM BIOL, V10, P1225, DOI 10.1016/j.chembiol.2003.11.009; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kapur S, 2012, P NATL ACAD SCI USA, V109, P4110, DOI 10.1073/pnas.1118734109; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Khare D, 2015, STRUCTURE, V23, P2213, DOI 10.1016/j.str.2015.09.013; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medek P, 2007, JOURNAL WSCG, V15, P107; Moss SJ, 2004, NAT PROD REP, V21, P575, DOI 10.1039/b315020h; Olano C, 2004, CHEM BIOL, V11, P87, DOI 10.1016/j.chembiol.2003.12.018; Pappenberger G, 2010, J MOL BIOL, V397, P508, DOI 10.1016/j.jmb.2010.01.066; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sippel KH, 2014, J BIOL CHEM, V289, P33287, DOI 10.1074/jbc.M114.608547; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Sugimoto Y, 2015, CHEM BIOL, V22, P229, DOI 10.1016/j.chembiol.2014.12.014; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Tang YY, 2007, CHEM BIOL, V14, P931, DOI 10.1016/j.chembiol.2007.07.012; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Weissman KJ, 2015, NAT PROD REP, V32, P436, DOI 10.1039/c4np00098f; Whicher JR, 2014, NATURE, V510, P560, DOI 10.1038/nature13409; Whicher JR, 2013, CHEM BIOL, V20, P1340, DOI 10.1016/j.chembiol.2013.09.015; Wong FT, 2012, CURR OPIN CHEM BIOL, V16, P117, DOI 10.1016/j.cbpa.2012.01.018; Zheng JT, 2012, NAT CHEM BIOL, V8, P615, DOI [10.1038/nchembio.964, 10.1038/NCHEMBIO.964]; Zheng WJ, 2011, BIOPHYS J, V101, P2981, DOI 10.1016/j.bpj.2011.11.003	67	46	47	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					533	+		10.1038/nature16993	http://dx.doi.org/10.1038/nature16993			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26976449	Green Accepted			2022-12-28	WOS:000372701300047
J	Hood, B				Hood, Bruce			Make recycled goods covetable	NATURE			English	Editorial Material							POSSESSIONS		[Hood, Bruce] Univ Bristol, Dev Psychol Soc, Bristol BS8 1TH, Avon, England; [Hood, Bruce] Speakezee Org, London, England	University of Bristol	Hood, B (corresponding author), Univ Bristol, Dev Psychol Soc, Bristol BS8 1TH, Avon, England.	bruce.hood@bristol.ac.uk		hood, bruce/0000-0001-7258-981X				BELK RW, 1988, J CONSUM RES, V15, P139, DOI 10.1086/209154; Gino F, 2010, PSYCHOL SCI, V21, P712, DOI 10.1177/0956797610366545; Gosling S.D., 2009, SNOOP WHAT YOUR STUF; HAY DF, 1982, CHILD DEV, V53, P105, DOI 10.1111/j.1467-8624.1982.tb01297.x; Hood BM, 2008, COGNITION, V106, P455, DOI 10.1016/j.cognition.2007.01.012; Maddux WW, 2010, PSYCHOL SCI, V21, P1910, DOI 10.1177/0956797610388818; Newman GE, 2014, P NATL ACAD SCI USA, V111, P3705, DOI 10.1073/pnas.1313637111; Nishi A, 2015, NATURE, V526, P426, DOI 10.1038/nature15392; Stake JE, 2004, PHILOS T R SOC B, V359, P1763, DOI 10.1098/rstb.2004.1551; Veblen Thorstein, 1975, THEORY LEISURE CLASS	10	17	20	2	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					438	440		10.1038/531438a	http://dx.doi.org/10.1038/531438a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QK	27008953	Bronze, Green Submitted			2022-12-28	WOS:000372701300014
J	Malladi, S; Macalinao, DG; Jin, X; He, L; Basnet, H; Zou, YL; de Stanchina, E; Massague, J				Malladi, Srinivas; Macalinao, Danilo G.; Jin, Xin; He, Lan; Basnet, Harihar; Zou, Yilong; de Stanchina, Elisa; Massague, Joan			Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT	CELL			English	Article							NATURAL-KILLER-CELLS; BREAST-CANCER CELLS; STEM-CELLS; ADULT STEM; TUMOR; LUNG; SURVIVAL; SOX2; DORMANCY; BONE	Metastasis frequently develops years after the removal of a primary tumor, from a minority of disseminated cancer cells that survived as latent entities through unknown mechanisms. We isolated latency competent cancer (LCC) cells from early stage human lung and breast carcinoma cell lines and defined the mechanisms that suppress outgrowth, support long-term survival, and maintain tumor-initiating potential in these cells during the latent metastasis stage. LCC cells show stem-cell-like characteristics and express SOX2 and SOX9 transcription factors, which are essential for their survival in host organs under immune surveillance and for metastatic outgrowth under permissive conditions. Through expression of the WNT inhibitor DKK1, LCC cells self-impose a slow-cycling state with broad downregulation of ULBP ligands for NK cells and evasion of NK-cell-mediated clearance. By expressing a Sox-dependent stem-like state and actively silencing WNT signaling, LCC cells can enter quiescence and evade innate immunity to remain latent for extended periods.	[Malladi, Srinivas; Macalinao, Danilo G.; Jin, Xin; He, Lan; Basnet, Harihar; Zou, Yilong; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Macalinao, Danilo G.; Zou, Yilong] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA; [de Stanchina, Elisa] Mem Sloan Kettering Canc Ctr, Antitumor Assessment Core, New York, NY 10065 USA; [Jin, Xin] Eli & Edythe L Broad Inst, Canc Program, Cambridge, MA 02142 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	j-massague@ski.mskcc.org		Zou, Yilong/0000-0001-8198-6067; Massague, Joan/0000-0001-9324-8408; Macalinao, Danilo/0000-0002-3188-2611	Memorial Sloan Kettering Cancer Center (MSKCC) Genomics Core Facility and Molecular Cytology Core Facility; NIH [P01-CA094060, P01-CA129243, P30-CA008748]; DOD Innovator Award [W81XWH-12-1-0074]; American Cancer Society post-doctoral fellowship; NATIONAL CANCER INSTITUTE [P01CA129243, P01CA094060, P30CA008748] Funding Source: NIH RePORTER	Memorial Sloan Kettering Cancer Center (MSKCC) Genomics Core Facility and Molecular Cytology Core Facility; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Innovator Award; American Cancer Society post-doctoral fellowship(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Bos, T. O'Sullivan, and J. Sun for insightful discussions and advice on NK cell depletion experiments; A. Welm for breast PDX models; S. Monette for review of pathology slides; T. Jacks and F. Giancotti for cell lines; and A. Obenauf, K. Ganesh, A. Laughney, and E. Er for critical reading of the manuscript. We acknowledge the support of the Memorial Sloan Kettering Cancer Center (MSKCC) Genomics Core Facility and Molecular Cytology Core Facility. This work was supported by NIH grants P01-CA094060 and P01-CA129243, and DOD Innovator Award W81XWH-12-1-0074 (J.M.), and NIH grant P30-CA008748 (MSKCC). S.M. is supported by an American Cancer Society post-doctoral fellowship. X.J. is a Susan G. Komen Fellow. H.B. is a Damon Runyon Fellow.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bradley M, 1998, BLOOD, V92, P4248, DOI 10.1182/blood.V92.11.4248.423k20_4248_4255; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duchnowska R, 2009, BREAST CANCER RES TR, V117, P297, DOI 10.1007/s10549-008-0275-z; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Gazdar AF, 1996, J CELL BIOCHEM, P1; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109976; KASAI M, 1981, NATURE, V291, P334, DOI 10.1038/291334a0; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Kordes U, 2006, J NEURO-ONCOL, V80, P151, DOI 10.1007/s11060-006-9180-7; Lanier LL, 2015, CANCER IMMUNOL RES, V3, P575, DOI 10.1158/2326-6066.CIR-15-0098; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lien WH, 2014, GENE DEV, V28, P1517, DOI 10.1101/gad.244772.114; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; MacKie RM, 2003, NEW ENGL J MED, V348, P567, DOI 10.1056/NEJM200302063480620; Maeda R, 2010, CHEST, V138, P145, DOI 10.1378/chest.09-2361; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; O'Sullivan T, 2012, J EXP MED, V209, P1869, DOI 10.1084/jem.20112738; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Park SB, 2012, CELL DEATH DIFFER, V19, P534, DOI 10.1038/cdd.2011.137; Pelleitier M, 1975, Methods Achiev Exp Pathol, V7, P149; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Seo E, 2013, CELL REP, V3, P2075, DOI 10.1016/j.celrep.2013.05.029; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Sun JC, 2008, J IMMUNOL, V181, P7453, DOI 10.4049/jimmunol.181.11.7453; Takeda K, 2001, CELL IMMUNOL, V214, P194, DOI 10.1006/cimm.2001.1896; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Villegas FR, 2002, LUNG CANCER-J IASLC, V35, P23, DOI 10.1016/S0169-5002(01)00292-6; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wu J, 2003, ADV CANCER RES, V90, P127, DOI 10.1016/S0065-230X(03)90004-2; Xiao D, 2013, AM J TRANSPLANT, V13, P2645, DOI 10.1111/ajt.12430; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	57	400	409	5	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					45	60		10.1016/j.cell.2016.02.025	http://dx.doi.org/10.1016/j.cell.2016.02.025			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015306	Green Accepted, Bronze			2022-12-28	WOS:000372785600009
J	Siegler, MA; Miller, RS; Keane, JT; Laneuville, M; Paige, DA; Matsuyama, I; Lawrence, DJ; Crotts, A; Poston, MJ				Siegler, M. A.; Miller, R. S.; Keane, J. T.; Laneuville, M.; Paige, D. A.; Matsuyama, I.; Lawrence, D. J.; Crotts, A.; Poston, M. J.			Lunar true polar wander inferred from polar hydrogen	NATURE			English	Article							GRAVITY-FIELD; WATER ICE; SURFACE; MOON; PROSPECTOR; FINES; CONSTRAINTS; TEMPERATURE; EVOLUTION; DEPOSITS	The earliest dynamic and thermal history of the Moon is not well understood. The hydrogen content of deposits near the lunar poles may yield insight into this history, because these deposits (which are probably composed of water ice) survive only if they remain in permanent shadow. If the orientation of the Moon has changed, then the locations of the shadowed regions will also have changed. The polar hydrogen deposits have been mapped by orbiting neutron spectrometers(1-3), and their observed spatial distribution does not match the expected distribution of water ice inferred from present-day lunar temperatures(4,5). This finding is in contrast to the distribution of volatiles observed in similar thermal environments at Mercury's poles(6). Here we show that polar hydrogen preserves evidence that the spin axis of the Moon has shifted: the hydrogen deposits are antipodal and displaced equally from each pole along opposite longitudes. From the direction and magnitude of the inferred reorientation, and from analysis of the moments of inertia of the Moon, we hypothesize that this change in the spin axis, known as true polar wander, was caused by a low-density thermal anomaly beneath the Procellarum region. Radiogenic heating within this region resulted in the bulk of lunar mare volcanism(7-11) and altered the density structure of the Moon, changing its moments of inertia. This resulted in true polar wander consistent with the observed remnant polar hydrogen. This thermal anomaly still exists and, in part, controls the current orientation of the Moon. The Procellarum region was most geologically active early in lunar history(7-9), which implies that polar wander initiated billions of years ago and that a large portion of the measured polar hydrogen is ancient, recording early delivery of water to the inner Solar System. Our hypothesis provides an explanation for the antipodal distribution of lunar polar hydrogen, and connects polar volatiles to the geologic and geophysical evolution of the Moon and the bombardment history of the early Solar System.	[Siegler, M. A.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Siegler, M. A.] So Methodist Univ, Dallas, TX 75275 USA; [Miller, R. S.] Univ Alabama, Huntsville, AL 35899 USA; [Keane, J. T.; Matsuyama, I.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Laneuville, M.] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, Tokyo 1528551, Japan; [Paige, D. A.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Lawrence, D. J.] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA; [Crotts, A.] Columbia Univ, New York, NY 10027 USA; [Poston, M. J.] CALTECH, Pasadena, CA 91125 USA	Southern Methodist University; University of Alabama System; University of Alabama Huntsville; University of Arizona; Tokyo Institute of Technology; University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Columbia University; California Institute of Technology	Siegler, MA (corresponding author), Planetary Sci Inst, Tucson, AZ 85719 USA.; Siegler, MA (corresponding author), So Methodist Univ, Dallas, TX 75275 USA.	msiegler@psi.edu	Lawrence, David J/E-7463-2015; Keane, James/AAI-5137-2020; Laneuville, Matthieu/F-8523-2010; Miller, Richard S/G-7299-2018	Lawrence, David J/0000-0002-7696-6667; Laneuville, Matthieu/0000-0001-6022-0046; Miller, Richard S/0000-0003-4496-7128; Matsuyama, Isamu/0000-0002-2917-8633; Poston, Michael/0000-0001-5113-1017; Keane, James/0000-0002-4803-5793	NASA's SSERVI VORTICES node; Lunar Reconnaissance Orbiter; NASA Lunar Advanced Science and Exploration Research (LASER) programme	NASA's SSERVI VORTICES node; Lunar Reconnaissance Orbiter; NASA Lunar Advanced Science and Exploration Research (LASER) programme	This project was supported in part (M.A.S., R.S.M. and D.J.L.) by NASA's SSERVI VORTICES node, the Lunar Reconnaissance Orbiter (M.A.S. and D.A.P.) and the NASA Lunar Advanced Science and Exploration Research (LASER) programme (J.T.K. and I.M.). We thank L. L. Hood for sharing insight on palaeomagnetic data. We dedicate this project to Arlin Crotts, who passed shortly after the completion of this paper.	Andrews-Hanna JC, 2014, NATURE, V514, P68, DOI 10.1038/nature13697; Arfken G. B., 1995, MATH METHODS PHYS, P797; ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Bills BG, 1995, J GEOPHYS RES-PLANET, V100, P26305, DOI 10.1029/95JE02776; Brady JB, 1995, MINERAL PHYSICS CRYS, p269~290; Cadenhead D. A., 1972, GEOCHIM COSM SUPPL, P2243; Chabot NL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051526; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; COLOMBO G, 1967, MEASURE MOON, P12; Cournede C, 2012, EARTH PLANET SC LETT, V331, P31, DOI 10.1016/j.epsl.2012.03.004; Crider D, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022689; Eke VR, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/6; Farrell WM, 2015, ICARUS, V255, P116, DOI 10.1016/j.icarus.2014.09.014; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002207; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; Fick, 1855, PHILOS MAG, V170, P59, DOI [10.1080/14786445508641925, DOI 10.1080/14786445508641925, 10.1016/0376-7388(94)00230-V]; Fisher RA, 1914, BIOMETRIKA, V10, P507; FULLER EL, 1976, J COLLOID INTERF SCI, V55, P358, DOI 10.1016/0021-9797(76)90043-6; Gammage R B, 1975, 6 LUN SCI C LUN PLAN, P3305; GAMMAGE RB, 1977, EARTH PLANET SC LETT, V34, P445, DOI 10.1016/0012-821X(77)90056-5; GAMMAGE RB, 1976, J COLLOID INTERF SCI, V55, P243, DOI 10.1016/0021-9797(76)90031-X; Garrick-Bethell I, 2014, NATURE, V512, P181, DOI 10.1038/nature13639; GOLD T, 1955, NATURE, V175, P526, DOI 10.1038/175526a0; GOLDREICH P, 1969, J GEOPHYS RES, V74, P2555, DOI 10.1029/JB074i010p02555; Grimm RE, 2013, J GEOPHYS RES-PLANET, V118, DOI 10.1029/2012JE004114; Harmon JK, 2011, ICARUS, V211, P37, DOI 10.1016/j.icarus.2010.08.007; Heiken GH, 1991, LUNAR SOURCEBOOK, P285; HOLMES HF, 1975, EARTH PLANET SC LETT, V28, P33, DOI 10.1016/0012-821X(75)90070-9; Hood LL, 2011, ICARUS, V211, P1109, DOI 10.1016/j.icarus.2010.08.012; Hurley DM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051105; Iess L, 2014, SCIENCE, V344, P78, DOI 10.1126/science.1250551; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Keane JT, 2014, GEOPHYS RES LETT, V41, P6610, DOI 10.1002/2014GL061195; Kendall J. D., 2015, LUNAR PLANET SCI C, V46, P2765; Kim H. R., 2015, LUNAR PLANET SCI C, V46, P1914; Kite ES, 2009, EARTH PLANET SC LETT, V280, P254, DOI 10.1016/j.epsl.2009.01.040; Konopliv AS, 1998, SCIENCE, V281, P1476, DOI 10.1126/science.281.5382.1476; Lambeck K., 1980, EARTHS VARIABLE ROTA; Laneuville M, 2013, J GEOPHYS RES-PLANET, V118, P1435, DOI 10.1002/jgre.20103; Lawrence DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002637; Lawrence DJ, 2015, ACTA ASTRONAUT, V115, P452, DOI 10.1016/j.actaastro.2015.06.010; Lawrence DJ, 2013, SCIENCE, V339, P292, DOI 10.1126/science.1229953; Lawrence DJ, 2011, SCIENCE, V334, DOI 10.1126/science.1203341; Lawrence DJ, 2010, ASTROBIOLOGY, V10, P183, DOI 10.1089/ast.2009.0401; Lawrence DJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002050; Litvak ML, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003949; Matsuyama I, 2008, ICARUS, V195, P459, DOI 10.1016/j.icarus.2007.12.003; Matsuyama I, 2014, ANNU REV EARTH PL SC, V42, P605, DOI 10.1146/annurev-earth-060313-054724; Matsuyama I, 2013, ICARUS, V222, P411, DOI 10.1016/j.icarus.2012.10.025; Maurice S, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002208; Melosh HJ, 2013, SCIENCE, V340, P1552, DOI [10.1126/science.1235768, 10.1126/science.1238663]; MELOSH HJ, 1975, EARTH PLANET SC LETT, V26, P353, DOI 10.1016/0012-821X(75)90011-4; MELOSH HJ, 1975, EARTH PLANET SC LETT, V25, P322, DOI 10.1016/0012-821X(75)90248-4; Miller RS, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004112; Miller RS, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003984; Miller RS, 2014, ICARUS, V233, P229, DOI 10.1016/j.icarus.2014.02.007; Mitrofanov IG, 2008, ASTROBIOLOGY, V8, P793, DOI 10.1089/ast.2007.0158; Mitrofanov IG, 2010, SCIENCE, V330, P483, DOI 10.1126/science.1185696; MULLER PM, 1968, SCIENCE, V161, P680, DOI 10.1126/science.161.3842.680; Nimmo F., 2004, EUROPA, P381; Paige DA, 2013, SCIENCE, V339, P300, DOI 10.1126/science.1231106; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; PEALE SJ, 1969, ASTRON J, V74, P483, DOI 10.1086/110825; Perron JT, 2007, NATURE, V447, P840, DOI 10.1038/nature05873; Poston MJ, 2015, ICARUS, V255, P24, DOI 10.1016/j.icarus.2014.09.049; Press W. H., 1992, NUMERICAL RECIPES C, V2nd, P636; RUNCORN SK, 1983, NATURE, V304, P589, DOI 10.1038/304589a0; RUNCORN SK, 1984, PHILOS T R SOC A, V313, P77, DOI 10.1098/rsta.1984.0084; Sabadini R., 2004, GLOBAL DYNAMICS EART; Schenk P, 2008, NATURE, V453, P368, DOI 10.1038/nature06911; Schorghofer N, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002779; Schorghofer N, 2008, ASTROPHYS J, V682, P697, DOI 10.1086/588633; Siegler M, 2015, ICARUS, V255, P78, DOI 10.1016/j.icarus.2014.09.037; Siegler MA, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003652; Smith DE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043751; Starukhina L, 2012, MOON PROSPECTIVE ENE, P57, DOI [10.1007/978-3-642-27969-0, DOI 10.1007/978-3-642-27969-0]; Starukhina LV, 2006, ADV SPACE RES, V37, P50, DOI 10.1016/j.asr.2005.04.033; Takahashi F, 2014, NAT GEOSCI, V7, P409, DOI [10.1038/NGEO2150, 10.1038/ngeo2150]; Teodoro LFA, 2014, J GEOPHYS RES-PLANET, V119, P574, DOI 10.1002/2013JE004421; Teodoro LFA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042889; Tsunakawa H, 2015, J GEOPHYS RES-PLANET, V120, P1160, DOI 10.1002/2014JE004785; Turcotte D., 2002, GEODYNAMICS, P132, DOI [10.1017/CBO9780511807442.006, DOI 10.1017/CBO9780511807442.006]; Tye AR, 2015, ICARUS, V255, P70, DOI 10.1016/j.icarus.2015.03.016; Van Hoolst T., 2009, TREATISE GEOPHYS PLA, P123; WARD WR, 1975, SCIENCE, V189, P377, DOI 10.1126/science.189.4200.377; WATSON K, 1961, J GEOPHYS RES, V66, P1598, DOI 10.1029/JZ066i005p01598; Weiss BP, 2014, SCIENCE, V346, P1198, DOI 10.1126/science.1246753; Wieczorek MA, 2000, J GEOPHYS RES-PLANET, V105, P20417, DOI 10.1029/1999JE001092; Zhang N, 2013, J GEOPHYS RES-PLANET, V118, P1789, DOI 10.1002/jgre.20121; Zhang YX, 2010, REV MINERAL GEOCHEM, V72, P5, DOI 10.2138/rmg.2010.72.2; Zhong SJ, 2000, J GEOPHYS RES-PLANET, V105, P4153, DOI 10.1029/1999JE001075; Zhong SJ, 2000, EARTH PLANET SC LETT, V177, P131, DOI 10.1016/S0012-821X(00)00041-8; Zuber MT, 2013, SCIENCE, V339, P668, DOI 10.1126/science.1231507	94	58	58	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					480	+		10.1038/nature17166	http://dx.doi.org/10.1038/nature17166			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	27008966				2022-12-28	WOS:000372701300035
J	Khullar, D; Jena, A				Khullar, Dhruv; Jena, Anupam			Reducing prognostic errors: a new imperative in quality healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSTIC ERRORS		[Khullar, Dhruv; Jena, Anupam] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Jena, Anupam] Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Jena, Anupam] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Bureau of Economic Research	Jena, A (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Jena, A (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.; Jena, A (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.	jena@hcp.med.harvard.edu			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Brown JC, 2015, BRIT J CANCER, V112, P194, DOI 10.1038/bjc.2014.568; Chandra A, 2015, NEW ENGL J MED, V372, P203, DOI 10.1056/NEJMp1409696; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Croskerry P, 2013, NEW ENGL J MED, V368, P2445, DOI 10.1056/NEJMp1303712; Daskivich TJ, 2014, CANCER-AM CANCER SOC, V120, P3642, DOI 10.1002/cncr.28926; DeFilippis AP, 2015, ANN INTERN MED, V162, P266, DOI 10.7326/M14-1281; Fowler NR, 2014, JAMA INTERN MED, V174, P1514, DOI 10.1001/jamainternmed.2014.3450; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; Gill TM, 2012, JAMA-J AM MED ASSOC, V307, P199, DOI 10.1001/jama.2011.1992; Graber ML, 2013, BMJ QUAL SAF, V22, pii21, DOI 10.1136/bmjqs-2012-001615; Institute of Medicine, 2015, IMPR DIAGN HLTH CAR; Jena AB, 2015, JAMA INTERN MED, V175, P237, DOI 10.1001/jamainternmed.2014.6781; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Saini SD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1247; Singh H, 2014, BMJ QUAL SAF, V23, P727, DOI 10.1136/bmjqs-2013-002627; Tehrani ASS, 2013, BMJ QUAL SAF, V22, P672, DOI 10.1136/bmjqs-2012-001550; Wachter RM, 2010, HEALTH AFFAIR, V29, P1605, DOI 10.1377/hlthaff.2009.0513	17	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2016	352								i1417	10.1136/bmj.i1417	http://dx.doi.org/10.1136/bmj.i1417			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AI	26993146	Green Published			2022-12-28	WOS:000372586000001
J	Pakulska, MM; Miersch, S; Shoichet, MS				Pakulska, Malgosia M.; Miersch, Shane; Shoichet, Molly S.			Designer protein delivery: From natural to engineered affinity-controlled release systems	SCIENCE			English	Review							YEAST SURFACE DISPLAY; ENDOTHELIAL GROWTH-FACTOR; IN-VITRO SELECTION; MOLECULARLY IMPRINTED POLYMERS; MESSENGER-RNA DISPLAY; SINGLE-CHAIN ANTIBODY; COMPUTATIONAL DESIGN; DRUG-DELIVERY; DIRECTED EVOLUTION; SUSTAINED-RELEASE	Exploiting binding affinities between molecules is an established practice in many fields, including biochemical separations, diagnostics, and drug development; however, using these affinities to control biomolecule release is a more recent strategy. Affinity-controlled release takes advantage of the reversible nature of noncovalent interactions between a therapeutic protein and a binding partner to slow the diffusive release of the protein from a vehicle. This process, in contrast to degradation-controlled sustained-release formulations such as poly(lactic-co-glycolic acid) microspheres, is controlled through the strength of the binding interaction, the binding kinetics, and the concentration of binding partners. In the context of affinity-controlled release-and specifically the discovery or design of binding partners-we review advances in in vitro selection and directed evolution of proteins, peptides, and oligonucleotides (aptamers), aided by computational design.	[Pakulska, Malgosia M.; Shoichet, Molly S.] Univ Toronto, Dept Chem Engn & Appl Chem, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Pakulska, Malgosia M.; Shoichet, Molly S.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Miersch, Shane] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Shoichet, Molly S.] Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 1A1, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto	Shoichet, MS (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Inst Biomat & Biomed Engn, Toronto, ON, Canada.; Shoichet, MS (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.; Shoichet, MS (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 1A1, Canada.	molly.shoichet@utoronto.ca			Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We are grateful to B. Shoichet (University of California-San Francisco) for his thoughtful review of this manuscript. We thank the Natural Sciences and Engineering Research Council (Discovery grant to M.S.S. and Vanier Scholarship to M.M.P.) and the Canadian Institutes of Health Research (operating grant to M.S.S.) for funding our research in affinity-controlled release.	Acevedo-Rocha CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep10654; Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Attana, 2016, FREQ ASK QUEST; Bagalkot V, 2006, ANGEW CHEM INT EDIT, V45, P8149, DOI 10.1002/anie.200602251; Baker M, 2011, NAT METHODS, V8, P623, DOI 10.1038/nmeth.1654; Battig MR, 2014, BIOMATERIALS, V35, P8040, DOI 10.1016/j.biomaterials.2014.06.001; BCC Research, 2014, GLOB MARK BIOENG PRO; Beehar G, 2013, PROTEIN ENG DES SEL, V26, P267, DOI 10.1093/protein/gzs106; Bessette PH, 2004, PROTEIN ENG DES SEL, V17, P731, DOI 10.1093/protein/gzh084; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bossi A, 2007, BIOSENS BIOELECTRON, V22, P1131, DOI 10.1016/j.bios.2006.06.023; Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; Burch L, 2004, J MOL BIOL, V337, P129, DOI 10.1016/j.jmb.2004.01.017; Campbell CT, 2007, BIOMATERIALS, V28, P2380, DOI 10.1016/j.biomaterials.2007.01.047; Carothers JM, 2006, J AM CHEM SOC, V128, P7929, DOI 10.1021/ja060952q; Cho M, 2013, P NATL ACAD SCI USA, V110, P18460, DOI 10.1073/pnas.1315866110; Choi YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092513; Christmann A, 1999, PROTEIN ENG, V12, P797, DOI 10.1093/protein/12.9.797; CREMERS HFM, 1990, J CONTROL RELEASE, V11, P167, DOI 10.1016/0168-3659(90)90130-L; Daugherty PS, 1998, PROTEIN ENG, V11, P825, DOI 10.1093/protein/11.9.825; Davis SJ, 1998, P NATL ACAD SCI USA, V95, P5490, DOI 10.1073/pnas.95.10.5490; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; Dixon Matthew C, 2008, J Biomol Tech, V19, P151; EDELMAN ER, 1992, J CLIN INVEST, V89, P465, DOI 10.1172/JCI115607; EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L; EL-Sharif HF, 2014, PHYS CHEM CHEM PHYS, V16, P15483, DOI 10.1039/c4cp01798f; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Emanuel SL, 2011, MABS-AUSTIN, V3, P38, DOI 10.4161/mabs.3.1.14168; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Farokhzad OC, 2006, EXPERT OPIN DRUG DEL, V3, P311, DOI 10.1517/17425247.3.3.311; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Feldwisch J, 2010, J MOL BIOL, V398, P232, DOI 10.1016/j.jmb.2010.03.002; Fellouse F. A., 2015, PHAGE DISPLAY BIOTEC, P111; Fischer M, 2014, NAT CHEM, V6, P575, DOI [10.1038/NCHEM.1954, 10.1038/nchem.1954]; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FRANCISCO JA, 1993, P NATL ACAD SCI USA, V90, P10444, DOI 10.1073/pnas.90.22.10444; Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025; Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057; Fu AS, 2011, ANN BIOMED ENG, V39, P2466, DOI 10.1007/s10439-011-0336-z; Fuh G, 2000, J BIOL CHEM, V275, P21486, DOI 10.1074/jbc.275.28.21486; FURKA A, 1991, INT J PEPT PROT RES, V37, P487, DOI 10.1111/j.1399-3011.1991.tb00765.x; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Geertz M, 2012, P NATL ACAD SCI USA, V109, P16540, DOI 10.1073/pnas.1206011109; Gerweck LE, 1996, CANCER RES, V56, P1194; Golden MC, 2000, J BIOTECHNOL, V81, P167, DOI 10.1016/S0168-1656(00)00290-X; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Heyduk T., 1996, METHODS ENZYMOLOGY B, V274; Hida K, 2007, ADV DRUG DELIVER REV, V59, P1562, DOI 10.1016/j.addr.2007.08.022; Howell SM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06008; Huang GS, 2006, ANALYST, V131, P382, DOI 10.1039/b515722f; Huang J, 2012, NUCLEIC ACIDS RES, V40, pD271, DOI 10.1093/nar/gkr922; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Jelkmann W, 2008, BRIT J HAEMATOL, V141, P287, DOI 10.1111/j.1365-2141.2007.06948.x; Jensen KB, 1995, P NATL ACAD SCI USA, V92, P12220, DOI 10.1073/pnas.92.26.12220; Jeon E, 2014, J BIOMED MATER RES A, V102, P1, DOI 10.1002/jbm.a.34689; Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Karlsson Robert, 2004, Methods Mol Biol, V248, P389; Kastritis PL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0835; Kille S, 2013, ACS SYNTH BIOL, V2, P83, DOI 10.1021/sb300037w; Koide A, 2012, J MOL BIOL, V415, P393, DOI 10.1016/j.jmb.2011.12.019; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; Levitt M, 2007, P NATL ACAD SCI USA, V104, P3183, DOI 10.1073/pnas.0611678104; Lin CC, 2007, J BIOMED MATER RES A, V83A, P954, DOI 10.1002/jbm.a.31282; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; London N, 2015, BIOCHEMISTRY-US, V54, P528, DOI 10.1021/bi501140k; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Mane Krishnappa, 2012, J Basic Clin Pharm, V3, P283; Maxwell DJ, 2005, ACTA BIOMATER, V1, P101, DOI 10.1016/j.actbio.2004.09.002; Maynard HD, 2005, ACTA BIOMATER, V1, P451, DOI 10.1016/j.actbio.2005.04.004; Miersch S, 2012, METHODS, V57, P486, DOI 10.1016/j.ymeth.2012.06.012; Millward SW, 2007, ACS CHEM BIOL, V2, P625, DOI 10.1021/cb7001126; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; Morin A, 2011, TRENDS BIOTECHNOL, V29, P159, DOI 10.1016/j.tibtech.2011.01.002; Mross K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083232; Neuner P, 1998, NUCLEIC ACIDS RES, V26, P1223, DOI 10.1093/nar/26.5.1223; Neylon C, 2004, NUCLEIC ACIDS RES, V32, P1448, DOI 10.1093/nar/gkh315; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nilvebrant J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103094; Nord K, 1997, NAT BIOTECHNOL, V15, P772, DOI 10.1038/nbt0897-772; Oh SS, 2013, ACS NANO, V7, P9675, DOI 10.1021/nn404079v; Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008; ONO A, 1995, NUCLEIC ACIDS RES, V23, P4677, DOI 10.1093/nar/23.22.4677; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; Oss-Ronen L, 2010, ADV ENG MATER, V12, pB45, DOI 10.1002/adem.200980005; Ouellet E, 2010, LAB CHIP, V10, P581, DOI 10.1039/b920589f; Ozkiris A, 2010, EXPERT OPIN THER PAT, V20, P103, DOI 10.1517/13543770902762885; Pakulska MM, 2013, J CONTROL RELEASE, V171, P11, DOI 10.1016/j.jconrel.2013.06.029; Parker J, 2016, BIOMACROMOLECULES, V17, P476, DOI 10.1021/acs.biomac.5b01366; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Perry G, 1997, NEW ENGL J MED, V336, P525; Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Rice JJ, 2006, PROTEIN SCI, V15, P825, DOI 10.1110/ps.051897806; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0; Sakiyama-Elbert SE, 2014, ACTA BIOMATER, V10, P1581, DOI 10.1016/j.actbio.2013.08.045; Schonfeld D, 2009, P NATL ACAD SCI USA, V106, P8198, DOI 10.1073/pnas.0813399106; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; Soontornworajit B, 2010, CHEM COMMUN, V46, P1857, DOI 10.1039/b924909e; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stoop AA, 2003, NAT BIOTECHNOL, V21, P1063, DOI 10.1038/nbt860; Strauch EM, 2014, P NATL ACAD SCI USA, V111, P675, DOI 10.1073/pnas.1313605111; Strohl WR, 2009, CURR OPIN BIOTECH, V20, P668, DOI 10.1016/j.copbio.2009.10.012; Sutter M, 2007, J CONTROL RELEASE, V119, P301, DOI 10.1016/j.jconrel.2007.03.003; Szwajkajzer D, 1997, BIOPOLYMERS, V44, P181, DOI 10.1002/(SICI)1097-0282(1997)44:2<181::AID-BIP5>3.0.CO;2-R; Tae G, 2006, J BIOMAT SCI-POLYM E, V17, P187, DOI 10.1163/156856206774879090; Taimeh Z, 2013, NAT REV CARDIOL, V10, P519, DOI 10.1038/nrcardio.2013.94; Tang LX, 2012, BIOTECHNIQUES, V52, P149, DOI 10.2144/000113820; Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003; Tinberg CE, 2013, NATURE, V501, P212, DOI 10.1038/nature12443; Torres FE, 2010, CURR OPIN STRUC BIOL, V20, P598, DOI 10.1016/j.sbi.2010.09.001; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaishya R, 2015, EXPERT OPIN DRUG DEL, V12, P415, DOI 10.1517/17425247.2015.961420; VanderVaart JM, 1997, APPL ENVIRON MICROB, V63, P615, DOI 10.1128/AEM.63.2.615-620.1997; Vazquez-Lombardi R, 2015, DRUG DISCOV TODAY, V20, P1271, DOI 10.1016/j.drudis.2015.09.004; VIRNEKAS B, 1994, NUCLEIC ACIDS RES, V22, P5600, DOI 10.1093/nar/22.25.5600; Vuignier K, 2010, ANAL BIOANAL CHEM, V398, P53, DOI 10.1007/s00216-010-3737-1; Vulic K, 2015, J CONTROL RELEASE, V197, P69, DOI 10.1016/j.jconrel.2014.10.032; Vulic K, 2014, BIOMACROMOLECULES, V15, P3867, DOI 10.1021/bm501084u; Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x; Wang NX, 2011, MACROMOL BIOSCI, V11, P321, DOI 10.1002/mabi.201000206; Wang W, 2012, NAT CHEM, V4, P846, DOI [10.1038/NCHEM.1434, 10.1038/nchem.1434]; Weber KS, 2005, P NATL ACAD SCI USA, V102, P19033, DOI 10.1073/pnas.0507554102; Wei YH, 2010, ANAL CHEM, V82, P8780, DOI 10.1021/ac102055a; White RR, 2000, J CLIN INVEST, V106, P929, DOI 10.1172/JCI11325; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Willander M., 2009, METHODS MOL BIOL, V544; Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844; Wu F, 2008, AAPS PHARMSCITECH, V9, P1218, DOI 10.1208/s12249-008-9148-3; Yates BP, 2013, MOL BIOTECHNOL, V54, P829, DOI 10.1007/s12033-012-9631-7; Yoon JJ, 2006, J BIOMED MATER RES A, V79A, P934, DOI 10.1002/jbm.a.30843; Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023; Zahnd C, 2004, J BIOL CHEM, V279, P18870, DOI 10.1074/jbc.M309169200; Zhang XL, 2012, BIOMACROMOLECULES, V13, P2202, DOI 10.1021/bm3006227; Zhao YN, 2010, J CONTROL RELEASE, V141, P30, DOI 10.1016/j.jconrel.2009.06.032	146	109	112	12	461	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279							aac4750	10.1126/science.aac4750	http://dx.doi.org/10.1126/science.aac4750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989257				2022-12-28	WOS:000372397700030
J	Macilwain, C				Macilwain, Colin			The elephant in the room we can't ignore	NATURE			English	Editorial Material												cfmworldview@googlemail.com							0	2	3	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					277	277		10.1038/531277a	http://dx.doi.org/10.1038/531277a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26983505	Bronze			2022-12-28	WOS:000372064300019
J	Torjesen, I				Torjesen, Ingrid			Sit-stand desks offer little evidence of health benefits, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Buckley JP, 2015, BRIT J SPORT MED, V49, P1357, DOI 10.1136/bjsports-2015-094618; Shrestha N, 2016, COCHRANE DB SYST REV, V1	2	0	0	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2016	352								i1595	10.1136/bmj.i1595	http://dx.doi.org/10.1136/bmj.i1595			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AD	26989208				2022-12-28	WOS:000372585400008
J	Zanoni, P; Khetarpal, SA; Larach, DB; Hancock-Cerutti, WF; Millar, JS; Cuchel, M; DerOhannessian, S; Kontush, A; Surendran, P; Saleheen, D; Trompet, S; Jukema, JW; De Craen, A; Deloukas, P; Sattar, N; Ford, I; Packard, C; Majumder, AA; Alam, DS; Di Angelantonio, E; Abecasis, G; Chowdhury, R; Erdmann, J; Nordestgaard, BG; Nielsen, SF; Tybjaerg-Hansen, A; Schmidt, RF; Kuulasmaa, K; Liu, DJ; Perola, M; Blankenberg, S; Salomaa, V; Mannisto, S; Amouyel, P; Arveiler, D; Ferrieres, J; Muller-Nurasyid, M; Ferrario, M; Kee, F; Willer, CJ; Samani, N; Schunkert, H; Butterworth, AS; Howson, JMM; Peloso, GM; Stitziel, NO; Danesh, J; Kathiresan, S; Rader, DJ				Zanoni, Paolo; Khetarpal, Sumeet A.; Larach, Daniel B.; Hancock-Cerutti, William F.; Millar, John S.; Cuchel, Marina; DerOhannessian, Stephanie; Kontush, Anatol; Surendran, Praveen; Saleheen, Danish; Trompet, Stella; Jukema, J. Wouter; De Craen, Anton; Deloukas, Panos; Sattar, Naveed; Ford, Ian; Packard, Chris; Majumder, Abdullah al Shafi; Alam, Dewan S.; Di Angelantonio, Emanuele; Abecasis, Goncalo; Chowdhury, Rajiv; Erdmann, Jeanette; Nordestgaard, Borge G.; Nielsen, Sune F.; Tybjaerg-Hansen, Anne; Schmidt, Ruth Frikke; Kuulasmaa, Kari; Liu, Dajiang J.; Perola, Markus; Blankenberg, Stefan; Salomaa, Veikko; Mannisto, Satu; Amouyel, Philippe; Arveiler, Dominique; Ferrieres, Jean; Muller-Nurasyid, Martina; Ferrario, Marco; Kee, Frank; Willer, Cristen J.; Samani, Nilesh; Schunkert, Heribert; Butterworth, Adam S.; Howson, Joanna M. M.; Peloso, Gina M.; Stitziel, Nathan O.; Danesh, John; Kathiresan, Sekar; Rader, Daniel J.		Consortium, CE; CARDIoGRAM Exome Consortium; Global Lipids Genetics Consortium	Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease	SCIENCE			English	Article							HIGH-DENSITY-LIPOPROTEIN; SELECTIVE LIPID UPTAKE; I SR-BI; DEFICIENT MICE; TARGETED MUTATION; TRANSGENIC MICE; METABOLISM; EXPRESSION; ESTER; ATHEROSCLEROSIS	Scavenger receptor BI (SR-BI) is the major receptor for high-density lipoprotein (HDL) cholesterol (HDL-C). In humans, high amounts of HDL-C in plasma are associated with a lower risk of coronary heart disease (CHD). Mice that have depleted Scarb1 (SR-BI knockout mice) have markedly elevated HDL-C levels but, paradoxically, increased atherosclerosis. The impact of SR-BI on HDL metabolism and CHD risk in humans remains unclear. Through targeted sequencing of coding regions of lipid-modifying genes in 328 individuals with extremely high plasma HDL-C levels, we identified a homozygote for a loss-of-function variant, in which leucine replaces proline 376 (P376L), in SCARB1, the gene encoding SR-BI. The P376L variant impairs posttranslational processing of SR-BI and abrogates selective HDL cholesterol uptake in transfected cells, in hepatocyte-like cells derived from induced pluripotent stem cells from the homozygous subject, and in mice. Large population-based studies revealed that subjects who are heterozygous carriers of the P376L variant have significantly increased levels of plasma HDL-C. P376L carriers have a profound HDL-related phenotype and an increased risk of CHD (odds ratio = 1.79, which is statistically significant).	[Zanoni, Paolo; Khetarpal, Sumeet A.; Larach, Daniel B.; Hancock-Cerutti, William F.; Millar, John S.; Cuchel, Marina; DerOhannessian, Stephanie; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Dept Genet, Philadelphia, PA 19104 USA; [Zanoni, Paolo; Khetarpal, Sumeet A.; Larach, Daniel B.; Hancock-Cerutti, William F.; Millar, John S.; Cuchel, Marina; DerOhannessian, Stephanie; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Dept Med, Philadelphia, PA 19104 USA; [Hancock-Cerutti, William F.; Kontush, Anatol] Univ Paris 06, Hop Pitie, INSERM UMR ICAN 1166, Paris, France; [Surendran, Praveen; Saleheen, Danish; Di Angelantonio, Emanuele; Chowdhury, Rajiv; Butterworth, Adam S.; Howson, Joanna M. M.; Danesh, John] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England; [Saleheen, Danish] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Trompet, Stella; De Craen, Anton] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Trompet, Stella; Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Jukema, J. Wouter] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Deloukas, Panos; Danesh, John] Wellcome Trust Sanger Inst, Genome Campus, Hinxton, England; [Sattar, Naveed] Univ Glasgow, Glasgow Cardiovasc Res Ctr, British Heart Fdn, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Packard, Chris] Western Infirm & Associated Hosp, Glasgow Clin Res Facil, Glasgow, Lanark, Scotland; [Majumder, Abdullah al Shafi] Natl Inst Cardiovasc Dis, Dhaka, Bangladesh; [Alam, Dewan S.] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Abecasis, Goncalo] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Erdmann, Jeanette] Univ Lubeck, Inst Integrat & Expt Genom, D-23562 Lubeck, Germany; [Nordestgaard, Borge G.; Nielsen, Sune F.] Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, Herlev, Denmark; [Tybjaerg-Hansen, Anne] Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen, Denmark; [Schmidt, Ruth Frikke] Copenhagen Univ Hosp, Dept Clin Biochem, Rigshosp, Copenhagen, Denmark; [Kuulasmaa, Kari; Perola, Markus; Salomaa, Veikko; Mannisto, Satu] Natl Inst Hlth & Welf, Dept Hlth, Helsinki, Finland; [Liu, Dajiang J.] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Perola, Markus] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland; [Blankenberg, Stefan] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Blankenberg, Stefan] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Amouyel, Philippe] Inst Pasteur, Dept Epidemiol & Publ Hlth, Lille, France; [Arveiler, Dominique] Univ Strasbourg, Dept Epidemiol & Publ Hlth, Strasbourg, France; [Ferrieres, Jean] Toulouse Univ, Dept Epidemiol, CHU Toulouse, Toulouse, France; [Muller-Nurasyid, Martina] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Muller-Nurasyid, Martina] Univ Munich, Dept Med 1, Munich, Germany; [Ferrario, Marco] Univ Insubria, Dept Clin & Expt Med, Res Ctr Epidemiol & Prevent Med, Varese, Italy; [Kee, Frank] Queens Univ, UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland; [Willer, Cristen J.] Univ Michigan, Dept Computat Med & Bioinformat, Dept Human Genet, Ann Arbor, MI 48109 USA; [Willer, Cristen J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Samani, Nilesh] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh] Glenfield Hotel, Natl Inst Hlth Res NIHR, Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Schunkert, Heribert] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Peloso, Gina M.; Kathiresan, Sekar] Massachusetts Gen Hosp, Broad Inst, Boston, MA 02114 USA; [Peloso, Gina M.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, Dept Genet, Dept Med,Div Cardiol, St Louis, MO 63110 USA; [Stitziel, Nathan O.] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO 63110 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Wellcome Trust Sanger Institute; University of Glasgow; University of Glasgow; International Centre for Diarrhoeal Disease Research (ICDDR); University of Michigan System; University of Michigan; University of Lubeck; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; Finland National Institute for Health & Welfare; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Helsinki; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Insubria; Queens University Belfast; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Leicester; German Heart Centre Munich; Technical University of Munich; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); Washington University (WUSTL)	Rader, DJ (corresponding author), Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Dept Genet, Philadelphia, PA 19104 USA.; Rader, DJ (corresponding author), Univ Penn, Perelman Sch Med, Div Translat Med & Human Genet, Dept Med, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu	Bochud, Murielle/A-3981-2010; Kontush, Anatol/J-2198-2016; Colaus, PsyColaus/K-6607-2013; Wijmenga, Cisca/D-2173-2009; Girelli, Domenico/B-1183-2008; Deloukas, Panos/B-2922-2013; Ford, Ian/ABE-6145-2020; Bovet, Pascal/F-4477-2011; Erdmann, Jeanette/A-4417-2009; Stitziel, Nathan/AAL-8413-2021; Ferrario, Marco M./ABH-2115-2021; Müller-Nurasyid, Martina/I-8735-2018; DiAngelantonio, Emanuele/ABE-6852-2020; Boehm, Bernhard Otto/F-8750-2015; Erdmann, Jeanette/P-7513-2014; Kanoni, Stavroula/AAN-7161-2021; Chowdhury, Rajiv/AHB-1253-2022; Nordestgaard, Borge Gronne/ABF-1310-2020; Feitosa, Mary F/K-8044-2012; Langenberg, Claudia/ABG-9067-2021; Strawbridge, Rona/H-5422-2012; Hicks, Andrew/E-9518-2017; Gudnason, Vilmundur/K-6885-2015; Hypponen, Elina/B-2596-2014; Magnusson, Patrik/C-4458-2017; Rudan, Igor/I-1467-2012; Ferrieres, Jean/S-7993-2016	Bochud, Murielle/0000-0002-5727-0218; Girelli, Domenico/0000-0001-9684-1899; Deloukas, Panos/0000-0001-9251-070X; Bovet, Pascal/0000-0002-0242-4259; Stitziel, Nathan/0000-0002-4963-8211; Müller-Nurasyid, Martina/0000-0003-3793-5910; Erdmann, Jeanette/0000-0002-4486-6231; Kanoni, Stavroula/0000-0002-1691-9615; Feitosa, Mary F/0000-0002-0933-2410; Langenberg, Claudia/0000-0002-5017-7344; Nordestgaard, Borge/0000-0002-1954-7220; Howson, Joanna/0000-0001-7618-0050; Price, Jackie/0000-0003-3251-3970; Munroe, Patricia/0000-0002-4176-2947; Ganna, Andrea/0000-0002-8147-240X; Kuulasmaa, Kari/0000-0003-2165-1411; Van Duijn, Cornelia/0000-0002-2374-9204; Elliott, Paul/0000-0002-7511-5684; Hancock-Cerutti, William/0000-0002-8051-1112; Lindgren, Cecilia/0000-0002-4903-9374; Gigante, Bruna/0000-0003-4508-7990; Strawbridge, Rona/0000-0001-8506-3585; Ferrario, Marco M/0000-0003-2741-7124; Humphries, Stephen E/0000-0002-8221-6547; Hicks, Andrew/0000-0001-6320-0411; Kleber, Marcus/0000-0003-0663-7275; Gudnason, Vilmundur/0000-0001-5696-0084; Amouyel, Philippe/0000-0001-9088-234X; Mannisto, Satu/0000-0002-8668-3046; Hypponen, Elina/0000-0003-3670-9399; Magnusson, Patrik/0000-0002-7315-7899; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Willemsen, Gonneke/0000-0003-3755-0236; Liu, Dajiang/0000-0001-6553-858X; Kumari, Meena/0000-0001-9716-1035; Lakka, Timo/0000-0002-9199-2871; Larach, Daniel/0000-0001-8368-701X; Franks, Paul/0000-0002-0520-7604; Di Angelantonio, Emanuele/0000-0001-8776-6719; Asiki, Gershim/0000-0002-9966-1153; Rudan, Igor/0000-0001-6993-6884; Pramstaller, Peter P/0000-0002-9831-8302; Butterworth, Adam/0000-0002-6915-9015; Ferrieres, Jean/0000-0001-6144-1297; Palotie, Aarno/0000-0002-2527-5874; Demirkan, Ayse/0000-0002-7546-0867	National Center for Research Resources [TL1RR024133]; National Center for Advancing Translational Sciences of the NIH [TL1R000138]; Doris Duke Charitable Foundation; MRC [G0800270, MR/L003120/1, MR/K013351/1, MR/N003284/1, G0801566] Funding Source: UKRI; British Heart Foundation [RG/13/13/30194, RG/14/5/30893, PG/08/094/26019, RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0801566, G0800270, MR/K013351/1, MR/N003284/1, G0401527, MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10170, NF-SI-0507-10228, NF-SI-0514-10027, NF-SI-0512-10165, NF-SI-0512-10114] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024133] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089309, R01HL111398, R01HL117078, K08HL114642] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006398, R01HG008983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA040177] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We appreciate the participation and support of participants of the deep clinical phenotyping studies. We thank E. Mohler for assistance in interpretation of cIMT results and J. Billheimer and E. Pashos for helpful discussions. We also acknowledge J. Tabita-Martinez for expert assistance with clinical phenotyping studies. This work was supported in part by an award from the National Center for Research Resources (grant TL1RR024133) and National Center for Advancing Translational Sciences of the NIH (grant TL1R000138) to support patient recruitment. D.B.L. was supported by a fellowship from the Doris Duke Charitable Foundation. S.K. has financial relationships with Novartis, Aegerion, Bristol-Myers Squibb, Sanofi, AstraZeneca, Alnylam, Eli Lilly, Leerink Partners, Merck, Catabasis, Regeneron Genetic Center, San Therapeutics, and Celera. H.S. has financial relationships with MSD Sharp and Dohme, Sanofi-Aventis, and Amgen. S.B. has financial relationships with Boehringer Ingelheim, Bayer, Novartis, Roche, and Thermo Fisher. N.S has financial relationships with Amgen, Sanofi, Astrazeneca, and MSD Sharp and Dohme. A.K. has a financial relationship with Amgen. J.D. has a financial relationship with Novartis. A.T.-H. has financial relationships with Eli Lilly and LGC Genomics. Sequencing data have been deposited in GenBank (SRX1458096). Genotyping data have been deposited in the Gene Expression Omnibus (GSE76065).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; Calvo D, 1997, ARTERIOSCL THROM VAS, V17, P2341, DOI 10.1161/01.ATV.17.11.2341; Cayo MA, 2012, HEPATOLOGY, V56, P2163, DOI 10.1002/hep.25871; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Ghodsizadeh A, 2010, STEM CELL REV REP, V6, P622, DOI 10.1007/s12015-010-9189-3; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; Hildebrand RB, 2010, ARTERIOSCL THROM VAS, V30, P1439, DOI 10.1161/ATVBAHA.110.205153; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; Hoekstra M, 2010, WORLD J GASTROENTERO, V16, P5916, DOI 10.3748/wjg.v16.i47.5916; Hoekstra M, 2009, J LIPID RES, V50, P1039, DOI 10.1194/jlr.M800410-JLR200; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; LAGROST L, 1993, ARTERIOSCLER THROMB, V13, P815, DOI 10.1161/01.ATV.13.6.815; Mallanna Sunil K, 2013, Curr Protoc Stem Cell Biol, V26, DOI 10.1002/9780470151808.sc01g04s26; Miettinen HE, 2001, J CLIN INVEST, V108, P1717, DOI 10.1172/JCI13288; Mineo C, 2012, CURR OPIN LIPIDOL, V23, P487, DOI 10.1097/MOL.0b013e328357ba61; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Schwartz CC, 2004, J LIPID RES, V45, P1594, DOI 10.1194/jlr.M300511-JLR200; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang N, 1998, J BIOL CHEM, V273, P32920, DOI 10.1074/jbc.273.49.32920; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	39	336	350	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1166	1171		10.1126/science.aad3517	http://dx.doi.org/10.1126/science.aad3517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965621	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000386158400038
J	Stevens, S; Valderas, JM; Doran, T; Perera, R; Kontopantelis, E				Stevens, Sarah; Valderas, Jose M.; Doran, Tim; Perera, Rafael; Kontopantelis, Evangelos			Analysing indicators of performance, satisfaction, or safety using empirical logit transformation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FAMILY PRACTICES; PRIMARY-CARE; QUALITY; PAY	Performance, satisfaction, and safety indicators are commonly measured on a percentage scale. Such indicators are often subject to ceiling or floor effects and performance may be inherently non-linear. For example, improving from 85% to 95% might be more difficult and need more effort than improving from 55% to 65%. As such, analysis of these indicators is not always straightforward and standard linear analysis could be problematic. We present the most common approach to dealing with this problem: a logit transformation of the score, following which standard linear analysis can be conducted on the transformed score. We also demonstrate how estimates can be back-transformed to percentages for easier communication of findings. In this paper, we discuss the benefits of this method, use algebra to describe the relevant steps in the transformation process, provide guidance on interpretation, and provide a tool for analysis.	[Stevens, Sarah; Perera, Rafael] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Stevens, Sarah; Perera, Rafael; Kontopantelis, Evangelos] Nat Inst Hlth Res, Sch Primary Care Res, Oxford, England; [Valderas, Jose M.] Univ Exeter, Sch Med, Inst Hlth Serv Res, APEx Collaborat Acad Primary Care, Exeter, Devon, England; [Doran, Tim] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Kontopantelis, Evangelos] Univ Manchester, Inst Populat Hlth, Ctr Hlth Informat, Manchester M13 9GB, Lancs, England	University of Oxford; University of Exeter; University of York - UK; University of Manchester	Kontopantelis, E (corresponding author), Nat Inst Hlth Res, Sch Primary Care Res, Oxford, England.; Kontopantelis, E (corresponding author), Univ Manchester, Inst Populat Hlth, Ctr Hlth Informat, Manchester M13 9GB, Lancs, England.	Kontopantelise.kontopantelis@manchester.ac.uk	Kontopantelis, Evangelos/H-2966-2019; Valderas, Jose M/Y-9814-2019; Valderas, Jose M/G-7967-2014	Kontopantelis, Evangelos/0000-0001-6450-5815; Valderas, Jose M/0000-0002-9299-1555; Lay-Flurrie, Sarah/0000-0003-1094-8455	UK Medical Research Council Health eResearch Centre [MR/K006665/1]; MRC [MR/K006665/1] Funding Source: UKRI; Medical Research Council [MC_PC_13042, MR/K006665/1] Funding Source: researchfish; National Institute for Health Research [NIHR/CS/010/024] Funding Source: researchfish	UK Medical Research Council Health eResearch Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	UK Medical Research Council Health eResearch Centre grant MR/K006665/1 supported the time and facilities of EK.	Abraham B, 1998, QUALITY IMPROVEMENT, DOI [10.1007/978-1-4612-1776-3, DOI 10.1007/978-1-4612-1776-3]; ANSCOMBE FJ, 1956, BIOMETRIKA, V43, P461, DOI 10.1093/biomet/43.3-4.461; BERKSON J, 1955, J AM STAT ASSOC, V50, P130, DOI 10.2307/2281102; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Chung T., 2003, International Journal of Hospitality Management, V22, P119, DOI 10.1016/S0278-4319(02)00076-2; Cox DR., 1989, ANAL BINARY DATA; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; HippisleyCox J, 1997, BRIT MED J, V314, P1458, DOI 10.1136/bmj.314.7092.1458; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Kontopantelis E, 2013, BMJ QUAL SAF, V22, P53, DOI 10.1136/bmjqs-2012-001033; Reeves D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1717; Ricci-Cabello I, 2015, ANN FAM MED, V13, P514, DOI 10.1370/afm.1848; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; STIPAK B, 1979, PUBLIC ADMIN REV, V39, P46, DOI 10.2307/3110378; Stocks SJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5501	17	18	18	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2016	352								i1114	10.1136/bmj.i1114	http://dx.doi.org/10.1136/bmj.i1114			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NP	26964829	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000372049200003
J	Jelliffe, SE; White, WA				Jelliffe, Smith Ely; White, William A.			Principles Underlying the Classification of Diseases of the Nervous System (Reprinted from JAMA, vol 66, pg 781, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Jelliffe SE, 1916, J AMER MED ASSOC, V66, P781	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					1059	1059		10.1001/jama.2015.17077	http://dx.doi.org/10.1001/jama.2015.17077			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26954425				2022-12-28	WOS:000371540200028
J	Lipska, KJ; Krumholz, H; Soones, T; Lee, SJ				Lipska, Kasia J.; Krumholz, Harlan; Soones, Tacara; Lee, Sei J.			Polypharmacy in the Aging Patient A Review of Glycemic Control in Older Adults With Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INTENSIVE GLUCOSE CONTROL; CLINICAL-PRACTICE GUIDELINES; DRUG-DRUG INTERACTIONS; CARDIOVASCULAR OUTCOMES; RISK-FACTORS; FOLLOW-UP; SEVERE HYPOGLYCEMIA; INSULIN-RESISTANCE; HEMOGLOBIN A(1C); YOUNGER ADULTS	IMPORTANCE There is substantial uncertainty about optimal glycemic control in older adults with type 2 diabetes mellitus. OBSERVATIONS Four large randomized clinical trials (RCTs), ranging in size from 1791 to 11 440 patients, provide the majority of the evidence used to guide diabetes therapy. Most RCTs of intensive vs standard glycemic control excluded adults older than 80 years, used surrogate end points to evaluate microvascular outcomes and provided limited data on which subgroups are most likely to benefit or be harmed by specific therapies. Available data from randomized clinical trials suggest that intensive glycemic control does not reduce major macrovascular events in older adults for at least 10 years. Furthermore, intensive glycemic control does not lead to improved patient-centered microvascular outcomes for at least 8 years. Data from randomized clinical trials consistently suggest that intensive glycemic control immediately increases the risk of severe hypoglycemia 1.5-to 3-fold. Based on these data and observational studies, for the majority of adults older than 65 years, the harms associated with a hemoglobin A1c (HbA1c) target lower than 7.5% or higher than 9% are likely to outweigh the benefits. However, the optimal target depends on patient factors, medications used to reach the target, life expectancy, and patient preferences about treatment. If only medications with low treatment burden and hypoglycemia risk (such as metformin) are required, a lower HbA1c targetmay be appropriate. If patients strongly prefer to avoid injections or frequent fingerstick monitoring, a higher HbA1c target that obviates the need for insulin may be appropriate. CONCLUSIONS AND RELEVANCE High-quality evidence about glycemic treatment in older adults is lacking. Optimal decisions need to be made collaboratively with patients, incorporating the likelihood of benefits and harms and patient preferences about treatment and treatment burden. For the majority of older adults, an HbA1c target between 7.5% and 9% will maximize benefits and minimize harms.	[Lipska, Kasia J.] Yale Univ, Sch Med, Dept Internal Med, Endocrinol Sect, 333 Cedar St,POB 208020, New Haven, CT 06520 USA; [Krumholz, Harlan] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Krumholz, Harlan] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; [Krumholz, Harlan] Yale Univ, Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, New Haven, CT 06520 USA; [Krumholz, Harlan] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06520 USA; [Soones, Tacara] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Med, New York, NY 10029 USA; [Lee, Sei J.] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA USA; [Lee, Sei J.] San Francisco VA Med Ctr, San Francisco, CA USA	Yale University; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Lipska, KJ (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Endocrinol Sect, 333 Cedar St,POB 208020, New Haven, CT 06520 USA.	kasia.lipska@yale.edu	, Harlan/AAI-2875-2020		Beeson Career Development Award from the National Institute on Aging; American Federation of Aging Research [K23AG048359, K23AG040779]; Early Career Award from the S. D. Bechtel Jr Foundation; NATIONAL INSTITUTE ON AGING [K23AG048359, P30AG044281, K23AG040779, P30AG021342] Funding Source: NIH RePORTER	Beeson Career Development Award from the National Institute on Aging; American Federation of Aging Research; Early Career Award from the S. D. Bechtel Jr Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Lipska's effort on this project was supported through the Beeson Career Development Award from the National Institute on Aging and the American Federation of Aging Research (K23AG048359). Dr Lee's effort on this project was supported through the Beeson Career Development Award from the National Institute on Aging and the American Federation of Aging Research (K23AG040779) and an Early Career Award from the S. D. Bechtel Jr Foundation.	Abdelhafiz AH, 2015, AGING DIS, V6, P156, DOI 10.14336/AD.2014.0330; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Benner JS, 2009, AM J HEALTH-SYST PH, V66, P1471, DOI 10.2146/ajhp080238; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Bloomfield HE, 2012, 09009 VAESP; Bloomgarden ZT, 2006, DIABETES CARE, V29, P2137, DOI 10.2337/dc06-1120; Bohlen K, 2012, DIABETES CARE, V35, P47, DOI 10.2337/dc11-1082; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Cegelka A, 2013, J AM GERIATR SOC, V61, P2020, DOI 10.1111/jgs.12514; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002; Cheng YLJ, 2013, DIABETES CARE, V36, P2690, DOI 10.2337/dc12-2074; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Cruz-Jentoft AJ, 2013, J AM GERIATR SOC, V61, P734, DOI 10.1111/jgs.12215; Doan J, 2013, ANN PHARMACOTHER, V47, P324, DOI 10.1345/aph.1R621; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Duckworth WC, 2011, J DIABETES COMPLICAT, V25, P355, DOI 10.1016/j.jdiacomp.2011.10.003; Feil DG, 2011, J AM GERIATR SOC, V59, P2263, DOI 10.1111/j.1532-5415.2011.03726.x; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Field TS, 2001, ARCH INTERN MED, V161, P1629, DOI 10.1001/archinte.161.13.1629; Fitzgerald SP, 2010, J AM MED DIR ASSOC, V11, P475, DOI 10.1016/j.jamda.2010.05.008; Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2014, LANCET, V384, P1936, DOI 10.1016/S0140-6736(14)60611-5; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Gibbons RJ, 2003, CIRCULATION, V107, P2979, DOI 10.1161/01.CIR.0000063682.20730.A5; Godolphin William, 2009, Healthc Q, V12 Spec No Patient, pe186; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Haupt A, 2009, DIABETOLOGIA, V52, P457, DOI 10.1007/s00125-008-1250-2; Hayward RA, 2015, NEW ENGL J MED, V372, P2197, DOI 10.1056/NEJMoa1414266; Hemmingsen Bianca, 2014, CMAJ Open, V2, pE162, DOI 10.9778/cmajo.20130073; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; Ihm SH, 2006, DIABETES, V55, P1361, DOI 10.2337/db05-1333; Imamura F, 2013, AM J EPIDEMIOL, V177, P1418, DOI 10.1093/aje/kws440; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Inzucchi SE, 2014, JAMA-J AM MED ASSOC, V312, P2668, DOI 10.1001/jama.2014.15298; Iozzo P, 1999, J CLIN ENDOCR METAB, V84, P863, DOI 10.1210/jc.84.3.863; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Johnell K, 2007, DRUG SAFETY, V30, P911, DOI 10.2165/00002018-200730100-00009; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kirkman MS, 2012, J AM GERIATR SOC, V60, P2342, DOI 10.1111/jgs.12035; Kojima G, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.07.019; Lakey WC, 2013, DIABETOLOGIA, V56, P1226, DOI 10.1007/s00125-013-2890-4; Management of Diabetes Mellitus Guideline UpdateWorking Group, 2010, VA DOD CLIN PRACT GU; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; Marcum ZA, 2012, J AM GERIATR SOC, V60, P34, DOI 10.1111/j.1532-5415.2011.03772.x; Mayo Clinic Shared Decision Making National Resource Center, 2014, SHAR DEC MAK PHIL; Miller ME, 2010, BMJ-BRIT MED J, V340, pb5444; Miller ME, 2014, DIABETES CARE, V37, P634, DOI 10.2337/dc13-1545; Mullan RJ, 2009, ARCH INTERN MED, V169, P1560, DOI 10.1001/archinternmed.2009.293; Munshi MN, 2013, J AM GERIATR SOC, V61, P535, DOI 10.1111/jgs.12167; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Phung OJ, 2010, JAMA-J AM MED ASSOC, V303, P1410, DOI 10.1001/jama.2010.405; Punthakee Z, 2012, DIABETES CARE, V35, P787, DOI 10.2337/dc11-1855; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Riddle MC, 2015, DIABETES CARE, V38, P22, DOI 10.2337/dc14-1329; Sacks DB, 2014, JAMA-J AM MED ASSOC, V311, P2271, DOI 10.1001/jama.2014.6342; Sacks DB, 2012, DIABETES CARE, V35, P2674, DOI 10.2337/dc12-1348; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shorr RI, 1997, ARCH INTERN MED, V157, P1681, DOI 10.1001/archinte.157.15.1681; Sinclair A, 2013, J AM MED DIR ASSOC, V14, P777, DOI 10.1016/j.jamda.2013.09.001; Sinclair AJ, 2011, DIABETES METAB, V37, pS27, DOI 10.1016/S1262-3636(11)70962-4; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; Stoehr GP, 2008, AM J GERIATR PHARMAC, V6, P255, DOI 10.1016/j.amjopharm.2008.11.001; Szoke E, 2008, DIABETES CARE, V31, P539, DOI 10.2337/dc07-1443; Timbie JW, 2010, HEALTH SERV RES, V45, P437, DOI 10.1111/j.1475-6773.2009.01075.x; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vijan S, 2005, J GEN INTERN MED, V20, P479, DOI 10.1111/j.1525-1497.2005.0117.x; Vijan S, 1997, ANN INTERN MED, V127, P788, DOI 10.7326/0003-4819-127-9-199711010-00003; Vijan S, 2014, JAMA INTERN MED, V174, P1227, DOI 10.1001/jamainternmed.2014.2894; Yaffe K, 2013, JAMA INTERN MED, V173, P1300, DOI 10.1001/jamainternmed.2013.6176; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720; Zoungas S, 2014, NEW ENGL J MED, V371, P1392, DOI 10.1056/NEJMoa1407963; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	84	143	153	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					1034	1045		10.1001/jama.2016.0299	http://dx.doi.org/10.1001/jama.2016.0299			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26954412	Green Accepted			2022-12-28	WOS:000371540200016
J	da Costa, BR; Reichenbach, S; Keller, N; Nartey, L; Wandel, S; Juni, P; Trelle, S				da Costa, Bruno R.; Reichenbach, Stephan; Keller, Noah; Nartey, Linda; Wandel, Simon; Juni, Peter; Trelle, Sven			Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis	LANCET			English	Article							CLINICAL-TRIALS; RHEUMATOID-ARTHRITIS; PRIMARY-CARE; PLACEBO; INTERVENTIONS; MEDICATIONS; CHONDROITIN; MANAGEMENT; EFFICACY	Background Non-steroidal anti-inflammatory drugs (NSAIDs) are the backbone of osteoarthritis pain management. We aimed to assess the effectiveness of different preparations and doses of NSAIDs on osteoarthritis pain in a network meta-analysis. Methods For this network meta-analysis, we considered randomised trials comparing any of the following interventions: NSAIDs, paracetamol, or placebo, for the treatment of osteoarthritis pain. We searched the Cochrane Central Register of Controlled Trials (CENTRAL) and the reference lists of relevant articles for trials published between Jan 1, 1980, and Feb 24, 2015, with at least 100 patients per group. The prespecified primary and secondary outcomes were pain and physical function, and were extracted in duplicate for up to seven timepoints after the start of treatment. We used an extension of multivariable Bayesian random effects models for mixed multiple treatment comparisons with a random effect at the level of trials. For the primary analysis, a random walk of first order was used to account for multiple follow-up outcome data within a trial. Preparations that used different total daily dose were considered separately in the analysis. To assess a potential dose-response relation, we used preparation-specific covariates assuming linearity on log relative dose. Findings We identified 8973 manuscripts from our search, of which 74 randomised trials with a total of 58 556 patients were included in this analysis. 23 nodes concerning seven different NSAIDs or paracetamol with specific daily dose of administration or placebo were considered. All preparations, irrespective of dose, improved point estimates of pain symptoms when compared with placebo. For six interventions (diclofenac 150 mg/day, etoricoxib 30 mg/day, 60 mg/day, and 90 mg/day, and rofecoxib 25 mg/day and 50 mg/day), the probability that the difference to placebo is at or below a prespecified minimum clinically important effect for pain reduction (effect size [ES] -0.37) was at least 95%. Among maximally approved daily doses, diclofenac 150 mg/day (ES -0.57, 95% credibility interval [CrI] -0.69 to -0.46) and etoricoxib 60 mg/day (ES -0.58, -0.73 to -0.43) had the highest probability to be the best intervention, both with 100% probability to reach the minimum clinically important difference. Treatment effects increased as drug dose increased, but corresponding tests for a linear dose effect were significant only for celecoxib (p=0.030), diclofenac (p=0.031), and naproxen (p=0.026). We found no evidence that treatment effects varied over the duration of treatment. Model fit was good, and between-trial heterogeneity and inconsistency were low in all analyses. All trials were deemed to have a low risk of bias for blinding of patients. Effect estimates did not change in sensitivity analyses with two additional statistical models and accounting for methodological quality criteria in meta-regression analysis. Interpretation On the basis of the available data, we see no role for single-agent paracetamol for the treatment of patients with osteoarthritis irrespective of dose. We provide sound evidence that diclofenac 150 mg/day is the most effective NSAID available at present, in terms of improving both pain and function. Nevertheless, in view of the safety profile of these drugs, physicians need to consider our results together with all known safety information when selecting the preparation and dose for individual patients.	[da Costa, Bruno R.; Keller, Noah; Juni, Peter] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Reichenbach, Stephan; Trelle, Sven] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Nartey, Linda; Trelle, Sven] Univ Bern, CTU Bern, Dept Clin Res, Bern, Switzerland; [Reichenbach, Stephan] Univ Hosp, Dept Rheumatol Immunol & Allergol, Bern, Switzerland; [Reichenbach, Stephan] Univ Bern, CH-3012 Bern, Switzerland; [Wandel, Simon] Cogitars GmbH Liq, Wangen An Der Aare, Switzerland; [Juni, Peter] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Juni, Peter] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Trelle, S (corresponding author), Univ Bern, CTU Bern, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	sven.trelle@ctu.unibe.ch	Trelle, Sven/D-3760-2009; Juni, Peter/Q-8700-2016	Trelle, Sven/0000-0002-8162-8910; Juni, Peter/0000-0002-5985-0670; R. da Costa, Bruno/0000-0002-1786-6332; Reichenbach, Stephan/0000-0001-8098-6567	Swiss National Science Foundation [405340-104762]; Arco Foundation, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Arco Foundation, Switzerland	Swiss National Science Foundation (grant number 405340-104762) and Arco Foundation, Switzerland.; This study was funded by the Swiss National Science Foundation (grant number 405340-104762) and by a grant from the Arco Foundation, Switzerland. We thank Kali Tal for proofreading the manuscript and Toshi Furukawa for support with the development of the search strategy.	Adebajo A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-23; Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Arboleya LR, 2003, CURR MED RES OPIN, V19, P278, DOI 10.1185/030079903125001712; Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bjordal JM, 2007, EUR J PAIN, V11, P125, DOI 10.1016/j.ejpain.2006.02.013; Cahir C, 2010, BRIT J CLIN PHARMACO, V69, P543, DOI 10.1111/j.1365-2125.2010.03628.x; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chen YF, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12110; Chou R, 2011, ANALGESICS OSTEOARTH; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; Cordero-Ampuero J, 2012, QUAL LIFE RES, V21, P1391, DOI 10.1007/s11136-011-0058-6; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; FDA, 1998, GUID IND PROV CLIN E; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Gore M, 2012, PAIN PRACT, V12, P550, DOI 10.1111/j.1533-2500.2012.00532.x; Gore M, 2011, CLIN THER, V33, P1914, DOI 10.1016/j.clinthera.2011.10.019; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; JOHNSON AF, 1985, J CHRON DIS, V38, P265, DOI 10.1016/0021-9681(85)90069-4; Juni P, 2006, BEST PRACT RES CL RH, V20, P721, DOI 10.1016/j.berh.2006.05.002; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Machado GC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1225; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Porcheret M, 2007, RHEUMATOLOGY, V46, P1694, DOI 10.1093/rheumatology/kem232; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Rosemann T, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-48; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Smith TC, 1995, STAT MED, V14, P2685, DOI 10.1002/sim.4780142408; Spiegelhalter DJ., 2004, BAYESIAN APPROACHES; Tacconelli S, 2004, CURR PHARM DESIGN, V10, P589, DOI 10.2174/1381612043453108; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; van Walsem A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0554-0; Wadman M, 2013, NATURE, V500, P14, DOI 10.1038/500014a; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675	38	60	61	5	79	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2093	2105		10.1016/S0140-6736(16)30002-2	http://dx.doi.org/10.1016/S0140-6736(16)30002-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	26997557	Bronze			2022-12-28	WOS:000376450800033
J	Hemenway, D				Hemenway, David			Firearm legislation and mortality in the USA	LANCET			English	Editorial Material							STATES; VIOLENCE; RISK; LAWS		[Hemenway, David] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hemenway, D (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	hemenway@hsph.harvard.edu						Anglemyer A, 2014, ANN INTERN MED, V160, P101, DOI 10.7326/M13-1301; Cheng C, 2013, J HUM RESOUR, V48, P821; Dickey J, 2012, WASHINGTON POST; Fleegler EW, 2013, JAMA INTERN MED, V173, DOI [10.1001/jamainternmed.2013.9957, 10.1001/jamainternmed.2013.1286]; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Hahn RA, 2005, AM J PREV MED, V28, P40, DOI 10.1016/j.amepre.2004.10.005; Hemenway D, 2006, PRIVATE GUNS PUBLIC; Kalesan B, 2016, LANCET; Lanza SP, 2014, APPL ECON LETT, V21, P902, DOI 10.1080/13504851.2014.896977; National Research Council, 2005, FIREARMS VIOLENCE CR; Safavi A, 2014, J TRAUMA ACUTE CARE, V76, P146, DOI 10.1097/TA.0b013e3182ab10fb; Stroebe W, 2013, AGGRESS VIOLENT BEH, V18, P709, DOI 10.1016/j.avb.2013.07.025; Webster DW, 2015, ANNU REV PUBL HEALTH, V36, P21, DOI 10.1146/annurev-publhealth-031914-122516	13	1	1	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1796	1797		10.1016/S0140-6736(16)00206-3	http://dx.doi.org/10.1016/S0140-6736(16)00206-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DK6SS	26972841				2022-12-28	WOS:000375056100008
J	Heymann, DL; Liu, J; Lillywhite, L				Heymann, David L.; Liu, Joanne; Lillywhite, Louis			Partnerships, Not Parachutists, for Zika Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Heymann, David L.; Lillywhite, Louis] Ctr Global Hlth Secur, Chatham House, England; [Heymann, David L.] London Sch Hyg & Trop Med, Publ Hlth England, London WC1, England; [Liu, Joanne] Med Sans Frontieres, Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; Doctors Without Borders	Heymann, DL (corresponding author), Ctr Global Hlth Secur, Chatham House, England.; Heymann, DL (corresponding author), London Sch Hyg & Trop Med, Publ Hlth England, London WC1, England.							Barchfield J, 2016, BRAZIL CONSIDERS REF; Steenhuysen J., 2014, REUTERS; WHO statement on the first meeting of the International Health Regulations, 2005, WHO STAT 1 M INT HLT; Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a	4	20	21	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16					1504	1505		10.1056/NEJMp1602278	http://dx.doi.org/10.1056/NEJMp1602278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ7IA	26958936	Bronze, Green Published			2022-12-28	WOS:000374383900002
J	van Vught, LA; Klouwenberg, PMCK; Spitoni, C; Scicluna, BP; Wiewel, MA; Horn, J; Schultz, MJ; Nurnberg, P; Bonten, MJM; Cremer, OL; van der Poll, T				van Vught, Lonneke A.; Klouwenberg, Peter M. C. Klein; Spitoni, Cristian; Scicluna, Brendon P.; Wiewel, Maryse A.; Horn, Janneke; Schultz, Marcus J.; Nurnberg, Peter; Bonten, Marc J. M.; Cremer, Olaf L.; van der Poll, Tom		MARS Consortium	Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NOSOCOMIAL INFECTIONS; IMMUNOSUPPRESSION; DEFINITIONS; DECONTAMINATION; INFLAMMATION; OROPHARYNX; PARADIGM; MODELS; TRACT	IMPORTANCE Sepsis is considered to induce immune suppression, leading to increased susceptibility to secondary infections with associated late mortality. OBJECTIVE To determine the clinical and host genomic characteristics, incidence, and attributable mortality of intensive care unit (ICU)-acquired infections in patients admitted to the ICU with or without sepsis. DESIGN, SETTING, AND PARTICIPANTS Prospective observational study comprising consecutive admissions of more than 48 hours in 2 ICUs in the Netherlands from January 2011 to July 2013 stratified according to admission diagnosis (sepsis or noninfectious). MAIN OUTCOMES AND MEASURES The primary outcome was ICU-acquired infection (onset >48 hours). Attributable mortality risk (fraction of mortality that can be prevented by elimination of the risk factor, acquired infection) was determined using time-to-event models accounting for competing risk. In a subset of sepsis admissions (n = 461), blood gene expression (whole-genome transcriptome in leukocytes) was analyzed at baseline and at onset of ICU-acquired infectious (n = 19) and noninfectious (n = 9) events. RESULTS The primary cohort included 1719 sepsis admissions (1504 patients; median age, 62 years; interquartile range [IQR], 51-71 years]; 924 men [61.4%]). A comparative cohort included 1921 admissions (1825 patients, median age, 62 years; IQR, 49-71 years; 1128 men [61.8%] in whom infection was not present in the first 48 hours. Intensive care unit-acquired infections occurred in 13.5% of sepsis ICU admissions (n = 232) and 15.1% of nonsepsis ICU admissions (n = 291). Patients with sepsis who developed an ICU-acquired infection had higher disease severity scores on admission than patients with sepsis who did not develop an ICU-acquired infection (Acute Physiology and Chronic Health Evaluation IV [APACHE IV] median score, 90 [ IQR, 72-107] vs 79 [ IQR, 62-98]; P < .001) and throughout their ICU stay but did not have differences in baseline gene expression. The population attributable mortality fraction of ICU-acquired infections in patients with sepsis was 10.9% (95% CI, 0.9%-20.6%) by day 60; the estimated difference between mortality in all patients with a sepsis admission diagnosis and mortality in those without ICU-acquired infection was 2.0% (95% CI, 0.2%-3.8%; P = .03) by day 60. Among nonsepsis ICU admissions, ICU-acquired infections had a population attributable mortality fraction of 21.1% (95% CI, 0.6%-41.7%) by day 60. Compared with baseline, blood gene expression at the onset of ICU-acquired infections showed reduced expression of genes involved in gluconeogenesis and glycolysis. CONCLUSIONS AND RELEVANCE Intensive care unit-acquired infections occurred more commonly in patients with sepsis with higher disease severity, but such infections contributed only modestly to overall mortality. The genomic response of patients with sepsis was consistent with immune suppression at the onset of secondary infection.	[van Vught, Lonneke A.; Scicluna, Brendon P.; Wiewel, Maryse A.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Klouwenberg, Peter M. C. Klein; Cremer, Olaf L.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Klouwenberg, Peter M. C. Klein; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Klouwenberg, Peter M. C. Klein; Bonten, Marc J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Spitoni, Cristian] Univ Utrecht, Dept Math, Utrecht, Netherlands; [Scicluna, Brendon P.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Horn, Janneke; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Nurnberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nurnberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; University of Amsterdam; University of Amsterdam; University of Cologne; University of Cologne	van Vught, LA (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9,G2-130, NL-1105 AZ Amsterdam, Netherlands.	La.vanvught@amc.uva.nl	Bos, Lieuwe/H-2578-2018; Horn, Janneke/ACB-3607-2022; Scicluna, Brendon/T-8112-2018; Schultz, Marcus/AAB-6379-2021; Cremer, Olaf/G-3855-2016	Bos, Lieuwe/0000-0003-2911-4549; Scicluna, Brendon/0000-0003-2826-0341; Schultz, Marcus/0000-0003-3969-7792; Cremer, Olaf/0000-0003-4264-1108	Center for Translational Molecular Medicine (CTMM) [04I-201]	Center for Translational Molecular Medicine (CTMM)	This work was supported by grant 04I-201 from the Center for Translational Molecular Medicine (CTMM) (http://www.ctmm.nl), project MARS.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coeurjolly JF, 2012, BIOMETRICAL J, V54, P600, DOI 10.1002/bimj.201100222; de Smet AMGA, 2009, NEW ENGL J MED, V360, P20, DOI 10.1056/NEJMoa0800394; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hutchins NIA, 2014, TRENDS MOL MED, V20, P224, DOI 10.1016/j.molmed.2014.01.002; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Klouwenberg PMCK, 2014, AM J RESP CRIT CARE, V189, P947, DOI 10.1164/rccm.201307-1376OC; Klouwenberg PMCK, 2013, CRIT CARE MED, V41, P2373, DOI 10.1097/CCM.0b013e3182923712; Leentjens J, 2013, AM J RESP CRIT CARE, V187, P1287, DOI 10.1164/rccm.201301-0036CP; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Oostdijk EAN, 2014, JAMA-J AM MED ASSOC, V312, P1429, DOI 10.1001/jama.2014.7247; Opal SM, 2014, CRIT CARE MED, V42, P1714, DOI 10.1097/CCM.0000000000000325; Palsson-McDermott EM, 2013, BIOESSAYS, V35, P965, DOI 10.1002/bies.201300084; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; R Development Core Team, 2009, R LANG ENV STAT COMP; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Schumacher M, 2007, METHOD INFORM MED, V46, P595; Scicluna BP, 2015, AM J RESP CRIT CARE, V192, P826, DOI 10.1164/rccm.201502-0355OC; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; van Lieshout MH, 2014, AM J RESP CELL MOL, V50, P699, DOI 10.1165/rcmb.2013-0015OC; Vanzant EL, 2014, J TRAUMA ACUTE CARE, V76, P21, DOI 10.1097/TA.0b013e3182ab1ab5; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Wolkewitz M, 2014, CRIT CARE, V18, DOI 10.1186/cc13821; Wong HR, 2012, CRIT CARE, V16, DOI [10.1186/cc10537, 10.1186/cc10811]; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	34	274	276	3	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2016	315	14					1469	1479		10.1001/jama.2016.2691	http://dx.doi.org/10.1001/jama.2016.2691			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ0EE	26975785	Bronze, Green Published			2022-12-28	WOS:000373873800013
J	Wells, MF; Wimmer, RD; Schmitt, LI; Feng, GP; Halassa, MM				Wells, Michael F.; Wimmer, Ralf D.; Schmitt, L. Ian; Feng, Guoping; Halassa, Michael M.			Thalamic reticular impairment underlies attention deficit in Ptchd1(Y/-) mice	NATURE			English	Article							INTELLECTUAL DISABILITY; GABAERGIC NEURONS; SLEEP SPINDLES; AUTISM; NUCLEUS; ARCHITECTURE; INHIBITION; DISORDERS; VARIANTS; CHANNELS	Developmental disabilities, including attention-deficit hyperactivity disorder (ADHD), intellectual disability (ID), and autism spectrum disorders (ASD), affect one in six children in the USA. Recently, gene mutations in patched domain containing 1 (PTCHD1) have been found in similar to 1% of patients with ID and ASD. Individuals with PTCHD1 deletion show symptoms of ADHD, sleep disruption, hypotonia, aggression, ASD, and ID. Although PTCHD1 is probably critical for normal development, the connection between its deletion and the ensuing behavioural defects is poorly understood. Here we report that during early post-natal development, mouse Ptchd1 is selectively expressed in the thalamic reticular nucleus (TRN), a group of GABAergic neurons that regulate thalamocortical transmission, sleep rhythms, and attention. Ptchd1 deletion attenuates TRN activity through mechanisms involving small conductance calcium-dependent potassium currents (SK). TRN-restricted deletion of Ptchd1 leads to attention deficits and hyperactivity, both of which are rescued by pharmacological augmentation of SK channel activity. Global Ptchd1 deletion recapitulates learning impairment, hyper-aggression, and motor defects, all of which are insensitive to SK pharmacological targeting and not found in the TRN-restricted deletion mouse. This study maps clinically relevant behavioural phenotypes onto TRN dysfunction in a human disease model, while also identifying molecular and circuit targets for intervention.	[Wells, Michael F.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Wells, Michael F.; Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA; [Wimmer, Ralf D.; Schmitt, L. Ian; Halassa, Michael M.] NYU, Med Ctr, Neurosci Inst, New York, NY 10016 USA; [Wimmer, Ralf D.; Schmitt, L. Ian; Halassa, Michael M.] NYU, Langone Med Ctr, Dept Neurosci & Physiol, 550 1St Ave, New York, NY 10016 USA; [Feng, Guoping] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Halassa, Michael M.] NYU, Dept Psychiat, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Halassa, Michael M.] NYU, Ctr Neural Sci, New York, NY USA	Duke University; Massachusetts Institute of Technology (MIT); New York University; New York University; NYU Langone Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; New York University; NYU Langone Medical Center; New York University	Feng, GP (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.; Feng, GP (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.	fengg@mit.edu	Feng, Guoping/Y-2827-2019	Schmitt, Luke/0000-0002-1104-2666; Wells, Michael/0000-0002-1367-2565	Simons Foundation Autism Research Initiative (SFARI) [ID: 307913]; NIH (NIH/NIMH) [R01MH097104]; NIH [R01MH107680]; Poitras Center for Affective Disorders Research; Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard; Brain and Behavior Foundation; Sloan Foundation; Klingenstein Foundation; Feldstein Foundation; NIH Ruth L. Kirschstein National Research Service Award [FMH098641A]; Swiss National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH098641, R01MH107680, R01MH097104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS078115] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative (SFARI); NIH (NIH/NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Poitras Center for Affective Disorders Research; Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard; Brain and Behavior Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Klingenstein Foundation(Klingenstein Philanthropies); Feldstein Foundation; NIH Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Tang for insightful discussion during the initiation of the project, H. Wang, T. Dalia, E. Kwan, H. Zaniewski for technical support, and J. Vincent for insightful discussion. We thank J. Petravicz and T. Emery from the Sur laboratory for assistance with Ca<SUP>2+</SUP> imaging and A. Heynen from the Bear laboratory for technical advice on the inhibitory avoidance task. We thank all members of the Feng laboratory for their help and support. We thank M. Ball and J. Ball for their insight and inspiration throughout this project. We also thank S.F. Lin and R. Buxton for their support of this research. This work was supported by a grant from Simons Foundation Autism Research Initiative (SFARI Award ID: 307913) to G.F. and M. M. H., NIH grants to G.F. (NIH/NIMH, R01MH097104) and M. M. H. (R01MH107680), and funds from the Poitras Center for Affective Disorders Research and the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard to G.F. M. M. H. is additionally supported by the Brain and Behavior, Sloan, Klingenstein and Feldstein Foundations. M.F.W. is supported by an NIH Ruth L. Kirschstein National Research Service Award (FMH098641A). R.D.W. is supported by the Swiss National Science Foundation.	Astori S, 2011, P NATL ACAD SCI USA, V108, P13823, DOI 10.1073/pnas.1105115108; Bartho P, 2014, NEURON, V82, P1367, DOI 10.1016/j.neuron.2014.04.046; Brunetti PM, 2014, JOVE-J VIS EXP, DOI 10.3791/51675; Chaudhry A, 2015, CLIN GENET, V88, P224, DOI 10.1111/cge.12482; Chen Z., 2015, FRONT NEURAL CIRCUIT; Coe BP, 2012, CURR OPIN NEUROBIOL, V22, P829, DOI 10.1016/j.conb.2012.04.007; Coe BP, 2012, AM J MED GENET C, V160C, P118, DOI 10.1002/ajmg.c.31327; Coulon P, 2009, CELL CALCIUM, V46, P333, DOI 10.1016/j.ceca.2009.09.005; Cristino AS, 2014, MOL PSYCHIATR, V19, P294, DOI 10.1038/mp.2013.16; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Curzon P., 2009, METHODS BEHAV ANAL N, DOI DOI 10.1201/NOE1420052343.CH2; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; Erlij D, 2012, NEUROPHARMACOLOGY, V62, P1111, DOI 10.1016/j.neuropharm.2011.11.001; Ferrarelli F, 2007, AM J PSYCHIAT, V164, P483, DOI 10.1176/appi.ajp.164.3.483; Filges I, 2011, CLIN GENET, V79, P79, DOI 10.1111/j.1399-0004.2010.01590.x; Fisher SP, 2012, J BIOL RHYTHM, V27, P48, DOI 10.1177/0748730411431550; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GRAYBIEL AM, 1983, J NEUROSCI, V3, P1308; Grimley JS, 2013, J NEUROSCI, V33, P16297, DOI 10.1523/JNEUROSCI.4616-11.2013; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Halassa MM, 2014, CELL, V158, P808, DOI 10.1016/j.cell.2014.06.025; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; JAHNSEN H, 1984, ARCH ITAL BIOL, V122, P73; JASPER H, 1949, ELECTROEN CLIN NEURO, V1, P405, DOI 10.1016/0013-4694(49)90213-8; Leyfer OT, 2006, J AUTISM DEV DISORD, V36, P849, DOI 10.1007/s10803-006-0123-0; Limoges E, 2005, BRAIN, V128, P1049, DOI 10.1093/brain/awh425; Marlinski V, 2012, J NEUROSCI, V32, P15823, DOI 10.1523/JNEUROSCI.0782-12.2012; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Meyer AH, 2002, J NEUROSCI, V22, P7055; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Remington A, 2009, PSYCHOL SCI, V20, P1388, DOI 10.1111/j.1467-9280.2009.02454.x; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sachs GS, 2000, AM J PSYCHIAT, V157, P466, DOI 10.1176/appi.ajp.157.3.466; Spencer T, 2001, ARCH GEN PSYCHIAT, V58, P775, DOI 10.1001/archpsyc.58.8.775; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Torrico B, 2015, EUR J HUM GENET, V23, P1694, DOI 10.1038/ejhg.2015.37; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Whibley AC, 2010, AM J HUM GENET, V87, P173, DOI 10.1016/j.ajhg.2010.06.017; Wimmer RD, 2015, NATURE, V526, P705, DOI 10.1038/nature15398; Wimmer RD, 2012, J NEUROSCI, V32, P13917, DOI 10.1523/JNEUROSCI.2313-12.2012; Won H, 2011, NAT MED, V17, P566, DOI 10.1038/nm.2330; Ying SW, 2005, J NEUROPHYSIOL, V93, P1935, DOI 10.1152/jn.01058.2004; Zhong Y, 2014, GENET MOL RES, V13, P7318, DOI 10.4238/2014.February.13.11; Zhou Y, 2016, NEURON, V89, P147, DOI 10.1016/j.neuron.2015.11.023; Zikopoulos B, 2012, J NEUROSCI, V32, P5338, DOI 10.1523/JNEUROSCI.4793-11.2012	50	91	96	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					58	+		10.1038/nature17427	http://dx.doi.org/10.1038/nature17427			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27007844	Green Accepted, Green Published			2022-12-28	WOS:000373555500032
J	Latimer, KW; Yates, JL; Meister, MLR; Huk, AC; Pillow, JW				Latimer, Kenneth W.; Yates, Jacob L.; Meister, Miriam L. R.; Huk, Alexander C.; Pillow, Jonathan W.			Response to Comment on "Single-trial spike trains in parietal cortex reveal discrete steps during decision-making"	SCIENCE			English	Editorial Material							LATERAL INTRAPARIETAL AREA; PERCEPTUAL DECISION; REPRESENTATION; INTEGRATION; NEURONS; MONKEY	Shadlen et al.'s Comment focuses on extrapolations of our results that were not implied or asserted in our Report. They discuss alternate analyses of average firing rates in other tasks, the relationship between neural activity and behavior, and possible extensions of the standard models we examined. Although interesting to contemplate, these points are not germane to the findings of our Report: that stepping dynamics provided a better statistical description of lateral intraparietal area spike trains than diffusion-to-bound dynamics for a majority of neurons.	[Latimer, Kenneth W.; Yates, Jacob L.; Huk, Alexander C.; Pillow, Jonathan W.] Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA; [Latimer, Kenneth W.; Yates, Jacob L.; Huk, Alexander C.; Pillow, Jonathan W.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Latimer, Kenneth W.; Meister, Miriam L. R.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Huk, Alexander C.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Huk, Alexander C.; Pillow, Jonathan W.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Pillow, Jonathan W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Pillow, Jonathan W.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Princeton University; Princeton University	Pillow, JW (corresponding author), Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA.; Pillow, JW (corresponding author), Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA.; Pillow, JW (corresponding author), Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA.; Pillow, JW (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.; Pillow, JW (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	pillow@princeton.edu		, Kenneth/0000-0002-9981-3903	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099611] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH099611] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; de Lafuente V, 2015, J NEUROSCI, V35, P4306, DOI 10.1523/JNEUROSCI.2451-14.2015; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kira S, 2015, NEURON, V85, P861, DOI 10.1016/j.neuron.2015.01.007; Latimer KW, 2015, SCIENCE, V349, P184, DOI 10.1126/science.aaa4056; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; Park IM, 2014, NAT NEUROSCI, V17, P1395, DOI 10.1038/nn.3800; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2016, SCIENCE, V351, DOI 10.1126/science.aad3242; Shadlen MN, 2013, NEURON, V80, P791, DOI 10.1016/j.neuron.2013.10.047; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916	15	4	4	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280								10.1126/science.aad3596	http://dx.doi.org/10.1126/science.aad3596			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013724	Green Accepted			2022-12-28	WOS:000372756200033
J	Pazos-Outon, LM; Szumilo, M; Lamboll, R; Richter, JM; Crespo-Quesada, M; Abdi-Jalebi, M; Beeson, HJ; Vrucinic, M; Alsari, M; Snaith, HJ; Ehrler, B; Friend, RH; Deschler, F				Pazos-Outon, Luis M.; Szumilo, Monika; Lamboll, Robin; Richter, Johannes M.; Crespo-Quesada, Micaela; Abdi-Jalebi, Mojtaba; Beeson, Harry J.; Vrucinic, Milan; Alsari, Mejd; Snaith, Henry J.; Ehrler, Bruno; Friend, Richard H.; Deschler, Felix			Photon recycling in lead iodide perovskite solar cells	SCIENCE			English	Article							DIFFUSION-COEFFICIENT; HALIDE PEROVSKITES; LENGTHS; GAAS; RECOMBINATION; CH3NH3PBI3; EFFICIENCY; LIFETIME	Lead-halide perovskites have emerged as high-performance photovoltaic materials. We mapped the propagation of photogenerated luminescence and charges from a local photoexcitation spot in thin films of lead tri-iodide perovskites. We observed light emission at distances of >= 50 micrometers and found that the peak of the internal photon spectrum red-shifts from 765 to >= 800 nanometers. We used a lateral-contact solar cell with selective electron-and hole-collecting contacts and observed that charge extraction for photoexcitation >50 micrometers away from the contacts arose from repeated recycling between photons and electron-hole pairs. Thus, energy transport is not limited by diffusive charge transport but can occur over long distances through multiple absorption-diffusionemission events. This process creates high excitation densities within the perovskite layer and allows high open-circuit voltages.	[Pazos-Outon, Luis M.; Szumilo, Monika; Lamboll, Robin; Richter, Johannes M.; Abdi-Jalebi, Mojtaba; Beeson, Harry J.; Vrucinic, Milan; Alsari, Mejd; Friend, Richard H.; Deschler, Felix] Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England; [Crespo-Quesada, Micaela] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Snaith, Henry J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Ehrler, Bruno] FOM Inst AMOLF, Ctr Nanophoton, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands	University of Cambridge; University of Cambridge; University of Oxford; AMOLF	Friend, RH; Deschler, F (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	rhf10@cam.ac.uk; fd297@cam.ac.uk	Crespo Quesada, Rocio Micaela/N-5901-2014; Snaith, Henry J/A-7367-2016; Deschler, Felix/AAB-2192-2022; Ehrler, Bruno/L-5700-2016; Pazos Outón, Luis/P-5223-2016; Alsari, Mejd/X-6865-2019; Jalebi, Mojtaba Abdi/V-1405-2017	Crespo Quesada, Rocio Micaela/0000-0003-4129-1601; Snaith, Henry J/0000-0001-8511-790X; Deschler, Felix/0000-0002-0771-3324; Ehrler, Bruno/0000-0002-5307-3241; Pazos Outón, Luis/0000-0002-3157-5208; Alsari, Mejd/0000-0001-6005-4906; Jalebi, Mojtaba Abdi/0000-0002-9430-6371; Friend, Richard Henry/0000-0001-6565-6308; Lamboll, Robin/0000-0002-8410-037X; Beeson, Harry/0000-0002-3901-3920	Engineering and Physical Sciences Research Council of the UK (EPSRC); King Abdulaziz City for Science and Technology; Cambridge Home European Scheme; Nano Doctoral Training Center (NanoDTC) of the EPSRC; Marie Curie Actions (FP7-PEOPLE-IEF); UAE's Distinguished Student Scholarship Program (DSS) by the UAE's Ministry of Presidential Affairs; Nyak Technology Limited; Herchel Smith Research Fellowship; Engineering and Physical Sciences Research Council [EP/M005143/1, EP/G049653/1, 1353070, 1209452] Funding Source: researchfish; EPSRC [EP/G049653/1, EP/M005143/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council of the UK (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); King Abdulaziz City for Science and Technology; Cambridge Home European Scheme; Nano Doctoral Training Center (NanoDTC) of the EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Marie Curie Actions (FP7-PEOPLE-IEF); UAE's Distinguished Student Scholarship Program (DSS) by the UAE's Ministry of Presidential Affairs; Nyak Technology Limited; Herchel Smith Research Fellowship; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge financial support from the Engineering and Physical Sciences Research Council of the UK (EPSRC) and King Abdulaziz City for Science and Technology. L.M.P.-O. thanks the Cambridge Home European Scheme for financial support. L.M.P.-O. and H.J.B. also thank the Nano Doctoral Training Center (NanoDTC) of the EPSRC for financial support. M.S., M.V., and J.M.R. thank the Winton Programme for the Physics of Sustainability (University of Cambridge). M.C.-Q. would like to thank the Marie Curie Actions (FP7-PEOPLE-IEF2013) for funding. M.A. acknowledges financial support from the President of the UAE's Distinguished Student Scholarship Program (DSS), granted by the UAE's Ministry of Presidential Affairs. M.A.-J. thanks Nyak Technology Limited for a Ph.D. scholarship. B.E. acknowledges the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organisation for Scientific Research (NWO). F.D. acknowledges funding from a Herchel Smith Research Fellowship. We thank H. Sirringhaus, N. Greenham, U. Steiner, E. Reisner, and R. Phillips for providing support and access to their facilities. Experimental data are available at www.repository.cam.ac.uk/handle/1810/253689.	AHRENKIEL RK, 1989, APPL PHYS LETT, V55, P1088, DOI 10.1063/1.101713; Balenzategui JL, 2006, SOL ENERG MAT SOL C, V90, P1068, DOI 10.1016/j.solmat.2005.06.004; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; De Wolf S, 2014, J PHYS CHEM LETT, V5, P1035, DOI 10.1021/jz500279b; Deschler F, 2014, J PHYS CHEM LETT, V5, P1421, DOI 10.1021/jz5005285; Dong QF, 2015, SCIENCE, V347, P967, DOI 10.1126/science.aaa5760; Dupont E, 2000, APPL PHYS LETT, V76, P4, DOI 10.1063/1.125718; DURBIN SM, 1994, IEEE T ELECTRON DEV, V41, P239, DOI 10.1109/16.277372; Graaff R, 2000, OPT LETT, V25, P43, DOI 10.1364/OL.25.000043; Im JH, 2011, NANOSCALE, V3, P4088, DOI 10.1039/c1nr10867k; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Johnston MB, 2016, ACCOUNTS CHEM RES, V49, P146, DOI 10.1021/acs.accounts.5b00411; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Lin QQ, 2015, NAT PHOTONICS, V9, P106, DOI [10.1038/NPHOTON.2014.284, 10.1038/nphoton.2014.284]; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Mattos L. S., 2012, 38 IEEE PHOT SPEC C, P3187; Miller OD, 2012, IEEE J PHOTOVOLT, V2, P303, DOI 10.1109/JPHOTOV.2012.2198434; RENAUD P, 1992, J APPL PHYS, V71, P1907, DOI 10.1063/1.351179; Sadhanala A, 2014, J PHYS CHEM LETT, V5, P2501, DOI 10.1021/jz501332v; Shi D, 2015, SCIENCE, V347, P519, DOI 10.1126/science.aaa2725; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Suarez I, 2015, ADV MATER, V27, P6157, DOI 10.1002/adma.201503245; Wehrenfennig C, 2014, J PHYS CHEM LETT, V5, P1300, DOI 10.1021/jz500434p; Wehrenfennig C, 2014, ADV MATER, V26, P1584, DOI 10.1002/adma.201305172; Xing GC, 2013, SCIENCE, V342, P344, DOI 10.1126/science.1243167; Yablonovitch E., 2012, 38 IEEE PHOT SPEC C, P1556; Yamada Y, 2014, J AM CHEM SOC, V136, P11610, DOI 10.1021/ja506624n; Zhang W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7142	30	502	508	24	725	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1430	1433		10.1126/science.aaf1168	http://dx.doi.org/10.1126/science.aaf1168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013728				2022-12-28	WOS:000372756200043
J	Perez, TM; Stroud, JT; Feeley, KJ				Perez, Timothy M.; Stroud, James T.; Feeley, Kenneth J.			ECOLOGY Thermal trouble in the tropics	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; IMPACTS		[Perez, Timothy M.; Stroud, James T.; Feeley, Kenneth J.] Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA; [Perez, Timothy M.; Stroud, James T.; Feeley, Kenneth J.] Fairchild Trop Bot Garden, Coral Gables, FL 33156 USA	State University System of Florida; Florida International University	Feeley, KJ (corresponding author), Florida Int Univ, Dept Biol Sci, Int Ctr Trop Bot, Miami, FL 33199 USA.; Feeley, KJ (corresponding author), Fairchild Trop Bot Garden, Coral Gables, FL 33156 USA.	kjfeeley@gmail.com		Stroud, James/0000-0003-0734-6795; Feeley, Kenneth/0000-0002-3618-1144	Direct For Biological Sciences [1350125] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Chan WP, 2016, SCIENCE, V351, P1437, DOI 10.1126/science.aab4119; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Feeley K.J., 2012, FRONTIERS BIOGEOGRAP, V4, P69, DOI [10.21425/F5FBG12621, DOI 10.21425/F5FBG12621, 10.21425/f5fbg12621., DOI 10.21425/F54212621]; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Myhre G., 2013, CONTRIBUTION WORKING; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Schimel D, 2015, GLOBAL CHANGE BIOL, V21, P1762, DOI 10.1111/gcb.12822; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Vasseur DA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2612; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	12	59	60	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1392	1393		10.1126/science.aaf3343	http://dx.doi.org/10.1126/science.aaf3343			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013713				2022-12-28	WOS:000372756200019
J	Smith, KT; Berritt, S; Gonzalez-Moreiras, M; Ahn, S; Smith, MR; Baik, MH; Mindiola, DJ				Smith, Kyle T.; Berritt, Simon; Gonzalez-Moreiras, Mariano; Ahn, Seihwan; Smith, Milton R., III; Baik, Mu-Hyun; Mindiola, Daniel J.			Catalytic borylation of methane	SCIENCE			English	Article							C-H BONDS; ORGANOMETALLIC CHEMISTRY; ACETIC-ACID; ACTIVATION; COMPLEXES; FUNCTIONALIZATION; CONVERSION; CH4; HYDROCARBONS; FRONTIER	Despite steady progress in catalytic methods for the borylation of hydrocarbons, methane has not yet been subject to this transformation. Here we report the iridium-catalyzed borylation of methane using bis(pinacolborane) in cyclohexane solvent. Initially, trace amounts of borylated products were detected with phenanthroline-coordinated Ir complexes. A combination of experimental high-pressure and high-throughput screening, and computational mechanism discovery techniques helped to rationalize the foundation of the catalysis and identify improved phosphine-coordinated catalytic complexes. Optimized conditions of 150 degrees C and 3500-kilopascal pressure led to yields as high as similar to 52%, turnover numbers of 100, and improved chemoselectivity for monoborylated versus diborylated methane.	[Smith, Kyle T.; Berritt, Simon; Gonzalez-Moreiras, Mariano; Mindiola, Daniel J.] Univ Penn, Dept Chem, 231 South 34th St, Philadelphia, PA 19104 USA; [Ahn, Seihwan; Baik, Mu-Hyun] Inst Basic Sci Ctr Catalyt Hydrocarbon Functional, Daejeon, South Korea; [Ahn, Seihwan; Baik, Mu-Hyun] Korea Adv Inst Sci & Technol, Dept Chem, Daejeon, South Korea; [Smith, Milton R., III] Michigan State Univ, Dept Chem, 578 South Shaw Lane, E Lansing, MI 48824 USA	University of Pennsylvania; Institute for Basic Science - Korea (IBS); Korea Advanced Institute of Science & Technology (KAIST); Michigan State University	Mindiola, DJ (corresponding author), Univ Penn, Dept Chem, 231 South 34th St, Philadelphia, PA 19104 USA.; Baik, MH (corresponding author), Inst Basic Sci Ctr Catalyt Hydrocarbon Functional, Daejeon, South Korea.; Baik, MH (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Daejeon, South Korea.; Smith, MR (corresponding author), Michigan State Univ, Dept Chem, 578 South Shaw Lane, E Lansing, MI 48824 USA.	smithmil@msu.edu; mbaik2805@kaist.ac.kr; mindiola@sas.upenn.edu	Ahn, Seihwan/CAG-5406-2022; Smith, Milton/M-3511-2016; Baik, Mu-Hyun/K-7333-2015	Smith, Milton/0000-0002-8036-4503; Baik, Mu-Hyun/0000-0002-8832-8187; Berritt, Simon/0000-0001-5572-6771	University of Pennsylvania; Ministry of Education of Spain; Institute for Basic Science in Korea [IBS-R10-D1]; NIH [GM63188]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM063188, R01GM063188] Funding Source: NIH RePORTER	University of Pennsylvania; Ministry of Education of Spain(Spanish Government); Institute for Basic Science in Korea; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A U.S. provisional patent has been filed for this work. Financial support of this research was provided to D.J.M. by the University of Pennsylvania. M.G.-M. thanks the Ministry of Education of Spain for sponsoring his work in the United States. M.-H.B. thanks the Institute for Basic Science (IBS-R10-D1) in Korea for support. M.R.S. thanks the NIH (GM63188) for support. We thank B. Ghaffari and K. Gore for providing some catalysts and ligands and B.-C. Lee for help in some catalytic reactions. Experimental procedures, spectroscopic measurements, and theoretical calculations are provided in the supplementary materials.	Arakawa H, 2001, CHEM REV, V101, P953, DOI 10.1021/cr000018s; BERKOWITZ J, 1987, J CHEM PHYS, V86, P674, DOI 10.1063/1.452268; Blanksby SJ, 2003, ACCOUNTS CHEM RES, V36, P255, DOI 10.1021/ar020230d; Caballero A, 2013, CHEM SOC REV, V42, P8809, DOI 10.1039/c3cs60120j; Caballero A, 2011, SCIENCE, V332, P835, DOI 10.1126/science.1204131; Cavaliere VN, 2012, ADV ORGANOMET CHEM, V60, P1, DOI 10.1016/B978-0-12-396970-5.00001-3; Cavaliere VN, 2012, CHEM SCI, V3, P3356, DOI 10.1039/c2sc20530k; Chotana GA, 2009, CHEM COMMUN, P5731, DOI 10.1039/b914736e; CHUPKA WA, 1971, J CHEM PHYS, V54, P4256, DOI 10.1063/1.1674669; CRABTREE RH, 1985, CHEM REV, V85, P245, DOI 10.1021/cr00068a002; Crooks AB, 2015, ACS CATAL, V5, P3342, DOI 10.1021/acscatal.5b00347; Ghaffari B, 2015, ORGANOMETALLICS, V34, P4732, DOI 10.1021/acs.organomet.5b00525; Kirillova MV, 2007, J AM CHEM SOC, V129, P10531, DOI 10.1021/ja072531u; Li Q, 2014, J AM CHEM SOC, V136, P8755, DOI 10.1021/ja503676d; LIN M, 1994, NATURE, V368, P613, DOI 10.1038/368613a0; Liskey CW, 2009, CHEM COMMUN, P5603, DOI 10.1039/b913949d; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; NGUYEN P, 1993, J AM CHEM SOC, V115, P9329, DOI 10.1021/ja00073a075; Palmer WN, 2016, J AM CHEM SOC, V138, P766, DOI 10.1021/jacs.5b12249; Parshall G., 1982, HOMOGENEOUS CATALYSI; Periana RA, 2003, SCIENCE, V301, P814, DOI 10.1126/science.1086466; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560; Sadow AD, 2005, J AM CHEM SOC, V127, P643, DOI 10.1021/ja040141r; Sadow AD, 2003, ANGEW CHEM INT EDIT, V42, P803, DOI 10.1002/anie.200390213; Shilov AE, 1997, CHEM REV, V97, P2879, DOI 10.1021/cr9411886; Shimada S, 2001, ANGEW CHEM INT EDIT, V40, P2168, DOI 10.1002/1521-3773(20010601)40:11<2168::AID-ANIE2168>3.0.CO;2-0; Tagata T, 2004, ADV SYNTH CATAL, V346, P1655, DOI 10.1002/adsc.200404179; Tamura H, 2003, J AM CHEM SOC, V125, P16114, DOI 10.1021/ja0302937; Vanchura BA, 2010, CHEM COMMUN, V46, P7724, DOI 10.1039/c0cc02041a; Wei JM, 2004, ANGEW CHEM INT EDIT, V43, P3685, DOI 10.1002/anie.200352703; Zhu YH, 2008, INORG CHEM, V47, P5756, DOI 10.1021/ic8000152	31	105	107	3	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1424	1427		10.1126/science.aad9730	http://dx.doi.org/10.1126/science.aad9730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013726	Green Accepted			2022-12-28	WOS:000372756200041
J	Shrestha, P; Klann, E				Shrestha, Prerana; Klann, Eric			ALZHEIMER'S DISEASE Lost memories found	NATURE			English	Editorial Material							CORRELATE	Enhancing synaptic connections between neurons in the brain's hippocampus that are normally activated during memory formation rescues memory deficits in a mouse model of early Alzheimer's disease. See Letter p.508	[Shrestha, Prerana; Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Shrestha, P; Klann, E (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	ps755@nyu.edu; ek65@nyu.edu						Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Cazzulino A. S., 2015, HIPPOCAMPUS; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Joo JY, 2016, NAT NEUROSCI, V19, P75, DOI 10.1038/nn.4170; Leinenga G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2512; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Roy DS, 2016, NATURE, V531, P508, DOI 10.1038/nature17172; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; Van Cauwenberghe C, 2015, GENET MED	12	11	12	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					450	451		10.1038/nature17312	http://dx.doi.org/10.1038/nature17312			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26982731				2022-12-28	WOS:000372701300025
J	Steculorum, SM; Ruud, J; Karakasilioti, I; Backes, H; Ruud, LE; Timper, K; Hess, ME; Tsaousidou, E; Mauer, J; Vogt, MC; Paeger, L; Bremser, S; Klein, AC; Morgan, DA; Frommolt, P; Brinkkotter, PT; Hammerschmidt, P; Benzing, T; Rahmouni, K; Wunderlich, FT; Kloppenburg, P; Bruning, JC				Steculorum, Sophie M.; Ruud, Johan; Karakasilioti, Ismene; Backes, Heiko; Ruud, Linda Engstroem; Timper, Katharina; Hess, Martin E.; Tsaousidou, Eva; Mauer, Jan; Vogt, Merly C.; Paeger, Lars; Bremser, Stephan; Klein, Andreas C.; Morgan, Donald A.; Frommolt, Peter; Brinkkoetter, Paul T.; Hammerschmidt, Philipp; Benzing, Thomas; Rahmouni, Kamal; Wunderlich, F. Thomas; Kloppenburg, Peter; Bruening, Jens C.			AgRP Neurons Control Systemic Insulin Sensitivity via Myostatin Expression in Brown Adipose Tissue	CELL			English	Article							POMC NEURONS; GLUCOSE-HOMEOSTASIS; NPY/AGRP NEURONS; TRANSGENIC MICE; NEURAL CIRCUIT; ACTIVATION; LEPTIN; SUPPRESSION; OBESITY; CNS	Activation of Agouti-related peptide (AgRP) neurons potently promotes feeding, and chronically altering their activity also affects peripheral glucose homeostasis. We demonstrate that acute activation of AgRP neurons causes insulin resistance through impairment of insulin-stimulated glucose uptake into brown adipose tissue (BAT). AgRP neuron activation acutely reprograms gene expression in BAT toward a myogenic signature, including increased expression of myostatin. Interference with myostatin activity improves insulin sensitivity that was impaired by AgRP neurons activation. Optogenetic circuitry mapping reveals that feeding and insulin sensitivity are controlled by both distinct and overlapping projections. Stimulation of AgRP -> LHA projections impairs insulin sensitivity and promotes feeding while activation of AgRP -> anterior bed nucleus of the stria terminalis (aBNST)(vl) projections, distinct from AgRP -> aBNST(dm) projections controlling feeding, mediate the effect of AgRP neuron activation on BAT-myostatin expression and insulin sensitivity. Collectively, our results suggest that AgRP neurons in mice induce not only eating, but also insulin resistance by stimulating expression of muscle-related genes in BAT, revealing a mechanism by which these neurons rapidly coordinate hunger states with glucose homeostasis.	[Steculorum, Sophie M.; Ruud, Johan; Karakasilioti, Ismene; Backes, Heiko; Ruud, Linda Engstroem; Timper, Katharina; Hess, Martin E.; Tsaousidou, Eva; Mauer, Jan; Vogt, Merly C.; Hammerschmidt, Philipp; Wunderlich, F. Thomas; Bruening, Jens C.] Max Planck Inst Metab Res, Dept Neuronal Control Metab, Gleueler Str 50, D-50931 Cologne, Germany; [Steculorum, Sophie M.; Ruud, Johan; Karakasilioti, Ismene; Backes, Heiko; Ruud, Linda Engstroem; Timper, Katharina; Hess, Martin E.; Tsaousidou, Eva; Mauer, Jan; Vogt, Merly C.; Wunderlich, F. Thomas; Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Kerpener Str 26, D-50924 Cologne, Germany; [Steculorum, Sophie M.; Ruud, Johan; Karakasilioti, Ismene; Backes, Heiko; Ruud, Linda Engstroem; Timper, Katharina; Hess, Martin E.; Tsaousidou, Eva; Mauer, Jan; Vogt, Merly C.; Paeger, Lars; Bremser, Stephan; Klein, Andreas C.; Frommolt, Peter; Brinkkoetter, Paul T.; Benzing, Thomas; Wunderlich, F. Thomas; Kloppenburg, Peter; Bruening, Jens C.] Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Steculorum, Sophie M.; Ruud, Johan; Karakasilioti, Ismene; Backes, Heiko; Ruud, Linda Engstroem; Timper, Katharina; Hess, Martin E.; Tsaousidou, Eva; Mauer, Jan; Vogt, Merly C.; Paeger, Lars; Bremser, Stephan; Klein, Andreas C.; Frommolt, Peter; Brinkkoetter, Paul T.; Benzing, Thomas; Wunderlich, F. Thomas; Kloppenburg, Peter; Bruening, Jens C.] Univ Cologne, CMMC, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Paeger, Lars; Bremser, Stephan; Klein, Andreas C.; Kloppenburg, Peter] Univ Cologne, Inst Zool, Bioctr, Zulpicher Str 47b, D-50674 Cologne, Germany; [Morgan, Donald A.; Rahmouni, Kamal] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA; [Brinkkoetter, Paul T.; Benzing, Thomas] Univ Hosp Cologne, Dept Internal Med 2, Kerpener Str 62, D-50937 Cologne, Germany; [Rahmouni, Kamal] Univ Iowa, Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 55242 USA; [Bruening, Jens C.] Natl Ctr Diabet Res DZD, Ingolstadter Land Str 1, D-85764 Neuherberg, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Iowa; University of Cologne; University of Iowa	Bruning, JC (corresponding author), Max Planck Inst Metab Res, Dept Neuronal Control Metab, Gleueler Str 50, D-50931 Cologne, Germany.; Bruning, JC (corresponding author), Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, Kerpener Str 26, D-50924 Cologne, Germany.; Bruning, JC (corresponding author), Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.; Bruning, JC (corresponding author), Univ Cologne, CMMC, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.; Bruning, JC (corresponding author), Natl Ctr Diabet Res DZD, Ingolstadter Land Str 1, D-85764 Neuherberg, Germany.	bruening@sf.mpg.de	Tsaousidou, Eva/L-7602-2017; Morgan, Donald A/L-6907-2013; Ruud, Johan/W-7407-2019; Rahmouni, Kamal/Y-1788-2019; Vogt, Merly/AAF-3789-2021; Benzing, Thomas/X-5476-2019; Frommolt, Peter/L-9656-2016; Steculorum, Sophie/R-2704-2017	Tsaousidou, Eva/0000-0003-2751-1911; Morgan, Donald A/0000-0003-3167-1643; Frommolt, Peter/0000-0002-1966-8014; Paeger, Lars/0000-0001-8716-3483; Mauer, Jan/0000-0002-0189-5876; Steculorum, Sophie/0000-0002-5665-2732; Rahmouni, Kamal/0000-0001-5136-6748; Engstrom Ruud, Linda/0000-0002-3924-5844	DFG [BR 1492/7-1, BE2212, SFB635]; DFG within the framework of the TRR134; DFG within Excellence Initiative by German Federal Government (CECAD); DFG within Excellence Initiative by German State Government (CECAD); Helmholtz Alliance (Imaging and Curing Environmental Metabolic Diseases [ICEMED]); Helmholtz Association; European Union [266408]; US NIH [HL084207]; American Heart Association [14EIA18860041]; University of Iowa Fraternal Order of Eagles Diabetes Research Center; University of Iowa Center for Hypertension Research; Humboldt-Bayer program of the Alexander Von Humboldt foundation; CECAD; Swedish Research Council [2013-530]; EMBO fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); DFG within the framework of the TRR134(German Research Foundation (DFG)); DFG within Excellence Initiative by German Federal Government (CECAD); DFG within Excellence Initiative by German State Government (CECAD); Helmholtz Alliance (Imaging and Curing Environmental Metabolic Diseases [ICEMED]); Helmholtz Association(Helmholtz Association); European Union(European Commission); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Iowa Fraternal Order of Eagles Diabetes Research Center; University of Iowa Center for Hypertension Research; Humboldt-Bayer program of the Alexander Von Humboldt foundation(Alexander von Humboldt Foundation); CECAD; Swedish Research Council(Swedish Research CouncilEuropean Commission); EMBO fellowship(European Molecular Biology Organization (EMBO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to Eli Lilly and company for providing control- and anti-myostatin antibodies. We acknowledge Nadine Evers, Anne Lautenschlager, and Nadine Spenrath for outstanding technical assistance. We thank Michael Dubbert and Jan Sydow (Electronics Lab, Institute for Zoology, University of Cologne) for providing us with the laser sources used for optogenetic and Ca<SUP>2+</SUP>-imaging experiments. This work was supported by a grant from the DFG (BR 1492/7-1) to J.C.B. and to T.B. (BE2212 and SFB635), and we received funding by the DFG within the framework of the TRR134 and within the Excellence Initiative by German Federal and State Governments (CECAD). This work was funded (in part) by the Helmholtz Alliance (Imaging and Curing Environmental Metabolic Diseases [ICEMED]) through the Initiative and Networking Fund of the Helmholtz Association. Moreover, the research leading to these results has received funding from the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement 266408. K.R. is supported by the US NIH (HL084207), the American Heart Association (14EIA18860041), the University of Iowa Fraternal Order of Eagles Diabetes Research Center, and the University of Iowa Center for Hypertension Research. S.M.S. was funded by the Humboldt-Bayer program of the Alexander Von Humboldt foundation and received a grant from CECAD. J.R. was supported by a postdoctoral fellowship from the Swedish Research Council (2013-530). I.K. was supported by a long-term EMBO fellowship.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Atasoy D, 2014, NAT NEUROSCI, V17, P1830, DOI 10.1038/nn.3854; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Belgardt BF, 2010, ANN NY ACAD SCI, V1212, P97, DOI 10.1111/j.1749-6632.2010.05799.x; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Berglund ED, 2014, NAT NEUROSCI, V17, P911, DOI 10.1038/nn.3737; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Bonala S, 2014, J BIOL CHEM, V289, P7654, DOI 10.1074/jbc.M113.529925; Braga M, 2013, OBESITY, V21, P1180, DOI 10.1002/oby.20117; Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596; Dietrich MO, 2015, CELL, V160, P1222, DOI 10.1016/j.cell.2015.02.024; Dong HW, 2006, J COMP NEUROL, V494, P142, DOI 10.1002/cne.20788; Fournier B, 2012, MOL CELL BIOL, V32, P2871, DOI 10.1128/MCB.06575-11; Gautron L, 2015, CELL, V161, P133, DOI 10.1016/j.cell.2015.02.023; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Joly-Amado A, 2012, EMBO J, V31, P4276, DOI 10.1038/emboj.2012.250; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kim WK, 2012, INT J BIOCHEM CELL B, V44, P327, DOI 10.1016/j.biocel.2011.11.004; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Morgan DA, 2015, DIABETES, V64, P1976, DOI 10.2337/db14-1257; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Smith RC, 2015, MOL CANCER THER, V14, P1661, DOI 10.1158/1535-7163.MCT-14-0681; Steculorum SM, 2015, CELL, V162, P1404, DOI 10.1016/j.cell.2015.08.032; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tovar S, 2013, CELL METAB, V18, P445, DOI 10.1016/j.cmet.2013.08.006; Tsaousidou E, 2014, CELL REP, V9, P1495, DOI 10.1016/j.celrep.2014.10.045; Vogt MC, 2013, TRENDS ENDOCRIN MET, V24, P76, DOI 10.1016/j.tem.2012.11.004; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013; Zhang C, 2011, DIABETOLOGIA, V54, P1491, DOI 10.1007/s00125-011-2079-7	47	162	163	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					125	138		10.1016/j.cell.2016.02.044	http://dx.doi.org/10.1016/j.cell.2016.02.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015310	Bronze, Green Accepted			2022-12-28	WOS:000372785600015
J	Duffin, R; O'Connor, RA; Crittenden, S; Forster, T; Yu, CJ; Zheng, XZ; Smyth, D; Robb, CT; Rossi, F; Skouras, C; Tang, SH; Richards, J; Pellicoro, A; Weller, RB; Breyer, RM; Mole, DJ; Iredale, JP; Anderton, SM; Narumiya, S; Maizels, RM; Ghazal, P; Howie, SE; Rossi, AG; Yao, CC				Duffin, Rodger; O'Connor, Richard A.; Crittenden, Siobhan; Forster, Thorsten; Yu, Cunjing; Zheng, Xiaozhong; Smyth, Danielle; Robb, Calum T.; Rossi, Fiona; Skouras, Christos; Tang, Shaohui; Richards, James; Pellicoro, Antonella; Weller, Richard B.; Breyer, Richard M.; Mole, Damian J.; Iredale, John P.; Anderton, Stephen M.; Narumiya, Shuh; Maizels, Rick M.; Ghazal, Peter; Howie, Sarah E.; Rossi, Adriano G.; Yao, Chengcan			Prostaglandin E2 constrains systemic inflammation through an innate lymphoid cell-IL-22 axis	SCIENCE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SEPSIS; BARRIER; CELLS; MORTALITY; SHOCK; ACID	Systemic inflammation, which results from the massive release of proinflammatory molecules into the circulatory system, is a major risk factor for severe illness, but the precise mechanisms underlying its control are not fully understood. We observed that prostaglandin E-2 (PGE(2)), through its receptor EP4, is down -regulated in human systemic inflammatory disease. Mice with reduced PGE(2) synthesis develop systemic inflammation, associated with translocation of gut bacteria, which can be prevented by treatment with EP4 agonists. Mechanistically, we demonstrate that PGE(2)-EP4 signaling acts directly on type 3 innate lymphoid cells (ILCs), promoting their homeostasis and driving them to produce interleukin-22 (IL -22). Disruption of the ILC IL-22 axis impairs PGE(2)-mediated inhibition of systemic inflammation. Hence, the ILC IL-22 axis is essential in protecting against gut barrier dysfunction, enabling PGE(2)-EP4 signaling to impede systemic inflammation.	[Duffin, Rodger; O'Connor, Richard A.; Crittenden, Siobhan; Yu, Cunjing; Zheng, Xiaozhong; Robb, Calum T.; Skouras, Christos; Richards, James; Pellicoro, Antonella; Weller, Richard B.; Mole, Damian J.; Iredale, John P.; Anderton, Stephen M.; Howie, Sarah E.; Rossi, Adriano G.; Yao, Chengcan] Univ Edinburgh, MRC, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland; [Forster, Thorsten; Ghazal, Peter] Univ Edinburgh, Div Pathway Med, Edinburgh Infect Dis, Edinburgh EH16 4SB, Midlothian, Scotland; [Smyth, Danielle; Maizels, Rick M.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Rossi, Fiona] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Tang, Shaohui] Jinan Univ, Dept Gastroenterol, Affiliated Hosp 1, Guangzhou 510630, Guangdong, Peoples R China; [Breyer, Richard M.] Tennessee Valley Hlth Author, Dept Vet Affairs, Nashville, TN 37212 USA; [Breyer, Richard M.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut AK, Kyoto 6068501, Japan; [Narumiya, Shuh] Japan Sci & Technol Agcy JST, CREST, Tokyo 1020075, Japan; [Ghazal, Peter] Univ Edinburgh, Ctr Synthet & Syst Biol SynthSys, Edinburgh EH9 3JD, Midlothian, Scotland; [Smyth, Danielle; Maizels, Rick M.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; Jinan University; Vanderbilt University; Kyoto University; Japan Science & Technology Agency (JST); University of Edinburgh; University of Glasgow	Yao, CC (corresponding author), Univ Edinburgh, MRC, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland.	chengcan.yao@ed.ac.uk	Forster, Thorsten/F-4483-2017; Weller, Richard/B-4954-2010	Forster, Thorsten/0000-0002-4483-3069; Weller, Richard/0000-0003-2550-9586; O'Connor, Richard/0000-0001-7100-0233; Richards, James/0000-0001-9049-5745; Yao, Chengcan/0000-0003-3754-2842; Howie, Sarah/0000-0001-7291-3499; Iredale, John/0000-0003-2174-5127; Ghazal, Peter/0000-0003-0035-2228; Duffin, Rodger/0000-0002-3425-9745; Mole, Damian/0000-0001-6884-7302; Smyth, Danielle/0000-0001-6080-2679	University of Edinburgh; Wellcome Trust Institutional Strategic Support Kind; MRC UK; NIH [DK37097]; VA Merit Award [1BX000616]; Health Foundation/Academy of Medical Sciences; University of Edinburgh and GlagoSmithKline Discovery Partnerships with Academia (DPAC) collaboration; Wellcome Trust [106122]; Rainin Trust [13H6]; CREST of JST; European Union FP7 Industry Academia Partnerships and Pathways project ClouDx-I Chief Scientists Office [ETM202]; Biotechnology and Biological Sciences Research Council [BB/K091121/1]; BBSRC [BB/K019112/1] Funding Source: UKRI; MRC [MR/K013386/1, G0601481, G0901697, MR/L012766/1, G1000868] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037097] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000616] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/K019112/1] Funding Source: researchfish; Medical Research Council [G0901697, MR/K013386/1, MR/L012766/1, G0601481, G1000868] Funding Source: researchfish; Chief Scientist Office [ETM/202] Funding Source: researchfish	University of Edinburgh; Wellcome Trust Institutional Strategic Support Kind(Wellcome Trust); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); Health Foundation/Academy of Medical Sciences; University of Edinburgh and GlagoSmithKline Discovery Partnerships with Academia (DPAC) collaboration; Wellcome Trust(Wellcome Trust); Rainin Trust; CREST of JST(Core Research for Evolutional Science and Technology (CREST)); European Union FP7 Industry Academia Partnerships and Pathways project ClouDx-I Chief Scientists Office; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	We thank J. Allen for critically reading and editing the manuscript; P. J. Brophy and D. Mahad CD90.2(Thy1.2)-Cre mice; J.-C. Renauld for IL-22-deficient mice; J. Pollard, P. J. Spence, and J. Thompson for Rag1<SUP>-/-</SUP> mice; I. Walsh and J. Rennie tor human blood samples; Y. X. Hi, X. G. Guo, D. Rucked, T. Kendall, J. Hu, Q. Huang, and G. T. Ho for mace, technical assistance, and/or discussion; and S. Johnston and. W. Ramsay for cell sorting and a.nalysis. We also thank the Wellcome Trust Clinical Research Facility staff and the Department of Surgery, NHS Lothian. Mice deficient in IL-22 are available from the Jean-Ludwig Institute Far Cancer Research under a material transfer agreement with J.-C Renauld. This work was supported in part by the University of Edinburgh start-up funding (Ch.Y.), the Wellcome Trust Institutional Strategic Support Kind (Ch. Y., J.P.I., S.M.A), MRC UK (J.P.I., S.M.A., R.D., A.G.R.), NIH (grant DK37097 to R.M.B.), a VA Merit Award (1BX000616 to R.M.B.), Health Foundation/Academy of Medical Sciences (D.L.M.), University of Edinburgh and GlagoSmithKline Discovery Partnerships with Academia (DPAC) collaboration (D.J.M.), a Wellcome Trust Investigator Award (106122 to R.M.M.), the Rainin Trust (Award 13H6 to R.M.M.), CREST of JST (S.N.), European Union FP7 Industry Academia Partnerships and Pathways project ClouDx-I Chief Scientists Office (grant ETM202 to P.G.), and Biotechnology and Biological Sciences Research Council (grant BB/K091121/1 to P.G.). The data presented in this manuscript are tabulated. in the main paper and the supplementary materials. We declare no financial conflicts of interest.	Aronoff D. M., 2012, MEDIATORS INFLAMM, V2012; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; Bruegel M, 2012, CRIT CARE MED, V40, P1478, DOI 10.1097/CCM.0b013e3182416f05; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chinen T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1181; Cohen J, 2012, LANCET INFECT DIS, V12, P503, DOI 10.1016/S1473-3099(12)70136-6; Day R. O., 2013, BMJ-BRIT MED J, V346, pf3195; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Eisen DP, 2012, INTENS CARE MED, V38, P1249, DOI 10.1007/s00134-012-2570-8; Feng DC, 2012, INT J BIOL SCI, V8, P249, DOI 10.7150/ijbs.3967; Fishman JE, 2014, SHOCK, V42, P264, DOI 10.1097/SHK.0000000000000209; Fredenburgh LE, 2011, J IMMUNOL, V187, P5255, DOI 10.4049/jimmunol.1101186; Fullerton JN, 2014, TRENDS IMMUNOL, V35, P12, DOI 10.1016/j.it.2013.10.008; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Hamilton SM, 2014, J INFECT DIS, V209, P1429, DOI 10.1093/infdis/jit594; HAUPT MT, 1991, CRIT CARE MED, V19, P1339, DOI 10.1097/00003246-199111000-00006; Hirata T, 2012, ADV IMMUNOL, V116, P143, DOI 10.1016/B978-0-12-394300-2.00005-3; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; LaRosa SP, 2012, CURR INFECT DIS REP, V14, P474, DOI 10.1007/s11908-012-0276-2; Lee BH, 2012, CRIT CARE, V16, DOI 10.1186/cc11211; Legras A, 2009, CRIT CARE, V13, DOI 10.1186/cc7766; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Schneider A, 2004, GENESIS, V40, P7, DOI 10.1002/gene.20048; Smith CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5649; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; STEVENS DL, 1995, CLIN INFECT DIS, V21, P977, DOI 10.1093/clinids/21.4.977; Xiang BG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3657; Yao C, 2013, NAT COMMUN, V4, P1685; Zhang Y., 2015, SCIENCE, V348; Zonta B, 2011, NEURON, V69, P945, DOI 10.1016/j.neuron.2011.02.021	36	117	120	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1333	1338		10.1126/science.aad9903	http://dx.doi.org/10.1126/science.aad9903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989254	Green Accepted, Green Submitted			2022-12-28	WOS:000372397700046
J	O'Rourke, JG; Bogdanik, L; Yanez, A; Lall, D; Wolf, AJ; Muhammad, AKMG; Ho, R; Carmona, S; Vit, JP; Zarrow, J; Kim, KJ; Bell, S; Harms, MB; Miller, TM; Dangler, CA; Underhill, DM; Goodridge, HS; Lutz, CM; Baloh, RH				O'Rourke, J. G.; Bogdanik, L.; Yanez, A.; Lall, D.; Wolf, A. J.; Muhammad, A. K. M. G.; Ho, R.; Carmona, S.; Vit, J. P.; Zarrow, J.; Kim, K. J.; Bell, S.; Harms, M. B.; Miller, T. M.; Dangler, C. A.; Underhill, D. M.; Goodridge, H. S.; Lutz, C. M.; Baloh, R. H.			C9orf72 is required for proper macrophage and microglial function in mice	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GGGGCC REPEAT EXPANSION; FRONTOTEMPORAL DEMENTIA; NUCLEOCYTOPLASMIC TRANSPORT; NEURODEGENERATIVE DISEASE; HEXANUCLEOTIDE REPEAT; ALS; FTD; HYPERMETHYLATION; TRANSCRIPTOME	Expansions of a hexanucleotide repeat (GGGGCC) in the noncoding region of the C9orf72 gene are the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. Decreased expression of C9orf72 is seen in expansion carriers, suggesting that loss of function may play a role in disease. We found that two independent mouse lines lacking the C9orf72 ortholog (3110043021Rik) in all tissues developed normally and aged without motor neuron disease. Instead, C9orf72 null mice developed progressive splenomegaly and lymphadenopathy with accumulation of engorged macrophage-like cells. C9orf72 expression was highest in myeloid cells, and the loss of C9orf72 led to lysosomal accumulation and altered immune responses in macrophages and microglia, with age-related neuroinflammation similar to C9orf72 ALS but not sporadic ALS human patient tissue. Thus, C9orf72 is required for the normal function of myeloid cells, and altered microglial function may contribute to neurodegeneration in C9orf72 expansion carriers.	[O'Rourke, J. G.; Yanez, A.; Lall, D.; Muhammad, A. K. M. G.; Ho, R.; Carmona, S.; Zarrow, J.; Kim, K. J.; Bell, S.; Goodridge, H. S.; Baloh, R. H.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Bogdanik, L.; Dangler, C. A.; Lutz, C. M.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Wolf, A. J.; Vit, J. P.; Underhill, D. M.] Cedars Sinai Med Ctr, Div Biomed Sci, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Baloh, R. H.] Cedars Sinai Med Ctr, Dept Neurol, 8700 Beverly Blvd, Los Angeles, CA 90048 USA; [Harms, M. B.; Miller, T. M.] Washington Univ, Sch Med, Dept Neurol, 660 South Euclid Ave, St Louis, MO 63110 USA	Cedars Sinai Medical Center; Jackson Laboratory; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Washington University (WUSTL)	Baloh, RH (corresponding author), Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.; Baloh, RH (corresponding author), Cedars Sinai Med Ctr, Dept Neurol, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	robert.baloh@csmc.edu	vit, jean-philippe/Q-7286-2019; Boyer, Alberto Yáñez/R-1587-2018; UNDERHILL, DAVID/ABE-2185-2021	Boyer, Alberto Yáñez/0000-0002-7719-1963; Ho, Ritchie/0000-0003-1496-4436; Vit, Jean-Philippe/0000-0001-5057-8554; Underhill, David/0000-0002-2989-658X; Zarrow, Jonah/0000-0003-2536-2297	NIH [NS069669, NS087351, GM085796, NS078398, UL1TR000124]; Robert and Louise Schwab family; Cedars-Sinai ALS Research Fund; Cedars-Sinaj Board of Governors Regenerative Medicine Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078398, R21NS087351, R01NS069669, R01NS097545] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and Louise Schwab family; Cedars-Sinai ALS Research Fund; Cedars-Sinaj Board of Governors Regenerative Medicine Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank V. Funari for assistance with RNA sequencing, A. Cammack for assisting with patient tissue, and A. Koehne for assisting with pathology evaluation. This work was supported by NIH grants NS069669 (R.H.B), NS087351 (C.M.L), GM085796 (D.M.U.), NS078398 (T.M.M.) and UL1TR000124; the Robert and Louise Schwab family; the Cedars-Sinai ALS Research Fund (R.H.B.); and the Cedars-Sinaj Board of Governors Regenerative Medicine Institute. T.M.M. has served on medical advisory boards for lonis Pharmaceuticals and Biogen Idec. Mouse line F12 is available through the Jackson Repository, no. 27068, C57BL/6J-3110043021Rikem5Lutzy J RNA-seq data are located in the Gene Expression Omnibus, accession number GSE77681.	Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Belzil VV, 2013, ACTA NEUROPATHOL, V126, P895, DOI 10.1007/s00401-013-1199-1; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Cooper-Knock J, 2014, ACTA NEUROPATHOL, V127, P333, DOI 10.1007/s00401-014-1251-9; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Farg MA, 2014, HUM MOL GENET, V23, P3579, DOI 10.1093/hmg/ddu068; Fratta P, 2013, ACTA NEUROPATHOL, V126, P401, DOI 10.1007/s00401-013-1147-0; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Hooten KG, 2015, NEUROTHERAPEUTICS, V12, P364, DOI 10.1007/s13311-014-0329-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Koppers M, 2015, ANN NEUROL, V78, P426, DOI 10.1002/ana.24453; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Ma J, 2014, J IMMUNOL, V192, P1356, DOI 10.4049/jimmunol.1302835; Mizielinska S, 2014, CURR OPIN NEUROL, V27, P515, DOI 10.1097/WCO.0000000000000130; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Peters OM, 2015, J CLIN INVEST, V125, P2548, DOI 10.1172/JCI82693; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Russ J, 2015, ACTA NEUROPATHOL, V129, P39, DOI 10.1007/s00401-014-1365-0; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Suzuki N, 2013, NAT NEUROSCI, V16, P1725, DOI 10.1038/nn.3566; Xi ZR, 2013, AM J HUM GENET, V92, P981, DOI 10.1016/j.ajhg.2013.04.017; Zhang Dapeng, 2012, Frontiers in Genetics, V3, P283, DOI 10.3389/fgene.2012.00283; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	34	331	335	5	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1324	1329		10.1126/science.aaf1064	http://dx.doi.org/10.1126/science.aaf1064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989253	Green Accepted			2022-12-28	WOS:000372397700044
J	Yamaguchi, S				Yamaguchi, Shu			Large, soft, and polarizable hydride ions sneak around in an oxyhydride	SCIENCE			English	Editorial Material							HYDROGEN; OXIDE		[Yamaguchi, Shu] Univ Tokyo, Dept Mat Engn, Tokyo, Japan	University of Tokyo	Yamaguchi, S (corresponding author), Univ Tokyo, Dept Mat Engn, Tokyo, Japan.	yamaguchi@material.t.u-tokyo.ac.jp						ALTORFER F, 1994, SOLID STATE IONICS, V70, P272, DOI 10.1016/0167-2738(94)90322-0; ANDRESEN AF, 1977, J SOLID STATE CHEM, V20, P93, DOI 10.1016/0022-4596(77)90055-X; Funke K, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/4/043502; Hayashi K, 2005, J PHYS CHEM B, V109, P23836, DOI 10.1021/jp053990p; Hayashi K, 2002, NATURE, V419, P462, DOI 10.1038/nature01053; Hayward MA, 2002, SCIENCE, V295, P1882, DOI 10.1126/science.1068321; Kobayashi G, 2016, SCIENCE, V351, P1314, DOI 10.1126/science.aac9185; Kobayashi Y, 2012, NAT MATER, V11, P507, DOI [10.1038/nmat3302, 10.1038/NMAT3302]; lwahara H., 1981, SOLID STATE IONICS, V3-4, P359; Norby T, 2004, DALTON T, P3012, DOI 10.1039/b403011g; Verbraeken MC, 2015, NAT MATER, V14, P95, DOI [10.1038/nmat4136, 10.1038/NMAT4136]; Wideroe M, 2006, SOLID STATE IONICS, V177, P1469, DOI 10.1016/j.ssi.2006.07.029	12	11	11	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1263	1264		10.1126/science.aaf3361	http://dx.doi.org/10.1126/science.aaf3361			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989234				2022-12-28	WOS:000372397700017
J	Hayashi, R; Ishikawa, Y; Sasamoto, Y; Katori, R; Nomura, N; Ichikawa, T; Araki, S; Soma, T; Kawasaki, S; Sekiguchi, K; Quantock, AJ; Tsujikawa, M; Nishida, K				Hayashi, Ryuhei; Ishikawa, Yuki; Sasamoto, Yuzuru; Katori, Ryosuke; Nomura, Naoki; Ichikawa, Tatsuya; Araki, Saori; Soma, Takeshi; Kawasaki, Satoshi; Sekiguchi, Kiyotoshi; Quantock, Andrew J.; Tsujikawa, Motokazu; Nishida, Kohji			Co-ordinated ocular development from human iPS cells and recovery of corneal function	NATURE			English	Article							PLURIPOTENT STEM-CELLS; NEURAL RETINA; STEM/PROGENITOR CELLS; HUMAN FIBROBLASTS; EPITHELIAL-CELLS; DIFFERENTIATION; GENERATION; KERATINOCYTE; EXPRESSION; CULTURE	The eye is a complex organ with highly specialized constituent tissues derived from different primordial cell lineages. The retina, for example, develops from neuroectoderm via the optic vesicle, the corneal epithelium is descended from surface ectoderm, while the iris and collagen-rich stroma of the cornea have a neural crest origin. Recent work with pluripotent stem cells in culture has revealed a previously under-appreciated level of intrinsic cellular self-organization, with a focus on the retina and retinal cells(1-5). Moreover, we and others have demonstrated the in vitro induction of a corneal epithelial cell phenotype from pluripotent stem cells(6-9). These studies, however, have a single, tissue-specific focus and fail to reflect the complexity of whole eye development. Here we demonstrate the generation from human induced pluripotent stem cells of a self-formed ectodermal autonomous multi-zone (SEAM) of ocular cells. In some respects the concentric SEAM mimics whole-eye development because cell location within different zones is indicative of lineage, spanning the ocular surface ectoderm, lens, neuro-retina, and retinal pigment epithelium. It thus represents a promising resource for new and ongoing studies of ocular morphogenesis. The approach also has translational potential and to illustrate this we show that cells isolated from the ocular surface ectodermal zone of the SEAM can be sorted and expanded ex vivo to form a corneal epithelium that recovers function in an experimentally induced animal model of corneal blindness.	[Hayashi, Ryuhei] Osaka Univ, Grad Sch Med, Dept Stem Cells & Appl Med, Suita, Osaka 5650871, Japan; [Hayashi, Ryuhei; Ishikawa, Yuki; Sasamoto, Yuzuru; Katori, Ryosuke; Nomura, Naoki; Ichikawa, Tatsuya; Araki, Saori; Soma, Takeshi; Kawasaki, Satoshi; Tsujikawa, Motokazu; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan; [Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan; [Quantock, Andrew J.] Cardiff Univ, Coll Biomed & Life Sci, Sch Optometry & Vis Sci, Struct Biophys Grp, Cardiff CF24 4HQ, S Glam, Wales	Osaka University; Osaka University; Osaka University; Cardiff University	Nishida, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka 5650871, Japan.	knishida@ophthal.med.osaka-u.ac.jp	Hayashi, Ryuhei/AAW-4737-2020	Hayashi, Ryuhei/0000-0002-4699-8617; Nishida, Kohji/0000-0001-9069-3610	Japan Agency for Medical Research and Development (AMED); Japan Science and Technology Agency (JST); Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; BBSRC [BB/M025349/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M025349/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [24592675] Funding Source: KAKEN	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Baba, Y. Oie, H. Takayanagi, S. Hara, Y. Yasukawa, J. Toga and M. Yagi of Osaka University and M. Nakagawa of Kyoto University for technical assistance and scientific discussions. This work was supported in part by the project for the realization of regenerative medicine of The Japan Agency for Medical Research and Development (AMED), The Japan Science and Technology Agency (JST) and The Ministry of Health, Labour, and Welfare of Japan and the Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ahmad S, 2007, STEM CELLS, V25, P1145, DOI 10.1634/stemcells.2006-0516; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Brzeszczynska J, 2014, INT J MOL MED, V33, P1597, DOI 10.3892/ijmm.2014.1714; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; Hayashi R, 2007, STEM CELLS, V25, P289, DOI 10.1634/stemcells.2006-0167; Hayashi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045435; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Krenzer KL, 1997, INVEST OPHTH VIS SCI, V38, P142; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Mellough CB, 2015, STEM CELLS, V33, P2416, DOI 10.1002/stem.2023; Miyashita H, 2013, STEM CELL TRANSL MED, V2, P758, DOI 10.5966/sctm.2012-0156; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Reichman S, 2014, P NATL ACAD SCI USA, V111, P8518, DOI 10.1073/pnas.1324212111; Shalom-Feuerstein R, 2012, STEM CELLS, V30, P898, DOI 10.1002/stem.1068; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Truong TT, 2011, INVEST OPHTH VIS SCI, V52, P6315, DOI 10.1167/iovs.11-7518; Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047	28	128	141	5	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					376	+		10.1038/nature17000	http://dx.doi.org/10.1038/nature17000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26958835				2022-12-28	WOS:000372064300054
J	Phillips, N				Phillips, Nicky			nature INDEX 2016 JAPAN	NATURE			English	Editorial Material																			0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S97	S97		10.1038/531S97a	http://dx.doi.org/10.1038/531S97a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VI5NA	26982025	Bronze			2022-12-28	WOS:000494036100001
J	Finer, LB; Zolna, MR				Finer, Lawrence B.; Zolna, Mia R.			Declines in Unintended Pregnancy in the United States, 2008-2011	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIONAL-SURVEY; FAMILY GROWTH; ABORTION; CHILDBEARING; WOMEN; DISPARITIES; BEHAVIORS; HEALTH	BACKGROUND The rate of unintended pregnancy in the United States increased slightly between 2001 and 2008 and is higher than that in many other industrialized countries. National trends have not been reported since 2008. METHODS We calculated rates of pregnancy for the years 2008 and 2011 according to women's and girls' pregnancy intentions and the outcomes of those pregnancies. We obtained data on pregnancy intentions from the National Survey of Family Growth and a national survey of patients who had abortions, data on births from the National Center for Health Statistics, and data on induced abortions from a national census of abortion providers; the number of miscarriages was estimated using data from the National Survey of Family Growth. RESULTS Less than half (45%) of pregnancies were unintended in 2011, as compared with 51% in 2008. The rate of unintended pregnancy among women and girls 15 to 44 years of age declined by 18%, from 54 per 1000 in 2008 to 45 per 1000 in 2011. Rates of unintended pregnancy among those who were below the federal poverty level or cohabiting were two to three times the national average. Across population subgroups, disparities in the rates of unintended pregnancy persisted but narrowed between 2008 and 2011; the incidence of unintended pregnancy declined by more than 25% among girls who were 15 to 17 years of age, women who were cohabiting, those whose incomes were between 100% and 199% of the federal poverty level, those who did not have a high school education, and Hispanics. The percentage of unintended pregnancies that ended in abortion remained stable during the period studied (40% in 2008 and 42% in 2011). Among women and girls 15 to 44 years of age, the rate of unintended pregnancies that ended in birth declined from 27 per 1000 in 2008 to 22 per 1000 in 2011. CONCLUSIONS After a previous period of minimal change, the rate of unintended pregnancy in the United States declined substantially between 2008 and 2011, but unintended pregnancies remained most common among women and girls who were poor and those who were cohabiting.	[Finer, Lawrence B.; Zolna, Mia R.] Alan Guttmacher Inst, 125 Maiden Ln,7th Fl, New York, NY 10038 USA		Finer, LB (corresponding author), Alan Guttmacher Inst, 125 Maiden Ln,7th Fl, New York, NY 10038 USA.	lfiner@guttmacher.org			Susan Thompson Buffett Foundation; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD074034, R01HD059896] Funding Source: NIH RePORTER	Susan Thompson Buffett Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the Susan Thompson Buffett Foundation and the National Institutes of Health.	[Anonymous], 2011, CLIN PREV SERV WOM C; [Anonymous], 2011, SURG GEN CALL ACT SU; [Anonymous], 2013, CDC WONDER ONL DAT B; [Anonymous], 2010, HLTH PEOPL 2020 TOP; Axinn WG, 1998, DEMOGRAPHY, V35, P435, DOI 10.2307/3004012; Barber JS, 1999, J HEALTH SOC BEHAV, V40, P231, DOI 10.2307/2676350; Branum A, 2015, TRENDS LONGACTING RE; Chandra A, 2011, SEXUAL BEHAV SEXUAL; Daniels K., 2014, CURRENT CONTRACEPTIV; Dott M, 2010, MATERN CHILD HLTH J, V14, P373, DOI 10.1007/s10995-009-0458-1; Dye TD, 1997, AM J PUBLIC HEALTH, V87, P1709, DOI 10.2105/AJPH.87.10.1709; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Finer LB, 2014, AM J PUBLIC HEALTH, V104, pS43, DOI 10.2105/AJPH.2013.301416; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Fu HS, 1998, FAM PLANN PERSPECT, V30, P128, DOI 10.2307/2991627; Guttmacher Institute, 2014, US HIGHL EFF CONTR U; Guttmacher Institute, 2009, REAL TIM LOOK IMP RE; Hellerstedt WL, 1998, AM J PUBLIC HEALTH, V88, P663, DOI 10.2105/AJPH.88.4.663; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; Jones J, 2012, CURRENT CONTRACEPTIV; Jones RK, 2007, STUD FAMILY PLANN, V38, P187, DOI 10.1111/j.1728-4465.2007.00130.x; Jones RK, 2014, PERSPECT SEX REPRO H, V46, P3, DOI 10.1363/46e0414; Jones Rachel K., 2010, CHARACTERISTICS US A; Kavanaugh ML, 2015, OBSTET GYNECOL, V126, P917, DOI 10.1097/AOG.0000000000001094; Kost K., 2015, UNINTENDED PREGNANCY; Kost K, 2015, DEMOGRAPHY, V52, P83, DOI 10.1007/s13524-014-0359-9; Martin Joyce A, 2013, Natl Vital Stat Rep, V62, P1; Martin Joyce A, 2010, Natl Vital Stat Rep, V59, P3; Mayer JP, 1997, BIRTH-ISS PERINAT C, V24, P247, DOI 10.1111/j.1523-536X.1997.tb00598.x; Mosher W. D., 2012, INTENDED UNINTENDED; National Center for HIV/AIDS, 2014, TRENDS PREV SEX BEH; Orr ST, 2000, PAEDIATR PERINAT EP, V14, P309, DOI 10.1046/j.1365-3016.2000.00289.x; Pazol K, 2014, MMWR-MORBID MORTAL W, V63, P1; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Taylor JS, 2002, J FAM PRACTICE, V51, P431; U.S. Census Bureau. Current Population Survey, 2009, CURR POP SURV 2009 A; US Census Bureau, 2012, CURR POP SURV 2012 A; Ventura Stephanie J, 2012, Natl Vital Stat Rep, V60, P1; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855	39	1222	1225	5	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					843	852		10.1056/NEJMsa1506575	http://dx.doi.org/10.1056/NEJMsa1506575			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF2FT	26962904	Green Accepted, Bronze			2022-12-28	WOS:000371158400008
J	Jurecic, A; Marchalik, D				Jurecic, Ann; Marchalik, Daniel			The literary legacy of Oliver Sacks	LANCET			English	Editorial Material									[Jurecic, Ann] Rutgers State Univ, Dept English, New Brunswick, NJ 08901 USA; [Marchalik, Daniel] Georgetown Univ, Sch Med, Dept Urol & Literature & Med Track, Washington, DC 20007 USA	Rutgers State University New Brunswick; Georgetown University	Jurecic, A (corresponding author), Rutgers State Univ, Dept English, New Brunswick, NJ 08901 USA.	ann.jurecic@rutgers.edu		Marchalik, Daniel/0000-0002-6912-1252					0	0	0	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					835	835		10.1016/S0140-6736(16)00513-4	http://dx.doi.org/10.1016/S0140-6736(16)00513-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	DE9RA	26972068				2022-12-28	WOS:000370974400013
J	Bloch, EM; Simon, MS; Shaz, BH				Bloch, Evan M.; Simon, Matthew S.; Shaz, Beth H.			Emerging Infections and Blood Safety in the 21st Century	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES; TRANSFUSION; BABESIOSIS; VIRUS		Blood Syst Res Inst, San Francisco, CA USA; [Simon, Matthew S.] Weill Cornell Med Coll, 525 East 68th St,Box 130, New York, NY 10065 USA; [Shaz, Beth H.] New York Blood Ctr, 310 East 67th St, New York, NY 10065 USA; [Bloch, Evan M.] Johns Hopkins Univ, Sch Med, Dept Pathol, 600 North Wolfe St,Carnegie 446 D1, Baltimore, MD 21287 USA	Vitalant; Vitalant Research Institute; Cornell University; New York Blood Center; Johns Hopkins University	Bloch, EM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 600 North Wolfe St,Carnegie 446 D1, Baltimore, MD 21287 USA.	ebloch2@jhmi.edu	Bloch, Evan/G-7676-2018	Bloch, Evan/0000-0001-8181-9517; Shaz, Beth/0000-0002-2270-4821				Allain JP, 2005, TRANSFUS MED REV, V19, P110, DOI 10.1016/j.tmrv.2004.11.005; Custer B, 2009, TRANSFUS MED REV, V23, P1, DOI 10.1016/j.tmrv.2008.09.001; Gallian P, 2014, BLOOD, V123, P3679, DOI 10.1182/blood-2014-03-564880; Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362; Katz LM, 2014, TRANSFUSION, V54, P2154, DOI 10.1111/trf.12807; Musso D, 2014, EURO SURVEILL, V19; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Snyder EL, 2015, NEW ENGL J MED, V372, P1882, DOI 10.1056/NEJMp1500154; Wald M. L., 2014, NY TIMES	9	4	4	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					57	+		10.7326/M15-1329	http://dx.doi.org/10.7326/M15-1329			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	26974496				2022-12-28	WOS:000379215800010
J	Casey, SC; Tong, L; Li, YL; Do, R; Walz, S; Fitzgerald, KN; Gouw, AM; Baylot, V; Gutgemann, I; Eilers, M; Felsher, DW				Casey, Stephanie C.; Tong, Ling; Li, Yulin; Do, Rachel; Walz, Susanne; Fitzgerald, Kelly N.; Gouw, Arvin M.; Baylot, Virginie; Guetgemann, Ines; Eilers, Martin; Felsher, Dean W.			MYC regulates the antitumor immune response through CD47 and PD-L1	SCIENCE			English	Article							C-MYC; TUMOR-REGRESSION; GENE-EXPRESSION; CELL LEUKEMIA; CANCER; INACTIVATION; TARGET; THROMBOSPONDIN-1; CLASSIFICATION; TUMORIGENESIS	The MYC oncogene codes for a transcription factor that is overexpressed in many human cancers. Here we show that MYC regulates the expression of two immune checkpoint proteins on the tumor cell surface: the innate immune regulator CD47 (cluster of differentiation 47) and the adaptive immune checkpoint PD-L1 (programmed death-ligand 1). Suppression of MYC in mouse tumors and human tumor cells caused a reduction in the levels of CD47 and PD-L1 messenger RNA and protein. MYC was found to bind directly to the promoters of the Cd47 and Pd-l1 genes. MYC inactivation in mouse tumors down-regulated CD47 and PD-L1 expression and enhanced the antitumor immune response. In contrast, when MYC was inactivated in tumors with enforced expression of CD47 or PD-L1, the immune response was suppressed, and tumors continued to grow. Thus, MYC appears to initiate and maintain tumorigenesis, in part, through the modulation of immune regulatory molecules.	[Casey, Stephanie C.; Tong, Ling; Li, Yulin; Do, Rachel; Fitzgerald, Kelly N.; Gouw, Arvin M.; Baylot, Virginie; Guetgemann, Ines; Felsher, Dean W.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Casey, Stephanie C.; Tong, Ling; Li, Yulin; Do, Rachel; Fitzgerald, Kelly N.; Gouw, Arvin M.; Baylot, Virginie; Guetgemann, Ines; Felsher, Dean W.] Stanford Univ, Sch Med, Dept Pathol, Div Oncol, Stanford, CA 94305 USA; [Walz, Susanne; Eilers, Martin] Univ Wurzburg, Bioctr, Core Unit Bioinformat, Comprehens Canc Ctr Mainfranken, D-97074 Wurzburg, Germany; [Guetgemann, Ines] Univ Hosp Bonn, Inst Pathol, D-53127 Bonn, Germany; [Eilers, Martin] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany	Stanford University; Stanford University; University of Wurzburg; University of Bonn; University of Wurzburg	Felsher, DW (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA.; Felsher, DW (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Div Oncol, Stanford, CA 94305 USA.	dfelsher@stanford.edu	Baylot, Virginie/HCI-7158-2022; Baylot, Virginie/AAR-1416-2021; li, Yu/HCI-9086-2022; Gütgemann, Ines/ABH-6426-2020; Li, yu/HHZ-5236-2022	Baylot, Virginie/0000-0003-1313-2857; Gouw, Arvin/0000-0002-9552-635X; Eilers, Martin/0000-0002-0376-6533	NIH R01 [CA 089305, CA 170378, CA 184384, U01 CA 188383, U01 CA 114747]; Cancer Research Institute Clinic and Laboratory Innovation Program; NIH [1F32CA177139, 5T32AI07290]; Alex's Lemonade Stand Foundation; Deutsche Forschungsgemeinschaft (DFG) [Ei222/12-1]; Deutsche Krebshilfe via the Comprehensive Cancer Center Mainfranken; DFG [GU 1046/2-1]; NATIONAL CANCER INSTITUTE [U01CA188383, R01CA170378, P30CA124435, F32CA177139, T32CA196585, P50CA114747, R01CA184384, R01CA089305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	NIH R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute Clinic and Laboratory Innovation Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Krebshilfe via the Comprehensive Cancer Center Mainfranken(Deutsche Krebshilfe); DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Shroff, A. Deutzmann, J. Braun, D. Fruman, I. Weissman, and P. Betancur for helpful advice; P. Chu for pathology; N. Lacayo and G. Dahl for deidentified clinical specimens; C. Dang for nuclear run-on data sets; and the Small Animal Imaging Facility at the Stanford Center for Innovation in In-Vivo Imaging (SCI<SUP>3</SUP>). This work was supported by NIH R01 grants CA 089305, CA 170378, CA 184384, U01 CA 188383, and U01 CA 114747 and a Cancer Research Institute Clinic and Laboratory Innovation Program grant (D.W.F). S.C.C. was supported by NIH fellowships 1F32CA177139 and 5T32AI07290. K.N.F. was supported by a grant from Alex's Lemonade Stand Foundation. M.E. and S.W. were supported by Deutsche Forschungsgemeinschaft (DFG) grant Ei222/12-1 (to M.E.) and by the Deutsche Krebshilfe via the Comprehensive Cancer Center Mainfranken. I. G. was supported by DFG grant GU 1046/2-1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. All data are stored at the Division of Oncology, Department of Medicine, Stanford University School of Medicine.	Avice MN, 2001, J IMMUNOL, V167, P2459, DOI 10.4049/jimmunol.167.5.2459; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Dranoff G, 2012, NAT REV IMMUNOL, V12, P61, DOI 10.1038/nri3129; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Galluzzi L, 2014, ONCOTARGET, V5, P12472, DOI 10.18632/oncotarget.2998; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Giuriato S, 2006, P NATL ACAD SCI USA, V103, P16266, DOI 10.1073/pnas.0608017103; Hennighausen L, 1995, J CELL BIOCHEM, V59, P463, DOI 10.1002/jcb.240590407; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kaur S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01673; Li YL, 2014, CANCER CELL, V26, P262, DOI 10.1016/j.ccr.2014.06.014; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Marinkovic D, 2004, INT J CANCER, V110, P336, DOI 10.1002/ijc.20099; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Moreno BH, 2015, SEMIN ONCOL, V42, P466, DOI 10.1053/j.seminoncol.2015.02.008; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shanker A, 2007, J IMMUNOL, V179, P6651, DOI 10.4049/jimmunol.179.10.6651; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Tsushima F, 2007, BLOOD, V110, P180, DOI 10.1182/blood-2006-11-060087; Waclavicek M, 1997, J IMMUNOL, V159, P5345; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Wiese KE, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014290; Wolf E, 2015, TRENDS CELL BIOL, V25, P241, DOI 10.1016/j.tcb.2014.10.006; Woo SR, 2015, ANNU REV IMMUNOL, V33, P445, DOI 10.1146/annurev-immunol-032414-112043; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104	45	700	732	6	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					227	231		10.1126/science.aac9935	http://dx.doi.org/10.1126/science.aac9935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	26966191	Green Accepted			2022-12-28	WOS:000373681600047
J	Berenson, RA; Goodson, JD				Berenson, Robert A.; Goodson, John D.			Finding Value in Unexpected Places - Fixing the Medicare Physician Fee Schedule	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PAYMENT		[Berenson, Robert A.] Urban Inst, Washington, DC 20037 USA; [Goodson, John D.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Urban Institute; Harvard University; Massachusetts General Hospital	Berenson, RA (corresponding author), Urban Inst, Washington, DC 20037 USA.							[Anonymous], 1981, INTERNIST S, V22, P1; Berenson R, 2010, 101 MEDPAC; Berenson RA, 2011, NEW ENGL J MED, V364, P1892, DOI 10.1056/NEJMp1102099; Katerndahl D, 2009, J AM BOARD FAM MED, V22, P24, DOI 10.3122/jabfm.2009.01.080027; Kumetz EA, 2013, CHEST, V144, P740, DOI 10.1378/chest.13-0381	5	28	27	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2016	374	14					1306	1309		10.1056/NEJMp1600999	http://dx.doi.org/10.1056/NEJMp1600999			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DI3UW	26959109				2022-12-28	WOS:000373425000004
J	Ji, AP; Frebel, A; Chiti, A; Simon, JD				Ji, Alexander P.; Frebel, Anna; Chiti, Anirudh; Simon, Joshua D.			R-process enrichment from a single event in an ancient dwarf galaxy	NATURE			English	Article							NEUTRON-STAR MERGERS; METAL-POOR STARS; CHEMICAL SIGNATURES; CAPTURE ELEMENTS; PROCESS-RICH; RETICULUM 2; MILKY; ABUNDANCE; SPECTROSCOPY; EVOLUTION	Elements heavier than zinc are synthesized through the rapid (r) and slow (s) neutron-capture processes(1,2). The main site of production of the r-process elements (such as europium) has been debated for nearly 60 years(2). Initial studies of trends in chemical abundances in old Milky Way halo stars suggested that these elements are produced continually, in sites such as core-collapse supernovae(3,4). But evidence from the local Universe favours the idea that r-process production occurs mainly during rare events, such as neutron star mergers(5,6). The appearance of a plateau of europium abundance in some dwarf spheroidal galaxies has been suggested as evidence for rare r-process enrichment in the early Universe(7), but only under the assumption that no gas accretes into those dwarf galaxies; gas accretion(8) favours continual r-process enrichment in these systems. Furthermore, the universal r-process pattern(1,9) has not been cleanly identified in dwarf spheroidals. The smaller, chemically simpler, and more ancient ultrafaint dwarf galaxies assembled shortly after the first stars formed, and are ideal systems with which to study nucleosynthesis events such as the r-process(10,11). Reticulum II is one such galaxy(12-14). The abundances of non-neutron-capture elements in this galaxy (and others like it) are similar to those in other old stars(15). Here, we report that seven of the nine brightest stars in Reticulum II, observed with high-resolution spectroscopy, show strong enhancements in heavy neutron-capture elements, with abundances that follow the universal r-process pattern beyond barium. The enhancement seen in this 'r-process galaxy' is two to three orders of magnitude higher than that detected in any other ultrafaint dwarf galaxy(11,16,17). This implies that a single, rare event produced the r-process material in Reticulum II. The r-process yield and event rate are incompatible with the source being ordinary core-collapse supernovae(18), but consistent with other possible sources, such as neutron star mergers(19).	[Ji, Alexander P.; Frebel, Anna; Chiti, Anirudh] MIT, Dept Phys, Cambridge, MA 02139 USA; [Ji, Alexander P.; Frebel, Anna; Chiti, Anirudh] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Ji, Alexander P.; Frebel, Anna] Ctr Evolut Elements, Joint Inst Nucl Astrophys, E Lansing, MI 48824 USA; [Simon, Joshua D.] Observ Carnegie Inst Washington, Pasadena, CA 91101 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Carnegie Institution for Science	Ji, AP (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.; Ji, AP (corresponding author), MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA.	alexji@mit.edu	Simon, Joshua D/AAX-7117-2021	Ji, Alexander/0000-0002-4863-8842	National Science Foundation (NSF)-CAREER grant [AST-1255160]; Silverman Family Career Development Professorship; NSF [AST-1108811]; DOE; NSF (USA); MISE (Spain); STFC (UK); HEFCE (UK); NCSA (UIUC); KICP (Univ. Chicago); CCAPP (Ohio State); MIFPA (Texas AM); CNPQ; FAPERJ; FINEP (Brazil); MINECO (Spain); DFG (Germany); Dark Energy Survey; Argonne Lab; UC Santa Cruz; University of Cambridge; CIEMAT-Madrid; University of Chicago; University College London; DES-Brazil Consortium; University of Edinburgh; ETH Zurich; Fermilab; University of Illinois; ICE (IEEC-CSIC); IFAE Barcelona; Lawrence Berkeley Lab; LMU Munchen; associated Excellence Cluster Universe; University of Michigan; NOAO; University of Nottingham; Ohio State University; University of Pennsylvania; University of Portsmouth; SLAC National Lab; Stanford University; University of Sussex; Texas AM University; Direct For Mathematical & Physical Scien [1255160, 1108811] Funding Source: National Science Foundation; Division Of Physics [1430152] Funding Source: National Science Foundation	National Science Foundation (NSF)-CAREER grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); Silverman Family Career Development Professorship; NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); NSF (USA)(National Science Foundation (NSF)); MISE (Spain); STFC (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); HEFCE (UK)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); NCSA (UIUC); KICP (Univ. Chicago); CCAPP (Ohio State); MIFPA (Texas AM); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FINEP (Brazil)(Financiadora de Inovacao e Pesquisa (Finep)); MINECO (Spain)(Spanish Government); DFG (Germany)(German Research Foundation (DFG)); Dark Energy Survey; Argonne Lab(United States Department of Energy (DOE)); UC Santa Cruz; University of Cambridge(University of Cambridge); CIEMAT-Madrid; University of Chicago(University of Chicago); University College London(General Electric); DES-Brazil Consortium; University of Edinburgh; ETH Zurich(ETH Zurich); Fermilab; University of Illinois; ICE (IEEC-CSIC); IFAE Barcelona; Lawrence Berkeley Lab; LMU Munchen; associated Excellence Cluster Universe; University of Michigan(University of Michigan System); NOAO; University of Nottingham; Ohio State University(Ohio State University); University of Pennsylvania; University of Portsmouth; SLAC National Lab; Stanford University(Stanford University); University of Sussex; Texas AM University; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We gathered data using the 6.5-metre Magellan Clay telescope located at Las Campanas Observatory, Chile. A.P.J. thanks N. Weinberg and P. Schechter for discussions. A.P.J. and A.F. are supported by National Science Foundation (NSF)-CAREER grant AST-1255160. A.F. acknowledges support from the Silverman (1968) Family Career Development Professorship. J.D.S. acknowledges support from NSF grant AST-1108811. This work made use of NASA's Astrophysics Data System Bibliographic Services and the opensource Python libraries numpy, scipy, matplotlib, statsmodels, pandas, seaborn, and astropy. We also used data products originally obtained with the Dark Energy Camera (DECam), which was constructed by the Dark Energy Survey (DES) collaboration. The DES Projects have been funded by the DOE and the NSF (USA), MISE (Spain), STFC (UK), HEFCE (UK), NCSA (UIUC), KICP (Univ. Chicago), CCAPP (Ohio State), MIFPA (Texas A&M), CNPQ, FAPERJ and FINEP (Brazil), MINECO (Spain), DFG (Germany) and the collaborating institutions in the Dark Energy Survey, which are Argonne Lab, UC Santa Cruz, University of Cambridge, CIEMAT-Madrid, University of Chicago, University College London, DES-Brazil Consortium, University of Edinburgh, ETH Zurich, Fermilab, University of Illinois, ICE (IEEC-CSIC), IFAE Barcelona, Lawrence Berkeley Lab, LMU Munchen and the associated Excellence Cluster Universe, University of Michigan, NOAO, University of Nottingham, Ohio State University, University of Pennsylvania, University of Portsmouth, SLAC National Lab, Stanford University, University of Sussex, and Texas A&M University.	Abadie J, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/17/173001; Argast D, 2004, ASTRON ASTROPHYS, V416, P997, DOI 10.1051/0004-6361:20034265; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Bernstein RA, 2003, P SOC PHOTO-OPT INS, V4841, P1694, DOI 10.1117/12.461502; Bland-Hawthorn J, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/154; Bramante J., 2016, ARXIV160106784; Brown TM, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/91; BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; Burris DL, 2000, ASTROPHYS J, V544, P302, DOI 10.1086/317172; Casey A. R., 2014, ARXIV14055968; Castelli F., 2004, ARXIVASTROPH0405087; Dominik M, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/52; Dotter A, 2008, ASTROPHYS J SUPPL S, V178, P89, DOI 10.1086/589654; Francois P., 2015, ARXIV151005401; Frebel A, 2010, ASTRON NACHR, V331, P474, DOI 10.1002/asna.201011362; Frebel A, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/74; Frebel A, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/57; Frebel A, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/115; Geha M, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/29; Goriely S, 2011, ASTROPHYS J LETT, V738, DOI 10.1088/2041-8205/738/2/L32; Greif TH, 2010, ASTROPHYS J, V716, P510, DOI 10.1088/0004-637X/716/1/510; Hill V, 2002, ASTRON ASTROPHYS, V387, P560, DOI 10.1051/0004-6361:20020434; Ishimaru Y, 2015, ASTROPHYS J LETT, V804, DOI 10.1088/2041-8205/804/2/L35; Ivans II, 2006, ASTROPHYS J, V645, P613, DOI 10.1086/504069; Ji AP, 2016, ASTROPHYS J, V817, DOI 10.3847/0004-637X/817/1/41; Ji AP, 2015, MON NOT R ASTRON SOC, V454, P659, DOI 10.1093/mnras/stv2052; Keeping E. S., 1962, INTRO STAT INFERENCE; Kelson DD, 2003, PUBL ASTRON SOC PAC, V115, P688, DOI 10.1086/375502; Kim YC, 2002, ASTROPHYS J SUPPL S, V143, P499, DOI 10.1086/343041; Kirby EN, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/78; Kirby EN, 2008, ASTROPHYS J LETT, V685, pL43, DOI 10.1086/592432; Komiya Y, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/132; Koposov SE, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/1/62; Qian YZ, 2000, ASTROPHYS J, V534, pL67, DOI 10.1086/312659; Roederer I. U., 2016, PREPRINT; Shen SJ, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/115; Simon JD, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/1/95; Sneden C, 2008, ANNU REV ASTRON ASTR, V46, P241, DOI 10.1146/annurev.astro.46.060407.145207; Sneden C, 2009, ASTROPHYS J SUPPL S, V182, P80, DOI 10.1088/0067-0049/182/1/80; Tanvir NR, 2013, NATURE, V500, P547, DOI 10.1038/nature12505; Tsujimoto T, 2015, PUBL ASTRON SOC JPN, V67, DOI 10.1093/pasj/psv035; van de Voort F, 2015, MON NOT R ASTRON SOC, V447, P140, DOI 10.1093/mnras/stu2404; Walker MG, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/2/108; Wallner A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6956; Wanajo S, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/2/L22; Wehmeyer B, 2015, MON NOT R ASTRON SOC, V452, P1970, DOI 10.1093/mnras/stv1352	51	245	247	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					610	+		10.1038/nature17425	http://dx.doi.org/10.1038/nature17425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27001693	Green Published, Green Submitted			2022-12-28	WOS:000373027400032
J	Veshaguri, S; Christensen, SM; Kemmer, GC; Ghale, G; Moller, MP; Lohr, C; Christensen, AL; Justesen, BH; Jorgensen, IL; Schiller, J; Hatzakis, NS; Grabe, M; Pomorski, TG; Stamou, D				Veshaguri, Salome; Christensen, Sune M.; Kemmer, Gerdi C.; Ghale, Garima; Moller, Mads P.; Lohr, Christina; Christensen, Andreas L.; Justesen, Bo H.; Jorgensen, Ida L.; Schiller, Juergen; Hatzakis, Nikos S.; Grabe, Michael; Pomorski, Thomas Gunther; Stamou, Dimitrios			Direct observation of proton pumping by a eukaryotic P-type ATPase	SCIENCE			English	Article							H+-ATPASE; MEMBRANE; TRANSLATION; MICROARRAYS; ACTIVATION; DOMAIN	In eukaryotes, P-type adenosine triphosphatases (ATPases) generate the plasma membrane potential and drive secondary transport systems; however, despite their importance, their regulation remains poorly understood. We monitored at the singlemolecule level the activity of the prototypic proton-pumping P-type ATPase Arabidopsis thaliana isoform 2 (AHA2). Our measurements, combined with a physical nonequilibrium model of vesicle acidification, revealed that pumping is stochastically interrupted by longlived (similar to 100 seconds) inactive or leaky states. Allosteric regulation by pH gradients modulated the switch between these states but not the pumping or leakage rates. The autoinhibitory regulatory domain of AHA2 reduced the intrinsic pumping rates but increased the dwell time in the active pumping state. We anticipate that similar functional dynamics underlie the operation and regulation of many other active transporters.	[Veshaguri, Salome; Christensen, Sune M.; Ghale, Garima; Moller, Mads P.; Lohr, Christina; Christensen, Andreas L.; Hatzakis, Nikos S.; Stamou, Dimitrios] Univ Copenhagen, Bionanotecnol & Nanomed Lab, Copenhagen, Denmark; [Veshaguri, Salome; Christensen, Sune M.; Ghale, Garima; Moller, Mads P.; Lohr, Christina; Christensen, Andreas L.; Hatzakis, Nikos S.; Stamou, Dimitrios] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Veshaguri, Salome; Christensen, Sune M.; Ghale, Garima; Moller, Mads P.; Lohr, Christina; Christensen, Andreas L.; Hatzakis, Nikos S.; Stamou, Dimitrios] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Veshaguri, Salome; Christensen, Sune M.; Ghale, Garima; Moller, Mads P.; Lohr, Christina; Christensen, Andreas L.; Hatzakis, Nikos S.; Stamou, Dimitrios] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Copenhagen, Denmark; [Kemmer, Gerdi C.; Justesen, Bo H.; Jorgensen, Ida L.; Pomorski, Thomas Gunther] Univ Copenhagen, Ctr Membrane Pumps Cells & Dis PUMPKIN, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Schiller, Juergen] Univ Leipzig, Inst Med Phys & Biophys, Fac Med, D-04109 Leipzig, Germany; [Grabe, Michael] Univ Calif San Francisco, Dept Pharmaceut Chem, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of Copenhagen; University of Copenhagen; University of Copenhagen; Lundbeckfonden; University of Copenhagen; University of Copenhagen; Leipzig University; University of California System; University of California San Francisco	Stamou, D (corresponding author), Univ Copenhagen, Bionanotecnol & Nanomed Lab, Copenhagen, Denmark.; Stamou, D (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.; Stamou, D (corresponding author), Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark.; Stamou, D (corresponding author), Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Copenhagen, Denmark.	stamou@nano.ku.dk	Veshaguri, Salome/F-8052-2016; Pomorski, Thomas Günther/G-4804-2014; Hatzakis, Nikos S/C-2715-2015; Stamou, Dimitrios/D-5042-2016; Hatzakis, Nikos/P-3865-2019	Veshaguri, Salome/0000-0002-7439-6373; Pomorski, Thomas Günther/0000-0002-4889-0829; Hatzakis, Nikos S/0000-0003-4202-0328; Stamou, Dimitrios/0000-0001-8456-8995; Hatzakis, Nikos/0000-0003-4202-0328; Christensen, Sune/0000-0001-9650-6660	Lundbeck Foundation (Center of Excellence Biomembranes in Nanomedicine); Danish Councils for Independent and Strategic Research [1323-00297]; Danish National Research Foundation (Center of Excellence PUMPKIN) [DNRF85]; University of Copenhagen; National Institutes of Health [R21-GM100224]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM100224] Funding Source: NIH RePORTER	Lundbeck Foundation (Center of Excellence Biomembranes in Nanomedicine); Danish Councils for Independent and Strategic Research; Danish National Research Foundation (Center of Excellence PUMPKIN); University of Copenhagen; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Lundbeck Foundation (Center of Excellence Biomembranes in Nanomedicine); the Danish Councils for Independent (grant number 1323-00297) and Strategic Research; the Danish National Research Foundation (Center of Excellence PUMPKIN, grant number DNRF85); the University of Copenhagen programs of excellence Single Molecule Nanoscience, BioScaRT, and UNIK-Synthetic Biology; and the National Institutes of Health (grant number R21-GM100224). We are grateful to M. G. Palmgren, J. Mindell, and P. Nissen for stimulating discussions and comments on the manuscript; M. G. Palmgren for generously providing plasmids; U. Gether for instrumentation; and A.-M. Bjerg Petersen for excellent technical assistance. D.S. conceived the strategy and was responsible for the overall project supervision. B.H.J. performed cloning. G.C.K., B.H.J., and I.L.J. expressed, purified, and reconstituted AHA2<SUP>R</SUP> and AHA2 and performed macroscopic measurements and data analysis under the supervision of T.G.P. T.G.P. synthesized and G.C.K purified pHrodo-PE; J.S. performed and analyzed mass spectrometry experiments of pHrodo-PE. S.M.C. wrote software for analyzing time-lapse sequences of single vesicles. S.V. designed, performed, and analyzed most single-vesicle experiments, with help from M.P.M and G.G., under the supervision of S.M.C. and D.S.. C.L., A.L.C., and N.S.H. contributed with preliminary single-vesicle acidification measurements. M.G. contributed the model of vesicle acidification. D.S. wrote the manuscript, and S.V., G.G., M.P.M., B.H.J., G.C.K., I.L.J., and T.G.P. helped prepare figures and supplementary materials. All authors discussed the results and commented on the manuscript.	Aitken CE, 2010, NAT STRUCT MOL BIOL, V17, P793, DOI 10.1038/nsmb.1828; Akyuz N, 2015, NATURE, V518, P68, DOI 10.1038/nature14158; Ashcroft F, 2009, PHILOS T R SOC B, V364, P145, DOI 10.1098/rstb.2008.0245; Bendix PM, 2009, P NATL ACAD SCI USA, V106, P12341, DOI 10.1073/pnas.0903052106; Berman MC, 2001, BBA-BIOMEMBRANES, V1513, P95, DOI 10.1016/S0005-2736(01)00356-X; Comstock MJ, 2015, SCIENCE, V348, P352, DOI 10.1126/science.aaa0130; DeFelice LJ, 2007, ANNU REV PHYSIOL, V69, P87, DOI 10.1146/annurev.physiol.69.031905.164816; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Iversen L, 2014, SCIENCE, V345, P50, DOI 10.1126/science.1250373; Kemmer GC, 2015, ANALYST, V140, P6313, DOI 10.1039/c5an01180a; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Li M, 2015, J AM CHEM SOC, V137, P16055, DOI 10.1021/jacs.5b08798; Mathiasen S, 2014, NAT METHODS, V11, P931, DOI [10.1038/nmeth.3062, 10.1038/NMETH.3062]; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Nelson N, 2002, NAT REV MOL CELL BIO, V3, P876, DOI 10.1038/nrm955; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; PALMGREN MG, 1990, J BIOL CHEM, V265, P13423; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Peters R, 2003, ANNU REV BIOPH BIOM, V32, P47, DOI 10.1146/annurev.biophys.32.110601.142429; Sakmann B, 2009, SINGLE CHANNEL RECOR; Stamou D, 2003, ANGEW CHEM INT EDIT, V42, P5580, DOI 10.1002/anie.200351866; Subramaniam AR, 2014, CELL, V159, P1200, DOI 10.1016/j.cell.2014.10.043; Tonnesen A, 2014, BIOPHYS J, V106, P201, DOI 10.1016/j.bpj.2013.11.023; Watanabe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5519; Xie XS, 2010, SPRINGER SER CHEM PH, V96, P435, DOI 10.1007/978-3-642-02597-6_22; Yanagida T., 2009, SINGLE MOL DYNAMICS	28	55	58	4	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1469	1473		10.1126/science.aad6429	http://dx.doi.org/10.1126/science.aad6429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013734	Green Accepted			2022-12-28	WOS:000372756200053
J	Houri-Ze'evi, L; Korem, Y; Sheftel, H; Faigenbloom, L; Toker, IA; Dagan, Y; Awad, L; Degani, L; Alon, U; Rechavi, O				Houri-Ze'evi, Leah; Korem, Yael; Sheftel, Hila; Faigenbloom, Lior; Toker, Itai Antoine; Dagan, Yael; Awad, Lama; Degani, Luba; Alon, Uri; Rechavi, Oded			A Tunable Mechanism Determines the Duration of the Transgenerational Small RNA Inheritance in C. elegans	CELL			English	Article							DOUBLE-STRANDED-RNA; EPIGENETIC INHERITANCE; GENE-EXPRESSION; GERMLINE; INTERFERENCE; CSR-1; PATHWAY; MEMORY; PIRNAS; METHYLATION	In C. elegans, small RNAs enable transmission of epigenetic responses across multiple generations. While RNAi inheritance mechanisms that enable "memorization'' of ancestral responses are being elucidated, the mechanisms that determine the duration of inherited silencing and the ability to forget the inherited epigenetic effects are not known. We now show that exposure to dsRNA activates a feedback loop whereby gene-specific RNAi responses dictate the transgenerational duration of RNAi responses mounted against unrelated genes, elicited separately in previous generations. RNA-sequencing analysis reveals that, aside from silencing of genes with complementary sequences, dsRNA-induced RNAi affects the production of heritable endogenous small RNAs, which regulate the expression of RNAi factors. Manipulating genes in this feedback pathway changes the duration of heritable silencing. Such active control of transgenerational effects could be adaptive, since ancestral responses would be detrimental if the environments of the progeny and the ancestors were different.	[Houri-Ze'evi, Leah; Faigenbloom, Lior; Toker, Itai Antoine; Dagan, Yael; Awad, Lama; Degani, Luba; Rechavi, Oded] Tel Aviv Univ, Wise Fac Life Sci, Dept Neurobiol, IL-6997801 Tel Aviv, Israel; [Houri-Ze'evi, Leah; Faigenbloom, Lior; Toker, Itai Antoine; Dagan, Yael; Awad, Lama; Degani, Luba; Rechavi, Oded] Tel Aviv Univ, Sagol Sch, IL-6997801 Tel Aviv, Israel; [Korem, Yael; Sheftel, Hila; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel	Tel Aviv University; Tel Aviv University; Weizmann Institute of Science	Houri-Ze'evi, L; Rechavi, O (corresponding author), Tel Aviv Univ, Wise Fac Life Sci, Dept Neurobiol, IL-6997801 Tel Aviv, Israel.; Houri-Ze'evi, L; Rechavi, O (corresponding author), Tel Aviv Univ, Sagol Sch, IL-6997801 Tel Aviv, Israel.	leah.houri@gmail.com; odedrechavi@gmail.com	Houri-Zeevi, Leah/AAR-2327-2021	Toker, Itai Antoine/0000-0002-0349-1808	NIH Office of Research Infrastructure Programs [P40 OD010440]; ERC [335624]; JTF grant [44058]	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); JTF grant	We thank Christian Frokjaer-Jensen for providing the EG6089 and EG4885 strains. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We thank Tal Galili (statistics unit, Yoav Benjamini's group) for his help with the statistical analysis. We thank Jasmine Jacob for help with the microarrays. We are grateful to Yehu Moran for his helpful comments and advice and thank all members of O.R.'s and U.A.'s labs for fruitful discussions. This work was supported by ERC grant #335624 and JTF grant #44058.	Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Anava S., 2015, WORM, V3; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Axtell M.J., 2014, BUTTER HIGH PRECISIO; Billi Allison C, 2014, WormBook, P1, DOI 10.1895/wormbook.1.170.1; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Cecere G, 2014, NAT STRUCT MOL BIOL, V21, P358, DOI 10.1038/nsmb.2801; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Crews D, 2014, MOL CELL ENDOCRINOL, V398, P42, DOI 10.1016/j.mce.2014.07.013; de Albuquerque BFM, 2015, DEV CELL, V34, P448, DOI 10.1016/j.devcel.2015.07.010; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gaydos LJ, 2014, SCIENCE, V345, P1515, DOI 10.1126/science.1255023; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Greer EL, 2015, CELL, V161, P868, DOI 10.1016/j.cell.2015.04.005; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Jablonka E, 2008, GENET MOL BIOL, V31, P389, DOI 10.1590/S1415-47572008000300001; Jablonka E, 2013, PROG BIOPHYS MOL BIO, V111, P99, DOI 10.1016/j.pbiomolbio.2012.08.014; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kelly WG, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-6; Koonin EV, 2014, CELL, V158, P237, DOI 10.1016/j.cell.2014.07.004; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Luteijn MJ, 2012, EMBO J, V31, P3422, DOI 10.1038/emboj.2012.213; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Melo JA, 2012, CELL, V149, P452, DOI 10.1016/j.cell.2012.02.050; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Sapetschnig A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005078; Sarkies P, 2013, GENOME RES, V23, P1258, DOI 10.1101/gr.153296.112; Schott D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07387; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Spike CA, 2008, DEVELOPMENT, V135, P983, DOI 10.1242/dev.015552; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7; Tu SK, 2015, NUCLEIC ACIDS RES, V43, P208, DOI 10.1093/nar/gku1308; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Wang LL, 2002, J CLIN INVEST, V110, P1175, DOI 10.1172/JCI200215536; Wedeles CJ, 2013, DEV CELL, V27, P664, DOI 10.1016/j.devcel.2013.11.016; Weigel D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-249; Weldon WFR, 1902, BIOMETRIKA, V2, P286; Wu D, 2011, NAT STRUCT MOL BIOL, V18, P1094, DOI 10.1038/nsmb.2129; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhuang J.J., 2012, GENES BASEL     1019, V19, P3	56	86	87	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					88	99		10.1016/j.cell.2016.02.057	http://dx.doi.org/10.1016/j.cell.2016.02.057			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015309	Bronze			2022-12-28	WOS:000372785600012
J	Thingstad, TF; Bratbak, G				Thingstad, T. Frede; Bratbak, Gunnar			MICROBIAL OCEANOGRAPHY Viral strategies at sea	NATURE			English	Editorial Material							VIRUSES	The finding that marine environments with high levels of host microbes have fewer viruses per host than when host abundance is low challenges a theory on the relative roles of lysogenic and lytic viral-survival strategies. See Article p.466	[Thingstad, T. Frede; Bratbak, Gunnar] Univ Bergen, Dept Biol, N-5020 Bergen, Norway	University of Bergen	Thingstad, TF (corresponding author), Univ Bergen, Dept Biol, N-5020 Bergen, Norway.	frede.thingstad@uib.no	Bratbak, Gunnar/N-8786-2015; Thingstad, Tron Frede/B-2254-2008	Bratbak, Gunnar/0000-0001-8388-4945; Thingstad, Tron Frede/0000-0002-5593-819X				BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Knowles B, 2016, NATURE, V531, P466, DOI 10.1038/nature17193; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Rosario K, 2011, CURR OPIN VIROL, V1, P289, DOI 10.1016/j.coviro.2011.06.004; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thingstad TF, 2014, P NATL ACAD SCI USA, V111, P7813, DOI 10.1073/pnas.1400909111; Weinbauer MG, 1999, AQUAT MICROB ECOL, V18, P217, DOI 10.3354/ame018217	9	7	7	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					454	455		10.1038/nature17303	http://dx.doi.org/10.1038/nature17303			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26982732				2022-12-28	WOS:000372701300028
J	Arterburn, D; McCulloch, D				Arterburn, David; McCulloch, David			Bariatric Surgery for Type 2 Diabetes Getting Closer to the Long-term Goal	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								IMPORTANCE Questions remain about the role and durability of bariatric surgery for type 2 diabetes mellitus (T2DM). OBJECTIVE To compare the remission of T2DM following surgical and nonsurgical treatments. DESIGN, SETTING, AND PARTICIPANTS In this 3-arm randomized clinical trial conducted at the University of Pittsburgh Medical Center from October 1, 2009, to June 26, 2014, in Pittsburgh, Pennsylvania, outcomes were assessed 3 years after treating 61 obese participants aged 25 to 55 years with T2DM. Analysis was conducted with an intent-to-treat population. INTERVENTIONS Participants were randomized to either an intensive lifestyle weight loss intervention for 1 year followed by a low-level lifestyle intervention for 2 years or surgical treatments (Roux-en-Y gastric bypass [RYGB] or laparoscopic adjustable gastric banding [LAGB]) followed by low-level lifestyle intervention in years 2 and 3. MAIN OUTCOMES AND MEASURES Primary end points were partial and complete T2DM remission and secondary end points included diabetes medications and weight change. RESULTS Body mass index (calculated as weight in kilograms divided by height in meters squared) was less than 35 for 26 participants (43%), 50 (82%) were women, and 13 (21%) were African American. Mean (SD) values were 100.5 (13.7) kg for weight, 47.3 (6.6) years for age, 7.8%(1.9%) for hemoglobinA(1c) level, and 171.3 (72.5) mg/dL for fasting plasma glucose level. Partial or complete T2DM remission was achieved by 40%(n = 8) of RYGB, 29%(n = 6) of LAGB, and no intensive lifestyle weight loss intervention participants (P =.004). The use of diabetes medications was reduced more in the surgical groups than the lifestyle intervention-alone group, with 65% of RYGB, 33% of LAGB, and none of the intensive lifestyle weight loss intervention participants going from using insulin or oral medication at baseline to no medication at year 3 (P <.001). Mean (SE) reductions in percentage of body weight at 3 years were the greatest after RYGB at 25.0%(2.0%), followed by LAGB at 15.0%(2.0%) and lifestyle treatment at 5.7%(2.4%) (P <.01). CONCLUSIONS AND RELEVANCE Among obese participants with T2DM, bariatric surgery with 2 years of an adjunctive low-level lifestyle intervention resulted in more disease remission than did lifestyle intervention alone.	[Arterburn, David] Grp Hlth Res Inst, 1730 Minor Ave,Ste 1600, Seattle, WA 98101 USA; [McCulloch, David] Grp Hlth Phys, Seattle, WA USA		Arterburn, D (corresponding author), Grp Hlth Res Inst, 1730 Minor Ave,Ste 1600, Seattle, WA 98101 USA.	Arterburn.d@ghc.org			NIDDK NIH HHS [R01 DK092317] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092317] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altieri MS, 2016, SURG ENDOSC, V30, P1725, DOI 10.1007/s00464-015-4402-8; Arterburn DE, 2013, OBES SURG, V23, P93, DOI 10.1007/s11695-012-0802-1; Courcoulas AP, 2015, JAMA SURG, V150, P931, DOI 10.1001/jamasurg.2015.1534; Dixon JB, 2016, INT J OBESITY, V40, P291, DOI 10.1038/ijo.2015.156; Gloy VL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5934; Hutter MM, 2011, ANN SURG, V254, P410, DOI 10.1097/SLA.0b013e31822c9dac; Mechanick JI, 2013, OBESITY, V21, pS1, DOI 10.1002/oby.20461; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]	8	1	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1276	+		10.1001/jama.2016.1884	http://dx.doi.org/10.1001/jama.2016.1884			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	27002449	Green Accepted			2022-12-28	WOS:000372511100014
J	Reimer, C; Kues, M; Roztocki, P; Wetzel, B; Grazioso, F; Little, BE; Chu, ST; Johnston, T; Bromberg, Y; Caspani, L; Moss, DJ; Morandotti, R				Reimer, Christian; Kues, Michael; Roztocki, Piotr; Wetzel, Benjamin; Grazioso, Fabio; Little, Brent E.; Chu, Sai T.; Johnston, Tudor; Bromberg, Yaron; Caspani, Lucia; Moss, David J.; Morandotti, Roberto			Generation of multiphoton entangled quantum states by means of integrated frequency combs	SCIENCE			English	Article							PHOTON-PAIR GENERATION; TIME; CIRCUITS	Complex optical photon states with entanglement shared among several modes are critical to improving our fundamental understanding of quantum mechanics and have applications for quantum information processing, imaging, and microscopy. We demonstrate that optical integrated Kerr frequency combs can be used to generate several bi- and multiphoton entangled qubits, with direct applications for quantum communication and computation. Our method is compatible with contemporary fiber and quantum memory infrastructures and with chip-scale semiconductor technology, enabling compact, low-cost, and scalable implementations. The exploitation of integrated Kerr frequency combs, with their ability to generate multiple, customizable, and complex quantum states, can provide a scalable, practical, and compact platform for quantum technologies.	[Reimer, Christian; Kues, Michael; Roztocki, Piotr; Wetzel, Benjamin; Grazioso, Fabio; Johnston, Tudor; Morandotti, Roberto] Inst Natl Rech Sci Energie Mat Telecommun, 1650 Blvd Lionel Boulet, Varennes, PQ J3X 1S2, Canada; [Wetzel, Benjamin] Univ Sussex, Dept Phys & Astron, Brighton BN1 9RH, E Sussex, England; [Little, Brent E.] Chinese Acad Sci, Xian Inst Opt & Precis Mech, State Key Lab Transient Opt & Photon, Xian, Peoples R China; [Chu, Sai T.] City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Hong Kong, Hong Kong, Peoples R China; [Bromberg, Yaron] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Caspani, Lucia] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Moss, David J.] RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic 3001, Australia; [Morandotti, Roberto] Univ Elect Sci & Technol China, Inst Fundamental & Frontier Sci, Chengdu 610054, Peoples R China; [Bromberg, Yaron] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Caspani, Lucia] Univ Strathclyde, Inst Photon, Dept Phys, Glasgow G4 0NW, Lanark, Scotland; [Moss, David J.] Swinburne Univ Technol, Ctr Microphoton, Hawthorn, Vic 3122, Australia	University of Quebec; Institut national de la recherche scientifique (INRS); University of Sussex; Chinese Academy of Sciences; Xi'an Institute of Optics & Precision Mechanics, CAS; State Key Laboratory of Transient Optics & Photonics; City University of Hong Kong; Yale University; Heriot Watt University; Royal Melbourne Institute of Technology (RMIT); University of Electronic Science & Technology of China; Hebrew University of Jerusalem; University of Strathclyde; Swinburne University of Technology	Kues, M; Morandotti, R (corresponding author), Inst Natl Rech Sci Energie Mat Telecommun, 1650 Blvd Lionel Boulet, Varennes, PQ J3X 1S2, Canada.; Morandotti, R (corresponding author), Univ Elect Sci & Technol China, Inst Fundamental & Frontier Sci, Chengdu 610054, Peoples R China.	michael.kues@emt.inrs.ca; morandotti@emt.inrs.ca	Caspani, Lucia/C-3777-2009; Morandotti, Roberto/U-6712-2019; Bromberg, Yaron/F-6570-2010; Grazioso, Fabio/U-9600-2019; Morandotti, Roberto/AAU-4702-2020; Bromberg, Yaron/L-5447-2019; Chu, Sai T/D-3312-2014; Wetzel, Benjamin/E-9386-2016	Caspani, Lucia/0000-0003-2711-0448; Bromberg, Yaron/0000-0003-2565-7394; Grazioso, Fabio/0000-0002-3604-3374; Bromberg, Yaron/0000-0003-2565-7394; Chu, Sai T/0000-0001-8263-8507; Wetzel, Benjamin/0000-0002-2691-0307; moss, david/0000-0001-5195-1744	Natural Sciences and Engineering Research Council of Canada (NSERC); Australian Research Council; NSERC; FRQNT (Fonds de Recherche du Quebec-Nature et Technologies) through the MELS fellowship program (Merit Scholarship Program for Foreign Students; Ministere de l'Education, de l'Enseignement Superieur et de la Recherche du Quebec); European Union [656607]; European Union under Research Executive Agency (REA) [625466]; European Union under REA [627478]; Mitacs through the Accelerate Program; CityU SRG-Fd (Strategic Research Grant for fundable Competitive Earmarked Research Grant) program [7004189]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Research Council(Australian Research Council); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRQNT (Fonds de Recherche du Quebec-Nature et Technologies) through the MELS fellowship program (Merit Scholarship Program for Foreign Students; Ministere de l'Education, de l'Enseignement Superieur et de la Recherche du Quebec); European Union(European Commission); European Union under Research Executive Agency (REA); European Union under REA; Mitacs through the Accelerate Program; CityU SRG-Fd (Strategic Research Grant for fundable Competitive Earmarked Research Grant) program	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) through the Steacie Memorial Fellowship and Discovery Grants programs and by the Australian Research Council Discovery Projects program. C.R. and P.R. acknowledge the support of a NSERC Vanier Canada Graduate Scholarship and a NSERC Alexander Graham Bell Canada Graduate Scholarship (Master's), respectively. M.K. acknowledges support from FRQNT (Fonds de Recherche du Quebec-Nature et Technologies) through the MELS fellowship program (Merit Scholarship Program for Foreign Students; Ministere de l'Education, de l'Enseignement Superieur et de la Recherche du Quebec). M.K. also acknowledges funding from the European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant agreement no. 656607. We acknowledge support from the People Programme (Marie Curie Actions) of the European Union's 7th Framework Programme for Research and Technological Development [B.W. under Research Executive Agency (REA) grant agreement no. 625466 and L.C. under REA grant agreement no. 627478]. F.G. acknowledges support from Mitacs through the Accelerate Program. S.T.C. acknowledges support from the CityU SRG-Fd (Strategic Research Grant for fundable Competitive Earmarked Research Grant) program #7004189. We thank R. Helsten for the mechanical design of the interferometer housing; P. Saggu for assisting in the measurement of the single-photon spectrum; L. La Volpe for assisting in the evaluation of the tomography measurement; J. Azana, T. A. Denidni, S. O. Tatu, and L. Razzari for providing some of the required experimental equipment; and A. Tavares, A. Yurtsever, and M. A. Gauthier for helpful discussions. Special thanks go to QuantumOpus and N. Bertone of OptoElectronics Components for their help and for providing us with state-of-the-art photon detection equipment.	Azzini S, 2012, OPT EXPRESS, V20, P23100, DOI 10.1364/OE.20.023100; Bonneau D, 2016, TOP APPL PHYS, V122, P41, DOI 10.1007/978-3-642-10503-6_2; Brendel J, 1999, PHYS REV LETT, V82, P2594, DOI 10.1103/PhysRevLett.82.2594; Chen M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.120505; Clark AS, 2012, OPT EXPRESS, V20, P16807, DOI 10.1364/OE.20.016807; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; Eisaman MD, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3610677; Gerry C. C., 2005, INTRO QUANTUM OPTICS; Grassani D, 2015, OPTICA, V2, P88, DOI 10.1364/OPTICA.2.000088; Harris NC, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041047; Humphreys PC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.150501; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kippenberg TJ, 2011, SCIENCE, V332, P555, DOI 10.1126/science.1193968; Kolobov MI, 1999, REV MOD PHYS, V71, P1539, DOI 10.1103/RevModPhys.71.1539; Matthews JCF, 2009, NAT PHOTONICS, V3, P346, DOI 10.1038/NPHOTON.2009.93; Menicucci NC, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.120504; Moss DJ, 2013, NAT PHOTONICS, V7, P597, DOI [10.1038/NPHOTON.2013.183, 10.1038/nphoton.2013.183]; OU ZY, 1992, PHYS REV LETT, V68, P3663, DOI 10.1103/PhysRevLett.68.3663; Ou ZY, 1999, PHYS REV LETT, V83, P2556, DOI 10.1103/PhysRevLett.83.2556; Pittman T., 2013, PHYSICS, V6, P110; Politi A, 2008, SCIENCE, V320, P646, DOI 10.1126/science.1155441; Pysher M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.030505; Reimer C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9236; Reimer C, 2014, OPT EXPRESS, V22, P6535, DOI 10.1364/OE.22.006535; Roslund J, 2014, NAT PHOTONICS, V8, P109, DOI [10.1038/nphoton.2013.340, 10.1038/NPHOTON.2013.340]; Vallone G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.180502; Walther P, 2005, NATURE, V434, P169, DOI 10.1038/nature03347; Wieczorek W, 2009, IEEE J SEL TOP QUANT, V15, P1704, DOI 10.1109/JSTQE.2009.2025697	30	259	267	10	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1176	1180		10.1126/science.aad8532	http://dx.doi.org/10.1126/science.aad8532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965623	Green Accepted			2022-12-28	WOS:000386158400040
J	Alicea, J				Alicea, Jason			SUPERCONDUCTORS Exponential boost for quantum information	NATURE			English	Editorial Material							MAJORANA FERMIONS		[Alicea, Jason] CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA; [Alicea, Jason] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Alicea, J (corresponding author), CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA.; Alicea, J (corresponding author), CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA.	aliceaj@caltech.edu						Albrecht SM, 2016, NATURE, V531, P206, DOI 10.1038/nature17162; Hyart T, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035121; Kitaev AY., 2001, PHYS-USP+, V44, P131, DOI [10.1070/1063-7869/44/10S/S29, DOI 10.1070/1063-7869/44/10S/S29]; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Nadj-Perge S, 2014, SCIENCE, V346, P602, DOI 10.1126/science.1259327; Stanescu TD, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.094518	6	4	4	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					177	178		10.1038/531177a	http://dx.doi.org/10.1038/531177a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26961651				2022-12-28	WOS:000371665100026
J	Settleman, J; Cohen, RL				Settleman, Jeff; Cohen, Robert L.			Communication in Drug Development: "Translating'' Scientific Discovery	CELL			English	Editorial Material								The discovery and development of new medicines that promote human health and potentially extend natural life remains a remarkably challenging endeavor. In this Commentary, we identify key elements of communication required to successfully translate promising biological findings to novel approved drug therapies and discuss the attendant challenges and opportunities.	[Settleman, Jeff; Cohen, Robert L.] Calico Life Sci, 1170 Vet Blvd, San Francisco, CA 94080 USA		Settleman, J (corresponding author), Calico Life Sci, 1170 Vet Blvd, San Francisco, CA 94080 USA.	settleman@calicolabs.com						Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Committee on a Framework for Developing a New Taxonomy of Disease; National Research Council, 2011, PREC MED BUILD KNOWL; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; DiMasi Joseph A, 2016, J HLTH EC; Nature Editors, 2013, NATURE, V496, P398, DOI DOI 10.1038/496398A; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER), 2015, GUID BEST P IN PRESS	8	8	8	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1101	1104		10.1016/j.cell.2016.02.050	http://dx.doi.org/10.1016/j.cell.2016.02.050			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967277	Bronze			2022-12-28	WOS:000372784900008
J	Clarfield, AM				Clarfield, A. Mark			I'm over 65, but I don't need a discounted bus fare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Clarfield, A. Mark] Ben Gurion Univ Negev, Soroka Hosp, IL-84105 Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center	Clarfield, AM (corresponding author), Ben Gurion Univ Negev, Soroka Hosp, IL-84105 Beer Sheva, Israel.	markclar@bgu.ac.il							0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2016	352								i1365	10.1136/bmj.i1365	http://dx.doi.org/10.1136/bmj.i1365			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NL	26961702				2022-12-28	WOS:000372048800004
J	Daniels, E; Watchorn, R				Daniels, Ella; Watchorn, Richard			Unilateral facial flushing precipitated by eating	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Daniels, Ella] Tunbridge Wells Hosp, Tunbridge Wells TN2 4QJ, England; [Watchorn, Richard] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England	University of Exeter	Daniels, E (corresponding author), Tunbridge Wells Hosp, Tunbridge Wells TN2 4QJ, England.	ella.daniels@nhs.net							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2016	352								i1377	10.1136/bmj.i1377	http://dx.doi.org/10.1136/bmj.i1377			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NL	26960312	Green Submitted			2022-12-28	WOS:000372048800005
J	Wilbur, MB				Wilbur, MaryAnn B.			Skin Abscess	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					882	882		10.1056/NEJMclde1600286	http://dx.doi.org/10.1056/NEJMclde1600286			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF2FT	26962909				2022-12-28	WOS:000371158400015
J	Shoham, S; Antar, AAR; Auwaerter, PG; Durand, CM; Sulkowski, MS; Cotton, DJ				Shoham, Shmuel; Antar, Annukka A. R.; Auwaerter, Paul G.; Durand, Christine M.; Sulkowski, Mark S.; Cotton, Deborah J.			Antimicrobial Access in the 21st Century: Delays and Critical Shortages	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Shoham, Shmuel] Johns Hopkins Univ, Sch Med, Div Infect Dis, 1830 East Monument St,Room 447, Baltimore, MD 21205 USA; [Antar, Annukka A. R.] Johns Hopkins Univ, Sch Med, Div Infect Dis, 1830 East Monument St,Room 450-B, Baltimore, MD 21205 USA; [Auwaerter, Paul G.] Johns Hopkins Med, Sherrilyn & Ken Fisher Ctr Environm Infect Dis, 725 North Wolfe St,PTCB Room 231, Baltimore, MD 21287 USA; [Durand, Christine M.] Johns Hopkins Univ, Sch Med, Div Infect Dis, 1830 East Monument St,Room 450-D, Baltimore, MD 21205 USA; [Sulkowski, Mark S.] Johns Hopkins Univ, Sch Med, Div Infect Dis, 1830 East Monument St,Room 445, Baltimore, MD 21205 USA; [Cotton, Deborah J.] Boston Univ, Sch Med, One Boston Med Ctr Pl,Dowling 3 North, Boston, MA 02118 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Boston Medical Center; Boston University	Shoham, S (corresponding author), Johns Hopkins Univ, Sch Med, Div Infect Dis, 1830 East Monument St,Room 447, Baltimore, MD 21205 USA.	sshoham1@jhmi.edu		Antar, Annukka/0000-0002-6775-1103; Durand, Christine M./0000-0003-2605-9257				Alpern JD, 2014, NEW ENGL J MED, V371, P1859, DOI 10.1056/NEJMp1408376; American Society of Health-System Pharmacists, 2014, 2014 DRUG SHORT SUMM; American Society of Health-System Pharmacists, 2016, MER INJ; [Anonymous], 2015, OP APP TUR PHARM; [Anonymous], 2015, COMMUNICATION; Quadri F, 2015, CLIN INFECT DIS, V60, P1737, DOI 10.1093/cid/civ201; Rockoff Jonathan D., 2015, WALL STREET J; U.S. Government Accountability Office, 2014, DRUG SHORT PUBL HLTH; US Food and Drug Administration, 2013, STRAT PLAN PREV MIT	9	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					53	+		10.7326/M15-3076	http://dx.doi.org/10.7326/M15-3076			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	26999651				2022-12-28	WOS:000379215800008
J	Louder, RK; He, Y; Lopez-Blance, JR; Fang, J; Chacon, P; Nogales, E				Louder, Robert K.; He, Yuan; Ramon Lopez-Blance, Jose; Fang, Jie; Chacon, Pablo; Nogales, Eva			Structure of promoter-bound TFIID and model of human pre-initiation complex assembly	NATURE			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; CORE PROMOTER; TRANSCRIPTION INITIATION; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; HUMAN GENOME; CRYO-EM; TAFS; ARCHITECTURE	The general transcription factor IID (TFIID) plays a central role in the initiation of RNA polymerase II (Pol II)-dependent transcription by nucleating pre-initiation complex (PIC) assembly at the core promoter. TFIID comprises the TATA-binding protein (TBP) and 13 TBP-associated factors (TAF1-13), which specifically interact with a variety of core promoter DNA sequences. Here we present the structure of human TFIID in complex with TFIIA and core promoter DNA, determined by single-particle cryo-electron microscopy at sub-nanometre resolution. All core promoter elements are contacted by subunits of TFIID, with TAF1 and TAF2 mediating major interactions with the downstream promoter. TFIIA bridges the TBP-TATA complex with lobe B of TFIID. We also present the cryo-electron microscopy reconstruction of a fully assembled human TAF-less PIC. Superposition of common elements between the two structures provides novel insights into the general role of TFIID in promoter recognition, PIC assembly, and transcription initiation.	[Louder, Robert K.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [He, Yuan; Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Inst QB3, Berkeley, CA 94720 USA; [He, Yuan; Chacon, Pablo; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrat Bioimaging Div, Berkeley, CA 94720 USA; [Ramon Lopez-Blance, Jose] CSIC, Dept Biol Phys Chem, Rocasolano Phys Chem Inst, Serrano 119, Madrid 28006, Spain; [Fang, Jie; Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [He, Yuan] Northwestern Univ, Interdisciplinary Biol Sci Program, Evanston, IL 60208 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Howard Hughes Medical Institute; University of California System; University of California Berkeley; Northwestern University	Nogales, E (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Inst QB3, Berkeley, CA 94720 USA.; Nogales, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrat Bioimaging Div, Berkeley, CA 94720 USA.; Nogales, E (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	ENogales@lbl.gov	Chacon, Pablo/B-4211-2014; He, Yuan/GVT-7268-2022; Louder, Robert/F-4713-2014	Chacon, Pablo/0000-0002-3168-4826; He, Yuan/0000-0002-1455-3963; Louder, Robert/0000-0002-6944-9346	National Energy Research Scientific Computing Center [DE-AC02-05CH11231]; NIGMS [GM63072]; Spanish Ministry of Economy and Competitiveness [BFU2013-44306P]; NIGMS Molecular Biophysics Training Grant [GM008295]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008295, R01GM063072] Funding Source: NIH RePORTER	National Energy Research Scientific Computing Center; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Spanish Ministry of Economy and Competitiveness(Spanish Government); NIGMS Molecular Biophysics Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Grob, S. Howes, and R. Zhang for electron microscopy support; T. Houweling for computer support; S. Scheres for technical advice on image processing; A. Patel for discussion; C. Inouye for providing us with recombinant TFIIF; S. Zheng for providing TAF4 mAb; and D. King for providing peptides. We are thankful to R. Tjian and J. Kadonaga for their comments on the manuscript. Computational resources were provided in part by the National Energy Research Scientific Computing Center (DE-AC02-05CH11231). This work was funded by NIGMS (GM63072 to E.N.) and Spanish Ministry of Economy and Competitiveness (BFU2013-44306P to P.C.). R.K.L. was supported by the NIGMS Molecular Biophysics Training Grant (GM008295). E.N. is a Howard Hughes Medical Institute Investigator.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Anandapadamanaban M, 2013, NAT STRUCT MOL BIOL, V20, P1008, DOI 10.1038/nsmb.2611; Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Bhattacharya S, 2007, P NATL ACAD SCI USA, V104, P1189, DOI 10.1073/pnas.0610297104; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Birck C, 1998, CELL, V94, P239, DOI 10.1016/S0092-8674(00)81423-3; Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Chys P, 2013, J CHEM THEORY COMPUT, V9, P1821, DOI 10.1021/ct300977f; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Garzon JI, 2007, BIOINFORMATICS, V23, P427, DOI 10.1093/bioinformatics/btl625; Gegonne A, 2013, TRANSCR-AUSTIN, V4, P29, DOI 10.4161/trns.22842; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; HISATAKE K, 1995, P NATL ACAD SCI USA, V92, P8195, DOI 10.1073/pnas.92.18.8195; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Kokubo T, 1998, MOL CELL BIOL, V18, P1003, DOI 10.1128/MCB.18.2.1003; Kraemer SM, 2001, MOL CELL BIOL, V21, P1737, DOI 10.1128/MCB.21.5.1737-1746.2001; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Malkowska M, 2013, BIOCHIMIE, V95, P680, DOI 10.1016/j.biochi.2012.10.024; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Lopez-Blanco JR, 2013, J STRUCT BIOL, V184, P261, DOI 10.1016/j.jsb.2013.08.010; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; RUPPERT S, 1995, GENE DEV, V9, P2747, DOI 10.1101/gad.9.22.2747; Scheer E, 2012, J BIOL CHEM, V287, P27580, DOI 10.1074/jbc.M112.379206; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Theisen JWM, 2010, MOL CELL BIOL, V30, P3471, DOI 10.1128/MCB.00053-10; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Trowitzsch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7011; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang H, 2014, CELL RES, V24, P1433, DOI 10.1038/cr.2014.148; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Wu SY, 2001, J BIOL CHEM, V276, P34235, DOI 10.1074/jbc.M102463200; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yakovchuk P, 2010, J MOL BIOL, V397, P57, DOI 10.1016/j.jmb.2010.01.025; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang ZJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07777	73	140	143	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					604	+		10.1038/nature17394	http://dx.doi.org/10.1038/nature17394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27007846	Green Accepted, Green Submitted			2022-12-28	WOS:000373027400031
J	Bertuzzi, S; Jamaleddine, Z				Bertuzzi, Stefano; Jamaleddine, Zeina			Capturing the Value of Biomedical Research	CELL			English	Editorial Material							SCIENCE; IMPACT; QATAR	Assessing the real-world impact of biomedical research is notoriously difficult. Here, we present the framework for building a prospective science-centered information system from scratch that has been afforded by the Sidra Medical and Research Center in Qatar. This experiment is part of the global conversation on maximizing returns on research investment.	[Jamaleddine, Zeina] Out Patient Clin, Sidra Med & Res Ctr, POB 26999,Al Luqta St, Doha, Qatar; [Bertuzzi, Stefano] Amer Soc Cell Biol, 8120 Woodmont Ave,Suite 750, Bethesda, MD 20814 USA; [Bertuzzi, Stefano] Amer Soc Microbiol, 1752 North St NW, Washington, DC 20036 USA	Qatar Foundation (QF); Georgetown University in Qatar; Sidra Medical & Research Center	Jamaleddine, Z (corresponding author), Out Patient Clin, Sidra Med & Res Ctr, POB 26999,Al Luqta St, Doha, Qatar.	zjamaleddine@sidra.org		Jamaleddine, Zeina/0000-0002-5858-6046				Al-Mulla F, 2014, APPL TRANSL GENOM, V3, P132, DOI 10.1016/j.atg.2014.09.012; Benamer HTS, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-26; Bertuzzi S, 2013, MOL BIOL CELL, V24, P1505, DOI 10.1091/mbc.E13-04-0193; Bornmann L, 2013, J AM SOC INF SCI TEC, V64, P217, DOI 10.1002/asi.22803; Chouchane L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-16; Coleman R, 1999, ANAT RECORD, V257, P54; Hunter-Zinck H, 2010, AM J HUM GENET, V87, P17, DOI 10.1016/j.ajhg.2010.05.018; Jorgenson DW, 2008, J ECON PERSPECT, V22, P3, DOI 10.1257/jep.22.1.3; Lane J, 2011, SCIENCE, V331, P678, DOI 10.1126/science.1201865; Lane J, 2009, SCIENCE, V324, P1273, DOI 10.1126/science.1175335; Macilwain C, 2010, NATURE, V465, P682, DOI 10.1038/465682a; Marincola FM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-177; Weinberg BA, 2014, SCIENCE, V344, P41, DOI 10.1126/science.1250055	13	5	5	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					9	12		10.1016/j.cell.2016.03.004	http://dx.doi.org/10.1016/j.cell.2016.03.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015300	Bronze			2022-12-28	WOS:000372785600002
J	Hugo, W; Zaretsky, JM; Sun, L; Song, CY; Moreno, BH; Hu-Lieskovan, S; Berent-Maoz, B; Pang, J; Chmielowski, B; Cherry, G; Seja, E; Lomeli, S; Kong, XJ; Kelley, MC; Sosman, JA; Johnson, DB; Ribas, A; Lo, RS				Hugo, Willy; Zaretsky, Jesse M.; Sun, Lu; Song, Chunying; Moreno, Blanca Homet; Hu-Lieskovan, Siwen; Berent-Maoz, Beata; Pang, Jia; Chmielowski, Bartosz; Cherry, Grace; Seja, Elizabeth; Lomeli, Shirley; Kong, Xiangju; Kelley, Mark C.; Sosman, Jeffrey A.; Johnson, Douglas B.; Ribas, Antoni; Lo, Roger S.			Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma	CELL			English	Article							RNA-SEQ EXPERIMENTS; PD-1 BLOCKADE; EXPRESSION ANALYSIS; CTLA-4 BLOCKADE; COPY NUMBER; CANCER; GENE; PREDICTION; RESISTANCE; MUTATIONS	PD-1 immune checkpoint blockade provides significant clinical benefits for melanoma patients. We analyzed the somatic mutanomes and transcriptomes of pretreatment melanoma biopsies to identify factors that may influence innate sensitivity or resistance to anti-PD-1 therapy. We find that overall high mutational loads associate with improved survival, and tumors from responding patients are enriched for mutations in the DNA repair gene BRCA2. Innately resistant tumors display a transcriptional signature (referred to as the IPRES, or innate anti-PD-1 resistance), indicating concurrent up-expression of genes involved in the regulation of mesenchymal transition, cell adhesion, extracellular matrix remodeling, angiogenesis, and wound healing. Notably, mitogen-activated protein kinase (MAPK)-targeted therapy (MAPK inhibitor) induces similar signatures in melanoma, suggesting that a non-genomic form of MAPKinhibitor resistance mediates cross-resistance to anti-PD-1 therapy. Validation of the IPRES in other independent tumor cohorts defines a transcriptomic subset across distinct types of advanced cancer. These findings suggest that attenuating the biological processes that underlie IPRES may improve antiPD- 1 response in melanoma and other cancer types.	[Hugo, Willy; Sun, Lu; Song, Chunying; Lomeli, Shirley; Kong, Xiangju; Lo, Roger S.] Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Zaretsky, Jesse M.; Ribas, Antoni; Lo, Roger S.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Moreno, Blanca Homet; Hu-Lieskovan, Siwen; Berent-Maoz, Beata; Pang, Jia; Chmielowski, Bartosz; Cherry, Grace; Seja, Elizabeth; Ribas, Antoni] Univ Calif Los Angeles, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Ribas, Antoni] Univ Calif Los Angeles, Dept Surg, Div Surg Oncol, Los Angeles, CA 90095 USA; [Ribas, Antoni; Lo, Roger S.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Hugo, Willy; Zaretsky, Jesse M.; Sun, Lu; Song, Chunying; Lomeli, Shirley; Kong, Xiangju; Ribas, Antoni; Lo, Roger S.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kelley, Mark C.] Vanderbilt Ingram Canc Ctr, Dept Surg, Nashville, TN 37232 USA; [Sosman, Jeffrey A.; Johnson, Douglas B.] Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vanderbilt University; Vanderbilt University	Lo, RS (corresponding author), Univ Calif Los Angeles, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA.; Lo, RS (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Lo, RS (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA.; Lo, RS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	rlo@mednet.ucla.edu		Hugo, Willy/0000-0002-1426-7190	NIH [R35 CA197633, P01 CA168585, 1R01CA176111, K12CA0906525]; Ressler Family Foundation; Grimaldi Family Fund; Burroughs Wellcome Fund; Ian Cope-land Melanoma Fund; Wade F.B. Thompson/Cancer Research Institute CLIP Grant; Steven C. Gordon Family Foundation; American Skin Association; Dr. Robert Vigen Memorial Fund; Garcia-Corsini Family Fund; ASCO Conquer Cancer Career Development Award; American Cancer Society Research Professorship; NATIONAL CANCER INSTITUTE [R01CA176111, P30CA016042, P01CA168585, K12CA090625, R35CA197633] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ressler Family Foundation; Grimaldi Family Fund; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ian Cope-land Melanoma Fund; Wade F.B. Thompson/Cancer Research Institute CLIP Grant; Steven C. Gordon Family Foundation; American Skin Association; Dr. Robert Vigen Memorial Fund; Garcia-Corsini Family Fund; ASCO Conquer Cancer Career Development Award; American Cancer Society Research Professorship(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work has been funded by the NIH (R35 CA197633 to A.R., P01 CA168585 to A.R. and R.S.L., 1R01CA176111 to R.S.L., and K12CA0906525 to D.B.J.), the Ressler Family Foundation (to R.S.L. and A. R.), the Grimaldi Family Fund (to A. R. and R.S.L.), the Burroughs Wellcome Fund (to R.S.L.), the Ian Cope-land Melanoma Fund (to R.S.L.), the Wade F.B. Thompson/Cancer Research Institute CLIP Grant (to R.S.L.), the Steven C. Gordon Family Foundation (to R.S.L.), the American Skin Association (to W.H.), the Dr. Robert Vigen Memorial Fund (to A. R.), the Garcia-Corsini Family Fund (to A. R.), the ASCO Conquer Cancer Career Development Award (to D.B.J.), and the American Cancer Society Research Professorship (to J.A.S.). Informed consents were obtained from patients for the research performed in this study.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Chen LM, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.1002731; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Hoos A, 2015, CLIN CANCER RES, V21, P4989, DOI 10.1158/1078-0432.CCR-14-3128; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hugo W, 2015, CELL, V162, P1271, DOI 10.1016/j.cell.2015.07.061; Inkeles MS, 2015, J INVEST DERMATOL, V135, P151, DOI 10.1038/jid.2014.352; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Liu C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt481; Mak MP, 2016, CLIN CANCER RES, V22, P609, DOI 10.1158/1078-0432.CCR-15-0876; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Motz GT, 2011, NAT REV IMMUNOL, V11, P702, DOI 10.1038/nri3064; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Voron T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00070; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624	45	1665	1716	18	236	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					35	44		10.1016/j.cell.2016.02.065	http://dx.doi.org/10.1016/j.cell.2016.02.065			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	26997480	Green Accepted, Bronze			2022-12-28	WOS:000372785600008
J	Mathews, JA; Tan, H				Mathews, John A.; Tan, Hao			Lessons from China	NATURE			English	Editorial Material							INDUSTRIAL SYMBIOSIS		[Mathews, John A.] Macquarie Univ, Macquarie Grad Sch Management, Strategy, Sydney, NSW 2109, Australia; [Tan, Hao] Univ Newcastle, Newcastle Business Sch, Int Business, Callaghan, NSW 2308, Australia	Macquarie University; University of Newcastle	Mathews, JA (corresponding author), Macquarie Univ, Macquarie Grad Sch Management, Strategy, Sydney, NSW 2109, Australia.	john.mathews@mgsm.edu.au; haotan1@gmail.com		Tan, Hao/0000-0002-8347-7837; Mathews, John/0000-0002-4380-7563				Chertow MR, 2000, ANNU REV ENERG ENV, V25, P313, DOI 10.1146/annurev.energy.25.1.313; Hoornweg D, 2013, NATURE, V502, P615, DOI 10.1038/502615a; Mathews JA, 2015, BUILD SUS POLIT ECON, P1, DOI 10.1057/9781137546258; Mathews JA, 2011, J IND ECOL, V15, P435, DOI 10.1111/j.1530-9290.2011.00332.x; National Bureau of Statistics of the People's Republic of China, 2015, NAT CIRC EC DEV IND; State Council of the People's Republic of China (State Council), 2013, CIRC EC DEV STRAT IM; Wen ZG, 2015, J CLEAN PROD, V90, P211, DOI 10.1016/j.jclepro.2014.03.041; Xu Y., 2015, ENV PROT CIRC EC, V9, P10; Yu F, 2015, J CLEAN PROD, V87, P339, DOI 10.1016/j.jclepro.2014.10.058; Zhu Dajian, 1998, SCI TECHNOLOGY REV, V9, P39	10	116	120	6	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					440	442		10.1038/531440a	http://dx.doi.org/10.1038/531440a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QK	27008954	Bronze			2022-12-28	WOS:000372701300015
J	Morgan, JL; Berger, DR; Wetzel, AW; Lichtman, JW				Morgan, Josh Lyskowski; Berger, Daniel Raimund; Wetzel, Arthur Willis; Lichtman, Jeff William			The Fuzzy Logic of Network Connectivity in Mouse Visual Thalamus	CELL			English	Article							LATERAL GENICULATE-NUCLEUS; RELAY CELLS; Y-CELLS; RETINOGENICULATE CONNECTIONS; RECEPTIVE-FIELDS; X-CELLS; CAT; MORPHOLOGY; ORGANIZATION; RECONSTRUCTION	In an attempt to chart parallel sensory streams passing through the visual thalamus, we acquired a 100-trillion-voxel electron microscopy (EM) dataset and identified cohorts of retinal ganglion cell axons (RGCs) that innervated each of a diverse group of postsynaptic thalamocortical neurons (TCs). Tracing branches of these axons revealed the set of TCs innervated by each RGC cohort. Instead of finding separate sensory pathways, we found a single large network that could not be easily subdivided because individual RGCs innervated different kinds of TCs and different kinds of RGCs co-innervated individual TCs. We did find conspicuous network subdivisions organized on the basis of dendritic rather than neuronal properties. This work argues that, in the thalamus, neural circuits are not based on a canonical set of connections between intrinsically different neuronal types but, rather, may arise by experience-based mixing of different kinds of inputs onto individual postsynaptic cells.	[Morgan, Josh Lyskowski; Berger, Daniel Raimund; Lichtman, Jeff William] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Morgan, Josh Lyskowski; Berger, Daniel Raimund; Lichtman, Jeff William] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Wetzel, Arthur Willis] Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA	Harvard University; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Morgan, JL; Lichtman, JW (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; Morgan, JL; Lichtman, JW (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.	joshmorgan@fas.harvard.ed; jeff@mcb.harvard.edu			NIH/NINDS [1DP2OD006514-01, TR01 1R01NS076467-01, 1U01NS090449-01]; IARPA via DoI/IBC [D16PC00002]; Conte [1P50MH094271-01]; MURI Army Research Office [W911NF1210594, IIS-1447786]; NSF [OIA-1125087, IIS-1110955]; Human Frontier Science Program [RGP0051/2014]; NIH; NIGMS via the National Center for Multiscale Modeling of Biological Systems [P41GM10371]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076467, U01NS090449] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006514] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); IARPA via DoI/IBC; Conte; MURI Army Research Office; NSF(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS via the National Center for Multiscale Modeling of Biological Systems; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We gratefully acknowledge support from the NIH/NINDS (1DP2OD006514-01, TR01 1R01NS076467-01, and 1U01NS090449-01), IARPA via DoI/IBC (D16PC00002), Conte (1P50MH094271-01), MURI Army Research Office (contract no. W911NF1210594 and IIS-1447786), NSF (OIA-1125087 and IIS-1110955), the Human Frontier Science Program (RGP0051/2014), and the NIH and NIGMS via the National Center for Multiscale Modeling of Biological Systems (P41GM10371). We are grateful to Linda Xu, Jacob Wasag, Aidan Piper, Seaun Yoo, Shana Attar, Katherine Mateos, Abigail Orlando, Anne Crosby, Kyla Cordrey, Allan Ordonez, and Marquise Bartley, who helped segment the data. We are grateful to James Cuff and his expert staff at Harvard Research Computing for data management, to Hanspeter Pfister and his lab members for help with image storage and alignment, and to Richard Schalek for management and troubleshooting of the EM hardware. We are also grateful to R. Clay Reid, who was involved in the initial planning and support.	Alonso JM, 2006, PROG BRAIN RES, V154, P3, DOI 10.1016/S0079-6123(06)54001-4; Caron SJC, 2013, NATURE, V497, P113, DOI 10.1038/nature12063; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; CLELAND BG, 1971, NATURE-NEW BIOL, V231, P191, DOI 10.1038/newbio231191a0; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; Dhande OS, 2014, CURR OPIN NEUROBIOL, V24, P133, DOI 10.1016/j.conb.2013.08.006; FAMIGLIETTI EV, 1972, J COMP NEUROL, V144, P285, DOI 10.1002/cne.901440304; FRIEDLANDER MJ, 1981, J NEUROPHYSIOL, V46, P80, DOI 10.1152/jn.1981.46.1.80; Gao EQ, 2010, J NEUROSCI, V30, P5912, DOI 10.1523/JNEUROSCI.6456-09.2010; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; GUILLERY RW, 1969, Z ZELLFORSCH MIK ANA, V96, P1, DOI 10.1007/BF00321474; Hammer S, 2015, CELL REP, V12, P1575, DOI 10.1016/j.celrep.2015.08.003; HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202; Hayworth KJ, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00068; Hong YK, 2014, NEURON, V84, P332, DOI 10.1016/j.neuron.2014.08.059; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; KADOTA T, 1979, BRAIN RES, V177, P49, DOI 10.1016/0006-8993(79)90917-X; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Krahe TE, 2011, J NEUROSCI, V31, P17437, DOI 10.1523/JNEUROSCI.4370-11.2011; LEE BB, 1983, EXP BRAIN RES, V52, P50; LEVENTHAL AG, 1981, SCIENCE, V213, P1139, DOI 10.1126/science.7268423; Lieberman A R, 1974, Anat Embryol (Berl), V145, P261; Ling CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049161; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; Martinez LM, 2014, NEURON, V81, P943, DOI 10.1016/j.neuron.2013.12.014; MASTRONARDE DN, 1992, VISUAL NEUROSCI, V8, P407, DOI 10.1017/S0952523800004934; Morgan JL, 2013, NAT METHODS, V10, P494, DOI 10.1038/nmeth.2480; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; SHERMAN SM, 1982, PHYSIOL REV, V62, P738, DOI 10.1152/physrev.1982.62.2.738; SPACEK J, 1974, J ANAT, V117, P487; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; STANFORD LR, 1983, J NEUROPHYSIOL, V50, P582, DOI 10.1152/jn.1983.50.3.582; SUR M, 1987, J NEUROPHYSIOL, V58, P1; Tapia JC, 2012, NEURON, V74, P816, DOI 10.1016/j.neuron.2012.04.017; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Yeh CI, 2003, J NEUROPHYSIOL, V90, P1852, DOI 10.1152/jn.00417.2003; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	42	129	131	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					192	206		10.1016/j.cell.2016.02.033	http://dx.doi.org/10.1016/j.cell.2016.02.033			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015312	Bronze, Green Accepted			2022-12-28	WOS:000372785600020
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Looking for dementia-in the name of "awareness"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2016, PRIME MINISTERS CHAL	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2016	352								i1621	10.1136/bmj.i1621	http://dx.doi.org/10.1136/bmj.i1621			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LI	27000934	Bronze, Green Published			2022-12-28	WOS:000373044300009
J	Schwartz, GJ				Schwartz, Gary J.			A satiating signal	SCIENCE			English	Editorial Material									[Schwartz, Gary J.] Albert Einstein Coll Med, Dept Med & Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Schwartz, GJ (corresponding author), Albert Einstein Coll Med, Dept Med & Neurosci, Bronx, NY 10461 USA.	gary.schwartz@einstein.yu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, P30DK020541, P60DK020541, R01DK105441] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 026687, P60 DK020541, P30 DK026687, P30 DK020541, DK 020541, R01 DK105441, DK 105441] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blouet C., 2009, J NEUROSCI, V29, P8302; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Moran TH, 2010, FORUM NUTR, V63, P94, DOI 10.1159/000264397; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Schwartz GJ, 2013, ANNU REV NUTR, V33, P1, DOI 10.1146/annurev-nutr-071812-161125	5	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1269	1270		10.1126/science.aaf5216	http://dx.doi.org/10.1126/science.aaf5216			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989239	Green Accepted			2022-12-28	WOS:000372397700022
J	Struzhkin, V				Struzhkin, Viktor			Squeezing into superconductivity	SCIENCE			English	Editorial Material							HIGH-PRESSURES		[Struzhkin, Viktor] Carnegie Inst Sci, 5251 Broad Branch Rd NW, Washington, DC 20015 USA	Carnegie Institution for Science	Struzhkin, V (corresponding author), Carnegie Inst Sci, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	vstruzhkin@ciw.edu	Struzhkin, Viktor V/J-9847-2013	Struzhkin, Viktor V/0000-0002-3468-0548				Ashcroft NW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187002; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; CHU CW, 1993, NATURE, V365, P323, DOI 10.1038/365323a0; Dean D., 2014, SCI REP, V4, P6968; Drozdov AP, 2015, NATURE, V525, P73, DOI 10.1038/nature14964; Dubrovinsky L, 2015, NATURE, V525, P226, DOI 10.1038/nature14681; McMahon JM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.144515; Meissner W, 1933, NATURWISSENSCHAFTEN, V21, P787, DOI 10.1007/BF01504252; Struzhkin VV, 2015, PHYSICA C, V514, P77, DOI 10.1016/j.physc.2015.02.017; Troyan I, 2016, SCIENCE, V351, P1303, DOI 10.1126/science.aac8176	10	11	11	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1260	1262		10.1126/science.aaf2541	http://dx.doi.org/10.1126/science.aaf2541			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989233				2022-12-28	WOS:000372397700016
J	Gaines, JM				Gaines, James M.			FLOODING Water potential	NATURE			English	Editorial Material																		Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Lin N, 2012, NAT CLIM CHANGE, V2, P462, DOI 10.1038/NCLIMATE1389; Rotzoll K, 2013, NAT CLIM CHANGE, V3, P477, DOI [10.1038/NCLIMATE1725, 10.1038/nclimate1725]	3	23	25	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S54	S55		10.1038/531S54a	http://dx.doi.org/10.1038/531S54a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26981728				2022-12-28	WOS:000372064300002
J	Jacobsson, D; Panciera, F; Tersoff, J; Reuter, MC; Lehmann, S; Hofmann, S; Dick, KA; Ross, FM				Jacobsson, Daniel; Panciera, Federico; Tersoff, Jerry; Reuter, Mark C.; Lehmann, Sebastian; Hofmann, Stephan; Dick, Kimberly A.; Ross, Frances M.			Interface dynamics and crystal phase switching in GaAs nanowires	NATURE			English	Article							SELF-CATALYZED GAAS; III-V NANOWIRES; PHOSPHIDE NANOWIRES; SILICON NANOWIRES; GROWTH-KINETICS; SOLID GROWTH; ZINC BLENDE; INAS; MECHANISMS; ZINCBLENDE	Controlled formation of non-equilibrium crystal structures is one of the most important challenges in crystal growth. Catalytically grown nanowires are ideal systems for studying the fundamental physics of phase selection, and could lead to new electronic applications based on the engineering of crystal phases. Here we image gallium arsenide (GaAs) nanowires during growth as they switch between phases as a result of varying growth conditions. We find clear differences between the growth dynamics of the phases, including differences in interface morphology, step flow and catalyst geometry. We explain these differences, and the phase selection, using a model that relates the catalyst volume, the contact angle at the trijunction (the point at which solid, liquid and vapour meet) and the nucleation site of each new layer of GaAs. This model allows us to predict the conditions under which each phase should be observed, and use these predictions to design GaAs heterostructures. These results could apply to phase selection in other nanowire systems.	[Jacobsson, Daniel; Lehmann, Sebastian; Dick, Kimberly A.] Lund Univ, Solid State Phys & NanoLund, Box 118, S-22100 Lund, Sweden; [Jacobsson, Daniel; Dick, Kimberly A.] Lund Univ, Ctr Anal & Synth, Box 124, S-22100 Lund, Sweden; [Panciera, Federico; Hofmann, Stephan] Univ Cambridge, Dept Engn, 9 JJ Thomson Ave, Cambridge CB3 0FA, England; [Panciera, Federico; Tersoff, Jerry; Reuter, Mark C.; Ross, Frances M.] IBM TJ Watson Res Ctr, 1101 Kitchawan Rd, Yorktown Hts, NY 10598 USA	Lund University; Lund University; University of Cambridge; International Business Machines (IBM)	Jacobsson, D (corresponding author), Lund Univ, Solid State Phys & NanoLund, Box 118, S-22100 Lund, Sweden.; Jacobsson, D (corresponding author), Lund Univ, Ctr Anal & Synth, Box 124, S-22100 Lund, Sweden.; Ross, FM (corresponding author), IBM TJ Watson Res Ctr, 1101 Kitchawan Rd, Yorktown Hts, NY 10598 USA.	Daniel.jacobsson@ftf.lth.se; fmross@us.ibm.com	Hofmann, Stephan/D-3906-2012; Jacobsson, Daniel/B-3150-2014; Dick, Kimberly A/A-8579-2008; Lehmann, Sebastian/B-7540-2012; Ross, Frances/P-8919-2015	Hofmann, Stephan/0000-0001-6375-1459; Jacobsson, Daniel/0000-0001-5774-5116; Dick, Kimberly A/0000-0003-4125-2039; Lehmann, Sebastian/0000-0002-4091-905X; Panciera, Federico/0000-0003-2455-6516; Ross, Frances/0000-0003-0838-9770	Knut and Alice Wallenberg Foundation (KAW); Swedish Research Council (VR); Nanometer Structure Consortium at Lund University (nmC@LU); ERC [279342]	Knut and Alice Wallenberg Foundation (KAW)(Knut & Alice Wallenberg Foundation); Swedish Research Council (VR)(Swedish Research Council); Nanometer Structure Consortium at Lund University (nmC@LU); ERC(European Research Council (ERC)European Commission)	D.J., S.L. and K.A.D. acknowledge financial support from the Knut and Alice Wallenberg Foundation (KAW), the Swedish Research Council (VR) and the Nanometer Structure Consortium at Lund University (nmC@LU). F.P. and S.H. acknowledge support from ERC Grant 279342: InSituNANO. We acknowledge A. Ellis for technical support.	Akopian N, 2010, NANO LETT, V10, P1198, DOI 10.1021/nl903534n; Algra RE, 2011, NANO LETT, V11, P1259, DOI 10.1021/nl104267p; Assali S, 2013, NANO LETT, V13, P1559, DOI 10.1021/nl304723c; Caroff P, 2009, NAT NANOTECHNOL, V4, P50, DOI [10.1038/nnano.2008.359, 10.1038/NNANO.2008.359]; Chou YC, 2014, SCIENCE, V343, P281, DOI 10.1126/science.1244623; Cirlin GE, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.035302; De A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.155210; Dheeraj DL, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/1/015601; Dick KA, 2010, NANO LETT, V10, P3494, DOI 10.1021/nl101632a; Dubrovskii VG, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864276; Dubrovskii VG, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.235301; Gamalski AD, 2011, J PHYS CHEM C, V115, P4413, DOI 10.1021/jp1095882; Glas F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.146101; Hillerich K, 2013, NANO LETT, V13, P903, DOI 10.1021/nl303660h; Hilner E, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2416315; Husanu E, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/20/205601; Ikejiri K, 2011, NANO LETT, V11, P4314, DOI 10.1021/nl202365q; Jiang N, 2014, NANO LETT, V14, P5865, DOI 10.1021/nl5027937; Johansson J, 2016, CRYST GROWTH DES, V16, P371, DOI 10.1021/acs.cgd.5b01339; Johansson J, 2009, CRYST GROWTH DES, V9, P766, DOI 10.1021/cg800270q; Johansson J, 2008, J CRYST GROWTH, V310, P5102, DOI 10.1016/j.jcrysgro.2008.08.003; Joyce HJ, 2010, NANO LETT, V10, P908, DOI 10.1021/nl903688v; KOGUCHI M, 1992, JPN J APPL PHYS 1, V31, P2061, DOI 10.1143/JJAP.31.2061; Krogstrup P, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/31/313001; Krogstrup P, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3688489; Krogstrup P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.125505; Krogstrup P, 2010, NANO LETT, V10, P4475, DOI 10.1021/nl102308k; LARSEN CA, 1988, APPL PHYS LETT, V52, P480, DOI 10.1063/1.99450; Lehmann S, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/30/301001; Lehmann S, 2013, NANO LETT, V13, P4099, DOI 10.1021/nl401554w; Munshi AM, 2013, J CRYST GROWTH, V372, P163, DOI 10.1016/j.jcrysgro.2013.03.004; Oh SH, 2010, SCIENCE, V330, P489, DOI 10.1126/science.1190596; Raynor G. V., 1990, PHASE DIAGRAMS TERNA, P123; Ross FM, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/11/114501; Schmidt V, 2005, APPL PHYS A-MATER, V80, P445, DOI 10.1007/s00339-004-3092-1; Schwarz KW, 2011, NANO LETT, V11, P316, DOI 10.1021/nl1027815; Spirkoska D, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245325; Takahasi M, 2015, CRYST GROWTH DES, V15, P4979, DOI 10.1021/acs.cgd.5b00915; TAMARU K, 1955, J PHYS CHEM-US, V59, P777, DOI 10.1021/j150530a020; Vainorius N, 2015, NANO LETT, V15, P2652, DOI 10.1021/acs.nanolett.5b00253; Wallentin J, 2010, NANO LETT, V10, P4807, DOI 10.1021/nl101747z; Wen CY, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.025503; Wen CY, 2010, NANO LETT, V10, P514, DOI 10.1021/nl903362y; Xu T, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/9/095702; Yu XZ, 2012, NANO LETT, V12, P5436, DOI 10.1021/nl303323t; Yuan XM, 2015, ADV MATER, V27, P6096, DOI 10.1002/adma.201503540	46	229	232	2	394	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					317	+		10.1038/nature17148	http://dx.doi.org/10.1038/nature17148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26983538	Green Accepted			2022-12-28	WOS:000372064300042
J	Warraich, HJ; Schulman, KA				Warraich, Haider Javed; Schulman, Kevin A.			Health Care Tax Inversions - Robbing Both Peter and Paul	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Warraich, Haider Javed; Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Schulman, Kevin A.] Harvard Univ, Business Sch, Boston, MA 02115 USA	Duke University; Duke University; Harvard University	Warraich, HJ (corresponding author), Duke Univ, Sch Med, Dept Med, Durham, NC USA.							[Anonymous], 2015, FORTUNE; Bach P., 2015, WASHINGTON POST; Congressional Budget Office, 2015, MED BAS; International Federation of Health Plans, 2013, 2013 COMP PRIC REP V; US Senate Permanent Subcommittee on Investigations, 2011, REP OFFSH FUNDS 2004	5	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1005	1007		10.1056/NEJMp1515769	http://dx.doi.org/10.1056/NEJMp1515769			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG4TR	26981932				2022-12-28	WOS:000372066100003
J	Bates, ER				Bates, Eric R.			Review: In patients with chest pain, risk scores better predict high risk for ACS than individual risk factors	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bates, Eric R.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Korley FK, 2013, J AM COLL CARDIOL, V61, P1753, DOI 10.1016/j.jacc.2012.09.069	1	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					JC34	JC34		10.7326/ACPJC-2016-164-6-034	http://dx.doi.org/10.7326/ACPJC-2016-164-6-034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26974734				2022-12-28	WOS:000372207200009
J	Burbach, JPH				Burbach, J. Peter H.			Unraveling a pathway to autism	SCIENCE			English	Editorial Material									[Burbach, J. Peter H.] Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Burbach, JPH (corresponding author), Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	j.p.h.burbach@umcutrecht.nl						Berry-Kravis E, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aab4109; Bidinosti M, 2016, SCIENCE, V351, P1199, DOI 10.1126/science.aad5487; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Mei Y, 2016, NATURE, V530, P481, DOI 10.1038/nature16971; Sahin M, 2015, SCIENCE, V350, P890, DOI 10.1126/science.aab3897; Yi F, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2669	8	3	3	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1153	1154		10.1126/science.aaf5097	http://dx.doi.org/10.1126/science.aaf5097			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ8YI	26965613				2022-12-28	WOS:000386158400027
J	Kuiken, T				Kuiken, Todd			Learn from DIY biologists	NATURE			English	Editorial Material									[Kuiken, Todd] Woodrow Wilson Int Ctr Scholars, Synthet Biol Project, Washington, DC 20560 USA		Kuiken, T (corresponding author), Woodrow Wilson Int Ctr Scholars, Synthet Biol Project, Washington, DC 20560 USA.	todd.kuiken@wilsoncenter.org	Kuiken, Todd/U-3476-2019	Kuiken, Todd/0000-0001-7851-6232				Charo RA, 2015, AM J BIOETHICS, V15, P11, DOI 10.1080/15265161.2015.1104138; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945	2	20	20	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					167	168		10.1038/531167a	http://dx.doi.org/10.1038/531167a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26961642	Bronze			2022-12-28	WOS:000371665100016
J	Appleby, J				Appleby, John			Crossing the line: NICE's value for money threshold	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Kings Fund Inst, London NW1 7NF, England		Appleby, J (corresponding author), Kings Fund Inst, London NW1 7NF, England.	j.appleby@kingsfund.org.uk						Claxton K, 2013, 81 CHE; Culyer AJ, 2016, 121 CHE; Dakin H, 2015, HEALTH ECON, V24, P1256, DOI 10.1002/hec.3086; Timmins N, 2016, TERRIBLE BEAUTY SHOR; World Health Organization (WHO), 2016, COST EFF STRAT PLANN	5	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2016	352								i1336	10.1136/bmj.i1336	http://dx.doi.org/10.1136/bmj.i1336			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NL	26960807				2022-12-28	WOS:000372048800002
J	Pathan, SA; Mitra, B; Straney, LD; Afzal, MS; Anjum, S; Shukla, D; Morley, K; Al Hilli, SA; Al Rumaihi, K; Thomas, SH; Cameron, PA				Pathan, Sameer A.; Mitra, Biswadev; Straney, Lahn D.; Afzal, Muhammad Shuaib; Anjum, Shahzad; Shukla, Dharmesh; Morley, Kostantinos; Al Hilli, Shatha A.; Al Rumaihi, Khalid; Thomas, Stephen H.; Cameron, Peter A.			Delivering safe and effective analgesia for management of renal colic in the emergency department: a double-blind, multigroup, randomised controlled trial	LANCET			English	Article							PLACEBO-CONTROLLED TRIAL; SEVERE ACUTE PAIN; ANTIINFLAMMATORY DRUGS; 0.10 MG/KG; MORPHINE; DICLOFENAC; KETOROLAC; EFFICACY; ACETAMINOPHEN; UROLITHIASIS	Background The excruciating pain of patients with renal colic on presentation to the emergency department requires effective analgesia to be administered in the shortest possible time. Trials comparing intramuscular non-steroidal anti-inflammatory drugs with intravenous opioids or paracetamol have been inconclusive because of the challenges associated with concealment of randomisation, small sample size, differences in outcome measures, and inadequate masking of participants and assessors. We did this trial to develop definitive evidence regarding the choice of initial analgesia and route of administration in participants presenting with renal colic to the emergency department. Methods In this three-treatment group, double-blind, randomised controlled trial, adult participants (aged 18-65 years) presenting to the emergency department of an academic, tertiary care hospital in Qatar, with moderate to severe renal colic (Numerical pain Rating Scale >= 4) were recruited. With the use of computer-generated block randomisation (block sizes of six and nine), participants were assigned (1:1:1) to receive diclofenac (75 mg/3 mL intramuscular), morphine (0.1 mg/kg intravenous), or paracetamol (1 g/100 mL intravenous). Participants, clinicians, and trial personnel were masked to treatment assignment. The primary outcome was the proportion of participants achieving at least a 50% reduction in initial pain score at 30 min after analgesia, assessed by intention-to-treat analysis and per-protocol analysis, which included patients where a calculus in the urinary tract was detected with imaging. This trial is registered with ClinicalTrials.gov, number NCT02187614. Findings Between Aug 5, 2014, and March 15, 2015, we randomly assigned 1645 participants, of whom 1644 were included in the intention-to-treat analysis (547 in the diclofenac group, 548 in the paracetemol group, and 549 in the morphine group). Ureteric calculi were detected in 1316 patients, who were analysed as the per-protocol population (438 in the diclofenac group, 435 in the paracetemol group, and 443 in the morphine group). The primary outcome was achieved in 371 (68%) patients in the diclofenac group, 364 (66%) in the paracetamol group, and 335 (61%) in the morphine group in the intention-to-treat population. Compared to morphine, diclofenac was significantly more effective in achieving the primary outcome (odds ratio [OR] 1.35, 95% CI 1.05-1.73, p = 0.0187), whereas no difference was detected in the effectiveness of morphine compared with intravenous paracetamol (1.26, 0.99-1.62, p = 0.0629). In the per-protocol population, diclofenac (OR 1.49, 95% CI 1.13-1.97, p = 0.0046) and paracetamol (1.40, 1.06-1.85, p = 0.0166) were more effective than morphine in achieving the primary outcome. Acute adverse events in the morphine group occurred in 19 (3%) participants. Significantly lower numbers of adverse events were recorded in the diclofenac group (7 [1%] participants, OR 0.31, 95% CI 0.12-0.78, p = 0.0088) and paracetamol group (7 [1%] participants, 0.36, 0.15-0.87, p = 0.0175) than in the morphine group. During the 2 week follow-up, no additional adverse events were noted in any group. Interpretation Intramuscular non-steroidal anti-infl ammatory drugs off er the most effective sustained analgesia for renal colic in the emergency department and seem to have fewer side-effects.	[Pathan, Sameer A.; Afzal, Muhammad Shuaib; Anjum, Shahzad; Morley, Kostantinos; Thomas, Stephen H.; Cameron, Peter A.] Hamad Med Corp, Hamad Gen Hosp, Emergency Dept, Doha, Qatar; [Al Hilli, Shatha A.] Hamad Med Corp, Hamad Gen Hosp, Emergency Radiol Sect, Dept Radiol, Doha, Qatar; [Al Rumaihi, Khalid] Hamad Med Corp, Hamad Gen Hosp, Dept Urol, Doha, Qatar; [Pathan, Sameer A.; Mitra, Biswadev; Straney, Lahn D.; Cameron, Peter A.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Mitra, Biswadev; Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Mitra, Biswadev; Cameron, Peter A.] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Thomas, Stephen H.] Weill Cornell Med Coll Qatar, Doha, Qatar	Hamad Medical Corporation; Hamad General Hospital; Hamad Medical Corporation; Hamad General Hospital; Hamad Medical Corporation; Hamad General Hospital; Monash University; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Pathan, SA (corresponding author), POB 50107, Mesaieed, Qatar.	drsameer_pathan@live.com	Mitra, Biswadev/AAC-3724-2019	Mitra, Biswadev/0000-0002-0508-2450; Thomas, Stephen/0000-0003-4153-3965; Cameron, Peter/0000-0002-1443-557X; Sayed Abdelmoneim, Mohamed/0000-0001-5073-6532	Hamad Medical Corporation Medical Research Center, Doha, Qatar [IRGC-01-NI-045]	Hamad Medical Corporation Medical Research Center, Doha, Qatar	The trial was funded by Hamad Medical Corporation Medical Research Center, Doha, Qatar (grant number IRGC-01-NI-045). We thank all trial participants and the staff at HGH-ED for taking part in this trial. We especially thank Ramzi Mohammad, Kirti S Prabhu (Interim Translational Research Institute [iTRI]-HMC), Saleem Farook, Yogdutt Sharma, Dominic Jenkins, Warda Ali Alsaad, Aftab Azad, Mandar Marathe, Zain A Bhutta, Isma Qureshi, Furqan B Irfan, Galal Saleh Alessai, Hany H Ali Kamel, Mohammed A Majeed, Vajjalaravi Kumar, Syed Nabir, Salman Mirza, Andrew Frazer, Noor B Khial, Hani S Ali Aljazzazi, Mohamed Sayed Abdelmoneim, Hani Abdelaziz, Rajaa Ghallab Abdelhadi, Sathish Munirathinam, Sithik Ajees Khan, Sana Nadeem, Amjad Ali, Asmaa Abdul Hameed, Mohammed Yousuf Shariff, Muhammad Masood Khalid, Hamdy Nasser Awad Abdullah, Mujeed Ur Rehman, Mizanur Rahman, and Ramsha Tahir for their assistance with the conduct of the trial.	Afshar K, 2015, COCHRANE DB SYST REV, V6; Ahmad F, 2015, SAUDI J KIDNEY DIS T, V26, P386, DOI 10.4103/1319-2442.152557; [Anonymous], 2002, BMJ-BRIT MED J, V325, P1408; Ay MO, 2014, AM J THER, V21, P296, DOI 10.1097/MJT.0b013e318274db78; Azizkhani R, 2013, J RES MED SCI, V18, P772; Bektas F, 2009, ANN EMERG MED, V54, P568, DOI 10.1016/j.annemergmed.2009.06.501; Birnbaum A, 2007, ANN EMERG MED, V49, P445, DOI 10.1016/j.annemergmed.2006.06.030; Burton JH, 2008, EMERGENCY SEDATION AND PAIN MANAGEMENT, P1, DOI 10.1017/CBO9780511547225; Cohen E, 1998, EUR J CLIN PHARMACOL, V54, P455, DOI 10.1007/s002280050492; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; Ducharme J, 2011, TINTINALLIS EMERGENC; Farsi D, 2013, ULUS TRAVMA ACIL CER, V19, P398, DOI 10.5505/tjtes.2013.86383; Fisang C, 2015, DTSCH ARZTEBL INT, V112, P83, DOI 10.3238/arztebl.2015.0083; Forrest JB, 2002, BRIT J ANAESTH, V88, P227, DOI 10.1093/bja/88.2.227; Ghani KR, 2014, J UROLOGY, V191, P90, DOI 10.1016/j.juro.2013.07.098; Grissa MH, 2011, AM J EMERG MED, V29, P203, DOI 10.1016/j.ajem.2009.09.019; Hindle A, 2003, BRIT MED J, V326, P502, DOI 10.1136/bmj.326.7387.502; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Holdgate A, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004137.PUB2; Kaynar M, 2015, AM J EMERG MED, V33, P749, DOI 10.1016/j.ajem.2015.02.033; Keane Michael, 2007, ACUTE PAIN, V9, P87; LABRECQUE M, 1994, ARCH INTERN MED, V154, P1381, DOI 10.1001/archinte.154.12.1381; Larkin GL, 1999, AM J EMERG MED, V17, P6, DOI 10.1016/S0735-6757(99)90003-7; Macintyre PE, 2009, ACUTE PAIN MANAGEMENT, P204, DOI 10.1017/CBO9780511576706.016; Manjiani D, 2014, OCHSNER J, V14, P208; Masoumi K, 2014, EMERG MED INT, V2014, DOI 10.1155/2014/571326; Patanwala AE, 2010, ANN PHARMACOTHER, V44, P1800, DOI 10.1345/aph.1P438; Pickard R, 2015, USE DRUG THERAPY MAN; Safdar B, 2006, ANN EMERG MED, V48, P173, DOI 10.1016/j.annemergmed.2006.03.013; Sakhaee K, 2012, J CLIN ENDOCR METAB, V97, P1847, DOI 10.1210/jc.2011-3492; Salameh S, 2011, OPEN EMERG MED J, V4, P9; Serinken M, 2012, EMERG MED J, V29, P902, DOI 10.1136/emermed-2011-200165; Stein A, 1996, AM J EMERG MED, V14, P385, DOI 10.1016/S0735-6757(96)90055-8; Strope SA, 2010, UROLOGY, V75, P543, DOI 10.1016/j.urology.2009.08.007; Thomas SH, 2013, INT SCHOLARLY RES NO, V2013, DOI [10.1155/2013/583132, DOI 10.1155/2013/583132]; Tramer MR, 1998, ACTA ANAESTH SCAND, V42, P71; Tuomilehto H, 2002, ACTA ANAESTH SCAND, V46, P184, DOI 10.1034/j.1399-6576.2002.460211.x; Tveita T, 2008, ACTA ANAESTH SCAND, V52, P920, DOI 10.1111/j.1399-6576.2008.01608.x	38	66	68	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					1999	2007		10.1016/S0140-6736(16)00652-8	http://dx.doi.org/10.1016/S0140-6736(16)00652-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	26993881				2022-12-28	WOS:000375881500028
J	Bolkan, S; Gordon, JA				Bolkan, Scott; Gordon, Joshua A.			NEUROSCIENCE Untangling autism	NATURE			English	Editorial Material							ATTENTION		[Bolkan, Scott] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Gordon, Joshua A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA	Columbia University; Columbia University	Gordon, JA (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	jg343@cumc.columbia.edu			NIMH NIH HHS [F31 MH102041] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bartho P, 2014, NEURON, V82, P1367, DOI 10.1016/j.neuron.2014.04.046; Chaudhry A, 2015, CLIN GENET, V88, P224, DOI 10.1111/cge.12482; Coe BP, 2012, CURR OPIN NEUROBIOL, V22, P829, DOI 10.1016/j.conb.2012.04.007; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Wells MF, 2016, NATURE, V532, P58, DOI 10.1038/nature17427; Wimmer RD, 2015, NATURE, V526, P705, DOI 10.1038/nature15398	8	2	2	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					45	46		10.1038/nature17311	http://dx.doi.org/10.1038/nature17311			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27007842	Green Accepted			2022-12-28	WOS:000373555500029
J	Mariani, TJ				Mariani, Thomas J.			Ironing out smoking-related airway disease	NATURE			English	Editorial Material									[Mariani, Thomas J.] Univ Rochester, Med Ctr, Div Neonatol, Rochester, NY 14642 USA; [Mariani, Thomas J.] Univ Rochester, Med Ctr, Pediat Mol & Personalized Med Program, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Mariani, TJ (corresponding author), Univ Rochester, Med Ctr, Div Neonatol, Rochester, NY 14642 USA.; Mariani, TJ (corresponding author), Univ Rochester, Med Ctr, Pediat Mol & Personalized Med Program, Rochester, NY 14642 USA.	tom_mariani@urmc.rochester.edu						Aravamudan B, 2013, EXPERT REV RESP MED, V7, P631, DOI 10.1586/17476348.2013.834252; BURROWS B, 1977, AM REV RESPIR DIS, V115, P195; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Cloonan SM, 2016, NAT MED, V22, P163, DOI 10.1038/nm.4021; Demeo DL, 2009, AM J HUM GENET, V85, P493, DOI 10.1016/j.ajhg.2009.09.004; Dubey S, 2009, AM J RESP CRIT CARE, V179, P860, DOI 10.1164/rccm.200902-0289UP; Ghio AJ, 2009, BBA-GEN SUBJECTS, V1790, P731, DOI 10.1016/j.bbagen.2008.11.004; Gordon SB, 2014, LANCET RESP MED, V2, P823, DOI 10.1016/S2213-2600(14)70168-7; Islam JY, 2015, AM J RESP CRIT CARE, V192, P134, DOI 10.1164/rccm.201412-2142PP; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; LIEBERMAN J, 1986, CHEST, V89, P370, DOI 10.1378/chest.89.3.370; Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1; Silverman EK, 2002, AM J HUM GENET, V70, P1229, DOI 10.1086/340316; Weiss ST, 2010, NAT GENET, V42, P14, DOI 10.1038/ng0110-14	14	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					586	587		10.1038/nature17309	http://dx.doi.org/10.1038/nature17309			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	26958829				2022-12-28	WOS:000373027400026
J	Shadlen, MN; Kiani, R; Newsome, WT; Gold, JI; Wolpert, DM; Zylberberg, A; Ditterich, J; de Lafuente, V; Yang, TM; Roitman, J				Shadlen, Michael N.; Kiani, Roozbeh; Newsome, William T.; Gold, Joshua I.; Wolpert, Daniel M.; Zylberberg, Ariel; Ditterich, Jochen; de Lafuente, Victor; Yang, Tianming; Roitman, Jamie			Comment on "Single-trial spike trains in parietal cortex reveal discrete steps during decision-making"	SCIENCE			English	Editorial Material							LATERAL INTRAPARIETAL AREA; CHANGE-POINT; NEURONS	Latimer et al. (Reports, 10 July 2015, p. 184) claim that during perceptual decision formation, parietal neurons undergo one-time, discrete steps in firing rate instead of gradual changes that represent the accumulation of evidence. However, that conclusion rests on unsubstantiated assumptions about the time window of evidence accumulation, and their stepping model cannot explain existing data as effectively as evidence-accumulation models.	[Shadlen, Michael N.; Zylberberg, Ariel] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Shadlen, Michael N.; Zylberberg, Ariel] Columbia Univ, Dept Neurosci, New York, NY USA; [Kiani, Roozbeh] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Newsome, William T.] HHMI, Stanford, CA USA; [Newsome, William T.] Stanford Univ, Stanford, CA 94305 USA; [Gold, Joshua I.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Wolpert, Daniel M.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Ditterich, Jochen] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Ditterich, Jochen] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [de Lafuente, Victor] Univ Nacl Autonoma Mexico, Inst Neurosci, Queretaro, Mexico; [Yang, Tianming] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Roitman, Jamie] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; New York University; Howard Hughes Medical Institute; Stanford University; University of Pennsylvania; University of Cambridge; University of California System; University of California Davis; University of California System; University of California Davis; Universidad Nacional Autonoma de Mexico; Chinese Academy of Sciences; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shadlen, MN (corresponding author), Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.; Shadlen, MN (corresponding author), Columbia Univ, Dept Neurosci, New York, NY USA.	shadlen@columbia.edu	Shadlen, Michael Neil/AAL-1870-2020; Yang, Tianming/D-3582-2014; Newsome, William T./W-7171-2019	Yang, Tianming/0000-0001-6976-9246; Wolpert, Daniel/0000-0003-2011-2790; Zylberberg, Ariel/0000-0002-2572-4748; de Lafuente, Victor/0000-0002-1047-1354	Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY011378] Funding Source: Medline; Wellcome Trust [097803] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; Bollimunta A, 2012, J NEUROSCI, V32, P12684, DOI 10.1523/JNEUROSCI.5752-11.2012; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; COMMENGES D, 1985, STAT MED, V4, P91, DOI 10.1002/sim.4780040113; COMMENGES D, 1986, MATH BIOSCI, V80, P81, DOI 10.1016/0025-5564(86)90068-4; de Lafuente V, 2015, J NEUROSCI, V35, P4306, DOI 10.1523/JNEUROSCI.2451-14.2015; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kira S, 2015, NEURON, V85, P861, DOI 10.1016/j.neuron.2015.01.007; Latimer KW, 2015, SCIENCE, V349, P184, DOI 10.1126/science.aaa4056; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; Roitman JD, 2002, J NEUROSCI, V22, P9475; Wilson RC, 2010, NEURAL COMPUT, V22, P2452, DOI 10.1162/NECO_a_00007; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	14	21	21	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280								10.1126/science.aad3242	http://dx.doi.org/10.1126/science.aad3242			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013723	Green Accepted			2022-12-28	WOS:000372756200034
J	Walshe, K; Coleman, A; McDonald, R; Lorne, C; Munford, L				Walshe, Kieran; Coleman, Anna; McDonald, Ruth; Lorne, Colin; Munford, Luke			Health and social care devolution: the Greater Manchester experiment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Walshe, Kieran; McDonald, Ruth; Lorne, Colin] Univ Manchester, Manchester Business Sch, Manchester M15 6PB, Lancs, England; [Coleman, Anna] Univ Manchester, Ctr Primary Care, Manchester M15 6PB, Lancs, England; [Munford, Luke] Univ Manchester, Ctr Hlth Econ, Manchester M15 6PB, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Walshe, K (corresponding author), Univ Manchester, Manchester Business Sch, Manchester M15 6PB, Lancs, England.	kieran.walshe@mbs.ac.uk		McDonald, Ruth/0000-0002-3488-4209; Lorne, Colin/0000-0002-1000-0800; Munford, Luke/0000-0003-4540-6744; Walshe, Kieran/0000-0002-0696-480X				[Anonymous], 2015, JOINT GREAT MANCH CO; [Anonymous], 2016, CITIES LOCAL GOVT DE; Cairney P., 2011, ALL POINTS N SCOTTIS; City Growth Commission, 2014, UNL METR FIN REC CIT; CLAHRC GM/Health Foundation, 2015, DEV HLTH SOC CAR LEA; Costa- I- Font J, 2012, FISCAL FEDERALISM EU; Cox E, 2014, STATE N SETTING BASE; England NHS, 2015, GREAT MANCH HLTH SOC; Greater Manchester Combined Authority, 2015, TAK CHARG OUR HLTH S; Greater Manchester Combined Authority, 2013, STRONG TOG GREAT MAN; Greater MCA, 2015, TAK CHARG OUR HLTH S; Hazell R, 2015, DEVOLUTION FUTURE UN; Jenkins S, 2015, GUARDIAN; Local Government Association, 2015, DEV NEXT ENGL DEV LO; Local Government Association, 2015, ENGL DEV LOC SOL SUC; McKenna H, 2015, DEVOLUTION WHAT IT M; Sandford M, 2004, COMMENTARY DRAFT REG; Smith DM, 2014, DEVOLUTION AND LOCALISM IN ENGLAND, P1; Travers T, 2002, REG STUD, V36, P779, DOI 10.1080/0034340022000006097; Ward R, 2005, CITY STATE NATION BI	20	18	18	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2016	352								i1495	10.1136/bmj.i1495	http://dx.doi.org/10.1136/bmj.i1495			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LK	27006416				2022-12-28	WOS:000373044500006
J	Harris, N				Harris, Nicola			The enigmatic tuft cell in immunity	SCIENCE			English	Editorial Material									[Harris, Nicola] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Harris, N (corresponding author), Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland.	nicola.harris@epfl.ch	harris, nicola/E-5342-2019	harris, nicola/0000-0003-2922-0210				Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bezencon C, 2008, J COMP NEUROL, V509, P514, DOI 10.1002/cne.21768; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gerbe F, 2012, CELL MOL LIFE SCI, V69, P2907, DOI 10.1007/s00018-012-0984-7; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161	7	12	13	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1265	1266		10.1126/science.aaf5215	http://dx.doi.org/10.1126/science.aaf5215			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989236				2022-12-28	WOS:000372397700019
J	Jolly, K; Douglas, JA; Hamnett, N; Natalwala, I; van Niekerk, WJC				Jolly, Karan; Douglas, James Andrew; Hamnett, Nathan; Natalwala, Ibrahim; van Niekerk, William J. C.			CASE REVIEW Ongoing effects of burns	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Jolly, Karan; Hamnett, Nathan; Natalwala, Ibrahim; van Niekerk, William J. C.] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England; [Douglas, James Andrew] Royal Hosp Wolverhampton, Wolverhampton, W Midlands, England	University of Birmingham	Jolly, K (corresponding author), Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England.	kjolly@nhs.net						Baker RHJ, 2007, J PLAST RECONSTR AES, V60, P682, DOI 10.1016/j.bjps.2006.09.003; Barnes J, 2014, EMERG MED J, DOI [10.1136/emermed-2013-203416, DOI 10.1136/EMERMED-2013-203416.25371408]; Brusselaers N, 2010, CRIT CARE, V14, DOI 10.1186/cc9300; Devgan Lara, 2006, J Burns Wounds, V5, pe2; Doull J, 1980, TOXICOLOGY BASIC SCI; Hall AH, 2002, VET HUM TOXICOL, V44, P228; Hettiaratchy S, 2004, BMJ-BRIT MED J, V329, P101, DOI 10.1136/bmj.329.7457.101; Janzekovic Z, 1970, J Trauma, V10, P1103; Judkins K, 2000, TRAUMA, V2, P239, DOI [10.1177/146040860000200401, DOI 10.1177/146040860000200401]; LEONARD LG, 1982, J TRAUMA, V22, P420, DOI 10.1097/00005373-198205000-00013; Luterman A, 1990, PLASTIC SURG PRINCIP, P1355; Moriarty TF, 1979, DRUG THER, V3, P89; Palao R, 2010, BURNS, V36, P295, DOI 10.1016/j.burns.2009.07.009; Pham TN, 2008, J BURN CARE RES, V29, P257, DOI 10.1097/BCR.0b013e31815f3876; Pruitt BA, 1990, ANN M AM BURNS ASS; Robson MC, 1990, PLASTIC SURG PRINCIP, P1355; Rossiter ND, 1996, BURNS, V22, P230, DOI 10.1016/0305-4179(95)00118-2; Sandford AP, 2002, TOTAL BURN CARE, P475; Saydjari R, 1986, J Burn Care Rehabil, V7, P404, DOI 10.1097/00004630-198609000-00005; SHERIDAN RL, 1995, BURNS, V21, P62, DOI 10.1016/0305-4179(95)90785-X; STEWART CE, 1985, AM FAM PHYSICIAN, V31, P149; Sykes R A, 1986, J Burn Care Rehabil, V7, P343, DOI 10.1097/00004630-198607000-00008	22	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2016	352								i1104	10.1136/bmj.i1104	http://dx.doi.org/10.1136/bmj.i1104			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1ZT	26979783				2022-12-28	WOS:000372584400003
J	Maki, DG				Maki, Dennis G.			TDF-FTC before and after sex reduced HIV infection but increased GI and renal events in men who have sex with men	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Maki, Dennis G.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA.							Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; JUUSOLA JL, 2012, ANN INTERN MED, V156, P541, DOI DOI 10.1059/0003-4819-156-8-201204170-00001; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Okwundu CI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007189.pub3; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Walensky RP, 2015, J INFECT DIS; WHO, 2013, HANDBOOK ON HEALTH INEQUALITY MONITORING: WITH A SPECIAL FOCUS ON LOW- AND MIDDLE-INCOME COUNTRIES, P1	7	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					JC28	JC28		10.7326/ACPJC-2016-164-6-028	http://dx.doi.org/10.7326/ACPJC-2016-164-6-028			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26974728				2022-12-28	WOS:000372207200003
J	Santos, RD				Santos, Raul D.			Review: PCSK9 inhibitors reduce mortality but increase neurocognitive events in hypercholesterolemia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Santos, Raul D.] Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo	Santos, RD (corresponding author), Univ Sao Paulo, Heart Inst InCor, Sao Paulo, Brazil.		Santos, Raul/A-1170-2010	Santos, Raul/0000-0002-9860-6582				Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Pandya A, 2015, JAMA-J AM MED ASSOC, V314, P142, DOI 10.1001/jama.2015.6822; Santos RD, 2015, LANCET, V385, P307, DOI 10.1016/S0140-6736(14)61702-5	3	7	7	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					JC31	JC31		10.7326/ACPJC-2016-164-6-031	http://dx.doi.org/10.7326/ACPJC-2016-164-6-031			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26974731				2022-12-28	WOS:000372207200006
J	Berkowitz, T; Schaeffer, MW; Rozek, CS; Maloney, EA; Levine, SC; Beilock, SL				Berkowitz, Talia; Schaeffer, Marjorie W.; Rozek, Christopher S.; Maloney, Erin A.; Levine, Susan C.; Beilock, Sian L.			Response to Comment on "Math at home adds up to achievement in school"	SCIENCE			English	Editorial Material							ANXIETY	Frank presents an alternative interpretation of our data, yet reports largely similar results to those in our original Report. A critical difference centers on how to interpret and test interaction effects. Frank finds no mistakes in our analyses. We stand by our original conclusions of meaningful effects of the Bedtime Learning Together (BLT) math app on children's math achievement.	[Berkowitz, Talia; Schaeffer, Marjorie W.; Rozek, Christopher S.; Maloney, Erin A.; Levine, Susan C.; Beilock, Sian L.] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Levine, SC; Beilock, SL (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	s-levine@uchicago.edu; beilock@uchicago.edu		Schaeffer, Marjorie/0000-0003-1168-6741				Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Beilock SL, 2010, P NATL ACAD SCI USA, V107, P1860, DOI 10.1073/pnas.0910967107; Berkowitz T, 2015, SCIENCE, V350, P196, DOI 10.1126/science.aac7427; Frank MC, 2016, SCIENCE, V351, DOI 10.1126/science.aad8008; Gunderson EA, 2011, DEVELOPMENTAL SCI, V14, P1021, DOI 10.1111/j.1467-7687.2011.01050.x; HEMBREE R, 1990, J RES MATH EDUC, V21, P33, DOI 10.2307/749455; Levine SC, 2012, DEV PSYCHOL, V48, P530, DOI 10.1037/a0025913; Levine SC, 2010, DEV PSYCHOL, V46, P1309, DOI 10.1037/a0019671; Maloney EA, 2015, PSYCHOL SCI, V26, P1480, DOI 10.1177/0956797615592630; Manski CF, 2005, SOCIAL CHOICE PARTIA; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; Pruden SM, 2011, DEVELOPMENTAL SCI, V14, P1417, DOI 10.1111/j.1467-7687.2011.01088.x; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; Verdine BN, 2014, J EXP CHILD PSYCHOL, V126, P37, DOI 10.1016/j.jecp.2014.02.012	14	2	2	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278								10.1126/science.aad8555	http://dx.doi.org/10.1126/science.aad8555			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ8YI	26965620				2022-12-28	WOS:000386158400036
J	Haas, NB; Manola, J; Uzzo, RG; Flaherty, KT; Wood, CG; Kane, C; Jewett, M; Dutcher, JP; Atkins, MB; Pins, M; Wilding, G; Cella, D; Wagner, L; Matin, S; Kuzel, TM; Sexton, WJ; Wong, YN; Choueiri, TK; Pili, R; Puzanov, I; Kohli, M; Stadler, W; Carducci, M; Coomes, R; DiPaola, RS				Haas, Naomi B.; Manola, Judith; Uzzo, Robert G.; Flaherty, Keith T.; Wood, Christopher G.; Kane, Christopher; Jewett, Michael; Dutcher, Janice P.; Atkins, Michael B.; Pins, Michael; Wilding, George; Cella, David; Wagner, Lynne; Matin, Surena; Kuzel, Timothy M.; Sexton, Wade J.; Wong, Yu-Ning; Choueiri, Toni K.; Pili, Roberto; Puzanov, Igor; Kohli, Manish; Stadler, Walter; Carducci, Michael; Coomes, Robert; DiPaola, Robert S.			Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial	LANCET			English	Article							PROGNOSTIC NOMOGRAM; INTERFERON-ALPHA; BEVACIZUMAB; THERAPY; CANCER; BREAST; HYPERTENSION; PACLITAXEL; RESISTANCE; PAZOPANIB	Background Renal-cell carcinoma is highly vascular, and proliferates primarily through dysregulation of the vascular endothelial growth factor (VEGF) pathway. We tested sunitinib and sorafenib, two oral anti-angiogenic agents that are effective in advanced renal-cell carcinoma, in patients with resected local disease at high risk for recurrence. Methods In this double-blind, placebo-controlled, randomised, phase 3 trial, we enrolled patients at 226 study centres in the USA and Canada. Eligible patients had pathological stage high-grade T1b or greater with completely resected non-metastatic renal-cell carcinoma and adequate cardiac, renal, and hepatic function. Patients were stratified by recurrence risk, histology, Eastern Cooperative Oncology Group (ECOG) performance status, and surgical approach, and computerised double-blind randomisation was done centrally with permuted blocks. Patients were randomly assigned (1: 1: 1) to receive 54 weeks of sunitinib 50 mg per day orally throughout the first 4 weeks of each 6 week cycle, sorafenib 400 mg twice per day orally throughout each cycle, or placebo. Placebo could be sunitinib placebo given continuously for 4 weeks of every 6 week cycle or sorafenib placebo given twice per day throughout the study. The primary objective was to compare disease-free survival between each experimental group and placebo in the intention-to-treat population. All treated patients with at least one follow-up assessment were included in the safety analysis. This trial is registered with ClinicalTrials.gov, number NCT00326898. Findings Between April 24, 2006, and Sept 1, 2010, 1943 patients from the National Clinical Trials Network were randomly assigned to sunitinib (n = 647), sorafenib (n = 649), or placebo (n = 647). Following high rates of toxicity-related discontinuation after 1323 patients had enrolled (treatment discontinued by 193 [44%] of 438 patients on sunitinib, 199 [45%] of 441 patients on sorafenib), the starting dose of each drug was reduced and then individually titrated up to the original full doses. On Oct 16, 2014, because of low conditional power for the primary endpoint, the ECOG-ACRIN Data Safety Monitoring Committee recommended that blinded follow-up cease and the results be released. The primary analysis showed no significant differences in disease-free survival. Median disease-free survival was 5.8 years (IQR 1.6-8.2) for sunitinib (hazard ratio [HR] 1.02, 97.5% CI 0.85-1.23, p = 0.8038), 6.1 years (IQR 1.7-not estimable [NE]) for sorafenib (HR 0.97, 97.5% CI 0.80-1.17, p = 0.7184), and 6.6 years (IQR 1.5-NE) for placebo. The most common grade 3 or worse adverse events were hypertension (105 [17%] patients on sunitinib and 102 [16%] patients on sorafenib), hand-foot syndrome (94 [15%] patients on sunitinib and 208 [33%] patients on sorafenib), rash (15 [2%] patients on sunitinib and 95 [15%] patients on sorafenib), and fatigue (110 [18%] patients on sunitinib and 44 [7%] patients on sorafenib). There were five deaths related to treatment or occurring within 30 days of the end of treatment; one patient receiving sorafenib died from infectious colitis while on treatment and four patients receiving sunitinib died, with one death due to each of neurological sequelae, sequelae of gastric perforation, pulmonary embolus, and disease progression. Revised dosing still resulted in high toxicity. Interpretation Adjuvant treatment with the VEGF receptor tyrosine kinase inhibitors sorafenib or sunitinib showed no survival benefit relative to placebo in a definitive phase 3 study. Furthermore, substantial treatment discontinuation occurred because of excessive toxicity, despite dose reductions. These results provide a strong rationale against the use of these drugs for high-risk kidney cancer in the adjuvant setting and suggest that the biology of cancer recurrence might be independent of angiogenesis.	[Haas, Naomi B.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Manola, Judith; Choueiri, Toni K.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Uzzo, Robert G.; Wong, Yu-Ning] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Flaherty, Keith T.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Wood, Christopher G.; Wilding, George; Matin, Surena] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Kane, Christopher] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Jewett, Michael] Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada; [Dutcher, Janice P.] Canc Res Fdn, New York, NY USA; [Atkins, Michael B.] Lombardi Comprehens Canc Ctr, Washington, DC USA; [Pins, Michael] Univ Illinois, Coll Med, Chicago, IL USA; [Cella, David; Kuzel, Timothy M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Wagner, Lynne] Wake Forest Sch Med, Salem, NC USA; [Sexton, Wade J.] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Pili, Roberto] Indiana Univ, Indianapolis, IN 46204 USA; [Puzanov, Igor] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Kohli, Manish] Mayo Clin, Rochester, MN USA; [Stadler, Walter] Univ Chicago, Chicago, IL 60637 USA; [Carducci, Michael] Johns Hopkins, Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Coomes, Robert] Canc Res Patient Advocate, Atlanta, GA USA; [DiPaola, Robert S.] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Dana-Farber Cancer Institute; Fox Chase Cancer Center; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Indiana University System; Indiana University-Purdue University Indianapolis; Vanderbilt University; Mayo Clinic; University of Chicago; Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Haas, NB (corresponding author), Abramson Canc Ctr, Philadelphia, PA 19104 USA.	naomi.haas@uphs.upenn.edu	Uzzo, Robert G./U-5238-2019; Kohli, Manish/AAN-8862-2021; Choueiri, Toni/K-5238-2019; Carducci, Michael/R-8164-2019; PUZANOV, IGOR/AAP-2966-2020	Choueiri, Toni/0000-0002-9201-3217; PUZANOV, IGOR/0000-0002-9803-3497	Public Health Service [CA21115, CA66636, CA23318, CA180820, CA180794, CA15488, CA180867, CA27525, CA80775, CA21076, CA180799, CA14958, CA189859, CA17145, CA16116, CA180802, CA49883, CA49957, CA180847, CA13650, CA180790, CA107868, CA180821, CA31946, CA41287, CA32291, CA180836, CA11789, CA077202]; Pfizer; Bayer; NATIONAL CANCER INSTITUTE [U10CA180799, U10CA180820, U10CA031946, U10CA180836, UG1CA189953, U10CA107868, U10CA027525, U10CA016116, UG1CA189859, U10CA049883, P30CA060553, P30CA016672, U10CA014958, U10CA013650, U10CA017145, UG1CA233329, U10CA032291, U10CA180858, U10CA180790, U10CA080775, U10CA049957, U10CA077202, U10CA180794, U10CA041287, U10CA021076, U10CA032102, U10CA066636, U10CA021115, U10CA015488, U10CA011789, U10CA020319, U10CA180821, U24CA196172, U10CA180867, P30CA006927, UG1CA189828, U10CA023318, U10CA180847, U10CA105409, P30CA082709, U10CA180863, U10CA180888, U10CA180802] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Pfizer(Pfizer); Bayer(Bayer AG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by Public Health Service Grants to the ECOG-ACRIN Cancer Research Group (CA21115, CA66636, CA23318, CA180820, CA180794, CA15488, CA180867, CA27525, CA80775, CA21076, CA180799, CA14958, CA189859, CA17145, CA16116, CA180802, CA49883, CA49957, CA180847, CA13650, CA180790, CA107868, CA180821, CA31946, CA41287, CA32291, CA180836, CA11789, CA077202, CA180863, CA180888, CA180858, CA32102, CA105409, CA189953, CA20319). Support, including masked study drug, was also provided by Pfizer and Bayer. We thank Subramanian Hariharan for his advice in the design and conduct of the trial, and Tanya Mustacchio, who coordinated data management.	Allegra CJ, 2013, J CLIN ONCOL, V31, P359, DOI 10.1200/JCO.2012.44.4711; Cameron D, 2013, LANCET ONCOL, V14, P933, DOI 10.1016/S1470-2045(13)70335-8; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Ebos JML, 2007, P NATL ACAD SCI USA, V104, P17069, DOI 10.1073/pnas.0708148104; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Griffioen AW, 2012, CLIN CANCER RES, V18, P3961, DOI 10.1158/1078-0432.CCR-12-0002; Haas NB, 2015, CLIN CANCER RES, V21, P4048, DOI 10.1158/1078-0432.CCR-15-0215; Hammers HJ, 2010, MOL CANCER THER, V9, P1525, DOI 10.1158/1535-7163.MCT-09-1106; International Agency for Research on Cancer, GLOBOCAN 2012 EST CA; JENNISON C, 1989, J R STAT SOC B, V51, P305; Lam JS, 2005, J UROLOGY, V174, P466, DOI 10.1097/01.ju.0000165572.38887.da; Leibovich BC, 2005, J UROLOGY, V174, P1759, DOI 10.1097/01.ju.0000177487.64651.3a; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Pal SK, 2014, ONCOLOGIST, V19, P851, DOI 10.1634/theoncologist.2014-0105; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Rini BI, 2011, JNCI-J NATL CANCER I, V103, P763, DOI 10.1093/jnci/djr128; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schor-Bardach R, 2009, RADIOLOGY, V251, P731, DOI 10.1148/radiol.2521081059; Schwartz LH, 2003, CANCER-AM CANCER SOC, V98, P1611, DOI 10.1002/cncr.11712; Sorbellini M, 2005, J UROLOGY, V173, P48, DOI 10.1097/01.ju.0000148261.19532.2c; Spigel DR, 2010, J CLIN ONCOL, V28, P43, DOI 10.1200/JCO.2009.24.7353; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; van Beijnum JR, 2015, PHARMACOL REV, V67, P441, DOI 10.1124/pr.114.010215; Veronese ML, 2006, J CLIN ONCOL, V24, P1363, DOI 10.1200/JCO.2005.02.0503; Zisman A, 2001, J CLIN ONCOL, V19, P1649, DOI 10.1200/JCO.2001.19.6.1649	31	398	403	2	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					2008	2016		10.1016/S0140-6736(16)00559-6	http://dx.doi.org/10.1016/S0140-6736(16)00559-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	26969090	Green Accepted			2022-12-28	WOS:000375881500029
J	Knoedler, JJ; Lieske, JC				Knoedler, John J.; Lieske, John C.			Non-steroidal anti-inflammatory drugs for renal colic	LANCET			English	Editorial Material							UNITED-STATES; DICLOFENAC; KETOROLAC; STONES		[Knoedler, John J.] Mayo Clin, Dept Urol, Rochester, MN 55902 USA; [Lieske, John C.] Mayo Clin, Dept Nephrol, Rochester, MN 55902 USA	Mayo Clinic; Mayo Clinic	Lieske, JC (corresponding author), Mayo Clin, Dept Nephrol, Rochester, MN 55902 USA.	lieske.john@mayo.edu	Lieske, John/ABA-4829-2020					Afshar K, 2015, COCHRANE DB SYST REV, V29; Brady KT, 2016, AM J PSYCHIAT, V173, P18, DOI 10.1176/appi.ajp.2015.15020262; Carter Michelle R, 2011, Emerg Med Pract, V13, P1; Chen Li Hui, 2014, NCHS Data Brief, P1; Cohen E, 1998, EUR J CLIN PHARMACOL, V54, P455, DOI 10.1007/s002280050492; Forrest JB, 2002, BRIT J ANAESTH, V88, P227, DOI 10.1093/bja/88.2.227; Ghani KR, 2014, J UROLOGY, V191, P90, DOI 10.1016/j.juro.2013.07.098; HOLDGATE A, 2005, COCHRANE DB SYST REV, V18; Pathan SA, 2016, LANCET, V387, P1999, DOI 10.1016/S0140-6736(16)00652-8; Romero Victoriano, 2010, Rev Urol, V12, pe86; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Stein A, 1996, AM J EMERG MED, V14, P385, DOI 10.1016/S0735-6757(96)90055-8	12	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 14	2016	387	10032					1971	1972		10.1016/S0140-6736(16)00745-5	http://dx.doi.org/10.1016/S0140-6736(16)00745-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8HJ	26993882				2022-12-28	WOS:000375881500004
J	Fehrenbacher, L; Spira, A; Ballinger, M; Kowanetz, M; Vansteenkiste, J; Mazieres, J; Park, K; Smith, D; Artal-Cortes, A; Lewanski, C; Braiteh, F; Waterkamp, D; He, P; Zou, W; Chen, DS; Yi, J; Sandler, A; Rittmeyer, A				Fehrenbacher, Louis; Spira, Alexander; Ballinger, Marcus; Kowanetz, Marcin; Vansteenkiste, Johan; Mazieres, Julien; Park, Keunchil; Smith, David; Artal-Cortes, Angel; Lewanski, Conrad; Braiteh, Fadi; Waterkamp, Daniel; He, Pei; Zou, Wei; Chen, Daniel S.; Yi, Jing; Sandler, Alan; Rittmeyer, Achim		POPLAR Study Grp	Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial	LANCET			English	Article							CLINICAL ACTIVITY; TRANSCRIPTION FACTOR; MPDL3280A ANTI-PDL1; ANTIBODY MPDL3280A; III TRIAL; LIGAND; NIVOLUMAB; SAFETY; 2ND	Background Outcomes are poor for patients with previously treated, advanced or metastatic non-small-cell lung cancer (NSCLC). The anti-programmed death ligand 1 (PD-L1) antibody atezolizumab is clinically active against cancer, including NSCLC, especially cancers expressing PD-L1 on tumour cells, tumour-infiltrating immune cells, or both. We assessed efficacy and safety of atezolizumab versus docetaxel in previously treated NSCLC, analysed by PD-L1 expression levels on tumour cells and tumour-infiltrating immune cells and in the intention-to-treat population. Methods In this open-label, phase 2 randomised controlled trial, patients with NSCLC who progressed on post-platinum chemotherapy were recruited in 61 academic medical centres and community oncology practices across 13 countries in Europe and North America. Key inclusion criteria were Eastern Cooperative Oncology Group performance status 0 or 1, measurable disease by Response Evaluation Criteria In Solid Tumors version 1.1 (RECIST v1.1), and adequate haematological and end-organ function. Patients were stratified by PD-L1 tumour-infiltrating immune cell status, histology, and previous lines of therapy, and randomly assigned (1: 1) by permuted block randomisation (with a block size of four) using an interactive voice or web system to receive intravenous atezolizumab 1200 mg or docetaxel 75 mg/m(2) once every 3 weeks. Baseline PD-L1 expression was scored by immunohistochemistry in tumour cells (as percentage of PD-L1-expressing tumour cells TC3 >= 50%, TC2 >= 5% and <50%, TC1 >= 1% and <5%, and TC0<1%) and tumour-infiltrating immune cells (as percentage of tumour area: IC3 >= 10%, IC2 >= 5% and <10%, IC1 >= 1% and <5%, and IC0<1%). The primary endpoint was overall survival in the intention-to-treat population and PD-L1 subgroups at 173 deaths. Biomarkers were assessed in an exploratory analysis. We assessed safety in all patients who received at least one dose of study drug. This study is registered with ClinicalTrials.gov, number NCT01903993. Findings Patients were enrolled between Aug 5, 2013, and March 31, 2014. 144 patients were randomly allocated to the atezolizumab group, and 143 to the docetaxel group. 142 patients received at least one dose of atezolizumab and 135 received docetaxel. Overall survival in the intention-to-treat population was 12.6 months (95% CI 9.7-16.4) for atezolizumab versus 9.7 months (8.6-12.0) for docetaxel (hazard ratio [HR] 0.73 [95% CI 0.53-0.99]; p=0.04). Increasing improvement in overall survival was associated with increasing PD-L1 expression (TC3 or IC3 HR 0.49 [0.22-1.07; p=0.068], TC2/3 or IC2/3 HR 0.54 [0.33-0.89; p=0.014], TC1/2/3 or IC1/2/3 HR 0.59 [0.40-0.85; p=0.005], TC0 and IC0 HR 1.04 [0.62-1.75; p=0.871]). In our exploratory analysis, patients with pre-existing immunity, defined by high T-effector-interferon-gamma-associated gene expression, had improved overall survival with atezolizumab. 11 (8%) patients in the atezolizumab group discontinued because of adverse events versus 30 (22%) patients in the docetaxel group. 16 (11%) patients in the atezolizumab group versus 52 (39%) patients in the docetaxel group had treatment-related grade 3-4 adverse events, and one (<1%) patient in the atezolizumab group versus three (2%) patients in the docetaxel group died from a treatment-related adverse event. Interpretation Atezolizumab significantly improved survival compared with docetaxel in patients with previously treated NSCLC. Improvement correlated with PD-L1 immunohistochemistry expression on tumour cells and tumour-infiltrating immune cells, suggesting that PD-L1 expression is predictive for atezolizumab benefit. Atezolizumab was well tolerated, with a safety profile distinct from chemotherapy.	[Fehrenbacher, Louis] Kaiser Permanente Med Ctr, Vallejo, CA USA; [Spira, Alexander; Smith, David; Braiteh, Fadi] US Oncol Res, The Woodlands, TX USA; [Spira, Alexander] Virginia Canc Specialists Res Inst, Fairfax, VA USA; [Ballinger, Marcus; Kowanetz, Marcin; Waterkamp, Daniel; He, Pei; Zou, Wei; Chen, Daniel S.; Yi, Jing; Sandler, Alan] Genentech Inc, San Francisco, CA 94080 USA; [Vansteenkiste, Johan] Univ Hosp KU Leuven, Leuven, Belgium; [Mazieres, Julien] Univ Toulouse 3, Toulouse Univ Hosp, F-31062 Toulouse, France; [Park, Keunchil] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Smith, David] Compass Oncol, Vancouver, WA USA; [Artal-Cortes, Angel] Hosp Univ Miguel Servet, Serv Oncol Med, Zaragoza, Spain; [Lewanski, Conrad] Charing Cross Hosp, Dept Oncol, London, England; [Braiteh, Fadi] Comprehens Canc Ctr Nevada, Las Vegas, NV USA; [Rittmeyer, Achim] Lungenfachklin Immenhausen, Immenhausen, Germany; Kaiser Permanente Med Ctr, Dept Oncol, Vallejo, CA 94589 USA	Kaiser Permanente; US Oncology Network; Roche Holding; Genentech; KU Leuven; University Hospital Leuven; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Sungkyunkwan University (SKKU); Samsung Medical Center; Miguel Servet University Hospital; Imperial College London; Comprehensive Cancer Centers of Nevada; Kaiser Permanente	Fehrenbacher, L (corresponding author), Kaiser Permanente Med Ctr, Dept Oncol, Vallejo, CA 94589 USA.	Lou.Fehrenbacher@kp.org	Vansteenkiste, Johan F/B-8191-2014; MAZIERES, JULIEN/M-3986-2014; Gridelli, Cesare/K-7909-2016; Akewanlop, Charuwan/AFU-5176-2022; Chen, Daniel Shin-Yu/AGD-8923-2022; Park, Keunchil/ABD-7072-2021; Rittmeyer, Achim/W-2405-2019; Park, Keunchil/ABD-5852-2021; Artal, Angel/D-1555-2011	Vansteenkiste, Johan F/0000-0002-6721-2775; Akewanlop, Charuwan/0000-0003-1022-3745; Chen, Daniel Shin-Yu/0000-0001-5085-3579; Park, Keunchil/0000-0002-4846-7449; MAZIERES, JULIEN/0000-0002-5921-7613; Rittmeyer, Achim/0000-0002-5280-6052; Smith, David/0000-0002-9465-988X; Artal, Angel/0000-0002-9778-706X; MORO-SIBILOT, Denis/0000-0001-6776-8610; Kowalski, Dariusz/0000-0002-9452-3229; Vikstrom, Anders/0000-0003-3549-3944	F Hoffmann-La Roche Ltd/Genentech Inc; Genentech, Inc.	F Hoffmann-La Roche Ltd/Genentech Inc(Hoffmann-La RocheRoche HoldingGenentech); Genentech, Inc.(Roche HoldingGenentech)	This study was supported by F Hoffmann-La Roche Ltd/Genentech Inc, a member of the Roche Group. We thank Gregg Fine and Cathi Ahearn of Genentech, Inc, for their contributions to the design of this study, and Dustin Smith, Natasha Miley, Susan Flynn, and Priti Hegde of Genentech, Inc, for contributions to the biomarker analyses. Ventana Medical Systems, Inc (Tucson, AZ, USA) did central PD-L1 testing. Daniel Clyde (Health Interactions, Manchester, UK) provided third-party writing assistance, with funding from Genentech, Inc.	Akbari O, 2010, MUCOSAL IMMUNOL, V3, P81, DOI 10.1038/mi.2009.112; Al-Farsi A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00157; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Boyd ZS, 2016, CANC IMMUNOL RES S, V4; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen DS, 2012, CLIN CANCER RES, V18, P6580, DOI 10.1158/1078-0432.CCR-12-1362; Fossella FV, 2000, J CLIN ONCOL, V18, P2354, DOI 10.1200/JCO.2000.18.12.2354; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Herbst RS, 2015, LANCET; Horn L, 2015, J CLIN ONCOL S, V33, P8029; Johnson BJ, 2003, P NATL ACAD SCI USA, V100, P2657, DOI 10.1073/pnas.0538056100; Kohrt H, 2013, J IMMUNOTHER CANC S1, V1, pO12; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Matsumoto K, 2008, BIOCHEM BIOPH RES CO, V365, P170, DOI 10.1016/j.bbrc.2007.10.156; NCI NIH DHHS, 2009, NIH PUBL; PAESMANS M, 1995, J CLIN ONCOL, V13, P1221, DOI 10.1200/JCO.1995.13.5.1221; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Ramlau R, 2012, J CLIN ONCOL, V30, P3640, DOI 10.1200/JCO.2012.42.6932; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; Spigel DR, 2015, J CLIN ONCOL S, V33, P8028; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Yang J, 2011, J IMMUNOL, V187, P1113, DOI 10.4049/jimmunol.1100056; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	32	1469	1542	8	207	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1837	1846		10.1016/S0140-6736(16)00587-0	http://dx.doi.org/10.1016/S0140-6736(16)00587-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK6SS	26970723				2022-12-28	WOS:000375056100032
J	Mehanna, H; Wong, WL; McConkey, CC; Rahman, JK; Robinson, M; Hartley, AGJ; Nutting, C; Powell, N; Al-Booz, H; Robinson, M; Junor, E; Rizwanullah, M; von Zeidler, SV; Wieshmann, H; Hulme, C; Smith, AF; Hall, P; Dunn, J				Mehanna, Hisham; Wong, Wai-Lup; McConkey, Christopher C.; Rahman, Joy K.; Robinson, Max; Hartley, Andrew G. J.; Nutting, Christopher; Powell, Ned; Al-Booz, Hoda; Robinson, Martin; Junor, Elizabeth; Rizwanullah, Mohammed; von Zeidler, Sandra V.; Wieshmann, Hulya; Hulme, Claire; Smith, Alison F.; Hall, Peter; Dunn, Janet		PET-NECK Trial Management Grp	PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; POSITRON-EMISSION-TOMOGRAPHY; NODE-POSITIVE HEAD; COMPUTED-TOMOGRAPHY; EORTC QLQ-C30; CHEMORADIOTHERAPY; RADIOTHERAPY; MANAGEMENT; RISK	BACKGROUND The role of image-guided surveillance as compared with planned neck dissection in the treatment of patients with squamous-cell carcinoma of the head and neck who have advanced nodal disease (stage N2 or N3) and who have received chemoradiotherapy for primary treatment is a matter of debate. METHODS In this prospective, randomized, controlled trial, we assessed the noninferiority of positron-emission tomography-computed tomography (PET-CT)-guided surveillance (performed 12 weeks after the end of chemoradiotherapy, with neck dissection performed only if PET-CT showed an incomplete or equivocal response) to planned neck dissection in patients with stage N2 or N3 disease. The primary end point was overall survival. RESULTS From 2007 through 2012, we recruited 564 patients (282 patients in the planned-surgery group and 282 patients in the surveillance group) from 37 centers in the United Kingdom. Among these patients, 17% had nodal stage N2a disease and 61% had stage N2b disease. A total of 84% of the patients had oropharyngeal cancer, and 75% had tumor specimens that stained positive for the p16 protein, an indicator that human papillomavirus had a role in the causation of the cancer. The median follow-up was 36 months. PET-CT-guided surveillance resulted in fewer neck dissections than did planned dissection surgery (54 vs. 221); rates of surgical complications were similar in the two groups (42% and 38%, respectively). The 2-year overall survival rate was 84.9% (95% confidence interval [CI], 80.7 to 89.1) in the surveillance group and 81.5% (95% CI, 76.9 to 86.3) in the planned-surgery group. The hazard ratio for death slightly favored PET-CT-guided surveillance and indicated noninferiority (upper boundary of the 95% CI for the hazard ratio, <1.50; P = 0.004). There was no significant difference between the groups with respect to p16 expression. Quality of life was similar in the two groups. PET-CT-guided surveillance, as compared with neck dissection, resulted in savings of 1,492 pound (approximately $2,190 in U.S. dollars) per person over the duration of the trial. CONCLUSIONS Survival was similar among patients who underwent PET-CT-guided surveillance and those who underwent planned neck dissection, but surveillance resulted in considerably fewer operations and it was more cost-effective.	[Mehanna, Hisham] Univ Birmingham, Inst Head & Neck Studies & Educ, Birmingham, W Midlands, England; [Hartley, Andrew G. J.] Univ Hosp Birmingham, Birmingham, W Midlands, England; [Wong, Wai-Lup] Mt Vernon Hosp, Paul Strickland Scanner Ctr, Northwood HA6 2RN, Middx, England; [McConkey, Christopher C.; Rahman, Joy K.; Dunn, Janet] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Robinson, Max] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Nutting, Christopher] Royal Marsden Hosp, London SW3 6JJ, England; [Powell, Ned] Cardiff Univ, Cardiff CF10 3AX, S Glam, Wales; [Al-Booz, Hoda] Bristol Haematol & Oncol Ctr, Bristol, Avon, England; [Robinson, Martin] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Junor, Elizabeth] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Rizwanullah, Mohammed] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Wieshmann, Hulya] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Hulme, Claire; Smith, Alison F.; Hall, Peter] Univ Leeds, Acad Unit Hlth Econ, Leeds, W Yorkshire, England; [von Zeidler, Sandra V.] Univ Fed Espirito Santo, Dept Pathol, Vitoria, Brazil	University of Birmingham; University of Birmingham; University of Warwick; Newcastle University - UK; Royal Marsden NHS Foundation Trust; Cardiff University; Bristol Haematology & Oncology Centre; Weston Park Hospital; University of Edinburgh; Beatson Oncology Centre; University of Liverpool; University of Leeds; Universidade Federal do Espirito Santo	Mehanna, H (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Head & Neck Studies & Educ, Birmingham B15 2TT, W Midlands, England.	h.mehanna@bham.ac.uk	von Zeidler, Sandra Ventorin/D-1952-2015; Robinson, Max/R-5280-2018	von Zeidler, Sandra Ventorin/0000-0002-8897-5747; Smith, Alison/0000-0001-7709-1869; Dunn, Janet/0000-0001-7313-4446; Sanghera, Bal/0000-0003-0206-7834; Robinson, Max/0000-0003-4491-6865; Mehanna, Hisham/0000-0002-5544-6224; Hulme, Claire/0000-0003-2077-0419; hartley, andrew/0000-0001-8848-4916	National Institute for Health Research Health Technology Assessment Programme [06/302/129]; Cancer Research UK [C19677/A9674]; University of Warwick; University Hospital Coventry; University Hospital Warwickshire NHS Trust; National Institute for Health Research [06/302/129, NF-SI-0507-10244] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); University of Warwick; University Hospital Coventry; University Hospital Warwickshire NHS Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by academic grants from the National Institute for Health Research Health Technology Assessment Programme (06/302/129) and Cancer Research UK (C19677/A9674, for tissue-sample collection).; We thank all the patients and their clinicians for their participation in the trial; the trial steering committee: Dr. Jonathan Ledermann, Mr. Malcolm Babb, Dr. Michael Langman (deceased), Dr. Patrick Bradley, and Mrs. Ethel Culling (independent members) and Drs. Roger A'Hearn, Vincent Gregoire, and Alfons Balm (independent data and safety monitoring committee); Ms. Jo Grumett and Mr. Dharmesh Patel (Warwick Clinical Trials Unit) for trial coordination; Mrs. June Jones and Ms. Lynda Wagstaff (the Institute of Head and Neck Studies and Education, University of Birmingham) for collection of health economic data; Mr. Bal Sanghera and Ms. Wendy Sookham (Mount Vernon Hospital) for coordinating the central PET-CT laboratory; the University of Warwick and University Hospitals Coventry and Warwickshire NHS Trust for acting as legal cosponsors of the study; and Dr. John Chester (Cardiff University) and Dr. Kevin Harrington (Royal Marsden Hospital, London) for reviewing an earlier version of the manuscript and Ms. Gemma Jones for transcribing an earlier version of the manuscript.	[Anonymous], 2012, 8 HLTH SOC CAR INF C, P22; Bjordal K, 2000, EUR J CANCER, V36, P1796, DOI 10.1016/S0959-8049(00)00186-6; Brizel DM, 2004, INT J RADIAT ONCOL, V58, P1418, DOI 10.1016/j.ijrobp.2003.09.004; Carinci F, 2001, J CRANIOFAC SURG, V12, P438, DOI 10.1097/00001665-200109000-00007; Chen AY, 2001, ARCH OTOLARYNGOL, V127, P870; Early Breast Cancer Trialists' Collaborative Group, 1990, TREATM EARL BREAST C; Edge S, 2010, TNM STAGING HEAD NEC; Fayers PM, 2001, EUR J CANCER, V37, P1331, DOI 10.1016/S0959-8049(01)00127-7; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Gupta T, 2011, EUR J NUCL MED MOL I, V38, P2083, DOI 10.1007/s00259-011-1893-y; Hanna E, 2004, ARCH OTOLARYNGOL, V130, P861, DOI 10.1001/archotol.130.7.861; Huang SH, 2013, INT J RADIAT ONCOL, V87, P1078, DOI 10.1016/j.ijrobp.2013.08.049; Isles MG, 2008, CLIN OTOLARYNGOL, V33, P210, DOI 10.1111/j.1749-4486.2008.01688.x; Lavertu P, 1997, HEAD NECK-J SCI SPEC, V19, P559, DOI 10.1002/(SICI)1097-0347(199710)19:7<559::AID-HED1>3.0.CO;2-6; Liauw SL, 2006, J CLIN ONCOL, V24, P1421, DOI 10.1200/JCO.2005.04.6052; Mak D, 2013, J MED IMAG RADIAT ON, V57, P364, DOI 10.1111/1754-9485.12024; Mehanna H, 2016, HEAD NECK; Mehanna H, 2013, HEAD NECK-J SCI SPEC, V35, P747, DOI 10.1002/hed.22015; Moeller BJ, 2009, J CLIN ONCOL, V27, P2509, DOI 10.1200/JCO.2008.19.3300; Porceddu SV, 2011, HEAD NECK-J SCI SPEC, V33, P1675, DOI 10.1002/hed.21655; Pryor DI, 2013, HEAD NECK-J SCI SPEC, V35, P1287, DOI 10.1002/hed.23108; Robbins KT, 2002, ARCH OTOLARYNGOL, V128, P751, DOI 10.1001/archotol.128.7.751; Singhi AD, 2010, CANCER-AM CANCER SOC, V116, P2166, DOI 10.1002/cncr.25033; Stenson KM, 2000, ARCH OTOLARYNGOL, V126, P950, DOI 10.1001/archotol.126.8.950; Thariat J, 2012, INT J RADIAT ONCOL, V82, pE367, DOI 10.1016/j.ijrobp.2011.03.062; Waldron J, 2011, 2011 ANN M AM SOC CL	26	353	360	0	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2016	374	15					1444	1454		10.1056/NEJMoa1514493	http://dx.doi.org/10.1056/NEJMoa1514493			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ3TD	27007578	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000374128400008
J	Vernot, B; Tucci, S; Kelso, J; Schraiber, JG; Wolf, AB; Gittelman, RM; Dannemann, M; Grote, S; McCoy, RC; Norton, H; Scheinfeldt, LB; Merriwether, DA; Koki, G; Friedlaender, JS; Wakefield, J; Paabo, S; Akey, JM				Vernot, Benjamin; Tucci, Serena; Kelso, Janet; Schraiber, Joshua G.; Wolf, Aaron B.; Gittelman, Rachel M.; Dannemann, Michael; Grote, Steffi; McCoy, Rajiv C.; Norton, Heather; Scheinfeldt, Laura B.; Merriwether, David A.; Koki, George; Friedlaender, Jonathan S.; Wakefield, Jon; Paeaebo, Svante; Akey, Joshua M.			Excavating Neandertal and Denisovan DNA from the genomes of Melanesian individuals	SCIENCE			English	Article							HUMAN HISTORY; ANCESTRY; POPULATIONS; ADMIXTURE; SEQUENCE; EUROPEANS; HUMANS	Although Neandertal sequences that persist in the genomes of modern humans have been identified in Eurasians, comparable studies in people whose ancestors hybridized with both Neandertals and Denisovans are lacking. We developed an approach to identify DNA inherited from multiple archaic hominin ancestors and applied it to whole-genome sequences from 1523 geographically diverse individuals, including 35 previously unknown Island Melanesian genomes. In aggregate, we recovered 1.34 gigabases and 303 megabases of the Neandertal and Denisovan genome, respectively. We use these maps of archaic sequences to show that Neandertal admixture occurred multiple times in different non-African populations, characterize genomic regions that are significantly depleted of archaic sequences, and identify signatures of adaptive introgression.	[Vernot, Benjamin; Tucci, Serena; Schraiber, Joshua G.; Wolf, Aaron B.; Gittelman, Rachel M.; McCoy, Rajiv C.; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Tucci, Serena] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Kelso, Janet; Dannemann, Michael; Grote, Steffi; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Norton, Heather] Univ Cincinnati, Dept Anthropol, Cincinnati, OH USA; [Scheinfeldt, Laura B.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Scheinfeldt, Laura B.] Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA; [Merriwether, David A.] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA; [Koki, George] Inst Med Res, Goroka, Eastern Highlan, Papua N Guinea; [Friedlaender, Jonathan S.] Temple Univ, Dept Anthropol, Philadelphia, PA 19122 USA; [Wakefield, Jon] Univ Washington, Dept Stat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Ferrara; Max Planck Society; University System of Ohio; University of Cincinnati; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; PNG Institute Of Medical Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Washington; University of Washington Seattle	Akey, JM (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany.	paabo@eva.mpg.de; akeyj@uw.edu	Tucci, Serena/AAU-4728-2021; McCoy, Rajiv/AEW-9951-2022; Vernot, Benjamin/ABH-1495-2021; Kelso, Janet/N-1812-2019	McCoy, Rajiv/0000-0003-0615-146X; Vernot, Benjamin/0000-0002-6820-2181; Kelso, Janet/0000-0002-3618-322X; Gittelman, Rachel/0000-0003-3202-6582; Akey, Joshua/0000-0002-4411-1330; Scheinfeldt, Laura/0000-0001-6529-6701	NIH [5R01GM110068]; NSF [DBI-1402120, 9601020, 0413449]; Deutsche Forschungsgemeinschaft [SFB1052]; Presidential Fund of the Max Planck Society; Glenview Capital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Presidential Fund of the Max Planck Society; Glenview Capital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Akey and Paabo laboratories for helpful feedback related to this work, F. Friedlaender for help in data management, J. Lorenz and J. Madeoy for DNA extractions and purifications, L. Jauregui for help in figure preparation, and the participants in this study. Whole-genome sequence data have been deposited into the Database of Genotypes and Phenotypes (dbGAP) with the accession number phs001085.v1.p1. This work was supported by an NIH grant (5R01GM110068) to J.M.A., an NSF fellowship (DBI-1402120) to J.G.S., and grants from the Deutsche Forschungsgemeinschaft (SFB1052, project A02) to J.K. and from the Presidential Fund of the Max Planck Society to S.P. Sample collection was supported in part by NSF grants 9601020 and 0413449 to D.A.M. J.M.A. is a paid consultant of Glenview Capital.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Kim BY, 2015, AM J HUM GENET, V96, P454, DOI 10.1016/j.ajhg.2014.12.029; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Maricic T, 2013, MOL BIOL EVOL, V30, P844, DOI 10.1093/molbev/mss271; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Qin PF, 2015, MOL BIOL EVOL, V32, P2665, DOI 10.1093/molbev/msv141; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Sikora M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004353; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Vattathil S, 2015, CELL, V163, P281, DOI 10.1016/j.cell.2015.09.042; Vernot B, 2015, AM J HUM GENET, V96, P448, DOI 10.1016/j.ajhg.2015.01.006; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Yang MA, 2012, MOL BIOL EVOL, V29, P2987, DOI 10.1093/molbev/mss117	22	218	225	3	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					235	239		10.1126/science.aad9416	http://dx.doi.org/10.1126/science.aad9416			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	26989198	Green Accepted			2022-12-28	WOS:000373681600049
J	Dove, ES; Townend, D; Meslin, EM; Bobrow, M; Littler, K; Nicol, D; de Vries, J; Junker, A; Garattini, C; Bovenberg, J; Shabani, M; Levesque, E; Knoppers, BM				Dove, Edward S.; Townend, David; Meslin, Eric M.; Bobrow, Martin; Littler, Katherine; Nicol, Dianne; de Vries, Jantina; Junker, Anne; Garattini, Chiara; Bovenberg, Jasper; Shabani, Mahsa; Levesque, Emmanuelle; Knoppers, Bartha M.			RESEARCH ETHICS Ethics review for international data-intensive research	SCIENCE			English	Editorial Material									[Dove, Edward S.] Univ Edinburgh, J Kenyon Mason Inst Med Life Sci & Law, Sch Law, Edinburgh EH8 9YL, Midlothian, Scotland; [Townend, David] Maastricht Univ, Dept Hlth Eth & Soc, CAPHRI Res Sch, NL-6200 MD Maastricht, Netherlands; [Meslin, Eric M.] Indiana Univ Sch Med, Indiana Univ, Ctr Bioeth, Indianapolis, IN 46202 USA; [Bobrow, Martin] Wellcome Trust Sanger Inst, Honorary Fac, Hinxton, England; [Bobrow, Martin] Univ Cambridge, Dept Med Genet, Cambridge CB2 1TN, England; [Littler, Katherine] Wellcome Trust Res Labs, London, England; [Nicol, Dianne] Univ Tasmania, Ctr Law & Genet, Fac Law, Hobart, Tas 7001, Australia; [de Vries, Jantina] Univ Cape Town, Fac Hlth Sci, Dept Med, ZA-7700 Rondebosch, South Africa; [Junker, Anne] Univ British Columbia, Dept Pediat, Fac Med, Vancouver, BC V6T 1W5, Canada; [Garattini, Chiara] Intel Corp, Hlth & Life Sci, London, England; [Bovenberg, Jasper] Legal Pathways, Aerdenhout, Netherlands; [Shabani, Mahsa] Katholieke Univ Leuven, Ctr Biomed Eth & Law, Leuven, Belgium; [Levesque, Emmanuelle; Knoppers, Bartha M.] McGill Univ, Fac Med, Ctr Genom & Policy, Montreal, PQ, Canada	University of Edinburgh; Maastricht University; Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis; Wellcome Trust Sanger Institute; University of Cambridge; University of Tasmania; University of Cape Town; University of British Columbia; Intel Corporation; KU Leuven; McGill University	Dove, ES (corresponding author), Univ Edinburgh, J Kenyon Mason Inst Med Life Sci & Law, Sch Law, Edinburgh EH8 9YL, Midlothian, Scotland.	edward.dove@ed.ac.uk	De Vries, Jantina/I-2752-2014; Nicol, Dianne/J-7253-2014	De Vries, Jantina/0000-0001-7192-2633; Nicol, Dianne/0000-0002-6553-2839; Townend, David/0000-0002-2409-0288	NHGRI NIH HHS [U01 HG008226] Funding Source: Medline; Wellcome Trust [099313, 103360] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008226] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abbott L, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.1.3; Angus DC, 2015, JAMA-J AM MED ASSOC, V314, P767, DOI 10.1001/jama.2015.7762; [Anonymous], 2015, INT COUNC HARM TECHN; Council of Canadian Academies, 2015, ACCESSING HLTH HEALT; Health Research Authority, 2014, CONS REC REV; National Health and Medical Research Council, 2015, NAT APPR SINGL ETH R; Nicholls SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133639; Panel on Research Ethics, 2014, TRIC POL STAT ETH CO	8	35	36	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1399	1400		10.1126/science.aad5269	http://dx.doi.org/10.1126/science.aad5269			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH4KZ	27013718	Green Submitted, Green Accepted			2022-12-28	WOS:000372756200024
J	Skylaris, CK				Skylaris, Chris-Kriton			PHYSICS A benchmark for materials simulation	SCIENCE			English	Editorial Material							DENSITY-FUNCTIONAL THEORY; MOLECULAR-DYNAMICS		[Skylaris, Chris-Kriton] Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England	University of Southampton	Skylaris, CK (corresponding author), Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England.	c.skylaris@soton.ac.uk						Bowler DR, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/3/036503; Calandrini V, 2015, J INORG BIOCHEM, V153, P231, DOI 10.1016/j.jinorgbio.2015.10.001; Davies C, 2015, NAT GEOSCI, V8, P678, DOI 10.1038/NGEO2492; Fox SJ, 2014, PROTEINS, V82, P3335, DOI 10.1002/prot.24686; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Kohn W, 1999, REV MOD PHYS, V71, P1253, DOI 10.1103/RevModPhys.71.1253; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Lejaeghere K, 2016, SCIENCE, V351, DOI 10.1126/science.aad3000; Lyle MJ, 2015, P NATL ACAD SCI USA, V112, P6898, DOI 10.1073/pnas.1500604112; Mardirossian N, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4868117; Norskov JK, 2011, P NATL ACAD SCI USA, V108, P937, DOI 10.1073/pnas.1006652108; PAYNE MC, 1992, REV MOD PHYS, V64, P1045, DOI 10.1103/RevModPhys.64.1045; Romero NA, 2015, COMPUTER, V48, P33, DOI 10.1109/MC.2015.337; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9	14	17	18	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1394	1395		10.1126/science.aaf3412	http://dx.doi.org/10.1126/science.aaf3412			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013714				2022-12-28	WOS:000372756200020
J	Ravindran, R; Loebbermann, J; Nakaya, HI; Khan, N; Ma, HL; Gama, L; Machiah, DK; Lawson, B; Hakimpour, P; Wang, YC; Li, SZ; Sharma, P; Kaufman, RJ; Martinez, J; Pulendran, B				Ravindran, Rajesh; Loebbermann, Jens; Nakaya, Helder I.; Khan, Nooruddin; Ma, Hualing; Gama, Leonardo; Machiah, Deepa K.; Lawson, Benton; Hakimpour, Paul; Wang, Yi-chong; Li, Shuzhao; Sharma, Prachi; Kaufman, Randal J.; Martinez, Jennifer; Pulendran, Bali			The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation	NATURE			English	Article							EIF2-ALPHA KINASE; OXIDATIVE STRESS; DENDRITIC CELLS; PROTEIN; TRANSLATION; AUTOPHAGY; PHOSPHORYLATION; DIFFERENTIATION; DEPRIVATION; HOMEOSTASIS	The integrated stress response (ISR) is a homeostatic mechanism by which eukaryotic cells sense and respond to stress-inducing signals, such as amino acid starvation. General controlled non-repressed (GCN2) kinase is a key orchestrator of the ISR, and modulates protein synthesis in response to amino acid starvation. Here we demonstrate in mice that GCN2 controls intestinal inflammation by suppressing inflammasome activation. Enhanced activation of ISR was observed in intestinal antigen presenting cells (APCs) and epithelial cells during amino acid starvation, or intestinal inflammation. Genetic deletion of Gcn2 (also known as Eif2ka4) in CD11c(+) APCs or intestinal epithelial cells resulted in enhanced intestinal inflammation and T helper 17 cell (T(H)17) responses, owing to enhanced inflammasome activation and interleukin (IL)-1 beta production. This was caused by reduced autophagy in Gcn2(-/-) intestinal APCs and epithelial cells, leading to increased reactive oxygen species (ROS), a potent activator of inflammasomes(1). Thus, conditional ablation of Atg5 or Atg7 in intestinal APCs resulted in enhanced ROS and T(H)17 responses. Furthermore, in vivo blockade of ROS and IL-1 beta resulted in inhibition of T(H)17 responses and reduced inflammation in Gcn2(-/-) mice. Importantly, acute amino acid starvation suppressed intestinal inflammation via a mechanism dependent on GCN2. These results reveal a mechanism that couples amino acid sensing with control of intestinal inflammation via GCN2.	[Ravindran, Rajesh; Loebbermann, Jens; Ma, Hualing; Hakimpour, Paul; Wang, Yi-chong; Li, Shuzhao; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA; [Nakaya, Helder I.; Gama, Leonardo] Univ Sao Paulo, Sch Pharmaceut Sci, BR-05508 Sao Paulo, Brazil; [Khan, Nooruddin] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Hyderabad 500046, Andhra Pradesh, India; [Machiah, Deepa K.; Sharma, Prachi] Yerkes Natl Primate Res Ctr, Div Pathol, 954 Gatewood Rd, Atlanta, GA 30329 USA; [Lawson, Benton] Emory Vaccine Ctr, Virol Core, 954 Gatewood Rd, Atlanta, GA 30329 USA; [Lawson, Benton] Yerkes Natl Primate Res Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA; [Kaufman, Randal J.] Sanford Burnham Prebys Med Discovery Inst, Degenerat Dis Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Martinez, Jennifer] NIEHS, Mail Drop D2-01, Res Triangle Pk, NC 27709 USA	Emory University; Universidade de Sao Paulo; University of Hyderabad; Emory University; Sanford Burnham Prebys Medical Discovery Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Pulendran, B (corresponding author), Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.	bpulend@emory.edu	Pulendran, Bali/AAW-9550-2021; Martinez, Jennifer/C-3740-2019; Khan, Nooruddin/AAF-5417-2019; Sharma, Prachi/HGD-0637-2022; Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010; Ma, Huailiang/C-3403-2017	Martinez, Jennifer/0000-0002-3060-2518; Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108; Li, Shuzhao/0000-0002-7386-2539; Hakimata, Paul/0000-0002-2526-6003; Pulendran, Bali/0000-0001-6517-4333	US National Institutes of Health (NIH) [R37 DK057665, R37 AI048638, U19 AI090023, U19 AI057266]; Bill & Melinda Gates Foundation; NIH [R01 DK088227, R37 DK042394, R01 DK103185]; Crohn's & Colitis Foundation of America Senior Fellow Award [3800]; Center for AIDS Research core at Yerkes Primate Research Center [P30-AI-50409]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, U19AI090023, R37AI048638, U19AI057266, R56AI048638, R01AI048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R01DK088227, R01DK103185, R37DK057665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES103286] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America Senior Fellow Award; Center for AIDS Research core at Yerkes Primate Research Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the US National Institutes of Health (NIH; grants R37 DK057665, R37 AI048638, U19 AI090023, U19 AI057266) and from the Bill & Melinda Gates Foundation to B.P. R.J.K. was supported by NIH grants R01 DK088227, R37 DK042394, R01 DK103185 and the Crohn's & Colitis Foundation of America Senior Fellow Award 3800. We thank B. Cervasi and K. P. Gill for help with sorting and D. Levesque, D. Hampton, S. Weismann and colleagues for animal husbandry and veterinary support. We thank the Center for AIDS Research core at Yerkes Primate Research Center for help with qPCR (grant P30-AI-50409) and the Integrated Cellular Imaging Center at Winship Cancer Center, Emory University for help with confocal microscopy. We also thank the Yerkes Pathology Core for performing the immunofluorescence and histology analysis. We thank S. Virgin for his advice and review of the autophagy experiments.	Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Ariyasinghe A, 2006, J PARASITOL, V92, P531, DOI 10.1645/GE-551R1.1; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Brubacher JL, 2001, J IMMUNOL METHODS, V251, P81, DOI 10.1016/S0022-1759(01)00308-8; Cao SS, 2014, INFLAMM BOWEL DIS, V20, P712, DOI 10.1097/MIB.0000000000000010; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Damiani CR, 2007, J GASTROEN HEPATOL, V22, P1846, DOI 10.1111/j.1440-1746.2007.04890.x; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Funke B, 2009, GUT, V58, P483, DOI 10.1136/gut.2008.148908; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hu JF, 1997, ONCOGENE, V15, P2795, DOI 10.1038/sj.onc.1201444; Julian D, 2005, J EXP BIOL, V208, P4109, DOI 10.1242/jeb.01867; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; KLEENE SJ, 1977, J BIOL CHEM, V252, P3214; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Li CC, 2004, CELL IMMUNOL, V231, P96, DOI 10.1016/j.cellimm.2004.12.005; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima Noboru, 2008, V445, P119, DOI 10.1007/978-1-59745-157-4_7; Oarada M, 2009, NUTRITION, V25, P954, DOI 10.1016/j.nut.2009.02.004; Peng W., 2012, SCI TRANSL MED, V4; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	35	170	182	7	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					523	+		10.1038/nature17186	http://dx.doi.org/10.1038/nature17186			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26982722	Green Accepted			2022-12-28	WOS:000372701300045
J	Lin, HT; Ouyang, H; Zhu, J; Huang, S; Liu, ZZ; Chen, SY; Cao, GQ; Li, G; Signer, RAJ; Xu, YX; Chung, C; Zhang, Y; Lin, DN; Patel, S; Wu, F; Cai, HM; Hou, JY; Wen, C; Jafari, M; Liu, XL; Luo, LX; Zhu, J; Qiu, A; Hou, R; Chen, BX; Chen, JN; Granet, D; Heichel, C; Shang, F; Li, XR; Krawczyk, M; Skowronska-Krawczyk, D; Wang, YJ; Shi, W; Chen, D; Zhong, Z; Zhong, S; Zhang, LF; Chen, SC; Morrison, SJ; Maas, RL; Zhang, K; Liu, YZ				Lin, Haotian; Ouyang, Hong; Zhu, Jie; Huang, Shan; Liu, Zhenzhen; Chen, Shuyi; Cao, Guiqun; Li, Gen; Signer, Robert A. J.; Xu, Yanxin; Chung, Christopher; Zhang, Ying; Lin, Danni; Patel, Sherrina; Wu, Frances; Cai, Huimin; Hou, Jiayi; Wen, Cindy; Jafari, Maryam; Liu, Xialin; Luo, Lixia; Zhu, Jin; Qiu, Austin; Hou, Rui; Chen, Baoxin; Chen, Jiangna; Granet, David; Heichel, Christopher; Shang, Fu; Li, Xuri; Krawczyk, Michal; Skowronska-Krawczyk, Dorota; Wang, Yujuan; Shi, William; Chen, Daniel; Zhong, Zheng; Zhong, Sheng; Zhang, Liangfang; Chen, Shaochen; Morrison, Sean J.; Maas, Richard L.; Zhang, Kang; Liu, Yizhi			Lens regeneration using endogenous stem cells with gain of visual function	NATURE			English	Article							PEDIATRIC CATARACT-SURGERY; INFANT APHAKIA TREATMENT; RETINA REGENERATION; ACCOMMODATION; COMPLICATIONS; BMI-1; MAINTENANCE; OUTCOMES; RABBITS	The repair and regeneration of tissues using endogenous stem cells represents an ultimate goal in regenerative medicine. To our knowledge, human lens regeneration has not yet been demonstrated. Currently, the only treatment for cataracts, the leading cause of blindness worldwide, is to extract the cataractous lens and implant an artificial intraocular lens. However, this procedure poses notable risks of complications. Here we isolate lens epithelial stem/progenitor cells (LECs) in mammals and show that Pax6 and Bmi1 are required for LEC renewal. We design a surgical method of cataract removal that preserves endogenous LECs and achieves functional lens regeneration in rabbits and macaques, as well as in human infants with cataracts. Our method differs conceptually from current practice, as it preserves endogenous LECs and their natural environment maximally, and regenerates lenses with visual function. Our approach demonstrates a novel treatment strategy for cataracts and provides a new paradigm for tissue regeneration using endogenous stem cells.	[Lin, Haotian; Ouyang, Hong; Huang, Shan; Liu, Zhenzhen; Chen, Shuyi; Liu, Xialin; Luo, Lixia; Chen, Baoxin; Chen, Jiangna; Shang, Fu; Li, Xuri; Wang, Yujuan; Zhong, Zheng; Zhang, Kang; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Zhu, Jie; Chung, Christopher; Lin, Danni; Patel, Sherrina; Wu, Frances; Wen, Cindy; Jafari, Maryam; Zhu, Jin; Qiu, Austin; Granet, David; Heichel, Christopher; Krawczyk, Michal; Skowronska-Krawczyk, Dorota; Shi, William; Chen, Daniel; Zhong, Zheng; Zhong, Sheng; Zhang, Liangfang; Chen, Shaochen; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, Inst Engn Med, Shiley Eye Inst, La Jolla, CA 92093 USA; [Cao, Guiqun; Li, Gen; Xu, Yanxin; Cai, Huimin; Zhang, Kang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Li, Gen; Cai, Huimin; Hou, Rui] Guangzhou KangRui Biol Pharmaceut Technol Co, Guangzhou 510005, Guangdong, Peoples R China; [Signer, Robert A. J.; Morrison, Sean J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Childrens Res Inst, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Xu, Yanxin] Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Ying; Maas, Richard L.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Zhang, Ying; Maas, Richard L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hou, Jiayi] Univ Calif San Diego, Clin & Translat Res Inst, La Jolla, CA 92093 USA; [Zhang, Kang] Vet Adm Healthcare Syst, San Diego, CA 92093 USA	Sun Yat Sen University; University of California System; University of California San Diego; Sichuan University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sichuan University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Zhang, K; Liu, YZ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.; Zhang, K (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China.	kang.zhang@gmail.com; yzliu62@yahoo.com	Morrison, Sean/ABD-5326-2021; Zhang, Kang/Y-2740-2019; Zhong, Zheng/ABC-4681-2022; Zhu, Jie/AAD-1330-2022	Zhang, Kang/0000-0002-4549-1697; Zhong, Zheng/0000-0003-4103-4752; Zhu, Jie/0000-0001-6862-9022; Signer, Robert/0000-0003-3286-1334; Shi, William/0000-0001-5452-2902; Lin, Haotian/0000-0003-4672-9721; Huang, Shan/0000-0003-3038-5688; Jafari, Maryam/0000-0001-5552-1127; Huang, Shan/0000-0001-8492-9658; Ouyang, Hong/0000-0002-7622-7733; Liu, Yizhi/0000-0003-4108-9593; Morrison, Sean/0000-0003-1587-8329; liu, zhenzhen/0000-0002-4853-2474	973 Program [2015CB964600, 2014CB964900, 2013CB967504]; Major International Joint Research Project [81320108008]; 863 Program [2014AA021604]; NSFC [81270981]; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University; Research to Prevent Blindness; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY010123, P30EY022589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG024945] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); Major International Joint Research Project(National Natural Science Foundation of China (NSFC)); 863 Program(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Yeh, L. Xi, J. Shelton, A. Pineda and R. Ufret-Vincenty for technical assistance. This study was funded by 973 Program (2015CB964600, 2014CB964900, 2013CB967504); a Major International Joint Research Project (No. 81320108008); 863 Program (2014AA021604), NSFC (No. 81270981); the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University; Research to Prevent Blindness and the Howard Hughes Medical Institute.	BANKS MS, 1980, CHILD DEV, V51, P646, DOI 10.1111/j.1467-8624.1980.tb02599.x; Barbosa-Sabanero K, 2012, BIOCHEM J, V447, P321, DOI 10.1042/BJ20120813; Beebe DC, 2010, OPHTHALMIC RES, V44, P155, DOI 10.1159/000316481; Bothun ED, 2013, OPHTHALMOLOGY, V120, P1227, DOI 10.1016/j.ophtha.2012.11.039; Gabriel GM, 2009, OPTOMETRY VISION SCI, V86, P208, DOI 10.1097/OPX.0b013e3181960652; Gogate P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000177; Gwon A, 2006, SURV OPHTHALMOL, V51, P51, DOI 10.1016/j.survophthal.2005.11.005; GWON A, 1993, J CATARACT REFR SURG, V19, P735, DOI 10.1016/S0886-3350(13)80343-4; GWON AE, 1990, INVEST OPHTH VIS SCI, V31, P540; HAINLINE L, 1992, BEHAV BRAIN RES, V49, P33, DOI 10.1016/S0166-4328(05)80192-5; Jacobi PC, 2001, OPHTHALMOLOGY, V108, P1375, DOI 10.1016/S0161-6420(01)00595-4; Lambert SR, 2010, ARCH OPHTHALMOL-CHIC, V128, P810, DOI 10.1001/archophthalmol.2010.101; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lois N, 2005, ARCH OPHTHALMOL-CHIC, V123, P71, DOI 10.1001/archopht.123.1.71; Mamalis N, 2004, J CATARACT REFR SURG, V30, P2209, DOI 10.1016/j.jcrs.2004.06.051; Mich JK, 2014, ELIFE, V3, DOI 10.7554/eLife.02669; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nihalani BR, 2010, SEMIN OPHTHALMOL, V25, P271, DOI 10.3109/08820538.2010.518836; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Plager DA, 2011, OPHTHALMOLOGY, V118, P2330, DOI 10.1016/j.ophtha.2011.06.017; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsonis PA, 2008, ANIMAL MODELS IN EYE RESEARCH, P1; Tsonis PA, 2004, EXP EYE RES, V78, P161, DOI 10.1016/j.exer.2003.10.022; Visser N, 2013, J CATARACT REFR SURG, V39, P624, DOI 10.1016/j.jcrs.2013.02.020; Wilson M., 2005, PEDIAT CATARACT SURG; Wilson ME, 2009, PEDIAT OPHTHALMOLOGY; You CY, 2011, OPHTHALMOLOGY, V118, P17, DOI 10.1016/j.ophtha.2010.04.014; Zheng Q, 2012, EYE, V26, P1058, DOI 10.1038/eye.2012.87; Zhou MY, 2006, INVEST OPHTH VIS SCI, V47, P2997, DOI 10.1167/iovs.06-0130	31	111	121	5	243	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					323	+		10.1038/nature17181	http://dx.doi.org/10.1038/nature17181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26958831	Green Accepted			2022-12-28	WOS:000372064300043
J	Barnes, GD; Douketis, JD				Barnes, Geoffrey D.; Douketis, James D.			Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTRACRANIAL HEMORRHAGE; MORTALITY		[Barnes, Geoffrey D.] Univ Michigan, Ann Arbor, MI 48109 USA; [Douketis, James D.] McMaster Univ, Hamilton, ON, Canada	University of Michigan System; University of Michigan; McMaster University	Barnes, GD (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.		Barnes, Geoffrey/AAK-1780-2020; Douketis, James/AAO-5659-2021	Barnes, Geoffrey/0000-0002-6532-8440; 				Nielsen PB, 2015, CIRCULATION, V132, P517, DOI 10.1161/CIRCULATIONAHA.115.015735; Qureshi W, 2014, AM J CARDIOL, V113, P662, DOI 10.1016/j.amjcard.2013.10.044; Witt DM, 2012, ARCH INTERN MED, V172, P1484, DOI 10.1001/archinternmed.2012.4261; Yung D, 2012, CAN J CARDIOL, V28, P33, DOI 10.1016/j.cjca.2011.10.002	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					JC33	JC33		10.7326/ACPJC-2016-164-6-033	http://dx.doi.org/10.7326/ACPJC-2016-164-6-033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26974733				2022-12-28	WOS:000372207200008
J	Ghinea, N; Lipworth, W; Kerridge, I				Ghinea, Narcyz; Lipworth, Wendy; Kerridge, Ian			Propaganda or the cost of innovation? Challenging the high price of new drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ghinea, Narcyz; Lipworth, Wendy; Kerridge, Ian] Univ Sydney, Ctr Values Ethics & Law Med, Sydney, NSW 2006, Australia	University of Sydney	Ghinea, N (corresponding author), Univ Sydney, Ctr Values Ethics & Law Med, Sydney, NSW 2006, Australia.	narcyz.ghinea@sydney.edu.au		Kerridge, Ian/0000-0001-7445-4660; Lipworth, Wendy/0000-0002-0234-657X; Ghinea, Narcyz/0000-0002-1457-7252				Abboud C, 2013, BLOOD, V121, P4439, DOI 10.1182/blood-2013-03-490003; Adams B, 2015, PMLIVE          0612; Angell M., 2005, TRUTH DRUG CO THEY D; [Anonymous], 2015, ECONOMIST; Appleby J., 2014, CANC DRUGS FUND INEQ; Avorn J, 2015, NEW ENGL J MED, V372, P1877, DOI 10.1056/NEJMp1500848; Bach PB, 2014, JAMA-J AM MED ASSOC, V312, P1629, DOI 10.1001/jama.2014.13235; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Cancer Research UK, 2015, CANC DRUGS FUND; Cohen D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1445; Cohen Joshua P, 2014, J Mark Access Health Policy, V2, DOI 10.3402/jmahp.v2.23513; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Deloitte Access Economics, 2013, ACC CANC MED AUSTR M; Department of Health, 2015, OTH SUPPL ARR OUTS P; Gatesman ML, 2011, NEW ENGL J MED, V365, P1653, DOI 10.1056/NEJMp1109772; Gilchrist A, 2015, PHARM TIMES; GlobalGenes, RAR DIS FACTS STAT; Godman B, 2015, EXPERT REV CLIN PHAR, V8, P77, DOI 10.1586/17512433.2015.990380; Herper M., 2010, FORBES; Herper M, 2012, FORBES; Howell J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d622; IMS Institute for Healthcare Informatics, 2015, DEV CANC TREATM MARK; IMS Institute for Healthcare Informatics, 2014, GLOB OUTL MED 2018; Investopedia, DEF FREE MARK; Japsen B., 2012, FORBES; Johnson S, SPECIALTY DRUGS ARE; Kantarjian H, 2015, MAYO CLIN PROC, V90, P500, DOI 10.1016/j.mayocp.2015.01.014; Lakdawalla DN, 2012, HEALTH AFFAIR, V31, P676, DOI 10.1377/hlthaff.2011.1300; Lawson C, 2013, J LAW MED, V21, P379; Moir H, 2014, THE CONVERSATIO 1106; Pollack A, 2015, NY TIMES, pB2; Senior M, 2014, NAT BIOTECHNOL, V32, P501, DOI 10.1038/nbt0614-501; Simoens S, 2013, APPL HEALTH ECON HEA, V11, P1, DOI 10.1007/s40258-012-0004-y; Spitz J, 2012, AM J ECON SOCIOL, V71, P1, DOI 10.1111/j.1536-7150.2011.00820.x; Toumi M., 2014, EXTERNAL REFERENCE P; Tufts Centre for the Study of Drug Development, 2014, BRIEF COST DEV NEW D; Wellman-Labadie O, 2010, HEALTH POLICY, V95, P216, DOI 10.1016/j.healthpol.2009.12.001; World Health Organisation, 2015, TRAD FOR POL DIPL HL	38	12	13	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2016	352								i1284	10.1136/bmj.i1284	http://dx.doi.org/10.1136/bmj.i1284			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG4NV	26968991	Green Published			2022-12-28	WOS:000372049800001
J	Peacock, AC; Steel, MJ				Peacock, Anna C.; Steel, Michael J.			The time is right for multiphoton entangled states	SCIENCE			English	Editorial Material							BELL INEQUALITY		[Peacock, Anna C.] Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England; [Steel, Michael J.] Macquarie Univ, Dept Phys & Astron, N Ryde, NSW 2109, Australia	University of Southampton; Macquarie University	Peacock, AC (corresponding author), Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England.	acp@orc.soton.ac.uk; michael.steel@mq.edu.au	Peacock, Anna C/P-1602-2014	Peacock, Anna C/0000-0002-1940-7172; Steel, Michael/0000-0003-3541-6439				Clark A. S., 2016, ALL OPTICAL SIGNAL P, P355; FRANSON JD, 1989, PHYS REV LETT, V62, P2205, DOI 10.1103/PhysRevLett.62.2205; Grassani D, 2015, OPTICA, V2, P88, DOI 10.1364/OPTICA.2.000088; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; Humphreys PC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.150501; Migdall A, 2013, SINGLE PHOTON GENERA; Reimer C, 2016, SCIENCE, V351, P1176, DOI 10.1126/science.aad8532; Silverstone JW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8948; Xiong C, 2015, OPTICA, V2, P724, DOI 10.1364/OPTICA.2.000724	10	6	6	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1152	1153		10.1126/science.aaf2919	http://dx.doi.org/10.1126/science.aaf2919			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965612				2022-12-28	WOS:000386158400026
J	Ingber, DE				Ingber, Donald E.			Reverse Engineering Human Pathophysiology with Organs-on-Chips	CELL			English	Editorial Material							MODEL	While studies of cultured cells have led to new insights into biological control, greater understanding of human pathophysiology requires the development of experimental systems that permit analysis of intercellular communications and tissue-tissue interactions in a more relevant organ context. Human organs-on-chips offer a potentially powerful new approach to confront this long-standing problem.	[Ingber, Donald E.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Ingber, Donald E.] Boston Childrens Hosp, Vasc Biol Program, Dept Pathol, Boston, MA 02115 USA; [Ingber, Donald E.] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Boston Childrens Hosp, Vasc Biol Program, Dept Pathol, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Harvard John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	don.ingber@wyss.harvard.edu	Ingber, Donald E/AAC-5894-2019					Achyuta AKH, 2013, LAB CHIP, V13, P542, DOI 10.1039/c2lc41033h; Benam KH, 2016, NAT METHODS, V13, P151, DOI [10.1038/nmeth.3697, 10.1038/NMETH.3697]; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Bischel LL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1007-5; Douville NJ, 2010, ANAL CHEM, V82, P2505, DOI 10.1021/ac9029345; Esch MB, 2014, LAB CHIP, V14, P3081, DOI 10.1039/c4lc00371c; Herland A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150360; Huh D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004249; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Leist M, 2013, ALTEX-ALTERN ANIM EX, V30, P227, DOI 10.14573/altex.2013.2.227; Maschmeyer I, 2015, LAB CHIP, V15, P2688, DOI 10.1039/c5lc00392j; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852	15	129	137	3	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1105	1109		10.1016/j.cell.2016.02.049	http://dx.doi.org/10.1016/j.cell.2016.02.049			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967278	Bronze			2022-12-28	WOS:000372784900009
J	Boyle, RJ; Ierodiakonou, D; Khan, T; Chivinge, J; Robinson, Z; Geoghegan, N; Jarrold, K; Afxentiou, T; Reeves, T; Cunha, S; Trivella, M; Garcia-Larsen, V; Leonardi-Bee, J				Boyle, Robert J.; Ierodiakonou, Despo; Khan, Tasnia; Chivinge, Jennifer; Robinson, Zoe; Geoghegan, Natalie; Jarrold, Katharine; Afxentiou, Thalia; Reeves, Tim; Cunha, Sergio; Trivella, Marialena; Garcia-Larsen, Vanessa; Leonardi-Bee, Jo			Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INFANT NUTRITIONAL INTERVENTION; BETA-CELL AUTOIMMUNITY; FED WHEY HYDROLYSATE; COWS MILK FORMULA; PRIMARY PREVENTION; ATOPIC DISEASE; GENETIC RISK; BREAST-MILK; PROTEIN; EXPOSURE	OBJECTIVE To determine whether feeding infants with hydrolysed formula reduces their risk of allergic or autoimmune disease. DESIGN Systematic review and meta-analysis, as part of a series of systematic reviews commissioned by the UK Food Standards Agency to inform guidelines on infant feeding. Two authors selected studies by consensus, independently extracted data, and assessed the quality of included studies using the Cochrane risk of bias tool. DATA SOURCES Medline, Embase, Web of Science, CENTRAL, and LILACS searched between January 1946 and April 2015. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Prospective intervention trials of hydrolysed cows' milk formula compared with another hydrolysed formula, human breast milk, or a standard cows' milk formula, which reported on allergic or autoimmune disease or allergic sensitisation. RESULTS 37 eligible intervention trials of hydrolysed formula were identified, including over 19 000 participants. There was evidence of conflict of interest and high or unclear risk of bias in most studies of allergic outcomes and evidence of publication bias for studies of eczema and wheeze. Overall there was no consistent evidence that partially or extensively hydrolysed formulas reduce risk of allergic or autoimmune outcomes in infants at high pre-existing risk of these outcomes. Odds ratios for eczema at age 0-4, compared with standard cows' milk formula, were 0.84 (95% confidence interval 0.67 to 1.07; I-2=30%) for partially hydrolysed formula; 0.55 (0.28 to 1.09; I-2=74%) for extensively hydrolysed casein based formula; and 1.12 (0.88 to 1.42; I-2=0%) for extensively hydrolysed whey based formula. There was no evidence to support the health claim approved by the US Food and Drug Administration that a partially hydrolysed formula could reduce the risk of eczema nor the conclusion of the Cochrane review that hydrolysed formula could prevent allergy to cows' milk. CONCLUSION These findings do not support current guidelines that recommend the use of hydrolysed formula to prevent allergic disease in high risk infants. REVIEW REGISTRATION PROSPERO CRD42013004252.	[Boyle, Robert J.; Ierodiakonou, Despo; Khan, Tasnia; Chivinge, Jennifer; Robinson, Zoe; Geoghegan, Natalie; Jarrold, Katharine; Afxentiou, Thalia] Univ London Imperial Coll Sci Technol & Med, Sect Paediat, London W2 1PG, England; [Ierodiakonou, Despo; Reeves, Tim; Garcia-Larsen, Vanessa] Univ London Imperial Coll Sci Technol & Med, Resp Epidemiol, Occupat Med & Publ Hlth, Natl Heart & Lung Inst, London SW3 6LR, England; [Cunha, Sergio] Imperial Consultants, London SW7 2PG, England; [Trivella, Marialena] Univ Oxford, Ctr Stat Med, Oxford OX3 7LD, England; [Leonardi-Bee, Jo] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG5 1PB, England	Imperial College London; Imperial College London; University of Oxford; University of Nottingham	Boyle, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Paediat, London W2 1PG, England.	r.boyle@nhs.net		Garcia Larsen, Vanessa/0000-0002-0003-1988; Souza da Cunha, Sergio/0000-0002-4926-3827; Ierodiakonou, Despo/0000-0002-7862-2016; Boyle, Robert/0000-0002-4913-7580; Trivella, Marialena/0000-0003-4492-1760; Leonardi-Bee, Jo/0000-0003-0893-6068	Food Standards Agency; National Institute for Health Research Biomedical Research Centre; Cancer Research UK [16895] Funding Source: researchfish	Food Standards Agency; National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK)	This work was funded by the Food Standards Agency and supported by a National Institute for Health Research Biomedical Research Centre. The Food Standards Agency commissioned this work, commissioned external peer review of the study protocol, statistical methods, and study report and approved the decision to submit this manuscript for publication. The National Institute for Health Research was not directly involved in the study design, implementation, analysis or the decision to submit for publication.	Akerblom HK, 2005, DIABETOLOGIA, V48, P829, DOI 10.1007/s00125-005-1733-3; Akimoto K, 1997, Arerugi, V46, P1044; ASCIA, 2008, INFANT FEEDING ADVIC; BJORKSTEN B, 1993, ACTA PAEDIATR, V82, P660; Boyle RJ, 2015, CLIN TRANSL ALLERGY, V5, pP30, DOI [10.1186/2045-7022-5-S3-P30, DOI 10.1186/2045-7022-5-S3-P30]; Chan YH, 2002, J PAEDIATR CHILD H, V38, P84, DOI 10.1046/j.1440-1754.2002.00725.x; Chan-Yeung M, 2000, ARCH PEDIAT ADOL MED, V154, P657, DOI 10.1001/archpedi.154.7.657; CHANDRA RK, 1989, BMJ-BRIT MED J, V299, P228, DOI 10.1136/bmj.299.6693.228; CHANDRA RK, 1991, ANN ALLERGY, V67, P129; Chandra RK, 1997, J PEDIATR GASTR NUTR, V24, P380, DOI 10.1097/00005176-199704000-00005; Chirico G, 1997, ALLERGY, V52, P82, DOI 10.1111/j.1398-9995.1997.tb02549.x; Chung CS, 2012, PEDIATRICS, V130, pE408, DOI 10.1542/peds.2012-0333; de Seta L, 1994, Pediatr Med Chir, V16, P251; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Dupont C, 2009, ALLERGY, V64, P63; Exl BM, 1998, NUTR RES, V18, P1443, DOI 10.1016/S0271-5317(98)00121-3; Fleischer DM, 2013, J ALLER CL IMM-PRACT, V1, P29, DOI 10.1016/j.jaip.2012.09.003; Grulee CG, 1936, J PEDIATR-US, V9, P223, DOI 10.1016/S0022-3476(36)80058-4; Halken S, 1993, Pediatr Allergy Immunol, V4, P173, DOI 10.1111/j.1399-3038.1993.tb00088.x; Halken S, 2000, PEDIATR ALLERGY IMMU, V11, P149, DOI 10.1034/j.1399-3038.2000.00081.x; Han YS, 2003, J KOREAN MED SCI, V18, P547, DOI 10.3346/jkms.2003.18.4.547; JUVONEN P, 1994, J PEDIATR GASTR NUTR, V18, P344, DOI 10.1097/00005176-199404000-00016; Knip M, 2014, JAMA-J AM MED ASSOC, V311, P2279, DOI 10.1001/jama.2014.5610; Kung Jason, 2010, Open Dent J, V4, P84, DOI 10.2174/1874210601004020084; LOVEGROVE JA, 1994, BRIT J NUTR, V71, P223, DOI 10.1079/BJN19940129; Lowe AJ, 2011, J ALLERGY CLIN IMMUN, V128, P360, DOI 10.1016/j.jaci.2010.05.006; Ludman S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5424; MALLET E, 1992, J PEDIATR-US, V121, pS95, DOI 10.1016/S0022-3476(05)81415-5; Marini A, 1996, ACTA PAEDIATR, V85, P1, DOI 10.1111/j.1651-2227.1996.tb14267.x; Martikainen A, 1996, DIABETES, V45, P1706, DOI 10.2337/diabetes.45.12.1706; MORAN JR, 1992, J PEDIATR-US, V121, pS90, DOI 10.1016/S0022-3476(05)81414-3; Muraro A, 2014, ALLERGY, V69, P590, DOI 10.1111/all.12398; Nentwich I, 2001, ALLERGY, V56, P1144, DOI 10.1111/j.1398-9995.2001x.00926.x; Odelram H, 1996, ALLERGY, V51, P192, DOI 10.1111/j.1398-9995.1996.tb00063.x; Oldaeus G, 1997, ARCH DIS CHILD, V77, P4, DOI 10.1136/adc.77.1.4; Osborn D, 2013, ALLERGY, V68, P627; Osborn DA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003664.pub3; Paronen J, 2000, DIABETES, V49, P1657, DOI 10.2337/diabetes.49.10.1657; Porch MC, 1998, NUTR RES, V18, P1413, DOI 10.1016/S0271-5317(98)00119-5; Prescott SL, 2013, J ALLERGY CLIN IMMUN, V131, P23, DOI 10.1016/j.jaci.2012.11.019; Saarinen KM, 1999, J ALLERGY CLIN IMMUN, V104, P457, DOI 10.1016/S0091-6749(99)70393-3; Scalabrin DM, 2009, CLIN PEDIATR, V48, P734, DOI 10.1177/0009922809332682; SCHMITZ J, 1992, J PEDIATR-US, V121, pS85, DOI 10.1016/S0022-3476(05)81413-1; Schonberger HJAM, 2005, EUR RESPIR J, V25, P660, DOI 10.1183/09031936.05.00067704; Shao Jie, 2006, Zhonghua Er Ke Za Zhi, V44, P684; Tsai Y T, 1991, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V32, P137; Vaarala O, 1999, DIABETES, V48, P1389, DOI 10.2337/diabetes.48.7.1389; Vaarala O, 2012, ARCH PEDIAT ADOL MED, V166, P608, DOI 10.1001/archpediatrics.2011.1559; VANDENPLAS Y, 1992, LANCET, V339, P1118, DOI 10.1016/0140-6736(92)90716-G; VANDENPLAS Y, 1988, EUR J PEDIATR, V148, P274, DOI 10.1007/BF00441420; von Berg A, 2003, J ALLERGY CLIN IMMUN, V111, P533, DOI 10.1067/mai.2003.101; von Berg A, 2010, CLIN EXP ALLERGY, V40, P627, DOI 10.1111/j.1365-2222.2009.03444.x; von Berg A, 2008, J ALLERGY CLIN IMMUN, V121, P1442, DOI 10.1016/j.jaci.2008.04.021; von Berg A, 2013, J ALLERGY CLIN IMMUN, V131, P1565, DOI 10.1016/j.jaci.2013.01.006; WHO, 1981, INTERNATIONAL CODE O; WILLEMS R, 1993, ANN ALLERGY, V71, P147	57	137	144	1	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2016	352								i974	10.1136/bmj.i974	http://dx.doi.org/10.1136/bmj.i974			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NI	26956579	Green Published, hybrid			2022-12-28	WOS:000372048500002
J	Watts, G				Watts, Geoff			Norman Edward Breslow Obituary	LANCET			English	Biographical-Item																		BRESLOW NE, PUBLICATION LIST	1	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					842	842		10.1016/S0140-6736(16)00518-3	http://dx.doi.org/10.1016/S0140-6736(16)00518-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE9RA	26977481				2022-12-28	WOS:000370974400016
J	Cauchemez, S; Besnard, M; Bompard, P; Dub, T; Guillemette-Artur, P; Eyrolle-Guignot, D; Salje, H; Van Kerkhove, MD; Abadie, V; Garel, C; Fontanet, A; Mallet, HP				Cauchemez, Simon; Besnard, Marianne; Bompard, Priscillia; Dub, Timothee; Guillemette-Artur, Prisca; Eyrolle-Guignot, Dominique; Salje, Henrik; Van Kerkhove, Maria D.; Abadie, VRonique; Garel, Catherine; Fontanet, Arnaud; Mallet, Henri-Pierre			Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study	LANCET			English	Article							PREGNANT-WOMEN; UNITED-STATES; INFECTION; OUTBREAK; CHILDREN; MOTHER	Background The emergence of Zika virus in the Americas has coincided with increased reports of babies born with microcephaly. On Feb 1, 2016, WHO declared the suspected link between Zika virus and microcephaly to be a Public Health Emergency of International Concern. This association, however, has not been precisely quantified. Methods We retrospectively analysed data from a Zika virus outbreak in French Polynesia, which was the largest documented outbreak before that in the Americas. We used serological and surveillance data to estimate the probability of infection with Zika virus for each week of the epidemic and searched medical records to identify all cases of microcephaly from September, 2013, to July, 2015. Simple models were used to assess periods of risk in pregnancy when Zika virus might increase the risk of microcephaly and estimate the associated risk. Findings The Zika virus outbreak began in October, 2013, and ended in April, 2014, and 66% (95% CI 62-70) of the general population were infected. Of the eight microcephaly cases identified during the 23-month study period, seven (88%) occurred in the 4-month period March 1 to July 10, 2014. The timing of these cases was best explained by a period of risk in the first trimester of pregnancy. In this model, the baseline prevalence of microcephaly was two cases (95% CI 0-8) per 10 000 neonates, and the risk of microcephaly associated with Zika virus infection was 95 cases (34-191) per 10 000 women infected in the first trimester. We could not rule out an increased risk of microcephaly from infection in other trimesters, but models that excluded the first trimester were not supported by the data. Interpretation Our findings provide a quantitative estimate of the risk of microcephaly in fetuses and neonates whose mothers are infected with Zika virus.	[Cauchemez, Simon; Salje, Henrik] Inst Pasteur, Math Modelling Infect Dis, Paris, France; [Dub, Timothee; Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France; [Van Kerkhove, Maria D.; Fontanet, Arnaud] Inst Pasteur, Ctr Global Hlth, Paris, France; [Besnard, Marianne] French Polynesia Hosp Ctr, Neonatal Care Dept, Pirae, Tahiti, France; [Guillemette-Artur, Prisca] French Polynesia Hosp Ctr, Dept Med Imaging, Pirae, Tahiti, France; [Eyrolle-Guignot, Dominique] French Polynesia Hosp Ctr, Dept Obstet Gynecol, Pirae, Tahiti, France; [Bompard, Priscillia; Mallet, Henri-Pierre] Bur Veille Sanitaire, Direct Sante, Papeete, Tahiti, France; [Salje, Henrik] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Abadie, VRonique] Hop Necker Enfants Malad, Gen Paediat Dept, Paris, France; [Garel, Catherine] Hop Enfants Armand Trousseau, Dept Paediat Radiol, Paris, France; [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Johns Hopkins University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Cauchemez, S (corresponding author), Inst Pasteur, Math Modelling Infect Dis Unit, 28 Rue Dr Roux, F-75015 Paris, France.	simon.cauchemez@pasteur.fr	Dub, Timothee/AAX-4663-2020	Dub, Timothee/0000-0002-1819-518X; Salje, Henrik/0000-0003-3626-4254; , arnaud/0000-0002-5239-6110; Van Kerkhove, Maria/0000-0002-6135-0018	Labex-IBEID; NIH-MIDAS; AXA Research fund; EU-PREDEMICS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110721] Funding Source: NIH RePORTER	Labex-IBEID; NIH-MIDAS; AXA Research fund(AXA Research Fund); EU-PREDEMICS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Labex-IBEID, NIH-MIDAS, AXA Research fund, EU-PREDEMICS.	Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003; [Anonymous], 2016, WASHINGTON POST; Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7; Aubry M, 2015, 64 ANN M AM SOC TROP; Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Butler D, 2016, NATURE, V530, P12; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; de Jong EP, 2011, PRENATAL DIAG, V31, P419, DOI 10.1002/pd.2714; De Santis M, 2006, REPROD TOXICOL, V21, P390, DOI 10.1016/j.reprotox.2005.01.014; DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974; Dorigatti I, 2013, P NATL ACAD SCI USA, V110, P13422, DOI 10.1073/pnas.1303117110; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; ECDC, 2015, RAP RISK ASS ZIK VIR; Eurocat, 2003, EUR SURV CONG AN EUR; Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Institut de Statistique de Polynesie Francaise, 2014, GRANDS IND POP ISS E; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452; Liu J.S., 2001, MONTE CARLO STRATEGI; Mallet HP, 2015, BISES B INFORM SANIT, V13, P1; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Naing ZW, 2016, AUST NZ J OBSTET GYN, V56, P9, DOI 10.1111/ajo.12408; Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061; O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024; Olusanya BO, 2012, INT HEALTH, V4, P128, DOI 10.1016/j.inhe.2011.12.006; Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0; Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1; Regis CT, MICROCEPHALY NE BRAZ; Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355; Stoler-Poria S, 2010, ULTRASOUND OBST GYN, V36, P154, DOI 10.1002/uog.7556; Tarrant A, 2009, PEDIATR RADIOL, V39, P772, DOI 10.1007/s00247-009-1266-x; Vauloup-Fellous C, 2013, ANN BIOL CLIN-PARIS, V71, P5, DOI 10.1684/abc.2013.0897; Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7; Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425; Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232; Whitehouse AJO, 2012, ARCH DIS CHILD, V97, P49, DOI 10.1136/adc.2009.180331; WHO, 2016, WHO STAT 1 M INT HLT; WHO, 2016, GUILL BARR SYNDR SAL; World Health Organization, 2016, WHO DIR GEN SUMM OUT; World Health Organization, 2016, ZIK SIT REP NEUR SYN	44	604	620	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2125	2132		10.1016/S0140-6736(16)00651-6	http://dx.doi.org/10.1016/S0140-6736(16)00651-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	26993883	Green Accepted, Bronze			2022-12-28	WOS:000376450800036
J	Moore, N; Salvo, F; Duong, M; Gulmez, SE				Moore, Nicholas; Salvo, Francesco; Duong, Mai; Gulmez, Sinem Ezgi			Does paracetamol still have a future in osteoarthritis?	LANCET			English	Editorial Material							CELECOXIB; EFFICACY; SAFETY		[Moore, Nicholas; Salvo, Francesco; Duong, Mai; Gulmez, Sinem Ezgi] Univ Bordeaux, INSERM, U657, Bordeaux Pharmacoepi,Dept Pharmacol,CIC1401, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Moore, N (corresponding author), Univ Bordeaux, INSERM, U657, Bordeaux Pharmacoepi,Dept Pharmacol,CIC1401, F-33076 Bordeaux, France.	nicholas.moore@u-bordeaux.fr	Gulmez, Sinem Ezgi/HCH-7357-2022; Salvo, Francesco/S-9254-2019; Gulmez, Sinem Ezgi/K-6001-2019	Gulmez, Sinem Ezgi/0000-0001-8815-9128; Gulmez, Sinem Ezgi/0000-0001-8815-9128; Moore, Nicholas/0000-0003-1212-2817; Salvo, Francesco/0000-0003-3210-7171				Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Cameron M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002947.pub2; da Costa BR, 2015, LANCET; Duong M, 2014, BRIT J CLIN PHARMACO, V77, P887, DOI 10.1111/bcp.12239; Gulmez SE, 2013, DRUG SAFETY, V36, P135, DOI 10.1007/s40264-012-0013-7; Kellner HL, 2012, CURR MED RES OPIN, V28, P1537, DOI 10.1185/03007995.2012.717528; Laharie D, 2010, BRIT J CLIN PHARMACO, V69, P295, DOI 10.1111/j.1365-2125.2009.03588.x; Moore N, 1999, CLIN DRUG INVEST, V18, P89, DOI 10.2165/00044011-199918020-00001; Moore N, 2004, THERAPIE, V59, P541, DOI 10.2515/therapie:2004092; Riendeau D, 2001, J PHARMACOL EXP THER, V296, P558; Roberts E, 2016, ANN RHEUM DIS, V75, P552, DOI 10.1136/annrheumdis-2014-206914; Sawitzke AD, 2010, ANN RHEUM DIS, V69, P1459, DOI 10.1136/ard.2009.120469	12	7	8	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2065	2066		10.1016/S0140-6736(15)01170-8	http://dx.doi.org/10.1016/S0140-6736(15)01170-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	26997558				2022-12-28	WOS:000376450800005
J	Glover, TW; Wilson, TE				Glover, Thomas W.; Wilson, Thomas E.			MOLECULAR BIOLOGY Breaks in the brain	NATURE			English	Editorial Material							COPY-NUMBER VARIATION; REPLICATION STRESS; FRAGILE SITES; DNA		[Glover, Thomas W.; Wilson, Thomas E.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Glover, Thomas W.; Wilson, Thomas E.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Glover, TW; Wilson, TE (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA.; Glover, TW; Wilson, TE (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	glover@med.umich.edu; wilsonte@med.umich.edu			NIEHS NIH HHS [R21 ES022311] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES022311] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Cai XY, 2014, CELL REP, V8, P1280, DOI 10.1016/j.celrep.2014.07.043; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Hannibal RL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004290; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Minocherhomji S, 2015, NATURE, V528, P286, DOI 10.1038/nature16139; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; O'Huallachain M, 2012, P NATL ACAD SCI USA, V109, P18018, DOI 10.1073/pnas.1213736109; Wei PC, 2016, CELL, V164, P644, DOI 10.1016/j.cell.2015.12.039; Wilson TE, 2015, GENOME RES, V25, P189, DOI 10.1101/gr.177121.114	12	8	8	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					46	47		10.1038/nature17316	http://dx.doi.org/10.1038/nature17316			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27007850				2022-12-28	WOS:000373555500030
J	Schaefer, H; Fletcher, SEM; Veidt, C; Lassey, KR; Brailsford, GW; Bromley, TM; Dlugokencky, EJ; Michel, SE; Miller, JB; Levin, I; Lowe, DC; Martin, RJ; Vaughn, BH; White, JWC				Schaefer, Hinrich; Fletcher, Sara E. Mikaloff; Veidt, Cordelia; Lassey, Keith R.; Brailsford, Gordon W.; Bromley, Tony M.; Dlugokencky, Edward J.; Michel, Sylvia E.; Miller, John B.; Levin, Ingeborg; Lowe, Dave C.; Martin, Ross J.; Vaughn, Bruce H.; White, James W. C.			A 21st-century shift from fossil-fuel to biogenic methane emissions indicated by (CH4)-C-13	SCIENCE			English	Article							ATMOSPHERIC METHANE; INTERANNUAL VARIABILITY; MIXING-RATIO; ATTRIBUTION; DECADES; BUDGET; TREND; STATE	Between 1999 and 2006, a plateau interrupted the otherwise continuous increase of atmospheric methane concentration [CH4] since preindustrial times. Causes could be sink variability or a temporary reduction in industrial or climate-sensitive sources. We reconstructed the global history of [CH4] and its stable carbon isotopes from ice cores, archived air, and a global network of monitoring stations. A box-model analysis suggests that diminishing thermogenic emissions, probably from the fossil-fuel industry, and/or variations in the hydroxyl CH4 sink caused the [CH4] plateau. Thermogenic emissions did not resume to cause the renewed [CH4] rise after 2006, which contradicts emission inventories. Post-2006 source increases are predominantly biogenic, outside the Arctic, and arguably more consistent with agriculture than wetlands. If so, mitigating CH4 emissions must be balanced with the need for food production.	[Schaefer, Hinrich; Fletcher, Sara E. Mikaloff; Lassey, Keith R.; Brailsford, Gordon W.; Bromley, Tony M.; Lowe, Dave C.; Martin, Ross J.] Natl Inst Water & Atmospher Res NIWA, Climate & Atmosphere Ctr, 301 Evans Bay Parade, Wellington 6021, New Zealand; [Veidt, Cordelia; Levin, Ingeborg] Heidelberg Univ, Inst Umweltphys, Neuenheimer Feld 229, D-69120 Heidelberg, Germany; [Dlugokencky, Edward J.; Miller, John B.] NOAA, ESRL, Global Monitoring Div, 325 Broadway, Boulder, CO 80305 USA; [Michel, Sylvia E.; Vaughn, Bruce H.; White, James W. C.] Univ Colorado, Inst Arctic & Alpine Res INSTAAR, Boulder, CO 80309 USA; [Lassey, Keith R.] Lassey Res & Educ, 4 Witako St, Lower Hutt 5011, New Zealand; [Lowe, Dave C.] LoweNZ, 31 Queen St, Lower Hutt 5012, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Ruprecht Karls University Heidelberg; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder	Schaefer, H (corresponding author), Natl Inst Water & Atmospher Res NIWA, Climate & Atmosphere Ctr, 301 Evans Bay Parade, Wellington 6021, New Zealand.	hinrich.schaefer@niwa.co.nz	Vaughn, Bruce/AAO-8867-2020; White, James W.C./A-7845-2009; Miller, John B./AAE-7714-2019; Dlugokencky, Edward/AAN-8746-2020; Michel, Sylvia Englund/AAQ-2028-2020	White, James W.C./0000-0001-6041-4684; Miller, John B./0000-0001-8630-1610; Dlugokencky, Edward/0000-0003-0612-6985; Michel, Sylvia Englund/0000-0002-5651-1163; Schaefer, Hinrich/0000-0002-1163-2818; VAUGHN, BRUCE/0000-0001-6503-957X	Marsden Fund Council from New Zealand Government; NIWA under Climate and Atmosphere Research Programme [CAAC1504 (2014/15 SCI)]; Directorate For Engineering [1240584] Funding Source: National Science Foundation	Marsden Fund Council from New Zealand Government(Royal Society of New ZealandMarsden Fund (NZ)); NIWA under Climate and Atmosphere Research Programme; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank S. Montzka for supplying OH-reconstruction data. M. Harvey and K. Steinkamp provided helpful discussions. Feedback from two anonymous reviewers improved the manuscript. Antarctica NZ supports air sampling at Arrival Heights, Antarctica (ARH). Raw data for individual stations measured by INSTAAR and NIWA are available from the World Data Centre for Greenhouse Gases http://ds.data.jma.go.jp/gmd/wdcgg/introduction.html; data from INSTAAR are also available from ftp://aftp.cmdl.noaa.gov/data/trace_gases. Data from Heidelberg University are available from http://www.iup.uni-heidelberg.de/institut/forschung/groups/kk/en/Data_html. Data measured by University of Washington and University of California, Irvine, were taken from http://cdiac.ornl.gov/ndps/quay.html and http://cdiac.ornl.gov/epubs/db/db1022/db1022.html, respectively. Yearly delta<SUP>13</SUP> C values for individual stations and global annual averages are presented in tables S3 and S4. This research was supported by the Marsden Fund Council from New Zealand Government funding, administered by the Royal Society of New Zealand. Further support came from NIWA under Climate and Atmosphere Research Programme CAAC1504 (2014/15 SCI). The authors declare no competing interests. H. S. designed the data analysis; G. W. B., T. M. B., R. J. M., J. B. M., D. C. L., B. H. V., C. V., and S. E. M. performed delta<SUP>13</SUP>C measurements; C. V., J. B. M., I. L., D. C. L., and J. W. C. W. designed sampling and analytical programmes and performed data quality control; E. J. D. provided [CH<INF>4</INF>] data; K. R. L. and H. S. designed the box model; S. E. M. F. and H. S. performed uncertainty analyses; and all authors contributed to the interpretation and the writing of the manuscript.	Banda N, 2013, ATMOS CHEM PHYS, V13, P2267, DOI 10.5194/acp-13-2267-2013; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Bousquet P, 2011, ATMOS CHEM PHYS, V11, P3689, DOI 10.5194/acp-11-3689-2011; Breas O, 2002, ISOT ENVIRON HEALT S, V37, P257, DOI 10.1080/10256010108033302; Dlugokencky EJ, 2011, PHILOS T R SOC A, V369, P2058, DOI 10.1098/rsta.2010.0341; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; European Commission, 2011, EM DAT GLOB ATM RES; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Food and Agriculture Organization of the United Nations, 2014, FAOSTAT DAT; Ghosh A, 2015, ATMOS CHEM PHYS, V15, P2595, DOI 10.5194/acp-15-2595-2015; Hodson EL, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046861; Houweling S, 2014, ATMOS CHEM PHYS, V14, P3991, DOI 10.5194/acp-14-3991-2014; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/NGEO1955, 10.1038/ngeo1955]; Lassey KR, 2010, J INTEGR ENVIRON SCI, V7, P109, DOI 10.1080/19438151003621441; Lassey KR, 2000, GLOBAL BIOGEOCHEM CY, V14, P41, DOI 10.1029/1999GB900094; Levin I, 2012, NATURE, V486, pE3, DOI 10.1038/nature11175; Meure CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026152; Melton JR, 2013, BIOGEOSCIENCES, V10, P753, DOI 10.5194/bg-10-753-2013; Monteil G, 2011, ATMOS CHEM PHYS, V11, P9141, DOI 10.5194/acp-11-9141-2011; Montzka SA, 2011, SCIENCE, V331, P67, DOI 10.1126/science.1197640; Naik V, 2013, ATMOS CHEM PHYS, V13, P5277, DOI 10.5194/acp-13-5277-2013; National Oceanic and Atmospheric Administration, 2014, OC NIN IND; Nisbet EG, 2014, SCIENCE, V343, P493, DOI 10.1126/science.1247828; Rigby M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036037; Schaefer H, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002889; Schultz MG, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003031; Schuur EAG, 2015, NATURE, V520, P171, DOI 10.1038/nature14338; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; Simpson IJ, 2012, NATURE, V488, P490, DOI 10.1038/nature11342; US EPA, 2012, GLOB ANTHR NONCO2 GR; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010	32	254	256	13	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					80	84		10.1126/science.aad2705	http://dx.doi.org/10.1126/science.aad2705			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	26966190				2022-12-28	WOS:000373039600039
J	Segal, RA				Segal, Rosalind A.			Lessons from a bridge generation	SCIENCE			English	Editorial Material									[Segal, Rosalind A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Segal, Rosalind A.] Dana Farber Canc Inst, Canc Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Dana-Farber Cancer Institute	Segal, RA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.; Segal, RA (corresponding author), Dana Farber Canc Inst, Canc Biol, Boston, MA 02115 USA.								0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1494	1494		10.1126/science.351.6280.1494	http://dx.doi.org/10.1126/science.351.6280.1494			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH4KZ	27013735				2022-12-28	WOS:000372756200055
J	Waqas, A				Waqas, Ahmed			How I made my own opportunities	SCIENCE			English	Editorial Material								Like many other medical students in Pakistan, during my first year of medical school I aspired to become a neurosurgeon to enjoy a lucrative lifestyle and high social status. But all that changed when I was diagnosed with depression during my second year. Although painful, the experience instilled in me a passion for psychiatry, a field that has yet to establish itself in Pakistan. Today, my dream is to improve mental health care for mothers and children in low- and middle-income countries. I want to take a combined academic and clinical approach, but. I have found many obstacles to pursuing research in Pakistan. Persistence and an ability to leverage whatever resources I can find have been key to my success thus far.	[Waqas, Ahmed] CMH Lahore Med Coll, Surg, Lahore, Pakistan; [Waqas, Ahmed] Inst Dent, Lahore, Pakistan		Waqas, A (corresponding author), CMH Lahore Med Coll, Surg, Lahore, Pakistan.; Waqas, A (corresponding author), Inst Dent, Lahore, Pakistan.		Waqas, Ahmed/V-6682-2019	Waqas, Ahmed/0000-0002-3772-194X					0	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1358	1358		10.1126/science.351.6279.1358	http://dx.doi.org/10.1126/science.351.6279.1358			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989255				2022-12-28	WOS:000372397700049
J	Wu, HL; Sato, R; Yamaguchi, A; Kimura, M; Haruta, M; Kurata, H; Teranishi, T				Wu, Hsin-Lun; Sato, Ryota; Yamaguchi, Atsushi; Kimura, Masato; Haruta, Mitsutaka; Kurata, Hiroki; Teranishi, Toshiharu			Formation of pseudomorphic nanocages from Cu2O nanocrystals through anion exchange reactions	SCIENCE			English	Article							CATION-EXCHANGE; SIZE; TRANSFORMATIONS; PHASE	The crystal structure of ionic nanocrystals (NCs) is usually controlled through reaction temperature, according to their phase diagram. We show that when ionic NCs with different shapes, but identical crystal structures, were subjected to anion exchange reactions under ambient conditions, pseudomorphic products with different crystal systems were obtained. The shape-dependent anionic framework (surface anion sublattice and stacking pattern) of Cu2O NCs determined the crystal system of anion-exchanged products of CuxS nanocages. This method enabled us to convert a body-centered cubic lattice into either a face-centered cubic or a hexagonally close-packed lattice to form crystallographically unusual, multiply twinned structures. Subsequent cation exchange reactions produced CdS nanocages while preserving the multiply-twinned structures. A high-temperature stable phase such as wurtzite ZnS was also obtained with this method at ambient conditions.	[Wu, Hsin-Lun; Sato, Ryota; Yamaguchi, Atsushi; Kimura, Masato; Haruta, Mitsutaka; Kurata, Hiroki; Teranishi, Toshiharu] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan	Kyoto University	Teranishi, T (corresponding author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	teranisi@scl.kyoto-u.ac.jp			Artificial Photosynthesis Project (ARPChem) of the New Energy and Industrial Technology Development Organization (NEDO) of Japan	Artificial Photosynthesis Project (ARPChem) of the New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was partly supported by the Artificial Photosynthesis Project (ARPChem) of the New Energy and Industrial Technology Development Organization (NEDO) of Japan.	Ha DH, 2014, NANO LETT, V14, P7090, DOI 10.1021/nl5035607; Huang WC, 2012, J AM CHEM SOC, V134, P1261, DOI 10.1021/ja209662v; Jain PK, 2010, J AM CHEM SOC, V132, P9997, DOI 10.1021/ja104126u; Kanehara M, 2012, CHEM-EUR J, V18, P9230, DOI 10.1002/chem.201201159; Kuo CH, 2007, ADV FUNCT MATER, V17, P3773, DOI 10.1002/adfm.200700356; Kuo CH, 2011, ADV FUNCT MATER, V21, P792, DOI 10.1002/adfm.201002108; Kuo CH, 2008, J PHYS CHEM C, V112, P18355, DOI 10.1021/jp8060027; Li HB, 2011, NANO LETT, V11, P4964, DOI 10.1021/nl202927a; Moon GD, 2011, NANO TODAY, V6, P186, DOI 10.1016/j.nantod.2011.02.006; Mumme WG, 2012, CAN MINERAL, V50, P423, DOI 10.3749/canmin.50.2.423; Park J, 2009, J AM CHEM SOC, V131, P13943, DOI 10.1021/ja905732q; Qadri SB, 2001, J APPL PHYS, V89, P115, DOI 10.1063/1.1328066; Qadri SB, 1999, PHYS REV B, V60, P9191, DOI 10.1103/PhysRevB.60.9191; Rivest JB, 2013, CHEM SOC REV, V42, P89, DOI 10.1039/c2cs35241a; Robinson RD, 2007, SCIENCE, V317, P355, DOI 10.1126/science.1142593; Saruyama M, 2011, J AM CHEM SOC, V133, P17598, DOI 10.1021/ja2078224; Son DH, 2004, SCIENCE, V306, P1009, DOI 10.1126/science.1103755; Teranishi T, 2013, J PHYS CHEM LETT, V4, P2867, DOI 10.1021/jz4013504; Wang ZW, 2005, NAT MATER, V4, P922, DOI 10.1038/nmat1522; Yu WW, 2002, ANGEW CHEM INT EDIT, V41, P2368, DOI 10.1002/1521-3773(20020703)41:13<2368::AID-ANIE2368>3.0.CO;2-G; Zhang DD, 2014, J AM CHEM SOC, V136, P17430, DOI 10.1021/ja511010q	21	81	81	6	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1306	1310		10.1126/science.aad5520	http://dx.doi.org/10.1126/science.aad5520			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989249	Green Published			2022-12-28	WOS:000372397700039
J	Bailey, P				Bailey, Peter			PERSONAL VIEW This mismanagement of the NHS amounts to neglect	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												peter.bailey@nhs.net							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2016	352								i1536	10.1136/bmj.i1536	http://dx.doi.org/10.1136/bmj.i1536			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AD	26989210				2022-12-28	WOS:000372585400005
J	Fuyuno, I				Fuyuno, Ichiko			FLAGGING FORTUNES INVITE REFORM	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S104	S107		10.1038/531S104a	http://dx.doi.org/10.1038/531S104a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG4TA	26982020	Bronze			2022-12-28	WOS:000372064300009
J	Kakuru, A; Jagannathan, P; Muhindo, MK; Natureeba, P; Awori, P; Nakalembe, M; Opira, B; Olwoch, P; Ategeka, J; Nayebare, P; Clark, TD; Feeney, ME; Charlebois, ED; Rizzuto, G; Muehlenbachs, A; Havlir, DV; Kamya, MR; Dorsey, G				Kakuru, Abel; Jagannathan, Prasanna; Muhindo, Mary K.; Natureeba, Paul; Awori, Patricia; Nakalembe, Miriam; Opira, Bishop; Olwoch, Peter; Ategeka, John; Nayebare, Patience; Clark, Tamara D.; Feeney, Margaret E.; Charlebois, Edwin D.; Rizzuto, Gabrielle; Muehlenbachs, Atis; Havlir, Diane V.; Kamya, Moses R.; Dorsey, Grant			Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERMITTENT SULFADOXINE-PYRIMETHAMINE; CONTROLLED-TRIAL; WOMEN; RESISTANCE; INFECTION; ANEMIA; MARKERS; BURDEN; IMPACT; GUIDE	BACKGROUND Intermittent treatment with sulfadoxine-pyrimethamine is widely recommended for the prevention of malaria in pregnant women in Africa. However, with the spread of resistance to sulfadoxine-pyrimethamine, new interventions are needed. METHODS We conducted a double-blind, randomized, controlled trial involving 300 human immunodeficiency virus (HIV)-uninfected pregnant adolescents or women in Uganda, where sulfadoxine-pyrimethamine resistance is widespread. We randomly assigned participants to a sulfadoxine-pyrimethamine regimen (106 participants), a three-dose dihydroartemisinin-piperaquine regimen (94 participants), or a monthly dihydroartemisinin-piperaquine regimen (100 participants). The primary outcome was the prevalence of histopathologically confirmed placental malaria. RESULTS The prevalence of histopathologically confirmed placental malaria was significantly higher in the sulfadoxine-pyrimethamine group (50.0%) than in the three-dose dihydroartemisinin-piperaquine group (34.1%, P=0.03) or the monthly dihydroartemisinin-piperaquine group (27.1%, P=0.001). The prevalence of a composite adverse birth outcome was lower in the monthly dihydroartemisinin-piperaquine group (9.2%) than in the sulfadoxine-pyrimethamine group (18.6%, P=0.05) or the three-dose dihydroartemisinin-piperaquine group (21.3%, P=0.02). During pregnancy, the incidence of symptomatic malaria was significantly higher in the sulfadoxine-pyrimethamine group (41 episodes over 43.0 person-years at risk) than in the three-dose dihydroartemisinin-piperaquine group (12 episodes over 38.2 person-years at risk, P=0.001) or the monthly dihydroartemisinin-piperaquine group (0 episodes over 42.3 personyears at risk, P<0.001), as was the prevalence of parasitemia (40.5% in the sulfadoxine-pyrimethamine group vs. 16.6% in the three-dose dihydroartemisinin-piperaquine group [P<0.001] and 5.2% in the monthly dihydroartemisinin-piperaquine group [P<0.001]). In each treatment group, the risk of vomiting after administration of any dose of the study agents was less than 0.4%, and there were no significant differences among the groups in the risk of adverse events. CONCLUSIONS The burden of malaria in pregnancy was significantly lower among adolescent girls or women who received intermittent preventive treatment with dihydroartemisinin-piperaquine than among those who received sulfadoxine-pyrimethamine, and monthly treatment with dihydroartemisinin-piperaquine was superior to three-dose dihydroartemisinin-piperaquine with regard to several outcomes. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development; ClinicalTrials. gov number, NCT02163447.)	[Kakuru, Abel; Muhindo, Mary K.; Natureeba, Paul; Awori, Patricia; Nakalembe, Miriam; Opira, Bishop; Olwoch, Peter; Ategeka, John; Nayebare, Patience] Makerere Univ, Coll Hlth Sci, Infect Dis Res Collaborat, Kampala, Uganda; [Nakalembe, Miriam] Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynecol, Kampala, Uganda; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Jagannathan, Prasanna; Clark, Tamara D.; Feeney, Margaret E.; Havlir, Diane V.; Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Feeney, Margaret E.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Rizzuto, Gabrielle] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Charlebois, Edwin D.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Muehlenbachs, Atis] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA	Makerere University; Makerere University; Makerere University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA	Dorsey, G (corresponding author), San Francisco Gen Hosp, 1001 Potrero Ave,Bldg 30,Rm 3420, San Francisco, CA 94110 USA.	gdorsey@medsfgh.ucsf.edu	Rizzuto, Gabrielle/GWR-2224-2022; Jagannathan, Prasanna/AAC-4176-2022	Jagannathan, Prasanna/0000-0001-6305-758X; Rizzuto, Gabrielle/0000-0003-3052-0253; Kakuru, Abel/0000-0001-9941-1309	Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD059454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093615, K23AI100949, K24AI113002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development; ClinicalTrials.gov number, NCT02163447.	Arinaitwe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073073; Bertin G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-196; Bigira V, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001689; Clerk CA, 2008, J INFECT DIS, V198, P1202, DOI 10.1086/591944; Cohee LM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-274; Cottrell G, 2015, CLIN INFECT DIS, V60, P1481, DOI 10.1093/cid/civ122; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2015, LANCET, V386, P2507, DOI 10.1016/S0140-6736(15)00310-4; European Medicines Agency, 2013, EUR; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Gutman J, 2013, J INFECT DIS, V208, P907, DOI 10.1093/infdis/jit276; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Kamya MR, 2015, AM J TROP MED HYG, V92, P903, DOI 10.4269/ajtmh.14-0312; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Lwin KM, 2012, ANTIMICROB AGENTS CH, V56, P1571, DOI 10.1128/AAC.05877-11; Matondo SI, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-152; Mbonye AK, 2015, ANTIMICROB AGENTS CH, V59, P5475, DOI 10.1128/AAC.00507-15; Moussiliou A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-195; Muehlenbachs A, 2010, J INFECT DIS, V202, P1608, DOI 10.1086/656723; Naidoo I, 2011, PARASITOLOGY, V138, P1469, DOI 10.1017/S0031182011000746; Nankabirwa JI, 2014, CLIN INFECT DIS, V58, P1404, DOI 10.1093/cid/ciu150; Natureeba P, 2014, J INFECT DIS, V210, P1938, DOI 10.1093/infdis/jiu346; Piola P, 2010, LANCET INFECT DIS, V10, P762, DOI 10.1016/S1473-3099(10)70202-4; Poespoprodjo JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084976; Rijken MJ, 2008, AM J TROP MED HYG, V78, P543, DOI 10.4269/ajtmh.2008.78.543; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; SCHULTZ LJ, 1994, AM J TROP MED HYG, V51, P515, DOI 10.4269/ajtmh.1994.51.515; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Verhoeff FH, 1998, ANN TROP MED PARASIT, V92, P141, DOI 10.1080/00034989859979; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; Zani B, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010927	34	143	144	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					928	939		10.1056/NEJMoa1509150	http://dx.doi.org/10.1056/NEJMoa1509150			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF9DH	26962728	Bronze, Green Accepted			2022-12-28	WOS:000371660000006
J	Kornberg, K				Kornberg, Ken			You, Me, and We: Biolabs for the 21st Century	CELL			English	Editorial Material								Twenty-first century biomedical research is advantaged by institutional infrastructures that foster a collaborative, multidisciplinary approach. A few critical elements in the design of labs, research buildings, or campus can make interaction easier while preserving privacy and comfort for the individual researcher.	[Kornberg, Ken] Kornberg Associates Architects, 687 Bay Rd, Menlo Pk, CA 94025 USA		Kornberg, K (corresponding author), Kornberg Associates Architects, 687 Bay Rd, Menlo Pk, CA 94025 USA.	ken@kornberg.com							0	0	0	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1097	1100		10.1016/j.cell.2016.02.017	http://dx.doi.org/10.1016/j.cell.2016.02.017			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967276	Bronze			2022-12-28	WOS:000372784900007
J	Pekyi, D; Ampromfi, AA; Tinto, H; Traore-Coulibaly, M; Tahita, MC; Valea, I; Mwapasa, V; Kalilani-Phiri, L; Kalanda, G; Madanitsa, M; Ravinetto, R; Mutabingwa, T; Gbekor, P; Tagbor, H; Antwi, G; Menten, J; De Crop, M; Claeys, Y; Schurmans, C; Van Overmeir, C; Thriemer, K; Van Geertruyden, JP; D'Alessandro, U; Nambozi, M; Mulenga, M; Hachizovu, S; Kabuya, JBB; Mulenga, J				Pekyi, D.; Ampromfi, A. A.; Tinto, H.; Traore-Coulibaly, M.; Tahita, M. C.; Valea, I.; Mwapasa, V.; Kalilani-Phiri, L.; Kalanda, G.; Madanitsa, M.; Ravinetto, R.; Mutabingwa, T.; Gbekor, P.; Tagbor, H.; Antwi, G.; Menten, J.; De Crop, M.; Claeys, Y.; Schurmans, C.; Van Overmeir, C.; Thriemer, K.; Van Geertruyden, J. -P.; D'Alessandro, U.; Nambozi, M.; Mulenga, M.; Hachizovu, S.; Kabuya, J. -B. B.; Mulenga, J.		PREGACT Study Grp	Four Artemisinin-Based Treatments in African Pregnant Women with Malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; NONPREGNANT WOMEN; SULFADOXINE-PYRIMETHAMINE; ARTEMETHER-LUMEFANTRINE; CONTROLLED-TRIAL; PHARMACOKINETICS; COMBINATION; AMODIAQUINE; EFFICACY; SAFETY	BACKGROUND Information regarding the safety and efficacy of artemisinin combination treatments for malaria in pregnant women is limited, particularly among women who live in sub-Saharan Africa. METHODS We conducted a multicenter, randomized, open-label trial of treatments for malaria in pregnant women in four African countries. A total of 3428 pregnant women in the second or third trimester who had falciparum malaria (at any parasite density and regardless of symptoms) were treated with artemether-lumefantrine, amodiaquine-artesunate, mefloquine-artesunate, or dihydroartemisinin-piperaquine. The primary end points were the polymerase-chain-reaction (PCR)-adjusted cure rates (i.e., cure of the original infection; new infections during follow-up were not considered to be treatment failures) at day 63 and safety outcomes. RESULTS The PCR-adjusted cure rates in the per-protocol analysis were 94.8% in the artemether-lumefantrine group, 98.5% in the amodiaquine-artesunate group, 99.2% in the dihydroartemisinin-piperaquine group, and 96.8% in the mefloquine-artesunate group; the PCR-adjusted cure rates in the intention-to-treat analysis were 94.2%, 96.9%, 98.0%, and 95.5%, respectively. There was no significant difference among the amodiaquine-artesunate group, dihydroartemisinin-piperaquine group, and the mefloquine-artesunate group. The cure rate in the artemether-lumefantrine group was significantly lower than that in the other three groups, although the absolute difference was within the 5-percentage-point margin for equivalence. The unadjusted cure rates, used as a measure of the post-treatment prophylactic effect, were significantly lower in the artemether-lumefantrine group (52.5%) than in groups that received amodiaquine-artesunate (82.3%), dihydroartemisinin-piperaquine (86.9%), or mefloquine-artesunate (73.8%). No significant difference in the rate of serious adverse events and in birth outcomes was found among the treatment groups. Drug-related adverse events such as asthenia, poor appetite, dizziness, nausea, and vomiting occurred significantly more frequently in the mefloquine-artesunate group (50.6%) and the amodiaquine-artesunate group (48.5%) than in the dihydroartemisinin-piperaquine group (20.6%) and the artemether-lumefantrine group (11.5%) (P<0.001 for comparison among the four groups). CONCLUSIONS Artemether-lumefantrine was associated with the fewest adverse effects and with acceptable cure rates but provided the shortest post-treatment prophylaxis, whereas dihydroartemisinin-piperaquine had the best efficacy and an acceptable safety profile. (Funded by the European and Developing Countries Clinical Trials Partnership and others; ClinicalTrials.gov number, NCT00852423.)	[D'Alessandro, U.] MRC Unit, Atlantic Blvd, Fajara, Gambia; [Pekyi, D.; Ampromfi, A. A.] Ctr Global Hlth Res, Kumasi, Ghana; [Tinto, H.; Antwi, G.] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Gbekor, P.] Juaben Govt Hosp, Juaben, Ghana; [Tinto, H.; Traore-Coulibaly, M.; Tahita, M. C.; Valea, I.] Clin Trial Unit Nanoro, Nanoro, Burkina Faso; [Mwapasa, V.; Kalilani-Phiri, L.; Kalanda, G.; Madanitsa, M.] Coll Med, Blantyre, Malawi; [Ravinetto, R.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Ravinetto, R.; Menten, J.; De Crop, M.; Claeys, Y.; Schurmans, C.; Van Overmeir, C.; Thriemer, K.; D'Alessandro, U.] Inst Trop Med, B-2000 Antwerp, Belgium; [Van Geertruyden, J. -P.] Univ Antwerp, Int Hlth Unit, B-2020 Antwerp, Belgium; [Mutabingwa, T.] Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania; [Thriemer, K.] Menzies Sch Hlth Res, Darwin, NT, Australia; [D'Alessandro, U.] London Sch Hyg & Trop Med, London, England; [Nambozi, M.; Mulenga, M.; Hachizovu, S.; Kabuya, J. -B. B.; Mulenga, J.] Trop Dis Res Ctr, Ndola, Zambia	University of London; London School of Hygiene & Tropical Medicine; Kwame Nkrumah University Science & Technology; University of Malawi; KU Leuven; Institute of Tropical Medicine (ITM); University of Antwerp; Charles Darwin University; Menzies School of Health Research; University of London; London School of Hygiene & Tropical Medicine	D'Alessandro, U (corresponding author), MRC Unit, Atlantic Blvd, Fajara, Gambia.	udalessandro@mrc.gm	Valea, Innocent/ABE-6694-2020; Madanitsa, Mwayiwawo/AAM-1834-2021; Tahita, Marc/AAG-6549-2019; TRAORE /COULIBALY, Maminata/AAC-1303-2022; Van geertruyden, Jean-Pierre/K-6425-2014	Tahita, Marc/0000-0003-2158-0182; Tinto, Halidou/0000-0002-0472-3586; Valea, Innocent/0000-0002-3085-0490; Thriemer, Kamala/0000-0001-7536-7497; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Kabuya, Jean-Bertin/0000-0003-0339-9101; Chapotera, Gertrude/0000-0002-7870-2294; Mwapasa, Victor/0000-0002-2748-8902	European and Developing Countries Clinical Trials Partnership	European and Developing Countries Clinical Trials Partnership	Funded by the European and Developing Countries Clinical Trials Partnership and others; ClinicalTrials.gov number, NCT00852423.	Adam I, 2012, AM J TROP MED HYG, V87, P35, DOI 10.4269/ajtmh.2012.11-0410; [Anonymous], 2007, METHODS TECHNIQUES C; Atwine D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001119; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Clerk CA, 2008, J INFECT DIS, V198, P1202, DOI 10.1086/591944; D'Alessandro U, 2009, EXPERT OPIN PHARMACO, V10, P1291, DOI 10.1517/14656560902942319; Dmitrienko A, 2013, STAT MED, V32, P5172, DOI 10.1002/sim.5990; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Gonzalez R, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-75; Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07; Gupta V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-19; Hoglund RM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-398; Kloprogge F, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.59; Lutje V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-61; Manyando C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-141; McGready R, 2011, BJOG-INT J OBSTET GY, V118, P123, DOI 10.1111/j.1471-0528.2010.02810.x; McGready R, 2008, PLOS MED, V5, P1699, DOI 10.1371/journal.pmed.0050253; Nambozi M, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-5; Orton LC, 2008, COCHRANE DB SYST REV, V4; Piola P, 2010, LANCET INFECT DIS, V10, P762, DOI 10.1016/S1473-3099(10)70202-4; Rijken MJ, 2011, ANTIMICROB AGENTS CH, V55, P4338, DOI 10.1128/AAC.00154-11; Tagbor H, 2006, LANCET, V368, P1349, DOI 10.1016/S0140-6736(06)69559-7; Takem EN, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.010; Valea I, 2014, J ANTIMICROB CHEMOTH, V69, P2499, DOI 10.1093/jac/dku154; van Riemsdijk MM, 2004, BRIT J CLIN PHARMACO, V57, P506, DOI 10.1046/j.1365-2125.2003.02035.x; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; World Health Organization, 2015, GUID TREATM MAL; WorldWide Antimalarial Resistance Network (WWARN), 2012, CLIN MOD DAT MAN STA	29	67	67	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					913	927		10.1056/NEJMoa1508606	http://dx.doi.org/10.1056/NEJMoa1508606			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF9DH	26962727	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000371660000005
J	Brouwers, MC; Kerkvliet, K; Spithoff, K				Brouwers, Melissa C.; Kerkvliet, Kate; Spithoff, Karen		AGREE Next Steps Consortium	The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Brouwers, Melissa C.; Kerkvliet, Kate; Spithoff, Karen] McMaster Univ, Dept Oncol, Juravinski Hosp & Canc Ctr, 1280 Main St West, Hamilton, ON L8S 4L8, Canada	McMaster University	Brouwers, MC (corresponding author), McMaster Univ, Dept Oncol, Juravinski Hosp & Canc Ctr, 1280 Main St West, Hamilton, ON L8S 4L8, Canada.	mbrouwer@mcmaster.ca	Fervers, Béatrice/AAD-1847-2022	Fervers, Béatrice/0000-0003-3498-6499	Canadian Institutes of Health Research (CIHR) [125987]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Development of the AGREE Reporting Checklist was supported by grants from the Canadian Institutes of Health Research (CIHR #125987).	Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Cluzeau FA, 1999, INT J QUAL HEALTH C, V11, P21, DOI 10.1093/intqhc/11.1.21; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Makarski J, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0103-2; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Schunemann HJ, 2014, CAN MED ASSOC J, V186, pE123, DOI 10.1503/cmaj.131237; Shiffman RN, 2003, ANN INTERN MED, V139, P493, DOI 10.7326/0003-4819-139-6-200309160-00013	12	331	355	3	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2016	352								i1152	10.1136/bmj.i1152	http://dx.doi.org/10.1136/bmj.i1152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NI	26957104	Green Published, hybrid			2022-12-28	WOS:000372048500005
J	DeAngelis, AM; Qu, X; Zelinka, MD; Hall, A				DeAngelis, Anthony M.; Qu, Xin; Zelinka, Mark D.; Hall, Alex			An observational radiative constraint on hydrologic cycle intensification (vol 528, pg 249, 2015)	NATURE			English	Correction													Zelinka, Mark/C-4627-2011	Zelinka, Mark/0000-0002-6570-5445				DeAngelis AM, 2015, NATURE, V528, P249, DOI 10.1038/nature15770	1	0	0	5	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					580	580		10.1038/nature17621	http://dx.doi.org/10.1038/nature17621			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS5XP	27007843	Bronze			2022-12-28	WOS:000380856600035
J	Noziere, B				Noziere, Barbara			CLOUDS Don't forget the surface	SCIENCE			English	Editorial Material							NUCLEUS; GROWTH		[Noziere, Barbara] CNRS, Villeurbanne, France; [Noziere, Barbara] Univ Lyon 1, Ircelyon, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Noziere, B (corresponding author), CNRS, Villeurbanne, France.; Noziere, B (corresponding author), Univ Lyon 1, Ircelyon, F-69622 Villeurbanne, France.	barbara.noziere@ircelyon.univ-lyon1.fr		Noziere, Barbara/0000-0001-5841-1310				Aitken J., 1881, EARTH ENV SCI T R SO, V30, P337, DOI DOI 10.1017/S0080456800029069; Boucher O, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P571, DOI 10.1017/cbo9781107415324.016; Farmer DK, 2015, CHEM REV, V115, P4199, DOI 10.1021/cr5006292; Gerard V, 2016, ENVIRON SCI TECHNOL, V50, P2974, DOI 10.1021/acs.est.5b05809; Cisneros BEJ, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P229; Kohler H, 1936, T FARADAY SOC, V32, P1152, DOI 10.1039/tf9363201152; McFiggans G, 2006, ATMOS CHEM PHYS, V6, P2593, DOI 10.5194/acp-6-2593-2006; Petters MD, 2007, ATMOS CHEM PHYS, V7, P1961, DOI 10.5194/acp-7-1961-2007; Ruehl CR, 2016, SCIENCE, V351, P1447, DOI 10.1126/science.aad4889	9	23	23	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1396	1397		10.1126/science.aaf3253	http://dx.doi.org/10.1126/science.aaf3253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013716				2022-12-28	WOS:000372756200022
J	Abramowski, A; Aharonian, F; Benkhali, FA; Akhperjanian, AG; Anguner, EO; Backes, M; Balzer, A; Becherini, Y; Tjus, JB; Berge, D; Bernhard, S; Bernlohr, K; Birsin, E; Blackwell, R; Bottcher, M; Boisson, C; Bolmont, J; Bordas, P; Bregeon, J; Brun, F; Brun, P; Bryan, M; Bulik, T; Carr, J; Casanova, S; Chakraborty, N; Chalme-Calvet, R; Chaves, RCG; Chen, A; Chretien, M; Colafrancesco, S; Cologna, G; Conrad, J; Couturier, C; Cui, Y; Davids, ID; Degrange, B; Deil, C; deWilt, P; Djannati-Ata, A; Domainko, W; Donath, A; Drury, LO; Dubus, G; Dutson, K; Dyks, J; Dyrda, M; Edwards, T; Egberts, K; Eger, P; Ernenwein, JP; Espigat, P; Farnier, C; Fegan, S; Feinstein, F; Fernandes, MV; Fernandez, D; Fiasson, A; Fontaine, G; Forster, A; Fuessling, M; Gabici, S; Gajdus, M; Gallant, YA; Garrigoux, T; Giavitto, G; Giebels, B; Glicenstein, JF; Gottschall, D; Goyal, A; Grondin, MH; Grudzinska, M; Hadasch, D; Haffner, S; Hahn, J; Hawkes, J; Heinzelmann, G; Henri, G; Hermann, G; Hervet, O; Hillert, A; Hinton, JA; Hofmann, W; Hofverberg, P; Hoischen, C; Holler, M; Horns, D; Ivascenko, A; Jacholkowska, A; Jamrozy, M; Janiak, M; Jankowsky, F; Jung-Richardt, I; Kastendieck, MA; Katarzynski, K; Katz, U; Kerszberg, D; Khelifi, B; Kieffer, M; Klepser, S; Klochkov, D; Kluzniak, W; Kolitzus, D; Komin, N; Kosack, K; Krakau, S; Krayzel, F; Kruger, PP; Laffon, H; Lamanna, G; Lau, J; Lefaucheur, J; Lefranc, V; Lemiere, A; Lemoine-Goumard, M; Lenain, JP; Lohse, T; Lopatin, A; Lu, CC; Lui, R; Marandon, V; Marcowith, A; Mariaud, C; Marx, R; Maurin, G; Maxted, N; Mayer, M; Meintjes, PJ; Menzler, U; Meyer, M; Mitchell, AMW; Moderski, R; Mohamed, M; Mora, K; Moulin, E; Murach, T; de Naurois, M; Niemiec, J; Oakes, L; Odaka, H; Ottl, S; Ohm, S; Opitz, B; Ostrowski, M; Oya, I; Panter, M; Parsons, RD; Arribas, MP; Pekeur, NW; Pelletier, G; Petrucci, PO; Peyaud, B; Pita, S; Poon, H; Prokoph, H; Puhlhofer, G; Punch, M; Quirrenbach, A; Raab, S; Reichardt, I; Reimer, A; Reimer, O; Renaud, M; de los Reyes, R; Rieger, F; Romoli, C; Rosier-Lees, S; Rowell, G; Rudak, B; Rulten, CB; Sahakian, V; Salek, D; Sanchez, DA; Santangelo, A; Sasaki, M; Schlickeiser, R; Schussler, F; Schulz, A; Schwanke, U; Schwemmer, S; Seyffert, AS; Simoni, R; Sol, H; Spanier, F; Spengler, G; Spies, F; Stawarz, L; Steenkamp, R; Stegmann, C; Stinzing, F; Stycz, K; Sushch, I; Tavernet, JP; Tavernier, T; Taylor, AM; Terrier, R; Tluczykont, M; Trichard, C; Tuffs, R; Valerius, K; van der Walt, J; van Eldik, C; van Soelen, B; Vasileiadis, G; Veh, J; Venter, C; Viana, A; Vincent, P; Vink, J; Voisin, F; Volk, HJ; Vuillaume, T; Wagner, SJ; Wagner, P; Wagner, RM; Weidinger, M; Weitzel, Q; White, R; Wierzcholska, A; Willmann, P; Wornlein, A; Wouters, D; Yang, R; Zabalza, V; Zaborov, D; Zacharias, M; Zdziarski, AA; Zech, A; Zefi, F; Zywucka, N				Abramowski, A.; Aharonian, F.; Benkhali, F. Ait; Akhperjanian, A. G.; Anguener, E. O.; Backes, M.; Balzer, A.; Becherini, Y.; Tjus, J. Becker; Berge, D.; Bernhard, S.; Bernloehr, K.; Birsin, E.; Blackwell, R.; Boettcher, M.; Boisson, C.; Bolmont, J.; Bordas, P.; Bregeon, J.; Brun, F.; Brun, P.; Bryan, M.; Bulik, T.; Carr, J.; Casanova, S.; Chakraborty, N.; Chalme-Calvet, R.; Chaves, R. C. G.; Chen, A.; Chretien, M.; Colafrancesco, S.; Cologna, G.; Conrad, J.; Couturier, C.; Cui, Y.; Davids, I. D.; Degrange, B.; Deil, C.; deWilt, P.; Djannati-Ata, A.; Domainko, W.; Donath, A.; Drury, L. O'C.; Dubus, G.; Dutson, K.; Dyks, J.; Dyrda, M.; Edwards, T.; Egberts, K.; Eger, P.; Ernenwein, J-P.; Espigat, P.; Farnier, C.; Fegan, S.; Feinstein, F.; Fernandes, M. V.; Fernandez, D.; Fiasson, A.; Fontaine, G.; Foerster, A.; Fuessling, M.; Gabici, S.; Gajdus, M.; Gallant, Y. A.; Garrigoux, T.; Giavitto, G.; Giebels, B.; Glicenstein, J. F.; Gottschall, D.; Goyal, A.; Grondin, M-H.; Grudzinska, M.; Hadasch, D.; Haeffner, S.; Hahn, J.; Hawkes, J.; Heinzelmann, G.; Henri, G.; Hermann, G.; Hervet, O.; Hillert, A.; Hinton, J. A.; Hofmann, W.; Hofverberg, P.; Hoischen, C.; Holler, M.; Horns, D.; Ivascenko, A.; Jacholkowska, A.; Jamrozy, M.; Janiak, M.; Jankowsky, F.; Jung-Richardt, I.; Kastendieck, M. A.; Katarzynski, K.; Katz, U.; Kerszberg, D.; Khelifi, B.; Kieffer, M.; Klepser, S.; Klochkov, D.; Kluzniak, W.; Kolitzus, D.; Komin, Nu.; Kosack, K.; Krakau, S.; Krayzel, F.; Krueger, P. P.; Laffon, H.; Lamanna, G.; Lau, J.; Lefaucheur, J.; Lefranc, V.; Lemiere, A.; Lemoine-Goumard, M.; Lenain, J-P.; Lohse, T.; Lopatin, A.; Lu, C-C.; Lui, R.; Marandon, V.; Marcowith, A.; Mariaud, C.; Marx, R.; Maurin, G.; Maxted, N.; Mayer, M.; Meintjes, P. J.; Menzler, U.; Meyer, M.; Mitchell, A. M. W.; Moderski, R.; Mohamed, M.; Mora, K.; Moulin, E.; Murach, T.; de Naurois, M.; Niemiec, J.; Oakes, L.; Odaka, H.; Oettl, S.; Ohm, S.; Opitz, B.; Ostrowski, M.; Oya, I.; Panter, M.; Parsons, R. D.; Arribas, M. Paz; Pekeur, N. W.; Pelletier, G.; Petrucci, P-O.; Peyaud, B.; Pita, S.; Poon, H.; Prokoph, H.; Puehlhofer, G.; Punch, M.; Quirrenbach, A.; Raab, S.; Reichardt, I.; Reimer, A.; Reimer, O.; Renaud, M.; de los Reyes, R.; Rieger, F.; Romoli, C.; Rosier-Lees, S.; Rowell, G.; Rudak, B.; Rulten, C. B.; Sahakian, V.; Salek, D.; Sanchez, D. A.; Santangelo, A.; Sasaki, M.; Schlickeiser, R.; Schuessler, F.; Schulz, A.; Schwanke, U.; Schwemmer, S.; Seyffert, A. S.; Simoni, R.; Sol, H.; Spanier, F.; Spengler, G.; Spies, F.; Stawarz, L.; Steenkamp, R.; Stegmann, C.; Stinzing, F.; Stycz, K.; Sushch, I.; Tavernet, J-P.; Tavernier, T.; Taylor, A. M.; Terrier, R.; Tluczykont, M.; Trichard, C.; Tuffs, R.; Valerius, K.; van der Walt, J.; van Eldik, C.; van Soelen, B.; Vasileiadis, G.; Veh, J.; Venter, C.; Viana, A.; Vincent, P.; Vink, J.; Voisin, F.; Voelk, H. J.; Vuillaume, T.; Wagner, S. J.; Wagner, P.; Wagner, R. M.; Weidinger, M.; Weitzel, Q.; White, R.; Wierzcholska, A.; Willmann, P.; Woernlein, A.; Wouters, D.; Yang, R.; Zabalza, V.; Zaborov, D.; Zacharias, M.; Zdziarski, A. A.; Zech, A.; Zefi, F.; Zywucka, N.		HESS Collaboration	Acceleration of petaelectronvolt protons in the Galactic Centre	NATURE			English	Article							GAMMA-RAY EMISSION; MASSIVE BLACK-HOLE; CENTER REGION; COSMIC-RAYS; X-RAY; SUPERNOVA-REMNANTS; MOLECULAR CLOUDS; MAGNETIC-FIELD; ORIGIN; PROPAGATION	Galactic cosmic rays reach energies of at least a few petaelectronvolts(1) (of the order of 1015 electronvolts). This implies that our Galaxy contains petaelectronvolt accelerators ('PeVatrons'), but all proposed models of Galactic cosmic-ray accelerators encounter difficulties at exactly these energies(2). Dozens of Galactic accelerators capable of accelerating particles to energies of tens of teraelectronvolts (of the order of 10(13) electronvolts) were inferred from recent gamma-ray observations(3). However, none of the currently known accelerators-not even the handful of shell-type supernova remnants commonly believed to supply most Galactic cosmic rays-has shown the characteristic tracers of petaelectronvolt particles, namely, power-law spectra of.-rays extending without a cut-off or a spectral break to tens of teraelectronvolts(4). Here we report deep.-ray observations with arcminute angular resolution of the region surrounding the Galactic Centre, which show the expected tracer of the presence of petaelectronvolt protons within the central 10 parsecs of the Galaxy. We propose that the supermassive black hole Sagittarius A* is linked to this PeVatron. Sagittarius A* went through active phases in the past, as demonstrated by X-ray outbursts(5) and an outflow from the Galactic Centre(6). Although its current rate of particle acceleration is not sufficient to provide a substantial contribution to Galactic cosmic rays, Sagittarius A* could have plausibly been more active over the last 10(6)-10(7) years, and therefore should be considered as a viable alternative to supernova remnants as a source of petaelectronvolt Galactic cosmic rays.	[Abramowski, A.; Fernandes, M. V.; Heinzelmann, G.; Horns, D.; Kastendieck, M. A.; Opitz, B.; Spies, F.; Tluczykont, M.] Univ Hamburg, Inst Expt Phys, Luruper Chaussee 149, D-22761 Hamburg, Germany; [Aharonian, F.; Benkhali, F. Ait; Bernloehr, K.; Bordas, P.; Casanova, S.; Chakraborty, N.; Deil, C.; Domainko, W.; Donath, A.; Edwards, T.; Eger, P.; Foerster, A.; Hahn, J.; Hermann, G.; Hillert, A.; Hinton, J. A.; Hofmann, W.; Hofverberg, P.; Lu, C-C.; Lui, R.; Marandon, V.; Marx, R.; Mitchell, A. M. W.; Odaka, H.; Panter, M.; Parsons, R. D.; Poon, H.; de los Reyes, R.; Rieger, F.; Tuffs, R.; Viana, A.; Voelk, H. J.; Weitzel, Q.; Yang, R.] Max Planck Inst Kernphys, POB 103980, D-69029 Heidelberg, Germany; [Aharonian, F.; Drury, L. O'C.; Romoli, C.; Taylor, A. M.] Dublin Inst Adv Studies, 31 Fitzwilliam Pl, Dublin 2, Ireland; [Aharonian, F.; Akhperjanian, A. G.; Sahakian, V.] Natl Acad Sci Republ Armenia, Marshall Baghramian Ave 24, Yerevan 0019, Armenia; [Akhperjanian, A. G.; Sahakian, V.] Yerevan Phys Inst, 2 Alikhanian Bros St, Yerevan 375036, Armenia; [Anguener, E. O.; Birsin, E.; Gajdus, M.; Lohse, T.; Mayer, M.; Murach, T.; Oakes, L.; Arribas, M. Paz; Schwanke, U.; Wagner, P.] Humboldt Univ, Inst Phys, Newtonstr 15, D-12489 Berlin, Germany; [Backes, M.; Davids, I. D.; Steenkamp, R.] Univ Namibia, Dept Phys, Private Bag 13301, Windhoek, Namibia; [Balzer, A.; Berge, D.; Bryan, M.; Simoni, R.; Vink, J.] Univ Amsterdam, Astron Inst Anton Pannekoek, GRAPPA, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Becherini, Y.; Prokoph, H.] Linnaeus Univ, Dept Phys & Elect Engn, S-35195 Vaxjo, Sweden; [Tjus, J. Becker; Krakau, S.; Menzler, U.; Schlickeiser, R.; Weidinger, M.] Ruhr Univ Bochum, Inst Theoret Phys, Lehrstuhl Weltraum & Astrophys 4, D-44780 Bochum, Germany; [Berge, D.] Univ Amsterdam, Inst High Energy Phys, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Bernhard, S.; Hadasch, D.; Kolitzus, D.; Oettl, S.; Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro Teilchenphys, A-6020 Innsbruck, Austria; [Blackwell, R.; deWilt, P.; Hawkes, J.; Lau, J.; Rowell, G.; Voisin, F.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Boettcher, M.; Davids, I. D.; Ivascenko, A.; Krueger, P. P.; Pekeur, N. W.; Seyffert, A. S.; Spanier, F.; Sushch, I.; van der Walt, J.; Venter, C.] North West Univ, Ctr Space Res, ZA-2520 Potchefstroom, South Africa; [Boisson, C.; Hervet, O.; Rulten, C. B.; Sol, H.; Zech, A.] Univ Paris Diderot, LUTH, Observ Paris, CNRS, 5 Pl Jules Janssen, F-92190 Meudon, France; [Bolmont, J.; Chalme-Calvet, R.; Chretien, M.; Couturier, C.; Garrigoux, T.; Jacholkowska, A.; Kerszberg, D.; Kieffer, M.; Lenain, J-P.; Tavernet, J-P.; Vincent, P.] Univ Paris 06, Univ Paris 07, LPNHE, CNRS,IN2P3, 4 Pl Jussieu, F-75252 Paris 5, France; [Bregeon, J.; Chaves, R. C. G.; Feinstein, F.; Fernandez, D.; Gallant, Y. A.; Marcowith, A.; Maxted, N.; Renaud, M.; Vasileiadis, G.] Univ Montpellier 2, Lab Universe & Particules Montpellier, CNRS, IN2P3, CC 72,Pl Eugene Bataillon, F-34095 Montpellier 5, France; [Brun, F.; Brun, P.; Glicenstein, J. F.; Kosack, K.; Lefranc, V.; Moulin, E.; Peyaud, B.; Schuessler, F.; Wouters, D.] CEA Saclay, DSM, Irfu, F-91191 Gif Sur Yvette, France; [Bulik, T.; Grudzinska, M.] Univ Warsaw, Astron Observ, Al Ujazdowskie 4, PL-00478 Warsaw, Poland; [Carr, J.; Ernenwein, J-P.] Aix Marseille Univ, CNRS, IN2P3, CPPM,UMR 7346, F-13288 Marseille, France; [Casanova, S.; Dyrda, M.; Niemiec, J.; Wierzcholska, A.] Inst Fizyki Jadrowej PAN, Ul Radzikowskiego 152, PL-31342 Krakow, Poland; [Chen, A.; Colafrancesco, S.; Komin, Nu.] Univ Witwatersrand, Sch Phys, 1 Jan Smuts Ave, ZA-2050 Johannesburg, South Africa; [Cologna, G.; Jankowsky, F.; Mohamed, M.; Quirrenbach, A.; Schwemmer, S.; Wagner, S. J.; Wierzcholska, A.; Zacharias, M.] Heidelberg Univ, Landessternwarte, D-69117 Heidelberg, Germany; [Conrad, J.; Farnier, C.; Meyer, M.; Mora, K.; Spengler, G.; Wagner, R. M.] Stockholm Univ, Albanova Univ Ctr, Dept Phys, Oskar Klein Ctr, SE-10691 Stockholm, Sweden; [Cui, Y.; Gottschall, D.; Klochkov, D.; Puehlhofer, G.; Santangelo, A.; Sasaki, M.] Univ Tubingen, Inst Astron & Astrophys, Sand 1, D-72076 Tubingen, Germany; [Degrange, B.; Fegan, S.; Fontaine, G.; Giebels, B.; Holler, M.; Mariaud, C.; de Naurois, M.; Zaborov, D.; Zefi, F.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Djannati-Ata, A.; Espigat, P.; Gabici, S.; Khelifi, B.; Lefaucheur, J.; Lemiere, A.; Pita, S.; Punch, M.; Reichardt, I.; Tavernier, T.; Terrier, R.] Univ Paris Diderot, APC, AstroParticule & Cosmol, CNRS,IN2P3,CEA,Irfu,Observ Paris,Sorbonne Paris C, 10 Rue Alice Domon & Leonie Duquet, F-75205 Paris 13, France; [Dubus, G.; Henri, G.; Pelletier, G.; Petrucci, P-O.; Vuillaume, T.] Univ Grenoble Alpes, IPAG, F-38000 Grenoble, France; [Dubus, G.; Henri, G.; Pelletier, G.; Petrucci, P-O.; Vuillaume, T.] CNRS, IPAG, F-38000 Grenoble, France; [Dutson, K.; Hinton, J. A.; White, R.; Zabalza, V.] Univ Leicester, Dept Phys & Astron, Univ Rd, Leicester LE1 7RH, Leics, England; [Dyks, J.; Janiak, M.; Kluzniak, W.; Moderski, R.; Rudak, B.; Zdziarski, A. A.] Nicolaus Copernicus Astron Ctr, Ul Bartycka 18, PL-00716 Warsaw, Poland; [Egberts, K.; Hoischen, C.; Stegmann, C.] Univ Potsdam, Inst Phys & Astron, Karl Liebknecht Str 24-25, D-14476 Golm, Germany; [Fiasson, A.; Krayzel, F.; Lamanna, G.; Maurin, G.; Rosier-Lees, S.; Sanchez, D. A.; Trichard, C.] Univ Savoie Mt Blanc, Lab Annecy le Vieux Phys Particules, CNRS, IN2P3, F-74941 Annecy Le Vieux, France; [Fuessling, M.; Giavitto, G.; Klepser, S.; Ohm, S.; Oya, I.; Schulz, A.; Stegmann, C.; Stycz, K.] DESY, D-15738 Zeuthen, Germany; [Goyal, A.; Jamrozy, M.; Ostrowski, M.; Stawarz, L.; Zywucka, N.] Uniwersytet Jagiellonski, Obserwatorium Astron, Ul Orla 171, PL-30244 Krakow, Poland; [Grondin, M-H.; Laffon, H.; Lemoine-Goumard, M.] Univ Bordeaux, CNRS, IN2P3, Ctr Etud Nucl Bordeaux Gradignan, F-33175 Gradignan, France; [Haeffner, S.; Jung-Richardt, I.; Katz, U.; Lopatin, A.; Raab, S.; Stinzing, F.; Valerius, K.; van Eldik, C.; Veh, J.; Willmann, P.; Woernlein, A.] Univ Erlangen Nurnberg, Phys Inst, Erwin Rommel Str 1, D-91058 Erlangen, Germany; [Katarzynski, K.] Nicolaus Copernicus Univ, Fac Phys Astron & Informat, Ctr Astron, Grudziadzka 5, PL-87100 Torun, Poland; [Meintjes, P. J.; van Soelen, B.] Univ Orange Free State, Dept Phys, POB 339, ZA-9300 Bloemfontein, South Africa; [Rieger, F.] ITA Univ Heidelberg, Heidelberg, Germany; [Salek, D.] Univ Amsterdam, Inst High Energy Phys, GRAPPA, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands	University of Hamburg; Max Planck Society; Dublin Institute for Advanced Studies; National Academy of Sciences of Armenia; Yerevan Physics Institute; Humboldt University of Berlin; University of Namibia; University of Amsterdam; Linnaeus University; Ruhr University Bochum; University of Amsterdam; University of Innsbruck; University of Adelaide; North West University - South Africa; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Warsaw; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Aix-Marseille Universite; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; University of Witwatersrand; Ruprecht Karls University Heidelberg; Oskar Klein Centre; Stockholm University; Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); Centre National de la Recherche Scientifique (CNRS); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); University of Leicester; Polish Academy of Sciences; Nicolaus Copernicus Astronomical Center of the Polish Academy of Sciences; University of Potsdam; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Savoie; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Jagiellonian University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; University of Erlangen Nuremberg; Nicolaus Copernicus University; University of the Free State; University of Amsterdam	Abramowski, A (corresponding author), Univ Hamburg, Inst Expt Phys, Luruper Chaussee 149, D-22761 Hamburg, Germany.	contact.hess@hess-experiment.eu	Niemiec, Jacek/R-5432-2017; Oya, Igor/GYU-6580-2022; Bulik, Tomasz/AAJ-6742-2020; Coma, Pol Bordas/AAA-2332-2020; Pühlhofer, Gerd/Q-2336-2018; Reimer, Olaf/A-3117-2013; Maxted, Nigel I/M-9666-2017; Zaborov, Dmitry/AAD-8694-2019; Couturier, Camille/GOJ-9076-2022; Valerius, Kathrin/P-4253-2018; Viana, Aion/E-5820-2019; Hadasch, Daniela/N-7819-2016; Schüssler, Fabian/G-5313-2013; Maxted, Nigel/AAA-7306-2019; Sasaki, Manami/P-3045-2016; Reichardt, Ignasi/GLQ-7340-2022; Wierzcholska, Alicja/AAV-2997-2021; Meyer, Manuel E/E-2697-2016; Backes, Michael/N-5126-2016; Katarzyński, Krzysztof/G-4528-2014; Jamrozy, Marek/AAH-2495-2020; Schüssler, Fabian/M-3789-2019; van Eldik, Christopher/C-3901-2013; Sushch, Iurii/AAH-8354-2019; Fontaine, Gerard/D-6420-2014; Berge, David/P-2179-2017; Reichardt, Ignasi/P-7478-2016; White, Richard/AAF-4527-2019; Chen, Andrew/AAC-3979-2020; Moderski, Rafal/ABG-8777-2020; Marcowith, Alexandre/ABH-1254-2020; Viana, Aion/S-7336-2019; Tjus, Julia/G-8145-2012; Jung-Richardt, Ira/AAT-8884-2020; Horns, Dieter/ABE-9516-2020; Kerszberg, Daniel/AAB-3175-2019; Katz, Uli F/E-1925-2013; Venter, Christo/E-6884-2011; Komin, Nukri/J-6781-2015; Moulin, Emmanuel/B-5959-2017; Casanova, Sabrina/J-8935-2013	Niemiec, Jacek/0000-0001-6036-8569; Coma, Pol Bordas/0000-0002-0266-8536; Reimer, Olaf/0000-0001-6953-1385; Maxted, Nigel I/0000-0003-2762-8378; Zaborov, Dmitry/0000-0002-9335-1410; Couturier, Camille/0000-0002-0168-1106; Valerius, Kathrin/0000-0001-7964-974X; Viana, Aion/0000-0001-9253-1850; Hadasch, Daniela/0000-0001-8663-6461; Schüssler, Fabian/0000-0003-1500-6571; Maxted, Nigel/0000-0003-2762-8378; Sasaki, Manami/0000-0001-5302-1866; Reichardt, Ignasi/0000-0003-3694-3820; Wierzcholska, Alicja/0000-0003-4472-7204; Meyer, Manuel E/0000-0002-0738-7581; Backes, Michael/0000-0002-9326-6400; Katarzyński, Krzysztof/0000-0002-8806-4863; Jamrozy, Marek/0000-0002-0870-7778; Schüssler, Fabian/0000-0003-1500-6571; van Eldik, Christopher/0000-0001-9669-645X; Fontaine, Gerard/0000-0002-6443-5025; Berge, David/0000-0002-2918-1824; Reichardt, Ignasi/0000-0003-3694-3820; White, Richard/0000-0002-3356-0763; Moderski, Rafal/0000-0002-8663-3882; Marcowith, Alexandre/0000-0002-3971-0910; Viana, Aion/0000-0001-9253-1850; Tjus, Julia/0000-0002-1748-7367; Horns, Dieter/0000-0003-1945-0119; Kerszberg, Daniel/0000-0002-5289-1509; Katz, Uli F/0000-0002-7063-4418; Dyks, Jaroslaw/0000-0002-8383-2472; Meintjes, Petrus Johannes/0000-0001-8890-5418; Venter, Christo/0000-0002-2666-4812; Marandon, Vincent/0000-0001-9077-4058; Bernlohr, Konrad/0000-0001-8065-3252; Vink, Jacco/0000-0002-4708-4219; Zacharias, Michael/0000-0001-5801-3945; Santangelo, Andrea/0000-0003-4187-9560; Rulten, Cameron/0000-0001-7483-4348; Komin, Nukri/0000-0003-3280-0582; Quirrenbach, Andreas/0000-0002-3302-1962; Hermann, German/0000-0002-4595-1032; Lamanna, Giovanni/0000-0002-2307-0023; Chen, Andrew/0000-0001-6425-5692; Moulin, Emmanuel/0000-0003-4007-0145; Terrier, Regis/0000-0002-8219-4667; Davids, Isak D./0000-0002-6476-964X; Rowell, Gavin/0000-0002-9516-1581; Rieger, Frank/0000-0003-1334-2993; Zdziarski, Andrzej/0000-0002-0333-2452; Dubus, Guillaume/0000-0002-5130-2514; Sushch, Iurii/0000-0002-2814-1257; SANCHEZ, David/0000-0002-7210-4496; Lenain, Jean-Philippe/0000-0001-7284-9220; Casanova, Sabrina/0000-0002-6144-9122; Romoli, Carlo/0000-0003-2541-4499; Parsons, Robert/0000-0003-3457-9308; Hinton, James/0000-0002-1031-7760; Bulik, Tomasz/0000-0003-2045-4803; Colafrancesco, Sergio/0000-0001-8963-0540; van der Walt, Johan/0000-0001-6666-6866; Spanier, Felix/0000-0001-6802-4744; Bolmont, Julien/0000-0003-4739-8389; Khelifi, Bruno/0000-0001-6876-5577; Rudak, Bronislaw/0000-0003-0452-3805	German Ministry for Education and Research (BMBF); Max Planck Society; German Research Foundation (DFG); French Ministry for Research; CNRS-IN2P3; Astroparticle Interdisciplinary Programme of the CNRS; UK Science and Technology Facilities Council (STFC); IPNP of the Charles University; Czech Science Foundation; Polish Ministry of Science and Higher Education; South African Department of Science and Technology; National Research Foundation; University of Namibia; EU FP7 Marie Curie grant [PIEF-GA-2012-332350]; ESRC [ES/N013956/1] Funding Source: UKRI; STFC [ST/N002881/1] Funding Source: UKRI	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); German Research Foundation (DFG)(German Research Foundation (DFG)); French Ministry for Research(Ministry of Research, France); CNRS-IN2P3(Centre National de la Recherche Scientifique (CNRS)); Astroparticle Interdisciplinary Programme of the CNRS; UK Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); IPNP of the Charles University; Czech Science Foundation(Grant Agency of the Czech Republic); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); South African Department of Science and Technology; National Research Foundation; University of Namibia; EU FP7 Marie Curie grant; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The support of the Namibian authorities and of the University of Namibia in facilitating the construction and operation of HESS is gratefully acknowledged, as is the support by the German Ministry for Education and Research (BMBF), the Max Planck Society, the German Research Foundation (DFG), the French Ministry for Research, the CNRS-IN2P3 and the Astroparticle Interdisciplinary Programme of the CNRS, the UK Science and Technology Facilities Council (STFC), the IPNP of the Charles University, the Czech Science Foundation, the Polish Ministry of Science and Higher Education, the South African Department of Science and Technology and National Research Foundation, and the University of Namibia. We thank the technical support staff in Berlin, Durham, Hamburg, Heidelberg, Palaiseau, Paris, Saclay and Namibia for the construction and operation of the equipment. R.C.G.C. is funded by an EU FP7 Marie Curie grant (PIEF-GA-2012-332350), J. Conrad is a Wallenberg Academy Fellow, and F.R. is a Heisenberg Fellow (DFG).	Acero F, 2010, MON NOT R ASTRON SOC, V402, P1877, DOI 10.1111/j.1365-2966.2009.16014.x; Aguilar M, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.231102; Aharonian F, 2006, ASTRON ASTROPHYS, V457, P899, DOI 10.1051/0004-6361:20065351; Aharonian F, 2006, NATURE, V439, P695, DOI 10.1038/nature04467; Aharonian F, 2005, ASTROPHYS J, V619, P306, DOI 10.1086/426426; Aharonian F, 2004, ASTRON ASTROPHYS, V425, pL13, DOI 10.1051/0004-6361:200400055; Aharonian F, 2009, ASTRON ASTROPHYS, V503, P817, DOI 10.1051/0004-6361/200811569; Aharonian FA, 2013, ASTROPART PHYS, V43, P71, DOI 10.1016/j.astropartphys.2012.08.007; Albert J, 2006, ASTROPHYS J, V638, pL101, DOI 10.1086/501164; Archer A, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/149; Atoyan A, 2004, ASTROPHYS J, V617, pL123, DOI 10.1086/427390; Belikov AV, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.083516; Bell AR, 2013, MON NOT R ASTRON SOC, V431, P415, DOI 10.1093/mnras/stt179; Bell AR, 2004, MON NOT R ASTRON SOC, V353, P550, DOI 10.1111/j.1365-2966.2004.08097.x; BEREZINSKII VS, 1990, ASTROPHYSICS COSMIC, P33; Berge D, 2007, ASTRON ASTROPHYS, V466, P1219, DOI 10.1051/0004-6361:20066674; Busching I, 2007, ASTROPHYS J, V656, P841, DOI 10.1086/510611; Bykov AM, 2014, ASTRON ASTROPHYS REV, V22, DOI 10.1007/s00159-014-0077-8; Clavel M, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321667; Cristofari P, 2013, MON NOT R ASTRON SOC, V434, P2748, DOI 10.1093/mnras/stt1096; Crocker RM, 2011, MON NOT R ASTRON SOC, V411, pL11, DOI 10.1111/j.1745-3933.2010.00983.x; Crocker RM, 2010, NATURE, V463, P65, DOI 10.1038/nature08635; de Naurois M, 2009, ASTROPART PHYS, V32, P231, DOI 10.1016/j.astropartphys.2009.09.001; Ferriere K, 2007, ASTRON ASTROPHYS, V467, P611, DOI 10.1051/0004-6361:20066992; Genzel R, 2010, REV MOD PHYS, V82, DOI 10.1103/RevModPhys.82.3121; Heard V, 2013, MON NOT R ASTRON SOC, V428, P3462, DOI 10.1093/mnras/sts284; Hillas AM, 2013, ASTROPART PHYS, V43, P19, DOI 10.1016/j.astropartphys.2012.06.002; Hinton JA, 2007, ASTROPHYS J, V657, P302, DOI 10.1086/510283; Istomin YN, 2014, NEW ASTRON, V27, P13, DOI 10.1016/j.newast.2013.08.001; Jones PA, 2012, MON NOT R ASTRON SOC, V419, P2961, DOI 10.1111/j.1365-2966.2011.19941.x; Kelner SR, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.034018; Kosack K, 2004, ASTROPHYS J, V608, pL97, DOI 10.1086/422469; Malkov MA, 2001, REP PROG PHYS, V64, P429, DOI 10.1088/0034-4885/64/4/201; Oka T, 1998, ASTROPHYS J SUPPL S, V118, P455, DOI 10.1086/313138; Parizot E, 2014, NUCL PHYS B-PROC SUP, V256, P197, DOI 10.1016/j.nuclphysbps.2014.10.023; Piron F, 2001, ASTRON ASTROPHYS, V374, P895, DOI 10.1051/0004-6361:20010798; Strong AW, 2007, ANNU REV NUCL PART S, V57, P285, DOI 10.1146/annurev.nucl.57.090506.123011; Strong AW, 1998, ASTROPHYS J, V509, P212, DOI 10.1086/306470; Su M, 2010, ASTROPHYS J, V724, P1044, DOI 10.1088/0004-637X/724/2/1044; Tsuboi M, 1999, ASTROPHYS J SUPPL S, V120, P1, DOI 10.1086/313165; Tsuchiya K, 2004, ASTROPHYS J, V606, pL115, DOI 10.1086/421292; Vink J, 2011, ASTRON ASTROPHYS REV, V20, P1, DOI 10.1007/s00159-011-0049-1; Vissani F, 2011, ASTROPART PHYS, V34, P778, DOI 10.1016/j.astropartphys.2011.01.011; Wang QD, 2006, MON NOT R ASTRON SOC, V367, P937, DOI 10.1111/J.1365-2966.2006.09998.X; Yang RZ, 2015, ASTRON ASTROPHYS, V580, DOI 10.1051/0004-6361/201425233; Yusef-Zadeh F, 2007, ASTROPHYS J, V656, P847, DOI 10.1086/510663; Yusef-Zadeh F, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/33	47	229	235	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					476	+		10.1038/nature17147	http://dx.doi.org/10.1038/nature17147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26982725	Green Submitted, Green Published			2022-12-28	WOS:000372701300034
J	Hawkes, N				Hawkes, Nigel			Innovation into practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2016	352								i1667	10.1136/bmj.i1667	http://dx.doi.org/10.1136/bmj.i1667			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LN	27012267				2022-12-28	WOS:000373044800005
J	Oliver, D				Oliver, David			David Oliver: Acutely ill patients on trolleys and beds-why not chairs?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Appleby J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1563; Cowling TE, 2014, J ROY SOC MED, V107, P432, DOI 10.1177/0141076814542669; Hall K, 2012, UNDERSTANDING IMPROV; Koduah DY, 2014, AGE AGEING, V43, pi3, DOI [10.1093/ageing/afu036.11, DOI 10.1093/AGEING/AFU036.11]; Lasserson D., AUT 2014 M BRIT GER; Le Jeune I, 2013, Acute Med, V12, P214; Royal College of Physicians, 2015, AC CAR TOOLK 3 AC ME; Royal College of Physicians, 2015, AC CAR TOOLK 10 AMB; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026; Thompson D, 2014, HLTH SERV J; Tian Y, 2012, KINGS FUND DATA BRIE	11	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2016	352								i1684	10.1136/bmj.i1684	http://dx.doi.org/10.1136/bmj.i1684			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LN	27012582	Green Published, Bronze			2022-12-28	WOS:000373044800007
J	de Montjoye, YA; Pentland, A				de Montjoye, Yves-Alexandre; Pentland, Alex Sandy			Response to Comment on "Unique in the shopping mall: On the reidentifiability of credit card metadata"	SCIENCE			English	Editorial Material								Sanchez et al.'s textbook k-anonymization example does not prove, or even suggest, that location and other big-data data sets can be anonymized and of general use. The synthetic data set that they "successfully anonymize" bears no resemblance to modern high-dimensional data sets on which their methods fail. Moving forward, deidentification should not be considered a useful basis for policy.	[de Montjoye, Yves-Alexandre; Pentland, Alex Sandy] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [de Montjoye, Yves-Alexandre] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University	de Montjoye, YA (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; de Montjoye, YA (corresponding author), Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA.	yvesalexandre@demontjoye.com						de Montjoye YA, 2015, SCIENCE, V348, P195, DOI 10.1126/science.348.6231.195-a; de Montjoye YA, 2015, SCIENCE, V347, P536, DOI 10.1126/science.1256297; de Montjoye YA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01376; Dwork, 2011, ENCY CRYPTOGRAPHY SE, P338, DOI DOI 10.1007/978-1-4419-5906-5_752; Gramaglia M., 2014, ARXIV150100100; Miritello G, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.045102; Narayanan A., 2014, NO SILVER BULLET DE; PRESIDENT'S COUNCIL OF ADVISORS ON SCI. & TECH. EXEC. OFFICE OF THE PRESIDENT, 2014, BIG DAT PRIV TECHN P, p[38, 40]; Ratti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014248; Sanchez D, 2016, SCIENCE, V351, DOI 10.1126/science.aad9295; Toole JL, 2015, COMPUT SOC SCI, P15, DOI 10.1007/978-3-319-14011-7_2	11	6	6	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279								10.1126/science.aaf1578	http://dx.doi.org/10.1126/science.aaf1578			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG9JD	26989244				2022-12-28	WOS:000372397700029
J	Carr, PC; Brodell, RT				Carr, Patrick C.; Brodell, Robert T.			Scabies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Carr, Patrick C.; Brodell, Robert T.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Brodell, RT (corresponding author), Univ Mississippi, Med Ctr, Jackson, MS 39216 USA.	rbrodell@umc.edu							0	2	2	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					E13	E13		10.1056/NEJMicm1500116	http://dx.doi.org/10.1056/NEJMicm1500116			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4TR	26981951				2022-12-28	WOS:000372066100013
J	Baime, MJ				Baime, Michael J.			In chronic nonspecific neck pain, adding Alexander Technique lessons or acupuncture to usual care reduced pain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Baime, Michael J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Baime, MJ (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.							Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2	1	3	3	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					JC29	JC29		10.7326/ACPJC-2016-164-6-029	http://dx.doi.org/10.7326/ACPJC-2016-164-6-029			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26974729				2022-12-28	WOS:000372207200004
J	Knight, J; Perkovic, V				Knight, John; Perkovic, Vlado			The Affordable Dialysis Prize steams ahead	LANCET			English	Editorial Material							KIDNEY		[Knight, John; Perkovic, Vlado] George Inst Global Hlth, Sydney, NSW 2000, Australia	George Institute for Global Health; University of Sydney	Perkovic, V (corresponding author), George Inst Global Hlth, Sydney, NSW 2000, Australia.	VPerkovic@georgeinstitute.org.au	Perkovic, Vlado/AAY-1933-2021					Karopadi AN, 2013, NEPHROL DIAL TRANSPL, V28, P2553, DOI 10.1093/ndt/gft214; Kolff WJ, 1944, ACTA MED SCAND, V117, P121; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9	3	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1040	1040		10.1016/S0140-6736(16)00657-7	http://dx.doi.org/10.1016/S0140-6736(16)00657-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG0SD	26970720				2022-12-28	WOS:000371775000010
J	Cheung, AY; Wu, HM				Cheung, Alice Y.; Wu, Hen-Ming			PLANT BIOLOGY LURE is bait for multiple receptors	NATURE			English	Editorial Material							DOUBLE FERTILIZATION; POLLEN TUBES; GROWTH; GUIDANCE		[Cheung, Alice Y.; Wu, Hen-Ming] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Cheung, AY; Wu, HM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	acheung@biochem.umass.edu; hmwu@biochem.umass.edu						Cheung AY, 2008, ANNU REV PLANT BIOL, V59, P547, DOI 10.1146/annurev.arplant.59.032607.092921; Dresselhaus T, 2013, MOL PLANT, V6, P1018, DOI 10.1093/mp/sst061; Fisher K, 2007, CURR BIOL, V17, P1061, DOI 10.1016/j.cub.2007.05.049; Higashiyama T, 2015, ANNU REV PLANT BIOL, V66, P393, DOI 10.1146/annurev-arplant-043014-115635; Lee JS, 2015, NATURE, V522, P435, DOI 10.1038/nature14561; Qu LJ, 2015, J EXP BOT, V66, P5139, DOI 10.1093/jxb/erv275; Takeuchi H, 2016, NATURE, V531, P245, DOI 10.1038/nature17413; Takeuchi H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001449; Wang T, 2016, NATURE, V531, P241, DOI 10.1038/nature16975; WU HM, 1995, CELL, V82, P395, DOI 10.1016/0092-8674(95)90428-X	10	12	13	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					178	180		10.1038/531178a	http://dx.doi.org/10.1038/531178a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26961652				2022-12-28	WOS:000371665100027
J	Walker, KF; Bugg, GJ; Macpherson, M; McCormick, C; Grace, N; Wildsmith, C; Bradshaw, L; Smith, GCS; Thornton, JG				Walker, Kate F.; Bugg, George J.; Macpherson, Marion; McCormick, Carol; Grace, Nicky; Wildsmith, Chris; Bradshaw, Lucy; Smith, Gordon C. S.; Thornton, James G.		35 39 Trial Grp	Randomized Trial of Labor Induction in Women 35 Years of Age or Older	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADVANCED MATERNAL AGE; EXPECTANT MANAGEMENT; ELECTIVE INDUCTION; CESAREAN DELIVERY; GESTATIONAL-AGE; RISK; TERM; PREGNANCY	BACKGROUND The risk of antepartum stillbirth at term is higher among women 35 years of age or older than among younger women. Labor induction may reduce the risk of stillbirth, but it also may increase the risk of cesarean delivery, which already is common in this older age group. METHODS We conducted a randomized, controlled trial involving primigravid women who were 35 years of age or older. Women were randomly assigned to labor induction between 39 weeks 0 days and 39 weeks 6 days of gestation or to expectant management (i.e., waiting until the spontaneous onset of labor or until the development of a medical problem that mandated induction). The primary outcome was cesarean delivery. The trial was not designed or powered to assess the effects of labor induction on stillbirth. RESULTS A total of 619 women underwent randomization. In an intention-to-treat analysis, there were no significant between-group differences in the percentage of women who underwent a cesarean section (98 of 304 women in the induction group [32%] and 103 of 314 women in the expectant-management group [33%]; relative risk, 0.99; 95% confidence interval [CI], 0.87 to 1.14) or in the percentage of women who had a vaginal delivery with the use of forceps or vacuum (115 of 304 women [38%] and 104 of 314 women [33%], respectively; relative risk, 1.30; 95% CI, 0.96 to 1.77). There were no maternal or infant deaths and no significant between-group differences in the women's experience of childbirth or in the frequency of adverse maternal or neonatal outcomes. CONCLUSIONS Among women of advanced maternal age, induction of labor at 39 weeks of gestation, as compared with expectant management, had no significant effect on the rate of cesarean section and no adverse short-term effects on maternal or neonatal outcomes.	[Walker, Kate F.; Macpherson, Marion; McCormick, Carol; Thornton, James G.] Univ Nottingham, Sch Clin Sci, Div Child Hlth Obstet & Gynaecol, Nottingham NG5 1PB, England; [Bradshaw, Lucy] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham NG5 1PB, England; [Bugg, George J.; Grace, Nicky] Univ Nottingham, Div Obstet & Gynaecol, Nottingham Univ Hosp NHS Trust, Nottingham NG7 2RD, England; [Wildsmith, Chris] Stillbirth & Neonatal Death Char, London, England; [Smith, Gordon C. S.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; [Smith, Gordon C. S.] Univ Cambridge, Biomed Res Ctr, Inst Hlth Res, Cambridge, England	University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; University of Cambridge; University of Cambridge	Thornton, JG (corresponding author), Univ Nottingham, Sch Med, Div Child Hlth Obstet & Gynaecol, Hucknall Rd, Nottingham NG5 1PB, England.	jim.thornton@nottingham.ac.uk	Thornton, Jim/B-8336-2008; Smith, Gordon/A-8070-2008	Thornton, Jim/0000-0001-9764-6876; Grace, Nicky/0000-0002-8543-1162; Smith, Gordon/0000-0003-2124-0997; Walker, Kate F./0000-0001-5794-7324; Tower, Clare/0000-0001-8532-5354	Research for Patient Benefit Programme of the National Institute for Health Research; National Institute for Health Research [PB-PG-0610-22275] Funding Source: researchfish	Research for Patient Benefit Programme of the National Institute for Health Research; National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the Research for Patient Benefit Programme of the National Institute for Health Research; Current Controlled Trials number, ISRCTN11517275.	Amano K, 1999, J Obstet Gynaecol Res, V25, P33; [Anonymous], 2008, IND OF LAB; [Anonymous], 2006, LIVE BIRTHS ENGL WAL; Boers KE, 2010, BMJ-BRIT MED J, V341, P1; Boulvain M, 2015, LANCET, V385, P2600, DOI 10.1016/S0140-6736(14)61904-8; BREART G, 1982, J GYNECOL OBST BIO R, V11, P107; Cheng YW, 2012, AM J OBSTET GYNECOL, V207, p501e2; CMACE, 2011, CTR MAT CHILD ENQ CM; COLE RA, 1975, LANCET, V1, P767; Dencker A, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-81; Favilli A, 2013, J MATERN-FETAL NEO M, V26, P665, DOI 10.3109/14767058.2012.746658; Gulmezoglu AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945; Hannah ME, 1996, NEW ENGL J MED, V334, P1005, DOI 10.1056/NEJM199604183341601; Jacobsson B, 2004, OBSTET GYNECOL, V104, P727, DOI 10.1097/01.AOG.0000140682.63746.be; Joseph KS, 2005, OBSTET GYNECOL, V105, P1410, DOI 10.1097/01.AOG.0000163256.83313.36; KJOS SL, 1993, AM J OBSTET GYNECOL, V169, P611, DOI 10.1016/0002-9378(93)90631-R; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; MARTIN DH, 1978, BRIT J OBSTET GYNAEC, V85, P109, DOI 10.1111/j.1471-0528.1978.tb10462.x; Mishanina E, 2014, CAN MED ASSOC J, V186, P665, DOI 10.1503/cmaj.130925; Noble KG, 2012, PEDIATRICS, V130, pE257, DOI 10.1542/peds.2011-2157; RAYMOND EG, 1994, BRIT J OBSTET GYNAEC, V101, P301, DOI 10.1111/j.1471-0528.1994.tb13614.x; Reddy UM, 2006, AM J OBSTET GYNECOL, V195, P764, DOI 10.1016/j.ajog.2006.06.019; Rose O, 2013, PEDIATRICS, V131, pE1475, DOI 10.1542/peds.2012-3215; Saccone G, 2015, AM J OBSTET GYNECOL, V213, P629, DOI 10.1016/j.ajog.2015.04.004; Seyb ST, 1999, OBSTET GYNECOL, V94, P600, DOI 10.1016/S0029-7844(99)00377-4; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; Smith GCS, 2008, PLOS MED, V5, P1123, DOI 10.1371/journal.pmed.0050144; Walker KF, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-145; Walker KF, 2012, EUR J OBSTET GYN R B, V162, P144, DOI 10.1016/j.ejogrb.2012.02.016; Wood S, 2013, BJOG, V121, P674; Yang S, 2010, AM J EPIDEMIOL, V171, P399, DOI 10.1093/aje/kwp413	32	136	141	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					813	822		10.1056/NEJMoa1509117	http://dx.doi.org/10.1056/NEJMoa1509117			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF2FT	26962902	Green Published, Green Accepted			2022-12-28	WOS:000371158400005
J	Pucci, F; Garris, C; Lai, CP; Newton, A; Pfirschke, C; Engblom, C; Alvarez, D; Sprachman, M; Evavold, C; Magnuson, A; von Andrian, UH; Glatz, K; Breakefield, XO; Mempel, TR; Weissleder, R; Pittet, MJ				Pucci, Ferdinando; Garris, Christopher; Lai, Charles P.; Newton, Andita; Pfirschke, Christina; Engblom, Camilla; Alvarez, David; Sprachman, Melissa; Evavold, Charles; Magnuson, Angela; von Andrian, Ulrich H.; Glatz, Katharina; Breakefield, Xandra O.; Mempel, Thorsten R.; Weissleder, Ralph; Pittet, Mikael J.			SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions	SCIENCE			English	Article							SUBCAPSULAR SINUS MACROPHAGES; LYMPH-NODES; INFLAMMATION; EXOSOMES; MICROVESICLES; INFECTION; RNA	Tumor-derived extracellular vesicles (tEVs) are important signals in tumor-host cell communication, yet it remains unclear how endogenously produced tEVs affect the host in different areas of the body. We combined imaging and genetic analysis to track melanoma-derived vesicles at organismal, cellular, and molecular scales to show that endogenous tEVs efficiently disseminate via lymphatics and preferentially bind subcapsular sinus (SCS) CD169(+) macrophages in tumor-draining lymph nodes (tdLNs) in mice and humans. The CD169(+) macrophage layer physically blocks tEVdissemination but is undermined during tumor progression and by therapeutic agents. A disrupted SCS macrophage barrier enables tEVs to enter the lymph node cortex, interact with B cells, and foster tumor-promoting humoral immunity. Thus, CD169(+) macrophages may act as tumor suppressors by containing tEV spread and ensuing cancer-enhancing immunity.	[Pucci, Ferdinando; Garris, Christopher; Newton, Andita; Pfirschke, Christina; Engblom, Camilla; Sprachman, Melissa; Evavold, Charles; Magnuson, Angela; Weissleder, Ralph; Pittet, Mikael J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Res Inst, Boston, MA 02114 USA; [Garris, Christopher; Engblom, Camilla; Evavold, Charles] Harvard Univ, Sch Med, Grad Program Immunol, Boston, MA 02115 USA; [Lai, Charles P.; Breakefield, Xandra O.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol,Res Inst, Charlestown, MA 02129 USA; [Alvarez, David; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Glatz, Katharina] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Mempel, Thorsten R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis,Res Inst, Charlestown, MA 02129 USA; [Pucci, Ferdinando] Torque Therapeut Inc, Cambridge, MA 02142 USA; [Lai, Charles P.] Natl Tsing Hua Univ, Inst Biomed Engn, Hsinchu, Taiwan	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Basel; Harvard University; Massachusetts General Hospital; National Tsing Hua University	Pittet, MJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Res Inst, Boston, MA 02114 USA.	mpittet@mgh.harvard.edu	Pucci, Ferdinando/AAT-8239-2020; Pittet, Mikael/ABD-6300-2021; Lai, Charles Pin-Kuang/D-5442-2017	Pucci, Ferdinando/0000-0002-1300-9931; Lai, Charles Pin-Kuang/0000-0001-8050-7060; Evavold, Charles/0000-0003-3913-5626; /0000-0003-0828-4143	Samana Cay MGH Research Scholar Fund; NIH [R21-CA190344, P50-CA86355, R01-AI084880, U54-CA126515, T32CA79443, RO1EB010011, 1R01CA164448, 1R33CA202064, P01-CA069246, U19 CA179563, R01 AI097052, F31-CA196035]; EMBO long-term fellowship; MGH ECOR Funds for Medical Discovery Fellowship; Deutsche Forschungsgemeinschaft [PF809/1-1]; Canadian Institutes of Health Research; Boehringer Ingelheim; NATIONAL CANCER INSTITUTE [F31CA196035, R01CA164448, U54CA126515, R21CA190344, P01CA069246, T32CA079443, R33CA202064, U19CA179563, P50CA086355, R01CA204019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084880, R01AI097052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER	Samana Cay MGH Research Scholar Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); MGH ECOR Funds for Medical Discovery Fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Ericsson for helping with electron microscopy studies, T. Murooka for multiphoton microscopy experiments, and S. Mordecai for imaging flow cytometry. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Supported by the Samana Cay MGH Research Scholar Fund and NIH grants R21-CA190344, P50-CA86355, and R01-AI084880 (M.J.P.); NIH grants U54-CA126515, T32CA79443, RO1EB010011, 1R01CA164448, and 1R33CA202064 (R.W.); NIH grant P01-CA069246 (X.O.B. and R.W.); NIH grant U19 CA179563 (X.O.B. and T.R.M.); NIH grant R01 AI097052 (T.R.M.); NIH grant F31-CA196035 (C.G.); an EMBO long-term fellowship and an MGH ECOR Funds for Medical Discovery Fellowship (F.P.); Deutsche Forschungsgemeinschaft grant PF809/1-1 (C.P.); a Canadian Institutes of Health Research postdoctoral fellowship (C.P.L.); and Boehringer Ingelheim Funds (C.E.).	Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hogarth PM, 2012, NAT REV DRUG DISCOV, V11, P311, DOI 10.1038/nrd2909; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Lai CP, 2014, ACS NANO, V8, P483, DOI 10.1021/nn404945r; Magnuson AM, 2015, P NATL ACAD SCI USA, V112, P1511, DOI 10.1073/pnas.1423769112; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Moseman EA, 2012, IMMUNITY, V36, P415, DOI 10.1016/j.immuni.2012.01.013; Ohnishi K, 2013, CANCER SCI, V104, P1236, DOI 10.1111/cas.12212; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Pucci F, 2013, CLIN CANCER RES, V19, P2598, DOI 10.1158/1078-0432.CCR-12-0962; Ries CH, 2015, CURR OPIN PHARMACOL, V23, P45, DOI 10.1016/j.coph.2015.05.008; Shao HL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7999; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yaziji H, 2003, INT J SURG PATHOL, V11, P11, DOI 10.1177/106689690301100103; Zomer A, 2015, CELL, V161, P1046, DOI 10.1016/j.cell.2015.04.042	29	190	194	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2016	352	6282					242	246		10.1126/science.aaf1328	http://dx.doi.org/10.1126/science.aaf1328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI7LM	26989197	Green Accepted			2022-12-28	WOS:000373681600051
J	Hiruma, K; Gerlach, N; Sacristan, S; Nakano, RT; Hacquard, S; Kracher, B; Neumann, U; Ramirez, D; Bucher, M; O'Connell, RJ; Schulze-Lefert, P				Hiruma, Kei; Gerlach, Nina; Sacristan, Soledad; Nakano, Ryohei Thomas; Hacquard, Stephane; Kracher, Barbara; Neumann, Ulla; Ramirez, Diana; Bucher, Marcel; O'Connell, Richard J.; Schulze-Lefert, Paul			Root Endophyte Colletotrichum tofieldiae Confers Plant Fitness Benefits that Are Phosphate Status Dependent	CELL			English	Article							ARABIDOPSIS-THALIANA; GLUCOSINOLATE METABOLISM; MYCORRHIZAL SYMBIOSIS; SECONDARY METABOLITES; PIRIFORMOSPORA-INDICA; TRANSPORTER; MICROBIOME; DIVERSIFICATION; COLONIZATION; INFECTION	A staggering diversity of endophytic fungi associate with healthy plants in nature, but it is usually unclear whether these represent stochastic encounters or provide host fitness benefits. Although most characterized species of the fungal genus Colletotrichum are destructive pathogens, we show here that C. tofieldiae (Ct) is an endemic endophyte in natural Arabidopsis thaliana populations in central Spain. Colonization by Ct initiates in roots but can also spread systemically into shoots. Ct transfers the macronutrient phosphorus to shoots, promotes plant growth, and increases fertility only under phosphorus-deficient conditions, a nutrient status that might have facilitated the transition from pathogenic to beneficial lifestyles. The host's phosphate starvation response (PSR) system controls Ct root colonization and is needed for plant growth promotion (PGP). PGP also requires PEN2-dependent indole glucosinolate metabolism, a component of innate immune responses, indicating a functional link between innate immunity and the PSR system during beneficial interactions with Ct.	[Hiruma, Kei; Nakano, Ryohei Thomas; Hacquard, Stephane; Kracher, Barbara; Neumann, Ulla; O'Connell, Richard J.; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; [Hiruma, Kei] Nara Inst Sci & Technol, Dept Biol Sci, Nara 6300192, Japan; [Gerlach, Nina; Bucher, Marcel] Univ Cologne, Cologne Bioctr, Bot Inst, D-50931 Cologne, Germany; [Sacristan, Soledad; Ramirez, Diana] Univ Politecn Madrid, Ctr Biotecnol Genom Plantas UPM INIA, Campus Montegancedo, Madrid 28223, Spain; [Sacristan, Soledad; Bucher, Marcel] Univ Politecn Madrid, ETSI Agronomos, Campus Montegancedo, Madrid 28223, Spain; [O'Connell, Richard J.] Univ Paris Saclay, UMR BIOGER, INRA, AgroParisTech, F-78850 Thiverval Grignon, France; [Nakano, Ryohei Thomas; Bucher, Marcel; Schulze-Lefert, Paul] Univ Cologne, Cluster Excellence Plant Sci CEPLAS, D-50931 Cologne, Germany	Max Planck Society; Nara Institute of Science & Technology; University of Cologne; Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Cologne	O'Connell, RJ; Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany.; O'Connell, RJ (corresponding author), Univ Paris Saclay, UMR BIOGER, INRA, AgroParisTech, F-78850 Thiverval Grignon, France.; Schulze-Lefert, P (corresponding author), Univ Cologne, Cluster Excellence Plant Sci CEPLAS, D-50931 Cologne, Germany.	richard.oconnell@versailles.inra.fr; schlef@mpipz.mpg.de	Schulze-Lefert, Paul/B-6707-2011; Nakano, Ryohei Thomas/K-1509-2015; Hiruma, Kei/U-1626-2019; Bucher, Marcel/D-4596-2013; SACRISTAN, SOLEDAD/H-1062-2015	Nakano, Ryohei Thomas/0000-0001-5973-2300; Bucher, Marcel/0000-0003-1680-9413; SACRISTAN, SOLEDAD/0000-0002-5753-2644; Hiruma, Kei/0000-0002-5487-5414	Japan Society for the Promotion of Science (JSPS) [15K18645]; Max Planck Society; European Research Council advanced grant ROOTMICROBIOTA; "Cluster of Excellence on Plant Sciences'' program of the Deutsche Forschungsgemeinschaft; Agence Nationale de la Recherche Chaire d'Excellence [ANR-12-CHEX-0008-01]; Ministerio de Economia y Competitividad [BIO2012-32910]; COST action Endophytes in Biotechnology and Agriculture [FA1103]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council advanced grant ROOTMICROBIOTA(European Research Council (ERC)); "Cluster of Excellence on Plant Sciences'' program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Agence Nationale de la Recherche Chaire d'Excellence(French National Research Agency (ANR)); Ministerio de Economia y Competitividad(Spanish Government); COST action Endophytes in Biotechnology and Agriculture	K.H. was supported by Japan Society for the Promotion of Science (JSPS) grant 15K18645. This work was supported by funding from the Max Planck Society (P.S.-L. and R.J.O.), European Research Council advanced grant ROOTMICROBIOTA (P. S.-L.), the "Cluster of Excellence on Plant Sciences'' program of the Deutsche Forschungsgemeinschaft (P.S.-L.), Agence Nationale de la Recherche Chaire d'Excellence grant ANR-12-CHEX-0008-01 (R.J.O.), Ministerio de Economia y Competitividad grant BIO2012-32910 (S.S.), and COST action FA1103 Endophytes in Biotechnology and Agriculture (S.S.). We thank Kathrin Schlucking and Stefanie Junkermann for technical support; Kenichi Tsuda, Tamara Gigolashvili, and Javier Paz-Ares for providing Arabidopsis mutants; and Pawel Bednarek, Nina Dombrowski, and Yusuke Saijo for helpful discussions.	Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bednarek P, 2011, NEW PHYTOL, V192, P713, DOI 10.1111/j.1469-8137.2011.03824.x; BLAKEMAN JP, 1966, BR MYCOL SOC TRANS, V49, P227; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Bucher M, 2007, NEW PHYTOL, V173, P11, DOI 10.1111/j.1469-8137.2006.01935.x; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Chen JY, 2011, PLANT PHYSIOL, V157, P269, DOI 10.1104/pp.111.181669; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Coleman-Derr D, 2016, NEW PHYTOL, V209, P798, DOI 10.1111/nph.13697; Damm U, 2009, FUNGAL DIVERS, V39, P45; Deising HB, 2000, MICROBES INFECT, V2, P1631, DOI 10.1016/S1286-4579(00)01319-8; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Frerigmann H, 2014, MOL PLANT, V7, P814, DOI 10.1093/mp/ssu004; Garcia E, 2013, FUNGAL DIVERS, V60, P71, DOI 10.1007/s13225-012-0219-0; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; Gruber BD, 2013, PLANT PHYSIOL, V163, P161, DOI 10.1104/pp.113.218453; Hacquard S., 2016, NAT COMMUN; Hacquard S, 2015, NEW PHYTOL, V205, P1424, DOI 10.1111/nph.13133; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Kovinich N, 2014, PLANTA, V240, P931, DOI 10.1007/s00425-014-2079-1; Lahrmann U, 2015, NEW PHYTOL, V207, P841, DOI 10.1111/nph.13411; Lopez-Arredondo DL, 2014, ANNU REV PLANT BIOL, V65, P95, DOI 10.1146/annurev-arplant-050213-035949; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Millet YA, 2010, PLANT CELL, V22, P973, DOI 10.1105/tpc.109.069658; Montanarella L., 2013, JRC TECHNICAL REPORT; Muller TM, 2015, PLANT PHYSIOL, V168, P849, DOI 10.1104/pp.15.00481; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nongbri PL, 2012, MOL PLANT MICROBE IN, V25, P1186, DOI 10.1094/MPMI-03-12-0071-R; Pant BD, 2015, PLANT CELL ENVIRON, V38, P172, DOI 10.1111/pce.12378; Poirier Yves, 2002, Arabidopsis Book, V1, pe0024, DOI 10.1199/tab.0024; Rajniak J, 2015, NATURE, V525, P376, DOI 10.1038/nature14907; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Sato Toyozo, 2005, Journal of General Plant Pathology, V71, P380, DOI 10.1007/s10327-005-0214-3; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Strehmel N, 2014, PHYTOCHEMISTRY, V108, P35, DOI 10.1016/j.phytochem.2014.10.003; Sukno SA, 2008, APPL ENVIRON MICROB, V74, P823, DOI 10.1128/AEM.01165-07; Tao G, 2013, FUNGAL DIVERS, V61, P139, DOI 10.1007/s13225-013-0254-5; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Windsor AJ, 2005, PHYTOCHEMISTRY, V66, P1321, DOI 10.1016/j.phytochem.2005.04.016; Yadav V, 2010, J BIOL CHEM, V285, P26532, DOI 10.1074/jbc.M110.111021; Zhou J, 2008, PLANT PHYSIOL, V146, P1673, DOI 10.1104/pp.107.111443	47	304	323	34	302	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2016	165	2					464	474		10.1016/j.cell.2016.02.028	http://dx.doi.org/10.1016/j.cell.2016.02.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DJ3RJ	26997485	Green Published, hybrid			2022-12-28	WOS:000374123000023
J	Jardine, JG; Kulp, DW; Havenar-Daughton, C; Sarkar, A; Briney, B; Sok, D; Sesterhenn, F; Ereno-Orbea, J; Kalyuzhniy, O; Deresa, I; Hu, XZ; Spencer, S; Jones, M; Georgeson, E; Adachi, Y; Kubitz, M; deCamp, AC; Julien, JP; Wilson, IA; Burton, DR; Crotty, S; Schief, WR				Jardine, Joseph G.; Kulp, Daniel W.; Havenar-Daughton, Colin; Sarkar, Anita; Briney, Bryan; Sok, Devin; Sesterhenn, Fabian; Ereno-Orbea, June; Kalyuzhniy, Oleksandr; Deresa, Isaiah; Hu, Xiaozhen; Spencer, Skye; Jones, Meaghan; Georgeson, Erik; Adachi, Yumiko; Kubitz, Michael; deCamp, Allan C.; Julien, Jean-Philippe; Wilson, Ian A.; Burton, Dennis R.; Crotty, Shane; Schief, William R.			HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogene	SCIENCE			English	Article							STRUCTURAL BASIS; RESPONSES; AFFINITY; REPERTOIRE; RECEPTORS; BINDING; DESIGN; SITE	Induction of broadly neutralizing antibodies (bnAbs) is a major HIV vaccine goal. Germlinetargeting immunogens aim to initiate bnAb induction by activating bnAb germline precursor B cells. Critical unmet challenges are to determine whether bnAb precursor naive B cells bind germlinetargeting immunogens and occur at sufficient frequency in humans for reliable vaccine responses. Using deep mutational scanning and multitarget optimization, we developed a germlinetargeting immunogen (eODGT8) for diverse VRC01class bnAbs. We then used the immunogen to isolate VRC01class precursor naive B cells from HIVuninfected donors. Frequencies of true VRC01class precursors, their structures, and their eODGT8 affinities support this immunogen as a candidate human vaccine prime. These methods could be applied to germline targeting for other classes of HIV bnAbs and for Abs to other pathogens.	[Jardine, Joseph G.; Kulp, Daniel W.; Briney, Bryan; Sok, Devin; Sesterhenn, Fabian; Kalyuzhniy, Oleksandr; Hu, Xiaozhen; Spencer, Skye; Jones, Meaghan; Georgeson, Erik; Adachi, Yumiko; Kubitz, Michael; Burton, Dennis R.; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Jardine, Joseph G.; Kulp, Daniel W.; Sarkar, Anita; Briney, Bryan; Sok, Devin; Kalyuzhniy, Oleksandr; Adachi, Yumiko; Kubitz, Michael; Julien, Jean-Philippe; Wilson, Ian A.; Burton, Dennis R.; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Jardine, Joseph G.; Kulp, Daniel W.; Havenar-Daughton, Colin; Sarkar, Anita; Briney, Bryan; Sok, Devin; Kalyuzhniy, Oleksandr; Deresa, Isaiah; Hu, Xiaozhen; Spencer, Skye; Jones, Meaghan; Georgeson, Erik; Adachi, Yumiko; Kubitz, Michael; Julien, Jean-Philippe; Wilson, Ian A.; Burton, Dennis R.; Crotty, Shane; Schief, William R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Havenar-Daughton, Colin; Deresa, Isaiah; Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Sarkar, Anita; Julien, Jean-Philippe; Wilson, Ian A.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Ereno-Orbea, June; Julien, Jean-Philippe] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [deCamp, Allan C.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, SCHARP, Seattle, WA 98109 USA; [Julien, Jean-Philippe] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Julien, Jean-Philippe] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Burton, Dennis R.; Schief, William R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA; [Crotty, Shane] Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; La Jolla Institute for Immunology; Scripps Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Fred Hutchinson Cancer Center; University of Toronto; University of Toronto; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of California System; University of California San Diego	Schief, WR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Schief, WR (corresponding author), Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA.; Crotty, S; Schief, WR (corresponding author), Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA.; Crotty, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.; Schief, WR (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA.; Crotty, S (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA.	shane@lji.org; schief@scripps.edu	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019; Schief, William/ABF-3645-2020	Crotty, Shane/0000-0002-6484-6262; Schief, William/0000-0002-1120-0150; Spencer, Skye/0000-0001-9570-9634; Kalyuzhniy, Oleksandr/0000-0002-5273-1951; Sarkar, Anita/0000-0001-5602-8406; ereno orbea, june/0000-0002-5076-2105; Sesterhenn, Fabian/0000-0001-8331-4344; Julien, Jean-Philippe/0000-0001-7602-3995; Havenar-Daughton, Colin/0000-0002-2880-3927	International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center; CAVD; CAVD Vaccine Immunology Statistical Center (VISC); Ragon Institute of MGH, MIT, and Harvard; Bayer Science and Education Foundation; Helen Hay Whitney Foundation; Howard Hughes Medical Institute; National Institute of Allergy and Infectious Diseases [P01 AI094419, CHAVI-ID UM1 AI100663, P01 AI110657, R01 AI084817]; DOE Office of Biological and Environmental Research; National Institute of General Medical Sciences [P41GM103393]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI094419, T32AI007244, P01AI110657, R01AI084817, UM1AI100663, R56AI084817, UM1AI068635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center; CAVD; CAVD Vaccine Immunology Statistical Center (VISC); Ragon Institute of MGH, MIT, and Harvard; Bayer Science and Education Foundation; Helen Hay Whitney Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Stamatatos, T. Whitehead, and M. Nussenzweig for discussions; the Flow Cytometry Core at the La Jolla Institute for Allergy and Immunology and L. Nosworthy for expert cell-sorting assistance; H. Tien for technical support with crystallization robots; and A. Irimia for discussions and technical help. This work was supported by the International AIDS Vaccine Initiative Neutralizing Antibody Consortium and Center (W.R.S., I.A.W., D.R.B.); CAVD funding for the IAVI NAC Center (W.R.S., I.A.W., D.R.B.); CAVD Vaccine Immunology Statistical Center (VISC) (A.C.D.); the Ragon Institute of MGH, MIT, and Harvard (D.R.B. and W.R.S.); the Bayer Science and Education Foundation (F.S.); the Helen Hay Whitney Foundation and Howard Hughes Medical Institute (J.G.J.); and National Institute of Allergy and Infectious Diseases grants P01 AI094419 (W.R.S.), CHAVI-ID UM1 AI100663 (W.R.S., S.C., I.A.W., D.R.B.), P01 AI110657 (I.A.W.), and R01 AI084817 (I.A.W.). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institute of General Medical Sciences (including P41GM103393). The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Coordinates and structure factors for VRC01c-HuGL2 Fab, VRC01c-HuGL2+eOD-GT8 (2.44 angstrom), and VRC01c-HuGL2+eOD-GT8 (2.16 angstrom) have been deposited with the Protein Data Bank with accession codes 5IFA, 5IFO, and 5IES, respectively. Sequences for heavy and light chains of HuGL1 through HuGL27 have been deposited at NCBI with GenBank accession codes KU760929 to KU760982. Materials and information are available by MTA from the Scripps Research Institute. IAVI and the Scripps Research Institute have filed a patent relating to the eOD-GT8 immunogens in this manuscript, which included inventors J.G.J., D.W.K., and W.R.S. W.R.S. is a co-founder and stockholder in Compuvax Inc., which has programs in non-HIV vaccine design that might benefit indirectly from this research.	Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; Diskin R, 2013, J EXP MED, V210, P1235, DOI 10.1084/jem.20130221; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	21	254	262	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1458	1463		10.1126/science.aad9195	http://dx.doi.org/10.1126/science.aad9195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013733	Green Submitted, Green Accepted			2022-12-28	WOS:000372756200051
J	Ruehl, CR; Davies, JF; Wilson, KR				Ruehl, Christopher R.; Davies, James F.; Wilson, Kevin R.			An interfacial mechanism for cloud droplet formation on organic aerosols	SCIENCE			English	Article							CONDENSATION NUCLEI; SURFACE-TENSION; HYGROSCOPIC GROWTH; SOLUBLE ORGANICS; CCN ACTIVITY; ACTIVATION; SITE	Accurate predictions of aerosol/cloud interactions require simple, physically accurate parameterizations of the cloud condensation nuclei (CCN) activity of aerosols. Current models assume that organic aerosol species contribute to CCN activity by lowering water activity. We measured droplet diameters at the point of CCN activation for particles composed of dicarboxylic acids or secondary organic aerosol and ammonium sulfate. Droplet activation diameters were 40 to 60% larger than predicted if the organic was assumed to be dissolved within the bulk droplet, suggesting that a new mechanism is needed to explain cloud droplet formation. A compressed film model explains how surface tension depression by interfacial organic molecules can alter the relationship between water vapor supersaturation and droplet size (i.e., the Kohler curve), leading to the larger diameters observed at activation.	[Ruehl, Christopher R.; Davies, James F.; Wilson, Kevin R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Ruehl, Christopher R.] Calif Air Resources Board, Sacramento, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Ruehl, CR; Wilson, KR (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA.; Ruehl, CR (corresponding author), Calif Air Resources Board, Sacramento, CA USA.	chris.ruehl@arb.ca.gov; krwilson@lbl.gov	Davies, James/G-1113-2015	Davies, James/0000-0002-7415-3638; Ruehl, Chris/0000-0002-8815-3014	Office of Science Early Career Research Program, through the Office of Energy Research, Office of Basic Energy Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Office of Science Early Career Research Program, through the Office of Energy Research, Office of Basic Energy Science of the U.S. Department of Energy(United States Department of Energy (DOE))	This work is supported by the Office of Science Early Career Research Program, through the Office of Energy Research, Office of Basic Energy Science of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. The continuous-flow streamwise thermal gradient chamber was originally developed by Patrick Chuang and Anthanasios Nenes with support from NASA's Atmospheric Radiation Measurement program.	Abdul-Razzak H, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000483; Broekhuizen K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018203; Chang RYW, 2010, ATMOS CHEM PHYS, V10, P5047, DOI 10.5194/acp-10-5047-2010; Ekstrom S, 2009, ATMOS CHEM PHYS, V9, P973, DOI 10.5194/acp-9-973-2009; Facchini MC, 1999, NATURE, V401, P257, DOI 10.1038/45758; Good N, 2010, ATMOS CHEM PHYS, V10, P3189, DOI 10.5194/acp-10-3189-2010; Gunthe SS, 2009, ATMOS CHEM PHYS, V9, P7551, DOI 10.5194/acp-9-7551-2009; Hammer E, 2014, ATMOS CHEM PHYS, V14, P10517, DOI 10.5194/acp-14-10517-2014; Hartz KEH, 2006, ATMOS ENVIRON, V40, P605, DOI 10.1016/j.atmosenv.2005.09.076; Henning S, 2005, ATMOS CHEM PHYS, V5, P575, DOI 10.5194/acp-5-575-2005; Hori M, 2003, J AEROSOL SCI, V34, P419, DOI 10.1016/S0021-8502(02)00190-8; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; JURA G, 1946, J AM CHEM SOC, V68, P1941, DOI 10.1021/ja01214a022; Kohler H, 1936, T FARADAY SOC, V32, P1152, DOI 10.1039/tf9363201152; Kristensson A, 2010, J PHYS CHEM A, V114, P379, DOI 10.1021/jp9055329; Kuwata M, 2013, ATMOS CHEM PHYS, V13, P5309, DOI 10.5194/acp-13-5309-2013; Levin EJT, 2014, ATMOS CHEM PHYS, V14, P2657, DOI 10.5194/acp-14-2657-2014; Moore RH, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017352; Noziere B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4335; Petters MD, 2007, ATMOS CHEM PHYS, V7, P1961, DOI 10.5194/acp-7-1961-2007; Petters MD, 2006, TELLUS B, V58, P196, DOI 10.1111/j.1600-0889.2006.00181.x; Roberts GC, 2005, AEROSOL SCI TECH, V39, P206, DOI 10.1080/027868290913988; Ruehl CR, 2014, J PHYS CHEM A, V118, P3952, DOI 10.1021/jp502844g; Shulman ML, 1996, GEOPHYS RES LETT, V23, P277, DOI 10.1029/95GL03810; Sorjamaa R, 2004, ATMOS CHEM PHYS, V4, P2107, DOI 10.5194/acp-4-2107-2004; Wang J, 2008, ATMOS CHEM PHYS, V8, P6325, DOI 10.5194/acp-8-6325-2008; Wex H, 2009, ATMOS CHEM PHYS, V9, P3987, DOI 10.5194/acp-9-3987-2009; Yakobi-Hancock JD, 2014, ATMOS CHEM PHYS, V14, P12307, DOI 10.5194/acp-14-12307-2014; YOUNG KC, 1992, J ATMOS SCI, V49, P1138, DOI 10.1175/1520-0469(1992)049<1138:AROTDO>2.0.CO;2	29	150	151	18	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1447	1450		10.1126/science.aad4889	http://dx.doi.org/10.1126/science.aad4889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013731	Green Submitted			2022-12-28	WOS:000372756200048
J	Chantranupong, L; Scaria, SM; Saxton, RA; Gygi, MP; Shen, K; Wyant, GA; Wang, T; Harper, JW; Gygi, SP; Sabatini, DM				Chantranupong, Lynne; Scaria, Sonia M.; Saxton, Robert A.; Gygi, Melanie P.; Shen, Kuang; Wyant, Gregory A.; Wang, Tim; Harper, J. Wade; Gygi, Steven P.; Sabatini, David M.			The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway	CELL			English	Article							AMINO-ACID SUFFICIENCY; GTP-BINDING PROTEINS; P70 S6 KINASE; ACT DOMAIN; TUMOR-SUPPRESSOR; INHIBIT MTORC1; RAG GTPASES; ACTIVATION; LEUCINE; COMPLEX	Amino acids signal to the mTOR complex I (mTORC1) growth pathway through the Rag GTPases. Multiple distinct complexes regulate the Rags, including GATOR1, a GTPase activating protein (GAP), and GATOR2, a positive regulator of unknown molecular function. Arginine stimulation of cells activates mTORC1, but how it is sensed is not well understood. Recently, SLC38A9 was identified as a putative lysosomal arginine sensor required for arginine to activate mTORC1 but how arginine deprivation represses mTORC1 is unknown. Here, we show that CASTOR1, a previously uncharacterized protein, interacts with GATOR2 and is required for arginine deprivation to inhibit mTORC1. CASTOR1 homodimerizes and can also heterodimerize with the related protein, CASTOR2. Arginine disrupts the CASTOR1-GATOR2 complex by binding to CASTOR1 with a dissociation constant of similar to 30 mu M, and its arginine-binding capacity is required for arginine to activate mTORC1 in cells. Collectively, these results establish CASTOR1 as an arginine sensor for the mTORC1 pathway.	[Chantranupong, Lynne; Scaria, Sonia M.; Saxton, Robert A.; Shen, Kuang; Wyant, Gregory A.; Wang, Tim; Sabatini, David M.] Whitehead Inst Biomed Res, Dept Biol, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Chantranupong, Lynne; Scaria, Sonia M.; Saxton, Robert A.; Shen, Kuang; Wyant, Gregory A.; Wang, Tim; Sabatini, David M.] MIT, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Chantranupong, Lynne; Scaria, Sonia M.; Saxton, Robert A.; Shen, Kuang; Wyant, Gregory A.; Wang, Tim; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Chantranupong, Lynne; Scaria, Sonia M.; Saxton, Robert A.; Shen, Kuang; Wyant, Gregory A.; Wang, Tim; Sabatini, David M.] Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chantranupong, Lynne; Scaria, Sonia M.; Saxton, Robert A.; Shen, Kuang; Wyant, Gregory A.; Wang, Tim; Sabatini, David M.] Broad Inst Harvard, 415 Main St, Cambridge, MA 02142 USA; [Chantranupong, Lynne; Scaria, Sonia M.; Saxton, Robert A.; Shen, Kuang; Wyant, Gregory A.; Wang, Tim; Sabatini, David M.] MIT, 415 Main St, Cambridge, MA 02142 USA; [Gygi, Melanie P.; Harper, J. Wade; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, Dept Biol, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Broad Inst Harvard, 415 Main St, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, 415 Main St, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Shen, Kuang/H-9441-2016	Harper, Jeffrey/0000-0002-6944-7236; Wang, Timothy/0000-0001-5730-3019; /0000-0002-1446-7256; Saxton, Robert/0000-0001-9777-8270	US NIH [R01CA103866, AI47389]; Department of Defense [W81XWH-07-0448]; John Reed UROP Fund; National Defense Science & Engineering Graduate Fellowship (NDSEG); NIH [F31 CA180271, F31 CA189437, U41 HG006673, GM095567]; NATIONAL CANCER INSTITUTE [P30CA014051, F31CA189437, R01CA103866, F31CA180271] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, R01GM095567] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); John Reed UROP Fund; National Defense Science & Engineering Graduate Fellowship (NDSEG); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the D.M.S. lab for helpful suggestions, in particular Monther Abu-Remaileh and Walter W. Chen for experimental insight and advice. We are grateful to Jianxin Xie of Cell Signaling Technologies for generously providing many antibodies, in particular the CASTOR1 and CASTOR2 anti-sera. This work has been supported by grants from the US NIH (R01CA103866 and AI47389) and the Department of Defense (W81XWH-07-0448) to D.M.S. Fellowship support was provided by the John Reed UROP Fund to S.M.S., the National Defense Science & Engineering Graduate Fellowship (NDSEG) to G.A.W., and by the NIH (F31 CA180271 to L.C.; F31 CA189437 to T.W.; U41 HG006673 to S.P.G. and J.W.H., and GM095567 to J.W.H.) K.S. is a Pfizer Fellow of the Life Sciences Research Foundation. D.M.S is an investigator of the Howard Hughes Medical Institute.	Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Ban H, 2004, INT J MOL MED, V13, P537; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Carluccio C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079482; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Cross PJ, 2013, P NATL ACAD SCI USA, V110, P2111, DOI 10.1073/pnas.1217923110; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Dumas R, 2012, ARCH BIOCHEM BIOPHYS, V519, P186, DOI 10.1016/j.abb.2011.10.016; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; FLOYD JC, 1966, J CLIN INVEST, V45, P1487, DOI 10.1172/JCI105456; Fox Heather L., 1998, American Journal of Physiology, V275, pC1232; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hirose E, 1998, J CELL SCI, V111, P11; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Jung J, 2015, MOL CELL BIOL, V35, P2479, DOI 10.1128/MCB.00125-15; Kim JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09502; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Rhoads JM, 2006, AM J PHYSIOL-GASTR L, V291, pG510, DOI 10.1152/ajpgi.00189.2005; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Siltberg-Liberles J, 2009, AMINO ACIDS, V36, P235, DOI 10.1007/s00726-008-0057-2; Tan KM, 2008, J STRUCT BIOL, V162, P94, DOI 10.1016/j.jsb.2007.11.009; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	50	418	442	8	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					153	164		10.1016/j.cell.2016.02.035	http://dx.doi.org/10.1016/j.cell.2016.02.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	26972053	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000372785600017
J	Ingolia, NT				Ingolia, Nicholas T.			Ribosome Footprint Profiling of Translation throughout the Genome	CELL			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RNA-SEQ EXPERIMENTS; MESSENGER-RNA; IN-VIVO; MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE RESOLUTION; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; NONCODING RNAS	Ribosome profiling has emerged as a technique for measuring translation comprehensively and quantitatively by deep sequencing of ribosome-protected mRNA fragments. By identifying the precise positions of ribosomes, footprinting experiments have unveiled key insights into the composition and regulation of the expressed proteome, including delineating potentially functional micropeptides, revealing pervasive translation on cytosolic RNAs, and identifying differences in elongation rates driven by codon usage or other factors. This Primer looks at important experimental and analytical concerns for executing ribosome profiling experiments and surveys recent examples where the approach was developed to explore protein biogenesis and homeostasis.	[Ingolia, Nicholas T.] Univ Calif Berkeley, Glenn Ctr Aging Res, Calif Inst Quantitat Biomed Sci, Dept Mol & Cell Biol,Ctr RNA Syst Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Ingolia, NT (corresponding author), Univ Calif Berkeley, Glenn Ctr Aging Res, Calif Inst Quantitat Biomed Sci, Dept Mol & Cell Biol,Ctr RNA Syst Biol, Berkeley, CA 94720 USA.	ingolia@berkeley.edu			NCI NIH HHS [DP2 CA195768] Funding Source: Medline; NATIONAL CANCER INSTITUTE [DP2CA195768] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Albert FW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004692; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; Behrmann E, 2015, CELL, V161, P845, DOI 10.1016/j.cell.2015.03.052; Brar GA, 2015, NAT REV MOL CELL BIO, V16, P651, DOI 10.1038/nrm4069; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Brubaker SW, 2014, CELL, V156, P800, DOI 10.1016/j.cell.2014.01.021; Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Calviello L, 2016, NAT METHODS, V13, P165, DOI [10.1038/NMETH.3688, 10.1038/nmeth.3688]; Cenik C, 2015, GENOME RES, V25, P1610, DOI 10.1101/gr.193342.115; Chew GL, 2013, DEVELOPMENT, V140, P2828, DOI 10.1242/dev.098343; Crappe J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1283; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; Fields AP, 2015, MOL CELL, V60, P816, DOI 10.1016/j.molcel.2015.11.013; Fritsch C, 2012, GENOME RES, V22, P2208, DOI 10.1101/gr.139568.112; Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208; Gardin J, 2014, ELIFE, V3, DOI 10.7554/eLife.03735; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Gritsenko AA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004336; Grun D, 2015, CELL, V163, P799, DOI 10.1016/j.cell.2015.10.039; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Han Y, 2012, P NATL ACAD SCI USA, V109, P12467, DOI 10.1073/pnas.1208138109; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Hussmann JA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005732; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Kronja I, 2014, CELL REP, V7, P1495, DOI 10.1016/j.celrep.2014.05.002; Larsson O, 2011, BIOINFORMATICS, V27, P1440, DOI 10.1093/bioinformatics/btr146; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Loayza-Puch F, 2016, NATURE, V530, P490, DOI 10.1038/nature16982; Love Michael I, 2015, F1000Res, V4, P1070, DOI 10.12688/f1000research.7035.1; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Michel AM, 2012, GENOME RES, V22, P2219, DOI 10.1101/gr.133249.111; Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Olexiouk V, 2016, NUCLEIC ACIDS RES, V44, pD324, DOI 10.1093/nar/gkv1175; Ori A, 2015, CELL SYST, V1, P224, DOI 10.1016/j.cels.2015.08.012; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Pelechano V, 2015, CELL, V161, P1400, DOI 10.1016/j.cell.2015.05.008; Pfeffer Sebastien, 2005, Curr Protoc Mol Biol, VChapter 26, DOI 10.1002/0471142727.mb2604s72; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Pulido R, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005560; Reid DW, 2014, CELL, V158, P1362, DOI 10.1016/j.cell.2014.08.012; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004; Reuveni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002127; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Saghatelianr A, 2015, NAT CHEM BIOL, V11, P909, DOI 10.1038/nchembio.1964; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shalgi R, 2013, MOL CELL, V49, P439, DOI 10.1016/j.molcel.2012.11.028; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; STEITZ JA, 1969, NATURE, V224, P957, DOI 10.1038/224957a0; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wan J, 2014, NUCLEIC ACIDS RES, V42, pD845, DOI 10.1093/nar/gkt1085; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Woolstenhulme CJ, 2015, CELL REP, V11, P13, DOI 10.1016/j.celrep.2015.03.014; Xie SQ, 2016, NUCLEIC ACIDS RES, V44, pD254, DOI 10.1093/nar/gkv972; Young DJ, 2015, CELL, V162, P872, DOI 10.1016/j.cell.2015.07.041; Zhou PZ, 2013, P NATL ACAD SCI USA, V110, P15395, DOI 10.1073/pnas.1304124110; Zinshteyn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003675; Zupanic A, 2014, RNA, V20, P1507, DOI 10.1261/rna.045286.114	95	220	226	3	77	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					22	33		10.1016/j.cell.2016.02.066	http://dx.doi.org/10.1016/j.cell.2016.02.066			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015305	Green Accepted, Bronze			2022-12-28	WOS:000372785600007
J	Torjesen, I				Torjesen, Ingrid			Austerity is linked to rising mortality among older pensioners	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Loopstra R, 2016, J ROY SOC MED, V109, P109, DOI 10.1177/0141076816632215	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2016	352								i1534	10.1136/bmj.i1534	http://dx.doi.org/10.1136/bmj.i1534			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1ZX	26984159				2022-12-28	WOS:000372584800004
J	Butt, CA				Butt, Carrie A.			The Lost Felice Marsden Hartley	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1088	1089		10.1001/jama.2015.14164	http://dx.doi.org/10.1001/jama.2015.14164			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978193				2022-12-28	WOS:000372159800001
J	Christensen, R; Hart, LE				Christensen, Robin; Hart, Lawrence E.			Evidence-Based Guideline: ACR made 10 strong treatment recommendations for RA, but high-quality evidence was sparse	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Christensen, Robin] Parker Inst, Musculoskeletal Stat Unit, Copenhagen, Denmark; [Hart, Lawrence E.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Christensen, R (corresponding author), Parker Inst, Musculoskeletal Stat Unit, Copenhagen, Denmark.			Christensen, Robin/0000-0002-6600-0631				Alexander PE, 2016, J CLIN EPIDEMIOL, V70, P111, DOI 10.1016/j.jclinepi.2015.09.006; Christensen R, 2015, J RHEUMATOL, V42, P1737, DOI 10.3899/jrheum.150846; Neumann I, 2016, J CLIN EPIDEMIOL	3	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					JC27	JC27		10.7326/ACPJC-2016-164-6-027	http://dx.doi.org/10.7326/ACPJC-2016-164-6-027			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26974727				2022-12-28	WOS:000372207200002
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Resuscitation orders and reality	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION					davidoliver372@googlemail.com						Etheridge Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2640; Murray K., 2012, GUARDIAN; Resuscitation Council, 2016, CONS EM CAR TREATM P; Sokol DK, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i26; Tresch DD, 1998, EMERG MED CLIN N AM, V16, P649, DOI 10.1016/S0733-8627(05)70023-7; van Gijn MS, 2014, AGE AGEING, V43, P456, DOI 10.1093/ageing/afu035; Varney M., 2015, LEIGH DAY       0821	7	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2016	352								i1494	10.1136/bmj.i1494	http://dx.doi.org/10.1136/bmj.i1494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1ZT	26980294	Green Published, hybrid			2022-12-28	WOS:000372584400020
J	Phadke, VK; Bednarczyk, RA; Salmon, DA; Omer, SB				Phadke, Varun K.; Bednarczyk, Robert A.; Salmon, Daniel A.; Omer, Saad B.			Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States A Review of Measles and Pertussis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SCHOOL IMMUNIZATION REQUIREMENTS; DOMESTIC TERMINAL GATE; INTERNATIONAL AIRPORT; NONMEDICAL EXEMPTIONS; RELIGIOUS EXEMPTIONS; PARENTAL REFUSAL; WANING IMMUNITY; LARGE OUTBREAK; HEALTH-CARE; RISK	IMPORTANCE Parents hesitant to vaccinate their children may delay routine immunizations or seek exemptions from state vaccine mandates. Recent outbreaks of vaccine-preventable diseases in the United States have drawn attention to this phenomenon. Improved understanding of the association between vaccine refusal and the epidemiology of these diseases is needed. OBJECTIVE To review the published literature to evaluate the association between vaccine delay, refusal, or exemption and the epidemiology of measles and pertussis, 2 vaccine-preventable diseases with recent US outbreaks. EVIDENCE REVIEW Search of PubMed through November 30, 2015, for reports of US measles outbreaks that have occurred since measles was declared eliminated in the United States (after January 1, 2000), endemic and epidemic pertussis since the lowest point in US pertussis incidence (after January 1, 1977), and for studies that assessed disease risk in the context of vaccine delay or exemption. FINDINGS We identified 18 published measles studies (9 annual summaries and 9 outbreak reports), which described 1416 measles cases (individual age range, 2 weeks-84 years; 178 cases younger than 12 months) and more than half (56.8%) had no history of measles vaccination. Of the 970 measles cases with detailed vaccination data, 574 cases were unvaccinated despite being vaccine eligible and 405 (70.6%) of these had nonmedical exemptions (eg, exemptions for religious or philosophical reasons, as opposed to medical contraindications; 41.8% of total). Among 32 reports of pertussis outbreaks, which included 10 609 individuals for whom vaccination status was reported (age range, 10 days-87 years), the 5 largest statewide epidemics had substantial proportions (range, 24%-45%) of unvaccinated or undervaccinated individuals. However, several pertussis outbreaks also occurred in highly vaccinated populations, indicating waning immunity. Nine reports (describing 12 outbreaks) provided detailed vaccination data on unimmunized cases; among 8 of these outbreaks from 59% through 93% of unvaccinated individuals were intentionally unvaccinated. CONCLUSIONS AND RELEVANCE A substantial proportion of the US measles cases in the era after elimination were intentionally unvaccinated. The phenomenon of vaccine refusal was associated with an increased risk for measles among people who refuse vaccines and among fully vaccinated individuals. Although pertussis resurgence has been attributed to waning immunity and other factors, vaccine refusal was still associated with an increased risk for pertussis in some populations.	[Phadke, Varun K.] Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA; [Bednarczyk, Robert A.; Omer, Saad B.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Bednarczyk, Robert A.; Omer, Saad B.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Salmon, Daniel A.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Vaccine Safety, Baltimore, MD USA; [Omer, Saad B.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Omer, Saad B.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Emory University; Emory University; Rollins School Public Health	Omer, SB (corresponding author), Emory Univ, Rollins Sch Publ Hlth, 1518 Clifton Rd NE,Room 7017 CNR Bldg, Atlanta, GA 30322 USA.	somer@emory.edu	Bednarczyk, Robert/L-9403-2017	Bednarczyk, Robert/0000-0002-6812-0928; salmon, daniel/0000-0002-1035-4422	Emory Vaccinology Training Program of the National Institute of Allergy and Infectious Diseases [T32AI074492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074492] Funding Source: NIH RePORTER	Emory Vaccinology Training Program of the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by award T32AI074492 from the Emory Vaccinology Training Program of the National Institute of Allergy and Infectious Diseases (Dr Phadke).	Advisory Committee on Immunization Practices, REC IMM SCHED PERS A; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1348; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P1229; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; [Anonymous], 1985, JAMA-J AM MED ASSOC, V254, P600; Atwell JE, 2013, PEDIATRICS, V132, P624, DOI 10.1542/peds.2013-0878; Bandyopadhyay Ananda Sankar, 2013, R I Med J (2013), V96, P41; Banerjee E, 2015, MMWR-MORBID MORTAL W, V64, P679; Bass Joseph B Jr, 2013, N C Med J, V74, P420; BIELLIK RJ, 1988, J INFECT DIS, V157, P1134, DOI 10.1093/infdis/157.6.1134; Bradford WD, 2015, HEALTH AFFAIR, V34, P1383, DOI 10.1377/hlthaff.2014.1428; Brennan M, 2000, J INFECT DIS, V181, P210, DOI 10.1086/315192; BROOME CV, 1981, J PEDIATR-US, V98, P362, DOI 10.1016/S0022-3476(81)80696-8; Cantey JB, 2014, J PEDIATR-US, V164, P1489, DOI 10.1016/j.jpeds.2014.01.023; Centers for Disease Control and Prevention, MEASL CAS OUTBR; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P216; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P952; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P323; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P822; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P306; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1281; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P969; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P120; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P197; Centers for Disease Control and Prevention (CDC), 1993, MMWR-MORBID MORTAL W, V42, P959; Centers for Disease Control (CDC), 1983, MMWR Morb Mortal Wkly Rep, V32, P297; Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P522; Chen SY, 2011, J INFECT DIS, V203, P1517, DOI 10.1093/infdis/jir115; Cherry J D, 1984, Curr Probl Pediatr, V14, P1; CHRISTIE CDC, 1994, NEW ENGL J MED, V331, P16, DOI 10.1056/NEJM199407073310104; Clemmon NS, 2015, MMWR-MORBID MORTAL W, V64, P373; Coleman MS, 2012, VACCINE, V30, P317, DOI 10.1016/j.vaccine.2011.10.091; Collier MG, 2013, J PEDIAT INF DIS SOC, V2, P110, DOI 10.1093/jpids/pis132; DAVIS SF, 1995, CLIN INFECT DIS, V20, P621, DOI 10.1093/clinids/20.3.621; Dayan G., 2004, Morbidity and Mortality Weekly Report, V53, P713; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; DECKER MD, 1995, PEDIATRICS, V96, P557; Decker MD, 2013, VACCINES; Eggers P., 2006, Morbidity and Mortality Weekly Report, V55, P817; Elam-Evans LD, 2014, MMWR-MORBID MORTAL W, V63, P741; Eshofonie AO, 2015, J COMMUN HEALTH, V40, P88, DOI 10.1007/s10900-014-9902-2; ETKIND P, 1992, AM J DIS CHILD, V146, P173, DOI 10.1001/archpedi.1992.02160140039017; EY JL, 1991, PEDIATR INFECT DIS J, V10, P576, DOI 10.1097/00006454-199108000-00005; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; Feikin DR, 2000, JAMA-J AM MED ASSOC, V284, P3145, DOI 10.1001/jama.284.24.3145; Gahr P, 2014, PEDIATRICS, V134, pE220, DOI 10.1542/peds.2013-4260; Gao FX, 2014, J CLIN MICROBIOL, V52, P302, DOI 10.1128/JCM.01656-13; Gastanaduy PA, 2014, MMWR-MORBID MORTAL W, V63, P496; Glanz JM, 2013, JAMA PEDIATR, V167, P1060, DOI 10.1001/jamapediatrics.2013.2353; Glanz JM, 2011, VACCINE, V29, P994, DOI 10.1016/j.vaccine.2010.11.085; Glanz JM, 2010, ARCH PEDIAT ADOL MED, V164, P66, DOI 10.1001/archpediatrics.2009.244; Glanz JM, 2009, PEDIATRICS, V123, P1446, DOI 10.1542/peds.2008-2150; Gostin LO, 2015, JAMA-J AM MED ASSOC, V313, P1099, DOI 10.1001/jama.2015.1518; Green Michael, 2012, Morbidity and Mortality Weekly Report, V61, P30; Grigg M. A., 2008, Morbidity and Mortality Weekly Report, V57, P893; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Hamborsky J, 2015, MEASLES EPIDEMIOLOGY; Hassidim A., 2008, Morbidity and Mortality Weekly Report, V57, P203; Hill M, 2013, MMWR-MORBID MORTAL W, V62, P222; Hunt E., 2008, Morbidity and Mortality Weekly Report, V57, P169; Imdad A, 2013, PEDIATRICS, V132, P37, DOI 10.1542/peds.2012-3449; Katz SL, 2004, J INFECT DIS, V189, pS43, DOI 10.1086/377696; Kenyon TA, 1996, PEDIATR INFECT DIS J, V15, P655, DOI 10.1097/00006454-199608000-00004; Khan FN, 2006, PEDIATR INFECT DIS J, V25, P1132, DOI 10.1097/01.inf.0000245099.01427.93; Khetsuriani N, 2001, PEDIATR INFECT DIS J, V20, P1108, DOI 10.1097/00006454-200112000-00003; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Kodagoda Dulmini, 2012, Morbidity and Mortality Weekly Report, V61, P385; Koepke R, 2014, J INFECT DIS, V210, P942, DOI 10.1093/infdis/jiu322; Lavine J, 2010, VACCINE, V29, P11, DOI 10.1016/j.vaccine.2010.10.029; Liko J, 2014, CLIN INFECT DIS, V59, P261, DOI 10.1093/cid/ciu273; Lofgren J. P., 2004, Morbidity and Mortality Weekly Report, V53, P32; Majumder MS, 2015, JAMA PEDIATR, V169, P494, DOI 10.1001/jamapediatrics.2015.0384; Matthias J, 2014, MMWR-MORBID MORTAL W, V63, P655; McGirr A, 2015, PEDIATRICS, V135, P331, DOI 10.1542/peds.2014-1729; McLean Huong, 2012, Morbidity and Mortality Weekly Report, V61, P253; Medina-Marino A, 2013, J RURAL HEALTH, V29, P413, DOI 10.1111/jrh.12019; Misegades LK, 2012, JAMA-J AM MED ASSOC, V308, P2126, DOI 10.1001/jama.2012.14939; NKOWANE BM, 1986, AM J DIS CHILD, V140, P433, DOI 10.1001/archpedi.1986.02140190043021; Nyangoma EN, 2014, MMWR-MORBID MORTAL W, V63, P388; Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; Omer SB, 2012, NEW ENGL J MED, V367, P1170, DOI 10.1056/NEJMc1209037; Omer SB, 2008, AM J EPIDEMIOL, V168, P1389, DOI 10.1093/aje/kwn263; Rainbow J., 2009, Morbidity and Mortality Weekly Report, V58, P58; Rodgers L, 2013, CLIN INFECT DIS, V56, P322, DOI 10.1093/cid/cis888; Rosen JB, 2014, CLIN INFECT DIS, V58, P1205, DOI 10.1093/cid/ciu105; Salmon DA, 1999, JAMA-J AM MED ASSOC, V282, P47, DOI 10.1001/jama.282.1.47; Salmon DA, 2015, AM J PREV MED, V49, pS391, DOI 10.1016/j.amepre.2015.06.009; Schafer S, 2006, ARCH INTERN MED, V166, P1317, DOI 10.1001/archinte.166.12.1317; Slade Tania A, 2014, MMWR Morb Mortal Wkly Rep, V63, P781; Sotir MJ, 2008, ARCH PEDIAT ADOL MED, V162, P79, DOI 10.1001/archpediatrics.2007.7; Tartof SY, 2013, PEDIATRICS, V131, pE1047, DOI 10.1542/peds.2012-1928; Theofiles AG, 2014, MAYO CLIN PROC, V89, P1378, DOI 10.1016/j.mayocp.2014.08.004; Vega JS, 2014, MMWR-MORBID MORTAL W, V63, P1211; Versteegh FGA, 2002, ACTA PAEDIATR, V91, P95, DOI 10.1080/080352502753458030; Vichyanond P, 1985, Kans Med, V86, P52; Wallace G, 2013, MMWR-MORBID MORTAL W, V62, P741; Whitney CG, 2014, MMWR-MORBID MORTAL W, V63, P352; Winter K, 2014, MMWR-MORBID MORTAL W, V63, P1129; Winter K, 2012, J PEDIATR-US, V161, P1091, DOI 10.1016/j.jpeds.2012.05.041; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287; Woodfill C., 2007, Morbidity and Mortality Weekly Report, V56, P144; Yang YT, 2015, JAMA-J AM MED ASSOC, V314, P1229, DOI 10.1001/jama.2015.9579; Yang YT, 2015, JAMA-J AM MED ASSOC, V313, P247, DOI 10.1001/jama.2014.16286; Yang YT, 2014, AM J PUBLIC HEALTH, V104, P371, DOI 10.2105/AJPH.2013.301538; Zipprich J, 2015, MMWR-MORBID MORTAL W, V64, P153	105	387	393	4	116	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1149	1158		10.1001/jama.2016.1353	http://dx.doi.org/10.1001/jama.2016.1353			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978210	Green Accepted			2022-12-28	WOS:000372159800020
J	Levin, A; Harris, D; Remuzzi, G; Horton, R; Berman, P				Levin, Adeera; Harris, David; Remuzzi, Giuseppe; Horton, Richard; Berman, Philippa			The Lancet Kidney Campaign: an opportunity for partnerships	LANCET			English	Editorial Material							GLOBAL BURDEN; SYSTEMATIC ANALYSIS; RISK-FACTORS; 21 REGIONS; DISEASE; INJURY		[Levin, Adeera] Univ British Columbia, Fac Med, Div Nephrol, Vancouver, BC V6Z 1Y6, Canada; [Harris, David] Univ Sydney, Dept Nephrol, Westmead Hosp, Sydney, NSW 2006, Australia; [Remuzzi, Giuseppe] IRCCS, Ist Ric Farmacol Mario Negri, Bergamo, Italy; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Dept Med, Unit Nephrol & Dialysis, Bergamo, Italy; [Remuzzi, Giuseppe] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy; [Levin, Adeera; Harris, David; Remuzzi, Giuseppe] Int Soc Nephrol, Brussels, Belgium; [Horton, Richard; Berman, Philippa] The Lancet, London, England	University of British Columbia; University of Sydney; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII; University of Milan	Levin, A (corresponding author), Univ British Columbia, Fac Med, Div Nephrol, Vancouver, BC V6Z 1Y6, Canada.	alevin@providenchealth.bc.ca	Harris, David/W-4786-2019; Remuzzi, Giuseppe/V-9766-2017	Remuzzi, Giuseppe/0000-0002-6194-3446				Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Grams ME, 2013, AM J KIDNEY DIS, V62, P245, DOI 10.1053/j.ajkd.2013.03.009; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Palmer SC, 2011, AM J KIDNEY DIS, V58, P335, DOI 10.1053/j.ajkd.2011.06.006; Pauly Robert P, 2014, Can J Kidney Health Dis, V1, P11, DOI 10.1186/2054-3581-1-11; Ruggenenti P, 2001, LANCET, V357, P1601, DOI 10.1016/S0140-6736(00)04728-0; Sood Manish M, 2014, CMAJ Open, V2, pE36, DOI 10.9778/cmajo.20130050; Tonelli M, 2001, AM J KIDNEY DIS, V37, P484, DOI 10.1053/ajkd.2001.22070	14	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 12	2016	387	10023					1038	1039		10.1016/S0140-6736(16)00621-8	http://dx.doi.org/10.1016/S0140-6736(16)00621-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG0SD	26970719				2022-12-28	WOS:000371775000009
J	Ambrosetti, A; Ferri, N; DiStasio, RA; Tkatchenko, A				Ambrosetti, Alberto; Ferri, Nicola; DiStasio, Robert A., Jr.; Tkatchenko, Alexandre			Wavelike charge density fluctuations and van der Waals interactions at the nanoscale	SCIENCE			English	Article							GRAPHENE; SILICON; FORCES; SYSTEM	Recent experiments on noncovalent interactions at the nanoscale have challenged the basic assumptions of commonly used particle-or fragment-based models for describing van der Waals (vdW) or dispersion forces. We demonstrate that a qualitatively correct description of the vdW interactions between polarizable nanostructures over a wide range of finite distances can only be attained by accounting for the wavelike nature of charge density fluctuations. By considering a diverse set of materials and biological systems with markedly different dimensionalities, topologies, and polarizabilities, we find a visible enhancement in the nonlocality of the charge density response in the range of 10 to 20 nanometers. These collective wavelike fluctuations are responsible for the emergence of nontrivial modifications of the power laws that govern noncovalent interactions at the nanoscale.	[Ambrosetti, Alberto; Ferri, Nicola; Tkatchenko, Alexandre] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany; [Ambrosetti, Alberto] Univ Padua, Dipartimento Fis & Astron, I-35131 Padua, Italy; [DiStasio, Robert A., Jr.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Tkatchenko, Alexandre] Univ Luxembourg, Phys & Mat Sci Res Unit, L-1511 Luxembourg, Luxembourg	Max Planck Society; Fritz Haber Institute of the Max Planck Society; University of Padua; Cornell University; University of Luxembourg	Tkatchenko, A (corresponding author), Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany.; DiStasio, RA (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.; Tkatchenko, A (corresponding author), Univ Luxembourg, Phys & Mat Sci Res Unit, L-1511 Luxembourg, Luxembourg.	distasio@cornell.edu; alexandre.tkatchenko@uni.lu	Tkatchenko, Alexandre/E-7148-2011; Chu, Sai T/D-3312-2014	Tkatchenko, Alexandre/0000-0002-1012-4854; Chu, Sai T/0000-0001-8263-8507	Cornell University; European Research Council; HIOS project [DFG/SFB-951]; Office of Science of the U.S. Department of Energy [DE-AC02-06CH11357]	Cornell University; European Research Council(European Research Council (ERC)European Commission); HIOS project; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	Supported by a startup grant from Cornell University (R.A.D.), European Research Council Starting Grant VDW-CMAT, and DFG/SFB-951 HIOS project A10. A.A. thanks F. Toigo and P. L. Silvestrelli for useful discussions. This research used resources of the Argonne Leadership Computing Facility at Argonne National Laboratory, which is supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-06CH11357.	Ambrosetti A, 2014, J PHYS CHEM LETT, V5, P849, DOI 10.1021/jz402663k; Ambrosetti A, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4865104; APPLEQUIST J, 1979, J CHEM PHYS, V70, P1240, DOI 10.1063/1.437616; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; BADE WL, 1957, J CHEM PHYS, V27, P1280, DOI 10.1063/1.1743991; Batista CAS, 2015, SCIENCE, V350, P138, DOI 10.1126/science.1242477; Berland K, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/6/066501; BOSTRM M, 2000, Patent No. 612204; CHANG DB, 1971, PHYS LETT A, VA 37, P311, DOI 10.1016/0375-9601(71)90685-2; Dai JY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3272008; Denis PA, 2011, CHEM PHYS LETT, V508, P95, DOI 10.1016/j.cplett.2011.04.018; Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401; DiStasio RA, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/21/213202; DiStasio RA, 2012, P NATL ACAD SCI USA, V109, P14791, DOI 10.1073/pnas.1208121109; Dobson JF, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.073201; Dobson JF, 2014, INT J QUANTUM CHEM, V114, P1157, DOI 10.1002/qua.24635; Dobson JF, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021040; Donchev AG, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2337283; Ferri N, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.176802; Gao W, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.096101; Gobre VV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3341; Grimme S, 2011, WIRES COMPUT MOL SCI, V1, P211, DOI 10.1002/wcms.30; Jones AP, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.144103; LIFSHITZ EM, 1956, SOV PHYS JETP-USSR, V2, P73; LIS LJ, 1982, BIOPHYS J, V37, P667; Liu RF, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3563596; Loskill P, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0587; Loskill P, 2012, ADV COLLOID INTERFAC, V179, P107, DOI 10.1016/j.cis.2012.06.006; Misquitta AJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.045140; Misquitta AJ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075312; Parsegian V. A., 2006, VANDERWAALS FORCES H; Rance GA, 2010, ACS NANO, V4, P4920, DOI 10.1021/nn101287u; Reilly AM, 2015, CHEM SCI, V6, P3289, DOI 10.1039/c5sc00410a; Reilly AM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.055701; Reilly AM, 2013, J PHYS CHEM LETT, V4, P1028, DOI 10.1021/jz400226x; Rupp M, 2012, PHYS REV LETT, V108, DOI [10.1103/PhysRevLett.108.236402, 10.1103/PhysRevLett.108.058301]; Shtogun YV, 2010, J PHYS CHEM LETT, V1, P1356, DOI 10.1021/jz100309m; Stone A. J., 2013, THEORY INTERMOLECULA; Tao JM, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4897957; Tkatchenko A, 2015, ADV FUNCT MATER, V25, P2054, DOI 10.1002/adfm.201403029; Tkatchenko A, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4789814; Tkatchenko A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073005; Tsoi S, 2014, ACS NANO, V8, P12410, DOI 10.1021/nn5050905; Wagner C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6568	45	184	183	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1171	1176		10.1126/science.aae0509	http://dx.doi.org/10.1126/science.aae0509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965622	Green Published, Green Submitted			2022-12-28	WOS:000386158400039
J	Holliday, A; Grider, D				Holliday, Alex; Grider, Douglas			Tinea Versicolor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Holliday, Alex; Grider, Douglas] Carilion Clin, Roanoke, VA USA		Holliday, A (corresponding author), Carilion Clin, Roanoke, VA USA.	acholliday@gmail.com		Grider, Douglas/0000-0002-6346-094X					0	2	2	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					E11	E11		10.1056/NEJMicm1501201	http://dx.doi.org/10.1056/NEJMicm1501201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF9DH	26962748				2022-12-28	WOS:000371660000011
J	Manson, JE; Kaunitz, AM				Manson, Joann E.; Kaunitz, Andrew M.			Menopause Management - Getting Clinical Care Back on Track	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HORMONE-THERAPY		[Manson, Joann E.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA USA; [Kaunitz, Andrew M.] Univ Florida, Coll Med, Gainesville, FL 32611 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; State University System of Florida; University of Florida	Manson, JE (corresponding author), Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA USA.		Kaunitz, Andrew/AAL-8448-2020					Gass MLS, 2015, MENOPAUSE, V22, P1276, DOI 10.1097/GME.0000000000000553; Hsieh E, 2013, J WOMENS HEALTH, V22, P667, DOI 10.1089/jwh.2013.4264; Manson JE, 2013, JAMA-J AM MED ASSOC, V310, P1353, DOI 10.1001/jama.2013.278040; Santen RJ, 2014, J WOMENS HEALTH, V23, P281, DOI 10.1089/jwh.2014.4746; Stuenkel CA, 2015, J CLIN ENDOCR METAB, V100, P3975, DOI 10.1210/jc.2015-2236	5	121	127	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					803	806		10.1056/NEJMp1514242	http://dx.doi.org/10.1056/NEJMp1514242			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF2FT	26962899				2022-12-28	WOS:000371158400002
J	Zak, DE; Penn-Nicholson, A; Scriba, TJ; Thompson, E; Suliman, S; Amon, LM; Mahomed, H; Erasmus, M; Whatney, W; Hussey, GD; Abrahams, D; Kafaar, F; Hawkridge, T; Verver, S; Hughes, EJ; Ota, M; Sutherland, J; Howe, R; Dockrell, HM; Boom, WH; Thiel, B; Ottenhoff, THM; Mayanja-Kizza, H; Crampin, AC; Downing, K; Hatherill, M; Valvo, J; Shankar, S; Parida, SK; Kaufmann, SHE; Walzl, G; Aderem, A; Hanekom, WA				Zak, Daniel E.; Penn-Nicholson, Adam; Scriba, Thomas J.; Thompson, Ethan; Suliman, Sara; Amon, Lynn M.; Mahomed, Hassan; Erasmus, Mzwandile; Whatney, Wendy; Hussey, Gregory D.; Abrahams, Deborah; Kafaar, Fazlin; Hawkridge, Tony; Verver, Suzanne; Hughes, E. Jane; Ota, Martin; Sutherland, Jayne; Howe, Rawleigh; Dockrell, Hazel M.; Boom, W. Henry; Thiel, Bonnie; Ottenhoff, Tom H. M.; Mayanja-Kizza, Harriet; Crampin, Amelia C.; Downing, Katrina; Hatherill, Mark; Valvo, Joe; Shankar, Smitha; Parida, Shreemanta K.; Kaufmann, Stefan H. E.; Walzl, Gerhard; Aderem, Alan; Hanekom, Willem A.		ACS Cohort Study Grp; GC6-74 Cohort Study Grp	A blood RNA signature for tuberculosis disease risk: a prospective cohort study	LANCET			English	Article							GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; REACTIVATION; BIOMARKERS; INFECTION; SELECTION	Background Identification of blood biomarkers that prospectively predict progression of Mycobacterium tuberculosis infection to tuberculosis disease might lead to interventions that combat the tuberculosis epidemic. We aimed to assess whether global gene expression measured in whole blood of healthy people allowed identification of prospective signatures of risk of active tuberculosis disease. Methods In this prospective cohort study, we followed up healthy, South African adolescents aged 12-18 years from the adolescent cohort study (ACS) who were infected with M tuberculosis for 2 years. We collected blood samples from study participants every 6 months and monitored the adolescents for progression to tuberculosis disease. A prospective signature of risk was derived from whole blood RNA sequencing data by comparing participants who developed active tuberculosis disease (progressors) with those who remained healthy (matched controls). After adaptation to multiplex quantitative real-time PCR (qRT-PCR), the signature was used to predict tuberculosis disease in untouched adolescent samples and in samples from independent cohorts of South African and Gambian adult progressors and controls. Participants of the independent cohorts were household contacts of adults with active pulmonary tuberculosis disease. Findings Between July 6, 2005, and April 23, 2007, we enrolled 6363 participants from the ACS study and 4466 from independent South African and Gambian cohorts. 46 progressors and 107 matched controls were identified in the ACS cohort. A 16 gene signature of risk was identified. The signature predicted tuberculosis progression with a sensitivity of 66.1% (95% CI 63.2-68.9) and a specificity of 80.6% (79.2-82.0) in the 12 months preceding tuberculosis diagnosis. The risk signature was validated in an untouched group of adolescents (p= 0.018 for RNA sequencing and p= 0.0095 for qRT-PCR) and in the independent South African and Gambian cohorts (p values < 0.0001 by qRT-PCR) with a sensitivity of 53.7% (42.6-64.3) and a specificity of 82.8% (76.7-86) in the 12 months preceding tuberculosis. Interpretation The whole blood tuberculosis risk signature prospectively identified people at risk of developing active tuberculosis, opening the possibility for targeted intervention to prevent the disease.	[Zak, Daniel E.; Thompson, Ethan; Amon, Lynn M.; Valvo, Joe; Shankar, Smitha; Aderem, Alan] Ctr Infect Dis Res, Seattle, WA USA; [Penn-Nicholson, Adam; Scriba, Thomas J.; Suliman, Sara; Mahomed, Hassan; Erasmus, Mzwandile; Whatney, Wendy; Hussey, Gregory D.; Abrahams, Deborah; Kafaar, Fazlin; Hawkridge, Tony; Hughes, E. Jane; Downing, Katrina; Hatherill, Mark; Hanekom, Willem A.] Univ Cape Town, Inst Infect Dis & Mol Med, South African TB Vaccine Initiat, ZA-7925 Cape Town, South Africa; [Penn-Nicholson, Adam; Scriba, Thomas J.; Suliman, Sara; Mahomed, Hassan; Erasmus, Mzwandile; Whatney, Wendy; Hussey, Gregory D.; Abrahams, Deborah; Kafaar, Fazlin; Hawkridge, Tony; Hughes, E. Jane; Downing, Katrina; Hatherill, Mark; Hanekom, Willem A.] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa; [Verver, Suzanne] KNCV TB Fdn, The Hague, Netherlands; [Ota, Martin; Sutherland, Jayne] MRC Unit, Vaccines & Immun, Fajara, Gambia; [Howe, Rawleigh] Armauer Hansen Res Inst, Immunol Unit, Addis Ababa, Ethiopia; [Dockrell, Hazel M.; Crampin, Amelia C.] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Boom, W. Henry; Thiel, Bonnie] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA; [Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Mayanja-Kizza, Harriet] Makerere Univ, Dept Med, Kampala, Uganda; [Mayanja-Kizza, Harriet] Makerere Univ, Dept Microbiol, Kampala, Uganda; [Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi; [Parida, Shreemanta K.; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Walzl, Gerhard] Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, ZA-7505 Tygerberg, South Africa; [Walzl, Gerhard] Univ Stellenbosch, MRC Ctr TB Res, Div Mol Biol & Human Genet, ZA-7505 Tygerberg, South Africa	Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); University of Cape Town; University of Cape Town; KNCV Tuberculosis Foundation; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Case Western Reserve University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Makerere University; Makerere University; Malawi Epidemiology and Intervention Research Unit; Max Planck Society; National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University	Hanekom, WA (corresponding author), Bill & Melinda Gates Fdn, Seattle, WA 98102 USA.	willem.hanekom@gatesfoundation.org	van der Spuy, Gian/AAY-7701-2020; Mayanja-Kizza, Harriet/AAM-5372-2020; Scriba, Thomas/AAH-9413-2020; Scriba, Thomas/GPX-2573-2022; Joosten, Simone/E-4731-2011; Walzl, Gerhard/N-6371-2016	van der Spuy, Gian/0000-0002-9067-5903; Mayanja-Kizza, Harriet/0000-0002-9297-6208; Scriba, Thomas/0000-0002-0641-1359; Sutherland, Jayne/0000-0002-7083-4997; Hanekom, Willem/0000-0003-3070-6154; Parida, Shreemanta K/0000-0003-2129-6691; du Plessis, Nelita/0000-0001-7881-925X; Penn-Nicholson, Adam/0000-0002-1883-0059; Chegou, Novel N/0000-0002-8690-1699; Walzl, Gerhard/0000-0003-2487-125X; Joloba, Moses/0000-0002-0334-9983; Crampin, Amelia/0000-0002-1513-4330	Bill & Melinda Gates Foundation; National Institutes of Health; European Union; South African Medical Research Council; Aeras; MRC [MC_U190071468, MC_UP_A900_1122, MC_U190074190, MC_U190081991] Funding Source: UKRI; Medical Research Council [MC_U190071468, MC_U190074190, MC_U190081991, MC_UP_A900_1122] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087915] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Aeras; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Bill & Melinda Gates Foundation, the National Institutes of Health, Aeras, the European Union, and the South African Medical Research Council.	Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Bo TH, 2002, GENOME BIOL, V3; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Dorhoi A, 2014, EUR J IMMUNOL, V44, P2380, DOI 10.1002/eji.201344219; Gray JW, 2004, CLIN BIOCHEM, V37, P450, DOI 10.1016/j.clinbiochem.2004.03.003; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Joosten SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073230; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Mahomed H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059652; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; SADOH, 2014, NAT TUB MAN GUID; Shea KM, 2014, AM J EPIDEMIOL, V179, P216, DOI 10.1093/aje/kwt246; Shi P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-375; Sloot R, 2015, EBIOMEDICINE, V2, P172, DOI 10.1016/j.ebiom.2014.12.001; Sutherland JS, 2014, CLIN MICROBIOL INFEC, V20, pO230, DOI 10.1111/1469-0691.12383; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; World Health Organization, 2014, GLOB TUB REP; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	38	450	464	5	70	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2016	387	10035					2312	2322		10.1016/S0140-6736(15)01316-1	http://dx.doi.org/10.1016/S0140-6736(15)01316-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN3NN	27017310	Green Accepted, Bronze			2022-12-28	WOS:000376969100034
J	Borowsky, A; Esserman, L				Borowsky, Alexander; Esserman, Laura			When the Gold Standard Loses Its Luster, Perhaps It Is Time to Change Nomenclature	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARCINOMA IN-SITU; BREAST-CANCER; FOLLOW-UP		[Borowsky, Alexander] Univ Calif Davis, Davis, CA 95616 USA; [Esserman, Laura] UCSF Med Ctr, San Francisco, CA 94115 USA; [Borowsky, Alexander] Univ Calif Davis, Ctr Comparat Med, Cty Rd 98 & Hutchinson Dr, Davis, CA 95616 USA; [Esserman, Laura] UCSF Med Ctr, Dept Surg, 1600 Divisadero St,Box 1710, San Francisco, CA 94115 USA	University of California System; University of California Davis; University of California System; University of California San Francisco; UCSF Medical Center; University of California System; University of California Davis; University of California System; University of California San Francisco; UCSF Medical Center	Borowsky, A (corresponding author), Univ Calif Davis, Ctr Comparat Med, Cty Rd 98 & Hutchinson Dr, Davis, CA 95616 USA.	adborowsky@ucdavis.edu	Borowsky, Alexander D/S-5404-2017					Cuzick J, 2015, LANCET ONCOL, V16, P67, DOI 10.1016/S1470-2045(14)71171-4; Davidson NE, 2015, JAMA-J AM MED ASSOC, V313, P1109, DOI 10.1001/jama.2015.1945; Elmore JG, 2016, ANN INTERN MED, V164, P649, DOI 10.7326/M15-0964; Elmore JG, 2015, JAMA-J AM MED ASSOC, V314, P83, DOI 10.1001/jama.2015.6239; Esserman L, 2015, JAMA ONCOL, V1, P881, DOI 10.1001/jamaoncol.2015.2607; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Leonard G, 2015, JAMA-J AM MED ASSOC, V314, P82, DOI 10.1001/jama.2015.6224; Sagara Y, 2015, JAMA SURG, V150, P739, DOI 10.1001/jamasurg.2015.0876; Sanders ME, 2015, MODERN PATHOL, V28, P662, DOI 10.1038/modpathol.2014.141	9	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2016	164	10					694	+		10.7326/M16-0526	http://dx.doi.org/10.7326/M16-0526			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL8GF	26999728				2022-12-28	WOS:000375878500021
J	Chen, CF; Bickford, ME; Hirsch, JA				Chen, Chinfei; Bickford, Martha E.; Hirsch, Judith A.			Untangling the Web between Eye and Brain	CELL			English	Editorial Material							LATERAL GENICULATE-NUCLEUS; RECEPTIVE-FIELDS; INPUTS	How is the picture of the visual scene that the eye encodes represented by neural circuits in the brain? In this issue of Cell, Morgan et al. address this question by forming an ultrastructural "connectome'' of the mouse's visual thalamus that depicts individual retinal afferents and every contact these form with target relay cells.	[Chen, Chinfei] Harvard Univ, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Sch Med, 3 Blackfan Circle, Boston, MA 02115 USA; [Bickford, Martha E.] Univ Louisville, Dept Anat Sci & Neurobiol, Sch Med, 511 South Floyd St, Louisville, KY 40292 USA; [Hirsch, Judith A.] Univ So Calif, Dept Biol Sci, 3641 Watt Way, Los Angeles, CA 90089 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of Louisville; University of Southern California	Hirsch, JA (corresponding author), Univ So Calif, Dept Biol Sci, 3641 Watt Way, Los Angeles, CA 90089 USA.	jhirsch@usc.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013613, R01EY024173] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY013613, R01 EY024173] Funding Source: Medline; NICHD NIH HHS [U54 HD090255] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bickford ME, 2015, J NEUROSCI, V35, P10523, DOI 10.1523/JNEUROSCI.3375-14.2015; Dhande OS, 2011, J NEUROSCI, V31, P3384, DOI 10.1523/JNEUROSCI.4899-10.2011; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Martinez LM, 2014, NEURON, V81, P943, DOI 10.1016/j.neuron.2013.12.014; Morgan JL, 2016, CELL, V165, P192, DOI 10.1016/j.cell.2016.02.033; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Sincich LC, 2009, NAT NEUROSCI, V12, P967, DOI 10.1038/nn.2352; SUR M, 1987, J NEUROPHYSIOL, V58, P1	10	13	13	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					20	21		10.1016/j.cell.2016.03.010	http://dx.doi.org/10.1016/j.cell.2016.03.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015304	Green Accepted, Bronze			2022-12-28	WOS:000372785600006
J	Agarwal, S; LeFevre, AE; Lee, J; L'Engle, K; Mehl, G; Sinha, C; Labrique, A				Agarwal, Smisha; LeFevre, Amnesty E.; Lee, Jaime; L'Engle, Kelly; Mehl, Garrett; Sinha, Chaitali; Labrique, Alain		WHO mHlth Tech Evidence Review Grp	Guidelines for reporting of health interventions using mobile phones: mobile health (mHealth) evidence reporting and assessment (mERA) checklist	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY; FEASIBILITY; STATEMENT; WORKERS; LINE; TOOL	To improve the completeness of reporting of mobile health (mHealth) interventions, the WHO mHealth Technical Evidence Review Group developed the mHealth evidence reporting and assessment (mERA) checklist. The development process for mERA consisted of convening an expert group to recommend an appropriate approach, convening a global expert review panel for checklist development, and pilot testing the checklist. The guiding principle for the development of these criteria was to identify a minimum set of information needed to define what the mHealth intervention is (content), where it is being implemented (context), and how it was implemented (technical features), to support replication of the intervention. This paper presents the resulting 16 item checklist and a detailed explanation and elaboration for each item, with illustrative reporting examples. Through widespread adoption, we expect that the use of these guidelines will standardise the quality of mHealth evidence reporting, and indirectly improve the quality of mHealth evidence.	[Agarwal, Smisha; LeFevre, Amnesty E.; Lee, Jaime; Labrique, Alain] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Agarwal, Smisha; LeFevre, Amnesty E.; Lee, Jaime; Labrique, Alain] Johns Hopkins Univ, Global mHlth Initiat, Baltimore, MD USA; [Agarwal, Smisha] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [L'Engle, Kelly] Family Hlth Int 360, Durham, NC USA; [L'Engle, Kelly] Univ San Francisco, Sch Nursing & Hlth Profess, San Francisco, CA 94117 USA; [Mehl, Garrett] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland; [Sinha, Chaitali] Int Dev Res Ctr, Ottawa, ON, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of San Francisco; World Health Organization	Labrique, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.; Labrique, A (corresponding author), Johns Hopkins Univ, Global mHlth Initiat, Baltimore, MD USA.	alabriq1@jhu.edu	LeFevre, Amnesty E/A-3162-2019; Sinha, Chaitali/AGG-8363-2022	LeFevre, Amnesty E/0000-0001-8437-7240; Vasudevan, Lavanya/0000-0003-2900-6070; Agarwal, Smisha/0000-0002-7407-0066; Kallander, Karin/0000-0002-5778-5780; Labrique, Alain/0000-0003-2502-7819; Sinha, Chaitali/0000-0001-8682-8121	WHO Department of Reproductive Health and Research	WHO Department of Reproductive Health and Research	Support and funding for the development of the mERA checklist was received from the WHO Department of Reproductive Health and Research.	Agarwal S, 2015, TROP MED INT HEALTH, V20, P1003, DOI 10.1111/tmi.12525; Agarwal S, 2014, JAMA-J AM MED ASSOC, V312, P229, DOI 10.1001/jama.2014.6371; Andreatta P, 2011, INT J GYNECOL OBSTET, V113, P148, DOI 10.1016/j.ijgo.2010.11.020; [Anonymous], 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001395; Arsand Eirik, 2010, J Diabetes Sci Technol, V4, P328; Chaiyachati KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064662; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Dowshen N, 2013, AIDS BEHAV, V17, P2237, DOI 10.1007/s10461-013-0464-6; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1923; Gold J, 2011, SEX TRANSM DIS, V38, P247, DOI 10.1097/OLQ.0b013e3181f68d7b; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Husereau D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-80; Jamison JC, 2013, MIXED METHOD EVALUAT; L'Engle KL, 2013, CONTRACEPTION, V87, P251, DOI 10.1016/j.contraception.2012.07.009; Lemay NV, 2012, J HEALTH COMMUN, V17, P105, DOI 10.1080/10810730.2011.649106; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Ngabo F, 2012, PAN AFR MED J, V13; Patrick K, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1100; Qiang CZ, 2011, MOBILE APPL HLTH SEC; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Stockwell MS, 2012, JAMA-J AM MED ASSOC, V307, P1702, DOI 10.1001/jama.2012.502; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; Tomlinson M, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-51; Vahdat Heather L, 2013, Int J Gynaecol Obstet, V123 Suppl 1, pe2, DOI 10.1016/j.ijgo.2013.07.009; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Zurovac D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052045	30	279	288	5	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2016	352								i1174\	10.1136/bmj.i1174	http://dx.doi.org/10.1136/bmj.i1174			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AD	26988021	Bronze, Green Published			2022-12-28	WOS:000372585400001
J	Dancel, R; Shaban, M				Dancel, Ria; Shaban, Mona			Froin's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dancel, Ria; Shaban, Mona] Univ N Carolina, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill	Dancel, R (corresponding author), Univ N Carolina, Chapel Hill, NC USA.	ria.dancel@unchealth.unc.edu		Dancel, Ria/0000-0003-4269-770X					0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1076	1076		10.1056/NEJMicm1509557	http://dx.doi.org/10.1056/NEJMicm1509557			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4TR	26981937				2022-12-28	WOS:000372066100012
J	DeWeerdt, S				DeWeerdt, Sarah			MOBILITY The urban downshift	NATURE			English	Editorial Material							NEIGHBORHOOD WALKABILITY; AIR-POLLUTION; ENVIRONMENTS											Chiu M, 2016, ENVIRON HEALTH PERSP, V124, P754, DOI 10.1289/ehp.1510425; James P, 2015, ENVIRON RES, V142, P703, DOI 10.1016/j.envres.2015.09.005; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Menec VH, 2016, J AGING HEALTH, V28, P546, DOI 10.1177/0898264315597352; Saelens BE, 2012, AM J PREV MED, V42, pE57, DOI 10.1016/j.amepre.2012.02.008; Steinmetz-Wood M, 2015, PREV MED, V81, P262, DOI 10.1016/j.ypmed.2015.09.008; Van Cauwenberg J, 2016, HEALTH PLACE, V37, P16, DOI 10.1016/j.healthplace.2015.11.003	7	13	13	3	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S52	S53		10.1038/531S52a	http://dx.doi.org/10.1038/531S52a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26981727	Bronze			2022-12-28	WOS:000372064300001
J	Smith, DA				Smith, Donald A.			In adults without CVD, the MESA score, including coronary artery calcium, predicted 10-y risk for CHD events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Smith, Donald A.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Smith, DA (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Baber U, 2015, J AM COLL CARDIOL, V65, P1065, DOI 10.1016/j.jacc.2015.01.017; Nasir K, 2015, J AM COLL CARDIOL, V66, P1657, DOI 10.1016/j.jacc.2015.07.066; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	3	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					JC35	JC35		10.7326/ACPJC-2016-164-6-035	http://dx.doi.org/10.7326/ACPJC-2016-164-6-035			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26974735				2022-12-28	WOS:000372207200010
J	Wen, L				Wen, Louise			Meeting the Organ Donor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wen, Louise] Stanford Univ Hosp & Clin, Dept Anesthesiol Perioperat & Pain Med, Palo Alto, CA USA	Stanford University	Wen, L (corresponding author), Stanford Univ Hosp & Clin, Dept Anesthesiol Perioperat & Pain Med, Palo Alto, CA USA.	louiseywen@gmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1111	1112		10.1001/jama.2015.18357	http://dx.doi.org/10.1001/jama.2015.18357			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978203				2022-12-28	WOS:000372159800013
J	Hibbett, D				Hibbett, David			The invisible dimension of fungal diversity	SCIENCE			English	Editorial Material							REVEALS		[Hibbett, David] Clark Univ, Dept Biol, Worcester, MA 01610 USA	Clark University	Hibbett, D (corresponding author), Clark Univ, Dept Biol, Worcester, MA 01610 USA.	dhibbett@clarku.edu						Davison J, 2015, SCIENCE, V349, P970, DOI 10.1126/science.aab1161; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Jones MDM, 2011, NATURE, V474, P200, DOI 10.1038/nature09984; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lazarus KL, 2015, FUNGAL ECOL, V14, P62, DOI 10.1016/j.funeco.2014.11.004; Menkis A, 2014, FUNGAL BIOL-UK, V118, P943, DOI 10.1016/j.funbio.2014.08.005; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Taylor DL, 2014, ECOL MONOGR, V84, P3, DOI 10.1890/12-1693.1; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688	10	53	56	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1150	1151		10.1126/science.aae0380	http://dx.doi.org/10.1126/science.aae0380			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965611				2022-12-28	WOS:000386158400025
J	Agrawal, S; Brown, D				Agrawal, Shantanu; Brown, Douglas			The Physician Payments Sunshine Act - Two Years of the Open Payments Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Agrawal, Shantanu; Brown, Douglas] Ctr Med & Medicaid Serv, Washington, DC USA		Agrawal, S (corresponding author), Ctr Med & Medicaid Serv, Washington, DC USA.							Accreditation Council for Continuing Medical Education (ACCME), 2013, ANN REP EX SUMM; Agrawal S, 2013, NEW ENGL J MED, V368, P2054, DOI 10.1056/NEJMp1303523; Lo B, 2009, CONFLICT INTEREST ME; MEDPAC, 2008, REP C REF DEL SYST	4	71	71	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					906	909		10.1056/NEJMp1509103	http://dx.doi.org/10.1056/NEJMp1509103			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF9DH	26962725				2022-12-28	WOS:000371660000003
J	Karsenty, G; Olson, EN				Karsenty, Gerard; Olson, Eric N.			Bone and Muscle Endocrine Functions: Unexpected Paradigms of Inter-organ Communication	CELL			English	Review							SYMPATHETIC-NERVOUS-SYSTEM; NATRIURETIC PEPTIDE; SKELETAL-MUSCLE; ENERGY-METABOLISM; LEPTIN REGULATION; DEFICIENT MICE; BROWN FAT; TGF-BETA; OSTEOCALCIN; MASS	Most physiological functions originate with the communication between organs. Mouse genetics has revived this holistic view of physiology through the identification of inter-organ communications that are unanticipated, functionally important, and would have been difficult to uncover otherwise. This Review highlights this point by showing how two tissues usually not seen as endocrine ones, bone and striated muscles, influence several physiological processes in a significant manner.	[Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, Coll Phys & Surg, New York, NY 10032 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Karsenty, G (corresponding author), Columbia Univ, Dept Genet & Dev, Coll Phys & Surg, New York, NY 10032 USA.	gk2172@cumc.columbia.edu		Karsenty, Gerard/0000-0002-9253-7627	NIA; NIDDK; NIAMS; NIH [HL-077439, HL-111665, HL-093039, DK-099653, U01-HL-100401]; Fondation Leducq Networks of Excellence; Robert A. Welch Foundation [1-0025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077439, R01HL111665, R01HL093039, U01HL100401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104727, R01DK099653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG049681, P01AG032959] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq Networks of Excellence; Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Ducy, M. Ferron, and S. Kousteni for critical reading of the manuscript. G.K. is a Senior Scholar in Aging from the Lawrence Ellison Foundation. Work in the G.K. lab is supported by grants from the NIA, NIDDK, and NIAMS; work in the E.N.O. lab is supported by grants from the NIH (HL-077439, HL-111665, HL-093039, DK-099653, and U01-HL-100401), Fondation Leducq Networks of Excellence, and the Robert A. Welch Foundation (grant 1-0025 to E.N.O.).	Baskin KK, 2015, CELL METAB, V21, P237, DOI 10.1016/j.cmet.2014.12.021; Baskin KK, 2014, EMBO MOL MED, V6, P1610, DOI 10.15252/emmm.201404218; Baskin KK, 2014, EMBO MOL MED, V6, P436, DOI 10.1002/emmm.201303800; Benatti FB, 2015, NAT REV RHEUMATOL, V11, P86, DOI 10.1038/nrrheum.2014.193; Birkenfeld AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043238; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Buehring B, 2013, CURR OSTEOPOROS REP, V11, P407, DOI 10.1007/s11914-013-0160-5; Chen W, 2011, SEMIN CELL DEV BIOL, V22, P749, DOI 10.1016/j.semcdb.2011.07.026; Collins S, 2014, NAT REV ENDOCRINOL, V10, P157, DOI 10.1038/nrendo.2013.234; Collins S, 2013, ADIPOCYTE, V2, P104, DOI 10.4161/adip.22515; Dankbar B, 2015, NAT MED, V21, P1085, DOI 10.1038/nm.3917; Doroudgar S, 2011, TRENDS MOL MED, V17, P207, DOI 10.1016/j.molmed.2010.12.003; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Engeli S, 2012, J CLIN INVEST, V122, P4675, DOI 10.1172/JCI64526; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Ferron M, 2015, J CELL BIOL, V208, P761, DOI 10.1083/jcb.201409111; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fukumoto S, 2011, J BONE MINER METAB, V29, P507, DOI 10.1007/s00774-011-0298-0; Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029; GUNDBERG CM, 1985, J CLIN ENDOCR METAB, V60, P736, DOI 10.1210/jcem-60-4-736; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Kajimura D, 2013, CELL METAB, V17, P901, DOI 10.1016/j.cmet.2013.04.009; Kondo E, 2015, ENDOCRINOLOGY, V156, P2518, DOI 10.1210/en.2014-1801; Lee JH, 2014, P NATL ACAD SCI USA, V111, P9491, DOI 10.1073/pnas.1409427111; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; LIAN JB, 1978, FED PROC, V37, P2615; Fernandez-Real JM, 2009, J CLIN ENDOCR METAB, V94, P237, DOI 10.1210/jc.2008-0270; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; MORGAN JM, 1974, ARCH INTERN MED, V134, P549, DOI 10.1001/archinte.134.3.549; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Nakao K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10554; Olney RC, 2015, J CLIN ENDOCR METAB, V100, pE355, DOI 10.1210/jc.2014-2814; Oury F, 2013, CELL, V155, P228, DOI 10.1016/j.cell.2013.08.042; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JCI65952; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Pivovarova O, 2012, J CLIN ENDOCR METAB, V97, pE731, DOI 10.1210/jc.2011-2839; Rai M, 2016, ANNU REV PHYSIOL, V78, P85, DOI 10.1146/annurev-physiol-021115-105305; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Sabek OM, 2015, ENDOCRINOLOGY, V156, P3137, DOI 10.1210/EN.2015-1143; Sartori R, 2014, TRENDS ENDOCRIN MET, V25, P464, DOI 10.1016/j.tem.2014.06.002; Shimano M, 2012, CIRCULATION, V126, pE327, DOI 10.1161/CIRCULATIONAHA.112.150656; Singh R, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00060; Tagliaferri C, 2015, AGEING RES REV, V21, P55, DOI 10.1016/j.arr.2015.03.002; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; Whittle AJ, 2012, J CLIN INVEST, V122, P804, DOI 10.1172/JCI62595; Woods A, 2007, ENDOCRINOLOGY, V148, P5030, DOI 10.1210/en.2007-0695; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yamada-Goto N, 2013, DIABETES, V62, P1500, DOI 10.2337/db12-0718	59	149	156	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1248	1256		10.1016/j.cell.2016.02.043	http://dx.doi.org/10.1016/j.cell.2016.02.043			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967290	Bronze, Green Accepted			2022-12-28	WOS:000372784900021
J	Namana, V; Balasubramanian, R				Namana, Vinod; Balasubramanian, Ram			Right Ventricular Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Namana, Vinod; Balasubramanian, Ram] Maimonides Hosp, New York, NY USA	Maimonides Medical Center	Namana, V (corresponding author), Maimonides Hosp, New York, NY USA.	vnamana@maimonidesmed.org							0	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					872	872		10.1056/NEJMicm1504379	http://dx.doi.org/10.1056/NEJMicm1504379			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF2FT	26962906				2022-12-28	WOS:000371158400011
J	Rodrigues, LC				Rodrigues, Laura C.			Microcephaly and Zika virus infection	LANCET			English	Editorial Material							BRAZIL		[Rodrigues, Laura C.] Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England; [Rodrigues, Laura C.] MERG, Recife, PE, Brazil	University of London; London School of Hygiene & Tropical Medicine	Rodrigues, LC (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.; Rodrigues, LC (corresponding author), MERG, Recife, PE, Brazil.	laura.rodrigues@lshtm.ac.uk	RODRIGUES, LAURA CUNHA/AAO-4130-2021		Medical Research Council [MC_PC_15088] Funding Source: Medline; MRC [MC_PC_15088] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Centre D'Hygiene et de Salubrite Publique, 2015, NOT INV AUT MALF CER; Centro de Operacoes de Emergencias em Saude Publica Sobre Microcefalias, 2016, INF EP 15 SEM EP SE; John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033; Mallet HP, 2015, BISES B INFORM SANIT, V13, P1; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113; Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7; World Health Organization, 2016, WHO DIR GEN SUMM OUT	11	46	47	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 21	2016	387	10033					2070	2072		10.1016/S0140-6736(16)00742-X	http://dx.doi.org/10.1016/S0140-6736(16)00742-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM6HC	26993880	Bronze			2022-12-28	WOS:000376450800008
J	Ferreira, GS; Steinberg, MB				Ferreira, Gabriela S.; Steinberg, Michael B.			Going Slow May Not Be Best When Quitting Smoking	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INCLUDING PREGNANT-WOMEN; PHARMACOTHERAPY INTERVENTIONS; CESSATION; ADULTS; ABRUPT		[Ferreira, Gabriela S.; Steinberg, Michael B.] Rutgers Robert Wood Johnson Med Sch, Div Gen Internal Med, 125 Paterson St,Suite 2300, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Steinberg, MB (corresponding author), Rutgers Robert Wood Johnson Med Sch, Div Gen Internal Med, 125 Paterson St,Suite 2300, New Brunswick, NJ 08903 USA.	michael.steinberg@rutgers.edu						Cheong Y, 2007, NICOTINE TOB RES, V9, P801, DOI 10.1080/14622200701484961; Hughes JR, 2010, DRUG ALCOHOL DEPEN, V111, P105, DOI 10.1016/j.drugalcdep.2010.04.007; Lindson-Hawley N, 2016, ANN INTERN MED, V164, P585, DOI 10.7326/M14-2805; Lindson-Hawley N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008033.pub3; Patnode CD, 2015, ANN INTERN MED, V163, P608, DOI 10.7326/M15-0171; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000124.pub2; Tobacco Use and Dependence Guideline Panel, 2008, TREATING TOBACCO USE; West R., 2012, SMOKING SMOKING CESS	9	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					622	+		10.7326/M16-0362	http://dx.doi.org/10.7326/M16-0362			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	26974591				2022-12-28	WOS:000375744000025
J	Baker, JA; Avorn, J; Levin, R; Bateman, BT				Baker, James A.; Avorn, Jerry; Levin, Raisa; Bateman, Brian T.			Opioid Prescribing After Surgical Extraction of Teeth in Medicaid Patients, 2000-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Baker, James A.; Avorn, Jerry; Levin, Raisa; Bateman, Brian T.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital	Bateman, BT (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.; Bateman, BT (corresponding author), Harvard Univ, Sch Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	bbateman@partners.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075831] Funding Source: NIH RePORTER; NICHD NIH HHS [K08 HD075831, K08HD075831] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Centers for Disease Control and Prevention, 1999, VIT SIGNS OV PRESCR; *CTR MED MED SERV, MED DAT SOURC GEN IN; Han B, 2015, JAMA-J AM MED ASSOC, V314, P1468, DOI 10.1001/jama.2015.11859; Moore PA, 2013, J AM DENT ASSOC, V144, P898, DOI 10.14219/jada.archive.2013.0207; Mutlu I, 2013, J ORAL MAXIL SURG, V71, P1500, DOI 10.1016/j.joms.2013.04.031; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401	6	48	50	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15					1653	1654		10.1001/jama.2015.19058	http://dx.doi.org/10.1001/jama.2015.19058			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5ZK	26978601	Green Accepted, Bronze			2022-12-28	WOS:000374289300025
J	Kondoh, K; Lu, ZH; Ye, XL; Olson, DP; Lowell, BB; Buck, LB				Kondoh, Kunio; Lu, Zhonghua; Ye, Xiaolan; Olson, David P.; Lowell, Bradford B.; Buck, Linda B.			A specific area of olfactory cortex involved in stress hormone responses to predator odours	NATURE			English	Article							GABAERGIC NEURONS; ORGANIZATION; EXPRESSION; EPITHELIUM; RECEPTORS; PROTEIN; BULB; INFORMATION; INNATE; FAMILY	Instinctive reactions to danger are critical to the perpetuation of species and are observed throughout the animal kingdom. The scent of predators induces an instinctive fear response in mice that includes behavioural changes, as well as a surge in blood stress hormones that mobilizes multiple body systems to escape impending danger(1,2). How the olfactory system routes predator signals detected in the nose to achieve these effects is unknown. Here we identify a specific area of the olfactory cortex in mice that induces stress hormone responses to volatile predator odours. Using monosynaptic and polysynaptic viral tracers, we found that multiple olfactory cortical areas transmit signals to hypothalamic corticotropin-releasing hormone (CRH) neurons, which control stress hormone levels. However, only one minor cortical area, the amygdalo-piriform transition area (AmPir), contained neurons upstream of CRH neurons that were activated by volatile predator odours. Chemogenetic stimulation of AmPir activated CRH neurons and induced an increase in blood stress hormones, mimicking an instinctive fear response. Moreover, chemogenetic silencing of AmPir markedly reduced the stress hormone response to predator odours without affecting a fear behaviour. These findings suggest that AmPir, a small area comprising < 5% of the olfactory cortex, plays a key part in the hormonal component of the instinctive fear response to volatile predator scents.	[Kondoh, Kunio; Lu, Zhonghua; Ye, Xiaolan; Buck, Linda B.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Howard Hughes Med Inst, 1100 Fairview Ave North, Seattle, WA 98109 USA; [Olson, David P.; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA; [Olson, David P.; Lowell, Bradford B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Olson, David P.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan	Buck, LB (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Howard Hughes Med Inst, 1100 Fairview Ave North, Seattle, WA 98109 USA.	lbuck@fhcrc.org	Core, Vector/CAF-4832-2022	Kondoh, Kunio/0000-0002-1139-328X	Howard Hughes Medical Institute (HHMI); National Institutes of Health (National Institute on Deafness and Other Communication Disorders); Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075632, P30DK057521, K08DK071561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015032] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); National Institutes of Health (National Institute on Deafness and Other Communication Disorders)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank L. Enquist for providing the parental PRV, PRV TK-BaBlu, and for helpful advice, and members of the Buck laboratory for discussions and comments. This work was supported by the Howard Hughes Medical Institute (HHMI) and by grants from the National Institutes of Health (National Institute on Deafness and Other Communication Disorders) (L.B.B.) and the Japan Society for the Promotion of Science (K.K.). L.B.B. is an Investigator of the HHMI.	Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Banfield Bruce W., 2009, V515, P227, DOI 10.1007/978-1-59745-559-6_15; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2012, PRINCIPLES NEUROSCIE, P712; Card J P, 2001, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0105s09; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Gorski JA, 2002, J NEUROSCI, V22, P6309; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hanchate NK, 2015, SCIENCE, V350, P1251, DOI 10.1126/science.aad2456; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Matsukawa M, 2011, BRAIN RES, V1381, P117, DOI 10.1016/j.brainres.2011.01.053; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Neville K.R., 2004, SYNAPTIC ORG BRAIN, P415, DOI DOI 10.1093/ACPR0F:0S0/9780195159561.003.0010; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Root CM, 2014, NATURE, V515, P269, DOI 10.1038/nature13897; SAWCHENKO PE, 1983, J COMP NEUROL, V218, P121, DOI 10.1002/cne.902180202; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Takahashi LK, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00072; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vernet-Maury E., 1980, OLFACTION TASTE, P407; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028	35	83	85	6	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					103	+		10.1038/nature17156	http://dx.doi.org/10.1038/nature17156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27001694	Green Accepted			2022-12-28	WOS:000373555500042
J	Zalocusky, KA; Ramakrishnan, C; Lerner, TN; Davidson, TJ; Knutson, B; Deisseroth, K				Zalocusky, Kelly A.; Ramakrishnan, Charu; Lerner, Talia N.; Davidson, Thomas J.; Knutson, Brian; Deisseroth, Karl			Nucleus accumbens D2R cells signal prior outcomes and control risky decision-making	NATURE			English	Article							ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; DOPAMINE; REINFORCEMENT; DISTINCT; PREFERENCES; UNCERTAINTY; ACTIVATION; SELECTION; BEHAVIOR	A marked bias towards risk aversion has been observed in nearly every species tested(1-4). A minority of individuals, however, instead seem to prefer risk (repeatedly choosing uncertain large rewards over certain but smaller rewards), and even risk-averse individuals sometimes opt for riskier alternatives(2,5). It is not known how neural activity underlies such important shifts in decision-making-either as a stable trait across individuals or at the level of variability within individuals. Here we describe a model of risk-preference in rats, in which stable individual differences, trial-by-trial choices, and responses to pharmacological agents all parallel human behaviour. By combining new genetic targeting strategies with optical recording of neural activity during behaviour in this model, we identify relevant temporally specific signals from a genetically and anatomically defined population of neurons. This activity occurred within dopamine receptor type-2 (D2R)-expressing cells in the nucleus accumbens (NAc), signalled unfavourable outcomes from the recent past at a time appropriate for influencing subsequent decisions, and also predicted subsequent choices made. Having uncovered this naturally occurring neural correlate of risk selection, we then mimicked the temporally specific signal with optogenetic control during decision-making and demonstrated its causal effect in driving risk-preference. Specifically, risk-preferring rats could be instantaneously converted to risk-averse rats with precisely timed phasic stimulation of NAc D2R cells. These findings suggest that individual differences in risk-preference, as well as real-time risky decision-making, can be largely explained by the encoding in D2R-expressing NAc cells of prior unfavourable outcomes during decision-making.	[Zalocusky, Kelly A.; Ramakrishnan, Charu; Lerner, Talia N.; Davidson, Thomas J.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Zalocusky, Kelly A.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Zalocusky, Kelly A.; Ramakrishnan, Charu; Lerner, Talia N.; Davidson, Thomas J.; Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Knutson, Brian] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, CNC Program, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	deissero@stanford.edu	Lerner, Talia/AAB-5439-2020; Lerner, Talia/AGW-7812-2022	Lerner, Talia/0000-0002-3875-0654; Knutson, Brian/0000-0002-7669-426X	Deisseroth laboratory; Stanford University Neurosciences Program; NSF Graduate Research Fellowship Program; Stanford Neurosciences Program NIH Training Grant; NRSA Predoctoral Fellowship from NIDA [1F31MH105151-01]; Stanford Dean's Postdoctoral Fellowship; NRSA Postdoctoral Fellowship [1F32MH105053-01]; Stanford Neuroscience Institute Big Ideas Grant; NIMH; NIDA; NSF; Wiegers Family Fund; Nancy and James Grosfeld Foundation; H.L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund; US Army Research Laboratory; Defense Advanced Research Projects Agency [W911NF-14-2-0013]	Deisseroth laboratory; Stanford University Neurosciences Program; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Stanford Neurosciences Program NIH Training Grant; NRSA Predoctoral Fellowship from NIDA; Stanford Dean's Postdoctoral Fellowship; NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Neuroscience Institute Big Ideas Grant; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NSF(National Science Foundation (NSF)); Wiegers Family Fund; Nancy and James Grosfeld Foundation; H.L. Snyder Medical Foundation; Samuel and Betsy Reeves Fund; US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We would like to thank R. Malenka and K. Shenoy for advice on experimental design; A. Andalman for advice on analysis; P. Kalanithi for advice in general; E. Ferenczi, C. Foldy, G. Panagiotakos, M. Bennett, A. Bryant, C. Beinat, and M. Palner for preliminary data collection and training in experimental techniques; S. Pak and C. Delacruz for administrative support; and the entire Deisseroth laboratory and Stanford University Neurosciences Program for training and support. All viruses were packaged at the Stanford Viral and Vector Core. K.A.Z. was supported by the NSF Graduate Research Fellowship Program, by the Stanford Neurosciences Program NIH Training Grant, and by an NRSA Predoctoral Fellowship from NIDA (1F31MH105151-01). T.N.L. was supported by a Stanford Dean's Postdoctoral Fellowship and by an NRSA Postdoctoral Fellowship (1F32MH105053-01). B.K. was supported by a Stanford Neuroscience Institute Big Ideas Grant. K.D. was supported by NIMH, NIDA, NSF, the Wiegers Family Fund, the Nancy and James Grosfeld Foundation, the H.L. Snyder Medical Foundation, the Samuel and Betsy Reeves Fund, and the US Army Research Laboratory and Defense Advanced Research Projects Agency (Cooperative Agreement Number W911NF-14-2-0013); nothing in this material represents official views or policies of our funders. All clones and resources are freely available (http://optogenetics.org, http://clarityresourcecenter.org).	BARKAN CPL, 1990, ECOLOGY, V71, P391, DOI 10.2307/1940276; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; CARACO T, 1980, ANIM BEHAV, V28, P820, DOI 10.1016/S0003-3472(80)80142-4; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Dodd ML, 2005, ARCH NEUROL-CHICAGO, V62, P1377, DOI 10.1001/archneur.62.9.noc50009; Dreyer JK, 2010, J NEUROSCI, V30, P14273, DOI 10.1523/JNEUROSCI.1894-10.2010; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hayden BY, 2009, ANIM COGN, V12, P201, DOI 10.1007/s10071-008-0186-8; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KEBABIAN JW, 1992, EUR J PHARMACOL, V229, P203, DOI 10.1016/0014-2999(92)90556-J; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Kopec CD, 2015, NEURON, V88, P367, DOI 10.1016/j.neuron.2015.08.033; Leong JK, 2016, NEURON, V89, P63, DOI 10.1016/j.neuron.2015.12.015; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; MINOWA T, 1992, BIOCHEMISTRY-US, V31, P8389, DOI 10.1021/bi00151a001; Nasrallah NA, 2011, P NATL ACAD SCI USA, V108, P5466, DOI 10.1073/pnas.1017732108; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; O'Neill M, 2010, NEURON, V68, P789, DOI 10.1016/j.neuron.2010.09.031; Porter-Stransky KA, 2013, EUR J NEUROSCI, V38, P2572, DOI 10.1111/ejn.12253; REAL LA, 1981, ECOLOGY, V62, P20, DOI 10.2307/1936663; Schultz W, 2008, PHILOS T R SOC B, V363, P3801, DOI 10.1098/rstb.2008.0152; St Onge JR, 2011, J NEUROSCI, V31, P8625, DOI 10.1523/JNEUROSCI.1020-11.2011; St Onge JR, 2009, NEUROPSYCHOPHARMACOL, V34, P681, DOI 10.1038/npp.2008.121; Stopper CM, 2014, NEURON, V84, P177, DOI 10.1016/j.neuron.2014.08.033; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; van Eimeren T, 2009, NEUROPSYCHOPHARMACOL, V34, P2758, DOI [10.1038/sj.npp.npp2009124, 10.1038/npp.2009.124]; Winstanley CA, 2005, NEUROPSYCHOPHARMACOL, V30, P669, DOI 10.1038/sj.npp.1300610; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028	35	121	123	3	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					642	+		10.1038/nature17400	http://dx.doi.org/10.1038/nature17400			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH8EX	27007845	Green Accepted			2022-12-28	WOS:000373027400039
J	Chan, WP; Chen, IC; Colwell, RK; Liu, WC; Huang, CY; Shen, SF				Chan, Wei-Ping; Chen, I-Ching; Colwell, Robert K.; Liu, Wei-Chung; Huang, Cho-ying; Shen, Sheng-Feng			Seasonal and daily climate variation have opposite effects on species elevational range size	SCIENCE			English	Article							THERMAL TOLERANCE; RAPOPORTS RULE; MOUNTAIN PASSES; TEMPERATURE; LATITUDE; GRADIENT	The climatic variability hypothesis posits that the magnitude of climatic variability increases with latitude, elevation, or both, and that greater variability selects for organisms with broader temperature tolerances, enabling them to be geographically widespread. We tested this classical hypothesis for the elevational range sizes of more than 16,500 terrestrial vertebrates on 180 montane gradients. In support of the hypothesis, mean elevational range size was positively correlated with the scope of seasonal temperature variation, whereas elevational range size was negatively correlated with daily temperature variation among gradients. In accordance with a previous life history model and our extended versions of it, our findings indicate that physiological specialization may be favored under shorter-term climatic variability.	[Chan, Wei-Ping; Chen, I-Ching; Shen, Sheng-Feng] Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan; [Chen, I-Ching] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Colwell, Robert K.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Colwell, Robert K.] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Colwell, Robert K.] Univ Fed Goias, Dept Ecol, CP 131, BR-74001970 Goiania, Go, Brazil; [Liu, Wei-Chung] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Huang, Cho-ying] Natl Taiwan Univ, Dept Geog, Taipei 10617, Taiwan	Academia Sinica - Taiwan; National Cheng Kung University; University of Connecticut; University of Colorado System; University of Colorado Boulder; Universidade Federal de Goias; Academia Sinica - Taiwan; National Taiwan University	Shen, SF (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan.	shensf@sinica.edu.tw	Shen, Sheng-Feng/R-1177-2019; Liu, Wei-chung/AAP-3893-2021; Chen, I-Ching/GWU-9667-2022; CHEN, I-CHING/Y-1535-2019	Shen, Sheng-Feng/0000-0002-0631-6343; CHEN, I-CHING/0000-0002-1909-7290; Liu, Wei-chung/0000-0001-8041-8789; Huang, Cho-ying/0000-0002-9174-7542	Academia Sinica (Career Development Award); Ministry of Science and Technology, Taiwan [NSC101-2313-B001-008-MY3, 103-3114-C-006-001-ESR, NSC100-2621-B-002-001-MY3]; U.S. NSF [DEB-0639979, DBI-0851245]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); National Taiwan University	Academia Sinica (Career Development Award); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); U.S. NSF(National Science Foundation (NSF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Taiwan University(National Taiwan University)	We thank T. Amano and anonymous referees for insightful comments and Y.-S. Jang for help with assembling the data for fig. S10. The sources for the data sets used in this paper can be found in table S1. S.-F.S. was supported by Academia Sinica (Career Development Award) and the Ministry of Science and Technology, Taiwan (grant NSC101-2313-B001-008-MY3). I.-C.C. was funded by the Ministry of Science and Technology, Taiwan (grant 103-3114-C-006-001-ESR). R.K.C. was supported by the U.S. NSF (grants DEB-0639979 and DBI-0851245) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil). C.H. was sponsored by National Taiwan University and the Ministry of Science and Technology, Taiwan (grant NSC100-2621-B-002-001-MY3).	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Beall C., 2012, HUMAN BIOL EVOLUTION; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; Buckley LB, 2012, GLOBAL ECOL BIOGEOGR, V21, P873, DOI 10.1111/j.1466-8238.2011.00737.x; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Gaston K.J., 2003, STRUCTURE DYNAMICS G; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Gaston KJ, 1999, OIKOS, V84, P309, DOI 10.2307/3546727; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; GILCHRIST GW, 1995, AM NAT, V146, P252, DOI 10.1086/285797; Grace J.B., 2006, STRUCT EQ MOD NAT; Gromping U., 2006, J STAT SOFTW, V17, P1, DOI DOI 10.1360/JOS170001; IPCC, 2018, SUMMARY POLICYMAKERS; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; KARL TR, 1991, GEOPHYS RES LETT, V18, P2253, DOI 10.1029/91GL02900; Khaliq I, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1097; Kiehl JT, 1997, B AM METEOROL SOC, V78, P197, DOI 10.1175/1520-0477(1997)078<0197:EAGMEB>2.0.CO;2; McCain CM, 2013, GLOBAL ECOL BIOGEOGR, V22, P750, DOI 10.1111/geb.12014; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; Ruggiero A, 2007, GLOBAL ECOL BIOGEOGR, V16, P401, DOI 10.1111/j.1466-8238.2006.00303.x; Sheldon KS, 2014, ECOLOGY, V95, P2134, DOI 10.1890/13-1703.1; Spicer J. I., 1999, PHYSL DIVERSITY ITS; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Vasseur DA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2612; Wang G, 2014, NAT CLIM CHANGE, V4, P988, DOI 10.1038/NCLIMATE2378; Whitton FJS, 2012, GLOBAL ECOL BIOGEOGR, V21, P179, DOI 10.1111/j.1466-8238.2011.00660.x	29	79	81	8	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1437	1439		10.1126/science.aab4119	http://dx.doi.org/10.1126/science.aab4119			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013729				2022-12-28	WOS:000372756200045
J	Kiser, B				Kiser, Barbara			CIRCULAR ECONOMY Getting the circulation going	NATURE			English	Editorial Material																			0	34	37	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					443	444		10.1038/531443a	http://dx.doi.org/10.1038/531443a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QK	27008955	Bronze			2022-12-28	WOS:000372701300016
J	Tanksley, A; Cifu, AS				Tanksley, Audrey; Cifu, Adam S.			Screening for Gonorrhea, Chlamydia, and Hepatitis B	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIRUS INFECTION; ADOLESCENTS; ADULTS		[Tanksley, Audrey; Cifu, Adam S.] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						[Anonymous], SEXUALLY TRANSMITTED; Centers For Disease Control and Prevention, 2015, SEX TRANSM DIS SURV; Chou R, 2014, ANN INTERN MED, V161, P31, DOI 10.7326/M13-2837; LeFevre ML, 2014, ANN INTERN MED, V161, P902, DOI 10.7326/M14-1981; LeFevre ML, 2014, ANN INTERN MED, V161, P58, DOI 10.7326/M14-1018; Mark H, 2015, AM J NURS, V115, P34, DOI 10.1097/01.NAJ.0000471245.76692.28; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Zakher B, 2014, ANN INTERN MED, V161, P884, DOI 10.7326/M14-1022	9	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1278	1279		10.1001/jama.2016.0223	http://dx.doi.org/10.1001/jama.2016.0223			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	27002450				2022-12-28	WOS:000372511100015
J	Bloche, MG				Bloche, M. Gregg			Scandal as a Sentinel Event - Recognizing Hidden Cost-Quality Trade-offs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bloche, M. Gregg] Georgetown Univ, Ctr Law, Washington, DC USA; [Bloche, M. Gregg] Ctr Transnat Legal Studies, London, England	Georgetown University	Bloche, MG (corresponding author), Georgetown Univ, Ctr Law, Washington, DC USA.; Bloche, MG (corresponding author), Ctr Transnat Legal Studies, London, England.							[Anonymous], 2014, ISS IMP ACC TIM CAR; Francis R, 2010, INDEPENDENT INQUIRY, VI; Linker B, 2011, WARS WASTE REHABILIT; Schreyogg J, 2010, HEALTH SERV RES, V45, P1585, DOI 10.1111/j.1475-6773.2010.01161.x; VA Office of Inspector General, 2014, REV ALL PAT DEATHS P	5	17	17	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1001	1003		10.1056/NEJMp1502629	http://dx.doi.org/10.1056/NEJMp1502629			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG4TR	26981930				2022-12-28	WOS:000372066100001
J	Shulkin, DJ				Shulkin, David J.			Beyond the VA Crisis - Becoming a High-Performance Network	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shulkin, David J.] Dept Vet Affairs, Washington, DC USA		Shulkin, DJ (corresponding author), Dept Vet Affairs, Washington, DC USA.							[Anonymous], 2010, COMP QUALITY CARE VA; Nuti SV, 2016, JAMA-J AM MED ASSOC, V315, P582, DOI 10.1001/jama.2016.0278; Trivedi AN, 2011, HEALTH AFFAIR, V30, P707, DOI 10.1377/hlthaff.2011.0074	3	40	40	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1003	1005		10.1056/NEJMp1600307	http://dx.doi.org/10.1056/NEJMp1600307			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG4TR	26981931				2022-12-28	WOS:000372066100002
J	Hollands, GJ; French, DP; Griffin, SJ; Prevost, AT; Sutton, S; King, S; Marteau, TM				Hollands, Gareth J.; French, David P.; Griffin, Simon J.; Prevost, A. Toby; Sutton, Stephen; King, Sarah; Marteau, Theresa M.			The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SMOKING-CESSATION; CANCER SUSCEPTIBILITY; PSYCHOLOGICAL IMPACT; PRIMARY-CARE; INTERVENTION; FEEDBACK; POPULATION; PROTOCOL; SMOKERS; COGNITIONS	OBJECTIVE To assess the impact of communicating DNA based disease risk estimates on risk-reducing health behaviours and motivation to engage in such behaviours. DESIGN Systematic review with meta-analysis, using Cochrane methods. DATA SOURCES Medline, Embase, PsycINFO, CINAHL, and the Cochrane Central Register of Controlled Trials up to 25 February 2015. Backward and forward citation searches were also conducted. STUDY SELECTION Randomised and quasi-randomised controlled trials involving adults in which one group received personalised DNA based estimates of disease risk for conditions where risk could be reduced by behaviour change. Eligible studies included a measure of risk-reducing behaviour. RESULTS We examined 10 515 abstracts and included 18 studies that reported on seven behavioural outcomes, including smoking cessation (six studies; n=2663), diet (seven studies; n=1784), and physical activity (six studies; n=1704). Meta-analysis revealed no significant effects of communicating DNA based risk estimates on smoking cessation (odds ratio 0.92, 95% confidence interval 0.63 to 1.35, P=0.67), diet (standardised mean difference 0.12, 95% confidence interval -0.00 to 0.24, P=0.05), or physical activity (standardised mean difference -0.03, 95% confidence interval -0.13 to 0.08, P=0.62). There were also no effects on any other behaviours (alcohol use, medication use, sun protection behaviours, and attendance at screening or behavioural support programmes) or on motivation to change behaviour, and no adverse effects, such as depression and anxiety. Subgroup analyses provided no clear evidence that communication of a risk-conferring genotype affected behaviour more than communication of the absence of such a genotype. However, studies were predominantly at high or unclear risk of bias, and evidence was typically of low quality. CONCLUSIONS Expectations that communicating DNA based risk estimates changes behaviour is not supported by existing evidence. These results do not support use of genetic testing or the search for risk-conferring gene variants for common complex diseases on the basis that they motivate risk-reducing behaviour. SYSTEMATIC REVIEW REGISTRATION This is a revised and updated version of a Cochrane review from 2010, adding 11 studies to the seven previously identified.	[Hollands, Gareth J.; King, Sarah; Marteau, Theresa M.] Univ Cambridge, Behav & Hlth Res Unit, Cambridge, England; [French, David P.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Griffin, Simon J.; Sutton, Stephen] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Prevost, A. Toby] Univ London Imperial Coll Sci Technol & Med, Imperial Clin Trials Unit, London, England	University of Cambridge; University of Manchester; University of Cambridge; Imperial College London	Marteau, TM (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Cambridge, England.	tmm388@cam.ac.uk	French, David P/K-7283-2012	French, David P/0000-0002-7663-7804; Sutton, Stephen/0000-0003-1610-0404; Marteau, Theresa/0000-0003-3025-1129; Hollands, Gareth/0000-0002-0492-3924; Prevost, A. Toby/0000-0003-1723-0796; King, Sarah/0000-0002-0637-7672	Medical Research Council, UK [G0500274]; National Institute for Health Research; MRC [G0500274, MC_U106179474, MC_UU_12015/4] Funding Source: UKRI; Medical Research Council [MC_UU_12015/4, MC_U106179474, G0500274] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10101] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	A previous version of this review was funded as part of a grant from the Medical Research Council, UK (Risk communication in preventive medicine: optimising the impact of DNA risk information; G0500274). Updating this review was funded by a National Institute for Health Research senior investigator award to TMM. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Academy of Medical Sciences, 2013, REAL POT STRAT MED; Allen NE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008601; Audrain J, 1997, ADDICT BEHAV, V22, P741, DOI 10.1016/S0306-4603(97)00060-9; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bates BR, 2003, AM J MED GENET A, V119A, P156, DOI 10.1002/ajmg.a.20113; Beery TA, 2007, GENET TEST, V11, P111, DOI 10.1089/gte.2006.0527; Bize R, 2012, COCHRANE DB SYST REV, V12; Bloss CS, 2011, NEW ENGL J MED, V364, P524, DOI 10.1056/NEJMoa1011893; Broadstock M, 2000, EUR J HUM GENET, V8, P731, DOI 10.1038/sj.ejhg.5200532; Burke W, 2006, GENET MED, V8, P451, DOI 10.1097/01.gim.0000228213.72256.8c; Chao S, 2008, ALZ DIS ASSOC DIS, V22, P94, DOI 10.1097/WAD.0b013e31815a9dcc; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; de Viron S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040230; Dzau VJ, 2015, LANCET, V385, P2118, DOI 10.1016/S0140-6736(15)60722-X; Evans JP, 2011, SCIENCE, V331, P861, DOI 10.1126/science.1198039; Fanshawe TR, 2008, GENET TEST, V12, P381, DOI 10.1089/gte.2007.0103; Glanz K, 2013, CANCER EPIDEM BIOMAR, V22, P607, DOI 10.1158/1055-9965.EPI-12-1174; Godino JG, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-444; Gramling R, 2003, GENET MED, V5, P172, DOI 10.1097/01.GIM.0000068986.03217.BB; Grant RW, 2013, DIABETES CARE, V36, P13, DOI 10.2337/dc12-0884; Hendershot CS, 2010, ANN BEHAV MED, V40, P77, DOI 10.1007/s12160-010-9207-3; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; Hietaranta-Luoma HL, 2014, J NUTRIGENET NUTRIGE, V7, P161, DOI 10.1159/000371743; Hishida A, 2010, CANCER EPIDEMIOL, V34, P96, DOI 10.1016/j.canep.2009.11.008; Hollands GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4708; Hollands GJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007434.pub2; Ito H, 2006, PREV MED, V42, P102, DOI 10.1016/j.ypmed.2005.10.006; Komiya Y, 2006, J OCCUP HEALTH, V48, P161, DOI 10.1539/joh.48.161; Lander ES, 2015, NEW ENGL J MED, V372, P1185, DOI 10.1056/NEJMp1501964; Lerman C, 1997, HEALTH PSYCHOL, V16, P87, DOI 10.1037/0278-6133.16.1.87; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Marteau T, 2004, AM J MED GENET A, V128A, P285, DOI 10.1002/ajmg.a.30102; Marteau TM, 2006, SOC SCI MED, V62, P1360, DOI 10.1016/j.socscimed.2005.08.005; Marteau TM, 2010, COCHRANE DB SYST REV; McBride CM, 2002, CANCER EPIDEM BIOMAR, V11, P521; McClure JB, 2002, AM J PREV MED, V22, P200, DOI 10.1016/S0749-3797(01)00425-1; Meisel SF, 2015, OBESITY, V23, P305, DOI 10.1002/oby.20958; Meisel SF, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-235; Meiser B, 2005, PSYCHO-ONCOL, V14, P1060, DOI 10.1002/pon.933; Milne S, 2000, J APPL SOC PSYCHOL, V30, P106, DOI 10.1111/j.1559-1816.2000.tb02308.x; Myers RE, 2011, CONTEMP CLIN TRIALS, V32, P25, DOI 10.1016/j.cct.2010.08.013; Nielsen DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112665; Sanderson SC, 2008, J HEALTH PSYCHOL, V13, P481, DOI 10.1177/1359105308088519; Scheuner MT, 2008, JAMA-J AM MED ASSOC, V299, P1320, DOI 10.1001/jama.299.11.1320; Senior V, 1999, PSYCHOL HEALTH, V14, P1077, DOI 10.1080/08870440008407368; Shiloh S, 2002, J BEHAV MED, V25, P373, DOI 10.1023/A:1015818532390; Smerecnik C, 2012, TOB CONTROL, V21, P347, DOI 10.1136/tc.2011.042739; Voils CI, 2015, J GEN INTERN MED, V30, P1591, DOI 10.1007/s11606-015-3315-5; Voils CI, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-121; Weinberg DS, 2014, ANN INTERN MED, V161, P537, DOI 10.7326/M14-0765; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; Whitwell SCL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-44	55	293	298	3	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2016	352								i1102	10.1136/bmj.i1102	http://dx.doi.org/10.1136/bmj.i1102			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DH1ZT	26979548	Green Published, hybrid			2022-12-28	WOS:000372584400002
J	McGrail, K; Lavergne, R; Lewis, S				McGrail, Kimberlyn; Lavergne, Ruth; Lewis, Steven			The chronic disease explosion: artificial bang or empirical whimper?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE		[McGrail, Kimberlyn] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada; [Lavergne, Ruth] McGill Univ, Montreal, PQ H3A 2T5, Canada; [Lewis, Steven] Access Consulting Saskatoon, Saskatoon, SK, Canada; [Lewis, Steven] Simon Fraser Univ Burnaby, Burnaby, BC, Canada	University of British Columbia; McGill University; Simon Fraser University	McGrail, K (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V6T 1Z3, Canada.	kim.mcgrail@ubc.ca		Lewis, Steven/0000-0002-4247-674X				Anderson G., 2010, CHRONIC CARE MAKING; Barnett ML, 2012, ARCH INTERN MED, V172, P163, DOI 10.1001/archinternmed.2011.722; British Columbia Ministry of Health, 2013, MEDICAL SERVICES PLA; British Columbia Ministry of Health, 2013, HOSP SEP EXTR HOSP C; British Columbia Ministry of Health, 2012, CONS FIL CENS GEOD; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Cavers WJR, 2010, CAN FAM PHYSICIAN, V56, P1318; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Gilbert Welch H., 2011, OVERDIAGNOSED; Harding Center for Risk Literacy, RISKS BEN PROST CANC; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Jayaraman G., 2013, COMP COMM INF ICCCI, P1; Kaplan RM, 2007, ANNU REV PUBL HEALTH, V28, P321, DOI 10.1146/annurev.publhealth.28.021406.144141; Lix L, 2006, DEFINING VALIDATING; Macdonald H, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1163; Manuel Douglas G, 2014, CMAJ Open, V2, pE94, DOI 10.9778/cmajo.2012-0015; May C, 2005, CHRONIC ILLN, V1, P15, DOI 10.1179/174239505X19581; May C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2803; Statistics Canada, 2005, PROF HLTH IND ANN ES; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4	21	13	13	0	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2016	352								i1312	10.1136/bmj.i1312	http://dx.doi.org/10.1136/bmj.i1312			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1ZT	26980185				2022-12-28	WOS:000372584400005
J	Venkataramani, AS; Bor, J; Jena, AB				Venkataramani, Atheendar S.; Bor, Jacob; Jena, Anupam B.			Regression discontinuity designs in healthcare research	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CAUSAL-INFERENCE; IMPROVE; ONTARIO	Clinical decisions are often driven by decision rules premised around specific thresholds. Specific laboratory measurements, dates, or policy eligibility criteria create cut-offs at which people become eligible for certain treatments or health services. The regression discontinuity design is a statistical approach that utilizes threshold based decision making to derive compelling causal estimates of different interventions. In this review, we argue that regression discontinuity is underutilized in healthcare research despite the ubiquity of threshold based decision making as well as the design's simplicity and transparency. Moreover, regression discontinuity provides evidence of "real world" therapeutic and policy effects, circumventing a major limitation of randomized controlled trials. We discuss the implementation, strengths, and weaknesses of regression discontinuity and review several examples from clinical medicine, public health, and health policy. We conclude by discussing the wide array of open research questions for which regression discontinuity stands to provide meaningful insights to clinicians and policymakers.	[Venkataramani, Atheendar S.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Venkataramani, Atheendar S.] Harvard Ctr Populat & Dev Studies, Cambridge, MA USA; [Bor, Jacob] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Jena, Anupam B.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Cambridge, MA USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research	Jena, AB (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	jena@hcp.med.harvard.edu			Office of the Director, National Institutes of Health (NIH) [1DP5OD017897-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All authors have read and understood the BMJ policy on declaration of interests and declare the following: ABJ had support from the Office of the Director, National Institutes of Health (NIH early independence award, grant 1DP5OD017897-01) for the submitted work.	Almond D, 2011, AM ECON J-ECON POLIC, V3, P1, DOI 10.1257/pol.3.3.1; Almond D, 2010, Q J ECON, V125, P591, DOI 10.1162/qjec.2010.125.2.591; Angrist J., 2015, MASTERING METRICS; Angrist JD, 2015, J AM STAT ASSOC, V110, P1331, DOI 10.1080/01621459.2015.1012259; Bharadwaj P, 2013, AM ECON REV, V103, P1862, DOI 10.1257/aer.103.5.1862; Bor J, 2015, POP ASS AM ANN M SAN; Bor J, 2014, BMJ-BRIT MED J, V349, pg5293, DOI DOI 10.1136/BMJ.G5293; Bor J, 2015, CURR OPIN HIV AIDS, V10, P495, DOI 10.1097/COH.0000000000000191; Bor J, 2015, EPIDEMIOLOGY, V26, pE28, DOI 10.1097/EDE.0000000000000256; Bor J, 2014, EPIDEMIOLOGY, V25, P729, DOI 10.1097/EDE.0000000000000138; Callaghan RC, 2013, AM J PUBLIC HEALTH, V103, P2284, DOI 10.2105/AJPH.2013.301320; Card D, 2009, Q J ECON, V124, P597, DOI 10.1162/qjec.2009.124.2.597; Chay KY, 2011, MEDICARE HOSP UNPUB; Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110; De La Mata D, 2012, HEALTH ECON, V21, P1061, DOI 10.1002/hec.2857; Gelman A, 2014, 20405 NBER; Geneletti S, 2015, STAT MED, V34, P2334, DOI 10.1002/sim.6486; Jensen VM, 2015, J HEALTH ECON, V39, P289, DOI 10.1016/j.jhealeco.2014.07.004; Lee DS, 2010, J ECON LIT, V48, P281, DOI 10.1257/jel.48.2.281; Ludwig J, 2007, Q J ECON, V122, P159, DOI 10.1162/qjec.122.1.159; Martin SS, 2014, ANN INTERN MED, V160, P356, DOI 10.7326/M13-2805; McCrary J, 2008, J ECONOMETRICS, V142, P698, DOI 10.1016/j.jeconom.2007.05.005; Moscoe E, 2015, J CLIN EPIDEMIOL, V68, P132, DOI 10.1016/j.jclinepi.2014.06.021; O'Keeffe AG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5293; Peterson ED, 2014, JAMA-J AM MED ASSOC, V311, P474, DOI 10.1001/jama.2013.284430; Rockers PC, 2015, HEALTH POLICY, V119, P511, DOI 10.1016/j.healthpol.2014.10.006; Schneeweiss S, 2014, NEW ENGL J MED, V370, P2161, DOI 10.1056/NEJMp1401111; Smith LM, 2015, CAN MED ASSOC J, V187, pE74, DOI 10.1503/cmaj.140900; Sood N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5114; Walkey AJ, 2015, AM J RESP CRIT CARE, V192, P1399, DOI 10.1164/rccm.201508-1533LE; Wherry LR, 2015, 20929 NBER	31	70	74	4	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2016	352								i1216	10.1136/bmj.i1216	http://dx.doi.org/10.1136/bmj.i1216			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DH1XO	26977086	Green Published, Bronze			2022-12-28	WOS:000372578500001
J	Fisher, ES; Lee, PV				Fisher, Elliott S.; Lee, Peter V.			Toward Lower Costs and Better Care - Averting a Collision between Consumer- and Provider-Focused Reforms	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Lee, Peter V.] Calif Hlth Benefits Exchange, Sacramento, CA USA	Dartmouth College	Fisher, ES (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA.							[Anonymous], 2015, 2015 EMPL HLTH BEN S; Brot-Goldberg ZC, 2015, 21632 NBER; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Newhouse JP, 1993, FREE ALL LESSONS RAN; Song Zirui, 2014, J Clin Outcomes Manag, V21, P364	5	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					903	906		10.1056/NEJMp1514921	http://dx.doi.org/10.1056/NEJMp1514921			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF9DH	26962724				2022-12-28	WOS:000371660000002
J	Nielsen, J; Keasling, JD				Nielsen, Jens; Keasling, Jay D.			Engineering Cellular Metabolism	CELL			English	Review							TRANSCRIPTIONAL REGULATORY NETWORKS; HIGH-LEVEL PRODUCTION; DE-NOVO PRODUCTION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PATHWAY OPTIMIZATION; MICROBIAL-PRODUCTION; YEAST; EXPRESSION; PLATFORM	Metabolic engineering is the science of rewiring the metabolism of cells to enhance production of native metabolites or to endow cells with the ability to produce new products. The potential applications of such efforts are wide ranging, including the generation of fuels, chemicals, foods, feeds, and pharmaceuticals. However, making cells into efficient factories is challenging because cells have evolved robust metabolic networks with hard-wired, tightly regulated lines of communication between molecular pathways that resist efforts to divert resources. Here, we will review the current status and challenges of metabolic engineering and will discuss how new technologies can enable metabolic engineering to be scaled up to the industrial level, either by cutting off the lines of control for endogenous metabolism or by infiltrating the system with disruptive, heterologous pathways that overcome cellular regulation.	[Nielsen, Jens] Chalmers Univ Technol, Dept Biol & Biol Engn, Kemivagen 10, SE-41296 Gothenburg, Sweden; [Nielsen, Jens; Keasling, Jay D.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark; [Nielsen, Jens] Royal Inst Technol, Sci Life Lab, SE-17121 Solna, Sweden; [Keasling, Jay D.] Joint Bioenergy Inst, Emeryville, CA 94608 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA; [Keasling, Jay D.] Synthet Biol Engn Res Ctr Synberc, Berkeley, CA 94720 USA	Chalmers University of Technology; Technical University of Denmark; Royal Institute of Technology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Nielsen, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Kemivagen 10, SE-41296 Gothenburg, Sweden.; Nielsen, J; Keasling, JD (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark.; Nielsen, J (corresponding author), Royal Inst Technol, Sci Life Lab, SE-17121 Solna, Sweden.; Keasling, JD (corresponding author), Joint Bioenergy Inst, Emeryville, CA 94608 USA.; Keasling, JD (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.; Keasling, JD (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Keasling, JD (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.; Keasling, JD (corresponding author), Synthet Biol Engn Res Ctr Synberc, Berkeley, CA 94720 USA.	nielsenj@chalmers.se; keasling@berkeley.edu	Keasling, Jay D/J-9162-2012; Nielsen, Jens/Q-1347-2017	Keasling, Jay D/0000-0003-4170-6088; Nielsen, Jens/0000-0002-9955-6003	Novo Nordisk Foundation; Knut and Alice Wallenberg Foundation; Vetenskapsradet; FORMAS; Joint Bio-Energy Institute - US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Synthetic Biology Engineering Research Center (SynBERC) through National Science Foundation [NSF EEC 0540879]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Yeast Cell Factories, Synthetic Biology Tools for Yeast] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Vetenskapsradet(Swedish Research Council); FORMAS(Swedish Research Council Formas); Joint Bio-Energy Institute - US Department of Energy, Office of Science, Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Synthetic Biology Engineering Research Center (SynBERC) through National Science Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	We acknowledge funding from the Novo Nordisk Foundation, the Knut and Alice Wallenberg Foundation, Vetenskapsradet, FORMAS, the Joint Bio-Energy Institute (http://www.jbei.org/), which is supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy, and by the Synthetic Biology Engineering Research Center (SynBERC) through National Science Foundation grant NSF EEC 0540879. We thank Yun Chen, Victor Chubukov, Nathan Hillson, Mingtao Huang, Dina Petranovic, and Yongjin Zhou for constructive comments.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Alonso-Gutierrez J, 2015, METAB ENG, V28, P123, DOI 10.1016/j.ymben.2014.11.011; Alper H, 2007, METAB ENG, V9, P258, DOI 10.1016/j.ymben.2006.12.002; Avalos JL, 2013, NAT BIOTECHNOL, V31, P335, DOI 10.1038/nbt.2509; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Bakke I, 2009, APPL ENVIRON MICROB, V75, P2002, DOI 10.1128/AEM.02315-08; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Brynildsen MP, 2013, NAT BIOTECHNOL, V31, P160, DOI 10.1038/nbt.2458; Caspeta L, 2014, SCIENCE, V346, P75, DOI 10.1126/science.1258137; Caspeta L, 2013, NAT BIOTECHNOL, V31, P789, DOI 10.1038/nbt.2683; Chen J, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-1; Chen XZ, 2013, BIOTECHNOL ADV, V31, P1200, DOI 10.1016/j.biotechadv.2013.02.009; Chen Y, 2013, METAB ENG, V15, P48, DOI 10.1016/j.ymben.2012.11.002; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042475; Choi YJ, 2013, NATURE, V502, P571, DOI 10.1038/nature12536; Chou HH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3595; CRAWFORD L, 1995, BIO-TECHNOL, V13, P58, DOI 10.1038/nbt0195-58; Dahl RH, 2013, NAT BIOTECHNOL, V31, P1039, DOI 10.1038/nbt.2689; David F, 2014, FEMS YEAST RES, V15, P1; de Jongh WA, 2008, BIOTECHNOL BIOENG, V101, P317, DOI 10.1002/bit.21890; Dietrich JA, 2013, ACS SYNTH BIOL, V2, P47, DOI 10.1021/sb300091d; Donald KAG, 1997, APPL ENVIRON MICROB, V63, P3341, DOI 10.1128/AEM.63.9.3341-3344.1997; Dragosits M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-64; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Farhi M, 2011, METAB ENG, V13, P474, DOI 10.1016/j.ymben.2011.05.001; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Garcia-Albornoz M.A., 2013, IND BIOTECHNOL, V9, P203, DOI [10.1089/ind.2013.0011, DOI 10.1089/IND.2013.0011]; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gill RT, 2000, METAB ENG, V2, P178, DOI 10.1006/mben.2000.0148; Hadadi N, 2015, CURR OPIN CHEM BIOL, V28, P99, DOI 10.1016/j.cbpa.2015.06.025; Hong KK, 2011, P NATL ACAD SCI USA, V108, P12179, DOI 10.1073/pnas.1103219108; Huang MT, 2015, P NATL ACAD SCI USA, V112, pE4689, DOI 10.1073/pnas.1506460112; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Jakounas T, 2015, METAB ENG, V28, P213, DOI 10.1016/j.ymben.2015.01.008; Jensen MK, 2015, FEMS YEAST RES, V15, DOI 10.1111/1567-1364.12185; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kim TY, 2012, CURR OPIN BIOTECH, V23, P617, DOI 10.1016/j.copbio.2011.10.007; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Koopman F, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-155; Kosuri S, 2014, NAT METHODS, V11, P499, DOI [10.1038/NMETH.2918, 10.1038/nmeth.2918]; Kozak BU, 2014, MBIO, V5, DOI 10.1128/mBio.01696-14; Kozak BU, 2014, METAB ENG, V21, P46, DOI 10.1016/j.ymben.2013.11.005; Krivoruchko A, 2015, METAB ENG, V28, P28, DOI 10.1016/j.ymben.2014.11.009; Kuyper M, 2005, FEMS YEAST RES, V5, P925, DOI 10.1016/j.femsyr.2005.04.004; Langer E.S., 2012, APPL ENVIRON MICROB, V25; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Lee SY, 2015, NAT BIOTECHNOL, V33, P1061, DOI 10.1038/nbt.3365; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Li MJ, 2015, METAB ENG, V32, P1, DOI 10.1016/j.ymben.2015.08.007; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; MURDOCK D, 1993, BIO-TECHNOL, V11, P381, DOI 10.1038/nbt0393-381; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Nielsen J, 2003, J BACTERIOL, V185, P7031, DOI 10.1128/JB.185.24.7031-7035.2003; Nielsen J, 2001, APPL MICROBIOL BIOT, V55, P263, DOI 10.1007/s002530000511; Nielsen J, 2015, SCIENCE, V349, P1050, DOI 10.1126/science.aad2081; Nielsen J, 2014, MBIO, V5, DOI 10.1128/mBio.02153-14; Nielsen J, 2009, FEBS LETT, V583, P3905, DOI 10.1016/j.febslet.2009.10.054; Nissen TL, 2000, METAB ENG, V2, P69, DOI 10.1006/mben.1999.0140; O'Brien EJ, 2015, CURR OPIN BIOTECH, V34, P125, DOI 10.1016/j.copbio.2014.12.017; O'Brien EJ, 2015, CELL, V161, P971, DOI 10.1016/j.cell.2015.05.019; Ostergaard S, 2000, NAT BIOTECHNOL, V18, P1283, DOI 10.1038/82400; Osterlund T, 2015, INTEGR BIOL-UK, V7, P560, DOI 10.1039/c4ib00247d; Otero JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054144; Paddon CJ, 2013, NATURE, V496, P528, DOI 10.1038/nature12051; Park JH, 2007, P NATL ACAD SCI USA, V104, P7797, DOI 10.1073/pnas.0702609104; Park SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5618; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; PATNAIK R, 1994, APPL ENVIRON MICROB, V60, P3903, DOI 10.1128/AEM.60.11.3903-3908.1994; PATNAIK R, 1995, BIOTECHNOL BIOENG, V46, P361, DOI 10.1002/bit.260460409; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Qin JF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9224; Redden H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8810; Redden H, 2015, FEMS YEAST RES, V15, DOI 10.1111/1567-1364.12188; Redding-Johanson AM, 2011, METAB ENG, V13, P194, DOI 10.1016/j.ymben.2010.12.005; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Renata H, 2015, ANGEW CHEM INT EDIT, V54, P3351, DOI 10.1002/anie.201409470; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rodriguez A, 2015, METAB ENG, V31, P181, DOI 10.1016/j.ymben.2015.08.003; Saling P, 2005, APPL MICROBIOL BIOT, V68, P1, DOI 10.1007/s00253-005-1951-0; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Scalcinati G, 2012, METAB ENG, V14, P91, DOI 10.1016/j.ymben.2012.01.007; Seo SW, 2015, CELL REP, V12, P1289, DOI 10.1016/j.celrep.2015.07.043; Seo SW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5910; Shi S., 2014, IMPROVING PRODUCTION, V5, P1, DOI DOI 10.1128/MBI0.01130-14; Shiba Y, 2007, METAB ENG, V9, P160, DOI 10.1016/j.ymben.2006.10.005; Shih SCC, 2015, ACS SYNTH BIOL, V4, P1151, DOI 10.1021/acssynbio.5b00062; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Simpson ML, 1998, TRENDS BIOTECHNOL, V16, P332, DOI 10.1016/S0167-7799(98)01199-8; Smolke CD, 2000, APPL ENVIRON MICROB, V66, P5399, DOI 10.1128/AEM.66.12.5399-5405.2000; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Thykaer J, 2003, METAB ENG, V5, P56, DOI 10.1016/S1096-7176(03)00003-X; Tsao CY, 2010, METAB ENG, V12, P291, DOI 10.1016/j.ymben.2010.01.002; Tyo KEJ, 2009, NAT BIOTECHNOL, V27, P760, DOI 10.1038/nbt.1555; Usaite R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.67; Waks Z, 2009, APPL ENVIRON MICROB, V75, P1867, DOI 10.1128/AEM.02009-08; Wang BL, 2014, NAT BIOTECHNOL, V32, P473, DOI 10.1038/nbt.2857; Wang TW, 2012, MOL BIOTECHNOL, V52, P300, DOI 10.1007/s12033-012-9514-y; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149; Zhang YM, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov024	111	627	653	27	418	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1185	1197		10.1016/j.cell.2016.02.004	http://dx.doi.org/10.1016/j.cell.2016.02.004			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967285	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000372784900016
J	Yajnik, V; McDermott, S; Khalili, H; Everett, JM				Yajnik, Vijay; McDermott, Shaunagh; Khalili, Hamed; Everett, Jamie M.			Case 7-2016: An 80-Year-Old Man with Weight Loss, Abdominal Pain, Diarrhea, and an Ileocecal Mass	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTESTINAL TUBERCULOSIS; CROHNS-DISEASE		[Yajnik, Vijay; Khalili, Hamed] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [McDermott, Shaunagh] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Everett, Jamie M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Yajnik, Vijay; Khalili, Hamed] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [McDermott, Shaunagh] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Everett, Jamie M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Yajnik, V (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Yajnik, V (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA USA.				AbbVie; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	AbbVie(AbbVie); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Khalili reports receiving consulting fees from AbbVie. No other potential conflict of interest relevant to this article was reported.	Almadi MA, 2009, AM J GASTROENTEROL, V104, P1003, DOI 10.1038/ajg.2008.162; Huang X, 2015, WORLD J GASTROENTERO, V21, P3650, DOI 10.3748/wjg.v21.i12.3650; Lee YJ, 2006, ENDOSCOPY, V38, P592, DOI 10.1055/s-2006-924996; Makharia GK, 2010, AM J GASTROENTEROL, V105, P642, DOI 10.1038/ajg.2009.585; Singh B, 2015, INDIAN J GASTROENTER, V34, P43, DOI 10.1007/s12664-015-0538-7; TANDON HD, 1972, GUT, V13, P260, DOI 10.1136/gut.13.4.260; Tandon R, 2014, INFLAMM BOWEL DIS, P41; Zhao XS, 2014, INFLAMM BOWEL DIS, V20, P916, DOI 10.1097/MIB.0000000000000025	8	3	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					970	979		10.1056/NEJMcpc1509455	http://dx.doi.org/10.1056/NEJMcpc1509455			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF9DH	26962732				2022-12-28	WOS:000371660000012
J	[Anonymous]				[Anonymous]			Communication In and Of Biology	CELL			English	Editorial Material																			0	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1079	1081		10.1016/j.cell.2016.02.053	http://dx.doi.org/10.1016/j.cell.2016.02.053			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967270	Bronze			2022-12-28	WOS:000372784900001
J	Behrens, I; Basit, S; Lykke, JA; Ranthe, MF; Wohlfahrt, J; Bundgaard, H; Melbye, M; Boyd, HA				Behrens, Ida; Basit, Saima; Lykke, Jacob Alexander; Ranthe, Mattis Flyvholm; Wohlfahrt, Jan; Bundgaard, Henning; Melbye, Mads; Boyd, Heather A.			Association Between Hypertensive Disorders of Pregnancy and Later Risk of Cardiomyopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE RISK; ANGIOGENIC FACTORS; ANTIANGIOGENIC FACTORS; PREECLAMPSIA; WOMEN; CLASSIFICATION; STATEMENT; DIAGNOSIS	IMPORTANCE Women with hypertensive disorders of pregnancy, preeclampsia in particular, have an increased risk of cardiomyopathy during the peripartum period. Whether hypertensive disorders of pregnancy are also associated with cardiomyopathy later in life is unknown. OBJECTIVE To determine whether hypertensive disorders of pregnancy are associated with cardiomyopathy beyond the peripartum period. DESIGN, SETTING, AND PARTICIPANTS Nationwide register-based cohort study using Cox regression to compare rates of cardiomyopathy in women with and without a history of hypertensive disorders of pregnancy in a cohort of 1 075 763 women with at least 1 pregnancy ending in live birth or stillbirth in Denmark, 1978-2012, with follow-up through December 31, 2012. EXPOSURES A hypertensive disorder of pregnancy (severe or moderate preeclampsia or gestational hypertension) registered in the National Patient Register. MAIN OUTCOMES AND MEASURES Cardiomyopathy more than 5 months after delivery (outside the peripartum period) up to 34 years 7 months. RESULT The women in the primary cohort had 2 067 633 eligible pregnancies during the study period, 76 108 of which were complicated by a hypertensive disorder of pregnancy. During follow-up, 1577 women (mean age, 48.5 years at cardiomyopathy diagnosis; 2.6% with multiple pregnancies) developed cardiomyopathy. Compared with women with normotensive pregnancies (18 211 603 person-years of follow-up; n = 1408 cardiomyopathy events, 7.7/100 000 person-years [95% CI, 7.3-8.2]), women with a history of hypertensive disorders of pregnancy had significantly increased rates of cardiomyopathy (in 173 062 person-years of follow-up among women with severe preeclampsia, n = 27 cardiomyopathy events; 15.6/100 000 person-years [95% CI, 10.7-22.7]; adjusted hazard ratio [HR], 2.20 [95% CI, 1.50-3.23]; in 697 447 person-years of follow-up among women with moderate preeclampsia, n = 102 cardiomyopathy events; 14.6/100 000 person-years [95% CI, 12.0-17.8]; adjusted HR, 1.89 [95% CI, 1.55-2.23]; in 213 197 person-years of follow-up among women with gestational hypertension, n = 40 cardiomyopathy events; 17.3/100 000 person-years [95% CI, 12.7-23.6]; adjusted HR, 2.06 [95% CI, 1.50-2.82]). These increases persisted more than 5 years after the latest pregnancy. Mediation analyses suggested that only about 50% of the association was an indirect association through postpregnancy chronic hypertension. In this cohort, 11% of all cardiomyopathy events occurred in women with a history of hypertensive disorders of pregnancy. CONCLUSIONS AND RELEVANCE Women with a history of hypertensive disorders of pregnancy, compared with women without such a history, had a small but statistically significant increased risk of cardiomyopathy more than 5 months after delivery. Further research is necessary to understand whether there is a causal mechanism behind this association.	[Behrens, Ida; Basit, Saima; Ranthe, Mattis Flyvholm; Wohlfahrt, Jan; Melbye, Mads; Boyd, Heather A.] Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark; [Lykke, Jacob Alexander] Rigshosp, Copenhagen Univ Hosp, Dept Obstet, DK-2100 Copenhagen, Denmark; [Bundgaard, Henning] Rigshosp, Copenhagen Univ Hosp, Unit Inherited Cardiac Dis, Ctr Heart, DK-2100 Copenhagen, Denmark; [Melbye, Mads] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Melbye, Mads] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	Statens Serum Institut; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Stanford University	Behrens, I (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	idbe@ssi.dk	Bundgaard, Henning/AAA-4381-2020	Bundgaard, Henning/0000-0002-0563-7049; Ranthe, Mattis Flyvholm/0000-0002-6363-6386; Lykke, Jacob Alexander/0000-0002-3698-9792; Boyd, Heather/0000-0001-6849-9985; Behrens, Ida/0000-0003-2216-3831; melbye, mads/0000-0001-8264-6785	Danish Heart Association; Danish Council for Independent Research	Danish Heart Association; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This study was funded by the Danish Heart Association and the Danish Council for Independent Research.	Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bello N, 2013, J AM COLL CARDIOL, V62, P1715, DOI 10.1016/j.jacc.2013.08.717; Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V17, P3, DOI 10.1080/14767050400028816; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Elkayam U, 2011, J AM COLL CARDIOL, V58, P659, DOI 10.1016/j.jacc.2011.03.047; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Lange T, 2012, AM J EPIDEMIOL, V176, P190, DOI 10.1093/aje/kwr525; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lykke JA, 2009, HYPERTENSION, V53, P944, DOI 10.1161/HYPERTENSIONAHA.109.130765; McDonald SD, 2008, AM HEART J, V156, P918, DOI 10.1016/j.ahj.2008.06.042; Melchiorre K, 2013, BJOG-INT J OBSTET GY, V120, P496, DOI 10.1111/1471-0528.12068; Melchiorre K, 2014, CIRCULATION, V130, P703, DOI 10.1161/CIRCULATIONAHA.113.003664; Melchiorre K, 2011, CURR OPIN OBSTET GYN, V23, P440, DOI 10.1097/GCO.0b013e32834cb7a4; Melchiorre K, 2011, HYPERTENSION, V58, P709, DOI 10.1161/HYPERTENSIONAHA.111.176537; Melchiorre K, 2011, HYPERTENSION, V57, P85, DOI 10.1161/HYPERTENSIONAHA.110.162321; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Sliwa K, 2006, LANCET, V368, P687, DOI 10.1016/S0140-6736(06)69253-2; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; THERNEAU TM, 1990, BIOMETRIKA, V77, P147, DOI 10.2307/2336057; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Wikstrom AK, 2005, BJOG-INT J OBSTET GY, V112, P1486, DOI 10.1111/j.1471-0528.2005.00733.x; Wilkins-Haug L, 2015, OBSTET GYNECOL, V125, P1287, DOI 10.1097/AOG.0000000000000856	33	69	74	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2016	315	10					1026	1033		10.1001/jama.2016.1869	http://dx.doi.org/10.1001/jama.2016.1869			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF7LW	26954411	Bronze			2022-12-28	WOS:000371540200015
J	Beste, LA; Moseley, RH; Saint, S; Cornia, PB				Beste, Lauren A.; Moseley, Richard H.; Saint, Sanjay; Cornia, Paul B.			Too Much of a Good Thing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PORTAL-HYPERTENSION; HISTORY		[Beste, Lauren A.] Vet Affairs VA Puget Sound Hlth Care Syst, Gen Med Serv, Seattle, WA USA; [Beste, Lauren A.] Vet Affairs VA Puget Sound Hlth Care Syst, Hlth Serv Res & Dev, Seattle, WA USA; [Beste, Lauren A.; Cornia, Paul B.] Vet Affairs VA Puget Sound Hlth Care Syst, Hosp & Specialty Med Serv, Seattle, WA USA; [Beste, Lauren A.; Cornia, Paul B.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Moseley, Richard H.; Saint, Sanjay] VA Ann Arbor Healthcare Syst, Med Serv, Ann Arbor, MI USA; [Moseley, Richard H.; Saint, Sanjay] Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Beste, LA (corresponding author), VA Puget Sound Hlth Care Syst, 1660 S Columbian Way S-111-GI, Seattle, WA 98108 USA.	lab25@uw.edu	Saint, Sanjay/AAF-5126-2019	Cornia, Paul/0000-0002-4949-9637	Doximity; Jvion	Doximity; Jvion	Dr. Saint reports receiving fees for serving on advisory boards from Doximity and Jvion. No other potential conflict of interest relevant to this article was reported.	Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; GEUBEL AP, 1991, GASTROENTEROLOGY, V100, P1701, DOI 10.1016/0016-5085(91)90672-8; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Hillaire S, 1997, Clin Liver Dis, V1, P223, DOI 10.1016/S1089-3261(05)70265-8; Institute of Medicine (US), 2001, DIET REF INT VIT C V; Navarro VJ, 2014, HEPATOLOGY, V60, P1399, DOI 10.1002/hep.27317; Schouten JNL, 2011, HEPATOLOGY, V54, P1071, DOI 10.1002/hep.24422; Siramolpiwat S, 2014, HEPATOLOGY, V59, P2276, DOI 10.1002/hep.26904; Wong CL, 2008, JAMA-J AM MED ASSOC, V299, P1166, DOI 10.1001/jama.299.10.1166	9	7	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					873	878		10.1056/NEJMcps1405984	http://dx.doi.org/10.1056/NEJMcps1405984			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF2FT	26962907				2022-12-28	WOS:000371158400013
J	Kirby, T				Kirby, Tony			Brendan Crabb-making research work for development Profile	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					839	839		10.1016/S0140-6736(16)00516-X	http://dx.doi.org/10.1016/S0140-6736(16)00516-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE9RA	26972069				2022-12-28	WOS:000370974400014
J	Lear, CH; Lunt, DJ				Lear, Caroline H.; Lunt, Dan J.			How Antarctica got its ice	SCIENCE			English	Editorial Material							OLIGOCENE CLIMATIC TRANSITION; ATMOSPHERIC CO2; GLACIATION; VARIABILITY; OCEAN		[Lear, Caroline H.] Cardif Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AT, S Glam, Wales; [Lunt, Dan J.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Lunt, Dan J.] Univ Bristol, Cabot Inst, Bristol BS8 1SS, Avon, England	Cardiff University; University of Bristol; University of Bristol	Lear, CH (corresponding author), Cardif Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AT, S Glam, Wales.; Lunt, DJ (corresponding author), Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England.; Lunt, DJ (corresponding author), Univ Bristol, Cabot Inst, Bristol BS8 1SS, Avon, England.	learc@cardif.ac.uk; d.j.lunt@bristol.ac.uk	Lunt, Daniel/G-9451-2011	Lunt, Daniel/0000-0003-3585-6928				DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Diester-Haass L, 2001, PALAEOGEOGR PALAEOCL, V172, P153, DOI 10.1016/S0031-0182(01)00280-2; Egan KE, 2013, EARTH PLANET SC LETT, V375, P34, DOI 10.1016/j.epsl.2013.04.030; Fyke JG, 2015, GLOBAL PLANET CHANGE, V128, P72, DOI 10.1016/j.gloplacha.2015.02.011; Galeotti S, 2016, SCIENCE, V352, P76, DOI 10.1126/science.aab0669; Goldner A, 2014, NATURE, V511, P574, DOI 10.1038/nature13597; Greenop R, 2014, PALEOCEANOGRAPHY, V29, P845, DOI 10.1002/2014PA002653; Heureux AMC, 2015, EARTH PLANET SC LETT, V409, P329, DOI 10.1016/j.epsl.2014.10.036; Kennedy AT, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0419; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Ladant JB, 2014, CLIM PAST, V10, P1957, DOI 10.5194/cp-10-1957-2014; Lunt D. J., 2015, CLIM PAST DISCUSS, V11, P5683, DOI [10.5194/cpd-11-5683-2015, DOI 10.5194/CPD-11-5683-2015]; Pearson PN, 2009, NATURE, V461, P1110, DOI 10.1038/nature08447; Zachos JC, 2005, GLOBAL PLANET CHANGE, V47, P51, DOI 10.1016/j.gloplacha.2005.01.001; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571	15	9	9	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2016	352	6281					34	35		10.1126/science.aad6284	http://dx.doi.org/10.1126/science.aad6284			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8JP	26966192				2022-12-28	WOS:000373039600020
J	Rosenfield, K; Ghoshhajra, BB; Dudzinski, DM; Stone, JR				Rosenfield, Kenneth; Ghoshhajra, Brian B.; Dudzinski, David M.; Stone, James R.			Case 9-2016: A 29-Year-Old Man with Dyspnea and Chest Pain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE PULMONARY-EMBOLISM; CLOT LOAD SCORES; MANAGEMENT; ECHOCARDIOGRAPHY; SYNCOPE		[Rosenfield, Kenneth; Dudzinski, David M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Ghoshhajra, Brian B.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Rosenfield, Kenneth; Dudzinski, David M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Ghoshhajra, Brian B.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Stone, James R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Rosenfield, K (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Rosenfield, K (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA USA.		Ghoshhajra, Brian/J-2114-2016	Ghoshhajra, Brian/0000-0002-3865-3432				[Anonymous], 2007, NEW ENGL J MED, V357, P1137; [Anonymous], 2014, NEW ENGL J MED, V371, P1143; Barreiro M, 2013, CARDIOVASC PATHOL, V22, P424, DOI 10.1016/j.carpath.2013.04.006; Clark AR, 2014, RESP PHYSIOL NEUROBI, V190, P1, DOI 10.1016/j.resp.2013.09.005; Dudzinski DM, 2016, CIRCULATION, V133, P98, DOI 10.1161/CIRCULATIONAHA.115.015086; Ghaye B, 2006, RADIOLOGY, V239, P884, DOI 10.1148/radiol.2392050075; Goldhaber SZ, 2002, ANN INTERN MED, V136, P691, DOI 10.7326/0003-4819-136-9-200205070-00012; Gowda RM, 2003, AM HEART J, V146, P404, DOI 10.1016/S0002-8703(03)00249-7; Grifoni S, 2000, CIRCULATION, V101, P2817, DOI 10.1161/01.CIR.101.24.2817; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Mastora I, 2003, EUR RADIOL, V13, P29, DOI 10.1007/s00330-002-1515-y; Provias Tim, 2014, Hosp Pract (1995), V42, P31, DOI 10.3810/hp.2014.02.1089; Qanadli SD, 2001, AM J ROENTGENOL, V176, P1415, DOI 10.2214/ajr.176.6.1761415; Reza Nosheen, 2015, Curr Treat Options Cardiovasc Med, V17, P387, DOI 10.1007/s11936-015-0387-9; Stefka J, 2003, HUM PATHOL, V34, P1074, DOI 10.1053/S0046-8177(03)00415-5; Strecker T, 2012, CARDIOVASC PATHOL, V21, P436, DOI 10.1016/j.carpath.2011.12.004; Sun JP, 2001, CIRCULATION, V103, P2687	18	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2016	374	12					1178	1188		10.1056/NEJMcpc1512452	http://dx.doi.org/10.1056/NEJMcpc1512452			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AA	27007962				2022-12-28	WOS:000372585100012
J	Gladstone, GR; Stern, SA; Ennico, K; Olkin, CB; Weaver, HA; Young, LA; Summers, ME; Strobel, DF; Hinson, DP; Kammer, JA; Parker, AH; Steffl, AJ; Linscott, IR; Parker, JW; Cheng, AF; Slater, DC; Versteeg, MH; Greathouse, TK; Retherford, KD; Throop, H; Cunningham, NJ; Woods, WW; Singer, KN; Tsang, CCC; Schindhelm, E; Lisse, CM; Wong, ML; Yung, YL; Zhu, X; Curdt, W; Lavvas, P; Young, EF; Tyler, GL				Gladstone, G. Randall; Stern, S. Alan; Ennico, Kimberly; Olkin, Catherine B.; Weaver, Harold A.; Young, Leslie A.; Summers, Michael E.; Strobel, Darrell F.; Hinson, David P.; Kammer, Joshua A.; Parker, Alex H.; Steffl, Andrew J.; Linscott, Ivan R.; Parker, Joel Wm.; Cheng, Andrew F.; Slater, David C.; Versteeg, Maarten H.; Greathouse, Thomas K.; Retherford, Kurt D.; Throop, Henry; Cunningham, Nathaniel J.; Woods, William W.; Singer, Kelsi N.; Tsang, Constantine C. C.; Schindhelm, Eric; Lisse, Carey M.; Wong, Michael L.; Yung, Yuk L.; Zhu, Xun; Curdt, Werner; Lavvas, Panayotis; Young, Eliot F.; Tyler, G. Leonard		New Horizons Sci Team	The atmosphere of Pluto as observed by New Horizons	SCIENCE			English	Article							RADIO OCCULTATION MEASUREMENTS; STELLAR OCCULTATIONS; THERMAL STRUCTURE; BELT MISSION; IONOSPHERE; METHANE; MODELS; SYSTEM; IMAGER; TITAN	Observations made during the New Horizons flyby provide a detailed snapshot of the current state of Pluto's atmosphere. Whereas the lower atmosphere (at altitudes of less than 200 kilometers) is consistent with ground-based stellar occultations, the upper atmosphere is much colder and more compact than indicated by pre-encounter models. Molecular nitrogen (N-2) dominates the atmosphere (at altitudes of less than 1800 kilometers or so), whereas methane (CH4), acetylene (C2H2), ethylene (C2H4), and ethane (C2H6) are abundant minor species and likely feed the production of an extensive haze that encompasses Pluto. The cold upper atmosphere shuts off the anticipated enhanced-Jeans, hydrodynamic-like escape of Pluto's atmosphere to space. It is unclear whether the current state of Pluto's atmosphere is representative of its average state-over seasonal or geologic time scales.	[Gladstone, G. Randall; Slater, David C.; Versteeg, Maarten H.; Greathouse, Thomas K.; Retherford, Kurt D.] SW Res Inst, San Antonio, TX 78238 USA; [Gladstone, G. Randall; Retherford, Kurt D.] Univ Texas San Antonio, San Antonio, TX 78249 USA; [Stern, S. Alan; Olkin, Catherine B.; Young, Leslie A.; Kammer, Joshua A.; Parker, Alex H.; Steffl, Andrew J.; Parker, Joel Wm.; Singer, Kelsi N.; Tsang, Constantine C. C.; Schindhelm, Eric; Young, Eliot F.] SW Res Inst, Boulder, CO 80302 USA; [Ennico, Kimberly] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Weaver, Harold A.; Cheng, Andrew F.; Lisse, Carey M.; Zhu, Xun] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA; [Summers, Michael E.] George Mason Univ, Fairfax, VA 22030 USA; [Strobel, Darrell F.; Throop, Henry] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Hinson, David P.] Search Extraterr Intelligence Inst, Mountain View, CA 94043 USA; [Linscott, Ivan R.; Woods, William W.; Tyler, G. Leonard] Stanford Univ, Stanford, CA 94305 USA; [Cunningham, Nathaniel J.] Nebraska Wesleyan Univ, Lincoln, NE 68504 USA; [Wong, Michael L.; Yung, Yuk L.] CALTECH, Pasadena, CA 91125 USA; [Curdt, Werner] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Lavvas, Panayotis] Univ Reims, Grp Spect Mol & Atmospher, F-51687 Reims, France	Southwest Research Institute; University of Texas System; University of Texas at San Antonio (UTSA); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; George Mason University; Johns Hopkins University; Stanford University; California Institute of Technology; Max Planck Society; Universite de Reims Champagne-Ardenne	Gladstone, GR (corresponding author), SW Res Inst, San Antonio, TX 78238 USA.; Gladstone, GR (corresponding author), Univ Texas San Antonio, San Antonio, TX 78249 USA.	rgladstone@swri.edu	Strobel, Darrell5/AAO-6643-2021; Núñez, Jorge I./J-4027-2015; Kollmann, Peter/C-2583-2016; Zhu, Xun/C-2097-2016; Yung, Yuk/AAM-4850-2021; Hill, Matthew/H-4312-2016; Olkin, Catherine/AAF-5160-2019; Weaver, Harold A/D-9188-2016; Lisse, Carey M/B-7772-2016; Roberts, James H/I-9030-2012; Ernst, Carolyn/I-4902-2012	Strobel, Darrell5/0000-0002-0944-8675; Núñez, Jorge I./0000-0003-0930-6674; Kollmann, Peter/0000-0002-4274-9760; Zhu, Xun/0000-0001-7860-6430; Yung, Yuk/0000-0002-4263-2562; Hill, Matthew/0000-0002-5674-4936; Olkin, Catherine/0000-0002-5846-716X; Weaver, Harold A/0000-0003-0951-7762; Lisse, Carey M/0000-0002-9548-1526; Roberts, James H/0000-0003-1766-6127; Lauer, Tod/0000-0003-3234-7247; Mutchler, Maximilian/0000-0002-0088-3021; Ernst, Carolyn/0000-0002-9434-7886; Retherford, Kurt/0000-0001-9470-150X; Lavvas, Panayotis/0000-0002-5360-3660; Parker, Joel/0000-0002-3672-0603; Hinson, David/0000-0002-1620-4011; Protopapa, Silvia/0000-0001-8541-8550; Bray, Veronica/0000-0002-7277-3980	Southwest Research Institute	Southwest Research Institute	We thank the NASA's New Horizons project for their excellent and long-term support. We thank our colleagues B. Bezard, J. Erwin, F. Forget, M. Gurwell, S. Gusewich, C. Hansen, A. Heays, K. L. Jessup, V. Krasnopolsky, E. Lellouch, B. Lewis, B. Sicardy, G. Stark, K. Stothoff, A. Toigo, R. Vervack, and R. Yelle for excellent advice, data, and useful comments. We thank the reviewers for their very useful comments. S.A.S. is also affiliated with Florida Space Institute, Uwingu, Golden Spike Co., and World View Enterprises. N.J.C. was a paid consultant to Southwest Research Institute. As contractually agreed to with NASA, fully calibrated New Horizons Pluto system data will be released via the NASA Planetary Data System at https://pds.nasa.gov in a series of stages in 2016 and 2017 owing to the time required to fully downlink and calibrate the data set.	Bagenal F, 2016, SCIENCE, V351, DOI 10.1126/science.aad9045; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Bosh AS, 2015, ICARUS, V246, P237, DOI 10.1016/j.icarus.2014.03.048; BROSCH N, 1995, MON NOT R ASTRON SOC, V276, P571, DOI 10.1093/mnras/276.2.571; Brown G. N.  Jr., 1980, Advances in Cryogenic Engineering. Vol.25. Proceedings of the 1979 Cryogenic Engineering Conference, P662; Cheng AF, 2008, SPACE SCI REV, V140, P189, DOI 10.1007/s11214-007-9271-6; CRUIKSHANK DP, 1980, ICARUS, V41, P96, DOI 10.1016/0019-1035(80)90162-1; Dias-Oliveira A, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/1/53; Elliot JL, 2007, ASTRON J, V134, P1, DOI 10.1086/517998; ELLIOT JL, 1989, ICARUS, V77, P148, DOI 10.1016/0019-1035(89)90014-6; FINK U, 1980, ICARUS, V44, P62, DOI 10.1016/0019-1035(80)90055-X; FRITTS DC, 1984, REV GEOPHYS, V22, P275, DOI 10.1029/RG022i003p00275; Gladstone GR, 2015, ICARUS, V246, P279, DOI 10.1016/j.icarus.2014.04.016; Golitsyn G.S., 1975, SOVIET ASTRON LETT, P38; Grundy WM, 2016, SCIENCE, V351, DOI 10.1126/science.aad9189; Grundy WM, 2013, ICARUS, V223, P710, DOI 10.1016/j.icarus.2013.01.019; Guo YP, 2008, SPACE SCI REV, V140, P49, DOI 10.1007/s11214-007-9242-y; HART MH, 1974, ICARUS, V21, P242, DOI 10.1016/0019-1035(74)90039-6; Hinson DP, 1999, J GEOPHYS RES-PLANET, V104, P26997, DOI 10.1029/1999JE001069; Horst SM, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/1/L10; Hubbard WB, 2009, ICARUS, V204, P284, DOI 10.1016/j.icarus.2009.06.022; HUBBARD WB, 1990, ICARUS, V84, P1, DOI 10.1016/0019-1035(90)90154-2; HUBBARD WB, 1988, NATURE, V336, P452, DOI 10.1038/336452a0; INGERSOLL AP, 1985, ICARUS, V64, P375, DOI 10.1016/0019-1035(85)90062-4; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; Krasnopolsky VA, 1999, J GEOPHYS RES-PLANET, V104, P21979, DOI 10.1029/1999JE001038; Lara LM, 1997, ICARUS, V130, P16, DOI 10.1006/icar.1997.5798; Lavvas P, 2013, P NATL ACAD SCI USA, V110, P2729, DOI 10.1073/pnas.1217059110; Lellouch E, 2015, ICARUS, V246, P268, DOI 10.1016/j.icarus.2014.03.027; Lellouch E, 2009, ASTRON ASTROPHYS, V495, pL17, DOI 10.1051/0004-6361/200911633; Lellouch E., 2015, IAUC, V9273, P1; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; MAROUF EA, 1986, ICARUS, V68, P120, DOI 10.1016/0019-1035(86)90078-3; Moore JM, 2016, SCIENCE, V351, P1284, DOI 10.1126/science.aad7055; Olkin CB, 2014, ICARUS, V239, P15, DOI 10.1016/j.icarus.2014.05.018; Person MJ, 2008, ASTRON J, V136, P1510, DOI 10.1088/0004-6256/136/4/1510; Reuter DC, 2008, SPACE SCI REV, V140, P129, DOI 10.1007/s11214-008-9375-7; Sicardy B, 2003, NATURE, V424, P168, DOI 10.1038/nature01766; Spencer J.R., 1997, PLUTO CHARON, P435; STANSBERRY JA, 1994, ICARUS, V111, P503, DOI 10.1006/icar.1994.1160; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; Stern SA, 2008, SPACE SCI REV, V140, P155, DOI 10.1007/s11214-008-9407-3; Strobel DF, 1996, ICARUS, V120, P266, DOI 10.1006/icar.1996.0050; Sumillers M. E., 1997, PLATO AND CHARON, P391; Toigo AD, 2010, ICARUS, V208, P402, DOI 10.1016/j.icarus.2010.01.027; TRAFTON L, 1983, ASTROPHYS J, V267, P872, DOI 10.1086/160921; Tucker OJ, 2015, ICARUS, V246, P291, DOI 10.1016/j.icarus.2014.05.002; Tyler GL, 2008, SPACE SCI REV, V140, P217, DOI 10.1007/s11214-007-9302-3; Wong ML, 2015, ICARUS, V246, P192, DOI 10.1016/j.icarus.2014.05.019; Young EF, 2008, ASTRON J, V136, P1757, DOI 10.1088/0004-6256/136/5/1757; Young L.A, 1994, THESIS MIT; Young LA, 2012, ICARUS, V221, P80, DOI 10.1016/j.icarus.2012.06.032; Young LA, 2008, SPACE SCI REV, V140, P93, DOI 10.1007/s11214-008-9462-9; Zalucha AM, 2011, ICARUS, V211, P804, DOI 10.1016/j.icarus.2010.08.018; Zhu X, 2014, ICARUS, V228, P301, DOI 10.1016/j.icarus.2013.10.011	55	158	159	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279							aad8866	10.1126/science.aad8866	http://dx.doi.org/10.1126/science.aad8866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989258	Green Submitted, Green Accepted			2022-12-28	WOS:000372397700031
J	Mayor, S				Mayor, Susan			Paracetamol does not reduce pain or improve function in osteoarthritis, study shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		da Costa BR, 2017, LANCET, V390, pE21, DOI 10.1016/S0140-6736(17)31744-0; Moore N, 2016, LANCET, V387, P2065, DOI 10.1016/S0140-6736(15)01170-8	2	1	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2016	352								i1609	10.1136/bmj.i1609	http://dx.doi.org/10.1136/bmj.i1609			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AI	26994150				2022-12-28	WOS:000372586000004
J	Moore, JM; McKinnon, WB; Spencer, JR; Howard, AD; Schenk, PM; Beyer, RA; Nimmo, F; Singer, KN; Umurhan, OM; White, OL; Stern, SA; Ennico, K; Olkin, CB; Weaver, HA; Young, LA; Binzel, RP; Buie, MW; Buratti, BJ; Cheng, AF; Cruikshank, DP; Grundy, WM; Linscott, IR; Reitsema, HJ; Reuter, DC; Showalter, MR; Bray, VJ; Chavez, CL; Howett, CJA; Lauer, TR; Lisse, CM; Parker, AH; Porter, SB; Robbins, SJ; Runyon, K; Stryk, T; Throop, HB; Tsang, CCC; Verbiscer, AJ; Zangari, AM; Chaikin, AL; Wilhelms, DE				Moore, Jeffrey M.; McKinnon, William B.; Spencer, John R.; Howard, Alan D.; Schenk, Paul M.; Beyer, Ross A.; Nimmo, Francis; Singer, Kelsi N.; Umurhan, Orkan M.; White, Oliver L.; Stern, S. Alan; Ennico, Kimberly; Olkin, Cathy B.; Weaver, Harold A.; Young, Leslie A.; Binzel, Richard P.; Buie, Marc W.; Buratti, Bonnie J.; Cheng, Andrew F.; Cruikshank, Dale P.; Grundy, Will M.; Linscott, Ivan R.; Reitsema, Harold J.; Reuter, Dennis C.; Showalter, Mark R.; Bray, Veronica J.; Chavez, Carrie L.; Howett, Carly J. A.; Lauer, Tod R.; Lisse, Carey M.; Parker, Alex Harrison; Porter, S. B.; Robbins, Stuart J.; Runyon, Kirby; Stryk, Ted; Throop, Henry B.; Tsang, Constantine C. C.; Verbiscer, Anne J.; Zangari, Amanda M.; Chaikin, Andrew L.; Wilhelms, Don E.		New Horizons Sci Team	The geology of Pluto and Charon through the eyes of New Horizons	SCIENCE			English	Article							SATELLITES; NITROGEN	NASA's New Horizons spacecraft has revealed the complex geology of Pluto and Charon. Pluto's encounter hemisphere shows ongoing surface geological activity centered on a vast basin containing a thick layer of volatile ices that appears to be involved in convection and advection, with a crater retention age no greater than similar to 10 million years. Surrounding terrains show active glacial flow, apparent transport and rotation of large buoyant water-ice crustal blocks, and pitting, the latter likely caused by sublimation erosion and/or collapse. More enigmatic features include tall mounds with central depressions that are conceivably cryovolcanic and ridges with complex bladed textures. Pluto also has ancient cratered terrains up to similar to 4 billion years old that are extensionally faulted and extensively mantled and perhaps eroded by glacial or other processes. Charon does not appear to be currently active, but experienced major extensional tectonism and resurfacing (probably cryovolcanic) nearly 4 billion years ago. Impact crater populations on Pluto and Charon are not consistent with the steepest impactor size-frequency distributions proposed for the Kuiper belt.	[Moore, Jeffrey M.; Beyer, Ross A.; Umurhan, Orkan M.; White, Oliver L.; Ennico, Kimberly; Cruikshank, Dale P.; Chavez, Carrie L.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [McKinnon, William B.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Spencer, John R.; Singer, Kelsi N.; Stern, S. Alan; Olkin, Cathy B.; Young, Leslie A.; Buie, Marc W.; Reitsema, Harold J.; Howett, Carly J. A.; Parker, Alex Harrison; Porter, S. B.; Robbins, Stuart J.; Tsang, Constantine C. C.; Zangari, Amanda M.] SW Res Inst, Boulder, CO 80302 USA; [Howard, Alan D.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Schenk, Paul M.] Lunar & Planetary Inst, 3303 NASA Rd 1, Houston, TX 77058 USA; [Beyer, Ross A.; Showalter, Mark R.; Chavez, Carrie L.] SETI Inst, Mountain View, CA 94043 USA; [Nimmo, Francis] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Weaver, Harold A.; Cheng, Andrew F.; Lisse, Carey M.; Runyon, Kirby] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA; [Binzel, Richard P.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Buratti, Bonnie J.] NASA, Jet Prop Lab, Pasadena, CA 91019 USA; [Grundy, Will M.] Lowell Observ, Flagstaff, AZ 86001 USA; [Linscott, Ivan R.] Stanford Univ, Stanford, CA 94305 USA; [Reuter, Dennis C.] NASA, Goddard Space Flight Ctr, Code 661, Greenbelt, MD 20771 USA; [Bray, Veronica J.] Univ Arizona, Tucson, AZ 85721 USA; [Lauer, Tod R.] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Stryk, Ted] Roane State Community Coll, Oak Ridge, TN 37830 USA; [Throop, Henry B.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Verbiscer, Anne J.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Wilhelms, Don E.] US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Washington University (WUSTL); University of Virginia; National Aeronautics & Space Administration (NASA); University of California System; University of California Santa Cruz; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Massachusetts Institute of Technology (MIT); National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Stanford University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; National Optical Astronomy Observatory; University of Virginia; United States Department of the Interior; United States Geological Survey	Moore, JM (corresponding author), NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA.	jeff.moore@nasa.gov	Núñez, Jorge I./J-4027-2015; Lisse, Carey M/B-7772-2016; Olkin, Catherine/AAF-5160-2019; Weaver, Harold A/D-9188-2016; Hill, Matthew/H-4312-2016; Barnouin, Olivier S/I-7475-2015; Kollmann, Peter/C-2583-2016; Bray, Veronica/K-6914-2017; Runyon, Kirby D/J-2878-2017; Roberts, James H/I-9030-2012; Ernst, Carolyn/I-4902-2012	Núñez, Jorge I./0000-0003-0930-6674; Lisse, Carey M/0000-0002-9548-1526; Olkin, Catherine/0000-0002-5846-716X; Weaver, Harold A/0000-0003-0951-7762; Hill, Matthew/0000-0002-5674-4936; Barnouin, Olivier S/0000-0002-3578-7750; Kollmann, Peter/0000-0002-4274-9760; Runyon, Kirby D/0000-0001-6361-6548; Roberts, James H/0000-0003-1766-6127; Porter, Simon/0000-0003-0333-6055; Lauer, Tod/0000-0003-3234-7247; Mutchler, Maximilian/0000-0002-0088-3021; Beyer, Ross/0000-0003-4503-3335; Reitsema, Harold/0000-0002-4119-5700; Parker, Joel/0000-0002-3672-0603; Grundy, Will/0000-0002-8296-6540; Ernst, Carolyn/0000-0002-9434-7886; Protopapa, Silvia/0000-0001-8541-8550; Bray, Veronica/0000-0002-7277-3980	NASA's New Horizons project	NASA's New Horizons project	We thank the many engineers who have contributed to the success of the New Horizons mission and NASA's Deep Space Network for a decade of excellent support to New Horizons. We thank the reviewers for close and meticulous reading, and P. Engebretson for contribution to figure production. S.A.S. is also affiliated with Florida Space Institute, Uwingu LLC, Golden Spike Co., and World View Enterprises. H.J.R. is also affiliated with B612 Foundation and Cornell Technical Service. Supporting imagery is available in the supplementary materials. As contractually agreed to with NASA, fully calibrated New Horizons Pluto system data will be released via the NASA Planetary Data System at https://pds.nasa.gov/ in a series of stages in 2016 and 2017 as the data set is fully downlinked and calibrated. This work was supported by NASA's New Horizons project.	Brozovic M, 2015, ICARUS, V246, P317, DOI 10.1016/j.icarus.2014.03.015; Collins G. C., 2010, PLANETARY TECTONICS, P264, DOI [10.1017/CBO9780511691645.008, DOI 10.1017/CBO9780511691645.008]; ELUSZKIEWICZ J, 1990, GEOPHYS RES LETT, V17, P1753, DOI 10.1029/GL017i010p01753; Gladstone GR, 2016, SCIENCE, V351, DOI 10.1126/science.aad8866; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Greenstreet S, 2015, ICARUS, V258, P267, DOI 10.1016/j.icarus.2015.05.026; Grundy WM, 2016, SCIENCE, V351, DOI 10.1126/science.aad9189; JANKOWSKI DG, 1988, SCIENCE, V241, P1322, DOI 10.1126/science.241.4871.1322; Manga M., 2007, GEOPHYS RES LETT, V34; McKinnon WB, 2015, TREATISE GEOPHYS, V10, P637; Moore JM, 2015, ICARUS, V246, P65, DOI 10.1016/j.icarus.2014.04.028; Prockter LM, 2010, SPACE SCI REV, V153, P63, DOI 10.1007/s11214-010-9649-8; Reuter DC, 2008, SPACE SCI REV, V140, P129, DOI 10.1007/s11214-008-9375-7; Robuchon G, 2011, ICARUS, V216, P426, DOI 10.1016/j.icarus.2011.08.015; Schaller EL, 2007, ASTROPHYS J, V659, pL61, DOI 10.1086/516709; Schenk PM, 1998, ASTROPHYS SPACE SC L, V227, P551, DOI 10.1007/978-94-011-5252-5_23; Schubert G, 2010, SPACE SCI REV, V153, P447, DOI 10.1007/s11214-010-9635-1; Singer KN, 2015, ASTROPHYS J LETT, V808, DOI 10.1088/2041-8205/808/2/L50; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; Weaver HA, 2008, SPACE SCI REV, V140, P75, DOI 10.1007/s11214-008-9376-6; Yamashita Y, 2010, ICARUS, V207, P972, DOI 10.1016/j.icarus.2009.11.032; Young LA, 2008, SPACE SCI REV, V140, P93, DOI 10.1007/s11214-008-9462-9	22	170	172	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1284	1293		10.1126/science.aad7055	http://dx.doi.org/10.1126/science.aad7055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989245	Green Submitted			2022-12-28	WOS:000372397700035
J	Pain, S				Pain, Stephanie			The rise of the urbanite	NATURE			English	Editorial Material																			0	6	6	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S50	S51		10.1038/531S50a	http://dx.doi.org/10.1038/531S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VH2TY	26981726	Green Published, Bronze			2022-12-28	WOS:000452214000001
J	Wise, J				Wise, Jacqui			Abrupt quitting is more likely to work than gradual reduction of cigarettes, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lindson-Hawley N, 2016, ANN INTERN MED, V164, P585, DOI 10.7326/M14-2805	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2016	352								i1521	10.1136/bmj.i1521	http://dx.doi.org/10.1136/bmj.i1521			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1ZT	26980739				2022-12-28	WOS:000372584400023
J	Bornscheuer, UT				Bornscheuer, Uwe T.			Feeding on plastic	SCIENCE			English	Editorial Material									[Bornscheuer, Uwe T.] Ernst Moritz Arndt Univ Greifswald, Dept Biotechnol & Enzyme Catalysis, Inst Biochem, D-17489 Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald	Bornscheuer, UT (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Biotechnol & Enzyme Catalysis, Inst Biochem, D-17489 Greifswald, Germany.	uwe.bornscheuer@uni-greifswald.de	Bornscheuer, Uwe T/C-4612-2012	Bornscheuer, Uwe T/0000-0003-0685-2696				Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Bornscheuer U, 2014, ANGEW CHEM INT EDIT, V53, P10876, DOI 10.1002/anie.201309953; Chung H, 2015, CURR OPIN BIOTECH, V36, P73, DOI 10.1016/j.copbio.2015.07.003; Law KL, 2014, SCIENCE, V345, P144, DOI 10.1126/science.1254065; MacArthur Ellen, 2016, WORLD EC FORUM; Muschiol J, 2015, CHEM COMMUN, V51, P5798, DOI 10.1039/c4cc08752f; Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a; Sefternick J.L., 2001, J BACTERIOL, V183, P2405; Wei R, 2016, BIOTECHNOL BIOENG, V113, P1658, DOI 10.1002/bit.25941; Yoshida S, 2016, SCIENCE, V351, P1196, DOI 10.1126/science.aad6359	10	83	86	19	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1154	1155		10.1126/science.aaf2853	http://dx.doi.org/10.1126/science.aaf2853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965614				2022-12-28	WOS:000386158400028
J	Kintzer, AF; Stroud, RM				Kintzer, Alexander F.; Stroud, Robert M.			Structure, inhibition and regulation of two-pore channel TPC1 from Arabidopsis thaliana	NATURE			English	Article							ION-CHANNEL; CRYSTAL-STRUCTURE; SEQUENCE ALIGNMENT; NAADP; CALCIUM; PREDICTION; SHAKER; ACTIVATION; MECHANISM; PROTEINS	Two-pore channels (TPCs) comprise a subfamily (TPC1-3) of eukaryotic voltage-and ligand-gated cation channels(1,2) with two non-equivalent tandem pore-forming subunits that dimerize to form quasi-tetramers. Found in vacuolar(3) or endolysosomal(4) membranes, they regulate the conductance of sodium(5) and calcium(3,6) ions, intravesicular pH(5), trafficking(7) and excitability(8,9). TPCs are activated by a decrease in transmembrane potential(1,3,9,10) and an increase in cytosolic calcium concentrations(1,10), are inhibited by low luminal pH and calcium(11), and are regulated by phosphorylation(12,13). Here we report the crystal structure of TPC1 from Arabidopsis thaliana at 2.87 angstrom resolution as a basis for understanding ion permeation(3,4,10), channel activation(1,5,10), the location of voltage-sensing domains(1,9,10) and regulatory ion-binding sites(11,14). We determined sites of phosphorylation3,4 in the amino-terminal and carboxy-terminal domains that are positioned to allosterically modulate cytoplasmic Ca2+ activation. One of the two voltage-sensing domains (VSD2) encodes voltage sensitivity and inhibition by luminal Ca2+ and adopts a conformation distinct from the activated state observed in structures of other voltage-gated ion channels(15,16). The structure shows that potent pharmacophore trans-Ned-19 (ref. 17) acts allosterically by clamping the pore domains to VSD2. In animals, Ned-19 prevents infection by Ebola virus and other filoviruses, presumably by altering their fusion with the endolysosome and delivery of their contents into the cytoplasm(7).	[Kintzer, Alexander F.; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	stroud@msg.ucsf.edu		Kintzer, Alexander/0000-0001-9630-7258	NIH [GM24485]; Sandler Foundation; NIGMS [P41-GM103311, P41-RR001614]; National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393];  [MR-15-328599]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311, R01GM024485, P41GM103393, R37GM024485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. M. Holton and G. Meigs at ALS beamline 8.3.1 and A. Gonzalez at SSRL beamline 12-2 for help with data collection and processing, B. P. Pedersen, B. H. Schmidt and J. S. Finer-Moore for critical analysis of the manuscript. This work was supported by NIH grant GM24485 to R.M.S. Beamline 8.3.1 at the Advanced Light Source is operated by the University of California Office of the President, Multicampus Research Programs and Initiatives grant MR-15-328599 and Program for Breakthrough Biomedical Research, which is partially funded by the Sandler Foundation. Figures were made with Chimera developed by the Resource for Biocomputing, Visualization and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311), and PyMOL developed by W. DeLano. Mass spectrometry was carried out by the UCSF mass spectrometry facility (supported by NIGMS P41-RR001614). The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARMSTRONG CM, 1966, J GEN PHYSIOL, V50, P491, DOI 10.1085/jgp.50.2.491; Beyhl D, 2009, PLANT J, V58, P715, DOI 10.1111/j.1365-313X.2009.03820.x; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2014, NAT CHEM BIOL, V10, P463, DOI 10.1038/nchembio.1522; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; HEDRICH R, 1986, FEBS LETT, V204, P228, DOI 10.1016/0014-5793(86)80817-1; HEDRICH R, 1987, NATURE, V329, P833, DOI 10.1038/329833a0; Hedrich R, 2011, MOL PLANT, V4, P428, DOI 10.1093/mp/ssr017; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Morgan AJ, 2015, BIOCHEM SOC T, V43, P384, DOI 10.1042/BST20140300; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; Patel S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3314; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pedersen BP, 2010, ACTA CRYSTALLOGR D, V66, P309, DOI 10.1107/S0907444909053244; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Peterson BZ, 1996, J BIOL CHEM, V271, P5293, DOI 10.1074/jbc.271.10.5293; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pitt SJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004854; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Schulze C, 2011, PLANT J, V68, P424, DOI 10.1111/j.1365-313X.2011.04697.x; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	51	113	114	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					258	+		10.1038/nature17194	http://dx.doi.org/10.1038/nature17194			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26961658	Green Submitted, Green Accepted			2022-12-28	WOS:000371665100047
J	Stoeger, T; Battich, N; Pelkmans, L				Stoeger, Thomas; Battich, Nico; Pelkmans, Lucas			Passive Noise Filtering by Cellular Compartmentalization	CELL			English	Review							STOCHASTIC GENE-EXPRESSION; MESSENGER-RNA EXPORT; NF-KAPPA-B; CELLS; VARIABILITY; ORIGINS; EVOLUTION; MEMBRANE; SEQUENCE; PROTEIN	Chemical reactions contain an inherent element of randomness, which presents itself as noise that interferes with cellular processes and communication. Here we discuss the ability of the spatial partitioning of molecular systems to filter and, thus, remove noise, while preserving regulated and predictable differences between single living cells. In contrast to active noise filtering by network motifs, cellular compartmentalization is highly effective and easily scales to numerous systems without requiring a substantial usage of cellular energy. We will use passive noise filtering by the eukaryotic cell nucleus as an example of how this increases predictability of transcriptional output, with possible implications for the evolution of complex multicellularity.	[Stoeger, Thomas; Battich, Nico; Pelkmans, Lucas] Univ Zurich, Fac Sci, Inst Mol Life Sci, CH-8006 Zurich, Switzerland; [Stoeger, Thomas; Battich, Nico] ETH, Life Sci Zurich Grad Sch, Syst Biol PhD Program, CH-8006 Zurich, Switzerland; [Stoeger, Thomas; Battich, Nico] Univ Zurich, CH-8006 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Pelkmans, L (corresponding author), Univ Zurich, Fac Sci, Inst Mol Life Sci, CH-8006 Zurich, Switzerland.	lucas.pelkmans@imls.uzh.ch	Battich, Nico/AAL-3955-2020	Battich, Nico/0000-0002-1700-1590; Pelkmans, Lucas/0000-0002-6754-9730; Stoeger, Thomas/0000-0002-5540-4278	Swiss National Science Foundation; Canton of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Zurich	The authors would like to thank all lab members for stimulating discussions, Felix Naef for insightful comments, Shalev Itzkovitz for sharing his work prior to publication, and Doris Berchtold for assistance with illustrations. The order of appearance of T.S. and N.B. in this review and related studies (Battich et al., 2013, 2015; Stoeger et al., 2015) reflects the outcome of a single random event (coin toss). L.P. acknowledges financial support from the Swiss National Science Foundation and the Canton of Zurich.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Albert J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134239; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141; Battich N, 2015, CELL, V163, P1596, DOI 10.1016/j.cell.2015.11.018; Battich N, 2013, NAT METHODS, V10, P1127, DOI 10.1038/nmeth.2657; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bies D.A., 2009, THEORY PRACTICE, V745; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; BOGORAD L, 1975, SCIENCE, V188, P891, DOI 10.1126/science.1138359; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chen AH, 2012, TRENDS CELL BIOL, V22, P662, DOI 10.1016/j.tcb.2012.07.002; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Costa A, 2013, ANNU REV BIOCHEM, V82, P25, DOI 10.1146/annurev-biochem-052610-094414; Culjkovic B, 2006, J CELL BIOL, V175, P415, DOI 10.1083/jcb.200607020; Diekmann Y, 2013, BIOCHEM J, V449, P319, DOI 10.1042/BJ20120957; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dolce M, 2000, EARTHQUAKE ENG STRUC, V29, P945, DOI 10.1002/1096-9845(200007)29:7<945::AID-EQE958>3.0.CO;2-#; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Erdmann T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.258101; Franchek MA, 1996, J SOUND VIB, V189, P565, DOI 10.1006/jsvi.1996.0037; Frechin M, 2015, NATURE, V523, P88, DOI 10.1038/nature14429; FUERST JA, 1991, P NATL ACAD SCI USA, V88, P8184, DOI 10.1073/pnas.88.18.8184; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Grunwald D, 2010, NATURE, V467, P604, DOI 10.1038/nature09438; GUSELLA J, 1976, CELL, V9, P221, DOI 10.1016/0092-8674(76)90113-6; Gut G, 2015, NAT METHODS, V12, P951, DOI [10.1038/NMETH.3545, 10.1038/nmeth.3545]; Halpern KB, 2015, CELL REP, V13, P2653, DOI 10.1016/j.celrep.2015.11.036; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hopgood A.A., 2012, INT SYST ENG SCIENT; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Johnston RJ, 2010, ANNU REV CELL DEV BI, V26, P689, DOI 10.1146/annurev-cellbio-100109-104113; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; KO MSH, 1991, J THEOR BIOL, V153, P181, DOI 10.1016/S0022-5193(05)80421-7; Kusumi A, 1996, CURR OPIN CELL BIOL, V8, P566, DOI 10.1016/S0955-0674(96)80036-6; Kusumi A, 2012, ANNU REV CELL DEV BI, V28, P215, DOI 10.1146/annurev-cellbio-100809-151736; Lan GH, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0489; Lei HX, 2011, P NATL ACAD SCI USA, V108, P17985, DOI 10.1073/pnas.1113076108; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Libby E, 2014, SCIENCE, V346, P426, DOI 10.1126/science.1262053; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Lopez-Garcia P, 2006, BIOESSAYS, V28, P525, DOI 10.1002/bies.20413; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Luby-Phelps K, 2013, MOL BIOL CELL, V24, P2593, DOI 10.1091/mbc.E12-08-0617; Madhani HD, 2013, CELL, V155, P744, DOI 10.1016/j.cell.2013.10.003; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; MAUL GG, 1972, J CELL BIOL, V55, P433, DOI 10.1083/jcb.55.2.433; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Mellis IA, 2015, GENOME RES, V25, P1466, DOI 10.1101/gr.190579.115; Mugler A, 2013, P NATL ACAD SCI USA, V110, P5927, DOI 10.1073/pnas.1218301110; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rao MD, 2003, J SOUND VIB, V262, P457, DOI 10.1016/S0022-460X(03)00106-8; Saunders TE, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.022704; Saunders TE, 2012, DEV CELL, V22, P558, DOI 10.1016/j.devcel.2012.01.001; Sero JE, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145644; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Singh A, 2012, BIOPHYS J, V103, P1087, DOI 10.1016/j.bpj.2012.07.015; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Stoeger T, 2015, METHODS, V85, P44, DOI 10.1016/j.ymeth.2015.05.016; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Tan CM, 2013, NAT NANOTECHNOL, V8, P602, DOI [10.1038/NNANO.2013.132, 10.1038/nnano.2013.132]; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thompson A, 1997, LECT NOTES COMPUT SC, V1259, P390; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Ver IL, 2006, NOISE AND VIBRATION CONTROL ENGINEERING: PRINCIPLES AND APPLICATIONS, 2ND EDITION, P1; Vinogradov AE, 1998, J THEOR BIOL, V193, P197, DOI 10.1006/jtbi.1997.0629; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Weber SC, 2012, CELL, V149, P1188, DOI 10.1016/j.cell.2012.05.022; Wong JV, 2011, MOL CELL, V41, P275, DOI 10.1016/j.molcel.2011.01.014; Wurm CA, 2011, P NATL ACAD SCI USA, V108, P13546, DOI 10.1073/pnas.1107553108; Xiong LP, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016005	93	64	66	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1151	1161		10.1016/j.cell.2016.02.005	http://dx.doi.org/10.1016/j.cell.2016.02.005			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967282	Bronze			2022-12-28	WOS:000372784900013
J	Lai, FYX; Groschel, MIP; van den Hende, L; Diercks, GFH; Rutgers, A; van der Werf, TS				Lai, Francis Y. X.; Groschel, Matthias I. P.; van den Hende, Lisette; Diercks, Gilles F. H.; Rutgers, Abraham; van der Werf, Tjip S.			Prolonged pyrexia and subtle skin lesions: polyarteritis nodosa	LANCET			English	Editorial Material									[Lai, Francis Y. X.] Monash Univ, Monash Hlth, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3004, Australia; [Groschel, Matthias I. P.; van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [Groschel, Matthias I. P.; van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [van den Hende, Lisette] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med Acute Med, NL-9700 RB Groningen, Netherlands; [Diercks, Gilles F. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9700 RB Groningen, Netherlands; [Rutgers, Abraham] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, NL-9700 RB Groningen, Netherlands	Monash University; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	van der Werf, TS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Hanzepl 1, NL-9700 RB Groningen, Netherlands.; van der Werf, TS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	t.s.van.der.werf@umcg.nl	Groeschel, Matthias/AAI-5984-2021; Diercks, Gilles/P-7413-2019	van der Werf, Tjip/0000-0002-4824-1642; Diercks, Gilles/0000-0001-8053-216X				Colmegna Ines, 2005, Curr Rheumatol Rep, V7, P288, DOI 10.1007/s11926-005-0039-2; Henegar C, 2008, ARTHRITIS RHEUM-US, V58, P1528, DOI 10.1002/art.23470; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kussmaul A, 1866, DTSCH ARCH KLIN MED, P484; Pang CL, 2012, BMJ CASE REP, V2012	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					1025	+		10.1016/S0140-6736(16)00501-8	http://dx.doi.org/10.1016/S0140-6736(16)00501-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF8XP	26972245				2022-12-28	WOS:000371644200035
J	Rosen, ED				Rosen, Evan D.			Burning Fat by Bugging the System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OBESITY; TALK		[Rosen, Evan D.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Rosen, Evan D.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Rosen, ED (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.; Rosen, ED (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.							Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414	5	0	0	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					885	887		10.1056/NEJMcibr1515457	http://dx.doi.org/10.1056/NEJMcibr1515457			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF2FT	26962910				2022-12-28	WOS:000371158400018
J	Herguedas, B; Garcia-Nafria, J; Cais, O; Fernandez-Leiro, R; Krieger, J; Ho, HZ; Greger, IH				Herguedas, Beatriz; Garcia-Nafria, Javier; Cais, Ondrej; Fernandez-Leiro, Rafael; Krieger, James; Ho, Hinze; Greger, Ingo H.			Structure and organization of heteromeric AMPA-type glutamate receptors	SCIENCE			English	Article							N-TERMINAL DOMAIN; CRYO-EM; QUATERNARY STRUCTURE; SUBUNIT ARRANGEMENT; DYNAMICS; NMDA; BINDING; DESENSITIZATION; ACTIVATION; MECHANISM	AMPA-type glutamate receptors (AMPARs), which are central mediators of rapid neurotransmission and synaptic plasticity, predominantly exist as heteromers of the subunits GluA1 to GluA4. Here we report the first AMPAR heteromer structures, which deviate substantially from existing GluA2 homomer structures. Crystal structures of the GluA2/3 and GluA2/4 N-terminal domains reveal a novel compact conformation with an alternating arrangement of the four subunits around a central axis. This organization is confirmed by cysteine cross-linking in full-length receptors, and it permitted us to determine the structure of an intact GluA2/3 receptor by cryogenic electron microscopy. Two models in the ligand-free state, at resolutions of 8.25 and 10.3 angstroms, exhibit substantial vertical compression and close associations between domain layers, reminiscent of N-methyl-D-aspartate receptors. Model 1 resembles a resting state and model 2 a desensitized state, thus providing snapshots of gating transitions in the nominal absence of ligand. Our data reveal organizational features of heteromeric AMPARs and provide a framework to decipher AMPAR architecture and signaling.	[Herguedas, Beatriz; Garcia-Nafria, Javier; Cais, Ondrej; Krieger, James; Ho, Hinze; Greger, Ingo H.] MRC, Mol Biol Lab, Div Neurobiol, Hills Rd, Cambridge CB2 2QH, England; [Fernandez-Leiro, Rafael] MRC, Mol Biol Lab, Struct Studies Div, Hills Rd, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology; MRC Laboratory Molecular Biology	Greger, IH (corresponding author), MRC, Mol Biol Lab, Div Neurobiol, Hills Rd, Cambridge CB2 2QH, England.	ig@mrc-lmb.cam.ac.uk	Krieger, James Michael/T-5806-2019; Garcia, Javier/R-5524-2019; Krieger, James Michael/AAS-7650-2020; Fernandez-Leiro, Rafael/L-6095-2017; Herguedas, Beatriz/AAB-8665-2022	Krieger, James Michael/0000-0001-6194-6244; Garcia, Javier/0000-0002-4254-3148; Fernandez-Leiro, Rafael/0000-0002-7941-0357; Ho, Hinze/0000-0003-1082-9851; Herguedas, Beatriz/0000-0003-2044-4795; Greger, Ingo/0000-0002-7291-2581	Medical Research Council [MC_U105174197]; MRC [MC_U105174197] Funding Source: UKRI; Medical Research Council [1273975] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank O. Paulsen, A. Penn, and M. Farrant for comments on the manuscript. We also acknowledge P. da Fonseca and S. Scherer for helpful comments regarding cryo-EM, N. Unwin for carbon-coated grids, and C. Savva for help with the EM We thank the staff at the Diamond Light Source (beamline I04-1) for the provision of synchrotron facilities. EH., J.G.-N., O.C., R.F.-L., J.K., H.H., and I.H.G. were supported by the Medical Research Council (MC_U105174197). Coordinates and structure factors for the NTD have been deposited in the PDB under IDs 5FWX (GluA2/4) and 5FWY (GluA2/3). The cryo-EM density maps representing GluA2/3 model I and GluA2/3 model II have been deposited in Electron Microscopy Data Bank with accession numbers EMD 8090 and EMD 8091; respectively, and the corresponding models have been deposited in the PDB under IDs 5IDE and 5IDF.	Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Cais O, 2014, CELL REP, V9, P728, DOI 10.1016/j.celrep.2014.09.029; Chen L, 2014, SCIENCE, V345, P1021, DOI 10.1126/science.1258409; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; DeLano WL, 2002, THE PYMOL MOLECULAR; Durr KL, 2014, CELL, V158, P778, DOI 10.1016/j.cell.2014.07.023; Dutta A, 2015, STRUCTURE, V23, P1692, DOI 10.1016/j.str.2015.07.002; Dutta A, 2012, STRUCTURE, V20, P1838, DOI 10.1016/j.str.2012.08.012; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Eyal E, 2015, BIOINFORMATICS, V31, P1487, DOI 10.1093/bioinformatics/btu847; Garcia-Nafria J, 2016, J PHYSIOL-LONDON, V594, P5449, DOI 10.1113/JP271844; Gonzalez J, 2010, P NATL ACAD SCI USA, V107, P9891, DOI 10.1073/pnas.0911854107; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Herguedas B, 2013, PROG MOL BIOL TRANSL, V117, P361, DOI 10.1016/B978-0-12-386931-9.00013-1; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2014, CURR OPIN STRUC BIOL, V27, P1, DOI 10.1016/j.sbi.2014.02.005; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyerson JR, 2014, NATURE, V514, P328, DOI 10.1038/nature13603; Midgett CR, 2008, J MOL BIOL, V382, P578, DOI 10.1016/j.jmb.2008.07.021; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Orain D, 2012, BIOORG MED CHEM LETT, V22, P996, DOI 10.1016/j.bmcl.2011.12.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Robert A, 2003, J NEUROSCI, V23, P847; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Seiradake Elena, 2015, Methods Mol Biol, V1261, P115, DOI 10.1007/978-1-4939-2230-7_6; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Suhre K, 2006, ACTA CRYSTALLOGR D, V62, P1098, DOI 10.1107/S090744490602244X; Sukumaran M, 2011, EMBO J, V30, P972, DOI 10.1038/emboj.2011.17; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Xu CY, 2003, J MOL BIOL, V333, P153, DOI 10.1016/j.jmb.2003.08.027; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhu SJ, 2015, CURR OPIN PHARMACOL, V20, P14, DOI 10.1016/j.coph.2014.10.009	68	78	78	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2016	352	6285							aad3873	10.1126/science.aad3873	http://dx.doi.org/10.1126/science.aad3873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5ZA	26966189	Green Accepted			2022-12-28	WOS:000374998600036
J	Cook, AK; Schimler, SD; Matzger, AJ; Sanford, MS				Cook, Amanda K.; Schimler, Sydonie D.; Matzger, Adam J.; Sanford, Melanie S.			Catalyst-controlled selectivity in the C-H borylation of methane and ethane	SCIENCE			English	Article							REGIOSPECIFIC FUNCTIONALIZATION; BONDS; ACTIVATION; ALKANES; COMPLEXES; CHEMISTRY; INSIGHTS; ORIGINS	The C-H bonds of methane are generally more kinetically inert than those of other hydrocarbons, reaction solvents, and methane functionalization products. Thus, developing strategies to achieve selective functionalization of CH4 remains a major challenge. Here, we report transitionmetal-catalyzed C-H borylation ofmethane with bis-pinacolborane (B(2)pin(2)) in cyclohexane solvent at 150 degrees C under 2800 to 3500 kilopascals of methane pressure. Iridium, rhodium, and ruthenium complexes all catalyze the reaction. Formation of mono-versus diborylatedmethane is tunable as a function of catalyst, with the ruthenium complex providing the highest ratio of CH(3)Bpin to CH2 (Bpin)(2). Despite the high relative concentration of cyclohexane, minimal quantities of borylated cyclohexane products are observed. Furthermore, all three metal complexes catalyze borylation of methane with >3.5:1 selectivity over ethane.	[Cook, Amanda K.; Schimler, Sydonie D.; Matzger, Adam J.; Sanford, Melanie S.] Univ Michigan, Dept Chem, 930 North Univ Ave, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sanford, MS (corresponding author), Univ Michigan, Dept Chem, 930 North Univ Ave, Ann Arbor, MI 48109 USA.	mssanfor@umich.edu	Matzger, Adam J/G-7497-2016; Cook, Amanda/T-9961-2019; Sanford, Melanie/G-8619-2016; Cook, Amanda/C-4821-2016	Matzger, Adam J/0000-0002-4926-2752; Sanford, Melanie/0000-0001-9342-9436; Cook, Amanda/0000-0003-3501-8502	NSF under the Centers for Chemical Innovation (CCI) Center for Enabling New Technologies through Catalysis (CENTC) [CHE-1205189]; U.S. Department of Energy Office of Basic Energy Sciences [DE-FG02-08ER 15997]; NSF under CCI CENTC [CHE-1205189]; Direct For Mathematical & Physical Scien [1205189] Funding Source: National Science Foundation	NSF under the Centers for Chemical Innovation (CCI) Center for Enabling New Technologies through Catalysis (CENTC); U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF under CCI CENTC; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The work conducted by A.K.C. (primarily involving evaluation of catalysts 1 and 2/3) was supported by NSF under the Centers for Chemical Innovation (CCI) Center for Enabling New Technologies through Catalysis (CENTC) Phase II Renewal, CHE-1205189. The work conducted by S.D.S. (primarily involving evaluation of catalyst 4 and gas solubility measurements) was supported by the U.S. Department of Energy Office of Basic Energy Sciences (contract DE-FG02-08ER 15997). The Parr reactors used in this work were purchased with funds from the NSF, under the CCI CENTC Phase II Renewal, CHE-1205189. We gratefully acknowledge D. Samblanet for assistance with the gas solubility measurements. The University of Michigan has filed for a provisional patent on this work.	Blanksby SJ, 2003, ACCOUNTS CHEM RES, V36, P255, DOI 10.1021/ar020230d; Caballero A, 2013, CHEM SOC REV, V42, P8809, DOI 10.1039/c3cs60120j; Caballero A, 2011, SCIENCE, V332, P835, DOI 10.1126/science.1204131; Cavaliere VN, 2012, ADV ORGANOMET CHEM, V60, P1, DOI 10.1016/B978-0-12-396970-5.00001-3; Chen HY, 1999, ANGEW CHEM INT EDIT, V38, P3391, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3391::AID-ANIE3391>3.0.CO;2-N; Chen HY, 2000, SCIENCE, V287, P1995, DOI 10.1126/science.287.5460.1995; Choi J, 2011, CHEM REV, V111, P1761, DOI 10.1021/cr1003503; Chotana GA, 2009, CHEM COMMUN, P5731, DOI 10.1039/b914736e; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Gunsalus NJ, 2014, ISR J CHEM, V54, P1467, DOI 10.1002/ijch.201300130; Hartwig JF, 2005, J AM CHEM SOC, V127, P2538, DOI 10.1021/ja045090c; Hartwig JF, 2012, ACCOUNTS CHEM RES, V45, P864, DOI 10.1021/ar200206a; Hartwig JF, 2011, CHEM SOC REV, V40, P1992, DOI 10.1039/c0cs00156b; Ishiyama T, 2003, J ORGANOMET CHEM, V680, P3, DOI 10.1016/S0022-328X(03)00176-1; Larsen MA, 2015, J AM CHEM SOC, V137, P8633, DOI 10.1021/jacs.5b04899; Lawrence JD, 2004, J AM CHEM SOC, V126, P15334, DOI 10.1021/ja044933x; Li Q, 2014, J AM CHEM SOC, V136, P8755, DOI 10.1021/ja503676d; Lide D. R., 2015, CRC HDB CHEM PHYS; Liskey CW, 2013, J AM CHEM SOC, V135, P3375, DOI 10.1021/ja400103p; Liskey CW, 2012, J AM CHEM SOC, V134, P12422, DOI 10.1021/ja305596v; MANSUY D, 1993, COORDIN CHEM REV, V125, P129, DOI 10.1016/0010-8545(93)85013-T; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Murphy JM, 2006, J AM CHEM SOC, V128, P13684, DOI 10.1021/ja064092p; NGUYEN P, 1993, J AM CHEM SOC, V115, P9329, DOI 10.1021/ja00073a075; SAKAKURA T, 1990, J AM CHEM SOC, V112, P7221, DOI 10.1021/ja00176a022; Schwarz H, 2011, ANGEW CHEM INT EDIT, V50, P10096, DOI 10.1002/anie.201006424; Shilov AE, 1997, CHEM REV, V97, P2879, DOI 10.1021/cr9411886; Shimada S, 2001, ANGEW CHEM INT EDIT, V40, P2168, DOI 10.1002/1521-3773(20010601)40:11<2168::AID-ANIE2168>3.0.CO;2-0; Tajuddin H, 2012, CHEM SCI, V3, P3505, DOI 10.1039/c2sc20776a; Tang P, 2014, ENERG ENVIRON SCI, V7, P2580, DOI 10.1039/c4ee00604f; Vanchura BA, 2010, CHEM COMMUN, V46, P7724, DOI 10.1039/c0cc02041a; Wei CS, 2010, J AM CHEM SOC, V132, P3078, DOI 10.1021/ja909453g	32	125	127	5	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1421	1424		10.1126/science.aad9289	http://dx.doi.org/10.1126/science.aad9289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013725				2022-12-28	WOS:000372756200040
J	Shalvi, S				Shalvi, Shaul			BEHAVIOURAL ECONOMICS Corruption corrupts	NATURE			English	Editorial Material								A cross-cultural experiment involving thousands of people worldwide shows that the prevalence of rule violations in a society, such as tax evasion and fraudulent politics, is detrimental to individuals' intrinsic honesty. See Letter p.496	[Shalvi, Shaul] Univ Amsterdam, Ctr Res Expt Econ & Polit Decis Making CREED, Kruislaan 403, NL-1018 WB Amsterdam, Netherlands; [Shalvi, Shaul] Univ Amsterdam, Dept Psychol, NL-1018 WB Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Shalvi, S (corresponding author), Univ Amsterdam, Ctr Res Expt Econ & Polit Decis Making CREED, Kruislaan 403, NL-1018 WB Amsterdam, Netherlands.; Shalvi, S (corresponding author), Univ Amsterdam, Dept Psychol, NL-1018 WB Amsterdam, Netherlands.	s.shalvi@uva.nl	Shalvi, Shaul/AGU-6425-2022; Shalvi, Shaul/D-6728-2011	Shalvi, Shaul/0000-0003-2225-7352; 				Cohn A, 2014, NATURE, V516, P86, DOI 10.1038/nature13977; European Commission, 2014, EU ANT REP EUR COMM; Fischbacher U, 2013, J EUR ECON ASSOC, V11, P525, DOI 10.1111/jeea.12014; Gachter S, 2016, NATURE, V531, P496, DOI 10.1038/nature17160; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Maggian V., 2015, EXP EC; Schweitzer ME, 2004, ACAD MANAGE J, V47, P422, DOI 10.2307/20159591; Shalvi S, 2011, ORGAN BEHAV HUM DEC, V115, P181, DOI 10.1016/j.obhdp.2011.02.001; Shu LL, 2012, P NATL ACAD SCI USA, V109, P15197, DOI 10.1073/pnas.1209746109; Weisel O, 2015, P NATL ACAD SCI USA, V112, P10651, DOI 10.1073/pnas.1423035112	10	13	13	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					456	457		10.1038/nature17307	http://dx.doi.org/10.1038/nature17307			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QK	26958839	Green Published			2022-12-28	WOS:000372701300030
J	Wu, J; Belmonte, JCI				Wu, Jun; Belmonte, Juan Carlos Izpisua			The Molecular Harbingers of Early Mammalian Embryo Patterning	CELL			English	Editorial Material							CELL FATE; LINEAGE; OCT4; SOX2	Random or not, the mechanisms at play during the first cell-fate determination in mammalian embryos have been debated for years. Studies by Goolam et al. and White et al. shed new light on the molecular mechanisms underlying the intrinsic biases that lead to non-random lineage segregation in early mammalian development.	[Wu, Jun; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Wu, Jun/AAF-1830-2019	Wu, Jun/0000-0001-9863-1668				Burton A, 2013, CELL REP, V5, P687, DOI 10.1016/j.celrep.2013.09.044; Goolam M, 2016, CELL, V165, P61, DOI 10.1016/j.cell.2016.01.047; Graham SJL, 2016, CURR TOP DEV BIOL, V117, P671, DOI 10.1016/bs.ctdb.2015.11.021; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; Kiso M, 2009, P NATL ACAD SCI USA, V106, P9292, DOI 10.1073/pnas.0808324106; Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; White MD, 2016, CELL, V165, P75, DOI 10.1016/j.cell.2016.02.032; Wicklow E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004618	9	5	6	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					13	15		10.1016/j.cell.2016.03.005	http://dx.doi.org/10.1016/j.cell.2016.03.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	27015301	Bronze			2022-12-28	WOS:000372785600003
J	Zink, KD; Lieberman, DE				Zink, Katherine D.; Lieberman, Daniel E.			Impact of meat and Lower Palaeolithic food processing techniques on chewing in humans	NATURE			English	Article							UNDERGROUND-STORAGE ORGANS; STONE TOOLS; PRACTICAL GUIDE; SENSORY QUALITY; HUMAN-EVOLUTION; COOKING; HOMO; HYPOTHESIS; FORCE; ENERGETICS	The origins of the genus Homo are murky, but by H. erectus, bigger brains and bodies had evolved that, along with larger foraging ranges, would have increased the daily energetic requirements of hominins(1,2). Yet H. erectus differs from earlier hominins in having relatively smaller teeth, reduced chewing muscles, weaker maximum bite force capabilities, and a relatively smaller gut(3-5). This paradoxical combination of increased energy demands along with decreased masticatory and digestive capacities is hypothesized to have been made possible by adding meat to the diet(6-8), by mechanically processing food using stone tools(7,9,10), or by cooking(11,12). Cooking, however, was apparently uncommon until 500,000 years ago(13,14), and the effects of carnivory and Palaeolithic processing techniques on mastication are unknown. Here we report experiments that tested how Lower Palaeolithic processing technologies affect chewing force production and efficacy in humans consuming meat and underground storage organs (USOs). We find that if meat comprised one-third of the diet, the number of chewing cycles per year would have declined by nearly 2 million (a 13% reduction) and total masticatory force required would have declined by 15%. Furthermore, by simply slicing meat and pounding USOs, hominins would have improved their ability to chew meat into smaller particles by 41%, reduced the number of chews per year by another 5%, and decreased masticatory force requirements by an additional 12%. Although cooking has important benefits, it appears that selection for smaller masticatory features in Homo would have been initially made possible by the combination of using stone tools and eating meat.	[Zink, Katherine D.; Lieberman, Daniel E.] Harvard Univ, Dept Human Evolutionary Biol, 11 Divin Ave, Cambridge, MA 02138 USA	Harvard University	Zink, KD; Lieberman, DE (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, 11 Divin Ave, Cambridge, MA 02138 USA.	kzink@oeb.harvard.edu; danlieb@fas.harvard.edu			National Science Foundation [0925688]; American School of Prehistoric Research (Peabody Museum, Harvard University)	National Science Foundation(National Science Foundation (NSF)); American School of Prehistoric Research (Peabody Museum, Harvard University)	We thank R. Carmody, P. Lucas, J. Shea, T. Smith and R. Wrangham for helpful discussions, and E. Castillo and S. Worthington for statistical guidance. This research was funded by the National Science Foundation (#0925688) and by the American School of Prehistoric Research (Peabody Museum, Harvard University).	Aiello LC, 2002, ANNU REV ANTHROPOL, V31, P323, DOI 10.1146/annurev.anthro.31.040402.085403; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Boback SM, 2007, COMP BIOCHEM PHYS A, V148, P651, DOI 10.1016/j.cbpa.2007.08.014; Boesch C, 2000, CHIMPANZEES TAI FORE; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Bunn HT, 2007, EVOLUTION HUMAN DIET, P191; Carmody RN, 2011, P NATL ACAD SCI USA, V108, P19199, DOI 10.1073/pnas.1112128108; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Dominguez-Rodrigo M, 2005, J HUM EVOL, V48, P109, DOI 10.1016/j.jhevol.2004.09.004; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; Eng CM, 2013, AM J PHYS ANTHROPOL, V151, P544, DOI 10.1002/ajpa.22296; Gould R.A., 1980, LIVING ARCHAEOLOGY; Gowlett JAJ, 2013, AZANIA, V48, P5, DOI 10.1080/0067270X.2012.756754; Harmand S, 2015, NATURE, V521, P310, DOI 10.1038/nature14464; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; KEELEY LH, 1981, NATURE, V293, P464, DOI 10.1038/293464a0; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; Lagerstedt A, 2008, MEAT SCI, V80, P457, DOI 10.1016/j.meatsci.2008.01.009; Larsen CS, 2003, J NUTR, V133, p3893S, DOI 10.1093/jn/133.11.3893S; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Lillford PJ, 2001, J TEXTURE STUD, V32, P397, DOI 10.1111/j.1745-4603.2001.tb01244.x; Lucas P., 2004, DENT FUNCTIONAL MORP; MCHENRY HM, 1994, P NATL ACAD SCI USA, V91, P6780, DOI 10.1073/pnas.91.15.6780; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; Organ C, 2011, P NATL ACAD SCI USA, V108, P14555, DOI 10.1073/pnas.1107806108; Pontzer H, 2012, CURR ANTHROPOL, V53, pS346, DOI 10.1086/667402; Proeschel PA, 2002, J DENT RES, V81, P464, DOI 10.1177/154405910208100706; R Development Core Team, 2014, R LANG ENV STAT COMP; Shimelmitz R, 2014, J HUM EVOL, V77, P196, DOI 10.1016/j.jhevol.2014.07.005; Smith AR, 2015, J HUM EVOL, V84, P62, DOI 10.1016/j.jhevol.2015.03.013; Thexton AJ, 1996, J NEUROSCI METH, V66, P93, DOI 10.1016/0165-0270(96)00004-0; Vieira C, 2009, MEAT SCI, V83, P398, DOI 10.1016/j.meatsci.2009.06.013; WOLPOFF MH, 1973, AM J PHYS ANTHROPOL, V39, P375, DOI 10.1002/ajpa.1330390306; Wrangham R, 2003, COMP BIOCHEM PHYS A, V136, P35, DOI 10.1016/S1095-6433(03)00020-5; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; Zink KD, 2014, J HUM EVOL, V77, P155, DOI 10.1016/j.jhevol.2014.06.012	37	112	111	9	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					500	+		10.1038/nature16990	http://dx.doi.org/10.1038/nature16990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26958832				2022-12-28	WOS:000372701300040
J	Bagenal, F; Horanyi, M; McComas, DJ; McNutt, RL; Elliott, HA; Hill, ME; Brown, LE; Delamere, PA; Kollmann, P; Krimigis, SM; Kusterer, M; Lisse, CM; Mitchell, DG; Piquette, M; Poppe, AR; Strobel, DF; Szalay, JR; Valek, P; Vandegriff, J; Weidner, S; Zirnstein, EJ; Stern, SA; Ennico, K; Olkin, CB; Weaver, HA; Young, LA				Bagenal, F.; Horanyi, M.; McComas, D. J.; McNutt, R. L., Jr.; Elliott, H. A.; Hill, M. E.; Brown, L. E.; Delamere, P. A.; Kollmann, P.; Krimigis, S. M.; Kusterer, M.; Lisse, C. M.; Mitchell, D. G.; Piquette, M.; Poppe, A. R.; Strobel, D. F.; Szalay, J. R.; Valek, P.; Vandegriff, J.; Weidner, S.; Zirnstein, E. J.; Stern, S. A.; Ennico, K.; Olkin, C. B.; Weaver, H. A.; Young, L. A.		New Horizons Sci Team	Pluto's interaction with its space environment: Solar wind, energetic particles, and dust	SCIENCE			English	Article							PICK-UP IONS; BOW SHOCK; ESCAPE; AU; ATMOSPHERE; VOYAGER-2; DENSITY; COUNTER; MODELS; SYSTEM	The New Horizons spacecraft carried three instruments that measured the space environment near Pluto as it flew by on 14 July 2015. The Solar Wind Around Pluto (SWAP) instrument revealed an interaction region confined sunward of Pluto to within about 6 Pluto radii. The region's surprisingly small size is consistent with a reduced atmospheric escape rate, as well as a particularly high solar wind flux. Observations from the Pluto Energetic Particle Spectrometer Science Investigation (PEPSSI) instrument suggest that ions are accelerated and/or deflected around Pluto. In the wake of the interaction region, PEPSSI observed suprathermal particle fluxes equal to about 1/10 of the flux in the interplanetary medium and increasing with distance downstream. The Venetia Burney Student Dust Counter, which measures grains with radii larger than 1.4 micrometers, detected one candidate impact in +/- 5 days around New Horizons' closest approach, indicating an upper limit of <4.6 kilometers(-3) for the dust density in the Pluto system.	[Bagenal, F.; Horanyi, M.; Piquette, M.; Szalay, J. R.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80600 USA; [McComas, D. J.; Elliott, H. A.; Valek, P.; Weidner, S.; Zirnstein, E. J.] SW Res Inst, 6220 Culebra Rd, San Antonio, TX 78228 USA; [McComas, D. J.] Univ Texas San Antonio, San Antonio, TX 78249 USA; [McNutt, R. L., Jr.; Hill, M. E.; Brown, L. E.; Kollmann, P.; Krimigis, S. M.; Kusterer, M.; Lisse, C. M.; Mitchell, D. G.; Vandegriff, J.; Weaver, H. A.] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA; [Delamere, P. A.] Univ Alaska, Fairbanks, AK 99775 USA; [Krimigis, S. M.] Acad Athens, 28 Panapistimiou, Athens 10679, Greece; [Poppe, A. R.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Strobel, D. F.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Szalay, J. R.; Stern, S. A.; Olkin, C. B.; Young, L. A.] SW Res Inst, Boulder, CO 80302 USA; [Ennico, K.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	University of Colorado System; University of Colorado Boulder; Southwest Research Institute; University of Texas System; University of Texas at San Antonio (UTSA); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Alaska System; University of Alaska Fairbanks; Academy of Athens; University of California System; University of California Berkeley; Johns Hopkins University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Bagenal, F (corresponding author), Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80600 USA.	bagenal@colorado.edu	Krimigis, Stamatios/G-4591-2019; Strobel, Darrell5/AAO-6643-2021; Lisse, Carey M/B-7772-2016; Kollmann, Peter/C-2583-2016; Roberts, James H/I-9030-2012; McNutt, Ralph L/E-8006-2010; Zirnstein, Eric/AAA-2836-2020; Núñez, Jorge I./J-4027-2015; Weaver, Harold A/D-9188-2016; Olkin, Catherine/AAF-5160-2019; Mitchell, Donald G/H-4601-2016; Hill, Matthew/H-4312-2016; Kusterer, Martha/AAE-5505-2021	Krimigis, Stamatios/0000-0003-2781-2386; Strobel, Darrell5/0000-0002-0944-8675; Lisse, Carey M/0000-0002-9548-1526; Kollmann, Peter/0000-0002-4274-9760; Roberts, James H/0000-0003-1766-6127; McNutt, Ralph L/0000-0002-4722-9166; Zirnstein, Eric/0000-0001-7240-0618; Núñez, Jorge I./0000-0003-0930-6674; Weaver, Harold A/0000-0003-0951-7762; Olkin, Catherine/0000-0002-5846-716X; Mitchell, Donald G/0000-0003-1960-2119; Hill, Matthew/0000-0002-5674-4936; Valek, Philip/0000-0002-2318-8750	NASA's New Frontiers Program; NASA's Planetary Atmospheres Program [NNX13AG55G]	NASA's New Frontiers Program; NASA's Planetary Atmospheres Program(National Aeronautics & Space Administration (NASA))	We thank the many contributors to the development of the SDC, SWAP, and PEPSSI instruments and acknowledge many useful discussions with colleagues. The New Horizons mission is supported by NASA's New Frontiers Program. S.A.S. is also affiliated with Florida Space Institute, Uwingu, Golden Spike, and World View Enterprises. A.R.P. acknowledges support from NASA's Planetary Atmospheres Program (grant NNX13AG55G). As contractually agreed to with NASA, fully calibrated New Horizons Pluto system data will be released via the NASA Planetary Data System (https://pds.nasa.gov/) in a series of stages in 2016 and 2017 as the data set is fully downlinked and calibrated.	BAGENAL F, 1987, J GEOPHYS RES, V92, P8603, DOI 10.1029/JA092iA08p08603; Bagenal F, 2015, J GEOPHYS RES-PLANET, V120, P1497, DOI 10.1002/2015JE004880; BAGENAL F, 1989, GEOPHYS RES LETT, V16, P1229, DOI 10.1029/GL016i011p01229; Bagenal F., 1997, PLUTO CHARON, P523; Bertucci C, 2015, GEOPHYS RES LETT, V42, P193, DOI 10.1002/2014GL062106; Broiles TW, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526046; Clack D, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018298; Cravens TE, 2015, ICARUS, V246, P303, DOI 10.1016/j.icarus.2014.04.011; Delamere PA, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013756; Delamere PA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018122; Ebert RW, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015938; Edberg NJT, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014998; ELLIOT JL, 1989, ICARUS, V77, P148, DOI 10.1016/0019-1035(89)90014-6; Gladstone GR, 2016, SCIENCE, V351, DOI 10.1126/science.aad8866; Gurnett DA, 1997, GEOPHYS RES LETT, V24, P3125, DOI 10.1029/97GL03228; Han D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050136; Harnett EM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023178; Hill ME, 2009, ASTROPHYS J LETT, V699, pL26, DOI 10.1088/0004-637X/699/1/L26; Horanyi M, 2008, SPACE SCI REV, V140, P387, DOI 10.1007/s11214-007-9250-y; HUNTEN DM, 1982, ICARUS, V51, P665, DOI 10.1016/0019-1035(82)90155-5; Ip WH, 2000, ADV SPACE RES, V26, P1559, DOI 10.1016/S0273-1177(00)00098-3; KECSKEMETY K, 1993, GEOPHYS RES LETT, V20, P543, DOI 10.1029/93GL00487; Krasnopolsky VA, 1999, J GEOPHYS RES-PLANET, V104, P5955, DOI 10.1029/1998JE900052; Lellouch E, 2015, ICARUS, V246, P268, DOI 10.1016/j.icarus.2014.03.027; McComas D, 2008, SPACE SCI REV, V140, P261, DOI 10.1007/s11214-007-9205-3; McComas DJ, 2007, SCIENCE, V318, P217, DOI 10.1126/science.1147393; McComas DJ, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014604; McNutt RL, 2008, SPACE SCI REV, V140, P315, DOI 10.1007/s11214-008-9436-y; MCNUTT RL, 1989, GEOPHYS RES LETT, V16, P1225, DOI 10.1029/GL016i011p01225; Nicolaou G, 2015, PLANET SPACE SCI, V119, P222, DOI 10.1016/j.pss.2015.10.001; Nicolaou G, 2015, PLANET SPACE SCI, V111, P116, DOI 10.1016/j.pss.2015.03.020; Nicolaou G, 2014, J GEOPHYS RES-SPACE, V119, P3463, DOI 10.1002/2013JA019665; Nilsson H, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526142; Nilsson H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0571; Poppe A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043300; Poppe AR, 2016, ICARUS, V264, P369, DOI 10.1016/j.icarus.2015.10.001; Randol BM, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/120; Randol BM, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/75; Richardson JD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018253; Sauer K, 1997, ADV SPACE RES-SERIES, V20, P295, DOI 10.1016/S0273-1177(97)00551-6; SCHWARTZ SJ, 1983, J GEOPHYS RES-SPACE, V88, P2039, DOI 10.1029/JA088iA03p02039; Shevchenko VI, 1997, GEOPHYS RES LETT, V24, P101, DOI 10.1029/96GL03696; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; Stern SA, 2008, SPACE SCI REV, V140, P3, DOI 10.1007/s11214-007-9295-y; Strobel DF, 2008, ICARUS, V193, P612, DOI 10.1016/j.icarus.2007.08.021; SZABO A, 1995, J GEOPHYS RES-SPACE, V100, P1723, DOI 10.1029/94JA02491; Szalay JR, 2013, EARTH PLANETS SPACE, V65, P1145, DOI 10.5047/eps.2013.02.005; Tian F, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023510; Tucker OJ, 2015, ICARUS, V246, P291, DOI 10.1016/j.icarus.2014.05.002; Tucker OJ, 2012, ICARUS, V217, P408, DOI 10.1016/j.icarus.2011.11.017; VILLANUEVA L, 1994, J GEOPHYS RES-SPACE, V99, P2553, DOI 10.1029/92JA02899; Young LA, 2001, ICARUS, V153, P148, DOI 10.1006/icar.2001.6662; Young LA, 2008, SPACE SCI REV, V140, P93, DOI 10.1007/s11214-008-9462-9; Zhu X, 2014, ICARUS, V228, P301, DOI 10.1016/j.icarus.2013.10.011	54	52	52	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279							aad9045	10.1126/science.aad9045	http://dx.doi.org/10.1126/science.aad9045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989259	Green Submitted			2022-12-28	WOS:000372397700033
J	Grundy, WM; Binzel, RP; Buratti, BJ; Cook, JC; Cruikshank, DP; Ore, CMD; Earle, AM; Ennico, K; Howett, CJA; Lunsford, AW; Olkin, CB; Parker, AH; Philippe, S; Protopapa, S; Quirico, E; Reuter, DC; Schmitt, B; Singer, KN; Verbiscer, AJ; Beyer, RA; Buie, MW; Cheng, AF; Jennings, DE; Linscott, IR; Parker, JW; Schenk, PM; Spencer, JR; Stansberry, JA; Stern, SA; Throop, HB; Tsang, CCC; Weaver, HA; Weigle, GE; Young, LA				Grundy, W. M.; Binzel, R. P.; Buratti, B. J.; Cook, J. C.; Cruikshank, D. P.; Ore, C. M. Dalle; Earle, A. M.; Ennico, K.; Howett, C. J. A.; Lunsford, A. W.; Olkin, C. B.; Parker, A. H.; Philippe, S.; Protopapa, S.; Quirico, E.; Reuter, D. C.; Schmitt, B.; Singer, K. N.; Verbiscer, A. J.; Beyer, R. A.; Buie, M. W.; Cheng, A. F.; Jennings, D. E.; Linscott, I. R.; Parker, J. Wm.; Schenk, P. M.; Spencer, J. R.; Stansberry, J. A.; Stern, S. A.; Throop, H. B.; Tsang, C. C. C.; Weaver, H. A.; Weigle, G. E., II; Young, L. A.		New Horizons Sci Team	Surface compositions across Pluto and Charon	SCIENCE			English	Article							NEAR-INFRARED SPECTROSCOPY; KUIPER-BELT; SOLID NITROGEN; ICE CHEMISTRY; METHANE; IRRADIATION; SPECTRA; TRITON; SYSTEM; WATER	The New Horizons spacecraft mapped colors and infrared spectra across the encounter hemispheres of Pluto and Charon. The volatile methane, carbon monoxide, and nitrogen ices that dominate Pluto's surface have complicated spatial distributions resulting from sublimation, condensation, and glacial flow acting over seasonal and geological time scales. Pluto's water ice "bedrock" was also mapped, with isolated outcrops occurring in a variety of settings. Pluto's surface exhibits complex regional color diversity associated with its distinct provinces. Charon's color pattern is simpler, dominated by neutral low latitudes and a reddish northern polar region. Charon's near-infrared spectra reveal highly localized areas with strong ammonia absorption tied to small craters with relatively fresh-appearing impact ejecta.	[Grundy, W. M.] Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA; [Binzel, R. P.; Earle, A. M.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Buratti, B. J.] NASA, Jet Prop Lab, La Canada Flintridge, CA 91011 USA; [Cook, J. C.; Howett, C. J. A.; Olkin, C. B.; Parker, A. H.; Singer, K. N.; Buie, M. W.; Parker, J. Wm.; Spencer, J. R.; Stern, S. A.; Tsang, C. C. C.; Young, L. A.] SW Res Inst, Boulder, CO 80302 USA; [Cruikshank, D. P.; Ore, C. M. Dalle; Ennico, K.; Beyer, R. A.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Ore, C. M. Dalle; Beyer, R. A.] SETT Inst, Carl Sagan Ctr, Mountain View, CA 94043 USA; [Lunsford, A. W.; Reuter, D. C.; Jennings, D. E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Philippe, S.; Quirico, E.; Schmitt, B.] Univ Grenoble Alpes, CNRS, IPAG, F-38000 Grenoble, France; [Protopapa, S.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Verbiscer, A. J.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Cheng, A. F.; Weaver, H. A.] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA; [Linscott, I. R.] Stanford Univ, Stanford, CA 94305 USA; [Schenk, P. M.] Lunar & Planetary Inst, 3303 NASA Rd 1, Houston, TX 77058 USA; [Stansberry, J. A.] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Throop, H. B.] Planetary Sci Inst, Bombay, Maharashtra, India; [Weigle, G. E., II] SW Res Inst, San Antonio, TX 28510 USA	Massachusetts Institute of Technology (MIT); National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); University System of Maryland; University of Maryland College Park; University of Virginia; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Stanford University; National Aeronautics & Space Administration (NASA); Space Telescope Science Institute; Southwest Research Institute	Grundy, WM (corresponding author), Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA.	w.grundy@lowell.edu	Schmitt, Bernard/A-1064-2009; quirico, eric/K-9650-2013; Olkin, Catherine/AAF-5160-2019; Weaver, Harold A/D-9188-2016	Schmitt, Bernard/0000-0002-1230-6627; quirico, eric/0000-0003-2768-0694; Olkin, Catherine/0000-0002-5846-716X; Weaver, Harold A/0000-0003-0951-7762; Protopapa, Silvia/0000-0001-8541-8550; Grundy, Will/0000-0002-8296-6540; Stansberry, John/0000-0003-2434-5225; Parker, Joel/0000-0002-3672-0603	NASA's New Horizons Project; Centre National d'Etudes Spatiales through its "Systeme Solaire" program	NASA's New Horizons Project; Centre National d'Etudes Spatiales through its "Systeme Solaire" program	This work was supported by NASA's New Horizons Project. Additional support was provided by the Centre National d'Etudes Spatiales through its "Systeme Solaire" program (E.Q., S. Philippe, and B.S.). S.A.S. is also affiliated with Florida Space Institute, Uwingu LLC, Golden Spike Co., and World View Enterprises. As contractually agreed to with NASA, fully calibrated New Horizons Pluto system data will be released via the NASA Planetary Data System at https://pds.nasa.gov/ in a series of stages in 2016 and 2017 as the data set is fully downlinked and calibrated.	Bagenal F, 2016, SCIENCE, V351, DOI 10.1126/science.aad9045; BINZEL RP, 1988, SCIENCE, V241, P1070, DOI 10.1126/science.241.4869.1070; Brown ME, 2000, SCIENCE, V287, P107, DOI 10.1126/science.287.5450.107; Buie MW, 2010, ASTRON J, V139, P1128, DOI 10.1088/0004-6256/139/3/1128; Buie MW, 2000, ICARUS, V148, P324, DOI 10.1006/icar.2000.6509; BUIE MW, 1987, NATURE, V329, P522, DOI 10.1038/329522a0; Buratti BJ, 2015, ASTROPHYS J LETT, V804, DOI 10.1088/2041-8205/804/1/L6; Buratti BJ, 2011, ICARUS, V212, P835, DOI 10.1016/j.icarus.2011.01.012; BURATTI BJ, 1984, ICARUS, V59, P392, DOI 10.1016/0019-1035(84)90109-X; Cheng AF, 2008, SPACE SCI REV, V140, P189, DOI 10.1007/s11214-007-9271-6; Cook JC, 2007, ASTROPHYS J, V663, P1406, DOI 10.1086/518222; Cooper JF, 2003, EARTH MOON PLANETS, V92, P261, DOI 10.1023/B:MOON.0000031944.41883.80; CRUIKSHANK DP, 1993, SCIENCE, V261, P742, DOI 10.1126/science.261.5122.742; Cruikshank DP, 2000, ICARUS, V147, P309, DOI 10.1006/icar.2000.6451; Demeo FE, 2015, ICARUS, V246, P213, DOI 10.1016/j.icarus.2014.04.010; Doute S, 1999, ICARUS, V142, P421, DOI 10.1006/icar.1999.6226; Dumas C, 2001, ASTRON J, V121, P1163, DOI 10.1086/318747; Earle AM, 2015, ICARUS, V250, P405, DOI 10.1016/j.icarus.2014.12.028; FINK U, 1988, ASTRON J, V95, P229, DOI 10.1086/114632; Fray N, 2009, PLANET SPACE SCI, V57, P2053, DOI 10.1016/j.pss.2009.09.011; Gladstone GR, 2016, SCIENCE, V351, DOI 10.1126/science.aad8866; Grundy WM, 2013, ICARUS, V223, P710, DOI 10.1016/j.icarus.2013.01.019; Grundy WM, 2010, ICARUS, V205, P594, DOI 10.1016/j.icarus.2009.08.005; Grundy WM, 2002, ICARUS, V155, P486, DOI 10.1006/icar.2001.6726; Grundy WM, 2002, ICARUS, V157, P128, DOI 10.1006/icar.2002.6833; Hansen CJ, 2015, ICARUS, V246, P183, DOI 10.1016/j.icarus.2014.03.014; Holler BJ, 2014, ICARUS, V243, P104, DOI 10.1016/j.icarus.2014.09.013; JOHNSON RE, 1989, GEOPHYS RES LETT, V16, P1233, DOI 10.1029/GL016i011p01233; Kim YS, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/37; Lellouch E, 2011, ICARUS, V214, P701, DOI 10.1016/j.icarus.2011.05.035; Materese CK, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/2/150; Materese CK, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/111; McKinnon W. B., 2009, SOLAR SYSTEM NEPTUNE, P213; Moore JM, 2016, SCIENCE, V351, P1284, DOI 10.1126/science.aad7055; OWEN TC, 1993, SCIENCE, V261, P745, DOI 10.1126/science.261.5122.745; Pilling S, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200912274; Quirico E, 1997, ICARUS, V127, P354, DOI 10.1006/icar.1996.5663; Reuter DC, 2008, SPACE SCI REV, V140, P129, DOI 10.1007/s11214-008-9375-7; ROSENBERG KP, 1994, P SOC PHOTO-OPT INS, V2262, P223, DOI 10.1117/12.185804; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; Stern S. A., 2009, SOLAR SYSTEM NEPTUNE, P365; Stern SA, 2015, ICARUS, V250, P287, DOI 10.1016/j.icarus.2014.12.006; Strazzulla G, 1998, PLANET SPACE SCI, V46, P1339, DOI 10.1016/S0032-0633(97)00210-9; Tokunaga AT, 2005, PUBL ASTRON SOC PAC, V117, P421, DOI 10.1086/429382; Trafton LM, 2015, ICARUS, V246, P197, DOI 10.1016/j.icarus.2014.05.022; Tucker OJ, 2015, ICARUS, V246, P291, DOI 10.1016/j.icarus.2014.05.002; Weaver HA, 2016, SCIENCE, V351, DOI 10.1126/science.aae0030; Weaver HA, 2008, SPACE SCI REV, V140, P75, DOI 10.1007/s11214-008-9376-6; Wu YJ, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/83; Wu YJ, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/175; Yamashita Y, 2010, ICARUS, V207, P972, DOI 10.1016/j.icarus.2009.11.032; Young LA, 2008, SPACE SCI REV, V140, P93, DOI 10.1007/s11214-008-9462-9	53	184	185	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279							aad9189	10.1126/science.aad9189	http://dx.doi.org/10.1126/science.aad9189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989260	Green Submitted			2022-12-28	WOS:000372397700034
J	Hawkes, N				Hawkes, Nigel			THE BMJ AWARDS 2016 Dermatology team	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2016	352								i1433	10.1136/bmj.i1433	http://dx.doi.org/10.1136/bmj.i1433			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1ZT	26980075				2022-12-28	WOS:000372584400007
J	Inoue, H; Gyenis, A; Wang, ZJ; Li, J; Oh, SW; Jiang, S; Ni, N; Bernevig, BA; Yazdani, A				Inoue, Hiroyuki; Gyenis, Andras; Wang, Zhijun; Li, Jian; Oh, Seong Woo; Jiang, Shan; Ni, Ni; Bernevig, B. Andrei; Yazdani, Ali			Quasiparticle interference of the Fermi arcs and surface-bulk connectivity of a Weyl semimetal	SCIENCE			English	Article							MAJORANA FERMIONS; DIRAC SEMIMETAL; TRANSITION; DISCOVERY; STATES; PHASE	Weyl semimetals host topologically protected surface states, with arced Fermi surface contours that are predicted to propagate through the bulk when their momentum matches that of the surface projections of the bulk's Weyl nodes. We used spectroscopic mapping with a scanning tunneling microscope to visualize quasiparticle scattering and interference at the surface of the Weyl semimetal TaAs. Our measurements reveal 10 different scattering wave vectors, which can be understood and precisely reproduced with a theory that takes into account the shape, spin texture, and momentum-dependent propagation of the Fermi arc surface states into the bulk. Our findings provide evidence that Weyl nodes act as sinks for electron transport on the surface of these materials.	[Inoue, Hiroyuki; Gyenis, Andras; Wang, Zhijun; Li, Jian; Oh, Seong Woo; Bernevig, B. Andrei; Yazdani, Ali] Princeton Univ, Dept Phys, Joseph Henry Labs Phys, Princeton, NJ 08540 USA; [Jiang, Shan; Ni, Ni] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Jiang, Shan; Ni, Ni] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	Princeton University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yazdani, A (corresponding author), Princeton Univ, Dept Phys, Joseph Henry Labs Phys, Princeton, NJ 08540 USA.	yazdani@princeton.edu	Wang, Zhijun/O-8015-2014; LI, RUIJIAN/GYJ-0470-2022; Li, Jian/B-8398-2011	Wang, Zhijun/0000-0003-2169-8068; Li, Jian/0000-0003-0297-6528; Ni, Ni/0000-0003-4602-3999; Yazdani, Ali/0000-0003-4996-8904	Army Research Office-Multidisciplinary University Research Initiative (ARO-MURI) [W911NF-12-1-0461]; Gordon and Betty Moore Foundation as part of Emergent Phenomena in Quantum System initiative [GBMF4530]; NSF-Materials Research Science and Engineering Centers programs through the Princeton Center for Complex Materials [DMR-1420541, NSF-DMR-1104612]; NSF CAREER [DMR-0952428]; Packard Foundation; Keck Foundation; U.S. Department of Energy-Basic Energy Sciences (DOE-BES) Defense Advanced Research Projects Agency-U.S. Space and Naval Warfare Systems Command Meso program [N6601-11-1-4110]; LPS; Eric and Wendy Schmidt Transformative Technology Fund at Princeton; DOE-BES [DE-SC0011978];  [ARO-W911NF-1-0262];  [ONR-N00014-14-1-0330];  [ONR-N00014-13-10661];  [ARO-W911NF-1-0606]; Division Of Materials Research [1104612] Funding Source: National Science Foundation	Army Research Office-Multidisciplinary University Research Initiative (ARO-MURI)(MURI); Gordon and Betty Moore Foundation as part of Emergent Phenomena in Quantum System initiative; NSF-Materials Research Science and Engineering Centers programs through the Princeton Center for Complex Materials; NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Packard Foundation(The David & Lucile Packard Foundation); Keck Foundation(W.M. Keck Foundation); U.S. Department of Energy-Basic Energy Sciences (DOE-BES) Defense Advanced Research Projects Agency-U.S. Space and Naval Warfare Systems Command Meso program; LPS; Eric and Wendy Schmidt Transformative Technology Fund at Princeton; DOE-BES(United States Department of Energy (DOE)); ; ; ; ; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Work at Princeton was supported by Army Research Office-Multidisciplinary University Research Initiative (ARO-MURI) program W911NF-12-1-0461, Gordon and Betty Moore Foundation as part of Emergent Phenomena in Quantum System initiative (GBMF4530), by NSF-Materials Research Science and Engineering Centers programs through the Princeton Center for Complex Materials DMR-1420541, NSF-DMR-1104612, NSF CAREER DMR-0952428, Packard Foundation, and Keck Foundation. This project was also made possible through use of the facilities at Princeton Nanoscale Microscopy Laboratory supported by grants through ARO-W911NF-1-0262, ONR-N00014-14-1-0330, ONR-N00014-13-10661, U.S. Department of Energy-Basic Energy Sciences (DOE-BES) Defense Advanced Research Projects Agency-U.S. Space and Naval Warfare Systems Command Meso program N6601-11-1-4110, LPS and ARO-W911NF-1-0606, and Eric and Wendy Schmidt Transformative Technology Fund at Princeton. Work at University of California-Los Angeles was supported by the DOE-BES (DE-SC0011978).	Alpichshev Z, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.016401; Baum Y, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041046; Beenakker CWJ, 2013, ANNU REV CONDEN MA P, V4, P113, DOI 10.1146/annurev-conmatphys-030212-184337; Borisenko S, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.027603; Burkov AA, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235126; Chang GQ, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.066601; Drozdov IK, 2014, NAT PHYS, V10, P664, DOI [10.1038/NPHYS3048, 10.1038/nphys3048]; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; Hosur P, 2013, CR PHYS, V14, P857, DOI 10.1016/j.crhy.2013.10.010; Hosur P, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195102; Huang SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8373; Jeon S, 2014, NAT MATER, V13, P851, DOI 10.1038/nmat4023; Liu ZK, 2014, SCIENCE, V343, P864, DOI 10.1126/science.1245085; Lv BQ, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.217601; Lv BQ, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031013; Mitchell AK, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.035137; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Murakami S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/9/356; Nadj-Perge S, 2014, SCIENCE, V346, P602, DOI 10.1126/science.1259327; NIELSEN HB, 1983, PHYS LETT B, V130, P389, DOI 10.1016/0370-2693(83)91529-0; Ojanen T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245112; Petersen L, 1998, PHYS REV B, V57, pR6858, DOI 10.1103/PhysRevB.57.R6858; Philip J. W., 2015, CHIRALITY TRANSFER D; Potter AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6161; Roushan P, 2009, NATURE, V460, P1106, DOI 10.1038/nature08308; Sun Y, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.115428; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wang ZJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195320; Weng HM, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.011029; Xu SY, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.096801; Xu SY, 2015, SCIENCE, V349, P613, DOI 10.1126/science.aaa9297; Yang LX, 2015, NAT PHYS, V11, P728, DOI [10.1038/nphys3425, 10.1038/NPHYS3425]; Young SM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140405; Zhang T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266803; Zheng H, 2016, ACS NANO, V10, P1378, DOI 10.1021/acsnano.5b06807	37	139	140	4	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1184	1187		10.1126/science.aad8766	http://dx.doi.org/10.1126/science.aad8766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965625	Green Submitted			2022-12-28	WOS:000386158400042
J	Ball, P				Ball, Philip			Kathy Niakan: at the forefront of gene editing in embryos	LANCET			English	Biographical-Item																			0	0	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2016	387	10022					935	935		10.1016/S0140-6736(16)00573-0	http://dx.doi.org/10.1016/S0140-6736(16)00573-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF8XP	26972240				2022-12-28	WOS:000371644200014
J	Fisher, K; Funke, J				Fisher, Kate; Funke, Jana			Sexual science beyond the medical	LANCET			English	Editorial Material									[Fisher, Kate] Univ Exeter, Ctr Med Hist, Exeter EX4 4QH, Devon, England; [Funke, Jana] Univ Exeter, Dept English, Exeter EX4 4QH, Devon, England	University of Exeter; University of Exeter	Funke, J (corresponding author), Univ Exeter, Dept English, Exeter EX4 4QH, Devon, England.	j.funke@exeter.ac.uk		Funke, Jana/0000-0003-3898-9638				Bauer H, 2015, SEXUALITY STUD, P1; Bland Lucy, 1998, CULTURE LABELLING BO, P183; Oosterhuis Harry, 2000, STEPCHILDREN NATURE; Rosario Vernon A., 1996, SCI HOMOSEXUALITIES; Terry J., 1999, AM OBSESSION SCI MED	5	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					840	841		10.1016/S0140-6736(16)00517-1	http://dx.doi.org/10.1016/S0140-6736(16)00517-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DE9RA	26977480				2022-12-28	WOS:000370974400015
J	Trasande, L				Trasande, Leonardo			Updating the Toxic Substances Control Act to Protect Human Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ENDOCRINE-DISRUPTING CHEMICALS		[Trasande, Leonardo] NYU, Dept Pediat, Sch Med, 403 E 34th St,Room 115, New York, NY 10016 USA; [Trasande, Leonardo] NYU, Wagner Sch Publ Serv, 550 1St Ave, New York, NY 10016 USA	New York University; New York University	Trasande, L (corresponding author), NYU, Dept Pediat, Sch Med, 403 E 34th St,Room 115, New York, NY 10016 USA.	leonardo.trasande@nyumc.org	Trasande, Leonardo/ABE-6339-2020	Trasande, Leonardo/0000-0002-1928-597X				Environmental Defense Fund, EPA SIMPL MUST BETT; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; Janesick AS, ENV HLTH PERSPECT, DOI 10.1289/ehp.1510352; Safer States website, AD POL; Trasande L, 2015, J CLIN ENDOCR METAB, V100, P1245, DOI 10.1210/jc.2014-4324; US Environmental Protection Agency, STAT NEW CHEM REV PR	6	7	7	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2016	315	15					1565	1566		10.1001/jama.2016.2037	http://dx.doi.org/10.1001/jama.2016.2037			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ5ZK	26974705				2022-12-28	WOS:000374289300011
J	Cate, JHD				Cate, Jamie H. D.			STRUCTURE A Big Bang in spliceosome structural biology	SCIENCE			English	Editorial Material							U4/U6.U5 TRI-SNRNP; CRYO-EM; RESOLUTION		[Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA.	jcate@lbl.gov						Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Kondo Y, 2015, ELIFE, V4, DOI 10.7554/eLife.04986; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Nogales E, 2016, NAT METHODS, V13, P24, DOI 10.1038/nmeth.3694; Ramakrishnan V, 2014, CELL, V159, P979, DOI 10.1016/j.cell.2014.10.052; Stepankiw N, 2015, NUCLEIC ACIDS RES, V43, P8488, DOI 10.1093/nar/gkv763; Nguyen THD, 2016, CURR OPIN STRUC BIOL, V36, P48, DOI 10.1016/j.sbi.2015.12.005; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629	12	9	9	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1390	1392		10.1126/science.aaf4465	http://dx.doi.org/10.1126/science.aaf4465			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013712				2022-12-28	WOS:000372756200018
J	Lejaeghere, K; Bihlmayer, G; Bjorkman, T; Blaha, P; Blugel, S; Blum, V; Caliste, D; Castelli, IE; Clark, SJ; Dal Corso, A; de Gironcoli, S; Deutsch, T; Dewhurst, JK; Di Marco, I; Draxl, C; Dulak, M; Eriksson, O; Flores-Livas, JA; Garrity, KF; Genovese, L; Giannozzi, P; Giantomassi, M; Goedecker, S; Gonze, X; Granas, O; Gross, EKU; Gulans, A; Gygi, F; Hamann, DR; Hasnip, PJ; Holzwarth, NAW; Iusan, D; Jochym, DB; Jollet, F; Jones, D; Kresse, G; Koepernik, K; Kucukbenli, E; Kvashnin, YO; Locht, ILM; Lubeck, S; Marsman, M; Marzari, N; Nitzsche, U; Nordstrom, L; Ozaki, T; Paulatto, L; Pickard, CJ; Poelmans, W; Probert, MIJ; Refson, K; Richter, M; Rignanese, GM; Saha, S; Scheffler, M; Schlipf, M; Schwarz, K; Sharma, S; Tavazza, F; Thunstrom, P; Tkatchenko, A; Torrent, M; Vanderbilt, D; van Setten, MJ; Van Speybroeck, V; Wills, JM; Yates, JR; Zhang, GX; Cottenier, S				Lejaeghere, Kurt; Bihlmayer, Gustav; Bjoerkman, Torbjoern; Blaha, Peter; Bluegel, Stefan; Blum, Volker; Caliste, Damien; Castelli, Ivano E.; Clark, Stewart J.; Dal Corso, Andrea; de Gironcoli, Stefano; Deutsch, Thierry; Dewhurst, John Kay; Di Marco, Igor; Draxl, Claudia; Dulak, Marcin; Eriksson, Olle; Flores-Livas, Jose A.; Garrity, Kevin F.; Genovese, Luigi; Giannozzi, Paolo; Giantomassi, Matteo; Goedecker, Stefan; Gonze, Xavier; Granaes, Oscar; Gross, E. K. U.; Gulans, Andris; Gygi, Francois; Hamann, D. R.; Hasnip, Phil J.; Holzwarth, N. A. W.; Iusan, Diana; Jochym, Dominik B.; Jollet, Francois; Jones, Daniel; Kresse, Georg; Koepernik, Klaus; Kuecuekbenli, Emine; Kvashnin, Yaroslav O.; Locht, Inka L. M.; Lubeck, Sven; Marsman, Martijn; Marzari, Nicola; Nitzsche, Ulrike; Nordstrom, Lars; Ozaki, Taisuke; Paulatto, Lorenzo; Pickard, Chris J.; Poelmans, Ward; Probert, Matt I. J.; Refson, Keith; Richter, Manuel; Rignanese, Gian-Marco; Saha, Santanu; Scheffler, Matthias; Schlipf, Martin; Schwarz, Karlheinz; Sharma, Sangeeta; Tavazza, Francesca; Thunstroem, Patrik; Tkatchenko, Alexandre; Torrent, Marc; Vanderbilt, David; van Setten, Michiel J.; Van Speybroeck, Veronique; Wills, John M.; Yates, Jonathan R.; Zhang, Guo-Xu; Cottenier, Stefaan			Reproducibility in density functional theory calculations of solids	SCIENCE			English	Article							GENERALIZED-GRADIENT APPROXIMATION; ENERGY; STATE; PSEUDOPOTENTIALS; 1ST-PRINCIPLES; SILICON	The widespread popularity of density functional theory has given rise to an extensive range of dedicated codes for predicting molecular and crystalline properties. However, each code implements the formalism in a different way, raising questions about the reproducibility of such predictions. We report the results of a community-wide effort that compared 15 solid-state codes, using 40 different potentials or basis set types, to assess the quality of the Perdew-Burke-Ernzerhof equations of state for 71 elemental crystals. We conclude that predictions from recent codes and pseudopotentials agree very well, with pairwise differences that are comparable to those between different high-precision experiments. Older methods, however, have less precise agreement. Our benchmark provides a framework for users and developers to document the precision of new applications and methodological improvements.	[Lejaeghere, Kurt; Poelmans, Ward; Van Speybroeck, Veronique; Cottenier, Stefaan] Univ Ghent, Ctr Mol Modeling, Technol Pk 903, BE-9052 Zwijnaarde, Belgium; [Bihlmayer, Gustav; Bluegel, Stefan] Forschungszentrum Julich, Peter Grunberg Inst, D-52425 Julich, Germany; [Bihlmayer, Gustav; Bluegel, Stefan] Forschungszentrum Julich, Inst Adv Simulat, D-52425 Julich, Germany; [Bjoerkman, Torbjoern] Abo Akad Univ, Dept Phys, FI-20500 Turku, Finland; [Bjoerkman, Torbjoern] Aalto Univ, Sch Sci, Ctr Excellence Computat Nanosci, POB 11100, FI-00076 Aalto, Finland; [Bjoerkman, Torbjoern] Aalto Univ, Sch Sci, Dept Appl Phys, POB 11100, FI-00076 Aalto, Finland; [Blaha, Peter; Schwarz, Karlheinz] Vienna Univ Technol, Inst Mat Chem, Getreidemarkt 9-165-TC, A-1060 Vienna, Austria; [Blum, Volker] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA; [Caliste, Damien; Deutsch, Thierry; Genovese, Luigi] Univ Grenoble Alpes, Inst Nanosci, F-38042 Grenoble, France; [Caliste, Damien; Deutsch, Thierry; Genovese, Luigi] Cryogenie Modeling & Mat Explorat Dept INAC MEM, L Sim, F-38042 Grenoble, France; [Caliste, Damien; Deutsch, Thierry; Genovese, Luigi] CEA, L Sim, INAC MEM, F-38054 Grenoble, France; [Castelli, Ivano E.; Kuecuekbenli, Emine; Marzari, Nicola] Ecole Polytech Fed Lausanne, Theory & Simulat Mat THEOS, CH-1015 Lausanne, Switzerland; [Castelli, Ivano E.; Kuecuekbenli, Emine; Marzari, Nicola] Ecole Polytech Fed Lausanne, Natl Ctr Computat Design & Discovery Novel Mat MA, CH-1015 Lausanne, Switzerland; [Clark, Stewart J.] Univ Durham, Dept Phys, South Rd, Durham DH1 3LE, England; [Dal Corso, Andrea; de Gironcoli, Stefano; Kuecuekbenli, Emine] SISSA, Via Bonomea 265, I-34136 Trieste, Italy; [Dewhurst, John Kay; Flores-Livas, Jose A.; Gross, E. K. U.; Sharma, Sangeeta] Max Planck Inst Mikrostrukturphys, Weinberg 2, D-06120 Halle, Germany; [Di Marco, Igor; Eriksson, Olle; Iusan, Diana; Kvashnin, Yaroslav O.; Locht, Inka L. M.; Nordstrom, Lars] Uppsala Univ, Div Mat Theory, Dept Phys & Astron, POB 516, SE-75120 Uppsala, Sweden; [Draxl, Claudia; Gulans, Andris; Lubeck, Sven] Humboldt Univ, Inst Phys, Windkanal 6, D-12489 Berlin, Germany; [Draxl, Claudia; Gulans, Andris; Lubeck, Sven] Humboldt Univ, IRIS, Windkanal 6, D-12489 Berlin, Germany; [Draxl, Claudia; Gulans, Andris; Scheffler, Matthias; Tkatchenko, Alexandre] Max Planck Gesell, Fritz Haber Inst, Faradayweg 4-6, D-14195 Berlin, Germany; [Dulak, Marcin] Tech Univ Denmark, Dept Phys, Ctr Atom Scale Mat Design, DK-2800 Lyngby, Denmark; [Garrity, Kevin F.; Tavazza, Francesca] NIST, Mat Measurement Lab, 100 Bur Dr,Stop 8553, Gaithersburg, MD 20899 USA; [Giannozzi, Paolo; Granaes, Oscar] Univ Udine, Dept Math Comp Sci & Phys, Via Sci 206, I-33100 Udine, Italy; [Giantomassi, Matteo; Gonze, Xavier; Rignanese, Gian-Marco; van Setten, Michiel J.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci Nanoscop, Chemin Etoiles 8, BE-1348 Louvain, Belgium; [Goedecker, Stefan; Saha, Santanu] Univ Basel, Inst Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland; [Granaes, Oscar] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Gygi, Francois; Schlipf, Martin] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Hamann, D. R.; Vanderbilt, David] Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA; [Hamann, D. R.] Mat Sim Res, POB 742, Murray Hill, NJ 07974 USA; [Hasnip, Phil J.; Probert, Matt I. J.] Univ York, Dept Phys, York YO10 5DD, N Yorkshire, England; [Holzwarth, N. A. W.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Jochym, Dominik B.] Rutherford Appleton Lab, Sci & Technol Facil Council, Sci Comp Dept, Didcot OX11 0QX, Oxon, England; [Jollet, Francois; Torrent, Marc] DIF, DAM, CEA, F-91297 Arpajon, France; [Jones, Daniel; Yates, Jonathan R.] Univ Oxford, Dept Mat, 16 Parks Rd, Oxford OX1 3PH, England; [Kresse, Georg; Marsman, Martijn] Univ Vienna, Fac Phys, Sensengasse 8-12, A-1090 Vienna, Austria; [Kresse, Georg; Marsman, Martijn] Univ Vienna, Ctr Computat Mat Sci, Sensengasse 8-12, A-1090 Vienna, Austria; [Koepernik, Klaus; Nitzsche, Ulrike; Richter, Manuel] Leibniz Inst Festkorper & Werkstoffforsch IFW Dre, POB 270 116, D-01171 Dresden, Germany; [Koepernik, Klaus; Richter, Manuel] Tech Univ Dresden, Dresden Ctr Computat Mat Sci DCMS, D-01069 Dresden, Germany; [Locht, Inka L. M.] Radboud Univ Nijmegen, Inst Mol & Mat, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands; [Ozaki, Taisuke] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Paulatto, Lorenzo] Univ Paris 06, IMPMC, CNRS, UMR 7590,Museum Natl Hist Nat,IRD,Unite Rech 206, 4 Pl Jussieu, F-75005 Paris, France; [Pickard, Chris J.] Univ Cambridge, Dept Mat Sci & Met, 27 Charles Babbage Rd, Cambridge CB3 0FS, England; [Poelmans, Ward] Univ Ghent, High Performance Comp Unit, Krijgslaan 281 S9, BE-9000 Ghent, Belgium; [Refson, Keith] Univ London, Royal Holloway & Bedford New Coll, Dept Phys, Egham TW20 0EX, Surrey, England; [Refson, Keith] Rutherford Appleton Lab, Sci & Technol Facil Council, ISIS Facil, Didcot OX11 0QX, Oxon, England; [Scheffler, Matthias] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Scheffler, Matthias] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Thunstroem, Patrik] Vienna Univ Technol, Inst Solid State Phys, A-1040 Vienna, Austria; [Tkatchenko, Alexandre] Univ Luxembourg, Phys & Mat Sci Res Unit, L-1511 Luxembourg, Luxembourg; [Wills, John M.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Zhang, Guo-Xu] Harbin Inst Technol, Sch Chem & Chem Engn, Inst Theoret & Simulat Chem, Harbin 150001, Peoples R China; [Cottenier, Stefaan] Univ Ghent, Dept Mat Sci & Engn, Technol Pk 903, BE-9052 Zwijnaarde, Belgium	Ghent University; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Abo Akademi University; Aalto University; Aalto University; Technische Universitat Wien; Duke University; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Durham University; International School for Advanced Studies (SISSA); Max Planck Society; Uppsala University; Humboldt University of Berlin; Humboldt University of Berlin; Max Planck Society; Fritz Haber Institute of the Max Planck Society; Technical University of Denmark; National Institute of Standards & Technology (NIST) - USA; University of Udine; Universite Catholique Louvain; University of Basel; Harvard University; University of California System; University of California Davis; Rutgers State University New Brunswick; University of York - UK; Wake Forest University; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; CEA; University of Oxford; University of Vienna; University of Vienna; Leibniz Institute for Solid State & Materials Research Dresden; Technische Universitat Dresden; Radboud University Nijmegen; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); University of Cambridge; Ghent University; University of London; Royal Holloway University London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Technische Universitat Wien; University of Luxembourg; United States Department of Energy (DOE); Los Alamos National Laboratory; Harbin Institute of Technology; Ghent University	Lejaeghere, K; Cottenier, S (corresponding author), Univ Ghent, Ctr Mol Modeling, Technol Pk 903, BE-9052 Zwijnaarde, Belgium.; Cottenier, S (corresponding author), Univ Ghent, Dept Mat Sci & Engn, Technol Pk 903, BE-9052 Zwijnaarde, Belgium.	kurt.lejaeghere@ugent.be; stefaan.cottenier@ugent.be	Gross, Eberhard K. U./M-1826-2017; van Setten, Michiel Jan/B-2766-2008; Castelli, Ivano E/N-1627-2015; Marzari, Nicola/AAZ-1971-2021; Björkman, Torbjörn/B-9844-2012; Refson, Keith/G-1407-2013; Scheffler, Matthias/O-4649-2016; Zhang, Guo-Xu/ABA-3466-2021; Deutsch, Thierry/A-6077-2009; Blum, Volker/AAZ-5379-2021; Iusan, Diana M/C-2356-2011; Sharma, Sangeeta/R-8269-2017; Torrent, Marc/AAS-5722-2021; Probert, Matt/A-6304-2009; Richter, Manuel/F-2485-2016; Zhang, Guo-Xu/N-4325-2018; Marzari, Nicola/D-6681-2016; Blügel, Stefan/J-8323-2013; Hasnip, Philip/CAG-5529-2022; Hasnip, Phil J/A-3555-2012; Flores-Livas, Jose A./T-4860-2018; Bihlmayer, Gustav/G-5279-2013; Blaha, Peter/F-2847-2010; de Gironcoli, Stefano/G-7236-2011; Paulatto, Lorenzo/E-3974-2016; Di Marco, Igor/O-5190-2014; Rignanese, Gian-Marco/A-7435-2008; Blum, Volker/J-6591-2012; Granas, Oscar/B-4594-2014; Dal Corso, Andrea/A-5745-2008; Clark, Stewart J/A-3462-2012; Tkatchenko, Alexandre/E-7148-2011; Kvashnin, Yaroslav/AAI-1040-2021; Draxl, Claudia/O-6189-2016; Genovese, Luigi/C-5937-2011; Kresse, Georg/X-2531-2018; Schlipf, Martin/G-6856-2018; Caliste, Damien/H-9752-2014	Gross, Eberhard K. U./0000-0002-0113-759X; van Setten, Michiel Jan/0000-0003-0557-5260; Castelli, Ivano E/0000-0001-5880-5045; Marzari, Nicola/0000-0002-9764-0199; Björkman, Torbjörn/0000-0002-1154-9846; Refson, Keith/0000-0002-8715-5835; Scheffler, Matthias/0000-0002-1280-9873; Zhang, Guo-Xu/0000-0003-1558-614X; Deutsch, Thierry/0000-0001-7503-3390; Iusan, Diana M/0000-0001-7467-9317; Probert, Matt/0000-0002-1130-9316; Richter, Manuel/0000-0002-9999-8290; Zhang, Guo-Xu/0000-0003-1558-614X; Marzari, Nicola/0000-0002-9764-0199; Blügel, Stefan/0000-0001-9987-4733; Hasnip, Philip/0000-0002-4314-4093; Hasnip, Phil J/0000-0002-4314-4093; Flores-Livas, Jose A./0000-0002-4183-1316; Bihlmayer, Gustav/0000-0002-6615-1122; Blaha, Peter/0000-0001-5849-5788; de Gironcoli, Stefano/0000-0002-2307-0998; Di Marco, Igor/0000-0003-1714-0942; Rignanese, Gian-Marco/0000-0002-1422-1205; Blum, Volker/0000-0001-8660-7230; Dal Corso, Andrea/0000-0003-1186-5133; Clark, Stewart J/0000-0003-4792-7738; Tkatchenko, Alexandre/0000-0002-1012-4854; Kvashnin, Yaroslav/0000-0002-4238-5733; Draxl, Claudia/0000-0003-3523-6657; Genovese, Luigi/0000-0003-1747-0247; Kresse, Georg/0000-0001-9102-4259; Schlipf, Martin/0000-0003-3198-0497; Saha, Santanu/0000-0001-7334-7214; Jochym, Dominik/0000-0002-1413-4179; Caliste, Damien/0000-0002-4967-9275; Poelmans, Ward/0000-0002-0399-3613; Torrent, Marc/0000-0003-4171-3165; Van Speybroeck, Veronique/0000-0003-2206-178X; Vanderbilt, David/0000-0002-2465-9091; Gulans, Andris/0000-0001-7304-1952; Sharma, Sangeeta/0000-0001-6914-1272; Lejaeghere, Kurt/0000-0002-4462-8209; Garrity, Kevin/0000-0003-0263-4157	Research Board of Ghent University; Fond de la Recherche Scientifique de Belgique (FRS-FNRS) through Projet de Recherches (PDR) [T.0238.13-AIXPHO, T.1031.14-HiT4FiT]; Communaute Francaise de Belgique through BATTAB project [ARC 14/19-057]; U.S. NSF [DMR-14-08838, DMR-1105485]; Swedish Research Council; Knut and Alice Wallenberg Foundation [2013.0020, 2012.0031]; Fund for Scientific Research-Flanders (FWO) [G0E0116N]; U.S. Department of Energy [DOE-BES DE-SC0008938]; European Union [329386, 676580]; eSSENCE; Academy of Finland [263416]; COMP Centre of Excellence; Deutsche Forschungsgemeinschaft (DFG); Einstein Foundation, Berlin; Novel Materials Discovery (NOMAD) Laboratory, a European Center of Excellence; Italian Ministry of Education, Universities, and Research (MIUR) through PRIN [20105ZZTSE_005]; Engineering and Physical Sciences Research Council (EPSRC) under UK Car-Parrinello (UKCP) grant [EP/K013564/1]; Collaborative Computational Project for NMR Crystallography under EPSRC grant [EP/J010510/1]; FWO; EPSRC [EP/J017639/1]; Swiss National Science Foundation (SNSF); FRS-FNRS; SNSF's National Centre of Competence in Research MARVEL; Austrian Science Fund [SFB-F41]; OCAS NV by an OCAS-endowed chair at Ghent University; Ghent University; Flemish Government (Economy, Science, and Innovation Department); Walloon Region [1117545]; FRS-FNRS [2.5020.11]; CASTEP by Biovia; EPSRC [EP/K013750/2, EP/K013750/1, EP/M022501/1, EP/K013718/1, EP/F037481/1, EP/K013564/1, EP/K014560/1] Funding Source: UKRI; Direct For Mathematical & Physical Scien [1408838] Funding Source: National Science Foundation; Engineering and Physical Sciences Research Council [EP/F037481/1, EP/K013564/1, EP/K013718/1, EP/K013750/2, EP/J017639/1, EP/K013750/1, EP/K014560/1, EP/M022501/1] Funding Source: researchfish	Research Board of Ghent University(Ghent University); Fond de la Recherche Scientifique de Belgique (FRS-FNRS) through Projet de Recherches (PDR)(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique through BATTAB project; U.S. NSF(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Fund for Scientific Research-Flanders (FWO)(FWO); U.S. Department of Energy(United States Department of Energy (DOE)); European Union(European Commission); eSSENCE; Academy of Finland(Academy of Finland); COMP Centre of Excellence; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Einstein Foundation, Berlin; Novel Materials Discovery (NOMAD) Laboratory, a European Center of Excellence; Italian Ministry of Education, Universities, and Research (MIUR) through PRIN(Ministry of Education, Universities and Research (MIUR)); Engineering and Physical Sciences Research Council (EPSRC) under UK Car-Parrinello (UKCP) grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Collaborative Computational Project for NMR Crystallography under EPSRC grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); FWO(FWO); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); SNSF's National Centre of Competence in Research MARVEL; Austrian Science Fund(Austrian Science Fund (FWF)); OCAS NV by an OCAS-endowed chair at Ghent University; Ghent University(Ghent University); Flemish Government (Economy, Science, and Innovation Department); Walloon Region; FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); CASTEP by Biovia; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research benefited from financial support from the Research Board of Ghent University; the Fond de la Recherche Scientifique de Belgique (FRS-FNRS), through Projet de Recherches (PDR) grants T.0238.13-AIXPHO and T.1031.14-HiT4FiT; the Communaute Francaise de Belgique, through the BATTAB project (grant ARC 14/19-057); the U.S. NSF (grant DMR-14-08838); the Swedish Research Council; the Knut and Alice Wallenberg Foundation (grants 2013.0020 and 2012.0031); the Fund for Scientific Research-Flanders (FWO) (project no. G0E0116N); and the U.S. Department of Energy (grant DOE-BES DE-SC0008938). N.A.W.H. was supported by U.S. NSF grant DMR-1105485. J.A.F.-L. acknowledges financial support from the European Union's 7th Framework Marie-Curie Scholarship Program within the ExMaMa Project (project no. 329386). I.D.M., O.E., O.G., D.I., Y.O.K., I.L.M.L., and L.N. acknowledge support from eSSENCE. T.B. was supported by the Academy of Finland (grant 263416) and the COMP Centre of Excellence. C.D., A.G., and S.L. acknowledge support from the Deutsche Forschungsgemeinschaft (DFG) and the Einstein Foundation, Berlin. M.Sche. and C.D. received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 676580 with The Novel Materials Discovery (NOMAD) Laboratory, a European Center of Excellence. A.D.C., S.d.G., and E.K. acknowledge support from the Italian Ministry of Education, Universities, and Research (MIUR) through PRIN (Projects of National Interest) 2010-2011 (registration no. 20105ZZTSE_005). P.J.H., D.B.J., and M.I.J.P. are grateful for financial support by the Engineering and Physical Sciences Research Council (EPSRC) under UK Car-Parrinello (UKCP) grant EP/K013564/1. C.J.P. and J.R.Y. acknowledge support from the Collaborative Computational Project for NMR Crystallography under EPSRC grant EP/J010510/1. W.P. acknowledges funding by FWO. D.J. is grateful for financial support by EPSRC under grant EP/J017639/1. S.Sa. acknowledges support from the Swiss National Science Foundation (SNSF). G.-M.R. is thankful for personal financial support from FRS-FNRS. The work by I.E.C. and N.M. was supported by the SNSF's National Centre of Competence in Research MARVEL. G.K. and P.B. acknowledge support by the Austrian Science Fund, project SFB-F41 (ViCoM). S.C. acknowledges financial support from OCAS NV by an OCAS-endowed chair at Ghent University. Computational resources were as follows: The Ghent University contributors used the Stevin Supercomputer Infrastructure at Ghent University, which is funded by Ghent University, FWO, and the Flemish Government (Economy, Science, and Innovation Department). The Universite Catholique de Louvain contributors used the Tier-1 supercomputer of the Federation Wallonie-Bruxelles (funded by the Walloon Region under grant agreement no. 1117545), the Centre de Calcul Intensif et de Stockage de Masse-Universite Catholique de Louvain supercomputing facilities, and the Consortium des Equipements de Calcul Intensif en Federation Wallonie-Bruxelles (CECI) (funded by the FRS-FNRS under convention 2.5020.11). The Science and Technology Facilities Council, Scientific Computing Department's SCARF (Scientific Computing Application Resource for Facilities) cluster was used for the CASTEP calculations. The Basel University and Ecole Polytechnique Federale de Lausanne contributors used the Swiss National Supercomputing Center in Lugano. Finland's IT Centre for Science was used for the RSPt calculations. K.L. and F.T. thank C.; Becker for instructive discussions on the comparison of atomic-scale simulations. K.L. and S.C. thank W. Dewitte for drafting the summary figure. S.J.C., P.J.H., C.J.P., M.I.J.P., K.R., and J.R.Y. declare the receipt of income from commercial sales of CASTEP by Biovia. N.M. and M.Sche. are members of the Board of Trustees of the Psi-k Electronic Structure Network. P.G. is director of the Quantum ESPRESSO Foundation, and N.M. is a representative member. X.G., D.R.H., M.T., D.C., F.J., and G.-M.R. are members of the Advisory Board of ABINIT, an organization that develops and publishes open-source software related to this article. Commercial software is identified to specify procedures. Such identification does not imply recommendation by the National Institute of Standards and Technology. Atomic Simulation Environment scripts (46) for several of the codes are available online (48). All data are listed in tables S3 to S42.	ANDERSEN OK, 1975, PHYS REV B, V12, P3060, DOI 10.1103/PhysRevB.12.3060; [Anonymous], 2015, NAT MATER, V14, P1073, DOI 10.1038/nmat4473; [Anonymous], 2015, SCIENCE, DOI [DOI 10.1126/SCIENCE.AAC4716, DOI 10.1126/science.aac4716]; Assali LVC, 2004, BRAZ J PHYS, V34, P602, DOI 10.1590/S0103-97332004000400016; Bahn SR, 2002, COMPUT SCI ENG, V4, P56, DOI 10.1109/5992.998641; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Blum V, 2009, COMPUT PHYS COMMUN, V180, P2175, DOI 10.1016/j.cpc.2009.06.022; Csonka GI, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155107; Curtarolo S, 2012, COMP MATER SCI, V58, P218, DOI 10.1016/j.commatsci.2012.02.005; Curtiss LA, 1997, J CHEM PHYS, V106, P1063, DOI 10.1063/1.473182; Drummond C, 2009, P 26 INT C MACH LEAR; Dyall KG, 1999, J CHEM PHYS, V111, P1366, DOI 10.1063/1.479395; Friak M, 2011, EUR PHYS J PLUS, V126, DOI 10.1140/epjp/i2011-11101-2; Fu CC, 2005, NAT MATER, V4, P68, DOI 10.1038/nmat1286; Goerigk L, 2011, PHYS CHEM CHEM PHYS, V13, P6670, DOI 10.1039/c0cp02984j; Grabowski B, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.024309; GROSSHANS WA, 1992, PHYS REV B, V45, P5171, DOI 10.1103/PhysRevB.45.5171; Haas P, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085104; HAMANN DR, 1979, PHYS REV LETT, V43, P1494, DOI 10.1103/PhysRevLett.43.1494; Heyd J, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1760074; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Holzapfel WB, 2001, J PHYS CHEM REF DATA, V30, P515, DOI 10.1063/1.1370170; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Jain A, 2013, APL MATER, V1, DOI 10.1063/1.4812323; Jollet F, 2014, COMPUT PHYS COMMUN, V185, P1246, DOI 10.1016/j.cpc.2013.12.023; Jones RO, 2015, REV MOD PHYS, V87, P897, DOI 10.1103/RevModPhys.87.897; Kiejna A, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035404; Kittel C, 2021, INTRO SOLID STATE PH; KLEINMAN L, 1982, PHYS REV LETT, V48, P1425, DOI 10.1103/PhysRevLett.48.1425; KNITTLE E, 1995, MINERAL PHYSICS CRYS, P98; KOELLING DD, 1977, J PHYS C SOLID STATE, V10, P3107, DOI 10.1088/0022-3719/10/16/019; Koepernik K, 1999, PHYS REV B, V59, P1743, DOI 10.1103/PhysRevB.59.1743; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kurth S, 1999, INT J QUANTUM CHEM, V75, P889, DOI 10.1002/(SICI)1097-461X(1999)75:4/5<889::AID-QUA54>3.0.CO;2-8; Lee IH, 1997, PHYS REV B, V56, P7197, DOI 10.1103/PhysRevB.56.7197; Lejaeghere K, 2014, CRIT REV SOLID STATE, V39, P1, DOI 10.1080/10408436.2013.772503; Madsen GKH, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195134; Miller G, 2006, SCIENCE, V314, P1856, DOI 10.1126/science.314.5807.1856; Miotto R, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125321; Miyake T, 1998, PHYS REV LETT, V81, P1873, DOI 10.1103/PhysRevLett.81.1873; Paier J, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2187006; Paier J, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1926272; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pernot P, 2015, J PHYS CHEM A, V119, P5288, DOI 10.1021/jp509980w; Pizzi G, 2016, COMP MATER SCI, V111, P218, DOI 10.1016/j.commatsci.2015.09.013; Ponce S, 2014, COMP MATER SCI, V83, P341, DOI 10.1016/j.commatsci.2013.11.031; Ramos LE, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.165210; Sjostedt E, 2000, SOLID STATE COMMUN, V114, P15, DOI 10.1016/S0038-1098(99)00577-3; Slater JC, 1937, PHYS REV, V51, P0846, DOI 10.1103/PhysRev.51.846; Staroverov VN, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.012502; Tran F, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.115131; van Gunsteren WF, 2013, ANGEW CHEM INT EDIT, V52, P118, DOI 10.1002/anie.201204076; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; VANLENTHE E, 1994, J CHEM PHYS, V101, P9783, DOI 10.1063/1.467943; Vihinen M, 2015, NATURE, V521, P261, DOI 10.1038/521261a; Vitos L, 2000, PHYS REV B, V62, P10046, DOI 10.1103/PhysRevB.62.10046; Wills JM, 2010, SPRINGER SER SOLID-S, V167, P3, DOI 10.1007/978-3-642-15144-6; Windl W, 1999, PHYS REV LETT, V83, P4345, DOI 10.1103/PhysRevLett.83.4345; Yuan Gary, 2010, Computational Science and Discovery, V3, DOI 10.1088/1749-4699/3/1/015004; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a	61	818	838	38	490	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280							aad3000	10.1126/science.aad3000	http://dx.doi.org/10.1126/science.aad3000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013736	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000372756200038
J	Headley, MB; Bins, A; Nip, A; Roberts, EW; Looney, MR; Gerard, A; Krummel, MF				Headley, Mark B.; Bins, Adriaan; Nip, Alyssa; Roberts, Edward W.; Looney, Mark R.; Gerard, Audrey; Krummel, Matthew F.			Visualization of immediate immune responses to pioneer metastatic cells in the lung	NATURE			English	Article							T-CELL; REPORTER MOUSE; ANTIGEN; DIFFERENTIATION; EXPRESSION; MONOCYTES; EXOSOMES; GROWTH; MICE	Lung metastasis is the lethal determinant in many cancers(1,2) and a number of lines of evidence point to monocytes and macrophages having key roles in its development(3-5). Yet little is known about the immediate fate of incoming tumour cells as they colonize this tissue, and even less known about how they make first contact with the immune system. Primary tumours liberate circulating tumour cells (CTCs) into the blood and we have developed a stable intravital two-photon lung imaging model in mice(6) for direct observation of the arrival of CTCs and subsequent host interaction. Here we show dynamic generation of tumour microparticles in shear flow in the capillaries within minutes of CTC entry. Rather than dispersing under flow, many of these microparticles remain attached to the lung vasculature or independently migrate along the inner walls of vessels. Using fluorescent lineage reporters and flow cytometry, we observed 'waves' of distinct myeloid cell subsets that load differentially and sequentially with this CTC-derived material. Many of these tumour-ingesting myeloid cells collectively accumulated in the lung interstitium along with the successful metastatic cells and, as previously understood, promote the development of successful metastases from surviving tumour cells(3). Although the numbers of these cells rise globally in the lung with metastatic exposure and ingesting myeloid cells undergo phenotypic changes associated with microparticle ingestion, a consistently sparse population of resident conventional dendritic cells, among the last cells to interact with CTCs, confer anti-metastatic protection. This work reveals that CTC fragmentation generates immune-interacting intermediates, and defines a competitive relationship between phagocyte populations for tumour loading during metastatic cell seeding.	[Headley, Mark B.; Bins, Adriaan; Nip, Alyssa; Roberts, Edward W.; Gerard, Audrey; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave,HSW512, San Francisco, CA 94143 USA; [Bins, Adriaan] Acad Med Ctr Amsterdam, Dept Med Oncol, Meibergdreef 9, NL-91105 AZ Amsterdam, Netherlands; [Looney, Mark R.] Univ Calif San Francisco, Dept Med, 513 Parnassus Ave,HSW512, San Francisco, CA 94143 USA; [Looney, Mark R.] Univ Calif San Francisco, Dept Lab Med, 513 Parnassus Ave,HSW512, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave,HSW512, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu		Headley, Mark/0000-0002-0924-9326; Roberts, Edward/0000-0002-8229-1715; Bins, Adriaan/0000-0002-9794-6526	Department of Defense [W81XWH-13-1-0009]; NIH [U54 CA163123, P01 HL024136, R21CA167601]; NATIONAL CANCER INSTITUTE [U54CA163123, R21CA167601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Hume for providing MacBlue mice; Z. Werb for providing MDA-MB231 GFP cells; J. Massegue and S. Abrams for providing PyMT-B cells; J. Cyster for providing us with CCR2-knockout mice. We would also like to thank E. Thornton for her initial work in developing lung intravital imaging. M. Werner for early technical assistance in this project. All members of the Krummel laboratory, BIDC, and M Koch for discussion, support, and guidance while developing this work. This work was supported in part by a Department of Defense post-doctoral fellowship to M.B.H. (W81XWH-13-1-0009) and NIH grants U54 CA163123, P01 HL024136 and R21CA167601.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Gerard A, 2013, NAT IMMUNOL, V14, P356, DOI 10.1038/ni.2547; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Khanna KM, 2010, J IMMUNOL, V185, P239, DOI 10.4049/jimmunol.0901047; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Mendoza A, 2010, J CLIN INVEST, V120, P2979, DOI 10.1172/JCI40252; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ovchinnikov DA, 2008, J LEUKOCYTE BIOL, V83, P430, DOI 10.1189/jlb.0807585; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Stewart TJ, 2007, J IMMUNOL, V179, P2851, DOI 10.4049/jimmunol.179.5.2851; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667	28	248	252	5	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					513	+		10.1038/nature16985	http://dx.doi.org/10.1038/nature16985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	26982733	Green Accepted			2022-12-28	WOS:000372701300043
J	L'Azou, M; Moureau, A; Sarti, E; Nealon, J; Zambrano, B; Wartel, TA; Villar, L; Capeding, MRZ; Ochiai, RL				L'Azou, Maina; Moureau, Annick; Sarti, Elsa; Nealon, Joshua; Zambrano, Betzana; Wartel, T. Anh; Villar, Luis; Capeding, Maria R. Z.; Ochiai, R. Leon		CYD14 & CYD15 Primary Study Grp	Symptomatic Dengue in Children in 10 Asian and Latin American Countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDEMIOLOGIC TRENDS; ACTIVE SURVEILLANCE; CASE CLASSIFICATION; PROSPECTIVE COHORT; SOUTHEAST-ASIA; DISEASE BURDEN; PUERTO-RICO; FEVER; INFECTION; THAILAND	BACKGROUND The control groups in two phase 3 trials of dengue vaccine efficacy included two large regional cohorts that were followed up for dengue infection. These cohorts provided a sample for epidemiologic analyses of symptomatic dengue in children across 10 countries in Southeast Asia and Latin America in which dengue is endemic. METHODS We monitored acute febrile illness and virologically confirmed dengue (VCD) in 3424 healthy children, 2 to 16 years of age, in Asia (Indonesia, Malaysia, the Philippines, Thailand, and Vietnam) from June 2011 through December 2013 and in 6939 children, 9 to 18 years of age, in Latin America (Brazil, Colombia, Honduras, Mexico, and Puerto Rico) from June 2011 through April 2014. Acute febrile episodes were determined to be VCD by means of a nonstructural protein 1 antigen immunoassay and reverse-transcriptase-polymerase-chain-reaction assays. Dengue hemorrhagic fever was defined according to 1997 World Health Organization criteria. RESULTS Approximately 10% of the febrile episodes in each cohort were confirmed to be VCD, with 319 VCD episodes (4.6 episodes per 100 person-years) occurring in the Asian cohort and 389 VCD episodes (2.9 episodes per 100 person-years) occurring in the Latin American cohort; no trend according to age group was observed. The incidence of dengue hemorrhagic fever was less than 0.3 episodes per 100 person-years in each cohort. The percentage of VCD episodes requiring hospitalization was 19.1% in the Asian cohort and 11.1% in the Latin American cohort. In comparable age groups (9 to 12 years and 13 to 16 years), the burden of dengue was higher in Asia than in Latin America. CONCLUSIONS The burdens of dengue were substantial in the two regions and in all age groups. Burdens varied widely according to country, but the rates were generally higher and the disease more frequently severe in Asian countries than in Latin American countries.	[L'Azou, Maina; Ochiai, R. Leon] Sanofi Pasteur, Global Epidemiol, 2 Ave Pont Pasteur, F-69367 Lyon, France; [Moureau, Annick] Sanofi Pasteur, Global Clin Dept, Marcy Letoile, France; [Sarti, Elsa] Sanofi Pasteur Latin Amer, Coyoacan, Mexico; [Nealon, Joshua; Wartel, T. Anh] Sanofi Pasteur Asia Pacific Reg, Singapore, Singapore; [Zambrano, Betzana] Sanofi Pasteur Uruguay, Montevideo, Uruguay; [Villar, Luis] Univ Ind Santander, Sch Med, Clin Epidemiol Unit, Bucaramanga, Colombia; [Capeding, Maria R. Z.] Res Inst Trop Med, Muntinlupa, Philippines	Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France; Universidad Industrial de Santander; Research Institute for Tropical Medicine - Philippines	Ochiai, RL (corresponding author), Sanofi Pasteur, Global Epidemiol, 2 Ave Pont Pasteur, F-69367 Lyon, France.	leon.ochiai@sanofipasteur.com	Sarti, Elsa/ABB-8450-2021	Miranda Montoya, Maria Consuelo/0000-0001-5730-0723; L'Azou Jackson, Maina/0000-0001-7753-0630	Sanofi Pasteur	Sanofi Pasteur	Supported by Sanofi Pasteur.	Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499; Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Bravo L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003027; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331; Dayan G, 2015, AM J TROP MED HYG, V93, P18, DOI 10.4269/ajtmh.13-0663; Endy TP, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00183; Dantes HG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003158; Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007; Horstick O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003311; Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676; L'Azou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003260; Lang J, 2012, REV INST MED TROP SP, V54, pS15, DOI 10.1590/S0036-46652012000700007; Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241; Mohd-Zaki AH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003159; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nguyen TKT, 2010, T ROY SOC TROP MED H, V104, P592, DOI 10.1016/j.trstmh.2010.06.003; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Punjabi NH, 2013, J INFECT DEV COUNTR, V7, P781, DOI 10.3855/jidc.2629; Ramos MM, 2008, AM J TROP MED HYG, V79, P123, DOI 10.4269/ajtmh.2008.79.123; Sabchareon A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001732; Sharp TM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002159; Shepard DS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003306; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520; Thisyakorn Usa, 2014, Ther Adv Vaccines, V2, P3, DOI 10.1177/2051013613507862; Timiryasova TM, 2013, AM J TROP MED HYG, V88, P962, DOI 10.4269/ajtmh.12-0461; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757; WHO, 1997, DENG HAEM FEV DIAGN	33	83	83	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2016	374	12					1155	1166		10.1056/NEJMoa1503877	http://dx.doi.org/10.1056/NEJMoa1503877			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AA	27007959	Bronze			2022-12-28	WOS:000372585100008
J	Berger, D; Miles, SH				Berger, David; Miles, Steven H.			Should doctors boycott working in Australia's immigration detention centres?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; TIME		[Berger, David] Broome Hosp, Broome, WA 6725, Australia; [Miles, Steven H.] Univ Minnesota, N504 Boynton, Minneapolis, MN 55414 USA	University of Minnesota System; University of Minnesota Twin Cities	Berger, D (corresponding author), Broome Hosp, Broome, WA 6725, Australia.; Miles, SH (corresponding author), Univ Minnesota, N504 Boynton, Minneapolis, MN 55414 USA.	daveberger@gmail.com; miles001@umn.edu						American Medical Association, OP 9 025 ADV CHANG L; Amnesty International, 2014, THIS IS BREAK HUM RI; [Anonymous], 2006, AMA CODE ETHICS; Australian Human Rights Commission, 2014, FORG CHILDR NAT INQ; Australian Medical Association, 2015, HLTH CAR AS SEEK REF; Australian Medical Association, 2015, BACKGR AMA POS STAT; Australian Medical Association, 2015, MED ETH CUST SETT; Berger D, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i996; Cresswell A, 2010, AUSTRALIAN; Farrell P, 2015, GUARDIAN; Green JP, 2010, MED J AUSTRALIA, V192, P65, DOI 10.5694/j.1326-5377.2010.tb03419.x; HASHAM, 2016, SYDNEY MORNING HERAL; Jabour B, 2015, GUARDIAN; Miles SH, 2015, DOCTORS WHO TORTURE; Miles Steven H, 2015, AMA J Ethics, V17, P945, DOI 10.1001/journalofethics.2015.17.10.pfor1-1510; Miles SH, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1088; Newhouse G, 2015, GUARDIAN; Owler B, 2016, SPEECH AMA ASYLUM SE; Passant J, 2016, BLOG; Sanggaran JP, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001960; UNHCR, 2013, REP UNHCR MON VIS RE; Woodhead M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1182; World Medical Association, 2012, STAT ETH IMPL COLL A; World Medical Association, 2007, RES RESP PHYS DOC DE	24	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2016	352								i1600	10.1136/bmj.i1600	http://dx.doi.org/10.1136/bmj.i1600			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LK	27006418				2022-12-28	WOS:000373044500007
J	Navar, AM; Pencina, MJ; Rymer, JA; Louzao, DM; Peterson, ED				Navar, Ann Marie; Pencina, Michael J.; Rymer, Jennifer A.; Louzao, Darcy M.; Peterson, Eric D.			Use of Open Access Platforms for Clinical Trial Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Navar, Ann Marie; Pencina, Michael J.; Rymer, Jennifer A.; Louzao, Darcy M.; Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, 2400 Pratt St,Ste 7521, Durham, NC 27705 USA	Duke University	Navar, AM (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, 2400 Pratt St,Ste 7521, Durham, NC 27705 USA.	navar006@dm.duke.edu	Peterson, Eric David/ABF-5033-2021	Rymer, Jennifer/0000-0001-9841-2393	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069749] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL069749] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Krumholz HM, 2014, JAMA-J AM MED ASSOC, V312, P1002, DOI 10.1001/jama.2014.9647; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320; Pencina MJ, 2016, AM HEART J, V172, P64, DOI 10.1016/j.ahj.2015.11.002	3	49	51	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1283	1284		10.1001/jama.2016.2374	http://dx.doi.org/10.1001/jama.2016.2374			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	27002452	Bronze, Green Accepted			2022-12-28	WOS:000372511100017
J	Samadder, NJ; Neklason, DW; Boucher, KM; Byrne, KR; Kanth, P; Samowitz, W; Jones, D; Tavtigian, SV; Done, MW; Berry, T; Jasperson, K; Pappas, L; Smith, L; Sample, D; Davis, R; Topham, MK; Lynch, P; Strait, E; McKinnon, W; Burt, RW; Kuwada, SK				Samadder, N. Jewel; Neklason, Deborah W.; Boucher, Kenneth M.; Byrne, Kathryn R.; Kanth, Priyanka; Samowitz, Wade; Jones, David; Tavtigian, Sean V.; Done, Michelle W.; Berry, Therese; Jasperson, Kory; Pappas, Lisa; Smith, Laurel; Sample, Danielle; Davis, Rian; Topham, Matthew K.; Lynch, Patrick; Strait, Elena; McKinnon, Wendy; Burt, Randall W.; Kuwada, Scott K.			Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CELL LUNG-CANCER; LONG-TERM TREATMENT; CYCLOOXYGENASE-2 INHIBITOR; CELECOXIB; RISK; COLI; CHEMOPREVENTION; METAANALYSIS; EXPRESSION; PREVENTION	IMPORTANCE Patients with familial adenomatous polyposis (FAP) are at markedly increased risk for duodenal polyps and cancer. Surgical and endoscopic management of duodenal neoplasia is difficult and chemoprevention has not been successful. OBJECTIVE To evaluate the effect of a combination of sulindac and erlotinib on duodenal adenoma regression in patients with FAP. DESIGN, SETTING, AND PARTICIPANTS Double-blind, randomized, placebo-controlled trial, enrolling 92 participants with FAP, conducted from July 2010 through June 2014 at Huntsman Cancer Institute in Salt Lake City, Utah. INTERVENTIONS Participants with FAP were randomized to sulindac (150mg) twice daily and erlotinib (75mg) daily (n = 46) vs placebo (n = 46) for 6 months. MAIN OUTCOMES AND MEASURES The total number and diameter of polyps in the proximal duodenum were mapped at baseline and 6 months. The primary outcome was change in total polyp burden at 6 months. Polyp burden was calculated as the sum of the diameters of polyps. The secondary outcomes were change in total duodenal polyp count, change in duodenal polyp burden or count stratified by genotype and initial polyp burden, and percentage of change from baseline in duodenal polyp burden. RESULTS Ninety-two participants (mean age, 41 years [range, 24-55]; women, 56 [61%]) were randomized when the trial was stopped by the external data and safety monitoring board because the second preplanned interim analysis met the prespecified stopping rule for superiority. Grade 1 and 2 adverse events were more common in the sulindac-erlotinib group, with an acne-like rash observed in 87% of participants receiving treatment and 20% of participants receiving placebo (P <.001). Only 2 participants experienced grade 3 adverse events. [GRAPHICS] . CONCLUSIONS AND RELEVANCE Among participants with FAP, the use of sulindac and erlotinib compared with placebo resulted in a lower duodenal polyp burden after 6 months. Adverse events may limit the use of these medications at the doses used in this study. Further research is necessary to evaluate these preliminary findings in a larger study population with longer follow-up to determine whether the observed effects will result in improved clinical outcomes.	[Samadder, N. Jewel; Neklason, Deborah W.; Boucher, Kenneth M.; Samowitz, Wade; Jones, David; Tavtigian, Sean V.; Done, Michelle W.; Berry, Therese; Jasperson, Kory; Pappas, Lisa; Smith, Laurel; Sample, Danielle; Davis, Rian; Topham, Matthew K.; Burt, Randall W.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Samadder, N. Jewel; Byrne, Kathryn R.; Kanth, Priyanka; Burt, Randall W.] Univ Utah, Dept Med Gastroenterol, Salt Lake City, UT USA; [Neklason, Deborah W.; Jones, David; Tavtigian, Sean V.; Topham, Matthew K.; Burt, Randall W.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA; [Neklason, Deborah W.] Univ Utah, Dept Med Genet Epidemiol, Salt Lake City, UT USA; [Boucher, Kenneth M.] Univ Utah, Dept Med Epidemiol, Salt Lake City, UT USA; [Samowitz, Wade] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Topham, Matthew K.] Univ Utah, Dept Med Pulm, Salt Lake City, UT USA; [Lynch, Patrick] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol, Houston, TX 77030 USA; [Strait, Elena] Penrose Community Hosp, Colorado Springs, CO USA; [McKinnon, Wendy] Univ Vermont, Ctr Canc, Burlington, VT 05405 USA; [Kuwada, Scott K.] Univ Hawaii, Dept Med, Honolulu, HI 96822 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; UTMD Anderson Cancer Center; University of Vermont; University of Hawaii System	Neklason, DW (corresponding author), Univ Utah, Huntsman Canc Inst, High Risk Canc Res Program, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	deb.neklason@hci.utah.edu			National Cancer Institute [P01-CA073992]; Huntsman Cancer Institute Cancer Center Support Grant [NCI P30CA042014]; Huntsman Cancer Foundation; American College of Gastroenterology; National Institutes of Health National Center for Advancing Translational Sciences [1ULTR001067]; NATIONAL CANCER INSTITUTE [P30CA042014, P01CA073992] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001067] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Huntsman Cancer Institute Cancer Center Support Grant; Huntsman Cancer Foundation; American College of Gastroenterology(General Electric); National Institutes of Health National Center for Advancing Translational Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was funded by provided by grant P01-CA073992 from the National Cancer Institute (Drs Burt and Tavtigian); the Huntsman Cancer Institute Cancer Center Support Grant (NCI P30CA042014), as well as by the Huntsman Cancer Foundation; by a junior faculty career development award from the American College of Gastroenterology (Dr Samadder); and by grant 1ULTR001067 from the National Institutes of Health National Center for Advancing Translational Sciences.	[Anonymous], 2008, SUL PACK INS; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Biasco G, 2004, GUT, V53, P1547; Bulow S, 2004, GUT, V53, P381, DOI 10.1136/gut.2003.027771; Bulow S, 2003, GUT, V52, P742, DOI 10.1136/gut.52.5.742; Coffey RJ, 1997, P NATL ACAD SCI USA, V94, P657, DOI 10.1073/pnas.94.2.657; Conio M, 2001, GASTROINTEST ENDOSC, V53, P265, DOI 10.1067/mge.2000.108721; Cruz-Correa M, 2002, GASTROENTEROLOGY, V122, P641, DOI 10.1053/gast.2002.31890; DEBINSKI HS, 1995, LANCET, V345, P855, DOI 10.1016/S0140-6736(95)92989-4; Eisinger AL, 2006, J BIOL CHEM, V281, P20474, DOI 10.1074/jbc.M602859200; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; Gibbons DC, 2011, FAM CANCER, V10, P11, DOI 10.1007/s10689-010-9394-x; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Heiskanen I, 1999, ENDOSCOPY, V31, P412; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Lynch PM, 2010, AM J GASTROENTEROL, V105, P1437, DOI 10.1038/ajg.2009.758; Lynch TJ, 2009, J THORAC ONCOL, V4, P1002, DOI 10.1097/JTO.0b013e3181aba89f; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; MORTON DG, 1993, BRIT J SURG, V80, P255, DOI 10.1002/bjs.1800800249; NIV Y, 1994, GASTROENTEROLOGY, V107, P854, DOI 10.1016/0016-5085(94)90136-8; NUGENT KP, 1993, BRIT J SURG, V80, P1618, DOI 10.1002/bjs.1800801244; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Phillips RKS, 2002, GUT, V50, P857, DOI 10.1136/gut.50.6.857; Qi WX, 2015, J CHEMOTHERAPY, V27, P40, DOI 10.1179/1973947814Y.0000000189; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Shi L, 2014, LUNG CANCER, V83, P231, DOI 10.1016/j.lungcan.2013.11.016; Sos ML, 2008, J THORAC ONCOL, V3, P170, DOI 10.1097/JTO.0b013e3181622c05; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; THORSON AG, 1994, LANCET, V343, P180, DOI 10.1016/S0140-6736(94)90974-1; Tonelli F, 2000, J SURG ONCOL, V74, P15, DOI 10.1002/1096-9098(200005)74:1<15::AID-JSO4>3.0.CO;2-Z; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; Wheatley-Price P, 2008, J CLIN ONCOL, V26, P2350, DOI 10.1200/JCO.2007.15.2280; Woodcock J., WITHDRAWAL APPROVAL	34	83	87	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1266	1275		10.1001/jama.2016.2522	http://dx.doi.org/10.1001/jama.2016.2522			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	27002448	Green Accepted, Bronze			2022-12-28	WOS:000372511100013
J	Weaver, HA; Buie, MW; Buratti, BJ; Grundy, WM; Lauer, TR; Olkin, CB; Parker, AH; Porter, SB; Showalter, MR; Spencer, JR; Stern, SA; Verbiscer, AJ; McKinnon, WB; Moore, JM; Robbins, SJ; Schenk, P; Singer, KN; Barnouin, OS; Cheng, AF; Ernst, CM; Lisse, CM; Lennings, DE; Lunsford, AW; Reuter, DC; Hamilton, DP; Kaufmann, DE; Ennico, K; Young, LA; Beyer, RA; Binzel, RP; Bray, VJ; Chaikin, AL; Cook, JC; Cruiksh, DP; Dalle Ore, CM; Earle, AM; Gladstone, GR; Howett, CJA; Linscott, IR; Nimmo, F; Parker, JW; Philippe, S; Protopapa, S; Reitsema, HJ; Schmitt, B; Stryk, T; Summers, ME; Tsang, CCC; Throop, HHB; White, OL; Zangari, AM				Weaver, H. A.; Buie, M. W.; Buratti, B. J.; Grundy, W. M.; Lauer, T. R.; Olkin, C. B.; Parker, A. H.; Porter, S. B.; Showalter, M. R.; Spencer, J. R.; Stern, S. A.; Verbiscer, A. J.; McKinnon, W. B.; Moore, J. M.; Robbins, S. J.; Schenk, P.; Singer, K. N.; Barnouin, O. S.; Cheng, A. F.; Ernst, C. M.; Lisse, C. M.; Lennings, D. E.; Lunsford, A. W.; Reuter, D. C.; Hamilton, D. P.; Kaufmann, D. E.; Ennico, K.; Young, L. A.; Beyer, R. A.; Binzel, R. P.; Bray, V. J.; Chaikin, A. L.; Cook, J. C.; Cruiksh, D. P.; Dalle Ore, C. M.; Earle, A. M.; Gladstone, G. R.; Howett, C. J. A.; Linscott, I. R.; Nimmo, F.; Parker, J. Wm.; Philippe, S.; Protopapa, S.; Reitsema, H. J.; Schmitt, B.; Stryk, T.; Summers, M. E.; Tsang, C. C. C.; Throop, H. H. B.; White, O. L.; Zangari, A. M.			The small satellites of Pluto as observed by New Horizons	SCIENCE			English	Article							KUIPER-BELT OBJECTS; GIANT IMPACT ORIGIN; VOLATILE LOSS; SMALL MOONS; IMAGER; MASSES; SYSTEM; HYDRA; NIX	The New Horizons mission has provided resolved measurements of Pluto's moons Styx, Nix, Kerberos, and Hydra. All four are small, with equivalent spherical diameters of similar to 40 kilometers for Nix and Hydra and similar to 10 kilometers for Styx and Kerberos. They are also highly elongated, with maximum to minimum axis ratios of similar to 2. All four moons have high albedos (similar to 50 to 90%) suggestive of a water-ice surface composition. Crater densities on Nix and Hydra imply surface ages of at least 4 billion years. The small moons rotate much faster than synchronous, with rotational poles clustered nearly orthogonal to the common pole directions of Pluto and Charon. These results reinforce the hypothesis that the small moons formed in the aftermath of a collision that produced the Pluto-Charon binary.	[Weaver, H. A.; Barnouin, O. S.; Cheng, A. F.; Ernst, C. M.; Lisse, C. M.] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA; [Buie, M. W.; Olkin, C. B.; Parker, A. H.; Porter, S. B.; Spencer, J. R.; Stern, S. A.; Robbins, S. J.; Singer, K. N.; Kaufmann, D. E.; Young, L. A.; Cook, J. C.; Howett, C. J. A.; Parker, J. Wm.; Reitsema, H. J.; Tsang, C. C. C.; Zangari, A. M.] SW Res Inst, Boulder, CO 80302 USA; [Buratti, B. J.] CALTECH, NASA Jet Prop Lab, Pasadena, CA 91109 USA; [Grundy, W. M.] Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA; [Lauer, T. R.] Natl Opt Astron Observ, Tucson, AZ 26732 USA; [Showalter, M. R.; Beyer, R. A.] SETI Inst, Mountain View, CA 94043 USA; [Verbiscer, A. J.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [McKinnon, W. B.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Moore, J. M.; Ennico, K.; Beyer, R. A.; Cruiksh, D. P.; Dalle Ore, C. M.; White, O. L.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Schenk, P.] Lunar & Planetary Inst, 3303 NASA Rd 1, Houston, TX 77058 USA; [Lennings, D. E.; Lunsford, A. W.; Reuter, D. C.] NASA, Goddard Space Flight Ctr, Code 661, Greenbelt, MD 20771 USA; [Hamilton, D. P.; Protopapa, S.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Binzel, R. P.] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bray, V. J.; Earle, A. M.] Univ Arizona, Tucson, AZ 85721 USA; [Gladstone, G. R.] SW Res Inst, San Antonio, TX 78238 USA; [Linscott, I. R.] Stanford Univ, Stanford, CA 94305 USA; [Nimmo, F.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Philippe, S.; Schmitt, B.] Univ Grenoble Alpes, CNRS, IPAG, F-38000 Grenoble, France; [Stryk, T.] Roane State Community Coll, Oak Ridge, TN 37830 USA; [Summers, M. E.] George Mason Univ, Fairfax, VA 22030 USA; [Throop, H. H. B.] Planetary Sci Inst, Tucson, AZ 85719 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Optical Astronomy Observatory; University of Virginia; Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland College Park; Massachusetts Institute of Technology (MIT); University of Arizona; Southwest Research Institute; Stanford University; University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); George Mason University	Weaver, HA (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	hal.weaver@jhuapl.edu	Barnouin, Olivier S/I-7475-2015; Olkin, Catherine/AAF-5160-2019; Lisse, Carey M/B-7772-2016; Ernst, Carolyn M/I-4902-2012; Bray, Veronica/K-6914-2017; Weaver, Harold A/D-9188-2016; Schmitt, Bernard/A-1064-2009	Barnouin, Olivier S/0000-0002-3578-7750; Olkin, Catherine/0000-0002-5846-716X; Lisse, Carey M/0000-0002-9548-1526; Ernst, Carolyn M/0000-0002-9434-7886; Weaver, Harold A/0000-0003-0951-7762; Schmitt, Bernard/0000-0002-1230-6627; Porter, Simon/0000-0003-0333-6055; Parker, Joel/0000-0002-3672-0603; Lauer, Tod/0000-0003-3234-7247; Reitsema, Harold/0000-0002-4119-5700; Bray, Veronica/0000-0002-7277-3980; Protopapa, Silvia/0000-0001-8541-8550; Grundy, Will/0000-0002-8296-6540	NASA's New Horizons project; NASA's Origins research program; Centre National d'Etudes Spatiales, France	NASA's New Horizons project; NASA's Origins research program; Centre National d'Etudes Spatiales, France(Centre National D'etudes Spatiales)	We thank the many dedicated engineers who contributed to the success of the New Horizons mission and NASA's Deep Space Network for a decade of excellent support to New Horizons. This work was supported by NASA's New Horizons project. As contractually agreed to with NASA, fully calibrated New Horizons Pluto system data will be released via the NASA Planetary Data System at https://pds.nasa.gov/ in a series of stages in 2016 and 2017 because of the time required to fully downlink and calibrate the data set. Also supported by NASA's Origins research program (D.P.H.) and Centre National d'Etudes Spatiales, France (S. Philippe and B.S.). S.A.S. is affiliated with Florida Space Institute, Uwingu LLC, Golden Spike Co., and World View Enterprises.	Brozovic M, 2015, ICARUS, V246, P317, DOI 10.1016/j.icarus.2014.03.015; Canup RM, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/2/35; Cheng AF, 2008, SPACE SCI REV, V140, P189, DOI 10.1007/s11214-007-9271-6; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Greenstreet S, 2015, ICARUS, V258, P267, DOI 10.1016/j.icarus.2015.05.026; Grundy WM, 2016, SCIENCE, V351, DOI 10.1126/science.aad9189; Johnson RE, 2015, ASTROPHYS J, V809, DOI 10.1088/0004-637X/809/1/43; Kenyon SJ, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/1/8; Lellouch E, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201322047; Moore JM, 2016, SCIENCE, V351, P1284, DOI 10.1126/science.aad7055; Porter SB, 2015, ICARUS, V246, P360, DOI 10.1016/j.icarus.2014.03.031; Reuter DC, 2008, SPACE SCI REV, V140, P129, DOI 10.1007/s11214-008-9375-7; Schaller EL, 2007, ASTROPHYS J, V659, pL61, DOI 10.1086/516709; Showalter MR, 2015, NATURE, V522, P45, DOI 10.1038/nature14469; Showalter M. R, 2012, 9253 IAU, P9253; Showalter MR., 2011, IAUC, V9221, P1; Stern SA, 2015, SCIENCE, V350, DOI 10.1126/science.aad1815; Stern SA, 2009, ICARUS, V199, P571, DOI 10.1016/j.icarus.2008.10.006; Stern SA, 2006, NATURE, V439, P946, DOI 10.1038/nature04548; Verbiscer A, 2007, SCIENCE, V315, P815, DOI 10.1126/science.1134681; Vilenius E, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118743; Weaver HA, 2006, NATURE, V439, P943, DOI 10.1038/nature04547; Youdin AN, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/17	23	64	65	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279							aae0030	10.1126/science.aae0030	http://dx.doi.org/10.1126/science.aae0030			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989256	Green Submitted			2022-12-28	WOS:000372397700032
J	Daniels, JT				Daniels, Julie T.			BIOMEDICINE Visionary stem-cell therapies	NATURE			English	Editorial Material							COMPLICATIONS		[Daniels, Julie T.] UCL, Inst Ophthalmol, London EC1V 9EL, England	University of London; University College London	Daniels, JT (corresponding author), UCL, Inst Ophthalmol, London EC1V 9EL, England.	j.daniels@ucl.ac.uk		Daniels, Julie/0000-0003-2099-9360				Armitage WJ, 2006, BRIT J OPHTHALMOL, V90, P1222, DOI 10.1136/bjo.2006.101527; Borderie VM, 2009, OPHTHALMOLOGY, V116, P2354, DOI 10.1016/j.ophtha.2009.05.009; Hayashi R, 2016, NATURE, V531, P376, DOI 10.1038/nature17000; Lin HT, 2016, NATURE, V531, P323, DOI 10.1038/nature17181; Mamalis N, 2004, J CATARACT REFR SURG, V30, P2209, DOI 10.1016/j.jcrs.2004.06.051; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Visser N, 2013, J CATARACT REFR SURG, V39, P624, DOI 10.1016/j.jcrs.2013.02.020	10	4	4	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					309	310		10.1038/nature17305	http://dx.doi.org/10.1038/nature17305			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26958834				2022-12-28	WOS:000372064300037
J	Hornyak, T				Hornyak, Tim			EYE ON THE PRIZE, BUT GRASP LOOSENS	NATURE			English	Editorial Material																			0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S114	S117		10.1038/531S114a	http://dx.doi.org/10.1038/531S114a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG4TA	26982021	Bronze			2022-12-28	WOS:000372064300010
J	Mallapaty, S; Pleasants, S; Phillips, N				Mallapaty, Smriti; Pleasants, Simon; Phillips, Nicky			TOP TEAMS TO BE RECKONED WITH	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S127	S130		10.1038/531S127a	http://dx.doi.org/10.1038/531S127a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26982023	Bronze			2022-12-28	WOS:000372064300012
J	Spracklen, DV				Spracklen, Dominick V.			GLOBAL WARMING China's contribution to climate change	NATURE			English	Editorial Material							AEROSOL; POLLUTION		[Spracklen, Dominick V.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Spracklen, DV (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	dominick@env.leeds.ac.uk	Spracklen, Dominick/AAA-6257-2019; Spracklen, Dominick V/B-4890-2014					Butt EW, 2016, ATMOS CHEM PHYS, V16, P873, DOI 10.5194/acp-16-873-2016; Fiore AM, 2012, CHEM SOC REV, V41, P6663, DOI 10.1039/c2cs35095e; Heald CL, 2015, CHEM REV, V115, P4476, DOI 10.1021/cr500446g; Huang RJ, 2014, NATURE, V514, P218, DOI 10.1038/nature13774; Kulmala M, 2015, NATURE, V526, P497, DOI 10.1038/526497a; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Li BG, 2016, NATURE, V531, P357, DOI 10.1038/nature17165; Mahowald N, 2011, SCIENCE, V334, P794, DOI 10.1126/science.1207374; Naudts K, 2016, SCIENCE, V351, P597, DOI 10.1126/science.aad7270; 2015, NATURE, V528, P315	10	15	15	3	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					310	312		10.1038/531310a	http://dx.doi.org/10.1038/531310a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26983534				2022-12-28	WOS:000372064300038
J	Kunisaki, K				Kunisaki, Ken			Review: In obstructive sleep apnea, CPAP and mandibular devices do not differ for reducing blood pressure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kunisaki, Ken] Minneapolis VA Hlth Care Syst, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Kunisaki, K (corresponding author), Minneapolis VA Hlth Care Syst, Minneapolis, MN USA.		Kunisaki, Ken/A-6950-2009	Kunisaki, Ken/0000-0001-8644-2827				Antic NA, 2015, SLEEP, V38, P1247, DOI 10.5665/sleep.4902; Marklund M, 2012, EUR RESPIR J, V39, P1241, DOI 10.1183/09031936.00144711	2	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2016	164	6					JC30	JC30		10.7326/ACPJC-2016-164-6-030	http://dx.doi.org/10.7326/ACPJC-2016-164-6-030			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG6PG	26974730				2022-12-28	WOS:000372207200005
J	Rough, K; Bateman, BT; Patorno, E; Desai, RJ; Park, Y; Hernandez-Diaz, S; Huybrechts, KF				Rough, Kathryn; Bateman, Brian T.; Patorno, Elisabetta; Desai, Rishi J.; Park, Yoonyoung; Hernandez-Diaz, Sonia; Huybrechts, Krista F.			Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non-Substance Abuse Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Rough, Kathryn; Bateman, Brian T.; Patorno, Elisabetta; Desai, Rishi J.; Park, Yoonyoung; Huybrechts, Krista F.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA; [Hernandez-Diaz, Sonia] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Rough, K (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	ker704@mail.harvard.edu	Desai, Rishi/AAH-8988-2021		NIAID NIH HHS [T32 AI007433] Funding Source: Medline; NICHD NIH HHS [K08 HD075831, K08HD075831] Funding Source: Medline; NIMH NIH HHS [K01MH099141, R01MH100216, K01 MH099141, R01 MH100216] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100216, K01MH099141] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Frakt AB, ADDICTION RES CARE C; Frakt AB, 2015, NEW ENGL J MED, V372, P1879, DOI 10.1056/NEJMp1501362; Research Data Assistance Center, RED SUBST AB CLAIMS	3	12	12	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1164	1166		10.1001/jama.2015.18417	http://dx.doi.org/10.1001/jama.2015.18417			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978213	Green Accepted, Bronze			2022-12-28	WOS:000372159800023
J	McCauley, DJ; Woods, P; Sullivan, B; Bergman, B; Jablonicky, C; Roan, A; Hirshfield, M; Boerder, K; Worm, B				McCauley, Douglas J.; Woods, Paul; Sullivan, Brian; Bergman, Bjorn; Jablonicky, Caroline; Roan, Aaron; Hirshfield, Michael; Boerder, Kristina; Worm, Boris			Ending hide and seek at sea	SCIENCE			English	Editorial Material							LIFE		[McCauley, Douglas J.; Jablonicky, Caroline] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; [Woods, Paul; Bergman, Bjorn] SkyTruth, Shepherdstown, WV 25443 USA; [Sullivan, Brian; Roan, Aaron] Google, Mountain View, CA 94043 USA; [Hirshfield, Michael] Oceana, Washington, DC 20036 USA; [Boerder, Kristina; Worm, Boris] Dalhousie Univ, Halifax, NS, Canada	University of California System; University of California Santa Barbara; Google Incorporated; Dalhousie University	McCauley, DJ (corresponding author), Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.	douglas.mccauley@lifesci.ucsb.edu		Worm, Boris/0000-0002-5742-8716				[Anonymous], 2013, STANFORD ENV LAW J; Collette BB, 2011, SCIENCE, V333, P291, DOI 10.1126/science.1208730; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Druel E, 2014, MAR POLICY, V49, P90, DOI 10.1016/j.marpol.2013.11.023; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Flothmann S, 2010, SCIENCE, V328, P1235, DOI 10.1126/science.1190245; Lubchenco J, 2015, SCIENCE, V350, P382, DOI 10.1126/science.aad5443; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; Natale F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130746; Pala C., 2014, THE ATLANTIC    1116; Pressey B, 2014, NATURE, V515, P28; United Nations General Assembly, 2015, A69922 UN GEN ASS	12	134	139	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1148	1150		10.1126/science.aad5686	http://dx.doi.org/10.1126/science.aad5686			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965610				2022-12-28	WOS:000386158400024
J	Fischbach, MA; Segre, JA				Fischbach, Michael A.; Segre, Julia A.			Signaling in Host-Associated Microbial Communities	CELL			English	Review							INVASIVE ESCHERICHIA-COLI; FUNGUS-GROWING ANTS; GUT MICROBIOTA; COMMENSAL; DIET; BACTERIA; SPECIFICITY; METABOLISM; PROMOTES; COLONIZATION	Human-associated microbiota form and stabilize communities based on interspecies interactions. We review how these microbe-microbe and microbe-host interactions are communicated to shape communities over a human's lifes pan,including periods of health and disease. Modeling and dissecting signaling in host-associated communities is crucial to understand their function and will open the door to therapies that prevent or correct microbial community dysfunction to promote health and treat disease.	[Fischbach, Michael A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Fischbach, Michael A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Segre, Julia A.] Natl Human Genome Res Inst, Microbial Genom Sect, Translat & Funct Genom Branch, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Fischbach, MA (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Fischbach, MA (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA.; Segre, JA (corresponding author), Natl Human Genome Res Inst, Microbial Genom Sect, Translat & Funct Genom Branch, Bethesda, MD 20892 USA.	fischbach@fischbachgroup.org; jsegre@nhgri.nih.gov		Fischbach, Michael/0000-0003-3079-8247	NIH [R01 DK101674, R01 AI101018]; Pfizer; David and Lucile Packard Foundation; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award; Byers Award in Basic Science from the Program for Breakthrough Biomedical Research; NIH NHGRI Intramural Research Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101674] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); Byers Award in Basic Science from the Program for Breakthrough Biomedical Research; NIH NHGRI Intramural Research Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.A.F. is supported by NIH R01 DK101674, NIH R01 AI101018, a research award from Pfizer, a Fellowship for Science and Engineering from the David and Lucile Packard Foundation, a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award, and the Byers Award in Basic Science from the Program for Breakthrough Biomedical Research. J.A.S. is supported by NIH NHGRI Intramural Research Program. M.A.F. is on the scientific advisory board of NGM Biopharmaceuticals, a co-founder of Revolution Medicines, and a director of Achaogen.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Aylward FO, 2014, MBIO, V5, DOI 10.1128/mBio.02077-14; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Byrd AL, 2016, SCIENCE, V351, P224, DOI 10.1126/science.aad6753; Cafaro MJ, 2011, P ROY SOC B-BIOL SCI, V278, P1814, DOI 10.1098/rspb.2010.2118; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Carmody RN, 2014, J CLIN INVEST, V124, P4173, DOI 10.1172/JCI72335; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chou S, 2015, NATURE, V518, P98, DOI 10.1038/nature13965; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; Cullen TW, 2015, SCIENCE, V347, P170, DOI 10.1126/science.1260580; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Dogan B, 2014, INFLAMM BOWEL DIS, V20, P1919, DOI 10.1097/MIB.0000000000000183; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Duraffourd C, 2012, CELL, V150, P377, DOI 10.1016/j.cell.2012.05.039; Durrett R, 1998, THEOR POPUL BIOL, V53, P30, DOI 10.1006/tpbi.1997.1338; Faith JJ, 2015, P NATL ACAD SCI USA, V112, P633, DOI 10.1073/pnas.1418781112; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Hegazy AN, 2015, SCIENCE, V349, P929, DOI 10.1126/science.aad0865; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Johansson MEV, 2015, CELL HOST MICROBE, V18, P582, DOI 10.1016/j.chom.2015.10.007; Kelsic ED, 2015, NATURE, V521, P516, DOI 10.1038/nature14485; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Knights D, 2014, CELL HOST MICROBE, V16, P433, DOI 10.1016/j.chom.2014.09.013; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447; Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Martens EC, 2014, J MOL BIOL, V426, P3851, DOI 10.1016/j.jmb.2014.06.022; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Martinez-del Campo A, 2015, MBIO, V6, DOI 10.1128/mBio.00042-15; Mithieux G, 2005, CELL METAB, V2, P321, DOI 10.1016/j.cmet.2005.09.010; Mukherjee S, 2014, NATURE, V505, P103, DOI 10.1038/nature12729; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Oh DC, 2009, NAT CHEM BIOL, V5, P391, DOI 10.1038/nchembio.159; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Org E, 2015, GENOME RES, V25, P1558, DOI 10.1101/gr.194118.115; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; Patterson AD, 2014, CELL METAB, V20, P761, DOI 10.1016/j.cmet.2014.07.002; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Ridaura V, 2015, CELL, V161, P193, DOI 10.1016/j.cell.2015.03.033; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; van Opstal EJ, 2015, SCIENCE, V349, P1172, DOI 10.1126/science.aab3958; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wilson M., 2005, MICROBIAL INHABITANT; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zhu W., 2016, CELL, V165	99	95	102	0	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1288	1300		10.1016/j.cell.2016.02.037	http://dx.doi.org/10.1016/j.cell.2016.02.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967294	Bronze, Green Accepted			2022-12-28	WOS:000372784900025
J	Smit, EF; van den Heuvel, MM				Smit, Egbert F.; van den Heuvel, Michel M.			PD-L1 in non-small-cell lung cancer: the third target for immunotherapy	LANCET			English	Editorial Material							DOCETAXEL; NIVOLUMAB		[Smit, Egbert F.] Vrije Univ Amsterdam, VU Med Ctr, Dept Pulm Dis, NL-1007 MB Amsterdam, Netherlands; [Smit, Egbert F.; van den Heuvel, Michel M.] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands Cancer Institute	Smit, EF (corresponding author), Vrije Univ Amsterdam, VU Med Ctr, Dept Pulm Dis, NL-1007 MB Amsterdam, Netherlands.; Smit, EF (corresponding author), Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands.	ef.smit@vumc.nl	van den Heuvel, Michel M/D-9491-2017	van den Heuvel, Michel M/0000-0002-6372-2153; Smit, Egbert/0000-0002-7329-6995				Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Fehrenbacher L, 2016, LANCET; Herbst RS, 2015, LANCET; Lynch TJ, 2012, J CLIN ONCOL, V30, P2046, DOI 10.1200/JCO.2011.38.4032; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095	6	7	9	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 30	2016	387	10030					1795	1796		10.1016/S0140-6736(16)00700-5	http://dx.doi.org/10.1016/S0140-6736(16)00700-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK6SS	26972842				2022-12-28	WOS:000375056100007
J	Keestra-Gounder, AM; Byndloss, MX; Seyffert, N; Young, BM; Chavez-Arroyo, A; Tsai, AY; Cevallos, SA; Winter, MG; Pham, OH; Tiffany, CR; de Jong, MF; Kerrinnes, T; Ravindran, R; Luciw, PA; McSorley, SJ; Baumler, AJ; Tsolis, RM				Keestra-Gounder, A. Marijke; Byndloss, Mariana X.; Seyffert, Nubia; Young, Briana M.; Chavez-Arroyo, Alfredo; Tsai, April Y.; Cevallos, Stephanie A.; Winter, Maria G.; Pham, Oanh H.; Tiffany, Connor R.; de Jong, Maarten F.; Kerrinnes, Tobias; Ravindran, Resmi; Luciw, Paul A.; McSorley, Stephen J.; Baumler, Andreas J.; Tsolis, Renee M.			NOD1/NOD2 signaling links ER stress with inflammation	NATURE			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM STRESS; IV SECRETION SYSTEM; ACTIVATION; KINASE; IRE1; MICE; INFECTION; RESPONSES; PATHOGEN	Endoplasmic reticulum (ER) stress is a major contributor to inflammatory diseases, such as Crohn's disease and type 2 diabetes(1,2). ER stress induces the unfolded protein response (UPR), which involves activation of three transmembrane receptors, ATF6 (activating transcription factor 6), PERK (protein kinase RNA-like endoplasmic reticulum kinase) and IRE1 alpha (inositol-requiring enzyme 1 alpha)(3) (Extended Data figure 1 alpha). Once activated, IRE1a recruits TRAF2 (TNF receptor-associated factor 2) to the ER membrane to initiate inflammatory responses via the nuclear factor kappa B (NF-kappa B) pathway(4). Inflammation is commonly triggered when pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) or nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs), detect tissue damage or microbial infection. However, it is not clear which PRRs play a major role in inducing inflammation during ER stress. Here we show that NOD1 and NOD2, two members of the NLR family of PRRs, are important mediators of ER stress-induced inflammation. The ER stress inducers thapsigargin and dithiothreitol (DTT) triggered production of the pro-inflammatory cytokine interleukin (IL)-6 in a NOD1/2-dependent fashion. Inflammation and IL-6 production triggered by infection with Brucella abortus, which induces ER stress by injecting the type IV secretion system (T4SS) effector protein VceC into host cells(5), was TRAF2, NOD1/2 and RIP2-dependent and could be blunted by treatment with the ER-stress inhibitor tauroursodeoxycholate (TUDCA) or an IRE1 alpha kinase inhibitor. The association of NOD1 and NOD2 with pro-inflammatory responses induced by the IRE1 alpha/TRAF2 signaling pathway provides a novel link between innate immunity and ER stress-induced inflammation.	[Keestra-Gounder, A. Marijke; Byndloss, Mariana X.; Seyffert, Nubia; Young, Briana M.; Chavez-Arroyo, Alfredo; Tsai, April Y.; Cevallos, Stephanie A.; Winter, Maria G.; Tiffany, Connor R.; de Jong, Maarten F.; Kerrinnes, Tobias; Baumler, Andreas J.; Tsolis, Renee M.] Univ Calif Davis, Dept Med Microbiol & Immunol, Sch Med, One Shields Ave, Davis, CA 95616 USA; [Pham, Oanh H.; Ravindran, Resmi; Luciw, Paul A.; McSorley, Stephen J.] Univ Calif Davis, Ctr Comparat Med, Sch Med, One Shields Ave, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Tsolis, RM (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Sch Med, One Shields Ave, Davis, CA 95616 USA.	rmtsolis@ucdavis.edu	Baumler, Andreas J/H-2301-2011; Seyffert, Nubia/N-6410-2014; Byndloss, Mariana X/D-9890-2014; Keestra-Gounder, A. Marijke/H-4394-2012; Byndloss, Mariana Xavier/ABD-5506-2021	Baumler, Andreas J/0000-0001-9152-7809; Seyffert, Nubia/0000-0002-2193-6508; Byndloss, Mariana X/0000-0002-2122-4156; Keestra-Gounder, A. Marijke/0000-0002-2231-652X; Byndloss, Mariana Xavier/0000-0002-2122-4156; Pham, Oanh/0000-0001-5307-6023; Tsolis, Renee/0000-0001-9131-6657; de jong, maarten/0000-0003-2278-286X; McSorley, Stephen/0000-0002-6363-3222	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117303, R21AI112258, R01AI109799, R01AI076278, R01AI096528, R01AI076246, R01AI044170, R01AI103422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086262, R25GM056765] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI103422, R01 AI076278, AI044170, AI109799, R01 AI076246, R01 AI044170, AI117303, R21 AI112258, R01 AI096528, AI076246, AI076278, R21 AI117303, AI112258, R01 AI109799, AI096528] Funding Source: Medline; NIGMS NIH HHS [R25 GM086262, GM056765, R25 GM056765] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Celli J, 2014, MICROBIOLOGY; de Jong MF, 2013, MBIO, V4, DOI 10.1128/mBio.00418-12; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; de Jong MF, 2013, PLOS ONE, V4; Derre I, 2015, CELL MICROBIOL, V17, P959, DOI 10.1111/cmi.12455; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Kaneko M, 2003, BIOL PHARM BULL, V26, P931, DOI 10.1248/bpb.26.931; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Keestra AM, 2011, MBIO, P2; Kim S, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-22; Li LY, 2005, J CELL SCI, V118, P555, DOI 10.1242/jcs.01641; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Montane J, 2014, DIABET METAB SYND OB, V7, P25, DOI 10.2147/DMSO.S37649; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Roberson EC, 2012, AM J RESP CELL MOL, V46, P573, DOI 10.1165/rcmb.2010-0460OC; Rolan HG, 2008, INFECT IMMUN, V76, P3207, DOI 10.1128/IAI.00203-08; Rolan HG, 2007, INFECT IMMUN, V75, P2965, DOI 10.1128/IAI.01896-06; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Roux CM, 2007, CELL MICROBIOL, V9, P1851, DOI 10.1111/j.1462-5822.2007.00922.x; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Tsolis RM, 2008, NAT REV MICROBIOL, V6, P883, DOI 10.1038/nrmicro2012; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664	29	294	309	9	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2016	532	7599					394	397		10.1038/nature17631	http://dx.doi.org/10.1038/nature17631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ2HW	27007849	Green Accepted			2022-12-28	WOS:000393031700001
J	Denais, CM; Gilbert, RM; Isermann, P; McGregor, AL; te Lindert, M; Weigelin, B; Davidson, PM; Friedl, P; Wolf, K; Lammerding, J				Denais, Celine M.; Gilbert, Rachel M.; Isermann, Philipp; McGregor, Alexandra L.; te Lindert, Mariska; Weigelin, Bettina; Davidson, Patricia M.; Friedl, Peter; Wolf, Katarina; Lammerding, Jan			Nuclear envelope rupture and repair during cancer cell migration	SCIENCE			English	Article							BREAST-CANCER; DNA-DAMAGE; LAMIN-A/C; DEFORMATION; DISEASE; LAMINOPATHIES; ORGANIZATION; MICRONUCLEI; THRESHOLD; MECHANICS	During cancer metastasis, tumor cells penetrate tissues through tight interstitial spaces, which requires extensive deformation of the cell and its nucleus. Here, we investigated mammalian tumor cell migration in confining microenvironments in vitro and in vivo. Nuclear deformation caused localized loss of nuclear envelope (NE) integrity, which led to the uncontrolled exchange of nucleo-cytoplasmic content, herniation of chromatin across the NE, and DNA damage. The incidence of NE rupture increased with cell confinement and with depletion of nuclear lamins, NE proteins that structurally support the nucleus. Cells restored NE integrity using components of the endosomal sorting complexes required for transport III (ESCRT III) machinery. Our findings indicate that cell migration incurs substantial physical stress on the NE and its content and requires efficient NE and DNA damage repair for cell survival.	[Denais, Celine M.; Gilbert, Rachel M.; Isermann, Philipp; McGregor, Alexandra L.; Davidson, Patricia M.; Lammerding, Jan] Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY USA; [Denais, Celine M.; Gilbert, Rachel M.; Isermann, Philipp; McGregor, Alexandra L.; Davidson, Patricia M.; Lammerding, Jan] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY USA; [te Lindert, Mariska; Weigelin, Bettina; Friedl, Peter; Wolf, Katarina] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands; [Friedl, Peter] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Friedl, Peter] Canc Genom Ctr, Amsterdam, Netherlands	Cornell University; Cornell University; Radboud University Nijmegen; University of Texas System; UTMD Anderson Cancer Center	Lammerding, J (corresponding author), Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY USA.; Lammerding, J (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY USA.	jan.lammerding@cornell.edu	Davidson, Patricia/J-5775-2014; Lammerding, Jan/A-9498-2016; Friedl, Peter/A-8961-2010; Davidson, Patricia/Q-5784-2019; Weigelin, Bettina/H-8604-2015; Wolf, Katarina/A-7787-2010	Davidson, Patricia/0000-0002-3939-3601; Lammerding, Jan/0000-0003-4335-8611; Friedl, Peter/0000-0002-0119-4041; Davidson, Patricia/0000-0002-3939-3601; Wolf, Katarina/0000-0003-0616-2708; Weigelin, Bettina/0000-0003-4460-3113	NIH [R01 HL082792, R01 NS059348, S10OD018516]; Department of Defense Breast Cancer Research Program [BC102152, BC150580]; NSF [CBET-1254846, ECCS-15420819, 1428922]; National Cancer Institute, NIH, through the Cornell Center on the Microenvironment and Metastasis [U54 CA143876]; NSF Graduate Research Fellowship [DGE-1144153]; Netherlands Science Organization [NWO-VIDI 917.10.364, NWO-VICI 918.11.626]; Cancer Genomics Center, Netherlands; New York Stem Cell Foundation (NYSTEM) [CO29155]; Radboud University Medical Center Microscopic Imaging Center and Preclinical Animal Imaging Center (PRIME); NATIONAL CANCER INSTITUTE [U54CA143876] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059348] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018516] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1428922] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NSF(National Science Foundation (NSF)); National Cancer Institute, NIH, through the Cornell Center on the Microenvironment and Metastasis; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Netherlands Science Organization(Netherlands Organization for Scientific Research (NWO)); Cancer Genomics Center, Netherlands; New York Stem Cell Foundation (NYSTEM); Radboud University Medical Center Microscopic Imaging Center and Preclinical Animal Imaging Center (PRIME); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank G. Lahav, A. Loewer, M. Zwerger, M. Smolka, S. Emr, N. Buchkovich, B. Burke, H. Worman, S. Young, L. Fong, D. Discher, J. Broers, J. Goedhart, H. Yu, and W. Zipfel for cells, reagents, and helpful discussion. The authors acknowledge E. Wagena for mouse surgery and cell transfection, C. Paus for generation of in vitro collagen data, and K. Zhang, E. Ghazoul, D. Huang, G. Fedorchak, G.-J. Bakker, and F. Ahmadpour for help with image analysis. The authors are grateful to M. Piel and colleagues for sharing their unpublished data and manuscript. This work was supported by awards from NIH (R01 HL082792 and R01 NS059348); the Department of Defense Breast Cancer Research Program (BC102152 and BC150580); NSF (CBET-1254846); the National Cancer Institute, NIH, through the Cornell Center on the Microenvironment and Metastasis (U54 CA143876); and an NSF Graduate Research Fellowship to A. L. M (DGE-1144153). This work was further supported by the Netherlands Science Organization (NWO-VIDI 917.10.364 to K.W. and NWO-VICI 918.11.626 to P.F.) and the Cancer Genomics Center, Netherlands. This work was performed in part at the Cornell NanoScale Science and Technology Facility, which is supported by NSF (grant ECCS-15420819). Imaging was performed in part through the Cornell University Biotechnology Resource Center, which is supported by New York Stem Cell Foundation (NYSTEM) (CO29155), NIH (S10OD018516), and NSF (1428922), and by the Radboud University Medical Center Microscopic Imaging Center and Preclinical Animal Imaging Center (PRIME). Additional experimental details and data are available in the supplementary materials.	Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Burke B, 2014, CURR TOP DEV BIOL, V109, P1, DOI 10.1016/B978-0-12-397920-9.00006-8; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Davidson PM, 2015, INTEGR BIOL-UK, V7, P1534, DOI 10.1039/c5ib00200a; Davidson PM, 2014, CELL MOL BIOENG, V7, P293, DOI 10.1007/s12195-014-0342-y; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Fu Y, 2012, LAB CHIP, V12, P3774, DOI 10.1039/c2lc40477j; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Hatch E, 2014, J CELL BIOL, V205, P133, DOI 10.1083/jcb.201402003; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Hurley JH, 2015, EMBO J, V34, P2398, DOI 10.15252/embj.201592484; Hutchison CJ, 2014, ADV EXP MED BIOL, V773, P593, DOI 10.1007/978-1-4899-8032-8_27; Jamin A, 2015, CURR OPIN CELL BIOL, V34, P61, DOI 10.1016/j.ceb.2015.05.006; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Le Berre M, 2012, INTEGR BIOL-UK, V4, P1406, DOI 10.1039/c2ib20056b; Loewer A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-114; Matsumoto A, 2015, CANCER MED-US, V4, P1547, DOI 10.1002/cam4.495; Nakamura AJ, 2010, CELL CYCLE, V9, P389, DOI 10.4161/cc.9.2.10475; Neelam S, 2015, P NATL ACAD SCI USA, V112, P5720, DOI 10.1073/pnas.1502111112; Olmos Y, 2015, NATURE, V522, P236, DOI 10.1038/nature14503; Petrie RJ, 2014, SCIENCE, V345, P1062, DOI 10.1126/science.1256965; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Rowat AC, 2013, J BIOL CHEM, V288, P8610, DOI 10.1074/jbc.M112.441535; Shimi T, 2015, MOL BIOL CELL, V26, P4075, DOI 10.1091/mbc.E15-07-0461; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Thomas DG, 2015, J CELL BIOL, V210, P583, DOI 10.1083/jcb.201502039; Vargas JD, 2012, NUCLEUS-PHILA, V3, P88, DOI 10.4161/nucl.18954; Vietri M, 2015, NATURE, V522, P231, DOI 10.1038/nature14408; Weigelin Bettina, 2012, Intravital, V1, P32, DOI 10.4161/intv.21223; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	33	678	689	15	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 15	2016	352	6283					353	358		10.1126/science.aad7297	http://dx.doi.org/10.1126/science.aad7297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ1UK	27013428	Green Accepted			2022-12-28	WOS:000373990100043
J	Yablonovitch, E				Yablonovitch, Eli			SOLAR CELLS Lead halides join the top optoelectronic league	SCIENCE			English	Editorial Material							EFFICIENCY; LIMIT		[Yablonovitch, Eli] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Yablonovitch, E (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.	eliy@eecs.berkeley.edu						Ha ST, 2016, NAT PHOTONICS, V10, P115, DOI 10.1038/NPHOTON.2015.243; LUSH G, 1991, SOL CELLS, V30, P337, DOI 10.1016/0379-6787(91)90066-X; Miller OD, 2012, IEEE J PHOTOVOLT, V2, P303, DOI 10.1109/JPHOTOV.2012.2198434; Pazos-Outon LM, 2016, SCIENCE, V351, P1430, DOI 10.1126/science.aaf1168; ROSS RT, 1967, J CHEM PHYS, V46, P4590, DOI 10.1063/1.1840606; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034	6	48	50	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2016	351	6280					1401	1401		10.1126/science.aaf4603	http://dx.doi.org/10.1126/science.aaf4603			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH4KZ	27013719				2022-12-28	WOS:000372756200025
J	Filion, KB; Azoulay, L; Platt, RW; Dahl, M; Dormuth, CR; Clemens, KK; Hu, NP; Paterson, JM; Targownik, L; Turin, TC; Udell, JA; Ernst, P				Filion, Kristian B.; Azoulay, Laurent; Platt, Robert W.; Dahl, Matthew; Dormuth, Colin R.; Clemens, Kristin K.; Hu, Nianping; Paterson, J. Michael; Targownik, Laura; Turin, Tanvir C.; Udell, Jacob A.; Ernst, Pierre		CNODES Investigators	A Multicenter Observational Study of Incretin-based Drugs and Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR OUTCOMES; DIABETES-MELLITUS; SITAGLIPTIN; METAANALYSIS; COHORT; TRIAL; RISK; DISEASE; EVENTS	BACKGROUND There is concern that antidiabetic incretin-based drugs, including dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) analogues, can increase the risk of heart failure. Ongoing clinical trials may not have large enough samples to effectively address this issue. METHODS We applied a common protocol in the analysis of multiple cohorts of patients with diabetes. We used health care data from four Canadian provinces, the United States, and the United Kingdom. With the use of a nested case-control analysis, we matched each patient who was hospitalized for heart failure with up to 20 controls from the same cohort; matching was based on sex, age, cohort-entry date, duration of treated diabetes, and follow-up time. Cohort-specific hazard ratios for hospitalization due to heart failure among patients receiving incretin-based drugs, as compared with those receiving oral antidiabetic-drug combinations, were estimated by means of conditional logistic regression and pooled across cohorts with the use of random-effects models. RESULTS The cohorts included a total of 1,499,650 patients, with 29,741 hospitalized for heart failure (incidence rate, 9.2 events per 1000 persons per year). The rate of hospitalization for heart failure did not increase with the use of incretin-based drugs as compared with oral antidiabetic-drug combinations among patients with a history of heart failure (hazard ratio, 0.86; 95% confidence interval [CI], 0.62 to 1.19) or among those without a history of heart failure (hazard ratio, 0.82; 95% CI, 0.67 to 1.00). The results were similar for DPP-4 inhibitors and GLP-1 analogues. CONCLUSIONS In this analysis of data from large cohorts of patients with diabetes, incretin-based drugs were not associated with an increased risk of hospitalization for heart failure, as compared with commonly used combinations of oral antidiabetic drugs.	[Filion, Kristian B.; Azoulay, Laurent; Ernst, Pierre] Jewish Gen Hosp, Lady Davis Res Inst, Ctr Clin Epidemiol, 3755 Cote Ste Catherine,Suite H4-16-1, Montreal, PQ H3T 1E2, Canada; [Filion, Kristian B.; Ernst, Pierre] McGill Univ, Dept Med, Montreal, PQ, Canada; [Azoulay, Laurent] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Platt, Robert W.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Platt, Robert W.] McGill Univ, Dept Epidemiol Biostat & Occupat, Montreal, PQ, Canada; [Platt, Robert W.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Dahl, Matthew; Targownik, Laura] Univ Manitoba, Dept Community Hlth Sci, Manitoba Ctr Hlth Policy, Winnipeg, MB R3T 2N2, Canada; [Targownik, Laura] Univ Manitoba, Div Internal Med, Gastroenterol Sect, Winnipeg, MB, Canada; [Dormuth, Colin R.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Clemens, Kristin K.] Univ Western Ontario, Dept Med, London, ON, Canada; [Hu, Nianping] Hlth Qual Council, Saskatoon, SK, Canada; [Paterson, J. Michael; Udell, Jacob A.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Paterson, J. Michael] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Udell, Jacob A.] Univ Hlth Network, Peter Munk Cardiac Ctr, Div Cardiovasc, Womens Coll Hosp, Toronto, ON, Canada; [Udell, Jacob A.] Univ Toronto, Toronto, ON, Canada; [Paterson, J. Michael] McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada; [Turin, Tanvir C.] Univ Calgary, Dept Family Med, Calgary, AB, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; University of Manitoba; University of Manitoba; University of British Columbia; Western University (University of Western Ontario); University of Toronto; University of Toronto; University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; Womens College Hospital; University of Toronto; McMaster University; University of Calgary	Filion, KB (corresponding author), Jewish Gen Hosp, Lady Davis Res Inst, Ctr Clin Epidemiol, 3755 Cote Ste Catherine,Suite H4-16-1, Montreal, PQ H3T 1E2, Canada.	kristian.filion@mcgill.ca	Clemens, Kristin K/K-8898-2016; Azoulay, Laurent/Z-4421-2019; Targownik, Laura/ABD-2427-2021; Turin, Tanvir C/L-7617-2016	Targownik, Laura/0000-0002-4366-9076; Turin, Tanvir C/0000-0002-7499-5050; Azoulay, Laurent/0000-0001-5162-3556; Udell, Jacob/0000-0001-7402-9584; Filion, Kristian/0000-0001-6055-0088	Canadian Institutes of Health Research [DSE-111845]; Canadian Institutes of Health Research New Investigator Award; Chercheur-National Award of Fonds de Recherche du Quebec - Sante (Quebec Foundation for Health Research)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Chercheur-National Award of Fonds de Recherche du Quebec - Sante (Quebec Foundation for Health Research)	Supported by a grant from the Canadian Institutes of Health Research (DSE-111845) and by a Canadian Institutes of Health Research New Investigator Award (to Dr. Filion) and a Chercheur-National Award of Fonds de Recherche du Quebec - Sante (Quebec Foundation for Health Research; to Dr. Platt).	[Anonymous], 2010, MIN SYST EV HLTH OUT; Chen DY, 2015, INT J CARDIOL, V181, P200, DOI 10.1016/j.ijcard.2014.12.029; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Green JB, 2013, AM HEART J, V166, P983, DOI 10.1016/j.ahj.2013.09.003; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Roumie CL, 2012, ANN INTERN MED, V157, P601, DOI 10.7326/0003-4819-157-9-201211060-00003; Saczynski JS, 2012, PHARMACOEPIDEM DR S, V21, P129, DOI 10.1002/pds.2313; Scirica BM, 2014, CIRCULATION, V130, P1579, DOI 10.1161/CIRCULATIONAHA.114.010389; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Suissa Samy, 2012, Open Med, V6, pe134; Udell JA, 2015, LANCET DIABETES ENDO, V3, P356, DOI 10.1016/S2213-8587(15)00044-3; Velez M, 2015, J CARD FAIL, V21, P2, DOI 10.1016/j.cardfail.2014.10.012; Wang KL, 2014, INT J CARDIOL, V177, P86, DOI 10.1016/j.ijcard.2014.09.038; Weir DL, 2014, JACC-HEART FAIL, V2, P573, DOI 10.1016/j.jchf.2014.04.005; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Yu OHY, 2015, DIABETES CARE, V38, P277, DOI 10.2337/dc14-1459; Zannad F, 2015, LANCET, V385, P2067, DOI 10.1016/S0140-6736(14)62225-X	21	162	168	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2016	374	12					1145	1154		10.1056/NEJMoa1506115	http://dx.doi.org/10.1056/NEJMoa1506115			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AA	27007958	Bronze			2022-12-28	WOS:000372585100007
J	Jansen, T; Hoff, NP				Jansen, Theresa; Hoff, Norman-Philipp			Diffuse Melanosis Cutis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jansen, Theresa; Hoff, Norman-Philipp] Univ Dusseldorf, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Hoff, NP (corresponding author), Univ Dusseldorf, Dusseldorf, Germany.	norman-philipp.hoff@med.uni-duesseldorf.de							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2016	374	12					1177	1177		10.1056/NEJMicm1508394	http://dx.doi.org/10.1056/NEJMicm1508394			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AA	27007961				2022-12-28	WOS:000372585100010
J	Richardson, JO; Perez, C; Lobsiger, S; Reid, AA; Temelso, B; Shields, GC; Kisiel, Z; Wales, DJ; Pate, BH; Althorpe, SC				Richardson, Jeremy O.; Perez, Cristobal; Lobsiger, Simon; Reid, Adam A.; Temelso, Berhane; Shields, George C.; Kisiel, Zbigniew; Wales, David J.; Pate, Brooks H.; Althorpe, Stuart C.			Concerted hydrogen-bond breaking by quantum tunneling in the water hexamer prism	SCIENCE			English	Article							COUPLED 6-DIMENSIONAL CALCULATIONS; 1ST PRINCIPLES; CAGE FORM; TRIMER; DIMER; CLUSTERS; STATES; SPECTROSCOPY; SIMULATIONS; DIFFUSION	The nature of the intermolecular forces between water molecules is the same in small hydrogen-bonded clusters as in the bulk. The rotational spectra of the clusters therefore give insight into the intermolecular forces present in liquid water and ice. The water hexamer is the smallest water cluster to support low-energy structures with branched three-dimensional hydrogen-bond networks, rather than cyclic two-dimensional topologies. Here we report measurements of splitting patterns in rotational transitions of the water hexamer prism, and we used quantum simulations to show that they result from geared and antigeared rotations of a pair of water molecules. Unlike previously reported tunneling motions in water clusters, the geared motion involves the concerted breaking of two hydrogen bonds. Similar types of motion may be feasible in interfacial and confined water.	[Richardson, Jeremy O.; Reid, Adam A.; Wales, David J.; Althorpe, Stuart C.] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Richardson, Jeremy O.] Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England; [Perez, Cristobal; Lobsiger, Simon; Pate, Brooks H.] Univ Virginia, Dept Chem, McCormick Rd, Charlottesville, VA 22903 USA; [Temelso, Berhane; Shields, George C.] Bucknell Univ, Coll Arts & Sci, Deans Off, Lewisburg, PA 17837 USA; [Temelso, Berhane; Shields, George C.] Bucknell Univ, Dept Chem, Lewisburg, PA 17837 USA; [Kisiel, Zbigniew] Polish Acad Sci, Inst Phys, Aleja Lotnikov 32-46, PL-02668 Warsaw, Poland; [Perez, Cristobal] Max Planck Inst Struct & Dynam Matter, Luruper Cnausse 119, D-22761 Hamburg, Germany; [Reid, Adam A.] Tonbridge Sch, Dept Math, High St, Tonbridge TN9 1JP, Kent, England	University of Cambridge; Durham University; University of Virginia; Bucknell University; Bucknell University; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; Max Planck Society	Richardson, JO; Althorpe, SC (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.; Richardson, JO (corresponding author), Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England.; Pate, BH (corresponding author), Univ Virginia, Dept Chem, McCormick Rd, Charlottesville, VA 22903 USA.	jeremy.richardson@durham.ac.uk; brookspate@virginia.edu; sca10@cam.ac.uk	Temelso, Berhane/V-3945-2018; Pérez, Cristóbal/V-4348-2019; Perez, Cristobal/D-2599-2016; Kisiel, Zbigniew/K-8798-2016; Shields, George C/C-6454-2012	Temelso, Berhane/0000-0002-5286-1983; Pérez, Cristóbal/0000-0001-5248-5212; Perez, Cristobal/0000-0001-5248-5212; Kisiel, Zbigniew/0000-0002-2570-3154; Shields, George C/0000-0003-1287-8585; Richardson, Jeremy/0000-0002-9429-151X; Lobsiger, Simon/0000-0002-4468-1130	European Union COFUND/Durham Junior Research Fellowship; Alexander von Humboldt Foundation; U.S. National Science Foundation [CHE-0960074, CHE-1213521, CHE-1229354]; Swiss National Science Foundation [PBBEP2-144907]; UK Engineering and Physical Sciences Research Council; Polish National Science Centre [DEC/2011/02/A/ST2/00298]; EPSRC [EP/N035003/1, EP/L010518/1] Funding Source: UKRI; Division Of Chemistry [1508556, 1662030] Funding Source: National Science Foundation; Engineering and Physical Sciences Research Council [EP/L010518/1] Funding Source: researchfish	European Union COFUND/Durham Junior Research Fellowship; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); U.S. National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Polish National Science Centre; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors acknowledge financial support from a European Union COFUND/Durham Junior Research Fellowship (J.O.R.), a Research Fellowship from the Alexander von Humboldt Foundation (C.P.), U.S. National Science Foundation grants CHE-0960074 (C.P. and B.H.P.) and CHE-1213521 and CHE-1229354 (B.T. and G.C.S.), Swiss National Science Foundation grant PBBEP2-144907 (S.L.), the UK Engineering and Physical Sciences Research Council (J.O.R., A.A.R., D.J.W., and S.C.A.), and a grant from the Polish National Science Centre, decision number DEC/2011/02/A/ST2/00298 (Z.K.).	ALTHORPE SC, 1994, J CHEM PHYS, V101, P3603, DOI 10.1063/1.467545; Babin V, 2014, J CHEM THEORY COMPUT, V10, P1599, DOI 10.1021/ct500079y; Babin V, 2013, CHEM PHYS LETT, V580, P1, DOI 10.1016/j.cplett.2013.06.041; Babin V, 2012, J PHYS CHEM LETT, V3, P3765, DOI 10.1021/jz3017733; Bukowski R, 2007, SCIENCE, V315, P1249, DOI 10.1126/science.1136371; CHAPMAN S, 1975, J CHEM PHYS, V63, P2710, DOI 10.1063/1.431620; Fellers RS, 1999, J CHEM PHYS, V110, P6306, DOI 10.1063/1.478535; Gora U, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3664730; GREGORY JK, 1995, J CHEM PHYS, V103, P8924, DOI 10.1063/1.470082; Gregory JK, 1997, J PHYS CHEM A, V101, P6813, DOI 10.1021/jp9703871; GREGORY JK, 1995, J CHEM PHYS, V102, P7817, DOI 10.1063/1.468982; Huang X, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2822115; Keutsch FN, 2003, CHEM REV, V103, P2533, DOI 10.1021/cr980125a; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Leforestier C, 1997, J CHEM PHYS, V106, P8527, DOI 10.1063/1.473908; LEGON AC, 1992, CHEM SOC REV, V21, P71, DOI 10.1039/cs9922100071; Liu K, 1997, J PHYS CHEM A, V101, P8995, DOI 10.1021/jp9707807; Liu K, 1996, SCIENCE, V271, P929, DOI 10.1126/science.271.5251.929; Liu K, 1996, NATURE, V381, P501, DOI 10.1038/381501a0; LONGUETHIGGINS HC, 1963, MOL PHYS, V6, P445, DOI 10.1080/00268976300100501; Mitsui T, 2002, SCIENCE, V297, P1850, DOI 10.1126/science.1075095; Olthof EHT, 1996, J CHEM PHYS, V105, P8051, DOI 10.1063/1.472661; Perez C, 2014, ANGEW CHEM INT EDIT, V53, P14368, DOI 10.1002/anie.201407447; Perez C, 2013, CHEM PHYS LETT, V571, P1, DOI 10.1016/j.cplett.2013.04.014; Perez C, 2012, SCIENCE, V336, P897, DOI 10.1126/science.1220574; PUGLIANO N, 1992, SCIENCE, V257, P1937, DOI 10.1126/science.1411509; Ranea VA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.136104; Richardson JO, 2013, J PHYS CHEM A, V117, P6960, DOI 10.1021/jp311306a; Richardson JO, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3640429; Richardson JO, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3530589; SABO D, 1995, CHEM PHYS LETT, V244, P283, DOI 10.1016/0009-2614(95)00923-R; Saykally RJ, 2012, SCIENCE, V336, P814, DOI 10.1126/science.1222007; SAYKALLY RJ, 1993, SCIENCE, V259, P1570, DOI 10.1126/science.259.5101.1570; Temelso B, 2011, J PHYS CHEM A, V115, P12034, DOI 10.1021/jp2069489; Wales D. J., 1999, Theory of atomic and molecular clusters. With a glimpse at experiments, P86; WALES DJ, 1993, J AM CHEM SOC, V115, P11180, DOI 10.1021/ja00077a016; Wales DJ, 1996, J CHEM PHYS, V105, P6957, DOI 10.1063/1.471987; Wales DJ, 1997, J CHEM PHYS, V106, P7193, DOI 10.1063/1.473681; Walsh TR, 1996, J CHEM SOC FARADAY T, V92, P2505, DOI 10.1039/ft9969202505; Wang YM, 2012, J AM CHEM SOC, V134, P11116, DOI 10.1021/ja304528m; Wang YM, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3554905; Wang YM, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3196178	42	182	186	8	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1310	1313		10.1126/science.aae0012	http://dx.doi.org/10.1126/science.aae0012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989250	Green Accepted, Green Published			2022-12-28	WOS:000372397700040
J	Eisenstein, M				Eisenstein, Michael			DISEASE Poverty and pathogens	NATURE			English	Editorial Material																			0	20	21	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S61	S63		10.1038/531S61a	http://dx.doi.org/10.1038/531S61a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG4TA	26981732	Bronze			2022-12-28	WOS:000372064300006
J	Kogleck, L				Kogleck, Larissa			A NETWORK OF KNOWLEDGE	NATURE			English	Editorial Material																			0	0	0	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S102	S103		10.1038/531S102a	http://dx.doi.org/10.1038/531S102a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26982019	Bronze			2022-12-28	WOS:000372064300008
J	Kelly, A				Kelly, Aine			WHAT YOUR PATIENT IS THINKING Growing up in care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rsnow@bmj.com							0	3	3	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2016	352								i1085	10.1136/bmj.i1085	http://dx.doi.org/10.1136/bmj.i1085			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1ZX	26984389	Green Published, Bronze			2022-12-28	WOS:000372584800001
J	Laitio, R; Hynninen, M; Arola, O; Virtanen, S; Parkkola, R; Saunavaara, J; Roine, RO; Gronlund, J; Ylikoski, E; Wennervirta, J; Backlund, M; Silvasti, P; Nukarinen, E; Tiainen, M; Saraste, A; Pietila, M; Airaksinen, J; Valanne, L; Martola, J; Silvennoinen, H; Scheinin, H; Harjola, VP; Niiranen, J; Korpi, K; Varpula, M; Inkinen, O; Olkkola, KT; Maze, M; Vahlberg, T; Laitio, T				Laitio, Ruut; Hynninen, Marja; Arola, Olli; Virtanen, Sami; Parkkola, Riitta; Saunavaara, Jani; Roine, Risto O.; Gronlund, Juha; Ylikoski, Emmi; Wennervirta, Johanna; Backlund, Minna; Silvasti, Paivi; Nukarinen, Eija; Tiainen, Marjaana; Saraste, Antti; Pietila, Mikko; Airaksinen, Juhani; Valanne, Leena; Martola, Juha; Silvennoinen, Heli; Scheinin, Harry; Harjola, Veli-Pekka; Niiranen, Jussi; Korpi, Kirsi; Varpula, Marjut; Inkinen, Outi; Olkkola, Klaus T.; Maze, Mervyn; Vahlberg, Tero; Laitio, Timo			Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TARGETED TEMPERATURE MANAGEMENT; THERAPEUTIC HYPOTHERMIA; HYPOXIA-ISCHEMIA; DIFFUSION; NEUROPROTECTION; BRAIN; 36-DEGREES-C; 33-DEGREES-C; STROKE; INJURY	IMPORTANCE Evidence from preclinical models indicates that xenon gas can prevent the development of cerebral damage after acute global hypoxic-ischemic brain injury but, thus far, these putative neuroprotective properties have not been reported in human studies. OBJECTIVE To determine the effect of inhaled xenon on ischemic white matter damage assessed with magnetic resonance imaging (MRI). DESIGN, SETTING, AND PARTICIPANTS A randomized single-blind phase 2 clinical drug trial conducted between August 2009 and March 2015 at 2 multipurpose intensive care units in Finland. One hundred ten comatose patients (aged 24-76 years) who had experienced out-of-hospital cardiac arrest were randomized. INTERVENTIONS Patients were randomly assigned to receive either inhaled xenon combined with hypothermia (33 degrees C) for 24 hours (n = 55 in the xenon group) or hypothermia treatment alone (n = 55 in the control group). MAIN OUTCOMES AND MEASURES The primary end point was cerebral white matter damage as evaluated by fractional anisotropy from diffusion tensor MRI scheduled to be performed between 36 and 52 hours after cardiac arrest. Secondary end points included neurological outcome assessed using the modified Rankin Scale (score 0 [no symptoms] through 6 [death]) and mortality at 6 months. RESULTS Among the 110 randomized patients (mean age, 61.5 years; 80 men [72.7%]), all completed the study. There were MRI data from 97 patients (88.2%) a median of 53 hours (interquartile range [IQR], 47-64 hours) after cardiac arrest. The mean global fractional anisotropy values were 0.433 (SD, 0.028) in the xenon group and 0.419 (SD, 0.033) in the control group. The age-, sex-, and site-adjusted mean global fractional anisotropy value was 3.8% higher (95% CI, 1.1%-6.4%) in the xenon group (adjusted mean difference, 0.016 [95% CI, 0.005-0.027], P = .006). At 6 months, 75 patients (68.2%) were alive. Secondary end points at 6 months did not reveal statistically significant differences between the groups. In ordinal analysis of the modified Rankin Scale, the median (IQR) value was 1 (1-6) in the xenon group and 1 (0-6) in the control group (median difference, 0 [95% CI, 0-0]; P = .68). The 6-month mortality rate was 27.3%(15/55) in the xenon group and 34.5%(19/55) in the control group (adjusted hazard ratio, 0.49 [95% CI, 0.23-1.01]; P = .053). CONCLUSIONS AND RELEVANCE Among comatose survivors of out-of-hospital cardiac arrest, inhaled xenon combined with hypothermia compared with hypothermia alone resulted in less white matter damage as measured by fractional anisotropy of diffusion tensor MRI. However, there was no statistically significant difference in neurological outcomes or mortality at 6 months. These preliminary findings require further evaluation in an adequately powered clinical trial designed to assess clinical outcomes associated with inhaled xenon among survivors of out-of-hospital cardiac arrest.	[Laitio, Timo] Turku Univ Hosp, Div Perioperat Serv Intens Care Med & Pain Manage, POB 52, FI-20521 Turku, Finland; [Laitio, Ruut; Arola, Olli; Gronlund, Juha; Scheinin, Harry; Inkinen, Outi; Laitio, Timo] Univ Turku, Dept Anaesthesiol & Intens Care, Turku, Finland; [Laitio, Ruut; Arola, Olli; Gronlund, Juha; Scheinin, Harry; Inkinen, Outi; Laitio, Timo] Turku Univ Hosp, Intens Care Med & Pain Management, Div Perioperat Serv, Turku, Finland; [Hynninen, Marja; Ylikoski, Emmi; Wennervirta, Johanna; Backlund, Minna; Silvasti, Paivi; Nukarinen, Eija; Olkkola, Klaus T.] Univ Helsinki, Dept Anaesthesiol Intens Care & Pain Med, Div Intens Care Med, Helsinki, Finland; [Hynninen, Marja; Ylikoski, Emmi; Wennervirta, Johanna; Backlund, Minna; Silvasti, Paivi; Nukarinen, Eija; Olkkola, Klaus T.] Helsinki Univ Hosp, Dept Anaesthesiol Intens Care & Pain Med, Div Intens Care Med, Helsinki, Finland; [Virtanen, Sami; Parkkola, Riitta] Univ Turku, Dept Radiol, Turku, Finland; [Virtanen, Sami; Parkkola, Riitta; Roine, Risto O.; Saraste, Antti; Pietila, Mikko; Airaksinen, Juhani] Turku Univ Hosp, FIN-20520 Turku, Finland; [Saunavaara, Jani] Turku Univ Hosp, Dept Med Phys, FIN-20520 Turku, Finland; [Saunavaara, Jani] Univ Turku, Turku, Finland; [Roine, Risto O.] Univ Turku, Div Clin Neurosci, Turku, Finland; [Tiainen, Marjaana] Univ Helsinki, Dept Neurol, Helsinki, Finland; [Tiainen, Marjaana] Helsinki Univ Hosp, Dept Neurol, Helsinki, Finland; [Saraste, Antti; Pietila, Mikko; Airaksinen, Juhani] Univ Turku, Ctr Heart, Turku, Finland; [Valanne, Leena; Martola, Juha; Silvennoinen, Heli] Univ Helsinki, Dept Radiol, Helsinki, Finland; [Valanne, Leena; Martola, Juha; Silvennoinen, Heli] Helsinki Univ Hosp, Dept Radiol, Helsinki, Finland; [Harjola, Veli-Pekka] Univ Helsinki, Dept Emergency Med & Serv, Emergency Med, Helsinki, Finland; [Harjola, Veli-Pekka] Helsinki Univ Hosp, Dept Emergency Med & Serv, Emergency Med, Helsinki, Finland; [Niiranen, Jussi; Korpi, Kirsi; Varpula, Marjut] Univ Helsinki, Dept Cariol, Mannerheimintie 172, SF-00300 Helsinki, Finland; [Niiranen, Jussi; Korpi, Kirsi; Varpula, Marjut] Helsinki Univ Hosp, Dept Cardiol, Helsinki, Finland; [Maze, Mervyn] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Vahlberg, Tero] Univ Turku, Dept Biostat, Turku, Finland	University of Turku; University of Turku; University of Turku; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of California System; University of California San Francisco; University of Turku	Laitio, T (corresponding author), Turku Univ Hosp, Div Perioperat Serv Intens Care Med & Pain Manage, POB 52, FI-20521 Turku, Finland.	timo.laitio@elisanet.fi	Laitio, Timo/GQB-4976-2022; Saunavaara, Jani P/P-3879-2017; Airaksinen, Juhani/AAC-7857-2021; Parkkola, Riitta/AAZ-1341-2020	Saunavaara, Jani P/0000-0002-0617-1105; Airaksinen, Juhani/0000-0002-0193-568X; Olkkola, Klaus/0000-0001-7872-8665; Scheinin, Harry/0000-0002-1171-3511; Roine, Risto/0000-0002-3824-3003; Valanne, Leena/0000-0002-8572-829X	Academy of Finland and via Hospital District of Southwest Finland	Academy of Finland and via Hospital District of Southwest Finland	The study was funded by the Academy of Finland and via clinical research funding from the Hospital District of Southwest Finland.	Arola OJ, 2013, CRIT CARE MED, V41, P2116, DOI 10.1097/CCM.0b013e31828a4337; Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Burback D, 1999, DEMENT GERIATR COGN, V10, P534, DOI 10.1159/000017201; Chaisinanunkul N, 2015, STROKE, V46, P2238, DOI 10.1161/STROKEAHA.114.008547; Chakkarapani E, 2010, ANN NEUROL, V68, P330, DOI 10.1002/ana.22016; Chua HR, 2012, RESUSCITATION, V83, P721, DOI 10.1016/j.resuscitation.2011.11.030; Cronberg T, 2015, JAMA NEUROL, V72, P634, DOI 10.1001/jamaneurol.2015.0169; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Hobbs C, 2008, STROKE, V39, P1307, DOI 10.1161/STROKEAHA.107.499822; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Langhelle A, 2005, RESUSCITATION, V66, P271, DOI 10.1016/j.resuscitation.2005.06.005; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lilja G, 2015, CIRCULATION, V131, P1340, DOI 10.1161/CIRCULATIONAHA.114.014414; Lin S, 2014, CRIT CARE MED, V42, P2565, DOI 10.1097/CCM.0000000000000551; Luyt CE, 2012, ANESTHESIOLOGY, V117, P1311, DOI 10.1097/ALN.0b013e318275148c; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nielsen N, 2009, ACTA ANAESTH SCAND, V53, P926, DOI 10.1111/j.1399-6576.2009.02021.x; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stiell IG, 2009, ANN EMERG MED, V53, P241, DOI 10.1016/j.annemergmed.2008.03.018; Thoresen M, 2009, J CEREBR BLOOD F MET, V29, P707, DOI 10.1038/jcbfm.2008.163; van der Eerden AW, 2014, RADIOLOGY, V270, P506, DOI 10.1148/radiol.13122720; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wilhelm S, 2002, ANESTHESIOLOGY, V96, P1485, DOI 10.1097/00000542-200206000-00031; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wu O, 2009, RADIOLOGY, V252, P173, DOI 10.1148/radiol.2521081232; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007	41	69	73	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1120	1128		10.1001/jama.2016.1933	http://dx.doi.org/10.1001/jama.2016.1933			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978207	Green Published, Bronze			2022-12-28	WOS:000372159800017
J	[Anonymous]				[Anonymous]			Reducing Medical Facilities (Reprint from JAMA, vol 116, pg 1146-1147, 1941)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		REILING J, 1941, JAMA-J AM MED ASSOC, V116, P1146; Smillie Wilson G., 1941, SURVEY FACILITIES CA	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1172	1172		10.1001/jama.2015.17078	http://dx.doi.org/10.1001/jama.2015.17078			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978221				2022-12-28	WOS:000372159800030
J	Clark, J				Clark, Jocalyn			The global push for institutional childbirths-in unhygienic facilities	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material														Clark, Jocalyn/0000-0002-8014-3989				Ali SM, 2015, IMPROVING MATERNAL N; Allchin J., 2014, MATERNAL DEATHS DECL; [Anonymous], 2015, BRIT MED J; [Anonymous], 2015, INF MORT SIT TRENDS; Benova L, 2014, TROP MED INT HEALTH, V19, P368, DOI 10.1111/tmi.12275; Chou D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4255; Department of Maternal Newborn Child and Adolescent Health, 2013, BANGL NEON CHILD HLT; Lamble L., 2015, GUARDIAN; Sanitation and Hygieine Applied Research for Equity Water Supply and Sanitation Collaborative Council, 2014, RES BRIEF NOT WASH C; Velleman Y, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001771; WaterAid, 2015, HLTH START 1 MONTH L; WHO, 2015, WATER SANITATION HYG; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990	13	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2016	352								i1473	10.1136/bmj.i1473	http://dx.doi.org/10.1136/bmj.i1473			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NP	26966184				2022-12-28	WOS:000372049200011
J	Reddy, M; Rilstone, S; Cooper, P; Oliver, NS				Reddy, Monika; Rilstone, Sian; Cooper, Philippa; Oliver, Nick S.			Type 1 diabetes in adults: supporting self management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							QUALITY-OF-LIFE; CONTROLLED CLINICAL-TRIAL; AWARENESS TRAINING BGAT; BLOOD-GLUCOSE PROFILES; EDUCATION-PROGRAM; METABOLIC-CONTROL; GLYCEMIC CONTROL; GLYCOSYLATED HEMOGLOBIN; TELEMEDICINE SYSTEM; SEVERE HYPOGLYCEMIA		[Reddy, Monika; Oliver, Nick S.] Univ London Imperial Coll Sci Technol & Med, Dept Diabet Endocrinol & Metab, St Marys Hosp Campus, London W2 1PG, England; [Reddy, Monika; Rilstone, Sian; Oliver, Nick S.] Imperial Healthcare NHS Trust, Diabet & Endocrinol, London, England	Imperial College London	Oliver, NS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Diabet Endocrinol & Metab, St Marys Hosp Campus, London W2 1PG, England.; Oliver, NS (corresponding author), Imperial Healthcare NHS Trust, Diabet & Endocrinol, London, England.	nick.oliver@imperial.ac.uk	Oliver, Nick S/G-9109-2016	Oliver, Nick S/0000-0003-3525-3633				Amiel S, 2002, BRIT MED J, V325, P746, DOI 10.1136/bmj.325.7367.746; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; CALLEPASCUAL AL, 1988, DIABETES METAB, V14, P629; Charpentier G, 2011, DIABETES CARE, V34, P533, DOI 10.2337/dc10-1259; CLARKE WL, 1995, DIABETES CARE, V18, P517, DOI 10.2337/diacare.18.4.517; Cox DJ, 2004, INT J BEHAV MED, V11, P212, DOI 10.1207/s15327558ijbm1104_4; DAGOGOJACK SE, 1993, J CLIN INVEST, V91, P819, DOI 10.1172/JCI116302; DEWEERDT I, 1991, DIABETIC MED, V8, P338; Dyson PA, 2011, DIABETIC MED, V28, P1282, DOI [10.1111/dme.13603, 10.1111/j.1464-5491.2011.03371.x]; Evert AB, 2013, DIABETES CARE, V36, P3821, DOI 10.2337/dc13-2042; Gadsby R, 2013, DIABETIC MED, V30, P799, DOI 10.1111/dme.12182; Galassetti P, 2013, COMPR PHYSIOL, V3, P1309, DOI 10.1002/cphy.c110040; George JT, 2008, DIABETIC MED, V25, P1447, DOI 10.1111/j.1464-5491.2008.02607.x; GOLD AE, 1994, DIABETES CARE, V17, P697, DOI 10.2337/diacare.17.7.697; Group TNA, 2014, 1 HLTH SOC CAR INF C, V1, P28; HELLER SR, 1991, DIABETES, V40, P223, DOI 10.2337/diabetes.40.2.223; Hermanns N, 2007, DIABETES-METAB RES, V23, P528, DOI 10.1002/dmrr.710; Hermanns N, 2013, DIABETES RES CLIN PR, V102, P149, DOI 10.1016/j.diabres.2013.10.009; ISO, 2013, ISO 15197; KORHONEN T, 1983, DIABETES CARE, V6, P256, DOI 10.2337/diacare.6.3.256; Kovatchev BP, 2000, METHOD ENZYMOL, V321, P410; Laffel LMB, 2006, DIABETIC MED, V23, P278, DOI 10.1111/j.1464-5491.2005.01771.x; Laurenzi A, 2011, DIABETES CARE, V34, P823, DOI 10.2337/dc10-1490; Lawton J, 2014, DIABETES CARE, V37, P109, DOI 10.2337/dc13-1154; Laxminarayan S, 2015, DIABETES TECHNOL THE, V17, P860, DOI 10.1089/dia.2015.0118; LENNON GM, 1990, DIABETIC MED, V7, P825, DOI 10.1111/j.1464-5491.1990.tb01500.x; Mann JI, 2004, NUTR METAB CARDIOVAS, V14, P373, DOI 10.1016/S0939-4753(04)80028-0; MCCULLOCH DK, 1985, DIABETOLOGIA, V28, P208, DOI 10.1007/BF00282234; McTavish L, 2015, DIABETIC MED, V32, P1143, DOI 10.1111/dme.12730; Miller KM, 2013, DIABETES CARE, V36, P2009, DOI 10.2337/dc12-1770; Monami M, 2009, DIABETES OBES METAB, V11, P372, DOI 10.1111/j.1463-1326.2008.00976.x; National Institute for Health and Care Excellence, 2015, TYP 1 DIAB AD DIAGN, P612; Nutrition SACo, 2015, CARB HLTH; Pickup JC, 2012, NAT REV ENDOCRINOL, V8, P425, DOI 10.1038/nrendo.2012.28; Rossi MCE, 2010, DIABETES CARE, V33, P109, DOI 10.2337/dc09-1327; Rossi MCE, 2009, DIABETES TECHNOL THE, V11, P19, DOI 10.1089/dia.2008.0020; Rossi MC, 2013, DIABETES TECHNOL THE, V15, P670, DOI 10.1089/dia.2013.0021; Scavone G, 2010, DIABETIC MED, V27, P477, DOI 10.1111/j.1464-5491.2010.02963.x; Schachinger H, 2005, J BEHAV MED, V28, P587, DOI 10.1007/s10865-005-9026-3; Schmidt S, 2012, DIABETES CARE, V35, P984, DOI 10.2337/dc11-2044; Service F John, 2007, Endocr Pract, V13, P350; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Skeie Svein, 2009, J Diabetes Sci Technol, V3, P83; Snoek FJ, 2008, DIABETIC MED, V25, P1337, DOI 10.1111/j.1464-5491.2008.02595.x; Snow R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003583; Sovik O, 1999, DIABETES CARE, V22, pB40; Speight J, 2007, DIABETIC MED, V24, P95; TERENT A, 1985, ACTA MED SCAND, V217, P47; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; Trento M, 2005, NUTR METAB CARDIOVAS, V15, P293, DOI 10.1016/j.numecd.2004.12.005; Trento M, 2011, J ENDOCRINOL INVEST, V34, P101, DOI [10.3275/7027, 10.1007/BF03347038]; Vervoort G, 1996, DIABETIC MED, V13, P794; Wei N, 2014, DIABETES CARE, V37, P1048, DOI 10.2337/dc13-2173; Ziegler R, 2013, DIABETES CARE, V36, P3613, DOI 10.2337/dc13-0251	55	29	32	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2016	352								i998	10.1136/bmj.i998	http://dx.doi.org/10.1136/bmj.i998			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NP	26965473	Green Published			2022-12-28	WOS:000372049200002
J	Weinberg, RA; Schuldiner, M; Wu, H; Stevens, B; Nielsen, J; Hiesinger, PR; Hassan, BA				Weinberg, Robert A.; Schuldiner, Maya; Wu, Hong; Stevens, Beth; Nielsen, Jens; Hiesinger, P. Robin; Hassan, Bassem A.			All You Need Is Mentorship	CELL			English	Editorial Material									[Weinberg, Robert A.] MIT, Whitehead Inst, Cambridge, MA 02139 USA; [Schuldiner, Maya] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Wu, Hong] Peking Univ, Beijing, Peoples R China; [Stevens, Beth] Boston Childrens Hosp, Boston, MA USA; [Nielsen, Jens] Chalmers, Gothenburg, Sweden; [Hiesinger, P. Robin] Free Univ Berlin, Berlin, Germany; [Hassan, Bassem A.] VIB KU LEUVEN ICM, Louvain, Belgium	Massachusetts Institute of Technology (MIT); Whitehead Institute; Weizmann Institute of Science; Peking University; Harvard University; Boston Children's Hospital; Chalmers University of Technology; Free University of Berlin; Flanders Institute for Biotechnology (VIB)	Weinberg, RA (corresponding author), MIT, Whitehead Inst, Cambridge, MA 02139 USA.		Schuldiner, Maya/C-9488-2009; Hassan, Bassem A/D-5221-2012	Hassan, Bassem A/0000-0001-9533-4908					0	0	0	4	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1092	1093		10.1016/j.cell.2016.02.055	http://dx.doi.org/10.1016/j.cell.2016.02.055			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967274	Bronze			2022-12-28	WOS:000372784900005
J	Broutet, N; Krauer, F; Riesen, M; Khalakdina, A; Almiron, M; Aldighieri, S; Espinal, M; Low, N; Dye, C				Broutet, Nathalie; Krauer, Fabienne; Riesen, Maurane; Khalakdina, Asheena; Almiron, Maria; Aldighieri, Sylvain; Espinal, Marcos; Low, Nicola; Dye, Christopher			Zika Virus as a Cause of Neurologic Disorders	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Broutet, Nathalie; Khalakdina, Asheena; Dye, Christopher] WHO, CH-1211 Geneva, Switzerland; [Krauer, Fabienne; Riesen, Maurane; Dye, Christopher] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Almiron, Maria; Aldighieri, Sylvain; Espinal, Marcos] Pan Amer Hlth Org, Washington, DC USA	World Health Organization; University of Bern; Pan American Health Organization	Broutet, N (corresponding author), WHO, CH-1211 Geneva, Switzerland.		Low, Nicola/H-4718-2019; Dye, Christopher/AIC-4659-2022	Low, Nicola/0000-0003-4817-8986; Dye, Christopher/0000-0002-2957-1793; Krauer, Fabienne/0000-0001-8341-4011	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Cao-Lormeau V-M, 2016, LANCET; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Vandenbroucke JP, 2001, ANN INTERN MED, V134, P330, DOI 10.7326/0003-4819-134-4-200102200-00017; World Health Organization, 2016, ZIK VIR POT COMPL	5	178	185	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2016	374	16					1506	1509		10.1056/NEJMp1602708	http://dx.doi.org/10.1056/NEJMp1602708			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DJ7IA	26959308	Green Published, Bronze			2022-12-28	WOS:000374383900003
J	Kawamura, S; Chu, H; Felding, J; Baran, PS				Kawamura, Shuhei; Chu, Hang; Felding, Jakob; Baran, Phil S.			Nineteen-step total synthesis of (+)-phorbol	NATURE			English	Article							C-H OXIDATION; TUMOR PROMOTERS; PART 14; PHORBOL	Phorbol, the flagship member of the tigliane diterpene family, has been known for over 80 years and has attracted attention from many chemists and biologists owing to its intriguing chemical structure and the medicinal potential of phorbol esters(1). Access to useful quantities of phorbol and related analogues has relied on isolation from natural sources and semisynthesis. Despite efforts spanning 40 years, chemical synthesis has been unable to compete with these strategies, owing to its complexity and unusual placement of oxygen atoms. Purely synthetic enantiopure phorbol has remained elusive, and biological synthesis has not led to even the simplest members of this terpene family. Recently, the chemical syntheses of eudesmanes(2), germacrenes(3), taxanes(4,5) and ingenanes(6-8) have all benefited from a strategy inspired by the logic of two-phase terpene biosynthesis in which powerful C-C bond constructions and C-H bond oxidations go hand in hand. Here we implement a two-phase terpene synthesis strategy to achieve enantiospecific total synthesis of (+)-phorbol in only 19 steps from the abundant monoterpene (+)-3-carene. The purpose of this synthesis route is not to displace isolation or semisynthesis as a means of generating the natural product per se, but rather to enable access to analogues containing unique placements of oxygen atoms that are otherwise inaccessible.	[Kawamura, Shuhei; Chu, Hang; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Felding, Jakob] LEO Pharma AS, Front End Innovat, Ind Pk 55, DK-2750 Ballerup, Denmark	Scripps Research Institute; LEO Pharma	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	pbaran@scripps.edu			LEO Pharma; Uehara Memorial Foundation; National Institute of General Medical Sciences [GM-097444]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118176, R01GM097444] Funding Source: NIH RePORTER	LEO Pharma(LEO Pharma); Uehara Memorial Foundation(Uehara Memorial Foundation); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by LEO Pharma, the Uehara Memorial Foundation (postdoctoral fellowship to S.K.) and the National Institute of General Medical Sciences Grant GM-097444. We are especially grateful to S. Natarajan of KemXtree and his team for providing ample quantities of compound 5. We thank D.-H. Huang and L. Pasternack for assistance with NMR spectroscopy, and A. L. Rheingold and C. E. Moore for X-ray crystallographic analysis.	BARTSCH H, 1969, LIEBIGS ANN CHEM, V725, P142; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Foo K, 2012, ANGEW CHEM INT EDIT, V51, P11491, DOI 10.1002/anie.201206904; Gutekunst WR, 2011, CHEM SOC REV, V40, P1976, DOI 10.1039/c0cs00182a; Isakov N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00384; Jin YH, 2015, ANGEW CHEM INT EDIT, V54, P14044, DOI 10.1002/anie.201507977; Jorgensen L, 2013, SCIENCE, V341, P878, DOI 10.1126/science.1241606; Krohn K, 2000, CHEM-EUR J, V6, P3887, DOI 10.1002/1521-3765(20001103)6:21<3887::AID-CHEM3887>3.0.CO;2-3; Lee K, 2001, J AM CHEM SOC, V123, P5590, DOI 10.1021/ja010643u; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; MCCORMICK JP, 1980, J ORG CHEM, V45, P2566, DOI 10.1021/jo01301a003; McKernan LN, 2012, ADV VIROL, V2012, DOI 10.1155/2012/805347; McKerrall SJ, 2014, J AM CHEM SOC, V136, P5799, DOI 10.1021/ja501881p; Mendoza A, 2012, NAT CHEM, V4, P21, DOI 10.1038/nchem.1196; Michaudel Q, 2014, ANGEW CHEM INT EDIT, V53, P12091, DOI 10.1002/anie.201407016; MIYOSHI N, 1993, CHEM LETT, P959, DOI 10.1246/cl.1993.959; Newhouse T, 2011, ANGEW CHEM INT EDIT, V50, P3362, DOI 10.1002/anie.201006368; Nicolaou K. C., 1996, CLASSICS TOTAL SYNTH, P821; SALMOND WG, 1978, J ORG CHEM, V43, P2057, DOI 10.1021/jo00404a049; SHA CK, 1995, TETRAHEDRON LETT, V36, P6927, DOI 10.1016/0040-4039(95)01478-Z; STILLE JK, 1986, ANGEW CHEM INT EDIT, V25, P508, DOI 10.1002/anie.198605081; SUGITA K, 1995, TETRAHEDRON LETT, V36, P1067, DOI 10.1016/0040-4039(94)02455-K; SUGITA K, 1994, SYNLETT, P325; Wang HB, 2015, CHEM REV, V115, P2975, DOI 10.1021/cr200397n; Wender PA, 1997, J AM CHEM SOC, V119, P7897, DOI 10.1021/ja9706256; WENDER PA, 1989, J AM CHEM SOC, V111, P8954, DOI 10.1021/ja00206a049; WENDER PA, 1990, J AM CHEM SOC, V112, P4956, DOI 10.1021/ja00168a050; WENDER PA, 1989, J AM CHEM SOC, V111, P8957, DOI 10.1021/ja00206a050; Wilde NC, 2014, J AM CHEM SOC, V136, P4909, DOI 10.1021/ja501782r; Zou LF, 2013, J ORG CHEM, V78, P4037, DOI 10.1021/jo400350v	30	135	139	10	269	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2016	532	7597					90	93		10.1038/nature17153	http://dx.doi.org/10.1038/nature17153			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI5RE	27007853	Green Accepted			2022-12-28	WOS:000373555500039
J	Delling, M; Indzhykulian, AA; Liu, X; Li, Y; Xie, T; Corey, DP; Clapham, DE				Delling, M.; Indzhykulian, A. A.; Liu, X.; Li, Y.; Xie, T.; Corey, D. P.; Clapham, D. E.			Primary cilia are not calcium-responsive mechanosensors	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; NODAL FLOW; MOUSE EMBRYOS; FLUID-FLOW; CHANNELS; CA2+; POLYCYSTIN-1; DYNAMICS; BREAKING; MICE	Primary cilia are solitary, generally non-motile, hair-like protrusions that extend from the surface of cells between cell divisions. Their antenna-like structure leads naturally to the assumption that they sense the surrounding environment, the most common hypothesis being sensation of mechanical force through calcium-permeable ion channels within the cilium(1). This Ca2+-responsive mechanosensor hypothesis for primary cilia has been invoked to explain a large range of biological responses, from control of left-right axis determination in embryonic development to adult progression of polycystic kidney disease and some cancers(2,3). Here we report the complete lack of mechanically induced calcium increases in primary cilia, in tissues upon which this hypothesis has been based. We developed a transgenic mouse, Arl13b-mCherry-GECO1.2, expressing a ratiometric genetically encoded calcium indicator in all primary cilia. We then measured responses to flow in primary cilia of cultured kidney epithelial cells, kidney thick ascending tubules, crown cells of the embryonic node, kinocilia of inner ear hair cells, and several cell lines. Cilia-specific Ca2+ influxes were not observed in physiological or even highly supraphysiological levels of fluid flow. We conclude that mechanosensation, if it originates in primary cilia, is not via calcium signalling.	[Delling, M.; Liu, X.; Clapham, D. E.] Boston Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; [Indzhykulian, A. A.; Li, Y.; Corey, D. P.; Clapham, D. E.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA; [Xie, T.] Harvard Univ, Sch Med, IDAC, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA.; Corey, DP; Clapham, DE (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	dcorey@hms.harvard.edu; dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Indzhykulian, Artur/L-9222-2018; Clapham, David/S-1123-2019	Indzhykulian, Artur/0000-0002-2076-6818; Clapham, David/0000-0002-4459-9428	Mouse Gene Manipulation Facility of the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (IDDRC) [NIHP30-HD 18655]; National Institutes of Health (NIH) [5R01 DC000304]; Kaplan Family; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000304] Funding Source: NIH RePORTER	Mouse Gene Manipulation Facility of the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (IDDRC); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kaplan Family; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the Mouse Gene Manipulation Facility of the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (IDDRC; NIHP30-HD 18655), National Institutes of Health (NIH) 5R01 DC000304 to D.P.C., and the Kaplan Family for financial support to M.D. We thank J. Rivera, J. Angelo, J. Mager and K. Tremblay for help with developmental staging of mouse embryos, L. Palmer and G. Frindt for teaching M.D. the kidney tubule dissection, A. Weinstein for discussions of fluid velocities in kidney tubules, W. Fowle for access to the scanning electron microscopy facility, R. Stepanyan and J. Shen for help with statistics, and members of the Clapham and Corey laboratories for advice and discussion. We thank H. Zeng for the Ai95 mouse line, L. Bonewald for the MLO-Y4-cell line, P. Divieti Pajevic and J. Spatz for the Ocy454 cell line, and T. Indzhykulian for support. D.E.C. and D.P.C. are Investigators of the Howard Hughes Medical Institute.	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Connelly T, 2015, P NATL ACAD SCI USA, V112, P590, DOI 10.1073/pnas.1418515112; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Faust D, 2013, JOVE-J VIS EXP, DOI 10.3791/50366; Hamada H, 2015, SEMIN CELL DEV BIOL, V47-48, P88, DOI 10.1016/j.semcdb.2015.10.011; Indzhykulian AA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001583; Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Kindt KS, 2012, DEV CELL, V23, P329, DOI 10.1016/j.devcel.2012.05.022; Lee JD, 2008, DEV DYNAM, V237, P3464, DOI 10.1002/dvdy.21598; Lee Kristen L, 2015, Cilia, V4, P7, DOI 10.1186/s13630-015-0016-y; Ma M, 2013, NAT GENET, V45, P1004, DOI 10.1038/ng.2715; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nagasawa H, 1973, Jikken Dobutsu, V22, P119; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; O'Connor Amber K, 2013, Cilia, V2, P8, DOI 10.1186/2046-2530-2-8; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Palmer LG, 1996, J GEN PHYSIOL, V107, P35, DOI 10.1085/jgp.107.1.35; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Schwartz EA, 1997, AM J PHYSIOL-RENAL, V272, pF132, DOI 10.1152/ajprenal.1997.272.1.F132; SELLICK PM, 1982, J ACOUST SOC AM, V72, P131, DOI 10.1121/1.387996; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; Su S, 2013, NAT METHODS, V10, P1105, DOI [10.1038/NMETH.2647, 10.1038/nmeth.2647]; Takao D, 2013, DEV BIOL, V376, P23, DOI 10.1016/j.ydbio.2013.01.018; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Weinstein AM, 2010, AM J PHYSIOL-RENAL, V298, pF543, DOI 10.1152/ajprenal.00232.2009; Xiao R, 2010, CURR BIOL, V20, pR936, DOI 10.1016/j.cub.2010.09.053; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Yoshiba S, 2014, TRENDS GENET, V30, P10, DOI 10.1016/j.tig.2013.09.001; Yoshiba S, 2012, SCIENCE, V338, P226, DOI 10.1126/science.1222538; Young YN, 2012, BIOPHYS J, V103, P629, DOI 10.1016/j.bpj.2012.07.009; Yuan SL, 2015, CURR BIOL, V25, P556, DOI 10.1016/j.cub.2014.12.051; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zimmerman K, 2015, CELL, V161, P692, DOI 10.1016/j.cell.2015.04.015	45	225	228	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					656	+		10.1038/nature17426	http://dx.doi.org/10.1038/nature17426			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	27007841	Green Accepted			2022-12-28	WOS:000373027400042
J	Yang, W; Bai, YB; Xiong, Y; Zhang, J; Chen, SK; Zheng, XJ; Meng, XB; Li, LY; Wang, J; Xu, CG; Yan, CS; Wang, LJ; Chang, CCY; Chang, TY; Zhang, T; Zhou, PH; Song, BL; Liu, WL; Sun, SC; Liu, XL; Li, BL; Xu, CQ				Yang, Wei; Bai, Yibing; Xiong, Ying; Zhang, Jin; Chen, Shuokai; Zheng, Xiaojun; Meng, Xiangbo; Li, Lunyi; Wang, Jing; Xu, Chenguang; Yan, Chengsong; Wang, Lijuan; Chang, Catharine C. Y.; Chang, Ta-Yuan; Zhang, Ti; Zhou, Penghui; Song, Bao-Liang; Liu, Wanli; Sun, Shao-Cong; Liu, Xiaolong; Li, Bo-liang; Xu, Chenqi			Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism	NATURE			English	Article							THYMOCYTE POSITIVE SELECTION; CANCER-IMMUNOTHERAPY; ACYL-COENZYME; IMMUNOLOGICAL SYNAPSE; IMMUNE MODULATION; MEMBRANE-BINDING; ACAT INHIBITORS; RECEPTOR; ACTIVATION; DOMAIN	CD8(+) T cells have a central role in antitumour immunity, but their activity is suppressed in the tumour microenvironment(1-4). Reactivating the cytotoxicity of CD8(+) T cells is of great clinical interest in cancer immunotherapy. Here we report a new mechanism by which the antitumour response of mouse CD8(+) T cells can be potentiated by modulating cholesterol metabolism. Inhibiting cholesterol esterification in T cells by genetic ablation or pharmacological inhibition of ACAT1, a key cholesterol esterification enzyme(5), led to potentiated effector function and enhanced proliferation of CD8(+) but not CD4(+) T cells. This is due to the increase in the plasma membrane cholesterol level of CD8(+) T cells, which causes enhanced T-cell receptor clustering and signalling as well as more efficient formation of the immunological synapse. ACAT1-deficient CD8(+) T cells were better than wildtype CD8(+) T cells at controlling melanoma growth and metastasis in mice. We used the ACAT inhibitor avasimibe, which was previously tested in clinical trials for treating atherosclerosis and showed a good human safety profile(6,7), to treat melanoma in mice and observed a good antitumour effect. A combined therapy of avasimibe plus an anti-PD-1 antibody showed better efficacy than monotherapies in controlling tumour progression. ACAT1, an established target for atherosclerosis, is therefore also a potential target for cancer immunotherapy.	[Yang, Wei; Bai, Yibing; Zhang, Jin; Chen, Shuokai; Meng, Xiangbo; Li, Lunyi; Yan, Chengsong; Xu, Chenqi] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol,Natl Ctr Prot Sci Shanghai, Shanghai Sci Res Ctr,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Xiong, Ying; Wang, Lijuan; Li, Bo-liang] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Zheng, Xiaojun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [Wang, Jing; Xu, Chenguang; Liu, Wanli] Tsinghua Univ, Collaborat Innovat Ctr Infect Dis, Sch Life Sci, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Chang, Catharine C. Y.; Chang, Ta-Yuan] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH USA; [Zhang, Ti] Second Mil Med Univ, ChangZheng Hosp, Rheumatol & Immunol Dept, Shanghai 200433, Peoples R China; [Zhou, Penghui] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China; [Song, Bao-Liang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei Province, Peoples R China; [Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; [Liu, Xiaolong] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Xu, Chenqi] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tsinghua University; Dartmouth College; Naval Medical University; State Key Lab Oncology South China; Sun Yat Sen University; Wuhan University; University of Texas System; UTMD Anderson Cancer Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Xu, CQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol,Natl Ctr Prot Sci Shanghai, Shanghai Sci Res Ctr,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.; Li, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.; Xu, CQ (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.	blli@sibcb.ac.cn; cqxu@sibcb.ac.cn	liu, wanli/H-5690-2011	liu, wanli/0000-0003-2624-6802; Song, Bao-Liang/0000-0002-6397-5935; Yang, Wei/0000-0001-9438-7215; Xu, Chenqi/0000-0002-4968-6782; Bai, Yibing/0000-0002-2944-5367; Wang, Jing/0000-0003-1140-6690; li, bo liang/0000-0002-7123-5638	NSFC [31370860, 31425009, 31530022, 31271377, 31400745]; CAS [XDB08020100, KSCX2-EW-J-11]; China Postdoctoral Science Foundation [2014M561533, 2014T70440]; NIH [HL 60306]; MOST [2011CB910901, 2012CB910804]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060306] Funding Source: NIH RePORTER	NSFC(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MOST; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Q. Leng for providing L. monocytogenes, F.-J. Nan for providing K604, and Y. Jiang for some preliminary experiments. We thank H. Gu and D. Li for careful reading of the manuscript. Imaging work was performed at the National Center for Protein Science Shanghai. Chenqi Xu is funded by MOST (2011CB910901 and 2012CB910804), NSFC grants (31370860, 31425009 and 31530022), and CAS grants (Strategic Priority Research Program XDB08020100; KSCX2-EW-J-11). B.L. is funded by MOST (2011CB910901) and NSFC grant 31271377. W.Y. is funded by NSFC grant (31400745) and China Postdoctoral Science Foundation (2014M561533 and 2014T70440). T.-Y.C. and C.C.Y.C. are funded by NIH grant HL 60306.	Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; Cao YH, 2011, EMBO J, V30, P2083, DOI 10.1038/emboj.2011.116; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chang CCY, 2000, J BIOL CHEM, V275, P28083; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Das A, 2013, P NATL ACAD SCI USA, V110, P10580, DOI 10.1073/pnas.1309273110; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gagnon E, 2012, J EXP MED, V209, P2423, DOI 10.1084/jem.20120790; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Huttunen HJ, 2008, NEURODEGENER DIS, V5, P212, DOI 10.1159/000113705; Ikenoya M, 2007, ATHEROSCLEROSIS, V191, P290, DOI 10.1016/j.atherosclerosis.2006.05.048; Jenkins MR, 2009, IMMUNITY, V31, P621, DOI 10.1016/j.immuni.2009.08.024; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Leon C, 2005, PHARM RES-DORDR, V22, P1578, DOI 10.1007/s11095-005-6306-0; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Liu WL, 2010, J IMMUNOL, V184, P1977, DOI 10.4049/jimmunol.0902334; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Molnar E, 2012, J BIOL CHEM, V287, P42664, DOI 10.1074/jbc.M112.386045; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Pal P, 2013, MINI-REV MED CHEM, V13, P1195, DOI 10.2174/1389557511313080007; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rossy J, 2013, NAT IMMUNOL, V14, P82, DOI 10.1038/ni.2488; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shi XS, 2013, NATURE, V493, P111, DOI 10.1038/nature11699; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yao S, 2013, NAT REV DRUG DISCOV, V12, P130, DOI 10.1038/nrd3877; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6	38	366	386	31	348	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2016	531	7596					651	+		10.1038/nature17412	http://dx.doi.org/10.1038/nature17412			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH8EX	26982734	Green Accepted			2022-12-28	WOS:000373027400041
J	Vigod, SN; Wilson, CA; Howard, LM				Vigod, Simone N.; Wilson, Claire A.; Howard, Louise M.			Depression in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEROTONIN REUPTAKE INHIBITORS; PERINATAL MENTAL-DISORDERS; MIDDLE-INCOME COUNTRIES; PERSISTENT PULMONARY-HYPERTENSION; COGNITIVE-BEHAVIORAL THERAPY; POPULATION-BASED COHORT; ANTIDEPRESSANT USE; ANTENATAL DEPRESSION; POSTPARTUM HEMORRHAGE; POSTNATAL DEPRESSION		[Vigod, Simone N.] Univ Toronto, Dept Psychiat, Fac Med, Toronto, ON M5S 2B1, Canada; [Vigod, Simone N.] Womens Coll Hosp, Toronto, ON M5S 2B1, Canada; [Vigod, Simone N.] Womens Coll Res Inst, Toronto, ON M5S 2B1, Canada; [Wilson, Claire A.; Howard, Louise M.] Kings Coll London, Sect Womens Mental Hlth, London, England	University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of London; King's College London	Vigod, SN (corresponding author), Univ Toronto, Dept Psychiat, Fac Med, Toronto, ON M5S 2B1, Canada.; Vigod, SN (corresponding author), Womens Coll Hosp, Toronto, ON M5S 2B1, Canada.; Vigod, SN (corresponding author), Womens Coll Res Inst, Toronto, ON M5S 2B1, Canada.	simone.vigod@wchospital.ca	Howard, Louise/E-3495-2010	Howard, Louise/0000-0001-9942-744X; Wilson, Claire Anna/0000-0003-2169-5115; Vigod, Simone/0000-0002-2736-9639	Canadian Institutes of Health Research; Hospital for Sick Children Foundation [NCT02308592, NCT02116127]; National Institute for Health Research (NIHR) [NCT02308592, NIHR-RP-R3-12-011, RP-PG-1210-12002]; National Institute for Health Research [NIHR-RP-R3-12-011] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children Foundation; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	We have read and understood the BMJ policy on declaration of interests and declare the following: SNV holds funding from the Canadian Institutes of Health Research and The Hospital for Sick Children Foundation to conduct two of the randomised controlled trials mentioned in this manuscript (NCT02308592; NCT02116127). LMH receives funding from the National Institute for Health Research (NIHR), including for two randomised controlled trials mentioned herein (NCT02308592; http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=17048) (NIHR research professorship in maternal mental health (NIHR-RP-R3-12-011) and NIHR programme grant for applied research (RP-PG-1210-12002) on the effectiveness of perinatal mental health services). She chaired the NICE update on Antenatal and Postnatal Mental Health Guidance (CG192) and she is also the National Clinical Advisor on the NICE/NCCMH technical advisory group for the NHS England access and waiting time perinatal mental health programme. Provenance and peer review: Commissioned; externally reviewed.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Andersen JT, 2014, OBSTET GYNECOL, V124, P655, DOI 10.1097/AOG.0000000000000447; Bar-Oz B, 2007, CLIN THER, V29, P918, DOI 10.1016/j.clinthera.2007.05.003; Bonari L, 2005, ARCH WOMEN MENT HLTH, V8, P214, DOI 10.1007/s00737-005-0094-8; Brandlistuen RE, 2015, INT J EPIDEMIOL, V44, P1397, DOI 10.1093/ije/dyv030; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Burns A, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-33; Byatt N, 2016, ARCH WOMEN MENT HLTH, V19, P187, DOI 10.1007/s00737-015-0524-1; Byatt N, 2012, J PSYCHOSOM OBST GYN, V33, P143, DOI 10.3109/0167482X.2012.728649; Casper RC, 2003, J PEDIATR-US, V142, P402, DOI 10.1067/mpd.2003.139; Chisolm MS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h5918; Clarke K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001541; ClinicalTrials.gov, 2015, US MOB DEV ADM SCREE; ClinicalTrials.gov, 2014, KEEP WELL ONL COGN B; ClinicalTrials.gov, 2015, PAT DEC AID ANT US P; ClinicalTrials.gov, 2014, STOP GO REL PREV TRA; ClinicalTrials.gov, 2013, EFF COST EFF TASK SH; ClinicalTrials.gov, 2014, CHRON PER DEPR; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; De Vera MA, 2012, BRIT J CLIN PHARMACO, V74, P362, DOI 10.1111/j.1365-2125.2012.04196.x; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dennis CL, 2006, BIRTH-ISS PERINAT C, V33, P323, DOI 10.1111/j.1523-536X.2006.00130.x; Dennis CL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006795.pub3; Dennis CL, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-38; Driessen E, 2010, J CONSULT CLIN PSYCH, V78, P668, DOI 10.1037/a0020570; Ewing G, 2015, CLIN PHARMACOKINET, V54, P359, DOI 10.1007/s40262-014-0233-3; Fava GA, 2015, PSYCHOTHER PSYCHOSOM, V84, P72, DOI 10.1159/000370338; Ferreira E, 2007, PEDIATRICS, V119, P52, DOI 10.1542/peds.2006-2133; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Flynn HA, 2008, J STUD ALCOHOL DRUGS, V69, P500, DOI 10.15288/jsad.2008.69.500; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Fuhr DC, 2014, LANCET PSYCHIAT, V1, P213, DOI 10.1016/S2215-0366(14)70282-2; Furu K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1798; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Geier ML, 2015, CNS SPECTRUMS, V20, P11, DOI 10.1017/S1092852914000510; Gentile S, 2010, CNS SPECTRUMS, V15, P167, DOI 10.1017/S1092852900027449; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2009, PSYCHIAT SERV, V60, P313, DOI 10.1176/appi.ps.60.3.313; Handal M, 2016, BJOG-INT J OBSTET GY, V123, P1908, DOI 10.1111/1471-0528.13582; Hanley GE, 2013, EARLY HUM DEV, V89, P519, DOI 10.1016/j.earlhumdev.2012.12.012; Harrington RA, 2014, PEDIATRICS, V133, pE1241, DOI 10.1542/peds.2013-3406; Hayes RM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.028; Howard LM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7394; Howard LM, 2014, LANCET, V384, P1775, DOI 10.1016/S0140-6736(14)61276-9; Huybrechts KF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092778; Huybrechts KF, 2015, JAMA-J AM MED ASSOC, V313, P2142, DOI 10.1001/jama.2015.5605; Huybrechts KF, 2014, NEW ENGL J MED, V370, P2397, DOI 10.1056/NEJMoa1312828; Hviid A, 2013, NEW ENGL J MED, V369, P2406, DOI 10.1056/NEJMoa1301449; Jimenez-Solem E, 2013, AM J PSYCHIAT, V170, P299, DOI 10.1176/appi.ajp.2012.11081251; Jones I, 2014, LANCET, V384, P1789, DOI 10.1016/S0140-6736(14)61278-2; Kennedy SH, 2009, J AFFECT DISORDERS, V117, pS1, DOI 10.1016/j.jad.2009.06.043; Khalifeh H, 2016, LANCET PSYCHIAT, V3, P233, DOI 10.1016/S2215-0366(16)00003-1; Kieler H, 2012, BMJ-BRIT MED J, V344, pd8012, DOI DOI 10.1136/BMJ.D8012; Kim DR, 2015, NEUROPSYCH DIS TREAT, V11, P975, DOI 10.2147/NDT.S80480; Kim DR, 2010, CURR PSYCHIAT REP, V12, P279, DOI 10.1007/s11920-010-0114-x; Kjaersgaard MIS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072095; Kozinszky Z, 2015, J AFFECT DISORDERS, V176, P95, DOI 10.1016/j.jad.2015.01.044; Lindahl V, 2005, ARCH WOMEN MENT HLTH, V8, P77, DOI 10.1007/s00737-005-0080-1; Lindqvist PG, 2014, J THROMB HAEMOST, V12, P1986, DOI 10.1111/jth.12757; Malm H, 2015, AM J PSYCHIAT, V172, P1224, DOI 10.1176/appi.ajp.2015.14121575; Marcus SM, 2008, INT J GYNECOL OBSTET, V100, P248, DOI 10.1016/j.ijgo.2007.09.016; McGregor M, 2014, EARLY INTERV PSYCHIA, V8, P348, DOI 10.1111/eip.12074; Megnin-Viggars O, 2015, ARCH WOMEN MENT HLTH, V18, P745, DOI 10.1007/s00737-015-0548-6; Milgrom J, 2015, ARCH WOMEN MENT HLTH, V18, P717, DOI 10.1007/s00737-015-0512-5; Molyneaux E, 2014, OBSTET GYNECOL, V123, P857, DOI 10.1097/AOG.0000000000000170; National Institute for Clinical Excellence (NICE), 2010, SMOK STOPP PREGN CHI; National Institute for Health and Care Excellence, 2014, ANT POSTN MENT HLTH; National Institute for Health Care and Excellence, 2014, DOMESTIC VIOLENCE AB; National Institute for Health Care and Excellence, 2010, WEIGHT MAN PREGN PH; National Institute for Health Care and Excellence, 2013, NICE PATHW COMM MENT; Netsi E, 2015, J AFFECT DISORDERS, V188, P252, DOI 10.1016/j.jad.2015.08.055; O'Connor A. M., 1997, NURSING DIAGNOSIS IN, P486; O'Mahen H, 2013, DEPRESS ANXIETY, V30, P679, DOI 10.1002/da.22050; Oestergaard S, 2011, J AFFECT DISORDERS, V131, P24, DOI 10.1016/j.jad.2010.08.014; Orsolini L, 2015, HUM PSYCHOPHARM CLIN, V30, P4, DOI 10.1002/hup.2451; Palmsten K, 2013, EPIDEMIOLOGY, V24, P682, DOI 10.1097/EDE.0b013e31829e0aaa; Palmsten K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4877; Patel SR, 2011, DEPRESS ANXIETY, V28, P589, DOI 10.1002/da.20844; Payne JL, 2009, HARVARD REV PSYCHIAT, V17, P72, DOI 10.1080/10673220902899706; Pinheiro E, 2015, ARCH WOMEN MENT HLTH, V18, P139, DOI 10.1007/s00737-015-0499-y; Rahman A, 2013, B WORLD HEALTH ORGAN, V91, P593, DOI 10.2471/BLT.12.109819; Ravitz Paula, 2014, Am J Psychother, V68, P463; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Siminerio L, 2016, BJOG-INT J OBSTET GY, V123, P1918, DOI 10.1111/1471-0528.13581; Skurtveit S, 2014, BJOG-INT J OBSTET GY, V121, P1621, DOI 10.1111/1471-0528.12821; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sorensen Merete Juul, 2013, Clin Epidemiol, V5, P449, DOI 10.2147/CLEP.S53009; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Stephansson O, 2013, JAMA-J AM MED ASSOC, V309, P48, DOI 10.1001/jama.2012.153812; Thase ME, 2006, CNS SPECTRUMS, V11, P12, DOI 10.1017/S1092852900015212; Udechuku A, 2010, AUST NZ J PSYCHIAT, V44, P978, DOI 10.3109/00048674.2010.507543; UK Clinical Research Network Study Portfolio, 2015, DEPR EXPL PAR GROUP; UK Clinical Research Network Study Portfolio, 2015, WELL BEING PREGN ID; Vigod S, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1233-4; Vigod S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-366; Walton GD, 2014, ARCH WOMEN MENT HLTH, V17, P493, DOI 10.1007/s00737-014-0448-1; Warburton W, 2010, ACTA PSYCHIAT SCAND, V121, P471, DOI 10.1111/j.1600-0447.2009.01490.x; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Wisner KL, 2000, AM J PSYCHIAT, V157, P1933, DOI 10.1176/appi.ajp.157.12.1933; World Health Organization, ICD 10 CLASS MENT BE; Yonkers KA, 2011, EPIDEMIOLOGY, V22, P848, DOI 10.1097/EDE.0b013e3182306847	104	79	81	1	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2016	352								i1547	10.1136/bmj.i1547	http://dx.doi.org/10.1136/bmj.i1547			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LN	27013603				2022-12-28	WOS:000373044800002
J	Gerber, JS; Bryan, M; Ross, RK; Daymont, C; Parks, EP; Localio, AR; Grundmeier, RW; Stallings, VA; Zaoutis, TE				Gerber, Jeffrey S.; Bryan, Matthew; Ross, Rachael K.; Daymont, Carrie; Parks, Elizabeth P.; Localio, A. Russell; Grundmeier, Robert W.; Stallings, Virginia A.; Zaoutis, Theoklis E.			Antibiotic Exposure During the First 6 Months of Life and Weight Gain During Childhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OVERWEIGHT; MICROBIOTA; INFANCY; RATES	IMPORTANCE Early-life antibiotic exposure has been associated with increased adiposity in animal models, mediated through the gut microbiome. Infant antibiotic exposure is common and often inappropriate. Studies of the association between infant antibiotics and childhood weight gain have reported inconsistent results. OBJECTIVE To assess the association between early-life antibiotic exposure and childhood weight gain. DESIGN AND SETTING Retrospective, longitudinal study of singleton births and matched longitudinal study of twin pairs conducted in a network of 30 pediatric primary care practices serving more than 200 000 children of diverse racial and socioeconomic backgrounds across Pennsylvania, New Jersey, and Delaware. PARTICIPANTS Children born between November 1, 2001, and December 31, 2011, at 35 weeks' gestational age or older, with birth weight of 2000 g or more and in the fifth percentile or higher for gestational age, and who had a preventive health visit within 14 days of life and at least 2 additional visits in the first year of life. Children with complex chronic conditions and those who received long-term antibiotics or multiple systemic corticosteroid prescriptions were excluded. We included 38 522 singleton children and 92 twins (46 matched pairs) discordant in antibiotic exposure. Final date of follow-up was December 31, 2012. EXPOSURE Systemic antibiotic use in the first 6 months of life. MAIN OUTCOMES AND MEASURES Weight, measured at preventive health visits from age 6 months through 7 years. RESULTS Of 38 522 singleton children (50% female; mean birth weight, 3.4 kg), 5287 (14%) were exposed to antibiotics during the first 6 months of life (at a mean age of 4.3 months). Antibiotic exposure was not significantly associated with rate of weight change (0.7%; 95% CI, -0.1% to 1.5%; P =.07, equivalent to approximately 0.05 kg; 95% CI, -0.004 to 0.11 kg of added weight gain between age 2 years and 5 years). Among 92 twins (38% female; mean birth weight, 2.8 kg), the 46 twins who were exposed to antibiotics during the first 6 months of life received them at a mean age of 4.5 months. Antibiotic exposure was not significantly associated with a weight difference (-0.09 kg; 95% CI, -0.26 to 0.08 kg; P =.30). CONCLUSIONS AND RELEVANCE Exposure to antibiotics within the first 6 months of life compared with no exposure was not associated with a statistically significant difference in weight gain through age 7 years. There are many reasons to limit antibiotic exposure in young, healthy children, but weight gain is likely not one of them.	[Gerber, Jeffrey S.; Ross, Rachael K.; Zaoutis, Theoklis E.] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Div Infect Dis, 3535 Market St,Ste 1518, Philadelphia, PA 19104 USA; [Gerber, Jeffrey S.; Parks, Elizabeth P.; Grundmeier, Robert W.; Stallings, Virginia A.; Zaoutis, Theoklis E.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bryan, Matthew; Localio, A. Russell] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Div Biostat, Philadelphia, PA 19104 USA; [Daymont, Carrie] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Daymont, Carrie] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Parks, Elizabeth P.; Stallings, Virginia A.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Grundmeier, Robert W.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Gerber, JS (corresponding author), Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Div Infect Dis, 3535 Market St,Ste 1518, Philadelphia, PA 19104 USA.	gerberj@email.chop.edu	Gerber, Jeffrey/GYD-3567-2022	Gerber, Jeffrey/0000-0002-3076-3186; Daymont, Carrie/0000-0003-1555-1502				Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Bailey LC, 2014, JAMA PEDIATR, V168, P1063, DOI 10.1001/jamapediatrics.2014.1539; Bryan M, 2014, STAT MED, V33, P2115, DOI 10.1002/sim.6102; Butaye P, 2003, CLIN MICROBIOL REV, V16, P175, DOI 10.1128/CMR.16.2.175-188.2003; Chai G, 2012, PEDIATRICS, V130, P23, DOI 10.1542/peds.2011-2879; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Dawson NV, 2012, MED DECIS MAKING, V32, P225, DOI 10.1177/0272989X12437605; Daymont C, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-9; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Feudtner C, 2000, PEDIATRICS, V106, P205; Fitzmaurice G, 2009, CH CRC HANDB MOD STA, P1; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Furuya EY, 2006, NAT REV MICROBIOL, V4, P36, DOI 10.1038/nrmicro1325; Gerber JS, 2015, J PEDIAT INF DIS SOC, V4, P297, DOI 10.1093/jpids/piu086; Gerber JS, 2013, PEDIATRICS, V131, P677, DOI 10.1542/peds.2012-2500; GOODMAN SN, 1994, ANN INTERN MED, V121, P200, DOI 10.7326/0003-4819-121-3-199408010-00008; Gough EK1, 2014, BMJ-BRIT MED J, V15, P348; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; Grundmeier RW, 2015, HEALTH SERV RES, V50, P946, DOI 10.1111/1475-6773.12295; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; KRONMAL RA, 1993, J ROY STAT SOC A STA, V156, P379, DOI 10.2307/2983064; Naumova EN, 2001, INT J EPIDEMIOL, V30, P1332, DOI 10.1093/ije/30.6.1332; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Saari A, 2015, PEDIATRICS, V135, P617, DOI 10.1542/peds.2014-3407; Senn S, 2009, STAT MED, V28, P3189, DOI 10.1002/sim.3603; Shehab N, 2008, CLIN INFECT DIS, V47, P735, DOI 10.1086/591126; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Yang S, 2011, INT J EPIDEMIOL, V40, P1215, DOI 10.1093/ije/dyr094	30	74	79	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1258	1265		10.1001/jama.2016.2395	http://dx.doi.org/10.1001/jama.2016.2395			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	27002447	Bronze			2022-12-28	WOS:000372511100012
J	de Aguero, MG; Ganal-Vonarburg, SC; Fuhrer, T; Rupp, S; Uchimura, Y; Li, H; Steinert, A; Heikenwalder, M; Hapfelmeier, S; Sauer, U; McCoy, KD; Macpherson, AJ				de Agueero, Mercedes Gomez; Ganal-Vonarburg, Stephanie C.; Fuhrer, Tobias; Rupp, Sandra; Uchimura, Yasuhiro; Li, Hai; Steinert, Anna; Heikenwalder, Mathias; Hapfelmeier, Siegfried; Sauer, Uwe; McCoy, Kathy D.; Macpherson, Andrew J.			The maternal microbiota drives early postnatal innate immune development	SCIENCE			English	Article							ARYL-HYDROCARBON RECEPTOR; ROR-GAMMA-T; DENDRITIC CELLS; LYMPHOID-CELLS; EARLY-LIFE; REVEALS; GUT; IGA; DIFFERENTIATION; COLONIZATION	Postnatal colonization of the body with microbes is assumed to be the main stimulus to postnatal immune development. By transiently colonizing pregnant female mice, we show that the maternal microbiota shapes the immune system of the offspring. Gestational colonization increases intestinal group 3 innate lymphoid cells and F4/80(+)CD11c(+) mononuclear cells in the pups. Maternal colonization reprograms intestinal transcriptional profiles of the offspring, including increased expression of genes encoding epithelial antibacterial peptides and metabolism of microbial molecules. Some of these effects are dependent on maternal antibodies that potentially retain microbial molecules and transmit them to the offspring during pregnancy and in milk. Pups born to mothers transiently colonized in pregnancy are better able to avoid inflammatory responses to microbial molecules and penetration of intestinal microbes.	[de Agueero, Mercedes Gomez; Ganal-Vonarburg, Stephanie C.; Rupp, Sandra; Uchimura, Yasuhiro; Li, Hai; Steinert, Anna; McCoy, Kathy D.; Macpherson, Andrew J.] Univ Bern, Maurice Muller Labs DKF, Univ Klin Viszerale Chirurg & Med, Inselspital, Murtenstr 35, CH-3010 Bern, Switzerland; [Fuhrer, Tobias; Sauer, Uwe] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Heikenwalder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany; [Hapfelmeier, Siegfried] Univ Bern, Inst Infect Dis, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; German Cancer Research Center (DKFZ); University of Bern	Macpherson, AJ (corresponding author), Univ Bern, Maurice Muller Labs DKF, Univ Klin Viszerale Chirurg & Med, Inselspital, Murtenstr 35, CH-3010 Bern, Switzerland.	andrew.macpherson@insel.ch	Ganal-Vonarburg, Stephanie C./AAE-5705-2019; McCoy, Kathy/ABD-5814-2021; Fuhrer, Tobias/B-5667-2013; Heikenwalder, Mathias/AAA-2269-2020; Li, Hai/AAI-9163-2021; Sauer, Uwe/Y-3556-2019; Hapfelmeier, Siegfried/B-6005-2011	Ganal-Vonarburg, Stephanie C./0000-0002-2548-7754; Fuhrer, Tobias/0000-0001-5006-6874; Hapfelmeier, Siegfried/0000-0002-6913-7932; Gomez de Aguero, Mercedes/0000-0002-7132-290X; Steinert, Anna/0000-0002-5450-4736; Li, Hai/0000-0002-4762-9362				Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Bizzarro MJ, 2015, J PEDIATR-US, V166, P1193, DOI 10.1016/j.jpeds.2015.02.009; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594; Esser C, 2015, PHARMACOL REV, V67, P259, DOI 10.1124/pr.114.009001; Fulde M, 2014, IMMUNOL REV, V260, P21, DOI 10.1111/imr.12190; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Ghetie V, 1997, IMMUNOL TODAY, V18, P592, DOI 10.1016/S0167-5699(97)01172-9; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; KRAMER DR, 1995, J IMMUNOL, V154, P2051; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; Rakoff-Nahoum S, 2015, P NATL ACAD SCI USA, V112, P1929, DOI 10.1073/pnas.1424886112; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Zinkernagel RM, 2001, NEW ENGL J MED, V345, P1331, DOI 10.1056/NEJMra012493	43	616	626	9	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279					1296	1301		10.1126/science.aad2571	http://dx.doi.org/10.1126/science.aad2571			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG9JD	26989247				2022-12-28	WOS:000372397700037
J	Hawkes, N				Hawkes, Nigel			People with autism die 16 years earlier on average, says charity	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Autistica, 2016, PERS TRAG PUBL CRIS; Hirvikoski T, 2016, BRIT J PSYCHIAT, V208, P232, DOI 10.1192/bjp.bp.114.160192	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2016	352								i1615	10.1136/bmj.i1615	http://dx.doi.org/10.1136/bmj.i1615			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AI	26992414				2022-12-28	WOS:000372586000006
J	Gilbert, N				Gilbert, Natasha			GREEN SPACE A natural high	NATURE			English	Editorial Material																		Alcock I, 2014, ENVIRON SCI TECHNOL, V48, P1247, DOI 10.1021/es403688w; Cohen-Cline Hannah, 2015, J Epidemiol Community Health, V69, P523, DOI 10.1136/jech-2014-204667; MacKerron G, 2013, GLOBAL ENVIRON CHANG, V23, P992, DOI 10.1016/j.gloenvcha.2013.03.010; Mitchell RJ, 2015, AM J PREV MED, V49, P80, DOI 10.1016/j.amepre.2015.01.017; Park Bum Jin, 2010, Environmental Health and Preventive Medicine, V15, P18, DOI 10.1007/s12199-009-0086-9; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x	6	10	12	6	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					S56	S57		10.1038/531S56a	http://dx.doi.org/10.1038/531S56a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26981729	Bronze			2022-12-28	WOS:000372064300003
J	Mardinly, AR; Spiegel, I; Patrizi, A; Centofante, E; Bazinet, JE; Tzeng, CP; Mandel-Brehm, C; Harmin, DA; Adesnik, H; Fagiolini, M; Greenberg, ME				Mardinly, A. R.; Spiegel, I.; Patrizi, A.; Centofante, E.; Bazinet, J. E.; Tzeng, C. P.; Mandel-Brehm, C.; Harmin, D. A.; Adesnik, H.; Fagiolini, M.; Greenberg, M. E.			Sensory experience regulates cortical inhibition by inducing IGF1 in VIP neurons	NATURE			English	Article							GROWTH-FACTOR-I; NEOCORTICAL GABAERGIC NEURONS; PRIMARY VISUAL-CORTEX; CRITICAL-PERIOD; GENE-EXPRESSION; TRANSGENIC MICE; INTERNEURONS; RNA; TRANSCRIPTION; PLASTICITY	Inhibitory neurons regulate the adaptation of neural circuits to sensory experience(1), but the molecular mechanisms by which experience controls the connectivity between different types of inhibitory neuron(2,3) to regulate cortical plasticity are largely unknown. Here we show that exposure of dark-housed mice to light induces a gene program in cortical vasoactive intestinal peptide (VIP)-expressing neurons that is markedly distinct from that induced in excitatory neurons and other subtypes of inhibitory neuron. We identify Igf1 as one of several activity-regulated genes that are specific to VIP neurons, and demonstrate that IGF1 functions cell-autonomously in VIP neurons to increase inhibitory synaptic input onto these neurons. Our findings further suggest that in cortical VIP neurons, experience-dependent gene transcription regulates visual acuity by activating the expression of IGF1, thus promoting the inhibition of disinhibitory neurons(3-5) and affecting inhibition onto cortical pyramidal neurons.	[Mardinly, A. R.; Adesnik, H.] Univ Calif Berkeley, Dept Mol & Cellular Biol, 205 Life Sci Addit, Berkeley, CA 94720 USA; [Spiegel, I.; Bazinet, J. E.; Tzeng, C. P.; Mandel-Brehm, C.; Harmin, D. A.; Greenberg, M. E.] Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA; [Patrizi, A.; Centofante, E.; Fagiolini, M.] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, 3 Blackfan Circle, Boston, MA 02115 USA	University of California System; University of California Berkeley; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	Michael_Greenberg@hms.harvard.edu	Core, Vector/CAF-4832-2022	mandel-brehm, caleigh/0000-0001-7764-6529; Tzeng, Christopher/0000-0003-4734-6298; fagiolini, michela/0000-0003-2807-803X; Spiegel, Ivo/0000-0003-0979-1358; Mardinly, Alan/0000-0001-9891-6719	Human Frontiers Science Program; Swiss National Science Foundation; National Institute of Health [R01 NS028829, P01 NS047572]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047572, R01NS028829, R37NS028829] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Chen for help with electrophysiology experiments, E. Griffith and T. Cherry for critical reading of the manuscript, P. Zhang for managing the mouse colony and the HMS Biopolymers Facility Next-Gen Sequencing Core for their expertise in constructing Seq libraries and sequencing of the library samples. The ReachR-tdTomato construct was a gift from J. Lin, and we thank M. Li for production of the ReachR-virus. H.A. is a New York Stem Cell Robertson Investigator. This work was funded by fellowships by the Human Frontiers Science Program and the Swiss National Science Foundation (I.S.) and the National Institute of Health grants R01 NS028829 and P01 NS047572 (M.E.G.).	Bloodgood BL, 2013, NATURE, V503, P121, DOI 10.1038/nature12743; BONDY CA, 1991, J NEUROSCI, V11, P3442; Cao P, 2011, CELL, V145, P300, DOI 10.1016/j.cell.2011.03.034; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; Davis MF, 2015, NEURON, V86, P1055, DOI 10.1016/j.neuron.2015.03.062; Durand S, 2012, NEURON, V76, P1078, DOI 10.1016/j.neuron.2012.12.004; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fu Y, 2015, ELIFE, V4, DOI 10.7554/eLife.05558; Gordon JA, 1996, J NEUROSCI, V16, P3274; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hede MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051152; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Kubota Y, 2011, CEREB CORTEX, V21, P1803, DOI 10.1093/cercor/bhq252; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lin JY, 2013, NAT NEUROSCI, V16, P1499, DOI 10.1038/nn.3502; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schopman NCT, 2010, ANTIVIR RES, V86, P204, DOI 10.1016/j.antiviral.2010.02.320; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238	36	94	98	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					371	+		10.1038/nature17187	http://dx.doi.org/10.1038/nature17187			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26958833	Green Accepted, Green Submitted			2022-12-28	WOS:000372064300053
J	Ortega, R; Canelli, RJ; Quillen, K; Mustafa, W; Kotova, F				Ortega, Rafael; Canelli, Robert J.; Quillen, Karen; Mustafa, Wissam; Kotova, Faina			Transfusion of Red Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ortega, Rafael; Canelli, Robert J.; Mustafa, Wissam; Kotova, Faina] Boston Med Ctr, Dept Anesthesiol, Boston, MA USA; [Quillen, Karen] Boston Med Ctr, Dept Pathol & Lab Med, Boston, MA USA	Boston Medical Center; Boston Medical Center	Ortega, R (corresponding author), Boston Univ, Med Ctr, Dept Anesthesiol, 88 E Newton St, Boston, MA 02118 USA.	rafael.ortega@bmc.org							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11							e12	10.1056/NEJMvcm1504413	http://dx.doi.org/10.1056/NEJMvcm1504413			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4TR	26981950				2022-12-28	WOS:000372066100011
J	Niranjan, U; Wright, NP				Niranjan, Usha; Wright, Neil P.			UNCERTAINTIES Should we treat subclinical hypothyroidism in obese children?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WEIGHT-LOSS; THYROID-FUNCTION; CHILDHOOD OBESITY; TSH		[Niranjan, Usha; Wright, Neil P.] Sheffield Childrens Hosp NHS Trust, Dept Paediat Endocrinol & Diabet, Sheffield S10 2TD, S Yorkshire, England	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital	Niranjan, U (corresponding author), Sheffield Childrens Hosp NHS Trust, Dept Paediat Endocrinol & Diabet, Sheffield S10 2TD, S Yorkshire, England.	usha.niranjan@nhs.net						de Moraes CMM, 2005, OBES SURG, V15, P1287; Eliakim A, 2006, INT J PEDIATR OBES, V1, P217, DOI 10.1080/17477160600805006; Grandone A, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-8; Kok P, 2005, J CLIN ENDOCR METAB, V90, P4659, DOI 10.1210/jc.2005-0920; Lazar L, 2009, J CLIN ENDOCR METAB, V94, P1678, DOI 10.1210/jc.2008-2615; Monzani A, 2013, EUR J ENDOCRINOL, V168, pR1, DOI 10.1530/EJE-12-0656; Pacifico L, 2012, CLIN CHIM ACTA, V413, P396, DOI 10.1016/j.cca.2011.11.013; Reinehr T, 2006, J CLIN ENDOCR METAB, V91, P3088, DOI 10.1210/jc.2006-0095; Rugge JB, 2015, ANN INTERN MED, V162, P35, DOI 10.7326/M14-1456; Santini F, 2014, EUR J ENDOCRINOL, V171, pR137, DOI 10.1530/EJE-14-0067; Souza AD, 2011, EUR J ENDOCRINOL, V165, P11, DOI 10.1530/EJE-11-0261; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Svare A, 2011, CLIN ENDOCRINOL, V74, P769, DOI 10.1111/j.1365-2265.2011.04009.x; Wolters B, 2013, EUR J ENDOCRINOL, V168, P323, DOI 10.1530/EJE-12-0981	14	14	15	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2016	352								i941	10.1136/bmj.i941	http://dx.doi.org/10.1136/bmj.i941			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1ZX	26984882				2022-12-28	WOS:000372584800012
J	Bryce, A; Hay, AD; Lane, IF; Thornton, HV; Wootton, M; Costelloe, C				Bryce, Ashley; Hay, Alastair D.; Lane, Isabel F.; Thornton, Hannah V.; Wootton, Mandy; Costelloe, Ceire			Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; OUTPATIENT CHILDREN; RISK-FACTORS; UROPATHOGENS; PATTERNS; SUSCEPTIBILITY; PATHOGENS; SENSITIVITY; AGE	OBJECTIVES To systematically review studies investigating the prevalence of antibiotic resistance in urinary tract infections caused by Escherichia coli in children and, when appropriate, to meta-analyse the relation between previous antibiotics prescribed in primary care and resistance. DESIGN AND DATA ANALYSIS Systematic review and meta-analysis. Pooled percentage prevalence of resistance to the most commonly used antibiotics in children in primary care, stratified by the OECD (Organisation for Economic Co-operation and Development) status of the study country. Random effects meta-analysis was used to quantify the association between previous exposure to antibiotics in primary care and resistance. DATA SOURCES Observational and experimental studies identified through Medline, Embase, Cochrane, and ISI Web of Knowledge databases, searched for articles published up to October 2015. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Studies were eligible if they investigated and reported resistance in community acquired urinary tract infection in children and young people aged 0-17. Electronic searches with MeSH terms and text words identified 3115 papers. Two independent reviewers assessed study quality and performed data extraction. RESULTS 58 observational studies investigated 77 783 E coli isolates in urine. In studies from OECD countries, the pooled prevalence of resistance was 53.4% (95% confidence interval 46.0% to 60.8%) for ampicillin, 23.6% (13.9% to 32.3%) for trimethoprim, 8.2% (7.9% to 9.6%) for co-amoxiclav, and 2.1% (0.8 to 4.4%) for ciprofloxacin; nitrofurantoin was the lowest at 1.3% (0.8% to 1.7%). Resistance in studies in countries outside the OECD was significantly higher: 79.8% (73.0% to 87.7%) for ampicillin, 60.3% (40.9% to 79.0%) for co-amoxiclav, 26.8% (11.1% to 43.0%) for ciprofloxacin, and 17.0% (9.8% to 24.2%) for nitrofurantoin. There was evidence that bacterial isolates from the urinary tract from individual children who had received previous prescriptions for antibiotics in primary care were more likely to be resistant to antibiotics, and this increased risk could persist for up to six months (odds ratio 13.23, 95% confidence interval 7.84 to 22.31). CONCLUSIONS Prevalence of resistance to commonly prescribed antibiotics in primary care in children with urinary tract infections caused by E coli is high, particularly in countries outside the OECD, where one possible explanation is the availability of antibiotics over the counter. This could render some antibiotics ineffective as first line treatments for urinary tract infection. Routine use of antibiotics in primary care contributes to antimicrobial resistance in children, which can persist for up to six months after treatment.	[Bryce, Ashley; Hay, Alastair D.; Lane, Isabel F.; Thornton, Hannah V.] Univ Bristol, Sch Social & Community Med, NIHR Sch Primary Care Res, Ctr Acad Primary Care, Bristol BS8 2PS, Avon, England; [Wootton, Mandy] Univ Wales Hosp, Publ Hlth Wales Microbiol Cardiff, Specialist Antimicrobial Chemotherapy Unit, Cardiff CF14 4XW, S Glam, Wales; [Costelloe, Ceire] Univ London Imperial Coll Sci Technol & Med, NIHR Hlth Protect Res Unit Healthcare Associated, London W12 0NN, England	University of Bristol; Cardiff University; Imperial College London	Bryce, A (corresponding author), Univ Bristol, Sch Social & Community Med, NIHR Sch Primary Care Res, Ctr Acad Primary Care, Bristol BS8 2PS, Avon, England.	ashley.bryce@bristol.ac.uk	Hay, Alastair/L-1818-2019	Hammond, Ashley/0000-0002-6657-1514; Hay, Alastair/0000-0003-3012-375X; Thornton, Hannah/0000-0003-0899-4102	National Institute for Health Research School for Primary Care Research (NIHR-SPCR); NIHR [NIHR RP-R2-12-012]; National Institute for Health Research [CDF-2009-02-10, NIHR-RP-02-12-012, SPCR-089, CDF-2016-09-015, SPCR-054] Funding Source: researchfish	National Institute for Health Research School for Primary Care Research (NIHR-SPCR); NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	AB was supported to conduct this study through a doctoral fellowship from the National Institute for Health Research School for Primary Care Research (NIHR-SPCR). ADH is supported by a NIHR research professorship (NIHR RP-R2-12-012). The views expressed in this publication are those of the authors and not necessarily those of the NIHR. The funder had no role in the study design; data collection, data analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Adjei O, 2004, INT J ANTIMICROB AG, V24, pS32, DOI 10.1016/j.ijantimicag.2004.02.007; Afsharpaiman S., 2012, J COMPREHENSIVE PEDI, V3, P16, DOI [10.5812/jcp.7078, DOI 10.5812/JCP.7078]; Akinyandenu O, 2014, J SCI INNOV RES, V3, P251; Al-Mardeni RI, 2009, SAUDI J KIDNEY DIS T, V20, P135; Al-Saif MA, 2012, SAUDI MED J, V33, P565; Allen UD, 1999, CAN MED ASSOC J, V160, P1436; AlMugeiren MM, 1996, CLIN THER, V18, P295, DOI 10.1016/S0149-2918(96)80010-5; Alshara M., 2011, Jordan Medical Journal, V45, P44; Anatoliotaki M, 2007, SCAND J INFECT DIS, V39, P671, DOI 10.1080/00365540701199899; [Anonymous], 2009, SPECIAL EUROBAROMETE, V338; [Anonymous], 2014, SUSC; ASHKENAZI S, 1991, PEDIATR INFECT DIS J, V10, P742, DOI 10.1097/00006454-199110000-00005; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Bean David C, 2008, Ann Clin Microbiol Antimicrob, V7, P13, DOI 10.1186/1476-0711-7-13; Bin Abdulhak AA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-538; Borsari AG, 2008, CLIN THER, V30, P2090, DOI 10.1016/j.clinthera.2008.11.002; Brown B J, 2003, West Afr J Med, V22, P110; Bryce A, 2011, J INFECTION, V63, pE61, DOI 10.1016/j.jinf.2011.04.112; Burman WJ, 2003, AM J MED, V115, P358, DOI 10.1016/S0002-9343(03)00372-3; Car J, 2006, BMJ-BRIT MED J, V332, P94, DOI 10.1136/bmj.332.7533.94; Caracciolo Alessandra, 2011, Ital J Pediatr, V37, P3, DOI 10.1186/1824-7288-37-3; Centre for Disease Dynamics Economics and Policy (CDDEP), 2010, RES MAP; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Cizman M, 2004, INT J ANTIMICROB AG, V24, P199, DOI 10.1016/j.ijantimicag.2004.03.016; Conway PH, 2007, JAMA-J AM MED ASSOC, V298, P179, DOI 10.1001/jama.298.2.179; Costelloe Ceire, 2010, BMJ, V340, pc2096, DOI 10.1136/bmj.c2096; Cullen IM, 2013, IRISH J MED SCI, V182, P81, DOI 10.1007/s11845-012-0834-5; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Duffy MA, 2013, BRIT J GEN PRACT, V63, pE238, DOI 10.3399/bjgp13X665198; Edlin RS, 2013, J UROLOGY, V190, P222, DOI 10.1016/j.juro.2013.01.069; European Centre for Disease Prevention and Control network, 2014, ANT RES INT DAT EARS; Falagas ME, 2008, MED SCI MONITOR, V14, pCR75; Farrell DJ, 2003, J INFECTION, V46, P94, DOI 10.1053/jinf.2002.1091; Farshad S, 2010, IRAN RED CRESCENT ME, V12, P33; Farshad S, 2012, ARCH IRAN MED, V15, P312, DOI 012155/AIM.0013; Farshad S, 2011, AFR J MICROBIOL RES, V5, P4476, DOI 10.5897/AJMR11.285; Fredrick F., 2013, African Journal of Microbiology Research, V7, P1029; Fritzsche M, 2005, EUR J CLIN MICROBIOL, V24, P233, DOI 10.1007/s10096-005-1301-2; Gallegos J, 2013, REV CHIL INFECTOL, V30, P474, DOI 10.4067/S0716-10182013000500002; Gaspari RJ, 2005, INT J ANTIMICROB AG, V26, P267, DOI 10.1016/j.ijantimicag.2005.07.009; Gaspari RJ, 2006, MICROB DRUG RESIST, V12, P126, DOI 10.1089/mdr.2006.12.126; Goldraich NP, 2002, PEDIATR NEPHROL, V17, P173, DOI 10.1007/s00467-001-0808-8; GRUNEBERG RN, 1976, J MED MICROBIOL, V9, P233, DOI 10.1099/00222615-9-2-233; Guner SN, 2012, TURK PEDIATR ARSIVI, V47, P107, DOI 10.4274/tpa.721; Guneysel O, 2009, J EMERG MED, V36, P338, DOI 10.1016/j.jemermed.2007.08.068; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; HELIN I, 1986, SCAND J INFECT DIS, V18, P447, DOI 10.3109/00365548609032362; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; HOLMBERG SD, 1987, REV INFECT DIS, V9, P1065; Holten KB, 2000, AM FAM PHYSICIAN, V62, P611; Ipek IO, 2011, SE ASIAN J TROP MED, V42, P355; Ismaili K, 2011, PEDIATR INFECT DIS J, V30, P371, DOI 10.1097/INF.0b013e318204dcf3; Karlowsky JA, 2002, ANTIMICROB AGENTS CH, V46, P2540, DOI 10.1128/AAC.46.8.2540-2545.2002; Ladhani S, 2003, ARCH DIS CHILD, V88, P444, DOI 10.1136/adc.88.5.444; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Majeed A, 1999, BRIT J GEN PRACT, V49, P735; Mandal J, 2012, INDIAN J MED RES, V136, P842; Mantadakis E, 2011, INT UROL NEPHROL, V43, P549, DOI 10.1007/s11255-010-9768-x; McGregor JC, 2014, J PEDIATR NURS, V29, P152, DOI 10.1016/j.pedn.2013.09.001; McLoughlin TG, 2003, ACAD EMERG MED, V10, P347, DOI 10.1111/j.1553-2712.2003.tb01347.x; Guidoni EBM, 2008, BRAZ J INFECT DIS, V12, P321, DOI 10.1590/S1413-86702008000400013; Mehr SS, 2004, J PAEDIATR CHILD H, V40, P48, DOI 10.1111/j.1440-1754.2004.00290.x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Muoneke VU, 2012, ANN MED HEALTH SCI R, V2, P29, DOI 10.4103/2141-9248.96933; Narchi H, 2008, J CHEMOTHERAPY, V20, P472, DOI 10.1179/joc.2008.20.4.472; Paschke AA, 2010, PEDIATRICS, V125, P664, DOI 10.1542/peds.2009-1527; Planta MB, 2007, J AM BOARD FAM MED, V20, P533, DOI 10.3122/jabfm.2007.06.070019; Pourakbari B, 2012, BRAZ J MICROBIOL, V43, P766, DOI 10.1590/S1517-83822012000200041; Prelog M, 2008, PEDIATR NEPHROL, V23, P597, DOI 10.1007/s00467-007-0701-1; Price E, 2010, J ANTIMICROB CHEMOTH, V65, P836, DOI 10.1093/jac/dkq045; Rai G K, 2008, Nepal Med Coll J, V10, P86; Ready D, 2004, ANTIMICROB AGENTS CH, V48, P2883, DOI 10.1128/AAC.48.8.2883-2887.2004; Sanchez GV, 2014, J ANTIMICROB CHEMOTH, V69, P3259, DOI 10.1093/jac/dku282; Sedighi I, 2014, IRAN J MICROBIOL, V6, P387; Senel S, 2010, MED PRIN PRACT, V19, P359, DOI 10.1159/000316373; Sharan R, 2013, INDIAN PEDIATR, V50, P707, DOI 10.1007/s13312-013-0195-9; Sharef SW, 2015, J INFECT PUBLIC HEAL, V8, P458, DOI 10.1016/j.jiph.2015.01.005; Sharma A, 2011, Nepal Med Coll J, V13, P24; Sommet A, 2004, J ANTIMICROB CHEMOTH, V54, P524, DOI 10.1093/jac/dkh342; Swerkersson S, 2014, EUR J PEDIATR, V173, P1075, DOI 10.1007/s00431-014-2289-3; Topaloglu R, 2010, PEDIATR NEPHROL, V25, P919, DOI 10.1007/s00467-009-1431-3; Turgut F, 2008, INT UROL NEPHROL, V40, P453, DOI [10.1007/s11255-008-9365-4, 10.1007/s11255-008-9445-5]; Turnidge J, 2005, LANCET, V365, P548; Uwaezuoke J. C., 2006, Journal of Applied Sciences and Environmental Management, V10, P103; Valavi E, 2013, JUNDISHAPUR J MICROB, V6, DOI 10.5812/jjm.4958; Wachter DA, 1999, TROP MED INT HEALTH, V4, P782, DOI 10.1046/j.1365-3156.1999.00476.x; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3; World Health Organization (WHO), 2015, ANT RES DRAFT GLOB A; Wu JH, 2012, PEDIATR NEONATOL, V53, P283, DOI 10.1016/j.pedneo.2012.08.003; Yildirim M, 2010, TURK KLIN TIP BILIM, V30, P533, DOI 10.5336/medsci.2008-9024; Yolbas I, 2013, EUR REV MED PHARMACO, V17, P971; Zhanel GG, 2005, INT J ANTIMICROB AG, V26, P380, DOI 10.1016/j.ijantimicag.2005.08.003	94	85	93	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2016	352								i939	10.1136/bmj.i939	http://dx.doi.org/10.1136/bmj.i939			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1ZT	26980184	Green Published, hybrid			2022-12-28	WOS:000372584400029
J	Herzlinger, RE; Schleicher, SM; Mullangi, S				Herzlinger, Regina E.; Schleicher, Stephen M.; Mullangi, Samyukta			Health Care Delivery Innovations That Integrate Care? Yes! But Integrating What?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICARE		[Herzlinger, Regina E.] Harvard Univ, Sch Business, Baker Lib 171, Boston, MA 02163 USA; [Schleicher, Stephen M.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Mullangi, Samyukta] Univ Michigan Hlth Syst, Ann Arbor, MI USA	Harvard University; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan	Herzlinger, RE (corresponding author), Harvard Univ, Sch Business, Baker Lib 171, Boston, MA 02163 USA.	rherzlinger@hbs.edu		Mullangi, Samyukta/0000-0002-9348-8492				Ajaikumar BS, 2012, J CLIN ONCOL, V30; Herzlinger R., 2007, WHO KILLED HLTH CARE; Herzlinger RE, 2014, NOTE BUNDLED PAYMENT; Herzlinger RE, 2014, HUB SPOKE HLTH CARE; National Compendium on Payment Reform, PAYM REF MOD PREV CA; Nyweide DJ, 2015, JAMA-J AM MED ASSOC, V313, P2152, DOI 10.1001/jama.2015.4930; Press MJ, 2016, JAMA-J AM MED ASSOC, V315, P131, DOI 10.1001/jama.2015.18161; Straub T, 2007, REASONS FREQUENT FAI	8	12	12	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1109	1110		10.1001/jama.2016.0505	http://dx.doi.org/10.1001/jama.2016.0505			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978202				2022-12-28	WOS:000372159800012
J	Feng, GD; Cheng, P; Yan, WF; Boronat, M; Li, X; Su, JH; Wang, JY; Li, Y; Corma, A; Xu, RR; Yu, JH				Feng, Guodong; Cheng, Peng; Yan, Wenfu; Boronat, Mercedes; Li, Xu; Su, Ji-Hu; Wang, Jianyu; Li, Yi; Corma, Avelino; Xu, Ruren; Yu, Jihong			Accelerated crystallization of zeolites via hydroxyl free radicals	SCIENCE			English	Article							ELECTRON-SPIN-RESONANCE; HYDROTHERMAL SYNTHESIS; PRECURSORS; MECHANISM; SURFACE	In the hydrothermal crystallization of zeolites from basic media, hydroxide ions (OH-) catalyze the depolymerization of the aluminosilicate gel by breaking the Si, Al-O-Si, Al bonds and catalyze the polymerization of the aluminosilicate anions around the hydrated cation species by remaking the Si, Al-O-Si, Al bonds. We report that hydroxyl free radicals (center dot OH) are involved in the zeolite crystallization under hydrothermal conditions. The crystallization processes of zeolites-such as Na-A, Na-X, NaZ-21, and silicalite-1-can be accelerated with hydroxyl free radicals generated by ultraviolet irradiation or Fenton's reagent.	[Feng, Guodong; Cheng, Peng; Yan, Wenfu; Li, Xu; Wang, Jianyu; Li, Yi; Xu, Ruren; Yu, Jihong] Jilin Univ, Coll Chem, State Key Lab Inorgan Synth & Preparat Chem, 2699 Qianjin St, Changchun 130012, Peoples R China; [Boronat, Mercedes; Corma, Avelino] Univ Politecn Valencia, CSIC, Inst Tecnol Quim, E-46022 Valencia, Spain; [Su, Ji-Hu] Univ Sci & Technol China, Dept Modern Phys, 96 Jinzhai Rd, Hefei 230026, Peoples R China	Jilin University; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ); Chinese Academy of Sciences; University of Science & Technology of China, CAS	Yu, JH (corresponding author), Jilin Univ, Coll Chem, State Key Lab Inorgan Synth & Preparat Chem, 2699 Qianjin St, Changchun 130012, Peoples R China.	jihong@jlu.edu.cn	Li, Yi/C-1180-2011; Feng, Guodong/Z-1194-2018; CANOS, AVELINO CORMA/A-3040-2013; min, guo/F-3813-2014; LI, Xu/P-9394-2016	Li, Yi/0000-0002-5222-3674; Feng, Guodong/0000-0001-8774-9599; CANOS, AVELINO CORMA/0000-0002-2232-3527; LI, Xu/0000-0003-0684-6923; Yu, Jihong/0000-0003-1615-5034	973 Project [2014CB931802, 2013CB921802]; National Natural Science Foundation of China [21320102001, 91122029, 21571075]; Program Severo Ochoa;  [ERC-AdG-2014-671093-SynCatMatch]	973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program Severo Ochoa(Spanish Government); 	This work was supported by the 973 Project (grants 2014CB931802 and 2013CB921802) and the National Natural Science Foundation of China (grants 21320102001, 91122029, and 21571075). A.C. thanks the Program Severo Ochoa for financial support and ERC-AdG-2014-671093-SynCatMatch. J.Y. designed and supervised the project; W.Y., A.C., and R.X. involved the design of the experiments; G.F., P.C., and J.W. performed the experiments; J.-H.S. performed the EPR analyses; M.B., X.L., and Y.L. contributed to the calculations; J.Y. and W.Y. analyzed the data; G.F. wrote the first draft; and J.Y. and W.Y. deeply revised the manuscript. A Chinese patent about the method for UV-assisted synthesis of zeolite materials has been applied for.	Angelo A., 2008, ELECT PARAMAGNETIC R, V4, P285; [Anonymous], 2010, ZEOLITES CATALYSIS; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Cundy CS, 2005, MICROPOR MESOPOR MAT, V82, P1, DOI 10.1016/j.micromeso.2005.02.016; Cundy CS, 2003, CHEM REV, V103, P663, DOI 10.1021/cr020060i; GRISCOM DL, 1987, J NON-CRYST SOLIDS, V92, P295, DOI 10.1016/S0022-3093(87)80047-9; Huang CH, 2013, CHEM COMMUN, V49, P6436, DOI 10.1039/c3cc42732c; Iler, 1979, CHEM SILICA SOLUBILI; Knight CTG, 2007, ANGEW CHEM INT EDIT, V46, P8148, DOI 10.1002/anie.200702986; Konecny R, 2001, J PHYS CHEM B, V105, P6221, DOI 10.1021/jp010752v; Li Y, 2014, CHEM REV, V114, P7268, DOI 10.1021/cr500010r; Lupulescu AI, 2014, SCIENCE, V344, P729, DOI 10.1126/science.1250984; Moad G., 2006, CHEM RADICAL POLYM; WARREN WL, 1991, J NON-CRYST SOLIDS, V136, P151, DOI 10.1016/0022-3093(91)90130-X; Xiao YT, 1996, GEOCHIM COSMOCHIM AC, V60, P2283, DOI 10.1016/0016-7037(96)00101-9; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Zard S. Z., 2003, RADICAL REACTIONS OR; Zhang HY, 2012, J AM CHEM SOC, V134, P15790, DOI 10.1021/ja304907c	18	227	241	92	1028	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1188	1191		10.1126/science.aaf1559	http://dx.doi.org/10.1126/science.aaf1559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965626	Green Submitted			2022-12-28	WOS:000386158400043
J	Beckman, EJ				Beckman, Eric J.			SUSTAINABLE CHEMISTRY Putting carbon dioxide to work	NATURE			English	Editorial Material									[Beckman, Eric J.] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Beckman, EJ (corresponding author), Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA.	beckman@pitt.edu						Banerjee A, 2016, NATURE, V531, P215, DOI 10.1038/nature17185; BARE JC, 2003, J IND ECOLOGY, V0006; Buysch H.-J., 2003, ULLMANNS ENCY IND CH, P427; Coates GW, 2004, ANGEW CHEM INT EDIT, V43, P6618, DOI 10.1002/anie.200460442; Eerhart AJJE, 2012, ENERG ENVIRON SCI, V5, P6407, DOI 10.1039/c2ee02480b; Haider K. W., 2011, U.S. Patent, Patent No. [7,977,501, 7977501]; Mavrovic I, 2010, KIRK OTHMER ENCY CHE; Raecke B., 1957, US Patent, Patent No. [2,794,830, 2794830]; Sheldon RA, 2014, GREEN CHEM, V16, P950, DOI [10.1039/c3gc41935e, 10.1039/C3GC41935E]	9	26	26	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					180	181		10.1038/531180a	http://dx.doi.org/10.1038/531180a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26961653				2022-12-28	WOS:000371665100028
J	Lemmon, MA; Freed, DM; Schlessinger, J; Kiyatkin, A				Lemmon, Mark A.; Freed, Daniel M.; Schlessinger, Joseph; Kiyatkin, Anatoly			The Dark Side of Cell Signaling: Positive Roles for Negative Regulators	CELL			English	Review							PROTEIN-TYROSINE PHOSPHATASES; LUNG-CANCER; DEPENDENCE RECEPTORS; FEEDBACK INHIBITION; PLASMA-MEMBRANE; EGF RECEPTOR; SPECIFICITY; MECHANISMS; TRANSDUCTION; ACTIVATION	Cell signaling is dominated by analyzing positive responses to stimuli. Signal activation is balanced by negative regulators that are generally considered to terminate signaling. Rather than exerting only negative effects, however, many such regulators play important roles in enhancing cell-signaling control. Considering responses downstream of selected cell-surface receptors, we discuss how receptor internalization affects signaling specificity and how rapid kinase/phosphatase and GTP/GDP cycles increase responsiveness and allow kinetic proofreading in receptor signaling. We highlight the blurring of distinctions between positive and negative signals, recasting signal termination as the response to a switch-like transition into a new cellular state.	[Lemmon, Mark A.; Freed, Daniel M.; Schlessinger, Joseph; Kiyatkin, Anatoly] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Lemmon, Mark A.; Freed, Daniel M.; Schlessinger, Joseph; Kiyatkin, Anatoly] Yale Canc Biol Inst, West Haven, CT 06516 USA	Yale University	Lemmon, MA (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.; Lemmon, MA (corresponding author), Yale Canc Biol Inst, West Haven, CT 06516 USA.	mark.lemmon@yale.edu	; Kiyatkin, Anatoly/A-8707-2009	Freed, Daniel/0000-0002-3564-6376; Lemmon, Mark/0000-0002-3379-5319; Kiyatkin, Anatoly/0000-0002-5060-6081	NIH [R01-GM099891, R01-GM107435, R01-CA198164, F32-GM109688]; PSOC@Penn [U54-CA193417]; NATIONAL CANCER INSTITUTE [U54CA193417, R01CA198164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099891, R01GM107435, F32GM109688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PSOC@Penn; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants R01-GM099891, R01-GM107435, and R01-CA198164 to M.A.L., F32-GM109688 to D.M.F., and PSOC@Penn (U54-CA193417) to D. Discher. We thank Kathryn Ferguson, Boris Kholodenko, Daryl Klein, John Ladbury, Mitchell Lazar, Matthew Lazzara, Robert Phair, Ravi Radhakrishnan, John Scott, and Alex Toker for discussions and for valuable comments on the manuscript.	Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Avraham R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000876; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Boucher J, 2014, P NATL ACAD SCI USA, V111, P14512, DOI 10.1073/pnas.1415475111; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; Cho CY, 2016, RNA, V22, P303, DOI 10.1261/rna.052571.115; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Clark K, 2013, NAT REV MOL CELL BIO, V14, P673, DOI 10.1038/nrm3644; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P496, DOI 10.1016/j.tibs.2014.08.003; Ferrell JE, 2013, CURR OPIN CELL BIOL, V25, P676, DOI 10.1016/j.ceb.2013.07.007; Fior R, 2009, INT J DEV BIOL, V53, P1379, DOI 10.1387/ijdb.072309rf; Fortian A, 2015, TRAFFIC, V16, P1137, DOI 10.1111/tra.12314; Garg AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003699; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Goldstein B, 2004, NAT REV IMMUNOL, V4, P445, DOI 10.1038/nri1374; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Graves LM, 2013, BIOCHEM J, V450, P1, DOI 10.1042/BJ20121456; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kario E, 2005, J BIOL CHEM, V280, P7038, DOI 10.1074/jbc.M408575200; Karunarathne WKA, 2013, P NATL ACAD SCI USA, V110, pE1575, DOI 10.1073/pnas.1220755110; Kazi JU, 2014, CELL MOL LIFE SCI, V71, P3297, DOI 10.1007/s00018-014-1619-y; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kleiman LB, 2011, MOL CELL, V43, P723, DOI 10.1016/j.molcel.2011.07.014; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Lui PY, 2015, CELL MOL LIFE SCI, V72, P3531, DOI 10.1007/s00018-015-1940-0; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mehlen P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001521; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Miaczynska M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009035; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Monast CS, 2012, BIOPHYS J, V102, P2012, DOI 10.1016/j.bpj.2012.03.037; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; NIXON AE, 1995, BIOCHEMISTRY-US, V34, P15592, DOI 10.1021/bi00047a026; Oh D, 2012, P NATL ACAD SCI USA, V109, P14024, DOI 10.1073/pnas.1203397109; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Park E, 2015, NAT STRUCT MOL BIOL, V22, P703, DOI 10.1038/nsmb.3074; Qian H, 2007, ANNU REV PHYS CHEM, V58, P113, DOI 10.1146/annurev.physchem.58.032806.104550; Ratner N, 2015, NAT REV CANCER, V15, P290, DOI 10.1038/nrc3911; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Roth S, 2015, MOL PHARMACOL, V88, P604, DOI 10.1124/mol.115.100057; Ryu H, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156458; Sancho R, 2015, EMBO REP, V16, P571, DOI 10.15252/embr.201540188; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Shao MH, 2011, NUCLEIC ACIDS RES, V39, P4035, DOI 10.1093/nar/gkq1305; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; Sparta B, 2015, J BIOL CHEM, V290, P24784, DOI 10.1074/jbc.M115.662247; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Swain PS, 2002, BIOPHYS J, V82, P2928, DOI 10.1016/S0006-3495(02)75633-6; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Tischer C, 2003, NAT REV MOL CELL BIO, V4, P971, DOI 10.1038/nrm1258; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459; Zhou XK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4619; Zhu YY, 2013, J CLIN INVEST, V123, P2935, DOI 10.1172/JCI65988	93	64	65	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1172	1184		10.1016/j.cell.2016.02.047	http://dx.doi.org/10.1016/j.cell.2016.02.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967284	Bronze, Green Accepted			2022-12-28	WOS:000372784900015
J	Tian, HQ; Lu, CQ; Ciais, P; Michalak, AM; Canadell, JG; Saikawa, E; Huntzinger, DN; Gurney, KR; Sitch, S; Zhang, BW; Yang, J; Bousquet, P; Bruhwiler, L; Chen, GS; Dlugokencky, E; Friedlingstein, P; Melillo, J; Pan, SF; Poulter, B; Prinn, R; Saunois, M; Schwalm, CR; Wofsy, SC				Tian, Hanqin; Lu, Chaoqun; Ciais, Philippe; Michalak, Anna M.; Canadell, Josep G.; Saikawa, Eri; Huntzinger, Deborah N.; Gurney, Kevin R.; Sitch, Stephen; Zhang, Bowen; Yang, Jia; Bousquet, Philippe; Bruhwiler, Lori; Chen, Guangsheng; Dlugokencky, Edward; Friedlingstein, Pierre; Melillo, Jerry; Pan, Shufen; Poulter, Benjamin; Prinn, Ronald; Saunois, Marielle; Schwalm, Christopher R.; Wofsy, Steven C.			The terrestrial biosphere as a net source of greenhouse gases to the atmosphere	NATURE			English	Article							CARBON-NITROGEN INTERACTIONS; LAND-USE; CLIMATE EXTREMES; OXIDE EMISSIONS; GLOBAL METHANE; BUDGET; CO2; FEEDBACKS; FLUXES; DEFORESTATION	The terrestrial biosphere can release or absorb the greenhouse gases, carbon dioxide (CO2), methane (CH4) and nitrous oxide (N2O), and therefore has an important role in regulating atmospheric composition and climate1. Anthropogenic activities such as land-use change, agriculture and waste management have altered terrestrial biogenic greenhouse gas fluxes, and the resulting increases in methane and nitrous oxide emissions in particular can contribute to climate change(2,3). The terrestrial biogenic fluxes of individual greenhouse gases have been studied extensively(4-6), but the net biogenic greenhouse gas balance resulting from anthropogenic activities and its effect on the climate system remains uncertain. Here we use bottom-up (inventory, statistical extrapolation of local flux measurements, and process-based modelling) and top-down (atmospheric inversions) approaches to quantify the global net biogenic greenhouse gas balance between 1981 and 2010 resulting from anthropogenic activities and its effect on the climate system. We find that the cumulative warming capacity of concurrent biogenic methane and nitrous oxide emissions is a factor of about two larger than the cooling effect resulting from the global land carbon dioxide uptake from 2001 to 2010. This results in a net positive cumulative impact of the three greenhouse gases on the planetary energy budget, with a best estimate (in petagrams of CO2 equivalent per year) of 3.9 +/- 3.8 (top down) and 5.4 +/- 4.8 (bottom up) based on the GWP100 metric (global warming potential on a 100-year time horizon). Our findings suggest that a reduction in agricultural methane and nitrous oxide emissions, particularly in Southern Asia, may help mitigate climate change.	[Tian, Hanqin; Lu, Chaoqun; Zhang, Bowen; Yang, Jia; Pan, Shufen] Auburn Univ, Sch Forestry & Wildlife Sci, Int Ctr Climate & Global Change Res, Auburn, AL 36849 USA; [Lu, Chaoqun] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Ciais, Philippe; Bousquet, Philippe; Saunois, Marielle] Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Michalak, Anna M.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Canadell, Josep G.] CSIRO Oceans & Atmosphere Res, Global Carbon Project, GPO Box 3023, Canberra, ACT 2601, Australia; [Saikawa, Eri] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA; [Huntzinger, Deborah N.; Schwalm, Christopher R.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ 86011 USA; [Gurney, Kevin R.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Sitch, Stephen] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4RJ, Devon, England; [Bruhwiler, Lori; Dlugokencky, Edward] NOAA, Earth Syst Res Lab, Global Monitoring Div, Boulder, CO 80305 USA; [Chen, Guangsheng] Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA; [Friedlingstein, Pierre] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England; [Melillo, Jerry] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Poulter, Benjamin] Montana State Univ, Inst Ecosyst, Bozeman, MT 59717 USA; [Poulter, Benjamin] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Prinn, Ronald] MIT, Ctr Global Change Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Schwalm, Christopher R.] Woods Hole Res Ctr, Falmouth, MA 02540 USA; [Wofsy, Steven C.] Harvard Univ, Dept Earth & Planetary Sci, 29 Oxford St, Cambridge, MA 02138 USA	Auburn University System; Auburn University; Iowa State University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Carnegie Institution for Science; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Emory University; Northern Arizona University; Arizona State University; Arizona State University-Tempe; University of Exeter; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Exeter; Marine Biological Laboratory - Woods Hole; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Massachusetts Institute of Technology (MIT); Woods Hole Research Center; Harvard University	Tian, HQ (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Int Ctr Climate & Global Change Res, Auburn, AL 36849 USA.	tianhan@auburn.edu	Chen, Guangsheng/AAC-4462-2022; Tian, Hanqin/A-6484-2012; Friedlingstein, Pierre/H-2700-2014; Lu, Chaoqun/HCH-9102-2022; Bruhwiler, Lori/AAQ-8502-2020; Lu, Chaoqun/A-6497-2012; Canadell, Pep/E-9419-2010; Dlugokencky, Edward/AAN-8746-2020; Saikawa, Eri/AAF-5390-2020; Saikawa, Eri/HCI-9996-2022; Yang, Jia/A-6483-2012; Lu, Chaoqun/D-6694-2018; Poulter, Ben/ABB-5886-2021; Ciais, Philippe/A-6840-2011; Sitch, Stephen A/F-8034-2015	Tian, Hanqin/0000-0002-1806-4091; Friedlingstein, Pierre/0000-0003-3309-4739; Lu, Chaoqun/0000-0002-1526-0513; Bruhwiler, Lori/0000-0002-3554-9250; Canadell, Pep/0000-0002-8788-3218; Dlugokencky, Edward/0000-0003-0612-6985; Saikawa, Eri/0000-0003-3166-8620; Yang, Jia/0000-0003-2019-9603; Lu, Chaoqun/0000-0002-1526-0513; Poulter, Ben/0000-0002-9493-8600; Ciais, Philippe/0000-0001-8560-4943; Sitch, Stephen A/0000-0003-1821-8561; Schwalm, Christopher/0000-0002-5035-5681; Zhang, Bowen/0000-0002-8370-0509; pan, shufen/0000-0001-7920-1427; Bousquet, Philippe/0000-0002-4444-2703	NASA [NNX08AL73G, NNX14AO73G, NNX10AU06G, NNX11AD47G, NNG04GM39C, NNX12AP74G, NNX10AG01A, NNX11AO08A]; NSF [AGS 1243232, AGS-1243220, CNH1210360]; Australian Climate Change Science Program; NOAA Climate Program Office [NA13OAR4310059]; NSF CAREER [AGS-0846358]; NASA Upper Atmosphere Research Program AGAGE grant [NNX11AF17G]; Directorate For Geosciences [1450657] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Australian Climate Change Science Program; NOAA Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NASA Upper Atmosphere Research Program AGAGE grant; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported partially by NASA grants (NNX08AL73G, NNX14AO73G, NNX10AU06G, NNX11AD47G, NNG04GM39C) and NSF grants (AGS 1243232, AGS-1243220, CNH1210360). J. G. C. was supported by the Australian Climate Change Science Program. E. S. was supported by the NOAA Climate Program Office (award NA13OAR4310059). C. R. S. was supported by NASA grants (NNX12AP74G, NNX10AG01A, NNX11AO08A). K. R. G. was supported by NSF CAREER (AGS-0846358). R. G. P. was supported by a NASA Upper Atmosphere Research Program AGAGE grant (NNX11AF17G to MIT). This study contributes to the Non-CO<INF>2</INF> Greenhouse Gases Synthesis of NACP (North American Carbon Program), and the Global Carbon Project (a joint project of IGBP, IHDP, WCRP and Diversitas).	Allen M, 2020, POLLUTANTS OXFORD MA; Archer-Nicholls S, 2015, GEOSCI MODEL DEV, V8, P549, DOI 10.5194/gmd-8-549-2015; Baker DF, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002439; Banger K, 2015, ATMOS ENVIRON, V119, P192, DOI 10.1016/j.atmosenv.2015.06.008; Banger K, 2012, GLOBAL CHANGE BIOL, V18, P3259, DOI 10.1111/j.1365-2486.2012.02762.x; Basu A., 2014, ATMOS CHEM PHYS DISC, V14, P3193; Bellassen V, 2011, GLOBAL CHANGE BIOL, V17, P3274, DOI 10.1111/j.1365-2486.2011.02476.x; Bouwman AF, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0112; Bruhwiler L, 2014, ATMOS CHEM PHYS, V14, P8269, DOI 10.5194/acp-14-8269-2014; Butterbach-Bahl K., 2014, HDB GLOBAL ENV POLLU, V1, P325; Canadell JG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6282; Ciais P., 2013, CLIMATE CHANGE 2013, P465, DOI [10.1017/CBO9781107415324.015, DOI 10.1017/CBO9781107415324.015]; Davidson EA, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/105012; Dlugokencky EJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039780; Dlugokencky EJ, 2011, PHILOS T R SOC A, V369, P2058, DOI 10.1098/rsta.2010.0341; FAO, 2011, CURR WORLD FERT TREN; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Goldewijk KK, 2001, GLOBAL BIOGEOCHEM CY, V15, P417, DOI 10.1029/1999GB001232; Goward S., 2008, EOS T AM GEOPHYS UNI, V89, P105, DOI DOI 10.1029/2008EO110001; Gurney KR, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003082; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Houweling S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002961; Huntzinger DN, 2013, GEOSCI MODEL DEV, V6, P2121, DOI 10.5194/gmd-6-2121-2013; Hurtt GC, 2006, GLOBAL CHANGE BIOL, V12, P1208, DOI 10.1111/j.1365-2486.2006.01150.x; Jacobson AR, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2005GB002556; Joosten H., 1920, GLOBAL PEATLAND CO2; King AW, 2015, BIOGEOSCIENCES, V12, P399, DOI 10.5194/bg-12-399-2015; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/NGEO1955, 10.1038/ngeo1955]; Le Quere C, 2014, EARTH SYST SCI DATA, V6, P235, DOI 10.5194/essd-6-235-2014; Li CS, 2005, CLIMATIC CHANGE, V72, P321, DOI 10.1007/s10584-005-6791-5; Liengaard L, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00433; Liu ML, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003687; Lovelock J. E., 1974, TELLUS A, V26; Lu CQ, 2013, GLOBAL CHANGE BIOL, V19, P571, DOI 10.1111/gcb.12049; Ludwig W., 2011, ISLSCP 2 ATMOSPHERIC; Melillo JM, 2009, SCIENCE, V326, P1397, DOI 10.1126/science.1180251; Melton JR, 2013, BIOGEOSCIENCES, V10, P753, DOI 10.5194/bg-10-753-2013; Montzka SA, 2011, NATURE, V476, P43, DOI 10.1038/nature10322; Murdiyarso D, 2010, P NATL ACAD SCI USA, V107, P19655, DOI 10.1073/pnas.0911966107; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Nisbet EG, 2014, SCIENCE, V343, P493, DOI 10.1126/science.1247828; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peylin P, 2013, BIOGEOSCIENCES, V10, P6699, DOI 10.5194/bg-10-6699-2013; Potter CS, 1996, J GEOPHYS RES-ATMOS, V101, P1361, DOI 10.1029/95JD02028; Prigent C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051276; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Ren W, 2011, TELLUS B, V63, P222, DOI 10.1111/j.1600-0889.2010.00522.x; Rigby M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036037; Saikawa E, 2014, ATMOS CHEM PHYS, V14, P4617, DOI 10.5194/acp-14-4617-2014; Saikawa E, 2013, GLOBAL BIOGEOCHEM CY, V27, P972, DOI 10.1002/gbc.20087; SARMIENTO JL, 1992, NATURE, V356, P589, DOI 10.1038/356589a0; Schulze ED, 2009, NAT GEOSCI, V2, P842, DOI 10.1038/ngeo686; Schwalm CR, 2015, GEOPHYS RES LETT, V42, P4418, DOI 10.1002/2015GL064002; Sitch S, 2015, BIOGEOSCIENCES, V12, P653, DOI 10.5194/bg-12-653-2015; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Sokolov AP, 2008, J CLIMATE, V21, P3776, DOI 10.1175/2008JCLI2038.1; Stocker BD, 2013, NAT CLIM CHANGE, V3, P666, DOI [10.1038/NCLIMATE1864, 10.1038/nclimate1864]; Thornton PE, 2009, BIOGEOSCIENCES, V6, P2099, DOI 10.5194/bg-6-2099-2009; Tian Hanqin, 2015, Ecosystem Health and Sustainability, V1, P4, DOI 10.1890/EHS14-0015.1; Tian HQ, 2014, GLOBAL PLANET CHANGE, V121, P78, DOI 10.1016/j.gloplacha.2014.07.005; Tian HQ, 2015, CLIMATIC CHANGE, V129, P413, DOI 10.1007/s10584-014-1072-9; Tian HQ, 2012, FRONT ECOL ENVIRON, V10, P528, DOI 10.1890/120057; Tian HQ, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001393; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tubiello FN, 2015, GLOBAL CHANGE BIOL, V21, P2655, DOI 10.1111/gcb.12865; Valentini R, 2014, BIOGEOSCIENCES, V11, P381, DOI 10.5194/bg-11-381-2014; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Williams CA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003947; Xu XF, 2008, GLOBAL CHANGE BIOL, V14, P1651, DOI 10.1111/j.1365-2486.2008.01595.x; Yan XY, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003299; Yu KW, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002251; Zaehle S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041345; Zhuang QL, 2013, GLOBAL BIOGEOCHEM CY, V27, P650, DOI 10.1002/gbc.20057; Zscheischler J, 2014, GLOBAL BIOGEOCHEM CY, V28, P585, DOI 10.1002/2014GB004826	77	293	310	75	883	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					225	+		10.1038/nature16946	http://dx.doi.org/10.1038/nature16946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26961656	Green Submitted, Green Accepted			2022-12-28	WOS:000371665100039
J	Wansink, J; van der Kleij, FGH				Wansink, Joris; van der Kleij, Frank G. H.			Vertebral-Body Erosion in Thoracic Aortic Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wansink, Joris; van der Kleij, Frank G. H.] Scheper Hosp, Emmen, Netherlands		Wansink, J (corresponding author), Scheper Hosp, Emmen, Netherlands.	j.wansink@gmail.com							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2016	374	9					E10	E10		10.1056/NEJMicm1506911	http://dx.doi.org/10.1056/NEJMicm1506911			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF2FT	26962928				2022-12-28	WOS:000371158400012
J	Harrison, PJ; Cader, MZ; Geddes, JR				Harrison, Paul J.; Cader, M. Zameel; Geddes, John R.			Reprogramming psychiatry: stem cells and bipolar disorder	LANCET			English	Editorial Material							LITHIUM; REVEALS		[Harrison, Paul J.; Geddes, John R.] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Harrison, Paul J.; Geddes, John R.] Warneford Hosp, Oxford Hlth NHS Fdn Trust, Oxford OX3 7JX, England; [Cader, M. Zameel] Univ Oxford, Nuffield Dept Clin Neurosci, Weatherall Inst Mol Med, Oxford OX3 7JX, England	University of Oxford; University of Oxford	Geddes, JR (corresponding author), Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England.; Geddes, JR (corresponding author), Warneford Hosp, Oxford Hlth NHS Fdn Trust, Oxford OX3 7JX, England.	john.geddes@psych.ox.ac.uk	Geddes, John/B-8240-2011	Geddes, John/0000-0002-5281-5960; Harrison, Paul/0000-0002-6719-1126; Cader, Zameel/0000-0002-6952-406X				Alda M, 2015, MOL PSYCHIATR, V20, P661, DOI 10.1038/mp.2015.4; Andreazza AC, 2014, INT J NEUROPSYCHOPH, V17, P1039, DOI 10.1017/S1461145713000096; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Chen HM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.12; Handel AE, 2016, HUM MOL GENET, V25, P989, DOI 10.1093/hmg/ddv637; Harrison PJ, 2016, CURR OPIN NEUROBIOL, V36, P1, DOI 10.1016/j.conb.2015.07.002; Kaiser T, 2015, NAT MED, V21, P979, DOI 10.1038/nm.3935; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Madison JM, 2015, MOL PSYCHIATR, V20, P703, DOI 10.1038/mp.2015.7; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526; Wang JL, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.72; Yoshimizu T, 2015, MOL PSYCHIATR, V20, P162, DOI 10.1038/mp.2014.143; Young-Pearse TL, 2016, CURR OPIN NEUROBIOL, V36, P66, DOI 10.1016/j.conb.2015.10.006	14	8	10	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2016	387	10021					823	825		10.1016/S0140-6736(16)00235-X	http://dx.doi.org/10.1016/S0140-6736(16)00235-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE9RA	26972063				2022-12-28	WOS:000370974400006
J	Navarese, EP; Kolodziejczak, M; Kereiakes, DJ; Tantry, US; O'Connor, C; Gurbel, PA				Navarese, Eliano P.; Kolodziejczak, Michalina; Kereiakes, Dean J.; Tantry, Udaya S.; O'Connor, Christopher; Gurbel, Paul A.			Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome A Narrative Review	ANNALS OF INTERNAL MEDICINE			English	Review							LOW-DENSITY-LIPOPROTEIN; MUSCLE-CELL-PROLIFERATION; I-KAPPA-B; PLASMA PCSK9 LEVELS; E-/-MICE; PLATELET ACTIVATION; TRANSGENIC RABBITS; ARTERY-DISEASE; STATIN THERAPY; OXIDANT STRESS	Monoclonal antibodies that inhibit proprotein convertase subtilisin/kexin type 9 (PCSK9) are an emerging therapy for dyslipidemia. Acute coronary events induce a dynamic increase of PCSK9 levels that may play a role in plaque vulnerability of both culprit and nonculprit coronary vessels. Growing evidence highlights a potential key role of PCSK9 antibodies in managing acute coronary syndrome. This review describes the influence of PCSK9 antibodies on plaque composition and instability, as well as the pharmacokinetic profile and the potential anti-inflammatory and antithrombotic mechanisms associated with PCSK9 inhibition that may confer benefits during the early phase of acute coronary syndrome. The authors posit a rationale for the use of PCSK9 antibodies in patients with acute coronary syndrome and highlight the need for further investigation in this area.	Univ Dusseldorf, Dusseldorf, Germany; Systemat Invest & Res Intervent & Outcomes MED, Fairfax, VA USA; [Tantry, Udaya S.; O'Connor, Christopher; Gurbel, Paul A.] Inova Heart & Vasc Inst, 3600 Gallows Rd, Fairfax, VA 22042 USA; Univ Nicolaus Copernicus, Coll Med Bydgoszcz, Torun, Poland; [Kereiakes, Dean J.] Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, 2123 Auburn Ave, Cincinnati, OH 45219 USA; [Navarese, Eliano P.; Kolodziejczak, Michalina] Univ Dusseldorf, Dept Internal Med, Div Cardiol, Div Cardiol Pulmonol & Vasc Med, Univ Str 1, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Inova Fairfax Hospital; Nicolaus Copernicus University; Christ Hospital - Ohio; Heinrich Heine University Dusseldorf	Navarese, EP (corresponding author), Univ Dusseldorf, Dept Internal Med, Div Cardiol, Div Cardiol Pulmonol & Vasc Med, Univ Str 1, D-40225 Dusseldorf, Germany.	elianonavarese@gmail.com	Kołodziejczak, Michalina/AAL-3968-2020	Kołodziejczak, Michalina/0000-0001-5969-6055; Navarese, Eliano/0000-0002-2355-4589	Sanofi-Regeneron; Sanofi; Amgen; Pfizer; AstraZeneca; Boehringer Ingelheim; Merck; Janssen Pharmaceuticals; New Haven Pharmaceuticals; Bayer; Haemonetics; Duke Clinical Research Institute; Harvard Clinical Research Institute; National Institutes of Health; Coramed Technologies; Sinnowa	Sanofi-Regeneron; Sanofi(Sanofi-Aventis); Amgen(Amgen); Pfizer(Pfizer); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Merck(Merck & Company); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); New Haven Pharmaceuticals; Bayer(Bayer AG); Haemonetics; Duke Clinical Research Institute; Harvard Clinical Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coramed Technologies; Sinnowa	Dr. Navarese reports personal fees from Sanofi-Regeneron outside the submitted work. Dr. Kereiakes reports personal fees from Sanofi and grants from Amgen and Pfizer during the conduct of the study. Dr. Gurbel reports personal fees from AstraZeneca, Boehringer Ingelheim, Merck, Janssen Pharmaceuticals, New Haven Pharmaceuticals, Bayer, and Haemonetics; grants from Haemonetics, Merck, Duke Clinical Research Institute, Harvard Clinical Research Institute, National Institutes of Health, New Haven Pharmaceuticals, Coramed Technologies, and Sinnowa; a patent for platelet function testing; and stock options in Merck outside the submitted work. Authors not named here have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-2994.	Akkerman JWN, 2008, INT J BIOCHEM CELL B, V40, P2374, DOI 10.1016/j.biocel.2008.04.002; Almontashiri NAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106294; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cheng J., 2015, CORONARY ARTERY DIS, P221; Chi HH, 2004, CIRCULATION, V110, P1678, DOI 10.1161/01.CIR.0000142085.39015.31; Davenport P, 2003, AM J PATHOL, V163, P1117, DOI 10.1016/S0002-9440(10)63471-2; Dias CS, 2012, J AM COLL CARDIOL, V60, P1888, DOI 10.1016/j.jacc.2012.08.986; Ding ZF, 2015, CARDIOVASC RES, V107, P556, DOI 10.1093/cvr/cvv178; Ding ZF, 2014, CARDIOVASC RES, V103, P619, DOI 10.1093/cvr/cvu114; Ding ZF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01077; Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955; Fan JL, 2001, ANN NY ACAD SCI, V947, P362; Ferri N, 2012, ATHEROSCLEROSIS, V220, P381, DOI 10.1016/j.atherosclerosis.2011.11.026; Fischetti D, 2000, J THROMB THROMBOLYS, V10, P265, DOI 10.1023/A:1026551409350; Fox KAA, 2008, NAT CLIN PRACT CARD, V5, P580, DOI 10.1038/ncpcardio1302; Ghattas A, 2013, J AM COLL CARDIOL, V62, P1541, DOI 10.1016/j.jacc.2013.07.043; Guler E, 2013, KARDIOL POL, V71, P695, DOI 10.5603/KP.2013.0156; Hoshi S, 2000, J BIOL CHEM, V275, P883, DOI 10.1074/jbc.275.2.883; Hulten E, 2006, ARCH INTERN MED, V166, P1814, DOI 10.1001/archinte.166.17.1814; Ichikawa T, 2002, AM J PATHOL, V160, P227, DOI 10.1016/S0002-9440(10)64366-0; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kita T, 2001, ANN NY ACAD SCI, V947, P199; Korporaal SJA, 2007, ARTERIOSCL THROM VAS, V27, P2476, DOI 10.1161/ATVBAHA.107.150698; Kuhnast S, 2014, J LIPID RES, V55, P2103, DOI 10.1194/jlr.M051326; Lambert G, 2014, J AM COLL CARDIOL, V64, P2299, DOI 10.1016/j.jacc.2014.07.995; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li S, 2015, J ATHEROSCLER THROMB, V22, P76, DOI 10.5551/jat.25841; Li S, 2014, INT J CARDIOL, V174, P863, DOI 10.1016/j.ijcard.2014.04.224; Lunven C, 2014, CARDIOVASC THER, V32, P297, DOI 10.1111/1755-5922.12093; Magwenzi S, 2015, BLOOD, V125, P2693, DOI 10.1182/blood-2014-05-574491; Naseem KM, 1997, PLATELETS, V8, P163, DOI 10.1080/09537109709169333; Navarese EP, 2011, QJM-INT J MED, V104, P193, DOI 10.1093/qjmed/hcq258; Navarese EP, 2016, EUR HEART J-CARD PHA, V2, P44, DOI 10.1093/ehjcvp/pvv045; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Navarese EP, 2014, AM J CARDIOL, V113, P1753, DOI 10.1016/j.amjcard.2014.02.034; ORTHNER CL, 1995, BLOOD, V86, P436, DOI 10.1182/blood.V86.2.436.bloodjournal862436; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; PAWLOWSKA Z, 1993, ATHEROSCLEROSIS, V103, P13, DOI 10.1016/0021-9150(93)90035-S; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Raal FJ, 2014, J AM COLL CARDIOL, V63, P1278, DOI 10.1016/j.jacc.2014.01.006; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Romagnuolo R, 2015, J BIOL CHEM, V290, P11649, DOI 10.1074/jbc.M114.611988; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Schwartz GG, 2014, AM HEART J, V168, P682, DOI 10.1016/j.ahj.2014.07.028; Sciahbasi A, 2002, J THROMB THROMBOLYS, V14, P131, DOI 10.1023/A:1023232928642; Selzman CH, 1999, ANN THORAC SURG, V67, P1227, DOI 10.1016/S0003-4975(99)00252-0; Shen L, 2013, FEBS LETT, V587, P1271, DOI 10.1016/j.febslet.2013.02.027; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tang ZH, 2012, INT J MOL MED, V30, P931, DOI 10.3892/ijmm.2012.1072; Tsimikas S, 2001, CIRCULATION, V103, P1930; Virmani Renu, 1999, Thrombosis and Haemostasis, V82, P1; Whitman SC, 2000, AM J PATHOL, V157, P1819, DOI 10.1016/S0002-9440(10)64820-1; Whitman SC, 2002, J INTERF CYTOK RES, V22, P661, DOI 10.1089/10799900260100141; Wu CY, 2012, MOL CELL BIOCHEM, V359, P347, DOI 10.1007/s11010-011-1028-6; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104608; Zhang Y, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-192; Zuckerbraun BS, 2003, J VASC SURG, V38, P812, DOI 10.1016/S0741-5214(03)00427-0	60	51	56	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2016	164	9					600	+		10.7326/M15-2994	http://dx.doi.org/10.7326/M15-2994			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL6IX	26999484				2022-12-28	WOS:000375744000018
J	Gachter, S; Schulz, JF				Gaechter, Simon; Schulz, Jonathan F.			Intrinsic honesty and the prevalence of rule violations across societies	NATURE			English	Article							CULTURAL TRANSMISSION; UNETHICAL BEHAVIOR; CORRUPTION; INSTITUTIONS; DISHONESTY; EVOLUTION	Deception is common in nature and humans are no exception(1). Modern societies have created institutions to control cheating, but many situations remain where only intrinsic honesty keeps people from cheating and violating rules. Psychological(2), sociological(3) and economic theories(4) suggest causal pathways to explain how the prevalence of rule violations in people's social environment, such as corruption, tax evasion or political fraud, can compromise individual intrinsic honesty. Here we present cross-societal experiments from 23 countries around the world that demonstrate a robust link between the prevalence of rule violations and intrinsic honesty. We developed an index of the 'prevalence of rule violations' (PRV) based on country-level data from the year 2003 of corruption, tax evasion and fraudulent politics. We measured intrinsic honesty in an anonymous die-rolling experiment(5). We conducted the experiments with 2,568 young participants (students) who, due to their young age in 2003, could not have influenced PRV in 2003. We find individual intrinsic honesty is stronger in the subject pools of low PRV countries than those of high PRV countries. The details of lying patterns support psychological theories of honesty(6,7). The results are consistent with theories of the cultural co-evolution of institutions and values(8), and show that weak institutions and cultural legacies(9-11) that generate rule violations not only have direct adverse economic consequences, but might also impair individual intrinsic honesty that is crucial for the smooth functioning of society.	[Gaechter, Simon; Schulz, Jonathan F.] Univ Nottingham, Univ Pk, Nottingham NG7 2RD, England; [Gaechter, Simon] CESifo, Schackstr 4, D-80539 Munich, Germany; [Gaechter, Simon] IZA, Schaumburg Lippe Str 5-9, D-53113 Bonn, Germany; [Schulz, Jonathan F.] Yale Univ, 1 Prospect St, New Haven, CT 06510 USA	University of Nottingham; Ifo Institut; IZA Institute Labor Economics; Yale University	Gachter, S; Schulz, JF (corresponding author), Univ Nottingham, Univ Pk, Nottingham NG7 2RD, England.; Gachter, S (corresponding author), CESifo, Schackstr 4, D-80539 Munich, Germany.; Gachter, S (corresponding author), IZA, Schaumburg Lippe Str 5-9, D-53113 Bonn, Germany.; Schulz, JF (corresponding author), Yale Univ, 1 Prospect St, New Haven, CT 06510 USA.	simon.gaechter@nottingham.ac.uk; jonathan.schulz@yale.edu	Gachter, Simon/C-9787-2009; Schulz, Jonathan/AAB-2734-2020	Gachter, Simon/0000-0002-7182-8505; Schulz, Jonathan/0000-0001-5341-3819	ERC-AdG [295707 COOPERATION]; ESRC Network on Integrated Behavioural Science (NIBS) [ES/K002201/1]; Economic and Social Research Council [ES/K002201/1] Funding Source: researchfish; ESRC [ES/K002201/1] Funding Source: UKRI	ERC-AdG; ESRC Network on Integrated Behavioural Science (NIBS); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	We thank A. Arechar, A. Barr, B. Beranek, M. Eberhardt, E. von Essen, E. Fehr, U. Fischbacher, M. Garcia-Vega, A. Greif, B. Herrmann, F. Kolle, L. Molleman, D. Rand, K. Schmelz, S. Shalvi, P. Thiemann, C. Thoni, O. Weisel and seminar audiences for comments. Support under ERC-AdG 295707 COOPERATION and the ESRC Network on Integrated Behavioural Science (NIBS, ES/K002201/1) is gratefully acknowledged. We thank numerous helpers (Supplementary Information) for their support in implementing the experiments.	Abeler J, 2014, J PUBLIC ECON, V113, P96, DOI 10.1016/j.jpubeco.2014.01.005; Barr A, 2010, J PUBLIC ECON, V94, P862, DOI 10.1016/j.jpubeco.2010.07.006; Besley T, 2011, PILLARS PROSPERITY P; Bowles S, 2011, PHILOS PUBLIC AFF, V39, P46, DOI 10.1111/j.1088-4963.2011.01201.x; Cohn A, 2014, NATURE, V516, P86, DOI 10.1038/nature13977; Crittenden VL, 2009, MARKET LETT, V20, P1, DOI 10.1007/s11002-008-9051-4; Fischbacher U, 2013, J EUR ECON ASSOC, V11, P525, DOI 10.1111/jeea.12014; Gino F, 2009, PSYCHOL SCI, V20, P393, DOI 10.1111/j.1467-9280.2009.02306.x; Gintis H, 2008, MORAL MARKETS: THE CRITICAL ROLE OF VALUES IN THE ECONOMY, P300; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; GREIF A, 1994, J POLIT ECON, V102, P912, DOI 10.1086/261959; Hauk E, 2002, J ECON THEORY, V107, P311, DOI 10.1006/jeth.2001.2956; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Heywood P.M., 2014, ROUTLEDGE HDB POLITI; Houser D, 2012, EUR ECON REV, V56, P1645, DOI 10.1016/j.euroecorev.2012.08.001; Hruschka D, 2014, HUM NATURE-INT BIOS, V25, P567, DOI 10.1007/s12110-014-9217-0; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Kimbrough E. O., 2015, J EUR EC ASS; Lefebvre M, 2015, INT TAX PUBLIC FINAN, V22, P401, DOI 10.1007/s10797-014-9318-z; Mazar N, 2011, PSYCHOL SCI, V22, P843, DOI 10.1177/0956797611412389; Mazar N, 2008, J MARKETING RES, V45, P633, DOI 10.1509/jmkr.45.6.633; Pascual-Ezama D, 2015, J ECON BEHAV ORGAN, V116, P379, DOI 10.1016/j.jebo.2015.04.020; Peysakhovich A, 2015, MANAGE SCI; Rosenbaum SM, 2014, J ECON PSYCHOL, V45, P181, DOI 10.1016/j.joep.2014.10.002; Shalvi S, 2011, ORGAN BEHAV HUM DEC, V115, P181, DOI 10.1016/j.obhdp.2011.02.001; Tabellini G, 2008, Q J ECON, V123, P905, DOI 10.1162/qjec.2008.123.3.905; Tabellini G, 2008, J EUR ECON ASSOC, V6, P255, DOI 10.1162/JEEA.2008.6.2-3.255; Trivers R. L., 2014, DECEIT SELF DECEPTIO; Weisel O, 2015, P NATL ACAD SCI USA, V112, P10651, DOI 10.1073/pnas.1423035112	30	215	228	11	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					496	+		10.1038/nature17160	http://dx.doi.org/10.1038/nature17160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QK	26958830	Green Accepted, Green Submitted			2022-12-28	WOS:000372701300039
J	Hilal, T; Romond, EH				Hilal, Talal; Romond, Edward H.			ERBB2 (HER2) Testing in Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NCCTG N9831; SURVIVAL		[Hilal, Talal] Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA; [Romond, Edward H.] Univ Kentucky, Markey Canc Ctr, Div Med Oncol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Romond, EH (corresponding author), Univ Kentucky, Markey Canc Ctr, Div Med Oncol, Rm CC413,800 Rose St, Lexington, KY 40536 USA.	ehromo1@uky.edu	Hilal, Talal/AAG-7598-2019	Hilal, Talal/0000-0001-8249-4128				Centers for Medicare and Medicaid Services, CLIN LAB FEE SCHED; Dekker TJA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3208; Hicks DG, 2008, AM J CLIN PATHOL, V129, P263, DOI 10.1309/99AE032R9FM8WND1; Paik S, 2002, JNCI-J NATL CANCER I, V94, P852, DOI 10.1093/jnci/94.11.852; Perez EA, 2014, J CLIN ONCOL, V32, P3744, DOI 10.1200/JCO.2014.55.5730; Perez EA, 2013, BREAST CANCER RES TR, V138, P99, DOI 10.1007/s10549-013-2444-y; Roche PC, 2002, JNCI-J NATL CANCER I, V94, P855, DOI 10.1093/jnci/94.11.855; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	9	4	4	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2016	315	12					1280	1281		10.1001/jama.2015.17463	http://dx.doi.org/10.1001/jama.2015.17463			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH0YQ	27002451				2022-12-28	WOS:000372511100016
J	Lenzer, J				Lenzer, Jeanne			MATERNAL AND CHILD HEALTH How Cuba eliminated mother-to-child transmission of HIV and syphilis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jlenzer@bmj.com						Matthews T J, 2015, Natl Vital Stat Rep, V64, P1; OMS, 2014, PREV TRANSM MAT SIF; Roig Álvarez Tania, 2013, Rev. Bras. Saude Mater. Infant., V13, P111, DOI 10.1590/S1519-38292013000200004	3	2	3	5	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2016	352								i1619	10.1136/bmj.i1619	http://dx.doi.org/10.1136/bmj.i1619			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LI	27000051				2022-12-28	WOS:000373044300008
J	Li, BG; Gasser, T; Ciais, P; Piao, SL; Tao, S; Balkanski, Y; Hauglustaine, D; Boisier, JP; Chen, Z; Huang, MT; Li, LZ; Li, Y; Liu, HY; Liu, JF; Peng, SS; Shen, ZH; Sun, ZZ; Wang, R; Wang, T; Yin, GD; Yin, Y; Zeng, H; Zeng, ZZ; Zhou, F				Li, Bengang; Gasser, Thomas; Ciais, Philippe; Piao, Shilong; Tao, Shu; Balkanski, Yves; Hauglustaine, Didier; Boisier, Juan-Pablo; Chen, Zhuo; Huang, Mengtian; Li, Laurent Zhaoxin; Li, Yue; Liu, Hongyan; Liu, Junfeng; Peng, Shushi; Shen, Zehao; Sun, Zhenzhong; Wang, Rong; Wang, Tao; Yin, Guodong; Yin, Yi; Zeng, Hui; Zeng, Zhenzhong; Zhou, Feng			The contribution of China's emissions to global climate forcing	NATURE			English	Article							LAND-USE CHANGE; CO2 EMISSIONS; CARBON; UNCERTAINTY	Knowledge of the contribution that individual countries have made to global radiative forcing is important to the implementation of the agreement on "common but differentiated responsibilities" reached by the United Nations Framework Convention on Climate Change. Over the past three decades, China has experienced rapid economic development(1), accompanied by increased emission of greenhouse gases, ozone precursors and aerosols(2,3), but the magnitude of the associated radiative forcing has remained unclear. Here we use a global coupled biogeochemistry-climate model(4,5) and a chemistry and transport model(6) to quantify China's present-day contribution to global radiative forcing due to well-mixed greenhouse gases, short-lived atmospheric climate forcers and land-use-induced regional surface albedo changes. We find that China contributes 10% +/- 4% of the current global radiative forcing. China's relative contribution to the positive (warming) component of global radiative forcing, mainly induced by well-mixed greenhouse gases and black carbon aerosols, is 12% +/- 2%. Its relative contribution to the negative (cooling) component is 15% +/- 6%, dominated by the effect of sulfate and nitrate aerosols. China's strongest contributions are 0.16 +/- 0.02 watts per square metre for CO2 from fossil fuel burning, 0.13 +/- 0.05 watts per square metre for CH4, -0.11 +/- 0.05 watts per square metre for sulfate aerosols, and 0.09 +/- 0.06 watts per square metre for black carbon aerosols. China's eventual goal of improving air quality will result in changes in radiative forcing in the coming years: a reduction of sulfur dioxide emissions would drive a faster future warming, unless offset by larger reductions of radiative forcing from well-mixed greenhouse gases and black carbon.	[Li, Bengang; Piao, Shilong; Tao, Shu; Chen, Zhuo; Huang, Mengtian; Li, Yue; Liu, Hongyan; Liu, Junfeng; Peng, Shushi; Shen, Zehao; Sun, Zhenzhong; Yin, Guodong; Zeng, Hui; Zeng, Zhenzhong; Zhou, Feng] Peking Univ, Coll Urban & Environm Sci, Lab Earth Surface Proc, Sinofrench Inst Earth Syst Sci, Beijing 100871, Peoples R China; [Li, Bengang] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China; [Gasser, Thomas; Ciais, Philippe; Balkanski, Yves; Hauglustaine, Didier; Boisier, Juan-Pablo; Wang, Rong; Wang, Tao; Yin, Yi] UVSQ, CNRS, CEA, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Gasser, Thomas] CIRAD, AgroParisTech, EHESS, Ctr Int Rech Environm & Dev,CNRS,PontsParisTech, F-94736 Nogent Sur Marne, France; [Piao, Shilong] Chinese Acad Sci, Ctr Excellence Tibetan Earth Sci, Inst Tibetan Plateau Res, Key Lab Alpine Ecol & Biodivers, Beijing 100085, Peoples R China; [Li, Laurent Zhaoxin] Univ Paris 06, CNRS, Lab Meteorol Dynam, F-75252 Paris, France	Peking University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CIRAD; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Li, BG (corresponding author), Peking Univ, Coll Urban & Environm Sci, Lab Earth Surface Proc, Sinofrench Inst Earth Syst Sci, Beijing 100871, Peoples R China.; Li, BG (corresponding author), Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China.	lbg@urban.pku.edu.cn	Shen, Zehao/GQI-1121-2022; Yin, Yi/U-9952-2019; Hauglustaine, Didier/A-4154-2012; Ciais, Philippe/A-6840-2011; Li, Laurent/X-3278-2019; Wang, Tao/ABE-7107-2020; PENG, Shushi/AAS-2603-2020; Zhou, Feng/C-9377-2011; Gasser, Thomas/E-9815-2018; Li, Yue/M-8824-2019; Peng, Shushi/J-4779-2014; Zeng, Zhenzhong/A-2212-2019; Balkanski, Yves/A-6616-2011	Yin, Yi/0000-0003-4750-4997; Hauglustaine, Didier/0000-0002-4826-5118; Ciais, Philippe/0000-0001-8560-4943; Li, Laurent/0000-0002-3855-3976; PENG, Shushi/0000-0001-5098-726X; Zhou, Feng/0000-0001-6122-0611; Gasser, Thomas/0000-0003-4882-2647; Li, Yue/0000-0003-2997-6368; Peng, Shushi/0000-0001-5098-726X; Zeng, Zhenzhong/0000-0001-6851-2756; Balkanski, Yves/0000-0001-8241-2858; Boisier, Juan Pablo/0000-0003-3872-2538; Tao, Shu/0000-0002-7374-7063	National Natural Science Foundation of China [41371443, 41390240]; 111 project [B14001]; GIS Climat-Environnement-Societe; European Research Council Synergy grant [ERC-2013-SyG-610028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project); GIS Climat-Environnement-Societe; European Research Council Synergy grant(European Research Council (ERC))	We thank M. Schulz for help with Supplementary Fig. 7, and H. Yu for sharing data from ref. 24. This study is supported by the National Natural Science Foundation of China (grant numbers 41371443, 41390240) and the 111 project (grant number B14001). It is also part of the ACACCYA project funded by the GIS Climat-Environnement-Societe. T.G. is supported by the European Research Council Synergy grant ERC-2013-SyG-610028 IMBALANCE-P.	[Anonymous], 2013, GLOBAL REGIONAL NATL; Boisier JP, 2013, BIOGEOSCIENCES, V10, P1501, DOI 10.5194/bg-10-1501-2013; Boucher O, 2008, ENERG POLICY, V36, P193, DOI 10.1016/j.enpol.2007.08.039; Boucher O, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P571, DOI 10.1017/cbo9781107415324.016; Carslaw KS, 2013, NATURE, V503, P67, DOI 10.1038/nature12674; Cherubini F, 2014, NAT CLIM CHANGE, V4, P983, DOI [10.1038/nclimate2399, 10.1038/NCLIMATE2399]; Ciais P, 2013, NAT CLIM CHANGE, V3, P926, DOI [10.1038/nclimate1942, 10.1038/NCLIMATE1942]; Davis SJ, 2010, SCIENCE, V329, P1330, DOI 10.1126/science.1188566; European Commission, 2011, EM DAT GLOB ATM RES; Fry MM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017134; Gasser T, 2013, EARTH SYST DYNAM, V4, P171, DOI 10.5194/esd-4-171-2013; Gasser T, 2014, THESIS U P M CURIE; Granier C, 2011, CLIMATIC CHANGE, V109, P163, DOI [10.1007/S10584-011-0154-1, 10.1007/s10584-011-0154-1]; HaDuong M, 1997, NATURE, V390, P270, DOI 10.1038/36825; Hauglustaine DA, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003957; Hohne N, 2011, CLIMATIC CHANGE, V106, P359, DOI 10.1007/s10584-010-9930-6; Houghton RA, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001970; Huneeus N, 2013, ATMOS CHEM PHYS, V13, P6555, DOI 10.5194/acp-13-6555-2013; Jain AK, 2013, GLOBAL CHANGE BIOL, V19, P2893, DOI 10.1111/gcb.12207; Klimont Z, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014003; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; National Bureau of Statistics of China, 2014, GROSS DOM PROD IND 1; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Stohl A, 2015, ATMOS CHEM PHYS, V15, P10529, DOI 10.5194/acp-15-10529-2015; Trudinger C, 2005, CLIMATIC CHANGE, V68, P67, DOI 10.1007/s10584-005-6012-2; United Nations Framework Convention on Climate Change (UNFCCC), 2002, EXP M NOT SECR; Wang R, 2013, ATMOS CHEM PHYS, V13, P5189, DOI 10.5194/acp-13-5189-2013; Yu HB, 2013, J GEOPHYS RES-ATMOS, V118, P700, DOI 10.1029/2012JD018148; Zhou F, 2014, ENVIRON SCI TECHNOL, V48, P8538, DOI 10.1021/es5018027	30	161	178	61	745	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2016	531	7594					357	+		10.1038/nature17165	http://dx.doi.org/10.1038/nature17165			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DG4TA	26983540				2022-12-28	WOS:000372064300050
J	Harris, M; Bhatti, Y; Darzi, A				Harris, Matthew; Bhatti, Yasser; Darzi, Ara			Does the Country of Origin Matter in Health Care Innovation Diffusion?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SERVICES		[Harris, Matthew; Bhatti, Yasser; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth Innovat, London, England	Imperial College London	Harris, M (corresponding author), St Marys Hosp, Inst Global Hlth Innovat, Acad Surg Unit, 10th Floor,QEQM Bldg,Praed St, London W2 1NY, England.	m.harris@imperial.ac.uk		Bhatti, Yasser/0000-0001-5284-0261; Harris, Matthew/0000-0002-0005-9710	National Institute for Health Research [NF-SI-0510-10186, CL-2010-21-014] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dinnie K, 2004, J CUSTOMER BEHAV, V3, P165, DOI DOI 10.1362/1475392041829537; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Harris M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008993; Harris M, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0130-z; Keown OP, 2014, HEALTH AFFAIR, V33, P1516, DOI 10.1377/hlthaff.2014.0382; Nosek BA., 2007, SOCIAL PSYCHOL UNCON, P265; Rogers E., 2003, DIFFUSION INNOVATION, VFifth	8	11	11	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2016	315	11					1103	1104		10.1001/jama.2016.0483	http://dx.doi.org/10.1001/jama.2016.0483			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG5ZB	26978200	Green Published			2022-12-28	WOS:000372159800009
J	Chang, YW; Rettberg, LA; Treuner-Lange, A; Iwasa, J; Sogaard-Andersen, L; Jensen, GJ				Chang, Yi-Wei; Rettberg, Lee A.; Treuner-Lange, Anke; Iwasa, Janet; Sogaard-Andersen, Lotte; Jensen, Grant J.			Architecture of the type IVa pilus machine	SCIENCE			English	Article							II SECRETION SYSTEM; TRYPSIN-RESISTANT CORE; TWITCHING MOTILITY; MYXOCOCCUS-XANTHUS; NEISSERIA-MENINGITIDIS; THERMUS-THERMOPHILUS; RETRACTION MOTOR; VIBRIO-CHOLERAE; ATPASE GSPE; PROTEIN	Type IVa pili are filamentous cell surface structures observed in many bacteria. They pull cells forward by extending, adhering to surfaces, and then retracting. We used cryo-electron tomography of intact Myxococcus xanthus cells to visualize type IVa pili and the protein machine that assembles and retracts them (the type IVa pilus machine, or T4PM) in situ, in both the piliated and nonpiliated states, at a resolution of 3 to 4 nanometers. We found that T4PM comprises an outer membrane pore, four interconnected ring structures in the periplasm and cytoplasm, a cytoplasmic disc and dome, and a periplasmic stem. By systematically imaging mutants lacking defined T4PM proteins or with individual proteins fused to tags, we mapped the locations of all 10 T4PM core components and the minor pilins, thereby providing insights into pilus assembly, structure, and function.	[Chang, Yi-Wei; Jensen, Grant J.] CALTECH, Pasadena, CA 91125 USA; [Chang, Yi-Wei; Rettberg, Lee A.; Jensen, Grant J.] Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Treuner-Lange, Anke; Sogaard-Andersen, Lotte] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Iwasa, Janet] Univ Utah, Salt Lake City, UT 84112 USA	California Institute of Technology; Howard Hughes Medical Institute; Max Planck Society; Utah System of Higher Education; University of Utah	Jensen, GJ (corresponding author), CALTECH, Pasadena, CA 91125 USA.	jensen@caltech.edu	Treuner-Lange, Anke U/AFQ-5368-2022; Chang, Yi-Wei/ABH-1418-2020	Treuner-Lange, Anke U/0000-0001-6435-5642; Chang, Yi-Wei/0000-0003-2391-473X; Sogaard-Andersen, Lotte/0000-0002-0674-0013; Rettberg, Lee/0000-0002-5366-1609	NIH [R01 GM094800B]; Howard Hughes Medical Institute; Max Planck Society; Deutsche Forschungsgemeinschaft within the framework of the Collaborative Research Center [(SFB) 987]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094800] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft within the framework of the Collaborative Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Oikonomou and D. Ortega for discussions. Supported by NIH grant R01 GM094800B (G.J.J.), the Howard Hughes Medical Institute, the Max Planck Society, and the Deutsche Forschungsgemeinschaft within the framework of the Collaborative Research Center (SFB) 987 "Microbial Diversity in Environmental Signal Response." The 18 subtomogram averages of T4PMs reported in this study have been deposited in the Electron Microscopy Data Bank with accession numbers EMD-3247 (wild type, piliated); EMD-3248 (wild type, empty); EMD-3249 (Delta pilP, empty); EMD-3250 (PilP-sfGFP, piliated); EMD-3251 (PilP-sfGFP, empty); EMD-3252 (Delta tsaP, piliated); EMD-3253 (Delta tsaP, empty); EMD-3254 (PilO-sfGFP, piliated); EMD-3255 (PilO-sfGFP, empty); EMD-3256 (Delta pilC, empty); EMD-3257 (Delta pilA, empty); EMD-3258 (Delta pilV pilW fimU 1+2+3, empty); EMD-3259 (Delta pilT, piliated); EMD-3260 (Delta pilB, empty); EMD-3261 (Delta pilB Delta pilT, empty); EMD-3262 (Delta pilM, empty); EMD-3263 (Delta pilQ<INF>beta 1-beta 2</INF>, piliated); and EMD-3264 (Delta pilQ<INF>beta 1-beta 2</INF>, empty). The coordinates of the hypothetical T4PM working models have been deposited in the Protein Data Bank with accession numbers 3JC8 (piliated) and 3JC9 (empty), respectively. Author contributions: Y.-W.C. collected the cryo-electron tomography data, which were analyzed by Y.-W.C. and L.A.R.; Y.-W.C. built the T4PM models and generated the movie describing the modeling process; A.T.-L. and L.S.-A. provided the M. xanthus strains and characterized their motility and T4PM component accumulation and localization; J.I. produced the animation of T4PM dynamics; and Y.-W.C., L.S.-A., and G.J.J. wrote the paper.	Abendroth J, 2005, J MOL BIOL, V348, P845, DOI 10.1016/j.jmb.2005.02.061; Abendroth J, 2009, J STRUCT BIOL, V166, P303, DOI 10.1016/j.jsb.2009.03.009; Albers SV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00023; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Balasingham SV, 2007, J BACTERIOL, V189, P5716, DOI 10.1128/JB.00060-07; Berry JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002923; Biais N, 2010, P NATL ACAD SCI USA, V107, P11358, DOI 10.1073/pnas.0911328107; Briegel A, 2014, BIOCHEMISTRY-US, V53, P1575, DOI 10.1021/bi5000614; Bulyha I, 2009, MOL MICROBIOL, V74, P691, DOI 10.1111/j.1365-2958.2009.06891.x; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; Clausen M, 2009, J BACTERIOL, V191, P4633, DOI 10.1128/JB.00396-09; Clausen M, 2009, BIOPHYS J, V96, P1169, DOI 10.1016/j.bpj.2008.10.017; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Evans KJ, 2007, J BACTERIOL, V189, P4850, DOI 10.1128/JB.01942-06; Friedrich C, 2014, J BACTERIOL, V196, P378, DOI 10.1128/JB.01094-13; Georgiadou M, 2012, MOL MICROBIOL, V84, P857, DOI 10.1111/j.1365-2958.2012.08062.x; Gu S, 2012, J BIOL CHEM, V287, P9072, DOI 10.1074/jbc.M111.300624; Hager AJ, 2006, MOL MICROBIOL, V62, P227, DOI 10.1111/j.1365-2958.2006.05365.x; Jarrell KF, 2012, TRENDS MICROBIOL, V20, P307, DOI 10.1016/j.tim.2012.04.007; Karuppiah V, 2013, P NATL ACAD SCI USA, V110, pE4638, DOI 10.1073/pnas.1312313110; Karuppiah V, 2011, J BIOL CHEM, V286, P24434, DOI 10.1074/jbc.M111.243535; Karuppiah V, 2010, PROTEINS, V78, P2049, DOI 10.1002/prot.22720; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Kowal J, 2013, STRUCTURE, V21, P2152, DOI 10.1016/j.str.2013.09.012; Leighton TL, 2015, J BACTERIOL, V197, P2229, DOI 10.1128/JB.00220-15; Li CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070144; Lu C, 2013, STRUCTURE, V21, P1707, DOI 10.1016/j.str.2013.06.027; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Morand PC, 2004, EMBO J, V23, P2009, DOI 10.1038/sj.emboj.7600200; Nunn D, 1999, TRENDS CELL BIOL, V9, P402, DOI 10.1016/S0962-8924(99)01634-7; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Sampaleanu LM, 2009, J MOL BIOL, V394, P143, DOI 10.1016/j.jmb.2009.09.037; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Siewering K, 2014, P NATL ACAD SCI USA, V111, pE953, DOI 10.1073/pnas.1322889111; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; Tammam S, 2011, MOL MICROBIOL, V82, P1496, DOI 10.1111/j.1365-2958.2011.07903.x; Tammam S, 2013, J BACTERIOL, V195, P2126, DOI 10.1128/JB.00032-13; Tosi T, 2014, STRUCTURE, V22, P1348, DOI 10.1016/j.str.2014.07.005; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544; Nguyen Y, 2015, J BIOL CHEM, V290, P601, DOI 10.1074/jbc.M114.616904	58	225	230	5	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278							aad2001	10.1126/science.aad2001	http://dx.doi.org/10.1126/science.aad2001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965631	Green Accepted			2022-12-28	WOS:000386158400037
J	Sepulveda, LA; Xu, H; Zhang, J; Wang, MY; Golding, I				Sepulveda, Leonardo A.; Xu, Heng; Zhang, Jing; Wang, Mengyu; Golding, Ido			Measurement of gene regulation in individual cells reveals rapid switching between promoter states	SCIENCE			English	Article							LAMBDA CI REPRESSOR; BACTERIOPHAGE-LAMBDA; COPY-NUMBER; EXPRESSION; TRANSCRIPTION; CHROMOSOME; MOLECULES; DYNAMICS; PROTEIN; NOISE	In vivo mapping of transcription-factor binding to the transcriptional output of the regulated gene is hindered by probabilistic promoter occupancy, the presence of multiple gene copies, and cell-to-cell variability. We demonstrate how to overcome these obstacles in the lysogeny maintenance promoter of bacteriophage lambda, PRM. We simultaneously measured the concentration of the lambda repressor CI and the number of messenger RNAs (mRNAs) from PRM in individual Escherichia coli cells, and used a theoretical model to identify the stochastic activity corresponding to different CI binding configurations. We found that switching between promoter configurations is faster than mRNA lifetime and that individual gene copies within the same cell act independently. The simultaneous quantification of transcription factor and promoter activity, followed by stochastic theoretical analysis, provides a tool that can be applied to other genetic circuits.	[Sepulveda, Leonardo A.; Xu, Heng; Zhang, Jing; Wang, Mengyu; Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sepulveda, Leonardo A.; Xu, Heng; Zhang, Jing; Wang, Mengyu; Golding, Ido] Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA; [Wang, Mengyu; Golding, Ido] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Golding, Ido] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA	Baylor College of Medicine; Rice University; Baylor College of Medicine; University of Illinois System; University of Illinois Urbana-Champaign	Golding, I (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Golding, I (corresponding author), Rice Univ, Ctr Theoret Biol Phys, Houston, TX 77005 USA.; Golding, I (corresponding author), Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA.; Golding, I (corresponding author), Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA.	golding@bcm.edu	Sepúlveda, Leonardo A./AAL-3981-2020	Sepúlveda, Leonardo A./0000-0003-3602-1009; WANG, MENGYU/0000-0002-5457-2456; Xu, Heng/0000-0002-3717-0412	NIH [R01 GM082837]; NSF [PHY 1147498, PHY 1430124, PHY 1427654]; Welch Foundation [Q-1759]; John S. Dunn Foundation; Burroughs Wellcome Fund Career Award at the Scientific Interface; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1147498, 1430124] Funding Source: National Science Foundation; Division Of Physics [1427654] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); John S. Dunn Foundation; Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We are grateful to the following people for generous advice and for providing reagents: I. Dodd, M. Elowitz, L. Finzi, H. Garcia, T. Gregor, T. Kuhlman, L. McLane, R. Phillips, A. Raj, E. Rothenberg, A. Sanchez, K. Shearwin, R. Singer, S. Skinner, L-H. So, A. Sokac, L. Zeng, and C. Zong. Work in the Golding lab is supported by grants from NIH (R01 GM082837), NSF (PHY 1147498, PHY 1430124 and PHY 1427654), The Welch Foundation (Q-1759), and The John S. Dunn Foundation (Collaborative Research Award). H.X. is supported by the Burroughs Wellcome Fund Career Award at the Scientific Interface. We gratefully acknowledge the computing resources provided by the Computational and Integrative Biomedical Research Center of Baylor College of Medicine.	Anderson LM, 2008, P NATL ACAD SCI USA, V105, P5827, DOI 10.1073/pnas.0705570105; Coulon A, 2013, NAT REV GENET, V14, P572, DOI 10.1038/nrg3484; Cui L, 2013, P NATL ACAD SCI USA, V110, P2922, DOI 10.1073/pnas.1221322110; Davidson EH, 2006, REG GEN GEN REG; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; Dodd IB, 2004, GENE DEV, V18, P344, DOI 10.1101/gad.1167904; Dodd IB, 2001, GENE DEV, V15, P3013, DOI 10.1101/gad.937301; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Hensel Z, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001591; Hensel Z, 2012, NAT STRUCT MOL BIOL, V19, P797, DOI 10.1038/nsmb.2336; Jones DL, 2014, SCIENCE, V346, P1533, DOI 10.1126/science.1255301; Joshi MC, 2011, P NATL ACAD SCI USA, V108, P2765, DOI 10.1073/pnas.1019593108; KOBLAN KS, 1991, BIOCHEMISTRY-US, V30, P7817, DOI 10.1021/bi00245a022; Levesque MJ, 2013, NAT METHODS, V10, P865, DOI [10.1038/NMETH.2589, 10.1038/nmeth.2589]; LEVINE A, 1979, J MOL BIOL, V131, P655, DOI 10.1016/0022-2836(79)90014-7; Lewis D, 2011, P NATL ACAD SCI USA, V108, P14807, DOI 10.1073/pnas.1111221108; Manzo C, 2012, BIOPHYS J, V103, P1753, DOI 10.1016/j.bpj.2012.09.006; Nordstrom K, 2006, EMBO REP, V7, P484, DOI 10.1038/sj.embor.7400681; Ptashne M, 2004, A GENETIC SWITCH, V3rd ed; PTASHNE M, 2002, GENES SIGNALS; Pulverer B., 2005, NAT REV MOL CELL BIO, V6, pS12; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; REICHARDT L, 1971, P NATL ACAD SCI USA, V68, P2185, DOI 10.1073/pnas.68.9.2185; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sanchez A, 2013, SCIENCE, V342, P1188, DOI 10.1126/science.1242975; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Skinner SO, 2013, NAT PROTOC, V8, P1100, DOI 10.1038/nprot.2013.066; So LH, 2011, NAT GENET, V43, P554, DOI 10.1038/ng.821; Xu H, 2015, NAT METHODS, V12, P739, DOI [10.1038/NMETH.3446, 10.1038/nmeth.3446]; Zong CH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.96	32	71	73	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2016	351	6278					1218	1222		10.1126/science.aad0635	http://dx.doi.org/10.1126/science.aad0635			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ8YI	26965629	Green Accepted			2022-12-28	WOS:000386158400050
J	Chaiwanon, J; Wang, WF; Zhu, JY; Oh, E; Wang, ZY				Chaiwanon, Juthamas; Wang, Wenfei; Zhu, Jia-Ying; Oh, Eunkyoo; Wang, Zhi-Yong			Information Integration and Communication in Plant Growth Regulation	CELL			English	Review							BRASSINOSTEROID SIGNAL-TRANSDUCTION; PHYTOCHROME INTERACTING FACTORS; SHADE-AVOIDANCE; AUXIN TRANSPORT; CELL ELONGATION; HYPOCOTYL ELONGATION; MOLECULAR FRAMEWORK; HORMONE CROSSTALK; CRYPTOCHROME 1; DNA-BINDING	Plants are equipped with the capacity to respond to a large number of diverse signals, both internal ones and those emanating from the environment, that are critical to their survival and adaption as sessile organisms. These signals need to be integrated through highly structured intracellular networks to ensure coherent cellular responses, and in addition, spatiotemporal actions of hormones and peptides both orchestrate local cell differentiation and coordinate growth and physiology over long distances. Further, signal interactions and signaling outputs vary significantly with developmental context. This review discusses our current understanding of the integrated intracellular and intercellular signaling networks that control plant growth.	[Chaiwanon, Juthamas; Wang, Wenfei; Wang, Zhi-Yong] FAFU, HIST, Basic Forestry & Prote Ctr, Fuzhou 350002, Peoples R China; [Chaiwanon, Juthamas; Wang, Wenfei; Zhu, Jia-Ying; Oh, Eunkyoo; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Chaiwanon, Juthamas] Chulalongkorn Univ, Dept Bot, Ctr Excellence Environm & Plant Physiol, Fac Sci, Bangkok 10330, Thailand	Fujian Agriculture & Forestry University; Carnegie Institution for Science; Chulalongkorn University	Wang, ZY (corresponding author), FAFU, HIST, Basic Forestry & Prote Ctr, Fuzhou 350002, Peoples R China.; Wang, ZY (corresponding author), Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA.	zywang24@stanford.edu	Wang, Zhi-Yong/E-3810-2012	Wang, Zhi-Yong/0000-0003-4602-3390; Chaiwanon, Juthamas/0000-0002-4802-0428	National Institutes of Health [5 R01GM066258]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-08ER15973]; Fujian Agriculture and Forestry University; Ratchadaphiseksomphot Endowment Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Fujian Agriculture and Forestry University; Ratchadaphiseksomphot Endowment Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (5 R01GM066258) and the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DE-FG02-08ER15973) to Z-Y.W, Fujian Agriculture and Forestry University (J.C. and W.W), and Ratchadaphiseksomphot Endowment Fund (J.C.). The authors thank Dr. Joanne Chory for comments on the manuscript. We apologize to the scientists whose important works are not cited here due to space limitation.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Babst BA, 2005, NEW PHYTOL, V167, P63, DOI 10.1111/j.1469-8137.2005.01388.x; Bai MY, 2012, PLANT CELL, V24, P4917, DOI 10.1105/tpc.112.105163; Bai MY, 2012, NAT CELL BIOL, V14, P810, DOI 10.1038/ncb2546; Band LR, 2014, PLANT CELL, V26, P862, DOI 10.1105/tpc.113.119495; Bargmann BOR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.40; Belkhadirl Y, 2014, TRENDS BIOCHEM SCI, V39, P447, DOI 10.1016/j.tibs.2014.06.006; Belkhadir Y, 2012, P NATL ACAD SCI USA, V109, P297, DOI 10.1073/pnas.1112840108; Bernardo-Garcia S, 2014, GENE DEV, V28, P1681, DOI 10.1101/gad.243675.114; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Carella P, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00775; Casal JJ, 2013, ANNU REV PLANT BIOL, V64, P403, DOI 10.1146/annurev-arplant-050312-120221; Chaiwanon J, 2015, CURR BIOL, V25, P1031, DOI 10.1016/j.cub.2015.02.046; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; Chory J, 2010, PLANT J, V61, P982, DOI 10.1111/j.1365-313X.2009.04105.x; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; de Lucas M, 2014, NEW PHYTOL, V202, P1126, DOI 10.1111/nph.12725; de Wit M, 2015, NEW PHYTOL, V208, P198, DOI 10.1111/nph.13449; de Wit M, 2014, PHYSIOL PLANTARUM, V151, P13, DOI 10.1111/ppl.12099; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Djakovic-Petrovic T, 2007, PLANT J, V51, P117, DOI 10.1111/j.1365-313X.2007.03122.x; Fan M, 2014, PLANT CELL, V26, P828, DOI 10.1105/tpc.113.121111; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Galvao VC, 2015, CURR OPIN NEUROBIOL, V34, P46, DOI 10.1016/j.conb.2015.01.013; Geng Y, 2013, PLANT CELL, V25, P2132, DOI 10.1105/tpc.113.112896; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Gupta A, 2015, PLANT PHYSIOL, V168, P307, DOI 10.1104/pp.114.256313; Hacham Y, 2011, DEVELOPMENT, V138, P839, DOI 10.1242/dev.061804; Hayes S, 2014, P NATL ACAD SCI USA, V111, P11894, DOI 10.1073/pnas.1403052111; Hornitschek P, 2012, PLANT J, V71, P699, DOI 10.1111/j.1365-313X.2012.05033.x; Hornitschek P, 2009, EMBO J, V28, P3893, DOI 10.1038/emboj.2009.306; Hou XL, 2010, DEV CELL, V19, P884, DOI 10.1016/j.devcel.2010.10.024; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Ikeda M, 2012, PLANT CELL, V24, P4483, DOI 10.1105/tpc.112.105023; Keller MM, 2011, PLANT J, V67, P195, DOI 10.1111/j.1365-313X.2011.04598.x; Keuskamp DH, 2011, PLANT J, V67, P208, DOI 10.1111/j.1365-313X.2011.04597.x; Keuskamp DH, 2010, P NATL ACAD SCI USA, V107, P22740, DOI 10.1073/pnas.1013457108; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kozuka T, 2010, PLANT PHYSIOL, V153, P1608, DOI 10.1104/pp.110.156802; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Larrieu A, 2015, ESSAYS BIOCHEM, V58, P165, DOI [10.1042/bse0580165, 10.1042/BSE0580165]; Larrieu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7043; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Leivar P, 2012, PLANT CELL, V24, P1398, DOI 10.1105/tpc.112.095711; Leone M, 2014, NEW PHYTOL, V204, P355, DOI 10.1111/nph.12971; Li L, 2012, GENE DEV, V26, P785, DOI 10.1101/gad.187849.112; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Locascio A, 2013, PLANT CELL PHYSIOL, V54, P1229, DOI 10.1093/pcp/pct082; Lozano-Duran R, 2015, TRENDS PLANT SCI, V20, P12, DOI 10.1016/j.tplants.2014.09.003; Ma DB, 2016, P NATL ACAD SCI USA, V113, P224, DOI 10.1073/pnas.1511437113; Mahonen AP, 2014, NATURE, V515, P125, DOI 10.1038/nature13663; Malinovsky FG, 2014, PLANT PHYSIOL, V164, P1443, DOI 10.1104/pp.113.234625; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Ni WM, 2014, SCIENCE, V344, P1160, DOI 10.1126/science.1250778; Nito K, 2015, PLANT CELL PHYSIOL, V56, P1306, DOI 10.1093/pcp/pcv057; Oh E, 2014, ELIFE, V3, DOI 10.7554/eLife.03031; Oh E, 2012, NAT CELL BIOL, V14, P802, DOI 10.1038/ncb2545; Okamoto S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3191; Otero S, 2016, CURR OPIN PLANT BIOL, V29, P21, DOI 10.1016/j.pbi.2015.10.007; Pedmale UV, 2016, CELL, V164, P233, DOI 10.1016/j.cell.2015.12.018; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Quint M, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.190, 10.1038/nplants.2015.190]; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rosa NM-dl, 2015, PLOS GENET, V11; Ruzicka K, 2009, P NATL ACAD SCI USA, V106, P4284, DOI 10.1073/pnas.0900060106; Salehin M, 2015, PLANT CELL, V27, P9, DOI 10.1105/tpc.114.133744; Sassi M, 2012, DEVELOPMENT, V139, P3402, DOI 10.1242/dev.078212; Singh AP, 2014, PLANT PHYSIOL, V166, P678, DOI 10.1104/pp.114.245019; Song SS, 2014, CURR OPIN PLANT BIOL, V21, P112, DOI 10.1016/j.pbi.2014.07.005; Soyano T, 2014, P NATL ACAD SCI USA, V111, P14607, DOI 10.1073/pnas.1412716111; Sparks E, 2013, NAT REV GENET, V14, P631, DOI 10.1038/nrg3541; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Street IH, 2015, PLANT PHYSIOL, V169, P338, DOI 10.1104/pp.15.00415; Sun TP, 2010, PLANT PHYSIOL, V154, P567, DOI 10.1104/pp.110.161554; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Tabata R, 2014, SCIENCE, V346, P343, DOI 10.1126/science.1257800; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Tavormina P, 2015, PLANT CELL, V27, P2095, DOI 10.1105/tpc.15.00440; Thole JM, 2014, G3-GENES GENOM GENET, V4, P1259, DOI 10.1534/g3.114.011080; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Vilarrasa-Blasi J, 2014, DEV CELL, V30, P36, DOI 10.1016/j.devcel.2014.05.020; Vragovic K, 2015, P NATL ACAD SCI USA, V112, P923, DOI 10.1073/pnas.1417947112; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang WF, 2014, CURR OPIN PLANT BIOL, V21, P147, DOI 10.1016/j.pbi.2014.07.012; Wang WF, 2014, CELL HOST MICROBE, V15, P401, DOI 10.1016/j.chom.2014.03.014; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Yang ZB, 2014, PLANT CELL, V26, P2889, DOI 10.1105/tpc.114.127993; Yoshida H, 2014, P NATL ACAD SCI USA, V111, P7861, DOI 10.1073/pnas.1321669111; Zhang LY, 2009, PLANT CELL, V21, P3767, DOI 10.1105/tpc.109.070441; Zhang WJ, 2013, CURR BIOL, V23, P1979, DOI 10.1016/j.cub.2013.08.008; Zhang YQ, 2015, PLANTA, V242, P881, DOI 10.1007/s00425-015-2328-y; Zhang ZL, 2014, J INTEGR PLANT BIOL, V56, P192, DOI 10.1111/jipb.12163; Zhong SW, 2012, CURR BIOL, V22, P1530, DOI 10.1016/j.cub.2012.06.039	97	146	152	11	169	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1257	1268		10.1016/j.cell.2016.01.044	http://dx.doi.org/10.1016/j.cell.2016.01.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967291	Green Accepted, Bronze			2022-12-28	WOS:000372784900022
J	Moore, M; Hopkins, J; Wainwright, P				Moore, Michael; Hopkins, James; Wainwright, Patrick			PRACTICE POINTER Primary care management of patients after weight loss surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POST-BARIATRIC SURGERY; OBESITY; SOCIETY; TRIAL		[Moore, Michael] Univ Southampton, Fac Med, Primary Care & Populat Sci, Southampton SO9 5NH, Hants, England; [Hopkins, James] Musgrove Pk Hosp, Taunton, Somerset, England; [Hopkins, James] Univ Bristol, Bristol, Avon, England; [Wainwright, Patrick] Southampton Univ Hosp, Clin Biochem, Southampton SO16 6YD, Hants, England	University of Southampton; Musgrove Park Hospital; University of Bristol; University of Southampton	Moore, M (corresponding author), Univ Southampton, Fac Med, Primary Care & Populat Sci, Southampton SO9 5NH, Hants, England.	mvm198@soton.ac.uk	Moore, Michael/C-3447-2011	Moore, Michael/0000-0002-5127-4509				Aminian A, 2015, DIABETES OBES METAB, V17, P198, DOI 10.1111/dom.12405; [Anonymous], 2014, BOMSS GUIDELINES PER; Arterburn DE, 2013, OBES SURG, V23, P93, DOI 10.1007/s11695-012-0802-1; Blazeby JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1763; Bonfrate L, 2014, BEST PRACT RES CL GA, V28, P623, DOI 10.1016/j.bpg.2014.07.013; British Obesity and Metabolic Surgery Society, 2014, GP GUID MAN NUTR FOL; British Obesity and Metabolic Surgery Society, 2014, PRIM CAR MAN POST PA; Carswell KA, 2015, OBES SURG, DOI [10.1007/s11695-015-1829-x, DOI 10.1007/S11695-015-1829-X.26210195]; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Colquitt JL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub4; Gloy VL, 2013, BMJ-BRIT MED J, V347, pf5934, DOI DOI 10.1136/BMJ.F5934.24149519; Heber D, 2010, J CLIN ENDOCR METAB, V95, P4823, DOI 10.1210/jc.2009-2128; Karmali S, 2013, OBES SURG, V23, P1922, DOI 10.1007/s11695-013-1070-4; Kim J, 2015, SURG OBES RELAT DIS, V11, P406, DOI 10.1016/j.soard.2014.03.010; Kjaer MM, 2013, ACTA OBSTET GYN SCAN, V92, P264, DOI 10.1111/aogs.12035; Lalmohamed A, 2012, BMJ-BRIT MED J, V345, pe5085, DOI [10.1136/bmj.e5085, DOI 10.1136/BMJ.E5085.22867649]; Mechanick JI, 2013, SURG OBES RELAT DIS, V9, P159, DOI 10.1016/j.soard.2012.12.010; National Clinical Guideline Center, 2014, LIP MOD CARD RISK AS; National Institute for Health and Care Excellence, 2014, OB ID ASS MAN OV OB; O'Brien PE, 2013, ANN SURG, V257, P87, DOI 10.1097/SLA.0b013e31827b6c02; Puzziferri N, 2014, JAMA-J AM MED ASSOC, V312, P934, DOI 10.1001/jama.2014.10706; Ribaric G, 2014, OBES SURG, V24, P437, DOI 10.1007/s11695-013-1160-3; Rogers CA, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-53; Shen XJ, 2015, SURG OBES RELAT DIS, V11, P956, DOI 10.1016/j.soard.2014.11.011; Sjostrom L, 2013, J INTERN MED, V273, P219, DOI 10.1111/joim.12012; Welbourn R, 2014, 2 UK NAT BAR SURG RE	26	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2016	352								i945	10.1136/bmj.i945	http://dx.doi.org/10.1136/bmj.i945			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NP	26964556				2022-12-28	WOS:000372049200001
J	Takeuchi, H; Higashiyama, T				Takeuchi, Hidenori; Higashiyama, Tetsuya			Tip-localized receptors control pollen tube growth and LURE sensing in Arabidopsis	NATURE			English	Article							KINASES LEPRK1; IN-VITRO; CELL; PROTEIN; FAMILY; ATTRACTION; DYNAMICS; FERTILIZATION; INTERACTS; MECHANISM	Directional control of tip-growing cells is essential for proper tissue organization and cell-to-cell communication in animals and plants(1,2). In the sexual reproduction of flowering plants, the tip growth of the male gametophyte, the pollen tube, is precisely guided by female cues to achieve fertilization(3). Several female-secreted peptides have recently been identified as species-specific attractants that directly control the direction of pollen tube growth(4-6). However, the method by which pollen tubes precisely and promptly respond to the guidance signal from their own species is unknown. Here we show that tip-localized pollen-specific receptor-like kinase 6 (PRK6) with an extracellular leucine-rich repeat domain is an essential receptor for sensing of the LURE1 attractant peptide in Arabidopsis thaliana under semi-in-vivo conditions, and is important for ovule targeting in the pistil. PRK6 interacted with pollen-expressed ROPGEFs (Rho of plant guanine nucleotide-exchange factors), which are important for pollen tube growth through activation of the signalling switch Rho GTPase ROP1 (refs 7, 8). PRK6 conferred responsiveness to AtLURE1 in pollen tubes of the related species Capsella rubella. Furthermore, our genetic and physiological data suggest that PRK6 signalling through ROPGEFs and sensing of AtLURE1 are achieved in cooperation with the other PRK family receptors, PRK1, PRK3 and PRK8. Notably, the tip-focused PRK6 accumulated asymmetrically towards an external AtLURE1 source before reorientation of pollen tube tip growth. These results demonstrate that PRK6 acts as a key membrane receptor for external AtLURE1 attractants, and recruits the core tip-growth machinery, including ROP signalling proteins. This work provides insights into the orchestration of efficient pollen tube growth and species-specific pollen tube attraction by multiple receptors during male-female communication.	[Takeuchi, Hidenori; Higashiyama, Tetsuya] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan; [Takeuchi, Hidenori; Higashiyama, Tetsuya] Nagoya Univ, JST ERATO Higashiyama Live Holon Project, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan; [Higashiyama, Tetsuya] Nagoya Univ, Inst Transformat Biomol ITbM, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan	Nagoya University; Nagoya University; Nagoya University	Takeuchi, H; Higashiyama, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.; Takeuchi, H; Higashiyama, T (corresponding author), Nagoya Univ, JST ERATO Higashiyama Live Holon Project, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.; Higashiyama, T (corresponding author), Nagoya Univ, Inst Transformat Biomol ITbM, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	hidenori.takeuchi@gmi.oeaw.ac.at; higashi@bio.nagoya-u.ac.jp	Takeuchi, Hidenori/AFG-8500-2022; Takeuchi, Hidenori/AAF-1988-2022; Higashiyama, Tetsuya/C-2882-2012	Takeuchi, Hidenori/0000-0002-0719-3736; Takeuchi, Hidenori/0000-0002-0719-3736; Higashiyama, Tetsuya/0000-0002-7346-360X	Japan Science and Technology Agency (ERATO project); Japan Society for the Promotion of Science [5834]	Japan Science and Technology Agency (ERATO project); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank M. Hasebe and S. Miyazaki for seeds of a part of mutant lines; Y. Matsubayashi, H. Shinohara, D. Maruyama, M. Ohtsu and K. Motomura for valuable comments and discussions; D. Kurihara, Y. Hamamura and S. Nagahara for technical assistance with confocal microscopy and physiological analyses; M. M. Kanaoka for agro-infiltration method using tobacco leaf; S. Oishi for reverse-phase high-pressure liquid chromatography (HPLC); and the Japan Advanced Plant Science Network for use of some microscopes. This work was supported by grants from the Japan Science and Technology Agency (ERATO project to T.H.) and the Japan Society for the Promotion of Science Fellowships (no. 5834 to H.T.).	Berken A, 2005, NATURE, V436, P1176, DOI 10.1038/nature03883; Chang F, 2013, MOL PLANT, V6, P1187, DOI 10.1093/mp/sss103; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Gu Y, 2005, J CELL BIOL, V169, P127, DOI 10.1083/jcb.200409140; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hamamura Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5722; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; Higashiyama T, 2015, ANNU REV PLANT BIOL, V66, P393, DOI 10.1146/annurev-arplant-043014-115635; Itofusa R, 2011, MOL CELL NEUROSCI, V48, P332, DOI 10.1016/j.mcn.2011.03.007; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Kaothien P, 2005, PLANT J, V42, P492, DOI 10.1111/j.1365-313X.2005.02388.x; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lee JS, 2015, NATURE, V522, P435, DOI 10.1038/nature14561; Lee JS, 2012, GENE DEV, V26, P126, DOI 10.1101/gad.179895.111; Li H, 1999, PLANT CELL, V11, P1731, DOI 10.1105/tpc.11.9.1731; Liu JJ, 2013, CURR BIOL, V23, P993, DOI 10.1016/j.cub.2013.04.043; Lu YX, 2011, PLANT CELL, V23, P81, DOI 10.1105/tpc.110.080499; Marton ML, 2012, CURR BIOL, V22, P1194, DOI 10.1016/j.cub.2012.04.061; Maruyama D, 2013, DEV CELL, V25, P317, DOI 10.1016/j.devcel.2013.03.013; Miyazaki S, 2009, CURR BIOL, V19, P1327, DOI 10.1016/j.cub.2009.06.064; Nagahara S, 2015, PLANT REPROD, V28, P33, DOI 10.1007/s00497-015-0256-4; Oda Y, 2012, SCIENCE, V337, P1333, DOI 10.1126/science.1222597; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Palanivelu R, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-7; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Slotte T, 2013, NAT GENET, V45, P831, DOI 10.1038/ng.2669; Susaki D, 2015, PLANT CELL PHYSIOL, V56, P1031, DOI 10.1093/pcp/pcv031; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Takeuchi H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001449; Tang WH, 2004, PLANT J, V39, P343, DOI 10.1111/j.1365-313X.2004.02139.x; Tang WH, 2002, PLANT CELL, V14, P2277, DOI 10.1105/tpc.003103; Wengier D, 2003, P NATL ACAD SCI USA, V100, P6860, DOI 10.1073/pnas.0631728100; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wrzaczek M, 2015, EMBO J, V34, P55, DOI 10.15252/embj.201488582; Yang ZB, 2008, ANNU REV CELL DEV BI, V24, P551, DOI 10.1146/annurev.cellbio.23.090506.123233; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18830, DOI 10.1073/pnas.0705874104	40	176	188	12	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2016	531	7593					245	+		10.1038/nature17413	http://dx.doi.org/10.1038/nature17413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF9EZ	26961657				2022-12-28	WOS:000371665100044
J	Poses, RM; Smith, WR				Poses, Roy M.; Smith, Wally R.			How Employed Physicians' Contracts May Threaten Their Patients and Professionalism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Alpert Med Sch, Providence, RI USA; Brown Univ, Providence, RI 02912 USA; [Poses, Roy M.] Fdn Integr & Responsibil Med, 16 Cutler St,Suite 104, Warren, RI 02885 USA; [Smith, Wally R.] Virginia Commonwealth Univ, Med Ctr, Box 980306,730 East Broad St,Suite 430, Richmond, VA 23298 USA	Brown University; Brown University; Virginia Commonwealth University	Poses, RM (corresponding author), Fdn Integr & Responsibil Med, 16 Cutler St,Suite 104, Warren, RI 02885 USA.	roy_poses@brown.edu						Chesanow N., 2015, MEDSCAPE        1020; Komesaroff PA, 2015, MED J AUSTRALIA, V202, P519, DOI 10.5694/mja15.00170; Mandrola J., 2015, MEDSCAPE        1029; Meyer C, 2013, GETTING OUR WAY; Neely TRC, 2011, MED EC; Page L, 2015, MEDSCAPE        1022; Poses RM., 2015, HLTH CARE RENEWAL; Poses RM., 2015, HLTH CARE RENEW 1027; Relman AS, 2007, JAMA-J AM MED ASSOC, V298, P2668, DOI 10.1001/jama.298.22.2668; Tahir D., 2015, POLITICO	10	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 5	2016	165	1					55	+		10.7326/M15-2979	http://dx.doi.org/10.7326/M15-2979			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ5AD	26954915				2022-12-28	WOS:000379215800009
J	Fanelli, D				Fanelli, Daniele			Set up a 'self-retraction' system for honest errors	NATURE			English	Editorial Material									[Fanelli, Daniele] Stanford Univ, Meta Res Innovat Ctr, Stanford, CA 94305 USA	Stanford University	Fanelli, D (corresponding author), Stanford Univ, Meta Res Innovat Ctr, Stanford, CA 94305 USA.	email@danielefanelli.com		Fanelli, Daniele/0000-0003-1780-1958					0	14	14	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2016	531	7595					415	415		10.1038/531415a	http://dx.doi.org/10.1038/531415a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QK	27008933	Bronze			2022-12-28	WOS:000372701300004
J	Hengen, KB; Pacheco, AT; McGregor, JN; Van Hooser, SD; Turrigiano, GG				Hengen, Keith B.; Pacheco, Alejandro Torrado; McGregor, James N.; Van Hooser, Stephen D.; Turrigiano, Gina G.			Neuronal Firing Rate Homeostasis Is Inhibited by Sleep and Promoted by Wake	CELL			English	Article							OCULAR DOMINANCE PLASTICITY; MOUSE VISUAL-CORTEX; SYNAPTIC PLASTICITY; NEOCORTICAL NEURONS; CORTICAL-NEURONS; GENE-EXPRESSION; NERVOUS-SYSTEM; MECHANISMS; EXPERIENCE; NETWORKS	Homeostatic mechanisms stabilize neural circuit function by keeping firing rates within a set-point range, but whether this process is gated by brain state is unknown. Here, we monitored firing rate homeostasis in individual visual cortical neurons in freely behaving rats as they cycled between sleep and wake states. When neuronal firing rates were perturbed by visual deprivation, they gradually returned to a precise, cell-autonomous set point during periods of active wake, with lengthening of the wake period enhancing firing rate rebound. Unexpectedly, this resetting of neuronal firing was suppressed during sleep. This raises the possibility that memory consolidation or other sleep-dependent processes are vulnerable to interference from homeostatic plasticity mechanisms.	[Hengen, Keith B.; Pacheco, Alejandro Torrado; McGregor, James N.; Van Hooser, Stephen D.; Turrigiano, Gina G.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [McGregor, James N.] Emory Univ, Neurosci Grad Program, Atlanta, GA 30322 USA	Brandeis University; Emory University	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	turrigiano@brandeis.edu		Hengen, Keith/0000-0001-5017-4090	NIH [R01EY014439, R37NS092635, K99NS089800-01]; NATIONAL EYE INSTITUTE [R01EY022122, R01EY014439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS089800, R37NS092635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R90DA033463] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants (R01EY014439 and R37NS092635 to G.G.T.; K99NS089800-01 to K.B.H.). We thank A. Kashanchi and E. Zheng for technical help with sleep/wake coding and D.B. Katz, M. Frank, P. Garrity, E. Marder, L. Griffith, and S. Jadhav for useful discussions and suggestions.	Abasolo D, 2015, J NEUROPHYSIOL, V113, P2742, DOI 10.1152/jn.00575.2014; Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abel T, 2013, CURR BIOL, V23, pR774, DOI 10.1016/j.cub.2013.07.025; Aton SJ, 2014, SLEEP, V37, P1163, DOI 10.5665/sleep.3830; Aton SJ, 2013, P NATL ACAD SCI USA, V110, P3101, DOI 10.1073/pnas.1208093110; Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Coleman CG, 2004, NEUROSCIENCE, V126, P821, DOI 10.1016/j.neuroscience.2004.04.029; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; EVARTS EV, 1962, SCIENCE, V135, P727, DOI 10.1126/science.135.3505.726; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frank MG, 2014, TRENDS NEUROSCI, V37, P491, DOI 10.1016/j.tins.2014.06.005; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Gainey MA, 2009, J NEUROSCI, V29, P6479, DOI 10.1523/JNEUROSCI.3753-08.2009; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hengen KB, 2013, NEURON, V80, P335, DOI 10.1016/j.neuron.2013.08.038; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Kaneko M, 2008, NEURON, V58, P673, DOI 10.1016/j.neuron.2008.04.023; Keck T, 2013, NEURON, V80, P327, DOI 10.1016/j.neuron.2013.08.018; Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006; Lambo ME, 2013, J NEUROSCI, V33, P8810, DOI 10.1523/JNEUROSCI.4502-12.2013; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Maffei A, 2008, J NEUROSCI, V28, P4377, DOI 10.1523/JNEUROSCI.5298-07.2008; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; Roxin A, 2011, J NEUROSCI, V31, P16217, DOI 10.1523/JNEUROSCI.1677-11.2011; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Scholvinck ML, 2015, J NEUROSCI, V35, P170, DOI 10.1523/JNEUROSCI.4994-13.2015; Slomowitz E, 2015, ELIFE, V4, DOI 10.7554/eLife.04378; Smith GB, 2009, PHILOS T R SOC B, V364, P357, DOI 10.1098/rstb.2008.0198; Steinmetz CC, 2010, J NEUROSCI, V30, P14685, DOI 10.1523/JNEUROSCI.2210-10.2010; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Sullivan D, 2014, J NEUROSCI, V34, P662, DOI 10.1523/JNEUROSCI.0552-13.2014; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Toyoizumi T, 2014, NEURON, V84, P497, DOI 10.1016/j.neuron.2014.09.036; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Vitureira N, 2013, J CELL BIOL, V203, P175, DOI 10.1083/jcb.201306030; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Wang G, 2011, TRENDS NEUROSCI, V34, P452, DOI 10.1016/j.tins.2011.07.005; WITTING W, 1993, BRAIN RES BULL, V30, P157, DOI 10.1016/0361-9230(93)90053-E; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	60	157	162	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2016	165	1					180	191		10.1016/j.cell.2016.01.046	http://dx.doi.org/10.1016/j.cell.2016.01.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4WF	26997481	Green Accepted, Bronze			2022-12-28	WOS:000372785600019
J	Kurotani, K; Akter, S; Kashino, I; Goto, A; Mizoue, T; Noda, M; Sasazuki, S; Sawada, N; Tsugane, S				Kurotani, Kayo; Akter, Shamima; Kashino, Ikuko; Goto, Atsushi; Mizoue, Tetsuya; Noda, Mitsuhiko; Sasazuki, Shizuka; Sawada, Norie; Tsugane, Shoichiro		Japan Public Hlth Ctr Based	Quality of diet and mortality among Japanese men and women: Japan Public Health Center based prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE; FOLLOW-UP SURVEY; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; MEDITERRANEAN DIET; PROSPECTIVE COHORT; EATING INDEX; FATTY-ACIDS; JPHC; RISK	OBJECTIVE To examine the association between adherence to the Japanese Food Guide Spinning Top and total and cause specific mortality. DESIGN Large scale population based prospective cohort study in Japan with follow-up for a median of 15 years. SETTING 11 public health centre areas across Japan. PARTICIPANTS 36 624 men and 42 970 women aged 45-75 who had no history of cancer, stroke, ischaemic heart disease, or chronic liver disease. MAIN OUTCOME MEASURES Deaths and causes of death identified with the residential registry and death certificates. RESULTS Higher scores on the food guide (better adherence) were associated with lower total mortality; the multivariable adjusted hazard ratios (95% confidence interval) of total mortality for the lowest through highest scores were 1.00, 0.92 (0.87 to 0.97), 0.88 (0.83 to 0.93), and 0.85 (0.79 to 0.91) (P< 0.001 for trend) and the multivariable adjusted hazard ratio associated with a 10 point increase in food guide scores was 0.93 (0.91 to 0.95; P< 0.001 for trend). This score was inversely associated with mortality from cardiovascular disease (hazard ratio associated with a 10 point increase 0.93, 0.89 to 0.98; P= 0.005 for trend) and particularly from cerebrovascular disease (0.89, 0.82 to 0.95; P= 0.002 for trend). There was some evidence, though not significant, of an inverse association for cancer mortality (0.96, 0.93 to 1.00; P= 0.053 for trend). CONCLUSION Closer adherence to Japanese dietary guidelines was associated with a lower risk of total mortality and mortality from cardiovascular disease, particularly from cerebrovascular disease, in Japanese adults.	[Kurotani, Kayo; Akter, Shamima; Kashino, Ikuko; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan; [Goto, Atsushi] Tokyo Womens Med Univ, Dept Publ Hlth, Shinjuku Ku, 8-1 Kawadacho, Tokyo 1628666, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Dept Diabet Res, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan; [Noda, Mitsuhiko] Saitama Med Univ, Dept Endocrinol & Diabet, 38 Moro Hongo, Moroyama, Saitama 3500495, Japan; [Sasazuki, Shizuka; Sawada, Norie; Tsugane, Shoichiro] Natl Canc Ctr, Epidemiol & Prevent Grp, Res Ctr Canc Prevent & Screening, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan	National Center for Global Health & Medicine - Japan; Tokyo Women's Medical University; National Center for Global Health & Medicine - Japan; Saitama Medical University; National Cancer Center - Japan	Kurotani, K (corresponding author), Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	kkurotani@ri.ncgm.go.jp	KASHINO, IKUKO/AAS-4008-2020; Tsugane, Shoichiro/A-2424-2015; Noda, Mitsuhiko/W-3905-2019	Tsugane, Shoichiro/0000-0003-4105-2774; Noda, Mitsuhiko/0000-0003-0413-4631; Goto, Atsushi/0000-0003-0669-654X	National Cancer Centre research and development fund [23-A-31[toku], 26-A-2]; Ministry of Health, Labour and Welfare of Japan; Japan Agency for Medical Research and Development [15ek0210021h0002]; JSPS KAKENHI [15H04779]; National Centre for Global Health and Medicine [26A-201]	National Cancer Centre research and development fund; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Centre for Global Health and Medicine	This study was supported by National Cancer Centre research and development fund (23-A-31[toku] and 26-A-2) (since 2011), a grant-in-aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan (from 1989 to 2010), Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus (15ek0210021h0002) from the Japan Agency for Medical Research and Development, JSPS KAKENHI Grant No 15H04779, and grants-in-aid for research from the National Centre for Global Health and Medicine (26A-201).	Akbaraly TN, 2011, AM J CLIN NUTR, V94, P247, DOI 10.3945/ajcn.111.013128; Atkins JL, 2014, J NUTR, V144, P673, DOI 10.3945/jn.113.186486; Bazelmans C, 2006, EUR J EPIDEMIOL, V21, P145, DOI 10.1007/s10654-005-5699-8; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Chowdhury R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6698; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; FAOSTAT, 2013, FISH SEAF; Hara M, 2002, JPN J CANCER RES, V93, P6, DOI 10.1111/j.1349-7006.2002.tb01194.x; Harmon BE, 2015, AM J CLIN NUTR, V101, P587, DOI 10.3945/ajcn.114.090688; Hata J, 2013, CIRC J, V77, P1923, DOI 10.1253/circj.CJ-13-0786; Ikeda N, 2011, LANCET, V378, P1094, DOI 10.1016/S0140-6736(11)61055-6; Ishihara J, 2003, J EPIDEMIOL, V13, pS134; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; Kant AK, 2000, JAMA-J AM MED ASSOC, V283, P2109, DOI 10.1001/jama.283.16.2109; Kenko Eiyo Joho Kenkyukai, 2010, NAT HLTH NUTR SURV J; KENNEDY ET, 1995, J AM DIET ASSOC, V95, P1103, DOI 10.1016/S0002-8223(95)00300-2; Knoops KTB, 2006, EUR J CLIN NUTR, V60, P746, DOI 10.1038/sj.ejcn.1602378; Lagiou P, 2006, BRIT J NUTR, V96, P384, DOI 10.1079/BJN20061824; Mai V, 2005, INT J EPIDEMIOL, V34, P54, DOI 10.1093/ije/dyh388; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Michels KB, 2002, INT J EPIDEMIOL, V31, P847, DOI 10.1093/ije/31.4.847; Mursu J, 2013, AM J CLIN NUTR, V98, P444, DOI 10.3945/ajcn.112.055681; National Institute of Health and Nutrition, 2005, NAT HLTH NUTR SURV 1; Oba S, 2009, J AM DIET ASSOC, V109, P1540, DOI 10.1016/j.jada.2009.06.367; Ohno Y, 1985, World Health Stat Q, V38, P176; Osler M, 1997, INT J EPIDEMIOL, V26, P155, DOI 10.1093/ije/26.1.155; Reidlinger DP, 2015, AM J CLIN NUTR, V101, P922, DOI 10.3945/ajcn.114.097352; Rubin DB, 1987, MULTIPLE IMPUTATION; Sasaki S, 2003, J EPIDEMIOL, V13, pS115; Sasaki S, 2003, J EPIDEMIOL, V13, pS13; Sasaki S, 2003, J EPIDEMIOL, V13, pS57; Science and Technology Agency, 2005, STAND TABL FOOD COMP, V5th ed.; Science and Technology Agency, 2005, 5 REV ENL; Seymour JD, 2003, AM J EPIDEMIOL, V157, P980, DOI 10.1093/aje/kwg077; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Takachi R, 2008, AM J EPIDEMIOL, V167, P59, DOI 10.1093/aje/kwm263; Takata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056963; Tominaga S, 1997, INT J CANCER, P2; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096; Wang X, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4490; Wirt A, 2009, PUBLIC HEALTH NUTR, V12, P2473, DOI 10.1017/S136898000900531X; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2015, WORLD HLTH STAT 2014; World Health Organization, 2018, INT CLASSIFICATION D; Yamagishi K, 2013, EUR HEART J, V34, P1225, DOI 10.1093/eurheartj/eht043; Yoshiike N, 2007, NUTR REV, V65, P149, DOI 10.1301/nr.2007.apr.149-154; Yu DX, 2014, AM J CLIN NUTR, V100, P693, DOI 10.3945/ajcn.113.079194	49	102	102	3	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2016	352								i1209	10.1136/bmj.i1209	http://dx.doi.org/10.1136/bmj.i1209			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LK	27005903	hybrid, Green Published			2022-12-28	WOS:000373044500001
J	Young, E				Young, Emma			PERSONAL VIEW My mum's decision changed my view of assisted dying	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Young, Emma] Newham Univ Hosp, Barts Hlth NHS Trust, London E13 8SL, England	Barts Health NHS Trust	Young, E (corresponding author), Newham Univ Hosp, Barts Hlth NHS Trust, London E13 8SL, England.	emmayoung1@nhs.net						Ryan J., 2015, GUARDIAN	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2016	352								i1589	10.1136/bmj.i1589	http://dx.doi.org/10.1136/bmj.i1589			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LI	27000931				2022-12-28	WOS:000373044300006
J	Kerkhoff, AD; Lawn, SD				Kerkhoff, Andrew D.; Lawn, Stephen D.			A breakthrough urine-based diagnostic test for HIV-associated tuberculosis	LANCET			English	Editorial Material							XPERT MTB/RIF; SETTINGS; ACCURACY; AFRICA; ASSAY		[Kerkhoff, Andrew D.] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; [Kerkhoff, Andrew D.] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Lawn, Stephen D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Kerkhoff, Andrew D.; Lawn, Stephen D.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa	University of California System; University of California San Francisco; University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Kerkhoff, AD (corresponding author), Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA.; Kerkhoff, AD (corresponding author), Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Kerkhoff, AD (corresponding author), Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	andrew.kerkhoff@ucsf.edu						Churchyard GJ, 2015, LANCET GLOB HEALTH, V3, pE450, DOI 10.1016/S2214-109X(15)00100-X; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Lawn SD, 2016, T ROY SOC TROP MED H, V110, P180, DOI 10.1093/trstmh/trw008; Lawn SD, 2015, JAIDS-J ACQ IMM DEF, V69, pE144, DOI 10.1097/QAI.0000000000000672; Lawn SD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-103; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Peter JG, 2016, LANCET, V387, P1187, DOI 10.1016/S0140-6736(15)01092-2; Shah M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011420.pub2; STANFORD JL, 1991, LANCET, V338, P557, DOI 10.1016/0140-6736(91)91113-9; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; WHO, 2015, US LAT FLOW UR LIP L; World Health Organization, 2015, GLOB TUB REP 2015	13	10	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2016	387	10024					1139	1141		10.1016/S0140-6736(16)00146-X	http://dx.doi.org/10.1016/S0140-6736(16)00146-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DG9OB	26970724				2022-12-28	WOS:000372412000006
J	Sanchez, D; Martinez, S; Domingo-Ferrer, J				Sanchez, David; Martinez, Sergio; Domingo-Ferrer, Josep			Comment on "Unique in the shopping mall: On the reidentifiability of credit card metadata"	SCIENCE			English	Editorial Material								De Montjoye et al. (Reports, 30 January 2015, p. 536) claimed that most individuals can be reidentified from a deidentified transaction database and that anonymization mechanisms are not effective against reidentification. We demonstrate that anonymization can be performed by techniques well established in the literature.	[Sanchez, David; Martinez, Sergio; Domingo-Ferrer, Josep] Univ Rovira & Virgili, Dept Comp Engn & Math, UNESCO Chair Data Privacy, Ave Paisos Catalans 26, E-43007 Tarragona, Catalonia, Spain	Universitat Rovira i Virgili	Sanchez, D (corresponding author), Univ Rovira & Virgili, Dept Comp Engn & Math, UNESCO Chair Data Privacy, Ave Paisos Catalans 26, E-43007 Tarragona, Catalonia, Spain.	david.sanchez@urv.cat	Sanchez, David/B-5275-2012	Sanchez, David/0000-0001-7275-7887; Domingo-Ferrer, Josep/0000-0001-7213-4962; Martinez, Sergio/0000-0002-3941-5348				Barth-Jones D, 2015, SCIENCE, V348, P194, DOI 10.1126/science.348.6231.194-b; Cao JN, 2011, IEEE T DEPEND SECURE, V8, P337, DOI 10.1109/TDSC.2009.47; Dalenius T, 1977, STAT TIDSKRIFT, V15, P2; de Montjoye YA, 2015, SCIENCE, V347, P536, DOI 10.1126/science.1256297; de Montjoye YA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01376; Fung BCM, 2010, ACM COMPUT SURV, V42, DOI 10.1145/1749603.1749605; Hundepool A., 2012, STAT DISCLOSURE CONT; Li N, 2007, INT CONF NANO MICRO, P692, DOI 10.1109/icde.2007.367856; Machanavajjhala A., 2012, XRDS, V19, P20, DOI [10.1145/2331042.2331051, DOI 10.1145/2331042.2331051]; PAASS G, 1988, J BUS ECON STAT, V6, P487, DOI 10.2307/1391468; Samarati P., 1998, PROTECTING PRIVACY D; Sanchez D., 2015, SUPPLEMENTARY MAT AV; Soria-Comas Jordi, 2015, Modeling Decisions for Artificial Intelligence. 12th International Conference, MDAI 2015. Proceedings: 9321, P192, DOI 10.1007/978-3-319-23240-9_16; Soria-Comas J., 2015, DATA SCI ENG; Soria-Comas J, 2015, IEEE T KNOWL DATA EN, V27, P3098, DOI 10.1109/TKDE.2015.2435777	15	24	24	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2016	351	6279								10.1126/science.aad9295	http://dx.doi.org/10.1126/science.aad9295			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DG9JD	26989243	Green Submitted			2022-12-28	WOS:000372397700028
J	Iacobucci, G				Iacobucci, Gareth			THE BMJ ROUND TABLE It's the workforce, stupid	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												giacobucci@bmj.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2016	352								i1510	10.1136/bmj.i1510	http://dx.doi.org/10.1136/bmj.i1510			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH2AD	26987345				2022-12-28	WOS:000372585400004
J	Hawkes, N				Hawkes, Nigel			THE BMJ AWARDS 2016 Cancer care team	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2016	352								i1443	10.1136/bmj.i1443	http://dx.doi.org/10.1136/bmj.i1443			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH1ZT	26979072				2022-12-28	WOS:000372584400008
J	Gulland, A				Gulland, Anne			TOBACCO CONTROL Pension funds: tobacco investment up in smoke	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Gornall J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8023; Law Commission, 2014, FID DUT INV INT	2	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2016	352								i1491	10.1136/bmj.i1491	http://dx.doi.org/10.1136/bmj.i1491			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4NV	26969491	Green Published			2022-12-28	WOS:000372049800005
J	Dekker, J; Mirny, L				Dekker, Job; Mirny, Leonid			The 3D Genome as Moderator of Chromosomal Communication	CELL			English	Review							GENE-EXPRESSION; CHROMATIN INTERACTIONS; SPATIAL-ORGANIZATION; X-INACTIVATION; INTERPHASE CHROMOSOMES; DOSAGE COMPENSATION; ASSOCIATING DOMAINS; TOPOLOGICAL DOMAINS; REGULATORY DOMAINS; DROSOPHILA GENOME	Proper expression of genes requires communication with their regulatory elements that can be located elsewhere along the chromosome. The physics of chromatin fibers imposes a range of constraints on such communication. The molecular and biophysical mechanisms by which chromosomal communication is established, or prevented, have become a topic of intense study, and important roles for the spatial organization of chromosomes are being discovered. Here we present a view of the interphase 3D genome characterized by extensive physical compartmentalization and insulation on the one hand and facilitated long-range interactions on the other. We propose the existence of topological machines dedicated to set up and to exploit a 3D genome organization to both promote and censor communication along and between chromosomes.	[Dekker, Job] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Syst Biol,Dept Biochem & Mol Pharmacol, 368 Plantat St, Worcester, MA USA; [Mirny, Leonid] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave,E25-526C, Cambridge, MA 02139 USA; [Mirny, Leonid] MIT, Dept Phys, 77 Massachusetts Ave,E25-526C, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Dekker, J (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Syst Biol,Dept Biochem & Mol Pharmacol, 368 Plantat St, Worcester, MA USA.; Mirny, L (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave,E25-526C, Cambridge, MA 02139 USA.; Mirny, L (corresponding author), MIT, Dept Phys, 77 Massachusetts Ave,E25-526C, Cambridge, MA 02139 USA.	job.dekker@umassmed.edu; leonid@mit.edu	Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410	National Human Genome Research Institute [R01 HG003143, U54 HG007010, U01 HG007910]; National Cancer Institute [U54 CA193419]; NIH Common Fund [U54 DK107980, U01 DA 040588]; National Institute of General Medical Sciences [R01 GM 112720]; National Institute of Allergy and Infectious Diseases [U01 R01 AI 117839]; NATIONAL CANCER INSTITUTE [U54CA193419] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143, U01HG007910, U54HG007010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114190, R01GM112720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA040588] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1504942] Funding Source: National Science Foundation	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank members of the Dekker and Mirny labs for discussion. Work in our labs is supported by the National Human Genome Research Institute (R01 HG003143, U54 HG007010, U01 HG007910), the National Cancer Institute (U54 CA193419), the NIH Common Fund (U54 DK107980, U01 DA 040588), the National Institute of General Medical Sciences (R01 GM 112720), and the National Institute of Allergy and Infectious Diseases (U01 R01 AI 117839). J.D. is an investigator of the Howard Hughes Medical Institute. The authors declare that they have no competing interests.	Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Allen DJ, 1997, EMBO J, V16, P4467, DOI 10.1093/emboj/16.14.4467; Augui S, 2007, SCIENCE, V318, P1632, DOI 10.1126/science.1149420; Barakat TS, 2014, MOL CELL, V53, P965, DOI 10.1016/j.molcel.2014.02.006; Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; Benedetti F, 2014, NUCLEIC ACIDS RES, V42, P10425, DOI 10.1093/nar/gku759; Benedetti F, 2014, NUCLEIC ACIDS RES, V42, P2848, DOI 10.1093/nar/gkt1353; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Bouwman BAM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0730-1; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Bronstein I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018102; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Crozat E, 2010, EMBO J, V29, P1423, DOI 10.1038/emboj.2010.29; Dalton RP, 2013, CELL, V155, P321, DOI 10.1016/j.cell.2013.09.033; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-25; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dong JC, 2015, NATURE, V525, P134, DOI 10.1038/nature14970; Doyle B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003867; EARNSHAW WC, 1983, J CELL BIOL, V96, P84, DOI 10.1083/jcb.96.1.84; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Fraser J, 2015, MICROBIOL MOL BIOL R, V79, P347, DOI 10.1128/MMBR.00006-15; Fudenberg G, 2015, BIORXIV; Galupa R, 2015, CURR OPIN GENET DEV, V31, P57, DOI 10.1016/j.gde.2015.04.002; Gendrel AV, 2014, ANNU REV CELL DEV BI, V30, P561, DOI 10.1146/annurev-cellbio-101512-122415; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Goloborodko A., 2015, BIORXIV; Goloborodko A., 2016, BIORXIV; Gomez-Marin C, 2015, P NATL ACAD SCI USA, V112, P7542, DOI 10.1073/pnas.1505463112; Gostissa M, 2014, P NATL ACAD SCI USA, V111, P2644, DOI 10.1073/pnas.1324176111; Gruber S, 2014, CURR OPIN MICROBIOL, V22, P102, DOI 10.1016/j.mib.2014.09.018; GUACCI V, 1993, COLD SPRING HARB SYM, V58, P677, DOI 10.1101/SQB.1993.058.01.075; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Hajjoul H, 2013, GENOME RES, V23, P1829, DOI 10.1101/gr.157008.113; Halverson JD, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/022601; HIRANO T, 1995, CURR OPIN CELL BIOL, V7, P329, DOI 10.1016/0955-0674(95)80087-5; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Hofmann A, 2015, FEBS LETT, V589, P2958, DOI 10.1016/j.febslet.2015.04.021; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Hsieh THS, 2015, CELL, V162, P108, DOI 10.1016/j.cell.2015.05.048; Hu JZ, 2015, CELL, V163, P947, DOI 10.1016/j.cell.2015.10.016; Jeon Y, 2012, CURR OPIN GENET DEV, V22, P62, DOI 10.1016/j.gde.2012.02.007; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jost D, 2014, NUCLEIC ACIDS RES, V42, P9553, DOI 10.1093/nar/gku698; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10200; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Krijger PHL, 2013, CURR OPIN GENET DEV, V23, P191, DOI 10.1016/j.gde.2012.12.010; Larkin JD, 2013, NUCLEIC ACIDS RES, V41, P2216, DOI 10.1093/nar/gks1441; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; Lee K, 2015, GENE DEV, V29, P1992, DOI 10.1101/gad.255265.114; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lucas JS, 2014, CELL, V158, P339, DOI 10.1016/j.cell.2014.05.036; Lupianez DG, 2015, CELL, V161, P1012, DOI 10.1016/j.cell.2015.04.004; Markenscoff-Papadimitriou E, 2014, CELL, V159, P543, DOI 10.1016/j.cell.2014.09.033; MARSDEN MPF, 1979, CELL, V17, P849, DOI 10.1016/0092-8674(79)90325-8; Masui O, 2011, CELL, V145, P447, DOI 10.1016/j.cell.2011.03.032; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Monahan K, 2015, ANNU REV CELL DEV BI, V31, P721, DOI 10.1146/annurev-cellbio-100814-125308; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nichols MH, 2015, CELL, V162, P702, DOI 10.1016/j.cell.2015.07.053; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; PETERSON CL, 1994, CELL, V79, P389, DOI 10.1016/0092-8674(94)90247-X; Ptashne M, 2014, J BIOL CHEM, V289, P5417, DOI 10.1074/jbc.X114.547323; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reyes-Lamothe R, 2012, ANNU REV GENET, V46, P121, DOI 10.1146/annurev-genet-110711-155421; Rosa A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000153; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schwarzer W, 2014, CURR OPIN GENET DEV, V27, P74, DOI 10.1016/j.gde.2014.03.014; Seitan VC, 2013, GENOME RES, V23, P2066, DOI 10.1101/gr.161620.113; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shachar S, 2015, CELL, V162, P911, DOI 10.1016/j.cell.2015.07.035; Shopland LS, 2006, J CELL BIOL, V174, P27, DOI 10.1083/jcb.200603083; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smith EM, 2016, AM J HUM GENET, V98, P185, DOI 10.1016/j.ajhg.2015.12.002; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tark-Dame M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003877; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115; Wang XD, 2015, GENE DEV, V29, P1661, DOI 10.1101/gad.265876.115; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Yang R, 2015, NUCL ACIDS RES; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	113	506	529	6	122	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1110	1121		10.1016/j.cell.2016.02.007	http://dx.doi.org/10.1016/j.cell.2016.02.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967279	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000372784900010
J	Kidia, KK				Kidia, Khameer K.			Disheartening Disparities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kidia, Khameer K.] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Kidia, KK (corresponding author), Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA.							Fuster V, 2011, CIRCULATION, V123, P1671, DOI 10.1161/CIRCULATIONAHA.110.009522; WHO, 2010, GLOB STAT REP NONC D; World Health Organization, GLOB HLTH OBS DAT RE	3	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 10	2016	374	10					909	911		10.1056/NEJMp1512888	http://dx.doi.org/10.1056/NEJMp1512888			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DF9DH	26962726				2022-12-28	WOS:000371660000004
J	Leonhardt, SD; Menzel, F; Nehring, V; Schmitt, T				Leonhardt, Sara Diana; Menzel, Florian; Nehring, Volker; Schmitt, Thomas			Ecology and Evolution of Communication in Social Insects	CELL			English	Review							QUEEN PHEROMONES; APIS-MELLIFERA; CUTICULAR HYDROCARBONS; REPRODUCTIVE STATUS; CHEMICAL COMMUNICATION; SURFACE HYDROCARBONS; NESTMATE-RECOGNITION; GUARDING BEHAVIOR; ALARM PHEROMONES; VENOM VOLATILES	Insect life strategies comprise all levels of sociality from solitary to eusocial, in which individuals form persistent groups and divide labor. With increasing social complexity, the need to communicate a greater diversity of messages arose to coordinate division of labor, group cohesion, and concerted actions. Here we summarize the knowledge on prominent messages in social insects that inform about reproduction, group membership, resource locations, and threats and discuss potential evolutionary trajectories of each message in the context of social complexity.	[Leonhardt, Sara Diana; Schmitt, Thomas] Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97074 Wurzburg, Germany; [Menzel, Florian] Johannes Gutenberg Univ Mainz, Inst Zool, Evolutionary Biol, D-55128 Mainz, Germany; [Nehring, Volker] Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, D-79104 Freiburg, Germany	University of Wurzburg; Johannes Gutenberg University of Mainz; University of Freiburg	Schmitt, T (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, D-97074 Wurzburg, Germany.	thomas.schmitt@uni-wuerzburg.de	Leonhardt, Sara/AAI-6901-2020; Menzel, Florian/H-2436-2017; Nehring, Volker/H-1908-2012	Leonhardt, Sara/0000-0002-8154-9569; Menzel, Florian/0000-0002-9673-3668; Nehring, Volker/0000-0002-0494-1428				Abrol D.P., 2013, ASIATIC HONEYBEE API; [Anonymous], 1992, SENSORY ECOLOGY; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P3, DOI 10.1017/CBO9780511711909.002; BLUM MS, 1969, ANNU REV ENTOMOL, V14, P57, DOI 10.1146/annurev.en.14.010169.000421; Bontonou Gwenaelle, 2014, Insects, V5, P439, DOI 10.3390/insects5020439; Boomsma JJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0050; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Bruschini C, 2008, J EXP BIOL, V211, P2442, DOI 10.1242/jeb.017749; BYERS JA, 1989, EXPERIENTIA, V45, P271, DOI 10.1007/BF01951813; Couvillon MJ, 2008, ANIM BEHAV, V76, P1653, DOI 10.1016/j.anbehav.2008.08.002; D'Ettorre P, 2004, J EXP BIOL, V207, P1085, DOI 10.1242/jeb.00865; d'Ettorre P, 2010, ANT ECOLOGY, P194; DeHeer CJ, 1997, BEHAV ECOL SOCIOBIOL, V40, P27, DOI 10.1007/s002650050312; Dornhaus A, 2003, J COMP PHYSIOL A, V189, P47, DOI 10.1007/s00359-002-0374-y; Dornhaus A, 2001, BEHAV ECOL SOCIOBIOL, V50, P570, DOI 10.1007/s002650100395; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Downs SG, 2000, BEHAV ECOL, V11, P326, DOI 10.1093/beheco/11.3.326; Endler A, 2004, P NATL ACAD SCI USA, V101, P2945, DOI 10.1073/pnas.0308447101; Errard C, 2006, BEHAV ECOL SOCIOBIOL, V59, P353, DOI 10.1007/s00265-005-0058-z; Esponda F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2838; Furst MA, 2012, P ROY SOC B-BIOL SCI, V279, P516, DOI 10.1098/rspb.2011.0581; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Hannonen M, 2003, NATURE, V421, P910, DOI 10.1038/421910a; Heifetz Y, 1998, J CHEM ECOL, V24, P1033, DOI 10.1023/A:1022302519373; Helantera H, 2015, EVOLUTION, V69, P520, DOI 10.1111/evo.12590; Helantera H, 2011, BEHAV ECOL, V22, P710, DOI 10.1093/beheco/arr037; Helantera H, 2009, BEHAV ECOL SOCIOBIOL, V63, P573, DOI 10.1007/s00265-008-0692-3; Helmkampf M, 2015, MOL BIOL EVOL, V32, P456, DOI 10.1093/molbev/msu315; Hoffmann K, 2014, MOL BIOL EVOL, V31, P2689, DOI 10.1093/molbev/msu214; Holldobler B, 1999, J COMP PHYSIOL A, V184, P129, DOI 10.1007/s003590050313; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM; Holman L, 2013, J EVOLUTION BIOL, V26, P1549, DOI 10.1111/jeb.12162; Holman L, 2010, P ROY SOC B-BIOL SCI, V277, P3793, DOI 10.1098/rspb.2010.0984; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Inta R, 2009, J ECON ENTOMOL, V102, P121, DOI 10.1603/029.102.0117; Jaffe Klaus, 2011, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/694910; Jarau S, 2009, CONTEMP TOP ENTOMOL, P223; Johnson BR, 2011, BEHAV ECOL SOCIOBIOL, V65, P935, DOI 10.1007/s00265-010-1094-x; Kather R, 2015, J CHEM ECOL, V41, P871, DOI 10.1007/s10886-015-0631-5; Keeling CI, 2003, P NATL ACAD SCI USA, V100, P4486, DOI 10.1073/pnas.0836984100; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; Kocher SD, 2011, J CHEM ECOL, V37, P1263, DOI 10.1007/s10886-011-0036-z; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Leonhardt SD, 2007, J COMP PHYSIOL A, V193, P993, DOI 10.1007/s00359-007-0252-8; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; Linsenmair K.E., 1987, P121; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; Martin SJ, 2011, P ROY SOC B-BIOL SCI, V278, P496, DOI 10.1098/rspb.2010.1047; Matsuura K, 2010, P NATL ACAD SCI USA, V107, P12963, DOI 10.1073/pnas.1004675107; Menzel F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-16; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Monnin T, 2006, ANN ZOOL FENN, V43, P515; Moore D, 2010, BEHAV ECOL SOCIOBIOL, V64, P1011, DOI 10.1007/s00265-010-0916-1; Morgan ED, 2009, PHYSIOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-3032.2008.00658.x; MORITZ RFA, 1987, ETHOLOGY, V76, P15, DOI 10.1111/j.1439-0310.1987.tb00668.x; Mucignat-Caretta C., 2014, NEUROBIOLOGY CHEM CO; NAUMANN K, 1991, BEHAV ECOL SOCIOBIOL, V29, P321, DOI 10.1007/BF00165956; Nehring V, 2013, ANIMAL COMMUNICATION, V2, P373, DOI [10.1007/978-3-642-41494-7_13, DOI 10.1007/978-3-642-41494-7_13]; Nehring V, 2011, P ROY SOC B-BIOL SCI, V278, P1942, DOI 10.1098/rspb.2010.2295; Oi CA, 2015, BIOESSAYS, V37, P808, DOI 10.1002/bies.201400180; Oliveira RC, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0509-8; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pamminger T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079616; Pasteels Jacques M., 1998, P193; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; RATNIEKS FLW, 1992, J THEOR BIOL, V158, P33, DOI 10.1016/S0022-5193(05)80647-2; Ratnieks FLW, 2008, TRENDS ECOL EVOL, V23, P45, DOI 10.1016/j.tree.2007.09.013; Saleh N, 2006, BEHAV ECOL SOCIOBIOL, V61, P215, DOI 10.1007/s00265-006-0252-7; Sharma KR, 2015, CELL REP, V12, P1261, DOI 10.1016/j.celrep.2015.07.031; Sheehan MJ, 2008, CURR BIOL, V18, pR851, DOI 10.1016/j.cub.2008.07.032; Sledge MF, 2004, J INSECT PHYSIOL, V50, P73, DOI 10.1016/j.jinsphys.2003.10.001; Sledge MF, 1999, PHYSIOL ENTOMOL, V24, P234, DOI 10.1046/j.1365-3032.1999.00137.x; Steiger S., 2015, SOCIAL RECOGNITION I, P249; Steiger S, 2011, P ROY SOC B-BIOL SCI, V278, P970, DOI 10.1098/rspb.2010.2285; Stout JC, 2001, ANIM BEHAV, V62, P183, DOI 10.1006/anbe.2001.1729; Tannure-Nascimento IC, 2008, P ROY SOC B-BIOL SCI, V275, P2555, DOI 10.1098/rspb.2008.0589; Thom C, 2007, PLOS BIOL, V5, P1862, DOI 10.1371/journal.pbio.0050228; Thomas ML, 2008, J INSECT PHYSIOL, V54, P1081, DOI 10.1016/j.jinsphys.2008.04.012; Thomas ML, 2011, BIOL REV, V86, P1, DOI 10.1111/j.1469-185X.2010.00130.x; Tsutsui ND, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0416; Van Oystaeyen A, 2014, SCIENCE, V343, P287, DOI 10.1126/science.1244899; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Verheggen FJ, 2010, VITAM HORM, V83, P215, DOI 10.1016/S0083-6729(10)83009-2; Virant-Doberlet M, 2004, NEOTROP ENTOMOL, V33, P121, DOI 10.1590/S1519-566X2004000200001; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wagner D, 2001, J CHEM ECOL, V27, P1805, DOI 10.1023/A:1010408725464; Weil T, 2009, NATURWISSENSCHAFTEN, V96, P315, DOI 10.1007/s00114-008-0475-8; Wenseleers T, 2011, BIOL LETTERS, V7, P173, DOI 10.1098/rsbl.2010.0819; WILSON EO, 1971, AM NAT, V105, P279, DOI 10.1086/282724; Witte V, 2007, CHEMOECOLOGY, V17, P57, DOI 10.1007/s00049-006-0364-6; Wong JWY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1236; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1; Zhou XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002930	96	185	189	7	193	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1277	1287		10.1016/j.cell.2016.01.035	http://dx.doi.org/10.1016/j.cell.2016.01.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967293	Bronze			2022-12-28	WOS:000372784900024
J	Savage, N				Savage, Neil			Spreading Knowledge and Wonder	CELL			English	Editorial Material																			0	2	2	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1085	1088		10.1016/j.cell.2016.02.051	http://dx.doi.org/10.1016/j.cell.2016.02.051			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967272	Bronze			2022-12-28	WOS:000372784900003
J	Tkach, M; Thery, C				Tkach, Mercedes; Thery, Clotilde			Communication by Extracellular Vesicles: Where We Are and Where We Need to Go	CELL			English	Review							EXOSOME SECRETION; CELLS; RNA; BIOGENESIS; MICRORNAS; DELIVERY; MICROENVIRONMENT; MECHANISMS; MODULATE; CGAMP	In multicellular organisms, distant cells can exchange information by sending out signals composed of single molecules or, as increasingly exemplified in the literature, via complex packets stuffed with a selection of proteins, lipids, and nucleic acids, called extracellular vesicles (EVs; also known as exosomes and microvesicles, among other names). This Review covers some of the most striking functions described for EV secretion but also presents the limitations on our knowledge of their physiological roles. While there are initial indications that EV-mediated pathways operate in vivo, the actual nature of the EVs involved in these effects still needs to be clarified. Here, we focus on the context of tumor cells and their microenvironment, but similar results and challenges apply to all patho/physiological systems in which EV-mediated communication is proposed to take place.	[Tkach, Mercedes; Thery, Clotilde] PSL Res Univ, Inst Curie, INSERM U932, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Thery, C (corresponding author), PSL Res Univ, Inst Curie, INSERM U932, F-75005 Paris, France.	clotilde.thery@curie.fr	thery, clotilde/F-6373-2013	thery, clotilde/0000-0001-8294-6884	program "Investissements d'Avenir''; Fondation ARC pour la Recherche sur le Cancer [SL220120605293]	program "Investissements d'Avenir''(French National Research Agency (ANR)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	Because of space restriction, only a few recent publications were discussed in this Review; we apologize to all our colleagues whose work has not been cited here. We thank Joanna Kowal, Claire Hivroz, and Lionel Navarro for critical reading of the manuscript. This work has received support under the program "Investissements d'Avenir'' launched by the French Government and implemented by ANR with the references ANR-11-LABX-0043 and ANR-10-IDEX-0001-02 PSL and by Fondation ARC pour la Recherche sur le Cancer through SL220120605293 grant to C.T. and post-doctoral grant to M.T.	Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Assil S, 2015, VIRUSES-BASEL, V7, P4707, DOI 10.3390/v7082840; Basu S, 2014, NUCLEIC ACIDS RES, V42, P7170, DOI 10.1093/nar/gku346; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; Buck AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6488; Caballero JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065364; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; Clancy JW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7919; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Corrigan L, 2014, J CELL BIOL, V206, P671, DOI 10.1083/jcb.201401072; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; de la Fuente A, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv184; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hoshino D, 2013, CELL REP, V5, P1159, DOI 10.1016/j.celrep.2013.10.050; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Lai CP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8029; Lai CP, 2014, ACS NANO, V8, P483, DOI 10.1021/nn404945r; Le MTN, 2014, J CLIN INVEST, V124, P5109, DOI 10.1172/JCI75695; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Tosar JP, 2015, NUCLEIC ACIDS RES, V43, P5601, DOI 10.1093/nar/gkv432; Palma J, 2012, NUCLEIC ACIDS RES, V40, P9125, DOI 10.1093/nar/gks656; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Ridder K, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1008371; Ridder K, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001874; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Sung BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8164; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Van Deun J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24858; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Webber JP, 2015, ONCOGENE, V34, P319, DOI 10.1038/onc.2013.560; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Yue SJ, 2015, ONCOTARGET, V6, P2366, DOI 10.18632/oncotarget.2958; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zomer A, 2015, CELL, V161, P1046, DOI 10.1016/j.cell.2015.04.042	45	1877	1994	58	813	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1226	1232		10.1016/j.cell.2016.01.043	http://dx.doi.org/10.1016/j.cell.2016.01.043			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967288	Bronze			2022-12-28	WOS:000372784900019
J	Xin, TC; Greco, V; Myung, P				Xin, Tianchi; Greco, Valentina; Myung, Peggy			Hardwiring Stem Cell Communication through Tissue Structure	CELL			English	Review							LABEL-RETAINING CELLS; HEMATOPOIETIC STEM; SELF-RENEWAL; PROGENITOR CELLS; EXTRACELLULAR-MATRIX; WNT/BETA-CATENIN; NICHE; SKIN; WNT; HOMEOSTASIS	Adult stem cells across diverse organs self-renew and differentiate to maintain tissue homeostasis. How stem cells receive input to preserve tissue structure and function largely relies on their communication with surrounding cellular and non-cellular elements. As such, how tissues are organized and patterned not only reflects organ function, but also inherently hardwires networks of communication between stem cells and their environment to direct tissue homeostasis and injury repair. This review highlights how different methods of stem cell communication reflect the unique organization and function of diverse tissues.	[Xin, Tianchi; Greco, Valentina] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Greco, Valentina; Myung, Peggy] Yale Univ, Sch Med, Dept Dermatol, Yale Canc Ctr, New Haven, CT 06510 USA; [Greco, Valentina] Yale Univ, Sch Med, Dept Cell Biol, Yale Stem Cell Ctr, New Haven, CT 06510 USA; [Greco, Valentina; Myung, Peggy] Yale Univ, Sch Med, Yale Canc Ctr, 333 Cedar St, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Greco, V (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.; Greco, V; Myung, P (corresponding author), Yale Univ, Sch Med, Dept Dermatol, Yale Canc Ctr, New Haven, CT 06510 USA.; Greco, V (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, Yale Stem Cell Ctr, New Haven, CT 06510 USA.; Greco, V; Myung, P (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, 333 Cedar St, New Haven, CT 06510 USA.	valentina.greco@yale.edu; peggy.myung@yale.edu	Xin, Tianchi/AAU-6803-2020	Xin, Tianchi/0000-0002-6982-8610	New York Stem Cell Foundation; American Cancer Society [RSG-12-059-02]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); Edward Mallinckrodt Jr. Foundation; NIH [1R01AR063663-01]; NIAMS [1K08AR066790-01]; Global Fibrosis Foundation Grant; James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067755, R01AR063663, R03AR072807, K08AR066790] Funding Source: NIH RePORTER	New York Stem Cell Foundation; American Cancer Society(American Cancer Society); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Edward Mallinckrodt Jr. Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Global Fibrosis Foundation Grant; James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank members of the Greco laboratory for their priceless input and review of this manuscript. This work is supported by the New York Stem Cell Foundation and grants to V.G. by the American Cancer Society (grant no. RSG-12-059-02); the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); the Edward Mallinckrodt Jr. Foundation; and NIH (grant no. 1R01AR063663-01). P.M. is supported by NIAMS 1K08AR066790-01 and the Global Fibrosis Foundation Grant. T.X. is supported by the James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowship. V.G. is a New York Stem Cell Foundation Robertson Investigator.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Bellas E, 2014, CURR OPIN CELL BIOL, V31, P92, DOI 10.1016/j.ceb.2014.09.006; Bhattacharya D, 2009, J EXP MED, V206, P2837, DOI 10.1084/jem.20090778; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Byrd DT, 2009, SEMIN CELL DEV BIOL, V20, P1107, DOI 10.1016/j.semcdb.2009.09.005; Castellana D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002002; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chi W, 2013, DEVELOPMENT, V140, P1676, DOI 10.1242/dev.090662; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Chou WC, 2013, NAT MED, V19, P924, DOI 10.1038/nm.3194; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dansereau David A., 2008, V450, P3, DOI 10.1007/978-1-60327-214-8_1; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Deschene ER, 2014, SCIENCE, V343, P1353, DOI 10.1126/science.1248373; Durand A, 2012, P NATL ACAD SCI USA, V109, P8965, DOI 10.1073/pnas.1201652109; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans ND, 2009, EUR CELLS MATER, V18, P1; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Flaherty MS, 2010, DEV CELL, V18, P556, DOI 10.1016/j.devcel.2010.02.006; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Gancz D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001202; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; Goodell MA, 2015, NAT REV MOL CELL BIO, V16, P299, DOI 10.1038/nrm3980; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Guo Z, 2009, DEVELOPMENT, V136, P3627, DOI 10.1242/dev.036939; Harris RE, 2011, EMBO REP, V12, P519, DOI 10.1038/embor.2011.80; Hayashi Y, 2009, J CELL BIOL, V187, P473, DOI 10.1083/jcb.200904118; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Inaba M, 2015, NATURE, V523, P329, DOI 10.1038/nature14602; INGBER D, 1991, J CELL BIOCHEM, V47, P236, DOI 10.1002/jcb.240470309; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; KINASHI T, 1994, BLOOD, V83, P1033; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; KOVACH NL, 1995, BLOOD, V85, P159, DOI 10.1182/blood.V85.1.159.bloodjournal851159; Krieger T, 2015, DEVELOPMENT, V142, P1396, DOI 10.1242/dev.101063; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; LEVESQUE JP, 1995, J EXP MED, V181, P1805, DOI 10.1084/jem.181.5.1805; Li D, 2011, REGEN MED, V6, P229, DOI 10.2217/RME.11.2; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mazo IB, 2011, TRENDS IMMUNOL, V32, P493, DOI 10.1016/j.it.2011.06.011; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Morgner J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9198; Morris LX, 2011, DEVELOPMENT, V138, P2207, DOI 10.1242/dev.065508; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Myung PS, 2013, J INVEST DERMATOL, V133, P31, DOI 10.1038/jid.2012.230; Nelson AM, 2015, CELL STEM CELL, V17, P139, DOI 10.1016/j.stem.2015.07.008; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Ouspenskaia T, 2016, CELL, V164, P156, DOI 10.1016/j.cell.2015.11.058; Pardo-Saganta A, 2015, NATURE, V523, P597, DOI 10.1038/nature14553; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; Raja, 2007, Front Biosci, V12, P2849; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Roman AKS, 2014, STEM CELL REP, V2, P127, DOI 10.1016/j.stemcr.2013.12.012; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Shyer AE, 2015, CELL, V161, P569, DOI 10.1016/j.cell.2015.03.041; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Stanganello E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6846; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Wabik A, 2015, EMBO J, V34, P1164, DOI 10.15252/embj.201490386; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Webster MT, 2016, CELL STEM CELL, V18, P243, DOI 10.1016/j.stem.2015.11.005; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Wozniak MA, 2012, CURR BIOL, V22, P2017, DOI 10.1016/j.cub.2012.08.050; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706; Zielins ER, 2014, REGEN MED, V9, P817, DOI [10.2217/RME.14.54, 10.2217/rme.14.54]; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	121	64	68	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2016	164	6					1212	1225		10.1016/j.cell.2016.02.041	http://dx.doi.org/10.1016/j.cell.2016.02.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DH4VY	26967287	Green Accepted, Bronze			2022-12-28	WOS:000372784900018
J	Strum, WB				Strum, Williamson B.			Colorectal Adenomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SOCIETY-TASK-FORCE; CT COLONOGRAPHY; SURVEILLANCE COLONOSCOPY; QUALITY INDICATORS; GREATER-THAN-9 MM; AMERICAN-COLLEGE; SCORING SYSTEM; POLYP SIZE; BASE-LINE; HIGH-RISK		[Strum, Williamson B.] Scripps Clin Med Grp, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA		Strum, WB (corresponding author), Scripps Clin Med Grp, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	fstrum@aol.com	Pericàs, Juan M/N-5674-2019	Pericàs, Juan M/0000-0002-3645-3293				Abdelsattar ZM, 2014, CANCER; Abu Dayyeh BK, 2015, GASTROINTEST ENDOSC, V81, P502, DOI 10.1016/j.gie.2014.12.022; Ahnen DJ, 2014, MAYO CLIN PROC, V89, P216, DOI 10.1016/j.mayocp.2013.09.006; American Cancer Society, 2016, CANC FACTS FIGURES 2; American Cancer Society, 2014, COL CANC FACTS FIG 2; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Barclay RL, 2008, CLIN GASTROENTEROL H, V6, P1091, DOI 10.1016/j.cgh.2008.04.018; Baron JA, 2015, NEW ENGL J MED, V373, P1519, DOI 10.1056/NEJMoa1500409; Benson M, 2010, AM J GASTROENTEROL, V105, P2578, DOI 10.1038/ajg.2010.362; Brenner H, 2015, GASTROENTEROLOGY, V149, P356, DOI 10.1053/j.gastro.2015.04.012; Brenner H, 2014, GASTROENTEROLOGY, V146, P709, DOI 10.1053/j.gastro.2013.09.001; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Chan AT, 2016, GASTROENTEROLOGY, V150, P14, DOI 10.1053/j.gastro.2015.11.018; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Corley DA, 2013, CLIN GASTROENTEROL H, V11, P172, DOI 10.1016/j.cgh.2012.09.010; Corley DA, 2011, GASTROENTEROLOGY, V141, P1956, DOI 10.1053/j.gastro.2011.10.007; Crockett SD, 2015, CLIN GASTROENTEROL H, V13, P11, DOI 10.1016/j.cgh.2013.10.035; Dominitz JA, 2014, GASTROENTEROLOGY, V147, P264, DOI 10.1053/j.gastro.2014.06.018; Fearon ER, 2015, GASTROENTEROLOGY, V148, P10, DOI 10.1053/j.gastro.2014.11.024; Fisher DA, 2011, GASTROINTEST ENDOSC, V74, P745, DOI 10.1016/j.gie.2011.07.025; Frenette Catherine T, 2007, J Gastrointest Cancer, V38, P148, DOI 10.1007/s12029-008-9027-x; Giardiello FM, 2014, GASTROENTEROLOGY, V147, P502, DOI 10.1053/j.gastro.2014.04.001; Gupta S, 2012, CLIN GASTROENTEROL H, V10, P1395, DOI 10.1016/j.cgh.2012.07.004; Hassan C, 2013, CANCER-AM CANCER SOC, V119, P2549, DOI 10.1002/cncr.28007; Hassan C, 2010, CLIN GASTROENTEROL H, V8, P865, DOI 10.1016/j.cgh.2010.05.018; Hazewinkel Y, 2014, GASTROENTEROLOGY, V147, P88, DOI 10.1053/j.gastro.2014.03.015; Hornick JL, 2015, SURG PATHOLOGY GI TR, P621; Hur C, 2007, CLIN GASTROENTEROL H, V5, P237, DOI 10.1016/j.cgh.2006.11.003; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Imperiale TF, 2015, ANN INTERN MED, V163, P339, DOI 10.7326/M14-1720; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Johnson MR, 2015, GASTROENTEROLOGY, V149, P938, DOI 10.1053/j.gastro.2015.06.026; Kahi CJ, 2008, GASTROENTEROLOGY, V135, P380, DOI 10.1053/j.gastro.2008.06.026; Kahi CJ, 2011, CLIN GASTROENTEROL H, V9, P42, DOI 10.1016/j.cgh.2010.09.013; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Kim DH, 2007, NEW ENGL J MED, V357, P1403, DOI 10.1056/NEJMoa070543; Kim DH, 2007, AM J ROENTGENOL, V188, P940, DOI 10.2214/AJR.06.0764; Laiyemo AO, 2009, CLIN GASTROENTEROL H, V7, P562, DOI 10.1016/j.cgh.2008.12.009; Lakoff J, 2008, CLIN GASTROENTEROL H, V6, P1117, DOI 10.1016/j.cgh.2008.05.016; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levine JS, 2006, NEW ENGL J MED, V355, P2551, DOI 10.1056/NEJMcp063038; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Lieberman D, 2008, GASTROENTEROLOGY, V135, P1100, DOI 10.1053/j.gastro.2008.06.083; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Lieberman DA, 2009, NEW ENGL J MED, V361, P1179, DOI 10.1056/NEJMcp0902176; Lieberman DA, 2014, GASTROENTEROLOGY, V147, P351, DOI 10.1053/j.gastro.2014.04.037; Lieberman DA, 2014, GASTROENTEROLOGY, V147, P343, DOI 10.1053/j.gastro.2014.04.020; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Luzzatto L, 2015, NEW ENGL J MED, V373, P84, DOI 10.1056/NEJMsb1502456; Manson JE, 2011, NEW ENGL J MED, V364, P1385, DOI 10.1056/NEJMp1102022; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Mittal S, 2014, CLIN GASTROENTEROL H, V12, P443, DOI 10.1016/j.cgh.2013.08.021; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Odze RD, 2007, MODERN PATHOL, V20, p125A; Pendergrass CJ, 2008, CLIN GASTROENTEROL H, V6, P1011, DOI 10.1016/j.cgh.2008.03.022; Pickhardt PJ, 2013, LANCET ONCOL, V14, P711, DOI 10.1016/S1470-2045(13)70216-X; Pickhardt PJ, 2010, CLIN GASTROENTEROL H, V8, P610, DOI 10.1016/j.cgh.2010.03.007; Pinsky PF, 2009, CLIN GASTROENTEROL H, V7, P86, DOI 10.1016/j.cgh.2008.07.014; Qaseem A, 2012, ANN INTERN MED, V156, P378, DOI 10.7326/0003-4819-156-5-201203060-00010; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Rex DK, 2015, AM J GASTROENTEROL, V110, P72, DOI 10.1038/ajg.2014.385; Robert ME, 2007, CLIN GASTROENTEROL H, V5, P662, DOI 10.1016/j.cgh.2007.04.001; Robertson DJ, 2015, GASTROENTEROLOGY, V149, P1286, DOI 10.1053/j.gastro.2015.05.045; Robertson DJ, 2009, ANN INTERN MED, V151, P103, DOI 10.7326/0003-4819-151-2-200907210-00007; Rundle AG, 2008, GASTROENTEROLOGY, V134, P1311, DOI 10.1053/j.gastro.2008.02.032; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Schoen RE, 2010, GASTROENTEROLOGY, V138, P73, DOI 10.1053/j.gastro.2009.09.062; Shaukat A, 2015, GASTROENTEROLOGY, V149, P952, DOI 10.1053/j.gastro.2015.06.044; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Snover DC, 2010, WHO CLASSIFICATION T, P160; Soetikno RM, 2008, JAMA-J AM MED ASSOC, V299, P1027, DOI 10.1001/jama.299.9.1027; Stoffel EM, 2015, GASTROENTEROLOGY, V149, P1191, DOI 10.1053/j.gastro.2015.07.021; Sweetser S, 2013, CLIN GASTROENTEROL H, V11, P760, DOI 10.1016/j.cgh.2012.12.004; Tao S, 2014, CLIN GASTROENTEROL H, V12, P478, DOI 10.1016/j.cgh.2013.08.042; Tsai FC, 2011, DIGEST DIS SCI, V56, P2384, DOI 10.1007/s10620-011-1598-x; van Hees F, 2014, ANN INTERN MED, V160, P750, DOI 10.7326/M13-2263; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	80	162	177	3	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2016	374	11					1065	1075		10.1056/NEJMra1513581	http://dx.doi.org/10.1056/NEJMra1513581			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG4TR	26981936				2022-12-28	WOS:000372066100010
J	Vize, R				Vize, Richard			The Greater Manchester experiment	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Vize R, 2016, BMJ-BRIT MED J, V352, DOI [10.1136/bmj.i1811, 10.1136/bmj.i1611]	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2016	352								i1811	10.1136/bmj.i1811	http://dx.doi.org/10.1136/bmj.i1811			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DI4TO	27004912	Bronze, Green Published			2022-12-28	WOS:000373492400018
J	Vize, R				Vize, Richard			The Greater Manchester experiment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												richard.vize@gmail.com						Greater Manchester Combined Authority, 2015, TAK CHARG OUR HLTH S, P28; NHS England, 2014, 5 YEAR FORWARD VIEW; Public Health England, PUBL HLTH OUTC FRAM	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2016	352								i1611	10.1136/bmj.i1611	http://dx.doi.org/10.1136/bmj.i1611			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH8LK	27004912	Green Published			2022-12-28	WOS:000373044500008
J	Pericas, JM; Corredoira, J; Miro, JM				Pericas, Juan M.; Corredoira, Juan; Miro, Jose M.		Hosp Clinic-Lucus Augusti Working	Colorectal Adenomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Pericas, Juan M.; Miro, Jose M.] Hosp Clin Barcelona, Barcelona, Spain; [Corredoira, Juan] Hosp Lucus Augusti, Lugo, Spain	University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Lucus Augusti-Lugo	Pericas, JM (corresponding author), Hosp Clin Barcelona, Barcelona, Spain.	pericasjm@gmail.com	Pericàs, Juan M/N-5674-2019	Pericàs, Juan M/0000-0002-3645-3293				KLEIN RS, 1977, NEW ENGL J MED, V297, P800, DOI 10.1056/NEJM197710132971503; Pericas JM, 2015, 13 INT S MOD CONC EN; Pericas JM, 2016, NEW ENGL J MED, V375, P387, DOI [10.1056/NEJMra1513581, 10.1056/NEJMc1604867]; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]	4	162	177	3	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2016	375	4					387	388						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0UV	26981936				2022-12-28	WOS:000380313200020
J	Dowell, D; Haegerich, TM; Chou, R				Dowell, Deborah; Haegerich, Tamara M.; Chou, Roger			CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016	MMWR RECOMMENDATIONS AND REPORTS			English	Article							LOW-BACK-PAIN; PRESCRIPTION DRUG-ABUSE; CLINICAL-PRACTICE GUIDELINE; OF-HEALTH PATHWAYS; NONCANCER PAIN; RISK-FACTORS; TRANSDERMAL FENTANYL; MONITORING PROGRAM; NEUROPATHIC PAIN; MENTAL-HEALTH	This guideline provides recommendations for primary care clinicians who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care. The guideline addresses 1) when to initiate or continue opioids for chronic pain; 2) opioid selection, dosage, duration, follow-up, and discontinuation; and 3) assessing risk and addressing harms of opioid use. CDC developed the guideline using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework, and recommendations are made on the basis of a systematic review of the scientific evidence while considering benefits and harms, values and preferences, and resource allocation. CDC obtained input from experts, stakeholders, the public, peer reviewers, and a federally chartered advisory committee. It is important that patients receive appropriate pain treatment with careful consideration of the benefits and risks of treatment options. This guideline is intended to improve communication between clinicians and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder, overdose, and death. CDC has provided a checklist for prescribing opioids for chronic pain (http://stacks.cdc.gov/view/cdc/38025) as well as a website (http://www.cdc.gov/drugoverdose/prescribingresources.html) with additional tools to guide clinicians in implementing the recommendations.	[Dowell, Deborah; Haegerich, Tamara M.; Chou, Roger] CDC, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Dowell, D (corresponding author), CDC, Div Unintent Injury Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA 30333 USA.	gdo7@cdc.gov		Chou, Roger/0000-0001-9889-8610				ACOG Committee on Health Care for Underserved Women, 2012, Obstet Gynecol, V119, P1070, DOI 10.1097/AOG.0b013e318256496e; Agency for Healthcare Research and Quality, 2013, AHRQ PUBLICATION, V10(13)-EHC063-EF; Ahmed F, 2013, ADVISORY COMMITTEE I; Akbik H, 2006, J PAIN SYMPTOM MANAG, V32, P287, DOI 10.1016/j.jpainsymman.2006.03.010; Alam A, 2012, ARCH INTERN MED, V172, P425, DOI 10.1001/archinternmed.2011.1827; Allan L, 2005, SPINE, V30, P2484, DOI 10.1097/01.brs.0000186860.23078.a8; Amato L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003352.pub3; American College of Emergency Physicians, 2014, MAR EM DEP AC CAR FA; American Pain Society American Academy of Pain Medicine, 2009, GUID US CHRON OP THE; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anastassopoulos Kathryn P, 2013, J Opioid Manag, V9, P97, DOI 10.5055/jom.2012.0151; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; [Anonymous], 2015, MIL MED, V180, P365, DOI 10.7205/MILMED-D-15-00005; [Anonymous], 2015, COMM EL GUID PRESCR; [Anonymous], 2013, GOAL LAB CHANG BETT; Ashburn MA, 2012, ANESTHESIOLOGY, V116, P248, DOI 10.1097/ALN.0b013e31823c1030; Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Bair MJ, 2010, PAIN PRACT, V10, P493, DOI 10.1111/j.1533-2500.2010.00425.x; Ballantyne JC, 2003, NEW ENGL J MED, V349, P1943, DOI 10.1056/NEJMra025411; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Banta-Green CJ, 2009, DRUG ALCOHOL DEPEN, V104, P34, DOI 10.1016/j.drugalcdep.2009.03.021; Baumblatt JAG, 2014, JAMA INTERN MED, V174, P796, DOI 10.1001/jamainternmed.2013.12711; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005328; Berlin D, 2013, MMWR-MORBID MORTAL W, V62, P777; Berna C, 2015, MAYO CLIN PROC, V90, P828, DOI 10.1016/j.mayocp.2015.04.003; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; Birnbaum HG, 2011, PAIN MED, V12, P657, DOI 10.1111/j.1526-4637.2011.01075.x; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Bohnert ASB, 2016, MED CARE; Boscarino JA, 2010, ADDICTION, V105, P1776, DOI 10.1111/j.1360-0443.2010.03052.x; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Bril V, 2011, NEUROLOGY, V77, P603, DOI 10.1212/WNL.0b013e31822b0fbc; Broussard CS, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.039; Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Busch A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003786.pub2; Cantrill SV, 2012, ANN EMERG MED, V60, P499, DOI 10.1016/j.annemergmed.2012.06.013; Carman WJ, 2011, PHARMACOEPIDEM DR S, V20, P754, DOI 10.1002/pds.2131; CDC, 2016, MULT CAUS DEATH DAT; CDC National Center for Health Statistics, 2015, HLTH US 2014 SPEC FE; Cerda M, 2015, J PEDIATR-US, V167, P605, DOI 10.1016/j.jpeds.2015.04.071; Chaparro LE, 2014, SPINE, V39, P556, DOI 10.1097/BRS.0000000000000249; Cheng D, 2013, CLIN PRACTICE STATEM; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou Roger, 2014, Evid Rep Technol Assess (Full Rep), P1, DOI 10.23970/AHRQEPCERTA218; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Chou R, 2014, J PAIN, V15, P321, DOI 10.1016/j.jpain.2014.01.494; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Chu J, 2013, NEW YORK CITY EMERGE; Cicero TJ, 2012, NEW ENGL J MED, V367, P187, DOI 10.1056/NEJMc1204141; ClinicalTrials.gov, 2021, PAT MAN HYP SUBJ REC; Coffin P, 2014, ANN INTERN MED, V160, P207, DOI 10.7326/M13-2781; Compton PA, 2008, J PAIN SYMPTOM MANAG, V36, P383, DOI 10.1016/j.jpainsymman.2007.11.006; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; COSTE J, 1994, BRIT MED J, V308, P577, DOI 10.1136/bmj.308.6928.577; Cowan DT, 2005, PAIN MED, V6, P113, DOI 10.1111/j.1526-4637.2005.05020.x; Cowan DT, 2003, PAIN MED, V4, P340, DOI 10.1111/j.1526-4637.2003.03038.x; Dasgupta N, 2015, PAIN MED; Daubresse M, 2013, MED CARE, V51, P870, DOI 10.1097/MLR.0b013e3182a95d86; DeVries A, 2014, J ADOLESCENT HEALTH, V55, P128, DOI 10.1016/j.jadohealth.2013.12.014; Deyo RA, 2013, SPINE, V38, P909, DOI 10.1097/BRS.0b013e3182830482; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Edlund MJ, 2007, PAIN, V129, P355, DOI 10.1016/j.pain.2007.02.014; Edlund MJ, 2014, CLIN J PAIN, V30, P557, DOI 10.1097/AJP.0000000000000021; Enteen L, 2010, J URBAN HEALTH, V87, P931, DOI 10.1007/s11524-010-9495-8; Ferrell B, 2009, J AM GERIATR SOC, V57, P1331, DOI 10.1111/j.1532-5415.2009.02376.x; Fiellin DA, 2014, JAMA INTERN MED, V174, P1947, DOI 10.1001/jamainternmed.2014.5302; Fleming MF, 2007, J PAIN, V8, P573, DOI 10.1016/j.jpain.2007.02.432; Food and Drug Administration, 2015, AB DET OP EV LAB GUI; Food and Drug Administration, 2014, EP CORT INJ DRUG SAF; Food and Drug Administration, 2014, FDA BLUEPR PRESCR ED; Food and Drug Administration, 2015, DISP UN MED WHAT YOU; Fransen M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007912; Fullerton CA, 2014, PSYCHIAT SERV, V65, P146, DOI 10.1176/appi.ps.201300235; Furlan AD, 2011, PAIN RES MANAG, V16, P337, DOI 10.1155/2011/465281; Ganann R, 2010, IMPLEMENT SCI, V5, P10, DOI 10.1186/1748-5908-5-56; Gaskell H, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010692.pub2; Gomes T, 2013, JAMA INTERN MED, V173, P196, DOI 10.1001/2013.jamainternmed.733; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Goodman LS, 1996, GODMAN GILMANS PHARM; Gore M, 2012, PAIN PRACT, V12, P550, DOI 10.1111/j.1533-2500.2012.00532.x; Graham E, 2014, PROSPERO INT PROSPEC; Green TC, 2012, PAIN MED, V13, P1314, DOI 10.1111/j.1526-4637.2012.01452.x; Gregorian RS, 2010, J PAIN, V11, P1095, DOI 10.1016/j.jpain.2010.02.007; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hadi Ibrahim, 2006, J Opioid Manag, V2, P31; Haegerich TM, 2014, DRUG ALCOHOL DEPEN, V145, P34, DOI 10.1016/j.drugalcdep.2014.10.001; Hagemeier NE, 2013, SUBST USE MISUSE, V48, P761, DOI 10.3109/10826084.2013.787101; Hansen RN, 2011, CLIN J PAIN, V27, P194, DOI 10.1097/AJP.0b013e3181ff04ca; Hardt J, 2008, PAIN MED, V9, P803, DOI 10.1111/j.1526-4637.2008.00425.x; Hartung DM, 2007, ANN PHARMACOTHER, V41, P921, DOI 10.1345/aph.1K066; Hayden J A, 2005, Cochrane Database Syst Rev, pCD000335; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Hojsted J, 2010, EUR J PAIN, V14, P1014, DOI 10.1016/j.ejpain.2010.04.006; Hooten W Michael, 2011, J Opioid Manag, V7, P417; Hooten WM, 2013, ASSESSMENT MANAGEMEN; Howe CQ, 2014, GEN HOSP PSYCHIAT, V36, P99, DOI 10.1016/j.genhosppsych.2013.10.003; Hwang CS, 2015, JAMA INTERN MED, V175, P302, DOI 10.1001/jamainternmed.2014.6520; Inocencio TJ, 2013, PAIN MED, V14, P1534, DOI 10.1111/pme.12183; Institute for Clinical Systems Improvement, 2019, PAIN ASS NON TREATM; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; International Association for the Study of Pain Subcommittee on Taxonomy, 1986, PAIN S3, V3, pS1; Irvine JM, 2014, J PAIN, V15, P747, DOI 10.1016/j.jpain.2014.04.003; Jamison RN, 1998, SPINE, V23, P2591, DOI 10.1097/00007632-199812010-00014; Jamison Robert N, 2014, J Opioid Manag, V10, P375, DOI 10.5055/jom.2014.0234; Jones CM, 2015, AM J PREV MED, V49, P493, DOI 10.1016/j.amepre.2015.03.040; Jones CM, 2015, AM J PUBLIC HEALTH, V105, pE55, DOI 10.2105/AJPH.2015.302664; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Jones Ted, 2014, J Opioid Manag, V10, P353, DOI 10.5055/jom.2014.0226; Jones Ted, 2013, J Opioid Manag, V9, P19, DOI 10.5055/jom.2013.0143; Jones T, 2012, CLIN J PAIN, V28, P93, DOI 10.1097/AJP.0b013e318225da9e; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kalso E, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-39; Kamper SJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h444; Kaplovitch E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134550; Keller CE, 2012, SUBST ABUS, V33, P103, DOI 10.1080/08897077.2011.630944; Krebs EE, 2011, PAIN, V152, P1789, DOI 10.1016/j.pain.2011.03.023; Krebs EE, 2009, J GEN INTERN MED, V24, P733, DOI 10.1007/s11606-009-0981-1; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Krupitsky E, 2011, LANCET, V377, P1506, DOI 10.1016/S0140-6736(11)60358-9; Laffer A, 2011, EC ANAL COSTS BENEFI; Lee C, 2014, PAIN MED, V15, pS76, DOI 10.1111/pme.12408; Levy B, 2015, AM J PREV MED, V49, P409, DOI 10.1016/j.amepre.2015.02.020; Li L, 2013, J INTERN MED, V273, P511, DOI 10.1111/joim.12035; Li L, 2013, AM J EPIDEMIOL, V178, P559, DOI 10.1093/aje/kwt013; Liang YY, 2015, J PAIN, V16, P318, DOI 10.1016/j.jpain.2014.11.007; Lin CWC, 2010, PHYS THER, V90, P839, DOI 10.2522/ptj.20100084; Liu Y, 2013, AM J MANAG CARE, V19, P648; Loder E, 2013, HEADACHE, V53, P1651, DOI 10.1111/head.12233; Mack KA, 2015, J HEALTH CARE POOR U, V26, P182, DOI 10.1353/hpu.2015.0009; Mangione MP, 2008, J GEN INTERN MED, V23, P1336, DOI 10.1007/s11606-008-0658-1; Mannion AF, 1999, SPINE, V24, P2435, DOI 10.1097/00007632-199912010-00004; Mark TL, 2015, J SUBST ABUSE TREAT, V55, P1, DOI 10.1016/j.jsat.2015.04.009; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Mazer-Amirshahi M, 2014, PEDIATR EMERG CARE, V30, P230, DOI 10.1097/PEC.0000000000000102; McCabe SE, 2013, PAIN, V154, P708, DOI 10.1016/j.pain.2013.01.011; McCabe SE, 2013, J ADOLESCENT HEALTH, V52, P480, DOI 10.1016/j.jadohealth.2012.08.007; Miech R, 2015, PEDIATRICS, V136, pE1169, DOI 10.1542/peds.2015-1364; Miller M, 2015, JAMA INTERN MED, V175, P608, DOI 10.1001/jamainternmed.2014.8071; Minozzi S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001333.pub2; Mitra F, 2013, PAIN MED, V14, P75, DOI 10.1111/pme.12011; Moore SK, 2013, PAIN MED, V14, P1730, DOI 10.1111/pme.12200; Moore TM, 2009, PAIN MED, V10, P1426, DOI 10.1111/j.1526-4637.2009.00743.x; Moulin DE, 2007, PAIN RES MANAG, V12, P13; Nahin RL, 2015, J PAIN, V16, P769, DOI 10.1016/j.jpain.2015.05.002; Naliboff BD, 2011, J PAIN, V12, P288, DOI 10.1016/j.jpain.2010.09.003; National Heart Lung Blood Institute, 2014, EVIDENCE BASED MANAG; National Opioid Use Guideline Group, 2010, CAN GUID SAF EFF US; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Nuckols TK, 2014, ANN INTERN MED, V160, P38, DOI 10.7326/0003-4819-160-1-201401070-00732; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Paone D, 2011, CITY HLTH INFORM, V30, P23; Paquin AM, 2014, EXPERT OPIN DRUG SAF, V13, P919, DOI 10.1517/14740338.2014.925444; Park TW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2698; Paulozzi Leonard, 2012, Morbidity and Mortality Weekly Report, V61, P10; Paulozzi LJ, 2014, MMWR-MORBID MORTAL W, V63, P563; Paulozzi Leonard J., 2012, Morbidity and Mortality Weekly Report, V61, P493; Paulozzi LJ, 2012, PAIN MED, V13, P87, DOI 10.1111/j.1526-4637.2011.01260.x; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Payne M, 2011, AM J GERIATR PHARMAC, V9, P164, DOI 10.1016/j.amjopharm.2011.04.004; Pennsylvania Department of Health Department of Drug and Alcohol Programs, 2015, PENNS GUID US OP DEN; Pergolizzi J, 2010, PAIN PRACT, V10, P497, DOI 10.1111/j.1533-2500.2010.00375.x; Portenoy RK, 2007, CLIN J PAIN, V23, P287, DOI 10.1097/AJP.0b013e31802b582f; RALPHS JA, 1994, PAIN, V56, P279, DOI 10.1016/0304-3959(94)90166-X; Ray WA, 2015, JAMA INTERN MED, V175, P420, DOI 10.1001/jamainternmed.2014.6294; Reid MC, 2002, J GEN INTERN MED, V17, P173, DOI 10.1046/j.1525-1497.2002.10435.x; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Reuben DB, 2015, ANN INTERN MED, V162, P295, DOI 10.7326/M14-2775; Ringwalt C, 2015, J PRIM PREV, V36, P131, DOI 10.1007/s10935-014-0381-0; Rolita L, 2013, J AM GERIATR SOC, V61, P335, DOI 10.1111/jgs.12148; ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155; Rubinstein A, 2014, AM J MED, V127, P1195, DOI 10.1016/j.amjmed.2014.07.015; Saffier K, 2007, J SUBST ABUSE TREAT, V33, P303, DOI 10.1016/j.jsat.2006.12.011; Saitz R, 2014, J STUD ALCOHOL DRUGS, V75, P153, DOI 10.15288/jsad.2014.75.153; Salzman RT, 1999, J PAIN SYMPTOM MANAG, V18, P271, DOI 10.1016/S0885-3924(99)00079-2; Saunders KW, 2010, J GEN INTERN MED, V25, P310, DOI 10.1007/s11606-009-1218-z; Schneider Jennifer P, 2010, J Opioid Manag, V6, P385; SCHWEIZER E, 1989, AM J PSYCHIAT, V146, P1242; Simmonds MJ, 2015, PAIN MED, V16, P726, DOI 10.1111/pme.12626; Smith PC, 2010, ARCH INTERN MED, V170, P1155, DOI 10.1001/archinternmed.2010.140; Smith RJ, 2015, PAIN MED, V16, P1122, DOI 10.1111/pme.12700; Spector W, 2007, J AM GERIATR SOC, V55, P327, DOI 10.1111/j.1532-5415.2007.01081.x; Starrels Joanna L, 2014, J Opioid Manag, V10, P95, DOI 10.5055/jom.2014.0198; Substance Abuse and Mental Health Services Administration, 2015, PHYS WAIV QUAL; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2013, DAWN REP HIGHL 2011; Substance Abuse and Mental Health Services Administration (SAMHSA), 2014, RES 2013 NAT SURV DR; Sullivan MD, 2006, ARCH INTERN MED, V166, P2087, DOI 10.1001/archinte.166.19.2087; TENNANT FS, 1982, ARCH INTERN MED, V142, P1845, DOI 10.1001/archinte.142.10.1845; The Interagency Pain Research Coordinating Committee, 2015, NAT PAIN ST IN PRESS; Thielke SM, 2014, CLIN J PAIN, V30, P93, DOI 10.1097/AJP.0b013e31828e361b; Thorson D, 2014, ACUTE PAIN ASSESSMEN; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Tsang A, 2009, J PAIN, V10, P553; Turner BJ, 2015, J GEN INTERN MED, V30, P1081, DOI 10.1007/s11606-015-3199-4; Twillman RK, 2014, CA-CANCER J CLIN, V64, P369, DOI 10.3322/caac.21243; US Food and Drug Administration, 2018, FDA DRUG SAF COMM FD; Veliz P, 2014, J ADOLESCENT HEALTH, V54, P333, DOI 10.1016/j.jadohealth.2013.09.002; Vestergaard P, 2006, J INTERN MED, V260, P76, DOI 10.1111/j.1365-2796.2006.01667.x; Von Korff M, 2011, PAIN, V152, P1256, DOI 10.1016/j.pain.2011.01.005; Wallen M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002824.pub2; Walley Alexander Y, 2013, BMJ, V346, pf174, DOI 10.1136/bmj.f174; Wasan AD, 2009, CLIN J PAIN, V25, P193, DOI 10.1097/AJP.0b013e318193a6c4; Washington State Agency Medical Directors' Group, 2015, AMDG 2015 INT GUID P; Webster BS, 2007, SPINE, V32, P2127, DOI 10.1097/BRS.0b013e318145a731; Webster LR, 2005, PAIN MED, V6, P432, DOI 10.1111/j.1526-4637.2005.00072.x; Webster LR, 2008, PAIN MED, V9, P425, DOI 10.1111/j.1526-4637.2007.00343.x; Weiss RD, 2011, ARCH GEN PSYCHIAT, V68, P1238, DOI 10.1001/archgenpsychiatry.2011.121; Whiteman VE, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/906723; Wild JE, 2010, PAIN PRACT, V10, P416, DOI 10.1111/j.1533-2500.2010.00397.x; Williams ACD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub3; Wilson HD, 2013, J PAIN, V14, P613, DOI 10.1016/j.jpain.2013.01.769; Yazdy MM, 2013, OBSTET GYNECOL, V122, P838, DOI 10.1097/AOG.0b013e3182a6643c; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002; Yue HJ, 2010, MED CLIN N AM, V94, P435, DOI 10.1016/j.mcna.2010.02.007; Zedler B, 2014, PAIN MED, V15, P1911, DOI 10.1111/pme.12480; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014; Zhang W, 2007, ANN RHEUM DIS, V66, P377, DOI 10.1136/ard.2006.062091; Zhang W, 2005, ANN RHEUM DIS, V64, P669, DOI 10.1136/ard.2004.028886	221	2426	2452	13	144	CENTERS  DISEASE CONTROL & PREVENTION	ATLANTA	1600 CLIFTON RD, ATLANTA, GA 30333 USA	1057-5987	1545-8601		MMWR RECOMM REP	MMWR Recomm. Rep.	MAR 18	2016	65	1					1	49		10.15585/mmwr.rr6501e1	http://dx.doi.org/10.15585/mmwr.rr6501e1			49	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	DJ4RM	36327391	gold, Green Accepted			2022-12-28	WOS:000374195400001
